PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huttunen, HJ; Peach, C; Bhattacharyya, R; Barren, C; Pettingell, W; Hutter-Paier, B; Windisch, M; Berezovska, O; Kovacs, DM				Huttunen, Henri J.; Peach, Camilla; Bhattacharyya, Raja; Barren, Cory; Pettingell, Warren; Hutter-Paier, Birgit; Windisch, Manfred; Berezovska, Oksana; Kovacs, Dora M.			Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway	FASEB JOURNAL			English	Article						Alzheimer's disease; cholesterol; endoplasmic reticulum; lipid; protein maturation	ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; BETA-PEPTIDE; QUALITY CONTROL; APP; CLEAVAGE; METABOLISM; GENERATION; CELLS; MODEL	Amyloid beta-peptide (A beta) has a central role in the pathogenesis of Alzheimer's disease (AD). Cellular cholesterol homeostasis regulates endoproteolytic generation of A beta from the amyloid precursor protein (APP). Previous studies have identified acylcoenzyme A: cholesterol acyltransferase (ACAT), an enzyme that regulates subcellular cholesterol distribution, as a potential therapeutic target for AD. Inhibition of ACAT activity decreases A beta generation in cell-and animal-based models of AD through an unknown mechanism. Here we show that ACAT inhibition retains a fraction of APP molecules in the early secretory pathway, limiting the availability of APP for secretase-mediated proteolytic processing. ACAT inhibitors delayed the trafficking of immature APP molecules from the endoplasmic reticulum (ER) as shown by metabolic labeling and live-cell imaging. This resulted in partial ER retention of APP and enhanced ER-associated degradation of APP by the proteasome, without activation of the unfolded protein response pathway. The ratio of mature APP to immature APP was reduced in brains of mice treated with ACAT inhibitors, and strongly correlated with reduced brain APP-C99 and cerebrospinal fluid A beta levels in individual animals. Our results identify a novel ACAT-dependent mechanism that regulates secretory trafficking of APP, likely contributing to decreased A beta generation in vivo.-Huttunen, H. J., Peach, C., Bhattacharyya, R., Barren, C., Pettingell, W., Hutter-Paier, B., Windisch, M., Berezovska, O., Kovacs, D. M. Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway. FASEB J. 23, 3819-3828 (2009). www.fasebj.org	[Huttunen, Henri J.; Peach, Camilla; Bhattacharyya, Raja; Barren, Cory; Pettingell, Warren; Kovacs, Dora M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurobiol Dis Lab,Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Huttunen, Henri J.; Peach, Camilla; Bhattacharyya, Raja; Barren, Cory; Pettingell, Warren; Berezovska, Oksana; Kovacs, Dora M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Huttunen, Henri J.; Peach, Camilla; Bhattacharyya, Raja; Barren, Cory; Pettingell, Warren; Hutter-Paier, Birgit; Windisch, Manfred; Berezovska, Oksana; Kovacs, Dora M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Hutter-Paier, Birgit; Windisch, Manfred] Inst Expt Pharmacol, JSW Res Forsch Lab, Graz, Austria	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kovacs, DM (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurobiol Dis Lab,Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	dora_kovacs@hms.harvard.edu		Huttunen, Henri/0000-0002-9867-4438	Cure Alzheimer's Fund; U.S. National Institutes of Health [R01 NS45860]; Helsingin Sanomat Centennial Foundation; Maud Kuistila Foundation [CI-1011, CP-113,818]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045860] Funding Source: NIH RePORTER	Cure Alzheimer's Fund; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helsingin Sanomat Centennial Foundation; Maud Kuistila Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Cure Alzheimer's Fund (D. M. K.), the U.S. National Institutes of Health (R01 NS45860; D. M. K.), the Helsingin Sanomat Centennial Foundation (H.J.H.), and the Maud Kuistila Foundation (H.J.H.). CI-1011 and CP-113,818 were kind gifts from Lit-Fui Lau and James Harwood (Pfizer, Groton, CT, USA), respectively.	Alegret M, 2004, METHOD FIND EXP CLIN, V26, P563, DOI 10.1358/mf.2004.26.7.863738; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Anliker B, 2006, NEURODEGENER DIS, V3, P239, DOI 10.1159/000095262; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Grimm MO, 2007, TRENDS MOL MED, V13, P337, DOI 10.1016/j.molmed.2007.06.004; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hare JF, 2001, BIOCHEM BIOPH RES CO, V281, P1298, DOI 10.1006/bbrc.2001.4507; Hirsch-Reinshagen V, 2007, CURR OPIN LIPIDOL, V18, P325, DOI 10.1097/MOL.0b013e32813aeabf; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Huttunen HJ, 2007, FEBS LETT, V581, P1688, DOI 10.1016/j.febslet.2007.03.056; Huttunen HJ, 2009, J MOL NEUROSCI, V37, P6, DOI 10.1007/s12031-008-9088-0; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kouchi Z, 1999, BIOCHEM BIOPH RES CO, V254, P804, DOI 10.1006/bbrc.1998.9977; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; Maltese WA, 2001, J BIOL CHEM, V276, P20267, DOI 10.1074/jbc.M007238200; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Senechal Y, 2006, NEURODEGENER DIS, V3, P134, DOI 10.1159/000094772; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; YEO KT, 1985, J BIOL CHEM, V260, P7896	50	42	43	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2009	23	11					3819	3828		10.1096/fj.09-134999	http://dx.doi.org/10.1096/fj.09-134999			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19625658	Green Published			2022-12-25	WOS:000271272500018
J	Xu, XR; Gammon, MD; Zeisel, SH; Bradshaw, PT; Wetmur, JG; Teitelbaum, SL; Neugut, AI; Santella, RM; Chen, J				Xu, Xinran; Gammon, Marilie D.; Zeisel, Steven H.; Bradshaw, Patrick T.; Wetmur, James G.; Teitelbaum, Susan L.; Neugut, Alfred I.; Santella, Regina M.; Chen, Jia			High intakes of choline and betaine reduce breast cancer mortality in a population-based study	FASEB JOURNAL			English	Article						risk; diet; BHMT; LIBCSP	ONE-CARBON METABOLISM; DNA METHYLATION; METHYLTRANSFERASE BHMT; LONG-ISLAND; RISK; HOMOCYSTEINE; DEFICIENCY; METHIONINE; NUTRIENTS; SURVIVAL	Choline and betaine provide methyl groups for one-carbon metabolism. Humans obtain these nutrients from a wide range of foods. Betaine can also be synthesized endogenously from its precursor, choline. Although animal studies have implied a causal relationship between choline deficiency and carcinogenesis, the role of these two nutrients in human carcinogenesis and tumor progression is not well understood. We investigated the associations of dietary intakes of choline and betaine and breast cancer risk and mortality in the population-based Long Island Breast Cancer Study Project. Among the 1508 case-group women, 308 (20.2%) deaths occurred, among whom 164 (53.2%) died of breast cancer by December 31, 2005. There was an indication that a higher intake of free choline was associated with reduced risk of breast cancer (P-trend=0.04). Higher intakes of betaine, phosphocholine, and free choline were associated with reduced all-cause as well as breast cancer-specific mortality in a dose-dependent fashion. We also explored associations of polymorphisms of three key choline-and betaine-metabolizing genes and breast cancer mortality. The betaine-homocysteine methyltransferase gene (BHMT) rs3733890 polymorphism was associated with reduced breast cancer-specific mortality (hazard ratio, 0.64; 95% confidence interval, 0.42-0.97). Our study supports the important roles of choline and betaine in breast carcinogenesis. It suggests that high intake of these nutrients may be a promising strategy to prevent the development of breast cancer and to reduce its mortality.-Xu, X., Gammon, M. D., Zeisal, S. H., Bradshaw, P. T., Wetmur, J. G., Teitelbaum, S. L., Neugut, A. I., Santella, R. M., Chen, J. High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J. 23, 4022-4028 (2009). www.fasebj.org	[Xu, Xinran; Teitelbaum, Susan L.; Chen, Jia] Mt Sinai Sch Med, Dept Community & Prevent Med, New York, NY 10029 USA; [Wetmur, James G.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Wetmur, James G.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Jia] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Chen, Jia] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Gammon, Marilie D.; Bradshaw, Patrick T.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Neugut, Alfred I.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Neugut, Alfred I.] Columbia Univ, Dept Med, New York, NY USA; [Santella, Regina M.] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Columbia University; Columbia University	Chen, J (corresponding author), Mt Sinai Sch Med, Dept Community & Prevent Med, Box 1057,1 Gustave L Levy Pl, New York, NY 10029 USA.	jia.chen@mssm.edu	Bradshaw, Patrick/AAJ-7529-2021	Bradshaw, Patrick/0000-0001-7761-3129; Xu, Xinran/0000-0001-6435-8181	National Institutes of Health [CA109753, DK55865]; Department of Defense [BC031746]; National Cancer Institute; National Institutes of Environmental Health and Sciences [UO1CA/ES66572, UO1CA66572, P30ES009089, P30ES10126]; University of North Carolina Clinical Nutrition Research Unit [DK56350]; Department of Defense Breast Cancer Research Program [W81XWH-06-1-0298]; NATIONAL CANCER INSTITUTE [R01CA109753, U01CA066572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Environmental Health and Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of North Carolina Clinical Nutrition Research Unit; Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institutes of Health (CA109753 to J. C. and DK55865 to S. H. Z.) and in part by grants from the Department of Defense (BC031746), National Cancer Institute, and the National Institutes of Environmental Health and Sciences (UO1CA/ES66572, UO1CA66572, P30ES009089, and P30ES10126), and by the University of North Carolina Clinical Nutrition Research Unit (DK56350). X. X. is a recipient of a Predoctoral Traineeship Award (W81XWH-06-1-0298) of the Department of Defense Breast Cancer Research Program.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Baker JA, 2006, J NUTR, V136, P166, DOI 10.1093/jn/136.1.166; Chiuve SE, 2007, AM J CLIN NUTR, V86, P1073, DOI 10.1093/ajcn/86.4.1073; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; Cleveland RJ, 2007, CANCER EPIDEM BIOMAR, V16, P1803, DOI 10.1158/1055-9965.EPI-06-0889; DACOSTA KA, 1995, CARCINOGENESIS, V16, P327, DOI 10.1093/carcin/16.2.327; Dalmeijer GW, 2008, EUR J CLIN NUTR, V62, P386, DOI 10.1038/sj.ejcn.1602725; Gammon MD, 2002, BREAST CANCER RES TR, V74, P235, DOI 10.1023/A:1016387020854; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P677; Ganmaa D, 2008, INT J CANCER, V122, P2071, DOI 10.1002/ijc.23336; Gaudet MM, 2004, CANCER EPIDEM BIOMAR, V13, P1485; GHOSHAL AK, 1984, CARCINOGENESIS, V5, P1367, DOI 10.1093/carcin/5.10.1367; Glunde K, 2006, PHARMACOGENOMICS, V7, P1109, DOI 10.2217/14622416.7.7.1109; Hosmer D. W., 1999, APPL SURVIVAL ANAL; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kovacheva VP, 2009, FASEB J, V23, P1054, DOI 10.1096/fj.08-122168; Morin I, 2003, AM J MED GENET A, V119A, P172, DOI 10.1002/ajmg.a.20115; NEWBERNE PM, 1986, ANNU REV NUTR, V6, P407, DOI 10.1146/annurev.nu.06.070186.002203; ROGERS AE, 1990, CARCINOGENESIS, V11, P1491, DOI 10.1093/carcin/11.9.1491; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schwahn BC, 2003, FASEB J, V17, P512, DOI 10.1096/fj.02-0456fje; Sohn KJ, 2009, INT J CANCER, V124, P1999, DOI 10.1002/ijc.24003; Tang NP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.019; Tsujiuchi T, 1999, JPN J CANCER RES, V90, P909, DOI 10.1111/j.1349-7006.1999.tb00834.x; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; WAINFAN E, 1990, CARCINOGENESIS, V11, P361, DOI 10.1093/carcin/11.3.361; Weisberg IS, 2003, ATHEROSCLEROSIS, V167, P205, DOI 10.1016/S0021-9150(03)00010-8; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Yan PS, 2001, CANCER RES, V61, P8375; Yang X, 2001, ENDOCR-RELAT CANCER, V8, P115, DOI 10.1677/erc.0.0080115; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2003, J NUTR, V133, P1302	36	70	71	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					4022	4028		10.1096/fj.09-136507	http://dx.doi.org/10.1096/fj.09-136507			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19635752	Green Submitted, Green Published			2022-12-25	WOS:000271272500037
J	Chang, MH; Plata, C; Sindic, A; Ranatunga, WK; Chen, AP; Zandi-Nejad, K; Chan, KW; Thompson, J; Mount, DB; Romero, MF				Chang, Min-Hwang; Plata, Consuelo; Sindic, Aleksandra; Ranatunga, Wasantha K.; Chen, An-Ping; Zandi-Nejad, Kambiz; Chan, Kim W.; Thompson, James; Mount, David B.; Romero, Michael F.			Slc26a Is Inhibited by the R-region of the Cystic Fibrosis Transmembrane Conductance Regulator via the STAS Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL CHLORIDE DIARRHEA; ELECTROGENIC NA+-HCO3-COTRANSPORTER; MULTIFUNCTIONAL ANION-EXCHANGERS; SULFATE-TRANSPORTER; PENDRED-SYNDROME; DIASTROPHIC DYSPLASIA; WNK KINASES; SUBUNIT STOICHIOMETRY; FUNCTIONAL EXPRESSION; BICARBONATE SECRETION	SLC26 proteins function as anion exchangers, channels, and sensors. Previous cellular studies have shown that Slc26a3 and Slc26a6 interact with the R-region of the cystic fibrosis transmembrane conductance regulator (CFTR), (R)CFTR, via the Slc26-STAS (sulfate transporter anti-sigma) domain, resulting in mutual transport activation. We recently showed that Slc26a9 has both nCl(-)-HCO3- exchanger and Cl- channel function. In this study, we show that the purified STAS domain of Slc26a9 (a9STAS) binds purified (R)CFTR. When Slc26a9 and (R)CFTR fragments are co-expressed in Xenopus oocytes, both Slc26a9-mediated nCl(-)-HCO3- exchange and Cl- currents are almost fully inhibited. Deletion of the Slc26a9 STAS domain (a9-Delta STAS) virtually eliminated the Cl- currents with only a modest affect on nCl(-)-HCO3- exchange activity. Co-expression of a9-Delta STAS and the (R)CFTR fragment did not alter the residual a9-Delta STAS function. Replacing the Slc26a9 STAS domain with the Slc26a6 STAS domain (a6-a9-a6) does not change Slc26a9 function and is no longer inhibited by (R)CFTR. These data indicate that the Slc26a9-STAS domain, like other Slc26-STAS domains, binds CFTR in the R-region. However, unlike previously reported data, this binding interaction inhibits Slc26a9 ion transport activity. These results imply that Slc26-STAS domains may all interact with (R)CFTR but that the physiological outcome is specific to differing Slc26 proteins, allowing for dynamic and acute fine tuning of ion transport for various epithelia.	[Chang, Min-Hwang; Sindic, Aleksandra; Ranatunga, Wasantha K.; Chen, An-Ping; Thompson, James; Romero, Michael F.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Chang, Min-Hwang; Plata, Consuelo; Sindic, Aleksandra; Chan, Kim W.; Romero, Michael F.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Plata, Consuelo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Zandi-Nejad, Kambiz; Mount, David B.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Mount, David B.] Vet Affairs Boston Healthcare Syst, Div Renal, W Roxbury, MA 02132 USA	Mayo Clinic; Case Western Reserve University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Romero, MF (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, 200 1st St SW, Rochester, MN 55905 USA.	romero.michael@mayo.edu	Plata, Consuelo/M-4482-2015; Dugandzic, Aleksandra/AAL-7581-2020; Plata, Consuelo/M-6461-2019; Chen, An-Ping/I-6455-2013	Plata, Consuelo/0000-0001-9340-8950; Chen, An-Ping/0000-0002-4577-3205	National Institutes of Health [DK056218, DK060845, EY017732, DK038226, DK57708]; Veterans Affairs; American Heart Association; Cystic Fibrosis Foundation [ROMERO-06GO, SINDIC-06F0]; NATIONAL EYE INSTITUTE [R01EY017732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056218, R01DK057708, P01DK038226, R21DK060845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK056218, DK060845, EY017732 (to M. F. R.), and DK038226 and DK57708 (to D. B. M.). This work was also supported by grants from the Veterans Affairs (to D. B. M.), a grant-in-aid from the American Heart Association (to D. B. M.), a postdoctoral fellowship from the American Heart Association (to M. H. C. and K. Z.), and Cystic Fibrosis Foundation Grants ROMERO-06GO and SINDIC-06F0.	Aronson PS, 2006, KIDNEY INT, V70, P1207, DOI 10.1038/sj.ki.5001741; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; BISSIG M, 1994, J BIOL CHEM, V269, P3017; Cai GM, 1998, AM J MED GENET, V78, P58, DOI 10.1002/(SICI)1096-8628(19980616)78:1<58::AID-AJMG12>3.3.CO;2-F; Chan KM, 2000, J GEN PHYSIOL, V116, P163, DOI 10.1085/jgp.116.2.163; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Chen AP, 2009, FASEB J, V23; Chernova MN, 2003, J PHYSIOL-LONDON, V549, P3, DOI 10.1113/jphysiol.2003.039818; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Coyle B, 1998, HUM MOL GENET, V7, P1105, DOI 10.1093/hmg/7.7.1105; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Drexl M, 2008, J NEUROPHYSIOL, V99, P1607, DOI 10.1152/jn.01216.2007; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Hastbacka J, 1999, EUR J HUM GENET, V7, P664, DOI 10.1038/sj.ejhg.5200361; Hastbacka J, 1996, AM J HUM GENET, V58, P255; Hoglund P, 2001, HUM MUTAT, V18, P233, DOI 10.1002/humu.1179; Hoglund P, 2001, GUT, V48, P724, DOI 10.1136/gut.48.5.724; Huth JR, 1997, PROTEIN SCI, V6, P2359; Ishiguro H, 2007, AM J PHYSIOL-GASTR L, V292, pG447, DOI 10.1152/ajpgi.00286.2006; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P14877, DOI 10.1073/pnas.0406172101; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Lohi H, 2003, AM J PHYSIOL-CELL PH, V284, pC769, DOI 10.1152/ajpcell.00270.2002; Loriol C, 2008, CELL PHYSIOL BIOCHEM, V22, P15, DOI 10.1159/000149780; Makela S, 2005, MOL HUM REPROD, V11, P129, DOI 10.1093/molehr/gah140; Makela S, 2002, HUM MUTAT, V20, P425, DOI 10.1002/humu.10139; Monico CG, 2008, AM J KIDNEY DIS, V52, P1096, DOI 10.1053/j.ajkd.2008.07.041; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; PLATA C, 2008, FASEB J, V22; Romero MF, 2000, J BIOL CHEM, V275, P24552, DOI 10.1074/jbc.M003476200; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; ROMERO MF, 2006, NOVART FDN SYMP, V273, P138; ROMERO MF, 2009, PHYSL PATHOLOGY CHLO; ROMERO MF, 2006, NOVART FDN SYMP, V273, P261; Romero Michael F, 2006, Novartis Found Symp, V273, P126; Rossi A, 2003, PEDIATR PATHOL MOL M, V22, P311, DOI 10.1080/15227950307720; Rossi A, 1996, HUM GENET, V98, P657, DOI 10.1007/s004390050279; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Sciortino CM, 1999, AM J PHYSIOL-RENAL, V277, pF611, DOI 10.1152/ajprenal.1999.277.4.F611; Seidler U, 2008, PFLUG ARCH EUR J PHY, V455, P757, DOI 10.1007/s00424-007-0318-z; Shcheynikov N, 2004, J BIOL CHEM, V279, P21857, DOI 10.1074/jbc.M313323200; Shcheynikov N, 2006, NOVART FDN SYMP, V273, P261; Shcheynikov N., 2006, NOVART FDN SYMP, V273, P186; Shcheynikov Nikolay, 2006, Novartis Found Symp, V273, P177; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; Singh AK, 2008, KIDNEY INT, V74, P438, DOI 10.1038/ki.2008.184; Soleimani M, 2008, J PHYSIOL-LONDON, V586, P1205, DOI 10.1113/jphysiol.2007.150565; Toure A, 2007, HUM MOL GENET, V16, P1783, DOI 10.1093/hmg/ddm117; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	70	60	61	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28306	28318		10.1074/jbc.M109.001669	http://dx.doi.org/10.1074/jbc.M109.001669			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19643730	Green Published, hybrid			2022-12-25	WOS:000270676300057
J	Klanrit, P; Taebunpakul, P; Flinterman, MB; Odell, EW; Riaz, MA; Melino, G; Salomoni, P; Mymryk, JS; Gaken, J; Farzaneh, F; Tavassoli, M				Klanrit, P.; Taebunpakul, P.; Flinterman, M. B.; Odell, E. W.; Riaz, M. A.; Melino, G.; Salomoni, P.; Mymryk, J. S.; Gaeken, J.; Farzaneh, F.; Tavassoli, M.			PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers	ONCOGENE			English	Article						PML; EGFR; p73; E1A; HNSCC	ACUTE PROMYELOCYTIC LEUKEMIA; SQUAMOUS-CELL CARCINOMAS; FACTOR RECEPTOR PROMOTER; P53 TARGET GENES; RAR-ALPHA; E1A-MEDIATED SUPPRESSION; TRANSCRIPTIONAL ACTIVITY; PREMATURE SENESCENCE; MESSENGER-RNA; P73	Epidermal growth factor receptor (EGFR) tyrosine kinase is commonly overexpressed in human cancers; however, the cellular mechanisms regulating EGFR expression remain unclear. p53, p63 and p73 are transcription factors regulating many cellular targets involved in controlling the cell cycle and apoptosis. p53 activates EGFR expression, whereas TAp63 represses EGFR transcription. The involvement of p73 in the regulation of EGFR has not been reported. Here, a strong correlation between EGFR overexpression and increased levels of the oncogenic Delta Np73 isoform in head and neck squamous cell carcinoma (HNSCC) cell lines was observed. Ectopic expression of TAp73, particularly TAp73 beta, resulted in suppression of the EGFR promoter, significant downregulation of EGFR protein and efficient induction of cell death in all six EGFR-overexpressing HNSCC cell lines. EGFR overexpression from a heterologous LTR promoter protected lung cancer cells from TAp73 beta-induced EGFR suppression and apoptosis. Expression of TAp73 beta efficiently induced promyelocytic leukaemia (PML) protein expression and PML knockdown by shRNA attenuated the downregulation of EGFR and induction of apoptosis by p73 in HNSCC cells. Furthermore, PML was found to be important for E1A-induced suppression of EGFR and subsequent killing of HNSCC cells. Our data therefore suggest a novel pathway involving PML and p73 in the regulation of EGFR expression. Oncogene (2009) 28, 3499-3512; doi: 10.1038/onc.2009.191; published online 13 July 2009	[Klanrit, P.; Taebunpakul, P.; Flinterman, M. B.; Riaz, M. A.; Tavassoli, M.] Kings Coll London, Inst Dent, Head & Neck Oncol Grp, London SE1 9RT, England; [Odell, E. W.] Kings Coll London, Inst Dent, Dept Oral Pathol, London SE1 9RT, England; [Melino, G.; Salomoni, P.] Univ Leicester, Toxicol Unit, MRC, Leicester, Leics, England; [Mymryk, J. S.] Univ Western Ontario, Dept Oncol, London Reg Canc Program, London, ON, Canada; [Mymryk, J. S.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Gaeken, J.; Farzaneh, F.] Kings Coll London, Dept Hematol & Mol Med, London SE1 9RT, England	University of London; King's College London; University of London; King's College London; University of Leicester; Western University (University of Western Ontario); Western University (University of Western Ontario); University of London; King's College London	Tavassoli, M (corresponding author), Kings Coll London, Inst Dent, Head & Neck Oncol Grp, Guys Hosp Campus,Floor 28 Tower Wing, London SE1 9RT, England.	mahvash.tavassoli@kcl.ac.uk	Klanrit, Poramaporn/X-4784-2019; odell, edward w/E-9920-2012; Farzaneh, Farzin/B-4902-2009; gaken, joop/B-3414-2009	odell, edward w/0000-0001-8435-0048; Farzaneh, Farzin/0000-0002-9275-2415; 	Cancer Research UK [C1116]; Rosetrees Trust; Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Royal Thai Government Scholarship; MRC [MC_U132670601, MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670601, MC_U132670600] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Royal Thai Government Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Prof Bert Vogelstein for providing Ad-GFP-p53 and Ad-GFP, Prof Karen Vousden for providing Ad-GFP-TAp73 beta, Prof Alfred Johnson for providing pER1-luc and Associate Prof Kun-Sang Chang for anti-PML clone 3573 antibody. We also thank Prof Alan Lehmann for 1BR3 and 1BR3-LT, Prof Hugh Paterson for 6689, Prof Barry Gusterson for HN5, Prof Kazuya Tominaga for HSC-3 and HSC-3 M3, Prof Fiona Watts for Km3, Prof Andrew Yeudall for HN30 and Prof Stephen Prime for H103 and H357 cell lines. We especially thank Prof Christoph Borner for the critical and helpful reading of this paper. This work was supported by grants from Cancer Research UK, the Rosetrees Trust and Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. Marcella Flinterman was supported by a grant from Cancer Research UK (C1116). Poramaporn Klanrit and Patrayu Taebunpakul were supported by the Royal Thai Government Scholarship.	Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Bernassola F, 2005, ONCOGENE, V24, P6982, DOI 10.1038/sj.onc.1208843; Bernassola F, 2004, J EXP MED, V199, P1545, DOI 10.1084/jem.20031943; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; de Melker AA, 2001, J CELL SCI, V114, P2167; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Denizot A, 2003, THYROID, V13, P867, DOI 10.1089/105072503322401069; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Flinterman M, 2005, J BIOL CHEM, V280, P5945, DOI 10.1074/jbc.M406661200; Flinterman M, 2003, ONCOGENE, V22, P1965, DOI 10.1038/sj.onc.1206190; Flinterman MB, 2007, ONCOGENE, V26, P6863, DOI 10.1038/sj.onc.1210497; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Goldschneider D, 2004, J CELL SCI, V117, P293, DOI 10.1242/jcs.00834; Guelen L, 2004, ONCOGENE, V23, P1153, DOI 10.1038/sj.onc.1207224; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; GUSTERSON BA, 1991, ONCOGENE, V6, P1785; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; KASTNER P, 1991, CR SOC BIOL, V185, P391; Klanrit P, 2008, CELL CYCLE, V7, P205, DOI 10.4161/cc.7.2.5361; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; LudesMeyers JH, 1996, MOL CELL BIOL, V16, P6009; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Racek T, 2005, J BIOL CHEM, V280, P40402, DOI 10.1074/jbc.C500193200; SAKAI E, 1992, ONCOGENE, V7, P927; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sayan AE, 2005, BIOCHEM BIOPH RES CO, V330, P186, DOI 10.1016/j.bbrc.2005.02.145; Sheikh MS, 1997, ONCOGENE, V15, P1095, DOI 10.1038/sj.onc.1201264; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Ueda Y, 1999, ONCOGENE, V18, P4993, DOI 10.1038/sj.onc.1202817; Vallian S, 1998, MOL CELL BIOL, V18, P7147, DOI 10.1128/MCB.18.12.7147; Wang ZG, 1998, SCIENCE, V279, P1547; Wu LQ, 2004, ONCOGENE, V23, P4032, DOI 10.1038/sj.onc.1207538; Wu Q, 2009, J BIOL CHEM, V284, P8738, DOI 10.1074/jbc.M807590200; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; YAN DH, 1991, ONCOGENE, V6, P343; Yeudall WA, 1997, MOL CARCINOGEN, V18, P89, DOI 10.1002/(SICI)1098-2744(199702)18:2<89::AID-MC4>3.0.CO;2-L; YEUDALL WA, 1995, ORAL ONCOL, V31B, P136, DOI 10.1016/0964-1955(94)00030-8; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhu JH, 1998, CANCER RES, V58, P5061	51	11	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	39					3499	3512		10.1038/onc.2009.191	http://dx.doi.org/10.1038/onc.2009.191			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	502RR	19597475	Green Accepted			2022-12-25	WOS:000270478300007
J	Heinzelman, P; Snow, CD; Smith, MA; Yu, XL; Kannan, A; Boulware, K; Villalobos, A; Govindarajan, S; Minshull, J; Arnold, FH				Heinzelman, Pete; Snow, Christopher D.; Smith, Matthew A.; Yu, Xinlin; Kannan, Arvind; Boulware, Kevin; Villalobos, Alan; Govindarajan, Sridhar; Minshull, Jeremy; Arnold, Frances H.			SCHEMA Recombination of a Fungal Cellulase Uncovers a Single Mutation That Contributes Markedly to Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE-GUIDED RECOMBINATION; FAMILY; PROTEINS; SITE	A quantitative linear model accurately (R-2 = 0.88) describes the thermostabilities of 54 characterized members of a family of fungal cellobiohydrolase class II (CBH II) cellulase chimeras made by SCHEMA recombination of three fungal enzymes, demonstrating that the contributions of SCHEMA sequence blocks to stability are predominantly additive. Thirty-one of 31 predicted thermostable CBH II chimeras have thermal inactivation temperatures higher than the most thermostable parent CBH II, from Humicola insolens, and the model predicts that hundreds more CBH II chimeras share this superior thermostability. Eight of eight thermostable chimeras assayed hydrolyze the solid cellulosic substrate Avicel at temperatures at least 5 degrees C above the most stable parent, and seven of these showed superior activity in 16-h Avicel hydrolysis assays. The sequence-stability model identified a single block of sequence that adds 8.5 degrees C to chimera thermostability. Mutating individual residues in this block identified the C313S substitution as responsible for the entire thermostabilizing effect. Introducing this mutation into the two recombination parent CBH IIs not featuring it (Hypocrea jecorina and H. insolens) decreased inactivation, increased maximum Avicel hydrolysis temperature, and improved long time hydrolysis performance. This mutation also stabilized and improved Avicel hydrolysis by Phanerochaete chrysosporium CBH II, which is only 55-56% identical to recombination parent CBH IIs. Furthermore, the C313S mutation increased total H. jecorina CBH II activity secreted by the Saccharomyces cerevisiae expression host more than 10-fold. Our results show that SCHEMA structure-guided recombination enables quantitative prediction of cellulase chimera thermostability and efficient identification of stabilizing mutations.	[Heinzelman, Pete; Snow, Christopher D.; Smith, Matthew A.; Yu, Xinlin; Kannan, Arvind; Boulware, Kevin; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Villalobos, Alan; Govindarajan, Sridhar; Minshull, Jeremy] DNA2 0 Inc, Menlo Pk, CA 94025 USA	California Institute of Technology	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 210-41, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu	Snow, Christopher/L-5624-2013	Snow, Christopher/0000-0002-7690-3519; Arnold, Frances H./0000-0002-4027-364X	Army-Industry Institute for Collaborative Biotechnologies; Caltech Innovation Institute	Army-Industry Institute for Collaborative Biotechnologies; Caltech Innovation Institute	This work was supported by grants from the Army-Industry Institute for Collaborative Biotechnologies and the Caltech Innovation Institute.	Endelman JB, 2004, PROTEIN ENG DES SEL, V17, P589, DOI 10.1093/protein/gzh067; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; Li YG, 2007, NAT BIOTECHNOL, V25, P1051, DOI 10.1038/nbt1333; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Loksha IV, 2009, J COMPUT CHEM, V30, P999, DOI 10.1002/jcc.21204; Otey CR, 2006, PLOS BIOL, V4, P789, DOI 10.1371/journal.pbio.0040112; PERRY LJ, 1987, PROTEIN ENG, V1, P101, DOI 10.1093/protein/1.2.101; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	14	94	105	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26229	26233		10.1074/jbc.C109.034058	http://dx.doi.org/10.1074/jbc.C109.034058			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625252	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-25	WOS:000269969600002
J	Kim, JH; Gurumurthy, CB; Naramura, M; Zhang, Y; Dudley, AT; Doglio, L; Band, H; Band, V				Kim, Jun Hyun; Gurumurthy, Channabasavaiah Basavaraju; Naramura, Mayumi; Zhang, Ying; Dudley, Andrew T.; Doglio, Lynn; Band, Hamid; Band, Vimla			Role of Mammalian Ecdysoneless in Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; DROSOPHILA DEVELOPMENT; FAMILY PROTEINS; GENE; CANCER; E2F; PRB; RB; DIFFERENTIATION; TARGETS	The Ecdysoneless (Ecd) protein is required for cell-autonomous roles in development and oogenesis in Drosophila, but the function of its evolutionarily conserved mammalian orthologs is not clear. To study the cellular function of Ecd in mammalian cells, we generated Ecd(lox/lox) mouse embryonic fibroblast cells from Ecd floxed mouse embryos. Cre-mediated deletion of Ecd in Ecd(lox/lox) mouse embryonic fibroblasts led to a proliferative block due to a delay in G1-S cell cycle progression; this defect was reversed by the introduction of human Ecd. Loss of Ecd led to marked down-regulation of E2F target gene expression. Furthermore, Ecd directly bound to Rb at the pocket domain and competed with E2F for binding to hypophosphorylated Rb. Our results demonstrate that mammalian Ecd plays a role in cell cycle progression via the Rb-E2F pathway.	[Kim, Jun Hyun; Gurumurthy, Channabasavaiah Basavaraju; Band, Vimla] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA; [Kim, Jun Hyun; Dudley, Andrew T.; Band, Hamid; Band, Vimla] Northwestern Univ, Interdept Biol Sci Grad Program, Evanston, IL 60208 USA; [Zhang, Ying; Doglio, Lynn] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Northwestern University; Northwestern University; Feinberg School of Medicine	Band, V (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	vband@unmc.edu	Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Naramura, Mayumi/0000-0003-3658-0767	Korea Science and Engineering Foundation [M06-2004-000-10547-0]; Department of Defense Predoctoral Traineeship [W81XWH-08-1-0366]; NATIONAL CANCER INSTITUTE [R01CA116552, R01CA096844, R01CA099163, R01CA094143, R01CA087986, R01CA099900, R01CA105489] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Department of Defense Predoctoral Traineeship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Korea Science and Engineering Foundation Grant M06-2004-000-10547-0 and Department of Defense Predoctoral Traineeship Grant W81XWH-08-1-0366.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Classon M, 2000, P NATL ACAD SCI USA, V97, P10820, DOI 10.1073/pnas.190343497; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Kainou T, 2006, YEAST, V23, P35, DOI 10.1002/yea.1336; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; KOUZARIDES T, 1995, SEMIN CANCER BIOL, V6, P91, DOI 10.1006/scbi.1995.0012; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; Sato T, 1999, MOL GEN GENET, V260, P535; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; Tikoo R, 2000, J NEUROSCI, V20, P4627, DOI 10.1523/JNEUROSCI.20-12-04627.2000; TODARO GJ, 1963, J CELL COMPAR PHYSL, V62, P257, DOI 10.1002/jcp.1030620305; Tsihlias J, 1999, ANNU REV MED, V50, P401; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wikenheiser-Brokamp KA, 2004, DEVELOPMENT, V131, P4299, DOI 10.1242/dev.01232; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Zhang Y, 2006, CANCER RES, V66, P7167, DOI 10.1158/0008-5472.CAN-06-0722; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; ZUR HH, 1994, ANNU REV MICROBIOL, V48, P427	36	23	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26402	26410		10.1074/jbc.M109.030551	http://dx.doi.org/10.1074/jbc.M109.030551			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640839	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000269969600021
J	Matthews, RG				Matthews, Rowena G.			A Love Affair with Vitamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEPENDENT METHIONINE SYNTHASE; HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE; COBALAMIN-BINDING DOMAIN; OLD YELLOW ENZYME; ESCHERICHIA-COLI; X-RAY; LIPOAMIDE DEHYDROGENASE; S-ADENOSYLMETHIONINE; RISK-FACTOR; PIG HEART		[Matthews, Rowena G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Matthews, Rowena G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Matthews, RG (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	rmatthew@umich.edu						Bandarian V, 2002, NAT STRUCT BIOL, V9, P53; Bandarian V, 2003, P NATL ACAD SCI USA, V100, P8156, DOI 10.1073/pnas.1133218100; BANERJEE RV, 1989, J BIOL CHEM, V264, P13888; BROWN KL, 1988, INORG CHEM, V27, P3548, DOI 10.1021/ic00293a023; Datta S, 2008, P NATL ACAD SCI USA, V105, P4115, DOI 10.1073/pnas.0800329105; DAUBNER SC, 1982, J BIOL CHEM, V257, P140; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; Fleischhacker AS, 2007, BIOCHEMISTRY-US, V46, P12382, DOI 10.1021/bi701367c; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; FUJII K, 1974, J BIOL CHEM, V249, P6745; Goulding CW, 1997, BIOCHEMISTRY-US, V36, P8082, DOI 10.1021/bi9705164; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Hagemeier CH, 2006, P NATL ACAD SCI USA, V103, P18917, DOI 10.1073/pnas.0603650103; Hoover DM, 1997, BIOCHEMISTRY-US, V36, P127, DOI 10.1021/bi961693s; Jarrett JT, 1996, BIOCHEMISTRY-US, V35, P2464, DOI 10.1021/bi952389m; JOHNSON LN, 1993, ANNU REV BIOPH BIOM, V22, P199, DOI 10.1146/annurev.bb.22.060193.001215; KANG SS, 1991, AM J HUM GENET, V48, P536; Kornberg A, 2000, J BACTERIOL, V182, P3613, DOI 10.1128/JB.182.13.3613-3618.2000; KOUTMOS M, 2009, P NATL ACAD IN PRESS; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LUSCHINSKY CL, 1992, J MOL BIOL, V225, P557, DOI 10.1016/0022-2836(92)90940-L; MANGUM JH, 1962, FED PROC, V21, P242; MARSH ENG, 1992, FEBS LETT, V310, P167, DOI 10.1016/0014-5793(92)81321-C; MATTHEWS RG, 1976, J BIOL CHEM, V251, P3956; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; MATTHEWS RG, 1969, J BIOL CHEM, V244, P1779; MATTHEWS RG, 1977, J BIOL CHEM, V252, P3199; MATTHEWS RG, 1975, J BIOL CHEM, V250, P9294; MATTHEWS RG, 2009, METAL IONS LIFE SCI; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; ROSSI M, 1985, J AM CHEM SOC, V107, P1729, DOI 10.1021/ja00292a046; Sheppard CA, 1999, J BACTERIOL, V181, P718, DOI 10.1128/JB.181.3.718-725.1999; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Weissbach H, 2008, J BIOL CHEM, V283, P23497, DOI 10.1074/jbc.X800006200; Wolthers KR, 2009, FEBS J, V276, P1942, DOI 10.1111/j.1742-4658.2009.06919.x; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998	40	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26217	26228		10.1074/jbc.X109.041178	http://dx.doi.org/10.1074/jbc.X109.041178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19596855	Green Published, hybrid			2022-12-25	WOS:000269969600001
J	Savino, B; Borroni, EM; Torres, NM; Proost, P; Struyf, S; Mortier, A; Mantovani, A; Locati, M; Bonecchi, R				Savino, Benedetta; Borroni, Elena Monica; Torres, Nina Machado; Proost, Paul; Struyf, Sofie; Mortier, Anneleen; Mantovani, Alberto; Locati, Massimo; Bonecchi, Raffaella			Recognition Versus Adaptive Up-regulation and Degradation of CC Chemokines by the Chemokine Decoy Receptor D6 Are Determined by Their N-terminal Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOFILTRATE CC-CHEMOKINE-1; INFLAMMATION; AGONISTS; ACTIVATION; LD78-BETA; PREVENTS; CLEAVAGE; LIGANDS; VARIANT; TUMORS	The chemokine decoy receptor D6 controls inflammatory responses by selective recognition and degradation of most CCR1 to CCR5 agonistic ligands. CCL14 is a homeostatic chemokine present at high concentrations in the serum with a weak agonist activity on CCR1. Under inflammatory conditions, plasmin and UPA-mediated truncation of 8 amino acids generates the potent CCR1/CCR3/CCR5 isoform CCL14(9-74), which is further processed and inactivated by dipeptidyl peptidase IV/CD26 that generates CCL14(11-74). Here we report that D6 efficiently binds both CCL14 and its truncated isoforms. Like other D6 ligands, the biologically active CCL14(9-74) induces adaptive up-regulation of D6 expression on the cell membrane and is rapidly and efficiently degraded. In contrast, the D6-mediated degradation of the biologically inactive isoforms CCL14(1-74) and CCL14(11-74) is very inefficient. Thus, D6 cooperates with CD26 in the negative regulation of CCL14 by the selective degradation of its biologically active isoform. Analysis of a panel of CC chemokines and their truncated isoforms revealed that D6-mediated chemokine degradation does not correlate with binding affinity. Conversely, degradation efficiency is positively correlated with D6 adaptive up-regulation. Sequence analysis indicated that a proline residue in position 2 of D6 ligands is dispensable for binding but crucial for D6 adaptive up-regulation and efficient degradation.	[Savino, Benedetta; Borroni, Elena Monica; Torres, Nina Machado; Mantovani, Alberto; Locati, Massimo; Bonecchi, Raffaella] Ist Clin Humanitas, Ist Ricovero & Cura Carattere Sci, I-20089 Rozzano, MI, Italy; [Savino, Benedetta; Borroni, Elena Monica; Torres, Nina Machado; Mantovani, Alberto; Locati, Massimo; Bonecchi, Raffaella] Univ Milan, Dept Translat Med, I-20089 Milan, Italy; [Proost, Paul; Struyf, Sofie; Mortier, Anneleen] Katholieke Univ Leuven, Lab Mol Immunol, Rega Inst, B-3000 Louvain, Belgium	IRCCS Humanitas Research Hospital; University of Milan; KU Leuven	Bonecchi, R (corresponding author), Ist Clin Humanitas, Ist Ricovero & Cura Carattere Sci, Via Manzoni 113, I-20089 Rozzano, MI, Italy.	raffaella.bonecchi@humanitas.it	Torres, Nina Patricia Machado/AAB-9215-2020; Mantovani, Alberto/HCI-7449-2022; Locati, Massimo/H-8404-2015; Proost, Paul/V-3052-2017; Borroni, Elena Monica/B-3600-2012; Locati, Massimo/ABF-6807-2021; Savino, Benedetta/K-4488-2014; Borroni, Elena Monica/O-7241-2019; Bonecchi, Raffaella/ABI-2390-2020; Struyf, Sofie/U-2455-2017	Mantovani, Alberto/0000-0001-5578-236X; Locati, Massimo/0000-0003-3077-590X; Proost, Paul/0000-0002-0133-5545; Borroni, Elena Monica/0000-0003-1157-8249; Savino, Benedetta/0000-0002-2996-9515; Borroni, Elena Monica/0000-0003-1157-8249; Struyf, Sofie/0000-0003-4558-0769; Mortier, Anneleen/0000-0002-9662-674X; Bonecchi, Raffaella/0000-0003-3346-5333	European Community [518167]; Ministero dell'Istruzione dell'Universita e della Ricerca [2002061255, 2007ENYMAN_003]; Fondo per gli Investimenti della Ricerca di Base [RBIN04EKCX]; Fondazione Cariplo; Centers of Excellence [EF/05/15]; Concerted Research Actions of the Regional Government of Flanders; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy; Fondazione Humanitas per la Ricerca; Italian Association for Cancer Research	European Community(European Commission); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Fondazione Cariplo(Fondazione Cariplo); Centers of Excellence; Concerted Research Actions of the Regional Government of Flanders; Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); Fondazione Humanitas per la Ricerca; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by research grants of the European Community (INNOCHEM project 518167), the Ministero dell'Istruzione dell'Universita e della Ricerca (Progetti di Ricerca di Interesse Nazionale projects 2002061255 and 2007ENYMAN_003; Fondo per gli Investimenti della Ricerca di Base project RBIN04EKCX), Fondazione Cariplo (NOBEL project), the Centers of Excellence (Credit EF/05/15) of the K. U. Leuven, the Concerted Research Actions of the Regional Government of Flanders, the Fund for Scientific Research of Flanders (FWO-Vlaanderen), and the Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy. This work was conducted in the context and with the support of the Fondazione Humanitas per la Ricerca. This work was also supported by the Italian Association for Cancer Research.; A Fondazione Italiana per la Ricerca sul Cancro fellowship recipient.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Di Liberto D, 2008, J EXP MED, V205, P2075, DOI 10.1084/jem.20070608; Forssmann U, 2004, J IMMUNOL, V173, P3456, DOI 10.4049/jimmunol.173.5.3456; Forssmann U, 2001, J LEUKOCYTE BIOL, V70, P357; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Locati M, 2005, CYTOKINE GROWTH F R, V16, P679, DOI 10.1016/j.cytogfr.2005.05.003; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; McKimmie CS, 2008, J IMMUNOL, V181, P8170, DOI 10.4049/jimmunol.181.11.8170-a; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; Proost P, 2006, BIOCHEM SOC T, V34, P997, DOI 10.1042/BST0340997; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; SchulzKnappe P, 1996, J EXP MED, V183, P295, DOI 10.1084/jem.183.1.295; Struyf S, 2003, ADV IMMUNOL, V81, P1, DOI 10.1016/S0065-2776(03)81001-5; Struyf S, 2009, EUR J IMMUNOL, V39, P843, DOI 10.1002/eji.200838660; Vakili J, 2001, J IMMUNOL, V167, P3406, DOI 10.4049/jimmunol.167.6.3406; VETRANO S, 2009, GUT IN PRESS	35	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26207	26215		10.1074/jbc.M109.029249	http://dx.doi.org/10.1074/jbc.M109.029249			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632987	Green Published, hybrid			2022-12-25	WOS:000269738000075
J	Schutt, J; Falley, K; Richter, D; Kreienkamp, HJ; Kindler, S				Schuett, Janin; Falley, Katrin; Richter, Dietmar; Kreienkamp, Hans-Juergen; Kindler, Stefan			Fragile X Mental Retardation Protein Regulates the Levels of Scaffold Proteins and Glutamate Receptors in Postsynaptic Densities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC TARGETING ELEMENT; LONG-TERM POTENTIATION; SHANK1 MESSENGER-RNA; DEVELOPING RAT-BRAIN; NMDA RECEPTOR; SYNAPTIC PLASTICITY; MOUSE MODEL; DEPENDENT TRANSLATION; SPINE MORPHOGENESIS; KNOCKOUT MICE	Functional absence of fragile X mental retardation protein (FMRP) causes the fragile X syndrome, a hereditary form of mental retardation characterized by a change in dendritic spine morphology. The RNA-binding protein FMRP has been implicated in regulating postsynaptic protein synthesis. Here we have analyzed whether the abundance of scaffold proteins and neurotransmitter receptor subunits in postsynaptic densities (PSDs) is altered in the neocortex and hippocampus of FMRP-deficient mice. Whereas the levels of several PSD components are unchanged, concentrations of Shank1 and SAPAP scaffold proteins and various glutamate receptor subunits are altered in both adult and juvenile knock-out mice. With the exception of slightly increased hippocampal SAPAP2 mRNA levels in adult animals, altered postsynaptic protein concentrations do not correlate with similar changes in total and synaptic levels of corresponding mRNAs. Thus, loss of FMRP in neurons appears to mainly affect the translation and not the abundance of particular brain transcripts. Semi-quantitative analysis of RNA levels in FMRP immunoprecipitates showed that in the mouse brain mRNAs encoding PSD components, such as Shank1, SAPAP1-3, PSD-95, and the glutamate receptor subunits NR1 and NR2B, are associated with FMRP. Luciferase reporter assays performed in primary cortical neurons from knock-out and wild-type mice indicate that FMRP silences translation of Shank1 mRNAs via their 3'-untranslated region. Activation of metabotropic glutamate receptors relieves translational suppression. As Shank1 controls dendritic spine morphology, our data suggest that dysregulation of Shank1 synthesis may significantly contribute to the abnormal spine development and function observed in brains of fragile X syndrome patients.	[Schuett, Janin; Falley, Katrin; Kreienkamp, Hans-Juergen; Kindler, Stefan] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Richter, Dietmar] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kindler, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Campus Forsch N27,Martinistr 52, D-20246 Hamburg, Germany.	kindler@uke.uni-hamburg.de			Deutsche Forschungsgemeinschaft [Ki 488/2-6, KR 1321/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants Ki488/2-6 ( to S. K.) and KR 1321/4-1 ( to H.-J. K. and S. K.) and Thyssen-Stiftung Az. 10.05.2.185 ( to D. R. and S. K.). This article is based in part on a doctoral study by J.S. at the Faculty of Biology, University of Hamburg.	Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bassell GJ, 2008, NAT MED, V14, P249, DOI 10.1038/nm0308-249; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Grossman AW, 2006, BRAIN RES, V1084, P158, DOI 10.1016/j.brainres.2006.02.044; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Huang YS, 2007, METHOD ENZYMOL, V431, P143, DOI 10.1016/S0076-6879(07)31008-2; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kindler S, 2004, MOL BRAIN RES, V126, P14, DOI 10.1016/j.molbrainres.2004.03.014; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Monshausen M, 2002, J NEUROCHEM, V81, P557, DOI 10.1046/j.1471-4159.2002.00887.x; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pedersen SK, 2002, BIOCHEM J, V363, P37, DOI 10.1042/0264-6021:3630037; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Redecker P, 2006, HISTOCHEM CELL BIOL, V126, P679, DOI 10.1007/s00418-006-0199-9; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sambrook J., 2002, MOL CLONING LAB MANU; Sawallisch C, 2009, J BIOL CHEM, V284, P9225, DOI 10.1074/jbc.M808425200; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Soltau M, 2004, J NEUROCHEM, V90, P659, DOI 10.1111/j.1471-4159.2004.02523.x; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Wang HD, 2002, J NEUROSCI, V22, P10232; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Wilson BM, 2007, P NATL ACAD SCI USA, V104, P2454, DOI 10.1073/pnas.0610875104; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	77	114	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25479	25487		10.1074/jbc.M109.042663	http://dx.doi.org/10.1074/jbc.M109.042663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640847	Green Published, hybrid			2022-12-25	WOS:000269738000005
J	Herlax, V; Mate, S; Rimoldi, O; Bakas, L				Herlax, Vanesa; Mate, Sabina; Rimoldi, Omar; Bakas, Laura			Relevance of Fatty Acid Covalently Bound to Escherichia coli alpha-Hemolysin and Membrane Microdomains in the Oligomerization Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; LIPID RAFTS; PORE FORMATION; TOXIN; MECHANISM; BINDING; HLYA; PALMITOYLATION; ERYTHROCYTES; PURIFICATION	alpha-Hemolysin (HlyA) is an exotoxin secreted by some pathogenic strains of Escherichia coli that causes lysis of several mammalian cells, including erythrocytes of different species. HlyA is synthesized as a protoxin, pro-HlyA, which is activated by acylation at two internal lysines Lys-563 and Lys-689. It has been proposed that pore formation is the mechanism of cytolytic activity for this toxin, as shown in experiments with whole cells, planar lipid membranes, and liposomes, but these experiments have yielded conflicting results about the structure of the pore. In this study, HlyA cysteine replacement mutant proteins of amino acids have been labeled with Alexa-488 and Alexa-546. Fluorescence resonance energy transfer measurements, employing labeled toxin bound to sheep ghost erythrocytes, have demonstrated that HlyA oligomerizes on erythrocyte membranes. As the cytotoxic activity is absolutely dependent on acylation, we have studied the role of acylation in the oligomerization, demonstrating that fatty acids are essential in this process. On the other hand, fluorescence resonance energy transfer and the hemolytic activity decrease when the erythrocyte ghosts are cholesterol-depleted, hence indicating the role of membrane microdomains in the clustering of HlyA. Simultaneously, HlyA was found in detergent-resistant membranes. Pro-HlyA has also been found in detergent-resistant membranes, thus demonstrating that the importance of acyl chains in toxin oligomerization is the promotion of protein-protein interaction. These results change the concept of the main role assigned to acyl chain in the targeting of proteins to membrane microdomains.	[Herlax, Vanesa; Mate, Sabina; Rimoldi, Omar; Bakas, Laura] Univ Nacl La Plata, Inst Invest Bioquim La Plata, CCT La Plata, Consejo Nacl Invest Cient & Tecn, RA-1900 La Plata, Argentina; [Bakas, Laura] Univ Nacl La Plata, Dept Ciencias Biol, Fac Ciencias Exactas, RA-1900 La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata	Herlax, V (corresponding author), Univ Nacl La Plata, Inst Invest Bioquim La Plata, CCT La Plata, Consejo Nacl Invest Cient & Tecn, 60 & 120, RA-1900 La Plata, Argentina.	vherlax@atlas.med.unlp.edu.ar	Mate, Sabina/AAO-7301-2021	Herlax, Vanesa/0000-0003-4218-8702	Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Agencia Nacional de Promocion Cientifica, Argentina [BID 1728/OC-AR 26228, PIP CONICET 5742]	Comision de Investigaciones Cientificas de la Provincia de Buenos Aires; Agencia Nacional de Promocion Cientifica, Argentina(ANPCyT)	This work was supported by grants from the Comision de Investigaciones Cientificas de la Provincia de Buenos Aires, Agencia Nacional de Promocion Cientifica Grant BID 1728/OC-AR 26228, and PIP CONICET 5742, Argentina.	Bakas L, 2006, BIOPHYS J, V91, P3748, DOI 10.1529/biophysj.106.090019; BENZ R, 1992, FEMS MICROBIOL IMMUN, V105, P55; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; GADEBERG OV, 1984, INFECT IMMUN, V45, P255, DOI 10.1128/IAI.45.1.255-260.1984; GIRAUD F, 1984, BIOCHIM BIOPHYS ACTA, V778, P191, DOI 10.1016/0005-2736(84)90462-0; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; Herlax V, 2003, CHEM PHYS LIPIDS, V122, P185, DOI 10.1016/S0009-3084(02)00191-3; Herlax V, 2007, BIOCHEMISTRY-US, V46, P5177, DOI 10.1021/bi0618013; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hyland C, 2001, J BACTERIOL, V183, P5364, DOI 10.1128/JB.183.18.5364-5370.2001; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Koumanov KS, 2005, ARCH BIOCHEM BIOPHYS, V434, P150, DOI 10.1016/j.abb.2004.10.025; LACKOWICZ J, 1984, PRINCIPLE FLUORESCEN, P305; LAKOWICZ JR, 1990, BIOPHYS CHEM, V36, P99, DOI 10.1016/0301-4622(90)85014-W; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lim KB, 2000, J BIOL CHEM, V275, P36698, DOI 10.1074/jbc.C000544200; LUDWIG A, 1993, MOL GEN GENET, V241, P89, DOI 10.1007/BF00280205; MENESTRINA G, 1987, BIOCHIM BIOPHYS ACTA, V905, P109, DOI 10.1016/0005-2736(87)90014-9; Moayeri M, 1997, INFECT IMMUN, V65, P2233, DOI 10.1128/IAI.65.6.2233-2239.1997; MOAYERI M, 1994, INFECT IMMUN, V62, P4124, DOI 10.1128/IAI.62.10.4124-4134.1994; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8720, DOI 10.1021/bi00489a031; Parsons M, 2004, BIOCHEM SOC T, V32, P431, DOI 10.1042/BST0320431; Pellett S, 1996, INFECT IMMUN, V64, P3081, DOI 10.1128/IAI.64.8.3081-3087.1996; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sanchez-Magraner L, 2006, J BIOL CHEM, V281, P5461, DOI 10.1074/jbc.M512897200; Sharpe JC, 1999, J MEMBRANE BIOL, V171, P209, DOI 10.1007/s002329900572; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Soloaga A, 1998, BIOCHEMISTRY-US, V37, P6387, DOI 10.1021/bi9730994; Soloaga A, 1996, EUR J BIOCHEM, V238, P418, DOI 10.1111/j.1432-1033.1996.0418z.x; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85	45	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25199	25210		10.1074/jbc.M109.009365	http://dx.doi.org/10.1074/jbc.M109.009365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19596862	Green Published, hybrid			2022-12-25	WOS:000269734000054
J	Russ, HA; Ravassard, P; Kerr-Conte, J; Pattou, F; Efrat, S				Russ, Holger A.; Ravassard, Philippe; Kerr-Conte, Julie; Pattou, Francois; Efrat, Shimon			Epithelial-Mesenchymal Transition in Cells Expanded In Vitro from Lineage-Traced Adult Human Pancreatic Beta Cells	PLOS ONE			English	Article								Background: In-vitro expansion of functional beta cells from adult human islets is an attractive approach for generating an abundant source of cells for beta-cell replacement therapy of diabetes. Using genetic cell-lineage tracing we have recently shown that beta cells cultured from adult human islets undergo rapid dedifferentiation and proliferate for up to 16 population doublings. These cells have raised interest as potential candidates for redifferentiation into functional insulin-producing cells. Previous work has associated dedifferentiation of cultured epithelial cells with epithelial-mesenchymal transition (EMT), and suggested that EMT generates cells with stem cell properties. Here we investigated the occurrence of EMT in these cultures and assessed their stem cell potential. Methodology/Principal Findings: Using cell-lineage tracing we provide direct evidence for occurrence of EMT in cells originating from beta cells in cultures of adult human islet cells. These cells express multiple mesenchymal markers, as well as markers associated with mesenchymal stem cells (MSC). However, we do not find evidence for the ability of such cells, nor of cells in these cultures derived from a non-beta-cell origin, to significantly differentiate into mesodermal cell types. Conclusions/Significance: These findings constitute the first demonstration based on genetic lineage-tracing of EMT in cultured adult primary human cells, and show that EMT does not induce multipotency in cells derived from human beta cells.			Russ, HA (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il	Pattou, Francois/O-6151-2017	Pattou, Francois/0000-0001-8388-3766; ravassard, philippe/0000-0002-0393-9262; Efrat, Shimon/0000-0001-5987-232X				Atouf F, 2007, DIABETES, V56, P699, DOI 10.2337/db06-1446; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Beattie GM, 1999, DIABETES, V48, P1013, DOI 10.2337/diabetes.48.5.1013; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Chase LG, 2007, DIABETES, V56, P3, DOI 10.2337/db06-1165; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Davani B, 2007, STEM CELLS, V25, P3215, DOI 10.1634/stemcells.2007-0323; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gallo R, 2007, CELL DEATH DIFFER, V14, P1860, DOI 10.1038/sj.cdd.4402199; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Lim YS, 2007, HISTOCHEM CELL BIOL, V127, P149, DOI 10.1007/s00418-006-0233-y; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morton RA, 2007, MOL CELL ENDOCRINOL, V270, P87, DOI 10.1016/j.mce.2007.02.005; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Seeberger KL, 2006, LAB INVEST, V86, P141, DOI 10.1038/labinvest.3700377; Shah GV, 2009, J BIOL CHEM, V284, P1018, DOI 10.1074/jbc.M807823200; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; VOULGARI A, 2009, BIOCH BIOPHYS ACTA; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654	29	99	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6417	10.1371/journal.pone.0006417	http://dx.doi.org/10.1371/journal.pone.0006417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641613	Green Submitted, Green Published, gold			2022-12-25	WOS:000268494500018
J	Waters, WR; Palmer, MV; Nonnecke, BJ; Thacker, TC; Estes, DM; Larsen, MH; Jacobs, WR; Andersen, P; McNair, J; Minion, FC; Lyashchenko, KP; Hewinson, RG; Vordermeier, HM; Sacco, RE				Waters, W. Ray; Palmer, Mitchell V.; Nonnecke, Brian J.; Thacker, Tyler C.; Estes, D. Mark; Larsen, Michelle H.; Jacobs, William R., Jr.; Andersen, Peter; McNair, James; Minion, F. C.; Lyashchenko, Konstantin P.; Hewinson, R. Glyn; Vordermeier, H. Martin; Sacco, Randy E.			Signal Regulatory Protein alpha (SIRP alpha)(+) Cells in the Adaptive Response to ESAT-6/CFP-10 Protein of Tuberculous Mycobacteria	PLOS ONE			English	Article							DENDRITIC CELLS; SIRP-ALPHA; MACROPHAGE FUSION; COMPLEX-FORMATION; BOVIS BCG; IMMUNE-RESPONSES; CALMETTE-GUERIN; T-LYMPHOCYTES; CD47; ESAT-6	Background: Early secretory antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) are co-secreted proteins of Mycobacterium tuberculosis complex mycobacteria ( includes M. bovis, the zoonotic agent of bovine tuberculosis) involved in phagolysosome escape of the bacillus and, potentially, in the efficient induction of granulomas. Upon tuberculosis infection, multi-nucleate giant cells are elicited, likely as a response aimed at containing mycobacteria. In tissue culture models, signal regulatory protein (SIRP)alpha ( also referred to as macrophage fusion receptor or CD172a) is essential for multi-nucleate giant cell formation. Methodology/Principal Findings: In the present study, ESAT-6/CFP-10 complex and SIRP alpha interactions were evaluated with samples obtained from calves experimentally infected with M. bovis. Peripheral blood CD172a(+) (SIRP alpha-expressing) cells from M. bovis-infected calves proliferated upon in vitro stimulation with ESAT-6/CFP-10 ( either as a fusion protein or a peptide cocktail), but not with cells from animals receiving M. bovis strains lacking ESAT-6/CFP-10 (i.e, M. bovis BCG or M. bovis Delta RD1). Sorted CD172a(+) cells from these cultures had a dendritic cell/macrophage morphology, bound fluorescently-tagged rESAT-6:CFP-10, bound and phagocytosed live M. bovis BCG, and co-expressed CD11c, DEC-205, CD44, MHC II, CD80/86 (a subset also co-expressed CD11b or CD8 alpha). Intradermal administration of rESAT-6: CFP-10 into tuberculous calves elicited a delayed type hypersensitive response consisting of CD11c(+), CD172a(+), and CD3(+) cells, including CD172a-expressing multinucleated giant cells. Conclusions/Significance: These findings demonstrate the ability of ESAT-6/CFP-10 to specifically expand CD172a(+) cells, bind to CD172a(+) cells, and induce multi-nucleated giant cells expressing CD172a.			Waters, WR (corresponding author), ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA.	ray.waters@ars.usda.gov	Hewinson, Glyn/J-1902-2014; Minion, Chris/A-2955-2015; Vordermeier, H Martin/C-6936-2011; Hewinson, Glyn/F-7077-2010; Thacker, Tyler/P-4271-2018; Hewinson, Glyn/AAA-2364-2019; Palmer, Mitchell/R-7091-2018	Minion, Chris/0000-0003-4876-8396; Thacker, Tyler/0000-0001-6779-7649; Palmer, Mitchell/0000-0002-5902-3333; Hewinson, Glyn/0000-0002-5517-4281; Jacobs, William/0000-0003-3321-3080	NIAID NIH HHS [R01 AI026170, AI26170, R37 AI026170] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI026170, R01AI026170, R37AI026170] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Baron R, 1996, REV RHUM, V63, P633; Bastos RG, 2007, VET IMMUNOL IMMUNOP, V115, P334, DOI 10.1016/j.vetimm.2006.11.001; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Brooke GP, 1998, EUR J IMMUNOL, V28, P1, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;1::AID-IMMU1&gt;3.0.CO;2-V; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Frink S, 2002, J VET MED B, V49, P476, DOI 10.1046/j.1439-0450.2002.00589.x; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Hagnerud S, 2006, J IMMUNOL, V176, P5772, DOI 10.4049/jimmunol.176.10.5772; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; Howard CJ, 2002, VET IMMUNOL IMMUNOP, V87, P123, DOI 10.1016/S0165-2427(02)00043-0; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kunkle RA, 1995, VET IMMUNOL IMMUNOP, V49, P271, DOI 10.1016/0165-2427(95)05464-2; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lightbody KL, 2008, J BIOL CHEM, V283, P17681, DOI 10.1074/jbc.M800123200; Lightbody KL, 2004, FEMS MICROBIOL LETT, V238, P255, DOI 10.1016/j.femsle.2004.07.043; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Maue AC, 2005, INFECT IMMUN, V73, P6659, DOI 10.1128/IAI.73.10.6659-6667.2005; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pollock JM, 2003, J CLIN MICROBIOL, V41, P1856, DOI 10.1128/JCM.41.5.1856-1860.2003; Porcelli SA, 2008, NAT IMMUNOL, V9, P1101, DOI 10.1038/ni1008-1101; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; van den Berg TK, 2004, TRENDS IMMUNOL, V25, P11, DOI 10.1016/j.it.2003.11.006; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; VANPITTIUS NCG, 2001, GENOME BIOL, V2; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Waters WR, 2004, CLIN DIAGN LAB IMMUN, V11, P729, DOI 10.1128/CDLI.11.4.729-735.2004; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0; Zhuang Y, 2006, CLIN VACCINE IMMUNOL, V13, P1064, DOI 10.1128/CVI.00178-06	59	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6414	10.1371/journal.pone.0006414	http://dx.doi.org/10.1371/journal.pone.0006414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641628	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500015
J	Zhu, XF; Gustafsson, CM				Zhu, Xuefeng; Gustafsson, Claes M.			Distinct Differences in Chromatin Structure at Subtelomeric X and Y ' Elements in Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; CHROMOSOME ENDS; HETEROCHROMATIN; TRANSCRIPTION; GENE; RAP1; EXPRESSION; EVOLUTION; POSITIONS; REGIONS	In Saccharomyces cerevisiae, all ends of telomeric DNA contain telomeric repeats of (TG(1-3)), but the number and position of subtelomeric X and Y' repeat elements vary. Using chromatin immunoprecipitation and genome-wide analyses, we here demonstrate that the subtelomeric X and Y' elements have distinct structural and functional properties. Y' elements are transcriptionally active and highly enriched in nucleosomes, whereas X elements are repressed and devoid of nucleosomes. In contrast to X elements, the Y' elements also lack the classical hallmarks of heterochromatin, such as high Sir3 and Rap1 occupancy as well as low levels of histone H4 lysine 16 acetylation. Our analyses suggest that the presence of X and Y' elements govern chromatin structure and transcription activity at individual chromosome ends.			Zhu, XF (corresponding author), Univ Gothenburg, Dept Biochem & Cell Biol, Gothenburg, Sweden.	xuefeng.zhu@medkem.gu.se		Gustafsson, Claes/0000-0003-3531-8468				Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P865, DOI 10.1093/nar/20.4.865; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; EBERL DF, 1993, GENETICS, V134, P277; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LOUIS EJ, 1990, GENETICS, V124, P533; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; LOUIS EJ, 1992, GENETICS, V131, P559; Mondoux MA, 2007, GENETICS, V177, P2541, DOI 10.1534/genetics.107.079806; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; PARDUE ML, 2008, DROSOPHILA TELOMERES, P2; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Valenzuela L, 2008, MOL CELL BIOL, V28, P1924, DOI 10.1128/MCB.01647-07; Vega-Palas MA, 2000, MOL GEN GENET, V263, P287, DOI 10.1007/s004380051170; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Zhengjian, 2006, Methods Mol Biol, V313, P245; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	28	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6363	10.1371/journal.pone.0006363	http://dx.doi.org/10.1371/journal.pone.0006363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626119	Green Submitted, Green Published, gold			2022-12-25	WOS:000268260200009
J	Ban, NC; Vincent, ACJ				Ban, Natalie C.; Vincent, Amanda C. J.			Beyond Marine Reserves: Exploring the Approach of Selecting Areas where Fishing Is Permitted, Rather than Prohibited	PLOS ONE			English	Article							PROTECTED AREAS; IMPACTS; POPULATIONS; DESIGN; SCALE; REEF; SIZE	Background: Marine populations have been declining at a worrying rate, due in large part to fishing pressures. The challenge is to secure a future for marine life while minimizing impacts on fishers and fishing communities. Methods and Principal Findings: Rather than selecting areas where fishing is banned - as is usually the case with spatial management - we assess the concept of designating areas where fishing is permitted. We use spatial catch statistics for thirteen commercial fisheries on Canada's west coast to determine the minimum area that would be needed to maintain a pre-ascribed target percentage of current catches. We found that small reductions in fisheries yields, if strategically allocated, could result in large unfished areas that are representative of biophysical regions and habitat types, and have the potential to achieve remarkable conservation gains. Conclusions: Our approach of selecting fishing areas instead of reserves could help redirect debate about the relative values that society places on conservation and extraction, in a framework that could gain much by losing little. Our ideas are intended to promote discussions about the current status quo in fisheries management, rather than providing a definitive solution.			Ban, NC (corresponding author), Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V5Z 1M9, Canada.	natalie.ban@jcu.edu.au	Ban, Natalie/C-6938-2009	Ban, Natalie/0000-0002-4682-2144				Ball I., 2000, MARXAN V1 8 2 MARINE; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Collie JS, 2001, CAN J FISH AQUAT SCI, V58, P2167, DOI 10.1139/cjfas-58-11-2167; Collie JS, 2000, J ANIM ECOL, V69, P785, DOI 10.1046/j.1365-2656.2000.00434.x; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Dayton PK, 1998, SCIENCE, V279, P821, DOI 10.1126/science.279.5352.821; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Game ET, 2008, MARXAN USER MANUAL M; Gaylord B, 2005, ECOL APPL, V15, P2180, DOI 10.1890/04-1810; *GOV BRIT COL, 2007, EC CONTR OC SECT BRI; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lindholm JB, 2001, CONSERV BIOL, V15, P424, DOI 10.1046/j.1523-1739.2001.015002424.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Schrank WE, 2007, MAR POLICY, V31, P299, DOI 10.1016/j.marpol.2006.09.001; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Stewart RR, 2003, MAR ECOL PROG SER, V253, P25, DOI 10.3354/meps253025; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Tetreault I, 2007, ECOL APPL, V17, P2251, DOI 10.1890/06-0161.1; Walters C, 2000, B MAR SCI, V66, P745; Walters C., 1998, REINVENTING FISHERIE, P279; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; WOOD LJ, 2007, UBC FISHERIES CTR WO, P1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zacharias MA, 1998, COAST MANAGE, V26, P105, DOI 10.1080/08920759809362347	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6258	10.1371/journal.pone.0006258	http://dx.doi.org/10.1371/journal.pone.0006258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623248	gold, Green Accepted, Green Published			2022-12-25	WOS:000268260100003
J	Lobo, FP; Mota, BEF; Pena, SDJ; Azevedo, V; Macedo, AM; Tauch, A; Machado, CR; Franco, GR				Lobo, Francisco P.; Mota, Bruno E. F.; Pena, Sergio D. J.; Azevedo, Vasco; Macedo, Andrea M.; Tauch, Andreas; Machado, Carlos R.; Franco, Gloria R.			Virus-Host Coevolution: Common Patterns of Nucleotide Motif Usage in Flaviviridae and Their Hosts	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SWINE-FEVER VIRUS; ANTIVIRAL RESPONSE; PHYLOGENETIC-RELATIONSHIPS; CYTOSINE METHYLATION; DISEASE ASSOCIATION; CODON USAGE; IN-VITRO; RNASE-L; INTERFERON	Virus-host biological interaction is a continuous coevolutionary process involving both host immune system and viral escape mechanisms. Flaviviridae family is composed of fast evolving RNA viruses that infects vertebrate (mammals and birds) and/or invertebrate (ticks and mosquitoes) organisms. These host groups are very distinct life forms separated by a long evolutionary time, so lineage-specific anti-viral mechanisms are likely to have evolved. Flaviviridae viruses which infect a single host lineage would be subjected to specific host-induced pressures and, therefore, selected by them. In this work we compare the genomic evolutionary patterns of Flaviviridae viruses and their hosts in an attempt to uncover coevolutionary processes inducing common features in such disparate groups. Especially, we have analyzed dinucleotide and codon usage patterns in the coding regions of vertebrate and invertebrate organisms as well as in Flaviviridae viruses which specifically infect one or both host types. The two host groups possess very distinctive dinucleotide and codon usage patterns. A pronounced CpG under-representation was found in the vertebrate group, possibly induced by the methylation-deamination process, as well as a prominent TpA decrease. The invertebrate group displayed only a TpA frequency reduction bias. Flaviviridae viruses mimicked host nucleotide motif usage in a host-specific manner. Vertebrate-infecting viruses possessed under-representation of CpG and TpA, and insect-only viruses displayed only a TpA under-representation bias. Single-host Flaviviridae members which persistently infect mammals or insect hosts (Hepacivirus and insect-only Flavivirus, respectively) were found to posses a codon usage profile more similar to that of their hosts than to related Flaviviridae. We demonstrated that vertebrates and mosquitoes genomes are under very distinct lineage-specific constraints, and Flaviviridae viruses which specifically infect these lineages appear to be subject to the same evolutionary pressures that shaped their host coding regions, evidencing the lineage-specific coevolutionary processes between the viral and host groups.			Lobo, FP (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	franciscolobo@gmail.com	Lobo, Francisco Pereira/AAG-3118-2021; Lobo, Francisco/A-1295-2011; Azevedo, Vasco/B-1556-2019; Macedo, Andréa M/C-1506-2013; Azevedo, Vasco A.C/F-4315-2011; MACHADO, CARLOS/AAW-1492-2020; Machado, Carlos Renato/H-1043-2015; Franco, Glória/I-3654-2013	Lobo, Francisco Pereira/0000-0002-9671-9313; Azevedo, Vasco/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; Machado, Carlos Renato/0000-0002-8724-3165; Franco, Glória/0000-0001-5245-2365; Mota, Bruno/0000-0003-0348-4875				Agrawal S, 2003, ANN NY ACAD SCI, V1002, P30, DOI 10.1196/annals.1281.005; Altenbach D, 2007, MOL PLANT MICROBE IN, V20, P1031, DOI 10.1094/MPMI-20-9-1031; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; BAXEVANIS AD, 2008, CURR PROTOC BIOINFOR, pCH1; Belshaw R, 2009, NUCLEIC ACIDS RES, V37, pD431, DOI 10.1093/nar/gkn729; BENSON DA, 2008, NUCL ACIDS RES; Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; BOUDRAA M, 1987, NUCLEIC ACIDS RES, V15, P5729; BuchenOsmond C, 1997, ARCH VIROL, V142, P1734; Bukh J, 1999, VIROLOGY, V262, P470, DOI 10.1006/viro.1999.9941; CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; de Lamballerie X, 2002, J GEN VIROL, V83, P2443, DOI 10.1099/0022-1317-83-10-2443; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Grard G, 2006, J GEN VIROL, V87, P3273, DOI 10.1099/vir.0.82071-0; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Gregorio GV, 2003, CLIN EXP IMMUNOL, V133, P404, DOI 10.1046/j.1365-2249.2003.02229.x; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/1079990042475698; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Hu YW, 2005, VIROLOGY, V332, P538, DOI 10.1016/j.virol.2004.11.041; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168; Jernigan RW, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-23; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kim WM, 2008, ADV EXP MED BIOL, V640, P325, DOI 10.1007/978-0-387-09789-3_22; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kow YW, 2002, FREE RADICAL BIO MED, V33, P886, DOI 10.1016/S0891-5849(02)00902-4; Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Major L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004375; Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Moelling K, 2006, COLD SPRING HARB SYM, V71, P365, DOI 10.1101/sqb.2006.71.010; Mogensen TH, 2005, J MOL MED, V83, P180, DOI 10.1007/s00109-004-0620-6; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; NOVELLA IS, 1995, J VIROL, V69, P6805, DOI 10.1128/JVI.69.11.6805-6809.1995; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R Core Team, 2021, R LANG ENV STAT COMP; REMOLD SK, 2002, J ECOL, V90, P11; Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859; Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Schweizer M, 2006, J VIROL, V80, P6926, DOI 10.1128/JVI.02443-05; Seago J, 2007, J GEN VIROL, V88, P3002, DOI 10.1099/vir.0.82934-0; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; SILVERMAN RH, 1994, J INTERFERON RES, V14, P101, DOI 10.1089/jir.1994.14.101; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Stram Y, 2006, VIRUS GENES, V32, P299, DOI 10.1007/s11262-005-6914-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Thimme R, 2006, ANTIVIR RES, V69, P129, DOI 10.1016/j.antiviral.2005.12.001; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Whittle CA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-169; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; YOMO T, 1989, P NATL ACAD SCI USA, V86, P8452, DOI 10.1073/pnas.86.21.8452; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	90	124	126	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6282	10.1371/journal.pone.0006282	http://dx.doi.org/10.1371/journal.pone.0006282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617912	gold, Green Published, Green Submitted			2022-12-25	WOS:000268119600002
J	Schleich, S; Teleman, AA				Schleich, Sibylle; Teleman, Aurelio A.			Akt Phosphorylates Both Tsc1 and Tsc2 in Drosophila, but Neither Phosphorylation Is Required for Normal Animal Growth	PLOS ONE			English	Article								Akt, an essential component of the insulin pathway, is a potent inducer of tissue growth. One of Akt's phosphorylation targets is Tsc2, an inhibitor of the anabolic kinase TOR. This could account for part of Akt's growth promoting activity. Although phosphorylation of Tsc2 by Akt does occur in vivo, and under certain circumstances can lead to reduced Tsc2 activity, the functional significance of this event is unclear since flies lacking Akt phosphorylation sites on Tsc2 are viable and normal in size and growth rate. Since Drosophila Tsc1, the obligate partner of Tsc2, has an Akt phosphorylation motif that is not conserved in mammals, we investigate here whether Akt redundantly phosphorylates the Tsc complex on Tsc1 and Tsc2. We provide evidence that Akt phosphorylates Tsc1 at Ser533. We show that flies lacking Akt phosphorylation sites on Tsc1 alone, or on both Tsc1 and Tsc2 concurrently, are viable and normal in size. This shows that phosphorylation of the Tsc1/2 complex by Akt is not required for Akt to activate TORC1 and to promote tissue growth in Drosophila.			Schleich, S (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	a.teleman@dkfz.de	Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019	Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368				Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200	25	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6305	10.1371/journal.pone.0006305	http://dx.doi.org/10.1371/journal.pone.0006305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609361	Green Submitted, gold, Green Published			2022-12-25	WOS:000268119500021
J	Windschiegl, B; Orth, A; Romer, W; Berland, L; Stechmann, B; Bassereau, P; Johannes, L; Steinem, C				Windschiegl, Barbara; Orth, Alexander; Roemer, Winfried; Berland, Ludwig; Stechmann, Bahne; Bassereau, Patricia; Johannes, Ludger; Steinem, Claudia			Lipid Reorganization Induced by Shiga Toxin Clustering on Planar Membranes	PLOS ONE			English	Article								The homopentameric B-subunit of bacterial protein Shiga toxin (STxB) binds to the glycolipid Gb(3) in plasma membranes, which is the initial step for entering cells by a clathrin-independent mechanism. It has been suggested that protein clustering and lipid reorganization determine toxin uptake into cells. Here, we elucidated the molecular requirements for STxB induced Gb(3) clustering and for the proposed lipid reorganization in planar membranes. The influence of binding site III of the B-subunit as well as the Gb(3) lipid structure was investigated by means of high resolution methods such as fluorescence and scanning force microscopy. STxB was found to form protein clusters on homogenous 1,2-dioleoyl-snglycero-3- phosphocholine (DOPC)/cholesterol/Gb(3) (65:30:5) bilayers. In contrast, membranes composed of DOPC/cholesterol/sphingomyelin/Gb(3) (40: 35: 20: 5) phase separate into a liquid ordered and liquid disordered phase. Dependent on the fatty acid composition of Gb(3), STxB-Gb(3) complexes organize within the liquid ordered phase upon protein binding. Our findings suggest that STxB is capable of forming a new membrane phase that is characterized by lipid compaction. The significance of this finding is discussed in the context of Shiga toxin-induced formation of endocytic membrane invaginations.			Windschiegl, B (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Gottingen, Germany.	claudia.steinem@chemie.uni-goettingen.de	Johannes, Ludger/M-9778-2017; Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019; Johannes, Ludger/W-8593-2019; Bassereau, Patricia/P-8657-2018	Johannes, Ludger/0000-0002-2168-0004; Steinem, Claudia/0000-0001-8778-9283; Johannes, Ludger/0000-0002-2168-0004; Bassereau, Patricia/0000-0002-8544-6778				Arab S, 1996, GLYCOCONJUGATE J, V13, P159, DOI 10.1007/BF00731490; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bast DJ, 1999, MOL MICROBIOL, V32, P953, DOI 10.1046/j.1365-2958.1999.01405.x; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Binder WH, 2003, ANGEW CHEM INT EDIT, V42, P5802, DOI 10.1002/anie.200300586; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Falguieres T, 2006, FEBS J, V273, P5205, DOI 10.1111/j.1742-4658.2006.05516.x; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Lacy DB, 1998, CURR OPIN STRUC BIOL, V8, P778; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Lipowsky R, 2002, J BIOL PHYS, V28, P195, DOI 10.1023/A:1019994628793; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Meder D., 2006, LIPID RAFTS CAVEOLAE, P1; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Menke M, 2002, EUR BIOPHYS J BIOPHY, V31, P317, DOI 10.1007/s00249-002-0232-4; Milhiet PE, 2002, J BIOL CHEM, V277, P875, DOI 10.1074/jbc.C100654200; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nyholm PG, 1996, CHEM BIOL, V3, P263, DOI 10.1016/S1074-5521(96)90106-4; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Pina DG, 2007, BBA-BIOMEMBRANES, V1768, P628, DOI 10.1016/j.bbamem.2006.12.011; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Rinia HA, 2001, FEBS LETT, V504, P194, DOI 10.1016/S0014-5793(01)02704-1; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; Sens P, 2000, EUR PHYS J E, V1, P237, DOI 10.1007/s101890050026; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Smith DC, 2004, SEMIN CELL DEV BIOL, V15, P397, DOI 10.1016/j.semcdb.2004.03.005; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; WANG FY, 2004, J COMPLEX SYSTEMS CO, V1, P33	40	73	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6238	10.1371/journal.pone.0006238	http://dx.doi.org/10.1371/journal.pone.0006238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606209	Green Published, gold			2022-12-25	WOS:000268036000002
J	Kaczer, L; Maldonado, H				Kaczer, Laura; Maldonado, Hector			Contrasting Role of Octopamine in Appetitive and Aversive Learning in the Crab Chasmagnathus	PLOS ONE			English	Article								Background: Biogenic amines are implicated in reinforcing associative learning. Octopamine (OA) is considered the invertebrate counterpart of noradrenaline and several studies in insects converge on the idea that OA mediates the reward in appetitive conditioning. However, it is possible to assume that OA could have a different role in an aversive conditioning. Methodology/Principal Findings: Here we pharmacologically studied the participation of OA in two learning processes in the crab Chasmagnathus granulatus, one appetitive and one aversive. It is shown that the aversive memory is impaired by an OA injection applied immediately or 30 minutes after the last training trial. By contrast, the appetitive memory is blocked by OA antagonists epinastine and mianserine, but enhanced by OA when injected together with the supply of a minimum amount of reinforcement. Finally, double-learning experiments in which crabs are given the aversive and the appetitive learning either successively or simultaneously allow us to study the interaction between both types of learning and analyze the presumed action of OA. We found that the appetitive training offered immediately, but not one hour, after an aversive training has an amnesic effect on the aversive memory, mimicking the effect and the kinetic of an OA injection. Conclusions/Significance: Our results demonstrate that the role of OA is divergent in two memory processes of opposite signs: on the one hand it would mediate the reinforcement in appetitive learning, and on the other hand it has a deleterious effect over aversive memory consolidation.			Kaczer, L (corresponding author), Univ Buenos Aires, Lab Neurobiol Memoria, Dept Fisiol & Biol Mol & Celular, IFIBYNE,CONICET,Fac Ciencias Exactas & Nat, Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	hector@fbmc.fcen.uba.ar						ABBOTT J, 1970, NATURE, V225, P291, DOI 10.1038/225291b0; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Tano MC, 2009, NEUROSCIENCE, V158, P387, DOI 10.1016/j.neuroscience.2008.10.039; Degen J, 2000, BRIT J PHARMACOL, V130, P587, DOI 10.1038/sj.bjp.0703338; DIMANT B, 1992, J COMP PHYSIOL A, V170, P749; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Farooqui T, 2003, J NEUROSCI, V23, P5370; Frenkel L, 2005, EUR J NEUROSCI, V22, P1757, DOI 10.1111/j.1460-9568.2005.04373.x; Freudenthal R, 1998, NEUROSCI LETT, V242, P143, DOI 10.1016/S0304-3940(98)00059-7; Giurfa M, 2006, CURR BIOL, V16, pR892, DOI 10.1016/j.cub.2006.09.021; GLEESON RA, 1977, COMP BIOCHEM PHYS A, V56, P411, DOI 10.1016/0300-9629(77)90258-4; Hammer M, 1998, LEARN MEMORY, V5, P146; HOEGER U, 1989, COMP BIOCHEM PHYS C, V92, P323, DOI 10.1016/0742-8413(89)90062-5; Howell DC, 1987, STAT METHODS PSYCHOL; Kaczer L, 2007, NEUROBIOL LEARN MEM, V87, P140, DOI 10.1016/j.nlm.2006.08.002; Keene AC, 2005, CURR BIOL, V15, pR932, DOI 10.1016/j.cub.2005.10.058; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Locatelli F, 2002, NEUROBIOL LEARN MEM, V77, P234, DOI 10.1006/nlme.2001.4007; Maldonado H, 1997, BRAZ J MED BIOL RES, V30, P813, DOI 10.1590/S0100-879X1997000700001; Maldonado H, 2002, CRUSTACEAN NERVOUS SYSTEM, P314; Pedreira ME, 1996, PHARMACOL BIOCHEM BE, V54, P611; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; PEDREIRA ME, 1995, PHARMACOL BIOCHEM BE, V52, P385, DOI 10.1016/0091-3057(95)00124-F; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Pereyra P, 2000, NEUROBIOL LEARN MEM, V74, P119, DOI 10.1006/nlme.1999.3945; Pereyra P, 1999, J COMP PHYSIOL A, V184, P301, DOI 10.1007/s003590050328; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Romano A, 2006, BIOL BULL-US, V210, P280, DOI 10.2307/4134564; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; SANDEMAN DC, 1967, PROC R SOC SER B-BIO, V168, P82, DOI 10.1098/rspb.1967.0052; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; ZIMMERFAUST RK, 1987, ECOLOGY, V68, P955, DOI 10.2307/1938367	43	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6223	10.1371/journal.pone.0006223	http://dx.doi.org/10.1371/journal.pone.0006223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603069	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035700004
J	Reynolds, V; Lloyd, AW; Babweteera, F; English, CJ				Reynolds, Vernon; Lloyd, Andrew W.; Babweteera, Fred; English, Christopher J.			Decaying Raphia farinifera Palm Trees Provide a Source of Sodium for Wild Chimpanzees in the Budongo Forest, Uganda	PLOS ONE			English	Article								For some years, chimpanzees have been observed eating the pith of decaying palm trees of Raphia farinifera in the Budongo Forest, Uganda. The reasons for doing this have until now been unknown. An analysis of the pith for mineral content showed high levels of sodium to be present in the samples. By contrast, lower levels were found in bark of other tree species, and also in leaf and fruit samples eaten by chimpanzees. The differences between the Raphia samples and the non-Raphia samples were highly significant (p < 0.001). It is concluded that Raphia provides a rich and possibly essential source of sodium for the Budongo chimpanzees. Comparison of a chewed sample (wadge) of Raphia pith with a sample from the tree showed a clear reduction in sodium content in the chewed sample. Black and white colobus monkeys in Budongo Forest also feed on the pith of Raphia. At present, the survival of Raphia palms in Budongo Forest is threatened by the use of this tree by local tobacco farmers.			Reynolds, V (corresponding author), Univ Oxford, Sch Anthropol, Oxford, England.	vreynolds@btopenworld.com	Lloyd, Andrew/D-1369-2011; Babweteera, Fred/AAC-3046-2022	Lloyd, Andrew/0000-0003-2778-8195; 				*BRIT GEOL SURV, 2001, GROUNDW QUAL; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; KYEYUNE S, 2003, THESIS MAKERERE U KA; Mahaney WC, 1996, PRIMATES, V37, P121, DOI 10.1007/BF02381400; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Reynolds V., 1965, PRIMATE BEHAV FIELD; Reynolds V., 2005, CHIMPANZEES BUDONGO; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480	10	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6194	10.1371/journal.pone.0006194	http://dx.doi.org/10.1371/journal.pone.0006194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593451	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035300007
J	Sun, L; Guo, RF; Gao, HW; Sarma, JV; Zetoune, FS; Ward, PA				Sun, Lei; Guo, Ren-Feng; Gao, Hongwei; Sarma, J. Vidya; Zetoune, Firas S.; Ward, Peter A.			Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells	FASEB JOURNAL			English	Article						complement; siRNA; PMNs; inflammation	ANAPHYLATOXIN RECEPTOR C5AR; SMALL INTERFERING RNA; IN-VIVO; INFLAMMATORY REACTIONS; CHEMOKINE GENERATION; ENDOTHELIAL-CELLS; MESSENGER-RNA; GENE-TRANSFER; UP-REGULATION; RAT-LIVER	Acute lung injury (ALI) in mouse lung occurs after distal airway deposition of IgG immune complexes (IgGICs), resulting in a breakdown of the vascular-airway barrier, causing intrapulmonary edema, hemorrhage, and accumulation of neutrophils [polymorphonuclear leukocytes (PMNs)] in the alveolar compartment, these changes being complement (C5a) and C5a receptor (C5aR) dependent. In this ALI model, C5aR expression (protein) was found to occur on upper (bronchial) and lower (alveolar) airway epithelial cells. An adenovirus construct (siRNA) was used to silence mRNA for C5aR in the lung. Under such conditions, C5aR protein was markedly reduced on lung epithelial cells, resulting in much reduced leakage of albumin into the lung, diminished buildup of PMNs, and lower levels of proinflammatory mediators in bronchoalveolar lavage fluids. These studies indicate that bronchial and alveolar epithelial cell C5aR is up-regulated and greatly contributes to inflammation and injury in the lung. The use of siRNA administered into the airways avoids systemic suppression of C5aR, which might compromise innate immunity. It is possible that such an intervention might be employed in humans with ALI or acute respiratory distress syndrome as well as in upper-airway inflammatory diseases, such as chronic obstructive pulmonary disease and asthma, where there is evidence for complement activation and buildup of PMNs.-Sun, L., Guo, R.-F., Gao, H., Sarma, J. V., Zetoune, F. S., Ward, P. A. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells. FASEB J. 23, 3808-3818 (2009). www.fasebj.org	[Sun, Lei; Guo, Ren-Feng; Gao, Hongwei; Sarma, J. Vidya; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; [Guo, Ren-Feng] Hannover Med Sch, Dept Trauma Surg, D-3000 Hannover, Germany	University of Michigan System; University of Michigan; Hannover Medical School	Ward, PA (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.	pward@umich.edu			U.S. National Institutes of Health [GM-61656, HL-31963]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the U.S. National Institutes of Health (grants GM-61656 and HL-31963). The authors thank Niels C. Riedemann for his significant assistance with the adenoviral construct and its application to the animal model.	AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Arts GJ, 2003, GENOME RES, V13, P2325, DOI 10.1101/gr.1332603; Arumugam TV, 2004, J HEPATOL, V40, P934, DOI 10.1016/j.jhep.2004.02.017; Boden D, 2004, MOL THER, V9, P396, DOI 10.1016/j.ymthe.2003.11.025; Bonniaud P, 2003, AM J RESP CRIT CARE, V168, P770, DOI 10.1164/rccm.200210-1254OC; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; BUCHNER RR, 1995, J IMMUNOL, V155, P308; CHENOWETH DE, 1978, P NATL ACAD SCI USA, V75, P3943, DOI 10.1073/pnas.75.8.3943; CHENOWETH DE, 1982, J EXP MED, V156, P68, DOI 10.1084/jem.156.1.68; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; Czermak BJ, 1999, J IMMUNOL, V162, P2321; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Czermak BJ, 1998, J LEUKOCYTE BIOL, V64, P40, DOI 10.1002/jlb.64.1.40; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Fayyazi A, 2000, IMMUNOLOGY, V99, P38, DOI 10.1046/j.1365-2567.2000.00911.x; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; GASQUE P, 1995, J IMMUNOL, V155, P4882; Gasque P, 1997, AM J PATHOL, V150, P31; GERARD NP, 1989, J BIOL CHEM, V264, P1760; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Guo RF, 2003, FASEB J, V17, P1889, DOI 10.1096/fj.03-0009fje; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAVILAND DL, 1995, J IMMUNOL, V154, P1861; HUANG SA, 1995, J VIROL, V69, P2257, DOI 10.1128/JVI.69.4.2257-2263.1995; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Hwang JI, 2004, P NATL ACAD SCI USA, V101, P488, DOI 10.1073/pnas.0307549100; Jagels MA, 2000, IMMUNOPHARMACOLOGY, V46, P209, DOI 10.1016/S0162-3109(99)00178-2; JOHNSON KJ, 1974, J CLIN INVEST, V54, P349, DOI 10.1172/JCI107770; Kaner RJ, 1999, AM J RESP CELL MOL, V20, P361, DOI 10.1165/ajrcmb.20.3.3398; Kay MA, 2003, NATURE, V424, P251, DOI 10.1038/424251b; Koleva M, 2002, GASTROENTEROLOGY, V122, P697, DOI 10.1053/gast.2002.31883; KURIMOTO Y, 1989, J EXP MED, V170, P467, DOI 10.1084/jem.170.2.467; MOLAD Y, 1994, BIOCHEM J, V299, P881, DOI 10.1042/bj2990881; Mulligan MS, 1997, J IMMUNOL, V158, P1857; MULLIGAN MS, 1995, J IMMUNOL, V154, P1350; MULLIGAN MS, 1993, J IMMUNOL, V150, P5585; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Naik N, 1997, J CELL SCI, V110, P2381; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Schieferdecker HL, 1997, FEBS LETT, V406, P305, DOI 10.1016/S0014-5793(97)00292-5; Schlaf G, 1999, LAB INVEST, V79, P1287; Schomber T, 2004, BLOOD, V103, P4511, DOI 10.1182/blood-2003-07-2397; Shanley TP, 1997, J IMMUNOL, V158, P3439; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; SICILIANO SJ, 1990, J BIOL CHEM, V265, P19568; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; Suda T, 2003, J THORAC CARDIOV SUR, V126, P1155, DOI 10.1016/S0022-5223(03)00939-5; Sun L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/28945; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Wang Y, 2004, AM J PHYSIOL-LUNG C, V286, pL1188, DOI 10.1152/ajplung.00288.2003; Ward PA, 1996, AM J PATHOL, V149, P1079; WERFEL T, 1992, BLOOD, V79, P152, DOI 10.1182/blood.V79.1.152.bloodjournal791152; WETSEL RA, 1995, IMMUNOL LETT, V44, P183, DOI 10.1016/0165-2478(94)00212-A; Woodruff TM, 2008, ADV EXP MED BIOL, V632, P143, DOI 10.1007/978-0-387-78952-1_11; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Zahedi R, 2000, CLIN EXP IMMUNOL, V121, P226, DOI 10.1046/j.1365-2249.2000.01249.x; Zhao LJ, 2003, GENE, V316, P137, DOI 10.1016/S0378-1119(03)00750-9	65	39	42	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3808	3818		10.1096/fj.09-133694	http://dx.doi.org/10.1096/fj.09-133694			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19620403	Green Published, Green Submitted			2022-12-25	WOS:000271272500017
J	Doroudgar, S; Thuerauf, DJ; Marcinko, MC; Belmont, PJ; Glembotski, CC				Doroudgar, Shirin; Thuerauf, Donna J.; Marcinko, Marie C.; Belmont, Peter J.; Glembotski, Christopher C.			Ischemia Activates the ATF6 Branch of the Endoplasmic Reticulum Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLUCOSE-REGULATED PROTEINS; TRANSCRIPTION FACTOR ATF6; DISULFIDE BOND FORMATION; INDUCIBLE FACTOR-I; NF-Y CBF; ER STRESS; REPERFUSION INJURY; MESSENGER-RNA; CARDIOMYOCYTE APOPTOSIS	Stresses that perturb the folding of nascent endoplasmic reticulum (ER) proteins activate the ER stress response. Upon ER stress, ER-associated ATF6 is cleaved; the resulting active cytosolic fragment of ATF6 translocates to the nucleus, binds to ER stress response elements (ERSEs), and induces genes, including the ER-targeted chaperone, GRP78. Recent studies showed that nutrient and oxygen starvation during tissue ischemia induce certain ER stress response genes, including GRP78; however, the role of ATF6 in mediating this induction has not been examined. In the current study, simulating ischemia (sI) in a primary cardiac myocyte model system caused a reduction in the level of ER-associated ATF6 with a coordinate increase of ATF6 in nuclear fractions. An ERSE in the GRP78 gene not previously shown to be required for induction by other ER stresses was found to bind ATF6 and to be critical for maximal ischemia-mediated GRP78 promoter induction. Activation of ATF6 and the GRP78 promoter, as well as grp78 mRNA accumulation during sI, were reversed upon simulated reperfusion (sI/R). Moreover, dominant-negative ATF6, or ATF6-targeted miRNA blocked sI-mediated grp78 induction, and the latter increased cardiac myocyte death upon simulated reperfusion, demonstrating critical roles for endogenous ATF6 in ischemia-mediated ER stress activation and cell survival. This is the first study to show that ATF6 is activated by ischemia but inactivated upon reperfusion, suggesting that it may play a role in the induction of ER stress response genes during ischemia that could have a preconditioning effect on cell survival during reperfusion.	San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), 5500 Campanile Dr, San Diego, CA 92182 USA.	cglembotski@sciences.sdsu.edu			National Institutes of Health [HL-075573, HL-085577]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085577, R01HL075573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-075573 and HL-085577.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bailey D, 2007, ANTIOXID REDOX SIGN, V9, P2305, DOI 10.1089/ars.2007.1796; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bose AK, 2007, CARDIOVASC DRUG THER, V21, P253, DOI 10.1007/s10557-007-6030-6; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chun YS, 2001, J CELL SCI, V114, P4051; Craig R, 2001, J BIOL CHEM, V276, P37621, DOI 10.1074/jbc.M103276200; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gothie E, 2000, J BIOL CHEM, V275, P6922, DOI 10.1074/jbc.275.10.6922; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; Harpster MH, 2006, MAMM GENOME, V17, P701, DOI 10.1007/s00335-005-0120-1; Hausenloy DJ, 2007, HEART, V93, P649, DOI 10.1136/hrt.2007.118828; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oida Y, 2008, BRAIN RES, V1208, P217, DOI 10.1016/j.brainres.2008.02.068; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pan Y. C., 2004, PROGR ELECTROMAGNETI, V44, P1; Paris S, 2005, FEBS LETT, V579, P105, DOI 10.1016/j.febslet.2004.11.055; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Prachasilchai W, 2008, EUR J PHARMACOL, V592, P138, DOI 10.1016/j.ejphar.2008.06.108; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Thuerauf DJ, 2007, J BIOL CHEM, V282, P22865, DOI 10.1074/jbc.M701213200; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Truettner JS, 2009, BRAIN RES, V1249, P9, DOI 10.1016/j.brainres.2008.10.032; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Vitadello M, 2003, FASEB J, V17, P923, DOI 10.1096/fj.02-0644fje; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Q, 1997, NUCLEIC ACIDS RES, V25, P2800, DOI 10.1093/nar/25.14.2800; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida H, 2007, ANTIOXID REDOX SIGN, V9, P2323, DOI 10.1089/ars.2007.1800; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	78	124	140	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29735	29745		10.1074/jbc.M109.018036	http://dx.doi.org/10.1074/jbc.M109.018036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19622751	hybrid, Green Published			2022-12-25	WOS:000270896800055
J	Ayoub, MA; Damian, M; Gespach, C; Ferrandis, E; Lavergne, O; De Wever, O; Baneres, JL; Pin, JP; Prevost, GP				Ayoub, Mohammed Akli; Damian, Marjorie; Gespach, Christian; Ferrandis, Eric; Lavergne, Olivier; De Wever, Olivier; Baneres, Jean-Louis; Pin, Jean-Philippe; Prevost, Gregoire Pierre			Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on G alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; CONFORMATIONAL-CHANGES; COUPLED RECEPTORS; DRUG TARGETS; SURAMIN ANALOGS; GAMMA-SUBUNIT; ACTIVATION; MASTOPARAN; COMPLEX	The simultaneous activation of many distinct G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play a major role in various pathological conditions. Pan-inhibition of GPCR signaling by small molecules thus represents a novel strategy to treat various diseases. To better understand such therapeutic approach, we have characterized the biomolecular target of BIM-46187, a small molecule pan-inhibitor of GPCR signaling. Combining bioluminescence and fluorescence resonance energy transfer techniques in living cells as well as in reconstituted receptor-G protein complexes, we observed that, by direct binding to the G alpha subunit, BIM-46187 prevents the conformational changes of the receptor-G protein complex associated with GPCR activation. Such a binding prevents the proper interaction of receptors with the G protein heterotrimer and inhibits the agonist-promoted GDP/GTP exchange. These observations bring further evidence that inhibiting G protein activation through direct binding to the G alpha subunit is feasible and should constitute a new strategy for therapeutic intervention.	[Ferrandis, Eric; Lavergne, Olivier; Prevost, Gregoire Pierre] Inst Henri Beaufour, IPSEN Innovat, F-91966 Les Ulis, France; [Pin, Jean-Philippe] Univ Montpellier, CNRS, INSERM, Inst Genom Fonct,UMR5203,U661, F-34094 Montpellier, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier I, CNRS, UMR 5247, Inst Biomol M Mousseron, F-34093 Montpellier 5, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier 2, Fac Pharm, F-34093 Montpellier 5, France; [Gespach, Christian; De Wever, Olivier] Univ Paris 06, INSERM, Hop St Antoine, U673, F-75012 Paris, France; [Gespach, Christian; De Wever, Olivier] Univ Paris 06, INSERM, U893, F-75012 Paris, France; [De Wever, Olivier] Ghent Univ Hosp, Expt Oncol Lab, B-9000 Ghent, Belgium	Ipsen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ghent University; Ghent University Hospital	Prevost, GP (corresponding author), Inst Henri Beaufour, IPSEN Innovat, 5 Ave Canada, F-91966 Les Ulis, France.	gregoire.prevost@ipsen.com	de wever, olivier/J-3094-2013; Pin, Jean-Philippe/Y-6668-2019	de wever, olivier/0000-0002-5453-760X; Pin, Jean-Philippe/0000-0002-1423-345X; Baneres, jean-louis/0000-0001-7078-1285; AYOUB, Mohammed Akli/0000-0003-0022-578X; Lavergne, Olivier/0000-0003-4922-5086				Ahmad Sultan, 2004, Curr Opin Investig Drugs, V5, P67; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Beindl W, 1996, MOL PHARMACOL, V50, P415; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Breitweg-Lehmann E, 2002, MOL PHARMACOL, V61, P628, DOI 10.1124/mol.61.3.628; Cotecchia S, 2003, ASSAY DRUG DEV TECHN, V1, P311, DOI 10.1089/15406580360545125; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; DANILENKO M, 1993, BIOCHEM BIOPH RES CO, V196, P1296, DOI 10.1006/bbrc.1993.2393; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Favre-Guilmard C, 2008, EUR J PHARMACOL, V594, P70, DOI 10.1016/j.ejphar.2008.07.016; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Freissmuth M, 1999, TRENDS PHARMACOL SCI, V20, P237, DOI 10.1016/S0165-6147(99)01337-1; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hickerson MJ, 2000, MOL BIOL EVOL, V17, P639, DOI 10.1093/oxfordjournals.molbev.a026342; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Holler C, 1999, CELL MOL LIFE SCI, V55, P257, DOI 10.1007/s000180050288; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; Nanoff C, 2002, METHOD ENZYMOL, V344, P469; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nguyen QD, 2002, FASEB J, V16, P565, DOI 10.1096/fj.01-0525com; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Taniguchi M, 2003, J ANTIBIOT, V56, P358, DOI 10.7164/antibiotics.56.358; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Tesmer JJG, 2006, SCIENCE, V312, P377, DOI 10.1126/science.1126903	40	57	59	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29136	29145		10.1074/jbc.M109.042333	http://dx.doi.org/10.1074/jbc.M109.042333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19648112	Green Published, hybrid			2022-12-25	WOS:000270678900069
J	Grillari, J; Loscher, M; Denegri, M; Lee, K; Fortschegger, K; Eisenhaber, F; Ajuh, P; Lamond, AI; Katinger, H; Grillari-Voglauer, R				Grillari, Johannes; Loescher, Marlies; Denegri, Marco; Lee, Kiseok; Fortschegger, Klaus; Eisenhaber, Frank; Ajuh, Paul; Lamond, Angus I.; Katinger, Hermann; Grillari-Voglauer, Regina			Blom7 alpha Is a Novel Heterogeneous Nuclear Ribonucleoprotein K Homology Domain Protein Involved in Pre-mRNA Splicing That Interacts with SNEVPrp19-Pso4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; IN-VIVO; FUNCTIONAL-ANALYSIS; B COMPLEXES; DNA-REPAIR; HUMAN PSO4; HNRNP-K; SPLICEOSOME; IDENTIFICATION; SITE	The removal of introns from pre-mRNA is performed by the spliceosome that stepwise assembles on the pre-mRNA before performing two catalytic steps. The spliceosome-associated CDC5L-SNEVPrp19-Pso4 complex is implicated in activation of the second catalytic step of pre-mRNA splicing, and one of its members, SNEVPrp19-Pso4, is also implicated in spliceosome assembly. To identify interaction partners of SNEVPrp19-Pso4, we have performed yeast two-hybrid screenings. Among the putative binding partners was a so far uncharacterized protein carrying two heterogeneous nuclear ribonucleoprotein K homology domains that we termed Blom7 alpha. Blom7 alpha is expressed in all tissues tested, and at least three splice variants exist. After confirming direct and physical interaction of SNEV and Blom7 alpha, we investigated if it plays a functional role during pre-mRNA splicing. Indeed, Blom7 alpha co-localizes and co-precipitates with splicing factors and pre-mRNA and is present in affinity-purified spliceosomes. More importantly, addition of Blom7 alpha to HeLa nuclear extracts increased splicing activity in a dose-dependent manner. Furthermore, we tested if Blom7 alpha influences splice site selection using two different minigene constructs. Indeed, both 5'- as well as 3'-site selection was altered upon Blom7 alpha overexpression. Thus we suggest that Blom7 alpha is a novel splicing factor of the K homology domain family that might be implicated in alternative splicing by helping to position the CDC5L-SNEVPrp19-Pso4 complex at the splice sites.	[Grillari, Johannes; Loescher, Marlies; Lee, Kiseok; Fortschegger, Klaus; Katinger, Hermann; Grillari-Voglauer, Regina] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, A-1190 Vienna, Austria; [Denegri, Marco; Ajuh, Paul; Lamond, Angus I.] Univ Dundee, Div Gene Regulat & Express, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; [Eisenhaber, Frank] Agcy Sci Technol & Res, Bioinformat Inst, Singapore 138671, Singapore; [Eisenhaber, Frank] Natl Univ Singapore, Dept Biol Sci, Singapore 117597, Singapore; [Eisenhaber, Frank] Nanyang Technol Univ, Sch Computater Engn, Singapore 637553, Singapore	University of Natural Resources & Life Sciences, Vienna; University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Grillari, J (corresponding author), Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Muthgasse 18, A-1190 Vienna, Austria.	johannes.grillari@boku.ac.at	denegri, marco/D-9307-2019; Klaus, Fortschegger/J-2222-2019; Grillari, Johannes/B-2967-2011	denegri, marco/0000-0003-1665-0625; Klaus, Fortschegger/0000-0003-1276-0368; Grillari, Johannes/0000-0001-5474-6332; Lamond, Angus/0000-0001-6204-6045; Grillari, Regina/0000-0002-5487-2838	Austrian Science Fund [S93-06]; Austrian Genome Research [820982]; Herzfelder-sche Familienstiftung; Wellcome Trust; Polymun Scientific	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Genome Research; Herzfelder-sche Familienstiftung; Wellcome Trust(Wellcome TrustEuropean Commission); Polymun Scientific	This work was supported by the Austrian Science Fund Project S93-06, by Austrian Genome Research Grant 820982 (Noncoding RNAs), by a grant from Herzfelder-sche Familienstiftung (to R. G.-V.), by Wellcome Trust, and by Polymun Scientific.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Ajuh P, 2003, NUCLEIC ACIDS RES, V31, P6104, DOI 10.1093/nar/gkg817; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Bai YD, 1999, NUCLEIC ACIDS RES, V27, P1126, DOI 10.1093/nar/27.4.1126; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bohm E, 2005, J IMMUNOL METHODS, V307, P13, DOI 10.1016/j.jim.2005.08.013; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CALVIO C, 1995, RNA, V1, P724; Cazalla D, 2005, MOL CELL BIOL, V25, P2969, DOI 10.1128/MCB.25.8.2969-2980.2005; CHENG SC, 1993, MOL CELL BIOL, V13, P1876, DOI 10.1128/MCB.13.3.1876; CHIARA MD, 1995, NATURE, V375, P510, DOI 10.1038/375510a0; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; Cho SY, 2007, BIOCHEM BIOPH RES CO, V364, P844, DOI 10.1016/j.bbrc.2007.10.091; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Cortes A, 1999, EMBO J, V18, P3820, DOI 10.1093/emboj/18.13.3820; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Eisenhaber Frank, 2006, P39; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Fortschegger K, 2007, MOL CELL BIOL, V27, P3123, DOI 10.1128/MCB.01188-06; GIBSON TJ, 1993, TRENDS BIOCHEM SCI, V18, P331, DOI 10.1016/0968-0004(93)90068-X; Gotzmann J, 2000, EXP CELL RES, V261, P166, DOI 10.1006/excr.2000.5025; Grillari J, 2000, EXP GERONTOL, V35, P187, DOI 10.1016/S0531-5565(00)00080-2; Grillari J, 2005, NUCLEIC ACIDS RES, V33, P6868, DOI 10.1093/nar/gki986; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; He LS, 2000, NUCLEIC ACIDS RES, V28, P4558, DOI 10.1093/nar/28.22.4558; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KANAZAWA M, 1993, ENZYME PROTEIN, V47, P9, DOI 10.1159/000468650; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kralovicova J, 2004, HUM MOL GENET, V13, P3189, DOI 10.1093/hmg/ddh334; Kuraoka I, 2008, J BIOL CHEM, V283, P940, DOI 10.1074/jbc.M706647200; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; LAMOND AI, 1988, P NATL ACAD SCI USA, V85, P411, DOI 10.1073/pnas.85.2.411; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Loscher M, 2005, BIOCHEM J, V388, P593, DOI 10.1042/BJ20041517; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Ribas G, 1999, J IMMUNOL, V163, P278; Robard C, 2006, BIOCHEM J, V400, P91, DOI 10.1042/BJ20060384; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schraml E, 2008, STEM CELLS DEV, V17, P355, DOI 10.1089/scd.2007.0107; Shitashige M, 2007, GASTROENTEROLOGY, V132, P1039, DOI 10.1053/j.gastro.2007.01.007; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; Sihn CR, 2007, BIOCHEM BIOPH RES CO, V356, P175, DOI 10.1016/j.bbrc.2007.02.134; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; URLAUB H, 1995, EMBO J, V14, P4578, DOI 10.1002/j.1460-2075.1995.tb00137.x; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Voglauer R, 2006, EXP CELL RES, V312, P746, DOI 10.1016/j.yexcr.2005.11.025; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang P, 2002, BIOCHEM BIOPH RES CO, V294, P448, DOI 10.1016/S0006-291X(02)00495-3; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; ZERLER B, 1986, MOL CELL BIOL, V6, P887, DOI 10.1128/MCB.6.3.887; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200	80	10	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29193	29204		10.1074/jbc.M109.036632	http://dx.doi.org/10.1074/jbc.M109.036632			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19641227	Green Published, hybrid			2022-12-25	WOS:000270678900074
J	Lee, JH; Park, H; Chung, H; Choi, S; Kim, Y; Yoo, H; Kim, TY; Hann, HJ; Seong, I; Kim, J; Kang, KG; Han, IO; Oh, ES				Lee, Jung-Hyun; Park, Haein; Chung, Heesung; Choi, Sojoong; Kim, Younghwa; Yoo, Hyun; Kim, Tae-Yoon; Hann, Hoo-Jae; Seong, Ikjoo; Kim, Jaesang; Kang, Kathleen G.; Han, Inn-Oc; Oh, Eok-Soo			Syndecan-2 Regulates the Migratory Potential of Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CUTANEOUS MALIGNANT-MELANOMA; COLON-CARCINOMA CELLS; MURINE B16 MELANOMA; STIMULATING-HORMONE; METASTATIC PHENOTYPE; TUMORIGENIC ACTIVITY; CANCER-CELLS; EXPRESSION; ALPHA	Syndecan-2, a transmembrane heparan sulfate proteoglycan, is a critical mediator in the tumorigenesis of colon carcinoma cells. We explored the function of syndecan-2 in melanoma, one of the most invasive types of cancers, and found that the expression of this protein was elevated in tissue samples from both nevus and malignant human melanomas but not in melanocytes of the normal human skin tissues. Similarly, elevated syndecan-2 expression was observed in various melanoma cell lines. Overexpression of syndecan-2 enhanced migration and invasion of melanoma cells, whereas the opposite was observed when syndecan-2 levels were knocked down using small inhibitory RNAs. Syndecan-2 expression was enhanced by fibroblast growth factor-2, which is known to stimulate melanoma cell migration; however, alpha-melanocyte-stimulating hormone decreased syndecan-2 expression and melanoma cell migration and invasion in a melanin synthesis-independent manner. Furthermore, syndecan-2 overexpression rescued the migration defects induced by alpha-melanocyte-stimulating hormone treatment. Together, these data strongly suggest that syndecan-2 plays a crucial role in the migratory potential of melanoma cells.	[Lee, Jung-Hyun; Park, Haein; Chung, Heesung; Choi, Sojoong; Seong, Ikjoo; Kim, Jaesang; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kim, Younghwa] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; [Yoo, Hyun; Kim, Tae-Yoon] Catholic Univ Korea, Catholic Res Inst Med Sci, Seoul 137701, South Korea; [Hann, Hoo-Jae] Ewha Womans Univ, Coll Med, Dept Anat, Seoul 158710, South Korea; [Kang, Kathleen G.] Torrey Pines High Sch, San Diego, CA 92130 USA; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Inchon 402751, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	OhES@ewha.ac.kr	Lee, Jung-Hyun/AAL-2954-2021	Lee, Jung-Hyun/0000-0003-1913-0027	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A084292]	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (A084292).	Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bohm M, 2004, HAUTARZT, V55, P436, DOI 10.1007/s00105-004-0729-0; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Contreras HR, 2001, BIOCHEM BIOPH RES CO, V286, P742, DOI 10.1006/bbrc.2001.5459; DONATIEN P, 1993, ARCH DERMATOL RES, V285, P385, DOI 10.1007/BF00372130; Dorr RT, 2004, ARCH DERMATOL, V140, P827, DOI 10.1001/archderm.140.7.827; Fears CY, 2006, J BIOL CHEM, V281, P14533, DOI 10.1074/jbc.C600075200; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hauck CR, 2001, CANCER RES, V61, P7079; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Jayson GC, 1999, INT J CANCER, V82, P298, DOI 10.1002/(SICI)1097-0215(19990719)82:2<298::AID-IJC23>3.3.CO;2-0; KAMEYAMA K, 1990, INT J CANCER, V45, P1151, DOI 10.1002/ijc.2910450627; Kim Y, 2003, ONCOGENE, V22, P826, DOI 10.1038/sj.onc.1206068; Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; LIU PY, 1995, J DERMATOL SCI, V10, P203, DOI 10.1016/0923-1811(95)00405-H; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Meier F, 2003, EXP DERMATOL, V12, P296, DOI 10.1034/j.1600-0625.2003.120310.x; Modrowski D, 2000, J BIOL CHEM, V275, P9178, DOI 10.1074/jbc.275.13.9178; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Munesue S, 2002, BIOCHEM J, V363, P201, DOI 10.1042/0264-6021:3630201; Murata J, 1997, INVAS METAST, V17, P82; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; Nagahama M, 1998, BRIT J DERMATOL, V138, P981; Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221; OWENS LV, 1995, CANCER RES, V55, P2752; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Park H, 2005, CANCER RES, V65, P9899, DOI 10.1158/0008-5472.CAN-05-1386; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Sato K, 2008, BIOL PHARM BULL, V31, P33, DOI 10.1248/bpb.31.33; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sebestyen A, 2000, TUMOR BIOL, V21, P349, DOI 10.1159/000030140; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Zhu N, 2004, BRIT J CANCER, V90, P1457, DOI 10.1038/sj.bjc.6601698	43	63	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27167	27175		10.1074/jbc.M109.034678	http://dx.doi.org/10.1074/jbc.M109.034678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19641225	Green Published, hybrid			2022-12-25	WOS:000270232300017
J	Bossuyt, J; Despa, S; Han, F; Hou, ZJ; Robia, SL; Lingrel, JB; Bers, DM				Bossuyt, Julie; Despa, Sanda; Han, Fei; Hou, Zhanjia; Robia, Seth L.; Lingrel, Jerry B.; Bers, Donald M.			Isoform Specificity of the Na/K-ATPase Association and Regulation by Phospholemman	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; SITE-DIRECTED MUTAGENESIS; RAT VENTRICULAR MYOCYTES; PROTEIN-KINASE-C; CARDIAC MYOCYTES; ALPHA-SUBUNIT; PUMP FUNCTION; PHOSPHOLAMBAN OLIGOMERIZATION; HEART-FAILURE; SODIUM-PUMP	Phospholemman (PLM) phosphorylation mediates enhanced Na/K-ATPase (NKA) function during adrenergic stimulation of the heart. Multiple NKA isoforms exist, and their function/regulation may differ. We combined fluorescence resonance energy transfer (FRET) and functional measurements to investigate isoform specificity of the NKA-PLM interaction. FRET was measured as the increase in the donor fluorescence (CFP-NKA-alpha 1 or CFP-NKA-alpha 2) during progressive acceptor (PLM-YFP) photobleach in HEK-293 cells. Both pairs exhibited robust FRET (maximum of 23.6 +/- 3.4% for NKA-alpha 1 and 27.5 +/- 2.5% for NKA-alpha 2). Donor fluorescence depended linearly on acceptor fluorescence, indicating a 1: 1 PLM: NKA stoichiometry for both isoforms. PLM phosphorylation induced by cAMP-dependent protein kinase and protein kinase C activation drastically reduced the FRET with both NKA isoforms. However, submaximal cAMP-dependent protein kinase activation had less effect on PLM-NKA-alpha 2 versus PLM-NKA-alpha 1. Surprisingly, ouabain virtually abolished NKA-PLM FRET but only partially reduced co-immunoprecipitation. PLM-CFP also showed FRET to PLM-YFP, but the relationship during progressive photobleach was highly nonlinear, indicating oligomers involving >= 3 monomers. Using cardiac myocytes from wild-type mice and mice where NKA-alpha 1 is ouabain-sensitive and NKA-alpha 2 is ouabain-resistant, we assessed the effects of PLM phosphorylation on NKA-alpha 1 and NKA-alpha 2 function. Isoproterenol enhanced internal Na+ affinity of both isoforms (K-1/2 decreased from 18.1 +/- 2.0 to 11.5 +/- 1.9 mM for NKA-alpha 1 and from 16.4 +/- 2.5 to 10.4 +/- 1.5 mM for NKA-alpha 2) without altering maximum transport rate (V-max). Protein kinase C activation also decreased K-1/2 for both NKA-alpha 1 and NKA-alpha 2 (to 9.4 +/- 1.0 and 9.1 +/- 1.1 mM, respectively) but increased V-max only for NKA-alpha 2 (1.9 +/- 0.4 versus 1.2 +/- 0.5 mM/min). In conclusion, PLM associates with and modulates both NKA-alpha 1 and NKA-alpha 2 in a comparable but not identical manner.	[Bossuyt, Julie; Despa, Sanda; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Han, Fei] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Hou, Zhanjia; Robia, Seth L.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA; [Lingrel, Jerry B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of California System; University of California Davis; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; University System of Ohio; University of Cincinnati	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Genome Bldg 3511, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483; Bossuyt, Julie/0000-0001-8874-4765	National Institutes of Health [HL-30077, HL-81526]; American Heart Association [0735084N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064724, R37HL030077, R01HL106189, R01HL030077, R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-30077 and HL-81526 (to D. M. B.). This work was also supported by American Heart Association Grant 0735084N (to S. D.).	Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Chen LSK, 1997, GENOMICS, V41, P435, DOI 10.1006/geno.1997.4665; Clayton JC, 2005, BIOCHEMISTRY-US, V44, P17016, DOI 10.1021/bi0511383; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; DeSantiago J, 2002, J MOL CELL CARDIOL, V34, P975, DOI 10.1006/jmcc.2002.2034; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2002, CIRCULATION, V105, P2543, DOI 10.1161/01.CIR.0000016701.85760.97; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Gao J, 1999, J PHYSIOL-LONDON, V516, P377, DOI 10.1111/j.1469-7793.1999.0377v.x; HAN F, 2006, BIOPHYS J, V90, pA281; HAN F, 2008, BIOPHYS J, V94, pA144; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; HENSLEY CB, 1992, AM J PHYSIOL, V262, pC484, DOI 10.1152/ajpcell.1992.262.2.C484; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Ishizuka N, 1996, JPN J PHYSIOL, V46, P215, DOI 10.2170/jjphysiol.46.215; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Lindzen M, 2006, J BIOL CHEM, V281, P5947, DOI 10.1074/jbc.M512063200; McDonough AA, 1996, AM J PHYSIOL-CELL PH, V270, pC1221, DOI 10.1152/ajpcell.1996.270.4.C1221; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moseley AE, 2005, CELL PHYSIOL BIOCHEM, V15, P145, DOI 10.1159/000083647; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Wang JF, 2006, J BIOL CHEM, V281, P32004, DOI 10.1074/jbc.M606876200; Yamamoto T, 2005, J MOL CELL CARDIOL, V39, P113, DOI 10.1016/j.yjmcc.2005.03.023	50	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26749	26757		10.1074/jbc.M109.047357	http://dx.doi.org/10.1074/jbc.M109.047357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638348	Green Published, hybrid			2022-12-25	WOS:000269969600056
J	Bugreev, DV; Mazina, OM; Mazin, AV				Bugreev, Dmitry V.; Mazina, Olga M.; Mazin, Alexander V.			Bloom Syndrome Helicase Stimulates RAD51 DNA Strand Exchange Activity through a Novel Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID EXCHANGES; HOMOLOGOUS RECOMBINATION; BREAK REPAIR; BRANCH MIGRATION; RECQ HELICASES; BLM HELICASE; DROSOPHILA BLM; RESECT DNA; D-LOOPS; PROTEIN	Loss or inactivation of BLM, a helicase of the RecQ family, causes Bloom syndrome, a genetic disorder with a strong predisposition to cancer. Although the precise function of BLM remains unknown, genetic data has implicated BLM in the process of genetic recombination and DNA repair. Previously, we demonstrated that BLM can disrupt the RAD51-single-stranded DNA filament that promotes the initial steps of homologous recombination. However, this disruption occurs only if RAD51 is present in an inactive ADP-bound form. Here, we investigate interactions of BLM with the active ATP-bound form of the RAD51-single-stranded DNA filament. Surprisingly, we found that BLM stimulates DNA strand exchange activity of RAD51. In contrast to the helicase activity of BLM, this stimulation does not require ATP hydrolysis. These data suggest a novel BLM function that is stimulation of the RAD51 DNA pairing. Our results demonstrate the important role of the RAD51 nucleoprotein filament conformation in stimulation of DNA pairing by BLM.	[Bugreev, Dmitry V.; Mazina, Olga M.; Mazin, Alexander V.] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19102 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Mazin, AV (corresponding author), Drexel Univ, Dept Biochem & Mol Biol, Coll Med, 245 N 15th St,NCB,Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu			National Institutes of Health [CA100839, MH084119]; Leukemia and Lymphoma Society Scholar Award [1054-09]; NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839 and MH084119. This work was also supported by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.).	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bianco P R, 1998, Front Biosci, V3, pD570; Branzei D, 2007, GENE DEV, V21, P3019, DOI 10.1101/gad.1624707; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; BUGREEV DV, 2006, NAT PROT; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; CHAN KL, 2007, EMBO J; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; CHOW SA, 1985, P NATL ACAD SCI USA, V82, P5646, DOI 10.1073/pnas.82.17.5646; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Foiani M, 2003, NATURE, V423, P234, DOI 10.1038/423234a; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kikuchi K, 2009, J BIOL CHEM, V284, P26360, DOI 10.1074/jbc.M109.029348; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moens PB, 2000, J CELL SCI, V113, P663; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rossi MJ, 2008, J BIOL CHEM, V283, P24698, DOI 10.1074/jbc.M800839200; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Shim KS, 2004, J BIOL CHEM, V279, P30385, DOI 10.1074/jbc.M306066200; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Steiner WW, 1998, J BACTERIOL, V180, P6269; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	59	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26349	26359		10.1074/jbc.M109.029371	http://dx.doi.org/10.1074/jbc.M109.029371			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632996	Green Published, hybrid			2022-12-25	WOS:000269969600015
J	Sobeck, A; Stone, S; Landais, I; de Graaf, B; Hoatlin, ME				Sobeck, Alexandra; Stone, Stacie; Landais, Igor; de Graaf, Bendert; Hoatlin, Maureen E.			The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; XENOPUS EGG EXTRACTS; DNA-DAMAGE RESPONSE; CORE COMPLEX; ATR ACTIVATION; CHECKPOINT; REPLICATION; PHOSPHORYLATION; REPAIR; MONOUBIQUITINATION	Genomic stability requires a functional Fanconi anemia (FA) pathway composed of an upstream "core complex" (FA proteins A/B/C/E/F/G/L/M) that mediates monoubiquitination of the downstream targets FANCD2 and FANCI. Unique among FA core complex members, FANCM has processing activities toward replication-associated DNA structures, suggesting a vital role for FANCM during replication. Using Xenopus egg extracts, we analyzed the functions of FANCM in replication and the DNA damage response. xFANCM binds chromatin in a replication-dependent manner and is phosphorylated in response to DNA damage structures. Chromatin binding and DNA damage-induced phosphorylation of xFANCM are mediated in part by the downstream FA pathway protein FANCD2. Moreover, phosphorylation and chromatin recruitment of FANCM is regulated by two mayor players in the DNA damage response: the cell cycle checkpoint kinases ATR and ATM. Our results indicate that functions of FANCM are controlled by FA- and non-FA pathways in the DNA damage response.	[Sobeck, Alexandra; Stone, Stacie; Landais, Igor; de Graaf, Bendert; Hoatlin, Maureen E.] Oregon Hlth & Sci Univ, Dept Biochem, Portland, OR 97239 USA	Oregon Health & Science University	Hoatlin, ME (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem, 3181 SW Sam Jackson Pk Rd,Med Res Bldg,Rm 518, Portland, OR 97239 USA.	hoatlinm@ohsu.edu	Ittershagen, Stacie/X-7658-2019	Ittershagen, Stacie (Stone)/0000-0003-3834-176X	National Institutes of Health [HL007781, CA101690, CA112775]; American Heart Association [0725942Z]; Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE [T32CA101690, R01CA112775] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL007781 ( to S. S.), CA101690 ( to I. L.), and CA112775 ( to M. E. H.). This work was also supported by American Heart Association Grant 0725942Z ( to A. S.) and by the Fanconi Anemia Research Fund ( to M. E. H.).	Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Bomgarden RD, 2004, J BIOL CHEM, V279, P13346, DOI 10.1074/jbc.M311098200; Centurion SA, 2000, EXP CELL RES, V260, P216, DOI 10.1006/excr.2000.4995; Cimprich KA, 2007, CELL CYCLE, V6, P2348, DOI 10.4161/cc.6.19.4755; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Freie BW, 2004, J BIOL CHEM, V279, P50986, DOI 10.1074/jbc.M407160200; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Gregory RC, 2003, SEMIN CANCER BIOL, V13, P77, DOI 10.1016/S1044-579X(02)00102-5; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Kee Y, 2009, GENE DEV, V23, P555, DOI 10.1101/gad.1761309; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lupardus PJ, 2007, METHODS, V41, P222, DOI 10.1016/j.ymeth.2006.07.024; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Rosselli F, 2003, BIOCHIMIE, V85, P1175, DOI 10.1016/j.biochi.2003.11.002; Sala-Trepat M, 2000, EXP CELL RES, V260, P208, DOI 10.1006/excr.2000.4994; Shechter D, 2005, CELL CYCLE, V4, P235; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2007, MOL CELL BIOL, V27, P4283, DOI 10.1128/MCB.02196-06; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25560	25568		10.1074/jbc.M109.007690	http://dx.doi.org/10.1074/jbc.M109.007690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633289	hybrid, Green Published			2022-12-25	WOS:000269738000013
J	Derler, I; Fahrner, M; Muik, M; Lackner, B; Schindl, R; Groschner, K; Romanin, C				Derler, Isabella; Fahrner, Marc; Muik, Martin; Lackner, Barbara; Schindl, Rainer; Groschner, Klaus; Romanin, Christoph			A Ca2+ Release-activated Ca2+ (CRAC) Modulatory Domain (CMD) within STIM1 Mediates Fast Ca2+-dependent Inactivation of ORAI1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CALCIUM SENSOR; T-LYMPHOCYTES; EF-HAND; ENTRY; PERMEATION; DEPLETION; CELLS; SELECTIVITY	STIM1 and ORAI1, the two limiting components in the Ca2+ release-activated Ca2+ (CRAC) signaling cascade, have been reported to interact upon store depletion, culminating in CRAC current activation. We have recently identified a modulatory domain between amino acids 474 and 485 in the cytosolic part of STIM1 that comprises 7 negatively charged residues. A STIM1 C-terminal fragment lacking this domain exhibits enhanced interaction with ORAI1 and 2-3-fold higher ORAI1/CRAC current densities. Here we focused on the role of this CRAC modulatory domain (CMD) in the fast inactivation of ORAI1/CRAC channels, utilizing the whole-cell patch clamp technique. STIM1 mutants either with C-terminal deletions including CMD or with 7 alanines replacing the negative amino acids within CMD gave rise to ORAI1 currents that displayed significantly reduced or even abolished inactivation when compared with STIM1 mutants with preserved CMD. Consistent results were obtained with cytosolic C-terminal fragments of STIM1, both in ORAI1-expressing HEK 293 cells and in RBL-2H3 mast cells containing endogenous CRAC channels. Inactivation of the latter, however, was much more pronounced than that of ORAI1. The extent of inactivation of ORAI3 channels, which is also considerably more prominent than that of ORAI1, was also substantially reduced by co-expression of STIM1 constructs missing CMD. Regarding the dependence of inactivation on Ca2+, a decrease in intracellular Ca2+ chelator concentrations promoted ORAI1 current fast inactivation, whereas Ba2+ substitution for extracellular Ca2+ completely abrogated it. In summary, CMD within the STIM1 cytosolic part provides a negative feedback signal to Ca2+ entry by triggering fast Ca2+-dependent inactivation of ORAI/CRAC channels.	[Derler, Isabella; Fahrner, Marc; Muik, Martin; Lackner, Barbara; Schindl, Rainer; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	christoph.romanin@jku.at	Groschner, Klaus/A-2550-2010; Fahrner, Marc/AAI-7927-2021; Derler, Isabella/B-7871-2019; Romanin, Christoph/D-5399-2009; Schindl, Rainer/E-3959-2013; Schindl, Rainer/V-4205-2019	Groschner, Klaus/0000-0002-8659-377X; Derler, Isabella/0000-0002-4768-146X; Romanin, Christoph/0000-0003-3756-4136; Schindl, Rainer/0000-0003-0896-8887; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Foundation (FWF) [P19820];  [P21118];  [W1201]	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); ; 	This work was supported by the Austrian Science Foundation (FWF) Project P19820 (to K. G.) and Project P21118 as well as Subproject 11 within W1201 (to C. R.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	39	94	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24933	24938		10.1074/jbc.C109.024083	http://dx.doi.org/10.1074/jbc.C109.024083			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19622747	Green Published, hybrid			2022-12-25	WOS:000269734000027
J	Li, YJ; Bolderson, E; Kumar, R; Muniandy, PA; Xue, YT; Richard, DJ; Seidman, M; Pandita, TK; Khanna, KK; Wang, WD				Li, Yongjiang; Bolderson, Emma; Kumar, Rakesh; Muniandy, Parameswary A.; Xue, Yutong; Richard, Derek J.; Seidman, Michael; Pandita, Tej K.; Khanna, Kum Kum; Wang, Weidong			hSSB1 and hSSB2 Form Similar Multiprotein Complexes That Participate in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; BLOOMS-SYNDROME PROTEIN; RNA-POLYMERASE-II; TOPOISOMERASE-I; FANCONI-ANEMIA; RAD52 PROTEIN; BINDING; REPAIR; STABILITY	hSSB1 (human single strand DNA-binding protein 1) has been shown to participate in homologous recombination (HR)dependent repair of DNA double strand breaks (DSBs) and ataxia telangiectasia-mutated (ATM)-mediated checkpoint pathways. Here we present evidence that hSSB2, a homolog of hSSB1, plays a role similar to hSSB1 in DNA damage-response pathways. This was evidenced by findings that hSSB2-depleted cells resemble hSSB1-depleted cells in hypersensitivity to DNA-damaging reagents, reduced efficiency in HR-dependent repair of DSBs, and defective ATM-dependent phosphorylation. Notably, hSSB1 and hSSB2 form separate complexes with two identical proteins, INTS3 and hSSBIP1 (C9ORF80). Cells depleted of INTS3 and hSSBIP1 also exhibited hypersensitivity to DNA damage reagents, chromosomal instability, and reduced ATM-dependent phosphorylation. hSSBIP1 was rapidly recruited to laser-induced DSBs, a feature also similar to that reported for hSSB1. Depletion of INTS3 decreased the stability of hSSB1 and hSSBIP1, suggesting that INTS3 may provide a scaffold to allow proper assembly of the hSSB complexes. Thus, our data demonstrate that hSSB1 and hSSB2 form two separate complexes with similar structures, and both are required for efficient HR-dependent repair of DSBs and ATM-dependent signaling pathways.	[Li, Yongjiang; Xue, Yutong; Wang, Weidong] NIA, Genet Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Muniandy, Parameswary A.; Seidman, Michael] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Bolderson, Emma; Richard, Derek J.; Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia; [Kumar, Rakesh; Pandita, Tej K.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); QIMR Berghofer Medical Research Institute; Washington University (WUSTL)	Wang, WD (corresponding author), 251 Bayview Blvd,Rm 10B113, Baltimore, MD 21224 USA.	wangw@grc.nia.nih.gov	Richard, Derek/J-1338-2012; Bolderson, Emma/B-8743-2013; Wang, Weidong/AAV-2446-2021; Khanna, Kum Kum/I-1747-2013; Pandita, Tej K/AAM-9188-2020	Richard, Derek/0000-0002-4839-8471; kumar, rakesh/0000-0002-0741-3663; Bolderson, Emma/0000-0002-2849-1177; Wang, Weidong/0000-0002-0658-7928; Khanna, Kum Kum/0000-0001-8650-5381	National Institutes of Health [Z01: AG000657-09]; National Institute on Aging and National Institutes of Health [CA123232, CA129537]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE ON AGING [ZIAAG000746, ZIAAG000747, ZIAAG000661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging and National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01: AG000657-09 from the Intramural Research Program of the National Institute on Aging and National Institutes of Health Grants CA123232 and CA129537 (to T. K. P.). This work was also supported by a grant from the National Health and Medical Research Council of Australia (to K. K. K.).	Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Inagaki Y, 2008, CANCER GENET CYTOGEN, V180, P30, DOI 10.1016/j.cancergencyto.2007.09.013; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Uguen P, 2003, EMBO J, V22, P4544, DOI 10.1093/emboj/cdg430; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	29	76	85	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23525	23531		10.1074/jbc.C109.039586	http://dx.doi.org/10.1074/jbc.C109.039586			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19605351	Green Published, hybrid			2022-12-25	WOS:000269180000037
J	Sen Sarma, M; Rodriguez-Zas, SL; Hong, F; Zhong, S; Robinson, GE				Sen Sarma, Moushumi; Rodriguez-Zas, Sandra L.; Hong, Feng; Zhong, Sheng; Robinson, Gene E.			Transcriptomic Profiling of Central Nervous System Regions in Three Species of Honey Bee during Dance Communication Behavior	PLOS ONE			English	Article								Background: We conducted a large-scale transcriptomic profiling of selected regions of the central nervous system (CNS) across three species of honey bees, in foragers that were performing dance behavior to communicate to their nestmates the location, direction and profitability of an attractive floral resource. We used microarrays to measure gene expression in bees from Apis mellifera, dorsata and florea, species that share major traits unique to the genus and also show striking differences in biology and dance communication. The goals of this study were to determine the extent of regional specialization in gene expression and to explore the molecular basis of dance communication. Principal Findings: This "snapshot'' of the honey bee CNS during dance behavior provides strong evidence for both species-consistent and species-specific differences in gene expression. Gene expression profiles in the mushroom bodies consistently showed the biggest differences relative to the other CNS regions. There were strong similarities in gene expression between the central brain and the second thoracic ganglion across all three species; many of the genes were related to metabolism and energy production. We also obtained gene expression differences between CNS regions that varied by species: A. mellifera differed the most, while dorsata and florea tended to be more similar. Significance: Species differences in gene expression perhaps mirror known differences in nesting habit, ecology and dance behavior between mellifera, florea and dorsata. Species-specific differences in gene expression in selected CNS regions that relate to synaptic activity and motor control provide particularly attractive candidate genes to explain the differences in dance behavior exhibited by these three honey bee species. Similarities between central brain and thoracic ganglion provide a unique perspective on the potential coupling of these two motor-related regions during dance behavior and perhaps provide a snapshot of the energy intensive process of dance output generation. Mushroom body results reflect known roles for this region in the regulation of learning, memory and rhythmic behavior.			Sen Sarma, M (corresponding author), Univ Illinois, Neurosci Program, Inst Genom Biol, Urbana, IL 61801 USA.	moushumi@life.illinois.edu		Rodriguez-Zas, Sandra/0000-0003-1122-4758	NIGMS NIH HHS [R01 GM068946, 5 R01 GM068946] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], ARRAYEXPRESS; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Brockmann A, 2007, BRAIN BEHAV EVOLUT, V70, P125, DOI 10.1159/000102974; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Cash AC, 2005, GENES BRAIN BEHAV, V4, P267, DOI 10.1111/j.1601-183X.2005.00131.x; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; DYER FC, 1991, ECOLOGY, V72, P156, DOI 10.2307/1938911; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; ERBER J, 1978, PHYSIOL ENTOMOL, V3, P77, DOI 10.1111/j.1365-3032.1978.tb00137.x; Farris SM, 2008, BRAIN BEHAV EVOLUT, V72, P1, DOI 10.1159/000139457; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Gronenberg W, 2004, ACTA BIOL HUNG, V55, P31, DOI 10.1556/ABiol.55.2004.1-4.5; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Hammock EAD, 2007, ADV GENET, V59, P107, DOI 10.1016/S0065-2660(07)59004-8; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; Heinrich R, 1997, J COMP PHYSIOL A, V180, P257, DOI 10.1007/s003590050046; Heinrich R, 2001, J COMP PHYSIOL A, V187, P155, DOI 10.1007/s003590100188; HOMBERG U, 1985, J INSECT PHYSIOL, V31, P251, DOI 10.1016/0022-1910(85)90127-1; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Jander U, 2002, ARTHROPOD STRUCT DEV, V30, P179, DOI 10.1016/S1467-8039(01)00035-4; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Komischke B, 2005, EUR J NEUROSCI, V21, P477, DOI 10.1111/j.1460-9568.2005.03879.x; Locatelli F, 2005, J NEUROSCI, V25, P11614, DOI 10.1523/JNEUROSCI.3180-05.2005; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Michel M, 2008, LEARN MEMORY, V15, P694, DOI 10.1101/lm.1088408; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Muller U, 1999, MICROSC RES TECHNIQ, V45, P165; Mustard JA, 2005, J COMP NEUROL, V483, P66, DOI 10.1002/cne.20420; Okada R, 2003, J COMP NEUROL, V458, P158, DOI 10.1002/cne.10580; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Oldroyd BP, 2006, ASIAN HONEY BEES BIO; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Paul RK, 2006, ZOOL SCI, V23, P1085, DOI 10.2108/zsj.23.1085; Popov AV, 2004, J EVOL BIOCHEM PHYS+, V40, P641, DOI 10.1007/s10893-004-0005-z; Raffiudin R, 2007, MOL PHYLOGENET EVOL, V43, P543, DOI 10.1016/j.ympev.2006.10.013; Roeder T, 2004, INVERTEBR NEUROSCI, V5, P77, DOI 10.1007/s10158-004-0030-z; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Sakura M, 2008, J NEUROPHYSIOL, V99, P667, DOI 10.1152/jn.00784.2007; Sen Sarma M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-202; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Smith LA, 1998, GENETICS, V149, P1407; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sunkin SM, 2007, HUM MOL GENET, V16, pR209, DOI 10.1093/hmg/ddm183; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; Takeuchi H, 2007, ZOOL SCI, V24, P596, DOI 10.2108/zsj.24.596; VARELA FG, 1970, J ULTRA MOL STRUCT R, V31, P178, DOI 10.1016/S0022-5320(70)90153-X; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wenzel B, 2005, J COMP NEUROL, V488, P129, DOI 10.1002/cne.20600; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WIITANEN W, 1973, J NEUROPHYSIOL, V36, P1080, DOI 10.1152/jn.1973.36.6.1080; WU H, 2003, ANAL GENE EXPRESSION; Zheng H, 2008, J BIOL RHYTHM, V23, P283, DOI 10.1177/0748730408318566	71	33	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6408	10.1371/journal.pone.0006408	http://dx.doi.org/10.1371/journal.pone.0006408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641619	gold, Green Published, Green Submitted			2022-12-25	WOS:000268494500009
J	von Haehling, S; Schefold, JC; Jankowska, E; Doehner, W; Springer, J; Strohschein, K; Genth-Zotz, S; Volk, HD; Poole-Wilson, P; Anker, SD				von Haehling, Stephan; Schefold, Joerg C.; Jankowska, Ewa; Doehner, Wolfram; Springer, Jochen; Strohschein, Kristin; Genth-Zotz, Sabine; Volk, Hans-Dieter; Poole-Wilson, Philip; Anker, Stefan D.			Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure	PLOS ONE			English	Article								Background: Overproduction of pro-inflammatory cytokines is a well established factor in the progression of chronic heart failure (CHF). Changes in cellular immunity have not been widely studied, and the impact of standard medication is uncertain. Here we investigate whether a leukocyte redistribution occurs in CHF and whether this effect is influenced by beta-blocker therapy. Methodology: We prospectively studied 75 patients with systolic CHF (age: 68 +/- 11 years, left ventricular ejection fraction 32 +/- 11%, New York Heart Association class 2.5 +/- 0.7) and 20 age-matched healthy control subjects ( age: 63 +/- 10 years). We measured the response of cells to endotoxin exposure in vitro, analysed subsets of lymphocytes using flow cytometry, and assessed plasma levels of the pro-inflammatory markers interleukin 1, 6, tumor necrosis factor-alpha, and soluble tumor necrosis factor receptors 1 and 2. Principal findings: While no differences in the number of leukocytes were noted between patients with CHF and healthy controls, we detected relative lymphopenia in patients with CHF (p < 0.001 vs. control), mostly driven by reductions in T helper cells and B cells (both p < 0.05). The number of neutrophils was increased (p < 0.01). These effects were pronounced in patients who were beta-blocker naive (32% of all patients with CHF). Increased plasma levels of soluble tumor necrosis receptor-1 correlated with the relative number of lymphocyte subsets. Conclusions: In patients with CHF, we detected a redistribution of leukocyte subsets, i.e. an increase in neutrophils with relative lymphopenia. These effects were pronounced in patients who were beta-blocker naive. The underlying mechanism remains to be elucidated.			von Haehling, S (corresponding author), Charite Univ Med Berlin, Dept Cardiol, Campus Virchow Clin, Berlin, Germany.	stephan.von.haehling@web.de	Jankowska, Ewa A/G-7960-2011; volk, hans-dieter/AAV-8053-2021; Jankowska, Ewa A/AAY-3040-2020; Jankowska, Ewa/ABD-4073-2021	volk, hans-dieter/0000-0002-7743-6668; Jankowska, Ewa A/0000-0002-9202-432X; Doehner, Wolfram/0000-0001-7598-708X; Schefold, Joerg C./0000-0001-9162-5724				ABRAHAM WT, 1990, CLIN SCI, V79, P429, DOI 10.1042/cs0790429; Anker SD, 1998, EUR HEART J, V19, pF56; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; BERKENBOSCH F, 1989, NEUROENDOCRINOLOGY, V50, P570, DOI 10.1159/000125283; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Deswal A, 2001, CIRCULATION, V103, P2055; Dibbs Z, 1999, J AM COLL CARDIOL, V33, P1935, DOI 10.1016/S0735-1097(99)00130-8; Doehner W, 2002, INT J CARDIOL, V83, P73, DOI 10.1016/S0167-5273(02)00022-0; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; ERIKSSON B, 1977, SCAND J HAEMATOL, V18, P121; Kinugawa T, 2002, CIRC J, V66, P261, DOI 10.1253/circj.66.261; MAISEL AS, 1989, CLIN PHARMACOL THER, V46, P429, DOI 10.1038/clpt.1989.161; MAISEL AS, 1990, J CLIN INVEST, V85, P462, DOI 10.1172/JCI114460; MAISEL AS, 1990, BRIT J CLIN PHARMACO, V30, pS49, DOI 10.1111/j.1365-2125.1990.tb05468.x; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Meldrum DR, 1999, J SURG RES, V85, P185, DOI 10.1006/jsre.1999.5660; von Haehling S, 2005, AM J CARDIOL, V95, P885, DOI 10.1016/j.amjcard.2004.12.022; von Haehling S, 2005, EXPERT OPIN INV DRUG, V14, P163, DOI 10.1517/13543784.14.2.163; von Haehling Stephan, 2008, Heart Fail Clin, V4, P141, DOI 10.1016/j.hfc.2008.01.009; YU DTY, 1976, CLIN EXP IMMUNOL, V25, P472	21	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6411	10.1371/journal.pone.0006411	http://dx.doi.org/10.1371/journal.pone.0006411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641622	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500012
J	Maertens, GN; El Messaoudi-Aubert, S; Racek, T; Stock, JK; Nicholls, J; Rodriguez-Niedenfuhr, M; Gil, J; Peters, G				Maertens, Goedele N.; El Messaoudi-Aubert, Selma; Racek, Tomas; Stock, Julie K.; Nicholls, James; Rodriguez-Niedenfuehr, Marc; Gil, Jesus; Peters, Gordon			Several Distinct Polycomb Complexes Regulate and Co-Localize on the INK4a Tumor Suppressor Locus	PLOS ONE			English	Article								Misexpression of Polycomb repressive complex 1 (PRC1) components in human cells profoundly influences the onset of cellular senescence by modulating transcription of the INK4a tumor suppressor gene. Using tandem affinity purification, we find that CBX7 and CBX8, two Polycomb (Pc) homologs that repress INK4a, both participate in PRC1-like complexes with at least two Posterior sex combs (Psc) proteins, MEL18 and BMI1. Each complex contains a single representative of the Pc and Psc families. In primary human fibroblasts, CBX7, CBX8, MEL18 and BMI1 are present at the INK4a locus and shRNA-mediated knockdown of any one of these components results in de-repression of INK4a and proliferative arrest. Sequential chromatin immunoprecipitation (ChIP) reveals that CBX7 and CBX8 bind simultaneously to the same region of chromatin and knockdown of one of the Pc or Psc proteins results in release of the other, suggesting that the binding of PRC1 complexes is interdependent. Our findings provide the first evidence that a single gene can be regulated by several distinct PRC1 complexes and raise important questions about their configuration and relative functions.			Maertens, GN (corresponding author), London Res Inst, Canc Res UK, London, England.	gordon.peters@cancer.org.uk	Gil, Jesus/C-7739-2012; Maertens, Goedele/D-8628-2015	Gil, Jesus/0000-0002-4303-6260; Maertens, Goedele/0000-0002-1963-8026	Cancer Research UK Funding Source: Medline; Medical Research Council [MC_U120085810] Funding Source: Medline; MRC [MC_U120085810] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akasaka T, 1996, DEVELOPMENT, V122, P1513; Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Ali JY, 2004, MOL CELL BIOL, V24, P7737, DOI 10.1128/MCB.24.17.7737-7747.2004; Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Calses C, 2008, MOL CELL BIOL, V28, P1018, DOI 10.1128/MCB.01136-07; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Miki J, 2007, GENES CELLS, V12, P1371, DOI 10.1111/j.1365-2443.2007.01135.x; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruas M, 1999, ONCOGENE, V18, P5423, DOI 10.1038/sj.onc.1202918; Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tetsu O, 1998, IMMUNITY, V9, P439, DOI 10.1016/S1074-7613(00)80627-5; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; TOLHUIS B, 2006, NAT GENET; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	72	81	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6380	10.1371/journal.pone.0006380	http://dx.doi.org/10.1371/journal.pone.0006380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636380	gold, Green Published, Green Submitted			2022-12-25	WOS:000268404900010
J	Poptsova, MS; Larionov, SA; Ryadchenko, EV; Rybalko, SD; Zakharov, IA; Loskutov, A				Poptsova, Maria S.; Larionov, Sergei A.; Ryadchenko, Eugeny V.; Rybalko, Sergei D.; Zakharov, Ilya A.; Loskutov, Alexander			Hidden Chromosome Symmetry: In Silico Transformation Reveals Symmetry in 2D DNA Walk Trajectories of 671 Chromosomes	PLOS ONE			English	Article							ASYMMETRIC SUBSTITUTION PATTERNS; STRAND ASYMMETRIES; BASE-COMPOSITION; MESSENGER-RNA; REPLICATION ORIENTATION; BIDIRECTIONAL PROMOTERS; COMPARATIVE GENOMICS; MAMMALIAN GENOMES; EVOLUTION; TRANSCRIPTION	Maps of 2D DNA walk of 671 examined chromosomes show composition complexity change from symmetrical half-turn in bacteria to pseudo-random trajectories in archaea, fungi and humans. In silico transformation of gene order and strand position returns most of the analyzed chromosomes to a symmetrical bacterial-like state with one transition point. The transformed chromosomal sequences also reveal remarkable segmental compositional symmetry between regions from different strands located equidistantly from the transition point. Despite extensive chromosome rearrangement the relation of gene numbers on opposite strands for chromosomes of different taxa varies in narrow limits around unity with Pearson coefficient r = 0.98. Similar relation is observed for total genes' length (r = 0.86) and cumulative GC (r = 0.95) and AT (r = 0.97) skews. This is also true for human coding sequences (CDS), which comprise only several percent of the entire chromosome length. We found that frequency distributions of the length of gene clusters, continuously located on the same strand, have close values for both strands. Eukaryotic gene distribution is believed to be non-random. Contribution of different subsystems to the noted symmetries and distributions, and evolutionary aspects of symmetry are discussed.			Poptsova, MS (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	maria.poptsova@gmail.com	Poptsova, Maria/G-6985-2014	Poptsova, Maria/0000-0002-7198-8234; RYBALKO, Sergei/0000-0003-0084-2067				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Bailly-Bechet M, 2006, PLOS COMPUT BIOL, V2, P263, DOI 10.1371/journal.pcbi.0020037; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; CHARGAFF E, 1951, J CELL COMPAR PHYSL, V38, P41, DOI 10.1002/jcp.1030380406; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Di Giulio M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-37; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Eisen JA, 2000, GENOME BIOL, V1; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Fairhead C, 2006, FEMS YEAST RES, V6, P428, DOI 10.1111/j.1567-1364.2006.00033.x; Forsdyke Donald R, 2004, Appl Bioinformatics, V3, P3; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; Frank AC, 2000, BIOINFORMATICS, V16, P560, DOI 10.1093/bioinformatics/16.6.560; GATES MA, 1985, NATURE, V316, P219, DOI 10.1038/316219a0; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Gutierrez G, 1996, NUCLEIC ACIDS RES, V24, P2525, DOI 10.1093/nar/24.13.2525; Hermsen R, 2008, TRENDS GENET, V24, P216, DOI 10.1016/j.tig.2008.02.004; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Koonin EV, 2009, INT J BIOCHEM CELL B, V41, P298, DOI 10.1016/j.biocel.2008.09.015; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; LAGUNEZOTERO J, 1992, J BIOMOL STRUCT DYN, V10, P455, DOI 10.1080/07391102.1992.10508662; LAGUNEZOTERO J, 1993, TRENDS BIOCHEM SCI, V18, P406, DOI 10.1016/0968-0004(93)90134-9; Lao PJ, 2000, GENOME RES, V10, P228, DOI 10.1101/gr.10.2.228; Larionov S, 2008, CHAOS, V18, DOI 10.1063/1.2826631; Lercher MJ, 2006, J MOL BIOL, V359, P825, DOI 10.1016/j.jmb.2006.03.051; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Lobry JR, 2002, GENOME BIOL, V3; Lobry JR, 1996, BIOCHIMIE, V78, P323, DOI 10.1016/0300-9084(96)84764-X; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lundgren M, 2004, P NATL ACAD SCI USA, V101, P7046, DOI 10.1073/pnas.0400656101; Mugal CF, 2009, MOL BIOL EVOL, V26, P131, DOI 10.1093/molbev/msn245; Necsulea A, 2007, MOL BIOL EVOL, V24, P2169, DOI 10.1093/molbev/msm148; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Nikolaou C, 2005, NUCLEIC ACIDS RES, V33, P6816, DOI 10.1093/nar/gki988; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Rucklidge W., 1996, EFFICIENT VISUAL REC; RUDNER R, 1968, P NATL ACAD SCI USA, V60, P921, DOI 10.1073/pnas.60.3.921; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Sukhodolets V. V., 2001, Genetika, V37, P591; SZYBALSKI W, 1966, COLD SPRING HARB SYM, V31, P123, DOI 10.1101/SQB.1966.031.01.019; Tillier ERM, 2000, J MOL EVOL, V51, P459, DOI 10.1007/s002390010108; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Touchon M, 2003, FEBS LETT, V555, P579, DOI 10.1016/S0014-5793(03)01306-1; TRIFONOV EN, 1987, J MOL BIOL, V194, P643, DOI 10.1016/0022-2836(87)90241-5; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Wegel E, 2005, CHROMOSOMA, V114, P331, DOI 10.1007/s00412-005-0015-7; Wolfe KH, 2006, PHILOS T ROY SOC B, V361, P403, DOI 10.1098/rstb.2005.1799; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; ZIPKAS D, 1975, P NATL ACAD SCI USA, V72, P1354, DOI 10.1073/pnas.72.4.1354; NATURE, V431, P931	69	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6396	10.1371/journal.pone.0006396	http://dx.doi.org/10.1371/journal.pone.0006396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636424	Green Published, gold, Green Submitted			2022-12-25	WOS:000268404900017
J	Amaral-Zettler, LA; McCliment, EA; Ducklow, HW; Huse, SM				Amaral-Zettler, Linda A.; McCliment, Elizabeth A.; Ducklow, Hugh W.; Huse, Susan M.			A Method for Studying Protistan Diversity Using Massively Parallel Sequencing of V9 Hypervariable Regions of Small-Subunit Ribosomal RNA Genes	PLOS ONE			English	Article							POPULATION-SIZE; SERIAL ANALYSIS; ECOSYSTEMS; QUALITY	Background: Massively parallel pyrosequencing of amplicons from the V6 hypervariable regions of small-subunit (SSU) ribosomal RNA (rRNA) genes is commonly used to assess diversity and richness in bacterial and archaeal populations. Recent advances in pyrosequencing technology provide read lengths of up to 240 nucleotides. Amplicon pyrosequencing can now be applied to longer variable regions of the SSU rRNA gene including the V9 region in eukaryotes. Methodology/Principal Findings: We present a protocol for the amplicon pyrosequencing of V9 regions for eukaryotic environmental samples for biodiversity inventories and species richness estimation. The International Census of Marine Microbes (ICoMM) and the Microbial Inventory Research Across Diverse Aquatic Long Term Ecological Research Sites (MIRADA-LTERs) projects are already employing this protocol for tag sequencing of eukaryotic samples in a wide diversity of both marine and freshwater environments. Conclusions/Significance: Massively parallel pyrosequencing of eukaryotic V9 hypervariable regions of SSU rRNA genes provides a means of estimating species richness from deeply-sampled populations and for discovering novel species from the environment.			Amaral-Zettler, LA (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA.	amaral@mbl.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012742] Funding Source: NIH RePORTER; Directorate For Geosciences [0911031] Funding Source: National Science Foundation; NIEHS NIH HHS [1 P50 ES012742-01, P50 ES012742] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amaral-Zettler Linda, 2008, Syst Appl Microbiol, V31, P258, DOI 10.1016/j.syapm.2008.08.004; [Anonymous], 2003, PROGRAM SPADE SPECIE; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kysela DT, 2005, ENVIRON MICROBIOL, V7, P356, DOI 10.1111/j.1462-2920.2004.00712.x; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Neufeld JD, 2004, ENVIRON MICROBIOL, V6, P131, DOI 10.1046/j.1462-2920.2003.00547.x; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; PACE NR, 1985, ASM NEWS, V51, P4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sinigalliano CD, 2007, P NATL ACAD SCI USA, V104, P9029, DOI 10.1073/pnas.0610552104; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	20	596	617	11	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6372	10.1371/journal.pone.0006372	http://dx.doi.org/10.1371/journal.pone.0006372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633714	Green Published, gold			2022-12-25	WOS:000268404800008
J	Chen, CG; Kuehn, C; Bretzel, RG; Linn, T				Chen, Chunguang; Kuehn, Carina; Bretzel, Reinhard G.; Linn, Thomas			Anti-Inflammatory Thalidomide Improves Islet Grafts Survival and Functions in a Xenogenic Environment	PLOS ONE			English	Article								Thalidomide possesses both anti-inflammatory and anti-angiogenic properties. This study investigates its potential application in islet transplantation with a xenogenic transplantation model. Transplantation was performed using C57Bl/6 mice and NMRI nu/nu mice as recipients of porcine islets. Moreover, islet graft vasculature and inflammation were investigated to identify the mechanisms of thalidomide action. In the immunocompetent environment of C57Bl/6 mice, a fast graft rejection was observed. The group treated with thalidomide 200 mg/kg BW per day achieved and maintained euglycemia in the complete observation period for 42 days. The treated mice had more functional islet graft mass with less leukocyte infiltration. The pro-inflammatory TNF-alpha and VEGF content in islet grafted kidneys was significantly lowered by the treatment. By comparison, thalidomide was not effective in improving graft survival in immunocompromised nude mice. It strongly inhibited the VEGF and TNF-alpha-induced endothelial proliferation of isolated pig islets in a dose dependent manner. The magnitude of thalidomide's inhibitory effect was nearly identical to the effect of VEGF- receptor 2 inhibitor SU416 and anti-TNF-receptor 1 neutralizing antibody, and was reversed by sphingosine-1-phosphate. In conclusion, the anti-inflammatory effect of thalidomide improved islet graft survival and function in a transplantation model with a maximum immune barrier.			Chen, CG (corresponding author), Univ Giessen, Med Clin & Policlin 3, Giessen, Germany.	thomas.linn@innere.med.uni-giessen.de						Barshes NR, 2004, TRANSPL P, V36, P1127, DOI 10.1016/j.transproceed.2004.04.057; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bennet W, 2000, TRANSPLANTATION, V69, P711; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; Brandhorst H, 1999, TRANSPLANTATION, V68, P355, DOI 10.1097/00007890-199908150-00006; Carlsson PO, 2002, CELL TRANSPLANT, V11, P813; Cattan P, 2001, TRANSPLANTATION, V71, P857, DOI 10.1097/00007890-200104150-00006; Chandrasekar B, 2001, CIRCULATION, V103, P2296; Contreras JL, 2003, AM J TRANSPLANT, V3, P128, DOI 10.1034/j.1600-6143.2003.00031.x; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Goss JA, 2002, TRANSPLANTATION, V74, P1761, DOI 10.1097/01.TP.0000038968.06766.D6; Goto M, 2004, XENOTRANSPLANTATION, V11, P195, DOI 10.1046/j.1399-3089.2003.00107.x; Hanley S, 2006, TRANSPLANTATION, V82, P813, DOI 10.1097/01.tp.0000234787.05789.23; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Keifer JA, 2001, J BIOL CHEM, V276, P22382, DOI 10.1074/jbc.M100938200; Kirchhof N, 2004, XENOTRANSPLANTATION, V11, P396, DOI 10.1111/j.1399-3089.2004.00157.x; Korsgren O, 2005, TRANSPLANTATION, V79, P1289, DOI 10.1097/01.TP.0000157273.60147.7C; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x; Linn T, 2003, FASEB J, V17, P881, DOI 10.1096/fj.02-0615fje; Lundgren T, 2001, TRANSPLANT P, V33, P725, DOI 10.1016/S0041-1345(00)02800-1; Malleo G, 2008, SHOCK, V29, P89, DOI 10.1097/shk.0b013e318067df68; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Moberg L, 2005, CLIN EXP IMMUNOL, V142, P125, DOI 10.1111/j.1365-2249.2005.02883.x; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Rajashekhar G, 2006, J VASC RES, V43, P193, DOI 10.1159/000090949; Robinson SD, 2004, ARTERIOSCL THROM VAS, V24, P2108, DOI 10.1161/01.ATV.0000143857.27408.de; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yildirim ND, 2007, JPN J CLIN ONCOL, V37, P704, DOI 10.1093/jjco/hym092	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6312	10.1371/journal.pone.0006312	http://dx.doi.org/10.1371/journal.pone.0006312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617916	gold, Green Submitted, Green Published			2022-12-25	WOS:000268119600009
J	Lee, MS; Bondugula, R; Desai, V; Zavaljevski, N; Yeh, IC; Wallqvist, A; Reifman, J				Lee, Michael S.; Bondugula, Rajkumar; Desai, Valmik; Zavaljevski, Nela; Yeh, In-Chul; Wallqvist, Anders; Reifman, Jaques			PSPP: A Protein Structure Prediction Pipeline for Computing Clusters	PLOS ONE			English	Article								Background: Protein structures are critical for understanding the mechanisms of biological systems and, subsequently, for drug and vaccine design. Unfortunately, protein sequence data exceed structural data by a factor of more than 200 to 1. This gap can be partially filled by using computational protein structure prediction. While structure prediction Web servers are a notable option, they often restrict the number of sequence queries and/or provide a limited set of prediction methodologies. Therefore, we present a standalone protein structure prediction software package suitable for high-throughput structural genomic applications that performs all three classes of prediction methodologies: comparative modeling, fold recognition, and ab initio. This software can be deployed on a user's own high-performance computing cluster. Methodology/Principal Findings: The pipeline consists of a Perl core that integrates more than 20 individual software packages and databases, most of which are freely available from other research laboratories. The query protein sequences are first divided into domains either by domain boundary recognition or Bayesian statistics. The structures of the individual domains are then predicted using template-based modeling or ab initio modeling. The predicted models are scored with a statistical potential and an all-atom force field. The top-scoring ab initio models are annotated by structural comparison against the Structural Classification of Proteins (SCOP) fold database. Furthermore, secondary structure, solvent accessibility, transmembrane helices, and structural disorder are predicted. The results are generated in text, tab-delimited, and hypertext markup language (HTML) formats. So far, the pipeline has been used to study viral and bacterial proteomes. Conclusions: The standalone pipeline that we introduce here, unlike protein structure prediction Web servers, allows users to devote their own computing assets to process a potentially unlimited number of queries as well as perform resource-intensive ab initio structure prediction.			Lee, MS (corresponding author), USA, Biotechnol HPC Software Applicat Inst, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD USA.	jaques.reifman@us.army.mil	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BONDUGULA R, 2006, P COMP SYST BIO CSB2, P195; Bondugula R, 2007, PROTEINS, V66, P664, DOI 10.1002/prot.21177; Bondugula R, 2009, NUCLEIC ACIDS RES, V37, P452, DOI 10.1093/nar/gkn944; Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Feig M, 2002, PROTEINS, V49, P232, DOI 10.1002/prot.10217; Guo JT, 2004, NUCLEIC ACIDS RES, V32, pW522, DOI 10.1093/nar/gkh414; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jefferson ER, 2007, NUCLEIC ACIDS RES, V35, pD580, DOI 10.1093/nar/gkl836; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Konc J, 2007, J CHEM INF MODEL, V47, P940, DOI 10.1021/ci6005257; Lee MS, 2007, J CHEM THEORY COMPUT, V3, P312, DOI 10.1021/ct600195f; Lee MS, 2009, J STRUCT BIOL, V167, P136, DOI 10.1016/j.jsb.2009.05.001; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; LEE MS, 2006, P 25 ARM SCI C ORL F, P423; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; SHCHELKUNOV SN, 1993, FEBS LETT, V319, P80, DOI 10.1016/0014-5793(93)80041-R; SHCHELKUNOV SN, 1995, VIRUS GENES, V9, P231, DOI 10.1007/BF01702879; SHCHELKUNOV SN, 1994, VIRUS RES, V34, P207, DOI 10.1016/0168-1702(94)90125-2; Shchelkunov SN, 1996, VIRUS RES, V40, P169, DOI 10.1016/0168-1702(95)01269-9; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530; Veretnik S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000136; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Yu CG, 2009, PROTEINS, V74, P449, DOI 10.1002/prot.22167; Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	51	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6254	10.1371/journal.pone.0006254	http://dx.doi.org/10.1371/journal.pone.0006254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606223	Green Published, gold			2022-12-25	WOS:000268036000010
J	Vazquez-Martin, A; Oliveras-Ferraros, C; Menendez, JA				Vazquez-Martin, Alejandro; Oliveras-Ferraros, Cristina; Menendez, Javier A.			Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab	PLOS ONE			English	Article								Autophagy has been emerging as a novel cytoprotective mechanism to increase tumor cell survival under conditions of metabolic stress and hypoxia as well as to escape chemotherapy-induced cell death. To elucidate whether autophagy might also protect cancer cells from the growth inhibitory effects of targeted therapies, we evaluated the autophagic status of preclinical breast cancer models exhibiting auto-acquired resistance to the anti-HER2 monoclonal antibody trastuzumab (Tzb). We first examined the basal autophagic levels in Tzb-naive SKBR3 cells and in two pools of Tzb-conditioned SKBR3 cells (TzbR), which optimally grow in the presence of Tzb doses as high as 200 mu g/ml Tzb. Fluorescence microscopic analyses revealed that the number of punctate LC3 structures -a hallmark of autophagy-was drastically higher in Tzb-refractory cells than in Tzb-sensitive SKBR3 parental cells. Immunoblotting analyses confirmed that the lipidation product of the autophagic conversion of LC3 was accumulated to high levels in TzbR cells. High levels of the LC3 lipidated form in Tzb-refractory cells were accompanied by decreased p62/sequestosome-1 protein expression, a phenomenon characterizing the occurrence of increased autophagic flux. Moreover, increased autophagy was actively used to survive Tzb therapy as TzbR pools were exquisitely sensitive to chemical inhibitors of autophagosomal formation/function. Knockdown of LC3 expression via siRNA similarly resulted in reduced TzbR cell proliferation and supra-additively interacted with Tzb to resensitize TzbR cells. Sub-groups of Tzb-naive SKBR3 parental cells accumulated LC3 punctate structures and decreased p62 expression after treatment with high-dose Tzb, likely promoting their own resistance. This is the first report showing that HER2-overexpressing breast cancer cells chronically exposed to Tzb exhibit a bona fide up-regulation of the autophagic activity that efficiently works to protect breast cancer cells from the growth-inhibitory effects of Tzb. Therapeutic targeting autophagosome formation/function might represent a novel molecular avenue to reduce the emergence of Tzb resistance in HER2-dependent breast carcinomas.			Vazquez-Martin, A (corresponding author), ICO, Girona, Catalonia, Spain.	jmenendez@iconcologia.net	MENENDEZ, JAVIER A/C-6148-2016	MENENDEZ, JAVIER A/0000-0001-8733-4561				Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Altundag O, 2005, LUNG CANCER-J IASLC, V49, P279, DOI 10.1016/j.lungcan.2005.02.013; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2008, J CLIN INVEST, V118, P3837, DOI 10.1172/JCI37667; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Cappuzzo F, 2006, NEW ENGL J MED, V354, P2619, DOI 10.1056/NEJMc060020; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; du Manoir JM, 2006, CLIN CANCER RES, V12, P904, DOI 10.1158/1078-0432.CCR-05-1109; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Esparis-Ogando A, 2008, ANN ONCOL, V19, P1860, DOI 10.1093/annonc/mdn406; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jin Q, 2008, J MAMMARY GLAND BIOL, V13, P485, DOI 10.1007/s10911-008-9107-3; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lan KH, 2005, ANN NY ACAD SCI, V1059, P70, DOI 10.1196/annals.1339.026; Liu XD, 2006, CANCER BIOL THER, V5, P648, DOI 10.4161/cbt.5.6.2707; Lu CH, 2007, CLIN CANCER RES, V13, P5883, DOI 10.1158/1078-0432.CCR-06-2837; Lu YH, 2004, INT J CANCER, V108, P334, DOI 10.1002/ijc.11445; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Marino G, 2008, AUTOPHAGY, V4, P807, DOI 10.4161/auto.6478; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Menendez JA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1773; Miselli F, 2008, TRANSL ONCOL, V1, P177, DOI 10.1593/tlo.08157; Mishima Y, 2008, CANCER SCI, V99, P2200, DOI 10.1111/j.1349-7006.2008.00932.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molina MA, 2001, CANCER RES, V61, P4744; Moretti L, 2007, DRUG RESIST UPDATE, V10, P135, DOI 10.1016/j.drup.2007.05.001; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nagy P, 2005, CANCER RES, V65, P473; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Ocana A, 2006, AM J CLIN ONCOL-CANC, V29, P90, DOI 10.1097/01.coc.0000190274.00570.0a; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkash J, 2007, NEURON GLIA BIOL, V3, P299, DOI 10.1017/S1740925X07000701; Pegram M D, 2000, Cancer Treat Res, V103, P57; Price-Schiavi SA, 2002, INT J CANCER, V99, P783, DOI 10.1002/ijc.10410; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ropero S, 2004, BREAST CANCER RES TR, V86, P125, DOI 10.1023/B:BREA.0000032981.20384.c6; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Samudio I, 2008, MOL CANCER THER, V7, P1130, DOI 10.1158/1535-7163.MCT-07-0553; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shingu T, 2009, AUTOPHAGY, V5, P537, DOI 10.4161/auto.5.4.8164; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Zakeri Z, 2008, METHOD ENZYMOL, V442, P289, DOI 10.1016/S0076-6879(08)01415-8	76	192	210	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6251	10.1371/journal.pone.0006251	http://dx.doi.org/10.1371/journal.pone.0006251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606230	gold, Green Published, Green Submitted			2022-12-25	WOS:000268036000008
J	Manni, I; Artuso, S; Careccia, S; Rizzo, MG; Baserga, R; Piaggio, G; Sacchi, A				Manni, Isabella; Artuso, Simona; Careccia, Silvia; Rizzo, Maria Giulia; Baserga, Renato; Piaggio, Giulia; Sacchi, Ada			The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms	FASEB JOURNAL			English	Article						3 ' UTR; hematopoiesis; p53 family; small non-coding RNAs	MIR-17-92 CLUSTER; LUNG CANCERS; CYCLE ARREST; P53 HOMOLOG; EXPRESSION; DIFFERENTIATION; GENE; TRANSCRIPTION; DELTA-NP63-ALPHA; POLYCISTRON	MicroRNAs (miRs) are 21- to 23-nucleotide RNA molecules that regulate the stability or translational efficiency of target messenger RNAs of proteins involved in cell growth and apoptosis. miR-92 is part of the mir-17-92 cluster, which comprises members with an effect on cell proliferation. However, the role of miR-92 is unknown, and its targets have not been identified. Here, we describe a mechanism through which miR-92 contributes to regulate cell proliferation. Using a miR-92 synthetic double-strand oligonucleotide, we demonstrate that miR-92 increases 32D myeloid cell proliferation and 5-bromo-2-deoxyuridine (BrdU) incorporation and inhibits cell death. The effect is miR-92 specific since the miR-92 antagomir inhibits cell proliferation. Moreover, we show that miR-92 acts by modulating p63-isoform abundance through down-regulatation of endogenous Delta Np63 beta. Using luciferase reporters containing p63 3'UTR fragments with wild-type or mutant miR-92 complementary sites, we demonstrate that the wild-type 3'UTR is a direct target of miR-92. Finally, we observed that a miR-92-resistant Delta Np63 beta isoform (without 3'UTR) inhibits cell proliferation and parallels the effect of the antagomir. We conclude that one of the molecular mechanisms through which miR-92 increases cell proliferation is by negative regulation of an isoform of the cell-cycle regulator p63.-Manni, I., Artuso, S., Careccia, S., Rizzo, M. G., Baserga, R., Piaggio, G., Sacchi, A. The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms. FASEB J. 23, 3957-3966 (2009). www.fasebj.org	[Manni, Isabella; Artuso, Simona; Careccia, Silvia; Rizzo, Maria Giulia; Piaggio, Giulia; Sacchi, Ada] Ist Regina Elena, Dept Expt Oncol, I-00158 Rome, Italy; [Piaggio, Giulia] Ist Regina Elena, ROC, I-00158 Rome, Italy; [Baserga, Renato] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Jefferson University	Piaggio, G (corresponding author), Ist Regina Elena, Dept Expt Oncol, Via Messi DOro 156, I-00158 Rome, Italy.	piaggio@ifo.it	Careccia, Silvia/K-6475-2016; Rizzo, Maria Giulia/B-2107-2018; Manni, Isabella/ABH-6460-2020; Piaggio, Giulia/AAD-7336-2022; Piaggio, Giulia/J-7214-2018	Careccia, Silvia/0000-0001-7221-8170; Rizzo, Maria Giulia/0000-0002-5009-2412; Manni, Isabella/0000-0003-4823-0596; Piaggio, Giulia/0000-0003-2114-1892	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero della Salute; Istituto Superiore di Sanita (ISS) Alleanza Contro il Cancro (ACC) [ICS-120.4/RA00-90, R.F.02/184]	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero della Salute; Istituto Superiore di Sanita (ISS) Alleanza Contro il Cancro (ACC)	The authors thank Bert Vogelstein and Kenneth W. Kinzler (Johns Hopkins University, Baltimore, MD, USA) for generously providing Dicer-KO cells; Barry Trink (Johns Hopkins University), Giulia Fontemaggi (Istituto Regina Elena, Rome, Italy), and Fabio Martelli (Istituto Dermatopatico dell'Immacolata, Rome, Italy) for providing p63 expression vectors, oligonucleotides for p63 RTPCR, and pMir expression vector; Antonio Costanzo for interesting discussions on the manuscript; Silvia Bacchetti for editing the manuscript; Maria Pia Gentileschi for technical advice; and Vincenzo Giusti for computing assistance. G. P. is supported by grants from Associazione Italiana Ricerca sul Cancro (AIRC), Ministero della Salute, and Istituto Superiore di Sanita (ISS) Alleanza Contro il Cancro (ACC) (ICS-120.4/RA00-90; R.F.02/184). A. S. is supported by the ISS-Italia-USA program.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANDO K, 1995, ONCOGENE, V10, P751; ASKEW DS, 1991, ONCOGENE, V6, P1915; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fei ZL, 1997, ONCOGENE, V15, P961, DOI 10.1038/sj.onc.1201265; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Koster MI, 2006, CANCER RES, V66, P3981, DOI 10.1158/0008-5472.CAN-06-0027; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; NAGEL S, 2009, LEUKEMIA LYMPHOMA, V15, P1; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Patterson M K Jr, 1979, Methods Enzymol, V58, P141; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Shi B, 2006, J CELL PHYSIOL, V207, P706, DOI 10.1002/jcp.20613; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wu GJ, 2005, CANCER RES, V65, P758; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yue JM, 2006, CANCER BIOL THER, V5, P573, DOI 10.4161/cbt.5.6.2872; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	50	69	75	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3957	3966		10.1096/fj.09-131847	http://dx.doi.org/10.1096/fj.09-131847			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19608627	Bronze			2022-12-25	WOS:000271272500031
J	Navarro, G; Aymerich, MS; Marcellino, D; Cortes, A; Casado, V; Mallol, J; Canela, EI; Agnati, L; Woods, AS; Fuxe, K; Lluis, C; Lanciego, JL; Ferre, S; Franco, R				Navarro, Gemma; Aymerich, Marisol S.; Marcellino, Daniel; Cortes, Antoni; Casado, Vicent; Mallol, Josefa; Canela, Enric I.; Agnati, Luigi; Woods, Amina S.; Fuxe, Kjell; Lluis, Carmen; Luis Lanciego, Jose; Ferre, Sergi; Franco, Rafael			Interactions between Calmodulin, Adenosine A(2A), and Dopamine D-2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ENERGY-TRANSFER BRET; ELECTROSTATIC INTERACTION; HETEROMERIZATION; ACTIVATION; BINDING; LOOP; OLIGOMERIZATION; PHARMACOLOGY; RECOGNITION	The Ca2+-binding protein calmodulin (CaM) has been shown to bind directly to cytoplasmic domains of some G protein-coupled receptors, including the dopamine D-2 receptor. CaM binds to the N-terminal portion of the long third intracellular loop of the D-2 receptor, within an Arg-rich epitope that is also involved in the binding to G(i/o) proteins and to the adenosine A(2A) receptor, with the formation of A(2A)-D-2 receptor heteromers. In the present work, by using proteomics and bioluminescence resonance energy transfer (BRET) techniques, we provide evidence for the binding of CaM to the A(2A) receptor. By using BRET and sequential resonance energy transfer techniques, evidence was obtained for CaM-A(2A)-D-2 receptor oligomerization. BRET competition experiments indicated that, in the A(2A)-D-2 receptor heteromer, CaM binds preferentially to a proximal C terminus epitope of the A(2A) receptor. Furthermore, Ca2+ was found to induce conformational changes in the CaM-A(2A)-D-2 receptor oligomer and to selectively modulate A(2A) and D-2 receptor-mediated MAPK signaling in the A(2A)-D-2 receptor heteromer. These results may have implications for basal ganglia disorders, since A(2A)-D-2 receptor heteromers are being considered as a target for anti-parkinsonian agents.	[Aymerich, Marisol S.; Luis Lanciego, Jose; Franco, Rafael] Univ Navarra, CIMA Neurociencias, Pamplona 31008, Spain; [Navarro, Gemma; Cortes, Antoni; Casado, Vicent; Mallol, Josefa; Canela, Enric I.; Lluis, Carmen; Franco, Rafael] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Navarro, Gemma; Cortes, Antoni; Casado, Vicent; Mallol, Josefa; Canela, Enric I.; Lluis, Carmen; Franco, Rafael] Univ Barcelona, Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Invest Biomed August Pi & Sunyer, E-08028 Barcelona, Spain; [Marcellino, Daniel; Agnati, Luigi; Fuxe, Kjell] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Woods, Amina S.; Ferre, Sergi] Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD 21224 USA	University of Navarra; University of Barcelona; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Franco, R (corresponding author), Univ Navarra, CIMA Neurociencias, Avda Pio XII 55, Pamplona 31008, Spain.	rfranco@unav.es	Mallol, Josefa/I-4194-2015; Aymerich, M. S./H-2873-2017; Marcellino, Daniel/HDM-8433-2022; Ferre, Sergi/K-6115-2014; Lanciego, Jose L./G-7759-2015; Casadó, Vicent/K-1660-2014; Canela, Enric I./M-8726-2013; Navarro, Gemma/AAO-7866-2021; Franco, Rafael/C-3694-2015	Mallol, Josefa/0000-0002-2479-4162; Aymerich, M. S./0000-0001-9750-1538; Marcellino, Daniel/0000-0002-4618-7267; Ferre, Sergi/0000-0002-1747-1779; Lanciego, Jose L./0000-0003-2301-5419; Casadó, Vicent/0000-0002-1764-3825; Canela, Enric I./0000-0003-4992-7440; Navarro, Gemma/0000-0003-4654-0873; Franco, Rafael/0000-0003-2549-4919; Fuxe, Kjell/0000-0001-8491-4288	National Institutes of Health; NIDA; Spanish Ministry of Education and Science [SAF2008-00146, SAF2006-05481]; Fundacio La Marato de [060110]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493, Z01DA000493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Spanish Ministry of Education and Science(Spanish Government); Fundacio La Marato de; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health, NIDA, Intramural Research Program (to S. F. and A. S. W.). This work was also supported by Spanish Ministry of Education and Science Grants SAF2008-00146 (to E. I. C) and SAF2006-05481 (to R. F.) and Fundacio La Marato de TV3 Grant 060110 (to E. I. Q. The Proteomics Laboratory at CIMA belongs to the network of the Spanish National Institute of Proteomics Facilities, ProteoRed.	Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Altamura AC, 2005, WORLD J BIOL PSYCHIA, V6, P23, DOI 10.1080/15622970510030027; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; FERRE S, 1991, P NATL ACAD SCI USA, V88, P7238, DOI 10.1073/pnas.88.16.7238; Ferre Sergi, 2007, ScientificWorldJournal, V7, P74; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Hillion J, 2002, J BIOL CHEM, V277, P18091, DOI 10.1074/jbc.M107731200; Kamiya T, 2003, BIOCHEM BIOPH RES CO, V306, P544, DOI 10.1016/S0006-291X(03)00991-4; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; Liu Y, 2007, J RECEPT SIG TRANSD, V27, P47, DOI 10.1080/10799890601094152; Lucas JL, 2006, PHARM RES-DORDR, V23, P647, DOI 10.1007/s11095-006-9784-9; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Muller Christa E, 2007, Recent Pat CNS Drug Discov, V2, P1, DOI 10.2174/157488907779561772; Munoz J, 2008, PROTEOMICS, V8, P1898, DOI 10.1002/pmic.200701085; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Prinster SC, 2006, J PHARMACOL EXP THER, V318, P974, DOI 10.1124/jpet.106.106526; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Senogles SE, 2004, J BIOL CHEM, V279, P1601, DOI 10.1074/jbc.M309792200; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Woods AS, 2008, J PROTEOME RES, V7, P3428, DOI 10.1021/pr8001782; Woods AS, 2004, J PROTEOME RES, V3, P478, DOI 10.1021/pr034091l; Woods AS, 2005, J MOL NEUROSCI, V26, P125, DOI 10.1385/JMN:26:2-3:125; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Woods AS, 2001, J AM SOC MASS SPECTR, V12, P88, DOI 10.1016/S1044-0305(00)00197-5; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	37	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28058	28068		10.1074/jbc.M109.034231	http://dx.doi.org/10.1074/jbc.M109.034231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19632986	Green Published, hybrid			2022-12-25	WOS:000270676300033
J	Tiwari, D; Singh, RK; Goswami, K; Verma, SK; Prakash, B; Nandicoori, VK				Tiwari, Divya; Singh, Rajnish Kumar; Goswami, Kasturi; Verma, Sunil Kumar; Prakash, Balaji; Nandicoori, Vinay Kumar			Key Residues in Mycobacterium tuberculosis Protein Kinase G Play a Role in Regulating Kinase Activity and Survival in the Host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE KINASE; SER/THR KINASE; CELL-DIVISION; PATHOGENIC MYCOBACTERIA; PHOSPHORYLATION SITES; ACTIVATION MECHANISM; VIRULENCE FACTOR; IN-VIVO; PKNB; DOMAIN	Protein kinase G (PknG) in Mycobacterium tuberculosis has been shown to modulate phagosome-lysosome fusion. The protein has three distinct domains, an N-terminal Trx domain, a kinase domain, and a C-terminal TPR domain. The present study extensively analyzes the roles of these domains in regulating PknG kinase activity and function. We find that the kinase domain of PknG by itself is inactive, signifying the importance of the flanking domains. Although the deletion of the Trx domain severely impacts the activity of the protein, the C-terminal region also contributes significantly in regulating the activity of the kinase. Apart from this, PknG kinase activity is dependent on the presence of threonine 309 in the p + 1 loop of the activation segment. Mutating the conserved cysteine residues in the Trx motifs makes PknG refractory to changes in the redox environment. In vitro experiments identify threonine 63 as the major phosphorylation site of the protein. Importantly, we find that this is the only site in the protein that is phosphorylated in vivo. Macrophage infection studies reveal that the first 73 residues, the Trx motifs, and the threonine 63 residue are independently essential for modulating PknG-mediated survival of mycobacteria in its host. We have extended these studies to investigate the role of PknG and PknG mutants in the pathogenesis of mycobacteria in mice. Our results reinforce the findings from the macrophage infection experiments, and for the first time demonstrate that the expression of PknG in non-pathogenic mycobacteria allows the continued existence of these bacteria in host tissues.	[Tiwari, Divya; Singh, Rajnish Kumar; Goswami, Kasturi; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Verma, Sunil Kumar; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in	Verma, Sunil Kumar/J-8838-2019	Verma, Sunil Kumar/0000-0001-9443-2493; SINGH, RAJNISH/0000-0001-7414-1170; Tiwari, Divya/0000-0001-7631-2471; Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology (DBT), India; International Research Fellowship; Wellcome Trust, United Kingdom	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); International Research Fellowship; Wellcome Trust, United Kingdom(Wellcome Trust)	This work was supported by the Department of Biotechnology (DBT), India (to V. K. N. and B. P.) and by an International Research Fellowship grant from the Wellcome Trust, United Kingdom (to B. P.).	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS FM, 1985, TUBERCLE, V66, P267, DOI 10.1016/0041-3879(85)90064-9; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Gay LM, 2006, J MOL BIOL, V360, P409, DOI 10.1016/j.jmb.2006.05.015; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, PROTEOMICS, V6, P3754, DOI 10.1002/pmic.200500900; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Weldingh K, 1998, INFECT IMMUN, V66, P3492, DOI 10.1128/IAI.66.8.3492-3500.1998; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	57	52	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27467	27479		10.1074/jbc.M109.036095	http://dx.doi.org/10.1074/jbc.M109.036095			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19638631	Green Published, hybrid			2022-12-25	WOS:000270232300049
J	Morikawa, RK; Aoki, J; Kano, F; Murata, M; Yamamoto, A; Tsujimoto, M; Arai, H				Morikawa, Rei K.; Aoki, Junken; Kano, Fumi; Murata, Masayuki; Yamamoto, Akitsugu; Tsujimoto, Masafumi; Arai, Hiroyuki			Intracellular Phospholipase A(1)gamma(iPLA(1)gamma) Is a Novel Factor Involved in Coat Protein Complex I- and Rab6-independent Retrograde Transport between the Endoplasmic Reticulum and the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEC23P-INTERACTING PROTEIN; BREFELDIN-A; PHOSPHATIDIC-ACID; MEMBRANE TRAFFICKING; INTERMEDIATE COMPARTMENT; RECYCLING PATHWAY; PLASMA-MEMBRANE; CHOLERA-TOXIN; BOVINE TESTIS; CELL-SURFACE	The mammalian intracellular phospholipase A(1) (iPLA1) family consists of three members, iPLA(1)alpha/PA-PLA(1), iPLA(1)beta/p125, and iPLA(1)gamma/KIAA0725p. Although iPLA(1)beta has been implicated in organization of the ER-Golgi compartments, little is known about the physiological role of its closest paralog, iPLA(1)gamma. Here we show that iPLA(1)gamma mediates a specific retrograde membrane transport pathway between the endoplasmic reticulum (ER) and the Golgi complex. iPLA(1)gamma appeared to be localized to the cytosol, the cis-Golgi, and the ER-Golgi intermediate compartment (ERGIC). Time-lapse microscopy revealed that a population of GFP-iPLA(1)gamma was associated with transport carriers moving out from the Golgi complex. Knockdown of iPLA(1)gamma expression by RNAi did not affect the anterograde transport of VSVGts045 but dramatically delayed two types of Golgi-to-ER retrograde membrane transport; that is, transfer of the Golgi membrane into the ER in the presence of brefeldin A and delivery of cholera toxin B subunit from the Golgi complex to the ER. Notably, knockdown of iPLA(1)gamma did not impair COPI- and Rab6-dependent retrograde transports represented by ERGIC-53 recycling and ER delivery of Shiga toxin, respectively. Thus, iPLA(1)gamma is a novel membrane transport factor that contributes to a specific Golgi-to-ER retrograde pathway distinct from presently characterized COPI- and Rab6-dependent pathways.	[Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Morikawa, Rei K.; Aoki, Junken; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kano, Fumi; Murata, Masayuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Yamamoto, Akitsugu] Nagahama Inst Bio Sci & Technol, Dept Biosci, Nagahama 5260829, Japan; [Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Aoki, Junken] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Tohoku University; University of Tokyo; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Aoki, J (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aobayama, Sendai, Miyagi 9808578, Japan.	jaoki@mail.pharm.tohoku.ac.jp		Aoki, Junken/0000-0001-9435-1896	Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology and PRESTO from the Japan Science and Technology Agency.	Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Basanez G, 1997, BIOPHYS J, V72, P2630, DOI 10.1016/S0006-3495(97)78906-9; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Bergmann JE, 1989, METHOD CELL BIOL, V32, P85; Blackwood RA, 1996, J LEUKOCYTE BIOL, V59, P663, DOI 10.1002/jlb.59.5.663; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chambers K, 2005, J CELL SCI, V118, P3061, DOI 10.1242/jcs.02435; Chen A, 2003, J CELL SCI, V116, P3503, DOI 10.1242/jcs.00641; de Figueiredo P, 2000, TRAFFIC, V1, P504, DOI 10.1034/j.1600-0854.2000.010608.x; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Drecktrah D, 2003, MOL BIOL CELL, V14, P3459, DOI 10.1091/mbc.E02-11-0711; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Hauri HP, 2000, J CELL SCI, V113, P587; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Higgs HN, 1996, J BIOL CHEM, V271, P10874, DOI 10.1074/jbc.271.18.10874; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Inoue A, 2006, FUTURE LIPIDOL, V1, P687, DOI 10.2217/17460875.1.6.687; INOUE K, 2004, PHOSPHOLIPASE A1 STR, P23; Johannes L, 2000, TRAFFIC, V1, P119, DOI 10.1034/j.1600-0854.2000.010204.x; Kanamori T, 2008, EMBO J, V27, P1647, DOI 10.1038/emboj.2008.102; Kano F, 2000, MOL BIOL CELL, V11, P3073, DOI 10.1091/mbc.11.9.3073; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klumperman J, 1998, J CELL SCI, V111, P3411; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Luo H, 2006, CELL STRUCT FUNCT, V31, P63, DOI 10.1247/csf.31.63; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Morikawa R, 2007, METHOD ENZYMOL, V434, P1, DOI 10.1016/S0076-6879(07)34001-9; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; PETE MJ, 1994, J BIOL CHEM, V269, P19494; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Sannerud R, 2003, CURR OPIN CELL BIOL, V15, P438, DOI 10.1016/S0955-0674(03)00077-2; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; SESSO A, 1994, J CELL SCI, V107, P517; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Stieglitz KA, 2001, BIOCHEMISTRY-US, V40, P13954, DOI 10.1021/bi011338o; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Uchiyama S, 1999, J BIOCHEM-TOKYO, V125, P1001, DOI 10.1093/oxfordjournals.jbchem.a022378; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260	58	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26620	26630		10.1074/jbc.M109.038869	http://dx.doi.org/10.1074/jbc.M109.038869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632984	Green Published, hybrid			2022-12-25	WOS:000269969600043
J	Shanmugam, M; McBrayer, SK; Qian, J; Raikoff, K; Avram, MJ; Singhal, S; Gandhi, V; Schumacker, PT; Krett, NL; Rosen, ST				Shanmugam, Mala; McBrayer, Samuel K.; Qian, Jun; Raikoff, Kiril; Avram, Michael J.; Singhal, Seema; Gandhi, Varsha; Schumacker, Paul T.; Krett, Nancy L.; Rosen, Steven T.			Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVERCOMES DRUG-RESISTANCE; MULTIPLE-MYELOMA; AEROBIC GLYCOLYSIS; CANCER-CELLS; PROTEIN-KINASE; APOPTOSIS; GROWTH; METABOLISM; INHIBITION; SURVIVAL	Multiple myeloma, an incurable plasma cell malignancy, is characterized by altered cellular metabolism and resistance to apoptosis. Recent connections between glucose metabolism and resistance to apoptosis provide a compelling rationale for targeting metabolic changes in cancer. In this study, we have examined the ability of the purine analogue 8-aminoadenosine to acutely reduce glucose consumption by regulating localization and expression of key glucose transporters. Myeloma cells counteracted the metabolic stress by activating autophagy. Co-treatment with inhibitors of autophagy results in marked enhancement of cell death. Glucose consumption by drug-resistant myeloma cells was unaffected by 8-aminoadenosine, and accordingly, no activation of autophagy was observed. However, these cells can be sensitized to 8-aminoadenosine under glucose-limiting conditions. The prosurvival autophagic response of myeloma to nutrient deprivation or to nucleoside analogue treatment has not been described previously. This study establishes the potential of metabolic targeting as a broader means to kill and sensitize myeloma and identifies a compound that can achieve this goal.	[Shanmugam, Mala; Schumacker, Paul T.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Shanmugam, Mala; McBrayer, Samuel K.; Qian, Jun; Singhal, Seema; Krett, Nancy L.; Rosen, Steven T.] Univ Texas MD Anderson Canc Ctr, Robert H Lurie Comprehens Canc Ctr, Houston, TX 77030 USA; [Singhal, Seema; Rosen, Steven T.] Univ Texas MD Anderson Canc Ctr, Div Hematol & Oncol, Houston, TX 77030 USA; [Raikoff, Kiril; Avram, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA; [Gandhi, Varsha] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Northwestern University; Feinberg School of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shanmugam, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, 3-250 Lurie Bldg,303 E Super St, Chicago, IL 60611 USA.	mala@northwestern.edu	Shanmugam, Mala/M-6491-2019; Avram, Michael/M-7681-2019	Shanmugam, Mala/0000-0002-4415-8083; Rosen, Steven/0000-0002-8818-7724	National Institutes of Health (NIH), NCI Cancer Nanotechnology Excellence (CCNE) Initiative [U54CA119341, T32CA09560, RO1CA 85919]; NATIONAL CANCER INSTITUTE [U54CA119341, T32CA009560] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI Cancer Nanotechnology Excellence (CCNE) Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI Cancer Nanotechnology Excellence (CCNE) Initiative Grant U54CA119341 (to M. S.), NIH (NCI) Grant T32CA09560 (to S. M.), and NIH Grant RO1CA 85919 (to S. R.).	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Bredella MA, 2005, AM J ROENTGENOL, V184, P1199, DOI 10.2214/ajr.184.4.01841199; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cao XH, 2007, CANCER CHEMOTH PHARM, V59, P495, DOI 10.1007/s00280-006-0291-9; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Durie BGM, 2002, J NUCL MED, V43, P1457; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gandhi V, 2001, CANCER RES, V61, P5474; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghias K, 2005, MOL CANCER THER, V4, P569, DOI 10.1158/1535-7163.MCT-04-0303; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Halgren RG, 1998, BLOOD, V92, P2893, DOI 10.1182/blood.V92.8.2893.420k01_2893_2898; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hu C, 2008, BIOORGAN MED CHEM, V16, P7888, DOI 10.1016/j.bmc.2008.07.076; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kawakami K, 2005, OBES RES, V13, P1661, DOI 10.1038/oby.2005.204; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Krett NL, 2004, MOL CANCER THER, V3, P1411; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Nabhan C, 2001, CURR OPIN ONCOL, V13, P514, DOI 10.1097/00001622-200111000-00015; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Richardson PG, 2005, ONCOLOGY-NY, V19, P1781; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Stryer L., 1988, BIOCHEMISTRY-US, P320; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vezmar M, 2000, BIOCHEM PHARMACOL, V59, P1245, DOI 10.1016/S0006-2952(00)00270-7; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Yamauchi T, 2004, J CHROMATOGR B, V799, P81, DOI 10.1016/j.jchromb.2003.10.011; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	49	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26816	26830		10.1074/jbc.M109.000646	http://dx.doi.org/10.1074/jbc.M109.000646			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648108	Green Published, hybrid			2022-12-25	WOS:000269969600063
J	Wang, PX; Wang, QH; Sun, J; Wu, J; Li, H; Zhang, NN; Huang, YC; Su, B; Li, RK; Liu, L; Zhang, Y; Elsholtz, HP; Hu, J; Gaisano, HY; Jin, TR				Wang, Peixiang; Wang, Qinghua; Sun, Jane; Wu, Jing; Li, Hang; Zhang, Nina; Huang, Yachi; Su, Brenda; Li, Ren-ke; Liu, Ling; Zhang, Yi; Elsholtz, Harry P.; Hu, Jim; Gaisano, Herbert Y.; Jin, Tianru			POU Homeodomain Protein Oct-1 Functions as a Sensor for Cyclic AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGLUCAGON GENE-EXPRESSION; ENDOCRINE-L-CELLS; PANCREATIC BETA-CELLS; HOMEOBOX GENE; TRANSCRIPTIONAL ACTIVATION; GLUCAGON GENE; INSULIN GENE; RESPONSE ELEMENT; BINDING PROTEIN; HORMONE GENE	Cyclic AMP is a fundamentally important second messenger for numerous peptide hormones and neurotransmitters that control gene expression, cell proliferation, and metabolic homeostasis. Here we show that cAMP works with the POU homeodomain protein Oct-1 to regulate gene expression in pancreatic and intestinal endocrine cells. This ubiquitously expressed transcription factor is known as a stress sensor. We found that it also functions as a repressor of Cdx-2, a proglucagon gene activator. Through a mechanism that involves the activation of exchange protein activated by cyclic AMP, elevation of cAMP leads to enhanced phosphorylation and nuclear exclusion of Oct-1 and reduced interactions between Oct-1 or nuclear co-repressors and the Cdx-2 gene promoter, detected by chromatin immunoprecipitation. In rat primary pancreatic islet cells, cAMP elevation also reduces nuclear Oct-1 content, which causes increased proglucagon and proinsulin mRNA expression. Our study therefore identifies a novel mechanism by which cAMP regulates hormone-gene expression and suggests that ubiquitously expressed Oct-1 may play a role in metabolic homeostasis by functioning as a sensor for cAMP.	[Liu, Ling; Jin, Tianru] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; [Li, Ren-ke] Univ Hlth Network, Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON M5G 1L7, Canada; [Wang, Qinghua; Zhang, Nina; Huang, Yachi; Zhang, Yi; Jin, Tianru] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Sun, Jane; Elsholtz, Harry P.; Hu, Jim; Jin, Tianru] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada; [Jin, Tianru] Univ Toronto, Dept Med, Toronto, ON M5G 1L7, Canada; [Wu, Jing; Hu, Jim] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wang, Qinghua; Zhang, Nina] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [Jin, Tianru] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510080, Guangdong, Peoples R China	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Sun Yat Sen University	Jin, TR (corresponding author), 10-354,Toronto Med Discovery Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	tianru.jin@utoronto.ca	zhang, nina/GXH-0962-2022; Wang, Qinghua/GVT-3252-2022	Huang, Ya-Chi/0000-0001-5168-1174; Li, Ren-Ke/0000-0002-2584-060X; Hu, Jim/0000-0001-9134-7103	Canadian Diabetes Association [2341]; Canadian Institutes of Health [62745, 79534, 86544, 77750]	Canadian Diabetes Association; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Diabetes Association Grant 2341 (to T. J.) and Canadian Institutes of Health Research Grants 62745 (to T. J.), 79534 (to Q. W.), 86544 (to H. Y. G.), and 77750 (to J. H.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; Belsham DD, 2000, MOL ENDOCRINOL, V14, P212, DOI 10.1210/me.14.2.212; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chandran UR, 1999, J BIOL CHEM, V274, P2372, DOI 10.1074/jbc.274.4.2372; Chandran UR, 1996, J BIOL CHEM, V271, P20412, DOI 10.1074/jbc.271.34.20412; Chen L, 2005, FEBS J, V272, P2746, DOI 10.1111/j.1742-4658.2005.04694.x; Cheng CK, 2002, MOL ENDOCRINOL, V16, P1552, DOI 10.1210/me.16.7.1552; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; GERMAN MS, 1994, GENOMICS, V24, P403, DOI 10.1006/geno.1994.1639; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gevrey JC, 2004, DIABETOLOGIA, V47, P926, DOI 10.1007/s00125-004-1380-0; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grenfell SJ, 1996, BIOCHEM J, V315, P889, DOI 10.1042/bj3150889; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Hitomi T, 2007, FEBS LETT, V581, P1087, DOI 10.1016/j.febslet.2007.01.092; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; JAMES R, 1994, J BIOL CHEM, V269, P15229; Jin T, 2008, J ENDOCRINOL, V198, P17, DOI 10.1677/JOE-08-0085; Jin TR, 1996, MOL CELL BIOL, V16, P19; Jin TR, 2001, J BIOL CHEM, V276, P14752, DOI 10.1074/jbc.M008277200; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; KNEPEL W, 1990, MOL CELL BIOL, V10, P6799, DOI 10.1128/MCB.10.12.6799; Laser B, 1996, J BIOL CHEM, V271, P28984, DOI 10.1074/jbc.271.46.28984; Lotfi S, 2006, ENDOCRINOLOGY, V147, P3727, DOI 10.1210/en.2006-0056; Lu F, 1996, ENDOCRINOLOGY, V137, P3710, DOI 10.1210/en.137.9.3710; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Ni ZY, 2003, J BIOL CHEM, V278, P1380, DOI 10.1074/jbc.M206006200; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Ritz-Laser B, 1999, J BIOL CHEM, V274, P4124, DOI 10.1074/jbc.274.7.4124; ROBERTS SB, 1991, SCIENCE, V253, P1022, DOI 10.1126/science.1887216; Schild-Poulter C, 2007, ONCOGENE, V26, P3980, DOI 10.1038/sj.onc.1210165; Schild-Poulter C, 2003, CANCER RES, V63, P7197; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEGIL N, 1991, COLD SPRING HARB SYM, V56, P285; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; SUN J, 2009, ONCOGENE IN PRESS; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tang QB, 2005, MOL ENDOCRINOL, V19, P2769, DOI 10.1210/me.2004-0463; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Thum T, 2008, J BIOL CHEM, V283, P19456, DOI 10.1074/jbc.M708309200; Trinh KY, 1999, J BIOL CHEM, V274, P6011, DOI 10.1074/jbc.274.9.6011; Vazquez-Martinez R, 2002, MOL ENDOCRINOL, V16, P2093, DOI 10.1210/me.2002-0139; Wang PX, 2006, ENDOCRINOLOGY, V147, P1950, DOI 10.1210/en.2005-0910; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao Y, 2005, J ENDOCRINOL, V186, P179, DOI 10.1677/joe.1.06152	72	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26456	26465		10.1074/jbc.M109.030668	http://dx.doi.org/10.1074/jbc.M109.030668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19617623	hybrid, Green Published			2022-12-25	WOS:000269969600027
J	Dai, J; Peng, L; Fan, K; Wang, H; Wei, R; Ji, G; Cai, J; Lu, B; Li, B; Zhang, D; Kang, Y; Tan, M; Qian, W; Guo, Y				Dai, J.; Peng, L.; Fan, K.; Wang, H.; Wei, R.; Ji, G.; Cai, J.; Lu, B.; Li, B.; Zhang, D.; Kang, Y.; Tan, M.; Qian, W.; Guo, Y.			Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells	ONCOGENE			English	Article						osteopontin; angiogenesis; HUVEC; VEGF; signal pathway	BREAST-CANCER CELLS; NF-KAPPA-B; GROWTH-FACTOR; TUMOR PROGRESSION; SURVIVAL FACTOR; PERMEABILITY; MECHANISMS; APOPTOSIS; MIGRATION; KINASE	Angiogenesis is a key step in tumor growth and metastasis. The mechanism by which osteopontin (OPN) induces the angiogenesis of endothelial cells remains unclear. Here, we show that OPN confers cytoprotection through the activation of the PI3K/Akt pathway with subsequent upregulation of Bcl-xL and activation of nuclear factor-kappa B. OPN enhances the expression of vascular endothelial growth factor (VEGF) through the phosphorylation of AKT and extracellular signal-regulated kinase (ERK). In turn, OPN-induced VEGF activates PI3K/AKT and the ERK1/2 pathway as a positive feedback signal. Blocking the feedback signal by anti-VEGF antibody, PI3-kinase inhibitor or ERK inhibitor can partially inhibit the OPN-induced human umbilical vein endothelial cell (HUVEC) motility, proliferation and tube formation, while blocking the signal by anti-OPN or anti-alpha v beta 3 antibody completely abrogates the biological effects of OPN on HUVECs. In addition, blood vessel formation is also investigated in vivo. The antiangiogenesis efficacy of anti-OPN antibody in vivo is more effective than that of anti-VEGF antibody, which only blocks the feedback signals. These data show that OPN enhances angiogenesis directly through PI3K/AKT and ERK-mediated pathways with VEGF acting as a positive feedback signal. The results suggest that OPN might be a valuable target for developing novel antiangiogenesis therapy for treatment of cancer. Oncogene (2009) 28, 3412-3422; doi: 10.1038/onc.2009.189; published online 13 July 2009	[Dai, J.; Peng, L.; Fan, K.; Wang, H.; Ji, G.; Lu, B.; Li, B.; Zhang, D.; Kang, Y.; Tan, M.; Qian, W.; Guo, Y.] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Dai, J.; Peng, L.; Fan, K.; Wang, H.; Ji, G.; Lu, B.; Li, B.; Zhang, D.; Kang, Y.; Tan, M.; Qian, W.; Guo, Y.] Second Mil Med Univ, Gen Hosp 301, Ctr Canc, Shanghai 200433, Peoples R China; [Zhang, D.; Tan, M.; Qian, W.; Guo, Y.] Shanghai Jiao Tong Univ, Coll Pharm, Natl Engn Res Ctr Antibody Med, Shanghai 200030, Peoples R China; [Zhang, D.; Tan, M.; Qian, W.; Guo, Y.] Shanghai Jiao Tong Univ, Coll Pharm, Shanghai Key Lab Cell Engn, Shanghai 200030, Peoples R China; [Wei, R.; Cai, J.] Shanghai Changzheng Hosp, Dept Ophthalmol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Naval Medical University	Guo, Y (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Adm Bldg 10th 11th Floor,800 Xiang Yin Rd, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn		Ji, Guanghui/0000-0003-3763-2311	National Natural Science Foundation of China; Shanghai Commission of Science and Technology; Ministry of Science and Technology of China; Shanghai Commission of Education; Shanghai Pudong Bureau of Science and Technology of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Education; Shanghai Pudong Bureau of Science and Technology of China	This study was supported in part by the grants from the National Natural Science Foundation of China, Shanghai Commission of Science and Technology, Ministry of Science and Technology of China (973 and 863 projects), Shanghai Commission of Education as well as a special grant from Shanghai Pudong Bureau of Science and Technology of China. JX Dai is a recipient of 'Pujiang' Research Scholarship from Shanghai Commission of Education.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; ASANO M, 1995, CANCER RES, V55, P5296; Beraud C, 1999, P NATL ACAD SCI USA, V96, P429, DOI 10.1073/pnas.96.2.429; Brady H, 2002, CANCER RES, V62, P1439; Cao ZG, 2008, MOL IMMUNOL, V45, P3683, DOI 10.1016/j.molimm.2008.06.008; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; Denhardt DT, 1996, CRIT REV ONCOGENESIS, V7, P261, DOI 10.1615/CritRevOncog.v7.i3-4.70; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; DENHARDT DT, 1994, J CELL BIOCHEM, V56, P48, DOI 10.1002/jcb.240560109; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Jain S, 2006, CANCER RES, V66, P6638, DOI 10.1158/0008-5472.CAN-06-0661; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Khan SA, 2002, J CELL BIOCHEM, V85, P728, DOI 10.1002/jcb.10170; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Nishiyama K, 2005, CIRCULATION, V112, P2840, DOI 10.1161/CIRCULATIONAHA.104.516898; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Senger DR, 1996, AM J PATHOL, V149, P293; Shijubo N, 2003, MICROSC RES TECHNIQ, V60, P186, DOI 10.1002/jemt.10257; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Solorzano CC, 2001, CANCER RES, V61, P7048; Standal T, 2004, EXP ONCOL, V26, P179; TOSHIFUMI S, 2003, J BIOL CHEM, V278, P5001; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; WU LW, 2000, J BIOL CHEM, V18; Xu GW, 2005, J CLIN INVEST, V115, P1060	33	220	232	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3412	3422		10.1038/onc.2009.189	http://dx.doi.org/10.1038/onc.2009.189			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19597469				2022-12-25	WOS:000270103300008
J	Ardi, VC; Van den Steen, PE; Opdenakker, G; Schweighofer, B; Deryugina, EI; Quigley, JP				Ardi, Veronica C.; Van den Steen, Philippe E.; Opdenakker, Ghislain; Schweighofer, Bernhard; Deryugina, Elena I.; Quigley, James P.			Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYO CHORIOALLANTOIC MEMBRANE; MARROW-DERIVED CELLS; GELATINASE-B; MATRIX METALLOPROTEINASES; MATRIX-METALLOPROTEINASE-9 MMP-9; ENDOTHELIAL-CELLS; HEMOPEXIN DOMAIN; IV COLLAGENASE; BINDING; VEGF	The structural and catalytic requirements for neutrophil MMP-9 proenzyme (proMMP-9) to induce angiogenesis were investigated using a quantitative angiogenesis model based on grafting of collagen onplants onto the chorioallantoic membrane of chick embryos. Both physiological activation of neutrophil proMMP-9 and proteolytic activity of the generated MMP-9 enzyme were critically dependent on the tissue inhibitor of metalloproteinase (TIMP)-free status of the zymogen. The presence of an intact active site and hemopexin domain were required for full angiogenesis-inducing activity of the MMP-9 enzyme. Timed additions of TIMP-1 to the onplants containing TIMP-free neutrophil proMMP-9 indicated that in vivo activation of the zymogen occurred during the first 24 h after grafting. Within the onplant tissue, MMP-9 activation was accompanied by proteolytic modifications of fibrillar collagen and an influx of host proteins, the rate of which depended on the TIMP-free status of the zymogen. By quantifying the levels of host angiogenic factors, we demonstrated that basic fibroblast growth factor(FGF-2) was a major cytokine becoming bioavailable in the onplant tissue undergoing a neutrophil proMMP-9-mediated angiogenic switch. Inhibition of angiogenesis with specific function-blocking antibodies further indicated an involvement of a FGF-2/FGFR-2 pathway in neutrophil proMMP-9-induced angiogenesis. The enhanced angiogenesis catalyzed by neutrophil MMP-9 appears to evoke also a localized, low threshold level vascular endothelial growth factor (VEGF)/VEGFR-2 pathway, likely functioning in the formation and/or stabilization of blood vessels. That neutrophil proMMP-9, unencumbered by TIMP-1, directly mediates FGF-2-dependent angiogenesis was also demonstrated in our quantitative mouse angiogenesis model employing subcutaneous collagen implants, thus implicating the novel TIMP-free MMP-9/FGF-2/FGFR-2 pathway in proMMP-9-induced angiogenesis in a mammalian setting.	[Ardi, Veronica C.; Schweighofer, Bernhard; Deryugina, Elena I.; Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Van den Steen, Philippe E.; Opdenakker, Ghislain] Univ Louvain, Rega Inst, Immunobiol Lab, B-3000 Louvain, Belgium	Scripps Research Institute; KU Leuven	Quigley, JP (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd,SP30-3120, La Jolla, CA 92037 USA.	jquigley@scripps.edu	Schweighofer, Bernhard/B-2763-2011; Van den Steen, Philippe E/K-5132-2012; Schweighofer, Bernhard/C-2796-2009; Opdenakker, Ghislain/V-8562-2019; Opdenakker, Ghislain/Q-3130-2017	Schweighofer, Bernhard/0000-0003-0793-7376; Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294	National Institutes of Health [CA55852, CA105412]; Postdoctoral Training [5T32 HL07195-31]; Geconcerteerde OnderzoeksActies [GOA/2007/15]; Excellentiefinanciering [EF/05/015]; Fund for Scientific Research of Flanders FWO-Vlaanderen; NATIONAL CANCER INSTITUTE [R01CA129484, R01CA055852, R01CA105412] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Training; Geconcerteerde OnderzoeksActies; Excellentiefinanciering(KU Leuven); Fund for Scientific Research of Flanders FWO-Vlaanderen(FWO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA55852 and CA105412 (to J. P. Q.) and Postdoctoral Training Grant 5T32 HL07195-31 (to V. C. A.). This work was also supported by Geconcerteerde OnderzoeksActies GOA/2007/15, Excellentiefinanciering EF/05/015, and the Fund for Scientific Research of Flanders FWO-Vlaanderen (to G. O.).	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; BADWEY JA, 1982, BIOCHEM BIOPH RES CO, V106, P170, DOI 10.1016/0006-291X(82)92073-3; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Claffey KP, 2001, LAB INVEST, V81, P61, DOI 10.1038/labinvest.3780212; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Dolo V, 1999, ANN NY ACAD SCI, V878, P497, DOI 10.1111/j.1749-6632.1999.tb07707.x; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Geurts N, 2008, BIOCHEMISTRY-US, V47, P2689, DOI 10.1021/bi702260q; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Huang SY, 2002, J NATL CANCER I, V94, P1134; Jodele S, 2005, CANCER RES, V65, P3200, DOI 10.1158/0008-5472.CAN-04-3770; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; Kanda S, 2004, J BIOL CHEM, V279, P4007, DOI 10.1074/jbc.M307569200; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; McDonnell K, 2005, LAB INVEST, V85, P747, DOI 10.1038/labinvest.3700269; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; MOLL UM, 1990, CANCER RES, V50, P6162; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Olson MW, 1998, J BIOL CHEM, V273, P10672, DOI 10.1074/jbc.273.17.10672; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Ribatti D, 1998, J SUBMICR CYTOL PATH, V30, P127; Ribatti D, 2002, J CELL MOL MED, V6, P439, DOI 10.1111/j.1582-4934.2002.tb00524.x; RIBATTI D, 1995, DEV BIOL, V170, P39, DOI 10.1006/dbio.1995.1193; Ribatti D, 1999, J CELL SCI, V112, P4213; Roeb E, 2002, J BIOL CHEM, V277, P50326, DOI 10.1074/jbc.M207446200; Seandel M, 2001, BLOOD, V97, P2323, DOI 10.1182/blood.V97.8.2323; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Tsunoda S, 2007, CANCER SCI, V98, P541, DOI 10.1111/j.1349-7006.2007.00432.x; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Vu TH, 1998, BIOL EXTRAC, P115; WATANABE H, 1993, J CELL SCI, V104, P991; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	64	91	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25854	25866		10.1074/jbc.M109.033472	http://dx.doi.org/10.1074/jbc.M109.033472			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608737	hybrid, Green Published			2022-12-25	WOS:000269738000043
J	Shen, MQ; Yen, A				Shen, Miaoqing; Yen, Andrew			c-Cbl Tyrosine Kinase-binding Domain Mutant G306E Abolishes the Interaction of c-Cbl with CD38 and Fails to Promote Retinoic Acid-induced Cell Differentiation and G(o) Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ACUTE PROMYELOCYTIC LEUKEMIA; HL-60 CELLS; FACTOR RECEPTOR; RING FINGER; T-CELLS; PHOSPHOINOSITIDE 3-KINASE; MYELOID DIFFERENTIATION; PHOSPHORYLATED VAV; MAP KINASES	Retinoic acid (RA) causes HL-60 human myeloblastic leukemia cell myeloid differentiation that is dependent on MAPK signaling. The process is propelled by c-Cbl, which binds the CD38 receptor as part of a signaling complex generating MAPK signaling. Here we report that the capability of c-Cbl to do this is lost in the G306E tyrosine kinase-binding domain mutant. Unlike wild-type (WT) c-Cbl, the G306E mutant c-Cbl fails to propel RA-induced differentiation, and disrupts the normal association with CD38. The G306E mutant does, like WT c-Cbl, co-immunoprecipitate with Vav, Slp-76, and p38. But unlike WT c-Cbl, does not cause MAPK signaling. In contrast, the C381A Ring finger domain mutant functions like WT c-Cbl. It binds CD38 and is part of the same apparent c-Cbl/Slp-76/Vav/p38 signaling complex. The C381A mutant causes MAPK signaling and propels RA-induced differentiation. In addition to HL-60 cells and their WT or mutant c-Cbl stable transfectants, the c-Cbl/Vav/Slp-76 complex is also found in NB4 cells where c-Cbl was previously also found to bind CD38. The data are consistent with a model in which the G306E mutant c-Cbl forms a signaling complex that includes Slp-76, Vav, and p38; but does not drive MAPK signaling because it fails to bind the CD38 receptor. Without the G306E mutation the c-Cbl unites CD38 with the signaling complex and delivers a MAPK signal that drives RA-induced differentiation. The results demonstrate the importance of the Gly306 residue in the ability of c-Cbl to propel RA-induced differentiation.	[Shen, Miaoqing; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Yen, A (corresponding author), VRT, T4-008, Ithaca, NY 14853 USA.	ay13@cornell.edu			National Institutes of Health of the USPHS; New York State Stem Cell Science	National Institutes of Health of the USPHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science	This work was supported, in whole or in part, by grants from the National Institutes of Health of the USPHS and New York State Stem Cell Science.	Albeniz I, 2007, HEMATOLOGY, V12, P409, DOI 10.1080/10245330701383841; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Bertagnolo V, 1998, FEBS LETT, V441, P480, DOI 10.1016/S0014-5793(98)01593-2; Bertagnolo V, 2001, CELL GROWTH DIFFER, V12, P193; Bhaumik SR, 2006, METHODS, V40, P353, DOI 10.1016/j.ymeth.2006.06.025; BIONDI A, 1991, BLOOD, V77, P1418; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brooks SC, 1996, BLOOD, V87, P227; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Chu J, 1998, BLOOD, V92, P1697, DOI 10.1182/blood.V92.5.1697.417a06_1697_1706; CLEVENGER CV, 1995, J BIOL CHEM, V270, P13246, DOI 10.1074/jbc.270.22.13246; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; DALTON WT, 1988, BLOOD, V71, P242; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Deaglio S, 2001, LEUKEMIA RES, V25, P1, DOI 10.1016/S0145-2126(00)00093-X; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Finkelstein LD, 2000, BIOCHEM J, V345, P385, DOI 10.1042/0264-6021:3450385; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kontani K, 1996, J BIOL CHEM, V271, P1534; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; Mann G, 2001, ANN HEMATOL, V80, P417, DOI 10.1007/s002770100304; March S, 2007, AM J PATHOL, V170, P176, DOI 10.2353/ajpath.2007.051212; Marengere LEM, 1997, J IMMUNOL, V159, P70; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Shen MQ, 2008, CANCER RES, V68, P8761, DOI 10.1158/0008-5472.CAN-08-1058; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; Visser GD, 2005, EXP CELL RES, V311, P281, DOI 10.1016/j.yexcr.2005.09.015; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wightman J, 2002, MOL CANCER THER, V1, P493; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yen A, 1999, IN VITRO CELL DEV-AN, V35, P527; Yen A, 1998, CANCER RES, V58, P3163; Yen A, 1990, HEMATOL REV, V4, P5; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200	54	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25664	25677		10.1074/jbc.M109.014241	http://dx.doi.org/10.1074/jbc.M109.014241			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19635790	Green Published, hybrid			2022-12-25	WOS:000269738000024
J	Li, H; Liang, SD				Li, Hua; Liang, Shoudan			Local Network Topology in Human Protein Interaction Data Predicts Functional Association	PLOS ONE			English	Article							INTERACTION MAP; BINDING PROTEIN; GROWTH; YEAST; IDENTIFICATION; COMPLEXES; SYSTEM; BMP; GENES; STRAP	The use of high-throughput techniques to generate large volumes of protein-protein interaction (PPI) data has increased the need for methods that systematically and automatically suggest functional relationships among proteins. In a yeast PPI network, previous work has shown that the local connection topology, particularly for two proteins sharing an unusually large number of neighbors, can predict functional association. In this study we improved the prediction scheme by developing a new algorithm and applied it on a human PPI network to make a genome-wide functional inference. We used the new algorithm to measure and reduce the influence of hub proteins on detecting function-associated protein pairs. We used the annotations of the Gene Ontology ( GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) as benchmarks to compare and evaluate the function relevance. The application of our algorithms to human PPI data yielded 4,233 significant functional associations among 1,754 proteins. Further functional comparisons between them allowed us to assign 466 KEGG pathway annotations to 274 proteins and 123 GO annotations to 114 proteins with estimated false discovery rates of <21% for KEGG and <30% for GO. We clustered 1,729 proteins by their functional associations and made functional inferences from detailed analysis on one subcluster highly enriched in the TGF-beta signaling pathway (P < 10(-50)). Analysis of another four subclusters also suggested potential new players in six signaling pathways worthy of further experimental investigations. Our study gives clear insight into the common neighbor-based prediction scheme and provides a reliable method for large-scale functional annotation in this post-genomic era.			Li, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	shoudan@mdanderson.org		LI, HUA/0000-0003-2153-2500	NATIONAL CANCER INSTITUTE [K25CA123344] Funding Source: NIH RePORTER; NCI NIH HHS [K25 CA123344] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Chen WJ, 2007, J BIOL CHEM, V282, P11365, DOI 10.1074/jbc.M700186200; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; D'haeseleer P, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P216; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Llewellyn R, 2008, P NATL ACAD SCI USA, V105, P17700, DOI 10.1073/pnas.0809583105; Mazzarella R, 1998, GENOMICS, V48, P157, DOI 10.1006/geno.1997.5156; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2005, J COMPUT BIOL, V12, P835, DOI 10.1089/cmb.2005.12.835; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	49	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6410	10.1371/journal.pone.0006410	http://dx.doi.org/10.1371/journal.pone.0006410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641626	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500011
J	Dodatko, T; Akoachere, M; Muehlbauer, SM; Helfrich, F; Howerton, A; Ross, C; Wysocki, V; Brojatsch, J; Abel-Santos, E				Dodatko, Tetyana; Akoachere, Monique; Muehlbauer, Stefan M.; Helfrich, Forrest; Howerton, Amber; Ross, Christian; Wysocki, Vicki; Brojatsch, Juegen; Abel-Santos, Ernesto			Bacillus cereus Spores Release Alanine that Synergizes with Inosine to Promote Germination	PLOS ONE			English	Article								Background: The first step of the bacterial lifecycle is the germination of bacterial spores into their vegetative form, which requires the presence of specific nutrients. In contrast to closely related Bacillus anthracis spores, Bacillus cereus spores germinate in the presence of a single germinant, inosine, yet with a significant lag period. Methods and Findings: We found that the initial lag period of inosine-treated germination of B. cereus spores disappeared in the presence of supernatants derived from already germinated spores. The lag period also dissipated when inosine was supplemented with the co-germinator alanine. In fact, HPLC-based analysis revealed the presence of amino acids in the supernatant of germinated B. cereus spores. The released amino acids included alanine in concentrations sufficient to promote rapid germination of inosine-treated spores. The alanine racemase inhibitor D-cycloserine enhanced germination of B. cereus spores, presumably by increasing the L-alanine concentration in the supernatant. Moreover, we found that B. cereus spores lacking the germination receptors gerI and gerQ did not germinate and release amino acids in the presence of inosine. These mutant spores, however, germinated efficiently when inosine was supplemented with alanine. Finally, removal of released amino acids in a washout experiment abrogated inosine-mediated germination of B. cereus spores. Conclusions: We found that the single germinant inosine is able to trigger a two-tier mechanism for inosine-mediated germination of B. cereus spores: Inosine mediates the release of alanine, an essential step to complete the germination process. Therefore, B. cereus spores appear to have developed a unique quorum-sensing feedback mechanism to monitor spore density and to coordinate germination.			Dodatko, T (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	ernesto.abelsantos@unlv.edu		brojatsch, jurgen/0000-0002-7424-365X; Wysocki, Vicki/0000-0003-0495-2538; Ross, Paige/0000-0002-4157-3951	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR-016464, P20 RR016464] Funding Source: Medline; NIAID NIH HHS [R21 AI075222, AI075222-01A1] Funding Source: Medline; NIGMS NIH HHS [T32GM007288, T32 GM007288] Funding Source: Medline; PHS HHS [1R01AIGM053212] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel-Santos E, 2007, NEW J CHEM, V31, P748, DOI 10.1039/b616695d; Akoachere M, 2007, J BIOL CHEM, V282, P12112, DOI 10.1074/jbc.M611432200; Alberto FO, 2005, FEMS MICROBIOL LETT, V253, P231, DOI 10.1016/j.femsle.2005.09.037; Atluri S, 2006, J BACTERIOL, V188, P28, DOI 10.1128/JB.188.1.28-36.2006; Barlass PJ, 2002, MICROBIOL-SGM, V148, P2089, DOI 10.1099/00221287-148-7-2089; Caipo ML, 2002, J APPL MICROBIOL, V92, P879, DOI 10.1046/j.1365-2672.2002.01597.x; Cantani A, 1974, Antibiotica, V12, P69; Chirakkal H, 2002, MICROBIOL-SGM, V148, P2383, DOI 10.1099/00221287-148-8-2383; Clements MO, 1998, J BACTERIOL, V180, P6729, DOI 10.1128/JB.180.24.6729-6735.1998; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Fisher N, 2005, J BACTERIOL, V187, P8055, DOI 10.1128/JB.187.23.8055-8062.2005; GOULD GW, 1966, J BACTERIOL, V92, P1261, DOI 10.1128/JB.92.4.1261-1262.1966; Hamouda T, 2002, LETT APPL MICROBIOL, V34, P86, DOI 10.1046/j.1472-765x.2002.01047.x; Hornstra LM, 2006, APPL ENVIRON MICROB, V72, P44, DOI 10.1128/AEM.72.1.44-53.2006; Ireland JAW, 2002, J BACTERIOL, V184, P1296, DOI 10.1128/JB.184.5.1296-1303.2002; Ireland JAW, 2002, INFECT IMMUN, V70, P5870, DOI 10.1128/IAI.70.10.5870-5872.2002; KEYNAN A, 1962, J BACTERIOL, V83, P100, DOI 10.1128/JB.83.1.100-105.1962; LEVINSON HS, 1966, J BACTERIOL, V91, P1811, DOI 10.1128/JB.91.5.1811-1818.1966; LEWIS JC, 1967, ANAL BIOCHEM, V19, P327, DOI 10.1016/0003-2697(67)90168-6; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; NELSON DL, 1970, J BIOL CHEM, V245, P1128; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Ragkousi K, 2003, J BACTERIOL, V185, P2315, DOI 10.1128/JB.185.7.2315-2329.2003; RIEMANN H, 1961, SCIENCE, V133, P1703, DOI 10.1126/science.133.3465.1703; SANCHEZSALAS JL, 1992, J BACTERIOL, V174, P807, DOI 10.1128/jb.174.3.807-814.1992; SENESI S, 1991, J GEN MICROBIOL, V137, P399, DOI 10.1099/00221287-137-2-399; Setlow B, 2008, J BACTERIOL, V190, P4759, DOI 10.1128/JB.00399-08; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1976, J BACTERIOL, V127, P1015, DOI 10.1128/JB.127.2.1015-1017.1976; SETLOW P, 1975, J BIOL CHEM, V250, P623; SHIBATA H, 1986, CAN J MICROBIOL, V32, P186, DOI 10.1139/m86-038; Spies MA, 2003, BIOCHEMISTRY-US, V42, P5099, DOI 10.1021/bi0274064; Stepaniak L, 2000, J FOOD PROTECT, V63, P1447, DOI 10.4315/0362-028X-63.10.1447; VARY JC, 1973, J BACTERIOL, V116, P797, DOI 10.1128/JB.116.2.797-802.1973; WARREN SC, 1968, BIOCHIM BIOPHYS ACTA, V170, P341, DOI 10.1016/0304-4165(68)90014-7; Weiner M, 2003, J BACTERIOL, V185, P1462, DOI 10.1128/JB.185.4.1462-1464.2003; Yan XH, 2007, ARCH MICROBIOL, V187, P371, DOI 10.1007/s00203-006-0201-x; YASUDA Y, 1985, MICROBIOL IMMUNOL, V29, P229, DOI 10.1111/j.1348-0421.1985.tb00822.x; Zhang QF, 2005, J AM SOC MASS SPECTR, V16, P1192, DOI 10.1016/j.jasms.2005.03.052	41	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6398	10.1371/journal.pone.0006398	http://dx.doi.org/10.1371/journal.pone.0006398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636427	gold, Green Published, Green Submitted			2022-12-25	WOS:000268404900019
J	Kingsford, C; Nagarajan, N; Salzberg, SL				Kingsford, Carl; Nagarajan, Niranjan; Salzberg, Steven L.			2009 Swine-Origin Influenza A (H1N1) Resembles Previous Influenza Isolates	PLOS ONE			English	Article							VIRUSES; PIGS	Background: In April 2009, novel swine-origin influenza viruses (S-OIV) were identified in patients from Mexico and the United States. The viruses were genetically characterized as a novel influenza A (H1N1) strain originating in swine, and within a very short time the S-OIV strain spread across the globe via human-to-human contact. Methodology: We conducted a comprehensive computational search of all available sequences of the surface proteins of H1N1 swine influenza isolates and found that a similar strain to S-OIV appeared in Thailand in 2000. The earlier isolates caused infections in pigs but only one sequenced human case, A/Thailand/271/2005 (H1N1). Significance: Differences between the Thai cases and S-OIV may help shed light on the ability of the current outbreak strain to spread rapidly among humans.			Kingsford, C (corresponding author), Univ Maryland, Inst Adv Comp Studies, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	carlk@umiacs.umd.edu	Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Nagarajan, Niranjan/0000-0003-0850-5604	NIGMS NIH HHS [R01 GM083873, R01-GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845, R01 LM006845-10] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Chutinimitkul S, 2008, ARCH VIROL, V153, P1049, DOI 10.1007/s00705-008-0097-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRASER C, 2009, SCIENCE; Komadina N, 2007, VIRUS GENES, V35, P161, DOI 10.1007/s11262-007-0097-9; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Nagarajan N, 2008, IEEE INT C BIOINFORM, P223, DOI 10.1109/BIBM.2008.78; *NOV SWIN OR INFL, 2009, N ENGL J MED; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SHINDE V, 2009, N ENGL J MED; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sreta D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-34; Takemae N, 2008, INFLUENZA OTHER RESP, V2, P181, DOI 10.1111/j.1750-2659.2008.00062.x; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	14	36	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6402	10.1371/journal.pone.0006402	http://dx.doi.org/10.1371/journal.pone.0006402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636415	Green Published, gold, Green Submitted			2022-12-25	WOS:000268404900022
J	Benson, SA; Ernst, JD				Benson, Sarah A.; Ernst, Joel D.			TLR2-Dependent Inhibition of Macrophage Responses to IFN-gamma Is Mediated by Distinct, Gene-Specific Mechanisms	PLOS ONE			English	Article								Mycobacterium tuberculosis uses multiple mechanisms to avoid elimination by the immune system. We have previously shown that M. tuberculosis can inhibit selected macrophage responses to IFN-gamma through TLR2-dependent and -independent mechanisms. To specifically address the role of TLR2 signaling in mediating this inhibition, we stimulated macrophages with the specific TLR2/1 ligand Pam(3)CSK(4) and assayed responses to IFN-gamma. Pam(3)CSK(4) stimulation prior to IFN-gamma inhibited transcription of the unrelated IFN-gamma-inducible genes, CIITA and CXCL11. Surface expression of MHC class II and secretion of CXCL11 were greatly reduced as well, indicating that the reduction in transcripts had downstream effects. Inhibition of both genes required new protein synthesis. Using chromatin immunoprecipitation, we found that TLR2 stimulation inhibited IFN-gamma-induced RNA polymerase II binding to the CIITA and CXCL11 promoters. Furthermore, TATA binding protein was unable to bind the TATA box of the CXCL11 promoter, suggesting that assembly of transcriptional machinery was disrupted. However, TLR2 stimulation affected chromatin modifications differently at each of the inhibited promoters. Histone H3 and H4 acetylation was reduced at the CIITA promoter but unaffected at the CXCL11 promoter. In addition, NF-kappa B signaling was required for inhibition of CXCL11 transcription, but not for inhibition of CIITA. Taken together, these results indicate that TLR2-dependent inhibition of IFN-gamma-induced gene expression is mediated by distinct, gene-specific mechanisms that disrupt binding of the transcriptional machinery to the promoters.			Benson, SA (corresponding author), NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10003 USA.	joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207	NIAID NIH HHS [R01 AI046097] Funding Source: Medline; PHS HHS [RAI046097] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046097] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; BARNES PF, 1989, J IMMUNOL, V142, P1114; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BHARDWAJ N, 1986, J IMMUNOL, V137, P2662; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; DOUVAS GS, 1985, INFECT IMMUN, V50, P1; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; Gaston K, 2003, CELL MOL LIFE SCI, V60, P721, DOI 10.1007/s00018-003-2260-3; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gupta AK, 1999, AM J PHYSIOL-RENAL, V276, pF599, DOI 10.1152/ajprenal.1999.276.4.F599; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Lafuse WP, 2006, J INTERF CYTOK RES, V26, P548, DOI 10.1089/jir.2006.26.548; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MURRAY HW, 1983, J CLIN INVEST, V72, P1506, DOI 10.1172/JCI111107; MURRAY HW, 1991, INFECT IMMUN, V59, P4684, DOI 10.1128/IAI.59.12.4684-4686.1991; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pennini ME, 2007, J IMMUNOL, V179, P6910, DOI 10.4049/jimmunol.179.10.6910; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Popkin DL, 2003, P NATL ACAD SCI USA, V100, P14309, DOI 10.1073/pnas.1835673100; ROOK GAW, 1986, IMMUNOLOGY, V59, P333; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; SKERRETT SJ, 1994, AM J RESP CRIT CARE, V149, P50, DOI 10.1164/ajrccm.149.1.8111597; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Stoiber D, 1999, J IMMUNOL, V163, P2640; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Ting LM, 1999, J IMMUNOL, V163, P3898; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Wang Y, 2005, J IMMUNOL, V174, P5687, DOI 10.4049/jimmunol.174.9.5687; Weidman MK, 2003, VIRUS RES, V95, P75, DOI 10.1016/S0168-1702(03)00164-3; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70; Yuan H, 1998, VIROLOGY, V251, P383, DOI 10.1006/viro.1998.9413; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	64	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6329	10.1371/journal.pone.0006329	http://dx.doi.org/10.1371/journal.pone.0006329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629181	Green Published, gold, Green Submitted			2022-12-25	WOS:000268318900003
J	Rosenfeld, R; Marcus, H; Ben-Arie, E; Lachmi, BE; Mechaly, A; Reuveny, S; Gat, O; Mazor, O; Ordentlich, A				Rosenfeld, Ronit; Marcus, Hadar; Ben-Arie, Einat; Lachmi, Bat-El; Mechaly, Adva; Reuveny, Shaul; Gat, Orit; Mazor, Ohad; Ordentlich, Arie			Isolation and Chimerization of a Highly Neutralizing Antibody Conferring Passive Protection against Lethal Bacillus anthracis Infection	PLOS ONE			English	Article								Several studies have demonstrated that the passive transfer of protective antigen (PA)-neutralizing antibodies can protect animals against Bacillus anthracis infection. The standard protocol for the isolation of PA-neutralizing monoclonal antibodies is based upon a primary selection of the highest PA-binders by ELISA, and usually yields only few candidates antibodies. We demonstrated that by applying a PA-neutralization functionality-based screen as the primary criterion for positive clones, it was possible to isolate more than 100 PA-neutralizing antibodies, some of which exhibited no measurable anti-PA titers in ELISA. Among the large panel of neutralizing antibodies identified, mAb 29 demonstrated the most potent activity, and was therefore chimerized. The variable region genes of the mAb 29 were fused to human constant region genes, to form the chimeric 29 antibody (cAb 29). Guinea pigs were fully protected against infection by 40LD(50) B. anthracis spores following two separate administrations with 10 mg/kg of cAb 29: the first administration was given before the challenge, and a second dose was administered on day 4 following exposure. Moreover, animals that survived the challenge and developed endogenous PA-neutralizing antibodies with neutralizing titers above 100 were fully protected against repeat challenges with 40LD(50) of B. anthracis spores. The data presented here emphasize the importance of toxin neutralization-based screens for the efficient isolation of protective antibodies that were probably overlooked in the standard screening protocol. The protective activity of the chimeric cAb 29 demonstrated in this study suggest that it may serve as an effective immunotherapeutic agent against anthrax.			Rosenfeld, R (corresponding author), Israel Inst Biol Res, Dept Biochem, IL-70450 Ness Ziona, Israel.	arieo@iibr.gov.il						Albrecht MT, 2007, INFECT IMMUN, V75, P5425, DOI 10.1128/IAI.00261-07; Atlas RM, 2001, CRIT REV MICROBIOL, V27, P355, DOI 10.1080/20014091096783; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; Chen ZC, 2006, J INFECT DIS, V193, P625, DOI 10.1086/500148; Cohen S, 2000, INFECT IMMUN, V68, P4549, DOI 10.1128/IAI.68.8.4549-4558.2000; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; Gubbins MJ, 2006, FEMS IMMUNOL MED MIC, V47, P436, DOI 10.1111/j.1574-695X.2006.00114.x; Ivins BE, 1998, VACCINE, V16, P1141, DOI 10.1016/S0264-410X(98)80112-6; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Karginov VA, 2004, FEMS IMMUNOL MED MIC, V40, P71, DOI 10.1016/S0928-8244(03)00302-X; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LUSTIG S, 2009, VACCINE; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Peterson JW, 2007, INFECT IMMUN, V75, P3414, DOI 10.1128/IAI.00352-07; Reiter Y, 2002, CURRENT PROTOCOLS IM, V10, p9B; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Rowland M, 1995, CLIN PHARMACOKINETIC; SAWADAHIRAI R, 2004, J IMMUNE BASED THERA, V2; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Tabrizi MA, 2007, DRUG DISCOV TODAY, V12, P540, DOI 10.1016/j.drudis.2007.05.010; Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004; Vitale L, 2006, INFECT IMMUN, V74, P5840, DOI 10.1128/IAI.00712-06; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; Zhang J, 2006, BIOCHEM BIOPH RES CO, V341, P1164, DOI 10.1016/j.bbrc.2006.01.080; Zhou B, 2008, BIOORGAN MED CHEM, V16, P1903, DOI 10.1016/j.bmc.2007.11.001	33	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6351	10.1371/journal.pone.0006351	http://dx.doi.org/10.1371/journal.pone.0006351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629185	gold, Green Published, Green Submitted			2022-12-25	WOS:000268318900005
J	Swistowski, A; Peng, J; Han, Y; Swistowska, AM; Rao, MS; Zeng, XM				Swistowski, Andrzej; Peng, Jun; Han, Yi; Swistowska, Anna Maria; Rao, Mahendra S.; Zeng, Xianmin			Xeno-Free Defined Conditions for Culture of Human Embryonic Stem Cells, Neural Stem Cells and Dopaminergic Neurons Derived from Them	PLOS ONE			English	Article							PARKINSONS-DISEASE; UNDIFFERENTIATED GROWTH; SUBSTANTIA-NIGRA; SELF-RENEWAL; TRANSPLANTATION; SURVIVAL; LINES; RATS; DIFFERENTIATION; GRAFTS	Background: Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To move hESCs towards the clinic it is important that cells with therapeutic potential be reproducibly generated under completely defined conditions. Methodology/Principal Findings: Here we report a four-step scalable process that is readily transferable to a Good Manufacture Practice (GMP) facility for the production of functional dopaminergic neurons from hESCs for potential clinical uses. We show that each of the steps (propagation of ESC -> generation of neural stem cells (NSC)-> induction of dopaminergic precursors -> maturation of dopaminergic neurons) could utilize xeno-free defined media and substrate, and that cells could be stored at intermediate stages in the process without losing their functional ability. Neurons generated by this process expressed midbrain and A9 dopaminergic markers and could be transplanted at an appropriate time point in development to survive after transplant. Conclusions/Significance: hESCs and NSCs can be maintained in xeno-free defined media for a prolonged period of time while retaining their ability to differentiate into authentic dopaminergic neurons. Our defined medium system provides a path to a scalable GMP-applicable process of generation of dopaminergic neurons from hESCs for therapeutic applications, and a ready source of large numbers of neurons for potential screening applications.			Swistowski, A (corresponding author), Buck Inst Age Res, Novato, CA USA.	xzeng@buckinstitute.org						Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; FREED WJ, 1980, ANN NEUROL, V8, P510, DOI 10.1002/ana.410080508; ILIC D, 2009, STEM CELLS DEV; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Peng J, 2002, J BIOL CHEM, V277, P44285, DOI 10.1074/jbc.M207407200; Peng J, 2007, J NEUROSCI, V27, P6914, DOI 10.1523/JNEUROSCI.1569-07.2007; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; ROY NS, 2006, NAT MED; Schulz TC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-478; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; SWISTOWSKA AM, 2009, STEM CELLS IN PRESS; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Zeng XM, 2003, STEM CELLS, V21, P647, DOI 10.1634/stemcells.21-6-647	30	108	119	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6233	10.1371/journal.pone.0006233	http://dx.doi.org/10.1371/journal.pone.0006233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597550	Green Submitted, gold, Green Published			2022-12-25	WOS:000268035600007
J	Trotard, M; Lepere-Douard, C; Regeard, M; Piquet-Pellorce, C; Lavillette, D; Cosset, FL; Gripon, P; Le Seyec, J				Trotard, Maud; Lepere-Douard, Charlotte; Regeard, Morgane; Piquet-Pellorce, Claire; Lavillette, Dimitri; Cosset, Francois-Loic; Gripon, Philippe; Le Seyec, Jacques			Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening	FASEB JOURNAL			English	Article						hepacivirus; virus internalization; endocytosis; replicon; 1-phosphatidylinositol 4-kinase	CLATHRIN-MEDIATED ENDOCYTOSIS; DENSITY-LIPOPROTEIN RECEPTOR; PRIMARY HUMAN HEPATOCYTES; EFFICIENT REPLICATION; SCAVENGER RECEPTOR; PHOSPHATIDYLINOSITOL 4-KINASE; CELL-CULTURE; HOST-CELLS; IN-VITRO; INFECTION	The entry pathway of the hepatitis C virus (HCV), a major human pathogen, into the cell is incompletely defined. To better characterize this viral life cycle stage, we screened a small interfering RNA library dedicated to the membrane trafficking and remodeling with the infection model of Huh-7.5.1 cells by HCV pseudoparticles (HCVpp). Results showed that the down-regulation of different factors implied in clathrin-mediated endocytosis (CME) inhibits HCVpp cell infection. In addition, knockdown of the phosphatidylinositol 4-kinase type III-alpha (PI4KIII alpha) prevented infection by HCVpp or by cell-culture grown JFH-1-based HCV. Moreover, the replication activity of an HCV replicon was also affected by the PI4KIII alpha knockdown. Additional investigations on the different members of the PI4K family revealed that the presence of PI4KIII beta in the host cells influenced their susceptibility to HCVpp infection and their capacity to sustain the HCV replication. The PI4KIII involvement during the HCV life cycle seemed to occur by other ways than the control of the CME or of the membranous expression of HCV receptors. Finally, our library screening completed data on the CME-dependant entry route of HCV and identified 2 kinases, PI4KIII alpha and beta, as relevant potential therapeutic targets.-Trotard, M., Lepere-Douard, C., Regeard, M., Piquet-Pellorce, C., Lavillette, D., Cosset, F.-L., Gripon, P., Le Seyec, J. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J. 23, 3780-3789 (2009). www.fasebj.org	[Le Seyec, Jacques] Univ Rennes 1, EA SERAIC 4427, Fac Pharm, IFR 140, F-35043 Rennes, France; [Lavillette, Dimitri; Cosset, Francois-Loic] Univ Lyon, UCB Lyon1, IFR 128, Lyon, France; [Trotard, Maud; Lepere-Douard, Charlotte; Regeard, Morgane; Gripon, Philippe; Le Seyec, Jacques] INSERM, U522, Rennes, France; [Lavillette, Dimitri; Cosset, Francois-Loic] INSERM, U758, F-69008 Lyon, France; [Lavillette, Dimitri; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France	Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON)	Le Seyec, J (corresponding author), Univ Rennes 1, EA SERAIC 4427, Fac Pharm, IFR 140, Ave Prof Leon Bernard, F-35043 Rennes, France.	jacques.leseyec@univ-rennes1.fr	Le Seyec, Jacques/J-5680-2015; GRIPON, Philippe/J-6068-2015; PIQUET-PELLORCE, Claire SL/I-4195-2015; Cosset, François-Loïc/M-5862-2019; Le Seyec, Jacques/GLU-3933-2022	PIQUET-PELLORCE, Claire SL/0000-0003-3198-1975; Cosset, François-Loïc/0000-0001-8842-3726; Le Seyec, Jacques/0000-0002-1118-3311; Lavillette, Dimitri/0000-0002-4706-1519				Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Ahn J, 2004, J BIOCHEM MOL BIOL, V37, P741; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Bruns JR, 2002, J BIOL CHEM, V277, P2012, DOI 10.1074/jbc.M108571200; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Molina S, 2008, J VIROL, V82, P569, DOI 10.1128/JVI.01443-07; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Rumin S, 1999, J GEN VIROL, V80, P3007, DOI 10.1099/0022-1317-80-11-3007; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Thomson BJ, 2005, CLIN MICROBIOL INFEC, V11, P86, DOI 10.1111/j.1469-0691.2004.01061.x; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	48	114	117	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3780	3789		10.1096/fj.09-131920	http://dx.doi.org/10.1096/fj.09-131920			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19608626				2022-12-25	WOS:000271272500015
J	Alencastre, IS; Rodrigues, TA; Grou, CP; Fransen, M; Sa-Miranda, C; Azevedo, JE				Alencastre, Ines S.; Rodrigues, Tony A.; Grou, Claudia P.; Fransen, Marc; Sa-Miranda, Clara; Azevedo, Jorge E.			Mapping the Cargo Protein Membrane Translocation Step into the PEX5 Cycling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL TARGETING SIGNAL; RAT-LIVER PEROXISOMES; ACYL-COA OXIDASE; IN-VITRO IMPORT; PTS1 RECEPTOR; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; 3-OXOACYL-COA THIOLASE; CONSERVED CYSTEINE; MASS-SPECTROMETRY	Newly synthesized peroxisomal matrix proteins are targeted to the organelle by PEX5, the peroxisomal cycling receptor. Over the last few years, valuable data on the mechanism of this process have been obtained using a PEX5-centered in vitro system. The data gathered until now suggest that cytosolic PEX5. cargo protein complexes dock at the peroxisomal docking/translocation machinery, where PEX5 becomes subsequently inserted in an ATP-independent manner. This PEX5 species is then monoubiquitinated at a conserved cysteine residue, a mandatory modification for the next step of the pathway, the ATP-dependent dislocation of the ubiquitin-PEX5 conjugate back into the cytosol. Finally, the ubiquitin moiety is removed, yielding free PEX5. Despite its usefulness, there are many unsolved mechanistic aspects that cannot be addressed with this in vitro system and that call for a cargo protein-centered perspective instead. Here we describe a robust peroxisomal in vitro import system that provides this perspective. The data obtained with it suggest that translocation of a cargo protein across the peroxisomal membrane, including its release into the organelle matrix, occurs prior to PEX5 ubiquitination.	[Alencastre, Ines S.; Rodrigues, Tony A.; Grou, Claudia P.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Alencastre, Ines S.; Grou, Claudia P.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4009003 Oporto, Portugal; [Fransen, Marc] Katholieke Univ Leuven, Dept Mol Celbiol, Fac Geneeskunde, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Fransen, Marc/C-6262-2008; Azevedo, Jorge E/A-4113-2008; Grou, Claudia P/K-5472-2013; Rodrigues, Tony A. Q./K-1141-2014; sá Miranda, Maria Clara/K-3920-2013; Fransen, Marc/ADL-0723-2022	Fransen, Marc/0000-0001-9284-1197; Azevedo, Jorge E/0000-0001-7714-5302; Grou, Claudia P/0000-0001-5197-2270; Rodrigues, Tony A. Q./0000-0003-2311-8258; sá Miranda, Maria Clara/0000-0003-0123-5525; Alencastre, Ines/0000-0002-5591-5596	Fundacao para a Ciencia e Tecnologia; Fundo Europeu de Desenvolvimento Regional, Portugal; European Union VI Framework program [LSHG-CT-2004-512018]; Peroxisomes in Health and Disease	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional, Portugal; European Union VI Framework program(European Commission); Peroxisomes in Health and Disease	The work was supported by grants from Fundacao para a Ciencia e Tecnologia (PTDC program) and Fundo Europeu de Desenvolvimento Regional, Portugal and by the European Union VI Framework program Grant LSHG-CT-2004-512018, Peroxisomes in Health and Disease.	Agah A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh159; Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; ALEXSON SEH, 1985, J CELL BIOL, V101, P294, DOI 10.1083/jcb.101.1.294; Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; BOUT A, 1988, NUCLEIC ACIDS RES, V16, P10369, DOI 10.1093/nar/16.21.10369; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; FUJIKI Y, 1985, J BIOL CHEM, V260, P5603; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Gatto GJ, 2000, PROTEINS, V38, P241, DOI 10.1002/(SICI)1097-0134(20000215)38:3<241::AID-PROT1>3.0.CO;2-1; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; Helm M, 2007, P NATL ACAD SCI USA, V104, P11501, DOI 10.1073/pnas.0704733104; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; KRUSE M, 1995, J BIOL CHEM, V270, P2588, DOI 10.1074/jbc.270.6.2588; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; MIURA S, 1994, J BIOCHEM-TOKYO, V115, P1064, DOI 10.1093/oxfordjournals.jbchem.a124458; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2009, BBA-MOL CELL RES, V1793, P860, DOI 10.1016/j.bbamcr.2009.02.007; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Omi S, 2008, J BIOCHEM, V143, P649, DOI 10.1093/jb/mvn020; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; VANVELDHOVEN P, 1983, BIOCHEM J, V210, P685, DOI 10.1042/bj2100685; WALTON PA, 1992, MOL CELL BIOL, V12, P531, DOI 10.1128/MCB.12.2.531; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Williams C, 2006, BBA-MOL CELL RES, V1763, P1585, DOI 10.1016/j.bbamcr.2006.09.007; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422	63	35	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27243	27251		10.1074/jbc.M109.032565	http://dx.doi.org/10.1074/jbc.M109.032565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19632994	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000270232300025
J	Said, N; Frierson, HF; Chernauskas, D; Conaway, M; Motamed, K; Theodorescu, D				Said, N.; Frierson, H. F., Jr.; Chernauskas, D.; Conaway, M.; Motamed, K.; Theodorescu, D.			The role of SPARC in the TRAMP model of prostate carcinogenesis and progression	ONCOGENE			English	Article						prostate neoplasms; SPARC/osteonectin; mice; TRAMP	CELL LUNG-CANCER; OVARIAN-CANCER; EXTRACELLULAR-MATRIX; TRANSGENIC MOUSE; CYSTEINE SPARC; POOR-PROGNOSIS; NULL MICE; PROMOTER HYPERMETHYLATION; ABERRANT METHYLATION; ENHANCED GROWTH	SPARC (Secreted Protein Acidic and Rich in Cysteine), is a matricellular glycoprotein that is produced by tumor and/or neighboring stroma. In human prostate cancer, SPARC immunoreactivity is highest in metastatic lesions but distinct contributions of tumoral and stromal SPARC to tumorigenesis and progression are unclear. To determine the role of SPARC in primary prostate tumorigenesis, we crossed SPARC-null (SP-/-) with TRAMP (Transgenic Adenocarcinoma of Mouse Prostate) mice. TRAMP(+)/SP-/- mice exhibited accelerated cancer development and progression. Compared to their TRAMP(+)/SP-/- counterparts, TRAMP(+)/SP+/+ tumors had fewer proliferating cells, and decreased cyclins A and D1 with increased p21(Cip) and p27(Kip). Similar effects on proliferation and cell-cycle regulators were observed in human prostate cancer cell lines, transiently transfected with pSPARC. TRAMP(+)/SP-/- tumors exhibited decreased stromal collagen, enhanced matrix metalloproteinase activity and increased vascular endothelial growth factor, proinflammatory cytokines. To determine the contribution of stromal SPARC, we evaluated subcutaneous tumor growth of TRAMP cell lines in syngeneic SP+/+ and SP-/- mice. Enhanced growth, decreased stromal collagen and increased proteolysis were noted in SP-/- mice. Our findings demonstrate that both tumor and stromal SPARC are limiting for primary prostate tumorigenesis and progression, through effects on the cell cycle and the creation of a less favorable tumor microenvironment. Oncogene (2009) 28, 3487-3498; doi: 10.1038/onc.2009.205; published online 13 July 2009	[Theodorescu, D.] Univ Virginia, Hlth Sci Ctr, Dept Urol, Charlottesville, VA 22908 USA; [Said, N.; Chernauskas, D.; Theodorescu, D.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Frierson, H. F., Jr.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Conaway, M.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Motamed, K.] Univ Virginia, Med Coll Georgia, Vasc Biol Ctr, Charlottesville, VA 22908 USA; [Theodorescu, D.] Univ Virginia, Paul Mellon Urol Canc Inst, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Theodorescu, D (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Urol, Box 800422, Charlottesville, VA 22908 USA.	dt9d@virginia.edu			NIH [CA104106, K01-CA089689]; Georgia Cancer Coalition [GCC0023]; NATIONAL CANCER INSTITUTE [P01CA104106, K01CA089689] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH CA104106 (DT) and Georgia Cancer Coalition grant GCC0023 (KM) and the National Institutes of Health grants K01-CA089689 (KM).	Aycock RL, 2004, J INVEST DERMATOL, V123, P592, DOI 10.1111/j.0022-202X.2004.23316.x; Basu A, 1999, CELL GROWTH DIFFER, V10, P721; Bennett WP, 1998, CLIN CANCER RES, V4, P1499; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4; Cheetham S, 2008, BRIT J CANCER, V98, P1810, DOI 10.1038/sj.bjc.6604377; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Chin D, 2005, INT J CANCER, V113, P789, DOI 10.1002/ijc.20608; Chlenski A, 2007, ONCOGENE, V26, P4513, DOI 10.1038/sj.onc.1210247; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Francki A, 2003, J CELL BIOCHEM, V88, P802, DOI 10.1002/jcb.10424; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Gingrich JR, 1996, CANCER RES, V56, P4096; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Jacob K, 1999, CANCER RES, V59, P4453; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kahn SL, 2008, CANCER CYTOPATHOL, V114, P57, DOI 10.1002/cncr.23258; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kato Y, 2005, INT J MOL MED, V16, P263; Kelloff GJ, 2006, CLIN CANCER RES, V12, P3661, DOI 10.1158/1078-0432.CCR-06-1104; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Koukourakis MI, 2003, CANCER RES, V63, P5376; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; MAITLAND N, 2008, METASTASIS PROSTATE, P21; Motamed K, 2002, J CELL BIOCHEM, V84, P759, DOI 10.1002/jcb.10095; Pan MR, 2008, EXP BIOL MED, V233, P456, DOI 10.3181/0709-RM-257; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Podhajcer OL, 2008, CANCER METAST REV, V27, P523, DOI 10.1007/s10555-008-9135-x; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Rodriguez-Jimenez FJ, 2007, ONCOL REP, V17, P1301; Roy S, 2007, MOL CANCER THER, V6, P2696, DOI 10.1158/1535-7163.MCT-07-0104; SAGE H, 1989, J MOL CELL CARDIOL, V21, P13, DOI 10.1016/0022-2828(89)90833-X; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2007, MOL CANCER RES, V5, P1015, DOI 10.1158/1541-7786.MCR-07-0001; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Said NA, 2007, NEOPLASIA, V9, P23, DOI 10.1593/neo.06658; Sangaletti S, 2003, J EXP MED, V198, P1475, DOI 10.1084/jem.20030202; Sansom OJ, 2007, GUT, V56, P1410, DOI 10.1136/gut.2006.116921; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schultz C, 2002, CANCER RES, V62, P6270; Seraj MJ, 2001, CLIN CANCER RES, V7, P1516; Socha MJ, 2009, NEOPLASIA, V11, P126, DOI 10.1593/neo.81146; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Suzuki M, 2005, BRIT J CANCER, V92, P942, DOI 10.1038/sj.bjc.6602376; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Wong SY, 2008, CLIN EXP METASTAS, V25, P109, DOI 10.1007/s10585-007-9126-2; Woodward JKL, 2007, BONE, V41, P912, DOI 10.1016/j.bone.2007.07.024; Yamashita K, 2003, CANCER, V97, P2412, DOI 10.1002/cncr.11368; Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706	60	50	53	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	39					3487	3498		10.1038/onc.2009.205	http://dx.doi.org/10.1038/onc.2009.205			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	502RR	19597474				2022-12-25	WOS:000270478300006
J	King, EM; Holden, NS; Gong, W; Rider, CF; Newton, R				King, Elizabeth M.; Holden, Neil S.; Gong, Wei; Rider, Christopher F.; Newton, Robert			Inhibition of NF-kappa B-dependent Transcription by MKP-1 TRANSCRIPTIONAL REPRESSION BY GLUCOCORTICOIDS OCCURRING VIA p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; DUAL-SPECIFICITY PHOSPHATASE-1; AIRWAY INFLAMMATORY DISEASE; PULMONARY EPITHELIAL-CELLS; INDUCED LEUCINE-ZIPPER; GLUCOCORTICOID-RECEPTOR; DNA-BINDING; GENE-EXPRESSION	Acting via the glucocorticoid receptor (GR), glucocorticoids exert potent anti-inflammatory effects partly by repressing inflammatory gene transcription occurring via factors such as NF-kappa B. In the present study, the synthetic glucocorticoid, dexamethasone, induces expression of MKP-1 (mitogen-activated protein kinase (MAPK) phosphatase-1) in human bronchial epithelial (BEAS-2B) and pulmonary (A549) cells. This correlates with reduced TNF alpha-stimulated p38 MAPK phosphorylation. Since NF-kappa B-dependent transcription and IL-8 protein, mRNA, and unspliced RNA (a surrogate of transcription rate) are sensitive to p38 MAPK inhibitors (SB203580 and SB239063), we explored the role of MKP-1 in repression of these outputs. Repression of TNF alpha-induced p38 MAPK phosphorylation, NF-kappa B-dependent transcription, and IL-8 expression by dexamethasone are sensitive to transcriptional or translational inhibitors. This indicates a role for de novo gene synthesis. Adenoviral expression of MKP-1 profoundly reduces p38 MAPK phosphorylation and IL-8 expression. Similarly, NF-kappa B-dependent transcription is significantly reduced to levels consistent with maximal p38 MAPK inhibition. Thus, MKP-1 attenuates TNF alpha-dependent activation of p38 MAPK, induction of IL-8 expression, and NF-kappa B-dependent transcription. Small interfering RNA knockdown of dexamethasone-induced MKP-1 expression partially reverses the repression of TNF alpha-activated p38 MAPK, demonstrating that MKP-1 participates in the dexamethasone-dependent repression of this pathway. In the presence of MKK6 (MAPK kinase 6), a p38 MAPK activator, dexamethasone dramatically represses TNF alpha-induced NF-kappa B-dependent transcription, and this is significantly reversed by MKP-1-targeting small interfering RNA. This reveals an important and novel role for transcriptional activation (transactivation) of MKP-1 in the repression of NF-kappa B-dependent transcription by glucocorticoids. We conclude that GR transactivation is essential to the anti-inflammatory properties of GR ligands.	[Newton, Robert] Univ Calgary, Dept Cell Biol & Anat, Fac Med, Airways Inflammat Grp, Calgary, AB T2N 4N1, Canada	University of Calgary	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Fac Med, Airways Inflammat Grp, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	Newton, Robert/C-6814-2012; Rider, Christopher F/H-7073-2019	Newton, Robert/0000-0002-4919-8498; Rider, Christopher F/0000-0003-0399-5931; Holden, Neil/0000-0001-5824-3417	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research (CIHR); Lung Association of Alberta and the North West Territories Studentship; Izaak Walton Killam Postdoctoral Fellowship; Canadian Fund of Innovation; Alberta Science and Research Authority	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta and the North West Territories Studentship; Izaak Walton Killam Postdoctoral Fellowship; Canadian Fund of Innovation; Alberta Science and Research Authority	This work was supported by a start-up grant from the Alberta Heritage Foundation for Medical Research (AHFMR) (to R. N.) and operating grants from the Canadian Institutes of Health Research (CIHR) (to R. N.), a Lung Association of Alberta and the North West Territories Studentship (to E. M. K.), and an Izaak Walton Killam Postdoctoral Fellowship (to N. S. H.). Real time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund of Innovation and the Alberta Science and Research Authority.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bratton MR, 2009, CARCINOGENESIS, V30, P106, DOI 10.1093/carcin/bgn213; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Catley MC, 2005, BRIT J PHARMACOL, V145, P114, DOI 10.1038/sj.bjp.0706170; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Cho IJ, 2009, MOL ENDOCRINOL, V23, P86, DOI 10.1210/me.2008-0257; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Holden NS, 2007, BRIT J PHARMACOL, V152, P891, DOI 10.1038/sj.bjp.0707457; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kang BN, 2008, AM J PHYSIOL-LUNG C, V295, pL186, DOI 10.1152/ajplung.00352.2007; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Newton Robert, 2006, Drug Discov Today Dis Mech, V3, P53, DOI 10.1016/j.ddmec.2006.02.007; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Simons SS, 2006, CURR TOP MED CHEM, V6, P271, DOI 10.2174/156802606776173465; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Uings IJ, 2005, CURR OPIN PHARMACOL, V5, P221, DOI 10.1016/j.coph.2004.12.003; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139	58	106	110	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26803	26815		10.1074/jbc.M109.028381	http://dx.doi.org/10.1074/jbc.M109.028381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648110	Green Published, hybrid			2022-12-25	WOS:000269969600062
J	Ichinose, H; Fujimoto, Z; Honda, M; Harazono, K; Nishimoto, Y; Uzura, A; Kaneko, S				Ichinose, Hitomi; Fujimoto, Zui; Honda, Mariko; Harazono, Koichi; Nishimoto, Yukifumi; Uzura, Atsuko; Kaneko, Satoshi			A beta-L-Arabinopyranosidase from Streptomyces avermitilis Is a Novel Member of Glycoside Hydrolase Family 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABINOGALACTAN-PROTEINS; MOLECULAR GRAPHICS; CAJANUS-INDICUS; L-ARABINOSIDASE; BINDING MODULE; NBRC14893; XYLANASE; GLYCOPROTEINS; CRYSTALS; ARABINAN	Arabinogalactan proteins (AGPs) are a family of plant cell surface proteoglycans and are considered to be involved in plant growth and development. Because AGPs are very complex molecules, glycoside hydrolases capable of degrading AGPs are powerful tools for analyses of the AGPs. We previously reported such enzymes from Streptomyces avermitilis. Recently, a beta-L-arabinopyranosidase was purified from the culture supernatant of the bacterium, and its corresponding gene was identified. The primary structure of the protein revealed that the catalytic module was highly similar to that of glycoside hydrolase family 27 (GH27) alpha-D-galactosidases. The recombinant protein was successfully expressed as a secreted 64-kDa protein using a Streptomyces expression system. The specific activity toward p-nitrophenyl-beta-L-arabinopyranoside was 18 mu mol of arabinose/min/mg, which was 67 times higher than that toward p-nitrophenyl-alpha-D-galactopyranoside. The enzyme could remove 0.1 and 45% L-arabinose from gum arabic or larch arabinogalactan, respectively. X-ray crystallographic analysis reveals that the protein had a GH27 catalytic domain, an antiparallel beta-domain containing Greek key motifs, another antiparallel beta-domain forming a jellyroll structure, and a carbohydrate-binding module family 13 domain. Comparison of the structure of this protein with that of alpha-D-galactosidase showed a single amino acid substitution (aspartic acid to glutamic acid) in the catalytic pocket of beta-L-arabinopyranosidase, and a space for the hydroxymethyl group on the C-5 carbon of D-galactose bound to alpha-galactosidase was changed in beta-L-arabinopyranosidase. Mutagenesis study revealed that the residue is critical for modulating the enzyme activity. This is the first report in which beta-L-arabinopyranosidase is classified as a new member of the GH27 family.	[Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Fujimoto, Zui] Natl Inst Agrobiol Sci, Prot Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Harazono, Koichi; Nishimoto, Yukifumi; Uzura, Atsuko] Nagase & Co Ltd, Ctr Res & Dev, Nishi Ku, Kobe, Hyogo 6512241, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan; Nagase & Co., Ltd.	Kaneko, S (corresponding author), Natl Food Res Inst, Food Biotechnol Div, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	sakaneko@affrc.go.jp		Fujimoto, Zui/0000-0002-3551-6854	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grand-in-aid for scientific research from the Japan Society for the Promotion of Science.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aspinall G O, 1969, Adv Carbohydr Chem Biochem, V24, P333; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; Boraston AB, 2000, BIOCHEM J, V350, P933, DOI 10.1042/0264-6021:3500933; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; DEY PM, 1973, BIOCHIM BIOPHYS ACTA, V302, P393, DOI 10.1016/0005-2744(73)90167-8; DEY PM, 1983, BIOCHIM BIOPHYS ACTA, V746, P8, DOI 10.1016/0167-4838(83)90003-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINCHER GB, 1974, BIOCHEM J, V139, P535, DOI 10.1042/bj1390535; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Fujimoto Z, 2009, ACTA CRYSTALLOGR F, V65, P632, DOI 10.1107/S1744309109017230; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; Hatanaka T, 2008, PROTEIN EXPRES PURIF, V62, P244, DOI 10.1016/j.pep.2008.09.001; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Ichinose H, 2008, APPL ENVIRON MICROB, V74, P2379, DOI 10.1128/AEM.01733-07; Ichinose H, 2006, BIOSCI BIOTECH BIOCH, V70, P2745, DOI 10.1271/bbb.60365; Ito S, 2004, J BIOTECHNOL, V110, P137, DOI 10.1016/j.jbiotec.2004.01.014; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; Kotake T, 2004, BIOCHEM J, V377, P749, DOI 10.1042/bj20031145; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ODONMAZIG P, 1994, CARBOHYD RES, V252, P317, DOI 10.1016/0008-6215(94)90028-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yang H, 2006, FOOD SCI TECHNOL RES, V12, P43, DOI 10.3136/fstr.12.43; Yao M, 2004, ACTA CRYSTALLOGR D, V60, P39, DOI 10.1107/S0907444903021188; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689	37	43	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25097	25106		10.1074/jbc.M109.022723	http://dx.doi.org/10.1074/jbc.M109.022723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608743	hybrid, Green Published			2022-12-25	WOS:000269734000044
J	Seong, C; Colavito, S; Kwon, Y; Sung, P; Krejci, L				Seong, Changhyun; Colavito, Sierra; Kwon, Youngho; Sung, Patrick; Krejci, Lumir			Regulation of Rad51 Recombinase Presynaptic Filament Assembly via Interactions with the Rad52 Mediator and the Srs2 Anti-recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; ATP HYDROLYSIS; REPAIR; MUTATIONS; DAMAGE; BREAK	Homologous recombination represents an important means for the error-free elimination of DNA double-strand breaks and other deleterious DNA lesions from chromosomes. The Rad51 recombinase, a member of the RAD52 group of recombination proteins, catalyzes the homologous recombination reaction in the context of a helical protein polymer assembled on single-stranded DNA (ssDNA) that is derived from the nucleolytic processing of a primary lesion. The assembly of the Rad51-ssDNA nucleoprotein filament, often referred to as the presynaptic filament, is prone to interference by the single-strand DNA-binding factor replication protein A (RPA). The Saccharomyces cerevisiae Rad52 protein facilitates presynaptic filament assembly by helping to mediate the displacement of RPA from ssDNA. On the other hand, disruption of the presynaptic filament by the Srs2 helicase leads to a net exchange of Rad51 for RPA. To understand the significance of protein-protein interactions in the control of Rad52- or Srs2-mediated presynaptic filament assembly or disassembly, we have examined two rad51 mutants, rad51 Y388H and rad51 G393D, that are simultaneously ablated for Rad52 and Srs2 interactions and one, rad51 A320V, that is differentially inactivated for Rad52 binding for their biochemical properties and also for functional interactions with Rad52 or Srs2. We show that these mutant rad51 proteins are impervious to the mediator activity of Rad52 or the disruptive function of Srs2 in concordance with their protein interaction defects. Our results thus provide insights into the functional significance of the Rad51-Rad52 and Rad51-Srs2 complexes in the control of presynaptic filament assembly and disassembly. Moreover, our biochemical studies have helped identify A320V as a separation-of-function mutation in Rad51 with regards to a differential ablation of Rad52 interaction.	[Seong, Changhyun; Colavito, Sierra; Kwon, Youngho; Sung, Patrick; Krejci, Lumir] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Dept Biol, Brno 62500, Czech Republic	Yale University; Masaryk University Brno	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,C130 Sterling Hall Med, New Haven, CT 06520 USA.	patrick.sung@yale.edu; lkrejci@chemi.muni.cz	Colavito, Sierra A/AAE-3957-2019; Krejci, Lumir/B-7842-2009; Classen, Scott/AAY-8176-2020	Krejci, Lumir/0000-0002-4732-1405; Colavito, Sierra/0000-0002-2814-4853	National Institutes of Health [RO1 ES07061, RO1 GM57814, PO1 CA92584]; Wellcome International Senior Research Fellowship [WT076476]; GACR [301/09/317 a 203/09/H046]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome International Senior Research Fellowship; GACR(Grant Agency of the Czech Republic); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES07061, RO1 GM57814, and PO1 CA92584. This work was also supported by Wellcome International Senior Research Fellowship WT076476 and GACR 301/09/317 a 203/09/H046.	AGUILERA A, 1988, GENETICS, V119, P779; Bianco P R, 1998, Front Biosci, V3, pD570; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; SCHIESTL RH, 1990, GENETICS, V124, P817; SCHILD D, 1995, GENETICS, V140, P115; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	33	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24363	24371		10.1074/jbc.M109.032953	http://dx.doi.org/10.1074/jbc.M109.032953			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605344	Green Published, hybrid			2022-12-25	WOS:000269380200049
J	Salillas, E; Grana, A; El-Yagoubi, R; Semenza, C				Salillas, Elena; Grana, Alessia; El-Yagoubi, Radouane; Semenza, Carlo			Numbers in the Blind's "Eye"	PLOS ONE			English	Article							ATTENTION; REPRESENTATION; SPACE; VISION; CORTEX; SHIFTS; ERP	Background: Although lacking visual experience with numerosities, recent evidence shows that the blind perform similarly to sighted persons on numerical comparison or parity judgement tasks. In particular, on tasks presented in the auditory modality, the blind surprisingly show the same effect that appears in sighted persons, demonstrating that numbers are represented through a spatial code, i.e. the Spatial-Numerical Association of Response Codes (SNARC) effect. But, if this is the case, how is this numerical spatial representation processed in the brain of the blind? Principal Findings: Here we report that, although blind and sighted people have similarly organized numerical representations, the attentional shifts generated by numbers have different electrophysiological correlates (sensorial N100 in the sighted and cognitive P300 in the blind). Conclusions: These results highlight possible differences in the use of spatial representations acquired through modalities other than vision in the blind population.			Salillas, E (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	Elena.Salillas@utsa.edu	Salillas, Elena/E-1262-2015	Salillas, Elena/0000-0002-0873-5357				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Castronovo J, 2007, J EXP PSYCHOL HUMAN, V33, P1089, DOI 10.1037/0096-1523.33.5.1089; Castronovo J, 2007, Q J EXP PSYCHOL, V60, P101, DOI 10.1080/17470210600598635; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, COGNITION, V44, P1; EDGAR JC, 2005, METHODS HDB, P85; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HILLYARD SA, 1987, HDB PHYSL 1; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Hugdahl K, 2000, HUM BRAIN MAPP, V10, P87, DOI 10.1002/(SICI)1097-0193(200006)10:2<87::AID-HBM50>3.0.CO;2-V; HULL T, 1995, J VISUAL IMPAIR BLIN, V89, P166; Johnson MR, 2007, NEUROIMAGE, V37, P290, DOI 10.1016/j.neuroimage.2007.05.017; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; LUCK SJ, 1998, ATTENTION E SUSSEX; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; ROSLER F, 1986, BIOL PSYCHOL, V22, P238; Salillas E, 2008, CORTEX, V44, P406, DOI 10.1016/j.cortex.2007.08.006; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Szucs D, 2005, NEUROSCI LETT, V384, P11, DOI 10.1016/j.neulet.2005.04.050; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; WOODS DL, 1990, EVENT RELATED POTENT	26	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6357	10.1371/journal.pone.0006357	http://dx.doi.org/10.1371/journal.pone.0006357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CO	19626126	gold, Green Submitted, Green Published			2022-12-25	WOS:000268260200004
J	Spanier, B; Lasch, K; Marsch, S; Benner, J; Liao, WJ; Hu, H; Kienberger, H; Eisenreich, W; Daniel, H				Spanier, Britta; Lasch, Katrin; Marsch, Silke; Benner, Jacqueline; Liao, Wenjuan; Hu, Hao; Kienberger, Hermine; Eisenreich, Wolfgang; Daniel, Hannelore			How the Intestinal Peptide Transporter PEPT-1 Contributes to an Obesity Phenotype in Caenorhabditits elegans	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; INTRACELLULAR PH; MEMBRANE; PROTEINS; INSULIN; MODEL	Background: Amino acid absorption in the form of di- and tripeptides is mediated by the intestinal proton-coupled peptide transporter PEPT-1 (formally OPT-2) in Caenorhabditits elegans. Transporter-deficient animals (pept-1(lg601)) show impaired growth, slowed postembryonal development and major changes in amino acid status. Principal Findings: Here we demonstrate that abolished intestinal peptide transport also leads to major metabolic alterations that culminate in a two fold increase in total body fat content. Feeding of C. elegans with [U-C-13]-labelled E. coli revealed a decreased de novo synthesis of long-chain fatty acids in pept-1(lg601) and reduced levels of polyunsaturated fatty acids. mRNA profiling revealed increased transcript levels of enzymes/transporters needed for peroxisomal beta-oxidation and decreased levels for those required for fatty acid synthesis, elongation and desaturation. As a prime and most fundamental process that may account for the increased fat content in pept-1(lg601) we identified a highly accelerated absorption of free fatty acids from the bacterial food in the intestine. Conclusions: The influx of free fatty acids into intestinal epithelial cells is strongly dependent on alterations in intracellular pH which is regulated by the interplay of PEPT-1 and the sodium-proton exchanger NHX-2. We here provide evidence for a central mechanism by which the PEPT-1/NHX-2 system strongly influences the in vivo fat content of C. elegans. Loss of PEPT-1 decreases intestinal proton influx leading to a higher uptake of free fatty acids with fat accumulation whereas loss of NHX-2 causes intracellular acidification by the PEPT-1 mediated proton/dipeptide symport with an almost abolished uptake of fatty acids and a lean phenotype.			Spanier, B (corresponding author), Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Biochem Abt, D-8050 Freising Weihenstephan, Germany.	spanier@wzw.tum.de	Eisenreich, Wolfgang/A-1258-2013; Daniel, Hannelore/B-8982-2009; Spanier, Britta/C-2672-2009	Eisenreich, Wolfgang/0000-0002-9832-8279; Wallwitz, Jacqueline/0000-0002-7335-362X				Anderson CMH, 2007, BBA-BIOMEMBRANES, V1768, P1822, DOI 10.1016/j.bbamem.2007.04.006; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi Kaveh, 2007, WormBook, P1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobulescu IA, 2006, SEMIN NEPHROL, V26, P334, DOI 10.1016/j.semnephrol.2006.07.001; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Civelek VN, 1996, P NATL ACAD SCI USA, V93, P10139, DOI 10.1073/pnas.93.19.10139; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Elsing C, 1996, AM J PHYSIOL-GASTR L, V271, pG1067, DOI 10.1152/ajpgi.1996.271.6.G1067; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; GANAPATHY V, 1983, J BIOL CHEM, V258, P4189; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Gurvitz A, 2000, YEAST, V17, P188, DOI 10.1002/1097-0061(20000930)17:3<188::AID-YEA27>3.0.CO;2-E; Hamilton JA, 1998, J LIPID RES, V39, P467; HAMILTON JA, 1994, J BIOL CHEM, V269, P20852; Hamilton JA, 2007, PROSTAG LEUKOTR ESS, V77, P355, DOI 10.1016/j.plefa.2007.10.020; Illarionov B, 2004, J ORG CHEM, V69, P5588, DOI 10.1021/jo0493222; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; McElwee JJ, 2006, MECH AGEING DEV, V127, P922, DOI 10.1016/j.mad.2006.10.002; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; SHEHATA AY, 1979, J CAN I FOOD TECHNOL, V3, P85; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	40	48	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6279	10.1371/journal.pone.0006279	http://dx.doi.org/10.1371/journal.pone.0006279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621081	gold, Green Published, Green Submitted			2022-12-25	WOS:000268147200001
J	Cantrell, MA; Carstens, BC; Wichman, HA				Cantrell, Michael A.; Carstens, Bryan C.; Wichman, Holly A.			X Chromosome Inactivation and Xist Evolution in a Rodent Lacking LINE-1 Activity	PLOS ONE			English	Article								Dosage compensation in eutherian mammals occurs by inactivation of one X chromosome in females. Silencing of that X chromosome is initiated by Xist, a large non-coding RNA, whose coating of the chromosome extends in cis from the X inactivation center. LINE-1 (L1) retrotransposons have been implicated as possible players for propagation of the Xist signal, but it has remained unclear whether they are essential components. We previously identified a group of South American rodents in which L1 retrotransposition ceased over 8 million years ago and have now determined that at least one species of these rodents, Oryzomys palustris, still retains X inactivation. We have also isolated and analyzed the majority of the Xist RNA from O. palustris and a sister species retaining L1 activity, Sigmodon hispidus, to determine if evolution in these sequences has left signatures that might suggest a critical role for L1 elements in Xist function. Comparison of rates of Xist evolution in the two species fails to support L1 involvement, although other explanations are possible. Similarly, comparison of known repeats and potential RNA secondary structures reveals no major differences with the exception of a new repeat in O. palustris that has potential to form new secondary structures.			Cantrell, MA (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	hwichman@uidaho.edu	Carstens, Bryan C/B-8602-2013	Carstens, Bryan C/0000-0002-1552-227X	NCRR NIH HHS [P20 RR016454, P20 RR016448, RR016448, RR016454] Funding Source: Medline; NIGMS NIH HHS [GM38737] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448, P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038737] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Baker RJ, 1994, CHROMOSOME RES, V2, P185, DOI 10.1007/BF01553318; BAKER RJ, 1990, EVOLUTION, V44, P2083, DOI 10.2307/2409617; Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOYLE AL, 1990, P NATL ACAD SCI USA, V87, P7757, DOI 10.1073/pnas.87.19.7757; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cantrell MA, 2005, J VIROL, V79, P14698, DOI 10.1128/JVI.79.23.14698-14707.2005; Cantrell MA, 2000, BIOTECHNIQUES, V29, P1310, DOI 10.2144/00296rr02; Caparros ML, 2002, CYTOGENET GENOME RES, V99, P99, DOI 10.1159/000071580; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 2006, PLOS GENET, V2, P1477, DOI 10.1371/journal.pgen.0020151; CASAVANT NC, 1994, J MOL BIOL, V241, P390, DOI 10.1006/jmbi.1994.1515; Casavant NC, 1996, GENETICS, V142, P1289; Casavant NC, 1998, GENETICS, V150, P345; Casavant NC, 2000, GENETICS, V154, P1809; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Dobigny G, 2004, CHROMOSOMA, V113, P34, DOI 10.1007/s00412-004-0292-6; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; Grahn RA, 2005, CYTOGENET GENOME RES, V110, P407, DOI 10.1159/000084973; Hall LL, 2002, HUM MOL GENET, V11, P3157, DOI 10.1093/hmg/11.25.3157; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x; Keohane AM, 1999, HUM MOL GENET, V8, P377, DOI 10.1093/hmg/8.2.377; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; LUOH SW, 1995, GENOMICS, V29, P353, DOI 10.1006/geno.1995.9994; Lyon MF, 2005, EUR J HUM GENET, V13, P796, DOI 10.1038/sj.ejhg.5201443; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Matarazzo MR, 2008, BIOL CELL, V100, P63, DOI 10.1042/BC20070073; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Noronha RCR, 2001, CARYOLOGIA, V54, P267, DOI 10.1080/00087114.2001.10589235; Parish DA, 2002, CYTOGENET GENOME RES, V96, P191, DOI 10.1159/000063038; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Popova BC, 2006, P NATL ACAD SCI USA, V103, P7706, DOI 10.1073/pnas.0602021103; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; RUSSELL LB, 1970, GENETICS, V64, P281; Salstrom JL, 2007, MOL GENET METAB, V92, P56, DOI 10.1016/j.ymgme.2007.05.015; Scott LA, 2006, CYTOGENET GENOME RES, V112, P261, DOI 10.1159/000089880; Sharp A, 2001, HUM GENET, V109, P295, DOI 10.1007/s004390100578; Sharp AJ, 2002, HUM MOL GENET, V11, P3145, DOI 10.1093/hmg/11.25.3145; Solari AJ, 2001, BIOCELL, V25, P155; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TRIBIOLI C, 1992, NUCLEIC ACIDS RES, V20, P727, DOI 10.1093/nar/20.4.727; Tsuchiya KD, 2004, GENOME RES, V14, P1275, DOI 10.1101/gr.2575904; Valley CM, 2006, CURR OPIN GENET DEV, V16, P240, DOI 10.1016/j.gde.2006.04.008; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Waters PD, 2004, CHROMOSOMA, V113, P137, DOI 10.1007/s00412-004-0301-9; White WM, 1998, AM J HUM GENET, V63, P20, DOI 10.1086/301922; WICHMAN HA, 1992, GENETICA, V86, P287, DOI 10.1007/BF00133727; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, TRENDS GENET, V23, P457, DOI 10.1016/j.tig.2007.07.004	78	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6252	10.1371/journal.pone.0006252	http://dx.doi.org/10.1371/journal.pone.0006252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603076	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035700008
J	Maruvada, R; Prasadarao, NV; Rubens, CE				Maruvada, Ravi; Prasadarao, Nemani V.; Rubens, C. E.			Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation	FASEB JOURNAL			English	Article						streptococcal histidine triad protein; CRASP; protease treatment; LC-MS; pathogenecity islands; membrane attack complex	ESCHERICHIA-COLI K1; CAPSULAR POLYSACCHARIDE; BORRELIA-BURGDORFERI; SERUM RESISTANCE; IMMUNE EVASION; BINDING; IDENTIFICATION; REGULATORS; DISEASE; MECHANISMS	Binding of the host complement regulator, factor H (FH), by some pathogenic microbes constitutes an important virulence mechanism, whereby complement is broken down to help microbes survive in the host. Although it has been hypothesized for the past two decades that GBS type III binds FH via sialic acid present on its capsule, neither the binding of FH to GBS has been demonstrated nor the mechanism of interaction identified. We observed that FH bound to both wild-type and capsule or sialic acid-deficient GBS that were used as negative controls. Wild-type and acapsular GBS were incubated with serum or pure FH degraded almost 90% of C3b, suggesting that the GBS-bound FH maintained cofactor activity. In addition, dot-blot analysis showed similar to 5-10% of C5 and C9 formation, as compared to an Escherichia coli control, suggesting breakdown at the C3b level. Protease treatment of the bacteria completely abolished binding of FH. Using overlay assays and mass spectroscopic analysis, we identified the FH receptor as the streptococcal histidine triad (SHT) surface protein. The ability of binding FH to SHT was further confirmed by using recombinant SHT. This report describes the identification of the SHT as an FH-binding protein on the surface of GBS type III, revealing a novel mechanism by which the bacterium acquires FH to evade complement opsonization.-Maruvada, R., Prasadarao, N. V., Rubens, C. E. Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J. 23, 3967-3977 (2009). www.fasebj.org	[Maruvada, Ravi] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Prasadarao, Nemani V.] Univ So Calif, Div Infect Dis, Childrens Hosp Los Angeles, Los Angeles, CA USA; [Prasadarao, Nemani V.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Rubens, C. E.] Univ Washington, Ctr Childhood Infect & Prematur Res, Seattle Childrens Hosp, Res Inst,Dept Pediat, Seattle, WA 98195 USA	Johns Hopkins University; Johns Hopkins Medicine; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Maruvada, R (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, 200 N Wolfe St, Baltimore, MD 21205 USA.	rmaruva1@jhmi.edu			NIH [AI22498, AI40567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040567, R23AI022498, R01AI040567, R01AI022498] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI22498 to C. E. R. and AI40567 to N. V. P. We thank Dr. Phil Gafken (Fred Hutchinson Cancer Research Institute, Seattle, WA, USA) for mass spectroscopy studies, and Dr. Hal Soucier (University of Southern California. Los Angeles, CA, USA) for flow cytometry studies. We thank Dr. Ravin Seepersaud and Donald Chaffin for technical advice. We thank Dr. Kellie Howard for careful review of the manuscript.	ABBAL M, 1991, COMPLEMENT INFLAMMAT, V8, P92, DOI 10.1159/000463185; Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; AHMED AEE, 1995, CLIN DIAGN LAB IMMUN, V2, P509, DOI 10.1128/CDLI.2.5.509-517.1995; Albanyan EA, 2000, INFECT IMMUN, V68, P2053, DOI 10.1128/IAI.68.4.2053-2060.2000; Alexander JJ, 2005, J AM SOC NEPHROL, V16, P52, DOI 10.1681/ASN.2004090778; ANTAL JM, 1992, INFECT IMMUN, V60, P1114, DOI 10.1128/IAI.60.3.1114-1121.1992; Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; AVERY VM, 1993, J IMMUNOL, V151, P5545; Baker C., 1995, INFECT DIS FETUS NEW, V4th ed., P980; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bingen E, 1997, J CLIN MICROBIOL, V35, P2981, DOI 10.1128/JCM.35.11.2981-2982.1997; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; CAMPBELL JR, 1992, INFECT IMMUN, V60, P4558, DOI 10.1128/IAI.60.11.4558-4562.1992; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; EDWARDS MS, 1980, J EXP MED, V151, P1275, DOI 10.1084/jem.151.5.1275; EDWARDS MS, 1993, INFECT IMMUN, V61, P2866, DOI 10.1128/IAI.61.7.2866-2871.1993; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Johnsson E, 1998, J IMMUNOL, V161, P4894; Kotarsky H, 2001, MOL MICROBIOL, V41, P817, DOI 10.1046/j.1365-2958.2001.02496.x; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Kraiczy P, 2002, WIEN KLIN WOCHENSCHR, V114, P568; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; KRISTENSEN T, 1986, P NATL ACAD SCI USA, V83, P3963, DOI 10.1073/pnas.83.11.3963; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; MARTIN TR, 1988, J INFECT DIS, V157, P91, DOI 10.1093/infdis/157.1.91; Maruvada R, 2008, IMMUNOLOGY, V124, P265, DOI 10.1111/j.1365-2567.2007.02764.x; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Nizet V, 1999, STREPTOCOCCAL INFECTIONS, P180; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; Perez-Caballero D, 2004, J IMMUNOL, V173, P6899, DOI 10.4049/jimmunol.173.11.6899; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Schlaf G, 2004, EUR J IMMUNOL, V34, P3257, DOI 10.1002/eji.200324806; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIM E, 1981, FEBS LETT, V132, P55, DOI 10.1016/0014-5793(81)80426-7; VIK DP, 1990, CURR TOP MICROBIOL, V153, P147; Vogel U, 1999, INFECT IMMUN, V67, P954, DOI 10.1128/IAI.67.2.954-957.1999; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WESSELS MR, 1992, INFECT IMMUN, V60, P392, DOI 10.1128/IAI.60.2.392-400.1992; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3; ZON LI, 1989, BIOTECHNIQUES, V7, P696	55	24	26	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3967	3977		10.1096/fj.09-138149	http://dx.doi.org/10.1096/fj.09-138149			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19608625	Green Published			2022-12-25	WOS:000271272500032
J	Messner, S; Schuermann, D; Altmeyer, M; Kassner, I; Schmidt, D; Schar, P; Muller, S; Hottiger, MO				Messner, Simon; Schuermann, David; Altmeyer, Matthias; Kassner, Ingrid; Schmidt, Darja; Schaer, Primo; Mueller, Stefan; Hottiger, Michael O.			Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function	FASEB JOURNAL			English	Article						NAD; SUMO; hypoxia; PARP-1	NF-KAPPA-B; SUMO-2 TARGET PROTEINS; GENE-EXPRESSION; ADP-RIBOSYLATION; PHOSPHORYLATION; HYPOXIA; BINDING; IDENTIFICATION; REPRESSION; PARP-1	Poly(ADP-ribose) polymerase 1 (PARP1) is a chromatin-associated nuclear protein and functions as a molecular stress sensor. At the cellular level, PARP1 has been implicated in a wide range of processes, such as maintenance of genome stability, cell death, and transcription. PARP1 functions as a transcriptional coactivator of nuclear factor kappa B (NF-kappa B) and hypoxia inducible factor 1 (HIF1). In proteomic studies, PARP1 was found to be modified by small ubiquitin-like modifiers (SUMOs). Here, we characterize PARP1 as a substrate for modification by SUMO1 and SUMO3, both in vitro and in vivo. PARP1 is sumoylated at the single lysine residue K486 within its automodification domain. Interestingly, modification of PARP1 with SUMO does not affect its ADP-ribosylation activity but completely abrogates p300-mediated acetylation of PARP1, revealing an intriguing crosstalk of sumoylation and acetylation on PARP1. Genetic complementation of PARP1-depleted cells with wildtype and sumoylation-deficient PARP1 revealed that SUMO modification of PARP1 restrains its transcriptional coactivator function and subsequently reduces gene expression of distinct PARP1-regulated target genes. Messner, S., Schuermann, D., Altmeyer, M., Kassner, I., Schmidt, D., Schar, P., Muller, S., and Hottiger, M. O. Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function. FASEB J. 23, 3978-3989 (2009). www.fasebj.org	[Messner, Simon; Altmeyer, Matthias; Kassner, Ingrid; Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Messner, Simon; Altmeyer, Matthias; Kassner, Ingrid] Univ Zurich, Life Sci Zurich Grad Sch, Mol Life Sci Program, CH-8057 Zurich, Switzerland; [Schuermann, David; Schaer, Primo] Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland; [Schmidt, Darja; Mueller, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	University of Zurich; University of Zurich; University of Basel; Max Planck Society	Hottiger, MO (corresponding author), Univ Zurich, Inst Vet Biochem & Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	hottiger@vetbio.uzh.ch	Schär, Primo/G-5967-2012; Hottiger, Michael O./J-7747-2013; Altmeyer, Matthias/AAE-8186-2019; Schuermann, David/AAC-4075-2019	Schär, Primo/0000-0003-1843-6147; Hottiger, Michael O./0000-0002-7323-2270; Altmeyer, Matthias/0000-0003-3780-1170; Schuermann, David/0000-0003-2904-1378; Muller, Stefan/0000-0002-8792-7700	Deutsche Forschungsgemeinschaft; Swiss National Science Foundation [31-109315.05, 31-122421/1]; Kanton of Zurich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton of Zurich	We are grateful to L. Sistonen and H. A. Blomster (University of Turku, Turku, Finland) for support and scientific insight. We thank G. Poirier and D. Gauvin (Laval University Medical Research Center, Laval University, Quebec, QC, Canada), D. Stiehl and R. Wenger (University of Zurich, Zurich, Switzerland), S. Pastorekova (Slovak Academy of Sciences, Bratislava, Slovak Republic), R. T. Hay (University of Dundee, Dundee, UK), and R. Niedenthal (Hannover Medical School, Hannover, Germany) for generously providing reagents. We are grateful to T. Valovka (University of Innsbruck, Innsbruck, Austria) and P. O. Hassa, M. Fey, and other members of the Institute of Veterinary Biochemistry and Molecular Biology (University of Zurich) for their critical and constructive comments on the manuscript. This work was supported in part by the Deutsche Forschungsgemeinschaft (to S. Muller), the Swiss National Science Foundation (grants 31-109315.05 and 31-122421/1 to M. O. H.), and the Kanton of Zurich (to M. O. H.).	Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Elser M, 2008, MOL CANCER RES, V6, P282, DOI 10.1158/1541-7786.MCR-07-0377; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Haenni SS, 2008, INT J BIOCHEM CELL B, V40, P2274, DOI 10.1016/j.biocel.2008.03.008; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim JH, 2009, BBA-MOL BASIS DIS, V1792, P155, DOI 10.1016/j.bbadis.2008.12.008; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; ZHU S, 2009, CELL, V33, P570	52	57	59	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3978	3989		10.1096/fj.09-137695	http://dx.doi.org/10.1096/fj.09-137695			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19622798	Green Accepted			2022-12-25	WOS:000271272500033
J	Rossignol, JF; La Frazia, S; Chiappa, L; Ciucci, A; Santoro, MG				Rossignol, Jean Francois; La Frazia, Simone; Chiappa, Lucia; Ciucci, Alessandra; Santoro, M. Gabriella			Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; KAPPA-B KINASE; EPITHELIAL-CELLS; DOUBLE-BLIND; HEPATITIS-B; NITAZOXANIDE; INHIBITORS; INFECTION; REPLICATION; DIARRHEA	The emergence of highly contagious influenza A virus strains, such as the new H1N1 swine influenza, represents a serious threat to global human health. Efforts to control emerging influenza strains focus on surveillance and early diagnosis, as well as development of effective vaccines and novel antiviral drugs. Herein we document the anti-influenza activity of the anti-infective drug nitazoxanide and its active circulating-metabolite tizoxanide and describe a class of second generation thiazolides effective against influenza A virus. Thiazolides inhibit the replication of H1N1 and different other strains of influenza A virus by a novel mechanism: they act at post-translational level by selectively blocking the maturation of the viral hemagglutinin at a stage preceding resistance to endoglycosidase H digestion, thus impairing hemagglutinin intracellular trafficking and insertion into the host plasma membrane, a key step for correct assembly and exit of the virus from the host cell. Targeting the maturation of the viral glycoprotein offers the opportunity to disrupt the production of infectious viral particles attacking the pathogen at a level different from the currently available anti-influenza drugs. The results indicate that thiazolides may represent a new class of antiviral drugs effective against influenza A infection.	[La Frazia, Simone; Chiappa, Lucia; Ciucci, Alessandra; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	University of Rome Tor Vergata; Stanford University	Santoro, MG (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	santoro@bio.uniroma2.it	Pham, Van/ABB-4933-2020	Santoro, Maria Gabriella/0000-0003-1432-4949; La Frazia, Simone/0000-0002-6987-5409	Romark Laboratories, LC; Italian Ministry of University and Scientific Research	Romark Laboratories, LC; Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Romark Laboratories, LC and by the Italian Ministry of University and Scientific Research.	Bernasconi D, 2005, J BIOL CHEM, V280, P24127, DOI 10.1074/jbc.M413726200; Caselli E, 2007, BLOOD, V109, P2718, DOI 10.1182/blood-2006-03-012500; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Donatelli I, 2001, J GEN VIROL, V82, P623, DOI 10.1099/0022-1317-82-3-623; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; La Frazia S, 2006, ANTIVIR THER, V11, P995; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Ohuchi R, 1997, J VIROL, V71, P3719, DOI 10.1128/JVI.71.5.3719-3725.1997; Palese P., 2007, FIELDS VIROLOGY, P1647; Pica F, 2000, ANTIMICROB AGENTS CH, V44, P200, DOI 10.1128/AAC.44.1.200-204.2000; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 2006, CANCER RES, V66, P7678, DOI 10.1158/0008-5472.CAN-05-4282; Rossignol JF, 2008, FUTURE MICROBIOL, V3, P539, DOI 10.2217/17460913.3.5.539; Rossignol JF, 2009, GASTROENTEROLOGY, V136, P856, DOI 10.1053/j.gastro.2008.11.037; Rossignol JF, 2006, LANCET, V368, P124, DOI 10.1016/S0140-6736(06)68852-1; Rossignol JF, 2006, CLIN GASTROENTEROL H, V4, P320, DOI 10.1016/j.cgh.2005.12.020; Rossignol JF, 2001, J INFECT DIS, V184, P381, DOI 10.1086/322038; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; SEKIKAWA K, 1983, P NATL ACAD SCI-BIOL, V80, P3563, DOI 10.1073/pnas.80.12.3563; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; TATU U, 1995, EMBO J, V14, P1340, DOI 10.1002/j.1460-2075.1995.tb07120.x; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	39	166	180	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29798	29808		10.1074/jbc.M109.029470	http://dx.doi.org/10.1074/jbc.M109.029470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19638339	hybrid, Green Published			2022-12-25	WOS:000270896800060
J	Fernando, P; Sandoz, JS; Ding, W; de Repentigny, Y; Brunette, S; Kelly, JF; Kothary, R; Megeney, LA				Fernando, Pasan; Sandoz, Jacqueline S.; Ding, Wen; de Repentigny, Yves; Brunette, Steve; Kelly, John F.; Kothary, Rashmi; Megeney, Lynn A.			Bin1 Src Homology 3 Domain Acts as a Scaffold for Myofiber Sarcomere Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR BIN1; SYNAPTIC VESICLE ENDOCYTOSIS; MYC-INTERACTING PROTEIN; RING-FINGER PROTEIN; C-TERMINAL REGION; SKELETAL-MUSCLE; SH3 DOMAIN; STRIATED-MUSCLE; SARCOPLASMIC-RETICULUM; M-CADHERIN	In skeletal muscle development, the genes and regulatory factors that govern the specification of myocytes are well described. Despite this knowledge, the mechanisms that regulate the coordinated assembly of myofiber proteins into the functional contractile unit or sarcomere remain undefined. Here we explored the hypothesis that modular domain proteins such as Bin1 coordinate protein interactions to promote sarcomere formation. We demonstrate that Bin1 facilitates sarcomere organization through protein-protein interactions as mediated by the Src homology 3 (SH3) domain. We observed a profound disorder in myofiber size and structural organization in a murine model expressing the Bin1 SH3 region. In addition, satellite cell-derived myogenesis was limited despite the accumulation of skeletal muscle-specific proteins. Our experiments revealed that the Bin1 SH3 domain formed transient protein complexes with both actin and myosin filaments and the pro-myogenic kinase Cdk5. Bin1 also associated with a Cdk5 phosphorylation domain of titin. Collectively, these observations suggest that Bin1 displays protein scaffold-like properties and binds with sarcomeric factors important in directing sarcomere protein assembly and myofiber maturation.	[Fernando, Pasan; Brunette, Steve; Megeney, Lynn A.] Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Sandoz, Jacqueline S.; de Repentigny, Yves; Kothary, Rashmi] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Ding, Wen; Kelly, John F.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; National Research Council Canada	Fernando, P (corresponding author), Univ Ottawa, MDS Nord, Inst Heart, 40 Ruskin St, Ottawa, ON NK1Y 4W7, Canada.	pasan.fernando@mdsinc.com		Fernando, Pasan/0000-0001-8792-9637; Kothary, Rashmi/0000-0002-9239-7310; Megeney, Lynn/0000-0002-6824-8569	Canadian Institutes of Health Research; Muscular Dystrophy Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported in part by grants from the Canadian Institutes of Health Research ( to L. A. M. and R. K.) and the Muscular Dystrophy Association ( to L. A. M.).	Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Au Y, 2004, CELL MOL LIFE SCI, V61, P3016, DOI 10.1007/s00018-004-4282-x; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Bang ML, 2002, J STRUCT BIOL, V137, P119, DOI 10.1006/jsbi.2002.4457; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Barnett P, 2000, EMBO J, V19, P6382, DOI 10.1093/emboj/19.23.6382; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Chang MY, 2007, CANCER RES, V67, P100, DOI 10.1158/0008-5472.CAN-06-2742; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Duhadaway J, 1999, CELL ADHES COMMUN, V7, P99, DOI 10.3109/15419069909034394; DuHadaway JB, 2001, CANCER RES, V61, P3151; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Elliott K, 2000, ONCOGENE, V19, P4669, DOI 10.1038/sj.onc.1203681; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; FRANZINIARMSTRONG C, 1991, DEV BIOL, V146, P353, DOI 10.1016/0012-1606(91)90237-W; Fukuda N, 2008, J PHYSIOL SCI, V58, P151, DOI 10.2170/physiolsci.RV005408; Galderisi U, 1999, J CELL BIOCHEM, V74, P313, DOI 10.1002/(SICI)1097-4644(19990901)74:3<313::AID-JCB1>3.3.CO;2-Q; GAUTEL M, 1993, EMBO J, V12, P3827, DOI 10.1002/j.1460-2075.1993.tb06061.x; Ge K, 2000, INT J CANCER, V86, P155, DOI 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Guy LG, 1996, EMBO J, V15, P3713, DOI 10.1002/j.1460-2075.1996.tb00741.x; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hogarty MD, 2000, MED PEDIATR ONCOL, V35, P559, DOI 10.1002/1096-911X(20001201)35:6<559::AID-MPO14>3.3.CO;2-A; Hollnagel A, 2002, MOL CELL BIOL, V22, P4760, DOI 10.1128/MCB.22.13.4760-4770.2002; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; LABEIT S, 1991, FEBS LETT, V282, P313, DOI 10.1016/0014-5793(91)80503-U; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Ma K, 2002, FEBS LETT, V532, P273, DOI 10.1016/S0014-5793(02)03655-4; Ma K, 2006, J BIOL CHEM, V281, P27539, DOI 10.1074/jbc.M604525200; MARUYAMA K, 1994, J BIOCHEM-TOKYO, V115, P147, DOI 10.1093/oxfordjournals.jbchem.a124290; Mayer BJ, 2001, J CELL SCI, V114, P1253; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; McElhinny AS, 2005, J CELL BIOL, V170, P947, DOI 10.1083/jcb.200502158; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Muller AJ, 2004, CANCER BIOL THER, V3, P1236, DOI 10.4161/cbt.3.12.1232; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; NAVE R, 1990, FEBS LETT, V269, P163, DOI 10.1016/0014-5793(90)81144-D; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Pineda-Lucena A, 2005, J MOL BIOL, V351, P182, DOI 10.1016/j.jmb.2005.05.046; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Politou AS, 1998, J MOL BIOL, V276, P189, DOI 10.1006/jmbi.1997.1521; Ramalingam A, 2007, CELL CYCLE, V6, P1914, DOI 10.4161/cc.6.15.4514; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Sharma P, 1999, J BIOL CHEM, V274, P9600, DOI 10.1074/jbc.274.14.9600; SHETTY KT, 1993, P NATL ACAD SCI USA, V90, P6844, DOI 10.1073/pnas.90.14.6844; Sinz A, 2001, BIOCHEMISTRY-US, V40, P7903, DOI 10.1021/bi010259+; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Tajiri T, 2003, CLIN CANCER RES, V9, P3345; Telfer JF, 2005, CELL SIGNAL, V17, P701, DOI 10.1016/j.cellsig.2004.10.009; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wrobel E, 2007, EUR J CELL BIOL, V86, P99, DOI 10.1016/j.ejcb.2006.11.004; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858; Zelhof AC, 2001, DEVELOPMENT, V128, P5005; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457	82	23	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27674	27686		10.1074/jbc.M109.029538	http://dx.doi.org/10.1074/jbc.M109.029538			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19633357	Green Published, hybrid			2022-12-25	WOS:000270232300069
J	Liu, Q; Graeff, R; Kriksunov, IA; Jiang, H; Zhang, B; Oppenheimer, N; Lin, HN; Potter, BVL; Lee, HC; Hao, Q				Liu, Qun; Graeff, Richard; Kriksunov, Irina A.; Jiang, Hong; Zhang, Bo; Oppenheimer, Norman; Lin, Hening; Potter, Barry V. L.; Lee, Hon Cheung; Hao, Quan			Structural Basis for Enzymatic Evolution from a Dedicated ADP-ribosyl Cyclase to a Multifunctional NAD Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-DENSITY MAPS; HUMAN CD38; ACTIVE-SITE; GLYCOHYDROLASE; FERMENTATION; HYDROLYSIS; MECHANISM; ENZYMES; BST-1; GENE	Cyclic ADP-ribose (cADPR) is a universal calcium messenger molecule that regulates many physiological processes. The production and degradation of cADPR are catalyzed by a family of related enzymes, including the ADP-ribosyl cyclase from Aplysia california (ADPRAC) and CD38 from human. Although ADPRC and CD38 share a common evolutionary ancestor, their enzymatic functions toward NAD and cADPR homeostasis have evolved divergently. Thus, ADPRC can only generate cADPR from NAD (cyclase), whereas CD38, in contrast, has multiple activities, i.e. in cADPR production and degradation, as well as NAD hydrolysis (NADase). In this study, we determined a number of ADPRC and CD38 structures bound with various nucleotides. From these complexes, we elucidated the structural features required for the cyclization (cyclase) reaction of ADPRC and the NADase reaction of CD38. Using the structural approach in combination with site-directed mutagenesis, we identified Phe-174 in ADPRC as a critical residue in directing the folding of the substrate during the cyclization reaction. Thus, a point mutation of Phe-174 to glycine can turn ADPRC from a cyclase toward an NADase. The equivalent residue in CD38, Thr-221, is shown to disfavor the cyclizing folding of the substrate, resulting in NADase being the dominant activity. The comprehensive structural comparison of CD38 and APDRC presented in this study thus provides insights into the structural determinants for the functional evolution from a cyclase to a hydrolase.	[Lee, Hon Cheung; Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Liu, Qun; Kriksunov, Irina A.; Hao, Quan] Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA; [Jiang, Hong; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Graeff, Richard] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Lee, Hon Cheung] Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA; [Zhang, Bo; Potter, Barry V. L.] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Oppenheimer, Norman] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of Hong Kong; Cornell University; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Bath; University of California System; University of California San Francisco	Lee, HC (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	leehc@hku.hk; qhao@hku.hk	Hao, Quan/C-4304-2009; Lee, Hon Cheung/C-4329-2009; Liu, Qun/A-8757-2011; Graeff, Richard Milton/B-3425-2011; Potter, Barry VL/A-1845-2012; Potter, Barry/AAX-4781-2020	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514	National Institutes of Health [GM061568]; National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme; Wellcome Trust [084068]; Dreyfus Foundation New Faculty Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Wellcome Trust(Wellcome TrustEuropean Commission); Dreyfus Foundation New Faculty Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061568 (to H. C. L. and Q. H.). This work was also supported by Hong Kong General Research Fund grants from the National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme (to Q. H. and H. C. L.), Project Grant 084068 from the Wellcome Trust (to B. V. L. P.), and the Dreyfus Foundation New Faculty Award (to H. L.).	Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Ferrero E, 1999, IMMUNOGENETICS, V49, P597, DOI 10.1007/s002510050654; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE HC, 1995, BIOCHIMIE, V77, P345, DOI 10.1016/0300-9084(96)88145-4; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Liu Q, 2007, J BIOL CHEM, V282, P24825, DOI 10.1074/jbc.M701653200; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Munshi C, 1997, PROTEIN EXPRES PURIF, V11, P104, DOI 10.1006/prep.1997.0773; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Munshi CB, 1997, METHOD ENZYMOL, V280, P318; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLEATH PR, 1991, J ORG CHEM, V56, P3608, DOI 10.1021/jo00011a029; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; Wagner GK, 2005, J ORG CHEM, V70, P4810, DOI 10.1021/jo050085s; Zhang B, 2007, BIOCHEMISTRY-US, V46, P4100, DOI 10.1021/bi061933w	29	50	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27637	27645		10.1074/jbc.M109.031005	http://dx.doi.org/10.1074/jbc.M109.031005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19640846	Green Published, hybrid			2022-12-25	WOS:000270232300065
J	Tsvetkov, P; Reuven, N; Prives, C; Shaul, Y				Tsvetkov, Peter; Reuven, Nina; Prives, Carol; Shaul, Yosef			Susceptibility of p53 Unstructured N Terminus to 20 S Proteasomal Degradation Programs the Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; UBIQUITIN-INDEPENDENT DEGRADATION; TRANSACTIVATION DOMAIN; PROTEIN-DEGRADATION; NEGATIVE REGULATOR; RAPID DEGRADATION; MDM2 ONCOPROTEIN; MAMMALIAN-CELLS; MOLECULAR-BASIS; C-TERMINUS	The N-terminal transcription activation domain of p53 is intrinsically unstructured. We show in vitro and in vivo that this domain initiates p53 degradation by the 20 S proteasome in a ubiquitin-independent fashion. The decay of metabolically labeled p53 follows biphasic kinetics with an immediate fast phase that is ubiquitin-independent and a second slower phase that is ubiquitin-dependent. The 20 S proteasome executes the first phase by default, whereas the second phase requires the 26 S proteasome. p53 N-terminal binding proteins, such as Hdmx, can selectively block the first phase of degradation. Remarkably, gamma-irradiation inhibits both p53 decay phases, whereas UV selectively negates the second phase, giving rise to discrete levels of p53 accumulation. Our data of a single protein experiencing double mode degradation mechanisms each with unique kinetics provide the mechanistic basis for programmable protein homeostasis (proteostasis).	[Tsvetkov, Peter; Reuven, Nina; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Weizmann Institute of Science; Columbia University	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il	Reuven, Nina/AAM-8711-2020; Tsvetkov, Peter/J-9878-2019; Tsvetkov, Peter/D-6458-2011	Reuven, Nina/0000-0003-1569-3818; Tsvetkov, Peter/0000-0002-7577-2342; 	Samuel Waxman Cancer Research Foundation; Israel Science Foundation; Federal German Ministry for Education and Research; Journal of Cell Science student travel fellowship	Samuel Waxman Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Journal of Cell Science student travel fellowship	This work was supported by grants from the Samuel Waxman Cancer Research Foundation, from the Israel Science Foundation, and from the Minerva Foundation with funding from the Federal German Ministry for Education and Research and Journal of Cell Science student travel fellowship.	Alvarez-Castelao B, 2005, FEBS LETT, V579, P4797, DOI 10.1016/j.febslet.2005.07.060; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cain C, 2000, J BIOL CHEM, V275, P39944, DOI 10.1074/jbc.M002509200; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Finch RA, 2002, CANCER RES, V62, P3221; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Jayaraman L, 1997, METHOD ENZYMOL, V283, P245; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Kroll M, 1997, ONCOGENE, V15, P1841, DOI 10.1038/sj.onc.1201560; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prives C, 1999, J PATHOL, V187, P112; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Stad R, 2000, J BIOL CHEM, V275, P28039; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WHEATLEY DN, 1980, CELL BIOL INT REP, V4, P1081, DOI 10.1016/0309-1651(80)90045-4; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	63	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26234	26242		10.1074/jbc.M109.040493	http://dx.doi.org/10.1074/jbc.M109.040493			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19617345	Green Published, hybrid			2022-12-25	WOS:000269969600003
J	Zhang, L; Bowen, T; Grennan-Jones, F; Paddon, C; Giles, P; Webber, J; Steadman, R; Ludgate, M				Zhang, Lei; Bowen, Timothy; Grennan-Jones, Fiona; Paddon, Carol; Giles, Peter; Webber, Jason; Steadman, Robert; Ludgate, Marian			Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts CONTRIBUTORY ROLE IN HYALURONAN ACCUMULATION IN THYROID DYSFUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN FIBROBLASTS; STIMULATING HORMONE; ORBITAL FIBROBLASTS; GLYCOSAMINOGLYCAN SYNTHESIS; BIOLOGICAL-ACTIVITY; CONNECTIVE-TISSUE; EPITHELIAL-CELLS; GRAVES-DISEASE; EXPRESSION; MYXEDEMA	The thyrotropin receptor (TSHR) is expressed during lineage-specific differentiation (e. g. adipogenesis) and is activated by TSH, thyroid-stimulating antibodies, and gain-of-function mutations (TSHR*). Comparison of gene expression profiles of nonmodified human preadipocytes (n = 4) with the parallel TSHR* population revealed significant up-regulation of 27 genes including hyaluronan (HA) synthases (HAS) 1 and 2. The array data were confirmed by quantitative PCR of HAS1 and HAS2 and enzyme-linked immunosorbent assay measurement of HA; all values were significantly increased (p < 0.03) in TSHR*-expressing preadipocytes (n = 10). Preadipocytes (n = 8) treated with dibutyryl (db)-cAMP display significantly increased HAS1 and HAS2 transcripts, HAS2 protein, and HA production (p < 0.02). HAS1 or HAS2 small interfering RNA treatment of db-cAMP-stimulated preadipocytes (n = 4) produced 80% knockdown in HAS1 or 61% knockdown in HAS2 transcripts (compared with scrambled), respectively; the corresponding HA production was reduced by 49 or 38%. Reporter assays using A293 cells transfected with HAS1 promoter-driven plasmids containing or not containing the proximal CRE and treated with db-cAMP revealed that it is functional. Chromatin immunoprecipitation, using a cAMP-responsive element-binding protein antibody, of db-cAMP-treated preadipocytes (n = 4) yielded products for HAS1 and HAS2 with relative fold increases of 3.3 +/- 0.8 and 2.6 +/- 0.9, respectively. HA accumulates in adipose/connective tissues of patients with thyroid dysfunction. We investigated the contributions of TSH andthyroid-stimulating antibodies and obtained small (9 - 24%) but significant (p < 0.02) increases in preadipocyte HA production with both ligands. Similar results were obtained with a TSHR monoclonal antibody lacking biological activity (p < 0.05). We conclude that TSHR activation is implicated in HA production in preadipocytes, which, along with thyroid hormone level variation, explains the HA overproduction in thyroid dysfunction.	[Zhang, Lei; Grennan-Jones, Fiona; Paddon, Carol; Ludgate, Marian] Cardiff Univ, Sch Med, Ctr Endocrine & Diabet Sci, Cardiff CF14 4XN, S Glam, Wales; [Bowen, Timothy; Webber, Jason; Steadman, Robert] Cardiff Univ, Sch Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales; [Giles, Peter] Cardiff Univ, Sch Med, Biostat & Bioinformat Unit, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Ludgate, M (corresponding author), Cardiff Univ, Sch Med, Ctr Endocrine & Diabet Sci, Cardiff CF14 4XN, S Glam, Wales.	ludgate@cf.ac.uk	Zhang, Lei/F-4055-2016; Webber, Jason P/O-1960-2017; Steadman, Robert/O-1614-2016	Zhang, Lei/0000-0003-3536-8692; Webber, Jason P/0000-0003-4772-3014; Steadman, Robert/0000-0002-1303-2496; Ludgate, Marian/0000-0002-7436-0821	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Wellcome Trust.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Al-Khafaji F, 2005, J MOL ENDOCRINOL, V34, P209, DOI 10.1677/jme.1.01590; ARBOGAST B, 1975, BIOCHEM BIOPH RES CO, V67, P376, DOI 10.1016/0006-291X(75)90326-5; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Costagliola S, 1998, J IMMUNOL, V160, P1458; Crisp M, 2000, INVEST OPHTH VIS SCI, V41, P3249; Crisp MS, 1997, J CLIN ENDOCR METAB, V82, P2003; Daumerie C, 2002, EUR J ENDOCRINOL, V146, P35, DOI 10.1530/eje.0.1460035; FINKE R, 1991, J CLIN ENDOCR METAB, V73, P919, DOI 10.1210/jcem-73-4-919; Fuhrer D, 2003, ENDOCRINOLOGY, V144, P4018, DOI 10.1210/en.2003-0438; GABRILOVE JL, 1957, J CLIN ENDOCR METAB, V17, P925, DOI 10.1210/jcem-17-8-925; GABRILOVE JL, 1960, J CLIN ENDOCR METAB, V20, P825, DOI 10.1210/jcem-20-6-825; Gianoukakis AG, 2007, ENDOCRINOLOGY, V148, P54, DOI 10.1210/en.2006-0736; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; LUND P, 1986, ACTA ENDOCRINOL-COP, V113, P56, DOI 10.1530/acta.0.1130056; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; METCALFE RA, 1993, THYROID, V3, P207, DOI 10.1089/thy.1993.3.207; PASCHKE R, 1994, J CLIN ENDOCR METAB, V79, P1234, DOI 10.1210/jc.79.5.1234; Paschke R, 1997, NEW ENGL J MED, V337, P1675, DOI 10.1056/NEJM199712043372307; SCHILLER S, 1962, BIOCHIM BIOPHYS ACTA, V58, P27, DOI 10.1016/0006-3002(62)90813-2; SHISHIBA Y, 1988, J BIOL CHEM, V263, P1745; SMITH TJ, 1989, ENDOCR REV, V10, P366, DOI 10.1210/edrv-10-3-366; SMITH TJ, 1989, J CLIN ENDOCR METAB, V69, P1019, DOI 10.1210/jcem-69-5-1019; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; SMITH TJ, 1982, J CLIN INVEST, V70, P1066, DOI 10.1172/JCI110694; Stair-Nawy S, 1999, BIOCHEM BIOPH RES CO, V266, P268, DOI 10.1006/bbrc.1999.1802; Tinti C, 1997, J BIOL CHEM, V272, P19158, DOI 10.1074/jbc.272.31.19158; TOMIDA M, 1977, BIOCHEM J, V162, P539, DOI 10.1042/bj1620539; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; WEETMAN AP, 1993, Q J MED, V86, P473, DOI 10.1093/qjmed/86.8.473; WEGROWSKI J, 1989, CELL BIOL INT REP, V13, P881, DOI 10.1016/0309-1651(89)90130-6; Zhang L, 2006, INVEST OPHTH VIS SCI, V47, P5197, DOI 10.1167/iovs.06-0596	40	64	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26447	26455		10.1074/jbc.M109.003616	http://dx.doi.org/10.1074/jbc.M109.003616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633293	Green Published, hybrid			2022-12-25	WOS:000269969600026
J	Alvares, K; Dixit, SN; Lux, E; Veis, A				Alvares, Keith; Dixit, Saryu N.; Lux, Elizabeth; Veis, Arthur			Echinoderm Phosphorylated Matrix Proteins UTMP16 and UTMP19 Have Different Functions in Sea Urchin Tooth Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYTECHINUS-VARIEGATUS; BIOMINERALIZATION; TEETH; DOMAIN; EXPRESSION; PREDICTION	Studies of mineralization of embryonic spicules and of the sea urchin genome have identified several putative mineralization-related proteins. These predicted proteins have not been isolated or confirmed in mature mineralized tissues. Mature Lyte-chinus variegatus teeth were demineralized with 0.6 N HCl after prior removal of non-mineralized constituents with 4.0 M guanidinium HCl. The HCl-extracted proteins were fractionated on ceramic hydroxyapatite and separated into bound and unbound pools. Gel electrophoresis compared the protein distributions. The differentially present bands were purified and digested with trypsin, and the tryptic peptides were separated by high pressure liquid chromatography. NH2-terminal sequences were determined by Edman degradation and compared with the genomic sequence bank data. Two of the putative mineralization-related proteins were found. Their complete amino acid sequences were cloned from our L. variegatus cDNA library. Apatite-binding UTMP16 was found to be present in two isoforms; both isoforms had a signal sequence, a Ser-Asp-rich extracellular matrix domain, and a transmembrane and cytosolic insertion sequence. UTMP19, although rich in Glu and Thr did not bind to apatite. It had neither signal peptide nor transmembrane domain but did have typical nuclear localization and nuclear exit signal sequences. Both proteins were phosphorylated and good substrates for phosphatase. Immunolocalization studies with anti-UTMP16 show it to concentrate at the syncytial membranes in contact with the mineral. On the basis of our TOF-SIMS analyses of magnesium ion and Asp mapping of the mineral phase composition, we speculate that UTMP16 may be important in establishing the high magnesium columns that fuse the calcite plates together to enhance the mechanical strength of the mineralized tooth.	[Alvares, Keith; Dixit, Saryu N.; Lux, Elizabeth; Veis, Arthur] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Veis, A (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	aveis@northwestern.edu		Alvares, Keith/0000-0003-3710-4367	National Institutes of Health [DE 001374]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE001374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE001374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 001374 (to A. V.).	Alvares K, 2007, J EXP ZOOL PART B, V308B, P357, DOI 10.1002/jez.b.21159; Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cheers MS, 2005, DEV BIOL, V283, P384, DOI 10.1016/j.ydbio.2005.02.037; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0; KNIPRATH E, 1974, CALC TISS RES, V14, P211, DOI 10.1007/BF02060296; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; MARKEL K, 1986, ZOOMORPHOLOGY, V106, P232, DOI 10.1007/BF00312044; Massa LF, 2005, HISTOCHEM CELL BIOL, V124, P197, DOI 10.1007/s00418-005-0009-9; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Ritchie HH, 2000, BBA-GENE STRUCT EXPR, V1493, P27, DOI 10.1016/S0167-4781(00)00150-0; Robach JS, 2006, J STRUCT BIOL, V155, P87, DOI 10.1016/j.jsb.2006.03.002; Robach JS, 2005, J STRUCT BIOL, V151, P18, DOI 10.1016/j.jsb.2005.04.001; SMITH AB, 1988, MOL BIOL EVOL, V5, P345; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Veis A., 2004, P365, DOI 10.1201/9780203970881.ch60; Veis A, 2002, MICROSC RES TECHNIQ, V59, P342, DOI 10.1002/jemt.10216; VEIS A, 2007, P 9 INT S BIOM, P329; VEIS DJ, 1986, J EXP ZOOL, V240, P35, DOI 10.1002/jez.1402400106; Wang RZ, 1997, PHILOS T R SOC B, V352, P469, DOI 10.1098/rstb.1997.0034; Wilt FH, 1999, J STRUCT BIOL, V126, P216, DOI 10.1006/jsbi.1999.4105	26	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26149	26160		10.1074/jbc.M109.024018	http://dx.doi.org/10.1074/jbc.M109.024018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596854	hybrid, Green Published			2022-12-25	WOS:000269738000070
J	Broer, S; Schneider, HP; Broer, A; Deitmer, JW				Broeer, Stefan; Schneider, Hans-Peter; Broeer, Angelika; Deitmer, Joachim W.			Mutation of Asparagine 76 in the Center of Glutamine Transporter SNAT3 Modulates Substrate-induced Conductances and Na+ Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN HOMOLOGY DETECTION; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; MOLECULAR-BASIS; AMINO-ACIDS; MECHANISM; NEUROTRANSMITTER; SYSTEM; SUPERFAMILY; EXPRESSION	The glutamine transporter SLC38A3 (SNAT3) plays an important role in the release of glutamine from brain astrocytes and the uptake of glutamine into hepatocytes. It is related to the vesicular GABA (gamma-aminobutyric acid) transporter and the SLC36 family of proton-amino acid cotransporters. The transporter carries out electroneutral Na+-glutamine cotransport-H+ antiport. In addition, substrate-induced uncoupled cation currents are observed. Mutation of asparagine 76 to glutamine or histidine in predicted transmembrane helix 1 abolished all substrate-induced currents. Mutation of asparagine 76 to aspartate rendered the transporter Na+-independent and resulted in a gain of a large substrate-induced chloride conductance in the absence of Na+. Thus, a single residue is critical for coupled and uncoupled ion flows in the glutamine transporter SNAT3. Homology modeling of SNAT3 along the structure of the related benzyl-hydantoin permease from Microbacterium liquefaciens reveals that Asn-76 is likely to be located in the center of the membrane close to the translocation pore and forms part of the predicted Na+-binding site.	[Broeer, Stefan; Broeer, Angelika] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Schneider, Hans-Peter; Deitmer, Joachim W.] Tech Univ Kaiserslautern, Fachbereich Biol, Abt Allgemeine Zool, D-67653 Kaiserslautern, Germany	Australian National University; University of Kaiserslautern	Broer, A (corresponding author), Australian Natl Univ, Res Sch Biol, Bldg 41, Canberra, ACT 0200, Australia.	stefan.broeer@anu.edu.au; deitmer@biologie.uni-kl.de	Broer, Stefan/A-1286-2008	Broer, Stefan/0000-0002-8040-1634	Deutsche Forschungsgemeinschaft [De 231/16-2]; Landesschwerpunkt "Membrantransport"; Australian Research Council [LX0881952]; National Health and Medical Research Council [366713]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesschwerpunkt "Membrantransport"; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Deutsche Forschungsgemeinschaft Grant De 231/16-2 and a grant from the Landesschwerpunkt "Membrantransport" (to J. W. D.), by Australian Research Council Grant LX0881952 (to J. W. D. and S. B.), and by National Health and Medical Research Council Grant 366713 (to S. B.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Albers A, 2001, PFLUG ARCH EUR J PHY, V443, P92, DOI 10.1007/s004240100663; Blakely RD, 2005, PHYSIOLOGY, V20, P225, DOI 10.1152/physiol.00013.2005; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 2002, J PHYSIOL-LONDON, V539, P3, DOI 10.1013/jphysiol.2001.013303; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FANG Y, 2009, NATURE IN PRESS; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Granseth E, 2006, BIOINFORMATICS, V22, pE191, DOI 10.1093/bioinformatics/btl206; Haussinger D, 2001, J NUTR, V131, p2509S, DOI 10.1093/jn/131.9.2509S; HAUSSINGER D, 2001, J NUTR S9, V131, P2523; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Liu YJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE380, DOI 10.1152/ajpendo.00008.2003; Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; MUNSCH T, 1994, J PHYSIOL-LONDON, V474, P43, DOI 10.1113/jphysiol.1994.sp020001; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	56	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25823	25831		10.1074/jbc.M109.031013	http://dx.doi.org/10.1074/jbc.M109.031013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596860	Green Published, hybrid			2022-12-25	WOS:000269738000040
J	Fullerton, MD; Hakimuddin, F; Bonen, A; Bakovic, M				Fullerton, Morgan D.; Hakimuddin, Fatima; Bonen, Arend; Bakovic, Marica			The Development of a Metabolic Disease Phenotype in CTP: Phosphoethanolamine Cytidylyltransferase-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; ISOLATED RAT HEPATOCYTES; LIVER CELL-CULTURE; PROTEIN-KINASE-C; SKELETAL-MUSCLE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHATIDYLETHANOLAMINE SYNTHESIS; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; EMBRYONIC LETHALITY	Phosphatidylethanolamine (PE) is an important inner membrane phospholipid mostly synthesized de novo via the PE-Kennedy pathway and by the decarboxylation of phosphatidylserine. CTP:phosphoethanolamine cytidylyltransferase (Pcyt2) catalyzes the formation of CDP-ethanolamine, which is often the rate regulatory step in the PE-Kennedy pathway. In the current investigation, we show that the reduced CDP-ethanolamine formation in Pcyt2(+/-) mice limits the rate of PE synthesis and increases the availability of diacylglycerol. This results in the increased formation of triglycerides, which is facilitated by stimulated de novo fatty acid synthesis and increased uptake of pre-existing fatty acids. Pcyt2(+/-) mice progressively accumulate more diacylglycerol and triglycerides with age and have modified fatty acid composition, predominantly in PE and triglycerides. Pcyt2(+/-) additionally have an inherent blockage in fatty acid utilization as energy substrate and develop impaired tolerance to glucose and insulin at an older age. Accordingly, gene expression analyses demonstrated the up-regulation of the main lipogenic genes and down-regulation of mitochondrial fatty acid beta-oxidation genes. These data demonstrate for the first time that to preserve membrane PE phospholipids, Pcyt2 deficiency generates compensatory changes in triglyceride and energy substrate metabolism, resulting in a progressive development of liver steatosis, hypertriglyceridemia, obesity, and insulin resistance, the main features of the metabolic syndrome.	[Fullerton, Morgan D.; Hakimuddin, Fatima; Bonen, Arend; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Bakovic, M (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Anim Sci & Nutr Bldg,Rm 346, Guelph, ON N1G 2W1, Canada.	mbakovic@uoguelph.ca			Ontario Graduate Scholarship; Canadian Institutes of Health Research [MOP-68962, 410-2007-86448]	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an Ontario Graduate Scholarship ( to M. D. F.) and Operating Grants MOP-68962 and 410-2007-86448 from the Canadian Institutes of Health Research ( to M.B.)	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; ARTHUR G, 1991, BIOCHEM J, V273, P121, DOI 10.1042/bj2730121; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Bladergroen BA, 1999, BIOCHEM J, V343, P107, DOI 10.1042/0264-6021:3430107; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; BORKENHAGEN LF, 1961, J BIOL CHEM, V236, P28; Caviglia JM, 2004, J LIPID RES, V45, P1500, DOI 10.1194/jlr.M400079-JLR200; Denomme J, 2005, J NUTR, V135, P206, DOI 10.1093/jn/135.2.206; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; HOUWELING M, 1992, BIOCHEM J, V283, P55, DOI 10.1042/bj2830055; IGAL A, 1994, INT J BIOCHROMATOGR, V1, P137; Igal RA, 2001, J LIPID RES, V42, P88; Igal RA, 1998, J LIPID RES, V39, P31; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; JAMIL H, 1992, J BIOL CHEM, V267, P1752; Jiang Joy, 2008, Metabolic Syndrome and Related Disorders, V6, P1, DOI 10.1089/met.2007.0026; Johnson CA, 2005, BBA-MOL CELL BIOL L, V1735, P230, DOI 10.1016/j.bbalip.2005.06.002; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P926; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; McFarland MJ, 2004, PHARMACOL THERAPEUT, V104, P117, DOI 10.1016/j.pharmthera.2004.07.008; MENON AK, 1992, J BIOL CHEM, V267, P15277; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; MinSeok R, 1996, J BIOCHEM, V120, P1040; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Nakashima A, 1997, J BIOL CHEM, V272, P9567; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Poloumienko A, 2004, GENE, V325, P145, DOI 10.1016/j.gene.2003.10.005; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; STALS HK, 1994, FEBS LETT, V343, P99, DOI 10.1016/0014-5793(94)80615-2; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; TIJBURG LBM, 1989, BIOCHEM J, V257, P645, DOI 10.1042/bj2570645; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; VOELKER DR, 1986, J BIOL CHEM, V261, P1002; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	55	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25704	25713		10.1074/jbc.M109.023846	http://dx.doi.org/10.1074/jbc.M109.023846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625253	hybrid, Green Published			2022-12-25	WOS:000269738000028
J	Guerin, ME; Kaur, D; Somashekar, BS; Gibbs, S; Gest, P; Chatterjee, D; Brennan, PJ; Jackson, M				Guerin, Marcelo E.; Kaur, Devinder; Somashekar, B. S.; Gibbs, Sara; Gest, Petra; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary			New Insights into the Early Steps of Phosphatidylinositol Mannoside Biosynthesis in Mycobacteria PimB' IS AN ESSENTIAL ENZYME OF MYCOBACTERIUM SMEGMATIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; ACYLATION STATE; MANNOSYLTRANSFERASE; TUBERCULOSIS; LIPOARABINOMANNAN; LIPOMANNAN; MUTANT; GENE; GLYCOSYLTRANSFERASES; MANNOPHOSPHOLIPIDS	Phosphatidyl-myo-inositol mannosides (PIMs) are key glycolipids of the mycobacterial cell envelope. They are considered not only essential structural components of the cell but also important molecules implicated in host-pathogen interactions. Although their chemical structures are well established, knowledge of the enzymes and sequential events leading to their biosynthesis is still incomplete. Here we show for the first time that although both mannosyltransferases PimA and PimB' (MSMEG_4253) recognize phosphatidyl-myo-inositol (PI) as a lipid acceptor, PimA specifically catalyzes the transfer of a Manp residue to the 2-position of the myo-inositol ring of PI, whereas PimB' exclusively transfers to the 6-position. Moreover, whereas PimB' can catalyze the transfer of a Manp residue onto the PI-monomannoside (PIM1) product of PimA, PimA is unable in vitro to transfer Manp onto the PIM1 product of PimB'. Further assays using membranes from Mycobacterium smegmatis and purified PimA and PimB' indicated that the acylation of the Manp residue transferred by PimA preferentially occurs after the second Manp residue has been added by PimB'. Importantly, genetic evidence is provided that pimB' is an essential gene of M. smegmatis. Altogether, our results support a model wherein Ac1PIM2, a major form of PIMs produced by mycobacteria, arises from the consecutive action of PimA, followed by PimB', and finally the acyltransferase MSMEG_2934. The essentiality of these three enzymes emphasizes the interest of novel anti-tuberculosis drugs targeting the initial steps of PIM biosynthesis.	[Guerin, Marcelo E.; Kaur, Devinder; Somashekar, B. S.; Gibbs, Sara; Gest, Petra; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Guerin, ME (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mrcguerin@gmail.com; Mary.Jackson@colostate.edu	Guerin, Marcelo M/N-7245-2016; Jackson, Mary/D-5345-2017	Guerin, Marcelo M/0000-0001-9524-3184; Jackson, Mary/0000-0002-9212-0258	NIAID [AI064798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798 from NIAID.	BRENNAN P, 1967, J BIOL CHEM, V242, P3046; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; GOREN MB, 1984, MYCOBACTERIA SOURCEB, V1, P379; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; HILL DL, 1966, J BIOL CHEM, V241, P895; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; KAUR D, 2009, ADV APPL MI IN PRESS; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Parish T, 1997, J BACTERIOL, V179, P7827, DOI 10.1128/jb.179.24.7827-7833.1997; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; TAKAYAMA K, 1969, BIOCHIM BIOPHYS ACTA, V176, P196, DOI 10.1016/0005-2760(69)90089-7; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Torrelles JB, 2009, GLYCOBIOLOGY, V19, P743, DOI 10.1093/glycob/cwp042; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	30	58	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25687	25696		10.1074/jbc.M109.030593	http://dx.doi.org/10.1074/jbc.M109.030593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19638342	Green Published, hybrid			2022-12-25	WOS:000269738000026
J	Halvey, EJ; Vernon, J; Roy, B; Garthwaite, J				Halvey, Edward J.; Vernon, Jeffrey; Roy, Brijesh; Garthwaite, John			Mechanisms of Activity-dependent Plasticity in Cellular Nitric Oxide-cGMP Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE; CYCLIC-GMP; CEREBELLAR CELLS; IN-VIVO; ACTIVATION; DESENSITIZATION; RECEPTOR; BINDING	Cellular responsiveness to nitric oxide (NO) is shaped by past history of NO exposure. The mechanisms behind this plasticity were explored using rat platelets in vitro, specifically to determine the relative contributions made by desensitization of NO receptors, which couple to cGMP formation, and by phosphodiesterase-5 (PDE5), which is activated by cGMP and also hydrolyzes it. Repeated delivery of brief NO pulses (50 nM peak) at 1-min intervals resulted in a progressive loss of the associated cGMP responses, which was the combined consequence of receptor desensitization and PDE5 activation, with the former dominating. Delivery of pulses of differing amplitude showed that NO stimulated and desensitized receptors with similar potency (EC50 = 10 - 20 nM). PDE5 activation was highly sensitive to NO, with a single pulse peaking at 2 nM being sufficient to evoke a 50% loss of response to a subsequent near-maximal NO pulse. However, the activated state of the PDE subsided quickly after removal of NO, the half-time for recovery being 25 s. In contrast, receptor desensitization reverted much more slowly, the half-time being 16 min. Accordingly, with long (20-min) exposures, NO concentrations as low as 600 pM provoked significant desensitization. The results indicate that PDE5 activation and receptor desensitization subserve distinct short term and longer term roles as mediators of plasticity in NO-cGMP signaling. A kinetic model explicitly describing the complex interplay between NO concentration, cGMP synthesis, PDE5 activation, and the resulting cGMP accumulation successfully simulated the present and previous data.	[Halvey, Edward J.; Vernon, Jeffrey; Roy, Brijesh; Garthwaite, John] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Garthwaite, J (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	john.garthwaite@ucl.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a Programme grant from The Wellcome Trust.	AXELSSON KL, 1983, EUR J PHARMACOL, V88, P71, DOI 10.1016/0014-2999(83)90393-X; Bellamy TC, 2000, P NATL ACAD SCI USA, V97, P2928, DOI 10.1073/pnas.97.6.2928; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Bellamy TC, 2001, MOL PHARMACOL, V59, P54, DOI 10.1124/mol.59.1.54; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; Brandes RP, 2000, HYPERTENSION, V35, P231, DOI 10.1161/01.HYP.35.1.231; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Clark DE, 1999, J PHARM SCI-US, V88, P807, DOI 10.1021/js9804011; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Fernandes D, 2006, MOL PHARMACOL, V69, P983, DOI 10.1124/mol.105.015479; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; Garthwaite J, 2005, FRONT BIOSCI-LANDMRK, V10, P1868; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gibson A, 2001, EUR J PHARMACOL, V411, P1, DOI 10.1016/S0014-2999(00)00824-4; GOLD ME, 1990, P NATL ACAD SCI USA, V87, P4430, DOI 10.1073/pnas.87.12.4430; Griffiths C, 2003, MOL PHARMACOL, V64, P1349, DOI 10.1124/mol.64.6.1349; HATAKEYAMA K, 1992, J BIOL CHEM, V267, P20734; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; HORIE M, 1989, J PHYSIOL-LONDON, V408, P313, DOI 10.1113/jphysiol.1989.sp017461; Hussain MB, 1999, BRIT J PHARMACOL, V128, P1082, DOI 10.1038/sj.bjp.0702874; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708; Mo E, 2004, J BIOL CHEM, V279, P26149, DOI 10.1074/jbc.M400916200; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mullershausen F, 2004, MOL BIOL CELL, V15, P4023, DOI 10.1091/mbc.E03-12-0890; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; Murthy KS, 2004, NEUROCHEM INT, V45, P845, DOI 10.1016/j.neuint.2004.03.014; Murthy KS, 2001, BIOCHEM J, V360, P199, DOI 10.1042/0264-6021:3600199; Okada D, 2002, BIOCHEMISTRY-US, V41, P9672, DOI 10.1021/bi025727+; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Scott WS, 1998, J SURG RES, V79, P66, DOI 10.1006/jsre.1998.5382; UJIIE K, 1994, J PHARMACOL EXP THER, V270, P761; WALDMAN SA, 1986, BIOCHEM PHARMACOL, V35, P3525, DOI 10.1016/0006-2952(86)90622-2; Wyatt TA, 1998, AM J PHYSIOL-HEART C, V274, pH448, DOI 10.1152/ajpheart.1998.274.2.H448; Wykes V, 2002, J NEUROCHEM, V83, P37, DOI 10.1046/j.1471-4159.2002.01106.x; Yamashita T, 2000, HYPERTENSION, V36, P97, DOI 10.1161/01.HYP.36.1.97; Zhou ZM, 2008, ARTERIOSCL THROM VAS, V28, P1803, DOI 10.1161/ATVBAHA.108.165043	56	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25630	25641		10.1074/jbc.M109.030338	http://dx.doi.org/10.1074/jbc.M109.030338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19605352	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000269738000021
J	Jones, RPO; Wang, MC; Jowitt, TA; Ridley, C; Mellody, KT; Howard, M; Wang, T; Bishop, PN; Lotery, AJ; Kielty, CM; Baldock, C; Trump, D				Jones, Richard P. O.; Wang, Ming-Chuan; Jowitt, Thomas A.; Ridley, Caroline; Mellody, Kieran T.; Howard, Marjorie; Wang, Tao; Bishop, Paul N.; Lotery, Andrew J.; Kielty, Cay M.; Baldock, Clair; Trump, Dorothy			Fibulin 5 Forms a Compact Dimer in Physiological Solutions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; CUTIS LAXA; IN-VIVO; HYDRODYNAMIC PROPERTIES; MACULAR DEGENERATION; PROTEIN INTERACTIONS; BINDING-PROTEIN; DOMAIN; DANCE/FIBULIN-5; FIBULIN-5/DANCE	Fibulin 5 is a 52-kDa calcium-binding epidermal growth factor (cbEGF)-rich extracellular matrix protein that is essential for the formation of elastic tissues. Missense mutations in fibulin 5 cause the elastin disorder cutis laxa and have been associated with age-related macular degeneration, a leading cause of blindness. We investigated the structure, hydrodynamics, and oligomerization of fibulin 5 using small angle x-ray scattering, EM, light scattering, circular dichroism, and sedimentation. Compact structures for the monomer were determined by small angle x-ray scattering and EM, and are supported by close agreement between the theoretical sedimentation of the structures and the experimental sedimentation of the monomer in solution. EM showed that monomers associate around a central cavity to form a dimer. Light scattering and equilibrium sedimentation demonstrated that the equilibrium between the monomer and the dimer is dependent upon NaCl and Ca2+ concentrations and that the dimer is dominant under physiological conditions. The dimerization of fragments containing just the cbEGF domains suggests that intermolecular interactions between cbEGFs cause dimerization of fibulin 5. It is possible that fibulin 5 functions as a dimer during elastinogenesis or that dimerization may provide a method for limiting interactions with binding partners such as tropoelastin.	[Jones, Richard P. O.; Wang, Tao; Bishop, Paul N.; Trump, Dorothy] Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Wang, Ming-Chuan; Jowitt, Thomas A.; Ridley, Caroline; Mellody, Kieran T.; Howard, Marjorie; Bishop, Paul N.; Kielty, Cay M.; Baldock, Clair] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PL, Lancs, England; [Lotery, Andrew J.] Univ Southampton, Clin Neurosci Div, Southampton SO17 1BJ, Hants, England	University of Manchester; University of Manchester; University of Southampton	Trump, D (corresponding author), Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester M13 9WL, Lancs, England.	dorothy.trump@manchester.ac.uk		Baldock, Clair/0000-0003-3497-1959; Jowitt, Thomas/0000-0002-4045-0933; Lotery, Andrew/0000-0001-5541-4305; Ridley, Caroline/0000-0002-5483-0320; Bishop, Paul/0000-0001-7937-7932; Mellody, Kieran/0000-0002-8164-9148	Wellcome Trust [123364, 072291]; VIP award; National Institute for Health Research, Manchester Biomedical Research Centre; Medical Research Council [G0200246] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10094] Funding Source: researchfish; MRC [G0200246] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); VIP award; National Institute for Health Research, Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grants 123364 (to D. T., A. J. L., P. N. B., C. M. K., R. P. O. J., and C. R.), 072291 (to C. B. and M. C. W.), and VIP award (to R. P. O. J., and D. T.), and the National Institute for Health Research, Manchester Biomedical Research Centre.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Claus S, 2008, J INVEST DERMATOL, V128, P1442, DOI 10.1038/sj.jid.5701211; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; de la Torre JG, 2001, EUR BIOPHYS J BIOPHY, V30, P457, DOI 10.1007/s002490100176; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80236-7; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Hayes D, 1995, PROGRAM SEDNTERP SED; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; HOPE RA, 1993, OXFORD HDB CLIN MED; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; Kapetanopoulos A, 2002, MOL GENET GENOMICS, V267, P440, DOI 10.1007/s00438-002-0673-6; Kielty CM, 2002, J CELL SCI, V115, P2817; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Lewis MS, 2000, METHOD ENZYMOL, V321, P136; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Markova D, 2003, AM J HUM GENET, V72, P998, DOI 10.1086/373940; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	47	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25938	25943		10.1074/jbc.M109.011627	http://dx.doi.org/10.1074/jbc.M109.011627			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617354	Green Published, hybrid			2022-12-25	WOS:000269738000050
J	Monaghan-Benson, E; Burridge, K				Monaghan-Benson, Elizabeth; Burridge, Keith			The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN TYROSINE PHOSPHORYLATION; ADHERENS-TYPE JUNCTIONS; CELL-CELL ADHESION; VE-CADHERIN; NADPH OXIDASE; BETA-CATENIN; PARACELLULAR PATHWAY; LEUKOCYTE TRANSMIGRATION; DEPENDENT ENDOCYTOSIS; SIGNAL-TRANSDUCTION	Vascular permeability is a complex process involving the coordinated regulation of multiple signaling pathways in the endothelial cell. It has long been documented that vascular endothelial growth factor (VEGF) greatly enhances microvascular permeability; however, the molecular mechanisms controlling VEGF-induced permeability remain unknown. Treatment of microvascular endothelial cells with VEGF led to an increase in reactive oxygen species (ROS) production. ROS are required for VEGF-induced permeability as treatment with the free radical scavenger, N-acetylcysteine, inhibited this effect. Additionally, treatment with VEGF caused ROS-dependent tyrosine phosphorylation of both vascular-endothelial (VE)-cadherin and beta-catenin. Rac1 was required for the VEGF-induced increase in permeability and adherens junction protein phosphorylation. Knockdown of Rac1 inhibited VEGF-induced ROS production consistent with Rac lying upstream of ROS in this pathway. Collectively, these data suggest that VEGF leads to a Rac-mediated generation of ROS, which, in turn, elevates the tyrosine phosphorylation of VE-cadherin and beta-catenin, ultimately regulating adherens junction integrity.	[Monaghan-Benson, Elizabeth] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Monaghan-Benson, E (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, 12-026 Lineberger Canc Ctr, Chapel Hill, NC 27599 USA.	ebenson@med.unc.edu			National Institutes of Health [HL080166, HL045100]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100, P01HL080166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080166 and HL045100 (to K. B.).	Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Babior BM, 2000, IUBMB LIFE, V50, P267, DOI 10.1080/15216540051080976; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bogatcheva NV, 2002, VASC PHARMACOL, V39, P201, DOI 10.1016/S1537-1891(03)00009-0; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Esser S, 1998, J CELL SCI, V111, P1853; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Garcia JGN, 2000, J APPL PHYSIOL, V89, P2333, DOI 10.1152/jappl.2000.89.6.2333; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; Gotsch U, 1997, J CELL SCI, V110, P583; Hordijk PL, 1999, J CELL SCI, V112, P1915; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Irani K, 1998, BIOCHEM PHARMACOL, V55, P1339; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; RHEE SG, 2000, SCI STKE, pE1; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SENGER DR, 1983, NATURE, V302, P714, DOI 10.1038/302714a0; SENGER DR, 1986, CANCER RES, V46, P5629; Sohn HY, 2000, J BIOL CHEM, V275, P18745, DOI 10.1074/jbc.M000026200; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003; van Wetering S, 2002, J CELL SCI, V115, P1837; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; VOLBERG T, 1991, CELL REGUL, V2, P105, DOI 10.1091/mbc.2.2.105; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yeh LH, 1999, AM J PHYSIOL-CELL PH, V276, pC838, DOI 10.1152/ajpcell.1999.276.4.C838; Young BA, 2003, AM J PHYSIOL-LUNG C, V285, pL63, DOI 10.1152/ajplung.00423.2002; Young BA, 1998, BIOCHEM BIOPH RES CO, V251, P320, DOI 10.1006/bbrc.1998.9475; Zeng HY, 2002, J BIOL CHEM, V277, P4003, DOI 10.1074/jbc.M110842200	62	157	165	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25602	25611		10.1074/jbc.M109.009894	http://dx.doi.org/10.1074/jbc.M109.009894			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633358	Green Published, hybrid			2022-12-25	WOS:000269738000018
J	Simioni, MB; De Thonel, A; Hammann, A; Joly, AL; Bossis, G; Fourmaux, E; Bouchot, A; Landry, J; Piechaczyk, M; Garrido, C				Simioni, M. Brunet; De Thonel, A.; Hammann, A.; Joly, A. L.; Bossis, G.; Fourmaux, E.; Bouchot, A.; Landry, J.; Piechaczyk, M.; Garrido, C.			Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity	ONCOGENE			English	Article						HSP27; SUMOylation; HSF1; transcriptional activity; stress; cancer	NECROSIS-FACTOR-ALPHA; HSP27 OLIGOMERIZATION; MODIFIER SUMO; CELL-DEATH; IN-VIVO; PHOSPHORYLATION; STRESS; SUMOYLATION; HEAT-SHOCK-PROTEIN-27; TUMORIGENICITY	Heat shock protein 27 (HSP27) accumulates in stressed cells and helps them to survive adverse conditions. We have already shown that HSP27 has a function in the ubiquitination process that is modulated by its oligomerization/phosphorylation status. Here, we show that HSP27 is also involved in protein sumoylation, a ubiquitinatio-nrelated process. HSP27 increases the number of cell proteins modified by small ubiquitin-like modi. er (SUMO)-2/3 but this effect shows some selectivity as it neither affects all proteins nor concerns SUMO-1. Moreover, no such alteration in SUMO-2/3 conjugation is achievable by another HSP, such as HSP70. Heat shock factor 1 (HSF1), a transcription factor responsible for HSP expression, is one of the targets of HSP27. In stressed cells, HSP27 enters the nucleus and, in the form of large oligomers, binds to HSF1 and induces its modification by SUMO-2/3 on lysine 298. HSP27-induced HSF1 modification by SUMO-2/3 takes place downstream of the transcription factor phosphorylation on S303 and S307 and does not affect its DNA-binding ability. In contrast, this modi. cation blocks HSF1 transactivation capacity. These data show that HSP27 exerts a feedback inhibition of HSF1 transactivation and enlighten the strictly regulated interplay between HSPs and HSF1. As we also show that HSP27 binds to the SUMO-E2-conjugating enzyme, Ubc9, our study raises the possibility that HSP27 may act as a SUMO-E3 ligase specific for SUMO-2/3. Oncogene (2009) 28, 3332-3344; doi:10.1038/onc.2009.188; published online 13 July 2009	[Garrido, C.] Fac Med, INSERM, U866, F-21000 Dijon, France; [Simioni, M. Brunet; De Thonel, A.; Hammann, A.; Joly, A. L.; Garrido, C.] Univ Burgundy, Fac Med & Pharm, Dijon, France; [Bossis, G.; Piechaczyk, M.] CNRS, Inst Genet Mol, UMR 5535, Montpellier 5, France; [Bossis, G.; Piechaczyk, M.] Univ Montpellier 2, F-34095 Montpellier 5, France; [Bossis, G.; Piechaczyk, M.] Univ Montpellier 1, Montpellier 2, France; [Landry, J.] Univ Laval, Ctr Rech Cancerol, Quebec City, PQ, Canada; [Landry, J.] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Garrido, C.] CHU Dijon, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Laval University; Laval University; CHU Dijon Bourgogne	Garrido, C (corresponding author), Fac Med, INSERM, U866, 7 Blvd Jeanne Arc, F-21000 Dijon, France.	cgarrido@u-bourgogne.fr	Garrido, Carolina/GWM-5557-2022; PIECHACZYK, Marc/E-7896-2013; Bossis, Guillaume/C-7172-2012; Garrido, carmen/G-1633-2018	PIECHACZYK, Marc/0000-0003-1367-2597; Garrido, carmen/0000-0003-1368-1493; bossis, guillaume/0000-0002-3349-8250; de Thonel, Aurelie/0000-0003-0405-0745	'Ligue Nationale Contre le Cancer'; 'Nievre'; 'Saone et Loire'; 'L' Association pour la Recherche contre le Cancer'; INCa	'Ligue Nationale Contre le Cancer'(Ligue nationale contre le cancer); 'Nievre'; 'Saone et Loire'; 'L' Association pour la Recherche contre le Cancer'; INCa(Institut National du Cancer (INCA) France)	We thank L Sistonen and J Anckar (Turku Centre for Biotechnology, Finland) for HSF1 and SUMO-2/3 tools, their helpful advices and discussions. We thank M Gaestel and A Vertii for sharing with us HSP27 phosphorylation mutants' constructions. This work was supported by grants from the 'Ligue Nationale Contre le Cancer' and its committees in the 'Nievre' and 'Saone et Loire'. MB and ALJ are recipients of a doctoral fellowship from the 'Ligue Nationale contre le Cancer', ADT has a postdoctoral fellowship from 'L' Association pour la Recherche contre le Cancer', and EF has an INCa financing. CG and MP lead teams 'Labellisees' from the 'Ligue Nationale contre le Cancer'.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; CAIGNARD A, 1990, INT J CANCER, V46, P633, DOI 10.1002/ijc.2910460414; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Garrido C, 1998, CANCER RES, V58, P5495; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Guo DH, 2005, BIOCHEM BIOPH RES CO, V337, P1308, DOI 10.1016/j.bbrc.2005.09.191; Gurbuxani S, 2001, ONCOGENE, V20, P7478, DOI 10.1038/sj.onc.1204948; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Joanisse DR, 1998, BIOCHEM BIOPH RES CO, V244, P102, DOI 10.1006/bbrc.1998.8214; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; MEHLEN P, 1995, J CELL BIOCHEM, V58, P248, DOI 10.1002/jcb.240580213; MEHLEN P, 1995, BIOCHEM J, V312, P367, DOI 10.1042/bj3120367; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	43	63	64	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2009	28	37					3332	3344		10.1038/onc.2009.188	http://dx.doi.org/10.1038/onc.2009.188			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	495LS	19597476				2022-12-25	WOS:000269893700007
J	Song, H; Zhang, B; Watson, MA; Humphrey, PA; Lim, H; Milbrandt, J				Song, H.; Zhang, B.; Watson, M. A.; Humphrey, P. A.; Lim, H.; Milbrandt, J.			Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis	ONCOGENE			English	Article						prostate cancer; Nkx3.1; pten; Akt; clusterin	PROLIFERATIVE INFLAMMATORY ATROPHY; LASER CAPTURE MICRODISSECTION; TRANSGENIC MOUSE MODEL; INTRAEPITHELIAL NEOPLASIA; SUPPRESSOR GENE; EXPRESSION PROFILES; MOLECULAR-FEATURES; OXIDATIVE DAMAGE; AKT ACTIVATION; PROTEIN NKX3.1	The expression of NKX3.1, a transcriptional regulator and tumor suppressor gene in prostate cancer, is downregulated during early stages of prostate tumorigenesis. However, little is known of the alterations in gene expression that occur as a result of this event. We combined laser capture microdissection and gene expression pro. ling to analyse the molecular consequences of Nkx3.1 loss during prostate cancer initiation using Nkx3.1-deficient mice. This analysis identified a cohort of genes (loss-of-Nkx3.1 signature) that are aberrantly overexpressed during loss-of-Nkx3.1-driven tumor initiation. We studied the expression of these genes in independent loss-of-Pten and c-myc overexpression prostate adenocarcinoma mouse models. Nkx3.1 expression is lost in prostate epithelial proliferation in both of these mouse models. However, Nkx3.1 loss is an early event of tumor development in the loss-of-Pten model, whereas it occurs at later stages in c-myc transgenic mice. A number of genes of the loss-of-Nkx3.1 signature, such as clusterin and quiescin Q6, are highly expressed in prostatic hyperplasia and intraepithelial neoplasia (PIN) lesions that also lack Nkx3.1 in the Pten-deficient prostate, but not in similar lesions in the c-myc transgenic model. Meta-analysis of multiple prostate cancer gene expression data sets, including those from loss-of-Nkx3.1, loss-of-Pten, c-myc overexpression and constitutively active Akt prostate cancer models, further confirmed that genes associated with the loss-of-Nkx3.1 signature integrate with PTEN-AKT signaling pathways, but do not overlap with molecular changes associated with the c-myc signaling pathway. In human prostate tissue samples, loss of NKX3.1 expression and corresponding clusterin overexpression are co-localized at sites of prostatic in. ammatory atrophy, a possible very early stage of human prostate tumorigenesis. Collectively, these results suggest that the molecular consequences of NKX3.1 loss depend on the epithelial proliferative stage at which its expression is lost, and that alterations in the PTEN-AKT-NKX3.1 axis are important for prostate cancer initiation. Oncogene (2009) 28, 3307-3319; doi:10.1038/onc.2009.181; published oline 13 July 2009	[Song, H.; Zhang, B.; Watson, M. A.; Humphrey, P. A.; Milbrandt, J.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Lim, H.] Washington Univ, Dept Obstet & Gynecol, Sch Med, St Louis, MO 63110 USA; [Song, H.] Kwandong Univ, Coll Med, Mol Oncol Lab, Cheil Gen Hosp, Seoul, South Korea; [Song, H.] Kwandong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea	Washington University (WUSTL); Washington University (WUSTL); Catholic Kwandong University; Catholic Kwandong University	Milbrandt, J (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu	Lim, Hyunjung J/D-5343-2011	Lim, Hyunjung J/0000-0003-2191-666X; Song, Haengseok/0000-0002-5027-7310; Milbrandt, Jeffrey/0000-0002-5477-7689	NIH [CA111966]; Washington University; Department of Defense [PC030380]; NATIONAL CANCER INSTITUTE [R01CA111966] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are deeply indebted to Rakesh Nagarajan for help with bioinformatic analysis and Robert Heuckeroth for careful review of the manuscript and helpful discussions of the data. We thank Amy Strickland, Tatiana Gorodinsky and Nina Panchenko for technical assistance. We are grateful to Hong Wu and Charles Sawyers (UCLA) for Pten conditional and cmyc transgenic mice, respectively. This work was supported by NIH grants CA111966 (to JM) and Washington University Cancer Biology Pathway Fellowship (to BZ). HS was supported by a postdoctoral fellowship from the Department of Defense (PC030380).	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bethel CR, 2007, PROSTATE, V67, P1740, DOI 10.1002/pros.20579; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; BOVA GS, 1993, CANCER RES, V53, P3869; Bowen C, 2000, CANCER RES, V60, P6111; Chan JM, 2005, J CLIN ONCOL, V23, P8152, DOI 10.1200/JCO.2005.03.1492; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; DAS SK, 1994, DEVELOPMENT, V120, P1071; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ehrig T, 2001, J MOL DIAGN, V3, P22, DOI 10.1016/S1525-1578(10)60645-9; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Eshel R, 2002, SEMIN CANCER BIOL, V12, P139, DOI 10.1006/scbi.2001.0422; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Gleave M, 2005, WORLD J UROL, V23, P38, DOI 10.1007/s00345-004-0474-0; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Kim MJ, 2002, CANCER RES, V62, P2999; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Luzzi V, 2003, J MOL DIAGN, V5, P9, DOI 10.1016/S1525-1578(10)60445-X; MACOSKA JA, 1995, CANCER RES, V55, P5390; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Nelson WG, 2001, ANN NY ACAD SCI, V952, P135, DOI 10.1111/j.1749-6632.2001.tb02734.x; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Oberley TD, 2002, AM J PATHOL, V160, P403, DOI 10.1016/S0002-9440(10)64857-2; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Simard J, 2003, ENDOCR-RELAT CANCER, V10, P225, DOI 10.1677/erc.0.0100225; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Song H, 2002, DEVELOPMENT, V129, P2879; Steadman DJ, 2000, NUCLEIC ACIDS RES, V28, P2389, DOI 10.1093/nar/28.12.2389; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tricoli JV, 2004, CLIN CANCER RES, V10, P3943, DOI 10.1158/1078-0432.CCR-03-0200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Zheng SL, 2006, CANCER RES, V66, P69, DOI 10.1158/0008-5472.CAN-05-1550	50	73	84	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2009	28	37					3307	3319		10.1038/onc.2009.181	http://dx.doi.org/10.1038/onc.2009.181			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	495LS	19597465	Green Accepted			2022-12-25	WOS:000269893700005
J	Kindler, S; Dieterich, DC; Schutt, J; Sahin, J; Karpova, A; Mikhaylova, M; Schob, C; Gundelfinger, ED; Kreienkamp, HJ; Kreutz, MR				Kindler, Stefan; Dieterich, Daniela C.; Schuett, Janin; Sahin, Jale; Karpova, Anna; Mikhaylova, Marina; Schob, Claudia; Gundelfinger, Eckart D.; Kreienkamp, Hans-Juergen; Kreutz, Michael R.			Dendritic mRNA Targeting of Jacob and N-Methyl-D-aspartate-induced Nuclear Translocation after Calpain-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; SPINE MORPHOGENESIS; EXPRESSION; TRANSPORT; IDENTIFICATION; GENE; FMRP; TRANSLATION; CALDENDRIN; PLASTICITY	Jacob is a recently identified plasticity-related protein that couples N-methyl-D-aspartate receptor activity to nuclear gene expression. An expression analysis by Northern blot and in situ hybridization shows that Jacob is almost exclusively present in brain, in particular in the cortex and the limbic system. Alternative splicing gives rise to multiple mRNA variants, all of which exhibit a prominent dendritic localization in the hippocampus. Functional analysis in primary hippocampal neurons revealed that a predominant cis-acting dendritic targeting element in the 3'-untranslated region of Jacob mRNAs is responsible for dendritic mRNA localization. In the mouse brain, Jacob transcripts are associated with both the fragile X mental retardation protein, a well described trans-acting factor regulating dendritic mRNA targeting and translation, and the kinesin family member 5C motor complex, which is known to mediate dendritic mRNA transport. Jacob is susceptible to rapid protein degradation in a Ca2+- and Calpain-dependent manner, and Calpain-mediated clipping of the myristoylated N terminus of Jacob is required for its nuclear translocation after N-methyl-D-aspartate receptor activation. Our data suggest that local synthesis in dendrites may be necessary to replenish dendritic Jacob pools after truncation of the N-terminal membrane anchor and concomitant translocation of Jacob to the nucleus.	[Dieterich, Daniela C.; Sahin, Jale; Karpova, Anna; Mikhaylova, Marina; Kreutz, Michael R.] Leibniz Inst Neurobiol, Project Grp Neuroplast, D-39118 Magdeburg, Germany; [Dieterich, Daniela C.] Leibniz Inst Neurobiol, Emmy Noether Res Grp, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem Mol Biol, D-39118 Magdeburg, Germany; [Kindler, Stefan; Schuett, Janin; Schob, Claudia; Kreienkamp, Hans-Juergen] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); University of Hamburg; University Medical Center Hamburg-Eppendorf	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Project Grp Neuroplast, Brenneckestr 6, D-39118 Magdeburg, Germany.	Kreutz@ifn-magdeburg.de	Mikhaylova, Marina/AAM-4368-2020	Mikhaylova, Marina/0000-0001-7646-1346; Dieterich, Daniela C./0000-0002-9880-1214	Bundesministerium fur Bildung und Forschung [GZ 01GA505]; Deutsche Forschungsgemeinschaft [SFB779, TPB8, Ki488/2-6, KR1321/4-1, GRK 1167]; Fonds der Chemische Industrie; Land Saxony-Anhalt/European Union [C1-TP4, C2-TP5]; Schram Foundation; Thyssen-Stiftung Grant Az. [10.05.2.185]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemische Industrie; Land Saxony-Anhalt/European Union(European Commission); Schram Foundation; Thyssen-Stiftung Grant Az.	This work was supported by Bundesministerium fur Bildung und Forschung Grant GZ 01GA505 (to M. R. K. and E. D. G.); Deutsche Forschungsgemeinschaft Grants SFB779, TPB8 (to M. R. K.), Ki488/2-6 (to S. K.), and KR1321/4-1 (to H.-J.K. and S. K.); the Fonds der Chemische Industrie (to E. D. G.); Land Saxony-Anhalt/European Union Grant C1-TP4 and C2-TP5 (to M. R. K.); the Schram Foundation (to M. R. K.); and Thyssen-Stiftung Grant Az. 10.05.2.185 (to S. K.).; Supported by Deutsche Forschungsgemeinschaft Stipend GRK 1167.	Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kindler S, 2004, MOL BRAIN RES, V126, P14, DOI 10.1016/j.molbrainres.2004.03.014; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008	32	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25431	25440		10.1074/jbc.M109.022137	http://dx.doi.org/10.1074/jbc.M109.022137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608740	Green Published, hybrid			2022-12-25	WOS:000269734000075
J	Liu, XY; Daiho, T; Yamasaki, K; Wang, GL; Danko, S; Suzuki, H				Liu, Xiaoyu; Daiho, Takashi; Yamasaki, Kazuo; Wang, Guoli; Danko, Stefania; Suzuki, Hiroshi			Roles of Interaction between Actuator and Nucleotide Binding Domains of Sarco(endo)plasmic Reticulum Ca2+-ATPase as Revealed by Single and Swap Mutational Analyses of Serine 186 and Glutamate 439	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; MUSCLE SARCOPLASMIC-RETICULUM; 1ST TRANSMEMBRANE HELIX; CALCIUM-PUMP; SKELETAL-MUSCLE; ATP-BINDING; PHOSPHORYLATED INTERMEDIATE; CONFORMATIONAL TRANSITION; REACTION-MECHANISM; CRYSTAL-STRUCTURES	Roles of hydrogen bonding interaction between Ser(186) of the actuator (A) domain and Glu(439) of nucleotide binding (N) domain seen in the structures of ADP-insensitive phosphorylated intermediate (E2P) of sarco(endo)plasmic reticulum Ca2+-ATPase were explored by their double alanine substitution S186A/E439A, swap substitution S186E/E439S, and each of these single substitutions. All the mutants except the swap mutant S186E/E439S showed markedly reduced Ca2+-ATPase activity, and S186E/E439S restored completely the wild-type activity. In all the mutants except S186E/E439S, the isomerization of ADP-sensitive phosphorylated intermediate (E1P) to E2P was markedly retarded, and the E2P hydrolysis was largely accelerated, whereas S186E/E439S restored almost the wildtype rates. Results showed that the Ser(186)-Glu(439) hydrogen bond stabilizes the E2P ground state structure. The modulatory ATP binding at sub-mM similar to mM range largely accelerated the EP isomerization in all the alanine mutants and E439S. In S186E, this acceleration as well as the acceleration of the ATPase activity was almost completely abolished, whereas the swap mutation S186E/E439S restored the modulatory ATP acceleration with a much higher ATP affinity than the wild type. Results indicated that Ser(186) and Glu(439) are closely located to the modulatory ATP binding site for the EP isomerization, and that their hydrogen bond fixes their side chain configurations thereby adjusts properly the modulatory ATP affinity to respond to the cellular ATP level.	[Liu, Xiaoyu; Daiho, Takashi; Yamasaki, Kazuo; Wang, Guoli; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Suzuki, H (corresponding author), Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	hisuzuki@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (B) (to H.S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Fersht A, 1999, STRUCTURE MECH PROTE, P132; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PICK U, 1982, J BIOL CHEM, V257, P6120; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMAMOTO T, 1967, J BIOCHEM-TOKYO, V62, P558, DOI 10.1093/oxfordjournals.jbchem.a128706; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200	53	7	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25190	25198		10.1074/jbc.M109.034140	http://dx.doi.org/10.1074/jbc.M109.034140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19628462	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000269734000053
J	Tumbale, P; Brew, K				Tumbale, Percy; Brew, Keith			Characterization of a Metal-independent CAZy Family 6 Glycosyltransferase from Bacteroides ovatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP-B; GROUP-A; STRUCTURAL BASIS; GENE; ALPHA-1,3-GALACTOSYLTRANSFERASE; SPECIFICITY; BINDING; GALACTOSYLTRANSFERASE; CLASSIFICATION; CONVERGENCE	The myriad functions of complex carbohydrates include modulating interactions between bacteria and their eukaryotic hosts. In humans and other vertebrates, variations in the activity of glycosyltransferases of CAZy family 6 generate antigenic variation between individuals and species that facilitates resistance to pathogens. The well characterized vertebrate glycosyltransferases of this family are multidomain membrane proteins with C-terminal catalytic domains. Genes for proteins homologous with their catalytic domains are found in at least nine species of anaerobic commensal bacteria and a cyanophage. Although the bacterial proteins are strikingly similar in sequence to the catalytic domains of their eukaryotic relatives, a metal-binding Asp-X-Asp sequence, present in a wide array of metal ion-dependent glycosyltransferases, is replaced by Asn-X-Asn. We have cloned and expressed one of these proteins from Bacteroides ovatus, a bacterium that is linked to inflammatory bowel disease. Functional characterization shows it to be a metal-independent glycosyltransferase with a 200-fold preference for UDP-GalNAc as substrate relative to UDP-Gal. It efficiently catalyzes the synthesis of oligosaccharides similar to human blood group A and may participate in the synthesis of the bacterial O-antigen. The kinetics for GalNAc transfer to 2'-fucosyl lactose are characteristic of a sequential mechanism, as observed previously for this family. Mutational studies indicate that despite the lack of a metal cofactor, there are pronounced similarities in structure-function relationships between the bacterial and vertebrate family 6 glycosyltransferases. These two groups appear to provide an example of horizontal gene transfer involving vertebrates and prokaryotes.	[Tumbale, Percy; Brew, Keith] Florida Atlantic Univ, Dept Basic Sci, Charles E Schmidt Coll Biomed Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Brew, K (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, 777 Glades Rd, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Brew, Keith/W-1643-2019; Brew, Keith/A-6746-2009	Brew, Keith/0000-0003-1306-1032	National Institutes of Health [AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR40994.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; GALILI U, 1988, J BIOL CHEM, V263, P17755; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; HENION TR, 1994, GLYCOBIOLOGY, V4, P193, DOI 10.1093/glycob/4.2.193; Hol W G, 1985, Adv Biophys, V19, P133, DOI 10.1016/0065-227X(85)90053-X; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Kona F, 2007, BIOCHEMISTRY-US, V46, P4532, DOI 10.1021/bi6024879; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Persson M, 2007, J BIOL CHEM, V282, P9564, DOI 10.1074/jbc.M610998200; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Shulami S, 2004, J BIOL CHEM, V279, P45110, DOI 10.1074/jbc.M404561200; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a; Tumbale P, 2008, GLYCOBIOLOGY, V18, P1036, DOI 10.1093/glycob/cwn083; Turcot-Dubois AL, 2007, GLYCOBIOLOGY, V17, P516, DOI 10.1093/glycob/cwm016; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Xu HJ, 1999, J BIOL CHEM, V274, P29390, DOI 10.1074/jbc.274.41.29390; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Yi W, 2008, J AM CHEM SOC, V130, P14420, DOI 10.1021/ja805844y; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r; Zhang YN, 2004, GLYCOBIOLOGY, V14, P1295, DOI 10.1093/glycob/cwh119; Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200	41	8	8	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25126	25134		10.1074/jbc.M109.033878	http://dx.doi.org/10.1074/jbc.M109.033878			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19622749	Green Published			2022-12-25	WOS:000269734000047
J	Smirnovas, V; Kim, JI; Lu, XJ; Atarashi, R; Caughey, B; Surewicz, WK				Smirnovas, Vytautas; Kim, Jae-Il; Lu, Xiaojun; Atarashi, Ryuichiro; Caughey, Byron; Surewicz, Witold K.			Distinct Structures of Scrapie Prion Protein (PrPSc)-seeded Versus Spontaneous Recombinant Prion Protein Fibrils Revealed by Hydrogen/Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; AMYLOID FIBRILS; EMERGING PRINCIPLES; CONVERSION; RESISTANT; CORE; FORM; INFECTIVITY; DOMAIN; INHERITANCE	The detailed structures of prion disease-associated, partially protease-resistant forms of prion protein (e. g. PrPSc) are largely unknown. PrPSc appears to propagate itself by autocatalyzing the conformational conversion and oligomerization of normal prion protein (PrPC). One manifestation of PrPSc templating activity is its ability, in protein misfolding cyclic amplification reactions, to seed the conversion of recombinant prion protein (rPrP) into aggregates that more closely resemble PrPSc than spontaneously nucleated rPrP amyloids in terms of proteolytic fragmentation and infrared spectra. The absence of posttranslational modifications makes these rPrP aggregates more amenable to detailed structural analyses than bona fide PrPSc. Here, we compare the structures of PrPSc-seeded and spontaneously nucleated aggregates of hamster rPrP by using H/D exchange coupled with mass spectrometry. In spontaneously formed fibrils, very slow H/D exchange in region similar to 163-223 represents a systematically H-bonded cross-beta amyloid core structure. PrPSc-seeded aggregates have a subpopulation of molecules in which this core region extends N-terminally as far as to residue similar to 145, and there is a significant degree of order within residues similar to 117-133. The formation of tightly H-bonded structures by these more N-terminal residues may account partially for the generation of longer protease-resistant regions in the PrPSc-seeded rPrP aggregates; however, part of the added protease resistance is dependent on the presence of SDS during proteolysis, emphasizing the multifactorial influences on proteolytic fragmentation patterns. These results demonstrate that PrPSc has a distinct templating activity that induces ordered, systematically H-bonded structure in regions that are dynamic and poorly defined in spontaneously formed aggregates of rPrP.	[Smirnovas, Vytautas; Kim, Jae-Il; Lu, Xiaojun; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Atarashi, Ryuichiro; Caughey, Byron] NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA	Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	Smirnovas, Vytautas/O-6270-2018	Smirnovas, Vytautas/0000-0002-1829-5455; Lu, Xiaojun/0000-0001-5251-4343	National Institutes of Health [NS44158, AG14359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or part, by National Institutes of Health Grants NS44158 and AG14359.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2001, TRENDS BIOCHEM SCI, V26, P235, DOI 10.1016/S0968-0004(01)01792-3; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; KASCSAK RJ, 1993, DEV BIOL STAND, V80, P141; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kheterpal I, 2006, ACCOUNTS CHEM RES, V39, P584, DOI 10.1021/ar050057w; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nazabal A, 2005, J BIOL CHEM, V280, P13220, DOI 10.1074/jbc.M413185200; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; RUBENSTEIN R, 1994, ARCH VIROL, V139, P301, DOI 10.1007/BF01310793; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821	48	64	65	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24233	24241		10.1074/jbc.M109.036558	http://dx.doi.org/10.1074/jbc.M109.036558			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19596861	hybrid, Green Published			2022-12-25	WOS:000269380200037
J	Koten, B; Simanski, M; Glaser, R; Podschun, R; Schroder, JM; Harder, J				Koeten, Bente; Simanski, Maren; Glaeser, Regine; Podschun, Rainer; Schroeder, Jens-Michael; Harder, Juergen			RNase 7 Contributes to the Cutaneous Defense against Enterococcus faecium	PLOS ONE			English	Article								Background: Human skin is able to mount a fast response against invading microorganisms by the release of antimicrobial proteins such as the ribonuclease RNase 7. Because RNase 7 exhibits high activity against Enterococcus faecium the aim of this study was to further explore the role of RNase 7 in the cutaneous innate defense system against E. faecium. Methodology/Principal Findings: Absolute quantification using real-time PCR and ELISA revealed that primary keratinocytes expressed high levels of RNase 7. Immunohistochemistry showed RNase 7 expression in all epidermal layers of the skin with an intensification in the upper more differentiated layers. Furthermore, RNase 7 was secreted by keratinocytes in vitro and in vivo in a site-dependent way. RNase 7 was still active against E. faecium at low pH (5.5) or high NaCl ( 150 mM) concentration and the bactericidal activity of RNase 7 against E. faecium required no ribonuclease activity as shown by recombinant RNase 7 lacking enzymatic activity. To further explore the role of RNase 7 in cutaneous defense against E. faecium, we investigated whether RNase 7 contributes to the E. faecium killing activity of skin extracts derived from stratum corneum. Treatment of the skin extract with an RNase 7 specific antibody, which neutralizes the antimicrobial activity of RNase 7, diminished its E. faecium killing activity. Conclusions/Significance: Our data indicate that RNase 7 contributes to the E. faecium-killing activity of skin extracts and suggest an important role for RNase 7 in the protection of human skin against E. faecium colonization.			Koten, B (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.	jharder@dermatology.uni-kiel.de	Gläser, Regine/B-3168-2010; Harder, Jürgen/B-3162-2010	Harder, Jurgen/0000-0002-4075-4603				ABTIN A, 2009, J INVEST DERMATOL; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Conner K, 2002, J AM ACAD DERMATOL, V47, P347, DOI 10.1067/mjd.2002.122190; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Dyer KD, 2006, MOL DIVERS, V10, P585, DOI 10.1007/s11030-006-9028-2; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Gambichler T, 2008, INT ARCH ALLERGY IMM, V147, P17, DOI 10.1159/000128582; Glasser R, 2009, J ALLERGY CLIN IMMUN, V123, P1117, DOI 10.1016/j.jaci.2009.01.043; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Nitto T, 2006, J BIOL CHEM, V281, P25622, DOI 10.1074/jbc.M604313200; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; REITHMAYER K, 2009, BR J DERMATOL; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Rosenberg HF, 1999, IMMUNOL RES, V20, P261, DOI 10.1007/BF02790409; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; Rudolph B, 2006, ANTIMICROB AGENTS CH, V50, P3194, DOI 10.1128/AAC.00246-06; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; SCHRODER JM, 1992, J INVEST DERMATOL, V98, P241, DOI 10.1111/1523-1747.ep12556058; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Wiedow O, 1998, BIOCHEM BIOPH RES CO, V248, P904, DOI 10.1006/bbrc.1998.9069; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang JZ, 2003, NUCLEIC ACIDS RES, V31, P602, DOI 10.1093/nar/gkg157	44	73	75	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6424	10.1371/journal.pone.0006424	http://dx.doi.org/10.1371/journal.pone.0006424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641608	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500024
J	MacCallum, DM; Castillo, L; Brown, AJP; Gow, NAR; Odds, FC				MacCallum, Donna M.; Castillo, Luis; Brown, Alistair J. P.; Gow, Neil A. R.; Odds, Frank C.			Early-Expressed Chemokines Predict Kidney Immunopathology in Experimental Disseminated Candida albicans Infections	PLOS ONE			English	Article								Background: The mouse intravenous challenge model of Candida albicans infection is widely used to determine aspects of host-fungus interaction. We investigated the production of cytokines in the kidneys and spleen of animals up to 48 h after challenge with virulent and attenuated isolates and related these responses to semi-quantitative estimations of histopathological changes in the kidney. Methodology/Principal Findings: Progression of Candida albicans infection of the kidney in response to highly virulent fungal strains was characterized by higher levels of host cellular infiltrate, higher lesion densities and greater quantities of fungal elements at 24 and 48 h, and by higher kidney concentrations of IL-1 beta, MCP-1, KC, IL-6, G-CSF, TNF, MIP-2 and MIP-1b, among the immune effectors measured. Levels of the chemokine KC as early as 12 h after challenge correlated significantly with all later measurements of lesion severity. Early renal IL-6 and MIP-1b concentrations also correlated with subsequent damage levels, but less significantly than for KC. All chemokines tested appeared in kidney homogenates, while most of the cytokines were undetectable in kidney and spleen homogenates. GM-CSF and IL-10 showed inverse correlations with measures of lesion severity, suggesting these alone may have exerted a defensive role. Spleen levels of KC at all times showed significant associations with kidney lesion measurements. Conclusions/Significance: Elevated chemokine levels, including KC, represent the earliest responses to C. albicans infection in the mouse kidney. Fungal strains of low mouse virulence stimulate a lower innate response and less host infiltrate than more virulent strains. These findings are consistent with immunopathological damage to kidneys in the mouse C. albicans infection model and with growing evidence implicating some TLR pathways as the main point of interaction between fungal surface polysaccharides and leukocytes.			MacCallum, DM (corresponding author), Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland.	f.odds@abdn.ac.uk	MacCallum, Donna M./D-7897-2011; Brown, Alistair J.P./B-6627-2014; GOW, Neil/AAS-5323-2021	MacCallum, Donna M./0000-0003-4833-0378; GOW, Neil/0000-0002-2776-5850; Brown, Alistair JP/0000-0003-1406-4251	Wellcome Trust [080088/Z/06/Z, 076954/Z/05/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashman RB, 1998, MICROB PATHOGENESIS, V25, P333, DOI 10.1006/mpat.1998.0240; Ashman RB, 1998, MICROB PATHOGENESIS, V25, P349, DOI 10.1006/mpat.1998.0248; Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Basu S, 2008, GROWTH FACTORS, V26, P23, DOI 10.1080/08977190801987513; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; LOURIA D. B., 1963, Sabouraudia, V2, P271; LOURIA DB, 1964, P SOC EXP BIOL MED, V115, P93, DOI 10.3181/00379727-115-28840; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Navarro-Garcia F, 2001, FEMS MICROBIOL REV, V25, P245, DOI 10.1016/S0168-6445(00)00066-8; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Odds F. C., 2006, MOL PRINCIPLES FUNGA, P305; Odds FC., 1988, CANDIDA CANDIDOSIS; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; RICHARDSON MD, 1981, J INFECT DIS, V144, P557, DOI 10.1093/infdis/144.6.557; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; ROMANI L, 2006, MOL PRINCIPLES FUNGA, P471; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Romani L, 2007, EXPERT REV ANTI-INFE, V5, P1007, DOI 10.1586/14787210.5.6.1007; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Spellberg B, 2003, INFECT IMMUN, V71, P5756, DOI 10.1128/IAI.71.10.5756-5764.2003; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; THOMAS L, 1972, NEW ENGL J MED, V287, P553, DOI 10.1056/NEJM197209142871109; Van Enckevort FHJ, 1999, MED MYCOL, V37, P419, DOI 10.1046/j.1365-280X.1999.00247.x; Yamamoto Y, 1997, INFECT IMMUN, V65, P1077, DOI 10.1128/IAI.65.3.1077-1082.1997; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	38	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6420	10.1371/journal.pone.0006420	http://dx.doi.org/10.1371/journal.pone.0006420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641609	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500021
J	Mujica-Parodi, LR; Strey, HH; Frederick, B; Savoy, R; Cox, D; Botanov, Y; Tolkunov, D; Rubin, D; Weber, J				Mujica-Parodi, Lilianne R.; Strey, Helmut H.; Frederick, Blaise; Savoy, Robert; Cox, David; Botanov, Yevgeny; Tolkunov, Denis; Rubin, Denis; Weber, Jochen			Chemosensory Cues to Conspecific Emotional Stress Activate Amygdala in Humans	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; OLFACTORY SENSITIVITY; PHYSIOLOGICAL AROUSAL; PSYCHOLOGICAL STRESS; NOVICE SKYDIVERS; HUMAN PHEROMONES; ANXIETY SIGNALS; MENSTRUAL-CYCLE; PERCEPTION; FMRI	Alarm substances are airborne chemical signals, released by an individual into the environment, which communicate emotional stress between conspecifics. Here we tested whether humans, like other mammals, are able to detect emotional stress in others by chemosensory cues. Sweat samples collected from individuals undergoing an acute emotional stressor, with exercise as a control, were pooled and presented to a separate group of participants ( blind to condition) during four experiments. In an fMRI experiment and its replication, we showed that scanned participants showed amygdala activation in response to samples obtained from donors undergoing an emotional, but not physical, stressor. An odor-discrimination experiment suggested the effect was primarily due to emotional, and not odor, differences between the two stimuli. A fourth experiment investigated behavioral effects, demonstrating that stress samples sharpened emotion-perception of ambiguous facial stimuli. Together, our findings suggest human chemosensory signaling of emotional stress, with neurobiological and behavioral effects.			Mujica-Parodi, LR (corresponding author), SUNY Stony Brook, Sch Med, Dept Biomed Engn, Stony Brook, NY 11794 USA.	lmujicaparodi@gmail.com	Strey, Helmut/B-5456-2009; Frederick, Blaise/G-6098-2012; Botanov, Yevgeny/AAH-9507-2020; Cox, David/C-4888-2008	Frederick, Blaise/0000-0001-5832-5279; Lauwereyns, Jan/0000-0003-0551-2550; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519; Weber, Jochen/0000-0002-2397-4954; Strey, Helmut/0000-0002-6554-5322; Cox, David/0000-0002-2189-9743; Rubin, Denis/0000-0002-0483-9458	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR010710, 5-M01-RR-10710] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Adolphs R, 2004, NAT NEUROSCI, V7, P1167, DOI 10.1038/nn1104-1167; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 2014, PHEROMONES ANIMAL BE; Bensafi M, 2004, PSYCHONEUROENDOCRINO, V29, P1290, DOI 10.1016/j.psyneuen.2004.03.007; Benschop RJ, 1996, FASEB J, V10, P517, DOI 10.1096/fasebj.10.4.8647351; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1011; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Campbell LA, 2007, BEHAV RES THER, V45, P1389, DOI 10.1016/j.brat.2006.05.011; Caruso S, 2001, HUM REPROD, V16, P2288, DOI 10.1093/humrep/16.11.2288; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; de Kock HL, 2001, MEAT SCI, V57, P61, DOI 10.1016/S0309-1740(00)00077-2; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FENZ WD, 1967, PSYCHOSOM MED, V29, P33, DOI 10.1097/00006842-196701000-00005; Gallagher P, 2006, J PSYCHOPHARMACOL, V20, P643, DOI 10.1177/0269881106060585; Gower DB, 1997, J STEROID BIOCHEM, V63, P81, DOI 10.1016/S0960-0760(97)00075-7; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; HUMMEL T, 1991, EXPERIENTIA, V47, P712, DOI 10.1007/BF01958823; Hideaki IA, 2008, PHYSIOL BEHAV, V93, P606, DOI 10.1016/j.physbeh.2007.10.021; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; KEVETTER GA, 1981, J COMP NEUROL, V197, P81, DOI 10.1002/cne.901970107; Kiyokawa Y, 2006, PHYSIOL BEHAV, V87, P383, DOI 10.1016/j.physbeh.2005.11.003; Kiyokawa Y, 2005, BRAIN RES, V1043, P145, DOI 10.1016/j.brainres.2005.02.061; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Lundstrom JN, 2006, NEUROIMAGE, V30, P1340, DOI 10.1016/j.neuroimage.2005.10.040; Lundstrom JN, 2006, BIOL PSYCHOL, V71, P244, DOI 10.1016/j.biopsycho.2005.07.001; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; MACKAY D, 1979, ENVIRON SCI TECHNOL, V13, P333, DOI 10.1021/es60151a012; MAIR RG, 1978, SENS PROCESS, V2, P90; MAKIN HLJ, 1998, MASS SPECTRA GC DATA, P790; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; Natsch A, 2003, J BIOL CHEM, V278, P5718, DOI 10.1074/jbc.M210142200; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Petrovic P, 1999, PAIN, V83, P459, DOI 10.1016/S0304-3959(99)00150-5; Petrovic P, 2004, J COGNITIVE NEUROSCI, V16, P1289, DOI 10.1162/0898929041920469; PFEIFFER W, 1963, EXPERIENTIA, V19, P113, DOI 10.1007/BF02171582; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; RAUCH SL, 1995, ARCH GEN PSYCHIAT, V52, P20; Rosenblatt D. H., 1982, HDB CHEM PROPERTY ES; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; SCHEDLOWSKI M, 1995, IMMUNOL TODAY, V16, P165, DOI 10.1016/0167-5699(95)80135-9; SCHEDLOWSKI M, 1992, PSYCHOPHYSIOLOGY, V29, P95, DOI 10.1111/j.1469-8986.1992.tb02020.x; SCHEDLOWSKI M, 1993, J CLIN IMMUNOL, V13, P119, DOI 10.1007/BF00919268; SCHEDLOWSKI M, 1995, PSYCHONEUROENDOCRINO, V20, P103, DOI 10.1016/0306-4530(94)00048-4; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Sterlini GL, 2002, BEHAV RES THER, V40, P431, DOI 10.1016/S0005-7967(01)00021-3; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Tabert MH, 2007, NEUROIMAGE, V34, P1375, DOI 10.1016/j.neuroimage.2006.11.020; Villemure C, 2007, EUR J PAIN, V11, P181, DOI 10.1016/j.ejpain.2006.02.005; WIK G, 1993, PSYCHIAT RES-NEUROIM, V50, P15; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Yokosuka M, 1999, PHYSIOL BEHAV, V68, P257, DOI 10.1016/S0031-9384(99)00160-2; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	73	139	144	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6415	10.1371/journal.pone.0006415	http://dx.doi.org/10.1371/journal.pone.0006415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CF	19641623	Green Submitted, Green Published, gold			2022-12-25	WOS:000268494500016
J	Hevezi, P; Moyer, BD; Lu, M; Gao, N; White, E; Echeverri, F; Kalabat, D; Soto, H; Laita, B; Li, C; Yeh, SA; Zoller, M; Zlotnik, A				Hevezi, Peter; Moyer, Bryan D.; Lu, Min; Gao, Na; White, Evan; Echeverri, Fernando; Kalabat, Dalia; Soto, Hortensia; Laita, Bianca; Li, Cherry; Yeh, Shaoyang Anthony; Zoller, Mark; Zlotnik, Albert			Genome-Wide Analysis of Gene Expression in Primate Taste Buds Reveals Links to Diverse Processes	PLOS ONE			English	Article								Efforts to unravel the mechanisms underlying taste sensation (gustation) have largely focused on rodents. Here we present the first comprehensive characterization of gene expression in primate taste buds. Our findings reveal unique new insights into the biology of taste buds. We generated a taste bud gene expression database using laser capture microdissection (LCM) procured fungiform (FG) and circumvallate (CV) taste buds from primates. We also used LCM to collect the top and bottom portions of CV taste buds. Affymetrix genome wide arrays were used to analyze gene expression in all samples. Known taste receptors are preferentially expressed in the top portion of taste buds. Genes associated with the cell cycle and stem cells are preferentially expressed in the bottom portion of taste buds, suggesting that precursor cells are located there. Several chemokines including CXCL14 and CXCL8 are among the highest expressed genes in taste buds, indicating that immune system related processes are active in taste buds. Several genes expressed specifically in endocrine glands including growth hormone releasing hormone and its receptor are also strongly expressed in taste buds, suggesting a link between metabolism and taste. Cell type-specific expression of transcription factors and signaling molecules involved in cell fate, including KIT, reveals the taste bud as an active site of cell regeneration, differentiation, and development. IKBKAP, a gene mutated in familial dysautonomia, a disease that results in loss of taste buds, is expressed in taste cells that communicate with afferent nerve fibers via synaptic transmission. This database highlights the power of LCM coupled with transcriptional profiling to dissect the molecular composition of normal tissues, represents the most comprehensive molecular analysis of primate taste buds to date, and provides a foundation for further studies in diverse aspects of taste biology.			Hevezi, P (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	bryan.moyer@senomyx.com		White, Evan/0000-0002-2640-5474				Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Aruga J, 2003, GENE EXPR PATTERNS, V3, P727, DOI 10.1016/S1567-133X(03)00141-8; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Bernhardson BM, 2008, SUPPORT CARE CANCER, V16, P275, DOI 10.1007/s00520-007-0319-7; Braissant O, 1998, BIOCHEMICA, V1, P10; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Ebermann I, 2007, HUM MUTAT, V28, P571, DOI 10.1002/humu.20478; Edgell CJS, 2004, INT REV CYTOL, V236, P101, DOI 10.1016/S0074-7696(04)36003-1; Esposito G, 2007, ADV EXP MED BIOL, V593, P54; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goldberg JL, 2004, J NEUROSCI, V24, P4989, DOI 10.1523/JNEUROSCI.4390-03.2004; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hall JM, 1999, J COMP NEUROL, V406, P143, DOI 10.1002/(SICI)1096-9861(19990405)406:2<143::AID-CNE1>3.0.CO;2-X; Horvat-Broecker A, 2008, NEUROSCIENCE, V152, P618, DOI 10.1016/j.neuroscience.2008.01.016; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Just T, 2008, APPETITE, V51, P622, DOI 10.1016/j.appet.2008.04.271; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; KIMURA S, 1992, NUTR REV, V50, P427, DOI 10.1111/j.1753-4887.1992.tb02497.x; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Krimm RF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S4; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Liu HX, 2004, DEV BIOL, V276, P280, DOI 10.1016/j.ydbio.2004.07.042; LopezJimenez ND, 2005, GENOMICS, V85, P472, DOI 10.1016/j.ygeno.2004.12.005; McLaughlin SK, 2000, J NEUROSCI, V20, P5679, DOI 10.1523/JNEUROSCI.20-15-05679.2000; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Miura H, 2003, GENE EXPR PATTERNS, V3, P427, DOI 10.1016/S1567-133X(03)00081-4; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Nakayama A, 2008, J COMP NEUROL, V509, P211, DOI 10.1002/cne.21738; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Neira M, 2001, MAMM GENOME, V12, P60, DOI 10.1007/s003350010227; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nishioka M, 2000, ONCOGENE, V19, P6251, DOI 10.1038/sj.onc.1204031; Orten DJ, 2008, HUM MUTAT, V29, P537, DOI 10.1002/humu.20691; PEARSON J, 1970, PEDIATRICS, V45, P739; Power ML, 2008, APPETITE, V50, P194, DOI 10.1016/j.appet.2007.10.006; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Ravasco Paula, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS84, DOI 10.1016/j.ejon.2005.09.003; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Sandow PL, 2006, J DENT RES, V85, P608, DOI 10.1177/154405910608500705; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Seta Y, 1999, FEBS LETT, V444, P43, DOI 10.1016/S0014-5793(99)00023-X; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; SMITH A, 1965, SCIENCE, V147, P1040, DOI 10.1126/science.147.3661.1040; Suzuki Y, 2007, ARCH HISTOL CYTOL, V70, P117, DOI 10.1679/aohc.70.117; TAKEDA M, 1992, J ELECTRON MICROSC, V41, P375; Tonosaki K, 2007, BIOMED RES-TOKYO, V28, P79, DOI 10.2220/biomedres.28.79; Turner HC, 2007, INVEST OPHTH VIS SCI, V48, P2050, DOI 10.1167/iovs.06-0998; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; WRIGHT DE, 1968, ARCH ORAL BIOL, V13, P1159, DOI 10.1016/0003-9969(68)90069-1; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Zhou YQ, 2006, DEV BIOL, V297, P198, DOI 10.1016/j.ydbio.2006.05.022	74	53	55	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6395	10.1371/journal.pone.0006395	http://dx.doi.org/10.1371/journal.pone.0006395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636377	gold, Green Published			2022-12-25	WOS:000268404900016
J	Noritake, A; Uttl, B; Terao, M; Nagai, M; Watanabe, J; Yagi, A				Noritake, Atsushi; Uttl, Bob; Terao, Masahiko; Nagai, Masayoshi; Watanabe, Junji; Yagi, Akihiro			Saccadic Compression of Rectangle and Kanizsa Figures: Now You See It, Now You Don't	PLOS ONE			English	Article							HORIZONTAL-VERTICAL ILLUSION; VISUAL SPACE; EYE-MOVEMENTS; PRESACCADIC COMPRESSION; PSYCHOPHYSICS TOOLBOX; PSYCHOMETRIC FUNCTION; CONFIDENCE-INTERVALS; DIRECTION	Background: Observers misperceive the location of points within a scene as compressed towards the goal of a saccade. However, recent studies suggest that saccadic compression does not occur for discrete elements such as dots when they are perceived as unified objects like a rectangle. Methodology/Principal Findings: We investigated the magnitude of horizontal vs. vertical compression for Kanizsa figure (a collection of discrete elements unified into single perceptual objects by illusory contours) and control rectangle figures. Participants were presented with Kanizsa and control figures and had to decide whether the horizontal or vertical length of stimulus was longer using the two-alternative force choice method. Our findings show that large but not small Kanizsa figures are perceived as compressed, that such compression is large in the horizontal dimension and small or nil in the vertical dimension. In contrast to recent findings, we found no saccadic compression for control rectangles. Conclusions: Our data suggest that compression of Kanizsa figure has been overestimated in previous research due to methodological artifacts, and highlight the importance of studying perceptual phenomena by multiple methods.			Noritake, A (corresponding author), Tamagawa Univ, Brain Sci Inst, Tokyo, Japan.	noritake.atsushi@gmail.com	Noritake, Atsushi/AAZ-7912-2020	Noritake, Atsushi/0000-0002-5081-6257				Armstrong L, 1997, PERCEPT PSYCHOPHYS, V59, P1200, DOI 10.3758/BF03214208; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cho S, 2003, J VISION, V3, P906, DOI 10.1167/3.11.22; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LOFTUS GR, PSYCHONOMIC B REV, V1, P476; MATIN L, 1966, VISION RES, V6, P453, DOI 10.1016/0042-6989(66)90053-8; Matsumiya K, 2001, VISION RES, V41, P3039, DOI 10.1016/S0042-6989(01)00174-2; MCMANUS IC, 1978, BRIT J PSYCHOL, V69, P369, DOI 10.1111/j.2044-8295.1978.tb01667.x; Morrone MC, 1997, J NEUROSCI, V17, P7941; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; Sogo H, 2005, VISION RES, V45, P301, DOI 10.1016/j.visres.2004.07.044; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	20	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6383	10.1371/journal.pone.0006383	http://dx.doi.org/10.1371/journal.pone.0006383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633711	Green Published, gold, Green Submitted			2022-12-25	WOS:000268404800010
J	Singh, A; Hitchcock-DeGregori, SE				Singh, Abhishek; Hitchcock-DeGregori, Sarah E.			A Peek into Tropomyosin Binding and Unfolding on the Actin Filament	PLOS ONE			English	Article								Background: Tropomyosin is a prototypical coiled coil along its length with subtle variations in structure that allow interactions with actin and other proteins. Actin binding globally stabilizes tropomyosin. Tropomyosin-actin interaction occurs periodically along the length of tropomyosin. However, it is not well understood how tropomyosin binds actin. Principal Findings: Tropomyosin's periodic binding sites make differential contributions to two components of actin binding, cooperativity and affinity, and can be classified as primary or secondary sites. We show through mutagenesis and analysis of recombinant striated muscle alpha-tropomyosins that primary actin binding sites have a destabilizing coiled-coil interface, typically alanine-rich, embedded within a non-interface recognition sequence. Introduction of an Ala cluster in place of the native, more stable interface in period 2 and/or period 3 sites (of seven) increased the affinity or cooperativity of actin binding, analysed by cosedimentation and differential scanning calorimetry. Replacement of period 3 with period 5 sequence, an unstable region of known importance for cooperative actin binding, increased the cooperativity of binding. Introduction of the fluorescent probe, pyrene, near the mutation sites in periods 2 and 3 reported local instability, stabilization by actin binding, and local unfolding before or coincident with dissociation from actin (measured using light scattering), and chain dissociation (analyzed using circular dichroism). Conclusions: This, and previous work, suggests that regions of tropomyosin involved in binding actin have non-interface residues specific for interaction with actin and an unstable interface that is locally stabilized upon binding. The destabilized interface allows residues on the coiled-coil surface to obtain an optimal conformation for interaction with actin by increasing the number of local substates that the side chains can sample. We suggest that local disorder is a property typical of coiled coil binding sites and proteins that have multiple binding partners, of which tropomyosin is one type.			Singh, A (corresponding author), Univ Calif San Francisco, Internal Med Residency Program, San Francisco, CA 94143 USA.	Abhishek.Singh@ucsf.edu			NIGMS NIH HHS [R01 GM036326, R01-GM36326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boudker O, 1997, J MOL BIOL, V272, P770, DOI 10.1006/jmbi.1997.1263; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; BUTTERS CA, 1993, J BIOL CHEM, V268, P15565; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Gazi AD, 2008, J BIOL CHEM, V283, P34062, DOI 10.1074/jbc.M803408200; Greenfield NJ, 2002, BIOPHYS J, V83, P2754, DOI 10.1016/S0006-3495(02)75285-5; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; Greenfield NJ, 2009, BIOCHEMISTRY-US, V48, P1272, DOI 10.1021/bi801861k; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; HEALD RW, 1988, J BIOL CHEM, V263, P5254; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; Hitchcock-DeGregori SE, 2001, BIOCHEMISTRY-US, V40, P2104, DOI 10.1021/bi002421z; HitchcockDeGregori SE, 1996, J BIOL CHEM, V271, P3600; HITCHCOCKDEGREGORI SE, 1982, J BIOL CHEM, V257, P2573; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; ISHII Y, 1985, BIOCHEMISTRY-US, V24, P6631, DOI 10.1021/bi00344a050; ISHII Y, 1990, BIOCHEMISTRY-US, V29, P1160, DOI 10.1021/bi00457a010; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; Kremneva E, 2006, FEBS J, V273, P588, DOI 10.1111/j.1742-4658.2005.05092.x; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Kremneva EV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P802, DOI 10.1023/A:1025043202615; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; LEHRER SS, 1978, J MOL BIOL, V118, P209, DOI 10.1016/0022-2836(78)90413-8; Levitsky DI, 2000, EUR J BIOCHEM, V267, P1869, DOI 10.1046/j.1432-1327.2000.01192.x; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Lu SM, 2004, PROTEIN SCI, V13, P714, DOI 10.1110/ps.03443204; MCLACHLAN AD, 1975, J MOL BIOL, V98, P281, DOI 10.1016/S0022-2836(75)80118-5; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; PARRY DAD, 1975, J MOL BIOL, V98, P519, DOI 10.1016/S0022-2836(75)80084-2; PATO MD, 1981, J BIOL CHEM, V256, P602; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; PHILLIPS GN, 1986, J MOL BIOL, V192, P128, DOI 10.1016/0022-2836(86)90469-9; RUIZOPAZO N, 1987, J BIOL CHEM, V262, P4755; Sakuma A, 2006, BIOCHEMISTRY-US, V45, P9550, DOI 10.1021/bi060963w; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Singh A, 2007, BIOCHEMISTRY-US, V46, P14917, DOI 10.1021/bi701570b; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; UENO H, 1984, BIOCHEMISTRY-US, V23, P4791, DOI 10.1021/bi00315a040; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; WEGNER A, 1981, BIOCHEMISTRY-US, V20, P5633, DOI 10.1021/bi00522a043; Whitby FG, 2000, PROTEINS, V38, P49	62	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6336	10.1371/journal.pone.0006336	http://dx.doi.org/10.1371/journal.pone.0006336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629180	Green Submitted, Green Published, gold			2022-12-25	WOS:000268318900004
J	Gerstl, S; Kiwila, G; Dhorda, M; Lonlas, S; Myatt, M; Ilunga, BK; Lemasson, D; Szumilin, E; Guerin, PJ; Ferradini, L				Gerstl, Sibylle; Kiwila, Gedeon; Dhorda, Mehul; Lonlas, Sylvaine; Myatt, Mark; Ilunga, Benoit Kebela; Lemasson, Denis; Szumilin, Elisabeth; Guerin, Philippe J.; Ferradini, Laurent			Prevalence Study of Yaws in the Democratic Republic of Congo Using the Lot Quality Assurance Sampling Method	PLOS ONE			English	Article								Background: Until the 1970s the prevalence of non-venereal trepanomatosis, including yaws, was greatly reduced after worldwide mass treatment. In 2005, cases were again reported in the Democratic Republic of the Congo. We carried out a survey to estimate the village-level prevalence of yaws in the region of Equator in the north of the country in order to define appropriate strategies to effectively treat the affected population. Methodology/Principal Findings: We designed a community-based survey using the Lot Quality Assurance Sampling method to classify the prevalence of active yaws in 14 groups of villages (lots). The classification into high, moderate, or low yaws prevalence corresponded to World Health Organization prevalence thresholds for identifying appropriate operational treatment strategies. Active yaws cases were defined by suggestive clinical signs and positive rapid plasma reagin and Treponema pallidum hemagglutination serological tests. The overall prevalence in the study area was 4.7% (95% confidence interval: 3.4-6.0). Two of 14 lots had high prevalence (>10%), three moderate prevalence (5-10%) and nine low prevalence (<5%.). Conclusions/Significance: Although yaws is no longer a World Health Organization priority disease, the presence of yaws in a region where it was supposed to be eradicated demonstrates the importance of continued surveillance and control efforts. Yaws should remain a public health priority in countries where previously it was known to be endemic. The integration of sensitive surveillance systems together with free access to effective treatment is recommended. As a consequence of our study results, more than 16,000 people received free treatment against yaws.			Gerstl, S (corresponding author), Epictr, Paris, France.	sgerstl@aol.com	Guerin, Philippe/AAH-8873-2021	Guerin, Philippe/0000-0002-6008-2963				AGADZI VK, 1985, REV INFECT DIS, V7, pS233; AGADZI VK, 1985, REV INFECT DIS, V7, pS332; Akogun OB, 1999, ZBL BAKT-INT J MED M, V289, P101, DOI 10.1016/S0934-8840(99)80130-3; Amir J, 1998, PEDIATR INFECT DIS J, V17, P890, DOI 10.1097/00006454-199810000-00008; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P125; ANSELMI M, 1995, GENITOURIN MED, V71, P343; ANTAL GM, 1985, REV INFECT DIS, V7, pS220; Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Asiedu K, 2008, B WORLD HEALTH ORGAN, V86, P499, DOI 10.2471/BLT.08.055608; [Anonymous], 2008, Bull World Health Organ, V86, P507; AUBRY P, 2008, TREPONEMATOSES ENDEM; Borah B, 2005, BONE, V37, P1, DOI 10.1016/j.bone.2005.03.017; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; de Noray G, 2003, Med Trop (Mars), V63, P159; EDORH AA, 1994, B SOC PATHOL EXOT, V87, P17; Farnsworth N, 2006, CLIN DERMATOL, V24, P181, DOI 10.1016/j.clindermatol.2005.11.004; Ghosh K, 2001, BRIT J BIOMED SCI, V58, P20; HOPKINS DR, 1976, AM J TROP MED HYG, V25, P860, DOI 10.4269/ajtmh.1976.25.860; *INT TASK FORC DIS, 2007, SUMM 11 M ITFDE 2; Joyanes P, 1998, SEX TRANSM DIS, V25, P569, DOI 10.1097/00007435-199811000-00013; Kish L, 1965, SURVEY SAMPLING; LEMESHOW S, 1991, World Health Statistics Quarterly, V44, P115; LO EKC, 1985, REV INFECT DIS, V7, pS251; MARTIN PMV, 1990, RES MICROBIOL, V141, P181, DOI 10.1016/0923-2508(90)90027-N; Meheus A., 1992, World Health Statistics Quarterly, V45, P228; *MIN HLTH, 2004, POP EST NAT VACC DAY; Murthy B N, 1999, Indian Pediatr, V36, P555; Myatt M, 2005, B WORLD HEALTH ORGAN, V83, P756; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; MYATT M, 2001, SAMPLELQ A SAMPLE SI; NDA K, 1985, REV INFECT DIS, V7, pS237; NOORDHOEK GT, 1990, J CLIN MICROBIOL, V28, P1600, DOI 10.1128/JCM.28.7.1600-1607.1990; OSEI L, 1981, J HYG EPID MICROB IM, V25, P293; PAMPIGLIONE S, 1975, BRIT J VENER DIS, V51, P165; PERINE PL, 1985, MANUEL TREPONEMATOSE; Rinaldi A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000275; ROMAN GC, 1986, REV INFECT DIS, V8, P760; SEHGAL VN, 1994, INT J DERMATOL, V33, P16, DOI 10.1111/j.1365-4362.1994.tb01485.x; Tharmaphornpilas P., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P152; Walker SL, 2000, INT J DERMATOL, V39, P258, DOI 10.1046/j.1365-4362.2000.00833.x; *WHO, 1982, 674 WHO; ZIEFER A, 1985, TROP MED PARASITOL, V36, P63	43	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6338	10.1371/journal.pone.0006338	http://dx.doi.org/10.1371/journal.pone.0006338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623266	Green Submitted, Green Published, gold			2022-12-25	WOS:000268260100015
J	Adler, H; El-Gogo, S; Guggemoos, S; Zimmermann, W; Beauchemin, N; Kammerer, R				Adler, Heiko; El-Gogo, Susanne; Guggemoos, Simone; Zimmermann, Wolfgang; Beauchemin, Nicole; Kammerer, Robert			Perturbation of Lytic and Latent Gammaherpesvirus Infection in the Absence of the Inhibitory Receptor CEACAM1	PLOS ONE			English	Article								Control of gammaherpesvirus infections requires a complex, well orchestrated immune response regulated by positive and negative co-signaling molecules. While the impact of co-stimulatory molecules has been addressed in various studies, the role of co-inhibitory receptors has not been tested. The ITIM-bearing CEACAM1 is an inhibitory receptor expressed by a variety of immune cells, including B, T and NK cells. Using Ceacam1(-/-) mice, we analyzed the in vivo function of CEACAM1 during acute and latent murine gammaherpesvirus 68 (MHV-68) infection. During acute lytic replication, we observed lower virus titers in the lungs of Ceacam1(-/-) mice than in WT mice. In contrast, during latency amplification, Ceacam1(-/-) mice displayed increased splenomegaly and a higher latent viral load in the spleen. Analysis of the immune response revealed increased virus-specific antibody levels in Ceacam1(-/-) mice, while the magnitude of the T cell-mediated antiviral immune response was reduced. These findings suggest that inhibitory receptors can modulate the efficacy of immune responses against gammaherpesvirus infections.			Adler, H (corresponding author), Helmholtz Zentrum Munchen, Natl Res Ctr Environm Hlth, Inst Mol Immunol, CCG HCT, Munich, Germany.	Robert.Kammerer@fli.bund.de	Adler, Heiko/M-7355-2014; Kammerer, Robert/AAQ-1338-2021; Zimmermann, Wolfgang/L-9277-2013	Adler, Heiko/0000-0002-6481-6709; Kammerer, Robert/0000-0003-3038-8205				Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Adler H, 2001, J VIROL, V75, P5692, DOI 10.1128/JVI.75.12.5692-5696.2001; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brooks JW, 1999, J VIROL, V73, P9650, DOI 10.1128/JVI.73.11.9650-9654.1999; BRUMMER J, 1995, ONCOGENE, V11, P1649; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Flano E, 2002, J EXP MED, V196, P1363, DOI 10.1084/jem.20020890; Fuse S, 2007, J IMMUNOL, V178, P5227, DOI 10.4049/jimmunol.178.8.5227; Fuse S, 2006, J VIROL, V80, P9159, DOI 10.1128/JVI.00422-06; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; Lee BJ, 2002, J VIROL, V76, P3049, DOI 10.1128/JVI.76.6.3049-3053.2002; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Liu LZ, 1999, J VIROL, V73, P9849, DOI 10.1128/JVI.73.12.9849-9857.1999; Lyon AB, 2006, VIROLOGY, V356, P50, DOI 10.1016/j.virol.2006.06.039; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nakajima A, 2002, J IMMUNOL, V168, P1028, DOI 10.4049/jimmunol.168.3.1028; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; REED LJ, 1938, AM J HYG, V27; Sarawar SR, 2004, VIRAL IMMUNOL, V17, P3, DOI 10.1089/088282404322875412; Sarawar SR, 2001, P NATL ACAD SCI USA, V98, P6325, DOI 10.1073/pnas.101136898; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; SKUBITZ KM, 1995, J IMMUNOL, V155, P5382; Speck SH, 1999, CURR OPIN MICROBIOL, V2, P403; Stevenson PG, 2002, MICROBES INFECT, V4, P1177, DOI 10.1016/S1286-4579(02)01643-X; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; Thirion G, 2008, IMMUNOLOGY, V125, P535, DOI 10.1111/j.1365-2567.2008.02867.x; Thomson RC, 2008, SCAND J IMMUNOL, V67, P489, DOI 10.1111/j.1365-3083.2008.02100.x; Tibbetts SA, 2003, J VIROL, V77, P7696, DOI 10.1128/JVI.77.13.7696-7701.2003; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Usherwood EJ, 2005, EUR J IMMUNOL, V35, P2956, DOI 10.1002/eji.200526245; Usherwood EJ, 1996, J GEN VIROL, V77, P627, DOI 10.1099/0022-1317-77-4-627; Vaerman JL, 2004, J BIOL REG HOMEOS AG, V18, P212; Virgin HW, 1999, CURR OPIN IMMUNOL, V11, P371, DOI 10.1016/S0952-7915(99)80063-6; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Weinberg JB, 2004, VIRAL IMMUNOL, V17, P69, DOI 10.1089/088282404322875467; Willer DO, 2005, J VIROL, V79, P2891, DOI 10.1128/JVI.79.5.2891-2899.2005; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003; Woodland DL, 2001, VIRAL IMMUNOL, V14, P217, DOI 10.1089/088282401753266747; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6317	10.1371/journal.pone.0006317	http://dx.doi.org/10.1371/journal.pone.0006317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621080	Green Submitted, Green Published, gold			2022-12-25	WOS:000268147200011
J	Ehren, J; Moron, B; Martin, E; Bethune, MT; Gray, GM; Khosla, C				Ehren, Jennifer; Moron, Belen; Martin, Edith; Bethune, Michael T.; Gray, Gary M.; Khosla, Chaitan			A Food-Grade Enzyme Preparation with Modest Gluten Detoxification Properties	PLOS ONE			English	Article								Background and Aims: Celiac sprue is a life-long disease characterized by an intestinal inflammatory response to dietary gluten. A gluten-free diet is an effective treatment for most patients, but accidental ingestion of gluten is common, leading to incomplete recovery or relapse. Food-grade proteases capable of detoxifying moderate quantities of dietary gluten could mitigate this problem. Methods: We evaluated the gluten detoxification properties of two food-grade enzymes, aspergillopepsin (ASP) from Aspergillus niger and dipeptidyl peptidase IV (DPPIV) from Aspergillus oryzae. The ability of each enzyme to hydrolyze gluten was tested against synthetic gluten peptides, a recombinant gluten protein, and simulated gastric digests of whole gluten and whole-wheat bread. Reaction products were analyzed by mass spectrometry, HPLC, ELISA with a monoclonal antibody that recognizes an immunodominant gluten epitope, and a T cell proliferation assay. Results: ASP markedly enhanced gluten digestion relative to pepsin, and cleaved recombinant alpha 2-gliadin at multiple sites in a non-specific manner. When used alone, neither ASP nor DPPIV efficiently cleaved synthetic immunotoxic gluten peptides. This lack of specificity for gluten was especially evident in the presence of casein, a competing dietary protein. However, supplementation of ASP with DPPIV enabled detoxification of moderate amounts of gluten in the presence of excess casein and in whole-wheat bread. ASP was also effective at enhancing the gluten-detoxifying efficacy of cysteine endoprotease EP-B2 under simulated gastric conditions. Conclusions: Clinical studies are warranted to evaluate whether a fixed dose ratio combination of ASP and DPPIV can provide near-term relief for celiac patients suffering from inadvertent gluten exposure. Due to its markedly greater hydrolytic activity against gluten than endogenous pepsin, food-grade ASP may also augment the activity of therapeutically relevant doses of glutenases such as EP-B2 and certain prolyl endopeptidases.			Ehren, J (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X; Moron, Belen/0000-0003-4815-7536	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK063158, DK 063158] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdulkarim AS, 2002, AM J GASTROENTEROL, V97, P2016; Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; Doumas A, 1998, APPL ENVIRON MICROB, V64, P4809; Gass J, 2005, BIOTECHNOL BIOENG, V92, P674, DOI 10.1002/bit.20643; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Hischenhuber C, 2006, ALIMENT PHARM THER, V23, P559, DOI 10.1111/j.1365-2036.2006.02768.x; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Pyle GG, 2005, CLIN GASTROENTEROL H, V3, P679, DOI 10.1016/S1542-3565(05)00365-4; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Takahashi K, 1997, BIOSCI BIOTECH BIOCH, V61, P381, DOI 10.1271/bbb.61.381; Xia J, 2005, BIOCHEMISTRY-US, V44, P4442, DOI 10.1021/bi047747c; Zhu LY, 2004, BIOSCI BIOTECH BIOCH, V68, P2607, DOI 10.1271/bbb.68.2607	22	69	81	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6313	10.1371/journal.pone.0006313	http://dx.doi.org/10.1371/journal.pone.0006313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621078	Green Published, Green Submitted, gold			2022-12-25	WOS:000268147200010
J	Richardson, TE; Chapman, KM; Dann, CT; Hammer, RE; Hamra, FK				Richardson, Timothy E.; Chapman, Karen M.; Dann, Christina Tenenhaus; Hammer, Robert E.; Hamra, F. Kent			Sterile Testis Complementation with Spermatogonial Lines Restores Fertility to DAZL-Deficient Rats and Maximizes Donor Germline Transmission	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; MALE-INFERTILITY; MOUSE TESTIS; Y-CHROMOSOME; MICE; TRANSPLANTATION; GENE; DIFFERENTIATION; CULTURE	Despite remarkable advances in assisted reproductive capabilities similar to 4% of all couples remain involuntarily infertile. In almost half of these cases, a lack of conception can in some measure be attributed to the male partner, wherein de novo Y-chromosomal deletions of sperm-specific Deleted-in-Azoospermia (DAZ) genes are particularly prevalent. In the current study, long-term cultures of rat spermatogonial stem cells were evaluated after cryo-storage for their potential to restore fertility to rats deficient in the DAZ-like (DAZL) gene. Detailed histological analysis of DAZL-deficient rat testes revealed an apparently intact spermatogonial stem cell compartment, but clear failure to produce mature haploid gametes resulting in infertility. After proliferating > 1 million-fold in cell number during culture post-thaw, as few as 50,000 donor spermatogonia transplanted into only a single testis/recipient effectively restored fecundity to DAZL-deficient rats, yielding 100% germline transmission to progeny by natural mating. Based on these results, the potency and efficacy of this donor stem cell line for restoring fertility to azoospermic rodents is currently unprecedented. Prospectively, similar successes in humans could be directly linked to the feasibility of obtaining enough fully functional spermatogonial stem cells from minimal testis biopsies to be therapeutically effective. Thus, regeneration of sperm production in this sterile recipient provides an advanced preclinical model for optimizing the efficacy of stem cell therapies to cure a paradoxically increasing number of azoospermic men. This includes males that are rendered infertile by cancer therapies, specific types of endocrine or developmental defects, and germline-specific de novo mutations; all of whom may harbor healthy sources of their own spermatogonial stem cells for treatment.			Richardson, TE (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	Kent.Hamra@UTSouthwestern.edu		Hammer, Robert E./0000-0001-5487-7551	NCRR NIH HHS [1 R21 RR023958, R21 RR023958] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR023958] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Barthold JS, 2003, J UROLOGY, V170, P2396, DOI 10.1097/01.ju.0000095793.04232.d8; BHASIN S, 1994, J CLIN ENDOCR METAB, V79, P1525, DOI 10.1210/jc.79.6.1525; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1995, DOI 10.1210/jc.2007-0634; BLEYER WA, 1990, CA-CANCER J CLIN, V40, P355, DOI 10.3322/canjclin.40.6.355; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Cronkhite JT, 2005, DEV BIOL, V284, P171, DOI 10.1016/j.ydbio.2005.05.015; Dann CT, 2006, P NATL ACAD SCI USA, V103, P11246, DOI 10.1073/pnas.0604657103; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Geens M, 2008, HUM REPROD UPDATE, V14, P121, DOI 10.1093/humupd/dmm047; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; HESS RA, 1990, BIOL REPROD, V43, P525, DOI 10.1095/biolreprod43.3.525; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Meistrich ML, 2008, REPRODUCTION, V136, P691, DOI 10.1530/REP-08-0096; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Oates RD, 2008, UROL CLIN N AM, V35, P257, DOI 10.1016/j.ucl.2008.01.015; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Orwig Kyle E, 2005, J Natl Cancer Inst Monogr, P51; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sadeghi-Nejad Hossein, 2006, Urol J, V3, P193; Sadeghi-Nejad Hossein, 2007, Urol J, V4, P192; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Shetty G, 2006, ENDOCRINOLOGY, V147, P472, DOI 10.1210/en.2005-0984; Shetty Gunapala, 2005, J Natl Cancer Inst Monogr, P36; Shindel AW, 2008, J UROLOGY, V179, P1056, DOI 10.1016/j.juro.2007.10.069; WU Z, 2009, BIOL REPROD     0318; Zhang Z, 2007, J CELL PHYSIOL, V211, P149, DOI 10.1002/jcp.20910	50	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6308	10.1371/journal.pone.0006308	http://dx.doi.org/10.1371/journal.pone.0006308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621088	Green Published, gold, Green Submitted			2022-12-25	WOS:000268147200008
J	Sheng, WY; Wang, TCV				Sheng, Wei-Yun; Wang, Tzu-Chien V.			Proteomic Analysis of the Differential Protein Expression Reveals Nuclear GAPDH in Activated T Lymphocytes	PLOS ONE			English	Article								Despite the important role of T cell activation in the adaptive immunity, very little is known about the functions of proteins that are differentially expressed in the activated T cells. In this study, we have employed proteomic approach to study the differentially expressed proteins in activated T cells. A total of 25 proteins was characterized that displayed a decreased expression, while a total of 20 proteins was characterized that displayed an increased expression in the activated T cells. Among them, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified unexpectedly as one of the up-regulated proteins. Western blot analysis of proteins separated by 2-dimensional gel electrophoresis had identified several modified GAPDHs which were detectable only in the activated T cells, but not in resting T cells. These modified GAPDHs had higher molecular mass and more basic PI, and were present in the nucleus of activated T cells. Promoter occupancy studies by chromatin immunoprecipitation assay revealed that nuclear GAPDH could be detected in the promoter of genes that were up-regulated during T cell activation, but not in the promoter of genes that were not unaffected or down-regulated. Our results suggest that nuclear GAPDH may function as transcriptional regulator in activated T cells.			Sheng, WY (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	tcvwg@mail.cgu.edu.tw		Wang, Tzu-Chien/0000-0002-6753-9639				Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOSSER R, 1995, MOL CELL BIOL, V15, P661; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Caron M, 2002, J CHROMATOGR B, V771, P197, DOI 10.1016/S1570-0232(02)00040-5; Cha H, 2004, BIOCHEM J, V378, P857, DOI 10.1042/BJ20031173; Ellisen LW, 2001, EUR J CELL BIOL, V80, P321, DOI 10.1078/0171-9335-00162; Epner DE, 1999, BIOL REPROD, V61, P687, DOI 10.1095/biolreprod61.3.687; Germain RN, 2003, IMMUNOL RES, V27, P277, DOI 10.1385/IR:27:2-3:277; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Kim D, 1999, IEEE COMMUN LETT, V3, P9, DOI 10.1109/4234.740114; Liu SC, 2000, J CELL SCI, V113, P3563; Nyman TA, 2001, ELECTROPHORESIS, V22, P4375, DOI 10.1002/1522-2683(200112)22:20<4375::AID-ELPS4375>3.0.CO;2-P; Rautajoki K, 2004, PROTEOMICS, V4, P84, DOI 10.1002/pmic.200300510; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; RYZLAK MT, 1988, BIOCHIM BIOPHYS ACTA, V954, P309, DOI 10.1016/0167-4838(88)90086-6; Sheng WY, 2006, FEBS LETT, V580, P6819, DOI 10.1016/j.febslet.2006.11.044; Sheng WY, 2003, FEBS LETT, V540, P91, DOI 10.1016/S0014-5793(03)00230-8; Sirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO;2-V; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	26	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6322	10.1371/journal.pone.0006322	http://dx.doi.org/10.1371/journal.pone.0006322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621076	Green Published, gold, Green Submitted			2022-12-25	WOS:000268147200013
J	Brown, AK; Taylor, RC; Bhatt, A; Futterer, K; Besra, GS				Brown, Alistair K.; Taylor, Rebecca C.; Bhatt, Apoorva; Fuetterer, Klaus; Besra, Gurdyal S.			Platensimycin Activity against Mycobacterial beta-Ketoacyl-ACP Synthases	PLOS ONE			English	Article							MYCOLIC ACID BIOSYNTHESIS; FATTY-ACID; ENZYMATIC CHARACTERIZATION; CONDENSING ENZYMES; III MTFABH; BOVIS BCG; TUBERCULOSIS; INHA; KASA; ETHIONAMIDE	There is an urgent need for the discovery and development of new drugs against Mycobacterium tuberculosis, the causative agent of tuberculosis, especially due to the recent emergence of multi-drug and extensively-drug resistant strains. Herein, we have examined the susceptibility of mycobacteria to the natural product platensimycin. Methods and Findings: We have demonstrated that platensimycin has bacteriostatic activity against the fast growing Mycobacterium smegmatis (MIC = 14 mu g/ml) and against Mycobacterium tuberculosis (MIC = 12 mu g/ml). Growth in the presence of paltensimycin specifically inhibited the biosynthesis of mycolic acids suggesting that the antibiotic targeted the components of the mycolate biosynthesis complex. Given the inhibitory activity of platensimycin against beta-ketoacyl-ACP synthases from Staphylococcus aureus, M. tuberculosis KasA, KasB or FabH were overexpressed in M. smegmatis to establish whether these mycobacterial KAS enzymes were targets of platensimycin. In M. smegmatis overexpression of kasA or kasB increased the MIC of the strains from 14 mu g/ml, to 30 and 124 mu g/ml respectively. However, overexpression of fabH on did not affect the MIC. Additionally, consistent with the overexpression data, in vitro assays using purified proteins demonstrated that platensimycin inhibited Mt-KasA and Mt-KasB, but not Mt-FabH. Significance: Our results have shown that platensimycin is active against mycobacterial KasA and KasB and is thus an exciting lead compound against M. tuberculosis and the development of new synthetic analogues.			Brown, AK (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham, W Midlands, England.	g.besra@bham.ac.uk		Futterer, Klaus/0000-0001-7445-5372; Besra, Gurdyal/0000-0002-5605-0395	Biotechnology and Biological Sciences Research Council [BB/E020615/1] Funding Source: Medline; Medical Research Council [G0500590, G0600105] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/E020615/1] Funding Source: UKRI; MRC [G0600105, G0500590] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Brown AK, 2007, MICROBIOL-SGM, V153, P3314, DOI 10.1099/mic.0.2007/009936-0; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobson G., 1985, CHEM METHODS BACTERI, P237; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Kaye K, 1996, EPIDEMIOL REV, V18, P52, DOI 10.1093/oxfordjournals.epirev.a017916; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Radmacher E, 2005, MICROBIOL-SGM, V151, P2421, DOI 10.1099/mic.0.28012-0; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; SINGH SB, 2008, Patent No. 2007020226; Singh SB, 2006, J AM CHEM SOC, V128, P11916, DOI 10.1021/ja062232p; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang J, 2007, P NATL ACAD SCI USA, V104, P7612, DOI 10.1073/pnas.0700746104; Wright A, 2006, JAMA-J AM MED ASSOC, V295, P2349	35	47	49	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6306	10.1371/journal.pone.0006306	http://dx.doi.org/10.1371/journal.pone.0006306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609444	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000268119500022
J	Meier-Trummer, CS; Rehrauer, H; Franchini, M; Patrignani, A; Wagner, U; Ackermann, M				Meier-Trummer, Claudia S.; Rehrauer, Hubert; Franchini, Marco; Patrignani, Andrea; Wagner, Ulrich; Ackermann, Mathias			Malignant Catarrhal Fever of Cattle Is Associated with Low Abundance of IL-2 Transcript and a Predominantly Latent Profile of Ovine Herpesvirus 2 Gene Expression	PLOS ONE			English	Article								Background: Malignant catarrhal fever (MCF) is a lethal disease of cattle, characterized by vasculitis, necrosis, and accumulation of activated, dysregulated cytotoxic lymphocytes in various tissues. Ovine gamma herpesvirus 2 (OvHV-2) is a causative agent of MCF, which may trigger the disease through immunopathogenic pathways. Lymphocytes are the main target of the virus. However, the pathogenic basis of the disease is still mysterious. Methods/Findings: We hypothesized that the gene expression patterns of OvHV-2 and the relative abundances of host cell transcripts in lymphnodes may be used to identify pathways that help to explain the pathogenesis of MCF. Therefore, viral and host cell gene expression patterns in lymph nodes of animals with MCF and healthy controls were analyzed by microarray. Two regions on the viral genome were transcriptionally active, one encoding an orthologue to the latencyassociated nuclear antigen (ORF73) of other gamma herpesviruses, the other with no predicted open reading frame. A vast number of transcripts related to inflammatory processes, lymphocyte activation, cell proliferation and apoptosis were detected at different abundances. However, the IL-2 transcript was eminent among the transcripts, which were, compared to healthy controls, less abundant in animals with MCF. The ratio between CD4-and CD8-positive T-lymphocytes was decreased in the lymphnodes of animals with MCF compared to healthy controls. In contrast, the same ratio was stable, when peripheral blood lymphocytes were analyzed. Conclusions/Significance: The phenotype of mice with a deficient IL-2-system almost perfectly matches the clinical signs observed in cattle with MCF, which feature a significantly decreased IL-2 transcript abundance, compared to healthy cattle. This supports the hypothesis that immunopathogenic events are linked to the pathogenesis of MCF. IL-2- deficiency may play an important role in the process. Therefore, this work opens new avenues for research on MCF.			Meier-Trummer, CS (corresponding author), Inst Virol, Zurich, Switzerland.	email@vetvir.uzh.ch		Partigiani, Andrea/0000-0001-8019-3911				Abril C, 2004, J VIROL, V78, P3644, DOI 10.1128/JVI.78.7.3644-3653.2004; Abu Elzein EME, 2003, J VET MED B, V50, P53, DOI 10.1046/j.1439-0450.2003.00541.x; Ackermann M, 2006, VET MICROBIOL, V113, P211, DOI 10.1016/j.vetmic.2005.11.008; Ackermann M, 2005, SCHWEIZ ARCH TIERH, V147, P155, DOI 10.1024/0036-7281.147.4.155; Albini S, 2003, SCHWEIZ ARCH TIERH, V145, P61, DOI 10.1024/0036-7281.145.2.61; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Almeida PE, 2007, VET IMMUNOL IMMUNOP, V120, P234, DOI 10.1016/j.vetimm.2007.06.028; Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Babcock GJ, 2000, P NATL ACAD SCI USA, V97, P12250, DOI 10.1073/pnas.200366597; BAXTER SIF, 1993, ARCH VIROL, V132, P145, DOI 10.1007/BF01309849; Berezowski JA, 2005, J VET DIAGN INVEST, V17, P55, DOI 10.1177/104063870501700110; Borah S, 2004, J VIROL, V78, P10336, DOI 10.1128/JVI.78.19.10336-10347.2004; BRIDGEN A, 1991, RES VET SCI, V50, P38, DOI 10.1016/0034-5288(91)90051-O; BRIDGEN A, 1992, J COMP PATHOL, V106, P351, DOI 10.1016/0021-9975(92)90021-L; BROWN CC, 1992, J WILDLIFE DIS, V28, P301, DOI 10.7589/0090-3558-28.2.301; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Collins JK, 2000, J VET DIAGN INVEST, V12, P406, DOI 10.1177/104063870001200503; Cunha CW, 2008, VIRUS RES, V132, P69, DOI 10.1016/j.virusres.2007.10.016; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Dewals B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001627; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Grell SN, 2005, VET IMMUNOL IMMUNOP, V103, P235, DOI 10.1016/j.vetimm.2004.09.025; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Haigh JC, 2002, REV SCI TECH OIE, V21, P219, DOI 10.20506/rst.21.2.1331; Hanichen T, 1998, TIERARZTL PRAX G N, V26, P294; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hussy D, 2002, J CLIN MICROBIOL, V40, P4700, DOI 10.1128/JCM.40.12.4700-4704.2002; Hussy D, 2001, CLIN DIAGN LAB IMMUN, V8, P123, DOI 10.1128/CDLI.8.1.123-128.2001; Jacobsen B, 2007, VET MICROBIOL, V124, P353, DOI 10.1016/j.vetmic.2007.04.037; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Li H, 2001, J VET DIAGN INVEST, V13, P361, DOI 10.1177/104063870101300417; LIGGITT HD, 1980, J WILDLIFE DIS, V16, P299, DOI 10.7589/0090-3558-16.2.299; LIGGITT HD, 1980, VET PATHOL, V17, P73, DOI 10.1177/030098588001700108; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; MEIERTRUMMER CS, 2009, VET MICROBIOL; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Muller-Doblies UU, 2001, SCHWEIZ ARCH TIERH, V143, P581; Muller-Doblies UU, 1998, J CLIN MICROBIOL, V36, P2970; Neilson JR, 2005, NAT METHODS, V2, P252, DOI 10.1038/nmeth0405-252; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; OTOOLE D, 1995, J VET DIAGN INVEST, V7, P108, DOI 10.1177/104063879500700118; Pahwa S, 1998, AIDS PATIENT CARE ST, V12, P187, DOI 10.1089/apc.1998.12.187; PATEL JR, 1980, J GEN VIROL, V48, P437, DOI 10.1099/0022-1317-48-2-437; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PLOWRIGHT W, 1990, EXPT AEROSOL INFECT, P123; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; REID HW, 1989, RES VET SCI, V47, P90, DOI 10.1016/S0034-5288(18)31237-2; REID HW, 1986, RES VET SCI, V41, P76, DOI 10.1016/S0034-5288(18)30575-7; REID HW, 1984, VET REC, V114, P581, DOI 10.1136/vr.114.24.581; Rosbottom J, 2002, J GEN VIROL, V83, P2999, DOI 10.1099/0022-1317-83-12-2999; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; Sasik R, 2002, BIOINFORMATICS, V18, P1633, DOI 10.1093/bioinformatics/18.12.1633; Schindler AR, 2007, MOL CELL PROBE, V21, P47, DOI 10.1016/j.mcp.2006.08.001; Schock A, 1996, VET MICROBIOL, V53, P111, DOI 10.1016/S0378-1135(96)01239-4; Schultheiss PC, 1998, J VET DIAGN INVEST, V10, P255, DOI 10.1177/104063879801000305; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stewart RJE, 2006, VET REC, V159, P668, DOI 10.1136/vr.159.20.668; Sugden B, 2006, NATURE, V442, P33, DOI 10.1038/442033a; Taus NS, 2006, VET MICROBIOL, V116, P29, DOI 10.1016/j.vetmic.2006.03.005; Thonur L, 2006, VIRUS GENES, V32, P27, DOI 10.1007/s11262-005-5842-3; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	86	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6265	10.1371/journal.pone.0006265	http://dx.doi.org/10.1371/journal.pone.0006265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603070	Green Published, gold			2022-12-25	WOS:000268035700011
J	Velamakanni, S; Lau, CHF; Gutmann, DAP; Venter, H; Barrera, NP; Seeger, MA; Woebking, B; Matak-Vinkovic, D; Balakrishnan, L; Yao, Y; Edmond, CYU; Shilling, RA; Robinson, CV; Thorn, P; van Veen, HW				Velamakanni, Saroj; Lau, Calvin H. F.; Gutmann, Daniel A. P.; Venter, Henrietta; Barrera, Nelson P.; Seeger, Markus A.; Woebking, Barbara; Matak-Vinkovic, Dijana; Balakrishnan, Lekshmy; Yao, Yao; Edmond, C. Y. U.; Shilling, Richard A.; Robinson, Carol V.; Thorn, Peter; van Veen, Hendrik W.			A Multidrug ABC Transporter with a Taste for Salt	PLOS ONE			English	Article							ESCHERICHIA-COLI; MECHANOSENSITIVE CHANNELS; LACTOBACILLUS-BREVIS; CHLORIDE CHANNELS; INTRACELLULAR PH; MOLECULAR-BASIS; EFFLUX PUMPS; RESISTANCE; BINDING; PROTEIN	Background: LmrA is a multidrug ATP-binding cassette (ABC) transporter from Lactococcus lactis with no known physiological substrate, which can transport a wide range of chemotherapeutic agents and toxins from the cell. The protein can functionally replace the human homologue ABCB1 (also termed multidrug resistance P-glycoprotein MDR1) in lung fibroblast cells. Even though LmrA mediates ATP-dependent transport, it can use the proton-motive force to transport substrates, such as ethidium bromide, across the membrane by a reversible, H+-dependent, secondary-active transport reaction. The mechanism and physiological context of this reaction are not known. Methodology/Principal Findings: We examined ion transport by LmrA in electrophysiological experiments and in transport studies using radioactive ions and fluorescent ion-selective probes. Here we show that LmrA itself can transport NaCl by a similar secondary-active mechanism as observed for ethidium bromide, by mediating apparent H+-Na+-Cl- symport. Remarkably, LmrA activity significantly enhances survival of high-salt adapted lactococcal cells during ionic downshift. Conclusions/Significance: The observations on H+-Na+-Cl- co-transport substantiate earlier suggestions of H+-coupled transport by LmrA, and indicate a novel link between the activity of LmrA and salt stress. Our findings demonstrate the relevance of investigations into the bioenergetics of substrate translocation by ABC transporters for our understanding of fundamental mechanisms in this superfamily. This study represents the first use of electrophysiological techniques to analyze substrate transport by a purified multidrug transporter.			Velamakanni, S (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	hwv20@cam.ac.uk	Thorn, Peter/F-7030-2010; Venter, Rietie/E-4795-2013; van Veen, Hendrik W./A-4162-2008	Thorn, Peter/0000-0002-3228-770X; Venter, Rietie/0000-0001-5569-7755; van Veen, Hendrik W./0000-0002-9658-8077; Barrera, Nelson/0000-0001-7825-1406; Seeger, Markus/0000-0003-1761-8571; U, Edmond Chun Ying/0000-0003-1672-6204; Gutmann, Daniel/0000-0001-7359-0206; Lau, Calvin (Ho-Fung)/0000-0003-3407-4924; robinson, carol/0000-0001-7829-5505	Biotechnology and Biological Sciences Research Council [BB/F008333/1, BB/C004663/1] Funding Source: Medline; Medical Research Council Funding Source: Medline; BBSRC [BB/F008333/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Dutzler R, 2006, CURR OPIN STRUC BIOL, V16, P439, DOI 10.1016/j.sbi.2006.06.002; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hellmich UA, 2008, FEBS LETT, V582, P3557, DOI 10.1016/j.febslet.2008.09.033; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; HOFFMAN MM, 1999, BIOCHEMISTRY-US, V36, P11153; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kolaczkowska A, 2008, FEBS LETT, V582, P977, DOI 10.1016/j.febslet.2008.02.045; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; MCKAY LL, 1990, FEMS MICROBIOL LETT, V87, P3, DOI 10.1111/j.1574-6968.1990.tb04876.x; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; RIORDAN JR, 1992, BIOCHIM BIOPHYS ACTA, V1101, P221, DOI 10.1016/0005-2728(92)90230-Y; ROEPE PD, 1994, BIOCHEMISTRY-US, V33, P11008, DOI 10.1021/bi00202a021; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Sami M, 1998, J GEN APPL MICROBIOL, V44, P361, DOI 10.2323/jgam.44.361; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Shilling R, 2005, FASEB J, V19, P1698, DOI 10.1096/fj.04-3558fje; Shilling RA, 2006, TRENDS PHARMACOL SCI, V27, P195, DOI 10.1016/j.tips.2006.02.008; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Thrower EC, 1999, METH MOL B, V114, P221; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; VANVEEN HW, 1993, J BIOL CHEM, V268, P19377; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d	53	32	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6137	10.1371/journal.pone.0006137	http://dx.doi.org/10.1371/journal.pone.0006137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593434	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035300003
J	Savino, C; Montemiglio, LC; Sciara, G; Miele, AE; Kendrew, SG; Jemth, P; Gianni, S; Vallone, B				Savino, Carmelinda; Montemiglio, Linda C.; Sciara, Giuliano; Miele, Adriana E.; Kendrew, Steven G.; Jemth, Per; Gianni, Stefano; Vallone, Beatrice			Investigating the Structural Plasticity of a Cytochrome P450 THREE-DIMENSIONAL STRUCTURES OF P450 EryK AND BINDING TO ITS PHYSIOLOGICAL SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; DRUG-INTERACTIONS; C-12 HYDROXYLASE; LIGAND-BINDING; NA+ BINDING; MECHANISM; KINETICS; DOMAIN; ERYK	Cytochrome P450s are heme-containing proteins that catalyze the oxidative metabolism of many physiological endogenous compounds. Because of their unique oxygen chemistry and their key role in drug and xenobiotic metabolism, particular attention has been devoted in elucidating their mechanism of substrate recognition. In this work, we analyzed the three-dimensional structures of a monomeric cytochrome P450 from Saccharopolyspora erythraea, commonly called EryK, and the binding kinetics to its physiological ligand, erythromycin D. Three different structures of EryK were obtained: two ligand-free forms and one in complex with its substrate. Analysis of the substrate-bound structure revealed the key structural determinants involved in substrate recognition and selectivity. Interestingly, the ligand-free structures of EryK suggested that the protein may explore an open and a closed conformation in the absence of substrate. In an effort to validate this hypothesis and to investigate the energetics between such alternative conformations, we performed stopped-flow absorbance experiments. Data demonstrated that EryK binds erythromycin D via a mechanism involving at least two steps. Contrary to previously characterized cytochrome P450s, analysis of double jump mixing experiments confirmed that this complex scenario arises from a pre-existing equilibrium between the open and closed subpopulations of EryK, rather than from an induced-fit type mechanism.	[Gianni, Stefano] CNR, Inst Mol Biol & Pathol, Dept Biochem Sci, I-00185 Rome, Italy; [Savino, Carmelinda; Montemiglio, Linda C.; Sciara, Giuliano; Miele, Adriana E.; Gianni, Stefano; Vallone, Beatrice] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Kendrew, Steven G.] Biot Technol Ltd, Saffron Walden CB10 1XL, Essex, England; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Uppsala University	Gianni, S (corresponding author), CNR, Inst Mol Biol & Pathol, Dept Biochem Sci, Ple Aldo Moro 5, I-00185 Rome, Italy.	Stefano.gianni@uniroma1.it; beatrice.vallone@uniroma1.it	Miele, Adriana E./F-4083-2011; gianni, stefano/C-8536-2009; sciara, giuliano/AAL-4478-2020; Vallone, Beatrice/F-4174-2012	Miele, Adriana E./0000-0002-4637-2606; Gianni, Stefano/0000-0003-1653-1925; SAVINO, CARMELINDA/0000-0002-1602-4838; VALLONE, Beatrice/0000-0003-0058-9049	Italian MIUR FIRB2003 [RBLA03B3KC_004]; CNR [RSTL2007-856]	Italian MIUR FIRB2003(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); CNR(Consiglio Nazionale delle Ricerche (CNR))	The work was supported by Italian MIUR FIRB2003 Grants RBLA03B3KC_004 and CNR RSTL2007-856.	Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell SG, 2006, BIOCHEM BIOPH RES CO, V342, P191, DOI 10.1016/j.bbrc.2006.01.133; Bell SG, 2008, J MOL BIOL, V383, P561, DOI 10.1016/j.jmb.2008.08.033; Chen Y, 2008, APPL ENVIRON MICROB, V74, P1820, DOI 10.1128/AEM.02770-07; Cheng G, 2005, NUCLEIC ACIDS RES, V33, P5861, DOI 10.1093/nar/gki894; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; Davydov DR, 2004, BIOCHEMISTRY-US, V43, P6475, DOI 10.1021/bi036260l; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Desai RP, 2004, BIOTECHNOL PROGR, V20, P1660, DOI 10.1021/bp0497435; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gianni S, 2007, BIOPHYS CHEM, V131, P111, DOI 10.1016/j.bpc.2007.09.009; GOTOH O, 1992, J BIOL CHEM, V267, P83; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Heringa J, 1999, PROTEINS, V37, P44, DOI 10.1002/(SICI)1097-0134(19991001)37:1<44::AID-PROT5>3.0.CO;2-F; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; LAMBALOT RH, 1995, BIOCHEMISTRY-US, V34, P1858, DOI 10.1021/bi00006a006; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; LI HY, 1995, ACTA CRYSTALLOGR D, V51, P21, DOI 10.1107/S0907444994009194; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacey MS, 1998, J ANTIBIOT, V51, P1029, DOI 10.7164/antibiotics.51.1029; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 2005, CYTOCHROME P450S STR, P377; Pylypenko O, 2004, ANNU REV BIOCHEM, V73, P991, DOI 10.1146/annurev.biochem.73.011303.073711; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Ruan X, 1997, J BACTERIOL, V179, P6416, DOI 10.1128/jb.179.20.6416-6425.1997; Savino C, 2008, PROTEIN PEPTIDE LETT, V15, P1138, DOI 10.2174/092986608786071201; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; STASSI D, 1993, J BACTERIOL, V175, P182, DOI 10.1128/JB.175.1.182-189.1993; Vagin A, 1998, ACTA CRYSTALLOGR D, V54, P400, DOI 10.1107/S0907444997014923; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; WRECKREICHHART D, 2000, GENOME BIOL, V3003, P1; Yun CH, 1996, J BIOL CHEM, V271, P31312, DOI 10.1074/jbc.271.49.31312	48	62	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29170	29179		10.1074/jbc.M109.003590	http://dx.doi.org/10.1074/jbc.M109.003590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19625248	Green Published, hybrid			2022-12-25	WOS:000270678900072
J	Mnatsakanyan, N; Hook, JA; Quisenberry, L; Weber, J				Mnatsakanyan, Nelli; Hook, Jonathon A.; Quisenberry, Leah; Weber, Joachim			ATP Synthase with Its gamma Subunit Reduced to the N-terminal Helix Can Still Catalyze ATP Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F-1-ATPASE; BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; EPSILON-SUBUNIT; NUCLEOTIDE-BINDING; F0F1-ATP SYNTHASE; F1F0-ATP SYNTHASE; MUTANT STRAINS; BETA-SUBUNITS; DELTA-SUBUNIT	ATP synthase uses a unique rotary mechanism to couple ATP synthesis and hydrolysis to transmembrane proton translocation. As part of the synthesis mechanism, the torque of the rotor has to be converted into conformational rearrangements of the catalytic binding sites on the stator to allow synthesis and release of ATP. The gamma subunit of the rotor, which plays a central role in the energy conversion, consists of two long helices inside the central cavity of the stator cylinder plus a globular portion outside the cylinder. Here, we show that the N-terminal helix alone is able to fulfill the function of full-length gamma in ATP synthesis as long as it connects to the rest of the rotor. This connection can occur via the epsilon subunit. No direct contact between gamma and the c ring seems to be required. In addition, the results indicate that the epsilon subunit of the rotor exists in two different conformations during ATP synthesis and ATP hydrolysis.	[Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health [GM071462]; Texas Tech University Health Sciences Center; Laura Bush Institute for Women's Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Tech University Health Sciences Center; Laura Bush Institute for Women's Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (to J. W.).; Supported by the Summer Accelerated Biomedical Research program of the Texas Tech University Health Sciences Center and the Laura Bush Institute for Women's Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Boltz KW, 2006, BIOCHEMISTRY-US, V45, P11190, DOI 10.1021/bi052592+; Boltz KW, 2005, BIOCHEMISTRY-US, V44, P9497, DOI 10.1021/bi050070o; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; DUNCAN TM, 2009, ASBMB ANN M NEW ORL; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GOELZ SE, 1982, BIOCHEMISTRY-US, V21, P189, DOI 10.1021/bi00530a032; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Ketchum CJ, 1998, J BIOL CHEM, V273, P22292, DOI 10.1074/jbc.273.35.22292; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Lowry DS, 2005, BIOCHEMISTRY-US, V44, P7275, DOI 10.1021/bi047293j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao HZ, 2008, J BIOL CHEM, V283, P24781, DOI 10.1074/jbc.M804142200; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Mao HZ, 2006, FEBS LETT, V580, P4131, DOI 10.1016/j.febslet.2006.06.059; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Vinogradov AD, 2000, J EXP BIOL, V203, P41; WALKER JE, 1986, CHEM SCR, V268, P263; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; Weber J, 2003, J BIOL CHEM, V278, P13409, DOI 10.1074/jbc.M212037200; Weber J, 2004, METHOD ENZYMOL, V380, P132; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Xiao Y, 2000, J BIOL CHEM, V275, P6963, DOI 10.1074/jbc.275.10.6963; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; YOSHIDA M, 1977, P NATL ACAD SCI USA, V74, P936, DOI 10.1073/pnas.74.3.936	56	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26519	26525		10.1074/jbc.M109.030528	http://dx.doi.org/10.1074/jbc.M109.030528			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19636076	hybrid, Green Published			2022-12-25	WOS:000269969600033
J	El Kaderi, B; Medler, S; Raghunayakula, S; Ansari, A				El Kaderi, Belal; Medler, Scott; Raghunayakula, Sarita; Ansari, Athar			Gene Looping Is Conferred by Activator-dependent Interaction of Transcription Initiation and Termination Machineries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; YEAST; REINITIATION; TFIIB; MECHANISM; PROMOTER; RELEASE; REGIONS; COMPLEX	Gene looping juxtaposes the promoter and terminator regions of RNA polymerase II-transcribed genes in yeast and mammalian cells. Here we report an activator-dependent interaction of transcription initiation and termination factors during gene looping in budding yeast. Chromatin analysis revealed that MET16, INO1, and GAL1p-BUD3 are in a stable looped configuration during activated transcription. Looping was nearly abolished in the absence of transcription activators Met28, Ino2, and Gal4 of MET16, INO1, and GAL1p-BUD3 genes, respectively. The activator-independent increase in transcription was not accompanied by loop formation, thereby suggesting an essential role for activators in gene looping. The activators did not facilitate loop formation directly because they did not exhibit an interaction with the 3' end of the genes. Instead, activators physically interacted with the general transcription factor TFIIB when the genes were activated and in a looped configuration. TFIIB cross-linked to both the promoter and the terminator regions during the transcriptionally activated state of a gene. The presence of TFIIB on the terminator was dependent on the Rna15 component of CF1 3' end processing complex. Coimmunoprecipitation revealed a physical interaction of Rna15 with TFIIB. We propose that the activators facilitate gene looping through their interaction with TFIIB during transcriptional activation of genes.	[El Kaderi, Belal; Medler, Scott; Raghunayakula, Sarita; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	Wayne State University	Wayne State University	This work was supported by start-up funds from Wayne State University.	AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; KULKENS T, 1992, EMBO J, V11, P4665, DOI 10.1002/j.1460-2075.1992.tb05568.x; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; MCNEIL JB, 1985, MOL CELL BIOL, V5, P3545, DOI 10.1128/MCB.5.12.3545; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; WACH A, 1994, YEAST, V10, P1808; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Yochum GS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-102; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	31	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25015	25025		10.1074/jbc.M109.007948	http://dx.doi.org/10.1074/jbc.M109.007948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602510	Green Published, hybrid			2022-12-25	WOS:000269734000037
J	Glazov, EA; Kongsuwan, K; Assavalapsakul, W; Horwood, PF; Mitter, N; Mahony, TJ				Glazov, Evgeny A.; Kongsuwan, Kritaya; Assavalapsakul, Wanchai; Horwood, Paul F.; Mitter, Neena; Mahony, Timothy J.			Repertoire of Bovine miRNA and miRNA-Like Small Regulatory RNAs Expressed upon Viral Infection	PLOS ONE			English	Article							GENOME BROWSER DATABASE; ENDOGENOUS SIRNAS; HUMAN MICRORNAS; DROSOPHILA; EVOLUTION; IDENTIFICATION; GENES; TRANSCRIPTION; UCSC; BIOGENESIS	MicroRNA (miRNA) and other types of small regulatory RNAs play a crucial role in the regulation of gene expression in eukaryotes. Several distinct classes of small regulatory RNAs have been discovered in recent years. To extend the repertoire of small RNAs characterized in mammals and to examine relationship between host miRNA expression and viral infection we used Illumina's ultrahigh throughput sequencing approach. We sequenced three small RNA libraries prepared from cell line derived from the adult bovine kidney under normal conditions and upon infection of the cell line with Bovine herpesvirus 1. We used a bioinformatics approach to distinguish authentic mature miRNA sequences from other classes of small RNAs and short RNA fragments represented in the sequencing data. Using this approach we detected 219 out of 356 known bovine miRNAs and 115 respective miRNA* sequences. In addition we identified five new bovine orthologs of known mammalian miRNAs and discovered 268 new cow miRNAs many of which are not identifiable in other mammalian genomes and thus might be specific to the ruminant lineage. In addition we found seven new bovine mirtron candidates. We also discovered 10 small nucleolar RNA (snoRNA) loci that give rise to small RNA with possible miRNA-like function. Results presented in this study extend our knowledge of the biology and evolution of small regulatory RNAs in mammals and illuminate mechanisms of small RNA biogenesis and function. New miRNA sequences and the original sequencing data have been submitted to miRNA repository (miRBase) and NCBI GEO archive respectively. We envisage that these resources will facilitate functional annotation of the bovine genome and promote further functional and comparative genomics studies of small regulatory RNA in mammals.			Glazov, EA (corresponding author), Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Woolloongabba, Qld, Australia.	e.glazov@uq.edu.au; timothy.mahony@dpi.qld.gov.au	Mahony, Timothy J./C-9307-2013; Assavalapsakul, Wanchai/H-8471-2015; mitter, neena/D-1862-2013; Glazov, Evgeny A/F-9951-2010; Mahony, Timothy J/A-7501-2011	Mahony, Timothy J./0000-0003-4573-7906; Assavalapsakul, Wanchai/0000-0003-2739-3177; mitter, neena/0000-0001-6146-6179; Horwood, Paul/0000-0001-9622-0742				Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Mahony TJ, 2002, J VIROL, V76, P6660, DOI 10.1128/JVI.76.13.6660-6668.2002; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MORIN R, 2008, GENOME RES; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; PROJECT AET, 2009, NATURE, V457, P1028; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Strozzi F, 2009, ANIM GENET, V40, P125, DOI 10.1111/j.1365-2052.2008.01780.x; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228	52	74	307	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6349	10.1371/journal.pone.0006349	http://dx.doi.org/10.1371/journal.pone.0006349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633723	gold, Green Accepted, Green Published			2022-12-25	WOS:000268404800004
J	Quanz, M; Chassoux, D; Berthault, N; Agrario, C; Sun, JS; Dutreix, M				Quanz, Maria; Chassoux, Danielle; Berthault, Nathalie; Agrario, Celine; Sun, Jian-Sheng; Dutreix, Marie			Hyperactivation of DNA-PK by Double-Strand Break Mimicking Molecules Disorganizes DNA Damage Response	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; HOMOLOGY-DIRECTED REPAIR; HISTONE H2AX; CATALYTIC SUBUNIT; S-PHASE; ATM; RADIATION; PHOSPHORYLATION; REPLICATION; ACTIVATION	Cellular response to DNA damage involves the coordinated activation of cell cycle checkpoints and DNA repair. The early steps of DNA damage recognition and signaling in mammalian cells are not yet fully understood. To investigate the regulation of the DNA damage response (DDR), we designed short and stabilized double stranded DNA molecules (Dbait) mimicking double-strand breaks. We compared the response induced by these molecules to the response induced by ionizing radiation. We show that stable 32-bp long Dbait, induce pan-nuclear phosphorylation of DDR components such as H2AX, Rpa32, Chk1, Chk2, Nbs1 and p53 in various cell lines. However, individual cell analyses reveal that differences exist in the cellular responses to Dbait compared to irradiation. Responses to Dbait: (i) are dependent only on DNA-PK kinase activity and not on ATM, (ii) result in a phosphorylation signal lasting several days and (iii) are distributed in the treated population in an "all-or-none'' pattern, in a Dbait-concentration threshold dependant manner. Moreover, despite extensive phosphorylation of the DNA-PK downstream targets, Dbait treated cells continue to proliferate without showing cell cycle delay or apoptosis. Dbait treatment prior to irradiation impaired foci formation of Nbs1, 53BP1 and Rad51 at DNA damage sites and inhibited non-homologous end joining as well as homologous recombination. Together, our results suggest that the hyperactivation of DNA-PK is insufficient for complete execution of the DDR but induces a "false'' DNA damage signaling that disorganizes the DNA repair system.			Quanz, M (corresponding author), Inst Curie, Dept Transfert, F-91405 Orsay, France.	marie.dutreix@curie.u-psud.fr	Quanz, Maria/AAA-4424-2020					ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chassoux D, 1999, ANAL QUANT CYTOL, V21, P489; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Dumay A, 2006, ONCOGENE, V25, P3196, DOI 10.1038/sj.onc.1209344; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Karagiannis TC, 2007, ONCOGENE, V26, P3963, DOI 10.1038/sj.onc.1210174; Lamas E, 2003, J HISTOCHEM CYTOCHEM, V51, P319, DOI 10.1177/002215540305100307; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lett J T, 1990, Prog Nucleic Acid Res Mol Biol, V39, P305, DOI 10.1016/S0079-6603(08)60630-3; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Ma H, 1998, J CELL BIOL, V143, P1415, DOI 10.1083/jcb.143.6.1415; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nimura Y, 2002, RADIAT RES, V157, P562, DOI 10.1667/0033-7587(2002)157[0562:DPAAAR]2.0.CO;2; Nur-E-Kamal A, 2003, J BIOL CHEM, V278, P12475, DOI 10.1074/jbc.M212915200; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Olive PL, 2004, METHOD CELL BIOL, V75, P355; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Quanz M, 2009, CLIN CANCER RES, V15, P1308, DOI 10.1158/1078-0432.CCR-08-2108; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; SIMONS JWIM, 1979, MUTAT RES, V59, P273, DOI 10.1016/0027-5107(79)90165-9; SPITZER S, 1988, NUCLEIC ACIDS RES, V16, P11691, DOI 10.1093/nar/16.24.11691; Stevens CW, 2001, INT J RADIAT BIOL, V77, P841, DOI 10.1080/09553000110053882; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yarosh DB, 2001, ENVIRON MOL MUTAGEN, V38, P132, DOI 10.1002/em.1063; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	50	62	66	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6298	10.1371/journal.pone.0006298	http://dx.doi.org/10.1371/journal.pone.0006298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621083	gold, Green Submitted, Green Published			2022-12-25	WOS:000268147200006
J	Li, JH; Paredes-Sabja, D; Sarker, MR; McClane, BA				Li, Jihong; Paredes-Sabja, Daniel; Sarker, Mahfuzur R.; McClane, Bruce A.			Further Characterization of Clostridium perfringens Small Acid Soluble Protein-4 (Ssp4) Properties and Expression	PLOS ONE			English	Article								Background: Clostridium perfringens type A food poisoning ( FP) is usually caused by C. perfringens type A strains that carry chromosomal enterotoxin gene (cpe) and produce spores with exceptional resistance against heat and nitrites. Previous studies showed that the extreme resistance of spores made by most FP strains is mediated, in large part, by a variant of small acid soluble protein 4 (Ssp4) that has Asp at residue 36; in contrast, the sensitive spores made by other C. perfringens type A isolates contain an Ssp4 variant with Gly at residue 36. Methodology/Principal Findings: The current study has further characterized Ssp4 properties and expression. Spores made by cpe-positive type C and D strains were found to contain the Ssp4 variant with Gly at residue 36 and were shown to be heat- and nitrite-sensitive; this finding may help to explain why cpe-positive type C and D isolates rarely cause food poisoning. Saturation mutagenesis indicated that both amino acid size and charge at Ssp4 residue 36 are important for DNA binding and for spore resistance. C. perfringens Ssp2 was shown to bind preferentially to GC-rich DNA on gel-shift assays, while Ssp4 preferred binding to AT-rich DNA sequences. Maximal spore heat and nitrite resistance required production of all four C. perfringens Ssps, indicating that these Ssps act cooperatively to protect the spore's DNA, perhaps by binding to different chromosomal sequences. The Ssp4 variant with Asp at residue 36 was also shown to facilitate exceptional spore survival at freezer and refrigerator temperatures. Finally, Ssp4 expression was shown to be dependent upon Spo0A, a master regulator. Conclusions/Significance: Collectively, these results provide additional support for the importance of Ssps, particularly the Ssp4 variant with Asp at residue 36, for the extreme spore resistance phenotype that likely contributes to C. perfringens type A food poisoning transmission.			Li, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	bamcc@pitt.edu	Paredes-Sabja, Daniel/ABI-4293-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019844] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI019844, R37AI19844] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Collie RE, 1998, J CLIN MICROBIOL, V36, P30, DOI 10.1128/JCM.36.1.30-36.1998; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Fisher DJ, 2006, INFECT IMMUN, V74, P5200, DOI 10.1128/IAI.00534-06; Grant KA, 2008, FOODBORNE PATHOG DIS, V5, P629, DOI 10.1089/fpd.2007.0066; Greene EA, 1996, J BIOL CHEM, V271, P11455, DOI 10.1074/jbc.271.19.11455; Huang IH, 2004, FEMS MICROBIOL LETT, V233, P233, DOI [10.1016/j.femsle.2004.02.014, 10.1111/j.1574-6968.2004.tb09487.x]; Lahti P, 2008, J CLIN MICROBIOL, V46, P371, DOI 10.1128/JCM.01650-07; Li JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000056; Li JH, 2006, APPL ENVIRON MICROB, V72, P4561, DOI 10.1128/AEM.00177-06; Li JH, 2006, APPL ENVIRON MICROB, V72, P7620, DOI 10.1128/AEM.01911-06; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; MCCLANE BA, 2007, CLOSTRIDIUM PERFRING, P423; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Novak JS, 2003, INT J FOOD MICROBIOL, V86, P239, DOI 10.1016/S0168-1605(02)00550-0; Orsburn B, 2008, APPL ENVIRON MICROB, V74, P3328, DOI 10.1128/AEM.02629-07; Raju D, 2007, CAN J MICROBIOL, V53, P514, DOI 10.1139/W07-016; Raju D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-50; Raju D, 2007, APPL ENVIRON MICROB, V73, P2048, DOI 10.1128/AEM.02500-06; Sarker MR, 1999, MOL MICROBIOL, V33, P946, DOI 10.1046/j.1365-2958.1999.01534.x; Sarker MR, 2000, APPL ENVIRON MICROB, V66, P3234, DOI 10.1128/AEM.66.8.3234-3240.2000; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sparks SG, 2001, J CLIN MICROBIOL, V39, P883, DOI 10.1128/JCM.39.3.883-888.2001; Tennen R, 2000, J APPL MICROBIOL, V89, P330, DOI 10.1046/j.1365-2672.2000.01114.x; Wen QY, 2004, APPL ENVIRON MICROB, V70, P2685, DOI 10.1128/AEM.70.5.2685-2691.2004; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	28	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6249	10.1371/journal.pone.0006249	http://dx.doi.org/10.1371/journal.pone.0006249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609432	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000268119500002
J	Petschnigg, J; Wolinski, H; Kolb, D; Zellnig, G; Kurat, CF; Natter, K; Kohlwein, SD				Petschnigg, Julia; Wolinski, Heimo; Kolb, Dagmar; Zellnig, Guenther; Kurat, Christoph F.; Natter, Klaus; Kohlwein, Sepp D.			Good Fat, Essential Cellular Requirements for Triacylglycerol Synthesis to Maintain Membrane Homeostasis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN-RESPONSE; MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; ENDOPLASMIC-RETICULUM MEMBRANE; GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; LIPID PARTICLES; ACID SYNTHESIS; PHOSPHOLIPID-SYNTHESIS; TRANSCRIPTION FACTOR; PATHWAY	Storage triacylglycerols (TAG) and membrane phospholipids share common precursors, i.e. phosphatidic acid and diacylglycerol, in the endoplasmic reticulum. In addition to providing a biophysically rather inert storage pool for fatty acids, TAG synthesis plays an important role to buffer excess fatty acids (FA). The inability to incorporate exogenous oleic acid into TAG in a yeast mutant lacking the acyltransferases Lro1p, Dga1p, Are1p, and Are2p contributing to TAG synthesis results in dysregulation of lipid synthesis, massive proliferation of intracellular membranes, and ultimately cell death. Carboxypeptidase Y trafficking from the endoplasmic reticulum to the vacuole is severely impaired, but the unfolded protein response is only moderately up-regulated, and dispensable for membrane proliferation, upon exposure to oleic acid. FA-induced toxicity is specific to oleic acid and much less pronounced with palmitoleic acid and is not detectable with the saturated fatty acids, palmitic and stearic acid. Palmitic acid supplementation partially suppresses oleic acid-induced lipotoxicity and restores carboxypeptidase Y trafficking to the vacuole. These data show the following: (i) FA uptake is not regulated by the cellular lipid requirements; (ii) TAG synthesis functions as a crucial intracellular buffer for detoxifying excess unsaturated fatty acids; (iii) membrane lipid synthesis and proliferation are responsive to and controlled by a balanced fatty acid composition.	[Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Zellnig, Guenther] Graz Univ, Inst Plant Sci, A-8010 Graz, Austria	University of Graz; University of Graz	Kohlwein, SD (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-11, A-8010 Graz, Austria.	sepp.kohlwein@uni-graz.at		Wolinski, Heimo/0000-0002-1583-6092; Kurat, Christoph/0000-0003-0962-3258; Kohlwein, Sepp Dieter/0000-0002-1030-0598	Federal Ministry for Science and Research; Austrian Science Fund [F3005]; Austrian Science Fund (FWF) [F 3005, W 901] Funding Source: researchfish	Federal Ministry for Science and Research; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants from the Federal Ministry for Science and Research (Project GOLD, Genomics of Lipid-associated Disorders, in the framework of the GEN-AU Program) and the Austrian Science Fund Project SFB Lipotox F3005 (to S. D. K.).	Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Collins RN, 2006, CELL, V124, P464, DOI 10.1016/j.cell.2006.01.017; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; KOHLWEIN SD, 1984, BIOCHIM BIOPHYS ACTA, V792, P310, DOI 10.1016/0005-2760(84)90198-X; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Larson LL, 2002, YEAST, V19, P373, DOI 10.1002/yea.839; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; MECHLER B, 1987, EMBO J, V6, P2157, DOI 10.1002/j.1460-2075.1987.tb02483.x; Menzel R, 1997, YEAST, V13, P1211, DOI 10.1002/(SICI)1097-0061(199710)13:13<1211::AID-YEA168>3.0.CO;2-8; MORRISON WR, 1964, J LIPID RES, V5, P600; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schneiter R, 1997, CELL, V88, P431, DOI 10.1016/S0092-8674(00)81882-6; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Skoneczny M, 1996, BIOCHIMIE, V78, P95, DOI 10.1016/0300-9084(96)82639-3; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2003, APPL MICROBIOL BIOT, V61, P289, DOI 10.1007/s00253-002-1212-4; Stroobants AK, 1999, FEBS LETT, V453, P210, DOI 10.1016/S0014-5793(99)00721-8; Tatzer V, 2002, MOL BIOL CELL, V13, P4429, DOI 10.1091/mbc.E02-04-0196; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Trotter PJ, 2001, ANNU REV NUTR, V21, P97, DOI 10.1146/annurev.nutr.21.1.97; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; Wolinski H, 2009, J PROTEOME RES, V8, P20, DOI 10.1021/pr800782n; Wolinski Heimo, 2008, V457, P151, DOI 10.1007/978-1-59745-261-8_11; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	74	149	154	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30981	30993		10.1074/jbc.M109.024752	http://dx.doi.org/10.1074/jbc.M109.024752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19608739	Green Published, hybrid			2022-12-25	WOS:000271378400028
J	Benton, G; Crooke, E; George, J				Benton, Gabriel; Crooke, Elliott; George, Jay			Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status	FASEB JOURNAL			English	Article						extracellular matrix; epigenetic; metastasis; microenvironment; mesenchymal to epithelial reverting transition; MErT	MAMMARY EPITHELIAL-CELLS; RECONSTITUTED BASEMENT-MEMBRANE; ALUI RESTRICTION ENZYME; GENE-EXPRESSION; MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; TUMOR PROGRESSION; CARCINOMA-CELLS; EXTRACELLULAR-MATRIX; TISSUE ARCHITECTURE	This study determines the role of laminin-1 in promoting metastatic colonization during breast cancer. For this purpose, human mammary epithelial cell lines representing normal (MCF-10A), adenocarcinoma (MCF-7), and malignant carcinoma (MDA-MB-231) were propagated in 3-dimensional cultures composed of laminin-1, collagen I, or mixtures of the two, and analyzed by Western blot, immunocytochemistry, semiquantitative reverse transcription polymerase chain reaction, and methylation-specific PCR. Here we demonstrate that laminin-1 decreases methylation of the E-cadherin promoter, resulting in increased mRNA and protein expression for malignant mammary epithelial cells. This decreased methylation is associated with dramatic changes in the cellular and structural morphology as well as a 70-fold decrease in DNA methyltransferase 1 (DNMT1) and a 6-fold decrease in cadherin 11 protein expression. To control for specificity of laminin-1 interactions, cells were also cultured on 2-dimensional plastic substrata and collagen I hydrogels for analysis, and the MCF-10A and MCF-7 were used as nonmalignant controls. Using a 3-dimensional model, we present evidence that laminin-1 is capable of inducing epigenetic change by inhibiting expression of DNMT1 and preventing methylation of the E-cadherin promoter, resulting in E-cadherin expression and the formation of cell-cell bonds in malignant carcinoma.-Benton, G., Crooke, E., George, J. Laminin-1 induces E-cadherin expression in 3-dimensional-cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status. FASEB J. 23, 3884-3895 (2009). www.fasebj.org	[Benton, Gabriel; Crooke, Elliott] Georgetown Univ, Washington, DC USA; [Benton, Gabriel; George, Jay] Trevigen Inc, Gaithersburg, MD USA	Georgetown University	Benton, G (corresponding author), 8405 Helgerman Ct, Gaithersburg, MD 20877 USA.	gjb2@georgetown.edu		Benton, Gabriel/0000-0003-4244-5764				Alpaugh ML, 1999, CANCER RES, V59, P5079; Ballestar E, 2005, BIOCHEM CELL BIOL, V83, P374, DOI 10.1139/o05-035; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Bissell MJ, 2003, BREAST CANCER RES, V5, P117, DOI 10.1186/bcr579; BOUDREAU N, 1995, TRENDS CELL BIOL, V5, P1, DOI 10.1016/S0962-8924(00)88924-2; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Day ML, 1999, J BIOL CHEM, V274, P9656, DOI 10.1074/jbc.274.14.9656; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fan H, 2007, EUR J GASTROEN HEPAT, V19, P952, DOI 10.1097/MEG.0b013e3282c3a89e; FRIDMAN R, 1991, JNCI-J NATL CANCER I, V83, P769, DOI 10.1093/jnci/83.11.769; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; GRAFF JR, 1995, CANCER RES, V55, P5195; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hurtubise A, 2004, ANTI-CANCER DRUG, V15, P161, DOI 10.1097/01.cad.0000113334.52071.97; Imamichi Y, 2007, CELLS TISSUES ORGANS, V185, P180, DOI 10.1159/000101319; Ivascu A, 2007, INT J ONCOL, V31, P1403; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; KANE RE, 1995, DRUG METAB DISPOS, V23, P303; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Kleinman H K, 2001, Surg Oncol Clin N Am, V10, P329; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; KOCAREK TA, 1993, MOL PHARMACOL, V43, P328; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Maniotis AJ, 2005, AM J PATHOL, V166, P1187, DOI 10.1016/S0002-9440(10)62338-3; McCabe MT, 2006, CANCER RES, V66, P385, DOI 10.1158/0008-5472.CAN-05-2020; Moiseeva EP, 2007, MOL CANCER THER, V6, P3071, DOI 10.1158/1535-7163.MCT-07-0117; MONAGHAN P, 1983, P NATL ACAD SCI-BIOL, V80, P3344, DOI 10.1073/pnas.80.11.3344; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olave IA, 2007, J BIOL CHEM, V282, P853, DOI 10.1074/jbc.M610404200; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PARRY G, 1987, J CELL BIOL, V105, P2043, DOI 10.1083/jcb.105.5.2043; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pishvaian MJ, 1999, CANCER RES, V59, P947; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Rahnama F, 2009, ENDOCRINOLOGY, V150, P1466, DOI 10.1210/en.2008-1142; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Sandal T, 2007, AM J PATHOL, V170, P1739, DOI 10.2353/ajpath.2007.060922; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; SCHUETZ EG, 1988, J CELL PHYSIOL, V134, P309, DOI 10.1002/jcp.1041340302; SEELY KA, 1991, J CELL PHYSIOL, V146, P117, DOI 10.1002/jcp.1041460116; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Thomlinson R H, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P105; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; WARBURTON MJ, 1982, J HISTOCHEM CYTOCHEM, V30, P667, DOI 10.1177/30.7.6179984; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wilsbacher Julie L, 2006, Cell Commun Signal, V4, P5, DOI 10.1186/1478-811X-4-5; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Yates C, 2007, ADV CANCER RES, V97, P225, DOI 10.1016/S0065-230X(06)97010-9; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	84	38	39	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3884	3895		10.1096/fj.08-128702	http://dx.doi.org/10.1096/fj.08-128702			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19635753				2022-12-25	WOS:000271272500024
J	Karlsson, C; Eliasson, M; Olin, AI; Morgelin, M; Karlsson, A; Malmsten, M; Egesten, A; Frick, IM				Karlsson, Christofer; Eliasson, Mette; Olin, Anders I.; Morgelin, Matthias; Karlsson, Anna; Malmsten, Martin; Egesten, Arne; Frick, Inga-Maria			SufA of the Opportunistic Pathogen Finegoldia magna Modulates Actions of the Antibacterial Chemokine MIG/CXCL9, Promoting Bacterial Survival during Epithelial Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO ACTIVITY; STREPTOCOCCUS-PYOGENES; ANAEROBIC COCCI; INNATE IMMUNITY; M1 PROTEIN; MIG; RECEPTOR; CELLS; OLIGOMERIZATION; ACTIVATION	The anaerobic bacterium Finegoldia magna is part of the human commensal microbiota, but is also an important opportunistic pathogen. This bacterium expresses a subtilisin-like serine proteinase, SufA, which partially degrade the antibacterial chemokine MIG/CXCL9. Here, we show that MIG/CXCL9 is produced by human keratinocytes in response to inflammatory stimuli. In contrast to the virulent human pathogen Streptococcus pyogenes, the presence of F. magna had no enhancing effect on the MIG/CXCL9 expression by keratinocytes, suggesting poor detection of the latter by pathogen-recognition receptors. When MIG/CXCL9 was exposed to SufA-expressing F. magna, the molecule was processed into several smaller fragments. Analysis by mass spectrometry showed that SufA cleaves MIG/CXCL9 at several sites in the COOH-terminal region of the molecule. At equimolar concentrations, SufA-generated MIG/CXCL9 fragments were not bactericidal against F. magna, but retained their ability to kill S. pyogenes. Moreover, the SufA-generated MIG/CXCL9 fragments were capable of activating the angiostasis-mediating CXCR3 receptor, which is expressed on endothelial cells, in an order of magnitude similar to that of intact MIG/CXCL9. F. magna expresses a surface protein called FAF that is released from the bacterial surface by SufA. Soluble FAF was found to bind and inactivate the antibacterial activity of MIG/CXCL9, thereby further potentially promoting the survival of F. magna. The findings suggest that SufA modulation of the inflammatory response could be a mechanism playing an important role in creating an ecologic niche for F. magna, decreasing antibacterial activity and suppressing angiogenesis, thus providing advantage in survival for this anaerobic opportunist compared with competing pathogens during inflammation.	[Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Karlsson, Anna] Univ Gothenburg, Dept Rheumatol & Inflammat Res, SE-41346 Gothenburg, Sweden; [Eliasson, Mette; Egesten, Arne] Lund Univ, Dept Clin Sci Lund, Div Resp Med, SE-22184 Lund, Sweden; [Karlsson, Christofer; Olin, Anders I.; Morgelin, Matthias; Frick, Inga-Maria] Lund Univ, Div Infect, SE-22184 Lund, Sweden	Uppsala University; University of Gothenburg; Lund University; Lund University	Frick, IM (corresponding author), BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	Inga-Maria.Frick@med.lu.se	Karlsson, Anna/A-4130-2012	Karlsson, Anna/0000-0001-6796-1154	Swedish Research Council [7480, 2007-2880, 621-2003-4022]; Swedish Heart and Lung Foundation; Medical Faculty; Foundations of Bergh, Bergvall, Crafoord, Ihre, Hedberg, Kock, O. E. and Edla Johansson, Marcus and Marianne Wallenberg, and Osterlund; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty; Foundations of Bergh, Bergvall, Crafoord, Ihre, Hedberg, Kock, O. E. and Edla Johansson, Marcus and Marianne Wallenberg, and Osterlund; Hansa Medical AB	This work was supported by grants from the Swedish Research Council (Projects 7480, 2007-2880, and 621-2003-4022), the Swedish Heart and Lung Foundation, the Medical Faculty at Lund University, the Foundations of Bergh, Bergvall, Crafoord, Ihre, Hedberg, Kock, O. E. and Edla Johansson, Marcus and Marianne Wallenberg, and Osterlund, and Hansa Medical AB.	Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; CARLEMALM E, 1989, TECHNIQUES IMMUNOCYT; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Eliasson M, 2007, MICROB PATHOGENESIS, V43, P224, DOI 10.1016/j.micpath.2007.06.007; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Frick IM, 2008, MOL MICROBIOL, V70, P695, DOI 10.1111/j.1365-2958.2008.06439.x; Goebeler M, 1998, J PATHOL, V184, P89, DOI 10.1002/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z; Higaki S, 2003, DRUG EXP CLIN RES, V29, P153; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karlsson C, 2007, MICROBIOL-SGM, V153, P4208, DOI 10.1099/mic.0.2007/010322-0; Karlsson C, 2009, MICROBIOL-SGM, V155, P238, DOI 10.1099/mic.0.021311-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Malkowski MG, 1997, J MOL BIOL, V266, P367, DOI 10.1006/jmbi.1996.0796; Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81, DOI 10.1128/CMR.11.1.81; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pahlman LI, 2008, CELL MICROBIOL, V10, P404, DOI 10.1111/j.1462-5822.2007.01053.x; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Sauty A, 1999, J IMMUNOL, V162, P3549; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Stephens P, 2003, BRIT J DERMATOL, V148, P456, DOI 10.1046/j.1365-2133.2003.05232.x; Stone, 1998, EFFICIENT LIB PARALL; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005	36	25	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29499	29508		10.1074/jbc.M109.025957	http://dx.doi.org/10.1074/jbc.M109.025957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19628464	Green Published, hybrid			2022-12-25	WOS:000270896800032
J	Pikkarainen, S; Kennedy, RA; Marshall, AK; Tham, EL; Lay, K; Kriz, TA; Handa, BS; Clerk, A; Sugden, PH				Pikkarainen, Sampsa; Kennedy, Robert A.; Marshall, Andrew K.; Tham, El Li; Lay, Kenneth; Kriz, Thomas A.; Handa, Balvinder S.; Clerk, Angela; Sugden, Peter H.			Regulation of Expression of the Rat Orthologue of Mouse Double Minute 2 (MDM2) by H2O2-induced Oxidative Stress in Neonatal Rat Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; OPEN READING FRAMES; TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; GENE-EXPRESSION; VENTRICULAR CARDIOMYOCYTES; CELL-PROLIFERATION; SIGNALING PATHWAYS; UBIQUITIN LIGASE; JUN EXPRESSION	The Mdm2 ubiquitin ligase is an important regulator of p53 abundance and p53-dependent apoptosis. Mdm2 expression is frequently regulated by a p53 Mdm2 autoregulatory loop whereby p53 stimulates Mdm2 expression and hence its own degradation. Although extensively studied in cell lines, relatively little is known about Mdm2 expression in heart where oxidative stress (exacerbated during ischemia-reperfusion) is an important pro-apoptotic stimulus. We demonstrate that Mdm2 transcript and protein expression are induced by oxidative stress (0.2 mM H2O2) in neonatal rat cardiac myocytes. In other cells, constitutive Mdm2 expression is regulated by the P1 promoter (5' to exon 1), with inducible expression regulated by the P2 promoter (in intron 1). In myocytes, H2O2 increased Mdm2 expression from the P2 promoter, which contains two p53-response elements (REs), one AP-1 RE, and two Ets REs. H2O2 did not detectably increase expression of p53 mRNA or protein but did increase expression of several AP-1 transcription factors. H2O2 increased binding of AP-1 proteins (c-Jun, JunB, JunD, c-Fos, FosB, and Fra-1) to an Mdm2 AP-1 oligodeoxynucleotide probe, and chromatin immunoprecipitation assays showed it increased binding of c-Jun or JunB to the P2 AP-1 RE. Finally, antisense oligonucleotide-mediated reduction of H2O2-induced Mdm2 expression increased caspase 3 activation. Thus, increased Mdm2 expression is associated with transactivation at the P2 AP-1 RE (rather than the p53 or Ets REs), and Mdm2 induction potentially represents a cardioprotective response to oxidative stress.	[Pikkarainen, Sampsa; Kennedy, Robert A.; Marshall, Andrew K.; Tham, El Li; Lay, Kenneth; Kriz, Thomas A.; Handa, Balvinder S.; Clerk, Angela; Sugden, Peter H.] Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div, London SW7 2AZ, England	Imperial College London	Sugden, PH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div, Flowers Bldg,4th Floor,Armstrong Rd, London SW7 2AZ, England.	p.sugden@imperial.ac.uk		Clerk, Angela/0000-0002-5658-0708	Sigrid Juse lius Foundation; Finnish Foundation for Cardiovascular Research; Instrumentarium Foundation; Aarne and Aili Turunen Foundation; Maud Kuistila Foundation; Paavo Nurmi Foundation; Fondation Leducq	Sigrid Juse lius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Instrumentarium Foundation; Aarne and Aili Turunen Foundation; Maud Kuistila Foundation; Paavo Nurmi Foundation; Fondation Leducq(Leducq Foundation)	Supported by fellowships from the Sigrid Juse lius Foundation, the Finnish Foundation for Cardiovascular Research, the Instrumentarium Foundation, the Aarne and Aili Turunen Foundation, the Maud Kuistila Foundation, and the Paavo Nurmi Foundation.; Supported in part by the Fondation Leducq.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; BOGOYEVITCH MA, 1995, BIOCHEM J, V309, P437, DOI 10.1042/bj3090437; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; Clerk A, 2002, BIOCHEM J, V368, P101, DOI 10.1042/BJ20021083; CLERK A, 1994, J BIOL CHEM, V269, P32848; Clerk A, 1998, BIOCHEM J, V333, P581, DOI 10.1042/bj3330581; Clerk A, 2007, PHYSIOL GENOMICS, V29, P118, DOI 10.1152/physiolgenomics.00168.2006; Cook SA, 1999, CIRC RES, V85, P940; Cullingford TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r32; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Harrison JG, 2004, BBA-MOL CELL RES, V1644, P17, DOI 10.1016/j.bbamcr.2003.10.008; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; HROMAS R, 1991, J BIOL CHEM, V266, P14183; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jin XP, 2003, J BIOL CHEM, V278, P25716, DOI 10.1074/jbc.M300316200; Karin M, 2001, IUBMB LIFE, V52, P17; Kawamura T, 2004, BIOCHEM BIOPH RES CO, V315, P733, DOI 10.1016/j.bbrc.2004.01.105; Kemp TJ, 2003, BIOCHEM BIOPH RES CO, V307, P416, DOI 10.1016/S0006-291X(03)01215-4; Leri A, 1999, AM J PATHOL, V154, P567, DOI 10.1016/S0002-9440(10)65302-3; Leri A, 1999, CIRC RES, V84, P752; Long X, 2007, MOL CELL BIOCHEM, V303, P167, DOI 10.1007/s11010-007-9470-1; McNeill-Blue C, 2006, BRAIN RES, V1112, P1, DOI 10.1016/j.brainres.2006.07.024; Mendrysa SM, 2001, GENE, V264, P139, DOI 10.1016/S0378-1119(00)00589-8; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Peirce SK, 2009, INT J ONCOL, V34, P1395, DOI 10.3892/ijo_00000267; Phelps M, 2003, CANCER RES, V63, P2616; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Saucedo LJ, 1999, J BIOL CHEM, V274, P8161, DOI 10.1074/jbc.274.12.8161; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Sugden PH, 2006, ANTIOXID REDOX SIGN, V8, P2111, DOI 10.1089/ars.2006.8.2111; Suzuki K, 2001, J MOL CELL CARDIOL, V33, P983, DOI 10.1006/jmcc.2001.1364; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tortora G, 2000, INT J CANCER, V88, P804, DOI 10.1002/1097-0215(20001201)88:5<804::AID-IJC19>3.0.CO;2-Z; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Truong AHL, 2005, ONCOGENE, V24, P962, DOI 10.1038/sj.onc.1208323; Uberti D, 1999, MOL BRAIN RES, V65, P167, DOI 10.1016/S0169-328X(98)00339-8; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Yoneda K, 2003, J AM SOC NEPHROL, V14, pS284, DOI 10.1097/01.ASN.0000078023.30954.05	57	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27195	27210		10.1074/jbc.M109.037887	http://dx.doi.org/10.1074/jbc.M109.037887			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19638633	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000270232300020
J	Hatherley, D; Graham, SC; Harlos, K; Stuart, DI; Barclay, AN				Hatherley, Deborah; Graham, Stephen C.; Harlos, Karl; Stuart, David I.; Barclay, A. Neil			Structure of Signal-regulatory Protein alpha A LINK TO ANTIGEN RECEPTOR EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SUPERFAMILY; MAXIMUM-LIKELIHOOD; DIFFRACTION DATA; CELL; GLYCOPROTEIN; DOMAINS; CD47; CRYSTALLIZATION; GLYCOSYLATION; REFINEMENT	Signal-regulatory protein alpha (SIRP alpha) is a myeloid membrane receptor that interacts with the membrane protein CD47, a marker of self. We have solved the structure of the complete extracellular portion of SIRP alpha,comprising three immunoglobulin superfamily domains, by x-ray crystallography to 2.5 angstrom resolution. These data, together with previous data on the N-terminal domain and its ligand CD47 (possessing a single immunoglobulin superfamily domain), show that the CD47-SIRP alpha interaction will span a distance of around 14 nm between interacting cells, comparable with that of an immunological synapse. The N-terminal (V-set) domain mediates binding to CD47, and the two others are found to be constant (C1-set) domains. C1-set domains are restricted to proteins involved in vertebrate antigen recognition: T cell antigen receptors, immunoglobulins, major histocompatibility complex antigens, tapasin, and beta 2-microglobulin. The domains of SIRP alpha (domains 2 and 3) are structurally more similar to C1-set domains than any cell surface protein not involved in antigen recognition. This strengthens the suggestion from sequence analysis that SIRP is evolutionarily closely related to antigen recognition proteins.	[Graham, Stephen C.; Harlos, Karl; Stuart, David I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Graham, Stephen C.; Harlos, Karl; Stuart, David I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford Prot Prod Facil, Oxford OX3 7BN, England; [Hatherley, Deborah; Barclay, A. Neil] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Stuart, DI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk; neil.barclay@path.ox.ac.uk		Stuart, David/0000-0002-3426-4210; Graham, Stephen/0000-0003-4547-4034	Medical Research Council [G0400808]; Wellcome Trust [WT084194]; European Community [LSHG-CT-2006-031220]; MRC [G0400808, G0500365] Funding Source: UKRI; Medical Research Council [G0500365] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Grant G0400808 and Wellcome Trust Grant WT084194 (to A. N. B., D. H., K. H., D. I. S., and the Oxford Protein Production Facility). This is a contribution of the European Community project SPINE2-Complexes (LSHG-CT-2006-031220).	Afonine PV, 2005, CCP4 NEWSL, V42; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; DAVIS SJ, 1993, PROTEIN ENG, V6, P229, DOI 10.1093/protein/6.2.229; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Mayer WE, 2001, IMMUNOGENETICS, V53, P719, DOI 10.1007/s00251-001-0403-y; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Tronrud DE, 1996, J APPL CRYSTALLOGR, V29, P100, DOI 10.1107/S002188989501421X; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; van den Berg TK, 2004, TRENDS IMMUNOL, V25, P11, DOI 10.1016/j.it.2003.11.006; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6	40	25	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26613	26619		10.1074/jbc.M109.017566	http://dx.doi.org/10.1074/jbc.M109.017566			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19628875	Green Published, hybrid			2022-12-25	WOS:000269969600042
J	Fukuda, H; Takamura-Enya, T; Masuda, Y; Nohmi, T; Seki, C; Kamiya, K; Sugimura, T; Masutani, C; Hanaoka, F; Nakagama, H				Fukuda, Hirokazu; Takamura-Enya, Takeji; Masuda, Yuji; Nohmi, Takehiko; Seki, Chiho; Kamiya, Kenji; Sugimura, Takashi; Masutani, Chikahide; Hanaoka, Fumio; Nakagama, Hitoshi			Translesional DNA Synthesis through a C8-Guanyl Adduct of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro REV1 INSERTS dC OPPOSITE THE LESION, AND DNA POLYMERASE kappa POTENTIALLY CATALYZES EXTENSION REACTION FROM THE 3 '-dC TERMINUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST REV1 PROTEIN; HETEROCYCLIC AMINES; 2-AMINO-1-METHYL-6-PHENYLIMIDAZO<4,5-B>PYRIDINE PHIP; ESCHERICHIA-COLI; COOKED FOOD; IDENTIFICATION; MUTATIONS; RAT; MUTAGENESIS; CARCINOGEN	2-Amino-1-methyl-6-phenylimidazo[4,5-b] pyridine ( PhIP) is the most abundant heterocyclic amine in cooked foods, and is both mutagenic and carcinogenic. It has been suspected that the carcinogenicity of PhIP is derived from its ability to form DNA adducts, principally dG-C8-PhIP. To shed further light on the molecular mechanisms underlying the induction of mutations by PhIP, in vitro DNA synthesis analyses were carried out using a dG-C8-PhIP-modified oligonucleotide template. In this template, the dG-C8-PhIP adduct was introduced into the second G of the TCC GGG AAC sequence located in the 5' region. This represents one of the mutation hot spots in the rat Apc gene that is targeted by PhIP. Guanine deletions at this site in the Apc gene have been found to be preferentially induced by PhIP in rat colon tumors. DNA synthesis with A- or B-family DNA polymerases, such as Escherichia coli polymerase (pol) I and human pol delta, was completely blocked at the adducted guanine base. Translesional synthesis polymerases of the Y-family, pol eta, pol iota, pol kappa, and REV1, were also used for in vitro DNA synthesis analyses with the same templates. REV1, pol eta, and pol kappa were able to insert dCTP opposite dG-C8-PhIP, although the efficiencies for pol eta and pol kappa were low. pol kappa was also able to catalyze the extension reaction from the dC opposite dG-C8-PhIP, during which it often skipped over one dG of the triple dG sequence on the template. This slippage probably leads to the single dG base deletion in colon tumors.	[Fukuda, Hirokazu; Seki, Chiho; Sugimura, Takashi; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Biochem, Chuo Ku, Tokyo 1040045, Japan; [Takamura-Enya, Takeji] Kanagawa Inst Technol, Fac Engn, Dept Appl Chem, Kanagawa 2430292, Japan; [Masuda, Yuji; Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Minami Ku, Hiroshima 7348553, Japan; [Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan; [Masutani, Chikahide; Hanaoka, Fumio] Osaka Univ, Cellular Biol Lab, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	National Cancer Center - Japan; Kanagawa Institute Technology; Hiroshima University; National Institute of Health Sciences - Japan; Osaka University	Nakagama, H (corresponding author), Natl Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 1-1 Tsukiji 5, Tokyo 1040045, Japan.	hnakagam@ncc.go.jp	Masuda, Yuji/I-6315-2014; Takamura, Takeji/AAR-7391-2021; Masutani, Chikahide/I-6160-2014	Masuda, Yuji/0000-0002-6229-1988; Masutani, Chikahide/0000-0002-8600-8227	Kakenhi [19570144]	Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kakenhi Grant 19570144.	Choi JY, 2006, J BIOL CHEM, V281, P25297, DOI 10.1074/jbc.M605699200; Dashwood RH, 1998, CANCER RES, V58, P1127; ENDO H, 1994, CANCER RES, V54, P3745; Felton J. S., 2000, Food borne carcinogens: heterocyclic amines., P31; FELTON JS, 1991, MUTAT RES, V259, P205, DOI 10.1016/0165-1218(91)90118-6; FELTON JS, 1986, CARCINOGENESIS, V7, P1081, DOI 10.1093/carcin/7.7.1081; FRANDSEN H, 1992, CARCINOGENESIS, V13, P629, DOI 10.1093/carcin/13.4.629; Fukuda H, 1997, GENES CELLS, V2, P735, DOI 10.1046/j.1365-2443.1997.1580356.x; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HOLME JA, 1989, CARCINOGENESIS, V10, P1389, DOI 10.1093/carcin/10.8.1389; Imaida K, 1996, JPN J CANCER RES, V87, P1116, DOI 10.1111/j.1349-7006.1996.tb03120.x; ITO N, 1991, CARCINOGENESIS, V12, P1503, DOI 10.1093/carcin/12.8.1503; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; KAKIUCHI H, 1995, P NATL ACAD SCI USA, V92, P910, DOI 10.1073/pnas.92.3.910; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; LIN DX, 1992, CHEM RES TOXICOL, V5, P691, DOI 10.1021/tx00029a016; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lynch AM, 1998, MUTAGENESIS, V13, P601, DOI 10.1093/mutage/13.6.601; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Masuda Y, 2002, FEBS LETT, V520, P88, DOI 10.1016/S0014-5793(02)02773-4; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; MORGENTHALER PML, 1995, CARCINOGENESIS, V16, P713, DOI 10.1093/carcin/16.4.713; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Nagao M, 1997, MUTAT RES-FUND MOL M, V376, P161, DOI 10.1016/S0027-5107(97)00039-0; Nagao M., 2000, Food borne carcinogens: heterocyclic amines., P163; Nagao M, 1999, MUTAT RES-FUND MOL M, V431, P3, DOI 10.1016/S0027-5107(99)00154-2; Nakagama H, 2002, MUTAT RES-FUND MOL M, V506, P137, DOI 10.1016/S0027-5107(02)00160-4; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; NIIMI N, 2009, BIOCHEMISTRY-US, V48; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; OHGAKI H, 1991, MUTAT RES, V259, P399, DOI 10.1016/0165-1218(91)90130-E; Okochi E, 1999, CARCINOGENESIS, V20, P1933, DOI 10.1093/carcin/20.10.1933; Okonogi H, 1997, MUTAT RES-GEN TOX EN, V395, P93, DOI 10.1016/S1383-5718(97)00146-0; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sambrook J., 2002, MOL CLONING LAB MANU; SCHUT HAJ, 1992, CANCER LETT, V67, P117, DOI 10.1016/0304-3835(92)90134-H; Schut HAJ, 1999, CARCINOGENESIS, V20, P353, DOI 10.1093/carcin/20.3.353; SNYDERWINE EG, 1993, CARCINOGENESIS, V14, P1389, DOI 10.1093/carcin/14.7.1389; Sugimoto T., 2000, FOOD BORNE CARCINOGE, P1; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821; Takamura-Enya T, 2006, CHEM RES TOXICOL, V19, P770, DOI 10.1021/tx050296s; YadollahiFarsani M, 1996, CARCINOGENESIS, V17, P617, DOI 10.1093/carcin/17.4.617	48	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25585	25592		10.1074/jbc.M109.037259	http://dx.doi.org/10.1074/jbc.M109.037259			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628463	hybrid, Green Published			2022-12-25	WOS:000269738000016
J	Khotskaya, YB; Dai, YM; Ritchie, JP; MacLeod, V; Yang, Y; Zinn, K; Sanderson, RD				Khotskaya, Yekaterina B.; Dai, Yuemeng; Ritchie, Joseph P.; MacLeod, Veronica; Yang, Yang; Zinn, Kurt; Sanderson, Ralph D.			Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BONE-MARROW MICROENVIRONMENT; MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODY; SOLUBLE SYNDECAN-1; CELL-SURFACE; CANCER-CELLS; ROUND-TABLE; ANGIOGENESIS; STIMULATION	Myeloma tumors are characterized by high expression of syndecan-1 (CD138), a heparan sulfate proteoglycan present on the myeloma cell surface and shed into the tumor microenvironment. High levels of shed syndecan-1 in the serum of patients are an indicator of poor prognosis, and numerous studies have implicated syndecan-1 in promoting the growth and progression of this cancer. In the present study we directly addressed the role of syndecan-1 in myeloma by stable knockdown of its expression using RNA interference. Knockdown cells that were negative for syndecan-1 expression became apoptotic and failed to grow in vitro. Knockdown cells expressing syndecan-1 at similar to 28% or similar to 14% of normal levels survived and grew well in vitro but formed fewer and much smaller subcutaneous tumors in mice compared with tumors formed by cells expressing normal levels of syndecan-1. When injected intravenously into mice (experimental metastasis model), knockdown cells formed very few metastases as compared with controls. This indicates that syndecan-1 may be required for the establishment of multi-focal metastasis, a hallmark of this cancer. One mechanism of syndecan-1 action occurs via stimulation of tumor angiogenesis because tumors formed by knockdown cells exhibited diminished levels of vascular endothelial growth factor and impaired development of blood vessels. Together, these data indicate that the effects of syndecan-1 on myeloma survival, growth, and dissemination are due, at least in part, to its positive regulation of tumor-host interactions that generate an environment capable of sustaining robust tumor growth.	[Khotskaya, Yekaterina B.; Ritchie, Joseph P.; Yang, Yang; Zinn, Kurt; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Zinn, Kurt] Univ Alabama, Dept Radiol, Birmingham, AL 35294 USA; [Zinn, Kurt] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Ritchie, Joseph P.; Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Metab Bone Dis, Birmingham, AL 35294 USA; [Dai, Yuemeng; MacLeod, Veronica] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Dai, Yuemeng] Univ Arkansas Med Sci, Dept Otolaryngol, Little Rock, AR 72205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Sanderson, RD (corresponding author), Univ Alabama, Dept Pathol, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu		Zinn, Kurt/0000-0001-7463-4741	National Institutes of Health [CA055819]; Comprehensive Cancer Center [P30CA013148]; University of Alabama at Birmingham Multi-Purpose Arthritis and Musculoskeletal Center [P30AR48311]; Institutional Training Grant [T32-AR047512]; NATIONAL CANCER INSTITUTE [P01CA055819, P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR047512, P30AR048311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center; University of Alabama at Birmingham Multi-Purpose Arthritis and Musculoskeletal Center; Institutional Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA055819 (to R. D. S.). This work was also supported by Comprehensive Cancer Center Core Support Grant P30CA013148 (to R. D. S.), University of Alabama at Birmingham Multi-Purpose Arthritis and Musculoskeletal Center Grant P30AR48311 (Flow Cytometry Core), and Institutional Training Grant Predoctoral Grant T32-AR047512 (to J. P. R.).	Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Anderson KC, 2002, MOL CANCER THER, V1, P1361; Anderson KC, 2007, EXP HEMATOL, V35, P155, DOI 10.1016/j.exphem.2007.01.024; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Barlogie B, 2006, WILLIAMS HEMATOLOGY, P1501; Bartlett AH, 2007, MOL CELLS, V24, P153; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Borset M, 2000, BLOOD, V96, P2528; Broek IV, 2008, CLIN EXP METASTAS, V25, P325, DOI 10.1007/s10585-007-9108-4; Caers J, 2008, B CANCER, V95, P301, DOI 10.1684/bdc.2008.0600; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dalton W, 2006, CLIN CANCER RES, V12, P6603, DOI 10.1158/1078-0432.CCR-06-1489; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Jourdan M, 1998, BRIT J HAEMATOL, V100, P637, DOI 10.1046/j.1365-2141.1998.00623.x; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Maeda T, 2004, CANCER RES, V64, P612, DOI 10.1158/0008-5472.CAN-03-2439; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Ribatti D, 2006, ONCOGENE, V25, P4257, DOI 10.1038/sj.onc.1209456; Ribatti D, 2008, GENES NUTR, V3, P29, DOI 10.1007/s12263-008-0076-3; Roodman GD, 2002, J BONE MINER RES, V17, P1921, DOI 10.1359/jbmr.2002.17.11.1921; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Vacca A, 2003, HAEMATOLOGICA, V88, P176; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Witzig TE, 1996, CYTOMETRY, V26, P113, DOI 10.1002/(SICI)1097-0320(19960615)26:2<113::AID-CYTO3>3.0.CO;2-H; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200	39	72	72	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26085	26095		10.1074/jbc.M109.018473	http://dx.doi.org/10.1074/jbc.M109.018473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596856	hybrid, Green Published			2022-12-25	WOS:000269738000064
J	Shi, LH; Ko, ML; Ko, GYP				Shi, Liheng; Ko, Michael L.; Ko, Gladys Y. -P.			Rhythmic Expression of MicroRNA-26a Regulates the L-type Voltage-gated Calcium Channel alpha 1C Subunit in Chicken Cone Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYLALKYLAMINE N-ACETYLTRANSFERASE; MAMMALIAN CIRCADIAN CLOCK; MELATONIN SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; PINEAL-GLAND; C-ELEGANS; CAMP; KINASE; RETINA	MicroRNAs (miRNAs) modulate gene expression by degrading or inhibiting translation of messenger RNAs (mRNAs). Here, we demonstrated that chicken microRNA-26a (gga-mir-26a) is a key posttranscriptional regulator of photoreceptor L-type voltage-gated calcium channel alpha 1C subunit (L-VGCC alpha 1C) expression, and its own expression has a diurnal rhythm, thereby explaining the rhythmic nature of L-VGCC alpha 1Cs. Circadian oscillators in retinal photoreceptors provide a mechanism that allows photoreceptors to anticipate daily illumination changes. In photoreceptors, L-VGCC activities are under circadian control, which are higher at night and lower during the day. Interestingly, the mRNA level of VGCC alpha 1D oscillates, but those for VGCC alpha 1C do not. However, the protein expression of both VGCC alpha 1C and alpha 1D are higher at night in cone photoreceptors. The underlying mechanism regulating L-VGCC alpha 1C protein expression was not clear until now. In vitro targeting reporter assays verified that gga-mir-26a specifically targeted the L-VGCC alpha 1C 3'-untranslated region, and gga-mir-26a expression in the retina peaked during the day. After transfection with gga-mir-26a, L-VGCC alpha 1C protein expression and L-VGCC current density decreased. Therefore, the rhythmic expression of gga-mir-26a regulated the protein expression of the L-VGCC alpha 1C subunit. Additionally, both CLOCK (circadian locomoter output cycles kaput) and CREB (cAMP-response element-binding protein-1) activated gga-mir-26a expression in vitro. This result implies that gga-mir-26a might be a downstream target of circadian oscillators. Our work has uncovered new functional roles for miRNAs in the regulation of circadian rhythms in cone photoreceptors. Circadian regulated miRNAs could serve as the link between the core oscillator and output signaling that further govern biological functions.	[Shi, Liheng; Ko, Michael L.; Ko, Gladys Y. -P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Ko, GYP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, 4458 TAMU, College Stn, TX 77843 USA.	gko@cvm.tamu.edu			National Institutes of Health [RO1EY017452]; Department of Veterinary Integrative Bioscience programmatic development minigrant; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004917, P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterinary Integrative Bioscience programmatic development minigrant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1EY017452 ( to G. K.). This work was also supported by a Department of Veterinary Integrative Bioscience programmatic development minigrant ( to G. K.).	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Altamirano J, 2007, CIRC RES, V101, P590, DOI 10.1161/CIRCRESAHA.107.152322; Bailey MJ, 2004, J BIOL CHEM, V279, P52247, DOI 10.1074/jbc.M405679200; Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bengert P, 2005, BRIEF BIOINFORM, V6, P72, DOI 10.1093/bib/6.1.72; Berger EM, 2005, IN VITRO CELL DEV-AN, V41, P12; Bernard M, 1997, J NEUROCHEM, V68, P213; Boden G, 1996, AM J PHYSIOL-ENDOC M, V271, pE246, DOI 10.1152/ajpendo.1996.271.2.E246; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; Chae KS, 2007, INVEST OPHTH VIS SCI, V48, P901, DOI 10.1167/iovs.06-0824; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HYM, 2007, CELL CYCLE, V6, P3034, DOI 10.4161/cc.6.24.5106; Chong NW, 2000, J BIOL CHEM, V275, P32991, DOI 10.1074/jbc.M005671200; Chong NW, 2003, J NEUROCHEM, V85, P851, DOI 10.1046/j.1471-4159.2003.01723.x; Dijk DJ, 2005, J BIOL RHYTHM, V20, P279, DOI 10.1177/0748730405278292; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Eide EJ, 2005, METHOD ENZYMOL, V393, P408, DOI 10.1016/S0076-6879(05)93019-X; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Huang KM, 2008, MAMM GENOME, V19, P510, DOI 10.1007/s00335-008-9127-8; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Ivanova TN, 2003, BRAIN RES, V973, P56, DOI 10.1016/S0006-8993(03)02540-X; Ivanova TN, 2003, BRAIN RES, V991, P96, DOI 10.1016/j.brainres.2003.08.003; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Ko GYP, 2003, J NEUROSCI, V23, P3145; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Ko ML, 2009, J NEUROCHEM, V108, P1607, DOI 10.1111/j.1471-4159.2009.05931.x; Kuss AW, 2008, CURR NEUROL NEUROSCI, V8, P190, DOI 10.1007/s11910-008-0031-0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Mao DL, 1998, MOL ENDOCRINOL, V12, P492, DOI 10.1210/me.12.4.492; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; O'Neill JS, 2007, CURR BIOL, V17, pR760, DOI 10.1016/j.cub.2007.07.001; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; REME C, 1986, BRAIN RES, V369, P356, DOI 10.1016/0006-8993(86)90550-0; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Ryan D, 2006, MOL VIS, V12, P1175; Sambrook J, 2001, MOL CLONING LAB MANU; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Spiwoks-Becker I, 2004, EUR J NEUROSCI, V19, P1559, DOI 10.1111/j.1460-9568.2004.03198.x; TOHSE N, 1992, CIRC RES, V71, P376, DOI 10.1161/01.RES.71.2.376; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Xu SP, 2009, CHINESE J STRUC CHEM, V28, P87; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200	69	33	37	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25791	25803		10.1074/jbc.M109.033993	http://dx.doi.org/10.1074/jbc.M109.033993			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608742	hybrid, Green Published			2022-12-25	WOS:000269738000037
J	Spiering, D; Schmolke, M; Ohnesorge, N; Schmidt, M; Goebeler, M; Wegener, J; Wixler, V; Ludwig, S				Spiering, Desiree; Schmolke, Mirco; Ohnesorge, Nils; Schmidt, Marc; Goebeler, Matthias; Wegener, Joachim; Wixler, Viktor; Ludwig, Stephan			MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; ADHESION KINASE; ERK5; MICE; P130(CAS); BMK1/ERK5; ACTIN; TRANSCRIPTION	The formation of new blood vessels from pre-existing ones requires highly coordinated restructuring of endothelial cells (EC) and the surrounding extracellular matrix. Directed EC migration is a central step in this process and depends on cellular signaling cascades that initiate and control the structural rearrangements. On the basis of earlier findings that ERK5 deficiency in mouse EC results in massive defects in vessel architecture, we focused on the impact of the MEK5/ERK5 signaling pathway on EC migration. Using a retroviral gene transfer approach, we found that constitutive activation of MEK5/ERK5 signaling strongly inhibits EC migration and results in massive morphological changes. The area covered by spread EC was dramatically enlarged, accompanied by an increase in focal contacts and altered organization of actin filaments. Consequently, cells were more rigid and show reduced motility. This phenotype was most likely based on decreased focal contact turnover caused by reduced expression of p130Cas, a key player in directed cell migration. We demonstrate for the first time that ERK5 signaling not only is involved in EC survival and stress response but also controls migration and morphology of EC.	[Wixler, Viktor; Ludwig, Stephan] Univ Klinikum Muenster, IMV, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Wixler, Viktor; Ludwig, Stephan] Univ Klinikum Muenster, Interdisciplinary Ctr Med Res IZKF, D-48149 Munster, Germany; [Ohnesorge, Nils; Schmidt, Marc; Goebeler, Matthias] Univ Heidelberg, Dept Dermatol, Univ Med Ctr Mannheim, D-68167 Mannheim, Germany; [Ohnesorge, Nils; Schmidt, Marc; Goebeler, Matthias] Univ Giessen, Dept Dermatol, D-35392 Giessen, Germany; [Wegener, Joachim] Univ Regensburg, Inst Analyt Chem, Chemo & Biosensors Grp, D-93040 Regensburg, Germany	University of Munster; University of Munster; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; University of Regensburg	Ludwig, S (corresponding author), Univ Klinikum Muenster, IMV, Ctr Mol Biol Inflammat ZMBE, von Esmarch Str 56, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Wegener, Joachim/AAR-3641-2020; Schmolke, Mirco/AAI-9081-2020; Schmidt, Marc/E-8821-2010; Goebeler, Matthias/F-7118-2013; Wegener, Joachim/A-1234-2011; Goebeler, Matthias/P-3612-2019	Schmolke, Mirco/0000-0002-2491-3029; Schmidt, Marc/0000-0002-8643-1615; Ludwig, Stephan/0000-0003-4490-3052				Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; GIAEVER I, 1986, IEEE T BIO-MED ENG, V33, P242, DOI 10.1109/TBME.1986.325896; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Kaneda T, 2008, CANCER LETT, V270, P354, DOI 10.1016/j.canlet.2008.05.042; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lindemann D, 1997, MOL MED, V3, P466, DOI 10.1007/BF03401693; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauriz JL, 2008, J PHARM SCI-US, V97, P4129, DOI 10.1002/jps.21286; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schramp M, 2008, J CELL BIOL, V181, P1195, DOI 10.1083/jcb.200801078; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Villa-Moruzzi E, 2007, BIOCHEM J, V408, P7, DOI 10.1042/BJ20070058; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	37	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24972	24980		10.1074/jbc.M109.042911	http://dx.doi.org/10.1074/jbc.M109.042911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605361	Green Published, hybrid			2022-12-25	WOS:000269734000032
J	Goker, M; Garcia-Blazquez, G; Voglmayr, H; Telleria, MT; Martin, MP				Goeker, Markus; Garcia-Blazquez, Gema; Voglmayr, Hermann; Telleria, M. Teresa; Martin, Maria P.			Molecular Taxonomy of Phytopathogenic Fungi: A Case Study in Peronospora	PLOS ONE			English	Article							DOWNY MILDEW PATHOGENS; PHYLOGENETIC ANALYSIS; SPECIES DELIMITATION; RE-CONSIDERATION; DNA; SEQUENCES; RDNA; HYALOPERONOSPORA; IDENTIFICATION; VARIABILITY	Background: Inappropriate taxon definitions may have severe consequences in many areas. For instance, biologically sensible species delimitation of plant pathogens is crucial for measures such as plant protection or biological control and for comparative studies involving model organisms. However, delimiting species is challenging in the case of organisms for which often only molecular data are available, such as prokaryotes, fungi, and many unicellular eukaryotes. Even in the case of organisms with well-established morphological characteristics, molecular taxonomy is often necessary to emend current taxonomic concepts and to analyze DNA sequences directly sampled from the environment. Typically, for this purpose clustering approaches to delineate molecular operational taxonomic units have been applied using arbitrary choices regarding the distance threshold values, and the clustering algorithms. Methodology: Here, we report on a clustering optimization method to establish a molecular taxonomy of Peronospora based on ITS nrDNA sequences. Peronospora is the largest genus within the downy mildews, which are obligate parasites of higher plants, and includes various economically important pathogens. The method determines the distance function and clustering setting that result in an optimal agreement with selected reference data. Optimization was based on both taxonomy-based and host-based reference information, yielding the same outcome. Resampling and permutation methods indicate that the method is robust regarding taxon sampling and errors in the reference data. Tests with newly obtained ITS sequences demonstrate the use of the re-classified dataset in molecular identification of downy mildews. Conclusions: A corrected taxonomy is provided for all Peronospora ITS sequences contained in public databases. Clustering optimization appears to be broadly applicable in automated, sequence-based taxonomy. The method connects traditional and modern taxonomic disciplines by specifically addressing the issue of how to optimally account for both traditional species concepts and genetic divergence.			Goker, M (corresponding author), Univ Tubingen, Tubingen, Germany.	peronospora@goeker.org	Telleria, M. Teresa/H-4928-2015; Voglmayr, Hermann/B-1484-2013; Martín, María/HDL-9512-2022; Martín, María/H-8069-2012; Göker, Markus/AAX-6258-2021	Telleria, M. Teresa/0000-0002-9876-6914; Voglmayr, Hermann/0000-0001-7666-993X; Martín, María/0000-0002-1235-4418; Göker, Markus/0000-0002-5144-6200				Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Bary De, 1863, ANN SCI NAT BOT BIOL, V20, P5; Belbahri L, 2005, MYCOL RES, V109, P1276, DOI 10.1017/S0953756205003928; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Choi YJ, 2005, MYCOL RES, V109, P841, DOI 10.1017/S0953756205002534; Choi YJ, 2003, MYCOL RES, V107, P1314, DOI 10.1017/S0953756203008578; Choi YJ, 2008, MYCOPATHOLOGIA, V165, P155, DOI 10.1007/s11046-007-9087-7; Choi YJ, 2007, MYCOL RES, V111, P381, DOI 10.1016/j.mycres.2007.02.003; Cunnington JH, 2006, NOVA HEDWIGIA, V82, P23, DOI 10.1127/0029-5035/2006/0082-0023; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dick MW, 2001, STRAMINIPILOUS FUNGI; Endo Y, 2008, SYST BOT, V33, P356, DOI 10.1600/036364408784571536; ESTABROOK GF, 1966, J THEOR BIOL, V12, P297, DOI 10.1016/0022-5193(66)90144-5; Farris J.S., 1983, Advances in Cladistics, V2, P7; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Garcia-Blazquez G, 2008, MYCOL RES, V112, P502, DOI 10.1016/j.mycres.2007.10.007; GAUMANN E, 1923, BEITR KRYPTOGAMENFL, V5, P1; GAUMANN E, 1918, BOT ZENTRALBLATT S, V35, P395; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Goker M., 2004, Mycological Progress, V3, P83, DOI 10.1007/s11557-006-0079-7; Goker M, 2003, CAN J BOT, V81, P672, DOI [10.1139/b03-066, 10.1139/B03-066]; Gustavsson A., 1959, OPERA BOT, V3, P1; Hall GS, 1996, PLANT PATHOL, V45, P1009, DOI 10.1046/j.1365-3059.1996.d01-191.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Kemler M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-35; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kress WJ, 2008, BIOTROPICA, V40, P405, DOI 10.1111/j.1744-7429.2008.00426.x; Landa BB, 2007, PHYTOPATHOLOGY, V97, P1380, DOI 10.1094/PHYTO-97-11-1380; LANYON SM, 1985, SYST ZOOL, V34, P397, DOI 10.2307/2413204; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Lee MSY, 2001, TRENDS ECOL EVOL, V16, P681, DOI 10.1016/S0169-5347(01)02313-8; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Linnen CR, 2008, SYST BIOL, V57, P876, DOI 10.1080/10635150802580949; Martin MP, 2000, LICHENOLOGIST, V32, P189, DOI 10.1006/lich.1999.0254; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SAVULESCU TR, 1948, SVDOWIA, V2, P255; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sokal R., 1958, U KANSAS SCI B, V38, P1409; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; Stamatakis A., 2006, P 20 INT PAR DISTR P, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Voglmayr H, 2003, MYCOL RES, V107, P1132, DOI 10.1017/S0953756203008438; Voglmayr H, 2004, MYCOL RES, V108, P1011, DOI 10.1017/S0953756204000954; Voglmayr H, 2008, MYCOL RES, V112, P487, DOI 10.1016/j.mycres.2007.10.009; Voglmayr H, 2006, MYCOL RES, V110, P633, DOI 10.1016/j.mycres.2006.03.005; White T., 1990, PCR PROTOCOLS GUIDE, P315; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wubet T, 2006, MYCOL RES, V110, P1059, DOI 10.1016/j.mycres.2006.04.005; YERKES WD, 1959, PHYTOPATHOLOGY, V49, P499; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982	71	130	136	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6319	10.1371/journal.pone.0006319	http://dx.doi.org/10.1371/journal.pone.0006319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641601	Green Published, gold			2022-12-25	WOS:000268494500003
J	Jittimanee, SX; Nateniyom, S; Kittikraisak, W; Burapat, C; Akksilp, S; Chumpathat, N; Sirinak, C; Sattayawuthipong, W; Varma, JK				Jittimanee, Sirinapha X.; Nateniyom, Sriprapa; Kittikraisak, Wanitchaya; Burapat, Channawong; Akksilp, Somsak; Chumpathat, Nopphanath; Sirinak, Chawin; Sattayawuthipong, Wanchai; Varma, Jay K.			Social Stigma and Knowledge of Tuberculosis and HIV among Patients with Both Diseases in Thailand	PLOS ONE			English	Article							TB PATIENTS; SOUTHERN THAILAND; IMPACT; INFECTION; HIV/AIDS; OPPORTUNITIES; BEHAVIOR; HAART; NORTH; RISK	Introduction: Disease-related stigma and knowledge are believed to be associated with patients' willingness to seek treatment and adherence to treatment. HIV-associated tuberculosis (TB) presents unique challenges, because TB and HIV are both medically complex and stigmatizing diseases. In Thailand, we assessed knowledge and beliefs about these diseases among HIV-infected TB patients. Methods: We prospectively interviewed and examined HIV-infected TB patients from three provinces and one national referral hospital in Thailand from 2005-2006. At the beginning of TB treatment, we asked patients standardized questions about TB stigma, TB knowledge, and HIV knowledge. Responses were grouped into scores; scores equal to or greater than the median score of study population were considered high. Multiple logistic regression analysis was used to identify factors associated with scores. Results: Of 769 patients enrolled, 500 (65%) reported high TB stigma, 177 (23%) low TB knowledge, and 379 (49%) low HIV knowledge. Patients reporting high TB stigma were more likely to have taken antibiotics before TB treatment, to have first visited a traditional healer or private provider, to not know that monogamy can reduce the risk of acquiring HIV infection, and to have been hospitalized at enrollment. Patients with low TB knowledge were more likely to have severe TB disease, to be hospitalized at enrollment, to be treated at the national infectious diseases referral hospital, and to have low HIV knowledge. Patients with low HIV knowledge were more likely to know a TB patient and to have low TB knowledge. Discussion: We found that stigma and low disease-specific knowledge were common among HIV-infected TB patients and associated with similar factors. Further research is needed to determine whether reducing stigma and increasing TB and HIV knowledge among the general community and patients reduces diagnostic delay and improves patient outcomes.			Jittimanee, SX (corresponding author), Thailand Minist Publ Hlth, Nonthaburi, Thailand.	sxj47@yahoo.com						Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Demissie M, 2003, SOC SCI MED, V56, P2009, DOI 10.1016/S0277-9536(02)00182-X; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Freudenberg N, 2006, AM J PUBLIC HEALTH, V96, P424, DOI 10.2105/AJPH.2005.063511; Gebrekristos HT, 2005, AIDS CARE, V17, P767, DOI 10.1080/09540120412331336661; Harries AD, 2004, TB HIV CLIN MANUAL; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Macq J, 2006, Psychol Health Med, V11, P346, DOI 10.1080/13548500600595277; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; Ngamvithayapong J, 2000, AIDS, V14, P1413, DOI 10.1097/00002030-200007070-00015; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sengupta S, 2006, INT J TUBERC LUNG D, V10, P1008; Todd CS, 2007, SEX TRANSM DIS, V34, P878, DOI 10.1097/OLQ.0b013e318095068a; UNAIDS, 2002, MON DECL COMM HIV AI; *UNAIDS, 2007, AIDS EP UPD SPEC REP; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Varma JK, 2007, B WORLD HEALTH ORGAN, V85, P586, DOI 10.2471/BLT.06.038067; World Health Organization, 1998, WHOTB98250; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, GLOB PLAN STOP TB 20; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959	34	40	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6360	10.1371/journal.pone.0006360	http://dx.doi.org/10.1371/journal.pone.0006360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CO	19626120	gold, Green Submitted, Green Published			2022-12-25	WOS:000268260200006
J	Carilli, JE; Norris, RD; Black, BA; Walsh, SM; McField, M				Carilli, Jessica E.; Norris, Richard D.; Black, Bryan A.; Walsh, Sheila M.; McField, Melanie			Local Stressors Reduce Coral Resilience to Bleaching	PLOS ONE			English	Article								Coral bleaching, during which corals lose their symbiotic dinoflagellates, typically corresponds with periods of intense heat stress, and appears to be increasing in frequency and geographic extent as the climate warms. A fundamental question in coral reef ecology is whether chronic local stress reduces coral resistance and resilience from episodic stress such as bleaching, or alternatively promotes acclimatization, potentially increasing resistance and resilience. Here we show that following a major bleaching event, Montastraea faveolata coral growth rates at sites with higher local anthropogenic stressors remained suppressed for at least 8 years, while coral growth rates at sites with lower stress recovered in 2-3 years. Instead of promoting acclimatization, our data indicate that background stress reduces coral fitness and resilience to episodic events. We also suggest that reducing chronic stress through local coral reef management efforts may increase coral resilience to global climate change.			Carilli, JE (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jcarilli@ucsd.edu	Black, Bryan/A-7057-2009	Black, Bryan/0000-0001-6851-257X				Andrefouet S, 2002, CORAL REEFS, V21, P43, DOI 10.1007/s00338-001-0199-0; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HELMLE KP, 2002, CORAL XRADIOGRAPHY D; *HLTH REEFS IN, 2008, ECOHEALTH REP CARD M; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; KOENIG A, COMP CHEM RECO UNPUB; Kramer P., 2000, STATUS CORAL REEFS W; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; MARAGOS JE, 1993, COAST MANAGE, V21, P235, DOI 10.1080/08920759309362207; MCFIELD M, 2005, STATUS CARIBBEAN COR; MCFIELD MD, 2000, P 9 INT COR REEF S, V1, P62; Omata T, 2006, GLOBAL PLANET CHANGE, V53, P137, DOI 10.1016/j.gloplacha.2006.01.009; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4	28	198	201	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6324	10.1371/journal.pone.0006324	http://dx.doi.org/10.1371/journal.pone.0006324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623250	Green Published, gold			2022-12-25	WOS:000268260100007
J	Palmer, SA; Moore, JD; Clapham, AJ; Rose, P; Allaby, RG				Palmer, Sarah A.; Moore, Jonathan D.; Clapham, Alan J.; Rose, Pamela; Allaby, Robin G.			Archaeogenetic Evidence of Ancient Nubian Barley Evolution from Six to Two-Row Indicates Local Adaptation	PLOS ONE			English	Article							GRAIN-YIELD; DNA; DOMESTICATION; INHERITANCE; LANDRACES; SPIKELETS; INSIGHTS; REGIONS; REMAINS; MAIZE	Background: Archaeobotanical samples of barley ( Hordeum vulgare L.) found at Qasr Ibrim display a two-row phenotype that is unique to the region of archaeological sites upriver of the first cataract of the Nile, characterised by the development of distinctive lateral bracts. The phenotype occurs throughout all strata at Qasr Ibrim, which range in age from 3000 to a few hundred years. Methodology and Findings: We extracted ancient DNA from barley samples from the entire range of occupancy of the site, and studied the Vrs1 gene responsible for row number in extant barley. Surprisingly, we found a discord between the genotype and phenotype in all samples; all the barley had a genotype consistent with the six-row condition. These results indicate a six-row ancestry for the Qasr Ibrim barley, followed by a reassertion of the two-row condition. Modelling demonstrates that this sequence of evolutionary events requires a strong selection pressure. Conclusions: The two-row phenotype at Qasr Ibrim is caused by a different mechanism to that in extant barley. The strength of selection required for this mechanism to prevail indicates that the barley became locally adapted in the region in response to a local selection pressure. The consistency of the genotype/phenotype discord over time supports a scenario of adoption of this barley type by successive cultures, rather than the importation of new barley varieties associated with individual cultures.			Palmer, SA (corresponding author), Univ Warwick, Warwick HRI, Wellesbourne, Warwick, England.	r.g.allaby@warwick.ac.uk	Moore, Jonathan D/D-1796-2013	Moore, Jonathan D/0000-0002-5486-0407	Natural Environment Research Council [NE/G005974/1] Funding Source: researchfish; NERC [NE/G005974/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; BROWN TA, 2006, DARWINS HARVEST NEW, P197; CLAPHAM AJ, 2007, GRONINGEN ARCHAEOLOG, V5, P157; Demissie A, 1996, HEREDITAS, V124, P17, DOI 10.1111/j.1601-5223.1996.00017.x; EVANS LT, 1976, ADV AGRON, V28, P301, DOI 10.1016/S0065-2113(08)60558-1; Forster BP, 2004, ANN APPL BIOL, V144, P157, DOI 10.1111/j.1744-7348.2004.tb00329.x; Freitas FO, 2003, J ARCHAEOL SCI, V30, P901, DOI 10.1016/S0305-4403(02)00269-8; Fuller D.Q., 2001, SUDAN NUBIA, V5, P97; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, AM J PHYS ANTHROPOL, V128, P110, DOI 10.1002/ajpa.20045; GRUNDBACHER FJ, 1963, BOT REV, V29, P366, DOI 10.1007/BF02860824; Gymer P. T., 1978, Barley Genetics Newsletter, V8, P44; Harris D. R, 1996, ORIGIN SPREAD AGR PA, P25; Helgason A, 2007, J MOL EVOL, V65, P92, DOI 10.1007/s00239-006-0259-8; Jarman RJ, 1996, PLANT VAR SEEDS, V9, P191; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Kjaer B, 1996, EUPHYTICA, V90, P39; Knupffer H, 2003, DEV PL GEN, V7, P53, DOI 10.1016/S0168-7972(03)80006-3; Komatsuda T, 2002, THEOR APPL GENET, V105, P85, DOI 10.1007/s00122-001-0858-0; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Leonard WH, 1942, GENETICS, V27, P0299; Lia VV, 2007, P ROY SOC B-BIOL SCI, V274, P545, DOI 10.1098/rspb.2006.3747; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lundqvist U, 1997, BARLEY GENET NEWSL, V26, P200; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Murray M. A., 2000, ANCIENT EGYPTIAN MAT, P505; NECAS J, 1963, BIOL PLANTARUM, V5, P89, DOI 10.1007/BF02933639; ODonoghue K, 1996, P ROY SOC B-BIOL SCI, V263, P541, DOI 10.1098/rspb.1996.0082; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; WETTERSTROM W, 1993, ARCHAEOLOGY AFRICA F, P165; WIEBE GA, 1961, TECHNICAL B USDA, V1224; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Zink A, 2003, AM J PHYS ANTHROPOL, V121, P109, DOI 10.1002/ajpa.10213; ZOHARY D, 2000, DOMESTICATION PLANTS, P67	38	53	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6301	10.1371/journal.pone.0006301	http://dx.doi.org/10.1371/journal.pone.0006301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CN	19623249	Green Published, Green Submitted, gold			2022-12-25	WOS:000268260100005
J	Pons, L; Battaglia-Hsu, SF; Orozco-Barrios, CE; Ortiou, S; Chery, C; Alberto, JM; Arango-Rodriguez, ML; Dumas, D; Martinez-Fong, D; Freund, JN; Gueant, JL				Pons, Laurent; Battaglia-Hsu, Shyue-Fang; Enrique Orozco-Barrios, Carlos; Ortiou, Sandrine; Chery, Celine; Alberto, Jean-Marc; Ligia Arango-Rodriguez, Martha; Dumas, Dominique; Martinez-Fong, Daniel; Freund, Jean-Noel; Gueant, Jean-Louis			Anchoring Secreted Proteins in Endoplasmic Reticulum by Plant Oleosin: The Example of Vitamin B12 Cellular Sequestration by Transcobalamin	PLOS ONE			English	Article							IN-VITRO; MEMBRANE; EXPRESSION; DEFICIENCY; RECEPTOR; CACO-2; TOPOLOGY; PURIFICATION; TRANSPORT; SEQUENCE	Background: Oleosin is a plant protein localized to lipid droplets and endoplasmic reticulum of plant cells. Our idea was to use it to target functional secretory proteins of interest to the cytosolic side of the endoplasmic reticulum of mammalian cells, through expressing oleosin-containing chimeras. We have designed this approach to create cellular models deficient in vitamin B12 (cobalamin) because of the known problematics associated to the obtainment of effective vitamin B12 deficient cell models. This was achieved by the overexpression of transcobalamin inside cells through anchoring to oleosin. Methodology: chimera gene constructs including transcobalamin-oleosin (TC-O), green fluorescent protein-transcobalamin-oleosin (GFP-TC-O) and oleosin-transcobalamin (O-TC) were inserted into pAcSG2 and pCDNA3 vectors for expression in sf9 insect cells, Caco2 (colon carcinoma), NIE-115 (mouse neuroblastoma), HEK (human embryonic kidney), COS-7 (Green Monkey SV40-transfected kidney fibroblasts) and CHO (Chinese hamster ovary cells). The subcellular localization, the changes in vitamin B12 binding activity and the metabolic consequences were investigated in both Caco2 and NIE-115 cells. Principal findings: vitamin B12 binding was dramatically higher in TC-O than that in O-TC and wild type (WT). The expression of GFP-TC-O was observed in all cell lines and found to be co-localized with an ER-targeted red fluorescent protein and calreticulin of the endoplasmic reticulum in Caco2 and COS-7 cells. The overexpression of TC-O led to B12 deficiency, evidenced by impaired conversion of cyano-cobalamin to ado-cobalamin and methyl-cobalamin, decreased methionine synthase activity and reduced S-adenosyl methionine to S-adenosyl homocysteine ratio, as well as increases in homocysteine and methylmalonic acid concentration. Conclusions/Significance: the heterologous expression of TC-O in mammalian cells can be used as an effective strategy for investigating the cellular consequences of vitamin B12 deficiency. More generally, expression of oleosin-anchored proteins could be an interesting tool in cell engineering for studying proteins of pharmacological interest.			Pons, L (corresponding author), Nancy Univ, Fac Med, INSERM, U954, Vandoeuvre Les Nancy, France.	jean-louis.gueant@medecine.uhp-nancy.fr	Freund, Jean-Noel/R-4383-2016; Dumas, Dominique DD/A-5633-2012	Freund, Jean-Noel/0000-0002-0971-3774; Orozco-Barrios, Carlos E./0000-0002-3989-1205				Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Abell BM, 2002, J BIOL CHEM, V277, P8602, DOI 10.1074/jbc.M103712200; Beaudoin F, 2000, PLANTA, V210, P439, DOI 10.1007/PL00008152; Beaudoin F, 2002, PLANTA, V215, P293, DOI 10.1007/s00425-002-0737-1; Birn H, 2000, J AM SOC NEPHROL, V11, P191, DOI 10.1681/ASN.V112191; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Capuano F, 2007, BIOTECHNOL ADV, V25, P203, DOI 10.1016/j.biotechadv.2006.11.006; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; CHANTRET I, 1994, J CELL SCI, V107, P213; Cheng TL, 2008, MED RES REV, V28, P885, DOI 10.1002/med.20127; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Chou WC, 1999, BIOTECHNOL BIOENG, V65, P160, DOI 10.1002/(SICI)1097-0290(19991020)65:2<160::AID-BIT5>3.0.CO;2-U; Giddings G, 2000, NAT BIOTECHNOL, V18, P1151, DOI 10.1038/81132; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Kozyraki R, 2007, CURR PHARM DESIGN, V13, P3038, DOI 10.2174/138161207782110507; Marler KJM, 2005, MOL CELL BIOL, V25, P5226, DOI 10.1128/MCB.25.12.5226-5241.2005; McLean GR, 1997, BLOOD, V89, P235, DOI 10.1182/blood.V89.1.235.235_235_242; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; Mu JZ, 1997, GASTROENTEROLOGY, V113, P1501, DOI 10.1053/gast.1997.v113.pm9352852; Namour F, 2003, BRIT J HAEMATOL, V123, P915, DOI 10.1046/j.1365-2141.2003.04685.x; Namour F, 2001, BLOOD, V97, P1092, DOI 10.1182/blood.V97.4.1092; Nykiforuk CL, 2006, PLANT BIOTECHNOL J, V4, P77, DOI 10.1111/j.1467-7652.2005.00159.x; Oltean S, 2005, J BIOL CHEM, V280, P32662, DOI 10.1074/jbc.M501964200; Ortiou S, 2004, CELL PHYSIOL BIOCHEM, V14, P407, DOI 10.1159/000080350; Peng CC, 2004, J BIOTECHNOL, V111, P51, DOI 10.1016/j.jbiotec.2004.03.013; Pons L, 2000, CELL PHYSIOL BIOCHEM, V10, P135, DOI 10.1159/000016344; Pons L, 2005, PLANT PHYSIOL BIOCH, V43, P659, DOI 10.1016/j.plaphy.2005.06.002; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; ROTHENBERG SP, 1995, BAILLIERE CLIN HAEM, V8, P499, DOI 10.1016/S0950-3536(05)80218-5; Scalabrino G, 2005, EXP NEUROL, V192, P463, DOI 10.1016/j.expneurol.2004.12.020; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Wahlroos T, 2003, GENESIS, V35, P125, DOI 10.1002/gene.10172; WEISSBACH H, 1963, J BIOL CHEM, V238, P3318; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103	37	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6325	10.1371/journal.pone.0006325	http://dx.doi.org/10.1371/journal.pone.0006325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623264	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260100008
J	Kobayashi, M; Kikuchi, D; Okamura, H				Kobayashi, Masaki; Kikuchi, Daisuke; Okamura, Hitoshi			Imaging of Ultraweak Spontaneous Photon Emission from Human Body Displaying Diurnal Rhythm	PLOS ONE			English	Article								The human body literally glimmers. The intensity of the light emitted by the body is 1000 times lower than the sensitivity of our naked eyes. Ultraweak photon emission is known as the energy released as light through the changes in energy metabolism. We successfully imaged the diurnal change of this ultraweak photon emission with an improved highly sensitive imaging system using cryogenic charge-coupled device (CCD) camera. We found that the human body directly and rhythmically emits light. The diurnal changes in photon emission might be linked to changes in energy metabolism.			Kobayashi, M (corresponding author), Tohoku Inst Technol, Dept Elect & Intelligent Syst, Sendai, Miyagi 982, Japan.	masaki@tohtech.ac.jp; okamurah@pharm.kyoto-u.ac.jp						CADENAS E, 1984, PHOTOCHEM PHOTOBIOL, V40, P823, DOI 10.1111/j.1751-1097.1984.tb04657.x; Kobayashi M, 1999, NEUROSCI RES, V34, P103, DOI 10.1016/S0168-0102(99)00040-1; Kobayashi T, 2003, KNEE, V10, P135, DOI 10.1016/S0968-0160(02)00055-8; Merrow M, 2001, CELL, V106, P141, DOI 10.1016/S0092-8674(01)00443-3; NAKANO M, 1989, J BIOLUM CHEMILUM, V4, P231, DOI 10.1002/bio.1170040133; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; POPP FA, 1988, EXPERIENTIA, V44, P543, DOI 10.1007/BF01953300; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Sauermann G, 1999, METHOD ENZYMOL, V300, P419; Schibler U, 2001, SCIENCE, V293, P437, DOI 10.1126/science.1063296; SCHWARTZ WJ, 1977, SCIENCE, V97, P89; Teuchner K, 1999, PHOTOCHEM PHOTOBIOL, V70, P146, DOI 10.1562/0031-8655(1999)070<0146:FTPEFO>2.3.CO;2; USA M, 1991, FINAL REPORT INABA B, P239; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	14	70	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6256	10.1371/journal.pone.0006256	http://dx.doi.org/10.1371/journal.pone.0006256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606225	gold, Green Published, Green Submitted			2022-12-25	WOS:000268036000012
J	Burnat, M; Diestra, E; Esteve, I; Sole, A				Burnat, Mireia; Diestra, Elia; Esteve, Isabel; Sole, Antonio			In Situ Determination of the Effects of Lead and Copper on Cyanobacterial Populations in Microcosms	PLOS ONE			English	Article								Background: Biomass has been studied as biomarker to evaluate the effect of heavy metals on microbial communities. Nevertheless, the most important methodological problem when working with natural and artificial microbial mats is the difficulty to evaluate changes produced on microorganism populations that are found in thicknesses of just a few mm depth. Methodology/Principal Findings: Here, we applied for first time a recently published new method based on confocal laser scanning microscopy and image-program analysis to determine in situ the effect of Pb and Cu stress in cyanobacterial populations. Conclusions/Significance: The results showed that both in the microcosm polluted by Cu and by Pb, a drastic reduction in total biomass for cyanobacterial and Microcoleus sp. (the dominant filamentous cyanobacterium in microbial mats) was detected within a week. According to the data presented in this report, this biomass inspection has a main advantage: besides total biomass, diversity, individual biomass of each population and their position can be analysed at microscale level. CLSM-IA could be a good method for analyzing changes in microbial biomass as a response to the addition of heavy metals and also to other kind of pollutants.			Burnat, M (corresponding author), Univ Autonoma Barcelona, Biosci Fac, Dept Genet & Microbiol, E-08193 Barcelona, Spain.	mireia.burnat@uab.cat	Burnat, Mireia/G-5502-2015; Solé, Antonio/L-4195-2014	Burnat, Mireia/0000-0001-5756-7794; Solé, Antonio/0000-0002-1151-319X				Abed RMM, 2002, ARCH MICROBIOL, V177, P361, DOI 10.1007/s00203-001-0390-2; Baath E, 2005, MICROB ECOL, V50, P496, DOI 10.1007/s00248-005-0008-3; Bauer K, 2008, FEMS MICROBIOL ECOL, V63, P205, DOI 10.1111/j.1574-6941.2007.00423.x; Becker JM, 2006, MICROB ECOL, V51, P220, DOI 10.1007/s00248-005-0002-9; BLOEM J, 1995, APPL ENVIRON MICROB, V61, P926, DOI 10.1128/AEM.61.3.926-936.1995; Boivin MEY, 2006, ENVIRON POLLUT, V140, P239, DOI 10.1016/j.envpol.2005.07.014; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; De Philippis R, 2003, J APPL PHYCOL, V15, P155, DOI 10.1023/A:1023889410912; ESTEVE I, 1994, NATO ASI SERIES G, V35, P415; Fourans A, 2004, FEMS MICROBIOL ECOL, V51, P55, DOI 10.1016/j.femsec.2004.07.012; Fourcans A, 2006, FEMS MICROBIOL ECOL, V57, P367, DOI 10.1111/j.1574-6941.2006.00124.x; FRY JC, 1990, METHOD MICROBIOL, V22, P411; Gillan DC, 2005, APPL ENVIRON MICROB, V71, P679, DOI 10.1128/AEM.71.2.679-690.2005; Heng LY, 2004, B ENVIRON CONTAM TOX, V72, P373, DOI 10.1007/s00128-003-8923-9; Incharoensakdi A, 2002, CURR MICROBIOL, V45, P261, DOI 10.1007/s00284-002-3747-0; Joynt J, 2006, MICROB ECOL, V51, P209, DOI 10.1007/s00248-005-0205-0; KOMAREK J, 2004, CYANODB CZ ON LINE D; Konopka A, 1999, APPL ENVIRON MICROB, V65, P2256; Lliros M, 2008, SCI TOTAL ENVIRON, V393, P39, DOI 10.1016/j.scitotenv.2007.11.034; Massieux B, 2004, APPL ENVIRON MICROB, V70, P4512, DOI 10.1128/AEM.70.8.4512-4521.2004; Rajapaksha RMCP, 2004, APPL ENVIRON MICROB, V70, P2966, DOI 10.1128/AEM.70.5.2966-2973.2004; Rasband W.S., 1997, IMAGE J; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; Sole A, 2007, ULTRAMICROSCOPY, V107, P669, DOI 10.1016/j.ultramic.2007.01.007; Sole A, 2009, MICROB ECOL, V57, P649, DOI 10.1007/s00248-008-9463-y; Sole A, 2001, J MICROSC-OXFORD, V204, P258, DOI 10.1046/j.1365-2818.2001.00951.x; Stal LJ, 1994, MICROBIAL MATS STRUC; Tripathi BN, 2003, ECOTOX ENVIRON SAFE, V56, P311, DOI 10.1016/S0147-6513(02)00164-1; Wieland A, 2003, MICROB ECOL, V46, P371, DOI 10.1007/s00248-002-0108-2; Yang YG, 2006, CHEMOSPHERE, V63, P1942, DOI 10.1016/j.chemosphere.2005.10.009	30	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6204	10.1371/journal.pone.0006204	http://dx.doi.org/10.1371/journal.pone.0006204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593432	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035300014
J	Kurian, SM; Heilman, R; Mondala, TS; Nakorchevsky, A; Hewel, JA; Campbell, D; Robison, EH; Wang, L; Lin, W; Gaber, L; Solez, K; Shidban, H; Mendez, R; Schaffer, RL; Fisher, JS; Flechner, SM; Head, SR; Horvath, S; Yates, JR; Marsh, CL; Salomon, DR				Kurian, Sunil M.; Heilman, Raymond; Mondala, Tony S.; Nakorchevsky, Aleksey; Hewel, Johannes A.; Campbell, Daniel; Robison, Elizabeth H.; Wang, Lin; Lin, Wen; Gaber, Lillian; Solez, Kim; Shidban, Hamid; Mendez, Robert; Schaffer, Randolph L.; Fisher, Jonathan S.; Flechner, Stuart M.; Head, Steve R.; Horvath, Steve; Yates, John R., III; Marsh, Christopher L.; Salomon, Daniel R.			Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood	PLOS ONE			English	Article								Background: Despite significant improvements in life expectancy of kidney transplant patients due to advances in surgery and immunosuppression, Chronic Allograft Nephropathy (CAN) remains a daunting problem. A complex network of cellular mechanisms in both graft and peripheral immune compartments complicates the non-invasive diagnosis of CAN, which still requires biopsy histology. This is compounded by non-immunological factors contributing to graft injury. There is a pressing need to identify and validate minimally invasive biomarkers for CAN to serve as early predictors of graft loss and as metrics for managing long-term immunosuppression. Methods: We used DNA microarrays, tandem mass spectroscopy proteomics and bioinformatics to identify genomic and proteomic markers of mild and moderate/severe CAN in peripheral blood of two distinct cohorts (n = 77 total) of kidney transplant patients with biopsy-documented histology. Findings: Gene expression profiles reveal over 2400 genes for mild CAN, and over 700 for moderate/severe CAN. A consensus analysis reveals 393 (mild) and 63 (moderate/severe) final candidates as CAN markers with predictive accuracy of 80% (mild) and 92% (moderate/severe). Proteomic profiles show over 500 candidates each, for both stages of CAN including 302 proteins unique to mild and 509 unique to moderate/severe CAN. Conclusions: This study identifies several unique signatures of transcript and protein biomarkers with high predictive accuracies for mild and moderate/ severe CAN, the most common cause of late allograft failure. These biomarkers are the necessary first step to a proteogenomic classification of CAN based on peripheral blood profiling and will be the targets of a prospective clinical validation study.			Kurian, SM (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Heilman, Raymond/AAW-5138-2020; Salomon, Daniel/E-9380-2012; Kurian, Sunil/C-4493-2008; Schaffer, Randolph/S-7432-2019	Kurian, Sunil/0000-0002-7782-7263; Marsh, Christopher/0000-0002-6517-076X	NIAID NIH HHS [R01 AI052349, R56 AI052349, U19 AI52349] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052349, R01AI052349] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banasik Miroslaw, 2006, Ann Transplant, V11, P7; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; CALNE RY, 1978, LANCET, V2, P1323; Clarke W, 2003, ANN SURG, V237, P660, DOI 10.1097/00000658-200305000-00008; Colvin RB, 2003, NEW ENGL J MED, V349, P2288, DOI 10.1056/NEJMp038178; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Flechner SM, 2004, AM J TRANSPLANT, V4, P1776, DOI 10.1111/j.1600-6143.2004.00627.x; Flechner SM, 2007, TRANSPLANTATION, V83, P883, DOI 10.1097/01.tp.0000258586.52777.4c; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Horwitz PA, 2004, CIRCULATION, V110, P3815, DOI 10.1161/01.CIR.0000150539.72783.BF; Huang CC, 2006, PEDIATR BLOOD CANCER, V46, P728, DOI 10.1002/pbc.20773; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; KURIAN S, 2005, CURRENT OPINION ORGA, V10, P193; Kurian S, 2007, INT IMMUNOPHARMACOL, V7, P1948, DOI 10.1016/j.intimp.2007.07.017; Lachenbruch PA, 2004, AM J TRANSPLANT, V4, P451, DOI 10.1111/j.1600-6143.2004.00386.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mas V, 2007, TRANSPLANTATION, V83, P448, DOI 10.1097/01.tp.0000251373.17997.9a; Meier-Kriesche HU, 2001, J AM SOC NEPHROL, V12, P1293, DOI 10.1681/ASN.V1261293; Nankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Oetting WS, 2006, AM J KIDNEY DIS, V47, P898, DOI 10.1053/j.ajkd.2006.01.034; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Pascual M, 1998, IMMUNOL TODAY, V19, P514, DOI 10.1016/S0167-5699(98)01324-3; Pascual M, 1999, TRANSPLANTATION, V67, P737, DOI 10.1097/00007890-199903150-00016; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Schaub S, 2005, AM J TRANSPLANT, V5, P729, DOI 10.1111/j.1600-6143.2005.00766.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107; Yates PJ, 2006, TRANSPL IMMUNOL, V16, P148, DOI 10.1016/j.trim.2006.10.001; Yilmaz S, 2007, TRANSPL INT, V20, P608, DOI 10.1111/j.1432-2277.2007.00494.x	39	63	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6212	10.1371/journal.pone.0006212	http://dx.doi.org/10.1371/journal.pone.0006212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593431	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035300018
J	Yang, EH; Almon, RR; DuBois, DC; Jusko, WJ; Androulakis, IP				Yang, Eric H.; Almon, Richard R.; DuBois, Debra C.; Jusko, Willian J.; Androulakis, Ioannis P.			Identification of Global Transcriptional Dynamics	PLOS ONE			English	Article							GENE-EXPRESSION; INFLAMMATORY RESPONSE; PHARMACOGENOMICS; INJURY; MODEL	Background: One of the challenges in exploiting high throughput measurement techniques such as microarrays is the conversion of the vast amounts of data obtained into relevant knowledge. Of particular importance is the identification of the intrinsic response of a transcriptional experiment and the characterization of the underlying dynamics. Methodology and Findings: The proposed algorithmseeks to provide the researcher a summary as to various aspects relating to the dynamic progression of a biological system, rather than that of individual genes. The approach is based on the identification of smaller number of expression motifs that define the transcriptional state of the system which quantifies the deviation of the cellular response from a control state in the presence of an external perturbation. The approach is demonstrated with a number of data sets including a synthetic base case and four animal studies. The synthetic dataset will be used to establish the response of the algorithm on a "null'' dataset, whereas the four different experimental datasets represent a spectrum of possible time course experiments in terms of the degree of perturbation associated with the experiment as well as representing a wide range of temporal sampling strategies. This wide range of experimental datasets will thus allow us to explore the performance of the proposed algorithm and determine its ability identify relevant information. Conclusions and Significance: In this work, we present a computational approach which operates on high throughput temporal gene expression data to assess the information content of the experiment, identify dynamic markers of important processes associated with the experimental perturbation, and summarize in a concise manner the evolution of the system over time with respect to the experimental perturbation.			Yang, EH (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	yannis@rci.rutgers.edu	Jusko, William J/G-4885-2015		NIGMS NIH HHS [R37 GM024211, R01 GM024211, GM 24211] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024211, R37GM024211] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Almon Richard R., 2003, Functional & Integrative Genomics, V3, P171, DOI 10.1007/s10142-003-0090-x; Balasubramaniyan R, 2005, BIOINFORMATICS, V21, P1069, DOI 10.1093/bioinformatics/bti095; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gottenberg JE, 2005, ANN RHEUM DIS, V64, P913, DOI 10.1136/ard.2004.029694; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Jayaraman A, 2005, TISSUE ENG, V11, P50, DOI 10.1089/ten.2005.11.50; Jayaraman A, 2000, METAB ENG, V2, P239, DOI 10.1006/mben.2000.0153; Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256; KEOGH E, 2005, HOT SAX EFFICIENTLY; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; *NIST, 1998, E HDB STAT METH; Peterson SN, 2001, GENOME BIOL, V2; Preiss B., 1999, WW SER COMP SCI; Ramakrishnan R, 2002, J PHARMACOL EXP THER, V300, P245, DOI 10.1124/jpet.300.1.245; Rassokhin DN, 2000, J MOL GRAPH MODEL, V18, P368, DOI 10.1016/S1093-3263(00)00063-2; Schliep A, 2003, BIOINFORMATICS, V19, pi255, DOI 10.1093/bioinformatics/btg1036; SPIEGEL MR, 1999, SCHAUMS OUTLINE THEO, pR17; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vemula M, 2004, PHYSIOL GENOMICS, V18, P87, DOI 10.1152/physiolgenomics.00189.2003; Yang E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-10	28	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e5992	10.1371/journal.pone.0005992	http://dx.doi.org/10.1371/journal.pone.0005992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593450	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035300001
J	Clement, M; Cabana, J; Holleran, BJ; Leduc, R; Guillemette, G; Lavigne, P; Escher, E				Clement, Martin; Cabana, Jerome; Holleran, Brian J.; Leduc, Richard; Guillemette, Gaetan; Lavigne, Pierre; Escher, Emanuel			Activation Induces Structural Changes in the Liganded Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; 3RD TRANSMEMBRANE DOMAIN; CONTAINING AMINO-ACIDS; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVATION; BINDING POCKET; AT(1) RECEPTOR; CONFORMATIONAL-CHANGES; RHODOPSIN ACTIVATION	The octapeptide hormone angiotensin II (AngII) binds to and activates the human angiotensin II type 1 receptor (hAT(1)) of the G protein-coupled receptor class A family. Several activation mechanisms have been proposed for this family, but they have not yet been experimentally validated. We previously used the methionine proximity assay to show that 11 residues in transmembrane domain (TMD) III, VI, and VII of the hAT(1) receptor reside in close proximity to the C-terminal residue of AngII. With the exception of a single change in TMD VI, the same contacts are present on N111G-hAT(1), a constitutively active mutant; this N111G-hAT(1) is a model for the active form of the receptor. In this study, two series of 53 individual methionine mutations were constructed in TMD I, II, IV, and V on both receptor forms. The mutants were photolabeled with a neutral antagonist, I-125-[Sar(1),p-benzoyl-L-Phe(8)] AngII, and the resulting complexes were digested with cyanogen bromide. Although no new contacts were found for the hAT(1) mutants, two were found in the constitutively active mutants, Phe-77 in TMD II and Asn-200 in TMD V. To our knowledge, this is the first time that a direct ligand contact with TMD II and TMD V has been reported. These contact point differences were used to identify the structural changes between the WT-hAT(1) and N111G-hAT(1) complexes through homology-based modeling and restrained molecular dynamics. The model generated revealed an important structural rearrangement of several TMDs from the basal to the activated form in the WT-hAT(1) receptor.	[Clement, Martin; Cabana, Jerome; Holleran, Brian J.; Leduc, Richard; Guillemette, Gaetan; Lavigne, Pierre; Escher, Emanuel] Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Escher, E (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Emanuel.Escher@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported in part by grants from the Canadian Institutes of Health Research and the Quebec Chapter of the Canadian Heart and Stroke Foundation.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; BOBROWSKI K, 1992, J AM CHEM SOC, V114, P10279, DOI 10.1021/ja00052a025; BOSSE R, 1993, REGUL PEPTIDES, V44, P215, DOI 10.1016/0167-0115(93)90245-4; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Boucard AA, 2003, BIOCHEM J, V370, P829, DOI 10.1042/BJ20021566; Bremer AA, 2001, J BIOL CHEM, V276, P22857, DOI 10.1074/jbc.M100824200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Charest G, 2006, BIOPOLYMERS, V81, P202, DOI 10.1002/bip.20401; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Clement M, 2006, J RECEPT SIG TRANSD, V26, P417, DOI 10.1080/10799890600923195; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kennedy AP, 1996, MOL PHARMACOL, V50, P789; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; MARCINIAK B, 1993, J PHYS CHEM-US, V97, P11937, DOI 10.1021/j100148a015; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; SHENKIN PS, 1987, BIOPOLYMERS, V26, P2053, DOI 10.1002/bip.360261207; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167	54	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26603	26612		10.1074/jbc.M109.012922	http://dx.doi.org/10.1074/jbc.M109.012922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635801	Green Published, hybrid			2022-12-25	WOS:000269969600041
J	Stark, R; Pasquel, F; Turcu, A; Pongratz, RL; Roden, M; Cline, GW; Shulman, GI; Kibbey, RG				Stark, Romana; Pasquel, Francisco; Turcu, Adina; Pongratz, Rebecca L.; Roden, Michael; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.			Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG LIVER; ADENINE-NUCLEOTIDE TRANSLOCASE; PANCREATIC-ISLETS CONTAIN; NMR ISOTOPOMER ANALYSIS; SENSITIVE-K+-CHANNELS; ATP-CITRATE LYASE; MALIC ENZYME; PYRUVATE-KINASE; BETA-CELLS; RAT-LIVER	Pancreatic beta-cells couple the oxidation of glucose to the secretion of insulin. Apart from the canonical K-ATP-dependent glucose-stimulated insulin secretion (GSIS), there are important K-ATP-independent mechanisms involving both anaplerosis and mitochondrial GTP (mtGTP). How mtGTP that is trapped within the mitochondrial matrix regulates the cytosolic calcium increases that drive GSIS remains a mystery. Here we have investigated whether the mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) is the GTPase linking hydrolysis of mtGTP made by succinyl-CoA synthetase (SCS-GTP) to an anaplerotic pathway producing phosphoenolpyruvate (PEP). Although cytosolic PEPCK (PEPCK-C) is absent, PEPCK-M message and protein were detected in INS-1 832/13 cells, rat islets, and mouse islets. PEPCK enzymatic activity is half that of primary hepatocytes and is localized exclusively to the mitochondria. Novel C-13-labeling strategies in INS-1 832/13 cells and islets measured substantial contribution of PEPCK-M to the synthesis of PEP. As high as 30% of PEP in INS-1 832/13 cells and 41% of PEP in rat islets came from PEPCK-M. The contribution of PEPCK-M to overall PEP synthesis more than tripled with glucose stimulation. Silencing the PEPCK-M gene completely inhibited GSIS underscoring its central role in mitochondrial metabolism-mediated insulin secretion. Given that mtGTP synthesized by SCS-GTP is an indicator of TCA flux that is crucial for GSIS, PEPCK-M is a strong candidate to link mtGTP synthesis with insulin release through anaplerotic PEP cycling.	[Stark, Romana; Pasquel, Francisco; Turcu, Adina; Pongratz, Rebecca L.; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Deutsches Diabetes-Zentrum (DDZ)	Kibbey, RG (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	richard.kibbey@yale.edu	Shulman, Gerald I./P-7176-2019; Roden, Michael/AAD-3843-2019	Shulman, Gerald I./0000-0003-1529-5668; Stark, Romana/0000-0002-4264-0060	United States Public Health Service [R01 DK-40936, R01 DK-71071, K08 DK-80142, P30 DK-45735, P30 DK-34989]; American Diabetes Association [1-09-RA-86]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, P30DK034989, R01DK071071, P30DK045735, U24DK059635, K08DK080142] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01 DK-40936, R01 DK-71071, K08 DK-80142, P30 DK-45735, and P30 DK-34989 and by American Diabetes Association Grant 1-09-RA-86.	BALLARD FJ, 1970, BIOCHEM J, V119, P735, DOI 10.1042/bj1190735; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BALY DL, 1984, J NUTR, V114, P1438, DOI 10.1093/jn/114.8.1438; BARZU O, 1976, BIOCHIM BIOPHYS ACTA, V452, P406, DOI 10.1016/0005-2744(76)90190-X; BOQUIST L, 1987, BIOCHEM INT, V14, P531; CHATTERTON TA, 1984, EXPERIENTIA, V40, P1426, DOI 10.1007/BF01951926; CHUDAPONGSE P, 1976, BIOCHIM BIOPHYS ACTA, V423, P196, DOI 10.1016/0005-2728(76)90178-X; CHUDAPONGSE P, 1973, BIOCHIM BIOPHYS ACTA, V307, P599, DOI 10.1016/0005-2736(73)90304-0; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CORNELL NW, 1986, J NUTR, V116, P1101, DOI 10.1093/jn/116.6.1101; DAVIS B, 1977, J PHYSIOL-LONDON, V271, P273, DOI 10.1113/jphysiol.1977.sp012000; DEACIUC IV, 1992, INT J BIOCHEM, V24, P129, DOI 10.1016/0020-711X(92)90238-V; EWART RBL, 1983, DIABETES, V32, P793, DOI 10.2337/diabetes.32.9.793; GARBER AJ, 1969, J BIOL CHEM, V244, P4696; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Ghanaat-Pour H, 2007, J MOL ENDOCRINOL, V39, P135, DOI 10.1677/JME-07-0002; GOTO Y, 1979, J BIOCHEM, V86, P71; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hanson R W, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P203; Heart E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1354, DOI 10.1152/ajpendo.90836.2008; Hedeskov C J, 1980, Horm Metab Res Suppl, VSuppl 10, P8; HEDESKOV CJ, 1984, BIOCHIM BIOPHYS ACTA, V791, P37, DOI 10.1016/0167-4838(84)90278-4; HEITZMAN RJ, 1972, FEBS LETT, V20, P19, DOI 10.1016/0014-5793(72)80006-1; Hlavaty JJ, 2000, BIOCHEMISTRY-US, V39, P1373, DOI 10.1021/bi991692a; HOHNADEL DC, 1973, FEBS LETT, V30, P18, DOI 10.1016/0014-5793(73)80609-X; HOLTEN DD, 1965, BIOCHEMISTRY-US, V4, P723, DOI 10.1021/bi00880a018; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P7054, DOI 10.1021/bi049707e; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Horn DB, 1997, METABOLISM, V46, P414, DOI 10.1016/S0026-0495(97)90058-5; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; ISHIHARA N, 1968, BIOCHIM BIOPHYS ACTA, V153, P733, DOI 10.1016/0005-2728(68)90001-7; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kebede M, 2008, DIABETES, V57, P1887, DOI 10.2337/db07-1326; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1985, DIABETES, V34, P246, DOI 10.2337/diabetes.34.3.246; MACDONALD MJ, 1985, MOL CELL BIOCHEM, V68, P115; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; NORDLIE RC, 1963, J BIOL CHEM, V238, P2259; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Passarella S, 2003, MITOCHONDRION, V2, P319, DOI 10.1016/S1567-7249(03)00008-4; PENG CF, 1974, BIOCHEM BIOPH RES CO, V56, P134, DOI 10.1016/S0006-291X(74)80325-6; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; PLOWMAN KM, 1965, BIOCHEMISTRY-US, V4, P2809, DOI 10.1021/bi00888a035; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pongratz RL, 2009, METHOD ENZYMOL, V457, P425, DOI 10.1016/S0076-6879(09)05024-1; PUNEKAR NS, 1987, J BIOL CHEM, V262, P6714; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; ROOS I, 1978, FEBS LETT, V94, P418, DOI 10.1016/0014-5793(78)80990-9; SAGGERSON ED, 1975, BIOCHEM J, V146, P329, DOI 10.1042/bj1460329; SATO A, 1986, J BIOCHEM-TOKYO, V100, P671, DOI 10.1093/oxfordjournals.jbchem.a121759; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHRAMM VL, 1982, TRENDS BIOCHEM SCI, V7, P369, DOI 10.1016/0968-0004(82)90117-7; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SHREEVE WW, 1964, J BIOL CHEM, V239, P729; SHUG AL, 1973, BIOCHEM BIOPH RES CO, V53, P659, DOI 10.1016/0006-291X(73)90712-2; SIES H, 1977, EUR J BIOCHEM, V72, P301, DOI 10.1111/j.1432-1033.1977.tb11253.x; SOLING HD, 1970, EUR J BIOCHEM, V16, P289, DOI 10.1111/j.1432-1033.1970.tb01084.x; SOLING HD, 1973, EUR J BIOCHEM, V37, P233, DOI 10.1111/j.1432-1033.1973.tb02980.x; SUGDEN MC, 1978, DIABETOLOGIA, V15, P173, DOI 10.1007/BF00421235; SUGDEN MC, 1977, DIABETOLOGIA, V13, P481, DOI 10.1007/BF01234500; SUL HS, 1976, ARCH BIOCHEM BIOPHYS, V172, P230, DOI 10.1016/0003-9861(76)90071-0; Suzuki M, 2004, GENE, V338, P157, DOI 10.1016/j.gene.2004.06.005; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; Szollosi A, 2007, J BIOL CHEM, V282, P1747, DOI 10.1074/jbc.M609875200; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; USATENKO MS, 1970, BIOCHEM MED METAB B, V3, P298, DOI 10.1016/0006-2944(70)90030-X; WIESE TJ, 1991, COMP BIOCHEM PHYS B, V100, P297, DOI 10.1016/0305-0491(91)90378-Q; WOOD HG, 1945, J BIOL CHEM, V159, P475	76	107	110	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26578	26590		10.1074/jbc.M109.011775	http://dx.doi.org/10.1074/jbc.M109.011775			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635791	Green Published, hybrid			2022-12-25	WOS:000269969600039
J	Klein, IK; Predescu, DN; Sharma, T; Knezevic, I; Malik, AB; Predescu, S				Klein, Irene K.; Predescu, Dan N.; Sharma, Tiffany; Knezevic, Ivana; Malik, Asrar B.; Predescu, Sanda			Intersectin-2L Regulates Caveola Endocytosis Secondary to Cdc42-mediated Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DBL HOMOLOGY DOMAIN; ENDOTHELIAL-CELLS; PROTEIN INTERSECTIN; ARP2/3 COMPLEX; CDC42; MEMBRANE; GTPASES; FAMILY; INTERNALIZATION	Here we addressed the role of intersectin-2L (ITSN-2L), a guanine nucleotide exchange factor for the Rho GTPase Cdc42, in the mechanism of caveola endocytosis in endothelial cells (ECs). Immunoprecipitation and co-localization studies showed that ITSN-2L associates with members of the Cdc42-WASp-Arp2/3 actin polymerization pathway. Expression of Dbl homology-pleckstrin homology (DH-PH) region of ITSN-2L (DH-PHITSN-2L) induced specific activation of Cdc42, resulting in formation of extensive filopodia, enhanced cortical actin, as well as a shift from G-actin to F-actin. The "catalytically dead" DH-PH domain reversed these effects and induced significant stress fiber formation, without a detectable shift in actin pools. A biotin assay for caveola internalization indicated a significant decrease in the uptake of biotinylated proteins in DH-PHITSN-2L-transfected cells compared with control and 1 mu M jasplakinolide-treated cells. ECs depleted of ITSN-2L by small interfering RNA, however, showed decreased Cdc42 activation and actin remodeling similar to the defective DH-PH, resulting in 62% increase in caveola-mediated uptake compared with controls. Thus, ITSN-2L, a guanine nucleotide exchange factor for Cdc42, regulates different steps of caveola endocytosis in ECs by controlling the temporal and spatial actin polymerization and remodeling sub-adjacent to the plasma membrane.	[Predescu, Dan N.; Knezevic, Ivana; Predescu, Sanda] Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL USA; [Klein, Irene K.; Sharma, Tiffany; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Predescu, S (corresponding author), 1750 W Harrison St, Chicago, IL 60612 USA.	sanda_predescu@rush.edu		Malik, Asrar/0000-0002-8205-7128; Predescu, Sanda/0000-0002-9386-6756	National Institutes of Health [R01 HL089462, HL007829]; American Heart Association [SDG 0635175N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007829, R01HL089462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL089462 (to S. P.) and HL007829 (to A. B. M.). This work was supported by American Heart Association Grant SDG 0635175N (to S. P.).	Bayless KJ, 2002, J CELL SCI, V115, P1123; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; Pruitt WM, 2003, BBA-MOL CELL RES, V1640, P61, DOI 10.1016/S0167-4889(03)00002-8; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	30	41	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25953	25961		10.1074/jbc.M109.035071	http://dx.doi.org/10.1074/jbc.M109.035071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19622753	Green Published, hybrid			2022-12-25	WOS:000269738000052
J	Abid, K; Rochat, B; Lassahn, PG; Stocklin, R; Michalet, S; Brakch, N; Aubert, JF; Vatansever, B; Tella, P; De Meester, I; Grouzmann, E				Abid, Karim; Rochat, Bertrand; Lassahn, Paul-Gerhard; Stoecklin, Reto; Michalet, Sophie; Brakch, Noureddine; Aubert, Jean-Francois; Vatansever, Bilgin; Tella, Patricia; De Meester, Ingrid; Grouzmann, Eric			Kinetic Study of Neuropeptide Y (NPY) Proteolysis in Blood and Identification of NPY3-35 A NEW PEPTIDE GENERATED BY PLASMA KALLIKREIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEINASE-INHIBITOR; ISOTOPE-DILUTION ASSAY; FEEDING-BEHAVIOR; AMINOPEPTIDASE-P; BENZOATE METHANESULFONATE; DIPEPTIDYLPEPTIDASE-IV; RECEPTOR; SYSTEM; ACTIVATION; THROMBIN	There is little information on how neuropeptide Y (NPY) proteolysis by peptidases occurs in serum, in part because reliable techniques are lacking to distinguish different NPY immunoreactive forms and also because the factors affecting the expression of these enzymes have been poorly studied. In the present study, LC-MS/MS was used to identify and quantify NPY fragments resulting from peptidolytic cleavage of NPY1-36 upon incubation with human serum. Kinetic studies indicated that NPY1-36 is rapidly cleaved in serum into 3 main fragments with the following order of efficacy: NPY3-36 >> NPY3-35 >> NPY2-36. Trace amounts of additional NPY forms were identified by accurate mass spectrometry. Specific inhibitors of dipeptidyl peptidase IV, kallikrein, and aminopeptidase P prevented the production of NPY3-36, NPY3-35, and NPY2-36, respectively. Plasma kallikrein at physiological concentrations converted NPY3-36 into NPY3-35. Receptor binding assays revealed that NPY3-35 is unable to bind to NPY Y1, Y2, and Y5 receptors; thus NPY3-35 may represent the major metabolic clearance product of the Y2/Y5 agonist, NPY3-36.	[Abid, Karim; Vatansever, Bilgin; Tella, Patricia; Grouzmann, Eric] CHUV, Div Clin Pharmacol & Toxicol, CH-1011 Lausanne, Switzerland; [Rochat, Bertrand] CHUV, Quantitat Mass Spectrometry Facil, CH-1011 Lausanne, Switzerland; [Brakch, Noureddine; Aubert, Jean-Francois] CHUV, Div Angiol, CH-1011 Lausanne, Switzerland; [Lassahn, Paul-Gerhard] ThermoFisher Sci, CH-4127 Birsfelden, Switzerland; [Stoecklin, Reto; Michalet, Sophie] Atheris Labs, CH-1233 Bernex, Switzerland; [De Meester, Ingrid] Univ Antwerp, Med Biochem Lab, B-2610 Antwerp, Belgium	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Antwerp	Grouzmann, E (corresponding author), Hop Beaumont, 29 Rue Beaumont, CH-1011 Lausanne, Switzerland.	Eric.Grouzmann@chuv.ch	De Meester, Ingrid/A-6881-2017	De Meester, Ingrid/0000-0002-3421-0124; Abid, Karim/0000-0003-0025-7335	Swiss National Science Foundation [3100 AO-101999]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 3100 AO-101999 (to E. G.).	Abdel-Samad D, 2007, PEPTIDES, V28, P281, DOI 10.1016/j.peptides.2006.09.028; ALLEN JM, 1984, REGUL PEPTIDES, V8, P61, DOI 10.1016/0167-0115(84)90029-6; Almeida PC, 2000, BBA-PROTEIN STRUCT M, V1479, P83, DOI 10.1016/S0167-4838(00)00049-2; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bitran M, 1999, BRAIN RES, V851, P87, DOI 10.1016/S0006-8993(99)02123-X; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Cardin A D, 1986, Adv Exp Med Biol, V198 Pt A, P195; Cavadas C, 2006, P NATL ACAD SCI USA, V103, P10497, DOI 10.1073/pnas.0600913103; CORDER R, 1985, PEPTIDES, V6, P1195, DOI 10.1016/0196-9781(85)90450-4; DE MI, 2003, ADV EXP MED BIOL, V524, P3; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Grouzmann E, 2002, FASEB J, V16, P1132, DOI 10.1096/fj.01-0939fje; Grouzmann E, 1997, J BIOL CHEM, V272, P7699, DOI 10.1074/jbc.272.12.7699; GROUZMANN E, 1989, J CLIN ENDOCR METAB, V68, P808, DOI 10.1210/jcem-68-4-808; ICHINOSE A, 1986, J BIOL CHEM, V261, P3486; Jackson DN, 2005, J PHYSIOL-LONDON, V568, P573, DOI 10.1113/jphysiol.2005.092700; Khan IU, 2007, BIOPOLYMERS, V88, P182, DOI 10.1002/bip.20666; Kippen AD, 1997, J BIOL CHEM, V272, P12513, DOI 10.1074/jbc.272.19.12513; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LEDUC R, 1990, LIFE SCI, V46, P1427, DOI 10.1016/0024-3205(90)90458-4; LUNDBERG JM, 1985, BIOCHEM BIOPH RES CO, V133, P30, DOI 10.1016/0006-291X(85)91837-6; Malis DD, 1999, BRIT J PHARMACOL, V126, P989, DOI 10.1038/sj.bjp.0702388; MEDEIROS MD, 1994, ENDOCRINOLOGY, V134, P2088, DOI 10.1210/en.134.5.2088; Mentlein R, 1996, PEPTIDES, V17, P709, DOI 10.1016/0196-9781(96)00066-6; MENTLEIN R, 1993, REGUL PEPTIDES, V49, P133, DOI 10.1016/0167-0115(93)90435-B; METTERS KM, 1988, J BIOL CHEM, V263, P12543; Michel MC, 1998, PHARMACOL REV, V50, P143; Moser C, 2000, CAN J PHYSIOL PHARM, V78, P134, DOI 10.1139/cjpp-78-2-134; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; OHNO H, 1980, THROMB RES, V19, P579, DOI 10.1016/0049-3848(80)90030-4; OHNO H, 1981, THROMB RES, V24, P445, DOI 10.1016/0049-3848(81)90078-5; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Pons Jennifer, 2004, Curr Opin Investig Drugs, V5, P957; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; SAHU A, 1993, TRENDS ENDOCRIN MET, V4, P217, DOI 10.1016/1043-2760(93)90125-X; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Silva AP, 2003, REGUL PEPTIDES, V116, P71, DOI 10.1016/S0167-0115(03)00191-5; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Stocklin R, 1997, DIABETES, V46, P44, DOI 10.2337/diabetes.46.1.44; THEODORSSONNORHEIM E, 1985, SCAND J CLIN LAB INV, V45, P355, DOI 10.3109/00365518509161019; Veloso D, 2003, SCAND J CLIN LAB INV, V63, P279, DOI 10.1080/00365510310001735; WAHLESTEDT C, 1985, J PHARMACOL EXP THER, V234, P735; WALKER P, 1991, TRENDS PHARMACOL SCI, V12, P111, DOI 10.1016/0165-6147(91)90518-W; WESTFALL TC, 1987, J CARDIOVASC PHARM, V10, P716, DOI 10.1097/00005344-198712000-00016; Wiest R, 2006, J HEPATOL, V44, P512, DOI 10.1016/j.jhep.2005.08.023; YARON A, 1968, BIOCHEM BIOPH RES CO, V32, P658, DOI 10.1016/0006-291X(68)90289-1	49	53	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24715	24724		10.1074/jbc.M109.035253	http://dx.doi.org/10.1074/jbc.M109.035253			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620246	Green Published, hybrid			2022-12-25	WOS:000269734000006
J	Cho, YD; Yoon, WJ; Woo, KM; Baek, JH; Lee, G; Cho, JY; Ryoo, HM				Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Lee, Gene; Cho, Je-Yoel; Ryoo, Hyun-Mo			Molecular Regulation of Matrix Extracellular Phosphoglycoprotein Expression by Bone Morphogenetic Protein-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; ALKALINE-PHOSPHATASE EXPRESSION; OSTEOBLAST DIFFERENTIATION; HOMEODOMAIN PROTEINS; SIBLING PROTEINS; GENE-EXPRESSION; MEPE; RUNX2; DLX5; BINDING	Matrix extracellular phosphoglycoprotein (MEPE) is mainly expressed in mineralizing tissues, and its C-terminal proteolytic cleavage product is an acidic-serine-asparate-rich-MEPE-associated motif (ASARM) that is a strong regulator of body phosphate metabolism and mineralization. There is sufficient data supporting a role for MEPE protein function in mineralization, however, little is known about the regulation of MEPE gene expression. As bone morphogenetic protein-2 (BMP-2) is one of the most important signals for calvarial mineralization and MEPE expression is higher in mineralized tissues, we attempted to uncover a regulatory circuit between BMP-2 and MEPE expression. Mepe expression is very low in proliferating MC3T3-E1 cells, but is dramatically increased in the mineralization stage and is strongly stimulated by treatment with BMP-2, even in proliferating cells. Overexpression and knockdown experiments of Smads, Dlx5, and Runx2 indicated that they are indispensable mediators of BMP-2-induced Mepe expression. In contrast, Msx2 showed strong inhibition of Mepe transcription. PHEX is an enzyme that prevents the release of the ASARM motif, a mineralization inhibitor, from the MEPE molecule. Thus, the MEPE/PHEX ratio may be a good indicator of mineralization progression because we found that the mRNA ratio and protein levels were low when osteoblasts were actively differentiating to the mineralization stage and the ratio was high when the cells reached the mineralization stage when it is assumed that osteocytes may protect themselves and make a space to survive from the mineralized matrix by releasing the ASARM motif. Collectively, MEPE expression is bone cell-specific and induced by the BMP-2 signaling pathway. In addition, the MEPE/PHEX ratio of the cell could be a very important barometer indicating the progression of tissue mineralization.	[Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Dept Cell & Dev Biol, Seoul 100749, South Korea; [Lee, Gene] Seoul Natl Univ, Dept Biochem, Sch Dent, Seoul 100749, South Korea; [Lee, Gene] Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 100749, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Dept Biochem, Sch Dent, Taegu 700422, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Skeletal Dis Genome Res Ctr, Taegu 700422, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Cho, Young-Dan/AAR-4573-2021; Baek, Jeong-Hwa/A-8628-2012; Woo, Kyung Mi/A-2793-2009; Ryoo, Hyun-Mo/D-5839-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341	Ministry of Health and Welfare [A010252]; Korean Government (MOEHRD) [KRF-2006-I00680A]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare Project A010252, and a Korea Research Foundation grant funded by Korean Government (MOEHRD) Grant KRF-2006-I00680A.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Argiro L, 2001, GENOMICS, V74, P342, DOI 10.1006/geno.2001.6553; Barnes GL, 2003, CANCER RES, V63, P2631; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cho JY, 2006, GENE, V372, P71, DOI 10.1016/j.gene.2005.12.010; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; Dodig M, 1996, J BIOL CHEM, V271, P16422, DOI 10.1074/jbc.271.27.16422; Econs MJ, 1997, J CLIN INVEST, V100, P2653, DOI 10.1172/JCI119809; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; HOFFMANN HM, 1994, P NATL ACAD SCI USA, V91, P12887, DOI 10.1073/pnas.91.26.12887; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Liu H, 2004, J DENT RES, V83, P496, DOI 10.1177/154405910408300612; MARTIN A, 2007, J BONE MINER RES, V22, pF1118; Nagel DE, 2004, J CELL BIOCHEM, V93, P1107, DOI 10.1002/jcb.20249; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Petersen DN, 2000, J BIOL CHEM, V275, P36172, DOI 10.1074/jbc.M003622200; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rowe PSN, 2004, CRIT REV ORAL BIOL M, V15, P264, DOI 10.1177/154411130401500503; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Six N, 2007, J DENT RES, V86, P780, DOI 10.1177/154405910708600818; Sprowson AP, 2008, J ORTHOP RES, V26, P1256, DOI 10.1002/jor.20606; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; White KE, 2006, ENDOCR REV, V27, P221, DOI 10.1210/er.2005-0019; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	37	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25230	25240		10.1074/jbc.M109.008391	http://dx.doi.org/10.1074/jbc.M109.008391			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617624	Green Published, hybrid			2022-12-25	WOS:000269734000057
J	Corda, D; Kudo, T; Zizza, P; Iurisci, C; Kawai, E; Kato, N; Yanaka, N; Mariggio, S				Corda, Daniela; Kudo, Takahiro; Zizza, Pasquale; Iurisci, Cristiano; Kawai, Eri; Kato, Norihisa; Yanaka, Noriyuki; Mariggio, Stefania			The Developmentally Regulated Osteoblast Phosphodiesterase GDE3 Is Glycerophosphoinositol-specific and Modulates Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; MEMBRANE-PROTEIN; PHOSPHOINOSITIDE METABOLITE; ESCHERICHIA-COLI; THYROID-CELLS; DIFFERENTIATION; 4-PHOSPHATE; TRANSPORTER; PROMOTES	The glycerophosphodiester phosphodiesterase enzyme family involved in the hydrolysis of glycerophosphodiesters has been characterized in bacteria and recently identified in mammals. Here, we have characterized the activity and function of GDE3, one of the seven mammalian enzymes. GDE3 is up-regulated during osteoblast differentiation and can affect cell morphology. We show that GDE3 is a glycerophosphoinositol (GroPIns) phosphodiesterase that hydrolyzes GroPIns, producing inositol 1-phosphate and glycerol, and thus suggesting specific roles for this enzyme in GroPIns metabolism. Substrate specificity analyses show that wild-type GDE3 selectively hydrolyzes GroPIns over glycerophosphocholine, glycerophosphoethanolamine, and glycerophosphoserine. A single point mutation in the catalytic domain of GDE3 (GDE3R231A) leads to loss of GroPIns enzymatic hydrolysis, identifying an arginine residue crucial for GDE3 activity. After heterologous GDE3 expression in HEK293T cells, phosphodiesterase activity is detected in the extracellular medium, with no effect on the intracellular GroPIns pool. Together with the millimolar concentrations of calcium required for GDE3 activity, this predicts an enzyme topology with an extracellular catalytic domain. Interestingly, GDE3 ectocellular activity is detected in a stable clone from a murine osteoblast cell line, further confirming the activity of GDE3 in a more physiological context. Finally, overexpression of wild-type GDE3 in osteoblasts promotes disassembly of actin stress fibers, decrease in growth rate, and increase in alkaline phosphatase activity and calcium content, indicating a role for GDE3 in induction of differentiation. Thus, we have identified the GDE3 substrate GroPIns as a candidate mediator for osteoblast proliferation, in line with the GroPIns activity observed previously in epithelial cells.	[Corda, Daniela; Zizza, Pasquale; Iurisci, Cristiano; Mariggio, Stefania] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Kudo, Takahiro; Kato, Norihisa; Yanaka, Noriyuki] Hiroshima Univ, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Kawai, Eri] Mitsubishi Tanabe Pharma Corp, Adv Med Res Dept, Yodogawa Ku, Osaka 5328505, Japan	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Hiroshima University; Mitsubishi Tanabe Pharma Corporation	Corda, D (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy.	corda@negrisud.it; yanaka@hiroshima-u.ac.jp; mariggio@negrisud.it	Yanaka, Noriyuki/P-9096-2016; Corda, Daniela/K-6385-2016; Mariggio', Stefania/H-5467-2015; Zizza, Pasquale/K-3292-2018	Corda, Daniela/0000-0002-3614-751X; Mariggio', Stefania/0000-0002-6397-3016; Zizza, Pasquale/0000-0001-7281-6090	Telethon Italia (Italy); Italian Association for Cancer Research (AIRC, Milan, Italy); MIUR (Italy)	Telethon Italia (Italy)(Fondazione Telethon); Italian Association for Cancer Research (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); MIUR (Italy)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Telethon Italia (Italy), the Italian Association for Cancer Research (AIRC, Milan, Italy), and the MIUR (Italy).	Ahren IL, 2001, MICROB PATHOGENESIS, V31, P151, DOI 10.1006/mpat.2001.0456; Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Chang PA, 2008, MOL MEMBR BIOL, V25, P557, DOI 10.1080/09687680802537605; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Datta NS, 2005, J BONE MINER RES, V20, P1051, DOI 10.1359/JBMR.050106; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Filippi BM, 2008, BBA-MOL CELL RES, V1783, P2311, DOI 10.1016/j.bbamcr.2008.07.021; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Mancini R, 2003, MOL BIOL CELL, V14, P503, DOI 10.1091/mbc.E02-04-0179; Mariggio S, 2007, CANCER RES, V67, P11769, DOI 10.1158/0008-5472.CAN-07-1997; Mariggio S, 2006, FEBS LETT, V580, P6789, DOI 10.1016/j.febslet.2006.11.039; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Patrussi L, 2007, CELL SIGNAL, V19, P2351, DOI 10.1016/j.cellsig.2007.07.014; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; VALITUTTI S, 1991, CELL SIGNAL, V3, P321, DOI 10.1016/0898-6568(91)90061-X; Waite M, 1999, BBA-MOL CELL BIOL L, V1439, P187, DOI 10.1016/S1388-1981(99)00094-3; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100	27	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24848	24856		10.1074/jbc.M109.035444	http://dx.doi.org/10.1074/jbc.M109.035444			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19596859	Green Published, hybrid			2022-12-25	WOS:000269734000019
J	Hiroi, M; Mori, K; Sekine, K; Sakaeda, Y; Shimada, J; Ohmori, Y				Hiroi, Miki; Mori, Kazumasa; Sekine, Keisuke; Sakaeda, Yoshiichi; Shimada, Jun; Ohmori, Yoshihiro			Mechanisms of Resistance to Interferon-gamma-mediated Cell Growth Arrest in Human Oral Squamous Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; MESSENGER-RNA STABILITY; C-MYC EXPRESSION; FACTOR-KAPPA-B; IFN-GAMMA; MELANOMA-CELLS; PROTEIN-KINASE; INHIBITOR P21(WAF1/CIP1); TARGETED DISRUPTION; SIGNAL TRANSDUCER	Interferon-gamma (IFN gamma) has an antiproliferative effect on a variety of tumor cells. However, many tumor cells resist treatment with IFNs. Here, we show that IFN gamma fails to inhibit the growth of some types of oral squamous cell carcinoma (OSCC) cells that possess a fully functional IFN gamma/STAT1 (signal transducer and activator of transcription-1) signaling pathway. IFN gamma inhibited the growth of the HSC-2, HSC-3, and HSC-4 OSCC cell lines. However, Ca9-22 cells were resistant to IFN gamma despite having intact STAT1-dependent signaling, such as normal tyrosine phosphorylation, DNA binding activity, and transcriptional activity of STAT1. The growth inhibition of HSC-2 cells resulted from S-phase arrest of the cell cycle. IFN gamma inhibited cyclin A2 (CcnA2)-associated kinase activity, which correlated with the IFN gamma-mediated down-regulation of CcnA2 and Cdk2 expression at both the transcriptional and post-transcriptional level in HSC-2 cells but not in Ca9-22 cells. RNAi-mediated knockdown of CcnA2 and Cdk2 resulted in growth inhibition in both cell lines. These results indicate that the resistance of OSCC to IFN gamma is not due simply to the deficiency in STAT1-dependent signaling but results from a defect in the signaling component that mediates this IFN gamma-induced down-regulation of CcnA2 and Cdk2 expression at the transcriptional and post-transcriptional levels.	[Mori, Kazumasa; Shimada, Jun] Meikai Univ, Div Oral & Maxillofacial Surg, Dept Diagnost & Therapeut Sci, Sch Dent, Sakado, Saitama 3500283, Japan; Meikai Univ, Div Microbiol & Immunol, Dept Oral Biol & Tissue Engn, Sch Dent, Sakado, Saitama 3500283, Japan	Meikai University; Meikai University		ohmori@dent.meikai.ac.jp		Ohmori, Yoshihiro/0000-0002-6069-357X; Sekine, Keisuke/0000-0001-5133-0876	Ministry of Education, Science, and Culture of Japan; Meikai University School of Dentistry	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Meikai University School of Dentistry	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan and from the Meikai University School of Dentistry.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Asao H, 2000, J BIOL CHEM, V275, P867, DOI 10.1074/jbc.275.2.867; BENNETT MR, 1994, BIOCHEM J, V302, P701, DOI 10.1042/bj3020701; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Chawla-Sarkar M, 2002, J INTERF CYTOK RES, V22, P603, DOI 10.1089/10799900252982089; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Clifford JL, 2002, CLIN CANCER RES, V8, P2067; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dovhey SE, 2000, CANCER RES, V60, P5789; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EL DW, 1993, CELL, V75, P817; Fang P, 2006, EXP CELL RES, V312, P1229, DOI 10.1016/j.yexcr.2005.12.011; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; HARPER JW, 1993, CELL, V75, P805; Harvat BL, 1996, CELL GROWTH DIFFER, V7, P289; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Hiroi M, 2003, BIOCHEM J, V376, P393, DOI 10.1042/BJ20030842; JONAK GJ, 1984, P NATL ACAD SCI-BIOL, V81, P1747, DOI 10.1073/pnas.81.6.1747; KAMATA N, 1986, CANCER RES, V46, P1648; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kominsky S, 1998, ONCOGENE, V17, P2973, DOI 10.1038/sj.onc.1202217; Kortylewski M, 2004, J INVEST DERMATOL, V122, P414, DOI 10.1046/j.0022-202X.2004.22237.x; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Lei HQ, 2005, CANCER BIOL THER, V4, P709, DOI 10.4161/cbt.4.7.1767; Mandal M, 1998, ONCOGENE, V16, P217, DOI 10.1038/sj.onc.1201529; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Ohmori Y, 1997, J IMMUNOL, V159, P5474; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Sangfelt O, 1997, ONCOGENE, V14, P415, DOI 10.1038/sj.onc.1200832; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; Sibinga NES, 1999, J BIOL CHEM, V274, P12139, DOI 10.1074/jbc.274.17.12139; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; Vivo C, 2001, ONCOGENE, V20, P1085, DOI 10.1038/sj.onc.1204199; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; XU B, 1994, BLOOD, V84, P1942; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928	55	7	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24869	24880		10.1074/jbc.M109.025932	http://dx.doi.org/10.1074/jbc.M109.025932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19596857	Green Published, hybrid			2022-12-25	WOS:000269734000021
J	Srivastava, S; Hamouda, AK; Pandhare, A; Duddempudi, PK; Sanghvi, M; Cohen, JB; Blanton, MP				Srivastava, Shouryadeep; Hamouda, Ayman K.; Pandhare, Akash; Duddempudi, Phaneendra K.; Sanghvi, Mitesh; Cohen, Jonathan B.; Blanton, Michael P.			[H-3]Epibatidine Photolabels Non-equivalent Amino Acids in the Agonist Binding Site of Torpedo and alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CURARIFORM ANTAGONISTS BIND; DIFFERENT ORIENTATIONS; MOLECULAR DOCKING; LIGAND; PROTEIN; DOMAIN; IDENTIFICATION; CONFORMATIONS; STOICHIOMETRY; PHARMACOLOGY	Nicotinic acetylcholine receptor (nAChR) agonists, such as epibatidine and its molecular derivatives, are potential therapeutic agents for a variety of neurological disorders. In order to identify determinants for subtype-selective agonist binding, it is important to determine whether an agonist binds in a common orientation in different nAChR subtypes. To compare the mode of binding of epibatidine in a muscle and a neuronal nAChR, we photolabeled Torpedo alpha(2)beta gamma delta and expressed human alpha 4 beta 2 nAChRs with [H-3]epibatidine and identified by Edman degradation the photolabeled amino acids. Irradiation at 254 nm resulted in photolabeling of alpha Tyr(198) in agonist binding site Segment C of the principal (+) face in both alpha subunits and of gamma Leu(109) and gamma Tyr(117) in Segment E of the complementary (-) face, with no labeling detected in the delta subunit. For affinity-purified alpha 4 beta 2 nAChRs, [H-3]epibatidine photolabeled alpha 4Tyr(195) (equivalent to Torpedo alpha Tyr(190)) in Segment C as well as beta 2Val(111) and beta 2Ser(113) in Segment E (equivalent to Torpedo gamma Leu(109) and gamma Tyr(111), respectively). Consideration of the location of the photolabeled amino acids in homology models of the nAChRs based upon the acetylcholine-binding protein structure and the results of ligand docking simulations suggests that epibatidine binds in a single preferred orientation within the alpha-gamma transmitter binding site, whereas it binds in two distinct orientations in the alpha 4 beta 2 nAChR.	[Srivastava, Shouryadeep; Pandhare, Akash; Duddempudi, Phaneendra K.; Sanghvi, Mitesh; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Sch Med, Lubbock, TX 79430 USA; [Srivastava, Shouryadeep; Pandhare, Akash; Duddempudi, Phaneendra K.; Sanghvi, Mitesh; Blanton, Michael P.] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Sch Med, Lubbock, TX 79430 USA; [Hamouda, Ayman K.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Harvard University; Harvard Medical School	Blanton, MP (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Sch Med, 3601 4th St, Lubbock, TX 79430 USA.	michael.blanton@ttuhsc.edu	Pandhare, Akash/M-1827-2016; Duddempudi, Phaneendra/AAL-8015-2020; Sanghvi, Mitesh/C-6740-2013	Duddempudi, Phaneendra/0000-0002-2625-8179; Hamouda, Ayman/0000-0001-7819-3074	National Institutes of Health [GM-58448]; American Heart Association South Central [0755029Y]; South Plains Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association South Central(American Heart Association); South Plains Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448 (to J. B. C.). This work was also supported in part by American Heart Association South Central Affiliate Grant-in-Aid 0755029Y (to M. P. B.) and the South Plains Foundation (to M. P. B.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; Chiara DC, 1998, FEBS LETT, V423, P223, DOI 10.1016/S0014-5793(98)00093-3; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HAMOUDA AK, 2008, BIOPHYS J, V94, pA1418; Hamouda AK, 2007, BIOCHEMISTRY-US, V46, P13837, DOI 10.1021/bi701705r; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; NEUBIG RR, 1979, BIOCHEMISTRY-US, V18, P5464, DOI 10.1021/bi00591a032; Nirthanan S, 2005, BIOCHEMISTRY-US, V44, P13447, DOI 10.1021/bi051209y; OHKURA K, 1989, TETRAHEDRON LETT, V30, P3433, DOI 10.1016/S0040-4039(00)99264-5; PEDERSEN SE, 1986, J BIOL CHEM, V261, P3735; Prince RJ, 1998, J BIOL CHEM, V273, P7843, DOI 10.1074/jbc.273.14.7843; Song XZ, 2003, BIOCHEMISTRY-US, V42, P4197, DOI 10.1021/bi027405b; Tomizawa M, 2008, P NATL ACAD SCI USA, V105, P1728, DOI 10.1073/pnas.0711724105; Tomizawa M, 2007, BIOCHEMISTRY-US, V46, P8798, DOI 10.1021/bi700667v; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vodovozova EL, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1, DOI 10.1134/S0006297907010014; Wang HL, 2003, J BIOL CHEM, V278, P32284, DOI 10.1074/jbc.M304366200; Wells GB, 2008, FRONT BIOSCI-LANDMRK, V13, P5479, DOI 10.2741/3094; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITTEN DG, 1976, PHOTOCHEMISTRY HETER, P524; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhang J, 2003, BRAIN RES, V959, P98, DOI 10.1016/S0006-8993(02)03733-2; ZOLTEWICZ JA, 1983, J ORG CHEM, V48, P4214, DOI 10.1021/jo00171a012	46	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24939	24947		10.1074/jbc.M109.019083	http://dx.doi.org/10.1074/jbc.M109.019083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620239	Green Published, hybrid			2022-12-25	WOS:000269734000028
J	Zhang, M; Wang, FC; Kou, ZH; Zhang, Y; Gao, SR				Zhang, Miao; Wang, Fengchao; Kou, Zhaohui; Zhang, Yu; Gao, Shaorong			Defective Chromatin Structure in Somatic Cell Cloned Mouse Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; STEM-CELLS; NUCLEAR TRANSFER; TRICHOSTATIN-A; DONOR CELLS; CLONING; PLURIPOTENCY; PROTEIN; OCT4	Epigenetic reprogramming plays a central role in the development of cloned embryos generated by somatic cell nuclear transfer, and it is believed that aberrant reprogramming leads to the abnormal development of most cloned embryos. Recent studies show that trimethylation of H3K27 (H3K27me3) contributes to the maintenance of embryonic stem cell pluripotency because the differentiation genes are always occupied by nucleosomes trimethylated at H3K27, which represses gene expression. Here, we provide evidence that differential H3K27me3 modification exists between normal fertilization-produced blastocysts and somatic cell nuclear transfer cloned blastocysts; H3K27me3 was specifically found in cells of the inner cell mass (ICM) of normal blastocysts, whereas there was no modification of H3K27me3 in the ICM of cloned blastocysts. Subsequently, we demonstrated that the differentiation-related genes, which are marked by H3K27me3 in embryonic stem cells, were expressed at significantly higher levels in cloned embryos than in normal embryos. The polycomb repressive complex 2 (PRC2) component genes (Eed, Ezh2, and Suz12), which are responsible for the generation of H3K27me3, were expressed at lower levels in the cloned embryos. Our results suggest that reduced expression of PRC2 component genes in cloned embryos results in defective modification of H3K27me3 to the differentiation-related genes in pluripotent ICM cells. This results in premature expression of developmental genes and death of somatic cloned embryos shortly after implantation. Taken together, these studies suggest that H3K27me3 might be an important epigenetic marker with which to evaluate the developmental potential of cloned embryos.	[Zhang, Miao; Wang, Fengchao; Kou, Zhaohui; Zhang, Yu; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn			Ministry of Science and Technology of China [2008AA022311, 2009CB941100]; National Natural Science Foundation [30670302]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 2008AA022311 and 2009CB941100 from the Ministry of Science and Technology of China and Grant 30670302 from the National Natural Science Foundation.	Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faust C, 1998, DEVELOPMENT, V125, P4495; Gao SR, 2003, BIOL REPROD, V69, P48, DOI 10.1095/biolreprod.102.014522; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamazaki Y, 2006, MOL REPROD DEV, V73, P180, DOI 10.1002/mrd.20411; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	36	52	59	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24981	24987		10.1074/jbc.M109.011973	http://dx.doi.org/10.1074/jbc.M109.011973			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602512	Green Published, hybrid			2022-12-25	WOS:000269734000033
J	Maass, D; Arango, J; Wust, F; Beyer, P; Welsch, R				Maass, Dirk; Arango, Jacobo; Wuest, Florian; Beyer, Peter; Welsch, Ralf			Carotenoid Crystal Formation in Arabidopsis and Carrot Roots Caused by Increased Phytoene Synthase Protein Levels	PLOS ONE			English	Article								Background: As the first pathway-specific enzyme in carotenoid biosynthesis, phytoene synthase (PSY) is a prime regulatory target. This includes a number of biotechnological approaches that have successfully increased the carotenoid content in agronomically relevant non-green plant tissues through tissue-specific PSY overexpression. We investigated the differential effects of constitutive AtPSY overexpression in green and non-green cells of transgenic Arabidopsis lines. This revealed striking similarities to the situation found in orange carrot roots with respect to carotenoid amounts and sequestration mechanism. Methology/Principal Findings: In Arabidopsis seedlings, carotenoid content remained unaffected by increased AtPSY levels although the protein was almost quantitatively imported into plastids, as shown by western blot analyses. In contrast, nonphotosynthetic calli and roots overexpressing AtPSY accumulated carotenoids 10 and 100-fold above the corresponding wild-type tissues and contained 1800 and 500 mu g carotenoids per g dry weight, respectively. This increase coincided with a change of the pattern of accumulated carotenoids, as xanthophylls decreased relative to beta-carotene and carotene intermediates accumulated. As shown by polarization microscopy, carotenoids were found deposited in crystals, similar to crystalline-type chromoplasts of non-green tissues present in several other taxa. In fact, orange-colored carrots showed a similar situation with increased PSY protein as well as carotenoid levels and accumulation patterns whereas wild white-rooted carrots were similar to Arabidopsis wild type roots in this respect. Initiation of carotenoid crystal formation by increased PSY protein amounts was further confirmed by overexpressing crtB, a bacterial PSY gene, in white carrots, resulting in increased carotenoid amounts deposited in crystals. Conclusions: The sequestration of carotenoids into crystals can be driven by the functional overexpression of one biosynthetic enzyme in non-green plastids not requiring a chromoplast developmental program as this does not exist in Arabidopsis. Thus, PSY expression plays a major, rate-limiting role in the transition from white to orange-colored carrots.			Maass, D (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.	ralf.welsch@biologie.uni-freiburg.de	Welsch, Ralf/H-3157-2019	Welsch, Ralf/0000-0002-2865-2743; Wust, Florian/0000-0002-9941-5550; Arango, Jacobo/0000-0002-4828-9398				Al-Babili S, 2006, J EXP BOT, V57, P1007, DOI 10.1093/jxb/erj086; Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; BANGA O., 1957, EUPHYTICA, V6, P64; Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; BARROS T, 2009, BIOCH BIOPH IN PRESS; BARTLEY GE, 1993, J BIOL CHEM, V268, P25718; BATHGATE B, 1985, PLANTA, V165, P197, DOI 10.1007/BF00395042; Bechtold N, 1998, METH MOL B, V82, P259; BENSHAUL Y, 1969, PROTOPLASMA, V67, P333, DOI 10.1007/BF01254899; BENSHAUL Y, 1965, BOT GAZ, V126, P79, DOI 10.1086/336299; Bonk M, 1997, EUR J BIOCHEM, V247, P942, DOI 10.1111/j.1432-1033.1997.00942.x; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Camara B, 1995, INT REV CYTOL, V163, P175, DOI 10.1016/S0074-7696(08)62211-1; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DERUERE J, 1994, PLANT CELL, V6, P119, DOI 10.1105/tpc.6.1.119; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Fraser PD, 2007, PLANT CELL, V19, P3194, DOI 10.1105/tpc.106.049817; Fraser PD, 1999, PLANT MOL BIOL, V40, P687, DOI 10.1023/A:1006256302570; FRAY RG, 1995, PLANT J, V8, P693, DOI 10.1046/j.1365-313X.1995.08050693.x; Giorio G, 2008, FEBS J, V275, P527, DOI 10.1111/j.1742-4658.2007.06219.x; Hardegger M, 1998, MOL BREEDING, V4, P119, DOI 10.1023/A:1009681725540; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Koch TC, 2005, J AGR FOOD CHEM, V53, P325, DOI 10.1021/jf048272z; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; Li L, 2001, PLANT J, V26, P59, DOI 10.1046/j.1365-313x.2001.01008.x; Li L, 2006, PHYTOCHEMISTRY, V67, P1177, DOI 10.1016/j.phytochem.2006.05.013; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Mathur J, 1998, METH MOL B, V82, P27; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Pyke KA, 2002, ANN BOT-LONDON, V90, P559, DOI 10.1093/aob/mcf235; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Santos CAF, 2005, GENET MOL BIOL, V28, P287, DOI 10.1590/S1415-47572005000200019; Schledz M, 1996, PLANT J, V10, P781, DOI 10.1046/j.1365-313X.1996.10050781.x; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; SCOLNIK PA, 1994, PLANT PHYSIOL, V104, P1471, DOI 10.1104/pp.104.4.1471; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; STRAUB O, 1998, KEY CAROTENOIDS; STRAUS W, 1961, PROTOPLASMA, V53, P405, DOI 10.1007/BF01247869; Surles RL, 2004, J AGR FOOD CHEM, V52, P3417, DOI 10.1021/jf035472m; Thelander M., 1986, CURR TOP PLANT BIOCH, V5, P128; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; WACKENRODER HW, 1831, CHEM ZENTRALBLATT, V1, P197; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2003, PLANTA, V216, P523, DOI 10.1007/s00425-002-0885-3; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	60	176	186	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6373	10.1371/journal.pone.0006373	http://dx.doi.org/10.1371/journal.pone.0006373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636414	gold, Green Published, Green Submitted			2022-12-25	WOS:000268404900008
J	Kostic, A; Lynch, CD; Sheetz, MP				Kostic, Ana; Lynch, Christopher D.; Sheetz, Michael P.			Differential Matrix Rigidity Response in Breast Cancer Cell Lines Correlates with the Tissue Tropism	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MAMMARY EPITHELIUM; METASTASIS GENES; SUBSTRATE; EXPRESSION; REGULATORS; PHENOTYPE; MECHANICS; PROGNOSIS; SIGNATURE	Metastasis to a variety of distant organs, such as lung, brain, bone, and liver, is a leading cause of mortality in the breast cancer patients. The tissue tropism of breast cancer metastasis has been recognized and studied extensively, but the cellular processes underlying this phenomenon, remain elusive. Modern technologies have enabled the discovery of a number of the genetic factors determining tissue tropism of malignant cells. However, the effect of these genetic differences on the cell motility and invasiveness is poorly understood. Here, we report that cellular responses to the mechanical rigidity of the extracellular matrix correlate with the rigidity of the target tissue. We tested a series of single cell populations isolated from MDA-MB-231 breast cancer cell line in a variety of assays where the extracellular matrix rigidity was varied to mimic the environment that these cells might encounter in vivo. There was increased proliferation and migration through the matrices of rigidities corresponding to the native rigidities of the organs where metastasis was observed. We were able to abolish the differential matrix rigidity response by knocking down Fyn kinase, which was previously identified as a critical component of the FN rigidity response pathway in healthy cells. This result suggests possible molecular mechanisms of the rigidity response in the malignant cells, indicating potential candidates for therapeutic interventions.			Kostic, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu						Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Bouzahzah B, 2001, MOL MED, V7, P816, DOI 10.1007/BF03401974; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; HART IR, 1980, CANCER RES, V40, P2281; INGBER DE, 2008, SEMIN CANC BIOL; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kirschmann DA, 1999, BREAST CANCER RES TR, V55, P127; Klein A, 2009, CANCER LETT, V276, P212, DOI 10.1016/j.canlet.2008.11.017; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Lee H, 2003, INT J CANCER, V107, P528, DOI 10.1002/ijc.11428; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Ma Y, 2007, CLIN CANCER RES, V13, P2014, DOI 10.1158/1078-0432.CCR-06-2222; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; PAGET S, 1989, CANCER METAST REV, V8, P98; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Taddei I, 2003, J MAMMARY GLAND BIOL, V8, P383, DOI 10.1023/B:JOMG.0000017426.74915.b9; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	32	113	116	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6361	10.1371/journal.pone.0006361	http://dx.doi.org/10.1371/journal.pone.0006361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626122	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260200007
J	Muzumdar, RH; Huffman, DM; Atzmon, G; Buettner, C; Cobb, LJ; Fishman, S; Budagov, T; Cui, LG; Einstein, FH; Poduval, A; Hwang, D; Barzilai, N; Cohen, P				Muzumdar, Radhika H.; Huffman, Derek M.; Atzmon, Gil; Buettner, Christoph; Cobb, Laura J.; Fishman, Sigal; Budagov, Temuri; Cui, Lingguang; Einstein, Francine H.; Poduval, Aruna; Hwang, David; Barzilai, Nir; Cohen, Pinchas			Humanin: A Novel Central Regulator of Peripheral Insulin Action	PLOS ONE			English	Article								Background: Decline in insulin action is a metabolic feature of aging and is involved in the development of age-related diseases including Type 2 Diabetes Mellitus (T2DM) and Alzheimer's disease (AD). A novel mitochondria-associated peptide, Humanin (HN), has a neuroprotective role against AD-related neurotoxicity. Considering the association between insulin resistance and AD, we investigated if HN influences insulin sensitivity. Methods and Findings: Using state of the art clamp technology, we examined the role of central and peripheral HN on insulin action. Continuous infusion of HN intra-cerebro-ventricularly significantly improved overall insulin sensitivity. The central effects of HN on insulin action were associated with activation of hypothalamic STAT-3 signaling; effects that were negated by co-inhibition of hypothalamic STAT-3. Peripheral intravenous infusions of novel and potent HN derivatives reproduced the insulin-sensitizing effects of central HN. Inhibition of hypothalamic STAT-3 completely negated the effects of IV HN analog on liver, suggesting that the hepatic actions of HN are centrally mediated. This is consistent with the lack of a direct effect of HN on primary hepatocytes. Furthermore, single treatment with a highly-potent HN analog significantly lowered blood glucose in Zucker diabetic fatty rats. Based upon the link of HN with two age-related diseases, we examined if there were age associated changes in HN levels. Indeed, the amount of detectable HN in hypothalamus, skeletal muscle, and cortex was decreased with age in rodents, and circulating levels of HN were decreased with age in humans and mice. Conclusions: We conclude that the decline in HN with age could play a role in the pathogenesis of age-related diseases including AD and T2DM. HN represents a novel link between T2DM and neurodegeneration and along with its analogues offers a potential therapeutic tool to improve insulin action and treat T2DM.			Muzumdar, RH (corresponding author), Childrens Hosp Montefiore, Dept Pediat, Inst Aging Res, Diabet Res & Training Ctr,Albert Einstein Coll Me, Bronx, NY 10467 USA.	barzilai@aecom.yu.edu	Buettner, Christoph/F-5793-2013; Muzumdar, Radhika/D-9860-2014	Buettner, Christoph/0000-0003-0412-4062; 	NCI NIH HHS [R01 CA100938] Funding Source: Medline; NIA NIH HHS [T32 AG23475, K08 AG027462, R01 AG018381, R01 AG18381, P01 AG021654, T32 AG023475] Funding Source: Medline; NICHD NIH HHS [R01 HD047013] Funding Source: Medline; NIDDK NIH HHS [P60 DK020541, P60 DK20541, P30 DK063491, R01 DK083658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA100938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK083658, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475, K08AG027462, P01AG021654, R01AG018381] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; BUETTNER C, 2006, CRITICAL ROLE STAT3, P49; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Duanmu Z, 1999, CLIN EXP HYPERTENS, V21, P1239, DOI 10.3109/10641969909070847; FREDERIKSEN AL, 2009, J CLIN ENDOCRINOL ME; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2004, EUR J NEUROSCI, V19, P2357, DOI 10.1111/j.1460-9568.2004.03298.x; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; HASHIMOTO Y, 2009, MOL BIOL CELL; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Kim HS, 2007, PEDIATR RES, V61, P159, DOI 10.1203/pdr.0b013e31802d8a30; Leffert H L, 1979, Methods Enzymol, V58, P536; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Muzumdar R, 2003, FASEB J, V17, P1130, DOI 10.1096/fj.02-0991fje; Muzumdar RH, 2006, DIABETES, V55, P2788, DOI 10.2337/db06-0318; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Rensink AAM, 2002, ACTA NEUROPATHOL, V104, P525, DOI 10.1007/s00401-002-0585-x; Richards Robert J, 2003, Curr Cardiol Rep, V5, P453, DOI 10.1007/s11886-003-0106-0; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Terashita K, 2003, J NEUROCHEM, V85, P1521, DOI 10.1046/j.1471-4159.2003.01797.x; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f	42	165	172	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6334	10.1371/journal.pone.0006334	http://dx.doi.org/10.1371/journal.pone.0006334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623253	gold, Green Published, Green Submitted			2022-12-25	WOS:000268260100012
J	Kobayashi, T; Washiyama, K; Ikeda, K				Kobayashi, Toru; Washiyama, Kazuo; Ikeda, Kazutaka			Pregnenolone Sulfate Potentiates the Inwardly Rectifying K+ Channel Kir2.3	PLOS ONE			English	Article								Background: Neurosteroids have various physiological and neuropsychopharmacological effects. In addition to the genomic effects of steroids, some neurosteroids modulate several neurotransmitter receptors and channels, such as N-methyl-D-aspartate receptors, gamma-aminobutyric acid type A (GABA(A)) receptors, and sigma(1) receptors, and voltage-gated Ca2+ and K+ channels. However, the molecular mechanisms underlying the various effects of neurosteroids have not yet been sufficiently clarified. In the nervous system, inwardly rectifying K+ (Kir) channels also play important roles in the control of resting membrane potential, cellular excitability and K+ homeostasis. Among constitutively active Kir2 channels in a major Kir subfamily, Kir2.3 channels are expressed predominantly in the forebrain, a brain area related to cognition, memory, emotion, and neuropsychiatric disorders. Methodology/Principal Findings: The present study examined the effects of various neurosteroids on Kir2.3 channels using the Xenopus oocyte expression assay. In oocytes injected with Kir2.3 mRNA, only pregnenolone sulfate (PREGS), among nine neurosteroids tested, reversibly potentiated Kir2.3 currents. The potentiation effect was concentration-dependent in the micromolar range, and the current-voltage relationship showed inward rectification. However, the potentiation effect of PREGS was not observed when PREGS was applied intracellularly and was not affected by extracellular pH conditions. Furthermore, although Kir1.1, Kir2.1, Kir2.2, and Kir3 channels were insensitive to PREGS, in oocytes injected with Kir2.1/Kir2.3 or Kir2.2/Kir2.3 mRNA, but not Kir2.1/Kir2.2 mRNA, PREGS potentiated Kir currents. These potentiation properties in the concentration-response relationships were less potent than for Kir2.3 channels, suggesting action of PREGS on Kir2.3-containing Kir2 heteromeric channels. Conclusions/Significance: The present results suggest that PREGS acts as a positive modulator of Kir2.3 channels. Kir2.3 channel potentiation may provide novel insights into the various effects of PREGS.			Kobayashi, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neuropathol, Chuo Ku, Niigata, Japan.	torukoba@bri.niigata-u.ac.jp	Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278				AKWA Y, 1993, CR ACAD SCI III-VIE, V316, P410; Barbaccia ML, 1996, NEUROENDOCRINOLOGY, V63, P166, DOI 10.1159/000126953; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bicikova M, 2000, NEUROCHEM RES, V25, P1623, DOI 10.1023/A:1026622704704; Caldeira JC, 2004, J NEUROCHEM, V90, P1530, DOI 10.1111/j.1471-4159.2004.02686.x; Chen SC, 2006, BIOCHEM BIOPH RES CO, V349, P626, DOI 10.1016/j.bbrc.2006.08.076; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; CORPECHOT C, 1983, BRAIN RES, V270, P119, DOI 10.1016/0006-8993(83)90797-7; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; DEPERETTI E, 1986, ACTA ENDOCRINOL-COP, V113, P259; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; FFRENCHMULLEN JMH, 1994, J NEUROSCI, V14, P1963; Havlikova H, 2002, J CLIN ENDOCR METAB, V87, P2225, DOI 10.1210/jc.87.5.2225; Higashi T, 2003, BIOL PHARM BULL, V26, P709; Hill M, 2005, STEROIDS, V70, P515, DOI 10.1016/j.steroids.2005.02.013; Hill M, 2002, J STEROID BIOCHEM, V82, P241, DOI 10.1016/S0960-0760(02)00188-7; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Ikeda K, 2003, METH MOLEC MED, V84, P53; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; IWAMORI M, 1976, J NEUROCHEM, V27, P1389, DOI 10.1111/j.1471-4159.1976.tb02620.x; Karschin C, 1996, J NEUROSCI, V16, P3559; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; Kobayashi T, 2000, BRIT J PHARMACOL, V129, P1716, DOI 10.1038/sj.bjp.0703224; Kobayashi T, 2003, BRIT J PHARMACOL, V138, P1119, DOI 10.1038/sj.bjp.0705172; Kobayashi T, 2002, BRIT J PHARMACOL, V135, P313, DOI 10.1038/sj.bjp.0704475; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; KOYAMA H, 1994, FEBS LETT, V341, P303, DOI 10.1016/0014-5793(94)80478-8; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LeMaout S, 1997, P NATL ACAD SCI USA, V94, P13329, DOI 10.1073/pnas.94.24.13329; Liu SY, 2003, ANAL CHEM, V75, P5835, DOI 10.1021/ac0346297; Liu Y, 2002, EUR J PHARMACOL, V435, P153, DOI 10.1016/S0014-2999(01)01590-4; Liu Y, 2001, MOL PHARMACOL, V59, P1061, DOI 10.1124/mol.59.5.1061; Mameli M, 2005, J NEUROSCI, V25, P2285, DOI 10.1523/JNEUROSCI.3877-04.2005; Mayo W, 2001, HORM BEHAV, V40, P215, DOI 10.1006/hbeh.2001.1677; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Mi HY, 1996, J NEUROSCI, V16, P2421; MORFIN R, 1992, P NATL ACAD SCI USA, V89, P6790, DOI 10.1073/pnas.89.15.6790; Munoz V, 2007, HEART RHYTHM, V4, P487, DOI 10.1016/j.hrthm.2006.12.033; Nguyen PN, 2004, J PHYSIOL-LONDON, V560, P593, DOI 10.1113/jphysiol.2004.069336; Park IH, 1997, J STEROID BIOCHEM, V62, P315, DOI 10.1016/S0960-0760(97)00042-3; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Reddy DS, 1998, NEUROREPORT, V9, P3069, DOI 10.1097/00001756-199809140-00028; Reddy DS, 1997, BRAIN RES, V752, P61, DOI 10.1016/S0006-8993(96)01447-3; Reddy DS, 1997, METHOD FIND EXP CLIN, V19, P395; Reddy DS, 1997, EUR J PHARMACOL, V337, P19, DOI 10.1016/S0014-2999(97)01294-6; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Schram G, 2003, CARDIOVASC RES, V59, P328, DOI 10.1016/S0008-6363(03)00366-3; Shirakawa H, 2005, EUR J NEUROSCI, V21, P2329, DOI 10.1111/j.1460-9568.2005.04079.x; Steckelbroeck S, 2004, J NEUROCHEM, V89, P403, DOI 10.1046/j.1471-4159.2004.02336.x; Stonehouse AH, 1999, HISTOCHEM CELL BIOL, V112, P457, DOI 10.1007/s004180050429; Tagawa N, 2000, CLIN CHEM, V46, P523; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; Topert C, 1998, J NEUROSCI, V18, P4096; Torres JM, 2003, NEUROCHEM RES, V28, P1187, DOI 10.1023/A:1024276328127; Ureche ON, 2008, CELL PHYSIOL BIOCHEM, V21, P347, DOI 10.1159/000129629; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang MD, 1997, J STEROID BIOCHEM, V62, P299, DOI 10.1016/S0960-0760(97)00041-1; Wang Q, 1998, PFLUG ARCH EUR J PHY, V437, P49, DOI 10.1007/s004240050745; Williamson J, 2004, NEUROPHARMACOLOGY, V46, P856, DOI 10.1016/j.neuropharm.2003.11.029; Yan CZ, 2004, ACTA PHARMACOL SIN, V25, P1285; Zhang HL, 2001, BIOPHYS J, V80, p629A	67	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6311	10.1371/journal.pone.0006311	http://dx.doi.org/10.1371/journal.pone.0006311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621089	Green Published, gold, Green Submitted			2022-12-25	WOS:000268147200009
J	Michelet, T; Bioulac, B; Guehl, D; Goillandeau, M; Burbaud, P				Michelet, Thomas; Bioulac, Bernard; Guehl, Dominique; Goillandeau, Michel; Burbaud, Pierre			Single Medial Prefrontal Neurons Cope with Error	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE CONTROL; LOCUS-COERULEUS; FRONTAL-CORTEX; NEURAL SYSTEM; MOTOR AREAS; PERFORMANCE; REWARD; SUPPLEMENTARY	Learning from mistakes is a key feature of human behavior. However, the mechanisms underlying short-term adaptation to erroneous action are still poorly understood. One possibility relies on the modulation of attentional systems after an error. To explore this possibility, we have designed a Stroop-like visuo-motor task in monkeys that favors incorrect action. Using this task, we previously found that single neurons recorded from the anterior cingulate cortex ( ACC) were closely tuned to behavioral performance and, more particularly, that the activity of most neurons was biased towards the evaluation of erroneous action. Here we describe single neurons engaged in both error detection and response alertness processing, whose activation is closely associated with the improvement of subsequent behavioral performance. Specifically, we show that the effect of a warning stimulus on neuronal firing is enhanced after an erroneous response rather than a successful one and that this outcome is correlated with an error rate decrease. Our results suggest that the anterior cingulate cortex, which exhibits this activity, serves as a powerful computational locus for rapid behavioral adaptation.			Michelet, T (corresponding author), Univ Victor Segalen Bordeaux 2, CNRS, UMR Mouvement Adaptat Cognit 5227, Bordeaux, France.	thomas.michelet@u-bordeaux2.fr		Michelet, Thomas/0000-0002-2104-2758				Adler CM, 2000, J PSYCHIATR RES, V34, P317, DOI 10.1016/S0022-3956(00)00022-4; Akkal D, 2002, EUR J NEUROSCI, V15, P887, DOI 10.1046/j.1460-9568.2002.01920.x; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Gehring W. J., 1990, PSYCHOPHYSIOLOGY, V27, pS34, DOI DOI 10.1111/J.1469-8986.1990.TB02175.X; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEMBA H, 1986, NEUROSCI LETT, V70, P223, DOI 10.1016/0304-3940(86)90467-2; HANES DP, 1995, EXP BRAIN RES, V103, P85; Hohnsbein J., 1989, J PSYCHOPHYSIOL, V3, P32; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Michelet T, 2007, J NEUROSCI, V27, P7482, DOI 10.1523/JNEUROSCI.4718-06.2007; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paus T, 2000, PROG BRAIN RES, V126, P65; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549	42	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6240	10.1371/journal.pone.0006240	http://dx.doi.org/10.1371/journal.pone.0006240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472GV	19609433	Green Submitted, Green Published, gold			2022-12-25	WOS:000268119500001
J	Duda, TF; Chang, D; Lewis, BD; Lee, TW				Duda, Thomas F., Jr.; Chang, Dan; Lewis, Brittany D.; Lee, Taehwan			Geographic Variation in Venom Allelic Composition and Diets of the Widespread Predatory Marine Gastropod Conus ebraeus	PLOS ONE			English	Article								Background: Members of the predatory gastropod genus Conus use a venom comprised of a cocktail of peptide neurotoxins, termed conotoxins or conopeptides, to paralyze prey and conotoxin gene family members diversify via strong positive selection. Because Conus venoms are used primarily to subdue prey, the evolution of venoms is likely affected by predator-prey interactions. Methodology/Principal Findings: To identify the selective forces that drive the differentiation of venoms within species of Conus, we examined the distribution of alleles of a polymorphic O-superfamily conotoxin locus of Conus ebraeus at Okinawa, Guam and Hawaii. Previous analyses of mitochondrial cytochrome oxidase I gene sequences suggest that populations of C. ebraeus, a worm-eating Conus, are not structured genetically in the western and central Pacific. Nonetheless, because the sample size from Guam was relatively low, we obtained additional data from this location and reexamined patterns of genetic variation at the mitochondrial gene at Okinawa, Guam and Hawaii. We also utilized a DNA-based approach to identify prey items of individuals of C. ebraeus from Guam and compared this information to published data on diets at Okinawa and Hawaii. Our results show that conotoxin allelic frequencies differ significantly among all three locations, with strongest differentiation at Hawaii. We also confirm previous inferences that C. ebraeus exhibits no genetic differentiation between Okinawa, Guam and Hawaii at the mitochondrial locus. Finally, DNA-based analyses show that eunicid polychaetes comprise the majority of the prey items of C. ebraeus at Guam; while this results compares well with observed diet of this species at Okinawa, C. ebraeus preys predominantly on nereid polychaetes at Hawaii. Conclusions/Significance: These results imply that strong selection pressures affect conotoxin allelic frequencies. Based on the dietary information, the selection may derive from geographic variation in dietary specialization and local coevolutionary arms races between Conus and their prey.			Duda, TF (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	tfduda@umich.edu		Chang, Dan/0000-0003-4942-3146				Adams DJ, 2003, J BIOL CHEM, V278, P4057, DOI 10.1074/jbc.M209969200; [Anonymous], [No title captured]; BIRKY CW, 1983, GENETICS, V103, P513; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Creer S, 2003, J MOL EVOL, V56, P317, DOI 10.1007/s00239-002-2403-4; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Duda TF, 2008, MOL ECOL, V17, P3018, DOI 10.1111/j.1365-294X.2008.03804.x; Duda TF, 2004, P ROY SOC B-BIOL SCI, V271, P1165, DOI 10.1098/rspb.2004.2708; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; DUDA TF, 2009, CORAL REEFS IN PRESS; DUDA TF, GENETIC MORPHOLOGICA; Duda TF, 2008, J MOL EVOL, V67, P315, DOI 10.1007/s00239-008-9155-8; Duda TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005558; EXCOFFIER L, 1992, GENETICS, V131, P491; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fry BG, 2001, TOXICOL APPL PHARM, V175, P140, DOI 10.1006/taap.2001.9233; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOHN AJ, 1975, MAR BIOL, V29, P211, DOI 10.1007/BF00391848; KOHN AJ, 1959, ECOL MONOGR, V29, P47, DOI 10.2307/1948541; KOHN AJ, 1978, ECOL MONOGR, V48, P323, DOI 10.2307/2937234; KOHN AJ, 1982, MAR ECOL PROG SER, V9, P147, DOI 10.3354/meps009147; Kohn AJ, 2001, CORAL REEFS, V20, P25; KOHN AJ, 1994, LIFE HIST BIOGEOGRAP, pR6; Kohn AJ, 1985, P 5 INT COR REEF C, P191; KOHN M, 1995, MOL ECOL, V4, P95, DOI 10.1111/j.1365-294X.1995.tb00196.x; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007; MARSH H, 1971, Veliger, V14, P45; MARTIN MF, 1987, TOXICON, V25, P569, DOI 10.1016/0041-0101(87)90293-5; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Rockel D, 1995, MANUAL LIVING CONIDA; Sasa M, 1999, TOXICON, V37, P249, DOI 10.1016/S0041-0101(98)00121-4; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Schulze A, 2006, BIOL BULL-US, V210, P25, DOI 10.2307/4134534; Sjolin E, 2005, MOL PHYLOGENET EVOL, V35, P431, DOI 10.1016/j.ympev.2004.12.018; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 1992, GENETICS, V132, P619; WHITTAKER RH, 1952, ECOL MONOGR, V22, P1, DOI 10.2307/1948527; Wuster W, 1999, TOXICON, V37, P253	47	44	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6245	10.1371/journal.pone.0006245	http://dx.doi.org/10.1371/journal.pone.0006245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606224	gold, Green Published, Green Submitted			2022-12-25	WOS:000268036000005
J	Guerin, R; Beauregard, PB; Leroux, A; Rokeach, LA				Guerin, Renee; Beauregard, Pascale B.; Leroux, Alexandre; Rokeach, Luis A.			Calnexin Regulates Apoptosis Induced by Inositol Starvation in Fission Yeast	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; TRISPHOSPHATE RECEPTOR; PHOSPHOLIPID-SYNTHESIS; CHAPERONE FUNCTION; SECRETORY PATHWAY	Inositol is a precursor of numerous phospholipids and signalling molecules essential for the cell. Schizosaccharomyces pombe is naturally auxotroph for inositol as its genome does not have a homologue of the INO1 gene encoding inositol-1-phosphate synthase, the enzyme responsible for inositol biosynthesis. In this work, we demonstrate that inositol starvation in S. pombe causes cell death with apoptotic features. This apoptotic death is dependent on the metacaspase Pca1p and is affected by the UPR transducer Ire1p. Previously, we demonstrated that calnexin is involved in apoptosis induced by ER stress. Here, we show that cells expressing a lumenal version of calnexin exhibit a 2-fold increase in the levels of apoptosis provoked by inositol starvation. This increase is reversed by co-expression of a calnexin mutant spanning the transmembrane domain and C-terminal cytosolic tail. Coherently, calnexin is physiologically cleaved at the end of its lumenal domain, under normal growth conditions when cells approach stationary phase. This cleavage suggests that the two naturally produced calnexin fragments are needed to continue growth into stationary phase and to prevent cell death. Collectively, our observations indicate that calnexin takes part in at least two apoptotic pathways in S. pombe, and suggest that the cleavage of calnexin has regulatory roles in apoptotic processes involving calnexin.			Guerin, R (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	luis.rokeach@umontreal.ca						Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2784, DOI 10.1074/jbc.270.6.2784; Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; Beaulieu H, 1999, BIOCHEM J, V340, P813, DOI 10.1042/0264-6021:3400813; BELDE PJM, 1993, FEBS LETT, V323, P113, DOI 10.1016/0014-5793(93)81460-H; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Burhans WC, 2007, MOL CELL, V25, P323, DOI 10.1016/j.molcel.2007.01.030; Carmody RJ, 2001, REDOX REP, V6, P77, DOI 10.1179/135100001101536085; Chang HJ, 2002, GENETICS, V162, P29; Chang Q, 2008, BBA-MOL CELL RES, V1783, P237, DOI 10.1016/j.bbamcr.2007.08.008; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; DEAN DC, 1989, AM J RESP CELL MOL, V1, P5, DOI 10.1165/ajrcmb/1.1.5; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Delom F, 2006, BIOCHEM BIOPH RES CO, V341, P39, DOI 10.1016/j.bbrc.2005.12.149; DELOM F, 2007, APOPTOSIS; DELOM F, 2006, CELL DEATH DIFFER; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; EISENBERG F, 1964, BIOCHEM BIOPH RES CO, V14, P419, DOI 10.1016/0006-291X(64)90079-8; Elagoz A, 1999, J CELL SCI, V112, P4449; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fernandez F, 1996, EMBO J, V15, P705, DOI 10.1002/j.1460-2075.1996.tb00406.x; FERNANDEZ S, 1986, J BACTERIOL, V166, P779, DOI 10.1128/jb.166.3.779-786.1986; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Groenendyk J, 2006, BIOCHEMISTRY-US, V45, P13219, DOI 10.1021/bi061428z; Guerin R, 2008, MOL BIOL CELL, V19, P4404, DOI 10.1091/mbc.E08-02-0188; Hajjar F, 2007, YEAST, V24, P89, DOI 10.1002/yea.1440; Hamann A, 2008, TRENDS MICROBIOL, V16, P276, DOI 10.1016/j.tim.2008.03.003; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harada Hisashi, 2003, Rev Clin Exp Hematol, V7, P117; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Ingavale SS, 1999, MICROBIOL-SGM, V145, P1903, DOI 10.1099/13500872-145-8-1903; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Jannatipour M, 1998, BIOCHEMISTRY-US, V37, P17253, DOI 10.1021/bi981785c; Jannatipour M, 1998, BBA-GENE STRUCT EXPR, V1399, P67, DOI 10.1016/S0167-4781(98)00097-9; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr JFR, 2002, TOXICOLOGY, V181, P471, DOI 10.1016/S0300-483X(02)00457-2; King DA, 2004, ARCH BIOCHEM BIOPHYS, V423, P170, DOI 10.1016/j.abb.2003.12.012; KLIG LS, 1984, P NATL ACAD SCI-BIOL, V81, P3816, DOI 10.1073/pnas.81.12.3816; KLIG LS, 1991, YEAST, V7, P325, DOI 10.1002/yea.320070403; Knorre DA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P264, DOI 10.1007/s10541-005-0110-7; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lam D, 2008, AUTOPHAGY, V4, P349, DOI 10.4161/auto.5521; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Lim HW, 2007, CAN J MICROBIOL, V53, P1016, DOI 10.1139/W07-067; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Low CP, 2005, FEMS YEAST RES, V5, P1199, DOI 10.1016/j.femsyr.2005.07.004; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; MacNeill SA, 2002, CURR BIOL, V12, pR294, DOI 10.1016/S0960-9822(02)00805-9; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marechal A, 2004, BIOCHEM J, V380, P441, DOI 10.1042/BJ20031546; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MINSKOFF SA, 1992, J BACTERIOL, V174, P4078, DOI 10.1128/jb.174.12.4078-4085.1992; Mitsui K, 2005, FEBS LETT, V579, P723, DOI 10.1016/j.febslet.2004.12.051; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Niederberger C, 1998, CURR GENET, V33, P255, DOI 10.1007/s002940050334; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PEREZSALA D, 1995, J CELL PHYSIOL, V163, P523, DOI 10.1002/jcp.1041630312; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Poitelea M, 1997, Rev Med Chir Soc Med Nat Iasi, V101, P87; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sarkar S, 2006, AUTOPHAGY, V2, P132, DOI 10.4161/auto.2387; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Severin FF, 2008, BBA-MOL CELL RES, V1783, P1350, DOI 10.1016/j.bbamcr.2008.02.001; Shahinian S, 1998, GENETICS, V149, P843; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; STEINER S, 1972, J BACTERIOL, V109, P81, DOI 10.1128/JB.109.1.81-88.1972; Sun Q, 2007, FEBS LETT, V581, P3991, DOI 10.1016/j.febslet.2007.07.030; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takizawa T, 2004, J BIOCHEM, V136, P399, DOI 10.1093/jb/mvh133; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Torgler CN, 1997, CELL DEATH DIFFER, V4, P263, DOI 10.1038/sj.cdd.4400239; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Turcotte C, 2007, FEMS YEAST RES, V7, P196, DOI 10.1111/j.1567-1364.2006.00145.x; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Voicu PM, 2002, ARCH MICROBIOL, V177, P251, DOI 10.1007/s00203-001-0383-1; WADA I, 1991, J BIOL CHEM, V266, P19599; Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; YARBROUGH HF, 1957, J BACTERIOL, V73, P318, DOI 10.1128/JB.73.3.318-323.1957; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	130	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6244	10.1371/journal.pone.0006244	http://dx.doi.org/10.1371/journal.pone.0006244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606215	Green Submitted, Green Published, gold			2022-12-25	WOS:000268036000004
J	Kwon, T; Park, J; Yang, J; Yoon, DS; Na, S; Kim, CW; Suh, JS; Huh, YM; Haam, S; Eom, K				Kwon, Taeyun; Park, Jinsung; Yang, Jaemoon; Yoon, Dae Sung; Na, Sungsoo; Kim, Chang-Wan; Suh, Jin-Suck; Huh, Yong-Min; Haam, Seungjoo; Eom, Kilho			Nanomechanical In Situ Monitoring of Proteolysis of Peptide by Cathepsin B	PLOS ONE			English	Article								Characterization and control of proteolysis of peptides by specific cellular protease is a priori requisite for effective drug discovery. Here, we report the nanomechanical, in situ monitoring of proteolysis of peptide chain attributed to protease (Cathepsin B) by using a resonant nanomechanical microcantilever immersed in a liquid. Specifically, the detection is based on measurement of resonant frequency shift arising from proteolysis of peptides (leading to decrease of cantilever's overall mass, and consequently, increases in the resonance). It is shown that resonant microcantilever enables the quantification of proteolysis efficacy with respect to protease concentration. Remarkably, the nanomechanical, in situ monitoring of proteolysis allows us to gain insight into the kinetics of proteolysis of peptides, which is well depicted by Langmuir kinetic model. This implies that nanomechanical biosensor enables the characterization of specific cellular protease such as its kinetics.			Kwon, T (corresponding author), Korea Univ, Res Inst Engn Technol, Seoul, South Korea.	tykwon@korea.ac.kr; haam@yonsei.ac.kr; kilhoeom@korea.ac.kr	Yang, Jaemoon/S-3900-2019; Park, Jinsung/AAR-7393-2021; Haam, Seungjoo/G-8042-2012; Eom, Kilho/B-1552-2008	Yang, Jaemoon/0000-0001-7365-0395; Eom, Kilho/0000-0001-5135-8473; Kim, Chang-wan/0000-0003-2952-9453; Park, Jinsung/0000-0001-8096-7286; Huh, Yong-Min/0000-0002-9831-4475; Suh, jin-suck/0000-0001-9455-9240				Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907; Braun T, 2009, NAT NANOTECHNOL, V4, P179, DOI [10.1038/NNANO.2008.398, 10.1038/nnano.2008.398]; Bunimovich YL, 2006, J AM CHEM SOC, V128, P16323, DOI 10.1021/ja065923u; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; DEFOEJONES D, 2000, NAT MED, V6, P1248; Eom K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.113408; Etrych T, 2001, J CONTROL RELEASE, V73, P89, DOI 10.1016/S0168-3659(01)00281-4; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Ghatkesar MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003610; GRAHAM NB, 1992, POLY ETHYLENE GLYCOL, P263; Gupta AK, 2006, P NATL ACAD SCI USA, V103, P13362, DOI 10.1073/pnas.0602022103; Hagan MF, 2002, J PHYS CHEM B, V106, P10163, DOI 10.1021/jp020972o; Heath JR, 2008, ANNU REV MED, V59, P251, DOI 10.1146/annurev.med.59.061506.185523; Ilic B, 2005, NANO LETT, V5, P925, DOI 10.1021/nl050456k; Kirstein S, 1998, J APPL PHYS, V84, P1782, DOI 10.1063/1.368335; Kodadek T, 2008, NATURE, V453, P861, DOI 10.1038/453861a; Kwon TY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2741053; Kwon T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006329; Lachut MJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.206102; Lee SH, 2002, J POLYM SCI POL CHEM, V40, P2545, DOI 10.1002/pola.10339; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; McKendry R, 2002, P NATL ACAD SCI USA, V99, P9783, DOI 10.1073/pnas.152330199; Mertens J, 2008, NAT NANOTECHNOL, V3, P301, DOI 10.1038/nnano.2008.91; Ndieyira JW, 2008, NAT NANOTECHNOL, V3, P691, DOI 10.1038/nnano.2008.275; Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021; Sushko ML, 2008, ADV MATER, V20, P3848, DOI 10.1002/adma.200801344; Tamayo J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388925; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Ulbrich K, 2004, INT J PHARM, V277, P63, DOI 10.1016/j.ijpharm.2003.02.001; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Wu GH, 2001, P NATL ACAD SCI USA, V98, P1560, DOI 10.1073/pnas.031362498; Yang J, 2007, ANGEW CHEM INT EDIT, V46, P8836, DOI 10.1002/anie.200703554; Zhang J, 2006, NAT NANOTECHNOL, V1, P214, DOI 10.1038/nnano.2006.134	34	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6248	10.1371/journal.pone.0006248	http://dx.doi.org/10.1371/journal.pone.0006248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606222	Green Submitted, Green Published, gold			2022-12-25	WOS:000268036000007
J	Lerner, Y; Papo, D; Zhdanov, A; Belozersky, L; Hendler, T				Lerner, Yulia; Papo, David; Zhdanov, Andrey; Belozersky, Libi; Hendler, Talma			Eyes Wide Shut: Amygdala Mediates Eyes-Closed Effect on Emotional Experience with Music	PLOS ONE			English	Article								The perceived emotional value of stimuli and, as a consequence the subjective emotional experience with them, can be affected by context-dependent styles of processing. Therefore, the investigation of the neural correlates of emotional experience requires accounting for such a variable, a matter of an experimental challenge. Closing the eyes affects the style of attending to auditory stimuli by modifying the perceptual relationship with the environment without changing the stimulus itself. In the current study, we used fMRI to characterize the neural mediators of such modification on the experience of emotionality in music. We assumed that closed eyes position will reveal interplay between different levels of neural processing of emotions. More specifically, we focused on the amygdala as a central node of the limbic system and on its co-activation with the Locus Ceruleus (LC) and Ventral Prefrontal Cortex (VPFC); regions involved in processing of, respectively, 'low', visceral-, and 'high', cognitive-related, values of emotional stimuli. Fifteen healthy subjects listened to negative and neutral music excerpts with eyes closed or open. As expected, behavioral results showed that closing the eyes while listening to emotional music resulted in enhanced rating of emotionality, specifically of negative music. In correspondence, fMRI results showed greater activation in the amygdala when subjects listened to the emotional music with eyes closed relative to eyes open. More so, by using voxel-based correlation and a dynamic causal model analyses we demonstrated that increased amygdala activation to negative music with eyes closed led to increased activations in the LC and VPFC. This finding supports a system-based model of perceived emotionality in which the amygdala has a central role in mediating the effect of context- based processing style by recruiting neural operations involved in both visceral (i.e. 'low') and cognitive (i.e. 'high') related processes of emotions.			Lerner, Y (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	talma@tasmc.health.gov.il	Zhdanov, Andrey/I-7136-2012; hendler, talma/C-7677-2012	Papo, David/0000-0003-1889-2791; Zhadnov, Andrey/0000-0002-3379-0251				AMARAL D G, 1992, P1; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Bechara A, 1999, J NEUROSCI, V19, P5473; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Beevers CG, 2005, CLIN PSYCHOL REV, V25, P975, DOI 10.1016/j.cpr.2005.03.003; Ben-Simon E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003984; Bennett MR, 2005, PROG NEUROBIOL, V75, P29, DOI 10.1016/j.pneurobio.2004.11.002; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Chaminade T, 2003, EUR J NEUROSCI, V18, P675, DOI 10.1046/j.1460-9568.2003.02787.x; Coull JT, 1999, NEUROIMAGE, V10, P705, DOI 10.1006/nimg.1999.0513; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Eldar E, 2007, CEREB CORTEX, V17, P2828, DOI 10.1093/cercor/bhm011; Ferguson ML, 1996, BIOL PSYCHOL, V42, P131, DOI 10.1016/0301-0511(95)05151-1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISTON J, 1994, HUM BRAIN MAPP, V2, P189; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Gosselin N, 2005, BRAIN, V128, P628, DOI 10.1093/brain/awh420; Gosselin N, 2006, BRAIN, V129, P2585, DOI 10.1093/brain/awl240; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Iidaka T, 2001, J COGNITIVE NEUROSCI, V13, P1035, DOI 10.1162/089892901753294338; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jeannerod M, 2004, NAT NEUROSCI, V7, P422, DOI 10.1038/nn0504-422; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Sander K, 2003, BRAIN RES PROTOC, V11, P81, DOI 10.1016/S1385-299X(03)00018-7; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schmithorst VJ, 2003, NEUROSCI LETT, V348, P65, DOI 10.1016/S0304-3940(03)00714-6; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Talairach J., 1988, COPLANAR STEREOTAXIC; VANHOESEN GW, 1985, ANN NY ACAD SCI, V444, P97; Williams LM, 2006, J NEUROSCI, V26, P9264, DOI 10.1523/JNEUROSCI.1016-06.2006; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	71	46	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6230	10.1371/journal.pone.0006230	http://dx.doi.org/10.1371/journal.pone.0006230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603072	gold, Green Submitted, Green Published			2022-12-25	WOS:000268035700005
J	Ma, YJ; Doni, A; Hummelshoj, T; Honore, C; Bastone, A; Mantovani, A; Thielens, NM; Garred, P				Ma, Ying Jie; Doni, Andrea; Hummelshoj, Tina; Honore, Christian; Bastone, Antonio; Mantovani, Alberto; Thielens, Nicole M.; Garred, Peter			Synergy between Ficolin-2 and Pentraxin 3 Boosts Innate Immune Recognition and Complement Deposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; MANNOSE-BINDING LECTIN; HAKATA ANTIGEN; PTX3; MOLECULE; BACTERIA; PATHWAY; POLYMORPHISMS; SIMILARITIES; DEFICIENCY	The long pentraxin 3 (PTX3) is a multifunctional soluble pattern recognition molecule that is crucial in innate immune protection against opportunistic fungal pathogens such as Aspergillus fumigatus. The mechanisms that mediate downstream effects of PTX3 are largely unknown. However, PTX3 interacts with C1q from the classical pathway of the complement. The ficolins are recognition molecules of the lectin complement pathway sharing structural and functional characteristics with C1q. Thus, we investigated whether the ficolins (Ficolin-1, -2, and -3) interact with PTX3 and whether the complexes are able to modulate complement activation on A. fumigatus. Ficolin-2 could be affinity-isolated from human plasma on immobilized PTX3. In binding studies, Ficolin-1 and particularly Ficolin-2 interacted with PTX3 in a calcium-independent manner. Ficolin-2, but not Ficolin-1 and Ficolin-3, bound A. fumigatus directly, but this binding was enhanced by PTX3 and vice versa. Ficolin-2-dependent complement deposition on the surface of A. fumigatus was enhanced by PTX3. A polymorphism in the FCN2 gene causing a T236M amino acid change in the fibrinogen-like binding domain of Ficolin-2, which affects the binding to GlcNAc, reduced Ficolin-2 binding to PTX3 andA.fumigatus significantly. These results demonstrate that PTX3 and Ficolin-2 may recruit each other on pathogens. The effect was alleviated by a common amino acid change in the fibrinogen-like domain of Ficolin-2. Thus, components of the humoral innate immune system, which activate different complement pathways, cooperate and amplify microbial recognition and effector functions.	[Ma, Ying Jie; Hummelshoj, Tina; Honore, Christian; Garred, Peter] Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark; [Doni, Andrea; Mantovani, Alberto] Ist Clin Humanitas, I-20089 Rozzano, Italy; [Bastone, Antonio] Mario Negri Inst Pharmacol Res, Dept Mol Pharmacol & Biochem, I-20157 Milan, Italy; [Thielens, Nicole M.] Univ Grenoble 1, Lab Enzymol Mol, Inst Biol Struct Jean Pierre Ebel, CNRS,CEA,UMR 5075, F-5075 Grenoble, France	Rigshospitalet; University of Copenhagen; IRCCS Humanitas Research Hospital; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Garred, P (corresponding author), Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Mantovani, Alberto/HCI-7449-2022; Thielens, Nicole M/F-2512-2013; Jie, Ying/AAJ-4697-2021	Mantovani, Alberto/0000-0001-5578-236X; Thielens, Nicole M/0000-0002-7354-0302; Jie, Ying/0000-0003-4003-2579; Honore, Christian/0000-0003-4846-1319; Garred, Peter/0000-0002-2876-8586; Doni, Andrea/0000-0001-9203-5814	The Benzon Foundation; The Lundbeck foundation; The Carlsberg Foundation; Rigshospitalet; The Capital Region of Denmark; The European Commission; Telethon; Italian Ministry of Health	The Benzon Foundation; The Lundbeck foundation(Lundbeckfonden); The Carlsberg Foundation(Carlsberg Foundation); Rigshospitalet; The Capital Region of Denmark; The European Commission(European CommissionEuropean Commission Joint Research Centre); Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the grants from The Benzon Foundation, The Lundbeck foundation, The Carlsberg Foundation, Rigshospitalet, The Capital Region of Denmark, The European Commission (Project Tolerage), Telethon, and the Italian Ministry of Health.	Beauvais A, 2001, DRUG RESIST UPDATE, V4, P38, DOI 10.1054/drup.2001.0185; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Goldman RC, 1999, CURR PHARM DESIGN, V5, P473; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu JH, 1996, BIOCHEM J, V313, P473, DOI 10.1042/bj3130473; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Marquart HV, 2007, CLIN IMMUNOL, V124, P33, DOI 10.1016/j.clim.2007.03.547; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; VOLANAKIS JE, 1982, ANN NY ACAD SCI, V389, P235, DOI 10.1111/j.1749-6632.1982.tb22140.x; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; YING SC, 1993, J IMMUNOL, V150, P169; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	41	143	144	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28263	28275		10.1074/jbc.M109.009225	http://dx.doi.org/10.1074/jbc.M109.009225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19632990	Green Published, hybrid			2022-12-25	WOS:000270676300054
J	Bourguignon, LYW; Spevak, CC; Wong, G; Xia, WL; Gilad, E				Bourguignon, Lilly Y. W.; Spevak, Christina C.; Wong, Gabriel; Xia, Weiliang; Gilad, Eli			Hyaluronan-CD44 Interaction with Protein Kinase C epsilon Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CD44 INTERACTION; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; HYALURONIC-ACID; CANCER-CELLS; TRANSMEMBRANE GLYCOPROTEIN; CYTOSKELETON FUNCTION; HOMING RECEPTOR; P-GLYCOPROTEIN; MIGRATION	Multidrug resistance and disease relapse is a challenging clinical problem in the treatment of breast cancer. In this study, we investigated the hyaluronan (HA)-induced interaction between CD44 (a primary HA receptor) and protein kinase C epsilon (PKC epsilon), which regulates a number of human breast tumor cell functions. Our results indicate that HA binding to CD44 promotes PKC epsilon activation, which, in turn, increases the phosphorylation of the stem cell marker, Nanog, in the breast tumor cell line MCF-7. Phosphorylated Nanog is then translocated from the cytosol to the nucleus and becomes associated with RNase III DROSHA and the RNA helicase p68. This process leads to microRNA-21 (miR-21) production and a tumor suppressor protein (e. g. PDCD4 (program cell death 4)) reduction. All of these events contribute to up-regulation of inhibitors of apoptosis proteins (IAPs) and MDR1 (multidrug-resistant protein), resulting in anti-apoptosis and chemotherapy resistance. Transfection of MCF-7 cells with PKC epsilon or Nanog-specific small interfering RNAs effectively blocks HA-mediated PKC epsilon-Nanog signaling events, abrogates miR-21 production, and increases PDCD4 expression/eIF4A binding. Subsequently, this PKC epsilon-Nanog signaling inhibition causes IAP/MDR1 down-regulation, apoptosis, and chemosensitivity. To further evaluate the role of miR-21 in oncogenesis and chemoresistance, MCF-7 cells were also transfected with a specific anti-miR-21 inhibitor in order to silence miR-21 expression and inhibit its target functions. Our results indicate that anti-miR-21 inhibitor not only enhances PDCD4 expression/eIF4A binding but also blocks HA-CD44-mediated tumor cell behaviors. Thus, this newly discovered HA-CD44 signaling pathway should provide important drug targets for sensitizing tumor cell apoptosis and overcoming chemotherapy resistance in breast cancer cells.	Univ Calif San Francisco, Dept Med, Endocrine Unit, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu	Xia, Weiliang/C-2650-2008; XIA, WEILIANG/AEA-0835-2022	Xia, Weiliang/0000-0002-0256-4219; XIA, WEILIANG/0000-0002-0256-4219	National Institutes of Health [R01 CA66163, R01 CA 78633, P01 AR39448]; Veterans Affairs Merit Review; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA66163, R01 CA 78633, and P01 AR39448. This work was also supported by a Veterans Affairs Merit Review grant and a Department of Defense grant.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baker EK, 2004, CANCER BIOL THER, V3, P819, DOI 10.4161/cbt.3.9.1101; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2009, HYALURONAN IN CANCER BIOLOGY, 1ST EDITION, P89, DOI 10.1016/B978-012374178-3.10006-7; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; BOURGUIGNON LYW, 1992, MOL CELL BIOL, V12, P4464, DOI 10.1128/MCB.12.10.4464; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chuthapisith S, 2006, SURG-J R COLL SURG E, V4, P211, DOI 10.1016/S1479-666X(06)80062-4; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; Do JT, 2006, E SCHERING RES FDN W, V60, P35; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Itano N, 1998, TRENDS GLYCOSCI GLYC, V10, P23, DOI 10.4052/tigg.10.23; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KALISH ED, 1999, FRONT BIOSCI, V4, P1; KALOMIRIS EL, 1989, J BIOL CHEM, V264, P8113; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lonning PE, 2003, LANCET ONCOL, V4, P177; Lu DM, 2007, APOPTOSIS, V12, P1893, DOI 10.1007/s10495-007-0111-7; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mackay HJ, 2003, ENDOCR-RELAT CANCER, V10, P389, DOI 10.1677/erc.0.0100389; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miletti-Gonzalez KE, 2005, CANCER RES, V65, P6660, DOI 10.1158/0008-5472.CAN-04-3478; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ohashi R, 2007, CANCER LETT, V252, P225, DOI 10.1016/j.canlet.2006.12.025; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; Salzman DW, 2007, J BIOL CHEM, V282, P32773, DOI 10.1074/jbc.M705054200; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smith H S, 1991, Basic Life Sci, V57, P329; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P19, DOI 10.1001/archotol.132.1.19; Wang SJ, 2007, ARCH OTOLARYNGOL, V133, P281, DOI 10.1001/archotol.133.3.281; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; ZHANG LR, 1995, CANCER RES, V55, P428	91	246	264	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26533	26546		10.1074/jbc.M109.027466	http://dx.doi.org/10.1074/jbc.M109.027466			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633292	Green Published, hybrid			2022-12-25	WOS:000269969600035
J	Mwaikambo, BR; Yang, C; Chemtob, S; Hardy, P				Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre			Hypoxia Up-regulates CD36 Expression and Function via Hypoxia-inducible Factor-1-and Phosphatidylinositol 3-Kinase-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; NF-KAPPA-B; OXIDATIVE STRESS; HIF-1-ALPHA ACCUMULATION; MEMBRANE-PROTEIN; OUTER SEGMENTS; COMPLEX-III; FATTY-ACIDS; VITAMIN-E; PHAGOCYTOSIS	Neovascular and degenerative diseases of the eye are leading causes of impaired vision and blindness in the world. Hypoxia or reduced oxygen tension is considered central to the pathogenesis of these disorders. Although the CD36 scavenger receptor features prominently in ocular homeostasis and pathology, little is known regarding its modulation by hypoxia. Herein we investigated the role and regulation of CD36 by hypoxia and by the major hypoxia effector, hypoxia-inducible factor (HIF)-1. In vivo, hypoxia markedly induced CD36 mRNA in corneal and retinal tissue. Subsequent experiments on human retinal pigment epithelial cells revealed that hypoxia time-dependently increased CD36 mRNA, protein, and surface expression; these responses were reliant upon reactive oxygen species production. As an important novel finding, we demonstrate that hypoxic stimulation of CD36 is mediated by HIF-1; HIF-1 alpha down-regulation abolished CD36 induction by both hypoxia and cobalt chloride. Sequence analysis of the human CD36 promoter region revealed a functional HIF-1 binding site. A luciferase reporter construct containing this promoter fragment was activated by hypoxia, whereas mutation at the HIF-1 consensus site decreased promoter activation. Specific binding of HIF-1 to this putative site in hypoxic cells was detected by a chromatin immunoprecipitation assay. Interestingly, inhibition of the phosphatidylinositol 3-kinase pathway blocked the hypoxia-dependent induction of CD36 expression and promoter activity. Functional ramifications of CD36 hypoxic accumulation were evinced by CD36-dependent increases in scavenging and anti-angiogenic activities. Together, our findings indicate a novel mechanism by which hypoxia induces CD36 expression via activation of HIF-1 and the phosphatidylinositol 3-kinase pathway.	[Mwaikambo, Bupe R.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre] Ctr Hop Univ St Justine, Res Ctr, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre] Ctr Hop Univ St Justine, Res Ctr, Dept Ophthalmol, Montreal, PQ H3T 1C5, Canada; [Mwaikambo, Bupe R.; Yang, Chun; Chemtob, Sylvain; Hardy, Pierre] CHU St Justine, Res Ctr, Dept Pharmacol, Montreal, PQ H3T 1C5, Canada	McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hardy, P (corresponding author), 3175 Cote St Catherine,Rm 2714, Montreal, PQ H3T 1C5, Canada.	pierre.hardy@recherche-ste-justine.qc.ca			Fight for Sight Foundation [GA05003]; Canadian Institutes of Health [MOP-79332]; Hospital for Sick Children [XG 03-105]; Canadian National Institute for the Blind (CNIB_E.A. Baker Foundation)	Fight for Sight Foundation; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children; Canadian National Institute for the Blind (CNIB_E.A. Baker Foundation)	This work was supported in part by Fight for Sight Foundation Grant GA05003, Canadian Institutes of Health Research Grant MOP-79332, Hospital for Sick Children Grant XG 03-105, and the Canadian National Institute for the Blind (CNIB_E.A. Baker Foundation).	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bazan HEP, 2005, EXP EYE RES, V80, P453, DOI 10.1016/j.exer.2004.12.023; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behn C, 2007, RESP PHYSIOL NEUROBI, V158, P143, DOI 10.1016/j.resp.2007.06.001; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Boyer JF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2133; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chabowski A, 2006, FEBS LETT, V580, P3617, DOI 10.1016/j.febslet.2006.05.045; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Cho S, 2007, J BIOL CHEM, V282, P4634, DOI 10.1074/jbc.M609388200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Favier J, 2005, J PATHOL, V207, P358, DOI 10.1002/path.1833; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gerasimovskaya EV, 2005, J APPL PHYSIOL, V98, P722, DOI 10.1152/japplphysiol.00715.2004; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Houssier M, 2008, PLOS MED, V5, P323, DOI 10.1371/journal.pmed.0050039; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kwapiszewska G, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-109; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Milne GL, 2005, BIOMARKERS, V10, pS10, DOI 10.1080/13547500500216546; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; MORROW JD, 1992, J CLIN INVEST, V90, P2502, DOI 10.1172/JCI116143; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Mwaikambo BR, 2008, CORNEA, V27, P1037, DOI 10.1097/ICO.0b013e31817780b6; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Phelan MW, 1998, J LAB CLIN MED, V132, P519, DOI 10.1016/S0022-2143(98)90131-7; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Ryeom SW, 1996, J CELL SCI, V109, P387; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Singh U, 2005, ANNU REV NUTR, V25, P151, DOI 10.1146/annurev.nutr.24.012003.132446; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Sun K, 2007, MOL VIS, V13, P2310; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Ward JPT, 2006, J APPL PHYSIOL, V101, P993, DOI 10.1152/japplphysiol.00480.2006; Yang C, 2008, AM J PHYSIOL-REG I, V294, pR467, DOI 10.1152/ajpregu.00432.2007; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Yeo EJ, 2004, BIOCHEM PHARMACOL, V68, P1061, DOI 10.1016/j.bcp.2004.02.040; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zampetaki A, 2004, FASEB J, V18, P1090, DOI 10.1096/fj.03-0991fje	70	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26695	26707		10.1074/jbc.M109.033480	http://dx.doi.org/10.1074/jbc.M109.033480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640849	hybrid, Green Published			2022-12-25	WOS:000269969600050
J	Ebi, H; Sato, T; Sugito, N; Hosono, Y; Yatabe, Y; Matsuyama, Y; Yamaguchi, T; Osada, H; Suzuki, M; Takahashi, T				Ebi, H.; Sato, T.; Sugito, N.; Hosono, Y.; Yatabe, Y.; Matsuyama, Y.; Yamaguchi, T.; Osada, H.; Suzuki, M.; Takahashi, T.			Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers	ONCOGENE			English	Article						small-cell lung cancer; DNA damage response; miRNA; RB; reactive oxygen species	CHECKPOINT IMPAIRMENT; E2F1; IDENTIFICATION; EXPRESSION; MICRORNAS; APOPTOSIS; PATHWAY; DELETION; MIR-20A; CLUSTER	Small-cell lung cancer (SCLC) is a highly aggressive disease that exhibits rapid growth and genetic instability. We found earlier frequent overexpression of the miR-17-92 microRNA cluster, and showed that SCLC cells were addicted to continued expressions of miR-17-5p and miR-20a, major components of this microRNA cluster. In this study, we identified the frequent presence of constitutively phosphorylated H2AX (gamma-H2AX), which reflects continuing DNA damage, preferentially in SCLC. Knockdown of RB induced gamma-H2AX foci formation in non-small cell lung cancer (NSCLC) cells with wild-type RB, in association with growth inhibition and reactive oxygen species (ROS) generation, which was canceled by overexpression of miR-17-92. Conversely, induction of gamma-H2AX was observed in a miR-17-92-overexpressing SCLC cell line with miR-20a antisense oligonucleotides. These findings suggest that miR-17-92 overexpression may serve as a fine-tuning influence to counterbalance the generation of DNA damage in RB-inactivated SCLC cells, thus reducing excessive DNA damage to a tolerable level and consequently leading to genetic instability. Therefore, miR-17-92 may be an excellent therapeutic target candidate to elicit excessive DNA damage in combination with DNA-damaging chemotherapeutics. Oncogene (2009) 28, 3371-3379; doi: 10.1038/onc.2009.201; published online 13 July 2009	[Ebi, H.; Sato, T.; Sugito, N.; Hosono, Y.; Matsuyama, Y.; Yamaguchi, T.; Suzuki, M.; Takahashi, T.] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc,Showa Ku, Nagoya, Aichi 4668550, Japan; [Yatabe, Y.] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diag, Showa Ku, Nagoya, Aichi 464, Japan; [Osada, H.] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Showa Ku, Nagoya, Aichi 464, Japan	Nagoya University; Aichi Cancer Center; Aichi Cancer Center	Takahashi, T (corresponding author), Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tak@med.nagoya-u.ac.jp	Suzuki, Motoshi/I-7246-2014; Takahashi, Takashi/I-7262-2014; Yamaguchi, Tomoya/AAN-7524-2020; Hosono, Yasuyuki/J-4295-2019; YATABE, Yasushi/J-6461-2014; Ebi, Hiromichi/AAA-7358-2019; Hosono, Yasuyuki/GOP-1342-2022	Suzuki, Motoshi/0000-0003-0682-5006; Takahashi, Takashi/0000-0003-0615-7001; Yamaguchi, Tomoya/0000-0001-6933-543X; YATABE, Yasushi/0000-0003-1788-559X; Ebi, Hiromichi/0000-0003-3155-7576; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Princess Takamatsu Cancer Research Fund [07-23903]; International Association for the Study of Lung Cancer (IASLC)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund; International Association for the Study of Lung Cancer (IASLC)	This work was financially supported in part by a Grant-in-Aid for Scientific Research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, and a Grant (07-23903) from the Princess Takamatsu Cancer Research Fund. HE was supported by the IASLC fellowship of the International Association for the Study of Lung Cancer (IASLC) during this study.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Ebi H, 2007, CANCER RES, V67, P11158, DOI 10.1158/0008-5472.CAN-07-1749; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Konishi H, 2002, CANCER RES, V62, P271; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Powers JT, 2004, MOL CANCER RES, V2, P203; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284	28	76	81	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3371	3379		10.1038/onc.2009.201	http://dx.doi.org/10.1038/onc.2009.201			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19597473				2022-12-25	WOS:000270103300004
J	Bundschuh, FA; Hannappel, A; Anderka, O; Ludwig, B				Bundschuh, Freya A.; Hannappel, Achim; Anderka, Oliver; Ludwig, Bernd			Surf1, Associated with Leigh Syndrome in Humans, Is a Heme-binding Protein in Bacterial Oxidase Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; MITOCHONDRIAL COX1P; COFACTOR INSERTION; TERMINAL OXIDASES; ESCHERICHIA-COLI; MEMBRANE; YEAST; EXPRESSION; DEFICIENCY	Biogenesis of mitochondrial cytochrome c oxidase (COX) relies on a large number of assembly factors, among them the transmembrane protein Surf1. The loss of human Surf1 function is associated with Leigh syndrome, a fatal neurodegenerative disorder caused by severe COX deficiency. In the bacterium Paracoccus denitrificans, two homologous proteins, Surf1c and Surf1q, were identified, which we characterize in the present study. When coexpressed in Escherichia coli together with enzymes for heme a synthesis, the bacterial Surf1 proteins bind heme a in vivo. Using redox difference spectroscopy and isothermal titration calorimetry, the binding of the heme cofactor to purified apo-Surf1c and apo-Surf1q is quantified: Each of the Paracoccus proteins binds heme a in a 1:1 stoichiometry and with K-d values in the submicromolar range. In addition, we identify a conserved histidine as a residue crucial for heme binding. Contrary to most earlier concepts, these data support a direct role of Surf1 in heme a cofactor insertion into COX subunit I by providing a protein-bound heme a pool.	[Bundschuh, Freya A.; Hannappel, Achim; Anderka, Oliver; Ludwig, Bernd] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Ludwig, Bernd] Cluster Excellence Macromol Complexes Frankfurt M, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Ludwig, B (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	ludwig@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [SFB 472]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 472, Cluster of Excellence Macromolecular Complexes Project EXC 115, and the Center of Membrane Proteomics Frankfurt.	Anderka O, 2008, BIOCHEMISTRY-US, V47, P4683, DOI 10.1021/bi702397d; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Belevich I, 2008, ANTIOXID REDOX SIGN, V10, P1, DOI 10.1089/ars.2007.1705; Bundschuh FA, 2008, BBA-BIOENERGETICS, V1777, P1336, DOI 10.1016/j.bbabio.2008.05.448; DEGIER JWL, 1994, MOL MICROBIOL, V13, P183, DOI 10.1111/j.1365-2958.1994.tb00414.x; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gibney BR, 2000, BIOCHEMISTRY-US, V39, P11041, DOI 10.1021/bi000925r; Greiner P, 2008, BBA-BIOENERGETICS, V1777, P904, DOI 10.1016/j.bbabio.2008.04.003; HENDLER RW, 1991, BIOPHYS J, V60, P415, DOI 10.1016/S0006-3495(91)82067-7; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDWIG B, 1980, P NATL ACAD SCI-BIOL, V77, P196, DOI 10.1073/pnas.77.1.196; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Poyau A, 1999, FEBS LETT, V462, P416, DOI 10.1016/S0014-5793(99)01571-9; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; WEINSTEIN JD, 1983, J BIOL CHEM, V258, P6799; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	43	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25735	25741		10.1074/jbc.M109.040295	http://dx.doi.org/10.1074/jbc.M109.040295			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625251	Green Published, hybrid			2022-12-25	WOS:000269738000031
J	Endo, R; Saito, T; Asada, A; Kawahara, H; Ohshima, T; Hisanaga, S				Endo, Ryo; Saito, Taro; Asada, Akiko; Kawahara, Hiroyuki; Ohshima, Toshio; Hisanaga, Shin-ichi			Commitment of 1-Methyl-4-phenylpyrinidinium Ion-induced Neuronal Cell Death by Proteasome-mediated Degradation of p35 Cyclin-dependent Kinase 5 Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; ORNITHINE-DECARBOXYLASE; INDUCED APOPTOSIS; SUBSTANTIA-NIGRA; CDK5 ACTIVITY; LEWY-BODIES; MOUSE MODEL; NEUROTOXICITY; PROTEIN	The dysfunction of proteasomes and mitochondria has been implicated in the pathogenesis of Parkinson disease. However, the mechanism by which this dysfunction causes neuronal cell death is unknown. We studied the role of cyclin-dependent kinase 5 (Cdk5)-p35 in the neuronal cell death induced by 1-methyl-4-phenylpyrinidinium ion (MPP+), which has been used as an in vitro model of Parkinson disease. When cultured neurons were treated with 100 mu M MPP+, p35 was degraded by proteasomes at 3 h, much earlier than the neurons underwent cell death at 12-24 h. The degradation of p35 was accompanied by the down-regulation of Cdk5 activity. We looked for the primary target of MPP+ that triggered the proteasome-mediated degradation of p35. MPP+ treatment for 3 h induced the fragmentation of the mitochondria, reduced complex I activity of the respiratory chain without affecting ATP levels, and impaired the mitochondrial import system. The dysfunction of the mitochondrial import system is suggested to up-regulate proteasome activity, leading to the ubiquitin-independent degradation of p35. The overexpression of p35 attenuated MPP+-induced neuronal cell death. In contrast, depletion of p35 with short hairpin RNA not only induced cell death but also sensitized to MPP+ treatment. These results indicate that a brief MPP+ treatment triggers the delayed neuronal cell death by the down-regulation of Cdk5 activity via mitochondrial dysfunction-induced up-regulation of proteasome activity. We propose a role for Cdk5-p35 as a survival factor in countering MPP+-induced neuronal cell death.	[Endo, Ryo; Saito, Taro; Asada, Akiko; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Grad Sch Sci, Lab Mol Neurosci, Tokyo 1920397, Japan; [Kawahara, Hiroyuki] Tokyo Metropolitan Univ, Grad Sch Sci, Lab Cellular Biochem, Dept Biol Sci, Tokyo 1920397, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Tokyo 1628480, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University; Waseda University	Endo, R (corresponding author), Minami Osawa 1-1, Tokyo 1920397, Japan.	endo-ryo@ed.tmu.ac.jp; hisanaga-shinichi@tmu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority area from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bai J, 2004, J BIOL CHEM, V279, P38710, DOI 10.1074/jbc.M403329200; BRION JP, 1995, AM J PATHOL, V147, P1465; Bu BT, 2002, J NEUROSCI, V22, P6515; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chalmers-Redman RME, 1999, BIOCHEM BIOPH RES CO, V257, P440, DOI 10.1006/bbrc.1999.0487; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Cheung Zelda H., 2007, Biotechnology Journal, V2, P949, DOI 10.1002/biot.200700056; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; da Costa CA, 2006, J BIOL CHEM, V281, P9824, DOI 10.1074/jbc.M513903200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Hirata Y, 2007, J NEUROCHEM, V102, P1606, DOI 10.1111/j.1471-4159.2007.04695.x; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Hood DA, 2004, P NUTR SOC, V63, P293, DOI 10.1079/PNS2004342; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Jackson-Lewis V, 2005, NEUROTOX RES, V7, P193, DOI 10.1007/BF03036449; Kahana C, 2005, CELL CYCLE, V4, P1461, DOI 10.4161/cc.4.11.2115; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MYTILINEOU C, 1985, NEUROSCI LETT, V57, P19, DOI 10.1016/0304-3940(85)90034-5; Nakamura S, 1997, ACTA NEUROPATHOL, V94, P153, DOI 10.1007/s004010050687; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Neystat M, 2001, J NEUROCHEM, V77, P1611, DOI 10.1046/j.1471-4159.2001.00376.x; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saito T, 1998, BIOCHEM BIOPH RES CO, V252, P775, DOI 10.1006/bbrc.1998.9739; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Sawada H, 2004, J BIOL CHEM, V279, P10710, DOI 10.1074/jbc.M308434200; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tiesong SS, 2005, J BIOL CHEM, V280, P34644, DOI 10.1074/jbc.M506466200; TURSKI L, 1991, NATURE, V349, P414, DOI 10.1038/349414a0; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wright G, 2001, EXP CELL RES, V263, P107, DOI 10.1006/excr.2000.5096	54	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26029	26039		10.1074/jbc.M109.026443	http://dx.doi.org/10.1074/jbc.M109.026443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19638632	Green Published, hybrid			2022-12-25	WOS:000269738000059
J	Goto, M; Yamauchi, T; Kamiya, N; Miyahara, I; Yoshimura, T; Mihara, H; Kurihara, T; Hirotsu, K; Esaki, N				Goto, Masaru; Yamauchi, Takae; Kamiya, Nobuo; Miyahara, Ikuko; Yoshimura, Tohru; Mihara, Hisaaki; Kurihara, Tatsuo; Hirotsu, Ken; Esaki, Nobuyoshi			Crystal Structure of a Homolog of Mammalian Serine Racemase from Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; COLI ASPARTATE-AMINOTRANSFERASE; D-AMINO ACIDS; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; THREONINE SYNTHASE; ALPHA(2)BETA(2) COMPLEX; CONFORMATIONAL-CHANGES; TRYPTOPHAN SYNTHASE; ALANINE RACEMASE	D-Serine is an endogenous coagonist for the N-methyl-D-as-partate receptor and is involved in excitatory neurotransmission in the brain. Mammalian pyridoxal 5'-phosphate-dependent serine racemase, which is localized in the mammalian brain, catalyzes the racemization of L-serine to yield D-serine and vice versa. The enzyme also catalyzes the dehydration of D- and L-serine. Both reactions are enhanced by Mg.ATP in vivo. We have determined the structures of the following three forms of the mammalian enzyme homolog from Schizosaccharomyces pombe: the wild-type enzyme, the wild-type enzyme in the complex with an ATP analog, and the modified enzyme in the complex with serine at 1.7, 1.9, and 2.2 angstrom resolution, respectively. On binding of the substrate, the small domain rotates toward the large domain to close the active site. The ATP binding site was identified at the domain and the subunit interface. Computer graphics models of the wild-type enzyme complexed with L-serine and D- serine provided an insight into the catalytic mechanisms of both reactions. Lys-57 and Ser-82 located on the protein and solvent sides, respectively, with respect to the cofactor plane, are acid-base catalysts that shuttle protons to the substrate. The modified enzyme, which has a unique "lysino-D-alanyl" residue at the active site, also exhibits catalytic activities. The crystal-soaking experiment showed that the substrate serine was actually trapped in the active site of the modified enzyme, suggesting that the lysino-D-alanyl residue acts as a catalytic base in the same manner as inherent Lys-57 of the wild-type enzyme.	[Goto, Masaru; Kamiya, Nobuo; Miyahara, Ikuko; Yoshimura, Tohru; Hirotsu, Ken] Osaka City Univ, Dept Chem, Grad Sch Sci, Osaka 5588585, Japan; [Yamauchi, Takae; Mihara, Hisaaki; Kurihara, Tatsuo; Esaki, Nobuyoshi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan	Osaka Metropolitan University; Kyoto University	Hirotsu, K (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	hirotsu@spring8.or.jp; esakin@scl.kyoto-u.ac.jp	Mihara, Hisaaki/F-2172-2010	Mihara, Hisaaki/0000-0002-5153-4403	Japan Society for the Promotion of Science; National Project on Protein Structural and Functional Analyses	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Japan Society for the Promotion of Science and National Project on Protein Structural and Functional Analyses (to N.E. and to K.H.).	Baumgart F, 2008, FEBS J, V275, P3538, DOI 10.1111/j.1742-4658.2008.06517.x; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; Daum S, 2003, BIOCHEMISTRY-US, V42, P106, DOI 10.1021/bi0268044; DE MJ, 2002, P NATL ACAD SCI USA, V99, P14542; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Garrido-Franco M, 2002, J BIOL CHEM, V277, P12396, DOI 10.1074/jbc.M108734200; GOLDBERG JM, 1991, BIOCHEMISTRY-US, V30, P305, DOI 10.1021/bi00215a041; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; Heine A, 2004, PROTEINS, V56, P387, DOI 10.1002/prot.20003; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; INOUE K, 1991, J BIOCHEM, V109, P570, DOI 10.1093/oxfordjournals.jbchem.a123421; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SJ, 2005, BIOCHEMISTRY-US, V44, P11417, DOI 10.1021/bi050317h; Mas-Droux C, 2006, J BIOL CHEM, V281, P5188, DOI 10.1074/jbc.M509798200; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MITCHELL JBO, 1992, J MOL BIOL, V226, P251, DOI 10.1016/0022-2836(92)90137-9; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Omi R, 2003, J BIOL CHEM, V278, P46035, DOI 10.1074/jbc.M308065200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Uo T, 1998, BIOCHEM BIOPH RES CO, V246, P31, DOI 10.1006/bbrc.1998.8561; Uo T, 2002, BIOSCI BIOTECH BIOCH, V66, P2639, DOI 10.1271/bbb.66.2639; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2002, NEUROCHEM INT, V41, P327, DOI 10.1016/S0197-0186(02)00055-4; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; WOLOSKER H, 2006, SCI STKE, pPE41; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yamada T, 2008, BBA-GEN SUBJECTS, V1780, P809, DOI 10.1016/j.bbagen.2008.01.020; Yamauchi T, 2009, J BIOCHEM, V145, P421, DOI 10.1093/jb/mvp010; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yoshimura T, 2008, FEBS J, V275, P3527, DOI 10.1111/j.1742-4658.2008.06516.x	56	68	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25944	25952		10.1074/jbc.M109.010470	http://dx.doi.org/10.1074/jbc.M109.010470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640845	Green Published, hybrid			2022-12-25	WOS:000269738000051
J	Chen, YH; Wendt-Pienkoski, E; Rajski, SR; Shen, B				Chen, Yihua; Wendt-Pienkoski, Evelyn; Rajski, Scott R.; Shen, Ben			In Vivo Investigation of the Roles of FdmM and FdmM1 in Fredericamycin Biosynthesis Unveiling a New Family of Oxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-GRISEUS; GENE-CLUSTER; IDENTIFICATION; ANTIBIOTICS; OXIDATION; COFACTOR; PATHWAY; CLONING	Fredericamycin (FDM) A, a highly oxidized aromatic penta-decaketide natural product, exhibits potent cytotoxicity and has been studied as a new anticancer drug lead. The FDM biosynthetic gene cluster has been previously cloned from Streptomyces griseus ATCC 49344 and successfully expressed in the heterologous host Streptomyces albus J1074. The fdmM and fdmM1 genes code for two proteins with high sequence homology to each other but unknown function. In-frame deletion of each of the genes from the fdm cluster was accomplished in the S. albus host. Each mutant failed to produce FDM A and the key biosynthetic intermediate FDM E but produced various new metabolites, the titers of which were dramatically increased via overexpression of an fdm pathway-specific activator fdmR1. The Delta fdmM mutant strain accumulated three new compounds FDM M-1, FDM M-2, and FDM M-3, whereas the Delta fdmM1 mutant strain produced one new compound FDM M1-1. Isolation and structural characterization of these compounds enable us to propose that FdmM and FdmM1 catalyze the C-6 and C-8 hydroxylations for FDM biosynthesis, respectively. Homologs of FdmM and FdmM1 can be found in biosynthetic gene clusters of many other aromatic polyketides, ranging from dodecaketides to pentadecaketides, but to date all of them were annotated as proteins of unknown function. Based on the findings reported here for FdmM and FdmM1, we now propose similar functions for those proteins, and FdmM and FdmM1 therefore represent an emerging family of novel oxygenases responsible for hydroxylation of aromatic polyketide natural products.	[Chen, Yihua; Wendt-Pienkoski, Evelyn; Rajski, Scott R.; Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Chen, Yihua/B-3550-2012		National Institutes of Health [CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113297.	Beinker P, 2006, J MOL BIOL, V359, P728, DOI 10.1016/j.jmb.2006.03.060; BOCKHOLT H, 1994, J ORG CHEM, V59, P2064, DOI 10.1021/jo00087a021; BYRNE KM, 1985, BIOCHEMISTRY-US, V24, P478, DOI 10.1021/bi00323a035; Chen Y, 2008, J BACTERIOL, V190, P5587, DOI 10.1128/JB.00592-08; Chen YH, 2008, J NAT PROD, V71, P431, DOI 10.1021/np070664n; Fetzner S, 2002, APPL MICROBIOL BIOT, V60, P243, DOI 10.1007/s00253-002-1123-4; Funa N, 2005, J BIOL CHEM, V280, P14514, DOI 10.1074/jbc.M500190200; Gatti DL, 1996, BIOCHEMISTRY-US, V35, P567, DOI 10.1021/bi951344i; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Jansson A, 2005, J BIOL CHEM, V280, P3636, DOI 10.1074/jbc.M412095200; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BC, 2007, J MICROBIOL BIOTECHN, V17, P830; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5; Martin R, 2001, J ANTIBIOT, V54, P239, DOI 10.7164/antibiotics.54.239; MISRA R, 1982, J AM CHEM SOC, V104, P4478, DOI 10.1021/ja00380a025; Niemi J, 1999, BBA-PROTEIN STRUCT M, V1430, P57, DOI 10.1016/S0167-4838(98)00265-9; PANDEY RC, 1981, J ANTIBIOT, V34, P1389, DOI 10.7164/antibiotics.34.1389; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schenk A, 2007, ANGEW CHEM INT EDIT, V46, P7035, DOI 10.1002/anie.200702033; SHEN B, 1993, BIOCHEMISTRY-US, V32, P6656, DOI 10.1021/bi00077a019; Sontag B, 2004, J ANTIBIOT, V57, P823, DOI 10.7164/antibiotics.57.823; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Widboom PF, 2007, NATURE, V447, P342, DOI 10.1038/nature05702; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b	25	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24735	24743		10.1074/jbc.M109.014191	http://dx.doi.org/10.1074/jbc.M109.014191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620242	Green Published, hybrid			2022-12-25	WOS:000269734000008
J	Winer, JP; Oake, S; Janmey, PA				Winer, Jessamine P.; Oake, Shaina; Janmey, Paul A.			Non-Linear Elasticity of Extracellular Matrices Enables Contractile Cells to Communicate Local Position and Orientation	PLOS ONE			English	Article								Most tissue cells grown in sparse cultures on linearly elastic substrates typically display a small, round phenotype on soft substrates and become increasingly spread as the modulus of the substrate increases until their spread area reaches a maximum value. As cell density increases, individual cells retain the same stiffness-dependent differences unless they are very close or in molecular contact. On nonlinear strain-stiffening fibrin gels, the same cell types become maximally spread even when the low strain elastic modulus would predict a round morphology, and cells are influenced by the presence of neighbors hundreds of microns away. Time lapse microscopy reveals that fibroblasts and human mesenchymal stem cells on fibrin deform the substrate by several microns up to five cell lengths away from their plasma membrane through a force limited mechanism. Atomic force microscopy and rheology confirm that these strains locally and globally stiffen the gel, depending on cell density, and this effect leads to long distance cell-cell communication and alignment. Thus cells are acutely responsive to the nonlinear elasticity of their substrates and can manipulate this rheological property to induce patterning.			Winer, JP (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	winer@seas.upenn.edu	Winer-Jones, Jessamine P/N-7458-2013	Winer-Jones, Jessamine P/0000-0002-6412-4139	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083272] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL007954, T32 HL007954] Funding Source: Medline; NIGMS NIH HHS [R01 GM083272, GM083272] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alge CS, 2006, J PROTEOME RES, V5, P862, DOI 10.1021/pr050420t; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown AEX, 2007, BIOPHYS J, p524A; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; CLARK P, 1991, J CELL SCI, V99, P73; Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9; Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130; Freyman TM, 2002, EXP CELL RES, V272, P153, DOI 10.1006/excr.2001.5408; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hertz H, 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hong H, 2008, J BIOMAT SCI-POLYM E, V19, P1279, DOI 10.1163/156856208786052380; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; KANG H, 2009, J PHYS CH B IN PRESS; Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; LANGER BG, 1988, J BIOL CHEM, V263, P15056; Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Michaud SE, 2002, THROMB RES, V107, P245, DOI 10.1016/S0049-3848(02)00333-X; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1999, MOL BIOL CELL, V10, P935, DOI 10.1091/mbc.10.4.935; Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; SCHINDLAUER G, 1986, BIOPOLYMERS, V25, P1315, DOI 10.1002/bip.360250711; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763; Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y; Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058	57	262	263	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6382	10.1371/journal.pone.0006382	http://dx.doi.org/10.1371/journal.pone.0006382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629190	Green Published, Green Submitted, gold			2022-12-25	WOS:000268318900011
J	George, MP; Kannass, M; Huang, L; Sciurba, FC; Morris, A				George, M. Patricia; Kannass, Mouhamed; Huang, Laurence; Sciurba, Frank C.; Morris, Alison			Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNODEFICIENCY-VIRUS-INFECTION; IMMUNE RECONSTITUTION; ANTIRETROVIRAL THERAPY; PULMONARY-FUNCTION; RISK-FACTORS; DISEASE; ASSOCIATION; AUTOANTIBODIES; COMPLICATIONS	Background: Prevalence and risk factors for respiratory symptoms and airway obstruction in HIV-infected subjects in the era of highly active antiretroviral therapy (HAART) are unknown. We evaluated respiratory symptoms and measured airway obstruction to identify the impact of HAART and other risk factors on respiratory symptoms and pulmonary function. Methodology/Principal Findings: Two hundred thirty-four HIV-infected adults without acute respiratory symptoms were recruited from an HIV clinic. All subjects were interviewed and performed spirometry. Multivariate linear and logistic regressions were performed to determine predictors of respiratory symptoms, forced expiratory volume in one second (FEV1) percent predicted, and FEV1/forced vital capacity (FEV1/FVC). Thirty- one percent of subjects reported at least one respiratory symptom. Smoking status (current or former versus never) (odds ratio [OR] = 2.7, 95% confidence interval [CI] = 1.41-5.22, p = 0.003), higher log plasma HIV viral levels (OR = 1.12, 95% CI = 1.02-1.24, p = 0.02), and lower FEV1/FVC (OR = 1.06 for every 0.01 decrease in FEV1/FVC, 95% CI = 1.02-1.14, p = 0.001) were independent predictors of respiratory symptoms. Age (p = 0.04), pack-year smoking history (p < 0.001), previous bacterial pneumonia (p = 0.007), and HAART use (p = 0.04) were independent predictors of decreased FEV1/FVC. Conclusions/Significance: Respiratory symptoms remain common in HIV-infected subjects, especially in those with a smoking history. Subjects who were older, had a greater pack- year history of smoking, or previous bacterial pneumonia had lower FEV1/FVC ratios. Interestingly, use of HAART was independently associated with a decreased FEV1/FVC, possibly secondary to an immune response to subclinical infections, increased autoimmunity, or other factors associated with HAART use.			George, MP (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.	morrisa@upmc.edu	Huang, Laurence/AAZ-7120-2021; Sciurba, Frank/AAZ-9339-2021; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; sciurba, frank/0000-0001-7468-2225; George, Marjorie Patricia/0000-0002-6534-1020	NCRR NIH HHS [UL1 RR024153] Funding Source: Medline; NHLBI NIH HHS [HL087713, HL072837, R01 HL090335, K23 HL072837, P50 HL084948, K24 HL087713, K24 HL087713-03, HL090335, R01 HL090335-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL072837, P50HL084948, R01HL090335, K24HL087713] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agusti A, 2003, THORAX, V58, P832, DOI 10.1136/thorax.58.10.832; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Calabrese LH, 2005, SEMIN ARTHRITIS RHEU, V35, P166, DOI 10.1016/j.semarthrit.2005.03.007; Chen F, 2005, MEDICINE, V84, P98, DOI 10.1097/01.md.0000159082.45703.90; Crothers K, 2007, CLIN CHEST MED, V28, P575, DOI 10.1016/j.ccm.2007.06.004; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Diaz PT, 2003, CHEST, V123, P1977, DOI 10.1378/chest.123.6.1977; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Diaz PT, 1999, AM J RESP CRIT CARE, V160, P272, DOI 10.1164/ajrccm.160.1.9812089; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Ermann J, 2001, NAT IMMUNOL, V2, P759, DOI 10.1038/ni0901-759; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Hosmer DW, 1997, STAT MED, V16, P965; Huang L, 2003, J EUKARYOT MICROBIOL, V50, P616, DOI 10.1111/j.1550-7408.2003.tb00651.x; Imami N, 1999, AIDS RES HUM RETROV, V15, P1499, DOI 10.1089/088922299309784; Jubault V, 2000, J CLIN ENDOCR METAB, V85, P4254, DOI 10.1210/jc.85.11.4254; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Koppel K, 2002, J ACQ IMMUN DEF SYND, V29, P441, DOI 10.1097/00042560-200204150-00003; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MITCHELL DM, 1992, AM REV RESPIR DIS, V146, P745, DOI 10.1164/ajrccm/146.3.745; Mondal Debasis, 2004, Cardiovasc Toxicol, V4, P287, DOI 10.1385/CT:4:3:287; Morris A, 2004, AM J RESP CRIT CARE, V170, P408, DOI 10.1164/rccm.200401-094OC; Morris AM, 2000, AM J RESP CRIT CARE, V162, P612, DOI 10.1164/ajrccm.162.2.9912058; Morris DG, 2003, CHEST, V124, P929, DOI 10.1378/chest.124.3.929; O'Leary Jacqueline G, 2008, Clin Infect Dis, V46, pe12, DOI 10.1086/524082; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PAUWELS RA, 2001, AM J RESP CRIT CARE, V163, P1276; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; ROSEN MJ, 1995, AM J RESP CRIT CARE, V152, P738, DOI 10.1164/ajrccm.152.2.7633736; Sethi S, 2000, CHEST, V117, p286S, DOI 10.1378/chest.117.5_suppl_1.286S; Sethi Sanjay, 2004, Proc Am Thorac Soc, V1, P109, DOI 10.1513/pats.2306029; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292; Wallace JM, 1997, CHEST, V111, P121, DOI 10.1378/chest.111.1.121; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1	41	110	114	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6328	10.1371/journal.pone.0006328	http://dx.doi.org/10.1371/journal.pone.0006328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621086	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000268147200015
J	Desclaux, M; Teigell, M; Amar, L; Vogel, R; Ribotta, MGY; Privat, A; Mallet, J				Desclaux, Mathieu; Teigell, Marisa; Amar, Lahouari; Vogel, Roland; Gimenez y Ribotta, Minerva; Privat, Alain; Mallet, Jacques			A Novel and Efficient Gene Transfer Strategy Reduces Glial Reactivity and Improves Neuronal Survival and Axonal Growth In Vitro	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SULFATE PROTEOGLYCANS NEUROCAN; INTERMEDIATE-FILAMENT PROTEIN; PROMOTES FUNCTIONAL RECOVERY; ANTIGEN-PRESENTING CELLS; BRAIN-BARRIER PROPERTIES; LENTIVIRAL VECTORS; TENASCIN-C; T-CELLS; ASTROCYTES	Background: The lack of axonal regeneration in the central nervous system is attributed among other factors to the formation of a glial scar. This cellular structure is mainly composed of reactive astrocytes that overexpress two intermediate filament proteins, the glial fibrillary acidic protein (GFAP) and vimentin. Indeed, in vitro, astrocytes lacking GFAP or both GFAP and vimentin were shown to be the substrate for increased neuronal plasticity. Moreover, double knockout mice lacking both GFAP and vimentin presented lower levels of glial reactivity in vivo, significant axonal regrowth and improved functional recovery in comparison with wild-type mice after spinal cord hemisection. From these results, our objective was to develop a novel therapeutic strategy for axonal regeneration, based on the targeted suppression of astroglial reactivity and scarring by lentiviral-mediated RNA-interference (RNAi). Methods and Findings: In this study, we constructed two lentiviral vectors, Lv-shGFAP and Lv-shVIM, which allow efficient and stable RNAi-mediated silencing of endogenous GFAP or vimentin in vitro. In cultured cortical and spinal reactive astrocytes, the use of these vectors resulted in a specific, stable and highly significant decrease in the corresponding protein levels. In a second model - scratched primary cultured astrocytes - Lv-shGFAP, alone or associated with Lv-shVIM, decreased astrocytic reactivity and glial scarring. Finally, in a heterotopic coculture model, cortical neurons displayed higher survival rates and increased neurite growth when cultured with astrocytes in which GFAP and vimentin had been invalidated by lentiviral-mediated RNAi. Conclusions: Lentiviral-mediated knockdown of GFAP and vimentin in astrocytes show that GFAP is a key target for modulating reactive gliosis and monitoring neuron/glia interactions. Thus, manipulation of reactive astrocytes with the Lv-shGFAP vector constitutes a promising therapeutic strategy for increasing glial permissiveness and permitting axonal regeneration after central nervous system lesions.	[Desclaux, Mathieu; Amar, Lahouari; Vogel, Roland; Mallet, Jacques] Univ Paris 06, Hop La Pitie Salpetriere, INSERM,Ctr Rech,UMRS 975, CNRS,Inst Cerveau & Moelle Epiniere,UMR 7225, Paris, France; [Teigell, Marisa] NEUREVA Inc, Montpellier, France; [Gimenez y Ribotta, Minerva] Univ Miguel Hernandez UMH, Inst Neurociencias Alicante, CSIC, St Joan Dalacant Nacl, Spain; [Privat, Alain] Univ Montpellier 2, INSERM, Physiopathol & Therapie Deficits Sensoriels & Mot, U583, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Desclaux, M (corresponding author), Univ Paris 06, Hop La Pitie Salpetriere, INSERM,Ctr Rech,UMRS 975, CNRS,Inst Cerveau & Moelle Epiniere,UMR 7225, Paris, France.	privat@univ-montp2.fr						Amar L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl034; Araque A, 2008, NEURON GLIA BIOL, V4, P3, DOI 10.1017/S1740925X09000064; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Couturier C, 2007, P NATL ACAD SCI USA, V104, P19476, DOI 10.1073/pnas.0706671104; DAHL D, 1981, EXP NEUROL, V73, P496, DOI 10.1016/0014-4886(81)90283-1; DAHL D, 1981, J NEUROSCI RES, V6, P741, DOI 10.1002/jnr.490060608; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; FIERZ W, 1985, J IMMUNOL, V134, P3785; FONTANA A, 1986, J NEUROIMMUNOL, V12, P15, DOI 10.1016/0165-5728(86)90093-7; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Galou M, 1996, J CELL BIOL, V133, P853, DOI 10.1083/jcb.133.4.853; Ge SJ, 2004, J BIOL CHEM, V279, P6688, DOI 10.1074/jbc.M311769200; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; GIMENEZ YRM, 2000, GLIA, V31, P69, DOI DOI 10.1002/(SICI)1098-1136(200007)31:1<69::AID-GLIA70>3.0.C0;2-W; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Lefrancois T, 1997, J NEUROSCI, V17, P4121; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Menet V, 2001, J NEUROSCI, V21, P6147; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morin-Richaud C, 1998, BRAIN RES, V783, P85, DOI 10.1016/S0006-8993(97)01282-1; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nishio T, 2005, NEUROSCIENCE, V132, P87, DOI 10.1016/j.neuroscience.2004.12.028; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 1998, GLIA, V22, P390, DOI 10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.0.CO;2-7; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; PERTUSA M, 2007, NEUROBIOL AGING; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; REIER PJ, 1983, ASTROCYTIC SCAR IMPE, P163; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rozovsky I, 2005, NEUROBIOL AGING, V26, P705, DOI 10.1016/j.neurobiolaging.2004.06.009; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Vogel R, 2004, HUM GENE THER, V15, P157, DOI 10.1089/104303404772679968; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	62	40	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6227	10.1371/journal.pone.0006227	http://dx.doi.org/10.1371/journal.pone.0006227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597552	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035600002
J	Lodes, MJ; Caraballo, M; Suciu, D; Munro, S; Kumar, A; Anderson, B				Lodes, Michael J.; Caraballo, Marcelo; Suciu, Dominic; Munro, Sandra; Kumar, Amit; Anderson, Brooke			Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray	PLOS ONE			English	Article							MICRORNA EXPRESSION; POLYMORPHISMS; BIOMARKERS; PATTERNS; SURVIVAL; TARGETS; COLON	Micro RNAs (miRNAs) are a class of small, non-coding RNA species that play critical roles throughout cellular development and regulation. miRNA expression patterns taken from various tissue types often point to the cellular lineage of an individual tissue type, thereby being a more invariant hallmark of tissue type. Recent work has shown that these miRNA expression patterns can be used to classify tumor cells, and that this classification can be more accurate than the classification achieved by using messenger RNA gene expression patterns. One aspect of miRNA biogenesis that makes them particularly attractive as a biomarker is the fact that they are maintained in a protected state in serum and plasma, thus allowing the detection of miRNA expression patterns directly from serum. This study is focused on the evaluation of miRNA expression patterns in human serum for five types of human cancer, prostate, colon, ovarian, breast and lung, using a pan-human microRNA, high density microarray. This microarray platform enables the simultaneous analysis of all human microRNAs by either fluorescent or electrochemical signals, and can be easily redesigned to include newly identified miRNAs. We show that sufficient miRNAs are present in one milliliter of serum to detect miRNA expression patterns, without the need for amplification techniques. In addition, we are able to use these expression patterns to correctly discriminate between normal and cancer patient samples.			Lodes, MJ (corresponding author), CombiMatrix Corp, Washington, DC USA.	mlodes@combimatrix.com	Munro, Sandra B/S-2611-2019	Munro, Sandra B/0000-0002-9643-0528				Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; CHIM SS, 2008, CLIN CHEM, V444, P291; Chin LJ, 2008, CELL RES, V18, P983, DOI 10.1038/cr.2008.290; Cleary JG, 1995, ED INN EC BUS ADM, P108; Corney DC, 2008, HISTOL HISTOPATHOL, V23, P1161, DOI 10.14670/HH-23.1161; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fontana L, 2008, BIOCHEM SOC T, V36, P1206, DOI 10.1042/BST0361206; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Jackson DB, 2009, P NATL ACAD SCI USA, V106, pE5, DOI 10.1073/pnas.0809999106; LAIOS A, 2008, MOL CANCER, V223, P7; Latronico MVG, 2008, PHYSIOL GENOMICS, V34, P239, DOI 10.1152/physiolgenomics.90254.2008; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; NEELY LA, 2008, UROL ONCOL      0915; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Shih KK, 2008, GYNECOL ONCOL, V110, P1, DOI 10.1016/j.ygyno.2008.05.020; Smith DD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-63; Tam W, 2008, J MOL DIAGN, V10, P411, DOI 10.2353/jmoldx.2008.080067; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Verghese ET, 2008, J PATHOL, V215, P214, DOI 10.1002/path.2359; WANG G, 2008, BIOMED GENOMICS, V9, P522; Witten I. H., 2005, DATA MINING PRACTICA; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	49	334	366	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6229	10.1371/journal.pone.0006229	http://dx.doi.org/10.1371/journal.pone.0006229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597549	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035600004
J	Fimbel, EJ; Michaud, R; Martin, M				Fimbel, Eric J.; Michaud, Rene; Martin, Mathieu			Certainty in Categorical Judgment of Size	PLOS ONE			English	Article							ABSOLUTE IDENTIFICATION; FUZZY SETS; NATURAL CATEGORIES; CONFIDENCE; MODEL; MAGNITUDE; PERCEPTION; RESOLUTION; CAPACITY; MEMORY	The certainty of judgment (or self-confidence) has been traditionally studied in relation with the accuracy. However, from an observer's viewpoint, certainty may be more closely related to the consistency of judgment than to its accuracy: consistent judgments are objectively certain in the sense that any external observer can rely on these judgments to happen. The regions of certain vs. uncertain judgment were determined in a categorical rating experiment. The participants rated the size of visual objects on a 5-point scale. There was no feedback so that there were no constraints of accuracy. Individual data was examined, and the ratings were characterized by their frequency distributions (or categories). The main result was that the individual categories always presented a core of certainty where judgment was totally consistent, and large peripheries where judgment was inconsistent. In addition, the geometry of cores and boundaries exhibited several phenomena compatible with the literature on visual categorical judgment. The ubiquitous presence of cores in absence of accuracy constraints provided insights about objective certainty that may complement the literature on subjective certainty (self-confidence) and the accuracy of judgment.			Fimbel, EJ (corresponding author), Fatronik Fdn Res Ctr, Donostia San Sebastian, Spain.	efimbel@fatronik.ca						Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Barsalou L. W., 1987, CONCEPTS CONCEPTUAL, P101; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BILGIC T, 1999, HDB FUZZY SETS SYSTE, V1, P195; Blais AR, 2005, PERS INDIV DIFFER, V38, P1701, DOI 10.1016/j.paid.2004.11.004; BRAIDA LD, 1972, J ACOUST SOC AM, V51, P483, DOI 10.1121/1.1912868; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; Ellison JW, 1997, J EXP PSYCHOL HUMAN, V23, P213, DOI 10.1037/0096-1523.23.1.213; Estes Z, 2004, PSYCHON B REV, V11, P1041, DOI 10.3758/BF03196734; Estes Z, 2003, MEM COGNITION, V31, P199, DOI 10.3758/BF03194379; FECHNER GT, 1860, CLASSICAL PSYCHOL, P562; Fimbel EJ, 2005, J NEUROSCI METH, V146, P183, DOI 10.1016/j.jneumeth.2005.02.007; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; Gonzalez-Vallejo C, 2007, ACTA PSYCHOL, V125, P221, DOI 10.1016/j.actpsy.2006.07.010; HAMPTON JAMES A, 1995, PSYCHOL BELG, V35, P103; Harvey N, 1997, TRENDS COGN SCI, V1, P78, DOI 10.1016/S1364-6613(97)01014-0; HAUBENSAK G, 1992, J EXP PSYCHOL HUMAN, V18, P303, DOI 10.1037/0096-1523.18.1.303; HERSH HM, 1976, J EXP PSYCHOL GEN, V105, P254, DOI 10.1037/0096-3445.105.3.254; Hornby Albert Sydney, 2005, OXFORD ADV LEARNERS, P1620; JESTEADT W, 1977, J EXP PSYCHOL HUMAN, V3, P92, DOI 10.1037/0096-1523.3.1.92; KANDEL A, 1978, P IEEE, V66, P1619, DOI 10.1109/PROC.1978.11171; Klir G.J., 1995, FUZZY SETS FUZZY LOG, DOI 10.1109/9780470544341.ch11; Koriat A, 2008, PSYCHON B REV, V15, P997, DOI 10.3758/PBR.15.5.997; Kvidera S, 2008, J BEHAV DECIS MAKING, V21, P253, DOI 10.1002/bdm.587; Lacouture Y, 1997, PSYCHOL RES-PSYCH FO, V60, P121, DOI 10.1007/BF00419760; Lacouture Y, 1995, J MATH PSYCHOL, V39, P383, DOI 10.1006/jmps.1995.1036; Lockhead GR, 2004, REV GEN PSYCHOL, V8, P265, DOI 10.1037/1089-2680.8.4.265; MARLEY AAJ, 1984, BRIT J MATH STAT PSY, V37, P136, DOI 10.1111/j.2044-8317.1984.tb00797.x; MCCLOSKEY ME, 1978, MEM COGNITION, V6, P462, DOI 10.3758/BF03197480; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; NORWICH AM, 1984, FUZZY SET SYST, V12, P1, DOI 10.1016/0165-0114(84)90047-2; Olsson H, 2000, FOOD QUAL PREFER, V11, P27, DOI 10.1016/S0950-3293(99)00026-9; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; Pastore RE, 1987, CATEGORICAL PERCEPTI, P29; Petrov AA, 2005, PSYCHOL REV, V112, P383, DOI 10.1037/0033-295X.112.2.383; Rosch Eleanor H., 1973, COGNITIVE DEV ACQUIS, P111; Shoben EJ, 1998, J MEM LANG, V38, P94, DOI 10.1006/jmla.1997.2534; SMITH J, 1984, AM J PSYCHOL, V97, P343, DOI 10.2307/1422523; SPENCE I, 1990, J EXP PSYCHOL HUMAN, V16, P683, DOI 10.1037/0096-1523.16.4.683; STEVENS SS, 1958, AM J PSYCHOL, V71, P633, DOI 10.2307/1420322; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; WARD LM, 1972, J EXP PSYCHOL, V94, P179, DOI 10.1037/h0032754; Ward LM, 1996, PERCEPT PSYCHOPHYS, V58, P793, DOI 10.3758/BF03213110; WARD LM, 1987, J EXP PSYCHOL HUMAN, V13, P216, DOI 10.1037/0096-1523.13.2.216; Wong W, 1997, BIOSYSTEMS, V43, P189, DOI 10.1016/S0303-2647(97)00040-3; Zadeh LA, 2005, INFORM SCIENCES, V172, P1, DOI 10.1016/j.ins.2005.01.017; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6198	10.1371/journal.pone.0006198	http://dx.doi.org/10.1371/journal.pone.0006198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DN	19593428	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035300011
J	Molnar, KS; Karabacak, NM; Johnson, JL; Wang, Q; Tiwari, A; Hayward, LJ; Coales, SJ; Hamuro, Y; Agar, JN				Molnar, Kathleen S.; Karabacak, N. Murat; Johnson, Joshua L.; Wang, Qi; Tiwari, Ashutosh; Hayward, Lawrence J.; Coales, Stephen J.; Hamuro, Yoshitomo; Agar, Jeffrey N.			A Common Property of Amyotrophic Lateral Sclerosis-associated Variants DESTABILIZATION OF THE COPPER/ZINC SUPEROXIDE DISMUTASE ELECTROSTATIC LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; MOTOR-NEURON DISEASE; TRANSGENIC MICE; MASS-SPECTROMETRY; FAMILIAL ALS; CU,ZN-SUPEROXIDE DISMUTASE; AXONAL-TRANSPORT; BINDING-SITE; SOD1 MUTANTS; MOUSE MODEL	At least 119 mutations in the gene encoding copper/zinc superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis by an unidentified toxic gain of function. We compared the dynamic properties of 13 as-isolated, partially metallated, SOD1 variant enzymes using hydrogen-deuterium exchange. We identified a shared property of these familial amyotrophic lateral sclerosis-related SOD1 variants, namely structural and dynamic change affecting the electrostatic loop (loop VII) of SOD1. Furthermore, SOD1 variants that have severely compromised metal binding affinities demonstrated additional structural and dynamic changes to the zinc-binding loop (loop IV) of SOD1. Although the biological consequences of increased loop VII mobility are not fully understood, this common property is consistent with the hypotheses that SOD1 mutations exert toxicity via aggregation or aberrant association with other cellular constituents.	[Karabacak, N. Murat; Wang, Qi; Agar, Jeffrey N.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Johnson, Joshua L.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Johnson, Joshua L.] Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; [Molnar, Kathleen S.; Coales, Stephen J.; Hamuro, Yoshitomo] ExSAR Corp, Monmouth Jct, NJ 08852 USA; [Tiwari, Ashutosh; Hayward, Lawrence J.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	Brandeis University; Brandeis University; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester	Agar, JN (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02454 USA.	agar@brandeis.edu	Tiwari, Ashutosh/A-7458-2008; Karabacak, Murat/AAG-2891-2019; Karabacak, N Murat/D-4184-2009; Karabacak, N Murat/D-7227-2013; Wang, Qi/A-2340-2012	Tiwari, Ashutosh/0000-0001-7373-349X; Karabacak, Murat/0000-0003-2761-5593; Karabacak, N Murat/0000-0003-2761-5593; Wang, Qi/0000-0001-8566-1120; Agar, Jeffery/0000-0003-2645-1873; Hayward, Lawrence/0000-0003-0579-0358; coales, stephen/0000-0002-8272-5456	National Institutes of Health [R01NS065263]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044170, R01NS065263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS065263.	Antonyuk S, 2005, PROTEIN SCI, V14, P1201, DOI 10.1110/ps.041256705; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Bartnikas TB, 2003, J BIOL CHEM, V278, P33602, DOI 10.1074/jbc.M305435200; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Crow JP, 1997, J NEUROCHEM, V69, P1945; Crow JP, 1997, J NEUROCHEM, V69, P1936; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Hart PJ, 1998, PROTEIN SCI, V7, P545; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Hyun DH, 2003, J NEUROCHEM, V86, P363, DOI 10.1046/j.1471-4159.2003.01841.x; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kong JM, 1998, J NEUROSCI, V18, P3241; KUROBE N, 1990, CLIN CHIM ACTA, V187, P11, DOI 10.1016/0009-8981(90)90257-S; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Petrovic N, 1996, J BIOL CHEM, V271, P28335, DOI 10.1074/jbc.271.45.28335; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Sivaraman T, 2001, NAT STRUCT BIOL, V8, P331, DOI 10.1038/86208; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2007, J BIOL CHEM, V282, P345, DOI 10.1074/jbc.M604503200; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Yates JR, 1996, J AM SOC MASS SPECTR, V7, P1089, DOI 10.1016/S1044-0305(96)00079-7; YOSHIDA E, 1994, J NEUROL SCI, V124, P25, DOI 10.1016/0022-510X(94)90006-X; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	65	47	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30965	30973		10.1074/jbc.M109.023945	http://dx.doi.org/10.1074/jbc.M109.023945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19635794	Green Published, hybrid			2022-12-25	WOS:000271378400026
J	Noubhani, A; Bunoust, O; Bonini, BM; Thevelein, JM; Devin, A; Rigoulet, M				Noubhani, Abdelmajid; Bunoust, Odile; Bonini, Beatriz Monge; Thevelein, Johan M.; Devin, Anne; Rigoulet, Michel			The Trehalose Pathway Regulates Mitochondrial Respiratory Chain Content through Hexokinase 2 and cAMP in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TREHALOSE-6-PHOSPHATE SYNTHASE; OXIDATIVE-PHOSPHORYLATION; GLYCOLYTIC-ENZYMES; MOLECULAR-CLONING; GROWTH DEFECT; WILD-TYPE; YEAST; GLUCOSE; GENE	In yeast, trehalose is synthesized by a multimeric enzymatic complex: TPS1 encodes trehalose 6-phosphate synthase, which belongs to a complex that is composed of at least three other subunits, including trehalose 6-phosphate phosphatase Tps2 and the redundant regulatory subunits Tps3 and Tsl1. The product of the TPS1 gene plays an essential role in the control of the glycolytic pathway by restricting the influx of glucose into glycolysis. In this paper, we investigated whether the trehalose synthesis pathway could be involved in the control of the other energy-generating pathway: oxidative phosphorylation. We show that the different mutants of the trehalose synthesis pathway (tps1 Delta, tps2 Delta, and tps1,2 Delta) exhibit modulation in the amount of respiratory chains, in terms of cytochrome content and maximal respiratory activity. Furthermore, these variations in mitochondrial enzymatic content are positively linked to the intracellular concentration in cAMP that is modulated by Tps1p through hexokinase2. This is the first time that a pathway involved in sugar storage, i.e. trehalose, is shown to regulate the mitochondrial enzymatic content.	[Noubhani, Abdelmajid; Bunoust, Odile; Devin, Anne; Rigoulet, Michel] CNRS, UMR5095, Inst Biochim & Genet Cellulaire, F-33077 Bordeaux, France; [Noubhani, Abdelmajid; Bunoust, Odile; Devin, Anne; Rigoulet, Michel] Univ Bordeaux 2, F-33076 Bordeaux, France; [Bonini, Beatriz Monge; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Flanders, Belgium; [Bonini, Beatriz Monge; Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Louvain, Flanders, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; KU Leuven; Flanders Institute for Biotechnology (VIB)	Rigoulet, M (corresponding author), CNRS, UMR5095, Inst Biochim & Genet Cellulaire, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	Michel.Rigoulet@ibgc.u-bordeaux2.fr	Thevelein, Johan M./AAK-4203-2021; Thevelein, Johan M./A-7897-2013	Thevelein, Johan M./0000-0002-2626-0180	Agence Nationale pour la Recherche [05-BLAN-0339-01]; Conseil Regional d'Aquitaine	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by Agence Nationale pour la Recherche 05-BLAN-0339-01 and the Conseil Regional d'Aquitaine.	BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; BLAZQUEZ MA, 1994, CURR GENET, V25, P89, DOI 10.1007/BF00309531; Bonini BM, 2003, BBA-BIOENERGETICS, V1606, P83, DOI 10.1016/S0005-2728(03)00086-0; BoyMarcotte E, 1996, MICROBIOL-UK, V142, P459, DOI 10.1099/13500872-142-3-459; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Dejean L, 2002, BIOCHEM BIOPH RES CO, V293, P1383, DOI 10.1016/S0006-291X(02)00391-1; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; ESTEVEZ AM, 1995, FEBS LETT, V374, P100, DOI 10.1016/0014-5793(95)01085-S; Gancedo C., 1989, YEASTS, V3, P205; GONZALEZ MI, 1992, YEAST, V8, P183, DOI 10.1002/yea.320080304; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; Hohmann S, 1996, MOL MICROBIOL, V20, P981, DOI 10.1111/j.1365-2958.1996.tb02539.x; Larsson C, 1997, J BACTERIOL, V179, P7243, DOI 10.1128/jb.179.23.7243-7250.1997; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; NAVAS MA, 1993, P NATL ACAD SCI USA, V90, P1290, DOI 10.1073/pnas.90.4.1290; NAVON G, 1979, BIOCHEMISTRY-US, V18, P4487, DOI 10.1021/bi00588a006; Noubhani A, 2000, EUR J BIOCHEM, V267, P4566, DOI 10.1046/j.1432-1327.2000.01511.x; ONISHI T, 1967, EUR J BIOCHEM, V1, P301, DOI 10.1111/j.1432-1033.1967.tb00074.x; Portela P, 2003, FEMS YEAST RES, V3, P119, DOI 10.1111/j.1567-1364.2003.tb00147.x; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; THEVELEIN JM, 1987, J GEN MICROBIOL, V133, P2191; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Van Vaeck C, 2001, BIOCHEM J, V353, P157; VANAELST L, 1993, MOL MICROBIOL, V8, P927; VANAELST L, 1991, EMBO J, V10, P2095, DOI 10.1002/j.1460-2075.1991.tb07742.x; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; VUORIO OE, 1993, EUR J BIOCHEM, V216, P849, DOI 10.1111/j.1432-1033.1993.tb18207.x	38	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27229	27234		10.1074/jbc.M109.029454	http://dx.doi.org/10.1074/jbc.M109.029454			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19620241	Green Published, hybrid			2022-12-25	WOS:000270232300023
J	Fuchs, P; Zorer, M; Reipert, S; Rezniczek, GA; Propst, F; Walko, G; Fischer, I; Bauer, J; Leschnik, MW; Luscher, B; Thalhammer, JG; Lassmann, H; Wiche, G				Fuchs, Peter; Zoerer, Michael; Reipert, Siegfried; Rezniczek, Guenther A.; Propst, Friedrich; Walko, Gernot; Fischer, Irmgard; Bauer, Jan; Leschnik, Michael W.; Luescher, Bernhard; Thalhammer, Johann G.; Lassmann, Hans; Wiche, Gerhard			Targeted Inactivation of a Developmentally Regulated Neural Plectin Isoform (Plectin 1c) in Mice Leads to Reduced Motor Nerve Conduction Velocity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTONIA-MUSCULORUM MICE; NEUROLOGIC DEGENERATION; EPIDERMOLYSIS-BULLOSA; STRATIFIED EPITHELIA; LINKER PROTEIN; GENE; SYSTEM; EXPRESSION; CYTOSKELETON; ACTIN	Cytolinker proteins stabilize cells mechanically, regulate cytoskeleton dynamics, and provide scaffolds for signaling molecules. For plectin, the prototype of these proteins, an unusual diversity of isoforms has been reported, which show distinct expression patterns, subcellular localizations, and functions. Plectin has been shown to have important functions in skin and muscle, but little is known about its role in neural cells. To address this issue, we generated two knock-out mouse lines, one which was selectively lacking plectin 1c (P1c), the major isoform expressed in neural cells, and another in which plectin was conditionally deleted in neuronal precursor cells. Using isoform-specific antibodies, we found P1c to be expressed late in development and to associate with postsynaptic dendrites of central nervous system neurons, motorneurons of spinal cord, sciatic nerve axons, and Schwann cells. Motor nerve conduction velocity was found significantly reduced in sciatic nerve from P1c-deficient as well as from conditional knock-out mice. This defect was traceable to an increased number of motor nerve fibers with small cross-sectional areas; the thicknesses of axons and of myelin sheaths were unaffected. This is the first report demonstrating an important role of plectin in a major nerve function.	[Fuchs, Peter; Zoerer, Michael; Reipert, Siegfried; Rezniczek, Guenther A.; Propst, Friedrich; Walko, Gernot; Fischer, Irmgard; Wiche, Gerhard] Univ Vienna, Max F Perutz Labs, Dept Biochem & Cell Biol, A-1030 Vienna, Austria; [Bauer, Jan; Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Dept Neuroimmunol, A-1090 Vienna, Austria; [Leschnik, Michael W.; Thalhammer, Johann G.] Univ Vet Med Vienna, Clin Internal Med & Infect Dis, A-1210 Vienna, Austria; [Luescher, Bernhard] Rhein Westfael TH Aachen Univ, Fac Med, Div Biochem & Mol Biol, D-52074 Aachen, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Veterinary Medicine Vienna; RWTH Aachen University	Wiche, G (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Biochem & Cell Biol, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	gerhard.wiche@univie.ac.at	Lassmann, Hans/Z-2269-2019; WICHE, Gerhard/AAA-3227-2021; Rezniczek, Günther/A-1493-2014; Bauer, Jan/F-5429-2011; Rezniczek, Günther/Q-9318-2016; Rezniczek, Günther/AAO-2963-2020; Reipert, Siegfried/A-4406-2014; Luscher, Bernhard/A-7330-2011	Lassmann, Hans/0000-0001-8617-5052; Rezniczek, Günther/0000-0002-0852-6002; Bauer, Jan/0000-0001-5802-8047; Rezniczek, Günther/0000-0002-0852-6002; Rezniczek, Günther/0000-0002-0852-6002; Wiche, Gerhard/0000-0001-9550-5463; Fuchs, Peter/0000-0003-3933-7674; Reipert, Siegfried/0000-0002-2043-3562; Luscher, Bernhard/0000-0002-9622-8709; Walko, Gernot/0000-0002-8504-1738	Austrian Science Research Fund [SFB 006/611, P17862-B09, P20744-B11]	Austrian Science Research Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Research Fund Grants SFB 006/611, P17862-B09, and P20744-B11.	Abrahamsberg C, 2005, P NATL ACAD SCI USA, V102, P18449, DOI 10.1073/pnas.0505380102; Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Bernier G, 1995, MOL CELL NEUROSCI, V6, P509, DOI 10.1006/mcne.1995.0003; Bernier G, 1998, DEVELOPMENT, V125, P2135; Bernier G, 2000, DEV DYNAM, V219, P216, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1041>3.0.CO;2-O; Bernier G, 1998, DEV GENET, V22, P160, DOI 10.1002/(SICI)1520-6408(1998)22:2<160::AID-DVG5>3.0.CO;2-4; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Dowling J, 1997, DEV BIOL, V187, P131, DOI 10.1006/dbio.1997.8567; Duchen L W, 1976, Adv Neurol, V14, P353; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; ERRANTE LD, 1994, J NEUROSCI RES, V37, P515, DOI 10.1002/jnr.490370411; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Fuchs P, 2005, CELL MOL NEUROBIOL, V25, P1141, DOI 10.1007/s10571-005-7826-1; Giorda R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012260; Gregor M, 2006, J CELL SCI, V119, P1864, DOI 10.1242/jcs.02891; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HERRMANN H, 1987, J BIOL CHEM, V262, P1320; Hogan B, 1994, MANIPULATING MOUSE E; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Lesniewicz K, 2005, GENOMICS, V86, P38, DOI 10.1016/j.ygeno.2005.03.009; Lie AA, 1998, ACTA NEUROPATHOL, V96, P215, DOI 10.1007/s004010050885; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rezniczek GA, 2004, METHOD CELL BIOL, V78, P721; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Waikar SS, 1996, BRAIN RES, V721, P91, DOI 10.1016/0006-8993(96)00165-5; WICHE G, 1982, EXP CELL RES, V138, P15, DOI 10.1016/0014-4827(82)90086-6; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5	49	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26502	26509		10.1074/jbc.M109.018150	http://dx.doi.org/10.1074/jbc.M109.018150			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625254	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000269969600031
J	Hacker, S; Dittrich, A; Mohr, A; Schweitzer, T; Rutkowski, S; Krauss, J; Debatin, KM; Fulda, S				Haecker, S.; Dittrich, A.; Mohr, A.; Schweitzer, T.; Rutkowski, S.; Krauss, J.; Debatin, K-M; Fulda, S.			Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8	ONCOGENE			English	Article						caspase-8; apoptosis; TRAIL; HDACI; medulloblastoma	UP-REGULATING CASPASE-8; DRUG-INDUCED APOPTOSIS; INTERFERON-GAMMA; DEATH RECEPTOR; CELL-DEATH; CHILDHOOD MEDULLOBLASTOMA; PANCREATIC-CARCINOMA; NEUROBLASTOMA-CELLS; EWINGS-SARCOMA; TUMOR CELLS	Evasion of apoptosis can be caused by epigenetic silencing of caspase-8, a key component of the extrinsic apoptosis pathway. Loss of caspase-8 correlates with poor prognosis in medulloblastoma, which highlights the relevance of strategies to upregulate caspase-8 to break apoptosis resistance. Here, we develop a new combinatorial approach, that is treatment using histone deacetylase inhibitors (HDACI) together with interferon (IFN)-gamma, to restore caspase-8 expression and to overcome resistance to the death-receptor ligand TNF-related apoptosis-inducing ligand (TRAIL) in medulloblastoma in vitro and in vivo. HDACI, for example, valproic acid (VA), suberoylanilide hydroxamic acid (SAHA) and MS-275, cooperate with IFN-gamma to upregulate caspase-8 in cancer cells lacking caspase-8, thereby restoring sensitivity to TRAIL-induced apoptosis. Molecular studies show that VA promotes histone acetylation and acts in concert with IFN-gamma to stimulate caspase-8 promoter activity. The resulting increase in caspase-8 mRNA and protein expression leads to enhanced TRAIL-induced activation of caspase-8 at the death-inducing signaling complex, mitochondrial outer-membrane permeabilization and caspase-dependent cell death. Intriguingly, pharmacological or genetic inhibition of caspase-8 also abolishes the VA/IFN-gamma-mediated sensitization for TRAIL-induced apoptosis. It is important to note that VA and IFN-gamma restore caspase-8 expression and sensitivity to TRAIL in primary medulloblastoma samples and significantly potentiate TRAIL-mediated suppression of medulloblastoma growth in vivo. These findings provide the rationale for further (pre)clinical evaluation of VA and IFN-gamma to restore caspase-8 expression and apoptosis sensitivity in cancers with caspase-8 silencing and open new perspectives to overcome TRAIL resistance. Oncogene (2009) 28, 3097-3110; doi: 10.1038/onc.2009.161; published online 13 July 2009	[Haecker, S.; Dittrich, A.; Debatin, K-M; Fulda, S.] Univ Childrens Hosp, D-89075 Ulm, Germany; [Mohr, A.] Natl Univ Ireland, NCBES, Mol Therapeut Grp, Galway, Ireland; [Schweitzer, T.; Krauss, J.] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany; [Rutkowski, S.] Univ Wurzburg, Dept Pediat, Wurzburg, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ollscoil na Gaillimhe-University of Galway; University of Wurzburg; University of Wurzburg	Fulda, S (corresponding author), Univ Childrens Hosp, Eythstr 24, D-89075 Ulm, Germany.	simone.fulda@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014; Schweitzer, Tilmann/K-6471-2014; Fulda, Simone/D-5864-2011	Debatin, Klaus-Michael/0000-0002-8397-1886; Mohr, Andrea/0000-0002-4295-0341; Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe [IAP6/18]; European Community	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); European Community(European Commission)	We thank R Agami (The Netherlands Cancer Institute, Amsterdam, Netherlands) for providing pRETRO-SUPER vector, CA Schmitt (Berlin, Germany) for mouse Bcl-2 vector, M. Romani (Genova, Italy) for caspase-8 pBL-CAT3 promoter construct, Apoxis (Lausanne, Switzerland) for mega-Fas ligand and F Beguinot (Naples, Italy) for anti-PED antibody. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, the Deutsche Krebshilfe, IAP6/18 and the European Community (ApopTrain, APOSYS) (to SF).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Banelli B, 2002, NAT MED, V8, P1333, DOI 10.1038/nm1202-1333; Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Fulda S, 2006, ONCOGENE, V25, P5125, DOI 10.1038/sj.onc.1209518; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; FULDA S, 2008, ENCY CANC; FULDA S, 2006, APOPTOSIS CANC THERA, P515; Giagkousiklidis S, 2005, CANCER RES, V65, P10502, DOI 10.1158/0008-5472.CAN-05-0866; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816; Guerrini Renzo, 2006, Paediatr Drugs, V8, P113, DOI 10.2165/00148581-200608020-00004; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; Lissat A, 2007, AM J PATHOL, V170, P1917, DOI 10.2353/ajpath.2007.060993; Meistey N, 2007, EUR J CANCER, V43, P1833, DOI 10.1016/j.ejca.2007.05.028; Merchant MS, 2004, CANCER RES, V64, P8349, DOI 10.1158/0008-5472.CAN-04-1705; Mohr A, 2004, CELL DEATH DIFFER, V11, P1153, DOI 10.1038/sj.cdd.4401480; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Ozoren N, 2002, NEOPLASIA, V4, P551, DOI 10.1038/sj.neo.7900270; Peter ME, 1997, EUR J IMMUNOL, V27, P1207, DOI 10.1002/eji.1830270523; Pingoud-Meier C, 2003, CLIN CANCER RES, V9, P6401; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; Rutkowski S, 2007, CLIN CANCER RES, V13, P2651, DOI 10.1158/1078-0432.CCR-06-1779; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shu Q, 2006, CLIN CANCER RES, V12, P4687, DOI 10.1158/1078-0432.CCR-05-2849; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; WEXLER L, 1992, P AN M AM SOC CLIN, V11, P368; Yang XZ, 2003, CANCER RES, V63, P1122	52	87	91	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2009	28	35					3097	3110		10.1038/onc.2009.161	http://dx.doi.org/10.1038/onc.2009.161			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	490QC	19597472				2022-12-25	WOS:000269515100002
J	Tokusumi, T; Sorrentino, RP; Russell, M; Ferrarese, R; Govind, S; Schulz, RA				Tokusumi, Tsuyoshi; Sorrentino, Richard Paul; Russell, Mark; Ferrarese, Roberto; Govind, Shubha; Schulz, Robert A.			Characterization of a Lamellocyte Transcriptional Enhancer Located within the misshapen Gene of Drosophila melanogaster	PLOS ONE			English	Article							LYMPH-GLAND; BLOOD; HEMOCYTES; HEMATOPOIESIS; VECTORS	Drosophila has emerged as an excellent model system in which to study cellular and genetic aspects of hematopoiesis. Under normal developmental conditions and in wild-type genetic backgrounds, Drosophila possesses two types of blood cells, crystal cells and plasmatocytes. Upon infestation by a parasitic wasp or in certain altered genetic backgrounds, a third hemocyte class called the lamellocyte becomes apparent. Herein we describe the characterization of a novel transcriptional regulatory module, a lamellocyte-active enhancer of the misshapen gene. This transcriptional control sequence appears to be inactive in all cell types of the wild-type larva, including crystal cells and plasmatocytes. However, in lamellocytes induced by wasp infestation or by particular genetic conditions, the enhancer is activated and it directs reporter GFP or DsRed expression exclusively in lamellocytes. The lamellocyte control region was delimited to a 140-bp intronic sequence that contains an essential DNA recognition element for the AP-1 transcription factor. Additionally, mutation of the kayak gene encoding the dFos subunit of AP-1 led to a strong suppression of lamellocyte production in tumorous larvae. As misshapen encodes a protein kinase within the Jun N-terminal kinase signaling pathway that functions to form an active AP-1 complex, the lamellocyte-active enhancer likely serves as a transcriptional target within a genetic auto-regulatory circuit that promotes the production of lamellocytes in immune-challenged or genetically-compromised animals.			Tokusumi, T (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	rschulz@nd.edu	Ferrarese, Roberto/GSJ-3449-2022	Ferrarese, Roberto/0000-0003-0625-3319; Govind, Shubha/0000-0002-6436-639X; Tokusumi, Tsuyoshi/0000-0001-9494-1888	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071540] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL071540, R01 HL071540] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Braun A, 1997, GENETICS, V147, P623; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Frandsen Joel L., 2008, Proceedings of the National Academy of Sciences of the United States of America, V105, P14952, DOI 10.1073/pnas.0808208105; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Gajewski KM, 2007, GENESIS, V45, P200, DOI 10.1002/dvg.20285; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Jindra M, 2004, EMBO J, V23, P3538, DOI 10.1038/sj.emboj.7600356; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino Richard Paul, 2006, Drosophila Information Service, V89, P103; Sorrentino RP, 2005, SEMIN CELL DEV BIOL, V16, P107, DOI 10.1016/j.semcdb.2004.10.005; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	27	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6429	10.1371/journal.pone.0006429	http://dx.doi.org/10.1371/journal.pone.0006429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641625	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500029
J	Huang, T; Wang, W; Bessaud, M; Ren, PJ; Sheng, J; Yan, HJ; Zhang, J; Lin, X; Wang, YJ; Delpeyroux, F; Deubel, V				Huang, Ting; Wang, Wei; Bessaud, Mael; Ren, Peijun; Sheng, Jun; Yan, Huajie; Zhang, Jing; Lin, Xin; Wang, Yongjin; Delpeyroux, Francis; Deubel, Vincent			Evidence of Recombination and Genetic Diversity in Human Rhinoviruses in Children with Acute Respiratory Infection	PLOS ONE			English	Article							5' NONCODING REGION; HUMAN BOCAVIRUS; RT-PCR; FEATURES; ILLNESS; PICORNAVIRUSES; IDENTIFICATION; ASSOCIATION; ENTEROVIRUS; SEROTYPES	Background: Human rhinoviruses (HRVs) are a highly prevalent cause of acute respiratory infection in children. They are classified into at least three species, HRV-A, HRV-B and HRV-C, which are characterized by sequencing the 59 untranslated region (UTR) or the VP4/VP2 region of the genome. Given the increased interest for novel HRV strain identification and their worldwide distribution, we have carried out clinical and molecular diagnosis of HRV strains in a 2-year study of children with acute respiratory infection visiting one district hospital in Shanghai. Methodology/Findings: We cloned and sequenced a 924-nt fragment that covered part of the 5'UTR and the VP4/VP2 capsid genes. Sixty-four HRV-infected outpatients were diagnosed amongst 827 children with acute low respiratory tract infection. Two samples were co-infected with HRV-A and HRV-B or HRV-C. By comparative analysis of the VP4/VP2 sequences of the 66 HRVs, we showed a high diversity of strains in HRV-A and HRV-B species, and a prevalence of 51.5% of strains that belonged to the recently identified HRV-C species. When analyzing a fragment of the 59 UTR, we characterized at least two subspecies of HRV-C: HRV-Cc, which clustered differently from HRV-A and HRV-B, and HRV-Ca, which resulted from previous recombination in this region with sequences related to HRV-A. The full-length sequence of one strain of each HRV-Ca and HRV-Cc subspecies was obtained for comparative analysis. We confirmed the close relationship of their structural proteins but showed apparent additional recombination events in the 2A gene and 3'UTR of the HRV-Ca strain. Double or triple infections with HRV-C and respiratory syncytial virus and/or bocavirus were diagnosed in 33.3% of the HRV-infected patients, but no correlation with severity of clinical outcome was observed. Conclusion: Our study showed a high diversity of HRV strains that cause bronchitis and pneumonia in children. A predominance of HRV-C over HRV-A and HRV-B was observed, and two subspecies of HRV-C were identified, the diversity of which seemed to be related to recombination with former HRV-A strains. None of the HRV-C strains appeared to have a higher clinical impact than HRV-A or HRV-B on respiratory compromise.			Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Unit Emerging Viruses, Shanghai, Peoples R China.	vdeubel@sibs.ac.cn	DELPEYROUX, Francis/ABA-5429-2021; Delpeyroux, Francis/H-8838-2016; Bessaud, Maël/J-3961-2019	DELPEYROUX, Francis/0000-0002-4895-823X; Delpeyroux, Francis/0000-0002-4895-823X; Bessaud, Maël/0000-0001-6758-9591				Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Briese T, 2008, EMERG INFECT DIS, V14, P944, DOI 10.3201/eid1406.080271; Brownlee JW, 2008, CURR OPIN PEDIATR, V20, P67, DOI 10.1097/MOP.0b013e3282f41cb6; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dina J, 2009, J PAEDIATR CHILD H, V45, P149, DOI 10.1111/j.1440-1754.2008.01442.x; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Jacques J, 2006, J CLIN VIROL, V35, P463, DOI 10.1016/j.jcv.2005.11.009; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Mackay IM, 2008, EMERG INFECT DIS, V14, P1823, DOI 10.3201/eid1411.080725; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; MILLER EK, 2008, J ALLERGY CLIN IMMUN; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; PALMENBERG AC, 2009, SCIENCE; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Rakoto-Andrianarivelo M, 2007, PLOS PATHOG, V3, P1950, DOI 10.1371/journal.ppat.0030191; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Savolainen-Kopra C, 2009, PEDIATR INFECT DIS J, V28, P59, DOI 10.1097/INF.0b013e318182c90a; Savolainen-Kopra C, 2009, J CLIN MICROBIOL, V47, P1278, DOI 10.1128/JCM.02130-08; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan BH, 2009, J MED VIROL, V81, P82, DOI 10.1002/jmv.21361; TAPPAREL C, 2008, 15 EUR STUD GROUP MO; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Xiang ZC, 2008, EMERG INFECT DIS, V14, P1665, DOI 10.3201/eid1410.080545	48	86	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6355	10.1371/journal.pone.0006355	http://dx.doi.org/10.1371/journal.pone.0006355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633719	Green Submitted, Green Published, gold			2022-12-25	WOS:000268404800006
J	Zouache, K; Voronin, D; Tran-Van, V; Mousson, L; Failloux, AB; Mavingui, P				Zouache, Karima; Voronin, Denis; Tran-Van, Van; Mousson, Laurence; Failloux, Anna-Bella; Mavingui, Patrick			Persistent Wolbachia and Cultivable Bacteria Infection in the Reproductive and Somatic Tissues of the Mosquito Vector Aedes albopictus	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; IN-SITU HYBRIDIZATION; ENDOSYMBIONT WOLBACHIA; INSECTICIDE RESISTANCE; ANOPHELES-GAMBIAE; MIDGUT BACTERIA; GENUS ASAIA; DIPTERA; POPULATIONS; CHIKUNGUNYA	Background: Commensal and symbiotic microbes have a considerable impact on the behavior of many arthropod hosts, including hematophagous species that transmit pathogens causing infectious diseases to human and animals. Little is known about the bacteria associated with mosquitoes other than the vectorized pathogens. This study investigated Wolbachia and cultivable bacteria that persist through generations in Ae. albopictus organs known to host transmitted arboviruses, such as dengue and chikungunya. Methodology/Principal Findings: We used culturing, diagnostic and quantitative PCR, as well as in situ hybridization, to detect and locate bacteria in whole individual mosquitoes and in dissected tissues. Wolbachia, cultivable bacteria of the genera Acinetobacter, Comamonas, Delftia and Pseudomonas co-occurred and persisted in the bodies of both males and females of Ae. albopictus initially collected in La Reunion during the chikungunya outbreak, and maintained as colonies in insectaries. In dissected tissues, Wolbachia and the cultivable Acinetobacter can be detected in the salivary glands. The other bacteria are commonly found in the gut. Quantitative PCR estimates suggest that Wolbachia densities are highest in ovaries, lower than those of Acinetobacter in the gut, and approximately equal to those of Acinetobacter in the salivary glands. Hybridization using specific fluorescent probes successfully localized Wolbachia in all germ cells, including the oocytes, and in the salivary glands, whereas the Acinetobacter hybridizing signal was mostly located in the foregut and in the anterior midgut. Conclusions/Significance: Our results show that Proteobacteria are distributed in the somatic and reproductive tissues of mosquito where transmissible pathogens reside and replicate. This location may portend the coexistence of symbionts and pathogens, and thus the possibility that competition or cooperation phenomena may occur in the mosquito vector Ae. albopictus. Improved understanding of the vectorial system, including the role of bacteria in the vector's biology and competence, could have major implications for understanding viral emergences and for disease control.			Zouache, K (corresponding author), Univ Lyon, Lyon, France.	patrick.mavingui@univ-lyon1.fr		Voronin, Denis/0000-0003-2652-0787				Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Allen JM, 2007, APPL ENVIRON MICROB, V73, P1659, DOI 10.1128/AEM.01877-06; Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; BEARD CB, 1993, PARASITOL TODAY, V9, P179, DOI 10.1016/0169-4758(93)90142-3; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; BRUCE KD, 1992, APPL ENVIRON MICROB, V58, P3413, DOI 10.1128/AEM.58.10.3413-3416.1992; BUCHNER P, 1965, INTERSCIENCE NEW YOR, V21; Chao J., 1960, Journal of Insect Pathology, V2, P220; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Chen WJ, 2005, J MED ENTOMOL, V42, P120, DOI 10.1603/0022-2585(2005)042[0120:UISHTD]2.0.CO;2; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hedges LM, 2008, J GEN VIROL, V89, P1497, DOI 10.1099/vir.0.83684-0; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Kenzaka T, 1998, MICROBIOL-UK, V144, P2085, DOI 10.1099/00221287-144-8-2085; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2; Kondo N, 2002, MOL ECOL, V11, P167, DOI 10.1046/j.0962-1083.2001.01432.x; Lee JS, 2009, J MICROBIOL BIOTECHN, V19, P250, DOI 10.4014/jmb.0901.083; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Luxananil P, 2001, J BIOSCI BIOENG, V92, P342, DOI 10.1016/S1389-1723(01)80237-1; Mavingui P, 2005, APPL ENVIRON MICROB, V71, P6910, DOI 10.1128/AEM.71.11.6910-6917.2005; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Curley CM, 2007, ANN ENTOMOL SOC AM, V100, P345, DOI 10.1603/0013-8746(2007)100[345:EFFEOG]2.0.CO;2; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Otsuka Yasushi, 1997, Medical Entomology and Zoology, V48, P257; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Paquet C, 2006, EUROSURVEILLANCE, V11; Pidiyar V, 2002, INT J SYST EVOL MICR, V52, P1723, DOI [10.1099/ijs.0.02019-0, 10.1099/00207713-52-5-1723]; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Sanguin H, 2006, ENVIRON MICROBIOL, V8, P289, DOI 10.1111/j.1462-2920.2005.00895.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Sinkins SP, 2004, TRENDS PARASITOL, V20, P413, DOI 10.1016/j.pt.2004.07.003; Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; Turell M. J., 1988, The arboviruses: epidemiology and ecology. Volume I., P127; Vasanthi V., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P312; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; WAGNER M, 1994, APPL ENVIRON MICROB, V60, P792, DOI 10.1128/AEM.60.3.792-800.1994; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Widmer F, 1998, APPL ENVIRON MICROB, V64, P2545; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zhong JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000405; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zouache K, 2009, APPL ENVIRON MICROB, V75, P3755, DOI 10.1128/AEM.02964-08	89	81	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6388	10.1371/journal.pone.0006388	http://dx.doi.org/10.1371/journal.pone.0006388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633721	Green Published, Green Submitted, gold			2022-12-25	WOS:000268404800012
J	Ramos, R; Gonzalez-Solis, J; Croxall, JP; Oro, D; Ruiz, X				Ramos, Rauel; Gonzalez-Solis, Jacob; Croxall, John P.; Oro, Daniel; Ruiz, Xavier			Understanding Oceanic Migrations with Intrinsic Biogeochemical Markers	PLOS ONE			English	Article							STABLE-ISOTOPE SIGNATURES; MOLT STRATEGIES; TRACE-METALS; CARBON; NITROGEN; PREDATORS; AREAS; DIET; SEX; DICHOTOMY	Migratory marine vertebrates move annually across remote oceanic water masses crossing international borders. Many anthropogenic threats such as overfishing, bycatch, pollution or global warming put millions of marine migrants at risk especially during their long-distance movements. Therefore, precise knowledge about these migratory movements to understand where and when these animals are more exposed to human impacts is vital for addressing marine conservation issues. Because electronic tracking devices suffer from several constraints, mainly logistical and financial, there is emerging interest in finding appropriate intrinsic markers, such as the chemical composition of inert tissues, to study long-distance migrations and identify wintering sites. Here, using tracked pelagic seabirds and some of their own feathers which were known to be grown at different places and times within the annual cycle, we proved the value of biogeochemical analyses of inert tissue as tracers of marine movements and habitat use. Analyses of feathers grown in summer showed that both stable isotope signatures and element concentrations can signal the origin of breeding birds feeding in distinct water masses. However, only stable isotopes signalled water masses used during winter because elements mainly accumulated during the long breeding period are incorporated into feathers grown in both summer and winter. Our findings shed new light on the simple and effective assignment of marine organisms to distinct oceanic areas, providing new opportunities to study unknown migration patterns of secretive species, including in relation to human-induced mortality on specific populations in the marine environment.	[Ramos, Rauel; Gonzalez-Solis, Jacob; Ruiz, Xavier] Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain; [Gonzalez-Solis, Jacob; Croxall, John P.] British Antarctic Survey, Nat Environm Res Council, Cambridge, England; [Oro, Daniel] CSIC UIB, Inst Mediterraneo Estudios Avanzados IMEDEA, Mallorca, Spain	University of Barcelona; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Ramos, R (corresponding author), Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain.	ramos@ub.edu	González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/C-3942-2008; Gonzalez-Solis, Jacob/AAZ-5338-2021; Oro, Daniel/H-4208-2012; Ramos, Raül/S-3112-2016	Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Oro, Daniel/0000-0003-4782-3007; Ramos, Raül/0000-0002-0551-8605	Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alonso H, 2009, J ORNITHOL, V150, P329, DOI 10.1007/s10336-008-0354-2; BirdLife International, 2008, STAT WORLDS BIRDS IN; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Cherel Y, 2000, OECOLOGIA, V122, P155, DOI 10.1007/PL00008843; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Edwards AE, 2008, J AVIAN BIOL, V39, P144, DOI 10.1111/j.2007.0908-8857.04139.x; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Furness R.W., 1993, P86; GOEDE AA, 1991, ENVIRON MONIT ASSESS, V18, P203, DOI 10.1007/BF00398699; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Hall-Aspland SA, 2005, MAR ECOL PROG SER, V305, P249, DOI 10.3354/meps305249; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Helmers E, 1996, MAR CHEM, V53, P51, DOI 10.1016/0304-4203(96)00012-6; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2008, BIRD CONSERV INT, V18, pS174, DOI 10.1017/S0959270908000361; Jennings S, 2001, MARINE FISHERIES ECO, P417; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; MARRA PP, 2006, CONNECTIVITY CONSERV, P157; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; MOUGIN JL, 1988, OISEAU RFO, V58, P303; Olmos F, 1997, IBIS, V139, P685, DOI 10.1111/j.1474-919X.1997.tb04692.x; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Ramos R, 2009, IBIS, V151, P151, DOI 10.1111/j.1474-919X.2008.00877.x; Ramos R, 2009, OECOLOGIA, V159, P345, DOI 10.1007/s00442-008-1215-7; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Ristow D, 2000, CONDOR, V102, P696, DOI 10.1650/0010-5422(2000)102[0696:STOCSS]2.0.CO;2; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Semmens JM, 2007, REV FISH BIOL FISHER, V17, P401, DOI 10.1007/s11160-007-9048-8; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Thibault J. C., 1997, CORYS SHEARWATER; Wallace BP, 2006, MAR BIOL, V149, P953, DOI 10.1007/s00227-006-0247-y; Wang WX, 2002, MAR ECOL PROG SER, V243, P295, DOI 10.3354/meps243295; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; Wells BK, 2008, MAR ECOL PROG SER, V364, P15, DOI 10.3354/meps07486	47	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6236	10.1371/journal.pone.0006236	http://dx.doi.org/10.1371/journal.pone.0006236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623244	Green Accepted, Green Published, gold			2022-12-25	WOS:000268260100002
J	Basal, E; Eghbali-Fatourechi, GZ; Kalli, KR; Hartmann, LC; Goodman, KM; Goode, EL; Kamen, BA; Low, PS; Knutson, KL				Basal, Eati; Eghbali-Fatourechi, Guiti Z.; Kalli, Kimberly R.; Hartmann, Lynn C.; Goodman, Karin M.; Goode, Ellen L.; Kamen, Barton A.; Low, Philip S.; Knutson, Keith L.			Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients	PLOS ONE			English	Article								Background: Despite low incidence, ovarian cancer is the fifth leading cause of cancer deaths and it has the highest mortality rate of all gynecologic malignancies among US women. The mortality rate would be reduced with an early detection marker. The folate receptor alpha (FR alpha) is one logical choice for a biomarker because of its prevalent overexpression in ovarian cancer and its exclusive expression in only a few normal tissues. In prior work, it was observed that patients with ovarian cancer had elevated serum levels of a protein that bound to a FR alpha-specific monoclonal antibody relative to healthy individuals. However, it was not shown that the protein detected was intact functional FR alpha. In the current study, the goal was to determine whether ovarian cancer patients (n = 30) had elevated serum levels of a fully functional intact FR alpha compared to matched healthy controls (n = 30). Methodology/Principal Findings: FR alpha levels in serum were analyzed by two methods, immunoblotting analysis and a radiolabeled folic acid-based microfiltration binding assay. Using the immunoassay, we observed that levels of FR alpha were higher in serum of ovarian cancer patients as compared to controls. Similar results were also observed using the microfiltration binding assay, which showed that the circulating FR alpha is functional. Importantly, we also found that the levels of FR alpha were comparable between early and advanced stage patients. Conclusions: Our results demonstrate that ovarian cancer patients have elevated levels of functional intact FR alpha. These findings support the potential use of circulating FR alpha as a biomarker of early ovarian cancer.			Basal, E (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	knutson.keith@mayo.edu	jain, amita/ABA-9223-2020	Low, Philip/0000-0001-9042-5528	NATIONAL CANCER INSTITUTE [K01CA100764, R03CA121386] Funding Source: NIH RePORTER; NCI NIH HHS [K01-CA100764, R03 CA121386, R03-CA121386, K01 CA100764] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bueno R, 2001, J THORAC CARDIOV SUR, V121, P225, DOI 10.1067/mtc.2001.111176; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; ELWOOD PC, 1986, J BIOL CHEM, V261, P5416; Fields Margaret M, 2006, Clin J Oncol Nurs, V10, P77, DOI 10.1188/06.CJON.77-81; Hartmann LC, 2007, INT J CANCER, V121, P938, DOI 10.1002/ijc.22811; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalli KR, 2008, GYNECOL ONCOL, V108, P619, DOI 10.1016/j.ygyno.2007.11.020; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; KAMEN BA, 1974, J LAB CLIN MED, V83, P164; KAMEN BA, 1975, P NATL ACAD SCI USA, V72, P4261, DOI 10.1073/pnas.72.11.4261; KANE MA, 1988, J CLIN INVEST, V81, P1398, DOI 10.1172/JCI113469; Kelemen LE, 2005, CANCER EPIDEM BIOMAR, V14, P2168, DOI 10.1158/1055-9965.EPI-05-0260; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; LUHRS CA, 1992, J CLIN INVEST, V90, P840, DOI 10.1172/JCI115959; MANTOVANI LT, 1994, EUR J CANCER, V30A, P363, DOI 10.1016/0959-8049(94)90257-7; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Toffoli G, 1998, INT J CANCER, V79, P121, DOI 10.1002/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Yang R, 2007, CLIN CANCER RES, V13, P2557, DOI 10.1158/1078-0432.CCR-06-1343	21	67	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6292	10.1371/journal.pone.0006292	http://dx.doi.org/10.1371/journal.pone.0006292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617914	gold, Green Published, Green Submitted			2022-12-25	WOS:000268119600005
J	Kyozuka, K; Chun, JT; Puppo, A; Gragnaniello, G; Garante, E; Santella, L				Kyozuka, Keiichiro; Chun, Jong T.; Puppo, Agostina; Gragnaniello, Gianni; Garante, Ezio; Santella, Luigia			Guanine Nucleotides in the Meiotic Maturation of Starfish Oocytes: Regulation of the Actin Cytoskeleton and of Ca2+ Signaling	PLOS ONE			English	Article								Background: Starfish oocytes are arrested at the first prophase of meiosis until they are stimulated by 1-methyladenine (1-MA). The two most immediate responses to the maturation-inducing hormone are the quick release of intracellular Ca2+ and the accelerated changes of the actin cytoskeleton in the cortex. Compared with the later events of oocyte maturation such as germinal vesicle breakdown, the molecular mechanisms underlying the early events involving Ca2+ signaling and actin changes are poorly understood. Herein, we have studied the roles of G-proteins in the early stage of meiotic maturation. Methodology/Principal Findings: By microinjecting starfish oocytes with nonhydrolyzable nucleotides that stabilize either active (GTP gamma S) or inactive (GDP beta S) forms of G-proteins, we have demonstrated that: i) GTP gamma S induces Ca2+ release that mimics the effect of 1-MA; ii) GDP beta S completely blocks 1-MA-induced Ca2+; iii) GDP beta S has little effect on the amplitude of the Ca2+ peak, but significantly expedites the initial Ca2+ waves induced by InsP(3) photoactivation, iv) GDP beta S induces unexpectedly striking modification of the cortical actin networks, suggesting a link between the cytoskeletal change and the modulation of the Ca2+ release kinetics; v) alteration of cortical actin networks with jasplakinolide, GDP beta S, or actinase E, all led to significant changes of 1-MA-induced Ca2+ signaling. Conclusions/Significance: Taken together, these results indicate that G-proteins are implicated in the early events of meiotic maturation and support our previous proposal that the dynamic change of the actin cytoskeleton may play a regulatory role in modulating intracellular Ca2+ release.			Kyozuka, K (corresponding author), Tohoku Univ, Res Ctr Marine Biol, Asamushi, Japan.	santella@szn.it	Chun, Jong Tai/AAM-3394-2020; Santella, Luigia/AAM-3524-2020	Chun, Jong Tai/0000-0002-6070-4953; Santella, Luigia/0000-0001-7159-0499				Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; CHIBA K, 1992, EUR J BIOCHEM, V207, P833, DOI 10.1111/j.1432-1033.1992.tb17114.x; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; CHIBA K, 1993, MOL BIOL CELL, V4, P1027, DOI 10.1091/mbc.4.10.1027; CHUEH SH, 1987, J BIOL CHEM, V262, P13857; Chun JT, 2009, ACTA PHYSIOL, V195, P61, DOI 10.1111/j.1748-1716.2008.01921.x; Chun JT, 2007, N COMP BIOC, V41, P425; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CROSSLEY I, 1991, CELL REGUL, V2, P121, DOI 10.1091/mbc.2.2.121; FUJIMOTO T, 1995, J CELL SCI, V108, P7; HILL TD, 1987, BIOCHEM BIOPH RES CO, V149, P897, DOI 10.1016/0006-291X(87)90492-X; JAFFE LA, 1994, DEV BIOL, V164, P579, DOI 10.1006/dbio.1994.1225; JAFFE LA, 1993, J CELL BIOL, V121, P775, DOI 10.1083/jcb.121.4.775; Kalinowski RR, 2003, DEV BIOL, V253, P139, DOI 10.1006/dbio.2002.0860; KANATANI H, 1970, EXP CELL RES, V61, P280, DOI 10.1016/0014-4827(70)90448-9; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; Kumakiri J, 2003, DEV BIOL, V260, P522, DOI 10.1016/S0012-1606(03)00273-2; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Mita M, 2005, ANN NY ACAD SCI, V1040, P413, DOI 10.1196/annals.1327.077; MORISAWA M, 1978, GAMETE RES, V1, P157, DOI 10.1002/mrd.1120010209; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; RAKOW TL, 1990, P NATL ACAD SCI USA, V87, P9285, DOI 10.1073/pnas.87.23.9285; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sadler KC, 1998, DEV BIOL, V197, P25, DOI 10.1006/dbio.1998.8869; Santella L, 2008, INT J DEV BIOL, V52, P571, DOI 10.1387/ijdb.072560ls; SCHROEDER TE, 1983, DEV BIOL, V98, P373, DOI 10.1016/0012-1606(83)90366-4; SCHROEDER TE, 1981, J CELL BIOL, V90, P362, DOI 10.1083/jcb.90.2.362; SHIDA H, 1976, NATURE, V263, P77, DOI 10.1038/263077a0; SHILLING F, 1989, DEV BIOL, V133, P605, DOI 10.1016/0012-1606(89)90063-8; TADENUMA H, 1992, BIOCHEM BIOPH RES CO, V186, P114, DOI 10.1016/S0006-291X(05)80782-X; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TURNER PR, 1986, J CELL BIOL, V102, P70, DOI 10.1083/jcb.102.1.70; Ueda H, 1997, J CELL SCI, V110, P1503; Voronina E, 2004, J CELL SCI, V117, P5995, DOI 10.1242/jcs.01518; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549; Zeng WZ, 2003, CURR BIOL, V13, P872, DOI 10.1016/S0960-9822(03)00330-0	40	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6296	10.1371/journal.pone.0006296	http://dx.doi.org/10.1371/journal.pone.0006296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617909	Green Submitted, Green Published, gold			2022-12-25	WOS:000268119600006
J	Thye, T; Scarisbrick, G; Browne, ENL; Chinbuah, MA; Gyapong, J; Osei, I; Owusu-Dabo, E; Niemann, S; Rusch-Gerdes, S; Meyer, CG; Horstmann, RD				Thye, Thorsten; Scarisbrick, Genevieve; Browne, Edmund N. L.; Chinbuah, Margaret Amanua; Gyapong, John; Osei, Ivy; Owusu-Dabo, Ellis; Niemann, Stefan; Ruesch-Gerdes, Sabine; Meyer, Christian G.; Horstmann, Rolf D.			CTLA4 Autoimmunity-Associated Genotype Contributes to Severe Pulmonary Tuberculosis in an African Population	PLOS ONE			English	Article								The gene of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA4), a negative regulator of T lymphocytes, contains a single-nucleotide polymorphism (SNP) at position +6230A->G (ct60A->G), which has been found associated with several autoimmune diseases and appears to reduce T-cell inhibitory activity. In Ghana, West Africa, we compared the frequencies of CTLA4 +6230 A/G and 6 haplotype-tagging SNPs in 2010 smear-positive, HIV-negative patients with pulmonary tuberculosis (TB) and 2346 controls matched for age, gender and ethnicity. We found no difference in allele frequencies between cases and controls. However, +6230A and a distinct CTLA4 haplotype and a diplotype comprising the +6230A allele were significantly less frequent among cases with large opacities in chest radiographs compared to those with small ones (P(corrected) ([cor]) = 0.002, P(cor) = 0.00045, P = 0.0005, respectively). This finding suggests that an increased T-cell activity associated with the CTLA4 +6230G allele contributes to pathology rather than to protection in pulmonary TB.			Thye, T (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	c.g.meyer@bni-hamburg.de	Niemann, Stefan/C-9327-2011	Gyapong, John/0000-0002-8415-1468; Niemann, Stefan/0000-0002-6604-0684				Bour-Jordan H, 2003, NAT IMMUNOL, V4, P182, DOI 10.1038/ni884; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Kirman J, 1999, INFECT IMMUN, V67, P3786, DOI 10.1128/IAI.67.8.3786-3792.1999; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lee JY, 2000, J COMPUT ASSIST TOMO, V24, P691, DOI 10.1097/00004728-200009000-00005; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; Nasta F, 2006, IMMUNOLOGY, V117, P358, DOI 10.1111/j.1365-2567.2005.02309.x; Quinn KM, 2006, IMMUNOL CELL BIOL, V84, P467, DOI 10.1111/j.1440-1711.2006.01460.x; Ramirez-Soriano A, 2005, GENES IMMUN, V6, P646, DOI 10.1038/sj.gene.6364251; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Thio CL, 2004, J VIROL, V78, P11258, DOI 10.1128/JVI.78.20.11258-11262.2004; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621	20	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6307	10.1371/journal.pone.0006307	http://dx.doi.org/10.1371/journal.pone.0006307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609446	Green Published, gold, Green Submitted			2022-12-25	WOS:000268119500023
J	Autiero, I; Costantini, S; Colonna, G				Autiero, Ida; Costantini, Susan; Colonna, Giovanni			Modeling of the Bacterial Mechanism of Methicillin-Resistance by a Systems Biology Approach	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; SIGNALING PATHWAY; INFECTIONS; VANCOMYCIN; ORFEOME; INVITRO; BINDING	Background: A microorganism is a complex biological system able to preserve its functional features against external perturbations and the ability of the living systems to oppose to these external perturbations is defined "robustness''. The antibiotic resistance, developed by different bacteria strains, is a clear example of robustness and of ability of the bacterial system to acquire a particular functional behaviour in response to environmental changes. In this work we have modeled the whole mechanism essential to the methicillin-resistance through a systems biology approach. The methicillin is a beta-lactamic antibiotic that act by inhibiting the penicillin-binding proteins (PBPs). These PBPs are involved in the synthesis of peptidoglycans, essential mesh-like polymers that surround cellular enzymes and are crucial for the bacterium survival. Methodology: The network of genes, mRNA, proteins and metabolites was created using CellDesigner program and the data of molecular interactions are stored in Systems Biology Markup Language (SBML). To simulate the dynamic behaviour of this biochemical network, the kinetic equations were associated with each reaction. Conclusions: Our model simulates the mechanism of the inactivation of the PBP by methicillin, as well as the expression of PBP2a isoform, the regulation of the SCCmec elements (SCC: staphylococcal cassette chromosome) and the synthesis of peptidoglycan by PBP2a. The obtained results by our integrated approach show that the model describes correctly the whole phenomenon of the methicillin resistance and is able to respond to the external perturbations in the same way of the real cell. Therefore, this model can be useful to develop new therapeutic approaches for the methicillin control and to understand the general mechanism regarding the cellular resistance to some antibiotics.			Autiero, I (corresponding author), Univ Naples 2, CRISCEB Interdept Res Ctr Computat & Biotechnol S, Naples, Italy.	susan.costantini@unina2.it	Autiero, Ida/P-7002-2018; Costantini, Susan/J-9914-2018; Autiero, Ida/HCI-1827-2022; Colonna, Giovanni/AAY-3568-2021	Autiero, Ida/0000-0001-8886-8063; Autiero, Ida/0000-0001-8886-8063; Colonna, Giovanni/0000-0002-0473-1455; Costantini, Susan/0000-0002-7538-4657				Ahn AC, 2006, PLOS MED, V3, P709, DOI 10.1371/journal.pmed.0030208; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Brandner CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-321; Brasch MA, 2004, GENOME RES, V14, P2001, DOI 10.1101/gr.2769804; CHAMBERS HF, 1994, BIOCHEM J, V301, P139, DOI 10.1042/bj3010139; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Costantini S, 2008, BIOINFORMATION, V3, P238, DOI 10.6026/97320630003238; CRAIG WA, 1993, J ANTIMICROB CHEMOTH, V31, P149, DOI 10.1093/jac/31.suppl_D.149; Drager A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-39; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; HALEY RW, 1995, J INFECT DIS, V171, P614, DOI 10.1093/infdis/171.3.614; Hucka M., 2004, Systems Biology, V1, P41, DOI 10.1049/sb:20045008; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Murphy JT, 2008, J THEOR BIOL, V254, P284, DOI 10.1016/j.jtbi.2008.05.037; O'Hara FP, 2008, J INFECT DIS, V197, P187, DOI 10.1086/524684; Olsen RJ, 2008, J CLIN MICROBIOL, V46, P1144, DOI 10.1128/JCM.02029-07; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Rehm SJ, 2008, CLEV CLIN J MED, V75, P177, DOI 10.3949/ccjm.75.3.177; Savic M, 2008, J BACTERIOL, V190, P5855, DOI 10.1128/JB.00076-08; Sheehy JE, 2008, NEW PHYTOL, V179, P579, DOI 10.1111/j.1469-8137.2008.02407.x; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Stapleton Paul D., 2002, Science Progress, V85, P57, DOI 10.3184/003685002783238870; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; ZHANEL GG, 1991, DICP ANN PHARMAC, V25, P153, DOI 10.1177/106002809102500210; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	31	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6226	10.1371/journal.pone.0006226	http://dx.doi.org/10.1371/journal.pone.0006226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593454	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035400010
J	Srivastava, N; Srivastava, PK				Srivastava, Nisheeth; Srivastava, Pramod K.			Modeling the Repertoire of True Tumor-Specific MHC I Epitopes in a Human Tumor	PLOS ONE			English	Article								DNA replication has a finite measurable error rate, net of repair, in all cells. Clonal proliferation of cancer cells leads therefore to accumulation of random mutations. A proportion of these mutational events can create new immunogenic epitopes that, if processed and presented by an MHC allele, may be recognized by the adaptive immune system. Here, we use probability theory to analyze the mutational and epitope composition of a tumor mass in successive division cycles and create a double Polya model for calculating the number of truly tumor-specific MHC I epitopes in a human tumor. We deduce that depending upon tumor size, the degree of genomic instability and the degree of death within a tumor, human tumors have several tens to low hundreds of new, truly tumor-specific epitopes. Parenthetically, cancer stem cells, due to the asymmetry in their proliferative properties, shall harbor significantly fewer mutations, and therefore significantly fewer immunogenic epitopes. As the overwhelming majority of the mutations in cancer cells are unrelated to malignancy, the mutation-generated epitopes shall be specific for each individual tumor, and constitute the antigenic fingerprint of each tumor. These calculations highlight the benefits for personalization of immunotherapy of human cancer, and in view of the substantial pre-existing antigenic repertoire of tumors, emphasize the enormous potential of therapies that modulate the anti-cancer immune response by liberating it from inhibitory influences.			Srivastava, N (corresponding author), Univ Minnesota, Dept Comp Sci, Minneapolis, MN 55455 USA.	srivastava@uchc.edu		Srivastava, Pramod/0000-0003-2837-2861				Andres A, 2005, CRIT REV ONCOL HEMAT, V56, P71, DOI 10.1016/j.critrevonc.2004.11.010; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; BASOMBRIO MA, 1970, CANCER RES, V30, P2458; Baurain JF, 2000, J IMMUNOL, V164, P6057, DOI 10.4049/jimmunol.164.11.6057; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Chiari R, 1999, CANCER RES, V59, P5785; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Echchakir H, 2001, CANCER RES, V61, P4078; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL R, 1993, CELL, V8, P167; Gatenby RA, 2002, CANCER RES, V62, P3675; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Ikeda H, 1997, P NATL ACAD SCI USA, V94, P6375, DOI 10.1073/pnas.94.12.6375; Karanikas V, 2001, CANCER RES, V61, P3718; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Matsutake T, 2001, P NATL ACAD SCI USA, V98, P3992, DOI 10.1073/pnas.071523398; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Rammensee HG, 2002, IMMUNOL REV, V188, P164, DOI 10.1034/j.1600-065X.2002.18815.x; SCANLAN M, 2004, CT GENE DATABASE; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Sensi M, 2005, CANCER RES, V65, P632; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Simpson AJG, 1997, ADV CANCER RES, V71, P209, DOI 10.1016/S0065-230X(08)60100-1; Srivastava P K, 1996, Semin Immunol, V8, P295, DOI 10.1006/smim.1996.0038; SRIVASTAVA PK, 1993, ADV CANCER RES, V62, P153, DOI 10.1016/S0065-230X(08)60318-8; SRIVASTAVA PK, 1988, IMMUNOL TODAY, V9, P78, DOI 10.1016/0167-5699(88)91269-8; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; *SYFPEITHI, SYFPEITHI DAT MHC LI; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; TESTORI A, 2008, J CLIN ONCO IN PRESS; Tomlinson I, 2002, AM J PATHOL, V160, P755, DOI 10.1016/S0002-9440(10)64896-1; URBAN JL, 1992, ANNU REV IMMUNOL, V10, P617, DOI 10.1146/annurev.iy.10.040192.003153; VANDERBRUGGEN P, 2001, T CELL DEFINED TUMOR; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zorn E, 1999, EUR J IMMUNOL, V29, P592, DOI 10.1002/(SICI)1521-4141(199902)29:02<592::AID-IMMU592>3.0.CO;2-2	45	18	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6094	10.1371/journal.pone.0006094	http://dx.doi.org/10.1371/journal.pone.0006094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593447	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035300002
J	Kupershmidt, L; Weinreb, O; Amit, T; Mandel, S; Carri, MT; Youdim, MBH				Kupershmidt, Lana; Weinreb, Orly; Amit, Tamar; Mandel, Silvia; Carri, Maria Teresa; Youdim, Moussa B. H.			Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis	FASEB JOURNAL			English	Article						motor neurodegenerative diseases; hypoxia-inducible factor; differentiation; G93A-SOD1 ALS mouse model	HYPOXIA-INDUCIBLE FACTOR; MONOAMINE-OXIDASE INHIBITION; SPINAL-CORD INJURY; PROTEIN-KINASE-C; NEURODEGENERATIVE DISEASES; GROWTH-FACTOR; IN-VIVO; SUPEROXIDE-DISMUTASE; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE	Novel therapeutic approaches for the treatment of neurodegenerative disorders comprise drug candidates designed specifically to act on multiple central nervous system targets. We have recently synthesized multifunctional, nontoxic, brain-permeable iron-chelating drugs, M30 and HLA20, possessing the N-propargylamine neuroprotective moiety of rasagiline (Azilect) and the iron-chelating moiety of VK28. The present study demonstrates that M30 and HLA20 possess a wide range of pharmacological activities in mouse NSC-34 motor neuron cells, including neuroprotective effects against hydrogen peroxide-and 3-morpholinosydnonimine-induced neurotoxicity, induction of differentiation, and up-regulation of hypoxia-inducible factor (HIF)-1 alpha and HIF-target genes (enolase1 and vascular endothelial growth factor)(+) Both compounds induced NSC-34 neuritogenesis, accompanied by a marked increase in the expression of brain-derived neurotrophic factor and growth-associated protein-43, which was inhibited by PD98059 and GF109203X, indicating the involvement of mitogen-activated protein kinase and protein kinase C pathways. A major finding was the ability of M30 to significantly extend the survival of G93A-SOD1 amyotrophic lateral sclerosis mice and delay the onset of the disease. These properties of the novel multimodal iron-chelating drugs possessing neuroprotective/neuritogenic activities may offer future therapeutic possibilities for motor neurodegenerative diseases.-Kupershmidt, L., Weinreb, O., Amit, T., Mandel, S., Carri, M. T., Youdim, M. B. H. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 23, 3766-3779 (2009). www.fasebj.org	[Kupershmidt, Lana; Weinreb, Orly; Amit, Tamar; Mandel, Silvia; Youdim, Moussa B. H.] Technion Israel Inst Technol, Fac Med, Dept Pharmacol, Rappaport Family Res Inst, IL-31096 Haifa, Israel; [Carri, Maria Teresa] Fdn Santa Lucia, IRCCS, Neurochem Lab, Rome, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; IRCCS Santa Lucia; University of Rome Tor Vergata	Youdim, MBH (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Pharmacol, Rappaport Family Res Inst, POB 9697, IL-31096 Haifa, Israel.	youdim@tx.technion.ac.il	Carri, Maria Teresa/K-5480-2016	Carri, Maria Teresa/0000-0002-1789-1546	The Israeli ALS Research Association (Haifa, Israel); Technion-Research and Development and Rappaport Family Research Institute, Technion-Israel Institute of Technology (Haifa, Israel)	The Israeli ALS Research Association (Haifa, Israel); Technion-Research and Development and Rappaport Family Research Institute, Technion-Israel Institute of Technology (Haifa, Israel)	The authors thank the personnel from Tor Vergata University, Rome, Italy, for generously providing the NSC-34 cell line and wt/G93A-SOD1 plasmids, and for their excellent assistance and kind advice. The authors gratefully acknowledged the support of The Israeli ALS Research Association (Haifa, Israel) and the Technion-Research and Development and Rappaport Family Research Institute, Technion-Israel Institute of Technology (Haifa, Israel).	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Almli LM, 2001, DEV BRAIN RES, V132, P121, DOI 10.1016/S0165-3806(01)00302-9; Amit T, 2008, FASEB J, V22, P1296, DOI 10.1096/fj.07-8627rev; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Avramovich-Tirosh Y, 2007, J NEUROCHEM, V100, P490, DOI 10.1111/j.1471-4159.2006.04258.x; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bar Am O, 2004, NEUROSCI LETT, V355, P169, DOI 10.1016/j.neulet.2003.10.067; Bar-Am O, 2004, J NEUROCHEM, V89, P1119, DOI 10.1111/j.1471-4159.2004.02425.x; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Blancher C, 2001, CANCER RES, V61, P7349; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Buck CR, 2000, J COMP NEUROL, V416, P309, DOI 10.1002/(SICI)1096-9861(20000117)416:3<309::AID-CNE3>3.0.CO;2-U; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; COMBS DJ, 1987, STROKE, V18, P503, DOI 10.1161/01.STR.18.2.503; Cookson MR, 1998, J NEUROCHEM, V70, P501; Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760; Danzeisen R, 2006, J BIOL INORG CHEM, V11, P489, DOI 10.1007/s00775-006-0099-4; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gal S, 2005, J NEUROCHEM, V95, P79, DOI 10.1111/j.1471-4159.2005.03341.x; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Harley A, 1993, Brain Res, V627, P349; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hoffman EK, 1996, J NEUROL SCI, V139, P15, DOI 10.1016/S0022-510X(96)00031-7; Ikeda O, 2002, J NEUROPATH EXP NEUR, V61, P142, DOI 10.1093/jnen/61.2.142; Imon Y, 1995, J NEUROL SCI, V134, P27, DOI 10.1016/0022-510X(95)00205-G; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; KASARSKIS EJ, 1995, J NEUROL SCI, V130, P203, DOI 10.1016/0022-510X(95)00037-3; Kulp KS, 1996, EXP CELL RES, V229, P60, DOI 10.1006/excr.1996.0343; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Mizuno Y, 2006, ACTA NEUROPATHOL, V112, P597, DOI 10.1007/s00401-006-0122-4; Moreau C, 2006, J NEUROL NEUROSUR PS, V77, P255, DOI 10.1136/jnnp.2005.070904; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; OBA H, 1993, RADIOLOGY, V189, P843, DOI 10.1148/radiology.189.3.8234713; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Qin DX, 2006, NEUROSCI LETT, V410, P222, DOI 10.1016/j.neulet.2006.10.006; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Shoham S, 2000, CELL MOL BIOL, V46, P743; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Singh AT, 2003, J BONE MINER RES, V18, P1453, DOI 10.1359/jbmr.2003.18.8.1453; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; TAKEDA E, 1981, LIFE SCI, V28, P1007, DOI 10.1016/0024-3205(81)90746-3; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Tolosa L, 2009, NEUROSCIENCE, V158, P1348, DOI 10.1016/j.neuroscience.2008.10.060; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; Weinreb O, 2004, FASEB J, V18, P1471, DOI 10.1096/fj.04-1916fje; Whitnall Megan, 2006, Semin Pediatr Neurol, V13, P186, DOI 10.1016/j.spen.2006.08.008; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zheng H, 2005, J NEUROCHEM, V95, P68, DOI 10.1111/j.1471-4159.2005.03340.x; Zheng HL, 2005, BIOORGAN MED CHEM, V13, P773, DOI 10.1016/j.bmc.2004.10.037; Zhu W, 2007, FASEB J, V21, P3835, DOI 10.1096/fj.07-8386com	71	100	102	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3766	3779		10.1096/fj.09-130047	http://dx.doi.org/10.1096/fj.09-130047			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19638399				2022-12-25	WOS:000271272500014
J	Masson, S; Kern, T; Le Gouellec, A; Giustini, C; Simorre, JP; Callow, P; Vernet, T; Gabel, F; Zapun, A				Masson, Soizic; Kern, Thomas; Le Gouellec, Audrey; Giustini, Cecile; Simorre, Jean-Pierre; Callow, Philip; Vernet, Thierry; Gabel, Frank; Zapun, Andre			Central Domain of DivIB Caps the C-terminal Regions of the FtsL/DivIC Coiled-coil Rod	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; MEMBRANE-BOUND DIVISION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SOLUTION SCATTERING; X-RAY; BIOLOGICAL MACROMOLECULES; FTSL; LOCALIZATION; DIVISOME	DivIB(FtsQ), FtsL, and DivIC(FtsB) are enigmatic membrane proteins that are central to the process of bacterial cell division. DivIB(FtsQ) is dispensable in specific conditions in some species, and appears to be absent in other bacterial species. The presence of FtsL and DivIC(FtsB) appears to be conserved despite very low sequence conservation. The three proteins form a complex at the division site, FtsL and DivIC(FtsB) being associated through their extracellular coiled-coil region. We report here structural investigations by NMR, small-angle neutron and x-ray scattering, and interaction studies by surface plasmon resonance, of the complex of DivIB, FtsL, and DivIC from Streptococcus pneumoniae, using soluble truncated forms of the proteins. We found that one side of the "bean"-shaped central beta-domain of DivIB interacts with the C-terminal regions of the dimer of FtsL and DivIC. This finding is corroborated by sequence comparisons across bacterial genomes. Indeed, DivIB is absent from species with shorter FtsL and DivIC proteins that have an extracellular domain consisting only of the coiled-coil segment without C-terminal conserved regions (Campylobacterales). We propose that the main role of the interaction of DivIB with FtsL and DivIC is to help the formation, or to stabilize, the coiled-coil of the latter proteins. The coiled-coil of FtsL and DivIC, itself or with transmembrane regions, could be free to interact with other partners.	[Masson, Soizic; Le Gouellec, Audrey; Vernet, Thierry; Zapun, Andre] Univ Grenoble 1, CNRS, CEA, Lab Ingenierie Macromol,Inst Biol Struct,UMR 5075, F-38027 Grenoble, France; [Kern, Thomas; Giustini, Cecile; Simorre, Jean-Pierre] Univ Grenoble 1, CNRS, Lab Resonance Magnet Nucl, CEA,Inst Biol Struct,UMR 5075, F-38027 Grenoble, France; [Gabel, Frank] Univ Grenoble 1, CNRS, CEA, Lab Biophys Mol,Inst Biol Struct,UMR 5075, F-38027 Grenoble, France; [Callow, Philip] Keele Univ, Inst Sci & Technol, Med Res Inst, Keele ST5 5BG, Staffs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Keele University	Vernet, T (corresponding author), Univ Grenoble 1, CNRS, CEA, Lab Ingenierie Macromol,Inst Biol Struct,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	thierry.vernet@ibs.fr	le gouellec, audrey/M-6072-2014; Vernet, Thierry/G-1118-2012; Le Gouellec, audrey/AAC-3013-2019	Le Gouellec, audrey/0000-0002-4905-3854; Gabel, Frank/0000-0003-3446-2601; Zapun, Andre/0000-0001-8953-4399; simorre, jean-pierre/0000-0002-7943-1342	European Union [LSMH-CT-EUR-INTAFAR 2004-512138]; Ministry of Research "allocation de recherche"; Engineering and Physical Sciences Research Council [GR/R99393/01, EP/C015452/1]; EPSRC [EP/C015452/1] Funding Source: UKRI	European Union(European Commission); Ministry of Research "allocation de recherche"; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by European Union Grant LSMH-CT-EUR-INTAFAR 2004-512138 (to T. V. and J.P.S.), a grant from tthe Ministry of Research "allocation de recherche" (to S. M.), and Engineering and Physical Sciences Research Council Grants GR/R99393/01 and EP/C015452/1 (to P. C.).	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEALL B, 1989, J BACTERIOL, V171, P6821, DOI 10.1128/jb.171.12.6821-6834.1989; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; Chao HM, 1996, BIOCHEMISTRY-US, V35, P12175, DOI 10.1021/bi9530604; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Ghigo JM, 1999, MOL MICROBIOL, V31, P725, DOI 10.1046/j.1365-2958.1999.01213.x; GHOSH R, 2006, ILL06GH05T; GLATTER O, 1979, J APPL CRYSTALLOGR, V12, P166, DOI 10.1107/S0021889879012139; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Guinier A., 1939, ANN PHYS, V12, P166; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; GUZMAN LM, 1992, J BACTERIOL, V174, P7716, DOI 10.1128/JB.174.23.7717-7728.1992; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Harry E., 2006, INT REV CYTOL, V253, P27; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Katis VL, 1999, J BACTERIOL, V181, P2710, DOI 10.1128/JB.181.9.2710-2718.1999; Katis VL, 2000, J BACTERIOL, V182, P3607, DOI 10.1128/JB.182.12.3607-3611.2000; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X; Le Gouellec A, 2008, J BACTERIOL, V190, P4501, DOI 10.1128/JB.00376-08; LEVIN PA, 1994, J BACTERIOL, V176, P1451, DOI 10.1128/jb.176.5.1451-1459.1994; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Robson SA, 2002, MOL MICROBIOL, V44, P663, DOI 10.1046/j.1365-2958.2002.02920.x; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Scheffers DJ, 2007, J BACTERIOL, V189, P7273, DOI 10.1128/JB.00723-07; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Wadsworth KD, 2008, MOL MICROBIOL, V67, P1143, DOI 10.1111/j.1365-2958.2008.06114.x	49	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27687	27700		10.1074/jbc.M109.019471	http://dx.doi.org/10.1074/jbc.M109.019471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19635793	hybrid, Green Published			2022-12-25	WOS:000270232300070
J	Carpena, X; Vidossich, P; Schroettner, K; Calisto, BM; Banerjee, S; Stampler, J; Soudi, M; Furtmuller, PG; Rovira, C; Fita, I; Obinger, C				Carpena, Xavier; Vidossich, Pietro; Schroettner, Klarissa; Calisto, Barbara M.; Banerjee, Srijib; Stampler, Johanna; Soudi, Monika; Furtmueller, Paul G.; Rovira, Carme; Fita, Ignacio; Obinger, Christian			Essential Role of Proximal Histidine-Asparagine Interaction in Mammalian Peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN MYELOPEROXIDASE; LINKAGE; REDOX; HEME; SUPERFAMILY; REACTIVITY; EVOLUTION; OXIDATION; BINDING	In heme enzymes belonging to the peroxidase-cyclooxygenase superfamily the proximal histidine is in close interaction with a fully conserved asparagine. The crystal structure of a mixture of glycoforms of myeloperoxidase (MPO) purified from granules of human leukocytes prompted us to revise the orientation of this asparagine and the protonation status of the proximal histidine. The data we present contrast with previous MPO structures, but are strongly supported by molecular dynamics simulations. Moreover, comprehensive analysis of published lactoperoxidase structures suggest that the described proximal heme architecture is a general structural feature of animal heme peroxidases. Its importance is underlined by the fact that the MPO variant N421D, recombinantly expressed in mammalian cell lines, exhibited modified spectral properties and diminished catalytic activity compared with wild-type recombinant MPO. It completely lost its ability to oxidize chloride to hypochlorous acid, which is a characteristic feature of MPO and essential for its role in host defense. The presented crystal structure of MPO revealed further important differences compared with the published structures including the extent of glycosylation, interaction between light and heavy polypeptides, as well as heme to protein covalent bonds. These data are discussed with respect to biosynthesis and post-translational maturation of MPO as well as to its peculiar biochemical and biophysical properties.	[Banerjee, Srijib; Stampler, Johanna; Soudi, Monika; Furtmueller, Paul G.; Obinger, Christian] Univ Nat Resources & Appl Life Sci, Div Biochem, Dept Chem, Metalloprot Res Grp, A-1190 Vienna, Austria; [Carpena, Xavier; Schroettner, Klarissa; Calisto, Barbara M.; Fita, Ignacio] Inst Res Biomed, Barcelona 08028, Spain; [Carpena, Xavier; Schroettner, Klarissa; Calisto, Barbara M.; Fita, Ignacio] CSIC, IBMB, Inst Mol Biol, E-08028 Barcelona, Spain; [Vidossich, Pietro; Rovira, Carme] CoSMoLab, Lab Simulacio Computac & Modelitzacio, Barcelona 08028, Spain; [Vidossich, Pietro; Rovira, Carme] Inst Quim Teor & Computac IQTCUB, Barcelona 08028, Spain; [Rovira, Carme] ICREA, Barcelona 08028, Spain	University of Natural Resources & Life Sciences, Vienna; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; ICREA	Obinger, C (corresponding author), Univ Nat Resources & Appl Life Sci, Div Biochem, Dept Chem, Metalloprot Res Grp, Muthgasse 18, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Carpena, Xavi/J-5877-2017; Rovira, Carme/K-5195-2014; Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021; Fita, Ignasi/R-4515-2019	Carpena, Xavi/0000-0002-8646-0440; Rovira, Carme/0000-0003-1477-5010; Furtmüller, Paul G./0000-0002-1199-2469; Fita, Ignasi/0000-0002-7521-2679; Obinger, Christian/0000-0002-7133-3430; Calisto, Barbara/0000-0003-1732-571X	Spanish Ministerio de Educacion y Ciencia [FIS2008-03845, BIO2005-08686-C02-01]; Generalitat de Catalunya [2005SGR-00112, 2005SGR-00036]; Austrian Science Fund [P20664]; Spanish Research Council; ICREA Funding Source: Custom	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Austrian Science Fund(Austrian Science Fund (FWF)); Spanish Research Council; ICREA(ICREA)	This work was supported by Spanish Ministerio de Educacion y Ciencia Grants FIS2008-03845 and BIO2005-08686-C02-01, Generalitat de Catalunya Grants 2005SGR-00112 and 2005SGR-00036, and Austrian Science Fund FWF project P20664 (to P. G. F.). This work was also supported by a grant from the I3P program of the Spanish Research Council (to X. C.).	Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; GLEICH GJ, 1989, INT ARCH ALLER A IMM, V88, P59, DOI 10.1159/000234749; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; JOHNSON KR, 1987, NUCLEIC ACIDS RES, V15, P2013, DOI 10.1093/nar/15.5.2013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHLSSON PI, 1983, ACTA CHEM SCAND B, V37, P917, DOI 10.3891/acta.chem.scand.37b-0917; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Passardi F, 2007, GENOMICS, V89, P567, DOI 10.1016/j.ygeno.2007.01.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Taurog A, 1970, Recent Prog Horm Res, V26, P189; THOMAS EL, 1999, PEROXIDASES CHEM BIO, P1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [DOI 10.1016/0959-440X(92)90230-5, 10.1016/0959-440x(92)90230-5]; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	41	62	64	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25929	25937		10.1074/jbc.M109.002154	http://dx.doi.org/10.1074/jbc.M109.002154			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608745	Green Published, hybrid			2022-12-25	WOS:000269738000049
J	Hankins, JV; Trent, MS				Hankins, Jessica V.; Trent, M. Stephen			Secondary Acylation of Vibrio cholerae Lipopolysaccharide Requires Phosphorylation of Kdo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-MANNO-OCTULOSONIC ACID TRANSFERASE; LIPID-A BIOSYNTHESIS; COLI-MSBB GENE; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; HELICOBACTER-PYLORI; SALMONELLA-TYPHIMURIUM; CHEMICAL-STRUCTURE; ACYL CHAINS; VIRULENCE	The lipopolysaccharide of Vibrio cholerae has been reported to contain a single 3-deoxy-D-manno-octulosonic acid (Kdo) residue that is phosphorylated. The phosphorylated Kdo sugar further links the hexa-acylated V. cholerae lipid A domain to the core oliogosaccharide and O-antigen. In this report, we confirm that V. cholerae possesses the enzymatic machinery to synthesize a phosphorylated Kdo residue. Further, we have determined that the presence of the phosphate group on the Kdo residue is necessary for secondary acylation in V. cholerae. The requirement for a secondary substituent on the Kdo residue (either an additional Kdo sugar or a phosphate group) was also found to be critical for secondary acylation catalyzed by LpxL proteins from Bordetella pertussis, Escherichia coli, and Haemophilus influenzae. Although three putative late acyltransferase orthologs have been identified in the V. cholerae genome (Vc0212, Vc0213, and Vc1577), only Vc0213 appears to be functional. Vc0213 functions as a myristoyl transferase acylating lipid A at the 2'-position of the glucosamine disaccharide. Generally acyl-ACPs serve as fatty acyl donors for the acyltransferases required for lipopolysaccharide biosynthesis; however, in vitro assays indicate that Vc0213 preferentially utilizes myristoyl-CoA as an acyl donor. This is the first report to biochemically characterize enzymes involved in the biosynthesis of the V. cholerae Kdo-lipid A domain.	[Trent, M. Stephen] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Trent, M. Stephen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hankins, Jessica V.] Med Coll Georgia, Dept Mol Biochem & Biochem, Augusta, GA 30912 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University System of Georgia; Augusta University	Trent, MS (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	strent@mail.utexas.edu			National Institutes of Health [AI076322, AI064184]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076322, R01AI064184, R01AI076322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076322 and AI064184 ( to M. S. T.).	BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Boutonnier A, 2001, INFECT IMMUN, V69, P3488, DOI 10.1128/IAI.69.5.3488-3493.2001; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; BRADE H, 1985, J BACTERIOL, V161, P795, DOI 10.1128/JB.161.2.795-798.1985; BROADY KW, 1981, EUR J BIOCHEM, V115, P463; BROZEK KA, 1992, METHOD ENZYMOL, V209, P476; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; Caroff M, 2001, J ENDOTOXIN RES, V7, P63, DOI 10.1177/09680519010070011101; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; HELANDER IM, 1988, EUR J BIOCHEM, V177, P483, DOI 10.1111/j.1432-1033.1988.tb14398.x; Hood DW, 2001, MOL MICROBIOL, V39, P341, DOI 10.1046/j.1365-2958.2001.02204.x; Isobe T, 1999, J BACTERIOL, V181, P2648, DOI 10.1128/JB.181.8.2648-2651.1999; Jones BD, 1997, INFECT IMMUN, V65, P4778, DOI 10.1128/IAI.65.11.4778-4783.1997; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; MOHAN S, 1994, J BACTERIOL, V176, P6944, DOI 10.1128/JB.176.22.6944-6951.1994; Nichols WA, 1997, J ENDOTOXIN RES, V4, P163, DOI 10.1177/096805199700400301; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; SIX DA, 2008, BIOCHEMISTRY-US, V65, P4778; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somerville JE, 1999, INFECT IMMUN, V67, P6583; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Stead CM, 2008, J BACTERIOL, V190, P7012, DOI 10.1128/JB.00667-08; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tran AX, 2006, J BACTERIOL, V188, P4531, DOI 10.1128/JB.00146-06; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; Villeneuve S, 2000, P NATL ACAD SCI USA, V97, P8433, DOI 10.1073/pnas.060022997; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; White KA, 1997, J BIOL CHEM, V272, P16555, DOI 10.1074/jbc.272.26.16555; White KA, 1999, J BIOL CHEM, V274, P31391, DOI 10.1074/jbc.274.44.31391	42	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25804	25812		10.1074/jbc.M109.022772	http://dx.doi.org/10.1074/jbc.M109.022772			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617350	Green Published, hybrid			2022-12-25	WOS:000269738000038
J	Gafni, J; Cong, X; Chen, SF; Gibson, BW; Ellerby, LM				Gafni, Juliette; Cong, Xin; Chen, Sylvia F.; Gibson, Bradford W.; Ellerby, Lisa M.			Calpain-1 Cleaves and Activates Caspase-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTIN REDUCES TOXICITY; CELL-DEATH; GRANZYME-B; EXECUTIONER CASPASE-3; THYMOCYTE APOPTOSIS; NEURONAL DAMAGE; INHIBITION; PROTEASES; GLUTAMATE; LOCALIZATION	Caspase-7 is an executioner caspase that plays a key role in apoptosis, cancer, and a number of neurodegenerative diseases. The mechanism of caspase-7 activation by granzyme B and caspase-3 has been well characterized. However, whether other proteases such as calpains activate or inactivate caspase-7 is not known. Here, we present that recombinant caspase-7 is directly cleaved by calpain-1 within the large subunit of caspase-7 to produce two novel products, large subunit p18 and p17. This new form of caspase-7 has a 6-fold increase in V-max when compared with the previously characterized p20/p12 form. Zymography revealed that the smaller caspase-7 product (p17) is 18-fold more active than either the caspase-3-cleaved product (p20) or the larger calpain-1 product of caspase-7 (p18). Mass spectrometry and site-directed mutagenesis identified the calpain cleavage sites within the caspase-7 large subunit at amino acid 36 and 45/47. These proteolysis events occur in vivo as indicated by the accumulation of caspase-7 p18 and p17 subunits in cortical neurons undergoing Ca2+ dysregulation. Further, cleavage at amino acid 45/47 of caspase-7 by calpain results in a reduction in nuclear localization when compared with the caspase-3 cleavage product of caspase-7 (p20). Our studies suggest the calpain-activated form of caspase-7 has unique enzymatic activity, localization, and binding affinity when compared with the caspase-activated form.	[Gafni, Juliette; Cong, Xin; Chen, Sylvia F.; Gibson, Bradford W.; Ellerby, Lisa M.] Buck Inst Age Res, Novato, CA 94945 USA	Buck Institute for Research on Aging	Ellerby, LM (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	lellerby@buckinstitute.org			National Institutes of Health [NS40251A]; Nathan Shock [P30 AG025708]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG025708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nathan Shock; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant NS40251A and Nathan Shock Grant P30 AG025708.	Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chaitanya GV, 2008, NEUROCHEM RES, V33, P2178, DOI 10.1007/s11064-007-9567-7; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Del Rio P, 2008, NEUROCHEM RES, V33, P1475, DOI 10.1007/s11064-008-9612-1; Del Rio P, 2008, EXP NEUROL, V212, P179, DOI 10.1016/j.expneurol.2008.03.023; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Hayashi N, 2006, NEUROSCI LETT, V397, P5, DOI 10.1016/j.neulet.2005.11.057; HONG SC, 1994, BRAIN RES, V661, P43, DOI 10.1016/0006-8993(94)91178-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kato M, 2000, J BIOCHEM, V127, P297, DOI 10.1093/oxfordjournals.jbchem.a022607; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Moore JD, 2002, BRIT J PHARMACOL, V135, P1069, DOI 10.1038/sj.bjp.0704538; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Ray SK, 2006, NEUROSCIENCE, V139, P577, DOI 10.1016/j.neuroscience.2005.12.057; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shikama Y, 2001, EXP CELL RES, V264, P315, DOI 10.1006/excr.2000.5153; Squier MKT, 1997, J IMMUNOL, V158, P3690; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Thornberry NA, 1999, CELL DEATH DIFFER, V6, P1023, DOI 10.1038/sj.cdd.4400607; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wu J, 2006, CELL MOL LIFE SCI, V63, P949, DOI 10.1007/s00018-005-5565-6; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; Yaoita Y, 2002, BIOCHEM BIOPH RES CO, V291, P79, DOI 10.1006/bbrc.2002.6408; Zhivotovsky B, 2004, CELL CYCLE, V3, P64; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; ZHIVOTOVSKY B, 1994, BIOCHEM BIOPH RES CO, V202, P120, DOI 10.1006/bbrc.1994.1901; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361	43	44	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25441	25449		10.1074/jbc.M109.038174	http://dx.doi.org/10.1074/jbc.M109.038174			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617626	Green Published, hybrid			2022-12-25	WOS:000269734000076
J	Podust, LM; Ouellet, H; von Kries, JP; de Montellano, PRO				Podust, Larissa M.; Ouellet, Hugues; von Kries, Jens P.; de Montellano, Paul R. Ortiz			Interaction of Mycobacterium tuberculosis CYP130 with Heterocyclic Arylamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC MICROSOMAL CYTOCHROME; ANTIMYCOBACTERIAL ACTIVITY; AZOLE ANTIFUNGALS; CRYSTAL-STRUCTURE; DRUG INTERACTION; IN-VITRO; IDENTIFICATION; DERIVATIVES; COMPLEXES; BINDING	The Mycobacterium tuberculosis P450 enzymes are of interest for their pharmacological development potential, as evidenced by their susceptibility to inhibition by antifungal azole drugs that normally target sterol 14 alpha-demethylase (CYP51). Although antifungal azoles show promise, direct screening of compounds against M. tuberculosis P450 enzymes may identify novel, more potent, and selective inhibitory scaffolds. Here we report that CYP130 from M. tuberculosis has a natural propensity to bind primary arylamines with particular chemical architectures. These compounds were identified via a high throughput screen of CYP130 with a library of synthetic organic molecules. As revealed by subsequent x-ray structure analysis, selected compounds bind in the active site by Fe-coordination and hydrogen bonding of the arylamine group to the carbonyl oxygen of Gly(243). As evidenced by the binding of structural analogs, the primary arylamine group is indispensable, but synergism due to hydrophobic contacts between the rest of the molecule and protein amino acid residues is responsible for a binding affinity comparable with that of the antifungal azole drugs. The topology of the CYP130 active site favors angular coordination of the arylamine group over the orthogonal coordination of azoles. Upon substitution of Gly(243) by an alanine, the binding mode of azoles and some arylamines reverted from type II to type I because of hydrophobic and steric interactions with the alanine side chain. We suggest a role for the conserved Ala(Gly)(243)-Gly(244) motif in the I-helix in modulating both the binding affinity of the axial water ligand and the ligand selectivity of cytochrome P450 enzymes.	[Podust, Larissa M.; Ouellet, Hugues; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [von Kries, Jens P.] Leibniz Inst Mol Pharmacol, Screening Unit, D-13125 Berlin, Germany	University of California System; University of California San Francisco; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760	National Institutes of Health [AI07824, GM25515, GM078553]; X-Mtb Consortium Bundesministerium fuer Bildung und Forschung/Projekttraeger Juelich (BMBF/PTJ) [BIO/0312992A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025515, R37GM025515, R01GM078553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); X-Mtb Consortium Bundesministerium fuer Bildung und Forschung/Projekttraeger Juelich (BMBF/PTJ)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants AI07824 and GM25515 (to P.O.d.M.) and GM078553 (to L. M. P.). This work was also supported by Grants BIO/0312992A (to J.P.K.) from the X-Mtb Consortium Bundesministerium fuer Bildung und Forschung/Projekttraeger Juelich (BMBF/PTJ).	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, FEMS MICROBIOL LETT, V258, P200, DOI 10.1111/j.1574-6968.2006.00224.x; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Banfi E, 2006, J ANTIMICROB CHEMOTH, V58, P76, DOI 10.1093/jac/dkl182; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Byrne ST, 2007, J MED MICROBIOL, V56, P1047, DOI 10.1099/jmm.0.47058-0; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chen CK, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000372; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FRANKLIN MR, 1976, CHEM-BIOL INTERACT, V14, P337, DOI 10.1016/0009-2797(76)90112-5; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hlavica P, 2006, BBA-PROTEINS PROTEOM, V1764, P645, DOI 10.1016/j.bbapap.2006.01.013; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Keilin D, 1943, NATURE, V151, P390, DOI 10.1038/151390a0; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; MANSUY D, 1978, EUR J BIOCHEM, V86, P573, DOI 10.1111/j.1432-1033.1978.tb12341.x; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Podust LM, 2007, ANTIMICROB AGENTS CH, V51, P3915, DOI 10.1128/AAC.00311-07; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; REMMER H, 1966, MOL PHARMACOL, V2, P187; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454	32	25	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25211	25219		10.1074/jbc.M109.017632	http://dx.doi.org/10.1074/jbc.M109.017632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605350	Green Published, hybrid			2022-12-25	WOS:000269734000055
J	Small, TW; Pickering, JG				Small, Theodore W.; Pickering, J. Geoffrey			Nuclear Degradation of Wilms Tumor 1-associating Protein and Survivin Splice Variant Switching Underlie IGF-1-mediated Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-I; PRE-MESSENGER-RNA; DROSOPHILA-MELANOGASTER; PROTEOMIC ANALYSIS; FL(2)D GENE; APOPTOSIS; RECEPTOR; ACTIVATION; EXPRESSION	WTAP (Wilms tumor 1-associating protein) is a recently identified nuclear protein that is essential for mouse embryo development. The Drosophila homolog of WTAP, Fl(2)d, regulates pre-mRNA splicing; however, the role of WTAP in mammalian cells is uncertain. To elucidate a context for WTAP action, we screened growth and survival factors for their effects on WTAP expression in vascular smooth muscle cells (SMCs), a cell type previously found to express WTAP dynamically. This revealed that insulin-like growth factor-1 (IGF-1) uniquely reduced WTAP abundance. This decline in WTAP proved to be necessary for IGF-1 to confer its antiapoptotic properties, which were blocked by transducing the WTAP gene into SMCs. WTAP down-regulation by IGF-1 was mediated by an IGF-1 receptor-phosphatidylinositol 3-kinase-Akt signaling axis that directed WTAP degradation via a nuclear 26 S proteasome. Moreover, by promoting the degradation of WTAP, IGF-1 shifted the pre-mRNA splicing program for the survival factor, survivin, to reduce expression of survivin-2B, which is proapoptotic, and increase expression of survivin, which is antiapoptotic. Knockdown of survivin-2B rescued the ability of IGF-1 to promote survival when WTAP was overexpressed. These data uncover a novel regulatory cascade for human SMC survival based on adjusting the nuclear abundance of WTAP to define the splice variant balance among survivin isoforms.	[Small, Theodore W.; Pickering, J. Geoffrey] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; [Pickering, J. Geoffrey] Univ Western Ontario, London Hlth Sci Ctr, London, ON N6A 5K8, Canada; [Pickering, J. Geoffrey] Univ Western Ontario, Dept Med Cardiol, London, ON N6A 5K8, Canada; [Small, Theodore W.; Pickering, J. Geoffrey] Univ Western Ontario, Dept Biochem, London, ON N6A 5K8, Canada; [Pickering, J. Geoffrey] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Pickering, JG (corresponding author), London Hlth Sci Ctr, 339 Windermere Rd, London, ON N6A 5A5, Canada.	gpickering@robarts.ca	Pickering, J. Geoffrey/G-3341-2011	Pickering, J. Geoffrey/0000-0001-6474-3274	Canadian Institutes of Health Research [FRN-11715]; Heart and Stroke Foundation of Canada [T5675]; Krembil Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Krembil Foundation	This work was supported by Canadian Institutes of Health Research Grant FRN-11715, Heart and Stroke Foundation of Canada Grant T5675, and the Krembil Foundation.	Allard D, 2008, J BIOL CHEM, V283, P19739, DOI 10.1074/jbc.M710098200; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Bai HZ, 1999, CIRC RES, V85, P229, DOI 10.1161/01.RES.85.3.229; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; Burnette JM, 1999, GENETICS, V151, P1517; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Cregan SP, 1999, J NEUROSCI, V19, P7860; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; Gable KL, 2006, MOL CANCER THER, V5, P1079, DOI 10.1158/1535-7163.MCT-05-0397; GENG YJ, 1995, AM J PATHOL, V147, P251; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; Granadino B, 1996, MOL GEN GENET, V253, P26, DOI 10.1007/s004380050292; Henricks DM, 1998, BIOL REPROD, V59, P330, DOI 10.1095/biolreprod59.2.330; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200; Li CY, 2004, CELL RES, V14, P473, DOI 10.1038/sj.cr.7290250; Li SH, 1999, CIRC RES, V85, P338, DOI 10.1161/01.RES.85.4.338; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Ling X, 2007, J BIOL CHEM, V282, P27204, DOI 10.1074/jbc.M705161200; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Mahotka C, 1999, CANCER RES, V59, P6097; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okura Y, 2001, J MOL CELL CARDIOL, V33, P1777, DOI 10.1006/jmcc.2001.1441; Ortega A, 2003, J BIOL CHEM, V278, P3040, DOI 10.1074/jbc.M210737200; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Patel VA, 2001, CIRC RES, V88, P895, DOI 10.1161/hh0901.090305; Penalva LOF, 2000, GENETICS, V155, P129; Penn JKM, 2008, GENETICS, V178, P737, DOI 10.1534/genetics.107.081679; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rockel TD, 2002, J STRUCT BIOL, V140, P189; Rocnik EF, 2002, J BIOL CHEM, V277, P38571, DOI 10.1074/jbc.M206689200; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Small TW, 2007, TRENDS CARDIOVAS MED, V17, P230, DOI 10.1016/j.tcm.2007.08.002; Small TW, 2006, CIRC RES, V99, P1338, DOI 10.1161/01.RES.0000252289.79841.d3; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	48	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24684	24695		10.1074/jbc.M109.034629	http://dx.doi.org/10.1074/jbc.M109.034629			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605357	hybrid, Green Published			2022-12-25	WOS:000269734000003
J	Cai, XY; Wang, XF; Li, SL; Qian, J; Qian, DG; Chen, F; Yang, YJ; Yuan, ZY; Xu, J; Bai, YD; Yu, SZ; Jin, L				Cai, Xiao-yun; Wang, Xiao-feng; Li, Shi-lin; Qian, Ji; Qian, De-gui; Chen, Fei; Yang, Ya-jun; Yuan, Zi-yu; Xu, Jun; Bai, Yidong; Yu, Shun-zhang; Jin, Li			Association of Mitochondrial DNA Haplogroups with Exceptional Longevity in a Chinese Population	PLOS ONE			English	Article								Background: Longevity is a multifactorial trait with a genetic contribution, and mitochondrial DNA (mtDNA) polymorphisms were found to be involved in the phenomenon of longevity. Methodology/Principal Findings: To explore the effects of mtDNA haplogroups on the prevalence of extreme longevity (EL), a population based case-control study was conducted in Rugao - a prefecture city in Jiangsu, China. Case subjects include 463 individuals aged >= 95 yr ( EL group). Control subjects include 926 individuals aged 60 - 69 years ( elderly group) and 463 individuals aged 40 - 49 years (middle-aged group) randomly recruited from Rugao. We observed significant reduction of M9 haplogroups in longevity subjects (0.2%) when compared with both elderly subjects (2.2%) and middle-aged subjects (1.7%). Linear-by-linear association test revealed a significant decreasing trend of N9 frequency from middle-aged subjects (8.6%), elderly subjects (7.2%) and longevity subjects (4.8%) (p = 0.018). In subsequent analysis stratified by gender, linear-by-linear association test revealed a significant increasing trend of D4 frequency from middle-aged subjects (15.8%), elderly subjects (16.4%) and longevity subjects (21.7%) in females ( p = 0.025). Conversely, a significant decreasing trend of B4a frequency was observed from middle-aged subjects (4.2%), elderly subjects (3.8%) and longevity subjects (1.7%) in females (p = 0.045). Conclusions: Our observations support the association of mitochondrial DNA haplogroups with exceptional longevity in a Chinese population.			Cai, XY (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai, Peoples R China.	ljin007@gmail.com	Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/M-5063-2019; Bai, Yidong/A-4959-2012; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415				BRAND FN, 1992, J CLIN EPIDEMIOL, V45, P169, DOI 10.1016/0895-4356(92)90009-C; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; RAND DM, 2005, SCI AGING KNOWLEDGE, V45, pRE5; Santoro A, 2006, BBA-BIOENERGETICS, V1757, P1388, DOI 10.1016/j.bbabio.2006.05.040; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	11	42	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6423	10.1371/journal.pone.0006423	http://dx.doi.org/10.1371/journal.pone.0006423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641616	Green Submitted, Green Published, gold			2022-12-25	WOS:000268494500023
J	Huszthy, PC; Giroglou, T; Tsinkalovsky, O; Euskirchen, P; Skaftnesmo, KO; Bjerkvig, R; von Laer, D; Miletic, H				Huszthy, Peter C.; Giroglou, Tsanan; Tsinkalovsky, Oleg; Euskirchen, Philipp; Skaftnesmo, Kai Ove; Bjerkvig, Rolf; von Laer, Dorothee; Miletic, Hrvoje			Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy	PLOS ONE			English	Article								Background: Glioblastoma is the most frequent and most malignant primary brain tumor with a poor prognosis. The translation of therapeutic strategies for glioblastoma from the experimental phase into the clinic has been limited by insufficient animal models, which lack important features of human tumors. Lentiviral gene therapy is an attractive therapeutic option for human glioblastoma, which we validated in a clinically relevant animal model. Methodology/Principal Findings: We used a rodent xenograft model that recapitulates the invasive and angiogenic features of human glioblastoma to analyze the transduction pattern and therapeutic efficacy of lentiviral pseudotyped vectors. Both, lymphocytic choriomeningitis virus glycoprotein (LCMV-GP) and vesicular stomatitis virus glycoprotein (VSVG) pseudotyped lentiviral vectors very efficiently transduced human glioblastoma cells in vitro and in vivo. In contrast, pseudotyped gammaretroviral vectors, similar to those evaluated for clinical therapy of glioblastoma, showed inefficient gene transfer in vitro and in vivo. Both pseudotyped lentiviral vectors transduced cancer stem-like cells characterized by their CD133-, nestin- and SOX2-expression, the ability to form spheroids in neural stem cell medium and to express astrocytic and neuronal differentiation markers under serum conditions. In a therapeutic approach using the suicide gene herpes simplex virus thymidine kinase (HSV-1-tk) fused to eGFP, both lentiviral vectors mediated a complete remission of solid tumors as seen on MRI resulting in a highly significant survival benefit (p < 0.001) compared to control groups. In all recurrent tumors, surviving eGFP-positive tumor cells were found, advocating prodrug application for several cycles to even enhance and prolong the therapeutic effect. Conclusions/Significance: In conclusion, lentiviral pseudotyped vectors are promising candidates for gene therapy of glioma in patients. The inefficient gene delivery by gammaretroviral vectors is in line with the results obtained in clinical therapy for GBM and thus confirms the high reproducibility of the invasive glioma animal model for translational research.			Huszthy, PC (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	hrvoje.miletic@biomed.uib.no	Skaftnesmo, kai ove/AAF-6071-2021; Euskirchen, Philipp/AFL-2848-2022; Huszthy, Peter Csaba/H-1414-2016	Euskirchen, Philipp/0000-0002-9138-805X; Huszthy, Peter Csaba/0000-0003-0184-8989; von Laer, Dorothee/0000-0001-5825-7237				Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Benedetti S, 1999, CANCER RES, V59, P645; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Beyer WR, 2001, J VIROL, V75, P1061, DOI 10.1128/JVI.75.2.1061-1064.2001; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Coil DA, 2004, J VIROL, V78, P10920, DOI 10.1128/JVI.78.20.10920-10926.2004; Ferguson Sherise, 2007, Current Drug Delivery, V4, P169, DOI 10.2174/156720107780362302; Fischer YH, 2007, J GENE MED, V9, P335, DOI 10.1002/jgm.1032; Galipeau J, 1999, CANCER RES, V59, P2384; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Huszthy PC, 2008, CLIN CANCER RES, V14, P1571, DOI 10.1158/1078-0432.CCR-07-2000; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kunkel P, 2001, CANCER RES, V61, P6624; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mahesparan R, 2003, ACTA NEUROPATHOL, V105, P49, DOI 10.1007/s00401-002-0610-0; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Miletic H, 2004, HUM GENE THER, V15, P1091, DOI 10.1089/hum.2004.15.1091; Miletic H, 1999, J VIROL, V73, P6114, DOI 10.1128/JVI.73.7.6114-6116.1999; Miletic H, 2007, CLIN CANCER RES, V13, P6761, DOI 10.1158/1078-0432.CCR-07-1240; Miletic H, 2007, MOL THER, V15, P1373, DOI 10.1038/sj.mt.6300155; MINETA T, 1995, NAT MED, V1, P938, DOI 10.1038/nm0995-938; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nandi S, 2008, CANCER RES, V68, P5778, DOI 10.1158/0008-5472.CAN-07-6441; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rainov NG, 2003, J NEURO-ONCOL, V65, P227, DOI 10.1023/B:NEON.0000003652.71665.f2; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Sandmair AM, 2000, HUM GENE THER, V11, P2197, DOI 10.1089/104303400750035726; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skog J, 2007, MOL THER, V15, P2140, DOI 10.1038/sj.mt.6300315; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tai CK, 2005, MOL THER, V12, P842, DOI 10.1016/j.ymthe.2005.03.017; Tamura K, 2001, GENE THER, V8, P215, DOI 10.1038/sj.gt.3301371; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang WJ, 2003, HUM GENE THER, V14, P117, DOI 10.1089/104303403321070810; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564	42	43	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6314	10.1371/journal.pone.0006314	http://dx.doi.org/10.1371/journal.pone.0006314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617915	Green Published, Green Submitted, gold			2022-12-25	WOS:000268119600010
J	Bergholdt, R; Brorsson, C; Lage, K; Nielsen, JH; Brunak, S; Pociot, F				Bergholdt, Regine; Brorsson, Caroline; Lage, Kasper; Nielsen, Jens Hoiriis; Brunak, Soren; Pociot, Flemming			Expression Profiling of Human Genetic and Protein Interaction Networks in Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; COMPLEXES; PTPN22; RISK; LOCI	Proteins contributing to a complex disease are often members of the same functional pathways. Elucidation of such pathways may provide increased knowledge about functional mechanisms underlying disease. By combining genetic interactions in Type 1 Diabetes (T1D) with protein interaction data we have previously identified sets of genes, likely to represent distinct cellular pathways involved in T1D risk. Here we evaluate the candidate genes involved in these putative interaction networks not only at the single gene level, but also in the context of the networks of which they form an integral part. mRNA expression levels for each gene were evaluated and profiling was performed by measuring and comparing constitutive expression in human islets versus cytokine-stimulated expression levels, and for lymphocytes by comparing expression levels among controls and T1D individuals. We identified differential regulation of several genes. In one of the networks four out of nine genes showed significant down regulation in human pancreatic islets after cytokine exposure supporting our prediction that the interaction network as a whole is a risk factor. In addition, we measured the enrichment of T1D associated SNPs in each of the four interaction networks to evaluate evidence of significant association at network level. This method provided additional support, in an independent data set, that two of the interaction networks could be involved in T1D and highlights the following processes as risk factors: oxidative stress, regulation of transcription and apoptosis. To understand biological systems, integration of genetic and functional information is necessary, and the current study has used this approach to improve understanding of T1D and the underlying biological mechanisms.			Bergholdt, R (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	rber@hagedorn.dk	; Brunak, Soren/O-6621-2016	Brorsson, Caroline Anna/0000-0003-3473-1744; Pociot, Flemming/0000-0003-3274-5448; Brunak, Soren/0000-0003-0316-5866; Nielsen, Jens Hoiriis/0000-0001-8252-3048	Wellcome Trust [076113] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adler HJ, 1999, GENOMICS, V56, P59, DOI 10.1006/geno.1998.5672; Allcock RJN, 2001, GENES CELLS, V6, P487, DOI 10.1046/j.1365-2443.2001.00435.x; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bergholdt R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r253; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cordell HJ, 2000, AM J HUM GENET, V66, P1273, DOI 10.1086/302847; D'Hertog W, 2007, MOL CELL PROTEOMICS, V6, P2180, DOI 10.1074/mcp.M700085-MCP200; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Holm P, 2001, AM J HUM GENET, V69, P1301; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; SHAU HG, 1994, IMMUNOGENETICS, V40, P129; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6250	10.1371/journal.pone.0006250	http://dx.doi.org/10.1371/journal.pone.0006250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609442	gold, Green Published, Green Submitted			2022-12-25	WOS:000268119500003
J	Yamashita, H; Kobiyama, A; Koike, K				Yamashita, Hiroshi; Kobiyama, Atsushi; Koike, Kazuhiko			Do Uric Acid Deposits in Zooxanthellae Function as Eye-Spots?	PLOS ONE			English	Article								The symbiosis between zooxanthellae (dinoflagellate genus Symbiodinium) and corals is a fundamental basis of tropical marine ecosystems. However the physiological interactions of the hosts and symbionts are poorly understood. Recently, intracellular crystalline deposits in Symbiodinium were revealed to be uric acid functioning for nutrient storage. This is the first exploration of these enigmatic crystalline materials that had previously been misidentified as oxalic acid, providing new insights into the nutritional strategies of Symbiodinium in oligotrophic tropical waters. However, we believe these deposits also function as eye-spots on the basis of light and electron microscopic observations of motile cells of cultured Symbiodinium. The cells possessed crystalline deposit clusters in rows with each row 100-150 nm thick corresponding to 1/4 the wavelength of light and making them suitable for maximum wave interference and reflection of light. Crystalline clusters in cells observed with a light microscope strongly refracted and polarized light, and reflected or absorbed short wavelength light. The facts that purines, including uric acid, have been identified as the main constituents of light reflectors in many organisms, and that the photoreceptor protein, opsin, was detected in our Symbiodinium strain, support the idea that uric acid deposits in Symbiodinium motile cells may function as a component of an eye-spot.			Yamashita, H (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	kazkoike@hiroshima-u.ac.jp	Koike, Kazuhiko/A-3392-2019	Kazuhiko, Koike/0000-0001-5380-5839; Yamashita, Hiroshi/0000-0002-3909-5073				CAVENEY S, 1971, PROC R SOC SER B-BIO, V178, P205, DOI 10.1098/rspb.1971.0062; Clode PL, 2009, PLANT CELL ENVIRON, V32, P170, DOI 10.1111/j.1365-3040.2008.01909.x; CRAFTS CB, 1995, B MAR SCI, V56, P822; Dodge J.D., 1984, Biosystems, V16, P259; Doyle M. M., 1940, PAP TORTUGAS LAB, VXXXII, P129; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; FITT WK, 1981, B MAR SCI, V31, P436; FITT WK, 1984, MAR BIOL, V81, P9, DOI 10.1007/BF00397620; FOSTER KW, 1984, NATURE, V311, P756, DOI 10.1038/311756a0; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Hirose M, 2008, MAR BIOL, V155, P105, DOI 10.1007/s00227-008-1011-2; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hollingsworth LL, 2005, CORAL REEFS, V24, P523, DOI 10.1007/s00338-005-0063-8; HORIGUCHI T, 1994, PROTOPLASMA, V179, P142, DOI 10.1007/BF01403952; Horiguchi Takeo, 1999, Phycological Research, V47, P101, DOI 10.1111/j.1440-1835.1999.tb00290.x; Horiguchi Takeo, 1994, Japanese Journal of Phycology, V42, P21; Koike K, 2004, BIOL BULL-US, V207, P80, DOI 10.2307/1543582; Kremp A, 2005, J PHYCOL, V41, P629, DOI 10.1111/j.1529-8817.2005.00070.x; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LAND MF, 1966, J EXP BIOL, V45, P433; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; MACLAUGHLIN JJA, 1957, P SOC EXP BIOL MED, V95, P115; MELKONIAN M, 1980, J ULTRA MOL STRUCT R, V72, P90, DOI 10.1016/S0022-5320(80)90138-0; Montresor M, 1999, J PHYCOL, V35, P186, DOI 10.1046/j.1529-8817.1999.3510186.x; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; NORTON JH, 1992, BIOL BULL, V183, P503, DOI 10.2307/1542028; Oh-Uchi, 2007, GALAXEA, V9, P1, DOI DOI 10.3755/JCRS.9.1; Porto I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002160; Savage AM, 2002, MAR ECOL PROG SER, V244, P17, DOI 10.3354/meps244017; Schwarz JA, 2002, MAR BIOL, V140, P471, DOI 10.1007/s00227-001-0736-y; TAYLOR DL, 1968, J MAR BIOL ASSOC UK, V48, P349, DOI 10.1017/S0025315400034548; TRENCH RK, 1995, EUR J PHYCOL, V30, P149, DOI 10.1080/09670269500650911; Yacobovitch T, 2004, J EXP MAR BIOL ECOL, V298, P35, DOI 10.1016/j.jembe.2003.08.003; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	34	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6303	10.1371/journal.pone.0006303	http://dx.doi.org/10.1371/journal.pone.0006303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609449	gold, Green Submitted, Green Published			2022-12-25	WOS:000268119500020
J	Chen, H; Simar, D; Morris, MJ				Chen, Hui; Simar, David; Morris, Margaret J.			Hypothalamic Neuroendocrine Circuitry is Programmed by Maternal Obesity: Interaction with Postnatal Nutritional Environment	PLOS ONE			English	Article								Objective: Early life nutrition is critical for the development of hypothalamic neurons involved in energy homeostasis. We previously showed that intrauterine and early postnatal overnutrition programmed hypothalamic neurons expressing the appetite stimulator neuropeptide Y (NPY) and suppressor proopiomelanocortin (POMC) in offspring at weaning. However, the long-term effects of such programming and its interactions with post-weaning high-fat-diet (HFD) consumption are unclear. Research Design and Methods: Female Sprague Dawley rats were exposed to chow or HFD for 5 weeks before mating, throughout gestation and lactation. On postnatal day 1, litters were adjusted to 3/litter to induce postnatal overnutrition (vs. 12 in control). At postnatal day 20, half of the rats from each maternal group were weaned onto chow or HFD for 15 weeks. Hypothalamic appetite regulators, and fuel (glucose and lipid) metabolic markers were measured. Results: Offspring from obese dams gained more weight than those from lean dams independent of post-weaning diet. Maternal obesity interacted with post-weaning HFD consumption to cause greater levels of hyperphagia, adiposity, hyperlipidemia, and glucose intolerance in offspring. This was linked to increased hypothalamic NPY signaling and leptin resistance in adult offspring. Litter size reduction had a detrimental impact on insulin and adiponectin, while hypothalamic NPY and POMC mRNA expression were suppressed in the face of normal energy intake and weight gain. Conclusions: Maternal obesity, postnatal litter size reduction and post-weaning HFD consumption caused obesity via different neuroendocrine mechanims. There were strong additive effects of maternal obesity and post-weaning HFD consumption to increase the metabolic disorders in offspring.			Chen, H (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Chen, Hui/R-6137-2019; Chen, Hui/D-2005-2014; Morris, Margaret J/J-4285-2013	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Morris, Margaret/0000-0003-2285-5117; Simar, David/0000-0002-3862-1932				Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bruce CR, 2005, DIABETES, V54, P3154, DOI 10.2337/diabetes.54.11.3154; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; CHEN H, 2009, OBESITY, DOI DOI 10.1038/OBY.2009.1056; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Dulloo AG, 2005, ACTA PHYSIOL SCAND, V184, P295, DOI 10.1111/j.1365-201X.2005.01466.x; Fekete C, 2002, ENDOCRINOLOGY, V143, P4513, DOI 10.1210/en.2002-220574; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Hansen MJ, 2005, BRAIN RES, V1039, P137, DOI 10.1016/j.brainres.2005.01.063; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Levin BE, 1997, AM J PHYSIOL-REG I, V272, pR1365, DOI 10.1152/ajpregu.1997.272.5.R1365; Levine AS, 2003, J NUTR, V133, p831S, DOI 10.1093/jn/133.3.831S; Marshall E, 2004, SCIENCE, V304, P804, DOI 10.1126/science.304.5672.804; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morris MJ, 2008, INT J OBESITY, V32, P249, DOI 10.1038/sj.ijo.0803716; Oda N, 2008, METABOLISM, V57, P268, DOI 10.1016/j.metabol.2007.09.011; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Prentice AM, 2005, PHYSIOL BEHAV, V86, P640, DOI 10.1016/j.physbeh.2005.08.055; SCHAALAN M, 2008, J DIABETES COMPLICAT, DOI DOI 10.1016/J.JDIACOMP.2008.1002.1003; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; WHITE CL, 2009, AM J PHYSL REGUL INT; Xita N, 2007, METABOLISM, V56, P766, DOI 10.1016/j.metabol.2007.01.008; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	40	132	133	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6259	10.1371/journal.pone.0006259	http://dx.doi.org/10.1371/journal.pone.0006259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606226	gold, Green Published			2022-12-25	WOS:000268036000014
J	Conibear, TCR; Collins, SL; Webb, JS				Conibear, Tim C. R.; Collins, Samuel L.; Webb, Jeremy S.			Role of Mutation in Pseudomonas aeruginosa Biofilm Development	PLOS ONE			English	Article								The survival of bacteria in nature is greatly enhanced by their ability to grow within surface-associated communities called biofilms. Commonly, biofilms generate proliferations of bacterial cells, called microcolonies, which are highly recalcitrant, 3-dimensional foci of bacterial growth. Microcolony growth is initiated by only a subpopulation of bacteria within biofilms, but processes responsible for this differentiation remain poorly understood. Under conditions of crowding and intense competition between bacteria within biofilms, microevolutionary processes such as mutation selection may be important for growth; however their influence on microcolony-based biofilm growth and architecture have not previously been explored. To study mutation in-situ within biofilms, we transformed Pseudomonas aeruginosa cells with a green fluorescent protein gene containing a +1 frameshift mutation. Transformed P. aeruginosa cells were non-fluorescent until a mutation causing reversion to the wildtype sequence occurs. Fluorescence-inducing mutations were observed in microcolony structures, but not in other biofilm cells, or in planktonic cultures of P. aeruginosa cells. Thus microcolonies may represent important foci for mutation and evolution within biofilms. We calculated that microcolony-specific increases in mutation frequency were at least 100-fold compared with planktonically grown cultures. We also observed that mutator phenotypes can enhance microcolony-based growth of P. aeruginosa cells. For P. aeruginosa strains defective in DNA fidelity and error repair, we found that microcolony initiation and growth was enhanced with increased mutation frequency of the organism. We suggest that microcolony-based growth can involve mutation and subsequent selection of mutants better adapted to grow on surfaces within crowded-cell environments. This model for biofilm growth is analogous to mutation selection that occurs during neoplastic progression and tumor development, and may help to explain why structural and genetic heterogeneity are characteristic features of bacterial biofilm populations.			Conibear, TCR (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	j.s.webb@soton.ac.uk		Conibear, Tim C R/0000-0003-3779-3385; Webb, Jeremy/0000-0003-2068-8589; Collins, Samuel/0000-0003-4721-0040	BBSRC [BB/C520655/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520655/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Bachl J, 1999, EUR J IMMUNOL, V29, P1383, DOI 10.1002/(SICI)1521-4141(199904)29:04<1383::AID-IMMU1383>3.3.CO;2-O; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Blazquez J, 2003, CLIN INFECT DIS, V37, P1201, DOI 10.1086/378810; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boles BR, 2005, P NATL ACAD SCI USA, V102, P955, DOI 10.1073/pnas.0407460101; Burcham PC, 1999, MUTAT RES-GEN TOX EN, V443, P11, DOI 10.1016/S1383-5742(99)00008-3; CALOS MP, 1981, J MOL BIOL, V153, P39, DOI 10.1016/0022-2836(81)90525-8; Cariello NF, 1998, MUTAT RES-GEN TOX EN, V414, P95, DOI 10.1016/S1383-5718(98)00043-6; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; COSTERTON JW, 1983, REV INFECT DIS, V5, pS867; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Haagensen JAJ, 2007, J BACTERIOL, V189, P28, DOI 10.1128/JB.00720-06; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hoffmann GR, 1996, MUTAT RES-FUND MOL M, V351, P33, DOI 10.1016/0027-5107(95)00206-5; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klayman BJ, 2008, ENVIRON MICROBIOL, V10, P2344, DOI 10.1111/j.1462-2920.2008.01660.x; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Loeb LA, 2001, CANCER RES, V61, P3230; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; MAIPROCHNOW A, 2008, J BACTERIOL; Marnett LJ, 2001, TRENDS GENET, V17, P214, DOI 10.1016/S0168-9525(01)02239-9; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Moller S, 1998, APPL ENVIRON MICROB, V64, P721; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Purevdorj-Gage B, 2005, MICROBIOL-SGM, V151, P1569, DOI 10.1099/mic.0.27536-0; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stoodley P, 2001, APPL ENVIRON MICROB, V67, P5608, DOI 10.1128/AEM.67.12.5608-5613.2001; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Townsend JP, 2003, GENETICS, V164, P13; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2	55	85	86	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6289	10.1371/journal.pone.0006289	http://dx.doi.org/10.1371/journal.pone.0006289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606212	gold, Green Published, Green Accepted			2022-12-25	WOS:000268036000019
J	Schleinitz, N; Chiche, L; Guia, S; Bouvier, G; Vernier, J; Morice, A; Houssaint, E; Harle, JR; Kaplanski, G; Montero-Julian, FA; Vely, F				Schleinitz, Nicolas; Chiche, Laurent; Guia, Sophie; Bouvier, Gaelle; Vernier, Julie; Morice, Alexis; Houssaint, Elisabeth; Harle, Jean Robert; Kaplanski, Gilles; Montero-Julian, Felix A.; Vely, Frederic			Pattern of DAP12 Expression in Leukocytes from Both Healthy and Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article								DAP12 is an ITAM-bearing transmembrane adaptor originally identified on the surface of Natural Killer cells. A broad expression among other immune cells was later found in myeloid and lymphoid cells. However, data on DAP12 expression pattern rely only on immunoblot and microarray analysis. Here, we describe the generation and the characterization of an anti-DAP12 monoclonal antibody. Using this novel reagent, we show that DAP12 expression is restricted to innate immune cells in basal condition. Since a decreased expression of DAP12 has been suggested in NK cells of systemic lupus erythematosus patients, we have further investigated the NK cell receptor repertoire and leukocyte expression of DAP12 in these patients and no major changes were detectable when compared to controls.			Schleinitz, N (corresponding author), CHU Concept, Dept Internal Med, AP HM, Marseille, France.	vely@univmed.fr	Vély, Frédéric/HHM-3894-2022; schleinitz, nicolas/AAL-6751-2020	schleinitz, nicolas/0000-0001-9449-3392; Vely, Frederic/0000-0002-1682-0949				Anfossi N, 2003, EUR J IMMUNOL, V33, P3514, DOI 10.1002/eji.200324573; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; ERKELLERYUKSEL F, 1993, LUPUS, V2, P227, DOI 10.1177/096120339300200404; Green MRJ, 2005, CLIN EXP IMMUNOL, V141, P165, DOI 10.1111/j.1365-2249.2005.02822.x; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Izumi Y, 2006, J LAB CLIN MED, V147, P242, DOI 10.1016/j.lab.2006.01.001; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Olcese L, 1997, J IMMUNOL, V158, P5083; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Pascal V, 2004, EUR J IMMUNOL, V34, P2930, DOI 10.1002/eji.200425146; Pellett F, 2007, TISSUE ANTIGENS, V69, P106, DOI 10.1111/j.1399-0039.2006.762_6.x; SCHEPIS D, 2008, IMMUNOLOGY; Sjolin H, 2006, J IMMUNOL, V177, P2908, DOI 10.4049/jimmunol.177.5.2908; Snyder MR, 2004, J IMMUNOL, V173, P3725, DOI 10.4049/jimmunol.173.6.3725; Snyder MR, 2003, J EXP MED, V197, P437, DOI 10.1084/jem.20020383; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Toyabe S, 2004, J AUTOIMMUN, V23, P371, DOI 10.1016/j.jaut.2004.09.003; van Bergen J, 2004, J IMMUNOL, V173, P6719, DOI 10.4049/jimmunol.173.11.6719; Vely F, 1997, HYBRIDOMA, V16, P519, DOI 10.1089/hyb.1997.16.519; Yabuhara A, 1996, J RHEUMATOL, V23, P171; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	31	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6264	10.1371/journal.pone.0006264	http://dx.doi.org/10.1371/journal.pone.0006264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606219	Green Submitted, Green Published, gold			2022-12-25	WOS:000268036000017
J	Graessler, J; Schwudke, D; Schwarz, PEH; Herzog, R; Shevchenko, A; Bornstein, SR				Graessler, Juergen; Schwudke, Dominik; Schwarz, Peter E. H.; Herzog, Ronny; Shevchenko, Andrej; Bornstein, Stefan R.			Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients	PLOS ONE			English	Article								Background: Dyslipoproteinemia, obesity and insulin resistance are integrative constituents of the metabolic syndrome and are major risk factors for hypertension. The objective of this study was to determine whether hypertension specifically affects the plasma lipidome independently and differently from the effects induced by obesity and insulin resistance. Methodology/Principal Findings: We screened the plasma lipidome of 19 men with hypertension and 51 normotensive male controls by top-down shotgun profiling on a LTQ Orbitrap hybrid mass spectrometer. The analysis encompassed 95 lipid species of 10 major lipid classes. Obesity resulted in generally higher lipid load in blood plasma, while the content of tri- and diacylglycerols increased dramatically. Insulin resistance, defined by HOMA-IR.3.5 and controlled for BMI, had little effect on the plasma lipidome. Importantly, we observed that in blood plasma of hypertensive individuals the overall content of ether lipids decreased. Ether phosphatidylcholines and ether phosphatidylethanolamines, that comprise arachidonic (20: 4) and docosapentaenoic (22: 5) fatty acid moieties, were specifically diminished. The content of free cholesterol also decreased, although conventional clinical lipid homeostasis indices remained unaffected. Conclusions/Significance: Top-down shotgun lipidomics demonstrated that hypertension is accompanied by specific reduction of the content of ether lipids and free cholesterol that occurred independently of lipidomic alterations induced by obesity and insulin resistance. These results may form the basis for novel preventive and dietary strategies alleviating the severity of hypertension.			Graessler, J (corresponding author), Tech Univ Dresden, Dept Internal Med 3, Carl Gustav Carus Med Sch, Dresden, Germany.	shevchenko@mpi-cbg.de; Stefan.Bornstein@uniklinikum-dresden.de	Schwudke, Dominik/B-3478-2013	Schwudke, Dominik/0000-0002-1379-9451				Bergmann A, 2008, EXP CLIN ENDOCR DIAB, V116, pS50, DOI 10.1055/s-2008-1081492; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLANK ML, 1983, BIOCHEM BIOPH RES CO, V113, P666, DOI 10.1016/0006-291X(83)91778-3; Bo S, 2009, J HYPERTENS, V27, P102, DOI 10.1097/HJH.0b013e328317a7bb; CASTELLI WP, 1986, AM J MED, V80, P23, DOI 10.1016/0002-9343(86)90157-9; Ding J, 2008, J CHROMATOGR B, V871, P243, DOI 10.1016/j.jchromb.2008.04.040; Dullaart RPF, 2008, J CLIN ENDOCR METAB, V93, P4860, DOI 10.1210/jc.2008-1213; Ehrhart-Bornstein M, 2004, ENDOCR RES, V30, P865, DOI 10.1081/ERC-200044122; Ehrhart-Bornstein M, 2003, P NATL ACAD SCI USA, V100, P14211, DOI 10.1073/pnas.2336140100; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Koh KK, 2006, DIABETES CARE, V29, P195, DOI 10.2337/diacare.29.02.06.dc05-1418; Kolodgie FD, 2007, CURR OPIN LIPIDOL, V18, P500, DOI 10.1097/MOL.0b013e3282efa35b; Kopprasch S, 2009, J ENDOCRINOL, V200, P45, DOI 10.1677/JOE-08-0293; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Lima NKC, 2009, AM J HYPERTENS, V22, P106, DOI 10.1038/ajh.2008.263; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MCGOWAN HM, 1988, CLIN SCI, V74, P393, DOI 10.1042/cs0740393; Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002; Neutel JM, 1998, AM J HYPERTENS, V11, p150S, DOI 10.1016/S0895-7061(98)00192-7; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Ponnuchamy B, 2009, AM J PHYSIOL-REG I, V296, pR1001, DOI 10.1152/ajpregu.90960.2008; REAVEN GM, 1991, DIABETES CARE, V14, P33, DOI 10.2337/diacare.14.4.33; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; Schwudke D, 2007, METHOD ENZYMOL, V433, P175, DOI 10.1016/S0076-6879(07)33010-3; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; SEIDELL JC, 1991, ATHEROSCLEROSIS, V87, P203, DOI 10.1016/0021-9150(91)90022-U; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Sironi AM, 2008, HYPERTENSION, V51, P282, DOI 10.1161/HYPERTENSIONAHA.107.098640; Sysi-Aho M, 2007, BIOINFORMATICS, V23, pI519, DOI 10.1093/bioinformatics/btm181; Sysi-Aho M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-93; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017	47	247	255	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6261	10.1371/journal.pone.0006261	http://dx.doi.org/10.1371/journal.pone.0006261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603071	gold, Green Published			2022-12-25	WOS:000268035700009
J	Macambira, SG; Vasconcelos, JF; Costa, CRS; Klein, W; Lima, RS; Guimaraes, P; Vidal, DTA; Mendez, LC; Ribeiro-dos-Santos, R; Soares, MBP				Macambira, Simone G.; Vasconcelos, Juliana F.; Costa, Claudio R. S.; Klein, Wilfried; Lima, Ricardo S.; Guimaraes, Patricia; Vidal, Daniel T. A.; Mendez, Lucas C.; Ribeiro-dos-Santos, Ricardo; Soares, Milena B. P.			Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function	FASEB JOURNAL			English	Article						chagasic cardiomyopathy; inflammation; arrhythmias; treadmill performance	BONE-MARROW-CELLS; ACUTE MYOCARDIAL-INFARCTION; G-CSF; HEART; REPAIR; MICE; TRANSPLANTATION; MOBILIZATION; RECRUITMENT; EXPRESSION	This study investigates the effects of granulocyte colony-stimulating factor (G-CSF) therapy in experimental chronic chagasic cardiomyopathy. Chagas disease is one of the leading causes of heart failure in Latin America and remains without an effective treatment other than cardiac transplantation. C57BL/6 mice were infected with 10(3) trypomastigotes of Trypanosoma cruzi, and chronic chagasic mice were treated with G-CSF or saline (control). Evaluations following treatment were functional, immunological, and histopathological. Comparing hearts of G-CSF-treated mice showed reduced inflammation and fibrosis compared to saline-treated chagasic mice. G-CSF treatment did not alter the parasite load but caused an increase in the number of apoptotic inflammatory cells in the heart. Cardiac conductance disturbances in all infected animals improved or remained stable due to the G-CSF treatment, whereas all of the saline-treated mice deteriorated. The distance run on a treadmill and the exercise time were significantly greater in G-CSF-treated mice when compared to chagasic controls, as well as oxygen consumption ((V) over dotO(2)), carbon dioxide production ((V) over dotCO(2)), and respiratory exchange ration (RER) during exercise. Administration of G-CSF in experimental cardiac ischemia had beneficial effects on cardiac structure, which were well correlated with improvements in cardiac function and whole animal performance.-Macambira, S. G., Vasconcelos, J. F., Costa, C. R. S., Klein, W., Lima, R. S., Guimaraes, P., Vidal, D. T. A., Mendez, L. C., Ribeiro-dos-Santos, R., Soares, M. B. P. Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function. FASEB J. 23, 3843-3850 (2009). www.fasebj.org	[Macambira, Simone G.; Vasconcelos, Juliana F.; Costa, Claudio R. S.; Lima, Ricardo S.; Guimaraes, Patricia; Vidal, Daniel T. A.; Mendez, Lucas C.; Ribeiro-dos-Santos, Ricardo; Soares, Milena B. P.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil; [Macambira, Simone G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Klein, Wilfried] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Ribeiro-dos-Santos, Ricardo; Soares, Milena B. P.] Hosp Sao Rafael, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal da Bahia	Soares, MBP (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, 121 Rua Waldemar Falcao, BR-40296710 Salvador, BA, Brazil.	milena@bahia.fiocruz.br	Soares, Milena B. P./O-3771-2018; Klein, Wilfried/A-2228-2008; Vasconcelos, Juliana/AAN-5274-2021; Fisiologia comparada, Inct/I-2427-2013; Oliveira, Claudia DL/G-8618-2011	Klein, Wilfried/0000-0001-6099-6178; Vasconcelos, Juliana/0000-0003-4553-0315; Santana de Lima, Ricardo/0000-0002-1279-3445; Soares, Milena/0000-0001-7549-2992; Mendez, Lucas C./0000-0002-0440-3320	Brazilian Ministry of Science and Technology [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)]; Financiadora de Estudos e Projetos (FINEP); Fiocruz, and Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)	Brazilian Ministry of Science and Technology [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fiocruz, and Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)	This work was supported by grants from the Brazilian Ministry of Science and Technology [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)], Financiadora de Estudos e Projetos (FINEP), Fiocruz, and Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB).	Adesse D, 2008, MICROBES INFECT, V10, P21, DOI 10.1016/j.micinf.2007.09.017; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; Brunner S, 2008, EXP HEMATOL, V36, P695, DOI 10.1016/j.exphem.2008.01.011; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Deindl E, 2006, FASEB J, V20, P956, DOI 10.1096/fj.05-4763fje; FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272; Fujita J, 2007, STEM CELLS, V25, P2750, DOI 10.1634/stemcells.2007-0275; Fukuhara S, 2004, CELL TRANSPLANT, V13, P741, DOI 10.3727/000000004783983486; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Iwanaga K, 2004, BIOCHEM BIOPH RES CO, V325, P1353, DOI 10.1016/j.bbrc.2004.10.149; JONES EM, 1993, AM J TROP MED HYG, V48, P348, DOI 10.4269/ajtmh.1993.48.348; Kanellakis P, 2006, CARDIOVASC RES, V70, P117, DOI 10.1016/j.cardiores.2006.01.005; Kuhlmann MT, 2006, J EXP MED, V203, P87, DOI 10.1084/jem.20051151; Kuwabara M, 2007, FEBS LETT, V581, P4821, DOI 10.1016/j.febslet.2007.09.007; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Leon JS, 2001, INFECT IMMUN, V69, P5643, DOI 10.1128/IAI.69.9.5643-5649.2001; Li YW, 2006, LAB INVEST, V86, P32, DOI 10.1038/labinvest.3700367; Mieno S, 2006, CIRCULATION, V114, pI186, DOI 10.1161/CIRCULATIONAHA.105.001610; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Okada H, 2008, J CELL MOL MED, V12, P1272, DOI 10.1111/j.1582-4934.2008.00294.x; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Palomino SAP, 2000, ANN TROP MED PARASIT, V94, P571, DOI 10.1080/00034983.2000.11813580; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Pontes-de-Carvalho L, 2002, J AUTOIMMUN, V18, P131, DOI 10.1006/jaut.2001.0574; Rocha NN, 2006, PARASITOLOGY, V133, P729, DOI 10.1017/S0031182006001193; Rutella S, 2002, BLOOD, V100, P2562, DOI 10.1182/blood-2001-12-0291; Rutella S, 2001, EXP HEMATOL, V29, P401, DOI 10.1016/S0301-472X(01)00617-8; Soares MBP, 2004, AM J PATHOL, V164, P441, DOI 10.1016/S0002-9440(10)63134-3; Soares MBP, 2001, AN ACAD BRAS CIENC, V73, P547, DOI 10.1590/S0001-37652001000400008; Soares MBP, 2001, AM J PATHOL, V159, P703, DOI 10.1016/S0002-9440(10)61741-5; Soares MBP, 2007, REGEN MED, V2, P257, DOI 10.2217/17460751.2.3.257; Sugano Y, 2005, CARDIOVASC RES, V65, P446, DOI 10.1016/j.cardiores.2004.10.008; Tanaka J, 2002, INT J HEMATOL, V75, P489, DOI 10.1007/BF02982111; Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02	37	22	24	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3843	3850		10.1096/fj.09-137869	http://dx.doi.org/10.1096/fj.09-137869			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19608624	Green Published			2022-12-25	WOS:000271272500020
J	Sim, H; Hu, B; Viapiano, MS				Sim, Hosung; Hu, Bin; Viapiano, Mariano S.			Reduced Expression of the Hyaluronan and Proteoglycan Link Proteins in Malignant Gliomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAIN EXTRACELLULAR-MATRIX; CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; PERINEURONAL NETS; CELL MOTILITY; IN-VITRO; PROTEOLYTIC CLEAVAGE; RAT CEREBELLUM; CDNA CLONING; BEHAB/BREVICAN	Malignant gliomas have a distinctive ability to infiltrate the brain parenchyma and disrupt the neural extracellular matrix that inhibits motility of axons and normal neural cells. Chondroitin sulfate proteoglycans (CSPGs) are among the major inhibitory components in the neural matrix, but surprisingly, some are up-regulated in gliomas and act as pro-invasive signals. In the normal brain, CSPGs are thought to associate with hyaluronic acid and glycoproteins such as the tenascins and link proteins to form the matrix scaffold. Here, we examined for the first time the expression of link proteins in human brain and malignant gliomas. Our results indicate that HAPLN4 and HAPLN2 are the predominant members of this family in the adult human brain but are strongly reduced in the tumor parenchyma. To test if their absence was related to a pro-invasive gain of function of CSPGs, we expressed HAPLN4 in glioma cells in combination with the CSPG brevican. Surprisingly, HAPLN4 increased glioma cell adhesion and migration and even potentiated the motogenic effect of brevican. Further characterization revealed that HAPLN4 expressed in glioma cells was largely soluble and did not reproduce the strong, hyaluronan-independent association of the native protein to brain subcellular membranes. Taken together, our results suggest that the tumor parenchyma is rich in CSPGs that are not associated to HAPLNs and could instead interact with other extracellular matrix proteins produced by glioma cells. This dissociation may contribute to changes in the matrix scaffold caused by invasive glioma cells.	[Viapiano, Mariano S.] Ohio State Univ, Ctr Mol Neurobiol, Med Ctr, Columbus, OH 43210 USA; [Viapiano, Mariano S.] Ohio State Univ, Dept Neurol Surg, Med Ctr, Columbus, OH 43210 USA; James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Viapiano, MS (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Med Ctr, 226B Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	viapiano.1@osu.edu	Hu, Bin/H-8804-2013; Viapiano, Mariano/AAE-5787-2019	Viapiano, Mariano/0000-0002-8756-388X	Dardinger Center; American Cancer Society [IRG-67003-44]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [R01CA152065] Funding Source: NIH RePORTER	Dardinger Center; American Cancer Society(American Cancer Society); American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by seed grants from the Dardinger Center Fund for Neuro-Oncology Research and American Cancer Society Grant IRG-67003-44 (to M. S. V.) and a Joel A. Gringras fellowship from the American Brain Tumor Association (to B. H.).	Bekku Y, 2003, MOL CELL NEUROSCI, V24, P148, DOI 10.1016/S1044-7431(03)00133-7; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; BINETTE F, 1994, J BIOL CHEM, V269, P19116; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; Chicoine MR, 1997, J NEURO-ONCOL, V35, P249, DOI 10.1023/A:1005808315821; CHICOINE MR, 1995, J NEUROSURG, V82, P615, DOI 10.3171/jns.1995.82.4.0615; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gary SC, 2000, GENE, V256, P139, DOI 10.1016/S0378-1119(00)00362-0; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hirakawa S, 2000, BIOCHEM BIOPH RES CO, V276, P982, DOI 10.1006/bbrc.2000.3583; Hu B, 2008, J BIOL CHEM, V283, P24848, DOI 10.1074/jbc.M801433200; JAWORSKI DM, 1995, J NEUROSCI, V15, P1352; Kearns SM, 2003, EXP NEUROL, V182, P240, DOI 10.1016/S0014-4886(03)00124-9; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Maleski M, 1997, GLIA, V20, P193, DOI 10.1002/(SICI)1098-1136(199707)20:3<193::AID-GLIA3>3.0.CO;2-9; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; Oohashi T, 2002, MOL CELL NEUROSCI, V19, P43, DOI 10.1006/mcne.2001.1061; OOHASHI T, 2005, HYALURONAN ITS STRUC, P766; Rauch U, 2004, MATRIX BIOL, V22, P629, DOI 10.1016/j.matbio.2003.11.007; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Shi SL, 2004, J BIOL CHEM, V279, P12060, DOI 10.1074/jbc.M310091200; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; Stein AM, 2007, APPL OPTICS, V46, P5110, DOI 10.1364/AO.46.005110; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Viapiano MS, 2003, J BIOL CHEM, V278, P33239, DOI 10.1074/jbc.M303480200; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BB, 1998, MATRIX BIOL, V16, P541, DOI 10.1016/S0945-053X(98)90066-X; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	41	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26547	26556		10.1074/jbc.M109.013185	http://dx.doi.org/10.1074/jbc.M109.013185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633295	Green Published, hybrid			2022-12-25	WOS:000269969600036
J	Zhao, LQ; Dong, HY; Zhang, CC; Kinch, L; Osawa, M; Iacovino, M; Grishin, NV; Kyba, M; Huang, LJS				Zhao, Lequn; Dong, Hongyun; Zhang, Cheng Cheng; Kinch, Lisa; Osawa, Mitsujiro; Iacovino, Michelina; Grishin, Nikolai V.; Kyba, Michael; Huang, Lily Jun-shen			A JAK2 Interdomain Linker Relays Epo Receptor Engagement Signals to Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ERYTHROPOIETIN RECEPTOR; POLYCYTHEMIA-VERA; TYROSINE KINASE; PSEUDOKINASE DOMAIN; MYELOPROLIFERATIVE DISORDERS; CYTOKINE RECEPTOR; SWISS-MODEL; SURFACE EXPRESSION; EXON-12 MUTATIONS	JAK2 (Janus kinase 2) is essential for cytokine receptor signaling, and several lines of evidence support a causal role of an activating JAK2 mutation in myeloproliferative disorders. JAK2 activity is autoinhibited by its pseudokinase domain in the basal state, and the inhibition is released by cytokine stimulation; how engagement of the cognate receptor triggers this release is unknown. From a functional screen for gain-of-function JAK2 mutations, we discovered 13 missense mutations, nine in the pseudokinase domain and four in the Src homology 2 (SH2)-pseudokinase domain linker. These mutations identified determinants for autoinhibition and inducible activation in JAK2. Two of the mutants, K539I and N622I, resulted in erythrocytosis in mice. Scanning mutagenesis of the SH2-pseudokinase domain linker indicated that its N-terminal part was essential for interaction of JAK2 with the Epo receptor, whereas certain mutations in the C-terminal region conferred constitutive activation. We further showed that substitutions for Glu543-Asp544 in this linker or Leu611, Arg683, or Phe694 in the hinge proximal region of the pseudokinase domain resulted in activated JAK2 mutants that could not be further stimulated by Epo. These results suggest that the SH2-pseudokinase domain linker acts as a switch that relays cytokine engagement to JAK2 activation by flexing the pseudokinase domain hinge.	[Huang, Lily Jun-shen] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng; Osawa, Mitsujiro; Iacovino, Michelina; Kyba, Michael] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nikolai V.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huang, LJS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Lily.Huang@utsouthwestern.edu	Zhang, Cheng/GRS-8698-2022	iacovino, michelina/0000-0002-1076-3146; Kinch, Lisa/0000-0003-3041-2615; Kyba, Michael/0000-0002-5579-7534	National Institutes of Health [R01 HL089966]; American Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089966, R01HL081186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089966 (to L. J. H.). This work was also supported by the American Cancer Society (to L. J. H.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azam Mohammad, 2003, Biol Proced Online, V5, P204, DOI 10.1251/bpo63; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Butcher CM, 2008, LEUKEMIA, V22, P870, DOI 10.1038/sj.leu.2404971; Cazzola M, 2007, HAEMATOLOGICA, V92, P1585, DOI 10.3324/haematol.11506; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dusa A, 2008, J BIOL CHEM, V283, P12941, DOI 10.1074/jbc.M709302200; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Ishida-Takahashi R, 2006, MOL CELL BIOL, V26, P4063, DOI 10.1128/MCB.01589-05; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kratz CP, 2006, LEUKEMIA, V20, P381, DOI 10.1038/sj.leu.2404060; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lee JW, 2006, ONCOGENE, V25, P1434, DOI 10.1038/sj.onc.1209163; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	54	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26988	26998		10.1074/jbc.M109.011387	http://dx.doi.org/10.1074/jbc.M109.011387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638629	hybrid, Green Published			2022-12-25	WOS:000269969600078
J	Russwurm, C; Zoidl, G; Koesling, D; Russwurm, M				Russwurm, Corina; Zoidl, Georg; Koesling, Doris; Russwurm, Michael			Dual Acylation of PDE2A Splice Variant 3 TARGETING TO SYNAPTIC MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; HUMAN ATRIAL MYOCYTES; GUANOSINE 3',5'-MONOPHOSPHATE; STIMULATED PHOSPHODIESTERASE; SUBCELLULAR-LOCALIZATION; BOVINE-TISSUES; RAT-BRAIN; CGMP	The cGMP-stimulated PDE2A hydrolyzes both cyclic nucleotides, cGMP and cAMP. Three splice variants have been cloned from several species. Whereas PDE2A1 is soluble, PDE2A2 and PDE2A3 are membrane-bound enzymes of rat and bovine origin, respectively. To date it is unclear whether one species expresses all three variants. The splice variants only differ in their N termini, which likely determine the subcellular localization. However, the mechanism for membrane attachment remains unknown. Here, we show that myristoylation underlies membrane targeting of PDE2A3. The myristoylated enzyme was bound to plasma membranes, whereas mutation of the myristoyl recipient Gly(2) prevented incorporation of [H-3]myristate and turned PDE2A3 completely soluble. Additionally, Cys(5) and to a minor extent Cys(11) are required for targeting of PDE2A3. Substitution of the putatively palmitoylated cysteines partially solubilized the enzyme and led to an accumulation in the endoplasmic reticulum/Golgi compartment, as shown by fluorescence microscopy in HEK 293 and PC12 cells. In vivo, PDE2A is expressed in many tissues. By using newly generated antibodies selectively detecting the splice variants PDE2A3 or PDE2A1, respectively, we demonstrate on the protein level PDE2A3 expression in mouse brain where it is entirely membrane-associated and a widespread expression of soluble PDE2A1 in mouse tissues. We show that PDE2A localizes to synaptosomal membranes and in primary cultures of hippocampal neurons partially overlaps with the presynaptic marker synaptophysin as demonstrated by immunofluorescence. In sum, these results demonstrate dual acylation as mechanism targeting neuronal PDE2A3 to synapses thereby ensuring local control of cyclic nucleotides.	[Russwurm, Michael] Ruhr Univ Bochum, MAN1, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany; [Zoidl, Georg] Ruhr Univ Bochum, Fak Med, Abt Neuroanat & Mol Hirnforsch, Inst Anat, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Russwurm, M (corresponding author), Ruhr Univ Bochum, MAN1, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany.	michael.russwurm@ruhr-uni-bochum.de			Deutsche Forschungsgemeinschaft [Ko1157]; Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty	This work was supported by the Deutsche Forschungsgemeinschaft (Grant Ko1157) and the Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty.	ALLAND L, 1994, J BIOL CHEM, V269, P16701; BEAVO JA, 1970, J BIOL CHEM, V245, P5649; BEAVO JA, 1971, J BIOL CHEM, V246, P3841; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Bon CLM, 2003, J NEUROSCI, V23, P1941; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; ERNEUX C, 1981, EUR J BIOCHEM, V115, P503; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; MACFARLAND RT, 1991, J BIOL CHEM, V266, P136; Makhinson M, 2006, NEUROSCIENCE, V140, P415, DOI 10.1016/j.neuroscience.2006.02.018; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; MURASHIMA S, 1990, BIOCHEMISTRY-US, V29, P5285, DOI 10.1021/bi00474a010; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; Noyama K, 2003, NEUROSCI RES, V45, P141, DOI 10.1016/S0168-0102(02)00208-0; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; PYNE NJ, 1986, BIOCHEM J, V234, P325, DOI 10.1042/bj2340325; REPASKE DR, 1993, NEUROSCIENCE, V56, P673, DOI 10.1016/0306-4522(93)90364-L; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RivetBastide M, 1997, J CLIN INVEST, V99, P2710, DOI 10.1172/JCI119460; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SONNENBURG WK, 1991, J BIOL CHEM, V266, P17655; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; TRONG HL, 1990, BIOCHEMISTRY-US, V29, P10280, DOI 10.1021/bi00496a018; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Vandecasteele G, 2001, J PHYSIOL-LONDON, V533, P329, DOI 10.1111/j.1469-7793.2001.0329a.x; Verde I, 1999, BRIT J PHARMACOL, V127, P65, DOI 10.1038/sj.bjp.0702506; WHALIN ME, 1988, BIOCHIM BIOPHYS ACTA, V972, P79; YAMAMOTO T, 1983, J BIOL CHEM, V258, P2526; YANG Q, 1994, BIOCHEM BIOPH RES CO, V205, P1850, DOI 10.1006/bbrc.1994.2886; Zoidl G, 2002, J NEUROSCI RES, V69, P448, DOI 10.1002/jnr.10284	42	42	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25782	25790		10.1074/jbc.M109.017194	http://dx.doi.org/10.1074/jbc.M109.017194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632989	Green Published, hybrid			2022-12-25	WOS:000269738000036
J	Warfel, JM; D'Agnillo, F				Warfel, Jason M.; D'Agnillo, Felice			Anthrax Lethal Toxin Enhances I kappa B Kinase Activation and Differentially Regulates Pro-inflammatory Genes in Human Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-ANTHRACIS; PROTECTIVE ANTIGEN; TNF-ALPHA; INHALATIONAL ANTHRAX; SIGNALING PATHWAYS; VCAM-1 EXPRESSION; MESSENGER-RNA; MAP KINASES; IKK-BETA; T-CELLS	Anthrax lethal toxin (LT) was previously shown to enhance transcriptional activity of NF-kappa B in tumor necrosis factor-alpha-activated primary human endothelial cells. Here we show that this LT-mediated increase in NF-kappa B activation is associated with the enhanced degradation of the inhibitory proteins I kappa B alpha and I kappa B beta but not I kappa B epsilon. Moreover, this was accompanied by enhanced activation of the I kappa B kinase complex (IKK), which is responsible for targeting I kappa B proteins for degradation. Importantly, LT enhancement of I kappa B alpha degradation was completely blocked by a selective IKK beta inhibitor, whereas I kappa B beta degradation was attenuated, suggesting a mechanistic link. Consistent with the above data, LT-cotreated cells show elevated phosphorylation of two IKK substrates, I kappa B alpha and p65, both of which were blocked by incubation with the IKK beta inhibitor. Consistent with NF-kappa B activation, LT increased transcription of the NF-kappa B regulated gene CD40. Conversely, LT inhibited transcription of another NF-kappa B-regulated gene, CCL2. This inhibition was linked to the LT-mediated suppression of another CCL2-regulating transcription factor, AP-1 (activator protein-1). These data suggest that LT-mediated enhancement of NF-kappa B is IKK-dependent, but importantly, the net effect of LT on the transcription of proinflammatory genes is driven by the cumulative effect of LT on the particular set of transcription factors that regulate a given promoter. Together, these findings provide new mechanistic insight on how LT may disrupt the host response to anthrax.	[Warfel, Jason M.; D'Agnillo, Felice] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Biochem & Vasc Biol, Bethesda, MD 20892 USA; [Warfel, Jason M.] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA	US Food & Drug Administration (FDA); Georgetown University	D'Agnillo, F (corresponding author), 29 Lincoln Dr,Bldg 29,Rm 129, Bethesda, MD 20892 USA.	felice.dagnillo@fda.hhs.gov	Warfel, Jason M/D-2557-2011		National Institutes of Health-Georgetown University Graduate Partnership Program; Oak Ridge Institute for Science and Education	National Institutes of Health-Georgetown University Graduate Partnership Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Institute for Science and Education(General Electric)	This work was supported, in whole or in part, by the National Institutes of Health-Georgetown University Graduate Partnership Program ( to J. M. W.) and by the Research Fellowship Program administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the United States Department of Energy and United States Food and Drug Administration.	Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Boyer AE, 2007, ANAL CHEM, V79, P8463, DOI 10.1021/ac701741s; Budde LM, 2002, MOL BIOL CELL, V13, P4179, DOI 10.1091/mbc.01-07-0373; Chakrabarti S, 2007, J BIOL CHEM, V282, P18307, DOI 10.1074/jbc.M700211200; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; Dal Molin F, 2008, TOXICON, V52, P824, DOI 10.1016/j.toxicon.2008.08.011; DeBusk LM, 2008, CANCER RES, V68, P10223, DOI 10.1158/0008-5472.CAN-08-1833; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Deshpande A, 2006, FEBS LETT, V580, P4172, DOI 10.1016/j.febslet.2006.06.070; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Gupta RA, 2001, J BIOL CHEM, V276, P31059, DOI 10.1074/jbc.M104141200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Johnson DR, 1996, J BIOL CHEM, V271, P16317, DOI 10.1074/jbc.271.27.16317; Kang ZG, 2009, J MOL BIOL, V389, P595, DOI 10.1016/j.jmb.2009.04.030; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Krzesz R, 1999, FEBS LETT, V453, P191, DOI 10.1016/S0014-5793(99)00683-3; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Kupfer R, 2002, J IMMUNOL METHODS, V266, P155, DOI 10.1016/S0022-1759(02)00146-1; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Park SK, 2004, NEPHROL DIAL TRANSPL, V19, P312, DOI 10.1093/ndt/gfg583; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Shieh WJ, 2003, AM J PATHOL, V163, P1901, DOI 10.1016/S0002-9440(10)63548-1; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Spiecker M, 2000, J IMMUNOL, V164, P3316, DOI 10.4049/jimmunol.164.6.3316; Steele AD, 2005, BIOCHEM BIOPH RES CO, V337, P1249, DOI 10.1016/j.bbrc.2005.09.180; Strnad J, 2007, TRENDS PHARMACOL SCI, V28, P142, DOI 10.1016/j.tips.2007.01.005; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Wagner AH, 2002, BLOOD, V99, P520, DOI 10.1182/blood.V99.2.520; Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372; Warfel JM, 2008, J IMMUNOL, V180, P7516, DOI 10.4049/jimmunol.180.11.7516; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Winsauer G, 2007, THROMB HAEMOSTASIS, V97, P364, DOI 10.1160/TH06-08-0473; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	71	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25761	25771		10.1074/jbc.M109.036970	http://dx.doi.org/10.1074/jbc.M109.036970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620708	Green Published, hybrid			2022-12-25	WOS:000269738000034
J	Markovic, J; Mora, NJ; Broseta, AM; Gimeno, A; de-la-Concepcion, N; Vina, J; Pallardo, FV				Markovic, Jelena; Mora, Nancy J.; Broseta, Ana M.; Gimeno, Amparo; de-la-Concepcion, Noelia; Vina, Jose; Pallardo, Federico V.			The Depletion of Nuclear Glutathione Impairs Cell Proliferation in 3t3 Fibroblasts	PLOS ONE			English	Article								Background: Glutathione is considered essential for survival in mammalian cells and yeast but not in prokaryotic cells. The presence of a nuclear pool of glutathione has been demonstrated but its role in cellular proliferation and differentiation is still a matter of debate. Principal Findings: We have studied proliferation of 3T3 fibroblasts for a period of 5 days. Cells were treated with two well known depleting agents, diethyl maleate (DEM) and buthionine sulfoximine (BSO), and the cellular and nuclear glutathione levels were assessed by analytical and confocal microscopic techniques, respectively. Both agents decreased total cellular glutathione although depletion by BSO was more sustained. However, the nuclear glutathione pool resisted depletion by BSO but not with DEM. Interestingly, cell proliferation was impaired by DEM, but not by BSO. Treating the cells simultaneously with DEM and with glutathione ethyl ester to restore intracellular GSH levels completely prevented the effects of DEM on cell proliferation. Conclusions: Our results demonstrate the importance of nuclear glutathione in the control of cell proliferation in 3T3 fibroblasts and suggest that a reduced nuclear environment is necessary for cells to progress in the cell cycle.			Markovic, J (corresponding author), Univ Valencia, Fac Med, Dept Physiol, Valencia, Spain.	pallardo@uv.es	Vina, Jose/AAB-3069-2021; Pallardo, Federico V./T-1156-2017	Vina, Jose/0000-0001-9709-0089; Pallardo, Federico V./0000-0003-3715-1980; Gimeno, Amparo/0000-0002-8112-5221				ABEI M, 1989, BIOCHIM BIOPHYS ACTA, V995, P279, DOI 10.1016/0167-4838(89)90047-2; ATZORI L, 1990, J CELL PHYSIOL, V143, P165, DOI 10.1002/jcp.1041430123; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412; Bellomo G, 1997, MICROSC RES TECHNIQ, V36, P243, DOI 10.1002/(SICI)1097-0029(19970215)36:4<243::AID-JEMT3>3.0.CO;2-N; BENNETT CF, 1986, J CELL BIOL, V102, P600, DOI 10.1083/jcb.102.2.600; Borras C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200; BORROZ KI, 1994, TOXICOL APPL PHARM, V126, P150, DOI 10.1006/taap.1994.1101; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X; BRITTEN RA, 1991, BIOCHEM PHARMACOL, V41, P647, DOI 10.1016/0006-2952(91)90642-I; BRIVIBA K, 1993, BIOCHEM J, V294, P631, DOI 10.1042/bj2940631; CAMPBELL JAH, 1991, CANCER, V67, P1608, DOI 10.1002/1097-0142(19910315)67:6<1608::AID-CNCR2820670623>3.0.CO;2-S; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Conour JE, 2004, PHYSIOL GENOMICS, V18, P196, DOI 10.1152/physiolgenomics.00058.2004; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Esposito F, 2002, METHOD ENZYMOL, V352, P258; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Green RM, 2006, MUTAGENESIS, V21, P383, DOI 10.1093/mutage/gel043; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halvey PJ, 2007, ANTIOXID REDOX SIGN, V9, P807, DOI 10.1089/ars.2007.1526; Hanon E., 1996, BIOCHEMICA, V2, P25; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; HARRIS JW, 1969, EXP CELL RES, V56, P134, DOI 10.1016/0014-4827(69)90406-6; HEDLEY DW, 1994, CYTOMETRY, V15, P349, DOI 10.1002/cyto.990150411; Hopkins FG, 1929, J BIOL CHEM, V84, P269; Hutter DE, 1997, EXP CELL RES, V232, P435, DOI 10.1006/excr.1997.3527; Jang JH, 2003, BIOCHEM PHARMACOL, V66, P1371, DOI 10.1016/S0006-2952(03)00487-8; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7; Li N, 1998, J CELL PHYSIOL, V177, P148, DOI 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; MASSEY V, 1965, J BIOL CHEM, V240, P4470; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Menon SG, 2003, CANCER RES, V63, P2109; Mirkovic N, 1997, ONCOGENE, V15, P1461, DOI 10.1038/sj.onc.1201310; Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002; OBERLEY LW, 1981, MED HYPOTHESES, V7, P21, DOI 10.1016/0306-9877(81)90018-9; PALLARDO FV, 2009, MOL ASPECTS MED; Pani G, 2000, J BIOL CHEM, V275, P38891, DOI 10.1074/jbc.M007319200; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Reddy NM, 2008, ONCOGENE; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rogers LK, 2002, TOXICOL SCI, V69, P279, DOI 10.1093/toxsci/69.1.279; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shiratori Y, 1987, Nihon Sanka Fujinka Gakkai Zasshi, V39, P547; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; SOBOLL S, 1995, BIOCHEM J, V311, P889, DOI 10.1042/bj3110889; Spyrou G, 1996, BIOCHEM BIOPH RES CO, V220, P42, DOI 10.1006/bbrc.1996.0353; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; THOMAS M, 1995, BRIT J CANCER, V72, P45, DOI 10.1038/bjc.1995.275; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Vina J., 1990, GLUTATHIONE METABOLI; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001	61	82	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6413	10.1371/journal.pone.0006413	http://dx.doi.org/10.1371/journal.pone.0006413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641610	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494500014
J	Bigot, Y; Renault, S; Nicolas, J; Moundras, C; Demattei, MV; Samain, S; Bideshi, DK; Federici, BA				Bigot, Yves; Renault, Sylvaine; Nicolas, Jacques; Moundras, Corinne; Demattei, Marie-Veronique; Samain, Sylvie; Bideshi, Dennis K.; Federici, Brian A.			Symbiotic Virus at the Evolutionary Intersection of Three Types of Large DNA Viruses; Iridoviruses, Ascoviruses, and Ichnoviruses	PLOS ONE			English	Article								Background: The ascovirus, DpAV4a (family Ascoviridae), is a symbiotic virus that markedly increases the fitness of its vector, the parasitic ichneumonid wasp, Diadromus puchellus, by increasing survival of wasp eggs and larvae in their lepidopteran host, Acrolepiopsis assectella. Previous phylogenetic studies have indicated that DpAV4a is related to the pathogenic ascoviruses, such as the Spodoptera frugiperda ascovirus 1a (SfAV1a) and the lepidopteran iridovirus (family Iridoviridae), Chilo iridescent virus (CIV), and is also likely related to the ancestral source of certain ichnoviruses (family Polydnaviridae). Methodology/Principal Findings: To clarify the evolutionary relationships of these large double-stranded DNA viruses, we sequenced the genome of DpAV4a and undertook phylogenetic analyses of the above viruses and others, including iridoviruses pathogenic to vertebrates. The DpAV4a genome consisted of 119,343 bp and contained at least 119 open reading frames (ORFs), the analysis of which confirmed the relatedness of this virus to iridoviruses and other ascoviruses. Conclusions: Analyses of core DpAV4a genes confirmed that ascoviruses and iridoviruses are evolutionary related. Nevertheless, our results suggested that the symbiotic DpAV4a had a separate origin in the iridoviruses from the pathogenic ascoviruses, and that these two types shared parallel evolutionary paths, which converged with respect to virion structure (icosahedral to bacilliform), genome configuration (linear to circular), and cytopathology (plasmalemma blebbing to virion-containing vesicles). Our analyses also revealed that DpAV4a shared more core genes with CIV than with other ascoviruses and iridoviruses, providing additional evidence that DpAV4a represents a separate lineage. Given the differences in the biology of the various iridoviruses and ascoviruses studied, these results provide an interesting model for how viruses of different families evolved from one another.			Bigot, Y (corresponding author), Univ Tours, CNRS, UMR 6239, UFR Sci & Tech Parc Grandmont, Tours, France.	bigot@univ-tours.fr		Bideshi, Dennis K./0000-0002-0210-4490; Renault, Sylvaine/0000-0002-6980-8855				Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Asgari S, 2007, J GEN VIROL, V88, P1120, DOI 10.1099/vir.0.82651-0; AVERY S W, 1977, Florida Entomologist, V60, P17, DOI 10.2307/3494478; Barratt BIP, 1999, J INVERTEBR PATHOL, V73, P182, DOI 10.1006/jipa.1998.4826; Benson SD, 2004, MOL CELL, V16, P673, DOI 10.1016/j.molcel.2004.11.016; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bideshi DK, 2006, J VIROL, V80, P11791, DOI 10.1128/JVI.01639-06; Bigot Y, 2000, J GEN VIROL, V81, P3073, DOI 10.1099/0022-1317-81-12-3073; Bigot Y, 1997, J GEN VIROL, V78, P1149, DOI 10.1099/0022-1317-78-5-1149; Bigot Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-253; Chinchar VG, 2009, CURR TOP MICROBIOL, V328, P123; Cui LW, 2007, J GEN VIROL, V88, P2194, DOI 10.1099/vir.0.82951-0; Delhon G, 2006, J VIROL, V80, P8439, DOI 10.1128/JVI.00464-06; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FAUQUET CM, 2005, 8 INT COMM TAX VIR, P12; Federici BA, 2009, CURR TOP MICROBIOL, V328, P171; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; HESS RT, 1975, J INVERTEBR PATHOL, V26, P181, DOI 10.1016/0022-2011(75)90047-6; Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08; Ince IA, 2008, VIROLOGY, V376, P124, DOI 10.1016/j.virol.2008.03.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Kuznetsov YG, 2005, J STRUCT BIOL, V149, P256, DOI 10.1016/j.jsb.2004.10.007; Lapointe R, 2007, J VIROL, V81, P6491, DOI 10.1128/JVI.02702-06; Lopez M, 2002, J INVERTEBR PATHOL, V80, P160, DOI 10.1016/S0022-2011(02)00106-4; McGeoch D.J., 1999, ORIGIN EVOLUTION VIR, P441; Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; Paul ER, 2007, ARCH VIROL, V152, P1353, DOI 10.1007/s00705-007-0945-x; Renault S, 2002, J INSECT PHYSIOL, V48, P297, DOI 10.1016/S0022-1910(01)00174-3; Simpson AA, 2003, ACTA CRYSTALLOGR D, V59, P2053, DOI 10.1107/S090744490302225X; Stasiak K, 2003, J GEN VIROL, V84, P2999, DOI 10.1099/vir.0.19290-0; STOLTZ DB, 1988, VIROLOGY, V162, P311, DOI 10.1016/0042-6822(88)90470-9; STOLTZ DB, 1978, CAN J MICROBIOL, V24, P1509, DOI 10.1139/m78-241; Tan YP, 2009, J GEN VIROL, V90, P359, DOI 10.1099/vir.0.005934-0; Traktman Paula, 2004, Methods Mol Biol, V269, P169; Tulman ER, 2009, CURR TOP MICROBIOL, V328, P43; Wang LH, 2006, VIROLOGY, V354, P167, DOI 10.1016/j.virol.2006.06.029; WEBB DA, 2005, 8 INT COMM TAX VIR, P253; Webby R, 1998, ARCH VIROL, V143, P1949, DOI 10.1007/s007050050432; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060; YAN X, 2002, NAT STRUCT BIOL, V7, P101	46	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6397	10.1371/journal.pone.0006397	http://dx.doi.org/10.1371/journal.pone.0006397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636425	gold, Green Published, Green Submitted			2022-12-25	WOS:000268404900018
J	Moen, I; Oyan, AM; Kalland, KH; Tronstad, KJ; Akslen, LA; Chekenya, M; Sakariassen, PO; Reed, RK; Stuhr, LEB				Moen, Ingrid; Oyan, Anne Margrete; Kalland, Karl-Henning; Tronstad, Karl Johan; Akslen, Lars Andreas; Chekenya, Martha; Sakariassen, Per Oystein; Reed, Rolf Kare; Stuhr, Linda Elin Birkhaug			Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model	PLOS ONE			English	Article								Tumor hypoxia is relevant for tumor growth, metabolism and epithelial-to-mesenchymal transition (EMT). We report that hyperbaric oxygen (HBO) treatment induced mesenchymal-to-epithelial transition (MET) in a dimetyl-alpha-benzantracene induced mammary rat adenocarcinoma model, and the MET was associated with extensive coordinated gene expression changes and less aggressive tumors. One group of tumor bearing rats was exposed to HBO (2 bar, pO(2) = 2 bar, 4 exposures a 90 minutes), whereas the control group was housed under normal atmosphere (1 bar, pO(2) = 0.2 bar). Treatment effects were determined by assessment of tumor growth, tumor vascularisation, tumor cell proliferation, cell death, collagen fibrils and gene expression profile. Tumor growth was significantly reduced (similar to 16%) after HBO treatment compared to day 1 levels, whereas control tumors increased almost 100% in volume. Significant decreases in tumor cell proliferation, tumor blood vessels and collagen fibrils, together with an increase in cell death, are consistent with tumor growth reduction and tumor stroma influence after hyperoxic treatment. Gene expression profiling showed that HBO induced MET. In conclusion, hyperoxia induced MET with coordinated expression of gene modules involved in cell junctions and attachments together with a shift towards non-tumorigenic metabolism. This leads to more differentiated and less aggressive tumors, and indicates that oxygen per se might be an important factor in the "switches'' of EMT and MET in vivo. HBO treatment also attenuated tumor growth and changed tumor stroma, by targeting the vascular system, having anti-proliferative and proapoptotic effects.			Moen, I (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	linda.stuhr@biomed.uib.no	Akslen, Lars A/C-1202-2017; Reed, Rolf K./B-9422-2017; Kalland, Karl-Henning/B-9445-2017; Akslen, Lars A./AAG-6097-2021	Akslen, Lars A/0000-0003-2710-9543; Reed, Rolf K./0000-0002-2633-6595; Kalland, Karl-Henning/0000-0003-4486-2334; Akslen, Lars A./0000-0003-2710-9543; Chekenya, PhD, Dr Philos, Dr. Martha/0000-0001-7241-3451; Tronstad, Karl Johan/0000-0003-3496-3123				Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Attardi LD, 2000, GENE DEV, V14, P704; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; BRIZEL DM, 1995, BRIT J CANCER, V72, P1120, DOI 10.1038/bjc.1995.474; Cannito S, 2008, CARCINOGENESIS; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Granowitz EV, 2005, ANTICANCER RES, V25, P3833; Hagland H, 2007, EXPERT OPIN THER TAR, V11, P1055, DOI 10.1517/14728222.11.8.1055; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hopf HW, 2005, WOUND REPAIR REGEN, V13, P558, DOI 10.1111/j.1524-475X.2005.00078.x; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kinoshita Y, 2000, BRIT J CANCER, V82, P88; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Milani M, 2008, EUR J CANCER, V44, P2766, DOI 10.1016/j.ejca.2008.09.025; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; RAA A, 2007, BMC CANC, V7; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Singaravelu K, 2009, AM J PHYSIOL-RENAL, V296, pF847, DOI 10.1152/ajprenal.90438.2008; STUHR LB, 2007, J NEUROONCOLOGY; Stuhr LEB, 2004, CANCER LETT, V210, P35, DOI 10.1016/j.canlet.2004.02.012; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thorn CC, 2009, GUT, V58, P404, DOI 10.1136/gut.2008.157255; THUAULT S, 2008, J BIOL CHEM; Vaupel P, 2008, ONCOLOGIST, V13, P21, DOI 10.1634/theoncologist.13-S3-21; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	39	57	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6381	10.1371/journal.pone.0006381	http://dx.doi.org/10.1371/journal.pone.0006381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636430	Green Published, gold, Green Submitted			2022-12-25	WOS:000268404900011
J	Wolschin, F; Gadau, J				Wolschin, Florian; Gadau, Juergen			Deciphering Proteomic Signatures of Early Diapause in Nasonia	PLOS ONE			English	Article							BOMBYX-MORI; COLD-HARDINESS; PROTEIN; GLYCEROL; CARBOHYDRATE; VITRIPENNIS; TERMINATION; METABOLISM; EXPRESSION; CONVERSION	Insect diapause is an alternative life-history strategy used to increase longevity and survival in harsh environmental conditions. Even though some aspects of diapause are well investigated, broader scale studies that elucidate the global metabolic adjustments required for this remarkable trait, are rare. In order to better understand the metabolic changes during early insect diapause, we used a shotgun proteomics approach on early diapausing and non-diapausing larvae of the recently sequenced hymenopteran model organism Nasonia vitripennis. Our results deliver insights into the molecular underpinnings of diapause in Nasonia and corroborate previously reported diapause-associated features for invertebrates, such as a diapause-dependent abundance change for heat shock and storage proteins. Furthermore, we observed a diapause-dependent switch in enzymes involved in glycerol synthesis and a vastly changed capacity for protein synthesis and degradation. The abundance of structural proteins and proteins involved in protein synthesis decreased with increasing diapause duration, while the abundance of proteins likely involved in diapause maintenance (e.g. ferritins) increased. Only few potentially diapause-specific proteins were identified suggesting that diapause in Nasonia relies to a large extent on a modulation of pre-existing pathways. Studying a diapause syndrome on a proteomic level rather than isolated pathways or physiological networks, has proven to be an efficient and successful avenue to understand molecular mechanisms involved in diapause.	[Wolschin, Florian; Gadau, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Wolschin, Florian] Norwegian Univ Life Sci, Dept Biotechnol Chem & Food Sci, As, Norway	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences	Wolschin, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	f.wolschin@gmail.com			Humboldt foundation; NIH [R21 1R21RR024199-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024199] Funding Source: NIH RePORTER	Humboldt foundation(Alexander von Humboldt Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: FW was supported by a Feodor-Lynen-fellowship provided by the Humboldt foundation (http://www.humboldt-foundation.de). JG was funded through NIH-R21 1R21RR024199-01 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, P NATL ACAD SCI USA, V105, P8914, DOI 10.1073/pnas.0801559105; Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun RP, 1996, J BIOL CHEM, V271, P31756, DOI 10.1074/jbc.271.49.31756; Chen B, 2005, GENE, V347, P115, DOI 10.1016/j.gene.2004.12.026; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; CHINO H, 1958, J INSECT PHYSIOL, V2, P1, DOI 10.1016/0022-1910(58)90024-6; CHINO H, 1957, NATURE, V180, P606, DOI 10.1038/180606b0; DELOOF A, 1979, PHYSIOL ENTOMOL, V4, P319, DOI 10.1111/j.1365-3032.1979.tb00623.x; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; DILLWITH JW, 1986, J COMP PHYSIOL B, V156, P783, DOI 10.1007/BF00694251; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; FLAU T, 2005, BIOESSAYS, V27, P999; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Godlewski J, 2001, J INSECT PHYSIOL, V47, P759, DOI 10.1016/S0022-1910(01)00050-6; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; HARVEY WR, 1962, ANNU REV ENTOMOL, V7, P57, DOI 10.1146/annurev.en.07.010162.000421; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Ishiguro S, 2007, J INSECT PHYSIOL, V53, P392, DOI 10.1016/j.jinsphys.2006.12.014; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P55, DOI 10.1080/13813450701422575; KOSTAL V, 2001, J INSECT PHYSL, V50, P303; Lee KY, 1998, ARCH INSECT BIOCHEM, V37, P197, DOI 10.1002/(SICI)1520-6327(1998)37:3&lt;197::AID-ARCH2&gt;3.0.CO;2-Q; Lewis DK, 2002, J INSECT PHYSIOL, V48, P887, DOI 10.1016/S0022-1910(02)00158-0; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Miura K, 1998, EUR J BIOCHEM, V258, P929, DOI 10.1046/j.1432-1327.1998.2580929.x; NELSON RA, 1980, FED PROC, V39, P2955; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rinchart J.P., 2007, P NATL ACAD SCI USA, V104, P11130; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; SAITO A, 1982, FEBS LETT, V150, P449, DOI 10.1016/0014-5793(82)80787-4; SANODA S, 2006, INSECT MOL BIOL, V15, P583; SAUNDERS D S, 1970, Journal of Insect Physiology, V16, P405, DOI 10.1016/0022-1910(70)90181-2; SAUNDERS DS, 1967, SCIENCE, V156, P1126, DOI 10.1126/science.156.3778.1126; SCHNEIDERMAN HA, 1958, J EXP BIOL, V35, P520; SESHACHALAM RV, 1992, PHYSIOL ENTOMOL, V17, P281, DOI 10.1111/j.1365-3032.1992.tb01023.x; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Singtripop T, 2002, J INSECT PHYSIOL, V48, P817, DOI 10.1016/S0022-1910(02)00104-X; SOULA B, 2005, ENTOMOLOGIA EXPT APP, V115, P533; SPYLIOTOPOULOS A, 2007, COMP BIOCH PHYSL B, V143, P14; Storey KB, 1997, COMP BIOCHEM PHYS A, V117, P319, DOI 10.1016/S0300-9629(96)00270-8; Tarrant AM, 2008, MAR ECOL PROG SER, V355, P193, DOI 10.3354/meps07207; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Tawfik AI, 2006, J INSECT PHYSIOL, V52, P255, DOI 10.1016/j.jinsphys.2005.11.005; TUNGITWITAYAKUL J, 2003, J INSECT PHYSL, V54, P62; TURUNEN S, 1981, COMP BIOCHEM PHYS B, V70, P759, DOI 10.1016/0305-0491(81)90013-4; Wang WW, 2007, PROTEOMICS, V7, P3580, DOI 10.1002/pmic.200700259; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; YIN CAI, 1976, J ESP BIOL, V61, P303; Zhou Q, 2008, MAR BIOTECHNOL, V10, P438, DOI 10.1007/s10126-007-9079-0	57	40	47	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6394	10.1371/journal.pone.0006394	http://dx.doi.org/10.1371/journal.pone.0006394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YJ	19636376	gold, Green Published, Green Submitted			2022-12-25	WOS:000207566600001
J	Li, Q; Cheung, C; Wei, R; Hui, ES; Feldon, J; Meyer, U; Chung, S; Chua, SE; Sham, PC; Wu, EX; McAlonan, GM				Li, Qi; Cheung, Charlton; Wei, Ran; Hui, Edward S.; Feldon, Joram; Meyer, Urs; Chung, Sookja; Chua, Siew E.; Sham, Pak C.; Wu, Ed X.; McAlonan, Grainne M.			Prenatal Immune Challenge Is an Environmental Risk Factor for Brain and Behavior Change Relevant to Schizophrenia: Evidence from MRI in a Mouse Model	PLOS ONE			English	Article								Objectives: Maternal infection during pregnancy increases risk of severe neuropsychiatric disorders, including schizophrenia and autism, in the offspring. The most consistent brain structural abnormality in patients with schizophrenia is enlarged lateral ventricles. However, it is unknown whether the aetiology of ventriculomegaly in schizophrenia involves prenatal infectious processes. The present experiments tested the hypothesis that there is a causal relationship between prenatal immune challenge and emergence of ventricular abnormalities relevant to schizophrenia in adulthood. Method: We used an established mouse model of maternal immune activation (MIA) by the viral mimic PolyI:C administered in early (day 9) or late (day 17) gestation. Automated voxel-based morphometry mapped cerebrospinal fluid across the whole brain of adult offspring and the results were validated by manual region-of-interest tracing of the lateral ventricles. Parallel behavioral testing determined the existence of schizophrenia-related sensorimotor gating abnormalities. Results: PolyI:C-induced immune activation, in early but not late gestation, caused marked enlargement of lateral ventricles in adulthood, without affecting total white and grey matter volumes. This early exposure disrupted sensorimotor gating, in the form of prepulse inhibition. Identical immune challenge in late gestation resulted in significant expansion of 4(th) ventricle volume but did not disrupt sensorimotor gating. Conclusions: Our results provide the first experimental evidence that prenatal immune activation is an environmental risk factor for adult ventricular enlargement relevant to schizophrenia. The data indicate immune-associated environmental insults targeting early foetal development may have more extensive neurodevelopmental impact than identical insults in late prenatal life.			Li, Q (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China.	mcalonan@hkucc.hku.hk	wei, wei/HHR-8613-2022; Meyer, Urs/C-4602-2016; Hui, Edward/GQO-9176-2022; Wei, ran/GXF-3452-2022; Wu, Ed/C-1579-2009; McAlonan, Grainne/G-1541-2011	Meyer, Urs/0000-0001-7244-0345; Wu, Ed/0000-0001-5581-1546; Hui, Sai Kam/0000-0002-1761-0169; McAlonan, Grainne/0000-0002-4466-2343				Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; BAILEY AJ, 1993, PSYCHOL MED, V23, P7, DOI 10.1017/S0033291700038794; Bauman ML, 2003, NOVART FDN SYMP, V251, P112; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Beckmann H, 1999, EUR ARCH PSY CLIN N, V249, P44; BELTINGER C, 1988, EUR J PEDIATR, V148, P206, DOI 10.1007/BF00441403; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X; BROWN AS, 2009, SCHIZOPHRENIA R 0109; BUNNEY BG, 1995, CLIN NEUROSCI, V3, P81; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P1084, DOI 10.1001/archpsyc.55.12.1084; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Chance SA, 2003, SCHIZOPHR RES, V62, P123, DOI 10.1016/S0920-9964(02)00344-4; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; Chua SE, 2003, ACTA PSYCHIAT SCAND, V108, P269, DOI 10.1034/j.1600-0447.2003.00134.x; Chua SE, 1996, ANN MED, V28, P547, DOI 10.3109/07853899608999119; Chua SE, 2002, SCHIZOPHR RES, V57, P123, DOI 10.1016/S0920-9964(01)00298-5; CHUA SE, 1995, BRIT J PSYCHIAT, V166, P563, DOI 10.1192/bjp.166.5.563; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Craig JS, 2004, SCHIZOPHR RES, V69, P29, DOI 10.1016/S0920-9964(03)00154-3; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Esterberg ML, 2008, SCHIZOPHR RES, V104, P265, DOI 10.1016/j.schres.2008.04.029; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Fatemi SH, 2002, MOL PSYCHIATR, V7, P633, DOI 10.1038/sj.mp.4001046; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; FATEMI SH, 2008, CEREBELLUM; Galani R, 2002, NEUROBIOL LEARN MEM, V77, P1, DOI 10.1006/nlme.2000.3998; Ghaziuddin M, 2005, J AUTISM DEV DISORD, V35, P177, DOI 10.1007/s10803-004-1996-4; Gilmore JH, 1997, SCHIZOPHR RES, V24, P365, DOI 10.1016/S0920-9964(96)00123-5; Gong XH, 2004, AM J MED GENET B, V127B, P113, DOI 10.1002/ajmg.b.20162; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hazlett EA, 2008, NEUROIMAGE, V42, P1164, DOI 10.1016/j.neuroimage.2008.05.039; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoptman MJ, 2004, NEUROREPORT, V15, P2467, DOI 10.1097/00001756-200411150-00007; Hornig M, 2001, ADV VIRUS RES, V56, P557, DOI 10.1016/S0065-3527(01)56038-8; Hornig M, 2001, CURR TOP MICROBIOL, V253, P157; Japha K, 1999, PSYCHOPHARMACOLOGY, V144, P347, DOI 10.1007/s002130051017; Kesner RP, 1998, HIPPOCAMPUS, V8, P416, DOI 10.1002/(SICI)1098-1063(1998)8:4<416::AID-HIPO9>3.0.CO;2-E; Kostovic Ivica, 1998, Croatian Medical Journal, V39, P107; Kumari V, 2008, CORTEX, V44, P1206, DOI 10.1016/j.cortex.2007.11.007; Lancaster K, 2007, BEHAV BRAIN RES, V176, P141, DOI 10.1016/j.bbr.2006.06.013; Limosin F, 2003, ACTA PSYCHIAT SCAND, V107, P331, DOI 10.1034/j.1600-0447.2003.00052.x; Lipkin WI, 2003, NOVART FDN SYMP, V251, P129; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; MEYER U, 2008, SCHIZOPHRENIA B; Meyer U., 2007, MOL PSYCHIAT; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Nopoulos PC, 1999, BIOL PSYCHIAT, V46, P703, DOI 10.1016/S0006-3223(99)00093-1; OCALLAGHAN E, 1991, LANCET, V337, P1248, DOI 10.1016/0140-6736(91)92919-S; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Pietropaolo S, 2008, PSYCHOPHARMACOLOGY, V197, P613, DOI 10.1007/s00213-008-1081-3; Rausch JL, 2005, J CLIN PSYCHIAT, V66, P1592, DOI 10.4088/JCP.v66n1216; Rehn AE, 2005, CLIN EXP PHARMACOL P, V32, P687, DOI 10.1111/j.1440-1681.2005.04257.x; Rijsdijk FV, 2005, PSYCHOL MED, V35, P1399, DOI 10.1017/S0033291705005167; ROMERO E, 2008, MOL PSYCHIAT; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Sanjuan J, 2006, PSYCHIAT GENET, V16, P67, DOI 10.1097/01.ypg.0000185029.35558.bb; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; SHAM PC, 1992, BRIT J PSYCHIAT, V160, P461, DOI 10.1192/bjp.160.4.461; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Sorensen HJ, 2008, SCHIZOPHR B; Staal WG, 2001, AM J PSYCHIAT, V158, P1140, DOI 10.1176/appi.ajp.158.7.1140; Staal WG, 1999, SCHIZOPHRENIA BULL, V25, P337, DOI 10.1093/oxfordjournals.schbul.a033382; Suvisaari J, 1999, AM J PSYCHIAT, V156, P1100; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; Swerdlow NR, 1995, PSYCHOPHARMACOLOGY, V122, P27, DOI 10.1007/BF02246438; Torres G, 2005, DEV BRAIN RES, V154, P35, DOI 10.1016/j.devbrainres.2004.08.011; Traynor TR, 2004, LIFE SCI, V74, P2563, DOI 10.1016/j.lfs.2003.10.010; Turetsky BI, 2002, NEUROPSYCHOLOGY, V16, P481, DOI 10.1037//0894-4105.16.4.481; Watanabe Y, 2004, NEUROSCI RES, V48, P345, DOI 10.1016/j.neures.2003.12.001; Wolf OT, 2002, BRAIN RES, V934, P87, DOI 10.1016/S0006-8993(02)02363-6; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41; Yamashita Y, 2003, J AUTISM DEV DISORD, V33, P455, DOI 10.1023/A:1025023131029; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	101	111	111	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6354	10.1371/journal.pone.0006354	http://dx.doi.org/10.1371/journal.pone.0006354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629183	Green Published, gold, Green Submitted			2022-12-25	WOS:000268318900006
J	Breslauer, DN; Maamari, RN; Switz, NA; Lam, WA; Fletcher, DA				Breslauer, David N.; Maamari, Robi N.; Switz, Neil A.; Lam, Wilbur A.; Fletcher, Daniel A.			Mobile Phone Based Clinical Microscopy for Global Health Applications	PLOS ONE			English	Article							FLUORESCENCE; TUBERCULOSIS; TELEMEDICINE	Light microscopy provides a simple, cost-effective, and vital method for the diagnosis and screening of hematologic and infectious diseases. In many regions of the world, however, the required equipment is either unavailable or insufficiently portable, and operators may not possess adequate training to make full use of the images obtained. Counterintuitively, these same regions are often well served by mobile phone networks, suggesting the possibility of leveraging portable, camera-enabled mobile phones for diagnostic imaging and telemedicine. Toward this end we have built a mobile phone-mounted light microscope and demonstrated its potential for clinical use by imaging P. falciparum-infected and sickle red blood cells in brightfield and M. tuberculosis-infected sputum samples in fluorescence with LED excitation. In all cases resolution exceeded that necessary to detect blood cell and microorganism morphology, and with the tuberculosis samples we took further advantage of the digitized images to demonstrate automated bacillus counting via image analysis software. We expect such a telemedicine system for global healthcare via mobile phone - offering inexpensive brightfield and fluorescence microscopy integrated with automated image analysis - to provide an important tool for disease diagnosis and screening, particularly in the developing world and rural areas where laboratory facilities are scarce but mobile phone infrastructure is extensive.			Breslauer, DN (corresponding author), Univ Calif Berkeley, UCSF, Bioengn Grad Grp, Berkeley, CA 94720 USA.	fletch@berkeley.edu		Switz, Neil/0000-0002-3639-4588				[Anonymous], 2008, AM FAM PHYSICIAN, V77, P1300; [Anonymous], 2008, DIG IM COMM MED DICO; Braun RP, 2005, ARCH DERMATOL, V141, P254, DOI 10.1001/archderm.141.2.254; CHUI DHK, 2004, LAB DIAGNOSIS HEMOGL; Frean J, 2007, T ROY SOC TROP MED H, V101, P1053, DOI 10.1016/j.trstmh.2007.06.008; Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075; Hanscheid T, 2007, LANCET INFECT DIS, V7, P236, DOI 10.1016/S1473-3099(07)70058-0; Hendry C, 2009, J CLIN MICROBIOL, V47, P1206, DOI 10.1128/JCM.02097-08; Hung NV, 2007, LANCET INFECT DIS, V7, P238; International Union Against Tuberculosis and Lung Disease, 2000, SPUT EX TUB DIR MICR; Jones D, 2007, TRENDS PARASITOL, V23, P468, DOI 10.1016/j.pt.2007.08.003; Murray CK, 2006, MIL MED, V171, P1167; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rasband W., 2006, IMAGEJ; *SCI DEV LAB I, 2007, PACK INS RAP MOD AUR; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Streetly A, 2008, J MED SCREEN, V15, P9, DOI 10.1258/jms.2008.007063; Tachakra S, 2003, TELEMED J E-HEALTH, V9, P247, DOI 10.1089/153056203322502632; Tshilolo L, 2008, PUBLIC HEALTH, V122, P933, DOI 10.1016/j.puhe.2007.12.005; *WHO, 2006, INF CONS QUAL CONTR; *WHO REG OFF W PAC, 2003, QUAL ASS SPUT MICR D; *WHO SEARO WPRO, 2005, WHO SEARO WPRO WORKS; Woodward B, 2001, IEEE T INF TECHNOL B, V5, P13, DOI 10.1109/4233.908361; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Zimic M, 2009, T ROY SOC TROP MED H, V103, P638, DOI 10.1016/j.trstmh.2008.10.015	25	482	513	5	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6320	10.1371/journal.pone.0006320	http://dx.doi.org/10.1371/journal.pone.0006320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623251	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260100006
J	Okuno, T; Nakayama, T; Konishi, N; Michibata, H; Wakimoto, K; Suzuki, Y; Nito, S; Inaba, T; Nakano, I; Muramatsu, S; Takano, M; Kondo, Y; Inoue, N				Okuno, Tsuyoshi; Nakayama, Takashi; Konishi, Nae; Michibata, Hideo; Wakimoto, Koji; Suzuki, Yutaka; Nito, Shinji; Inaba, Toshio; Nakano, Imaharu; Muramatsu, Shin-ichi; Takano, Makoto; Kondo, Yasushi; Inoue, Nobuo			Self-Contained Induction of Neurons from Human Embryonic Stem Cells	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; IN-VITRO; ES CELLS; DIFFERENTIATION; BLASTOCYSTS; GROWTH; LINES	Background: Neurons and glial cells can be efficiently induced from mouse embryonic stem (ES) cells in a conditioned medium collected from rat primary-cultured astrocytes (P-ACM). However, the use of rodent primary cells for clinical applications may be hampered by limited supply and risk of contamination with xeno-proteins. Methodology/Principal Findings: We have developed an alternative method for unimpeded production of human neurons under xeno-free conditions. Initially, neural stem cells in sphere-like clusters were induced from human ES (hES) cells after being cultured in P-ACM under free-floating conditions. The resultant neural stem cells could circumferentially proliferate under subsequent adhesive culture, and selectively differentiate into neurons or astrocytes by changing the medium to PACM or G5, respectively. These hES cell-derived neurons and astrocytes could procure functions similar to those of primary cells. Interestingly, a conditioned medium obtained from the hES cell-derived astrocytes (ES-ACM) could successfully be used to substitute P-ACM for induction of neurons. Neurons made by this method could survive in mice brain after xeno-transplantation. Conclusion/Significance: By inducing astrocytes from hES cells in a chemically defined medium, we could produce human neurons without the use of P-ACM. This self-serving method provides an unlimited source of human neural cells and may facilitate clinical applications of hES cells for neurological diseases.			Okuno, T (corresponding author), Mitsubishi Tanabe Pharma Corp, Adv Med Res Lab, Osaka, Japan.	kondo.yasushi@mc.mt-pharma.co.jp	Muramatsu, Shin-ichi/K-9420-2013; Muramatsu, Shinichi/ABC-6093-2021	Muramatsu, Shin-ichi/0000-0002-3185-7790; Muramatsu, Shinichi/0000-0002-3185-7790				BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Nakayama T, 2004, NEUROREPORT, V15, P487, DOI 10.1097/00001756-200403010-00021; Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4; Nakayama T, 2006, NEUROREPORT, V17, P1519, DOI 10.1097/01.wnr.0000234747.73312.e7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103	15	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6318	10.1371/journal.pone.0006318	http://dx.doi.org/10.1371/journal.pone.0006318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621077	Green Published, gold, Green Submitted			2022-12-25	WOS:000268147200012
J	Singh, S; Taneja, B; Salvi, SS; Agrawal, A				Singh, Suchita; Taneja, Bhupesh; Salvi, Sundeep Santosh; Agrawal, Anurag			Physical Properties of Intact Proteins May Predict Allergenicity or Lack Thereof	PLOS ONE			English	Article								Background: Predicting the allergenicity of proteins is challenging. We considered the possibility that the properties of the intact protein that may alter the likelihood of being taken up by antigen presenting cells, may be useful adjuncts in predicting allergens and non-allergens in silico. It has been shown that negatively charged acidic proteins are preferentially processed by dendritic cells. Methodology: Datasets (aeroallergen, food-allergen and non-allergen) for in-silico study were obtained from public databases. Isoelectric point (pI), net charge, and electrostatic potential (EP) were calculated from the protein sequence ( for pI and net charge) or predicted structure (for EP). Result: Allergens and non allergens differed significantly in pI, net charge, and EP (p < 0.0001). Cluster analysis based on these parameters resulted in well defined clusters. Non-allergens were characterized by neutral to basic pI (mean +/- SE, 7.6 +/- 0.16) and positive charge. In contrast allergens were acidic (5.7 +/- 0.15) and negatively charged. Surface electrostatic potentials calculated from predicted structures were mostly negative for allergens and mostly positive for non-allergens. The classification accuracy for non-allergens was superior to that for allergens. Thus neutral to basic pI, positive charge, and positive electrostatic potentials characterize non-allergens, and seem rare in allergens (p<0.0001). It may be possible to predict reduced likelihood of allergenicity in such proteins, but this needs to be prospectively validated.			Singh, S (corresponding author), Inst Genom & Integrat Biol, Delhi, India.	a.agrawal@igib.res.in	Eckhardt, Erik/G-1567-2010; Agrawal, Anurag/GZL-5821-2022	Agrawal, Anurag/0000-0002-0340-5252				Agresti A., 1996, INTRO CATEGORICAL DA; Bailey AG, 1997, J ELECTROSTAT, V42, P25, DOI 10.1016/S0304-3886(97)00134-4; Balachandran W, 1997, J ELECTROSTAT, V40-1, P579, DOI 10.1016/S0304-3886(97)00106-X; Brusic V, 2003, TRENDS IMMUNOL, V24, P225, DOI 10.1016/S1471-4906(03)00075-9; Furmonaviciene R, 2005, BIOINFORMATICS, V21, P4201, DOI 10.1093/bioinformatics/bti700; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I; JANSEN JJN, 1994, J ALLERGY CLIN IMMUN, V93, P446; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kanny G, 2001, J ALLERGY CLIN IMMUN, V108, P133, DOI 10.1067/mai.2001.116427; LEARY M, 2005, IND APPL C 2005 40 I, V2, P778; Lin HH, 2006, J LIPID RES, V47, P824, DOI 10.1194/jlr.M500530-JLR200; Malandain H, 2004, ALLERGY, V59, P1011, DOI 10.1111/j.1398-9995.2004.00462.x; Miteva MA, 2005, NUCLEIC ACIDS RES, V33, pW372, DOI 10.1093/nar/gki365; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Shakushiro K, 2004, IMMUNOLOGY, V112, P211, DOI 10.1111/j.1365-2567.2004.01871.x; TEITELBAUM D, 1975, J EXP MED, V42, P701; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Veronesi B, 2003, NEUROTOXICOLOGY, V24, P463, DOI 10.1016/S0161-813X(03)00022-6; WILLOUGHBY DA, 1994, LANCET, V344, P413, DOI 10.1016/S0140-6736(94)91442-7	22	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6273	10.1371/journal.pone.0006273	http://dx.doi.org/10.1371/journal.pone.0006273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609445	Green Published, gold, Green Submitted			2022-12-25	WOS:000268119500008
J	Zhou, HB; Yu, ZJ; Hu, Y; Tu, JG; Zou, W; Peng, YP; Zhu, JP; Li, YT; Zhang, AD; Yu, ZN; Ye, ZP; Chen, HC; Jin, ML				Zhou, Hongbo; Yu, Zhengjun; Hu, Yong; Tu, Jiagang; Zou, Wei; Peng, Yaping; Zhu, Jiping; Li, Yongtao; Zhang, Anding; Yu, Ziniu; Ye, Zhiping; Chen, Huanchun; Jin, Meilin			The Special Neuraminidase Stalk-Motif Responsible for Increased Virulence and Pathogenesis of H5N1 Influenza A Virus	PLOS ONE			English	Article								The variation of highly pathogenic avian influenza H5N1 virus results in gradually increased virulence in poultry, and human cases continue to accumulate. The neuraminidase (NA) stalk region of influenza virus varies considerably and may associate with its virulence. The NA stalk region of all N1 subtype influenza A viruses can be divided into six different stalk-motifs, H5N1/2004-like (NA-wt), WSN-like, H5N1/97-like, PR/8-like, H7N1/99-like and H5N1/96-like. The NA-wt is a special NA stalk-motif which was first observed in H5N1 influenza virus in 2000, with a 20-amino acid deletion in the 49(th) to 68(th) positions of the stalk region. Here we show that there is a gradual increase of the special NA stalk-motif in H5N1 isolates from 2000 to 2007, and notably, the special stalk-motif is observed in all 173 H5N1 human isolates from 2004 to 2007. The recombinant H5N1 virus with the special stalk-motif possesses the highest virulence and pathogenicity in chicken and mice, while the recombinant viruses with the other stalk-motifs display attenuated phenotype. This indicates that the special stalk-motif has contributed to the high virulence and pathogenicity of H5N1 isolates since 2000. The gradually increasing emergence of the special NA stalk-motif in H5N1 isolates, especially in human isolates, deserves attention by all.			Zhou, HB (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Peoples R China.	chenhch@mail.hzau.edu.cn; jinmeilin@mail.hzau.edu.cn	Zou, Wei/L-9082-2019; zhu, ji/HDM-1538-2022	Zou, Wei/0000-0001-8292-5127; 				Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; GRIFFIN JA, 1983, VIROLOGY, V125, P324, DOI 10.1016/0042-6822(83)90205-2; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guan Y, 2002, VIROLOGY, V292, P16, DOI 10.1006/viro.2001.1207; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Lee CW, 2004, AVIAN PATHOL, V33, P288, DOI 10.1080/0307945042000203407; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li Y, 2006, ARCH VIROL, V151, P1615, DOI 10.1007/s00705-006-0738-7; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; LUO GX, 1993, VIRUS RES, V29, P141; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; Yu ZJ, 2007, EMERG INFECT DIS, V13, P772, DOI 10.3201/eid1305.061209; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhou HB, 2006, VIRUS GENES, V32, P85, DOI 10.1007/s11262-005-5849-9	32	102	107	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6277	10.1371/journal.pone.0006277	http://dx.doi.org/10.1371/journal.pone.0006277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609439	Green Submitted, Green Published, gold			2022-12-25	WOS:000268119500012
J	Low, DHP; Ang, ZW; Yuan, Q; Frecer, V; Ho, B; Chen, JZ; Ding, JL				Low, Diana Hooi Ping; Ang, Zhiwei; Yuan, Quan; Frecer, Vladimir; Ho, Bow; Chen, Jianzhu; Ding, Jeak Ling			A Novel Human Tectonin Protein with Multivalent beta-Propeller Folds Interacts with Ficolin and Binds Bacterial LPS	PLOS ONE			English	Article							IMMUNE MOLECULE; INNATE IMMUNITY; PLASMA LECTINS; CONSERVATION; RECOGNITION; SEQUENCE; DOMAINS; CLONING	Background: Although the human genome database has been completed a decade ago, similar to 50% of the proteome remains hypothetical as their functions are unknown. The elucidation of the functions of these hypothetical proteins can lead to additional protein pathways and revelation of new cascades. However, many of these inferences are limited to proteins with substantial sequence similarity. Of particular interest here is the Tectonin domain-containing family of proteins. Methodology/Principal Findings: We have identified hTectonin, a hypothetical protein in the human genome database, as a distant ortholog of the limulus galactose binding protein (GBP). Phylogenetic analysis revealed strong evolutionary conservation of hTectonin homologues from parasite to human. By computational analysis, we showed that both the hTectonin and GBP form beta-propeller structures with multiple Tectonin domains, each containing beta-sheets of 4 strands per beta-sheet. hTectonin is present in the human leukocyte cDNA library and immune-related cell lines. It interacts with M-ficolin, a known human complement protein whose ancient homolog, carcinolectin (CL5), is the functional protein partner of GBP during infection. Yeast 2-hybrid assay showed that only the Tectonin domains of hTectonin recognize the fibrinogen-like domain of the M-ficolin. Surface plasmon resonance analysis showed real-time interaction between the Tectonin domains 6 & 11 and bacterial LPS, indicating that despite forming 2 beta-propellers with its different Tectonin domains, the hTectonin molecule could precisely employ domains 6 & 11 to recognise bacteria. Conclusions/Significance: By virtue of a recent finding of another Tectonin protein, leukolectin, in the human leukocyte, and our structure-function analysis of the hypothetical hTectonin, we propose that Tectonin domains of proteins could play a vital role in innate immune defense, and that this function has been conserved over several hundred million years, from invertebrates to vertebrates. Furthermore, the approach we have used could be employed in unraveling the characteristics and functions of other hypothetical proteins in the human proteome.			Low, DHP (corresponding author), Singapore MIT Alliance, Singapore, Singapore.	dbsdjl@nus.edu.sg	Frecer, Vladimir/AAY-3030-2021; Ding, Jeak/H-8057-2012; yuan, quan/GZM-5597-2022	Low, Diana/0000-0002-6054-8524; Ang, Zhiwei/0000-0001-6583-4733				Basak S, 2009, BIOCHEM BIOPH RES CO, V379, P803, DOI 10.1016/j.bbrc.2009.01.025; Bogdanov YF, 2007, INT REV CYTOL, V257, P83, DOI 10.1016/S0074-7696(07)57003-8; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; Frecer V, 2004, ANTIMICROB AGENTS CH, V48, P3349, DOI 10.1128/AAC.48.9.3349-3357.2004; Frecer V, 2000, EUR J BIOCHEM, V267, P837, DOI 10.1046/j.1432-1327.2000.01069.x; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Galliano M, 2003, BIOCHEM J, V376, P433, DOI 10.1042/BJ20030413; Huh CG, 1998, J BIOL CHEM, V273, P6565, DOI 10.1074/jbc.273.11.6565; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawabata S, 2002, BBA-GEN SUBJECTS, V1572, P414, DOI 10.1016/S0304-4165(02)00322-7; Kawai F, 1999, J IND MICROBIOL BIOT, V23, P400, DOI 10.1038/sj.jim.2900730; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Mali B, 2006, DEV COMP IMMUNOL, V30, P275, DOI 10.1016/j.dci.2005.04.004; MIFTARI MH, 2009, MOL CLONING CHARACTE; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Retief J D, 2000, Methods Mol Biol, V132, P243; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Schroder HC, 2003, J BIOL CHEM, V278, P32810, DOI 10.1074/jbc.M304116200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; *US DOE, HUM GEN PROJ INF; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yadid I, 2007, J MOL BIOL, V365, P10, DOI 10.1016/j.jmb.2006.09.055; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	33	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6260	10.1371/journal.pone.0006260	http://dx.doi.org/10.1371/journal.pone.0006260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606221	Green Published, Green Submitted, gold			2022-12-25	WOS:000268036000015
J	Holden, MTG; Hauser, H; Sanders, M; Thi, HN; Cherevach, I; Cronin, A; Goodhead, I; Mungall, K; Quail, MA; Price, C; Rabbinowitsch, E; Sharp, S; Croucher, NJ; Tran, BC; Nguyen, THM; To, SD; Nguyen, TC; Kehoe, M; Leigh, JA; Ward, PN; Dowson, CG; Whatmore, AM; Chanter, N; Iversen, P; Gottschalk, M; Slater, JD; Smith, HE; Spratt, BG; Xu, JG; Ye, CY; Bentley, S; Barrell, BG; Schultsz, C; Maskell, DJ; Parkhill, J				Holden, Matthew T. G.; Hauser, Heidi; Sanders, Mandy; Thi Hoa Ngo; Cherevach, Inna; Cronin, Ann; Goodhead, Ian; Mungall, Karen; Quail, Michael A.; Price, Claire; Rabbinowitsch, Ester; Sharp, Sarah; Croucher, Nicholas J.; Tran Bich Chieu; Nguyen Thi Hoang Mai; To Song Diep; Nguyen Tran Chinh; Kehoe, Michael; Leigh, James A.; Ward, Philip N.; Dowson, Christopher G.; Whatmore, Adrian M.; Chanter, Neil; Iversen, Pernille; Gottschalk, Marcelo; Slater, Josh D.; Smith, Hilde E.; Spratt, Brian G.; Xu, Jianguo; Ye, Changyun; Bentley, Stephen; Barrell, Barclay G.; Schultsz, Constance; Maskell, Duncan J.; Parkhill, Julian			Rapid Evolution of Virulence and Drug Resistance in the Emerging Zoonotic Pathogen Streptococcus suis	PLOS ONE			English	Article								Background: Streptococcus suis is a zoonotic pathogen that infects pigs and can occasionally cause serious infections in humans. S. suis infections occur sporadically in human Europe and North America, but a recent major outbreak has been described in China with high levels of mortality. The mechanisms of S. suis pathogenesis in humans and pigs are poorly understood. Methodology/Principal Findings: The sequencing of whole genomes of S. suis isolates provides opportunities to investigate the genetic basis of infection. Here we describe whole genome sequences of three S. suis strains from the same lineage: one from European pigs, and two from human cases from China and Vietnam. Comparative genomic analysis was used to investigate the variability of these strains. S. suis is phylogenetically distinct from other Streptococcus species for which genome sequences are currently available. Accordingly, similar to 40% of the similar to 2 Mb genome is unique in comparison to other Streptococcus species. Finer genomic comparisons within the species showed a high level of sequence conservation; virtually all of the genome is common to the S. suis strains. The only exceptions are three similar to 90 kb regions, present in the two isolates from humans, composed of integrative conjugative elements and transposons. Carried in these regions are coding sequences associated with drug resistance. In addition, small-scale sequence variation has generated pseudogenes in putative virulence and colonization factors. Conclusions/Significance: The genomic inventories of genetically related S. suis strains, isolated from distinct hosts and diseases, exhibit high levels of conservation. However, the genomes provide evidence that horizontal gene transfer has contributed to the evolution of drug resistance.			Holden, MTG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	mh3@sanger.ac.uk	Gottschalk, Marcelo/I-8116-2012; Parkhill, Julian/G-4703-2011; Whatmore, Adrian M/C-7744-2011; Dowson, Chris/N-6195-2014; Holden, Matthew TG/K-6449-2014; Leigh, James/G-9282-2011; Dowson, Christopher/ABG-5083-2021; Quail, michael/ABE-6131-2020; Goodhead, Ian/ABC-9200-2020	Parkhill, Julian/0000-0002-7069-5958; Whatmore, Adrian M/0000-0003-4218-156X; Dowson, Chris/0000-0002-8294-8836; Holden, Matthew TG/0000-0002-4958-2166; Leigh, James/0000-0002-0307-2814; Dowson, Christopher/0000-0002-8294-8836; Croucher, Nicholas/0000-0001-6303-8768; Goodhead, Ian/0000-0002-3110-9442; Ward, Philip/0000-0003-2546-3426	BBSRC [BB/G019274/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G019274/1] Funding Source: Medline; Wellcome Trust [089472] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Agniswamy J, 2004, J BIOL CHEM, V279, P52789, DOI 10.1074/jbc.M410698200; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Allen AG, 2001, INFECT IMMUN, V69, P2732, DOI 10.1128/IAI.69.4.2732-2735.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Baker C., 1995, INFECT DIS FETUS NEW, V4th ed., P980; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Broadbent JR, 2003, J DAIRY SCI, V86, P407, DOI 10.3168/jds.S0022-0302(03)73619-4; Burrus V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Clifton-Hadley FA, 1981, STUDIES STREPTOCOCCU; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dear S, 1998, GENOME RES, V8, P260, DOI 10.1101/gr.8.3.260; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; ELLIOTT SD, 1978, J EXP MED, V148, P1699, DOI 10.1084/jem.148.6.1699; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gottschalk M, 1998, CAN J VET RES, V62, P75; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; GUENZI E, 1994, MOL MICROBIOL, V12, P505, DOI 10.1111/j.1365-2958.1994.tb01038.x; Higgins R, 2001, CAN VET J, V42, P223; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Jacobs AAC, 1996, VET REC, V139, P225, DOI 10.1136/vr.139.10.225; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jobin MC, 2006, MICROB PATHOGENESIS, V40, P29, DOI 10.1016/j.micpath.2005.10.003; King SJ, 2004, J BACTERIOL, V186, P4740, DOI 10.1128/JB.186.14.4740-4747.2004; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; Kornelisse RF, 1996, J INFECT DIS, V174, P120, DOI 10.1093/infdis/174.1.120; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lannergard J, 2006, FEMS MICROBIOL LETT, V262, P230, DOI 10.1111/j.1574-6968.2006.00404.x; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lei BF, 2001, NAT MED, V7, P1298, DOI 10.1038/nm1201-1298; Lei BF, 2002, INFECT IMMUN, V70, P6880, DOI 10.1128/IAI.70.12.6880-6890.2002; Leppert D, 2000, CLIN INFECT DIS, V31, P80, DOI 10.1086/313922; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin V, 1997, INFECT IMMUN, V65, P2074, DOI 10.1128/IAI.65.6.2074-2079.1997; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Novak R, 2000, MOL MICROBIOL, V36, P366, DOI 10.1046/j.1365-2958.2000.01854.x; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; Ozaki K, 2002, FEBS LETT, V532, P159, DOI 10.1016/S0014-5793(02)03661-X; Paul R, 1998, ANN NEUROL, V44, P592, DOI 10.1002/ana.410440404; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Phelps HA, 2007, INFECT IMMUN, V75, P4541, DOI 10.1128/IAI.00518-07; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Poulsen K, 1996, INFECT IMMUN, V64, P3957, DOI 10.1128/IAI.64.10.3957-3966.1996; Rocha EPC, 1999, MOL MICROBIOL, V32, P11, DOI 10.1046/j.1365-2958.1999.01334.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shibata Y, 2002, INFECT IMMUN, V70, P2891, DOI 10.1128/IAI.70.6.2891-2898.2002; Short, 2000, Curr Infect Dis Rep, V2, P327, DOI 10.1007/s11908-000-0011-2; Sleator RD, 2005, MOL MICROBIOL, V55, P1183, DOI 10.1111/j.1365-2958.2004.04454.x; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Smith HE, 1999, INFECT IMMUN, V67, P1750; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; SOELL M, 1995, J IMMUNOL, V154, P851; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; TAKAMATSU D, 2009, VET MICROBI IN PRESS; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; TIMONEY JF, 2007, VET IMMUNOL IMMUNOPA; Tsuda H, 2000, INFECT IMMUN, V68, P644, DOI 10.1128/IAI.68.2.644-650.2000; Tsukioka Y, 1997, J BACTERIOL, V179, P1126, DOI 10.1128/jb.179.4.1126-1134.1997; Tsukioka Y, 1997, J BACTERIOL, V179, P4411, DOI 10.1128/jb.179.13.4411-4414.1997; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Ward PN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-54; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100; Wellmer A, 2002, INFECT IMMUN, V70, P6504, DOI 10.1128/IAI.70.11.6504-6508.2002; Wilm A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn174; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yamashita Y, 1999, J BACTERIOL, V181, P6556, DOI 10.1128/JB.181.20.6556-6559.1999; Yamashita Y, 1998, MICROBIOL-SGM, V144, P1235, DOI 10.1099/00221287-144-5-1235; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zwijnenburg RJG, 2001, J INFECT DIS, V183, P1143, DOI 10.1086/319271	111	184	199	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6072	10.1371/journal.pone.0006072	http://dx.doi.org/10.1371/journal.pone.0006072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603075	Green Published, gold			2022-12-25	WOS:000268035700001
J	Kassiri, Z; Defamie, V; Hariri, M; Oudit, GY; Anthwal, S; Dawood, F; Liu, P; Khokha, R				Kassiri, Zamaneh; Defamie, Virginie; Hariri, Mehrdad; Oudit, Gavin Y.; Anthwal, Shalini; Dawood, Fayez; Liu, Peter; Khokha, Rama			Simultaneous Transforming Growth Factor beta-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TISSUE INHIBITOR; GROWTH-FACTOR-BETA-1 GENE; MATRIX METALLOPROTEINASES; DIFFERENTIAL EXPRESSION; INTERSTITIAL FIBROSIS; CARDIAC FIBROBLASTS; COLLAGEN PRODUCTION; SYSTOLIC FUNCTION; TRANSGENIC MICE	The pleiotropic cytokines, transforming growth factor beta 1 (TGF beta 1), and tumor necrosis factor (TNF) play critical roles in tissue homeostasis in response to injury and are implicated in multiple human diseases and cancer. We reported that the loss of Timp3 (tissue inhibitor of metalloproteinase 3) leads to abnormal TNF signaling and cardiovascular function. Here we show that parallel deregulation of TGF beta 1 and TNF signaling in Timp3(-/-) mice amplifies their cross-talk at the onset of cardiac response to mechanical stress (pressure overload), resulting in fibrosis and early heart failure. Microarray analysis showed a distinct gene expression profile in Timp3(-/-) hearts, highlighting activation of TGF beta 1 signaling as a potential mechanism underlying fibrosis. Neonatal cardiomyocyte-cardiofibroblast co-cultures were established to measure fibrogenic response to agonists known to be induced following mechanical stress in vivo. A stronger response occurred in neonatal Timp3(-/-) cocultures, as determined by increased Smad signaling and collagen expression, due to increased TNF processing and precocious proteolytic maturation of TGF beta 1 to its active form. The relationship between TGF beta 1 and TNF was dissected using genetic and pharmacological manipulations. Timp3(-/-)/Tnf(-/-) mice had lower TGF beta 1 than Timp3(-/-), and anti-TGF beta 1 antibody (1D11) negated the abnormal TNF response, indicating their reciprocal stimulatory effects, with each manipulation abolishing fibrosis and improving heart function. Thus, TIMP3 is a common innate regulator of TGF beta 1 and TNF in tissue response to injury. The matrix-bound TIMP3 balances the anti-inflammatory and proinflammatory processes toward constructive tissue remodeling.	[Kassiri, Zamaneh; Defamie, Virginie; Hariri, Mehrdad; Oudit, Gavin Y.; Anthwal, Shalini; Khokha, Rama] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Dawood, Fayez; Liu, Peter] Univ Toronto, Div Cardiol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Khokha, R (corresponding author), Univ Toronto, Ontario Canc Inst, 610 Univ Ave,10-330, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca		Defamie, Virginie/0000-0002-6405-0539; Khokha, Rama/0000-0002-6028-1524	Heart and Stroke Foundation; Tailored Advanced Collaborative Training in Cardiovascular Sciences fellowship	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Tailored Advanced Collaborative Training in Cardiovascular Sciences fellowship	This work was supported by funding from the Heart and Stroke Foundation (to R. K.) and a Tailored Advanced Collaborative Training in Cardiovascular Sciences fellowship (to Z. K.).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aras Omer, 2008, Curr Cardiol Rep, V10, P128, DOI 10.1007/s11886-008-0022-4; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Bitzer M, 2000, GENE DEV, V14, P187; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brooks A, 2003, HEART, V89, P1255, DOI 10.1136/heart.89.10.1255; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; Herpel E, 2006, HISTOPATHOLOGY, V48, P736, DOI 10.1111/j.1365-2559.2006.02398.x; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Holweg CTJ, 2001, J HEART LUNG TRANSPL, V20, P979, DOI 10.1016/S1053-2498(01)00296-0; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Jester JV, 1997, CORNEA, V16, P177; Ju HS, 1996, MOL CELL BIOCHEM, V164, P231, DOI 10.1007/BF00408663; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Katz AM, 2006, CIRCULATION, V113, P1922, DOI 10.1161/CIRCULATIONAHA.106.620765; Kopp JB, 1996, LAB INVEST, V74, P991; Kuhl U, 1995, EUR HEART J, V16, P100, DOI 10.1093/eurheartj/16.suppl_O.100; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Li BG, 1999, HYPERTENSION, V33, P271, DOI 10.1161/01.HYP.33.1.271; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Pathak M, 2001, HYPERTENSION, V37, P833, DOI 10.1161/01.HYP.37.3.833; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Roman-Blas JA, 2007, OSTEOARTHR CARTILAGE, V15, P1367, DOI 10.1016/j.joca.2007.04.011; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stawowy P, 2004, CIRCULATION, V109, P770, DOI 10.1161/01.CIR.0000112583.50762.DE; Stawowy P, 2004, CARDIOVASC RES, V63, P87, DOI 10.1016/j.cardiores.2004.03.010; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Swiderski RE, 1998, AM J PATHOL, V152, P821; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Young DA, 2002, BIOCHEM J, V364, P89, DOI 10.1042/bj3640089; Yu L, 2004, KIDNEY INT, V66, P1774, DOI 10.1111/j.1523-1755.2004.00901.x; Yu Q, 2000, GENE DEV, V14, P163; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	59	75	75	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29893	29904		10.1074/jbc.M109.028449	http://dx.doi.org/10.1074/jbc.M109.028449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19625257	hybrid, Green Published			2022-12-25	WOS:000270896800069
J	Kedinger, V; Sansregret, L; Harada, R; Vadnais, C; Cadieux, C; Fathers, K; Park, M; Nepveu, A				Kedinger, Valerie; Sansregret, Laurent; Harada, Ryoko; Vadnais, Charles; Cadieux, Chantal; Fathers, Kelly; Park, Morag; Nepveu, Alain			p110 CUX1 Homeodomain Protein Stimulates Cell Migration and Invasion in Part through a Regulatory Cascade Culminating in the Repression of E-cadherin and Occludin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CDP/CUX TRANSCRIPTION FACTOR; DNA-BINDING; CUT HOMEODOMAIN; S-PHASE; TUMOR PROGRESSION; CATHEPSIN-L; SNAIL TRANSCRIPTION; GENE-EXPRESSION; KINASE-C	In this study, we investigated the mechanism by which the CUX1 transcription factor can stimulate cell migration and invasion. The full-length p200 CUX1 had a weaker effect than the proteolytically processed p110 isoform; moreover, treatments that affect processing similarly impacted cell migration. We conclude that the stimulatory effect of p200 CUX1 is mediated in part, if not entirely, through the generation of p110 CUX1. We established a list of putative transcriptional targets with functions related to cell motility, and we then identified those targets whose expression was directly regulated by CUX1 in a cell line whose migratory potential was strongly stimulated by CUX1. We identified 18 genes whose expression was directly modulated by p110 CUX1, and its binding to all target promoters was validated in independent chromatin immunoprecipitation assays. These genes code for regulators of Rho-GTPases, cell-cell and cell-matrix adhesion proteins, cytoskeleton-associated proteins, and markers of epithelial-to-mesenchymal transition. Interestingly, p110 CUX1 activated the expression of genes that promote cell motility and at the same time repressed genes that inhibit this process. Therefore, the role of p110 CUX1 in cell motility involves its functions in both activation and repression of transcription. This was best exemplified in the regulation of the E-cadherin gene. Indeed, we uncovered a regulatory cascade whereby p110 CUX1 binds to the snail and slug gene promoters, activates their expression, and then cooperates with these transcription factors in the repression of the E-cadherin gene, thereby causing disorganization of cell-cell junctions.	[Nepveu, Alain] McGill Univ, Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Kedinger, Valerie; Sansregret, Laurent; Harada, Ryoko; Vadnais, Charles; Cadieux, Chantal; Fathers, Kelly; Park, Morag; Nepveu, Alain] McGill Univ Canc Pavil, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University	Nepveu, A (corresponding author), McGill Univ, Goodman Canc Ctr, Dept Biochem, 1160 Pine Ave W,Rm 410, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020		Canadian Institute of Health Research [CTP-79857]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Team Grant CTP-79857 from the Canadian Institute of Health Research ( to A.N.).	Aleksic T, 2007, ONCOGENE, V26, P5939, DOI 10.1038/sj.onc.1210398; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; Goulet B, 2004, CELL CYCLE, V3, P986; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2002, CANCER RES, V62, P6625; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Goulet B, 2006, BIOL CHEM, V387, P1285, DOI 10.1515/BC.2006.159; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hajra KM, 2002, CANCER RES, V62, P1613; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Li SD, 2000, P NATL ACAD SCI USA, V97, P7166, DOI 10.1073/pnas.130028697; Mazzoni E, 2003, MOL CANCER RES, V1, P776; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Santaguida M, 2005, J BIOL CHEM, V280, P32712, DOI 10.1074/jbc.M505417200; Santaguida M, 2001, J BIOL CHEM, V276, P45780, DOI 10.1074/jbc.M107978200; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Truscott M, 2008, MOL CELL BIOL, V28, P3127, DOI 10.1128/MCB.02089-07; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516; vanWijnen AJ, 1997, J CELL BIOCHEM, V66, P512, DOI 10.1002/(SICI)1097-4644(19970915)66:4<512::AID-JCB10>3.0.CO;2-D; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2	54	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27701	27711		10.1074/jbc.M109.031849	http://dx.doi.org/10.1074/jbc.M109.031849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19635798	hybrid, Green Published			2022-12-25	WOS:000270232300071
J	Cazanave, SC; Mott, JL; Elmi, NA; Bronk, SF; Werneburg, NW; Akazawa, Y; Kahraman, A; Garrison, SP; Zambetti, GP; Charlton, MR; Gores, GJ				Cazanave, Sophie C.; Mott, Justin L.; Elmi, Nafisa A.; Bronk, Steven F.; Werneburg, Nathan W.; Akazawa, Yuko; Kahraman, Alisan; Garrison, Sean P.; Zambetti, Gerard P.; Charlton, Michael R.; Gores, Gregory J.			JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; BCL-2 FAMILY-MEMBERS; N-TERMINAL KINASE; NONALCOHOLIC STEATOHEPATITIS; BH3-ONLY PROTEIN; CELL-DEATH; INSULIN-RESISTANCE; BAX ACTIVATION; MITOCHONDRIAL ABNORMALITIES; JNK PHOSPHORYLATION	Free fatty acids (FFA) induce hepatocyte lipoapoptosis by a c-Jun N-terminal kinase (JNK)-dependent mechanism. However, the cellular processes by which JNK engages the core apoptotic machinery during lipotoxicity, especially activation of BH3-only proteins, remain incompletely understood. Thus, our aim was to determine whether JNK mediates induction of BH3-only proteins during hepatocyte lipoapoptosis. The saturated FFA palmitate, but not the monounsaturated FFA oleate, induces an increase in PUMA mRNA and protein levels. Palmitate induction of PUMA was JNK1-dependent in primary murine hepatocytes. Palmitate-mediated PUMA expression was inhibited by a dominant negative c-Jun, and direct binding of a phosphorylated c-Jun containing the activator protein 1 complex to the PUMA promoter was identified by electrophoretic mobility shift assay and a chromatin immunoprecipitation assay. Short hairpin RNA-targeted knockdown of PUMA attenuated Bax activation, caspase 3/7 activity, and cell death. Similarly, the genetic deficiency of Puma rendered murine hepatocytes resistant to lipoapoptosis. PUMA expression was also increased in liver biopsy specimens from patients with non-alcoholic steatohepatitis as compared with patients with simple steatosis or controls. Collectively, the data implicate JNK1-dependent PUMA expression as a mechanism contributing to hepatocyte lipoapoptosis.	[Kahraman, Alisan; Charlton, Michael R.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Miles & Shirley Fitterman Ctr Digest Dis, Rochester, MN 55905 USA; [Garrison, Sean P.; Zambetti, Gerard P.] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA	Mayo Clinic; St Jude Children's Research Hospital	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Miles & Shirley Fitterman Ctr Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007; Mott, Justin/0000-0002-2927-6962	National Institutes of Health [DK41876, DK069757-05, DK079875]; Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079875, R37DK041876, R01DK069757, R29DK041876, P30DK084567, R01DK041876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41876 (to G. J. G.), DK069757-05 (to M. R. C.), and DK079875 (to J. L. M.). This work was also supported by the Mayo Foundation.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bookman ID, 2006, LIVER INT, V26, P566, DOI 10.1111/j.1478-3231.2006.01256.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6; Caldwell Stephen H, 2004, Clin Liver Dis, V8, P595, DOI 10.1016/j.cld.2004.04.009; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Czaja MJ, 2003, AM J PHYSIOL-GASTR L, V284, pG875, DOI 10.1152/ajpgi.00549.2002; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Krishnan A, 2007, HEPATOL RES, V37, P854, DOI 10.1111/j.1872-034X.2007.00139.x; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Neise D, 2008, ONCOGENE, V27, P1387, DOI 10.1038/sj.onc.1210773; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Ratziu V, 2006, HEPATOLOGY, V44, P802, DOI 10.1002/hep.21391; RICHIERI GV, 1995, J LIPID RES, V36, P229; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schachter KA, 2006, J BIOL CHEM, V281, P19134, DOI 10.1074/jbc.M603324200; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	68	149	152	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26591	26602		10.1074/jbc.M109.022491	http://dx.doi.org/10.1074/jbc.M109.022491			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638343	Green Published, hybrid			2022-12-25	WOS:000269969600040
J	Ideo, H; Fukushima, K; Gengyo-Ando, K; Mitani, S; Dejima, K; Nomura, K; Yamashita, K				Ideo, Hiroko; Fukushima, Keiko; Gengyo-Ando, Keiko; Mitani, Shohei; Dejima, Katsufumi; Nomura, Kazuya; Yamashita, Katsuko			A Caenorhabditis elegans Glycolipid-binding Galectin Functions in Host Defense against Bacterial Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-THURINGIENSIS; MEMBRANE MICRODOMAINS; SPECIFICITY; MUTANTS; PROTEIN; GLYCOSPHINGOLIPIDS; EXPRESSION; SULFATIDES; NEMATODES; DOMAINS	Galectins are a family of beta-galactoside-binding proteins that are widely found among animal species and that regulate diverse biological phenomena. To study the biological function of glycolipid-binding galectins, we purified recombinant Caenorhabditis elegans galectins (LEC-1-11) and studied their binding to C. elegans glycolipids. We found that LEC-8 binds to glycolipids in C. elegans through carbohydrate recognition. It has been reported that Cry5B-producing Bacillus thuringiensis strains can infect C. elegans and that the C. elegans Cry5B receptor molecules are glycolipids. We found that Cry5B and LEC-8 bound to C. elegans glycolipid-coated plates in a dose-dependent manner and that Cry5B binding to glycolipids was inhibited by the addition of LEC-8. LEC-8 is usually expressed strongly in the pharyngeal-intestinal valve and intestinal-rectal valve and is expressed weakly in intestine. However, when C. elegans were fed Escherichia coli expressing Cry5B, intestinal LEC-8::EGFP protein levels increased markedly. In contrast, LEC-8::EGFP expression triggered by Cry5B was reduced in toxin-resistant C. elegans mutants, which had mutations in genes involved in biosynthesis of glycolipids. Moreover, the LEC-8-deficient mutant was more susceptible to Cry5B than wild-type worms. These results suggest that the glycolipid-binding lectin LEC-8 contributes to host defense against bacterial infection by competitive binding to target glycolipid molecules.	[Yamashita, Katsuko] Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Gengyo-Ando, Keiko; Mitani, Shohei; Nomura, Kazuya; Yamashita, Katsuko] Core Res Evolut Sci & Technol, Saitama 3320012, Japan; [Gengyo-Ando, Keiko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Dejima, Katsufumi; Nomura, Kazuya] Kyushu Univ, Fac Sci 33, Dept Biol, Fukuoka 8128581, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokyo Women's Medical University; Kyushu University	Yamashita, K (corresponding author), Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	kyamashi@bio.titech.ac.jp	Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019		New Energy and Industrial Technology Development Organization (NEDO) in Japan	New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) in Japan.	Ahmed H, 2002, GLYCOBIOLOGY, V12, P451, DOI 10.1093/glycob/cwf052; Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; BORGONIE G, 1995, J INVERTEBR PATHOL, V65, P61, DOI 10.1006/jipa.1995.1008; Borgonie G, 1996, FUND APPL NEMATOL, V19, P391; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; BRENNAN MJ, 1991, J BIOL CHEM, V266, P18827; COX GN, 1980, GENETICS, V95, P317; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Haslam SM, 2003, BIOCHIMIE, V85, P25, DOI 10.1016/S0300-9084(03)00041-5; Haslam SM, 2002, BIOCHEM SOC SYMP, V69, P117; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; HIDARI KIPJ, 1994, EUR J BIOCHEM, V221, P603, DOI 10.1111/j.1432-1033.1994.tb18772.x; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Ideo H, 2005, J BIOL CHEM, V280, P4730, DOI 10.1074/jbc.M410362200; Ideo H, 2002, GLYCOBIOLOGY, V12, P199, DOI 10.1093/glycob/12.3.199; Ideo H, 2007, J BIOL CHEM, V282, P21081, DOI 10.1074/jbc.M703770200; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marroquin LD, 2000, GENETICS, V155, P1693; Marza E, 2009, J CELL SCI, V122, P822, DOI 10.1242/jcs.042754; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nemoto-Sasaki Y, 2008, BBA-GEN SUBJECTS, V1780, P1131, DOI 10.1016/j.bbagen.2008.07.003; ODA Y, 1993, J BIOL CHEM, V268, P5929; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Skipski V P, 1975, Methods Enzymol, V35, P396, DOI 10.1016/0076-6879(75)35178-1; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Suzuki T, 1996, BIOCHEM J, V318, P389, DOI 10.1042/bj3180389; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067	39	47	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26493	26501		10.1074/jbc.M109.038257	http://dx.doi.org/10.1074/jbc.M109.038257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635802	Green Published, hybrid			2022-12-25	WOS:000269969600030
J	Okada, A; Okada, K; Miyamoto, K; Koga, J; Shibuya, N; Nojiri, H; Yamane, H				Okada, Atsushi; Okada, Kazunori; Miyamoto, Koji; Koga, Jinichiro; Shibuya, Naoto; Nojiri, Hideaki; Yamane, Hisakazu			OsTGAP1, a bZIP Transcription Factor, Coordinately Regulates the Inductive Production of Diterpenoid Phytoalexins in Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; GENE-EXPRESSION; PLASMA-MEMBRANE; PLANT DEFENSE; ORYZA-SATIVA; DNA-BINDING; BIOSYNTHESIS; ARABIDOPSIS; ELICITOR	Production of major diterpenoid phytoalexins, momilactones and phytocassanes, is induced in rice upon recognition of pathogenic invasion as plant defense-related compounds. We recently showed that biosynthetic genes for momilactones are clustered on rice chromosome 4 and co-expressed after elicitation, mimicking pathogen attack. Because genes for most metabolic pathways in plants are not organized in gene clusters, examination of the mechanism(s) regulating the expression of such clustered genes is needed. Here, we report a chitin oligosaccharide elicitor-inducible basic leucine zipper transcription factor, OsTGAP1, which is essential for momilactone biosynthesis and regulates the expression of the five genes in the cluster. The knock-out mutant for OsTGAP1 had almost no expression of the five clustered genes (OsCPS4, OsKSL4, CYP99A2, CYP99A3, and OsMAS) or production of momilactones upon elicitor treatment. Inductive expression of OsKSL7 for phytocassane biosynthesis was also largely affected in the ostgap1 mutant, although phytocassane accumulation still occurred. Conversely, OsTGAP1-overexpressing lines exhibited enhanced expression of the clustered genes and hyperaccumulation of momilactones in response to the elicitor. Furthermore, enhanced expression of OsKSL7 and hyperaccumulation of phytocassanes was also observed. We also found that OsTGAP1 overexpression can influence transcriptional up-regulation of OsDXS3 in the methylerythritol phosphate pathway, eventually leading to inductive production of diterpenoid phytoalexins. These results indicate that OsTGAP1 functions as a key regulator of the coordinated transcription of genes involved in inductive diterpenoid phytoalexin production in rice and mainly exerts an essential role on expression of the clustered genes for momilactone biosynthesis.	[Okada, Atsushi; Okada, Kazunori; Miyamoto, Koji; Nojiri, Hideaki; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Koga, Jinichiro] Meiji Seika Kaisha Ltd, Bio Sci Labs, Saitama 3500289, Japan; [Shibuya, Naoto] Meiji Univ, Fac Agr, Dept Life Sci, Tama Ku, Kanagawa 2148571, Japan	University of Tokyo; Meiji Holdings Co., Ltd.; Meiji University	Okada, K (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ukokada@mail.ecc.u-tokyo.ac.jp	Miyamoto, Koji/N-1504-2014	Miyamoto, Koji/0000-0002-9862-7412; Koga, Jinichiro/0000-0003-2106-9894	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science [18580102]	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 18580102 (to H. Y.).	AKATSUKA T, 1985, AGR BIOL CHEM TOKYO, V49, P1689, DOI 10.1080/00021369.1985.10866951; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Hirochika H, 1997, PLANT MOL BIOL, V35, P231, DOI 10.1023/A:1005774705893; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x; Jupin I, 1996, EMBO J, V15, P5679, DOI 10.1002/j.1460-2075.1996.tb00952.x; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; KATO H, 1993, PHYTOCHEMISTRY, V33, P79, DOI 10.1016/0031-9422(93)85399-C; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; KATO T, 1973, Tetrahedron Letters, V39, P3861; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; LAM E, 1989, PLANT CELL, V1, P1147, DOI 10.1105/tpc.1.12.1147; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Miyao A, 2007, PLANT MOL BIOL, V63, P625, DOI 10.1007/s11103-006-9118-7; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nemoto T, 2004, FEBS LETT, V571, P182, DOI 10.1016/j.febslet.2004.07.002; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Shikata M, 2003, BIOSCI BIOTECH BIOCH, V67, P2495, DOI 10.1271/bbb.67.2495; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; TAMOGAMI S, 1993, TETRAHEDRON, V49, P2025, DOI 10.1016/S0040-4020(01)86302-X; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Yajima A, 2000, EUR J ORG CHEM, V2000, P4079	37	107	115	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26510	26518		10.1074/jbc.M109.036871	http://dx.doi.org/10.1074/jbc.M109.036871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635799	Green Published, hybrid			2022-12-25	WOS:000269969600032
J	Romanova, L; Kellner, S; Katoku-Kikyo, N; Kikyo, N				Romanova, Liudmila; Kellner, Steven; Katoku-Kikyo, Nobuko; Kikyo, Nobuaki			Novel Role of Nucleostemin in the Maintenance of Nucleolar Architecture and Integrity of Small Nucleolar Ribonucleoproteins and the Telomerase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; DYSKERATOSIS-CONGENITA; PROTEIN; RNA; RNPS; PROLIFERATION; PURIFICATION; BIOGENESIS; PROMOTES; NUCLEAR	Nucleostemin (NS) is a nucleolar protein involved in the regulation of cell proliferation. Both overexpression and knockdown of NS increase the activity of the tumor suppressor protein p53, resulting in cell cycle arrest. In addition, NS regulates processing of pre-rRNA and consequently the level of total protein synthesis. Here, we describe a previously uncharacterized function of NS in the maintenance of the tripartite nucleolar structure as well as the integrity of small nucleolar ribonucleoproteins (snoRNPs). NS is also necessary to maintain the telomerase complex which shares common protein subunits with the H/ACA box snoRNPs. First, immunofluorescence microscopy and electron microscopy demonstrated that knockdown of NS disorganized the nucleolar architecture, in particular, the dense fibrillar component where snoRNPs are localized. Second, gel filtration chromatography and immunoprecipitation indicated that NS depletion leads to dissociation of the components of snoRNPs and the telomerase complex. Third, NS depletion reduced both telomerase activity and the cellular level of pseudouridine, an H/ACA snoRNP-mediated modification of rRNA and other RNAs that are important for their folding and stability. These morphological, biochemical and functional studies demonstrate that NS plays an important role to maintain nucleolar structure and function on a more fundamental level than previously thought.	[Romanova, Liudmila; Kellner, Steven; Katoku-Kikyo, Nobuko; Kikyo, Nobuaki] Univ Minnesota, Stem Cell Inst, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kikyo, N (corresponding author), Univ Minnesota, Stem Cell Inst, Dept Med, Div Hematol Oncol & Transplantat, Rm 2-216,MTRF,Mail Code 2873,2001 6th St SE, Minneapolis, MN 55455 USA.	kikyo001@umn.edu			National Institutes of Health [R01 GM068027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068027 (to N. K.).	Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Fan Y, 2006, BRIT J CANCER, V94, P1658, DOI 10.1038/sj.bjc.6603145; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gerbi SA, 2004, MOL BIOL INTELL UNIT, P170; Gonda K, 2006, J BIOL CHEM, V281, P8153, DOI 10.1074/jbc.M512890200; Grosjean Henri, 2004, Methods Mol Biol, V265, P357; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; Ma HH, 2008, MOL BIOL CELL, V19, P2870, DOI 10.1091/mbc.E08-02-0128; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Ma HH, 2008, TRENDS CELL BIOL, V18, P575, DOI 10.1016/j.tcb.2008.09.003; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Olson MOJ, 2002, INT REV CYTOL, V219, P199; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Politz JCR, 2005, MOL BIOL CELL, V16, P3401, DOI 10.1091/mbc.E05-02-0106; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	42	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26685	26694		10.1074/jbc.M109.013342	http://dx.doi.org/10.1074/jbc.M109.013342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648109	hybrid, Green Published			2022-12-25	WOS:000269969600049
J	Pochynyuk, O; Kucher, V; Boiko, N; Mironova, E; Staruschenko, A; Karpushev, AV; Tong, QS; Hendron, E; Stockand, J				Pochynyuk, Oleh; Kucher, Volodymyr; Boiko, Nina; Mironova, Elena; Staruschenko, Alexander; Karpushev, Alexey V.; Tong, Qiusheng; Hendron, Eunan; Stockand, James			Intrinsic Voltage Dependence of the Epithelial Na+ Channel Is Masked by a Conserved Transmembrane Domain Tryptophan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; CORTICAL COLLECTING TUBULE; M2 PROTON CHANNEL; INFLUENZA-A VIRUS; ION CHANNELS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; MOLECULAR MECHANISMS; STRUCTURAL BASIS; SODIUM-CHANNEL; MEMBRANE	Tryptophan residues critical to function are frequently located at the lipid-water interface of transmembrane domains. All members of the epithelial Na+ channel (ENaC)/Degenerin (Deg) channel superfamily contain an absolutely conserved Trp at the base of their first transmembrane domain. Here, we test the importance of this conserved Trp to ENaC/Deg function. Targeted substitution of this Trp in mouse ENaC and rat ASIC subunits decrease channel activity. Differential substitution with distinct amino acids in alpha-mENaC shows that it is loss of this critical Trp rather than introduction of residues having novel properties that changes channel activity. Surprisingly, Trp substitution unmasks voltage sensitivity. Mutant ENaC has increased steady-state activity at hyperpolarizing compared with depolarizing potentials associated with transient activation and deactivation times, respectively. The times of activation and deactivation change 1 ms/mV in a linear manner with rising and decreasing slopes, respectively. Increases in macroscopic currents at hyperpolarizing potentials results from a voltage-dependent increase in open probability. Voltage sensitivity is not influenced by divalent cations; however, it is Na+-dependentwitha 63-mV decrease in voltage required to reach half-maximal activity per log increase in [Na+]. Mutant channels are particularly sensitive to intracellular [Na+] for removing this sodium abolishes voltage dependence. We conclude that the conserved Trp at the base of TM1 in ENaC/Deg channels protects against voltage by masking an inhibitory allosteric or pore block mechanism, which decreases activity in response to intracellular Na+.	[Pochynyuk, Oleh; Kucher, Volodymyr; Boiko, Nina; Mironova, Elena; Tong, Qiusheng; Hendron, Eunan; Stockand, James] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Staruschenko, Alexander; Karpushev, Alexey V.] Med Coll Wisconsin, Dept Physiol, Kidney Dis Ctr, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Health San Antonio; Medical College of Wisconsin	Stockand, J (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	stockand@uthscsa.edu	Karpushev, Alexey/K-5371-2014	Karpushev, Alexey/0000-0001-8437-6424; Staruschenko, Alexander/0000-0002-5190-8356; Stockand, James/0000-0002-3817-4319	National Institutes of Health [R01DK70571]; AHA [0640054N, 0730111N]; Carl W. Gottschalk Research Scholar; American Heart Association [0825062F]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Carl W. Gottschalk Research Scholar; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK70571 and AHA Grants 0640054N ( to J.D.S.) and 0730111N. This work was also supported by a Carl W. Gottschalk Research Scholar Grant ( American Society of Nephrology) ( to A. S.) and 0825062F ( American Heart Association) ( to O.P.).	Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; Booth RE, 2003, AM J PHYSIOL-RENAL, V284, pF938, DOI 10.1152/ajprenal.00373.2002; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Haney EF, 2007, BBA-BIOMEMBRANES, V1768, P2355, DOI 10.1016/j.bbamem.2007.04.018; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2006, J BIOL CHEM, V281, P30455, DOI 10.1074/jbc.M604615200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loussouarn G, 2002, TRENDS CARDIOVAS MED, V12, P253, DOI 10.1016/S1050-1738(02)00170-6; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Oezdirekcan S, 2008, BIOPHYS J, V94, P1315, DOI 10.1529/biophysj.106.101782; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; PALMER LG, 1988, J GEN PHYSIOL, V92, P121, DOI 10.1085/jgp.92.1.121; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SILVER RB, 1993, AM J PHYSIOL, V264, pF557, DOI 10.1152/ajprenal.1993.264.3.F557; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2007, DEV NEUROBIOL, V67, P97, DOI 10.1002/dneu.20338; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tang P, 2002, P NATL ACAD SCI USA, V99, P16035, DOI 10.1073/pnas.252522299; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Williamson IM, 2003, CELL MOL LIFE SCI, V60, P1581, DOI 10.1007/s00018-003-3172-y; Witter R, 2008, J AM CHEM SOC, V130, P918, DOI 10.1021/ja0754305; Xiang F, 2007, J PHYS CHEM B, V111, P12282, DOI 10.1021/jp073883q; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	41	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25512	25521		10.1074/jbc.M109.015917	http://dx.doi.org/10.1074/jbc.M109.015917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620245	hybrid, Green Published			2022-12-25	WOS:000269738000008
J	Roman, AC; Carvajal-Gonzalez, JM; Rico-Leo, EM; Fernandez-Salguero, PM				Carlos Roman, Angel; Carvajal-Gonzalez, Jose M.; Rico-Leo, Eva M.; Fernandez-Salguero, Pedro M.			Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-beta Overexpression in the Stroma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; MOUSE EMBRYO FIBROBLASTS; TGF-BETA; NULL MICE; BRANCHING MORPHOGENESIS; CONSTITUTIVE EXPRESSION; TUMOR MICROENVIRONMENT; VASCULAR DEVELOPMENT; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY	Angiogenesis has key roles in development and in the progression of human diseases such as cancer. Consequently, identifying the novel markers and regulators of angiogenesis is a critical task. The dioxin receptor (AhR) contributes to vascular homeostasis and to the endothelial response to toxins, although the mechanisms involved are largely uncharacterized. Here, we show that AhR-null mice (AhR(-/-)) have impaired angiogenesis in vivo that compromises tumor xenograft growth. Aortic rings emigration experiments and RNA interference indicated that AhR(-/-) endothelial cells failed to branch and to form tube-like structures. Such a phenotype was found to be vascular endothelial growth factor (VEGF)-dependent, as AhR(-/-) aortic endothelial cells (MAECs) secreted lower amounts of active VEGF-A and their treatment with VEGF-A rescued angiogenesis in culture and in vivo. Further, the addition of anti-VEGF antibody to AhR(-/-) MAECs reduced angiogenesis. Treatment under hypoxic conditions with 2-methoxyestradiol suggested that HIF-1 alpha modulates endothelial VEGF expression in an AhR-dependent manner. Importantly, AhR-null stromal myofibroblasts produced increased transforming growth factor-beta (TGF beta) activity, which inhibited angiogenesis in human endothelial cells (HMECs) and AhR(-/-) mice, whereas the co-culture of HMECs with AhR(-/-) myofibroblasts or with their conditioned medium inhibited branching, which was restored by an anti-TGF beta antibody. Moreover, VEGF and TGF beta activities cooperated in modulating angiogenesis, as the addition of TGF beta to AhR(-/-) MAECs further reduced their low basal VEGF-A activity. Thus, AhR modulates angiogenesis through a mechanism requiring VEGF activation in the endothelium and TGF beta inactivation in the stroma. These data highlight the role of AhR in cardiovascular homeostasis and suggest that this receptor can be a novel regulator of angiogenesis during tumor development.	[Carlos Roman, Angel; Carvajal-Gonzalez, Jose M.; Rico-Leo, Eva M.; Fernandez-Salguero, Pedro M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain	Universidad de Extremadura	Fernandez-Salguero, PM (corresponding author), Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, Ave Elvas S-N, E-06071 Badajoz, Spain.	pmfersal@unex.es	Fernandez-Salguero, Pedro M./J-8437-2014; Carvajal-Gonzalez, Jose Maria/ABC-6780-2020	Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Carvajal-Gonzalez, Jose Maria/0000-0001-6576-830X	Spanish Ministry of Science and Innovation [SAF2008-00462]; Junta de Extremadura [GRU08012, GRU09001]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/1016]; European Union FEDER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); European Union FEDER(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF2008-00462), the Junta de Extremadura (GRU08012 and GRU09001), and the Red Tematica de Investigacion Cooperativa en Cancer (RTICC) (RD06/0020/1016, Fondo de Investigaciones Sanitarias (FIS), Carlos III Institute, Spanish Ministry of Health) (to P.M.F.-S.). All Spanish funding was co-sponsored by the European Union FEDER program.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bohnsack BL, 2004, CELL CYCLE, V3, P1506, DOI 10.4161/cc.3.12.1334; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Childs S, 2002, DEVELOPMENT, V129, P973; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Corchero J, 2004, INT J EXP PATHOL, V85, P295, DOI 10.1111/j.0959-9673.2004.00397.x; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dor Y, 2003, TRENDS CELL BIOL, V13, P131, DOI 10.1016/S0962-8924(03)00022-9; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; Feng Y, 2009, NEUROSCIENCE, V158, P823, DOI 10.1016/j.neuroscience.2008.10.024; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; GOMEZDURAN A, 2008, BIOCH PHARM; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Ichihara S, 2007, ARTERIOSCL THROM VAS, V27, P1297, DOI 10.1161/ATVBAHA.106.138701; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lloyd RV, 2003, MICROSC RES TECHNIQ, V60, P244, DOI 10.1002/jemt.10263; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lund AK, 2006, TOXICOL APPL PHARM, V212, P127, DOI 10.1016/j.taap.2005.07.005; Lund AK, 2003, TOXICOL APPL PHARM, V193, P177, DOI 10.1016/j.taap.2003.08.008; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Peng L, 2008, TOXICOLOGY, V246, P242, DOI 10.1016/j.tox.2008.01.002; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Pollenz RS, 1999, MOL PHARMACOL, V56, P1127, DOI 10.1124/mol.56.6.1127; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Santiago-Josefat B, 2004, J CELL SCI, V117, P849, DOI 10.1242/jcs.00932; Takeuchi A, 2009, INVEST OPHTH VIS SCI, V50, P3410, DOI 10.1167/iovs.08-2299; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tomanek RJ, 2001, DEV DYNAM, V221, P265, DOI 10.1002/dvdy.1137; Vasquez Alejandro, 2003, Cardiovasc Toxicol, V3, P153, DOI 10.1385/CT:3:2:153; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313; Zhang QZ, 2005, MOL CANCER THER, V4, P1465, DOI 10.1158/1535-7163.MCT-05-0198; Zhang ZH, 2008, BLOOD, V111, P1980, DOI 10.1182/blood-2007-06-094680	73	57	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25135	25148		10.1074/jbc.M109.013292	http://dx.doi.org/10.1074/jbc.M109.013292			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617630	hybrid, Green Published			2022-12-25	WOS:000269734000048
J	O'Leary, B; Rao, SK; Kim, J; Plaxton, WC				O'Leary, Brendan; Rao, Srinath K.; Kim, Julia; Plaxton, William C.			Bacterial-type Phosphoenolpyruvate Carboxylase (PEPC) Functions as a Catalytic and Regulatory Subunit of the Novel Class-2 PEPC Complex of Vascular Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASTOR-OIL SEEDS; ALGA SELENASTRUM-MINUTUM; MICROALGA CHLAMYDOMONAS-REINHARDTII; MOLECULAR-MASS ISOFORMS; FATTY-ACID SYNTHESIS; UNRELATED POLYPEPTIDES; ARABIDOPSIS-THALIANA; EXPRESSION ANALYSIS; KINETIC-PROPERTIES; PHOSPHORYLATION	Phosphoenolpyruvate carboxylase (PEPC) is a tightly regulated anaplerotic enzyme situated at a major branch point of the plant C metabolism. Two distinct oligomeric classes of PEPC occur in the triglyceride-rich endosperm of developing castor oil seeds (COS). Class-1 PEPC is a typical homotetramer composed of identical 107-kDa plant-type PEPC (PTPC) subunits (encoded by RcPpc3), whereas the novel Class-2 PEPC 910-kDa hetero-octameric complex arises from a tight interaction between Class-1 PEPC and distantly related 118-kDa bacterial-type PEPC (BTPC) polypeptides (encoded by RcPpc4). Here, COS BTPC was expressed from full-length RcPpc4 cDNA in Escherichia coli as an active PEPC that exhibited unusual properties relative to PTPCs, including a tendency to form large aggregates, enhanced thermal stability, a high K-m(PEP), and insensitivity to metabolite effectors. A chimeric 900-kDa Class-2 PEPC hetero-octamer having a 1:1 stoichiometry of BTPC: PTPC subunits was isolated from a mixture of clarified extracts containing recombinant RcPPC4 and an Arabidopsis thaliana Class-1 PEPC (the PTPC, AtPPC3). The purified Class-2 PEPC exhibited biphasic PEP saturation kinetics with high and low affinity sites attributed to its AtPPC3 and RcPPC4 subunits, respectively. The RcPPC4 subunits: (i) catalyzed the majority of the Class-2 PEPC V-max, particularly in the presence of the inhibitor L-malate, and (ii) also functioned as Class-2 PEPC regulatory subunits by modulating PEP binding and catalytic potential of its AtPPC3 subunits. BTPCs appear to associate with PTPCs to form stable Class-2 PEPC complexes in vivo that are hypothesized to maintain high flux from PEP under physiological conditions that would otherwise inhibit Class-1 PEPCs.	[O'Leary, Brendan; Rao, Srinath K.; Kim, Julia; Plaxton, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Plaxton, William C.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Plaxton, WC (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	plaxton@queensu.ca	O'Leary, Brendan M/C-4680-2014; Plaxton, William C/O-3353-2013	O'Leary, Brendan M/0000-0002-8770-155X; Plaxton, William C/0000-0002-8447-7249	Natural Sciences and Engineering Research Council of Canada (NSERC); Queen's Research Chairs program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen's Research Chairs program	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Queen's Research Chairs program (to W.C. P.).	Blonde JD, 2003, J BIOL CHEM, V278, P11867, DOI 10.1074/jbc.M211269200; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Eastmond PJ, 1997, PLANT PHYSIOL, V114, P851, DOI 10.1104/pp.114.3.851; Gennidakis S, 2007, PLANT J, V52, P839, DOI 10.1111/j.1365-313X.2007.03274.x; Gousset-Dupont A, 2005, PLANT SCI, V169, P1096, DOI 10.1016/j.plantsci.2005.07.014; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; Gregory AL, 2009, BIOCHEM J, V420, P57, DOI 10.1042/BJ20082397; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; Kim M, 2007, PROTEIN EXPRES PURIF, V52, P230, DOI 10.1016/j.pep.2006.11.003; Law RD, 1997, EUR J BIOCHEM, V247, P642, DOI 10.1111/j.1432-1033.1997.00642.x; Mamedov TG, 2005, PLANT J, V42, P832, DOI 10.1111/j.1365-313X.2005.02416.x; Moellering ER, 2007, FEBS LETT, V581, P4871, DOI 10.1016/j.febslet.2007.09.015; Moraes TF, 2000, EUR J BIOCHEM, V267, P4465, DOI 10.1046/j.1432-1327.2000.01495.x; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; Rivoal J, 1996, ARCH BIOCHEM BIOPHYS, V332, P47, DOI 10.1006/abbi.1996.0315; Rivoal J, 1998, BIOCHEM J, V331, P201, DOI 10.1042/bj3310201; Rivoal J, 2002, PLANT CELL PHYSIOL, V43, P785, DOI 10.1093/pcp/pcf092; Rivoal J, 2001, J BIOL CHEM, V276, P12588, DOI 10.1074/jbc.M010150200; Sanchez R, 2006, PLANTA, V223, P901, DOI 10.1007/s00425-005-0144-5; Sanchez R, 2003, PLANT PHYSIOL, V132, P949, DOI 10.1104/pp.102.019653; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; Takahashi-Terada A, 2005, J BIOL CHEM, V280, P11798, DOI 10.1074/jbc.M408768200; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796; Tripodi KE, 2005, PLANT PHYSIOL, V139, P969, DOI 10.1104/pp.105.066647; Uhrig RG, 2008, J BIOL CHEM, V283, P29650, DOI 10.1074/jbc.M806102200; Uhrig RG, 2008, PLANT PHYSIOL, V146, P1346, DOI 10.1104/pp.107.110361; Xu WX, 2006, J BIOL CHEM, V281, P17238, DOI 10.1074/jbc.M602299200; Yuan JP, 2006, PHOTOSYNTH RES, V88, P73, DOI 10.1007/s11120-005-9032-x	32	46	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24797	24805		10.1074/jbc.M109.022863	http://dx.doi.org/10.1074/jbc.M109.022863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605358	Green Published, hybrid			2022-12-25	WOS:000269734000014
J	Karanika, M; Vasilopoulou, VA; Katsioulis, AT; Papastergiou, P; Theodoridou, MN; Hadjichristodoulou, CS				Karanika, Maria; Vasilopoulou, Vasiliki A.; Katsioulis, Antonios T.; Papastergiou, Panagiotis; Theodoridou, Maria N.; Hadjichristodoulou, Christos S.			Diagnostic Clinical and Laboratory Findings in Response to Predetermining Bacterial Pathogen: Data from the Meningitis Registry	PLOS ONE			English	Article							INFLUENZAE TYPE-B; CEREBROSPINAL-FLUID PLEOCYTOSIS; PNEUMOCOCCAL MENINGITIS; PROGNOSTIC-FACTORS; CONJUGATE VACCINE; CHILDREN; FEATURES; DISEASE; SURVEILLANCE; INDICATORS	Background: Childhood Meningitis continues to be an important cause of mortality in many countries. The search for rapid diagnosis of acute bacterial meningitis has lead to the further exploration of prognostic factors. This study was scheduled in an attempt to analyze various clinical symptoms as well as rapid laboratory results and provide an algorithm for the prediction of specific bacterial aetiology of childhood bacterial meningitis. Methodology and Principal Findings: During the 32 year period, 2477 cases of probable bacterial meningitis (BM) were collected from the Meningitis Registry (MR). Analysis was performed on a total of 1331 confirmed bacterial meningitis cases of patients aged 1 month to 14 years. Data was analysed using EPI INFO (version 3.4.3-CDC-Atlanta) and SPSS (version 15.0 - Chicago) software. Statistically significant (p < 0.05) variables were included in a conditional backward logistic regression model. A total of 838 (63.0%) attributed to Neisseria meningitidis, 252 (18.9%) to Haemophilus influenzae, 186 (14.0%) to Streptococcus pneumoniae and 55 (4.1%) due to other bacteria. For the diagnosis of Meningococcal Meningitis, the most significant group of diagnostic criteria identified included haemorrhagic rash (OR 22.36), absence of seizures (OR 2.51), headache (OR 1.83) and negative gram stain result (OR 1.55) with a Positive Predictive Value (PPV) of 96.4% (95% CI 87.7-99.6). For the diagnosis of Streptococcus pneumoniae, the most significant group of diagnostic criteria identified included absence of haemorrhagic rash ( OR 13.62), positive gram stain (OR 2.10), coma (OR 3.11), seizures (OR 3.81) and peripheral WBC >= 15000/mu L (OR 2.19) with a PPV of 77.8% ( 95% CI 40.0-97.2). For the diagnosis of Haemophilus influenzae, the most significant group of diagnostic criteria included, absence of haemorrhagic rash (OR 13.61), age >= 1year (OR 2.04), absence of headache (OR 3.01), CSF Glu < 40 mg/dL (OR 3.62) and peripheral WBC < 15000/mu L (OR 1.74) with a PPV of 58.5% (95% CI 42.1-73.7). Conclusions: The use of clinical and laboratory predictors for the assessment of the causative bacterial pathogen rather than just for predicting outcome of mortality seems to be a useful tool in the clinical management and specific treatment of BM. These findings should be further explored and studied.			Karanika, M (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Thessaly, Greece.	xhatzi@med.uth.gr		Papastergiou, Panagiotis/0000-0002-2986-3163; Hadjichristodoulou, Christos/0000-0002-4769-8376				Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Arda B, 2008, MED PRIN PRACT, V17, P76, DOI 10.1159/000109595; Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; BAKER RC, 1989, PEDIATRICS, V84, P1051; Berkley JA, 2004, PEDIATRICS, V114, pE713, DOI 10.1542/peds.2004-0007; BOHR V, 1985, J INFECTION, V10, P143, DOI 10.1016/S0163-4453(85)91585-3; Bonsu BK, 2004, PEDIATR INFECT DIS J, V23, P511, DOI 10.1097/01.inf.0000129689.58211.9e; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P234; Ceyhan M, 2008, EMERG INFECT DIS, V14, P1089, DOI 10.3201/eid1407.070938; Chao YN, 2008, J MICROBIOL IMMUNOL, V41, P48; Chavez-Bueno S, 2005, PEDIATR CLIN N AM, V52, P795, DOI 10.1016/j.pcl.2005.02.011; CHAVEZBUENO S, 2005, PEDIATR CLIN N AM, V52, pR7; Dubos F, 2008, J PEDIATR-US, V152, P378, DOI 10.1016/j.jpeds.2007.07.012; Farag H F M, 2005, Indian J Med Microbiol, V23, P95; FEIGIN RD, 2003, TXB PEDIAT INFECT DI, P443; Freedman SB, 2001, ARCH PEDIAT ADOL MED, V155, P1301, DOI 10.1001/archpedi.155.12.1301; Heath PT, 2001, PEDIATR INFECT DIS J, V20, P300, DOI 10.1097/00006454-200103000-00016; Hoen B, 1993, Eur J Med, V2, P28; Howitz M, 2008, SCAND J INFECT DIS, V40, P881, DOI 10.1080/00365540802325914; Kim JS, 2004, VACCINE, V22, P3952, DOI 10.1016/j.vaccine.2004.04.003; Kornelisse RF, 1995, CLIN INFECT DIS, V21, P1390, DOI 10.1093/clinids/21.6.1390; Lagunju I A, 2008, Afr J Med Med Sci, V37, P185; Lazzarini L, 2008, J CHEMOTHERAPY, V20, P478, DOI 10.1179/joc.2008.20.4.478; Lovera D, 2005, TROP MED INT HEALTH, V10, P1235, DOI 10.1111/j.1365-3156.2005.01513.x; Manchanda V, 2006, Indian J Med Microbiol, V24, P7; Minz S, 2008, INDIAN J MED RES, V128, P57; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nigrovic LE, 2007, JAMA-J AM MED ASSOC, V297, P52, DOI 10.1001/jama.297.1.52; Nigrovic LE, 2008, ACAD EMERG MED, V15, P522, DOI 10.1111/j.1553-2712.2008.00117.x; Ostergaard C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-93; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Peltola V, 2006, J PEDIATR-US, V149, P721, DOI 10.1016/j.jpeds.2006.08.051; Ragunathan L, 2000, J INFECTION, V40, P74, DOI 10.1053/jinf.1999.0595; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Theodoridou MN, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-101; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; TSAI MH, 2008, J TROPICAL IN PRESS; Tsolia MN, 1998, SCAND J INFECT DIS, V30, P165, DOI 10.1080/003655498750003564; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; WILBERG K, 2008, SOUTH MED J, V101, P6; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445; World Health Organization, 1996, VACC RES DEV GEN PRO; 2005, 1 CAN COMM DIS, V31, P241	45	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6426	10.1371/journal.pone.0006426	http://dx.doi.org/10.1371/journal.pone.0006426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641629	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500026
J	Tavanez, JP; Bengoechea, R; Berciano, MT; Lafarga, M; Carmo-Fonseca, M; Enguita, FJ				Tavanez, Joao Paulo; Bengoechea, Rocio; Berciano, Maria T.; Lafarga, Miguel; Carmo-Fonseca, Maria; Enguita, Francisco J.			Hsp70 Chaperones and Type I PRMTs Are Sequestered at Intranuclear Inclusions Caused by Polyalanine Expansions in PABPN1	PLOS ONE			English	Article								Genomic instability at loci with tandem arrays of simple repeats is the cause for many neurological, neurodegenerative and neuromuscular diseases. When located in coding regions, disease-associated expansions of trinucleotide repeats are translated into homopolymeric amino acid stretches of glutamine or alanine. Polyalanine expansions in the poly(A)-binding protein nuclear 1 (PABPN1) gene causes oculopharyngeal muscular dystrophy (OPMD). To gain novel insight into the molecular pathophysiology of OPMD, we studied the interaction of cellular proteins with normal and expanded PABPN1. Pull-down assays show that heat shock proteins including Hsp70, and type I arginine methyl transferases (PRMT1 and PRMT3) associate preferentially with expanded PABPN1. Immunofluorescence microscopy further reveals accumulation of these proteins at intranuclear inclusions in muscle from OPMD patients. Recombinant PABPN1 with expanded polyalanine stretches binds Hsp70 with higher affinity, and data from molecular simulations suggest that expansions of the PABPN1 polyalanine tract result in transition from a disordered, flexible conformation to a stable helical secondary structure. Taken together, our results suggest that the pathological mutation in the PABPN1 gene alters the protein conformation and induces a preferential interaction with type I PRMTs and Hsp70 chaperones. This in turn causes sequestration in intranuclear inclusions, possibly leading to a progressive cellular defect in arginine methylation and chaperone activity.			Tavanez, JP (corresponding author), ICREA, Barcelona, Spain.	fenguita@fm.ul.pt	Lafarga, Miguel/K-3733-2014; Enguita, Francisco J./A-2347-2009; Tavanez, Joao/K-2179-2017	Enguita, Francisco J./0000-0002-8072-8557; Tavanez, Joao/0000-0001-6278-5454; Carmo-Fonseca, Maria/0000-0002-3402-7143; Lafarga, Miguel/0000-0003-3402-1152; Berciano, Maria T./0000-0002-8225-6995	ICREA Funding Source: Custom	ICREA(ICREA)		Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Almeida F, 1998, J CELL BIOL, V142, P899, DOI 10.1083/jcb.142.4.899; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Catoire H, 2008, HUM MOL GENET, V17, P2108, DOI 10.1093/hmg/ddn109; Chartier A, 2006, EMBO J, V25, P2253, DOI 10.1038/sj.emboj.7601117; COLLOCH N, 1993, PROTEIN ENG, V6, P377, DOI 10.1093/protein/6.4.377; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Enguita FJ, 1996, J BIOL CHEM, V271, P33225, DOI 10.1074/jbc.271.52.33225; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; Ge HH, 2008, PROTEINS, V71, P1539, DOI 10.1002/prot.21973; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Klein AF, 2008, EXP CELL RES, V314, P1652, DOI 10.1016/j.yexcr.2008.02.005; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lavoie H, 2003, HUM MOL GENET, V12, P2967, DOI 10.1093/hmg/ddg329; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Curto LM, 2009, PROTEIN SCI, V18, P735, DOI 10.1002/pro.71; OJEDA JL, 1989, STAIN TECHNOL, V64, P243, DOI 10.3109/10520298909107009; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Rohrberg J, 2008, FEBS LETT, V582, P1587, DOI 10.1016/j.febslet.2008.04.002; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Song JK, 2008, P NATL ACAD SCI USA, V105, P15317, DOI 10.1073/pnas.0801274105; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Weathers EA, 2004, FEBS LETT, V576, P348, DOI 10.1016/j.febslet.2004.09.036; Weaver TM, 2000, PROTEIN SCI, V9, P201; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200	53	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6418	10.1371/journal.pone.0006418	http://dx.doi.org/10.1371/journal.pone.0006418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641605	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500019
J	Abranches, E; Silva, M; Pradier, L; Schulz, H; Hummel, O; Henrique, D; Bekman, E				Abranches, Elsa; Silva, Margarida; Pradier, Laurent; Schulz, Herbert; Hummel, Oliver; Henrique, Domingos; Bekman, Evguenia			Neural Differentiation of Embryonic Stem Cells In Vitro: A Road Map to Neurogenesis in the Embryo	PLOS ONE			English	Article							ADULT SUBVENTRICULAR ZONE; VERTEBRATE BODY AXIS; NEURONAL DIFFERENTIATION; NEUROEPITHELIAL CELLS; RETINOID PATHWAYS; OPPOSING FGF; ES CELLS; EXPRESSION; INDUCTION; GENES	Background: The in vitro generation of neurons from embryonic stem (ES) cells is a promising approach to produce cells suitable for neural tissue repair and cell-based replacement therapies of the nervous system. Available methods to promote ES cell differentiation towards neural lineages attempt to replicate, in different ways, the multistep process of embryonic neural development. However, to achieve this aim in an efficient and reproducible way, a better knowledge of the cellular and molecular events that are involved in the process, from the initial specification of neuroepithelial progenitors to their terminal differentiation into neurons and glial cells, is required. Methodology/Principal Findings: In this work, we characterize the main stages and transitions that occur when ES cells are driven into a neural fate, using an adherent monolayer culture system. We established improved conditions to routinely produce highly homogeneous cultures of neuroepithelial progenitors, which organize into neural tube-like rosettes when they acquire competence for neuronal production. Within rosettes, neuroepithelial progenitors display morphological and functional characteristics of their embryonic counterparts, namely, apico-basal polarity, active Notch signalling, and proper timing of production of neurons and glia. In order to characterize the global gene activity correlated with each particular stage of neural development, the full transcriptome of different cell populations that arise during the in vitro differentiation protocol was determined by microarray analysis. By using embryo-oriented criteria to cluster the differentially expressed genes, we define five gene expression signatures that correlate with successive stages in the path from ES cells to neurons. These include a gene signature for a primitive ectoderm-like stage that appears after ES cells enter differentiation, and three gene signatures for subsequent stages of neural progenitor development, from an early stage that follows neural induction to a final stage preceding terminal differentiation. Conclusions/Significance: Overall, our work confirms and extends the cellular and molecular parallels between monolayer ES cell neural differentiation and embryonic neural development, revealing in addition novel aspects of the genetic network underlying the multistep process that leads from uncommitted cells to differentiated neurons.			Abranches, E (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	henrique@fm.ul.pt	Abranches, Elsa/D-4324-2012; Bekman, Evguenia/O-9840-2017; Henrique, Domingos M/E-5460-2010; Bekman, Evguenia Pavlovna/AAC-3218-2019	Abranches, Elsa/0000-0003-4493-6065; Bekman, Evguenia/0000-0002-3963-1358; Henrique, Domingos M/0000-0001-8869-1894; Bekman, Evguenia Pavlovna/0000-0002-3963-1358				Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cai C, 2007, DEV DYNAM, V236, P3255, DOI 10.1002/dvdy.21306; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Coffinier C, 2001, MECH DEVELOP, V100, P119, DOI 10.1016/S0925-4773(00)00507-4; Conti L, 2005, TRENDS NEUROSCI, V28, P57, DOI 10.1016/j.tins.2004.11.005; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Edwards YJK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002712; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hoang BH, 1998, DEV DYNAM, V212, P364, DOI 10.1002/(SICI)1097-0177(199807)212:3<364::AID-AJA4>3.0.CO;2-F; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MAGAVI SS, 2008, IMMUNOCYTOCHEMICAL A, P345; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Pelton TA, 2002, J CELL SCI, V115, P329; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pollard SM, 2006, REGEN MED, V1, P111, DOI 10.2217/17460751.1.1.111; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rathjen J, 1999, J CELL SCI, V112, P601; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Webb SE, 2005, CELL CALCIUM, V37, P375, DOI 10.1016/j.ceca.2005.01.005; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	58	156	164	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6286	10.1371/journal.pone.0006286	http://dx.doi.org/10.1371/journal.pone.0006286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621087	Green Published, gold, Green Accepted			2022-12-25	WOS:000268147200003
J	Palaninathan, SK; Mohamedmohaideen, NN; Orlandini, E; Ortore, G; Nencetti, S; Lapucci, A; Rossello, A; Freundlich, JS; Sacchettini, JC				Palaninathan, Satheesh K.; Mohamedmohaideen, Nilofar N.; Orlandini, Elisabetta; Ortore, Gabriella; Nencetti, Susanna; Lapucci, Annalina; Rossello, Armando; Freundlich, Joel S.; Sacchettini, James C.			Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis	PLOS ONE			English	Article								Transthyretin (TTR) is one of thirty non-homologous proteins whose misfolding, dissociation, aggregation, and deposition is linked to human amyloid diseases. Previous studies have identified that TTR amyloidogenesis can be inhibited through stabilization of the native tetramer state by small molecule binding to the thyroid hormone sites of TTR. We have evaluated a new series of beta-aminoxypropionic acids (compounds 5-21), with a single aromatic moiety (aryl or fluorenyl) linked through a flexible oxime tether to a carboxylic acid. These compounds are structurally distinct from the native ligand thyroxine and typical halogenated biaryl NSAID-like inhibitors to avoid off-target hormonal or anti-inflammatory activity. Based on an in vitro fibril formation assay, five of these compounds showed significant inhibition of TTR amyloidogenesis, with two fluorenyl compounds displaying inhibitor efficacy comparable to the well-known TTR inhibitor diflunisal. Fluorenyl 15 is the most potent compound in this series and importantly does not show off-target anti-inflammatory activity. Crystal structures of the TTR: inhibitor complexes, in agreement with molecular docking studies, revealed that the aromatic moiety, linked to the sp(2)-hybridized oxime carbon, specifically directed the ligand in either a forward or reverse binding mode. Compared to the aryl family members, the bulkier fluorenyl analogs achieved more extensive interactions with the binding pockets of TTR and demonstrated better inhibitory activity in the fibril formation assay. Preliminary optimization efforts are described that focused on replacement of the C-terminal acid in both the aryl and fluorenyl series (compounds 22-32). The compounds presented here constitute a new class of TTR inhibitors that may hold promise in treating amyloid diseases associated with TTR misfolding.			Palaninathan, SK (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	eorlandini@farm.unipi.it; sacchett@tamu.edu	Nencetti, Susanna/AAF-3442-2021; Rossello, Armando/C-5803-2014; Rossello, Armando/S-7332-2019; Ortore, Gabriella/ABF-8828-2020	Rossello, Armando/0000-0002-6795-8091; Rossello, Armando/0000-0002-6795-8091; Ortore, Gabriella/0000-0002-1541-6258; NENCETTI, SUSANNA/0000-0002-3547-7277; LAPUCCI, ANNALINA/0000-0003-2348-0871; ORLANDINI, Elisabetta/0000-0003-3398-2787				Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Balsamo A, 2001, EUR J MED CHEM, V36, P799, DOI 10.1016/S0223-5234(01)01275-2; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Buxbaum JN, 2000, ANNU REV MED, V51, P543, DOI 10.1146/annurev.med.51.1.543; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; CORNWELL GG, 1988, BIOCHEM BIOPH RES CO, V154, P648, DOI 10.1016/0006-291X(88)90188-X; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; Gambetti P, 1998, NEPHROL DIAL TRANSPL, V13, P33, DOI 10.1093/ndt/13.suppl_7.33; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; JOHNSON SM, 2009, J MED CHEM; Julius RL, 2008, DRUG NEWS PERSPECT, V21, P258, DOI 10.1358/dnp.2008.21.5.1219011; Julius RL, 2007, P NATL ACAD SCI USA, V104, P4808, DOI 10.1073/pnas.0700316104; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; LAPUCCI A, 1994, EUR J MED CHEM, V29, P33, DOI 10.1016/0223-5234(94)90123-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maccarrone M, 1999, EUR J BIOCHEM, V265, P27, DOI 10.1046/j.1432-1327.1999.00630.x; MACCHIA B, 1990, J MED CHEM, V33, P1423, DOI 10.1021/jm00167a023; Mairal T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004124; McCammon MG, 2002, STRUCTURE, V10, P851, DOI 10.1016/S0969-2126(02)00771-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NILSSON SF, 1975, J BIOL CHEM, V250, P8554; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Peterson SA, 1998, P NATL ACAD SCI USA, V95, P12956, DOI 10.1073/pnas.95.22.12956; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purkey HE, 2004, CHEM BIOL, V11, P1719, DOI 10.1016/j.chembiol.2004.10.009; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Razgulin AV, 2006, J MED CHEM, V49, P7902, DOI 10.1021/jm0600702; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; RICHARDSON SJ, 1994, AM J PHYSIOL, V266, pR1359, DOI 10.1152/ajpregu.1994.266.4.R1359; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wojtczak A, 1996, ACTA CRYSTALLOGR D, V52, P758, DOI 10.1107/S0907444996003046; ZANOTTI G, 1995, EUR J BIOCHEM, V234, P563, DOI 10.1111/j.1432-1033.1995.563_b.x	52	35	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6290	10.1371/journal.pone.0006290	http://dx.doi.org/10.1371/journal.pone.0006290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621084	Green Submitted, Green Published, gold			2022-12-25	WOS:000268147200004
J	Srivastava, SS; Pany, S; Sneh, A; Ahmed, N; Rahman, A; Musti, KV				Srivastava, Saumya S.; Pany, Satyabrata; Sneh, Amita; Ahmed, Neesar; Rahman, Aejazur; Musti, Krishnasastry V.			Membrane Bound Monomer of Staphylococcal alpha-Hemolysin Induces Caspase Activation and Apoptotic Cell Death despite Initiation of Membrane Repair Pathway	PLOS ONE			English	Article								Background: Wild type Staphylococcal alpha-hemolysin (alpha-HL) assembly on target mammalian cells usually results in necrotic form of cell death; however, caspase activation also occurs. The pathways of caspase activation due to binding/partial assembly by alpha-HL are unknown till date. Results: Cells treated with H35N (a mutant of alpha-HL that remains as membrane bound monomer), have been shown to accumulate hypodiploid nuclei, activate caspases and induce intrinsic mitochondrial apoptotic pathway. We have earlier shown that the binding and assembly of alpha-HL requires functional form of Caveolin-1 which is an integral part of caveolae. In this report, we show that the caveolae of mammalian cells, which undergo a continuous cycle of 'kiss and run' dynamics with the plasma membrane, have become immobile upon the binding of the monomer. The cells treated with H35N were unable to recover despite activation of membrane repair mechanism involving caspase-1 dependent activation of sterol regulatory element binding protein-1. Conclusions: This is for the first time we show the range of cellular changes and responses that take place immediately after the binding of the monomeric form of staphylococcal alpha-hemolysin.			Srivastava, SS (corresponding author), Univ Pune Campus, Natl Ctr Cell Sci, Pune, Maharashtra, India.	mvks@nccs.res.in	Ahmed, Neesar/AAW-5473-2021; Rhaman, Aejazur/AAC-5104-2019	Rhaman, Aejazur/0000-0002-2616-3372; Ahmed, Neesar/0000-0002-7367-2188				Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; KRISHNASASTRY M, 1994, FEBS LETT, V356, P66, DOI 10.1016/0014-5793(94)01240-7; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Nuzzo I, 2000, FEMS IMMUNOL MED MIC, V27, P235, DOI 10.1111/j.1574-695X.2000.tb01435.x; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Shajahan AN, 2007, J BIOL CHEM, V282, P5934, DOI 10.1074/jbc.M608857200; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Vandana S, 2003, FEBS LETT, V535, P71, DOI 10.1016/S0014-5793(02)03862-0; Vandana S, 1997, J BIOL CHEM, V272, P24858, DOI 10.1074/jbc.272.40.24858; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V325, P344, DOI 10.1016/j.bbrc.2004.10.038; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1130, DOI 10.1016/j.bbrc.2004.09.164; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1124, DOI 10.1016/j.bbrc.2004.09.165; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6293	10.1371/journal.pone.0006293	http://dx.doi.org/10.1371/journal.pone.0006293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621082	Green Published, gold, Green Submitted			2022-12-25	WOS:000268147200005
J	Cousin, B; Ravet, E; Poglio, S; De Toni, F; Bertuzzi, M; Lulka, H; Touil, I; Andre, M; Grolleau, JL; Peron, JM; Chavoin, JP; Bourin, P; Penicaud, L; Casteilla, L; Buscail, L; Cordelier, P				Cousin, Beatrice; Ravet, Emmanuel; Poglio, Sandrine; De Toni, Fabienne; Bertuzzi, Melanie; Lulka, Hubert; Touil, Ismahane; Andre, Mireille; Grolleau, Jean-Louis; Peron, Jean-Marie; Chavoin, Jean-Pierre; Bourin, Philippe; Penicaud, Luc; Casteilla, Louis; Buscail, Louis; Cordelier, Pierre			Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo	PLOS ONE			English	Article								Background: Normal tissue homeostasis is maintained by dynamic interactions between epithelial cells and their microenvironment. Disrupting this homeostasis can induce aberrant cell proliferation, adhesion, function and migration that might promote malignant behavior. Indeed, aberrant stromal-epithelial interactions contribute to pancreatic ductal adenocarcinoma (PDAC) spread and metastasis, and this raises the possibility that novel stroma-targeted therapies represent additional approaches for combating this malignant disease. The aim of the present study was to determine the effect of human stromal cells derived from adipose tissue (ADSC) on pancreatic tumor cell proliferation. Principal Findings: Co-culturing pancreatic tumor cells with ADSC and ADSC-conditioned medium sampled from different donors inhibited cancer cell viability and proliferation. ADSC-mediated inhibitory effect was further extended to other epithelial cancer-derived cell lines (liver, colon, prostate). ADSC conditioned medium induced cancer cell necrosis following G1-phase arrest, without evidence of apoptosis. In vivo, a single intra-tumoral injection of ADSC in a model of pancreatic adenocarcinoma induced a strong and long-lasting inhibition of tumor growth. Conclusion: These data indicate that ADSC strongly inhibit PDAC proliferation, both in vitro and in vivo and induce tumor cell death by altering cell cycle progression. Therefore, ADSC may constitute a potential cell-based therapeutic alternative for the treatment of PDAC for which no effective cure is available.			Cousin, B (corresponding author), Univ Toulouse, UPS, UMR Metab Plast & Mitochondrie 5241, BP 84225, Toulouse, France.	beatrice.cousin@inserm.fr	Bourin, Philippe/J-2693-2019; LULKA, Hubert/M-7382-2014; Cordelier, Pierre/D-1150-2014	Bourin, Philippe/0000-0002-9652-4380; Cordelier, Pierre/0000-0003-2096-7967; Poglio, Sandrine/0000-0001-8783-0709; Cousin, Beatrice/0000-0003-2952-4601; Casteilla, Louis/0000-0001-9647-3248				Al-Khaldi A, 2003, ANN THORAC SURG, V75, P204, DOI 10.1016/S0003-4975(02)04291-1; Bai XW, 2007, FEBS LETT, V581, P4681, DOI 10.1016/j.febslet.2007.08.063; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Carrere N, 2005, HUM GENE THER, V16, P1175, DOI 10.1089/hum.2005.16.1175; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Cordelier P, 2007, CANCER GENE THER, V14, P19, DOI 10.1038/sj.cgt.7700987; Cui D, 2007, J EXP NANOSCI, V2, P13, DOI 10.1080/17458080600935590; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; Estes BT, 2006, ARTHRITIS RHEUM-US, V54, P1222, DOI 10.1002/art.21779; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Lamfers M, 2009, CANCER LETT, V274, P78, DOI 10.1016/j.canlet.2008.08.035; Lin YF, 2006, MOL CELL BIOCHEM, V291, P1, DOI 10.1007/s11010-006-9188-5; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Muehlberg FL, 2009, CARCINOGENESIS, V30, P589, DOI 10.1093/carcin/bgp036; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Safioleas MC, 2004, HEPATO-GASTROENTEROL, V51, P862; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Scadden DT, 2004, NAT IMMUNOL, V5, P701, DOI 10.1038/ni0704-701; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Sirach E, 2007, CELL DEATH DIFFER, V14, P1202, DOI 10.1038/sj.cdd.4402114; Song YH, 2007, BIOCHEM BIOPH RES CO, V354, P999, DOI 10.1016/j.bbrc.2007.01.095; Suga H, 2009, STEM CELLS DEV; Sun B, 2005, STEM CELLS DEV, V14, P292, DOI 10.1089/scd.2005.14.292; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Torrisani J, 2001, GASTROENTEROLOGY, V120, P200, DOI 10.1053/gast.2001.21192; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	53	162	176	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6278	10.1371/journal.pone.0006278	http://dx.doi.org/10.1371/journal.pone.0006278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609435	gold, Green Published			2022-12-25	WOS:000268119500013
J	DiMezzo, TL; Ruthel, G; Brueggemann, EE; Hines, HB; Ribot, WJ; Chapman, CE; Powell, BS; Welkos, SL				DiMezzo, Tracy L.; Ruthel, Gordon; Brueggemann, Ernst E.; Hines, Harry B.; Ribot, Wilson J.; Chapman, Carol E.; Powell, Bradford S.; Welkos, Susan L.			In Vitro Intracellular Trafficking of Virulence Antigen during Infection by Yersinia pestis	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; INNATE IMMUNE-RESPONSE; V-ANTIGEN; SHIGA TOXIN; RETROGRADE TRANSPORT; DIPHTHERIA-TOXIN; COLOCALIZATION ANALYSIS; PROTEIN TOXINS; FUSION PEPTIDE; ANTHRAX TOXIN	Yersinia pestis, the causative agent of plague, encodes several essential virulence factors on a 70 kb plasmid, including the Yersinia outer proteins (Yops) and a multifunctional virulence antigen (V). V is uniquely able to inhibit the host immune response; aid in the expression, secretion, and injection of the cytotoxic Yops via a type III secretion system (T3SS)dependent mechanism; be secreted extracellularly; and enter the host cell by a T3SS-independent mechanism, where its activity is unknown. To elucidate the intracellular trafficking and target(s) of V, time-course experiments were performed with macrophages (MWs) infected with Y. pestis or Y. pseudotuberculosis at intervals from 5 min to 6 h. The trafficking pattern was discerned from results of parallel microscopy, immunoblotting, and flow cytometry experiments. The MWs were incubated with fluorescent or gold conjugated primary or secondary anti-V (antibodies [Abs]) in conjunction with organelle-associated Abs or dyes. The samples were observed for co-localization by immuno-fluorescence and electron microscopy. For fractionation studies, uninfected and infected MWs were lysed and subjected to density gradient centrifugation coupled with immunoblotting with Abs to V or to organelles. Samples were also analyzed by flow cytometry after lysis and dual-staining with anti-V and anti-organelle Abs. Our findings indicate a co-localization of V with (1) endosomal proteins between 10-45 min of infection, (2) lysosomal protein(s) between 1-2 h of infection, (3) mitochondrial proteins between 2.5-3 h infection, and (4) Golgi protein(s) between 4-6 h of infection. Further studies are being performed to determine the specific intracellular interactions and role in pathogenesis of intracellularly localized V.			DiMezzo, TL (corresponding author), USAMRIID, Bacteriol Div, Ft Detrick, MD USA.	susan.welkos@amedd.army.mil	Ruthel, Gordon/GYU-9133-2022	Welkos, Susan/0000-0002-7254-3480; Ruthel, Gordon/0000-0001-9193-5589; Ribot, Wilson/0000-0002-9691-4004				Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Bashaw J, 2007, CLIN VACCINE IMMUNOL, V14, P605, DOI 10.1128/CVI.00398-06; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BURROWS TW, 1958, BRIT J EXP PATHOL, V39, P278; BURROWS TW, 1963, ERG MIKROBIOL IMM E, V37, P59; Butler T, 1983, PLAGUE OTHER YERSINI; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2002, INT J MED MICROBIOL, V291, P455; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; FERBER DM, 1981, INFECT IMMUN, V31, P839, DOI 10.1128/IAI.31.2.839-841.1981; Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; GALYOV EE, 1990, FEBS LETT, V277, P230, DOI 10.1016/0014-5793(90)80852-A; GALYOV EE, 1991, FEBS LETT, V286, P79, DOI 10.1016/0014-5793(91)80945-Y; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hehnly H, 2006, MOL BIOL CELL, V17, P4379, DOI 10.1091/mbc.E06-04-0310; Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Johannes L, 2000, TRAFFIC, V1, P119, DOI 10.1034/j.1600-0854.2000.010204.x; Johannes L, 2005, GENE THER, V12, P1360, DOI 10.1038/sj.gt.3302557; Johannes L, 2002, AM J PHYSIOL-GASTR L, V283, pG1, DOI 10.1152/ajpgi.00088.2002; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; KARLYSHEV AV, 1992, FEBS LETT, V305, P37, DOI 10.1016/0014-5793(92)80650-6; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Khine AA, 2004, GLYCOBIOLOGY, V14, P701, DOI 10.1093/glycob/cwh085; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Lord JM, 1998, CURR BIOL, V8, pR56, DOI 10.1016/S0960-9822(98)70034-X; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MORRIS RE, 1985, INFECT IMMUN, V50, P721, DOI 10.1128/IAI.50.3.721-727.1985; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nedialkov YA, 1997, INFECT IMMUN, V65, P1196, DOI 10.1128/IAI.65.4.1196-1203.1997; Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Powell BS, 2005, BIOTECHNOL PROGR, V21, P1490, DOI 10.1021/bp050098r; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Sanchez JA, 2001, J PHYSIOL-LONDON, V536, P387, DOI 10.1111/j.1469-7793.2001.0387c.xd; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Sandvig K, 2000, INT J MED MICROBIOL, V290, P415; Shin JS, 2001, SCIENCE, V293, P1447, DOI 10.1126/science.1061079; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P31, DOI 10.1177/002215540305100105; Terebiznik MR, 2006, INFECT IMMUN, V74, P6599, DOI 10.1128/IAI.01085-06; Tuma PL, 2001, J CELL BIOL, V154, P1197, DOI 10.1083/jcb.200105138; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Une T, 1987, Contrib Microbiol Immunol, V9, P179; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Welkos SL, 2004, PLASMID, V51, P1, DOI 10.1016/j.plasmid.2003.09.003; Willhite DC, 2004, CELL MICROBIOL, V6, P143, DOI 10.1046/j.1462-5822.2003.00347.x; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	80	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6281	10.1371/journal.pone.0006281	http://dx.doi.org/10.1371/journal.pone.0006281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609450	gold, Green Submitted, Green Published			2022-12-25	WOS:000268119500015
J	Ling, YC; Vjestica, A; Oliferenko, S				Ling, Yuen Chyao; Vjestica, Aleksandar; Oliferenko, Snezhana			Nucleocytoplasmic Shuttling of the TACC Protein Mia1p/Alp7p Is Required for Remodeling of Microtubule Arrays during the Cell Cycle	PLOS ONE			English	Article								Microtubule arrays are remodeled as cells proceed through the cell cycle. It is important to understand how remodeling is regulated in time and space. In fission yeast, the conserved microtubule associated TACC/TOG complex plays an important role in organizing microtubules throughout the cell cycle. Here we show that this complex undergoes nucleocytoplasmic shuttling through the nuclear import and export signals located in the TACC protein Mia1p/Alp7p. When the Crm1p-dependent nuclear export signal of Mia1p is disabled, Mia1p accumulates in the nucleus while its partner protein Alp14p/TOG is restricted to the cytoplasm. This leads to defects in assembly of both interphase arrays and the mitotic spindle. Artificial targeting of Alp14p to the nucleus partially rescues the mitotic spindle defects caused by lack of Mia1p nuclear export. Interestingly, the nuclear export sequence of Mia1p appears to overlap with the Alp14p binding site. We propose that intricate regulation of the subcellular distribution of TACC/TOG complexes drives microtubule array remodeling as cells progress through the cell cycle.			Ling, YC (corresponding author), Temasek Life Sci Lab, Singapore, Singapore.	snejana@tll.org.sg		Oliferenko, Snezhana/0000-0002-8138-6851; Vjestica, Aleksandar/0000-0002-3095-4169				ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Albee AJ, 2006, J BIOL CHEM, V281, P38293, DOI 10.1074/jbc.M607203200; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Grallert A, 2006, GENE DEV, V20, P2421, DOI 10.1101/gad.381306; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zheng LF, 2006, MOL BIOL CELL, V17, P2212, DOI 10.1091/mbc.E05-08-0811	19	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6255	10.1371/journal.pone.0006255	http://dx.doi.org/10.1371/journal.pone.0006255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606211	Green Submitted, gold, Green Published			2022-12-25	WOS:000268036000011
J	Nicholls, B; Racey, PA				Nicholls, Barry; Racey, Paul A.			The Aversive Effect of Electromagnetic Radiation on Foraging Bats-A Possible Means of Discouraging Bats from Approaching Wind Turbines	PLOS ONE			English	Article							PIPISTRELLUS-PIPISTRELLUS; BUFFALO RIDGE; FIELDS; CHIROPTERA; THRESHOLDS; MICROWAVES; MORTALITY	Large numbers of bats are killed by collisions with wind turbines and there is at present no accepted method of reducing or preventing this mortality. Following our demonstration that bat activity is reduced in the vicinity of large air traffic control and weather radars, we tested the hypothesis that an electromagnetic signal from a small portable radar can act as a deterrent to foraging bats. From June to September 2007 bat activity was compared at 20 foraging sites in northeast Scotland during experimental trials (radar switched on) and control trials (no radar signal). Starting 45 minutes after sunset, bat activity was recorded for a period of 30 minutes during each trial and the order of trials were alternated between nights. From July to September 2008 aerial insects at 16 of these sites were sampled using two miniature light-suction traps. At each site one of the traps was exposed to a radar signal and the other functioned as a control. Bat activity and foraging effort per unit time were significantly reduced during experimental trials when the radar antenna was fixed to produce a unidirectional signal therefore maximising exposure of foraging bats to the radar beam. However, although bat activity was significantly reduced during such trials, the radar had no significant effect on the abundance of insects captured by the traps.			Nicholls, B (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	b.nicholls@abdn.ac.uk						ADAIR ER, 1983, MICROWAVES THERMOREG, P359; Ahlen I., 2007, BATS OFFSHORE WIND T; Arnett E.B., 2005, RELATIONSHIPS UNPUB; Arnett E.B., 2009, EFFECTIVENESS CHANGI; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; BAERWALD EF, 2009, J WILDL MAN IN PRESS, V73; Balmori A, 2005, ELECTROMAGN BIOL MED, V24, P109, DOI 10.1080/15368370500205472; Barlow J, 2003, MAR MAMMAL SCI, V19, P265, DOI 10.1111/j.1748-7692.2003.tb01108.x; Burchard JF, 1996, J DAIRY SCI, V79, P1549, DOI 10.3168/jds.S0022-0302(96)76516-5; CURRY RC, 2000, P NAT AV WIND POW PL, V3, P18; DOWNNS NC, 1999, BAT RES NEWS, V40, P69; Erickson WP, 2001, AVIAN COLLISIONS WIN; GREENBERG B, 1981, BIOELECTROMAGNETICS, V2, P315, DOI 10.1002/bem.2250020404; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; HENSHAW RE, 1966, PHYSIOL ZOOL, V39, P223, DOI 10.1086/physzool.39.3.30152849; HODOS W, 2001, NAT AV WIND POW PLAN, V4, P88; Horn JW, 2008, TESTING EFFECTIVENES; Johnson GD, 2002, WILDLIFE SOC B, V30, P879; Jones G, 2005, CURR BIOL, V15, pR484, DOI 10.1016/j.cub.2005.06.051; Jones Gareth, 2003, P345; JUSTESEN DR, 1979, B NEW YORK ACAD MED, V55, P1058; Kraus SD, 1997, NATURE, V388, P525, DOI 10.1038/41451; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Lai H, 2005, ELECTROMAGN BIOL MED, V24, P23, DOI 10.1081/JBC-200055046; LAI H, 1987, J NEUROCHEM, V48, P40, DOI 10.1111/j.1471-4159.1987.tb13124.x; LIN J C, 1976, Journal of Microwave Power, V11, P295; LIN JC, 1977, RADIO SCI, V12, P237, DOI 10.1029/RS012i06Sp00237; MELLOR PS, 1985, VET REC, V116, P589, DOI 10.1136/vr.116.22.589; Musters CJM, 1996, BIRD STUDY, V43, P124, DOI 10.1080/00063659609461003; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Nicholls B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000297; Orloff S., 1992, WIND TURBINE EFFECTS; Osborn RG, 2000, AM MIDL NAT, V143, P41, DOI 10.1674/0003-0031(2000)143[0041:BMAWWT]2.0.CO;2; RACEY PA, 1985, J ANIM ECOL, V54, P205, DOI 10.2307/4631; REEDER WG, 1951, J MAMMAL, V32, P389, DOI 10.2307/1375787; Ryan BF, 1994, MINITAB HDB; Sienkiewicz Z, 1998, POWER ENG J, V12, P131, DOI 10.1049/pe:19980306; Spanjer G. R., 2006, RESPONSES BIG UNPUB; SPEAKMAN JR, 1994, J THEOR BIOL, V171, P325, DOI 10.1006/jtbi.1994.1235; Trippel EA, 1999, CAN J FISH AQUAT SCI, V56, P113, DOI 10.1139/cjfas-56-1-113; *UNEP EUROBATS, 2006, AGR CONS POP EUR BAT; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wang BM, 2000, BIOELECTROMAGNETICS, V21, P52, DOI 10.1002/(SICI)1521-186X(200001)21:1<52::AID-BEM8>3.0.CO;2-6	45	35	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6246	10.1371/journal.pone.0006246	http://dx.doi.org/10.1371/journal.pone.0006246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606214	Green Published, Green Submitted, gold			2022-12-25	WOS:000268036000006
J	Skinner, AM; O'Neill, SL; Kurre, P				Skinner, Amy M.; O'Neill, S. Lee; Kurre, Peter			Cellular Microvesicle Pathways Can Be Targeted to Transfer Genetic Information between Non-Immune Cells	PLOS ONE			English	Article								Eukaryotic cell communication is based on protein signaling cascades that require direct cell-cell apposition, or receptor engagement by secreted molecules. The transmission of genetic information is thought to be uncommon, apart from recent reports of exosomal RNA transfer in immune and glioblastoma cells. We wished to examine if existing microvesicle pathways could be directly targeted for the horizontal transfer of RNA genomes in less specialized cell types. Using replication-deficient retrovirus vector, studies herein confirm that a range of cells routinely sequester a small population of these RNA genomes in a non-canonical compartment, refractory to antibody neutralization and unaffected by specific pharmacological inhibition of pathways involved in conventional viral trafficking. Our experiments further reveal the cytoplasmic colocalization of vector genomes with tetraspanin proteins as well as the PI-3-kinase sensitive trafficking and subsequent transmission to 2 degrees targets. Collectively, our results indicate a scalable process whereby cells route vector genomes to multivesicular bodies (MVB) for cytoplasmic trafficking and exosomal release. Our findings imply that cells can serve to deliver recombinant payload, targeted for the stable genetic modification of 2 degrees target cells.			Skinner, AM (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA.	kurrepe@ohsu.edu			NCRR NIH HHS [S10 RR023432, RR23432] Funding Source: Medline; NHLBI NIH HHS [R01 HL090765, F32 HL095351, HL90765, K08 HL077231, HL77231] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077231, R01HL090765, F32HL095351] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Blomer U, 2005, GENE THER, V12, P67, DOI 10.1038/sj.gt.3302384; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Coffin J, 1997, RETROVIRUSES; Cristiano Richard J., 1998, Frontiers in Bioscience, V3, pD1161; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x; Haas DL, 2000, MOL THER, V2, P71, DOI 10.1006/mthe.2000.0094; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Jolly C, 2007, J VIROL, V81, P7873, DOI 10.1128/JVI.01845-06; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Logan AC, 2004, J VIROL, V78, P8421, DOI 10.1128/JVI.78.16.8421-8436.2004; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; Meng YR, 2005, CANCER IMMUNOL IMMUN, V54, P807, DOI 10.1007/s00262-004-0642-5; Pan YW, 2007, J VIROL, V81, P639, DOI 10.1128/JVI.01089-06; PAUZA CD, 1994, VIROLOGY, V205, P470, DOI 10.1006/viro.1994.1667; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Maele B, 2003, J VIROL, V77, P4685, DOI 10.1128/JVI.77.8.4685-4694.2003; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vidal M, 1997, J CELL SCI, V110, P1867; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	41	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6219	10.1371/journal.pone.0006219	http://dx.doi.org/10.1371/journal.pone.0006219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593443	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035400004
J	Schmidt, F; Champy, P; Seon-Meniel, B; Franck, X; Raisman-Vozari, R; Figadere, B				Schmidt, Fanny; Champy, Pierre; Seon-Meniel, Blandine; Franck, Xavier; Raisman-Vozari, Rita; Figadere, Bruno			Chemicals Possessing a Neurotrophin-Like Activity on Dopaminergic Neurons in Primary Culture	PLOS ONE			English	Article								Background: Neurotrophic factors have been shown to possess strong neuroprotective and neurorestaurative properties in Parkinson's disease patients. However the issues to control their delivery into the interest areas of the brain and their surgical administration linked to their unability to cross the blood brain barrier are many drawbacks responsible of undesirable side effects limiting their clinical use. A strategy implying the use of neurotrophic small molecules could provide an interesting alternative avoiding neurotrophin administration and side effects. In an attempt to develop drugs mimicking neurotrophic factors, we have designed and synthesized low molecular weight molecules that exhibit neuroprotective and neuritogenic potential for dopaminergic neurons. Principal Findings: A cell-based screening of an in-house quinoline-derived compound collection led to the characterization of compounds exhibiting both activities in the nanomolar range on mesencephalic dopaminergic neurons in spontaneous or 1-methyl-4-phenylpyridinium (MPP+)-induced neurodegeneration. This study provides evidence that rescued neurons possess a functional dopamine transporter and underlines the involvement of the extracellular signal-regulated kinase 1/2 signaling pathway in these processes. Conclusion: Cell-based screening led to the discovery of a potent neurotrophic compound possessing expected physicochemical properties for blood brain barrier penetration as a serious candidate for therapeutic use in Parkinson disease.			Schmidt, F (corresponding author), Univ Paris 11, Fac Pharm, CNRS, Lab Pharmacognosie, F-92290 Chatenay Malabry, France.	fanny.schmidt@gmail.com; bruno.figadere@u-psud.fr	Franck, Xavier/A-9049-2010	Franck, Xavier/0000-0002-5615-7504				Aoki S, 2002, TETRAHEDRON, V58, P5417, DOI 10.1016/S0040-4020(02)00519-7; Aoki S, 2001, BIOCHEM BIOPH RES CO, V289, P558, DOI 10.1006/bbrc.2001.6012; Barker RA, 2006, LANCET NEUROL, V5, P285, DOI 10.1016/S1474-4422(06)70386-6; BROWN CA, 1975, J AM CHEM SOC, V97, P891, DOI 10.1021/ja00837a034; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x; Chun J, 2003, J ORG CHEM, V68, P348, DOI 10.1021/jo026240+; Coowar D, 2004, J MED CHEM, V47, P6270, DOI 10.1021/jm0493616; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Desrivot J, 2007, J CHROMATOGR B, V854, P230, DOI 10.1016/j.jchromb.2007.04.029; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Fahn S., 2000, MERRITTS NEUROLOGY, P679; Fakhfakh MA, 2003, BIOORGAN MED CHEM, V11, P5013, DOI 10.1016/j.bmc.2003.09.007; Franck X, 2004, BIOORG MED CHEM LETT, V14, P3635, DOI 10.1016/j.bmcl.2004.05.026; Ghosha J, 2008, INT J ANTIMICROB AG, V32, P349, DOI 10.1016/j.ijantimicag.2008.05.001; Guerreiro S, 2008, MOL PHARMACOL, V74, P980, DOI 10.1124/mol.108.048207; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lannuzel A, 2002, MOVEMENT DISORD, V17, P84, DOI 10.1002/mds.1246; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LUCHETTI F, 2008, FREE RADIC BIOL MED; MICHEL PP, 1990, J NEUROCHEM, V54, P1102, DOI 10.1111/j.1471-4159.1990.tb01935.x; Michel PP, 1996, J NEUROCHEM, V67, P1633; Michel PP, 1997, J NEUROCHEM, V69, P1499; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Mizuno Y, 2008, PHILOS T R SOC B, V363, P2215, DOI 10.1098/rstb.2008.2273; Mourlevat S, 2003, MOL PHARMACOL, V64, P578, DOI 10.1124/mol.64.3.578; Musiol R, 2007, BIOORGAN MED CHEM, V15, P1280, DOI 10.1016/j.bmc.2006.11.020; OMURA K, 1978, TETRAHEDRON, V34, P1651, DOI 10.1016/0040-4020(78)80197-5; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Quinn NP, 1998, NEUROLOGY, V51, pS25, DOI 10.1212/WNL.51.2_Suppl_2.S25; Riederer P, 2007, PARKINSONISM RELAT D, V13, P466, DOI 10.1016/j.parkreldis.2007.06.015; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; SARAGOVI HU, 1991, SCIENCE, V253, P792, DOI 10.1126/science.1876837; Seong CM, 2008, BIOORG MED CHEM LETT, V18, P738, DOI 10.1016/j.bmcl.2007.11.045; Sonogashira K., 1975, TETRAHEDRON LETT, V16, P4467, DOI DOI 10.1016/S0040-4039(00)91094-3; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Weinreb O, 2005, ANN NY ACAD SCI, V1053, P348, DOI 10.1196/annals.1344.030; Yogev-Falach M, 2003, FASEB J, V17, P2325, DOI 10.1096/fj.03-0078fje; Youdim MBH, 2007, PARKINSONISM RELAT D, V13, pS281, DOI 10.1016/S1353-8020(08)70017-8; Zhang LX, 2004, J NEUROCHEM, V91, P1358, DOI 10.1111/j.1471-4159.2004.02817.x; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	50	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6215	10.1371/journal.pone.0006215	http://dx.doi.org/10.1371/journal.pone.0006215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593444	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035300021
J	Bailey, JM; Mohr, AM; Hollingsworth, MA				Bailey, J. M.; Mohr, A. M.; Hollingsworth, M. A.			Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer	ONCOGENE			English	Article						pancreatic cancer; sonic hedgehog; lymphangiogenesis; metastasis	PRIMARY CILIA; N-CADHERIN; EXPRESSION; CELLS; PATHWAY; GROWTH; SHH	Sonic hedgehog (SHH) expression is tightly regulated throughout development. In the adult, aberrant expression of SHH is associated with the onset and progression of pancreatic cancer, as evidenced by increased levels of expression in premalignant and malignant lesions of the pancreas. We investigated the hypothesis that SHH, secreted from pancreatic tumors, functions in a paracrine manner to influence the biological condition of mesenchymal and endothelial cells. Orthotopic implantation of a pancreatic tumor cell line expressing SHH (Capan-2) and a transformed primary cell line that overexpresses SHH (T-HPNE.SHH) were used to show that overexpression of SHH increased primary tumor size and metastasis. Treatment with a neutralizing antibody, 5E1, decreased primary tumor volume and inhibited metastasis. Lyve-1+ vessels and stromal fibroblasts in tumors expressed primary cilium and showed localization of the receptor Smoothened to the primary cilium, providing evidence of active SHH signaling through this pathway. Although primary cilia are present on normal ductal cells of the pancreas, we did not observe primary cilium on the ductal tumor cells, suggesting decreased autocrine signaling through pathways mediated by the primary cilium in pancreatic cancer. These data support the hypothesis that SHH, secreted from pancreatic epithelia, is critical in establishing and regulating the tumor microenvironment and thereby contributes to progression of pancreatic cancer. Oncogene (2009) 28, 3513-3525; doi: 10.1038/onc.2009.220; published online 27 July 2009	[Bailey, J. M.; Mohr, A. M.; Hollingsworth, M. A.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Hollingsworth, MA (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	mahollin@unmc.edu		Bailey-Lundberg, Jennifer/0000-0002-4750-106X	National Institutes of Health [R01CA57362, P30CA36727, U01CA111294]; University of Nebraska [CA09476]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA057362, T32CA009476, U01CA111294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Kim McDermott for insight, comments and suggestions. We also thank Dr Rick Tempero and Dr Phil Kelley for the gift of HMVEC cells and suggestions related to their use. This work was supported by grants from the National Institutes of Health (R01CA57362, P30CA36727, U01CA111294), training grant awards to JMB and AMM (CA09476) and assistantship awards from the University of Nebraska (JMB).	Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Cano DA, 2006, GASTROENTEROLOGY, V131, P1856, DOI 10.1053/j.gastro.2006.10.050; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; HEESCHEN C, 2008, J CLIN INVEST; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hwang JM, 2008, MOL CELL BIOCHEM, V311, P179, DOI 10.1007/s11010-008-9708-6; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kawahira H, 2005, DEV BIOL, V280, P111, DOI 10.1016/j.ydbio.2005.01.008; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Liu MS, 2007, PANCREAS, V34, P340, DOI 10.1097/mpa.0b013e3180333ab5; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Nielsen SK, 2008, DEV DYNAM, V237, P2039, DOI 10.1002/dvdy.21610; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; SOLER AP, 1995, HUM PATHOL, V26, P1363, DOI 10.1016/0046-8177(95)90302-X; Straface G, 2009, J CELL MOL MED, V13, P2424, DOI 10.1111/j.1582-4934.2008.00440.x; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Velcheti Vamsidhar, 2007, Med Hypotheses, V69, P948, DOI 10.1016/j.mehy.2007.02.021; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang QH, 2005, LAB INVEST, V85, P45, DOI 10.1038/labinvest.3700207	40	207	230	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2009	28	40					3513	3525		10.1038/onc.2009.220	http://dx.doi.org/10.1038/onc.2009.220			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KI	19633682	Green Accepted			2022-12-25	WOS:000270851700001
J	Westhoff, MA; Kandenwein, JA; Karl, S; Vellanki, SHK; Braun, V; Eramo, A; Antoniadis, G; Debatin, KM; Fulda, S				Westhoff, M-A; Kandenwein, J. A.; Karl, S.; Vellanki, S. H. K.; Braun, V.; Eramo, A.; Antoniadis, G.; Debatin, K-M; Fulda, S.			The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair	ONCOGENE			English	Article						apoptosis; PI3 kinase; GBM	PEGYLATED LIPOSOMAL DOXORUBICIN; DEPENDENT PROTEIN-KINASE; DRUG-INDUCED APOPTOSIS; GROWTH-FACTOR RECEPTOR; HUMAN TUMOR-CELLS; MALIGNANT GLIOMA; STEM-CELLS; CANCER; ACTIVATION; STRAND	The failure of conventional therapies in glioblastoma (GBM) is largely due to an aberrant activity of survival cascades, such as PI3 kinase (PI3K)/Akt-mediated signaling. This study is the first to show that the class I PI3K inhibitor, PI-103, enhances chemotherapy-induced cell death of GBM cells. Concurrent treatment with PI-103 and DNA-damaging drugs, in particular doxorubicin, significantly increases apoptosis and reduces colony formation compared with chemotherapy treatment alone. The underlying molecular mechanism for this chemosensitization was shown by two independent approaches, that is, pharmacological and genetic inhibition of PI3K, DNA-PK and mTOR, to involve inhibition of DNA-PK-mediated DNA repair. Accordingly, blockage of PI3K or DNA-PK, but not of mTOR, significantly delays the resolution of doxorubicin-induced DNA damage and concomitantly increases apoptosis. Importantly, not only are several GBM cell lines chemosensitized by PI-103 but also GBM stem cells. Clinical relevance was further confirmed by the use of primary cultured GBM cells, which also exhibit increased cell death and reduced colony formation on combined treatment with PI-103 and doxorubicin. By identifying class I PI3K inhibitors as powerful agents in enhancing the lethality of DNA-damaging drugs, to which GBMs are usually considered unresponsive, our findings have important implications for the design of rational combination regimens in overcoming the frequent chemoresistance of GBM. Oncogene (2009) 28, 3586-3596; doi: 10.1038/onc.2009.215; published online 27 July 2009	[Westhoff, M-A; Kandenwein, J. A.; Karl, S.; Vellanki, S. H. K.; Antoniadis, G.; Debatin, K-M; Fulda, S.] Univ Childrens Hosp, D-89075 Ulm, Germany; [Kandenwein, J. A.] Univ Ulm, Dept Neurosurg, Bezirkskrankenhaus Guenzburg, D-89069 Ulm, Germany; [Braun, V.] Evangel Jung Stilling Krankenhaus, Dept Neurosurg, Siegen, Germany; [Eramo, A.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Istituto Superiore di Sanita (ISS)	Fulda, S (corresponding author), Univ Childrens Hosp, Eythstr 24, D-89075 Ulm, Germany.	simone.fulda@uniklinik-ulm.de	Westhoff, Mike-Andrew/ABA-9272-2021; Fulda, Simone/D-5864-2011; Debatin, Klaus-Michael/J-9704-2014; Eramo, Adriana/K-6694-2016	Westhoff, Mike-Andrew/0000-0003-3256-7100; Debatin, Klaus-Michael/0000-0002-8397-1886; Eramo, Adriana/0000-0002-0814-6683; Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; European Community; Novartis Stiftung fur therapeutische Forschung; University of Ulm junior research grant;  [IAP6/18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); European Community(European Commission); Novartis Stiftung fur therapeutische Forschung; University of Ulm junior research grant; 	We thank H Lane (Novartis Institute for BioMedical Research, Oncology Basel, Novartis Pharma AG, Basel, Switzerland) for providing everolimus, R Pallini and R De Maria for glioblastoma-initiating cells and S Piater for expert technical assistance. This work was supported by grants from Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, European Community (ApopTrain, APO-SYS), Novartis Stiftung fur therapeutische Forschung and IAP6/18 (to SF), and the University of Ulm junior research grant (to JAK).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brendler-Schwaab S, 2005, MUTAGENESIS, V20, P245, DOI 10.1093/mutage/gei033; Cavaliere R, 2007, NEUROL CLIN, V25, P1141, DOI 10.1016/j.ncl.2007.07.012; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chen JS, 2008, MOL CANCER THER, V7, P841, DOI 10.1158/1535-7163.MCT-07-0393; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; Colman H, 2008, ARCH NEUROL-CHICAGO, V65, P877, DOI 10.1001/archneur.65.7.877; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fulda S, 1997, CANCER RES, V57, P3823; Giagkousiklidis S, 2005, CANCER RES, V65, P10502, DOI 10.1158/0008-5472.CAN-05-0866; Glas M, 2007, ONCOLOGY-BASEL, V72, P302, DOI 10.1159/000113052; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hau P, 2004, CANCER, V100, P1199, DOI 10.1002/cncr.20073; Ihle NT, 2009, MOL CANCER THER, V8, P1, DOI 10.1158/1535-7163.MCT-08-0801; Ishii H, 2008, CANCER SCI, V99, P1871, DOI 10.1111/j.1349-7006.2008.00914.x; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Koehn H, 2007, ANTI-CANCER DRUG, V18, P419, DOI 10.1097/CAD.0b013e328012a9a0; Kreisl TN, 2009, J NEURO-ONCOL, V92, P99, DOI 10.1007/s11060-008-9741-z; Lees-Miller SP, 2008, CANCER CELL, V13, P379, DOI 10.1016/j.ccr.2008.04.010; Maira SM, 2008, EXPERT OPIN THER TAR, V12, P223, DOI 10.1517/14728222.12.2.223 ; Maira SM, 2009, BIOCHEM SOC T, V37, P265, DOI 10.1042/BST0370265; Newton HB, 2008, CURR TREAT OPTION NE, V10, P285, DOI 10.1007/s11940-008-0031-z; Nitiss John L, 2002, Curr Opin Investig Drugs, V3, P1512; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pawelczak KS, 2008, NUCLEIC ACIDS RES, V36, P4022, DOI 10.1093/nar/gkn344; Prevo R, 2008, CANCER RES, V68, P5915, DOI 10.1158/0008-5472.CAN-08-0757; Proud CG, 2004, DNA REPAIR, V3, P927, DOI 10.1016/j.dnarep.2004.03.012; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; TISDALE MJ, 1985, BRIT J CANCER, V52, P789, DOI 10.1038/bjc.1985.259; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; Veuger SJ, 2003, CANCER RES, V63, P6008; Yaneva M, 2005, NUCLEIC ACIDS RES, V33, P5320, DOI 10.1093/nar/gki821; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yavuzer U, 1998, GENE DEV, V12, P2188, DOI 10.1101/gad.12.14.2188; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	53	61	65	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2009	28	40					3586	3596		10.1038/onc.2009.215	http://dx.doi.org/10.1038/onc.2009.215			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KI	19633683				2022-12-25	WOS:000270851700007
J	Bass, R; Wagstaff, L; Ravenhill, L; Ellis, V				Bass, Rosemary; Wagstaff, Laura; Ravenhill, Lorna; Ellis, Vincent			Binding of Extracellular Maspin to beta 1 Integrins Inhibits Vascular Smooth Muscle Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSIVE MASPIN; INTEGRIN MONOCLONAL-ANTIBODY; MAMMARY EPITHELIAL-CELLS; PLASMINOGEN-ACTIVATOR; MATRIX METALLOPROTEINASES; FIBRONECTIN RECEPTOR; CRYSTAL-STRUCTURE; BREAST-CARCINOMA; CANCER CELLS; SERPIN	Maspin is a serpin that has multiple effects on cell behavior, including inhibition of migration. How maspin mediates these diverse effects remains unclear, as it is devoid of protease inhibitory activity. We have previously shown that maspin rapidly inhibits the migration of vascular smooth muscle cells(VSMC), suggesting the involvement of direct interactions with cell surface proteins. Here, using immunofluorescence microscopy, we demonstrate that maspin binds specifically to the surface of VSMC in the dedifferentiated, but not the differentiated, phenotype. Ligand blotting of VSMC lysates revealed the presence of several maspin-binding proteins, with a protein of 150 kDa differentially expressed between the two VSMC phenotypes. Western blotting suggested that this protein was the beta 1 integrin subunit, and subsequently both alpha 3 beta 1 and alpha 5 beta 1, but not alpha v beta 3, were shown to associate with maspin by coimmunoprecipitation. Specific binding of these integrins was also observed using maspin-affinity chromatography, using HT1080 cell lysates. Direct binding of maspin to alpha 5 beta 1 was confirmed using a recombinant alpha 5 beta 1-Fc fusion protein. Using conformation-dependent anti-beta 1 antibodies, maspin binding to VSMC was found to lead to a decrease in the activation status of the integrin. The functional involvement of alpha 5 beta 1 in mediating the effect of maspin was established by the inhibition of migration of CHO cells overexpressing human alpha 5 integrin, but not those lacking alpha 5 expression. Our observations suggest that maspin engages in specific interactions with a limited number of integrins on VSMC, leading to their inactivation, and that these interactions are responsible for the effects of maspin in the pericellular environment.	[Bass, Rosemary; Wagstaff, Laura; Ravenhill, Lorna; Ellis, Vincent] Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Ellis, V (corresponding author), Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England.	v.ellis@uea.ac.uk	Bass, Rosemary A/A-5328-2009; Ellis, Vincent/D-1860-2009	Bass, Rosemary A/0000-0003-4997-5207; Ellis, Vincent/0000-0003-1956-073X	British Heart Foundation [FS/05/063]; Norfolk and Waveney Big C Appeal, Biotechnology and Biological Sciences Research Council; EU [LSHC-CT-2003-503297]	British Heart Foundation(British Heart Foundation); Norfolk and Waveney Big C Appeal, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission)	This work was supported by grants from the British Heart Foundation (FS/05/063), Norfolk and Waveney Big C Appeal, Biotechnology and Biological Sciences Research Council, and by the EU Framework Programme 6 Cancerdegradome Project LSHC-CT-2003-503297.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, THROMB HAEMOSTASIS, V101, P954, DOI 10.1160/TH08-08-0558; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Biliran H, 2001, CANCER RES, V61, P8676; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Brown EJ, 2002, CURR OPIN CELL BIOL, V14, P603, DOI 10.1016/S0955-0674(02)00360-5; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; HAYRY P, 1993, IMMUNOL REV, V134, P33, DOI 10.1111/j.1600-065X.1993.tb00639.x; Humphries JD, 2005, J BIOL CHEM, V280, P10234, DOI 10.1074/jbc.M411102200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Khalkhali-Ellis Z, 2007, CANCER RES, V67, P3535, DOI 10.1158/0008-5472.CAN-06-4767; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Li ZG, 2005, ONCOGENE, V24, P2008, DOI 10.1038/sj.onc.1208449; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; McGowen R, 2000, CANCER RES, V60, P4771; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; OWENS GK, 1995, PHYSIOL REV, V75, P487; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Seftor REB, 1998, CANCER RES, V58, P5681; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; SHENG SJ, 1994, J BIOL CHEM, V269, P30988; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shi HY, 2001, CANCER RES, V61, P6945; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	51	18	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27712	27720		10.1074/jbc.M109.038919	http://dx.doi.org/10.1074/jbc.M109.038919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19638634	hybrid, Green Published			2022-12-25	WOS:000270232300072
J	Abdul-Sater, AA; Koo, E; Hacker, G; Ojcius, DM				Abdul-Sater, Ali A.; Koo, Evonne; Haecker, Georg; Ojcius, David M.			Inflammasome-dependent Caspase-1 Activation in Cervical Epithelial Cells Stimulates Growth of the Intracellular Pathogen Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENITAL-TRACT INFECTION; III SECRETION; PROINFLAMMATORY CYTOKINES; LYMPHOGRANULOMA-VENEREUM; NALP3 INFLAMMASOME; MACROPHAGES; RELEASE; PNEUMONIAE; METABOLISM; INCLUSION	Inflammasomes have been extensively characterized in monocytes and macrophages, but not in epithelial cells, which are the preferred host cells for many pathogens. Here we show that cervical epithelial cells express a functional inflammasome. Infection of the cells by Chlamydia trachomatis leads to activation of caspase-1, through a process requiring the NOD-like receptor family member NLRP3 and the inflammasome adaptor protein ASC. Secretion of newly synthesized virulence proteins from the chlamydial vacuole through a type III secretion apparatus results in efflux of K+ through glibenclamide-sensitive K+ channels, which in turn stimulates production of reactive oxygen species. Elevated levels of reactive oxygen species are responsible for NLRP3-dependent caspase-1 activation in the infected cells. In monocytes and macrophages, caspase-1 is involved in processing and secretion of pro-inflammatory cytokines such as interleukin-1 beta. However, in epithelial cells, which are not known to secrete large quantities of interleukin-1 beta, caspase-1 has been shown previously to enhance lipid metabolism. Here we show that, in cervical epithelial cells, caspase-1 activation is required for optimal growth of the intracellular chlamydiae.	[Abdul-Sater, Ali A.; Koo, Evonne; Ojcius, David M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Abdul-Sater, Ali A.; Koo, Evonne; Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Haecker, Georg] Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany	University of California System; University of California Merced; University of California System; University of California Merced; University of Freiburg	Ojcius, DM (corresponding author), Univ Calif, Sch Nat Sci, 5200 N Lake Rd, Merced, CA 95343 USA.	david.ojcius@gmail.com	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495	University of California; Else Kroner-Fresenius-Stiftung	University of California(University of California System); Else Kroner-Fresenius-Stiftung	This work was supported by the University of California (to D. M. O.) and the Else Kroner-Fresenius-Stiftung (to G. H.).	Bea F, 2003, CIRC RES, V92, P394, DOI 10.1161/01.RES.0000059982.43865.75; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; BIRKELUND S, 1994, INFECT IMMUN, V62, P4900, DOI 10.1128/IAI.62.11.4900-4908.1994; CAMERON AR, 1983, P NATL ACAD SCI-BIOL, V80, P3726, DOI 10.1073/pnas.80.12.3726; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; CHANG GT, 1978, INFECT IMMUN, V19, P827, DOI 10.1128/IAI.19.3.827-832.1978; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Cohen CR, 1999, SEX TRANSM INFECT, V75, P21, DOI 10.1136/sti.75.1.21; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Darville T, 2001, INFECT IMMUN, V69, P3556, DOI 10.1128/IAI.69.6.3556-3561.2001; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Entrican G, 1999, CLIN EXP IMMUNOL, V117, P309; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Gervassi A, 2004, INFECT IMMUN, V72, P7231, DOI 10.1128/IAI.72.12.7231-7239.2004; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Hatch GM, 1998, BIOCHEM BIOPH RES CO, V243, P356, DOI 10.1006/bbrc.1998.8101; Hess S, 2003, CELL MICROBIOL, V5, P785, DOI 10.1046/j.1462-5822.2003.00319.x; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; ITO JI, 1990, INFECT IMMUN, V58, P2021, DOI 10.1128/IAI.58.6.2021-2023.1990; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lu H, 2000, J IMMUNOL, V165, P1463, DOI 10.4049/jimmunol.165.3.1463; Mabey D, 2002, SEX TRANSM INFECT, V78, P90, DOI 10.1136/sti.78.2.90; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McClarty Grant, 1994, Trends in Microbiology, V2, P157, DOI 10.1016/0966-842X(94)90665-3; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prebeck S, 2003, MICROBES INFECT, V5, P463, DOI 10.1016/S1286-4579(03)00063-7; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; ROTHERMEL CD, 1989, INFECT IMMUN, V57, P2705, DOI 10.1128/IAI.57.9.2705-2711.1989; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Schachter J, 1999, CHLAMYDIA, P139; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tinmouth J, 2008, INT J STD AIDS, V19, P805, DOI 10.1258/ijsa.2008.008260; Ward ME, 1999, CHLAMYDIA, P171; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Xia MS, 2003, J INFECT DIS, V187, P424, DOI 10.1086/367962; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	74	91	95	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26789	26796		10.1074/jbc.M109.026823	http://dx.doi.org/10.1074/jbc.M109.026823			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648107	Green Published, hybrid			2022-12-25	WOS:000269969600060
J	Fallas, JA; Gauba, V; Hartgerink, JD				Fallas, Jorge A.; Gauba, Varun; Hartgerink, Jeffrey D.			Solution Structure of an ABC Collagen Heterotrimer Reveals a Single-register Helix Stabilized by Electrostatic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; NATURAL BREAK; BINDING-SITE; NMR; PEPTIDE; MODEL; CONFORMATION; SEQUENCE	Collagen, known for its structural role in tissues and also for its participation in the regulation of homeostatic and pathological processes in mammals, is assembled from triple helices that can be either homotrimers or heterotrimers. High resolution structural information for natural collagens has been difficult to obtain because of their size and the heterogeneity of their native environment. For this reason, peptides that self-assemble into collagen-like triple helices are used to gain insight into the structure, stability, and biochemistry of this important protein family. Although many of the most common collagens in humans are heterotrimers, almost all studies of collagen helices have been on homotrimers. Here we report the first structure of a collagen heterotrimer. Our structure, obtained by solution NMR, highlights the role of electrostatic interactions as stabilizing factors within the triple helical folding motif. This addresses an issue that has been actively researched because of the predominance of charged residues in the collagen family. We also find that it is possible to selectively form a collagen heterotrimer with a well defined composition and register of the peptide chains within the helix, based on information encoded solely in the collagenous domain. Globular domains are implicated in determining the composition of several collagen types, but it is unclear what their role in controlling register may be. We show that is possible to design peptides that not only selectively choose a composition but also a specific register without the assistance of other protein constructs. This mechanism may be used in nature as well.	[Fallas, Jorge A.; Gauba, Varun; Hartgerink, Jeffrey D.] Rice Univ, Dept Chem & Bioengn, Houston, TX 77005 USA	Rice University	Hartgerink, JD (corresponding author), 6100 Main St,MS-60, Houston, TX 77005 USA.	jdh@rice.edu	Hartgerink, Jeffrey D/G-4275-2016	Hartgerink, Jeffrey D/0000-0002-3186-5395	Robert A. Welch Foundation Research [C1557]; National Science Foundation [DMR-0645474]; Camille Dreyfus Teacher Scholar Awards Program	Robert A. Welch Foundation Research(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Camille Dreyfus Teacher Scholar Awards Program	This work was supported in part by Robert A. Welch Foundation Research Grant C1557, National Science Foundation Career Award DMR-0645474, and the Camille Dreyfus Teacher Scholar Awards Program.	ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; Baum J, 1997, FOLD DES, V2, pR53, DOI 10.1016/S1359-0278(97)00028-X; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Brodsky B, 2008, NATURE, V453, P998, DOI 10.1038/453998a; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; GAUBA V, 2007, J AM CHEM SOC, V129, P15304; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; GODDARD TD, 2008, SPARKY 3 VERSION 3 1; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; MUHANDIRAM DR, 1993, J BIOMOL NMR, V3, P463; Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288; OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7; Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; POWERS R, 1993, BIOCHEMISTRY-US, V32, P6744, DOI 10.1021/bi00077a030; Slatter DA, 2006, J MOL BIOL, V359, P289, DOI 10.1016/j.jmb.2006.02.071; Slatter DA, 2003, J MOL BIOL, V329, P175, DOI 10.1016/S0022-2836(03)00380-2; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; TUCKWELL DS, 1994, J CELL SCI, V107, P993; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024	47	69	71	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26851	26859		10.1074/jbc.M109.014753	http://dx.doi.org/10.1074/jbc.M109.014753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625247	hybrid, Green Published			2022-12-25	WOS:000269969600066
J	Su, KL; Liao, YF; Hung, HC; Liu, GY				Su, Kuo-Liang; Liao, Ya-Fan; Hung, Hui-Chih; Liu, Guang-Yaw			Critical Factors Determining Dimerization of Human Antizyme Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ORNITHINE-DECARBOXYLASE; METHOTREXATE-INDUCED APOPTOSIS; SIZE-DISTRIBUTION ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; ACTIVE-SITE; POLYAMINE METABOLISM; ANGSTROM RESOLUTION; HOMOLOGOUS PROTEIN; SUBSTRATE-BINDING; CELL-GROWTH	Ornithine decarboxylase (ODC) is the first enzyme involved in polyamine biosynthesis, and it catalyzes the decarboxylation of ornithine to putrescine. ODC is a dimeric enzyme, whereas antizyme inhibitor (AZI), a positive regulator of ODC that is homologous to ODC, exists predominantly as a monomer and lacks decarboxylase activity. The goal of this paper was to identify the essential amino acid residues that determine the dimerization of AZI. The nonconserved amino acid residues in the putative dimer interface of AZI (Ser-277, Ser-331, Glu-332, and Asp-389) were substituted with the corresponding residues in the putative dimer interface of ODC (Arg-277, Tyr-331, Asp-332, and Tyr-389, respectively). Analytical ultracentrifugation analysis was used to determine the size distribution of these AZI mutants. The size-distribution analysis data suggest that residue 331 may play a major role in the dimerization of AZI. Mutating Ser-331 to Tyr in AZI (AZI-S331Y) caused a shift from a monomer configuration to a dimer. Furthermore, in comparison with the single mutant AZI-S331Y, the AZI-S331Y/D389Y double mutant displayed a further reduction in the monomer-dimer K-d, suggesting that residue 389 is also crucial for AZI dimerization. Analysis of the triple mutant AZI-S331Y/D389Y/S277R showed that it formed a stable dimer (K-d value = 1.3 mu M). Finally, a quadruple mutant, S331Y/D389Y/S277R/E332D, behaved as a dimer with a K-d value of similar to 0.1 mu M, which is very close to that of the human ODC enzyme. The quadruple mutant, although forming a dimer, could still be disrupted by antizyme (AZ), further forming a heterodimer, and it could rescue the AZ-inhibited ODC activity, suggesting that the AZ-binding ability of the AZI dimer was retained.	[Su, Kuo-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Su, Kuo-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liao, Ya-Fan; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Immunol, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung 40201, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw; liugy@csmu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council [NSC-98-2113M- 005-009, NSC-96-2314-B-040-008]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by National Science Council Grants NSC-98-2113M- 005-009 and NSC-96-2314-B-040-008 and in part by the Ministry of Education, Taiwan, under the Aiming for Top University plan.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Auvinen M, 1997, CANCER RES, V57, P3016; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; Choi KS, 2005, BIOCHEM BIOPH RES CO, V328, P206, DOI 10.1016/j.bbrc.2004.11.172; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Coffino P, 1998, UBIQUITIN BIOL CELL, P411; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; Deng AH, 2003, DIABETES, V52, P1235, DOI 10.2337/diabetes.52.5.1235; Furumitsu Y, 2000, J RHEUMATOL, V27, P1352; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HAYASHI S, 1984, ADV ENZYME REGUL, V23, P311, DOI 10.1016/0065-2571(85)90054-8; Hsu HC, 1999, AUTOIMMUNITY, V29, P299, DOI 10.3109/08916939908994750; Hsu PC, 2006, APOPTOSIS, V11, P389, DOI 10.1007/s10495-006-4002-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; KITANI T, 1984, J BIOL CHEM, V259, P36; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu GY, 2005, APOPTOSIS, V10, P569, DOI 10.1007/s10495-005-1891-2; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; MITCHELL JLA, 1988, ARCH BIOCHEM BIOPHYS, V260, P585, DOI 10.1016/0003-9861(88)90485-7; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; Morrison LD, 1998, J NEUROCHEM, V71, P288; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; OBrien TG, 1997, CANCER RES, V57, P2630; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Park JK, 2002, MOL PHARMACOL, V62, P1400, DOI 10.1124/mol.62.6.1400; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; POULIN R, 1992, J BIOL CHEM, V267, P150; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seiler N, 1998, INT J ONCOL, V13, P993; Smith MK, 1997, CANCER RES, V57, P2104; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; TOBIAS KE, 1993, BIOCHEMISTRY-US, V32, P5842, DOI 10.1021/bi00073a017; TSIRKA S, 1992, J BIOL CHEM, V267, P23057; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	68	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26768	26777		10.1074/jbc.M109.007807	http://dx.doi.org/10.1074/jbc.M109.007807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635796	hybrid, Green Published			2022-12-25	WOS:000269969600058
J	Zhao, L; Pan, YL; Gang, Y; Wang, HH; Jin, HF; Tie, J; Xia, L; Zhang, YG; He, LJ; Yao, LP; Qiao, TD; Li, TT; Liu, ZG; Fan, DM				Zhao, Lina; Pan, Yanglin; Gang, Yi; Wang, Honghong; Jin, Haifeng; Tie, Jun; Xia, Lin; Zhang, Yongguo; He, Lijie; Yao, Liping; Qiao, Taidong; Li, Tingting; Liu, Zhiguo; Fan, Daiming			Identification of GAS1 as an Epirubicin Resistance-related Gene in Human Gastric Cancer Cells with a Partially Randomized Small Interfering RNA Library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; MAMMALIAN-CELLS; MULTIDRUG-RESISTANCE; FUNCTIONAL GENOMICS; DRUG-RESISTANCE; MEDIATED BCL-2; BREAST-CANCER; GROWTH ARREST; TUMOR-CELLS; SIRNA	Epirubicin has been widely used for chemotherapeutic treatment of gastric cancer; however, intrinsic and acquired chemoresistance remains an obstacle to successful management. The mechanisms underlying epirubicin resistance are still not well defined. Here we report the construction and application of a partially randomized retrovirus library of 4 x 10(6) small interfering RNAs to identify novel genes whose suppression confers epirubicin resistance in gastric cancer cells SGC7901. From 12 resistant cell colonies, two small interfering RNAs targeting GAS1 (growth arrest-specific 1) and PTEN (phosphatase and tensin homolog), respectively, were identified and validated. We identified a previously unrecognized chemoresistance role for GAS1. GAS1 suppression resulted in significant epirubicin resistance and cross-resistance to 5-fluorouracil and cisplatin in various gastric cancer cell lines. GAS1 suppression promoted multidrug resistance through apoptosis inhibition, partially by up-regulating the Bcl-2/Bax ratio that was abolished by Bcl-2 inhibition. GAS1 suppression induced chemoresistance partially by increasing drug efflux in an ATP-binding cassette transporter and drug-dependent manner. P-glycoprotein (P-gp) and BCRP (breast cancer resistance protein) but not MRP-1 were up-regulated, and targeted knockdown of P-gp and BCRP could partially reverse GAS1 suppression-induced epirubicin resistance. Verapamil, a P-gp inhibitor, could reverse P-gp substrate (epirubicin) but not non-P-gp substrate (5-fluorouracil and cisplatin) resistance in GAS1-suppressed gastric cancer cells. BCRP down-regulation could partially reverse 5-fluorouracil but not cisplatin resistance induced by GAS1 suppression, suggesting 5-fluorouracil but not cisplatin was a BCRP substrate. These results suggest that GAS1 might be a target to overcome multidrug resistance and provide a novel approach to identifying candidate genes that suppress chemoresistance of gastric cancers.	[Liu, Zhiguo; Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Liu, Zhiguo; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, ZG (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, 15 W Changle Rd, Xian 710032, Peoples R China.	liuzhiguo@fmmu.edu.cn; fandaim@fmmu.edu.cn	Cui, Tie Jun/Y-3224-2019	Tie, Jun/0000-0002-3669-0467; liu, zhiguo/0000-0002-8485-7356	National Natural Science Foundation of China [30672369, 30670970, 30400016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30672369, 30670970, and 30400016.	Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blow N, 2008, NAT METHODS, V5, P361, DOI 10.1038/nmeth0408-361; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Chen MH, 2007, EXPERT REV MOL DIAGN, V7, P281, DOI 10.1586/14737159.7.3.281; Chen MH, 2005, P NATL ACAD SCI USA, V102, P2356, DOI 10.1073/pnas.0401549101; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; Dominguez-Monzon G, 2009, INT J DEV NEUROSCI, V27, P305, DOI 10.1016/j.ijdevneu.2009.03.009; Dorn Alexandra, 1993, Paediatrie und Paedologie, V28, P157; Du Jing-ping, 2003, Zhonghua Yi Xue Za Zhi, V83, P328; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Guo Q, 2007, BIOCHEM BIOPH RES CO, V358, P272, DOI 10.1016/j.bbrc.2007.04.123; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Kaykas A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-16; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2177, DOI 10.1002/cncr.20636; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Konishi T, 2006, ONCOGENE, V25, P3160, DOI 10.1038/sj.onc.1209342; Lei XY, 2007, CLIN EXP PHARMACOL P, V34, P450, DOI 10.1111/j.1440-1681.2007.04593.x; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Liang ZC, 2005, IDRUGS, V8, P924; Liu H, 2008, ONCOL REP, V20, P963, DOI 10.3892/or_00000097; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez MA, 2008, INT J DEV NEUROSCI, V26, P497, DOI 10.1016/j.ijdevneu.2008.02.006; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Macdonald JS, 2006, NEW ENGL J MED, V355, P76, DOI 10.1056/NEJMe068121; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Martinelli DC, 2007, CELL CYCLE, V6, P2650, DOI 10.4161/cc.6.21.4877; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; Matsumoto Sahohime, 2007, Methods Mol Biol, V360, P131; Michaud WA, 2009, CLIN CANCER RES, V15, P1645, DOI 10.1158/1078-0432.CCR-08-2581; Miyagishi M, 2003, OLIGONUCLEOTIDES, V13, P325, DOI 10.1089/154545703322617005; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oki E, 2005, INT J CANCER, V117, P376, DOI 10.1002/ijc.21170; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Plati J, 2008, J CELL BIOCHEM, V104, P1124, DOI 10.1002/jcb.21707; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Sherbakova E A, 2008, Mol Biol (Mosk), V42, P487; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva J, 2004, ONCOGENE, V23, P8401, DOI 10.1038/sj.onc.1208176; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Singer O, 2004, P NATL ACAD SCI USA, V101, P5313, DOI 10.1073/pnas.0401209101; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Stebel M, 2000, FEBS LETT, V481, P152, DOI 10.1016/S0014-5793(00)02004-4; Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49; Villar J, 2009, CANCER RES, V69, P102, DOI 10.1158/0008-5472.CAN-08-2922; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003171; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wu HL, 2007, BIOL PROCED ONLINE, V9, P9, DOI 10.1251/bpo129; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yuan JH, 2009, CANCER CHEMOTH PHARM, V63, P1103, DOI 10.1007/s00280-008-0838-z; Zamorano A, 2004, NEUROBIOL DIS, V15, P483, DOI 10.1016/j.nbd.2003.11.022; Zamorano A, 2003, J NEUROSCI RES, V71, P256, DOI 10.1002/jnr.10461; Zhang CX, 2007, ANTI-CANCER DRUG, V18, P581, DOI 10.1097/CAD.0b013e3280146296; Zhang DX, 2007, EXPERT REV ANTICANC, V7, P1369, DOI 10.1586/14737140.7.10.1369; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	73	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26273	26285		10.1074/jbc.M109.028068	http://dx.doi.org/10.1074/jbc.M109.028068			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638344	Green Published			2022-12-25	WOS:000269969600007
J	Lee, KH; Chen, YL; Yeh, SD; Hsiao, M; Lin, JT; Goan, YG; Lu, PJ				Lee, K-H; Chen, Y-L; Yeh, S-D; Hsiao, M.; Lin, J-T; Goan, Y-G; Lu, P-J			MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation	ONCOGENE			English	Article						miR-330; E2F1; Akt; apoptosis; prostate cancer	GASTRIC-CANCER; EXPRESSION; SURVIVAL; PATHWAY; E2F1; GENE; AGGRESSIVENESS; TRANSCRIPTION; SENSITIVITY; CARCINOMA	MicroRNAs (miRNAs) make up a novel class of gene regulators; they function as oncogenes or tumor suppressors by targeting tumor-suppressor genes or oncogenes. A recent study that analysed a large number of human cancer cell lines showed that miR-330 is a potential tumor-suppressor gene. However, the function and molecular mechanism of miR-330 in determining the aggressiveness of human prostate cancer has not been studied. Here, we show that miR-330 is significantly lower expressed in human prostate cancer cell lines than in nontumorigenic prostate epithelial cells. Bioinformatics analyses reveal a conserved target site for miR-330 in the 3'-untranslated region (UTR) of E2F1 at nucleotides 1018-1024. MiR-330 significantly suppressed the activity of a luciferase reporter containing the E2F1-3'-UTR in the cells. This activity could be abolished with the transfection of anti-miR-330 or mutated E2F1-3'-UTR. In addition, the expression level of miR-330 and E2F1 was inversely correlated in cell lines and prostate cancer specimens. After overexpressing of miR-330 in PC-3 cells, cell growth was suppressed by reducing E2F1-mediated Akt phosphorylation and thereby inducing apoptosis. Collectively, this is the first study to show that E2F1 is negatively regulated by miR-330 and also show that miR-330 induces apoptosis in prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene (2009) 28, 3360-3370; doi: 10.1038/onc.2009.192; published online 13 July 2009	[Lu, P-J] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 704, Taiwan; [Lee, K-H] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chen, Y-L] Natl Cheng Kung Univ, Coll Med, Inst Oral Med, Tainan 70101, Taiwan; [Yeh, S-D] Taipei Med Univ, Dept Urol, Taipei, Taiwan; [Hsiao, M.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, J-T] Kaohsiung Vet Gen Hosp, Dept Surg, Div Urol Surg, Kaohsiung, Taiwan; [Goan, Y-G] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University; Academia Sinica - Taiwan; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Lu, PJ (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, 138,Sheng Li Rd, Tainan 704, Taiwan.	pjlu2190@mail.ncku.edu.tw	Hsiao, Michael/U-6238-2019; Jackson, Benjamin L/C-4297-2012; Chen, Yuh-Ling/AAS-7957-2021	Hsiao, Michael/0000-0001-8529-9213; 	National Cheng Kung University Hospital [NCKUH-9701004]; National Science Council [NSC 97-2311-B-006-003-MY3, NSC-98-3112-B-006-012]	National Cheng Kung University Hospital; National Science Council(Ministry of Science and Technology, Taiwan)	We thank the grant support from National Cheng Kung University Hospital Grant (NCKUH-9701004 to P-J Lu), National Science Council (NSC 97-2311-B-006-003-MY3 to P-J Lu and NSC-98-3112-B-006-012 to Y-L Chen). We also thank Dr Chen in the Department Urology College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, for his generous gifts of Akt plasmid DNA.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson DG, 2006, CURR MOL MED, V6, P731; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim R, 1999, ANTICANCER RES, V19, P1779; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Leung KW, 2009, ONCOL REP, V21, P1097, DOI 10.3892/or_00000329; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Matos P, 2008, GASTROENTEROLOGY, V135, P899, DOI 10.1053/j.gastro.2008.05.052; Neville PJ, 2003, GENE CHROMOSOME CANC, V36, P332, DOI 10.1002/gcc.10165; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pal P, 2007, HUM GENET, V122, P251, DOI 10.1007/s00439-007-0394-3; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Shiau CW, 2005, CANCER RES, V65, P1561, DOI 10.1158/0008-5472.CAN-04-1677; Slager SL, 2003, AM J HUM GENET, V72, P759, DOI 10.1086/368230; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Thomas GV, 2004, CLIN CANCER RES, V10, P8351, DOI 10.1158/1078-0432.CCR-04-0130; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Tyagi A, 2003, ONCOGENE, V22, P1302, DOI 10.1038/sj.onc.1206265; Uney JB, 2006, P NATL ACAD SCI USA, V103, P15278, DOI 10.1073/pnas.0607655103; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483	43	164	178	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3360	3370		10.1038/onc.2009.192	http://dx.doi.org/10.1038/onc.2009.192			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19597470				2022-12-25	WOS:000270103300003
J	Palamakumbura, AH; Vora, SR; Nugent, MA; Kirsch, KH; Sonenshein, GE; Trackman, PC				Palamakumbura, A. H.; Vora, S. R.; Nugent, M. A.; Kirsch, K. H.; Sonenshein, G. E.; Trackman, P. C.			Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling	ONCOGENE			English	Article						lysyl oxidase; tumor suppressor; prostate cancer; cell proliferation; fibroblast growth factor; Ras	HEPARAN-SULFATE PROTEOGLYCANS; TUMOR-SUPPRESSOR ACTIVITY; FACTOR RECEPTOR; MESSENGER-RNA; BREAST-CANCER; PHENOTYPIC REVERSION; MEDIATED MECHANISM; ANDROGEN RECEPTOR; IN-VITRO; H-RAS	Enhanced RAS signaling and decreased androgen dependence of prostate cancer cells accompany poor clinical outcomes. Elevated autocrine fibroblast growth factors 2 (FGF-2) signaling promotes prostate cancer cell growth and survival. Expression of lysyl oxidase (LOX) inhibits RAS transforming activity. LOX is secreted as 50 kDa pro-LOX protein and then undergoes extracellular proteolytic processing to form similar to 30 kDa LOX enzyme and similar to 18 kDa propeptide (LOX-PP). We have previously shown that LOX-PP inhibits breast cancer cell transformation and tumor formation, but mechanisms of action of LOX-PP have not been fully elucidated. Here we report that LOX expression is reduced in prostate cancer cell lines and that recombinant LOX-PP protein inhibits serum-stimulated DNA synthesis and MEK/ERK and PI3K/AKT pathways in DU 145 and PC-3 androgen-independent cell lines. In DU 145 cells, treatment with a pharmacologic FGF-receptor inhibitor or a neutralizing anti-FGFR1 antibody mimicked LOX-PP inhibition of serum-stimulated DNA synthesis. FGF-2-stimulated DNA synthesis, ERK1/2, AKT and FRS2 alpha activation were found all to be inhibited by LOX-PP in DU 145 cells. LOX-PP reduced specific binding of FGF-2 to DU 145 cells, suggesting that LOX-PP targets FGF signaling at the receptor. Interestingly, PC-3 cells did not respond to FGF-2, consistent with previous reports. We conclude that LOX-PP inhibits proliferation of DU 145 cells by interfering with FGFR(s) binding and signaling, and that LOX-PP has other mechanisms of action in PC-3 cells. Oncogene (2009) 28, 3390-3400; doi: 10.1038/onc.2009.203; published online 13 July 2009	[Palamakumbura, A. H.; Vora, S. R.; Trackman, P. C.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Div Oral Biol, Boston, MA 02118 USA; [Nugent, M. A.; Kirsch, K. H.; Sonenshein, G. E.; Trackman, P. C.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Trackman, PC (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Div Oral Biol, 700 Albany St,W-201, Boston, MA 02118 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Nugent, Matthew/0000-0002-8630-4712; Kirsch, Kathrin/0000-0003-1532-1715	NIH/NCI [CA082742]; DOD [W81XWH-08-1-0349]; NIH/NIDCR [DE14066]; NATIONAL CANCER INSTITUTE [R01CA082742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011004] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIH/NCI CA082742, DOD Award W81XWH-08-1-0349, NIH/NIDCR DE14066. We thank Danielle Stephens and Emilie Vu for expert preparation of rLOX-PP.	Bansal R, 2003, J NEUROSCI RES, V74, P486, DOI 10.1002/jnr.10773; Blanckaert VD, 2002, HYBRIDOMA HYBRIDOM, V21, P153, DOI 10.1089/153685902760173863; Bonaccorsi L, 2004, J CANCER RES CLIN, V130, P604, DOI 10.1007/s00432-004-0581-8; Chu CL, 2004, BIOCHEM J, V379, P331, DOI 10.1042/BJ20031082; Chua CC, 2004, CIRC RES, V94, P316, DOI 10.1161/01.RES.0000112965.70691.AC; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Contente S, 2009, BBA-MOL CELL RES, V1793, P1272, DOI 10.1016/j.bbamcr.2009.04.013; Cronauer MV, 1997, PROSTATE, V31, P223; CULIG Z, 1994, CANCER RES, V54, P5474; Erler JT, 2006, CANCER RES, V66, P10238, DOI 10.1158/0008-5472.CAN-06-3197; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Erlich S, 2006, BIOCHEM PHARMACOL, V72, P427, DOI 10.1016/j.bcp.2006.05.007; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; Forsten-Williams K, 2005, J THEOR BIOL, V233, P483, DOI 10.1016/j.jtbi.2004.10.020; Gioeli D, 2005, CLIN SCI, V108, P293, DOI 10.1042/CS20040329; Gioeli D, 1999, CANCER RES, V59, P279; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Giri D, 1999, CLIN CANCER RES, V5, P1063; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; HAJNAL A, 1993, CANCER RES, V53, P4670; HAMALAINEN ER, 1995, J BIOL CHEM, V270, P21590, DOI 10.1074/jbc.270.37.21590; Hatziapostolou M, 2006, J BIOL CHEM, V281, P32217, DOI 10.1074/jbc.M607104200; He QM, 2003, J BIOL CHEM, V278, P21831, DOI 10.1074/jbc.M300880200; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Jones HE, 1997, INT J CANCER, V71, P1010, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1010::AID-IJC17>3.0.CO;2-H; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kominsky SL, 2000, CANCER RES, V60, P3904; KRZYZOSIAK WJ, 1992, P NATL ACAD SCI USA, V89, P4879, DOI 10.1073/pnas.89.11.4879; KUIVANIEMI H, 1986, FEBS LETT, V195, P261, DOI 10.1016/0014-5793(86)80172-7; Kwabi-Addo B, 2004, ENDOCR-RELAT CANCER, V11, P709, DOI 10.1677/erc.1.00535; McPherson RA, 2004, PROSTATE, V58, P325, DOI 10.1002/pros.10336; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; NAKAMOTO T, 1992, CANCER RES, V52, P571; Natke B, 1999, Angiogenesis, V3, P249, DOI 10.1023/A:1009008824246; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ozen M, 2001, J NATL CANCER I, V93, P1783, DOI 10.1093/jnci/93.23.1783; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Palamakumbura AH, 2003, J BIOL CHEM, V278, P30781, DOI 10.1074/jbc.M305238200; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Planz B, 2001, J UROLOGY, V166, P678, DOI 10.1016/S0022-5347(05)66042-9; Polnaszek N, 2003, CANCER RES, V63, P5754; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ren CZ, 1998, CANCER RES, V58, P1285; Richardson TP, 1999, J BIOL CHEM, V274, P13534, DOI 10.1074/jbc.274.19.13534; Ropiquet F, 2000, CANCER RES, V60, P4245; Ropiquet F, 1999, J UROLOGY, V162, P595, DOI 10.1016/S0022-5347(05)68632-6; SAMID D, 1993, J CLIN INVEST, V91, P2288, DOI 10.1172/JCI116457; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Shain SA, 2004, MOL CANCER RES, V2, P653; Smith JA, 2001, BIOCHEM PHARMACOL, V62, P469, DOI 10.1016/S0006-2952(01)00690-6; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Zhang YL, 2001, J PHARMACOL EXP THER, V299, P426; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	70	60	63	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3390	3400		10.1038/onc.2009.203	http://dx.doi.org/10.1038/onc.2009.203			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19597471	Green Accepted			2022-12-25	WOS:000270103300006
J	Yang, CM; Hsieh, HL; Yao, CC; Hsiao, LD; Tseng, CP; Wu, CB				Yang, Chuen-Mao; Hsieh, Hsi-Lung; Yao, Chung-Chen; Hsiao, Li-Der; Tseng, Chin-Ping; Wu, Chou Bing			Protein Kinase C-delta Transactivates Platelet-derived Growth Factor Receptor-alpha in Mechanical Strain-induced Collagenase 3 (Matrix Metalloproteinase-13) Expression by Osteoblast-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA-RECEPTOR; SMOOTH-MUSCLE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; INTERSTITIAL COLLAGENASE; SIGNAL-TRANSDUCTION; BONE-CELLS; IN-VITRO; PDGF; DIFFERENTIATION; PATHWAYS	Matrix metalloproteinase-13 (MMP-13, or collagenase 3) has been shown to degrade intact collagen and to participate in situations where rapid and effective remodeling of collagenous ECM is required. Mechanical strain induction of MMP-13 is an example of how osteoblasts respond to high mechanical forces and participate in the bone-remodeling mechanism. Using MC3T3-E1 osteoblast-like cells, we dissected the signaling molecules involved in MMP-13 induction by mechanical strain. Reverse transcription-PCR and zymogram analysis showed that platelet-derived growth factor receptor (PDGFR) inhibitor, AG1296, inhibited the mechanical strain-induced MMP-13 gene and activity. However, the induction was not affected by anti-PDGF-AA serum. Immunoblot analysis revealed time-dependent phosphorylation of PDGFR-alpha up to 2.7-fold increases within 3 min under strain. Transfection with shPDGFR-alpha (at 4 and 8 mu g/ml) abolished PDGFR-alpha and reduced MMP-13 expression. Moreover, time-dependent recruitments of phosphoinositide 3-kinase (PI3K) by PDGFR-alpha were detected by immunoprecipitation with anti-PDGFR-alpha serum followed by immunoblot with anti-PI3K serum. AG1296 inhibited PDGFR-alpha/PI3K aggregation and Akt phosphorylation. Interestingly, protein kinase C-delta (PKC-delta) inhibitor, rottlerin, inhibited not only PDGFR-alpha/PI3K aggregation but PDGFR-alpha phosphorylation. The sequential activations were further confirmed by mutants Delta PKC-delta, Delta Akt, and Delta ERK1. Consistently, the primary mouse osteoblast cells used the same identified signaling molecules to express MMP-13 under mechanical strain. These results demonstrate that, in osteoblast-like cells, the MMP-13 induction by mechanical strain requires the transactivation of PDGFR-alpha by PKC-delta and the cross-talk between PDGFR-alpha/PI3K/Akt and MEK/ERK pathways.	[Yang, Chuen-Mao] Chang Gung Univ, Dept Pharmacol, Tao Yuan 333, Taiwan; [Hsieh, Hsi-Lung] Chang Gung Inst Technol, Dept Nursing, Tao Yuan 333, Taiwan; [Yao, Chung-Chen] Natl Taiwan Univ, Div Orthodont, Sch Dent, Taipei 100, Taiwan; [Hsiao, Li-Der] Chang Gung Mem Hosp, Dept Orthodont, Tao Yuan 333, Taiwan; [Tseng, Chin-Ping] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Wu, Chou Bing] Chang Gung Univ, Grad Inst Craniofacial & Dent Sci, Coll Med, Tao Yuan 333, Taiwan	Chang Gung University; Chang Gung University of Science & Technology; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wu, CB (corresponding author), 5 Fu Shing St, Tao Yuan, Taiwan.	cbw@adm.cgmh.org.tw	Yao, Chung-Chen/D-1470-2018	Hsieh, Hsi-Lung/0000-0001-8302-2472; TSENG, CHING-PING/0000-0002-2587-210X; YAO, JANE CHUNG-CHEN/0000-0002-2293-7000; Yang, Chuen-Mao/0000-0002-3208-5438	Chang Gung Memorial Hospital, Taiwan [CMRPG331103]; National Science Council, Taiwan [NSC-96-2320-B-182-003, NSC-95-2314-B-002-212]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant CMRPG331103 (to C. B. W.) from Chang Gung Memorial Hospital, Taiwan and by Grants NSC-96-2320-B-182-003 (to C. M. Y.) and NSC-95-2314-B-002-212 (to C. C. Y.) from National Science Council, Taiwan.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURR DB, 1993, CALCIFIED TISSUE INT, V53, pS75, DOI 10.1007/BF01673407; Buxton PG, 2008, BONE, V43, P377, DOI 10.1016/j.bone.2008.03.028; Chang HH, 2008, J DENT RES, V87, P692, DOI 10.1177/154405910808700714; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; FROST HM, 1994, ANGLE ORTHOD, V64, P175; Frost HM, 1998, CALCIFIED TISSUE INT, V62, P89, DOI 10.1007/s002239900399; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; GACK S, 1995, CELL GROWTH DIFFER, V6, P759; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HASEGAWA S, 1985, CALCIFIED TISSUE INT, V37, P431, DOI 10.1007/BF02553714; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HENRIET P, 1992, FEBS LETT, V310, P175, DOI 10.1016/0014-5793(92)81323-E; Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E; Karjalainen HM, 2003, BIORHEOLOGY, V40, P93; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; LAMBERT CA, 1992, LAB INVEST, V66, P444; LANYON LE, 1996, BONE S1, V18, P37; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Lee Yueh-Tse, 2009, Chang Gung Med J, V32, P320; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Ma YH, 1999, BIOCHEM BIOPH RES CO, V265, P606, DOI 10.1006/bbrc.1999.1718; MA YH, 1994, J BIOL CHEM, V269, P30734; MARTIN RB, 1989, STRUCTURE FUNCTION A, P186; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Rydziel S, 2000, J CELL PHYSIOL, V184, P326, DOI 10.1002/1097-4652(200009)184:3<326::AID-JCP6>3.0.CO;2-S; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SOMJEN D, 1980, BIOCHIM BIOPHYS ACTA, V627, P91, DOI 10.1016/0304-4165(80)90126-9; Soriano P, 1997, DEVELOPMENT, V124, P2691; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Suzuma I, 2002, J BIOL CHEM, V277, P1047, DOI 10.1074/jbc.M105336200; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Varghese S, 1996, ENDOCRINOLOGY, V137, P431, DOI 10.1210/en.137.2.431; Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang W, 1997, BIOCHEM MOL BIOL INT, V43, P339; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200	47	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26040	26050		10.1074/jbc.M109.040154	http://dx.doi.org/10.1074/jbc.M109.040154			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633290	Green Published, hybrid			2022-12-25	WOS:000269738000060
J	Pechlivanis, M; Samol, A; Kerkhoff, E				Pechlivanis, Markos; Samol, Annette; Kerkhoff, Eugen			Identification of a Short Spir Interaction Sequence at the C-terminal End of Formin Subgroup Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCALIZED MESSENGER-RNA; ACTIN; CAPPUCCINO; SPINDLE; DOMAINS	The actin nucleation factors Spire and Cappuccino interact with each other and regulate essential cellular events during Drosophila oogenesis in a cooperative fashion. The interaction blocks formin actin nucleation activity and enhances the Spire activity. Analogous to Spire and Cappuccino, the mammalian homologs Spir-1 and formin-2 show a regulatory interaction. To get an understanding of the nature of the Spir-formin cooperation, we have analyzed the interaction biochemically and biophysically. Our data shows that the association of Spir-1 and formin-2 is not significantly mediated by binding of the Spir-1-KIND domain to the formin FH2 core domain. Instead, a short sequence motif C-terminal adjacent to the formin-2-FH2 domain could be characterized that mediates the interaction and is conserved among the members of the Fmn subgroup of formins. In line with this, we found that both mammalian Spir proteins, Spir-1 and Spir-2, interact with mammalian Fmn subgroup proteins formin-1 and formin-2.	[Pechlivanis, Markos; Samol, Annette; Kerkhoff, Eugen] Univ Regensburg, Bavarian Genome Res Network BayGene Cell Struct &, Inst Funct Genom, D-93053 Regensburg, Germany	University of Regensburg	Kerkhoff, E (corresponding author), Univ Regensburg, Bavarian Genome Res Network BayGene Cell Struct &, Inst Funct Genom, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	Eugen.Kerkhoff@klinik.uni-regensburg.de			Bavarian Genome Research Network (Bay-Gene); Deutsche Forschungsgemeinschaft [SPP 1150, KE 447/4-3]	Bavarian Genome Research Network (Bay-Gene); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Bavarian Genome Research Network (Bay-Gene) and the Deutsche Forschungsgemeinschaft (SPP 1150, KE 447/4-3).	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Le Goff C, 2006, BIOL CELL, V98, P697, DOI 10.1042/BC20050095; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Satou Y, 1997, DEV BIOL, V192, P467, DOI 10.1006/dbio.1997.8730; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Schumacher N, 2004, GENE EXPR PATTERNS, V4, P249, DOI 10.1016/j.modgep.2003.11.006; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Wellington A, 1999, DEVELOPMENT, V126, P5267	22	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25324	25333		10.1074/jbc.M109.030320	http://dx.doi.org/10.1074/jbc.M109.030320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605360	Green Published, hybrid			2022-12-25	WOS:000269734000065
J	Li, J; Yang, L; Song, L; Xiong, H; Wang, L; Yan, X; Yuan, J; Wu, J; Li, M				Li, J.; Yang, L.; Song, L.; Xiong, H.; Wang, L.; Yan, X.; Yuan, J.; Wu, J.; Li, M.			Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1	ONCOGENE			English	Article						AEG-1; FOXO1; p27(Kip1); p21(Cip1); Akt; breast cancer	TUMOR PROGRESSION; PROSTATE-CANCER; CELL-SURVIVAL; BCCIP-ALPHA; PROTEIN; METASTASIS; DEGRADATION; INTEGRATION; ACTIVATION; EXPRESSION	We have previously reported that astrocyte elevated gene-1 (AEG-1) was upregulated in human breast cancer. However, the biological function of AEG-1 in the development and progression of breast cancer remains to be clarified. In this study, we examined the effect of AEG-1 on cell proliferation and found that AEG-1 upregulation was significantly linked to increased Ki67 (P < 0.001). Ectopic expression of AEG-1 in MCF-7 and MDA-MB-435 breast cancer cells dramatically enhanced cell proliferation and their ability of anchorage-independent growth, whereas silencing endogenous AEG-1 with shRNAs inhibited cell proliferation and colony-forming ability of the cells on soft agar. Furthermore, these proliferative effects were significantly associated with decreases of p27(Kip1) and p21(Cip1) two key cell-cycle inhibitors. Moreover, we further demonstrated that AEG-1 could downregulate the transcriptional activity of FOXO1 by inducing its phosphorylation through the PI3K/Akt signaling pathway. These observations were further confirmed in clinical human primary breast cancer specimens, in which high-level expression of AEG-1 was inversely correlated with the expression of FOXO1. Taken together, our results provide the first demonstration of a novel mechanism by which AEG-1 induces proliferation of breast cancer cell, and our findings suggest that AEG-1 might play an important role in tumorigenesis of breast cancer. Oncogene (2009) 28, 3188-3196; doi: 10.1038/onc.2009.171; published online 27 July 2009	[Yang, L.; Xiong, H.; Wang, L.; Wu, J.; Li, M.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510080, Guangdong, Peoples R China; [Li, J.; Yan, X.; Yuan, J.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Li, J.; Yang, L.; Xiong, H.; Wang, L.; Yan, X.; Yuan, J.; Wu, J.; Li, M.] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510080, Guangdong, Peoples R China; [Song, L.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, M (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, 74 Zhongshan Rd 2,Her Mu Bldg 9th Floor, Guangzhou 510080, Guangdong, Peoples R China.	limf@mail.sysu.edu.cn	Song, LB/AAL-1968-2020		Ministry of Science and Technology of China [2005CB724605]; Foundation of Ministry of Science and Technology of China [30670803, 30770836, 30771110, 30870963, 30831160517, 30872930]; Program for New Century Excellent Talents in University [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [07001503, 8251008901000006, 2008A030201006]; Foundation of Ministry of Education [(2008) 890, 200805580047]; Science and Technology Department of Guangdong Province, Zhuhai City [PC20071076]; Guangdong Provincial Natural Science Foundation [2006Z3-E4081]; 985-II project	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Foundation of Ministry of Science and Technology of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technology Department of Guangdong Province, China; Foundation of Ministry of Education; Science and Technology Department of Guangdong Province, Zhuhai City; Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); 985-II project	This study was supported by grants from the Ministry of Science and Technology of China (Grant (973) 2005CB724605); the Foundation of Ministry of Science and Technology of China (No. 30670803, 30770836, 30771110, 30870963, 30831160517, 30872930); Program for New Century Excellent Talents in University (Grant No. NCET-07-0877); the Science and Technology Department of Guangdong Province, China (No. 07001503, 8251008901000006, 2008A030201006); Foundation of Ministry of Education (No. (2008) 890 and No. 200805580047); the Science and Technology Department of Guangdong Province, Zhuhai City (PC20071076); Guangdong Provincial Natural Science Foundation (Grant 2006Z3-E4081) and a key grant from the 985-II project.	Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Doerfler W, 2001, ANN NY ACAD SCI, V945, P276; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Greene FL PDL, 2002, BREAST CANC AJCC CAN, P255; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Meng X, 2007, ONCOGENE, V26, P6253, DOI 10.1038/sj.onc.1210460; Meng XB, 2004, CELL CYCLE, V3, P1457, DOI 10.4161/cc.3.11.1213; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Roeb W, 2007, P NATL ACAD SCI USA, V104, P18085, DOI 10.1073/pnas.0708910104; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; TRENT RJ, 2006, MOL MED, P93; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756	29	111	127	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2009	28	36					3188	3196		10.1038/onc.2009.171	http://dx.doi.org/10.1038/onc.2009.171			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	492QF	19633686				2022-12-25	WOS:000269673400002
J	Harada, S; Uchida, M; Shimizu, N				Harada, Seiyu; Uchida, Masafumi; Shimizu, Noriaki			Episomal High Copy Number Maintenance of Hairpin-capped DNA Bearing a Replication Initiation Region in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE AMPLIFICATION; INVERTED REPEATS; HUMAN CANCER; S-PHASE; BREAKS; TRANSCRIPTION; CHROMOSOMES; PALINDROME; PLASMIDS; REPLICON	We previously found that a plasmid bearing a replication initiation region efficiently initiates gene amplification in mammalian cells and that it generates extrachromosomal double minutes and/or chromosomal homogeneously staining regions. During analysis of the underlying mechanism, we serendipitously found that hairpin-capped linear DNA was stably maintained as numerous extrachromosomal tiny episomes for more than a few months in a human cancer cell line. Generation of such episomes depended on the presence of the replication initiation region in the original plasmid. Despite extrachromosomal maintenance, episomal gene expression was epigenetically suppressed. The Southern blot analysis of the DNA of cloned cells revealed that the region around the hairpin end was diversified between the clones. Furthermore, the bisulfite-modified PCR and the sequencing analyses revealed that the palindrome sequence that derived from the original hairpin end or its end-resected structure were well preserved during clonal long term growth. From these data, we propose a model that explains the formation and maintenance of these episomes, in which replication of the hairpin-capped DNA and cruciform formation and its resolution play central roles. Our findings may be relevant for the dissection of mammalian replicator sequences.	[Harada, Seiyu; Uchida, Masafumi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398521, Japan	Hiroshima University	Shimizu, N (corresponding author), 1-7-1 Kagamiyama, Higashihiroshima 7398521, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [17370002]; Ministry of Education, Science, Sports and Culture of Japan [19038016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (B) 17370002 from the Japan Society for the Promotion of Science (to N. S.) and Grant-in-Aid for Scientific Research on Priority Areas, Nuclear Dynamics 19038016 from the Ministry of Education, Science, Sports and Culture of Japan (to N. S.).	Aladjem MI, 2004, EMBO REP, V5, P686, DOI 10.1038/sj.embor.7400185; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; CARROLL SM, 1988, MOL CELL BIOL, V8, P1525, DOI 10.1128/MCB.8.4.1525; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Haber JE, 2006, CELL, V125, P1237, DOI 10.1016/j.cell.2006.06.012; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Lobachev KS, 2007, FRONT BIOSCI-LANDMRK, V12, P4208, DOI 10.2741/2381; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Myllykangas S, 2006, CANCER LETT, V232, P79, DOI 10.1016/j.canlet.2005.07.045; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Rattray AJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh143; Schaarschmidt D, 2004, EMBO J, V23, P191, DOI 10.1038/sj.emboj.7600029; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P8772, DOI 10.1073/pnas.132275999; Tanaka H, 2007, MOL CELL BIOL, V27, P1993, DOI 10.1128/MCB.01313-06; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804	31	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24320	24327		10.1074/jbc.M109.008128	http://dx.doi.org/10.1074/jbc.M109.008128			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19617622	Green Published, hybrid			2022-12-25	WOS:000269380200045
J	Clancy, SM; Chen, B; Bertaso, F; Mamet, J; Jegla, T				Clancy, Sinead M.; Chen, Bihan; Bertaso, Federica; Mamet, Julien; Jegla, Timothy			KCNE1 and KCNE3 beta-Subunits Regulate Membrane Surface Expression of Kv12.2 K+ Channels In Vitro and Form a Tripartite Complex In Vivo	PLOS ONE			English	Article								Voltage-gated potassium channels that activate near the neuronal resting membrane potential are important regulators of excitation in the nervous system, but their functional diversity is still not well understood. For instance, Kv12.2 (ELK2, KCNH3) channels are highly expressed in the cerebral cortex and hippocampus, and although they are most likely to contribute to resting potassium conductance, surprisingly little is known about their function or regulation. Here we demonstrate that the auxiliary MinK (KCNE1) and MiRP2 (KCNE3) proteins are important regulators of Kv12.2 channel function. Reduction of endogenous KCNE1 or KCNE3 expression by siRNA silencing, significantly increased macroscopic Kv12.2 currents in Xenopus oocytes by around 4-fold. Interestingly, an almost 9-fold increase in Kv12.2 currents was observed with the dual injection of KCNE1 and KCNE3 siRNA, suggesting an additive effect. Consistent with these findings, over-expression of KCNE1 and/or KCNE3 suppressed Kv12.2 currents. Membrane surface biotinylation assays showed that surface expression of Kv12.2 was significantly increased by KCNE1 and KCNE3 siRNA, whereas total protein expression of Kv12.2 was not affected. KCNE1 and KCNE3 siRNA shifted the voltages for half-maximal activation to more hyperpolarized voltages, indicating that KCNE1 and KCNE3 may also inhibit activation gating of Kv12.2. Native co-immunoprecipitation assays from mouse brain membranes imply that KCNE1 and KCNE3 interact with Kv12.2 simultaneously in vivo, suggesting the existence of novel KCNE1-KCNE3-Kv12.2 channel tripartite complexes. Together these data indicate that KCNE1 and KCNE3 interact directly with Kv12.2 channels to regulate channel membrane trafficking.			Clancy, SM (corresponding author), Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA 92037 USA.	tjegla@scripps.edu	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X; Jegla, Timothy/0000-0001-8616-2390	NINDS NIH HHS [R21 NS057000, R21 NS057000I, R21 NS057000-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057000] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Grunnet M, 2003, BIOPHYS J, V85, P1525, DOI 10.1016/S0006-3495(03)74585-8; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Lundby A, 2006, BIOCHEM BIOPH RES CO, V346, P958, DOI 10.1016/j.bbrc.2006.06.004; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Miyashita T, 1997, BRAIN RES, V750, P251, DOI 10.1016/S0006-8993(96)01365-0; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Nicolas MT, 2001, HEARING RES, V153, P132, DOI 10.1016/S0378-5955(00)00268-9; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shi WM, 1998, J PHYSIOL-LONDON, V511, P675, DOI 10.1111/j.1469-7793.1998.675bg.x; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Strutz-Seebohm N, 2006, CELL PHYSIOL BIOCHEM, V18, P57, DOI 10.1159/000095158; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Tyson J, 2000, HUM GENET, V107, P499, DOI 10.1007/s004390000402; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Warth R, 2002, AM J PHYSIOL-REG I, V282, pR639, DOI 10.1152/ajpregu.00649.2001; Xu XH, 2009, CARDIOVASC RES, V82, P430, DOI 10.1093/cvr/cvp047; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; ZHANG X, 2009, BIOPHYSICAL IN PRESS; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6330	10.1371/journal.pone.0006330	http://dx.doi.org/10.1371/journal.pone.0006330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623261	Green Published, Green Submitted, gold			2022-12-25	WOS:000268260100009
J	Eshoo, MW; Whitehouse, CA; Nalca, A; Zoll, S; Ecker, JA; Hall, TA; Pennella, TTD; Duncan, DD; Desai, A; Moradi, EK; Rudnick, K; Libby, B; Ranken, R; Sampath, R; Hofstadler, SA; Ecker, DJ; Blyn, LB				Eshoo, Mark W.; Whitehouse, Chris A.; Nalca, Aysegul; Zoll, Scott; Ecker, Joseph A.; Hall, Thomas A.; Pennella, Thuy-Trang D.; Duncan, David D.; Desai, Anjali; Moradi, Emily K.; Rudnick, Karl; Libby, Brian; Ranken, Raymond; Sampath, Rangarajan; Hofstadler, Steven A.; Ecker, David J.; Blyn, Lawrence B.			Rapid and High-Throughput pan-Orthopoxvirus Detection and Identification using PCR and Mass Spectrometry	PLOS ONE			English	Article								The genus Orthopoxvirus contains several species of related viruses, including the causative agent of smallpox (Variola virus). In addition to smallpox, several other members of the genus are capable of causing human infection, including monkeypox, cowpox, and other zoonotic rodent-borne poxviruses. Therefore, a single assay that can accurately identify all orthopoxviruses could provide a valuable tool for rapid broad orthopovirus identification. We have developed a pan-Orthopoxvirus assay for identification of all members of the genus based on four PCR reactions targeting Orthopoxvirus DNA and RNA helicase and polymerase genes. The amplicons are detected using electrospray ionization-mass spectrometry (PCR/ESI-MS) on the Ibis T5000 system. We demonstrate that the assay can detect and identify a diverse collection of orthopoxviruses, provide sub-species information and characterize viruses from the blood of rabbitpox infected rabbits. The assay is sensitive at the stochastic limit of PCR and detected virus in blood containing approximately six plaque-forming units per milliliter from a rabbitpox virus-infected rabbit.			Eshoo, MW (corresponding author), Ibis Biosci, Carlsbad, CA USA.	meshoo@ibisbio.com	Nalca, Aysegul/L-8149-2019	Nalca, Aysegul/0000-0001-8581-7535; Ecker, David/0000-0003-4350-9037	PHS HHS [A120-B12] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams MM, 2007, J VIROL, V81, P11084, DOI 10.1128/JVI.00423-07; Blyn LB, 2008, J CLIN MICROBIOL, V46, P644, DOI 10.1128/JCM.00801-07; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; Ecker D, 2006, J ASS LAB AUTOM, P341; ECKER DJ, 2008, NAT REV MICROBIOL; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Espy MJ, 2002, J CLIN MICROBIOL, V40, P1985, DOI 10.1128/JCM.40.6.1985-1988.2002; Essbauer S., 2007, POXVIRUSES BIRKH USE; Eyler JM, 2003, J LAB CLIN MED, V142, P216, DOI 10.1016/S0022-2143(03)00102-1; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Henderson DA, 1999, EMERG INFECT DIS, V5, P537, DOI 10.3201/eid0504.990415; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Jezek Z, 1988, HUMAN MONKEYPOX; Kulesh DA, 2004, LAB INVEST, V84, P1200, DOI 10.1038/labinvest.3700143; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975; Muddiman DC, 1997, ANAL CHEM, V69, P1543, DOI 10.1021/ac961134r; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Nitsche A, 2004, J CLIN MICROBIOL, V42, P1207, DOI 10.1128/JCM.42.3.1207-1213.2004; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995; Sampath R, 2005, EMERG INFECT DIS, V11, P373, DOI 10.3201/eid1103.040629; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007; Smith G., 2007, Proceedings - International Fertiliser Society, P1, DOI 10.1007/978-3-7643-7557-7_1; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0; Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6342	10.1371/journal.pone.0006342	http://dx.doi.org/10.1371/journal.pone.0006342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623263	Green Submitted, Green Published, gold			2022-12-25	WOS:000268260100018
J	Butler, DC; Haramizu, S; Williamson, DL; Always, SE				Butler, David C.; Haramizu, Satoshi; Williamson, David L.; Always, Stephen E.			Phospho-Ablated Id2 Is Growth Suppressive and Pro-Apoptotic in Proliferating Myoblasts	PLOS ONE			English	Article								Inhibitor of differentiation protein-2 (Id2) is a dominant negative helix-loop-helix (HLH) protein, and a positive regulator of proliferation, in various cells. The N-terminal region of Id2 contains a consensus cdk2 phosphorylation sequence SPVR, which may be involved with the induction of apoptosis, at least in myeloid 32d. 3 cells. However, the role of Id2 phosphorylation at serine 5 in skeletal muscle cells is unknown. The objective of this study was to determine if the phosphorylation of Id2 at serine 5 alters its cellular localization and its role in apoptosis in C2C12 myoblasts. Overexpression of wild type Id2 decreased MyoD protein expression, which corresponded to the increased binding of Id2 to basic HLH proteins E47 and E12. Bromodeoxyuridine incorporation was significantly decreased by the overexpression of phospho-ablated Id2 ( S5A); conversely, overexpression of wild type Id2 increased cellular proliferation. The subcellular localization of Id2 and phospho-mimicking Id2 (S5D) were predominantly nuclear compared to S5A. The decreased nuclear localization of S5A corresponded to a decrease in cellular proliferation, and an increase in apoptosis. These data suggest that unphosphorylated Id2 is primarily localized in the cytosol, where it is growth suppressive and potentially pro-apoptotic. These results imply that reducing unphosphorylated Id2 may improve the pool of myoblasts available for differentiation by increasing proliferation and inhibiting apoptosis.			Butler, DC (corresponding author), David Axelrod Inst, Wadsworth Ctr NYS DOH, Albany, NY USA.	salway@hsc.wvu.edu		Alway, Stephen/0000-0002-0378-4707	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020866, P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021530] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016440, RR020866, RR16440, S10 RR020866] Funding Source: Medline; NIA NIH HHS [R01 AG021530, R01 AG021530-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alway SE, 2003, AM J PHYSIOL-REG I, V284, pR540, DOI 10.1152/ajpregu.00550.2002; Alway SE, 2002, AM J PHYSIOL-REG I, V282, pR411, DOI 10.1152/ajpregu.00332.2001; Alway SE, 2002, AM J PHYSIOL-CELL PH, V283, pC66, DOI 10.1152/ajpcell.00598.2001; Alway SE, 2008, EXERC SPORT SCI REV, V36, P51, DOI 10.1097/JES.0b013e318168e9dc; Atherton GT, 1996, CELL GROWTH DIFFER, V7, P1059; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Ferrari D, 1998, J EXP MED, V188, P979, DOI 10.1084/jem.188.5.979; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; GRANT B, 1998, JAVA REP, V3, P6; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; HARA E, 1994, J BIOL CHEM, V269, P2139; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Jansen KM, 2008, CELL DEATH DIFFER, V15, P1619, DOI 10.1038/cdd.2008.90; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Liu J, 2000, BIOCHEM BIOPH RES CO, V273, P1042, DOI 10.1006/bbrc.2000.3055; Matsumura ME, 2002, J BIOL CHEM, V277, P7293, DOI 10.1074/jbc.M108986200; NAGATA Y, 1995, BIOCHEM BIOPH RES CO, V207, P916, DOI 10.1006/bbrc.1995.1273; Norton JD, 1998, MOL CELL BIOL, V18, P2371, DOI 10.1128/MCB.18.4.2371; O'Flaherty J, 2006, APOPTOSIS, V11, P2103, DOI 10.1007/s10495-006-0196-4; Pagliuca A, 2000, CANCER RES, V60, P1376; Pirnia F, 2002, CELL DEATH DIFFER, V9, P905, DOI 10.1038/sj.cdd.4401062; Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245; Shaltouki A, 2007, APOPTOSIS, V12, P2143, DOI 10.1007/s10495-007-0135-z; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC1058, DOI 10.1152/ajpcell.00495.2004; Siu PM, 2006, J APPL PHYSIOL, V100, P907, DOI 10.1152/japplphysiol.01012.2005; Siu PM, 2005, J APPL PHYSIOL, V99, P1897, DOI 10.1152/japplphysiol.00374.2005; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042	42	8	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6302	10.1371/journal.pone.0006302	http://dx.doi.org/10.1371/journal.pone.0006302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609365	gold, Green Published, Green Submitted			2022-12-25	WOS:000268119500019
J	Zhu, Q; Li, XB; Chow, K; Liu, J				Zhu, Qi; Li, Xiaobai; Chow, Kari; Liu, Jia			The Part Task of the Part-Spacing Paradigm Is Not a Pure Measurement of Part-Based Information of Faces	PLOS ONE			English	Article								Background: Faces are arguably one of the most important object categories encountered by human observers, yet they present one of the most difficult challenges to both the human and artificial visual systems. A variety of experimental paradigms have been developed to study how faces are represented and recognized, among which is the part-spacing paradigm. This paradigm is presumed to characterize the processing of both the featural and configural information of faces, and it has become increasingly popular for testing hypotheses on face specificity and in the diagnosis of face perception in cognitive disorders. Methodology/Principal Findings: In two experiments we questioned the validity of the part task of this paradigm by showing that, in this task, measuring pure information about face parts is confounded by the effect of face configuration on the perception of those parts. First, we eliminated or reduced contributions from face configuration by either rearranging face parts into a non-face configuration or by removing the low spatial frequencies of face images. We found that face parts were no longer sensitive to inversion, suggesting that the previously reported inversion effect observed in the part task was due in fact to the presence of face configuration. Second, self-reported prosopagnosic patients who were selectively impaired in the holistic processing of faces failed to detect part changes when face configurations were presented. When face configurations were scrambled, however, their performance was as good as that of normal controls. Conclusions/Significance: In sum, consistent evidence from testing both normal and prosopagnosic subjects suggests the part task of the part-spacing paradigm is not an appropriate task for either measuring how face parts alone are processed or for providing a valid contrast to the spacing task. Therefore, conclusions from previous studies using the part-spacing paradigm may need re-evaluation with proper paradigms.			Zhu, Q (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Zhu, Qi/AAW-9090-2021; Liu, Jia/C-5630-2011	Zhu, Qi/0000-0002-0993-3400; Liu, Jia/0000-0003-0383-0934				BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Boutet I, 2003, PERCEPT PSYCHOPHYS, V65, P1078, DOI 10.3758/BF03194835; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Butler PD, 2008, SCHIZOPHR RES, V103, P283, DOI 10.1016/j.schres.2008.03.007; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Collin CA, 2004, J EXP PSYCHOL HUMAN, V30, P975, DOI 10.1037/0096-1523.30.5.975; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine B, 2007, SOC COGN AFFECT NEUR, V2, P104, DOI 10.1093/scan/nsm003; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Farkas L.G., 1981, ANTHROPOMETRY HEAD F; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gaspar C, 2008, VISION RES, V48, P2817, DOI 10.1016/j.visres.2008.09.015; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Goffaux V, 2008, ACTA PSYCHOL, V128, P119, DOI 10.1016/j.actpsy.2007.11.005; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Goffaux V, 2007, J EXP PSYCHOL HUMAN, V33, P995, DOI 10.1037/0096-1523.33.4.995; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; HOSIE JA, 1988, PERCEPTION, V17, P461, DOI 10.1068/p170461; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Leder H, 2006, BRIT J PSYCHOL, V97, P19, DOI 10.1348/000712605X54794; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Li XB, 2007, PROG NAT SCI, V17, P165; Liu J., 2009, J COGNITIVE NEUROSCI; Macho S, 1998, J EXP PSYCHOL HUMAN, V24, P1486, DOI 10.1037/0096-1523.24.5.1486; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Nishimura M, 2008, VIS COGN, V16, P859, DOI 10.1080/13506280701538514; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rhodes G, 2006, PSYCHON B REV, V13, P499, DOI 10.3758/BF03193876; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Searcy JH, 1996, J EXP PSYCHOL HUMAN, V22, P904, DOI 10.1037/0096-1523.22.4.904; Shin YW, 2008, SCHIZOPHRENIA BULL, V34, P538, DOI 10.1093/schbul/sbm118; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2006, J COGNITIVE NEUROSCI, V18, P580, DOI 10.1162/jocn.2006.18.4.580; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yovel G, 2008, PSYCHON B REV, V15, P933, DOI 10.3758/PBR.15.5.933	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6239	10.1371/journal.pone.0006239	http://dx.doi.org/10.1371/journal.pone.0006239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603077	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035700006
J	Kornblatt, JA				Kornblatt, Jack A.			Reduction of Canine Plasminogen Leads to an Expanded Molecule which Precipitates	PLOS ONE			English	Article								Canine plasminogen is made up of seven domains. In each domain there are several cysteines that are linked by disulfide bonds. Reduction of a limited number of the cystines destabilizes the protein such that it precipitates. The bond or bonds that are broken provide about 14 kcal of stabilization energy. Circular dichroism and dynamic light scattering indicate that there is probably an intermediate that is formed prior to precipitation and that the intermediate is somewhat larger than the compact form of plasminogen.			Kornblatt, JA (corresponding author), Concordia Univ, Dept Biol, Enzyme Res Grp, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	krnbltt@alcor.concordia.ca		kornblatt, jack/0000-0002-9802-8321				Abad MC, 2002, J MOL BIOL, V318, P1009, DOI 10.1016/S0022-2836(02)00211-5; ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; AZNAR J, 1980, THROMB HAEMOSTASIS, V43, P182; BACHMANN F, 1994, HAEMOSTASIS THROMBOS, P525; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Carter DM, 2005, CELL MOL BIOL, V51, pOL755, DOI 10.1170/90; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CASTELLINO FJ, 1973, BIOCHEMISTRY-US, V12, P2787, DOI 10.1021/bi00739a002; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Cockburn T, 1998, CHILDHOOD, V5, P99, DOI 10.1177/0907568298005001007; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Epple G, 2004, J THROMB HAEMOST, V2, P962, DOI 10.1111/j.1538-7836.2004.00675.x; ESTELLES A, 1980, THROMB RES, V18, P513, DOI 10.1016/0049-3848(80)90347-3; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; Kahn P C, 1979, Methods Enzymol, V61, P339; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Kornblatt JA, 2001, BIOCHEMISTRY-US, V40, P3639, DOI 10.1021/bi001857b; Kornblatt JA, 2000, BBA-PROTEIN STRUCT M, V1481, P1, DOI 10.1016/S0167-4838(00)00119-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Markus G, 1996, FIBRINOLYSIS, V10, P75, DOI 10.1016/S0268-9499(96)80082-8; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Miles LA, 2003, TRENDS CARDIOVAS MED, V13, P21, DOI 10.1016/S1050-1738(02)00190-1; MULICHAK AM, 1991, BIOCHEMISTRY-US, V30, P10576, DOI 10.1021/bi00107a029; OKAMOTO S, 1968, ANN NY ACAD SCI, V146, P414, DOI 10.1111/j.1749-6632.1968.tb20303.x; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Praus M, 2003, THROMB HAEMOSTASIS, V89, P812, DOI 10.1055/s-0037-1613466; PTITSYN OB, 1995, TRENDS BIOCHEM SCI, V20, P376, DOI 10.1016/S0968-0004(00)89081-7; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Salmona M, 2005, J VIROL, V79, P11225, DOI 10.1128/JVI.79.17.11225-11230.2005; SAWYER JT, 1994, J BIOL CHEM, V269, P22440; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; Steven L.G., 2001, FRONT BIOSCI-LANDMRK, V6, pd1403, DOI [10.2741/gonias, DOI 10.2741/GONIAS]; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; WEBER G, 1966, BIOCHEMISTRY-US, V5, P1900, DOI 10.1021/bi00870a017; WIMAN B, 1975, EUR J BIOCHEM, V57, P387, DOI 10.1111/j.1432-1033.1975.tb02312.x; WIMAN B, 1975, THROMB DIATH HAEMOST, V34, P350; YILLA M, 1992, J CELL BIOL, V118, P245, DOI 10.1083/jcb.118.2.245	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6196	10.1371/journal.pone.0006196	http://dx.doi.org/10.1371/journal.pone.0006196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593387	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035300009
J	Cormet-Boyaka, E; Hong, JS; Berdiev, BK; Fortenberry, JA; Rennolds, J; Clancy, JP; Benos, DJ; Boyaka, PN; Sorscher, EJ				Cormet-Boyaka, Estelle; Hong, Jeong S.; Berdiev, Bakhram K.; Fortenberry, James A.; Rennolds, Jessica; Clancy, J. P.; Benos, Dale J.; Boyaka, Prosper N.; Sorscher, Eric J.			A truncated CFTR protein rescues endogenous Delta F508-CFTR and corrects chloride transport in mice	FASEB JOURNAL			English	Article						cystic fibrosis; in vivo rescue; processing; transcomplementation	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATION; ENDOPLASMIC-RETICULUM; EPITHELIAL-CELLS; AIRWAY EPITHELIA; PLASMA-MEMBRANE; LOW-TEMPERATURE; GENE-THERAPY; CHANNELS; PROTEASOME	Cystic fibrosis (CF) is most frequently associated with deletion of phenylalanine at position 508 (Delta F508) in the CF transmembrane conductance regulator (CFTR) protein. The Delta F508-CFTR mutant protein exhibits a folding defect that affects its processing and impairs chloride-channel function. This study aimed to determine whether CFTR fragments approximately half the size of wild-type CFTR and complementary to the portion of CFTR bearing the mutation can specifically rescue the processing of endogenous Delta F508-CFTR in vivo. cDNA encoding CFTR fragments were delivered to human airway epithelial cells and mice harboring endogenous Delta F508-CFTR. Delivery of small CFTR fragments, which do not act as chloride channels by themselves, rescue Delta F508-CFTR. Therefore, we can speculate that the presence of the CFTR fragment, which does not harbor a mutation, might facilitate intermolecular interactions. The rescue of CFTR was evident by the restoration of chloride transport in human CFBE41o- bronchial epithelial cells expressing Delta F508-CFTR in vitro. More important, nasal administration of an adenovirus expressing a complementary CFTR fragment restored some degree of CFTR activity in the nasal airways of Delta F508 homozygous mice in vivo. These findings identify complementary protein fragments as a viable in vivo approach for correcting disease-causing misfolding of plasma membrane proteins.-Cormet-Boyaka, E., Hong, J. S., Berdiev, B. K., Fortenberry, J. A., Rennolds, J., Clancy, J. P., Benos, D. J., Boyaka, P. N., Sorscher, E. J. A truncated CFTR protein rescues endogenous Delta F508-CFTR and corrects chloride transport in mice. FASEB J. 23, 3743-3751 (2009). www.fasebj.org	[Cormet-Boyaka, Estelle; Rennolds, Jessica] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Columbus, OH 43201 USA; [Boyaka, Prosper N.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43201 USA; [Hong, Jeong S.; Berdiev, Bakhram K.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Fortenberry, James A.; Sorscher, Eric J.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Clancy, J. P.] Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA; [Benos, Dale J.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cormet-Boyaka, E (corresponding author), Ohio State Univ, Div Pulm Crit Care & Sleep Med, Columbus, OH 43201 USA.	estelle.boyaka@osumc.edu	Cormet-Boyaka, Estelle/H-5624-2011	Sorscher, Eric J./0000-0001-9341-3354; Boyaka, Prosper/0000-0001-6857-9088	Cystic Fibrosis Foundation; U.S. National Institutes of Health [DK37206]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, R56DK037206] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a research grant and a pilot and feasibility grant awarded by the Cystic Fibrosis Foundation (to E.C.-B.), and U.S. National Institutes of Health grant DK37206 (to D.J.B.).	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Clarke LL, 2004, AM J PHYSIOL-CELL PH, V287, pC192, DOI 10.1152/ajpcell.00337.2003; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Dorin JR, 1996, GENE THER, V3, P797; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Flotte TR, 2001, CHEST, V120, p124S, DOI 10.1378/chest.120.3_suppl.124S; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Heda GD, 2000, BIOCHEM BIOPH RES CO, V271, P659, DOI 10.1006/bbrc.2000.2684; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; KETNER G, 2006, ADENOVIRUS METHODS P, V1, P19; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Mazzei Mauro, 2003, Farmaco (Lausanne), V58, P961, DOI 10.1016/S0014-827X(03)00155-1; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Owsianik G, 2003, FEBS LETT, V554, P173, DOI 10.1016/S0014-5793(03)01162-1; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Rennolds J, 2008, J BIOL CHEM, V283, P833, DOI 10.1074/jbc.M706504200; Salinas DB, 2004, AM J PHYSIOL-LUNG C, V287, pL936, DOI 10.1152/ajplung.00354.2003; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Scaria A, 1998, J VIROL, V72, P7302, DOI 10.1128/JVI.72.9.7302-7309.1998; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996; Zsembery A, 2004, J BIOL CHEM, V279, P10720, DOI 10.1074/jbc.M313391200	45	10	10	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2009	23	11					3743	3751		10.1096/fj.08-127878	http://dx.doi.org/10.1096/fj.08-127878			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19620404	Green Published			2022-12-25	WOS:000271272500012
J	Elmasri, H; Karaaslan, C; Teper, Y; Ghelfi, E; Weng, MQ; Ince, TA; Kozakewich, H; Bischoff, J; Cataltepe, S				Elmasri, Harun; Karaaslan, Cagatay; Teper, Yaroslav; Ghelfi, Elisa; Weng, MeiQian; Ince, Tan A.; Kozakewich, Harry; Bischoff, Joyce; Cataltepe, Sule			Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; infantile hemangioma; microvessel; placenta	ACTIVATED RECEPTOR-GAMMA; GROWTH-FACTOR; PHENOTYPIC HETEROGENEITY; INSULIN-RESISTANCE; GENE-EXPRESSION; ADIPOSE-TISSUE; BABOON MODEL; MICE LACKING; IN-VITRO; AP2	Fatty acid binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis. FABP4 has been primarily regarded as an adipocyte-and macrophage-specific protein, but recent studies suggest that it may be more widely expressed. We found strong FABP4 expression in the endothelial cells (ECs) of capillaries and small veins in several mouse and human tissues, including the heart and kidney. FABP4 was also detected in the ECs of mature human placental vessels and infantile hemangiomas, the most common tumor of infancy and ECs. In most of these cases, FABP4 was detected in both the nucleus and cytoplasm. FABP4 mRNA and protein levels were significantly induced in cultured ECs by VEGF-A and bFGF treatment. The effect of VEGF-A on FABP4 expression was inhibited by chemical inhibition or short-hairpin (sh) RNA-mediated knockdown of VEGF-receptor-2 (R2), whereas the VEGFR1 agonists, placental growth factors 1 and 2, had no effect on FABP4 expression. Knockdown of FABP4 in ECs significantly reduced proliferation both under baseline conditions and in response to VEGF and bFGF. Thus, FABP4 emerged as a novel target of the VEGF/VEGFR2 pathway and a positive regulator of cell proliferation in ECs.-Elmasri, H., Karaaslan, C., Teper, Y., Ghelfi, E., Weng, M., Ince, T. A., Kozakewich, H., Bischoff, J., Cataltepe, S. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 23, 3865-3873 (2009). www.fasebj.org	[Elmasri, Harun; Karaaslan, Cagatay; Teper, Yaroslav; Ghelfi, Elisa; Weng, MeiQian; Cataltepe, Sule] Brigham & Womens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Ince, Tan A.] Brigham & Womens Hosp, Div Womens & Perinatal Pathol, Dept Pathol, Boston, MA 02115 USA; [Ince, Tan A.] Harvard Univ, Sch Med, Boston, MA USA; [Kozakewich, Harry] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bischoff, Joyce] Childrens Hosp, Dept Vasc Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Cataltepe, S (corresponding author), Brigham & Womens Hosp, Div Newborn Med, Thorn 1019,75 Francis St, Boston, MA 02115 USA.	scataltepe@partners.org	KARAASLAN, Cagatay/AAA-1621-2021; BISCHOFF, JOYCE/K-3354-2019	KARAASLAN, Cagatay/0000-0003-4857-0857; BISCHOFF, JOYCE/0000-0002-6367-1974; Ince, Tan/0000-0003-0315-6425	Peabody Foundation, Inc.; U.S. National Institutes of Health [5T32 HD007466-12]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER	Peabody Foundation, Inc.; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported in part by the Peabody Foundation, Inc. (S. C.) and U.S. National Institutes of Health grant 5T32 HD007466-12 (Y.T.). We are grateful to Dr. Gokhan Hotamisligil (Harvard School of Public Health, Boston, MA, USA) for the FABP4<SUP>-/-</SUP> mice and valuable discussions, and Drs. Patricia D'Amore and Stella Kourembanas for critical review of the manuscript. We also thank Drs. Alessia Di Nardo and Mustafa Sahin for the shRNA protocol. We are grateful to Marcia Filip, RN (Center for Clinical Investigation, Brigham and Women's Hospital, Boston, MA, USA), for her help with umbilical cord collection.	Adida A, 2006, BBA-MOL CELL BIOL L, V1761, P172, DOI 10.1016/j.bbalip.2006.02.006; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Aljada A, 2008, ANGIOGENESIS, V11, P361, DOI 10.1007/s10456-008-9118-0; Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Barlow C, 1997, NUCLEIC ACIDS RES, V25, P2543, DOI 10.1093/nar/25.12.2543; Barnes CM, 2005, P NATL ACAD SCI USA, V102, P19097, DOI 10.1073/pnas.0509579102; Biron-Shental T, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.066; Bischoff J, 2009, J CRANIOFAC SURG, V20, P695, DOI 10.1097/SCS.0b013e318193d6ac; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Calicchio ML, 2009, AM J PATHOL, V174, P1638, DOI 10.2353/ajpath.2009.080517; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Charan NB, 1997, J APPL PHYSIOL, V82, P284, DOI 10.1152/jappl.1997.82.1.284; Ferrell Robert E., 2008, Lymphatic Research and Biology, V6, P69, DOI 10.1089/lrb.2007.1022; FISHMAN SJ, 1993, PEDIATR CLIN N AM, V40, P1177; Fu YC, 2000, J LIPID RES, V41, P2017; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Goto Y, 2006, CANCER RES, V66, P4443, DOI 10.1158/0008-5472.CAN-05-2505; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kraling BM, 1998, IN VITRO CELL DEV-AN, V34, P308; Kusakari Y, 2006, MOL CELL BIOCHEM, V284, P183, DOI 10.1007/s11010-005-9048-8; Lee MYK, 2007, ARTERIOSCL THROM VAS, V27, P2443, DOI 10.1161/ATVBAHA.107.141705; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Masouye I, 1997, CIRC RES, V81, P297, DOI 10.1161/01.RES.81.3.297; Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Slipicevic A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-276; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Strawn LM, 1996, CANCER RES, V56, P3540; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; WATANABE K, 1993, J PATHOL, V170, P59, DOI 10.1002/path.1711700110; Whittles CE, 2002, MICROCIRCULATION, V9, P513, DOI 10.1038/sj.mn.7800164; Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Yasumatsu R, 2006, AM J PHYSIOL-LUNG C, V291, pL619, DOI 10.1152/ajplung.00507.2005; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	58	217	229	2	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3865	3873		10.1096/fj.09-134882	http://dx.doi.org/10.1096/fj.09-134882			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19625659	Green Published			2022-12-25	WOS:000271272500022
J	Baritaki, S; Chapman, A; Yeung, K; Spandidos, DA; Palladino, M; Bonavida, B				Baritaki, S.; Chapman, A.; Yeung, K.; Spandidos, D. A.; Palladino, M.; Bonavida, B.			Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction	ONCOGENE			English	Article						metastasis; epithelial to mesenchymal transition; proteasome inhibitor; NF-kappa B; Raf-1 kinase inhibitor protein; Snail	NF-KAPPA-B; RAF KINASE; E-CADHERIN; PROTEIN EXPRESSION; TRANSCRIPTION FACTORS; INDUCED APOPTOSIS; MULTIPLE-MYELOMA; TUMOR-CELLS; IN-VITRO; SUPPRESSES	Metastasis is associated with the loss of epithelial features and the acquisition of mesenchymal characteristics and invasive properties by tumor cells, a process known as epithelial to mesenchymal transition (EMT). Snail expression, through nuclear factor (NF)-kappa B activation, is an EMT determinant. The proteasome inhibitor, NPI-0052, induces the metastasis tumor suppressor/immune surveillance cancer gene, Raf kinase inhibitor protein (RKIP), via NF-kappa B inhibition. We hypothesized that NPI-0052 may inhibit Snail expression and, consequently, the metastatic phenotype in DU-145 prostate cancer cells. Cell treatment with NPI-0052 induced E-cadherin and inhibited Snail expression and both tumor cell invasion and migration. Inhibition of Snail inversely correlated with the induction of RKIP. The underlying mechanism of NPI-0052-induced inhibition of the metastatic phenotype was corroborated by: (1) treatment with Snail siRNA in DU-145 inhibited EMT and, in contrast, overexpression of Snail in the nonmetastatic LNCaP cells induced EMT, (2) NPI-0052-induced repression of Snail via inhibition of NF-kappa B was corroborated by the specific NF-kappa B inhibitor DHMEQ and (3) RKIP overexpression mimicked NPI-0052 in the inhibition of Snail and EMT. These findings demonstrate, for the first time, the role of NPI-0052 in the regulation of EMT via inhibition of NF-kappa B and Snail and induction of RKIP. Oncogene (2009) 28, 3573-3585; doi: 10.1038/onc.2009.214; published online 27 July 2009	[Baritaki, S.; Chapman, A.; Bonavida, B.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Jonsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Yeung, K.] Univ Toledo, Dept Canc Biol & Biochem, Coll Med, Toledo, OH 43606 USA; [Spandidos, D. A.] Univ Crete, Fac Med, Dept Clin Virol, Iraklion, Greece; [Palladino, M.] Nereus Pharmaceut, San Diego, CA USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; University of Toledo; University of Crete	Bonavida, B (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Jonsson Comprehens Canc Ctr, David Geffen Sch Med, 10833 Le Conte Ave,A2-060 CHS, Los Angeles, CA 90095 USA.	bbonavida@mednet.ucla.edu	Baritaki, Voula/AAA-9544-2021	Spandidos, Demetrios/0000-0002-1146-931X	NIH/NCI [CA107023-02S1, CA057152-13S1]; Bodossaki Foundation postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA057152, R01CA107023] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bodossaki Foundation postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the NIH/NCI research supplements CA107023-02S1, CA057152-13S1 and by Bodossaki Foundation postdoctoral fellowship (SB). We thank Chau Tran, Jose A Rodriguez and Haiming Chen for their help in the migration and invasion assays and the immuno. uorescence microscopy. We also thank Dr Kazuo Umezawa for providing us with the NF-kappa B inhibitor DHMEQ. In addition, we thank Tiffany Chin, Katherine Wu and Erica Keng for helping in the preparation of this article.	Ahn KS, 2007, BLOOD, V110, P2286, DOI 10.1182/blood-2007-04-084996; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Baritaki S, 2008, J IMMUNOL, V180, P6199, DOI 10.4049/jimmunol.180.9.6199; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Beach S, 2008, ONCOGENE, V27, P2243, DOI 10.1038/sj.onc.1210860; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chauhan D, 2006, BRIT J CANCER, V95, P961, DOI 10.1038/sj.bjc.6603406; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cusack JC, 2006, CLIN CANCER RES, V12, P6758, DOI 10.1158/1078-0432.CCR-06-1151; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; DEHERREROS AG, 2001, COMMON MOL DEV CARCI; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Elloul S, 2006, VIRCHOWS ARCH, V449, P520, DOI 10.1007/s00428-006-0274-6; Fenical W, 2009, BIOORGAN MED CHEM, V17, P2175, DOI 10.1016/j.bmc.2008.10.075; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Granovsky AE, 2008, CELL RES, V18, P452, DOI 10.1038/cr.2008.43; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jiao W, 2002, BRIT J CANCER, V86, P98, DOI 10.1038/sj.bjc.6600017; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Katsman A, 2007, DRUG RESIST UPDATE, V10, P1, DOI 10.1016/j.drup.2007.01.002; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Minoo P, 2007, AM J CLIN PATHOL, V127, P820, DOI 10.1309/5D7MM22DAVGDT1R8; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Roccaro AM, 2008, BLOOD, V111, P4752, DOI 10.1182/blood-2007-11-120972; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Ruiz S, 2006, MOL CANCER THER, V5, P1836, DOI 10.1158/1535-7163.MCT-06-0066; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Sloss CM, 2008, CLIN CANCER RES, V14, P5116, DOI 10.1158/1078-0432.CCR-07-4506; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sterz J, 2008, EXPERT OPIN INV DRUG, V17, P879, DOI 10.1517/13543784.17.6.879 ; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	115	124	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2009	28	40					3573	3585		10.1038/onc.2009.214	http://dx.doi.org/10.1038/onc.2009.214			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KI	19633685				2022-12-25	WOS:000270851700006
J	Graeff, R; Liu, Q; Kriksunov, IA; Kotaka, M; Oppenheimer, N; Hao, Q; Lee, HC				Graeff, Richard; Liu, Qun; Kriksunov, Irina A.; Kotaka, Masayo; Oppenheimer, Norman; Hao, Quan; Lee, Hon Cheung			Mechanism of Cyclizing NAD to Cyclic ADP-ribose by ADP-ribosyl Cyclase and CD38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-MOBILIZING METABOLITE; ELECTRON-DENSITY MAPS; ACTIVE-SITE; INOSITOL TRISPHOSPHATE; COVALENT INTERMEDIATE; NAADP; CA2+; HYDROLYSIS; RELEASE; STORES	Mammalian CD38 and its Aplysia homolog, ADP-ribosyl cyclase (cyclase), are two prominent enzymes that catalyze the synthesis and hydrolysis of cyclic ADP-ribose (cADPR), a Ca2+ messenger molecule responsible for regulating a wide range of cellular functions. Although both use NAD as a substrate, the cyclase produces cADPR, whereas CD38 produces mainly ADPribose (ADPR). To elucidate the catalytic differences and the mechanism of cyclizing NAD, the crystal structure of a stable complex of the cyclase with an NAD analog, ribosyl-2'F-2'deoxynicotinamide adenine dinucleotide (ribo-2'-F-NAD), was determined. The results show that the analog was a substrate of the cyclase and that during the reaction, the nicotinamide group was released and a stable intermediate was formed. The terminal ribosyl unit at one end of the intermediate formed a close linkage with the catalytic residue (Glu-179), whereas the adenine ring at the other end stacked closely with Phe-174, suggesting that the latter residue is likely to be responsible for folding the linear substrate so that the two ends can be cyclized. Mutating Phe-174 indeed reduced cADPR production but enhanced ADPR production, converting the cyclase to be more CD38-like. Changing the equivalent residue in CD38, Thr-221 to Phe, correspondingly enhanced cADPR production, and the double mutation, Thr-221 to Phe and Glu-146 to Ala, effectively converted CD38 to a cyclase. This study provides the first detailed evidence of the cyclization process and demonstrates the feasibility of engineering the reactivity of the enzymes by mutation, setting the stage for the development of tools to manipulate cADPR metabolism in vivo.	[Liu, Qun; Kriksunov, Irina A.; Hao, Quan] Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA; [Graeff, Richard; Lee, Hon Cheung] Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA; [Kotaka, Masayo; Hao, Quan; Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Oppenheimer, Norman] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Cornell University; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong; University of California System; University of California San Francisco	Hao, Q (corresponding author), Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA.	qhao@hku.hk; leehc@hku.hk	Lee, Hon Cheung/C-4329-2009; Liu, Qun/A-8757-2011; Hao, Quan/C-4304-2009; Kotaka, Masayo/C-4483-2009	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514; Kotaka, Masayo/0000-0001-9692-3843	National Institutes of Health [GM061568]; Hong Kong General Research Fund; National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong General Research Fund; National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061568 (to H.C.L./Q.H.). This work was also supported by grants from the Hong Kong General Research Fund and the National Science Foundation of China/Research Grant Council of Hong Kong (NSFC/RGC) Joint Research Scheme (to H. C. L.).	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff RM, 1996, BIOCHEMISTRY-US, V35, P379, DOI 10.1021/bi952083f; Graeff RM, 2003, COMB CHEM HIGH T SCR, V6, P367; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Lam CMC, 2009, CELL CALCIUM, V45, P346, DOI 10.1016/j.ceca.2008.12.006; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Love ML, 2004, STRUCTURE, V12, P477, DOI 10.1016/j.str.2004.02.006; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mothet JP, 1998, J PHYSIOL-LONDON, V507, P405, DOI 10.1111/j.1469-7793.1998.405bt.x; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLEATH PR, 1991, J ORG CHEM, V56, P3608, DOI 10.1021/jo00011a029; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052	39	56	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27629	27636		10.1074/jbc.M109.030965	http://dx.doi.org/10.1074/jbc.M109.030965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19640843	hybrid, Green Published			2022-12-25	WOS:000270232300064
J	Buch, TRH; Heling, D; Damm, E; Gudermann, T; Breit, A				Buech, Thomas R. H.; Heling, Dominik; Damm, Ellen; Gudermann, Thomas; Breit, Andreas			Pertussis Toxin-sensitive Signaling of Melanocortin-4 Receptors in Hypothalamic GT1-7 Cells Defines Agouti-related Protein as a Biased Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLYL-CYCLASE; BETA(2)-ADRENERGIC RECEPTOR; FUNCTIONAL-CHARACTERIZATION; LYSOPHOSPHATIDIC ACID; IN-VIVO; OBESITY; KINASE; MUTATIONS; GENE; NEURONS	Melanocortin-4 receptor (MC4R)-induced anorexigenic signaling in the hypothalamus controls body weight and energy homeostasis. So far, MC4R-induced signaling has been exclusively attributed to its coupling to G(s) proteins. In line with this monogamous G protein coupling profile, most MC4R mutants isolated from obese individuals showed a reduced ability to activate G(s). However, some mutants displayed enhanced G(s) coupling, suggesting that signaling pathways independent of G(s) may be involved in MC4R-mediated anorexigenic signaling. Here we report that the G(s) signaling-deficient MC4R-D90N mutant activates G proteins in a pertussis toxin-sensitive manner, indicating that this mutant is able to selectively interact with G(i/o) proteins. Analyzing a hypothalamic cell line (GT1-7 cells), we observed activation of pertussis toxin-sensitive G proteins by the wild-type MC4R as well, reflecting multiple coupling of the MC4R to G(s) and G(i/o) proteins in an endogenous cell system. Surprisingly, the agouti-related protein, which has been classified as a MC4R antagonist, selectively activates G(i/o) signaling in GT1-7 cells. Thus, the agouti-related protein antagonizes melanocortin-dependent G(s) activation not only by competitive antagonism but additionally by initiating G(i/o) protein-induced signaling as a biased agonist.	[Buech, Thomas R. H.; Damm, Ellen; Gudermann, Thomas; Breit, Andreas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Heling, Dominik] Univ Marburg, Inst Pharmakol & Toxikol, D-35033 Marburg, Germany	University of Munich; Philipps University Marburg	Breit, A (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, Goethestr 33, D-80336 Munich, Germany.	andreas.breit@lrz.uni-muenchen.de			Bundesministerium fur Bildung und Forschung; Nationales Genomforschungsnetzwerk Network [N2NV-S30T09]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Nationales Genomforschungsnetzwerk Network	This work was supported by the "Bundesministerium fur Bildung und Forschung" as a part of the NGFN-2 (Nationales Genomforschungsnetzwerk N2NV-S30T09) Network.	Biebermann H, 2003, DIABETES, V52, P2984, DOI 10.2337/diabetes.52.12.2984; Chai BX, 2006, PEPTIDES, V27, P2846, DOI 10.1016/j.peptides.2006.05.005; Czyzyk TA, 2008, P NATL ACAD SCI USA, V105, P276, DOI 10.1073/pnas.0710607105; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dumont LM, 2001, MOL CELL ENDOCRINOL, V184, P173, DOI 10.1016/S0303-7207(01)00558-5; Ferraguti F, 1999, EUR J NEUROSCI, V11, P2073, DOI 10.1046/j.1460-9568.1999.00626.x; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Fu LY, 2008, J NEUROSCI, V28, P5433, DOI 10.1523/JNEUROSCI.0749-08.2008; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Govaerts C, 2005, PEPTIDES, V26, P1909, DOI 10.1016/j.peptides.2004.11.042; Halls ML, 2007, J PHARMACOL EXP THER, V320, P281, DOI 10.1124/jpet.106.113225; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hinney A, 2006, J CLIN ENDOCR METAB, V91, P1761, DOI 10.1210/jc.2005-2056; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kask A, 1998, BIOCHEM BIOPH RES CO, V245, P90, DOI 10.1006/bbrc.1998.8389; Kask A, 2000, CAN J PHYSIOL PHARM, V78, P143, DOI 10.1139/cjpp-78-2-143; KAUPMANN K, 1993, FEBS LETT, V331, P53, DOI 10.1016/0014-5793(93)80296-7; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAW SF, 1993, J BIOL CHEM, V268, P10721; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Michel MC, 2007, MOL PHARMACOL, V72, P1097, DOI 10.1124/mol.107.040923; Milovic S, 2004, J BIOL CHEM, V279, P34240, DOI 10.1074/jbc.M403448200; Nasman J, 2002, J NEUROCHEM, V83, P1252, DOI 10.1046/j.1471-4159.2002.01270.x; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Noh SJ, 1998, J CELL PHYSIOL, V176, P412, DOI 10.1002/(SICI)1097-4652(199808)176:2<412::AID-JCP20>3.0.CO;2-3; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; Patel TB, 2001, GENE, V269, P13, DOI 10.1016/S0378-1119(01)00448-6; Reversi A, 2005, J BIOL CHEM, V280, P16311, DOI 10.1074/jbc.M409945200; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schallmach E, 2006, NEUROPHARMACOLOGY, V50, P998, DOI 10.1016/j.neuropharm.2006.01.004; Schonbrunn A, 2008, MOL CELL ENDOCRINOL, V286, P35, DOI 10.1016/j.mce.2007.09.009; Shahabi NA, 1999, J NEUROIMMUNOL, V94, P48, DOI 10.1016/S0165-5728(98)00211-2; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Smith MA, 2007, J PHYSIOL-LONDON, V578, P425, DOI 10.1113/jphysiol.2006.119479; Steiner D, 2005, J MOL NEUROSCI, V27, P195, DOI 10.1385/JMN:27:2:195; Sutton GM, 2005, ENDOCRINOLOGY, V146, P3739, DOI 10.1210/en.2005-0562; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057	51	77	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26411	26420		10.1074/jbc.M109.039339	http://dx.doi.org/10.1074/jbc.M109.039339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648111	Green Published, hybrid			2022-12-25	WOS:000269969600022
J	Nguyen, AD; Lee, SH; Debose-Boyd, RA				Nguyen, Andrew D.; Lee, Soo Hee; Debose-Boyd, Russell A.			Insig-mediated, Sterol-accelerated Degradation of the Membrane Domain of Hamster 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase in Insect Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; COENZYME-A REDUCTASE; ENDOPLASMIC-RETICULUM DEGRADATION; ANCHORED UBIQUITIN LIGASE; ER-ASSOCIATED DEGRADATION; REGULATED DEGRADATION; SENSING DOMAIN; PROTEIN-DEGRADATION; BINDING; CHOLESTEROL	Sterol-accelerated degradation of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase is one of several mechanisms through which cholesterol synthesis is controlled in mammalian cells. This degradation results from sterol-induced binding of the membrane domain of reductase to endoplasmic reticulum membrane proteins called Insig-1 and Insig-2, which are carriers of a ubiquitin ligase called gp78. The ensuing gp78-mediated ubiquitination of reductase is a prerequisite for its rapid, 26 S proteasome-mediated degradation from endoplasmic reticulum membranes, a reaction that slows a rate-limiting step in cholesterol synthesis. Here, we report that the membrane domain of hamster reductase is subject to sterol-accelerated degradation in Drosophila S2 cells, but only when mammalian Insig-1 or Insig-2 are co-expressed. This degradation mimics the reaction that occurs in mammalian cells with regard to its absolute requirement for the action of Insigs, sensitivity to proteasome inhibition, augmentation by nonsterol isoprenoids, and sterol specificity. RNA interference studies reveal that this degradation requires the Drosophila Hrd1 ubiquitin ligase and several other proteins, including a putative substrate selector, which associate with the enzyme in yeast and mammalian systems. These studies define Insigs as the minimal requirement for sterol-accelerated degradation of the membrane domain of reductase in Drosophila S2 cells.	[Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Nguyen, Andrew D.; Lee, Soo Hee; Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Debose-Boyd, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu	Lee, Soo Hee/E-9494-2012	Nguyen, Andrew/0000-0002-9492-9472	National Institutes of Health [HL20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL20948 and the Perot Family Foundation.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bordallo J, 1999, FEBS LETT, V448, P244, DOI 10.1016/S0014-5793(99)00362-2; BROWN K, 1983, J BIOL CHEM, V258, P8512; BROWN MS, 1980, J LIPID RES, V21, P505; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Clayton RB, 1964, J LIPID RES, V15, P3; CORRELL CC, 1994, J BIOL CHEM, V269, P633; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dobrosotskaya IY, 2003, J BIOL CHEM, V278, P35837, DOI 10.1074/jbc.M306476200; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; GERTLER FB, 1988, MOL CELL BIOL, V8, P2713, DOI 10.1128/MCB.8.7.2713; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee PCW, 2007, J LIPID RES, V48, P318, DOI 10.1194/jlr.M600476-JLR200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LISCUM L, 1985, J BIOL CHEM, V260, P522; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Roitelman J, 2004, J BIOL CHEM, V279, P6465, DOI 10.1074/jbc.M308094200; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Walters KJ, 2004, BBA-MOL CELL RES, V1695, P73, DOI 10.1016/j.bbamcr.2004.10.005; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	48	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26778	26788		10.1074/jbc.M109.032342	http://dx.doi.org/10.1074/jbc.M109.032342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638338	Green Published, hybrid			2022-12-25	WOS:000269969600059
J	Takei, N; Kawamura, M; Ishizuka, Y; Kakiya, N; Inamura, N; Namba, H; Nawa, H				Takei, Nobuyuki; Kawamura, Mihoko; Ishizuka, Yuta; Kakiya, Naomasa; Inamura, Naoko; Namba, Hisaaki; Nawa, Hiroyuki			Brain-derived Neurotrophic Factor Enhances the Basal Rate of Protein Synthesis by Increasing Active Eukaryotic Elongation Factor 2 Levels and Promoting Translation Elongation in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERM SYNAPTIC PLASTICITY; FACTOR-II; MAMMALIAN TARGET; KINASE; BDNF; EXPRESSION; INITIATION; MEMORY; PHOSPHORYLATION; RECEPTORS	The constitutive and activity-dependent components of protein synthesis are both critical for neural function. Although the mechanisms controlling extracellularly induced protein synthesis are becoming clear, less is understood about the molecular networks that regulate the basal translation rate. Here we describe the effects of chronic treatment with various neurotrophic factors and cytokines on the basal rate of protein synthesis in primary cortical neurons. Among the examined factors, brain-derived neurotrophic factor (BDNF) showed the strongest effect. The rate of protein synthesis increased in the cortical tissues of BDNF transgenic mice, whereas it decreased in BDNF knock-out mice. BDNF specifically increased the level of the active, unphosphorylated form of eukaryotic elongation factor 2 (eEF2). The levels of active eEF2 increased and decreased in BDNF transgenic and BDNF knock-out mice, respectively. BDNF decreased kinase activity and increased phosphatase activity against eEF2 in vitro. Additionally, BDNF shortened the ribosomal transit time, an index of translation elongation. In agreement with these results, overexpression of eEF2 enhanced protein synthesis. Taken together, our results demonstrate that the increased level of active eEF2 induced by chronic BDNF stimulation enhances translational elongation processes and increases the total rate of protein synthesis in neurons.	[Takei, Nobuyuki; Kawamura, Mihoko; Ishizuka, Yuta; Kakiya, Naomasa; Inamura, Naoko; Namba, Hisaaki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata 9518585, Japan	Niigata University	Takei, N (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Asahimachi 1, Niigata 9518585, Japan.	nobtak@bri.niigata-u.ac.jp	Ishizuka, Yuta/ACN-8245-2022; Ishizuka, Yuta/AAB-9170-2019	Ishizuka, Yuta/0000-0002-2036-902X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of science; Japan Science and Technology Corporation (Core Research for Evolutional Science and Technology, CREST); Niigata University Research project	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Corporation (Core Research for Evolutional Science and Technology, CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Niigata University Research project	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (a grant-in-aid for Priority Area (RNA Network), the Japan Society for the Promotion of science (a grant-in-aid for Scientific Research B), the Japan Science and Technology Corporation (Core Research for Evolutional Science and Technology, CREST), and a grant for the promotion of the Niigata University Research project.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Croll SD, 1999, NEUROSCIENCE, V93, P1491, DOI 10.1016/S0306-4522(99)00296-1; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; GSCHWENDT M, 1989, FEBS LETT, V257, P357, DOI 10.1016/0014-5793(89)81571-6; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inamura N, 2005, J NEUROCHEM, V95, P1438, DOI 10.1111/j.1471-4159.2005.03466.x; Inamura N, 2003, MOL BRAIN RES, V111, P165, DOI 10.1016/S0169-328X(03)00027-5; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; MATHEWS MB, 2000, TRANSLATIONAL CONTRO, P719; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Namba H, 2006, MOL CELL NEUROSCI, V31, P628, DOI 10.1016/j.mcn.2005.12.002; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; Nawa H, 2001, TRENDS NEUROSCI, V24, P683, DOI 10.1016/S0166-2236(00)01955-X; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Proud C, 2000, COLD SPRING HARBOR M, V39, P719; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; REDPATH NT, 1990, BIOCHEM J, V272, P175, DOI 10.1042/bj2720175; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1991, FEBS LETT, V285, P170, DOI 10.1016/0014-5793(91)80798-8; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sossin WS, 2008, PROG BRAIN RES, V169, P3, DOI 10.1016/S0079-6123(07)00001-5; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	46	37	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26340	26348		10.1074/jbc.M109.023010	http://dx.doi.org/10.1074/jbc.M109.023010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19625250	hybrid, Green Published			2022-12-25	WOS:000269969600014
J	Teng, HJ; Ballim, RD; Mowla, S; Prince, S				Teng, Huajian; Ballim, Reyna Deeya; Mowla, Shaheen; Prince, Sharon			Phosphorylation of Histone H3 by Protein Kinase C Signaling Plays a Critical Role in the Regulation of the Developmentally Important TBX2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; H3-SER10 PHOSPHORYLATION; CHROMATIN-STRUCTURE; MAP KINASE; EXPRESSION; ACTIVATION; CELLS; SP1; RECEPTOR; PROMOTER	The mechanism(s) regulating the expression of the TBX2 gene, a key regulator of development, is poorly understood and thus limits an understanding of its function(s). Here we demonstrate that 12-O-tetradecanoylphorbol-13-acetate (TPA) induces TBX2 expression in normal human fibroblasts in a protein kinase C (PKC)-dependent and MAPK-independent manner. Our data further reveal that TPA activates transcription of TBX2 through activating MSK1, which leads to an increase in phosphorylated histone H3 and the recruitment of Sp1 to the TBX2 gene. In addition, TPA was shown to activate MSK1 in a PKC-dependent and MAPK-independent manner. This study is the first to provide evidence that phosphorylation of histone H3 leads to the transcriptional activation of the TBX2 gene and to link MSK1 to PKC.	[Teng, Huajian; Ballim, Reyna Deeya; Mowla, Shaheen; Prince, Sharon] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of Cape Town	Prince, S (corresponding author), Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	sharon.prince@uct.ac.za	Mowla, Shaheen/AAR-8297-2021; Prince, Sharon/AFU-4911-2022	Mowla, Shaheen/0000-0001-6802-0495; Prince, Sharon/0000-0002-6975-5255	SA Medical Research Council; National Research Foundation; University of Cape Town	SA Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; University of Cape Town	This work was supported by grants from the SA Medical Research Council, the National Research Foundation, and the University of Cape Town.	Abrahams A, 2008, J BIOL CHEM, V283, P2223, DOI 10.1074/jbc.M705651200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; DAngelo DD, 1996, J BIOL CHEM, V271, P19696, DOI 10.1074/jbc.271.33.19696; Davis E, 2008, ONCOGENE, V27, P976, DOI 10.1038/sj.onc.1210701; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang W, 2006, MOL CELL BIOL, V26, P1307, DOI 10.1128/MCB.26.4.1307-1317.2006; Huang W, 2004, J LIPID RES, V45, P1519, DOI 10.1194/jlr.M400088-JLR200; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johansen KM, 2006, CHROMOSOME RES, V14, P393, DOI 10.1007/s10577-006-1063-4; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; NAMBA M, 1980, GANN, V71, P300; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nissim S, 2007, DEV BIOL, V304, P9, DOI 10.1016/j.ydbio.2006.12.010; Noe V, 2001, EUR J BIOCHEM, V268, P3163, DOI 10.1046/j.1432-1327.2001.02198.x; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Porntadavity S, 2001, DNA CELL BIOL, V20, P473, DOI 10.1089/104454901316976109; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Sinclair CS, 2002, CANCER RES, V62, P3587; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Teng HJ, 2008, GENE, V423, P8, DOI 10.1016/j.gene.2008.06.017; Teng H, 2007, J CELL BIOCHEM, V102, P618, DOI 10.1002/jcb.21315; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200	46	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26368	26376		10.1074/jbc.M109.021360	http://dx.doi.org/10.1074/jbc.M109.021360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633291	Green Published, hybrid			2022-12-25	WOS:000269969600017
J	Wu, HM; Liu, SW; Hsu, MT; Hung, CL; Lai, CC; Cheng, WC; Wang, HJ; Li, YK; Wang, WC				Wu, Hsin-Mao; Liu, Sheng-Wen; Hsu, Ming-Tsung; Hung, Chiu-Lien; Lai, Chun-Chieh; Cheng, Wen-Chi; Wang, Hung-Jung; Li, Yaw-Kuen; Wang, Wen-Ching			Structure, Mechanistic Action, and Essential Residues of a GH-64 Enzyme, Laminaripentaose-producing beta-1,3-Glucanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GLYCOSYL; CLASSIFICATION; HYDROLASE; PROTEIN; ENDO-BETA-1,3-GLUCANASE; PURIFICATION; REFINEMENT; RESOLUTION; FAMILIES	Laminaripentaose-producing beta-1,3-glucanase (LPHase), a member of glycoside hydrolase family 64, cleaves a long-chain polysaccharide beta-1,3-glucan into specific pentasaccharide oligomers. The crystal structure of LPHase from Streptomyces matensis DIC-108 was solved to 1.62 angstrom resolution using multiple-wavelength anomalous dispersion methods. The LPHase structure reveals a novel crescent-like fold; it consists of a barrel domain and a mixed (alpha/beta) domain, forming a wide-open groove between the two domains. The liganded crystal structure was also solved to 1.80 angstrom, showing limited conformational changes. Within the wide groove, a laminaritetraose molecule is found to sit in an electronegatively charged central region and is proximal to several conserved residues including two carboxylates (Glu(154) and Asp(170)) and four other sugar-binding residues (Thr156, Asn(158), Trp(163), and Thr(167)). Molecular modeling using a laminarihexaose as a substrate suggests roles for Glu(154) and Asp(170) as acid and base catalysts, respectively, whereas the side chains of Thr(156), Asn(158), and Trp(163) demarcate subsite +5. Site-directed mutagenesis of Glu(154) and Asp(170) confirms that both carboxylates are essential for catalysis. Together, our results suggest that LPHase uses a direct displacement mechanism involving Glu(154) and Asp(170) to cleave a beta-1,3-glucan into specific alpha-pentasaccharide oligomers.	[Liu, Sheng-Wen; Li, Yaw-Kuen] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 300, Taiwan; [Wu, Hsin-Mao; Hsu, Ming-Tsung; Hung, Chiu-Lien; Lai, Chun-Chieh; Cheng, Wen-Chi; Wang, Hung-Jung; Wang, Wen-Ching] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan; [Wu, Hsin-Mao; Hsu, Ming-Tsung; Hung, Chiu-Lien; Lai, Chun-Chieh; Cheng, Wen-Chi; Wang, Hung-Jung; Wang, Wen-Ching] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 300, Taiwan	National Yang Ming Chiao Tung University; National Tsing Hua University; National Tsing Hua University	Li, YK (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 300, Taiwan.	ykl@cc.nctu.edu.tw; wcwang@mx.nthu.edu.tw	Wang, Wen-Ching/ABI-2253-2020	Hsu, Ming-Tsung/0000-0002-6940-1844; Wang, Wen-Ching/0000-0002-7422-3667	National Science Council [NSC 94-2311-B-009-001, NSC96-2313-B-007-001, NSC97-3112-B007-005]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported, in part, by grants from the National Science Council (NSC 94-2311-B-009-001, NSC96-2313-B-007-001, and NSC97-3112-B007-005), Taiwan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ATKINS EDT, 1968, NATURE, V220, P784, DOI 10.1038/220784a0; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLUHM TL, 1977, CAN J CHEM, V55, P293, DOI 10.1139/v77-044; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DAY AG, 1985, BIOCHEM BIOPH RES CO, V133, P628, DOI 10.1016/0006-291X(85)90951-9; DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020; Fibriansah G, 2007, PROTEINS, V69, P683, DOI 10.1002/prot.21589; Fontaine T, 1997, J BACTERIOL, V179, P3154, DOI 10.1128/jb.179.10.3154-3163.1997; Fukuda K, 2008, BIOSCI BIOTECH BIOCH, V72, P3107, DOI 10.1271/bbb.80213; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HENRISSAT B, 1999, CARBOHYDRATE ACTIVE; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KO TP, 1994, ACTA CRYSTALLOGR D, V50, P813, DOI 10.1107/S0907444994005512; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leone P, 2006, BIOCHIMIE, V88, P45, DOI 10.1016/j.biochi.2005.07.001; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakabayashi M, 1998, J FERMENT BIOENG, V85, P459, DOI 10.1016/S0922-338X(98)80062-7; Nishimura T, 2001, FEBS LETT, V499, P187, DOI 10.1016/S0014-5793(01)02551-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Receveur-Brechot V, 2006, PROTEINS, V63, P235, DOI 10.1002/prot.20876; SAITO H, 1977, BIOCHEMISTRY-US, V16, P908, DOI 10.1021/bi00624a015; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VARGHESE JN, 1994, P NATL ACAD SCI USA, V91, P2785, DOI 10.1073/pnas.91.7.2785; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; YANG W, 1990, J BIOL CHEM, V265, P13553; Zekovic DB, 2005, CRIT REV BIOTECHNOL, V25, P205, DOI 10.1080/07388550500376166	42	21	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26708	26715		10.1074/jbc.M109.010983	http://dx.doi.org/10.1074/jbc.M109.010983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640850	Green Published, hybrid			2022-12-25	WOS:000269969600051
J	Kerr, ID; Lee, JH; Farady, CJ; Marion, R; Rickert, M; Sajid, M; Pandey, KC; Caffrey, CR; Legac, J; Hansell, E; McKerrow, JH; Craik, CS; Rosenthal, PJ; Brinen, LS				Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.			Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; MOLECULAR REPLACEMENT; PARASITIC DISEASES; CHAGAS-DISEASE; IN-VITRO; SUBSTRATE; HEMOGLOBIN; SPECIFICITY	Cysteine proteases of the papain superfamily are implicated in a number of cellular processes and are important virulence factors in the pathogenesis of parasitic disease. These enzymes have therefore emerged as promising targets for antiparasitic drugs. We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small molecule, cysteine protease inhibitors, the vinyl sulfones. These data, in conjunction with comparative inhibition kinetics, provide insight into the molecular mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.	[Kerr, Iain D.; Lee, Ji H.; Marion, Rachael; Rickert, Mathias; Brinen, Linda S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Farady, Christopher J.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Sajid, Mohammed; Caffrey, Conor R.; Hansell, Elizabeth; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Sajid, Mohammed; Caffrey, Conor R.; Hansell, Elizabeth; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94143 USA; [Pandey, Kailash C.; Legac, Jennifer; Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Brinen, LS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, QB3 Byers Hall 508C,1700 4th St, San Francisco, CA 94158 USA.	brinen@cmp.ucsf.edu	Pandey, Kailash/H-5048-2011		National Institutes of Health [AI35707, AI35800]; Sandler Foundation; Medicines for Malaria Venture; Charles E. Culpeper Biomedical Pilot Initiative Award; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology Program, NIH; NIGMS, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035800, R56AI035800, R01AI035800, P01AI035707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; Medicines for Malaria Venture; Charles E. Culpeper Biomedical Pilot Initiative Award; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI35707 and AI35800 (to C. R. C.). This work was also supported by the Sandler Foundation, the Medicines for Malaria Venture, and a Charles E. Culpeper Biomedical Pilot Initiative Award ( to C. R. C.). Part of this research was performed at SSRL, a national user facility operated by Stanford University on behalf of the U. S. Dept. of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Dept. of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, Biomedical Technology Program, NIH, and NIGMS, NIH.	BALAKRISHNAN I, 2002, PRINCIPLES PRACTICE, P91; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Chen YT, 2008, BIOORG MED CHEM LETT, V18, P5860, DOI 10.1016/j.bmcl.2008.06.012; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; EAKIN AE, 1993, J BIOL CHEM, V268, P6115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel JC, 1998, J CELL SCI, V111, P597; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Engel JC, 1999, MEDICINA-BUENOS AIRE, V59, P171; Ettari R, 2008, J MED CHEM, V51, P988, DOI 10.1021/jm701141u; Evans W, 1997, CHEM BRIT, V33, P22; Fujii N, 2005, BIOORG MED CHEM LETT, V15, P121, DOI 10.1016/j.bmcl.2004.10.023; Gillmor SA, 1997, PROTEIN SCI, V6, P1603, DOI 10.1002/pro.5560060801; Gonzalez FV, 2007, BIOORG MED CHEM LETT, V17, P6697, DOI 10.1016/j.bmcl.2007.10.056; Greenbaum DC, 2004, J MED CHEM, V47, P3212, DOI 10.1021/jm030549j; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Huang L, 2003, BIOORGAN MED CHEM, V11, P21, DOI 10.1016/S0968-0896(02)00427-3; Jacobsen W, 2000, DRUG METAB DISPOS, V28, P1343; Jaishankar P, 2008, BIOORG MED CHEM LETT, V18, P624, DOI 10.1016/j.bmcl.2007.11.070; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; Laufer MK, 2007, AM J TROP MED HYG, V77, P160, DOI 10.4269/ajtmh.2007.77.160; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; McPherson A, 1982, PREPARATION ANAL PRO; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nkemngu NJ, 2003, INT J ANTIMICROB AG, V22, P155, DOI 10.1016/S0924-8579(03)00096-7; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellette M, 2001, TROP MED INT HEALTH, V6, P874, DOI 10.1046/j.1365-3156.2001.00777.x; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Schulz F, 2007, CHEMMEDCHEM, V2, P1214, DOI 10.1002/cmdc.200700070; Shenai BR, 2003, ANTIMICROB AGENTS CH, V47, P154, DOI 10.1128/AAC.47.1.154-160.2003; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Steverding D, 2006, MINI-REV MED CHEM, V6, P1025, DOI 10.2174/138955706778195207; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vicik R, 2006, BIOORG MED CHEM LETT, V16, P2753, DOI 10.1016/j.bmcl.2006.02.026; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Zhang YC, 1998, DRUG METAB DISPOS, V26, P360	58	197	197	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25697	25703		10.1074/jbc.M109.014340	http://dx.doi.org/10.1074/jbc.M109.014340			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620707	Green Published, hybrid			2022-12-25	WOS:000269738000027
J	Eisenberg, S; Korza, G; Carson, J; Liachko, I; Tye, BK				Eisenberg, Shlomo; Korza, George; Carson, John; Liachko, Ivan; Tye, Bik-Kwoon			Novel DNA Binding Properties of the Mcm10 Protein from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTONOMOUSLY REPLICATING SEQUENCES; SEQUENTIAL BINDING; ESCHERICHIA-COLI; POLYMERASE-ALPHA; MCM2-7 COMPLEX; ORIGIN; PURIFICATION; CDC45; CHROMOSOME; INTERACTS	The Mcm10 protein is essential for chromosomal DNA replication in eukaryotic cells. We purified the Saccharomyces cerevisiae Mcm10 (ScMcm10) and characterized its DNA binding properties. Electrophoretic mobility shift assays and surface plasmon resonance analysis showed that ScMcm10 binds stably to both double strand (ds) DNA and single strand (ss) DNA. On short DNA templates of 25 or 50 bp, surface plasmon resonance analysis showed a similar to 1:1 stoichiometry of ScMcm10 to dsDNA. On longer dsDNA templates, however, multiple copies of ScMcm10 cooperated in the rapid assembly of a large, stable nucleoprotein complex. The amount of protein bound was directly proportional to the length of the DNA, with an average occupancy spacing of 21-24 bp. This tight spacing is consistent with a nucleoprotein structure in which ScMcm10 is aligned along the helical axis of the dsDNA. In contrast, the stoichiometry of ScMcm10 bound to ssDNA of 20-50 nucleotides was similar to 3:1 suggesting that interaction with ssDNA induces the assembly of a multisubunit ScMcm10 complex composed of at least three subunits. The tight packing of ScMcm10 on dsDNA and the assembly of a multisubunit complex on ssDNA suggests that, in addition to protein-DNA, protein-protein interactions may be involved in forming the nucleoprotein complex. We propose that these DNA binding properties have an important role in (i) initiation of DNA replication and (ii) formation and maintenance of a stable replication fork during the elongation phase of chromosomal DNA replication.	Univ Connecticut, Sch Med, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA; [Liachko, Ivan; Tye, Bik-Kwoon] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	University of Connecticut; Cornell University	Eisenberg, S (corresponding author), 263 Farmington Ave, Farmington, CT 06030 USA.	seisenberg@nso2.uchc.edu			National Institutes of Health [GM072557, NS15190, RR022232]; National Science Foundation [MCB-0453773]; University of Connecticut Health Center Research Advisorey Council Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015190, R56NS015190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Connecticut Health Center Research Advisorey Council Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072557 (to B. K. T.) and NS15190 and RR022232 (to J.H.C.). This work was also supported by National Science Foundation Grant MCB-0453773 (to B. K. T.) and by the University of Connecticut Health Center Research Advisorey Council Fund (to S. E.).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; DIFFLEY JFX, 1988, P NATL ACAD SCI USA, V85, P2120, DOI 10.1073/pnas.85.7.2120; DUMAS LB, 1982, MOL GEN GENET, V187, P42, DOI 10.1007/BF00384381; EISENBERG S, 1976, P NATL ACAD SCI USA, V73, P1594, DOI 10.1073/pnas.73.5.1594; EISENBERG S, 1988, P NATL ACAD SCI USA, V85, P743, DOI 10.1073/pnas.85.3.743; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fien K, 2006, J BIOL CHEM, V281, P22248, DOI 10.1074/jbc.M512997200; Fisher Robert J., 1994, Methods (Orlando), V6, P121, DOI 10.1006/meth.1994.1015; FRANCESCONI SC, 1989, MOL CELL BIOL, V9, P2906, DOI 10.1128/MCB.9.7.2906; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Homesley L, 2000, GENE DEV, V14, P913; Houchens CR, 2008, J BIOL CHEM, V283, P30216, DOI 10.1074/jbc.M802649200; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Lei M, 2001, J CELL SCI, V114, P1447; Liachko I, 2009, GENETICS, V181, P379, DOI 10.1534/genetics.108.099101; MAINE GT, 1984, GENETICS, V106, P365; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; PALZKILL TG, 1988, CELL, V53, P441, DOI 10.1016/0092-8674(88)90164-X; Raychaudhuri S, 1997, NUCLEIC ACIDS RES, V25, P5057, DOI 10.1093/nar/25.24.5057; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; SWEDER KS, 1988, J BIOL CHEM, V263, P17270; WALKER SS, 1990, P NATL ACAD SCI USA, V87, P4665, DOI 10.1073/pnas.87.12.4665; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	36	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25412	25420		10.1074/jbc.M109.033175	http://dx.doi.org/10.1074/jbc.M109.033175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605346	Green Published, hybrid			2022-12-25	WOS:000269734000073
J	Milne, K; Kobel, M; Kalloger, SE; Barnes, RO; Gao, DX; Gilks, CB; Watson, PH; Nelson, BH				Milne, Katy; Koebel, Martin; Kalloger, Steven E.; Barnes, Rebecca O.; Gao, Dongxia; Gilks, C. Blake; Watson, Peter H.; Nelson, Brad H.			Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; MEDIATED ANTITUMOR IMMUNITY; TRANSCRIPTION FACTOR FOXP3; MEDULLARY BREAST-CANCER; IN-VIVO; B-CELLS; FOLLICULAR LYMPHOMA; MESSENGER-RNA; AUTOIMMUNE-DISEASE	Background: Tumor-infiltrating T cells are associated with survival in epithelial ovarian cancer (EOC), but their functional status is poorly understood, especially relative to the different risk categories and histological subtypes of EOC. Methodology/Principal Findings: Tissue microarrays containing high-grade serous, endometrioid, mucinous and clear cell tumors were analyzed immunohistochemically for the presence of lymphocytes, dendritic cells, neutrophils, macrophages, MHC class I and II, and various markers of activation and inflammation. In high-grade serous tumors from optimally debulked patients, positive associations were seen between intraepithelial cells expressing CD3, CD4, CD8, CD45RO, CD25, TIA-1, Granzyme B, FoxP3, CD20, and CD68, as well as expression of MHC class I and II by tumor cells. Disease-specific survival was positively associated with the markers CD8, CD3, FoxP3, TIA-1, CD20, MHC class I and class II. In other histological subtypes, immune infiltrates were less prevalent, and the only markers associated with survival were MHC class II (positive association in endometrioid cases) and myeloperoxidase (negative association in clear cell cases). Conclusions/Significance: Host immune responses to EOC vary widely according to histological subtype and the extent of residual disease. TIA- 1, FoxP3 and CD20 emerge as new positive prognostic factors in high-grade serous EOC from optimally debulked patients.			Milne, K (corresponding author), BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada.	bnelson@bccancer.bc.ca	Nelson, Brad H/K-2622-2014; Köbel, Martin/A-7373-2011	Watson, Peter/0000-0002-1642-0638; Kobel, Martin/0000-0002-6615-2037; Milne, Katy/0000-0001-5616-1821; Nelson, Brad/0000-0002-4445-5539				Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Akahiro Jun-ichi, 2004, Int J Clin Oncol, V9, P42, DOI 10.1007/s10147-003-0360-6; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; ALVARO T, 2005, OUTCOME HODGKINS LYM; ALVARONARANJO T, 2005, TUMOR INFILTRATING C; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; ASANO N, 2006, PROGNOSTIC SIGNIFICA; AYYOUB M, 2009, HUMAN MEMORY FOXP3 T; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; BADOUAL C, 2009, J CLIN ONCOL; BAMIAS A, 2007, GYNECOL ONCOL; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brenchley JM, 2002, CLIN EXP IMMUNOL, V130, P431, DOI 10.1046/j.1365-2249.2002.02015.x; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; CHETAILLE B, 2009, MOL PROFILING CLASSI; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; CONSTANT S, 1995, J IMMUNOL, V155, P3734; Coronella JA, 2002, J IMMUNOL, V169, P1829, DOI 10.4049/jimmunol.169.4.1829; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Jong D, 2009, HAEMATOL-HEMATOL J, V94, P70, DOI 10.3324/haematol.13574; Denkert C, 2002, AM J PATHOL, V160, P893, DOI 10.1016/S0002-9440(10)64912-7; Dong HP, 2006, AM J CLIN PATHOL, V125, P451, DOI 10.1309/15B66DQMFYYM78CJ; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Duluc D, 2007, BLOOD; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; GILKS CB, 2008, HUMAN PATHO IN PRESS; Gimotty PA, 2007, DIS MARKERS, V23, P445, DOI 10.1155/2007/508350; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Hansen MH, 2002, J IMMUNOL, V169, P2701, DOI 10.4049/jimmunol.169.5.2701; Hansen MH, 2001, P NATL ACAD SCI USA, V98, P12659, DOI 10.1073/pnas.171460798; Hasselblom S, 2007, BRIT J HAEMATOL, V137, P364, DOI 10.1111/j.1365-2141.2007.06593.x; Hillen F, 2008, CANCER IMMUNOL IMMUN, V57, P97, DOI 10.1007/s00262-007-0353-9; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Imamichi H, 2008, EUR J IMMUNOL, V38, P1621, DOI 10.1002/eji.200737607; JANEWAY CA, 1987, J IMMUNOL, V138, P1051; Kanavaros P, 2000, LEUKEMIA LYMPHOMA, V38, P317, DOI 10.3109/10428190009087022; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Ke XY, 2008, FRONT BIOSCI-LANDMRK, V13, P3986, DOI 10.2741/2986; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; Kotlan B, 2005, J IMMUNOL, V175, P2278, DOI 10.4049/jimmunol.175.4.2278; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Kuroda H, 2005, VIRCHOWS ARCH, V446, P10, DOI 10.1007/s00428-004-1143-9; KURTJONES EA, 1988, J IMMUNOL, V140, P3773; Kusuda T, 2005, ONCOL REP, V13, P1153; Lang S, 2007, CANCER IMMUNOL IMMUN, V56, P1645, DOI 10.1007/s00262-007-0312-5; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Leffers N, 2008, GYNECOL ONCOL, V110, P365, DOI 10.1016/j.ygyno.2008.04.043; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Leveque L, 2009, J IMMUNOTHER, V32, P101, DOI 10.1097/CJI.0b013e318195b59e; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Liu M, 2009, MODERN PATHOL, V22, P373, DOI 10.1038/modpathol.2008.187; LIU Y, 1995, INT IMMUNOL, V7, P1353, DOI 10.1093/intimm/7.8.1353; Loercher AE, 1999, J IMMUNOL, V163, P6251; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; LYLE S, 2000, TIA 1 POSITIVE TUMOR; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Matsushita Norihiro, 2003, Journal of Nippon Medical School, V70, P40; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; MOORE DH, 1990, CLASS HISTOCOMPATIBI, V38, P458; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Nedergaard BS, 2008, GYNECOL ONCOL, V108, P106, DOI 10.1016/j.ygyno.2007.08.089; Negus RPM, 1997, AM J PATHOL, V150, P1723; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Nzula S, 2003, CANCER RES, V63, P3275; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 2000, SEMIN ONCOL, V27, P47; Piccirillo CA, 2008, CYTOKINE, V43, P395, DOI 10.1016/j.cyto.2008.07.469; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Powell DJ, 2008, J IMMUNOTHER, V31, P189, DOI 10.1097/CJI.0b013e31815dc0e8; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Rasku MA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-12; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; RON Y, 1987, J IMMUNOL, V138, P2848; RON Y, 1981, EUR J IMMUNOL, V11, P964, DOI 10.1002/eji.1830111203; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; RONCHESE F, 1993, J EXP MED, V177, P679, DOI 10.1084/jem.177.3.679; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Tamiolakis D, 2002, EUR J GYNAECOL ONCOL, V23, P433; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang Y, 2007, BREAST CANCER RES TR, V104, P129, DOI 10.1007/s10549-006-9409-3; Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043; Weinberg AD, 2002, TRENDS IMMUNOL, V23, P102, DOI 10.1016/S1471-4906(01)02127-5; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Woo EY, 2001, CANCER RES, V61, P4766; Woo YL, 2008, J CLIN PATHOL, V61, P969, DOI 10.1136/jcp.2008.056200; Yakirevich E, 1999, MODERN PATHOL, V12, P1050; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; ZEIMET AG, 2008, INT J CANC; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	137	293	297	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6412	10.1371/journal.pone.0006412	http://dx.doi.org/10.1371/journal.pone.0006412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641607	Green Submitted, gold, Green Published			2022-12-25	WOS:000268494500013
J	Liu, JK; She, ZS				Liu, Jian K.; She, Zhen-Su			A Spike-Timing Pattern Based Neural Network Model for the Study of Memory Dynamics	PLOS ONE			English	Article								It is well accepted that the brain's computation relies on spatiotemporal activity of neural networks. In particular, there is growing evidence of the importance of continuously and precisely timed spiking activity. Therefore, it is important to characterize memory states in terms of spike-timing patterns that give both reliable memory of firing activities and precise memory of firing timings. The relationship between memory states and spike-timing patterns has been studied empirically with large-scale recording of neuron population in recent years. Here, by using a recurrent neural network model with dynamics at two time scales, we construct a dynamical memory network model which embeds both fast neural and synaptic variation and slow learning dynamics. A state vector is proposed to describe memory states in terms of spike-timing patterns of neural population, and a distance measure of state vector is defined to study several important phenomena of memory dynamics: partial memory recall, learning efficiency, learning with correlated stimuli. We show that the distance measure can capture the timing difference of memory states. In addition, we examine the influence of network topology on learning ability, and show that local connections can increase the network's ability to embed more memory states. Together theses results suggest that the proposed system based on spike-timing patterns gives a productive model for the study of detailed learning and memory dynamics.			Liu, JK (corresponding author), Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA.	liujk@ucla.edu; she@pku.edu.cn	She, Zhen-Su/H-9722-2014; 佘, 振苏/C-1447-2010; Liu, Jian K./E-1748-2013	Liu, Jian K./0000-0002-5391-7213				BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Buzsaki G, 2007, NATURE, V446, P267, DOI 10.1038/446267a; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; de Almeida L, 2007, LEARN MEMORY, V14, P795, DOI 10.1101/lm.730207; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; GOLOMB D, 1994, J NEUROPHYSIOL, V72, P1109, DOI 10.1152/jn.1994.72.3.1109; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Jacobs A. L., 2009, P NATL ACAD SCI US; LIU JK, 2009, FRONT SYST NEUROSCI; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mehring C, 2003, BIOL CYBERN, V88, P395, DOI 10.1007/s00422-002-0384-4; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Siri B, 2008, NEURAL COMPUT, V20, P2937, DOI 10.1162/neco.2008.05-07-530; Siri B, 2007, J PHYSIOL-PARIS, V101, P136, DOI 10.1016/j.jphysparis.2007.10.003; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6247	10.1371/journal.pone.0006247	http://dx.doi.org/10.1371/journal.pone.0006247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629179	Green Published, Green Submitted, gold			2022-12-25	WOS:000268318900001
J	Aldhous, MC; Noble, CL; Satsangi, J				Aldhous, Marian C.; Noble, Colin L.; Satsangi, Jack			Dysregulation of Human beta-Defensin-2 Protein in Inflammatory Bowel Disease	PLOS ONE			English	Article							COPY NUMBER VARIATION; NF-KAPPA-B; CROHNS-DISEASE; ULCERATIVE-COLITIS; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; DEFENSIN EXPRESSION; CIGARETTE-SMOKING; EPITHELIAL-CELLS; ALPHA-DEFENSIN	Background: Human beta-defensin-2 (HBD2) is an antimicrobial peptide implicated in the pathogenesis of inflammatory bowel disease (IBD). Low copy number and concomitant low mRNA expression of the HBD2 gene have been implicated in susceptibility to colonic Crohn's Disease ( CD). We investigated the colonic distribution of HBD2 mRNA expression, and the contributions of genetic and environmental factors on HBD2 protein production. Methodology/Principal Findings: We examined HBD2 mRNA expression at three colonic locations by microarray analysis of biopsies from 151 patients ( 53 CD, 67 ulcerative colitis [UC], 31 controls). We investigated environmental and genetic influences on HBD2 protein production using ex vivo cultured sigmoid colon biopsies from 69 patients (22 CD, 26 UC, 21 controls) stimulated with lipopolysaccharide (LPS) and/or nicotine for 24 hours. HBD2 and cytokines were measured in culture supernatants. Using DNA samples from these patients, regions in the HBD2 gene promoter were sequenced for NF-kappa B binding-sites and HBD2 gene copy number was determined. HBD2 mRNA expression was highest in inflamed (vs. uninflamed p = 0.0122) ascending colon in CD and in inflamed (vs. uninflamed p < 0.0001) sigmoid colon in UC. HBD2 protein production was increased in inflamed UC biopsies (p = 0.0078). There was no difference in HBD2 protein production from unstimulated biopsies of CD, UC and controls. LPS-induced HBD2 production was significantly increased in CD (p = 0.0375) but not UC (p = 0.2017); this LPS-induced response was augmented by nicotine in UC (p = 0.0308) but not CD (p = 0.6872). Nicotine alone did not affect HBD2 production. HBD2 production correlated with IL8 production in UC (p < 0.001) and with IL10 in CD (p < 0.05). Variations in the HBD2 promoter and HBD2 gene copy number did not affect HBD2 production. Significance/Conclusions: Colonic HBD2 was dysregulated at mRNA and protein level in IBD. Inflammatory status and stimulus but not germline variations influenced these changes.			Aldhous, MC (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Gastrointestinal Unit,Sch Clin & Mol Med, Edinburgh, Midlothian, Scotland.	maldhous@ed.ac.uk			MRC [G0600329] Funding Source: UKRI; Medical Research Council [G0600329] Funding Source: Medline; Chief Scientist Office [CBZ/4/68] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aldhous MC, 2008, INFLAMM BOWEL DIS, V14, P1469, DOI 10.1002/ibd.20523; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P589, DOI 10.1111/j.1572-0241.2007.01065.x; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Armitage EL, 2004, GASTROENTEROLOGY, V127, P1051, DOI 10.1053/j.gastro.2004.06.024; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Arnott IDR, 2004, GENES IMMUN, V5, P417, DOI 10.1038/sj.gene.6364111; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Beaugerie L, 2001, AM J GASTROENTEROL, V96, P2113, DOI 10.1016/S0002-9270(01)02507-2; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; Brant SR, 2003, INFLAMM BOWEL DIS, V9, P281, DOI 10.1097/00054725-200309000-00001; Cosnes J, 1999, ALIMENT PHARM THERAP, V13, P1403; Dhaliwal W, 2009, CLIN EXP IMMUNOL, V156, P263, DOI 10.1111/j.1365-2249.2008.03808.x; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Eliakim R, 2002, EUR J GASTROEN HEPAT, V14, P607, DOI 10.1097/00042737-200206000-00005; Eliakim R, 2001, INT J COLORECTAL DIS, V16, P14, DOI 10.1007/s003840000262; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Geng YM, 1995, TOXICOL APPL PHARM, V135, P268, DOI 10.1006/taap.1995.1233; Groth M, 2008, HUM MUTAT, V29, P1247, DOI 10.1002/humu.20751; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Jansen PAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004725; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Kanda N, 2008, EUR J IMMUNOL, V38, P1287, DOI 10.1002/eji.200738051; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kiehne K, 2007, SCAND J GASTROENTERO, V42, P1063, DOI 10.1080/00365520701320489; Kiehne K, 2006, WORLD J GASTROENTERO, V12, P1056, DOI 10.3748/wjg.v12.i7.1056; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; MCCANN MF, 1992, CANCER EPIDEM BIOMAR, V1, P125; MCGRATH J, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004722.PUB2; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peyrin-Biroulet L, 2006, TRENDS MICROBIOL, V14, P432, DOI 10.1016/j.tim.2006.08.008; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; Schlee M, 2008, CLIN EXP IMMUNOL, V151, P528, DOI 10.1111/j.1365-2249.2007.03587.x; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SCHUG J, 1997, CBILTR19971001V00; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; STEINER AA, 2009, NICOTINE ADM WITHDRA; VANDIJK JPM, 1995, EUR J PHARMACOL, V278, pR11, DOI 10.1016/0014-2999(95)00211-3; Vassallo R, 2008, MOL IMMUNOL, V45, P3321, DOI 10.1016/j.molimm.2008.04.014; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wu WKK, 2004, J PHARMACOL SCI, V94, P348, DOI 10.1254/jphs.94.348	61	57	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6285	10.1371/journal.pone.0006285	http://dx.doi.org/10.1371/journal.pone.0006285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GW	19617917	Green Published, Green Submitted, gold			2022-12-25	WOS:000268119600003
J	Chiari, Y; Hyseni, C; Fritts, TH; Glaberman, S; Marquez, C; Gibbs, JP; Claude, J; Caccone, A				Chiari, Ylenia; Hyseni, Chaz; Fritts, Tom H.; Glaberman, Scott; Marquez, Cruz; Gibbs, James P.; Claude, Julien; Caccone, Adalgisa			Morphometrics Parallel Genetics in a Newly Discovered and Endangered Taxon of Galapagos Tortoise	PLOS ONE			English	Article							POPULATION-STRUCTURE; DARWINS FINCHES; GIANT TORTOISES; HARDY-WEINBERG; F-STATISTICS; CONSERVATION; DIVERGENCE; MITOCHONDRIAL; SOFTWARE; TURTLES	Galapagos tortoises represent the only surviving lineage of giant tortoises that exhibit two different types of shell morphology. The taxonomy of Galapagos tortoises was initially based mainly on diagnostic morphological characters of the shell, but has been clarified by molecular studies indicating that most islands harbor monophyletic lineages, with the exception of Isabela and Santa Cruz. On Santa Cruz there is strong genetic differentiation between the two tortoise populations (Cerro Fatal and La Reserva) exhibiting domed shell morphology. Here we integrate nuclear microsatellite and mitochondrial data with statistical analyses of shell shape morphology to evaluate whether the genetic distinction and variability of the two domed tortoise populations is paralleled by differences in shell shape. Based on our results, morphometric analyses support the genetic distinction of the two populations and also reveal that the level of genetic variation is associated with morphological shell shape variation in both populations. The Cerro Fatal population possesses lower levels of morphological and genetic variation compared to the La Reserva population. Because the turtle shell is a complex heritable trait, our results suggest that, for the Cerro Fatal population, non-neutral loci have probably experienced a parallel decrease in variability as that observed for the genetic data.			Chiari, Y (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	yle@yleniachiari.it	Chiari, Ylenia/AAW-3108-2020; Claude, julien/G-7411-2016; Chiari, Ylenia/L-5397-2013; Hyseni, Chaz/I-7633-2018; Caccone, Adalgisa/AAE-4238-2021	Chiari, Ylenia/0000-0003-2338-8602; Claude, julien/0000-0002-9267-1228; Chiari, Ylenia/0000-0003-2338-8602; Hyseni, Chaz/0000-0003-2567-8013; Caccone, Adalgisa/0000-0002-8949-9260; Glaberman, Scott/0000-0003-0594-4732				Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; Bonnet X, 2001, BIOL J LINN SOC, V72, P357, DOI 10.1006/bijl.2000.0504; Burns KJ, 2002, EVOLUTION, V56, P1240; Caccone A, 2002, EVOLUTION, V56, P2052; Carretero MA, 2005, ANIM BIOL, V55, P259, DOI 10.1163/1570756054472854; Chiari Y, 2006, CONSERV GENET, V7, P473, DOI 10.1007/s10592-005-9057-x; Ciofi C, 2002, MOL ECOL, V11, P2265, DOI 10.1046/j.1365-294X.2002.01617.x; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Claude J, 2004, SYST BIOL, V53, P933, DOI 10.1080/10635150490889498; Claude J, 2008, MORPHOMETRICS R; CORRAL MDT, 2002, THESIS PONTIFICA U C; DOMOKOS G, 2008, P R SOC B, V1630, P11; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Fritts T.H., 1983, P107; Fritz U, 2005, MOL PHYLOGENET EVOL, V37, P389, DOI 10.1016/j.ympev.2005.03.007; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Gilbert Scott F., 2008, P1; Grant PR, 2004, EVOLUTION, V58, P1588; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hendry AP, 2004, EVOLUTION, V58, P2319; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Huxley J., 1932, PROBLEMS RELATIVE GR; Le M, 2006, MOL PHYLOGENET EVOL, V40, P517, DOI 10.1016/j.ympev.2006.03.003; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; MACFARLAND C G, 1974, Biological Conservation, V6, P118, DOI 10.1016/0006-3207(74)90024-X; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Myers EM, 2006, EVOLUTION, V60, P563; Olafsdottir GA, 2007, J EVOLUTION BIOL, V20, P603, DOI 10.1111/j.1420-9101.2006.01250.x; Posada D, 2004, COLLAPSE VERSION 3 1; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Core Team, 2021, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Russello MA, 2007, CURR BIOL, V17, pR317, DOI 10.1016/j.cub.2007.03.002; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; SEIDEL ME, 1981, COPEIA, P119; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; SWINGLAND IR, 1989, J ANIM ECOL, V58, P971, DOI 10.2307/5136; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Denburgh J., 1914, Proceedings of the California Academy of Science (4th Series), V2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wikelski M, 2000, NATURE, V403, P37, DOI 10.1038/47396; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zani PA, 1995, COPEIA, P735, DOI 10.2307/1446772; Zuffi MAL, 2006, ITAL J ZOOL, V73, P363, DOI 10.1080/11250000600971323; Zug George R., 1997, Chelonian Conservation and Biology, V2, P618	59	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6272	10.1371/journal.pone.0006272	http://dx.doi.org/10.1371/journal.pone.0006272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609441	gold, Green Published			2022-12-25	WOS:000268119500007
J	Rochais, F; Dandonneau, M; Mesbah, K; Jarry, T; Mattei, MG; Kelly, RG				Rochais, Francesca; Dandonneau, Mathieu; Mesbah, Karim; Jarry, Therese; Mattei, Marie-Genevieve; Kelly, Robert G.			Hes1 Is Expressed in the Second Heart Field and Is Required for Outflow Tract Development	PLOS ONE			English	Article								Background: Rapid growth of the embryonic heart occurs by addition of progenitor cells of the second heart field to the poles of the elongating heart tube. Failure or perturbation of this process leads to congenital heart defects. In order to provide further insight into second heart field development we characterized the insertion site of a transgene expressed in the second heart field and outflow tract as the result of an integration site position effect. Results: Here we show that the integration site of the A17-Myf5-nlacZ-T55 transgene lies upstream of Hes1, encoding a basic helix-loop-helix containing transcriptional repressor required for the maintenance of diverse progenitor cell populations during embryonic development. Transgene expression in a subset of Hes1 expression sites, including the CNS, pharyngeal epithelia, pericardium, limb bud and lung endoderm suggests that Hes1 is the endogenous target of regulatory elements trapped by the transgene. Hes1 is expressed in pharyngeal endoderm and mesoderm including the second heart field. Analysis of Hes1 mutant hearts at embryonic day 15.5 reveals outflow tract alignment defects including ventricular septal defects and overriding aorta. At earlier developmental stages, Hes1 mutant embryos display defects in second heart field proliferation, a reduction in cardiac neural crest cells and failure to completely extend the outflow tract. Conclusions: Hes1 is expressed in cardiac progenitor cells in the early embryo and is required for development of the arterial pole of the heart.			Rochais, F (corresponding author), Univ Aix Marseille 2, Dev Biol Inst Marseilles Luminy, CNRS, UMR 6216, Campus Luminy, Marseille, France.	kelly@ibdml.univ-mrs.fr	Rochais, Francesca/A-5326-2017; Rochais, Francesca/ABF-4675-2021; Kelly, Robert G/F-2523-2013	Rochais, Francesca/0000-0001-9355-8916; Rochais, Francesca/0000-0001-9355-8916; Kelly, Robert G/0000-0003-4357-0073; Mattei, Marie-Genevieve/0000-0002-6027-7058				Bajolle F, 2008, DEV BIOL, V313, P25, DOI 10.1016/j.ydbio.2007.09.023; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JCI27704; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kokubo H, 2005, TRENDS CARDIOVAS MED, V15, P190, DOI 10.1016/j.tcm.2005.05.005; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Mesbah K, 2006, MOL CELL BIOL, V26, P7760, DOI 10.1128/MCB.00913-06; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Raetzman LT, 2007, DEV BIOL, V304, P455, DOI 10.1016/j.ydbio.2006.11.010; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Theveniau-Ruissy M, 2008, CIRC RES, V103, P142, DOI 10.1161/CIRCRESAHA.108.172189; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Waldo KL, 2005, DEV BIOL, V281, P66, DOI 10.1016/j.ydbio.2005.02.011; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174	37	59	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6267	10.1371/journal.pone.0006267	http://dx.doi.org/10.1371/journal.pone.0006267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609448	Green Published, gold, Green Submitted			2022-12-25	WOS:000268119500004
J	Comellas, G; Kaczmarska, Z; Tarrago, T; Teixido, M; Giralt, E				Comellas, Gemma; Kaczmarska, Zusanna; Tarrago, Teresa; Teixido, Meritxell; Giralt, Ernest			Exploration of the One-Bead One-Compound Methodology for the Design of Prolyl Oligopeptidase Substrates	PLOS ONE			English	Article							SUPPORTS	Here we describe the design, synthesis and evaluation of the first solid-phase substrates for prolyl oligopeptidase ( POP), a cytosolic serine peptidase associated with schizophrenia, bipolar affective disorder and related neuropsychiatric disorders. This study seeks to contribute to the future design of a one-bead one-compound (OBOC) peptide library of POP substrates, based on an intramolecular energy transfer substrate. Unexpectedly, the enzymatic evaluation of the substrates attached on solid-phase by means of the HMBA linker were cleaved through the ester bond, thereby suggesting an unknown esterase activity of POP, in addition to its known peptidase activity. By performing multiple activity assays, we have confirmed the esterase activity of this enzyme and its capacity to process the substrates on solid-phase. Finally, we tested a new linker, compatible with both the solid-phase peptide-synthesis used and the enzymatic assay, for application in the future design of an OBOC library.			Comellas, G (corresponding author), Inst Recerca Biomed IRB Barcelona, Parc Cient Barcelona, Barcelona, Spain.	ernest.giralt@irbbarcelona.org	giralt, ernest/N-1669-2014; teixido, meritxell/I-3282-2015	giralt, ernest/0000-0001-8381-1797; teixido, meritxell/0000-0002-7825-3695; Kaczmarska, Zuzanna/0000-0002-7668-1442				Farrera-Sinfreu J, 2002, TETRAHEDRON LETT, V43, P7813, DOI 10.1016/S0040-4039(02)01605-2; Felix A M, 1970, J Am Chem Soc, V92, P1385, DOI 10.1021/ja00708a046; Fulop V, 2001, J BIOL CHEM, V276, P1262, DOI 10.1074/jbc.M007003200; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Gershkovich A, 1996, J BIOCHEM BIOPH METH, V33, P135, DOI 10.1016/S0165-022X(96)00023-1; Halling PJ, 2006, BIOCHEM SOC T, V34, P309, DOI 10.1042/BST0340309; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kress J, 2002, CHEM-EUR J, V8, P3769, DOI 10.1002/1521-3765(20020816)8:16<3769::AID-CHEM3769>3.0.CO;2-V; Lam KS, 1997, CHEM REV, V97, P411, DOI 10.1021/cr9600114; Leger R, 1998, TETRAHEDRON LETT, V39, P4171, DOI 10.1016/S0040-4039(98)00777-1; Leon S, 1998, BIOORG MED CHEM LETT, V8, P2997, DOI 10.1016/S0960-894X(98)00534-4; LETSINGER RL, 1963, J AM CHEM SOC, V85, P3045, DOI 10.1021/ja00902a054; Madder A, 1999, EUR J ORG CHEM, V1999, P2787; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; Marani MM, 2007, J COMB CHEM, V9, P395, DOI 10.1021/cc070012h; Meldal M, 2005, QSAR COMB SCI, V24, P1141, DOI 10.1002/qsar.200540008; NANTEULI D, 1998, DRUGS FUTURE, V23, P167; Pastor JJ, 2007, J AM CHEM SOC, V129, P14922, DOI 10.1021/ja073969x; Renil M, 1998, J PEPT SCI, V4, P195, DOI 10.1002/(SICI)1099-1387(199805)4:3<195::AID-PSC141>3.3.CO;2-I; Sauerbrei B, 1998, ANGEW CHEM INT EDIT, V37, P1143, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1143::AID-ANIE1143>3.0.CO;2-E; Shin DS, 2008, J COMB CHEM, V10, P20, DOI 10.1021/cc7001217; Tarrago T, 2005, J PEPT SCI, V11, P283, DOI 10.1002/psc.676; Tarrago T, 2007, CHEMMEDCHEM, V2, P354, DOI 10.1002/cmdc.200600303; Tarrago T, 2006, CHEMBIOCHEM, V7, P827, DOI 10.1002/cbic.200500424; Vazquez JV, 2003, METHOD ENZYMOL, V369, P21; YAO N, 2008, PEPTIDE SCI, V9, P421	27	6	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6222	10.1371/journal.pone.0006222	http://dx.doi.org/10.1371/journal.pone.0006222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593439	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035400007
J	Stow, LR; Gumz, ML; Lynch, IJ; Greenlee, MM; Rudin, A; Cain, BD; Wingo, CS				Stow, Lisa R.; Gumz, Michelle L.; Lynch, I. Jeanette; Greenlee, Megan M.; Rudin, Alicia; Cain, Brian D.; Wingo, Charles S.			Aldosterone Modulates Steroid Receptor Binding to the Endothelin-1 Gene (edn1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; EPITHELIAL SODIUM-CHANNEL; HUMAN MINERALOCORTICOID RECEPTOR; GLUCOCORTICOID-RECEPTOR; RESPONSE ELEMENT; BLOOD-PRESSURE; CELL-LINE; 5'-FLANKING REGION; ETB RECEPTORS; IMMUNOREACTIVE ENDOTHELIN	Aldosterone and endothelin-1 (ET-1) act on collecting duct cells of the kidney and are important regulators of renal sodium transport and cardiovascular physiology. We recently identified the ET-1 gene (edn1) as a novel aldosterone-induced transcript. However, aldosterone action on edn1 has not been characterized at the present time. In this report, we show that aldosterone stimulated edn1 mRNA in acutely isolated rat inner medullary collecting duct cells ex vivo and ET-1 peptide in rat inner medulla in vivo. Aldosterone induction of edn1 mRNA occurred in cortical, outer medullary, and inner medullary collecting duct cells in vitro. Inspection of the edn1 promoter revealed two putative hormone response elements. Levels of heterogeneous nuclear RNA synthesis demonstrated that edn1 mRNA stimulation occurred at the level of transcription. RNA knockdowns corroborated pharmacological studies and demonstrated both mineralocorticoid receptor and glucocorticoid receptor participated in this response. Aldosterone resulted in dose-dependent nuclear translocation and binding of mineralocorticoid receptor and glucocorticoid receptor to the edn1 hormone response elements. Hormone receptors mediated the association of chromatin remodeling complexes, histone modification, and RNA polymerase II at the edn1 promoter. Direct interaction between aldosterone and ET-1 has important implications for renal and cardiovascular function.	[Stow, Lisa R.; Greenlee, Megan M.; Wingo, Charles S.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Gumz, Michelle L.; Lynch, I. Jeanette; Rudin, Alicia; Wingo, Charles S.] Univ Florida, Dept Med, Div Nephrol, Gainesville, FL 32610 USA; [Cain, Brian D.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Stow, Lisa R.; Gumz, Michelle L.; Lynch, I. Jeanette; Greenlee, Megan M.; Rudin, Alicia; Wingo, Charles S.] Vet Affairs Med Ctr, Gainesville, FL 32608 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Wingo, CS (corresponding author), 1601 SW Archer Rd,Res 151, Gainesville, FL 32608 USA.	charles.wingo@medicine.ufl.edu	Gumz, Michelle/AGX-2097-2022	Gumz, Michelle/0000-0002-1342-0878; Mitzelfelt, Megan/0000-0002-6578-3670	National Institutes of Health [RO1-DK049750]; Research Service of the Department of Veteran Affairs; Department of Medicine of the University of Florida; American Heart Association Predoctoral Fellowships [AHA071572B, AHA0825467E]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007518, R01DK049750, R01DK082680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Department of Veteran Affairs; Department of Medicine of the University of Florida; American Heart Association Predoctoral Fellowships(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK049750 (to C. S. W.) from USPHS. This work was also supported by the Research Service of the Department of Veteran Affairs, the Department of Medicine of the University of Florida, and American Heart Association Predoctoral (AHA071572B) and Postdoctoral (AHA0825467E) Fellowships (to L. R. S. and M. L. G., respectively).	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Aumais JP, 1996, J BIOL CHEM, V271, P12568, DOI 10.1074/jbc.271.21.12568; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Baylis C, 1999, CLIN EXP PHARMACOL P, V26, P253, DOI 10.1046/j.1440-1681.1999.03026.x; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhargava A, 2004, MOL CELL ENDOCRINOL, V217, P189, DOI 10.1016/j.mce.2003.10.020; Boesen EI, 2007, AM J PHYSIOL-RENAL, V292, pF185, DOI 10.1152/ajprenal.00021.2006; Bugaj V, 2008, AM J PHYSIOL-RENAL, V295, pF1063, DOI 10.1152/ajprenal.90321.2008; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Derfoul A, 1998, J BIOL CHEM, V273, P20702, DOI 10.1074/jbc.273.33.20702; Doi T, 2008, AM J PHYSIOL-HEART C, V295, pH1279, DOI 10.1152/ajpheart.00148.2008; EDWARDS RM, 1992, AM J PHYSIOL, V263, pF1020, DOI 10.1152/ajprenal.1992.263.6.F1020; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Funder JW, 2009, MOL CELL ENDOCRINOL, V301, P2, DOI 10.1016/j.mce.2008.10.029; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; FUNDER JW, 1993, SCIENCE, V259, P1132, DOI 10.1126/science.8382375; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gallego MS, 1996, AM J PHYSIOL-RENAL, V271, pF451, DOI 10.1152/ajprenal.1996.271.2.F451; Ge YQ, 2005, AM J PHYSIOL-RENAL, V289, pF692, DOI 10.1152/ajprenal.00100.2005; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Ge YQ, 2008, CAN J PHYSIOL PHARM, V86, P329, DOI 10.1139/Y08-028; Gilmore ES, 2001, J BIOL CHEM, V276, P42610, DOI 10.1074/jbc.M106919200; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Gumz ML, 2003, AM J PHYSIOL-RENAL, V285, pF664, DOI 10.1152/ajprenal.00353.2002; Guntupalli J, 1997, AM J PHYSIOL-CELL PH, V273, pC558, DOI 10.1152/ajpcell.1997.273.2.C558; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Hellal-Levy C, 2000, MOL ENDOCRINOL, V14, P1210, DOI 10.1210/me.14.8.1210; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Hoffman A, 2000, HYPERTENSION, V35, P732, DOI 10.1161/01.HYP.35.3.732; Hsieh TJ, 2000, AM J PHYSIOL-RENAL, V279, pF112, DOI 10.1152/ajprenal.2000.279.1.F112; Inscho EW, 2005, BRIT J PHARMACOL, V146, P1019, DOI 10.1038/sj.bjp.0706412; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Khanna A, 2005, J AM SOC NEPHROL, V16, P1929, DOI 10.1681/ASN.2004121054; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V162, P38, DOI 10.1016/0006-291X(89)91958-X; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P348, DOI 10.1016/0006-291X(89)91603-3; KIZER NL, 1995, AM J PHYSIOL-RENAL, V268, pF347, DOI 10.1152/ajprenal.1995.268.2.F347; Kohan DE, 2006, CURR OPIN NEPHROL HY, V15, P34, DOI 10.1097/01.mnh.0000186852.15889.1a; KOHAN DE, 1992, J BIOL CHEM, V267, P12336; Kohan DE, 2009, KIDNEY INT, V76, P481, DOI 10.1038/ki.2009.203; Kolla V, 1999, BIOCHEM BIOPH RES CO, V266, P5, DOI 10.1006/bbrc.1999.1765; Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Matsumura Y, 2000, J CARDIOVASC PHARM, V36, pS86, DOI 10.1097/00005344-200036051-00028; Matsumura Y, 2000, BRIT J PHARMACOL, V129, P1060, DOI 10.1038/sj.bjp.0703157; McManus F, 2008, NAT CLIN PRACT ENDOC, V4, P44, DOI 10.1038/ncpendmet0676; Mick VE, 2001, MOL ENDOCRINOL, V15, P575, DOI 10.1210/me.15.4.575; Montezano ACI, 2005, PEPTIDES, V26, P1454, DOI 10.1016/j.peptides.2005.03.038; Morris DJ, 2009, STEROIDS, V74, P1, DOI 10.1016/j.steroids.2008.10.005; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Nishi M, 2007, NEUROENDOCRINOLOGY, V85, P186, DOI 10.1159/000101917; Odermatt A, 2009, STEROIDS, V74, P163, DOI 10.1016/j.steroids.2008.10.010; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pollock DM, 2000, AM J PHYSIOL-RENAL, V278, pF279, DOI 10.1152/ajprenal.2000.278.2.F279; Pollock DM, 2000, CURR OPIN NEPHROL HY, V9, P157, DOI 10.1097/00041552-200003000-00010; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rogerson FM, 2003, MOL CELL ENDOCRINOL, V200, P45, DOI 10.1016/S0303-7207(02)00413-6; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Stricklett PK, 2006, AM J PHYSIOL-RENAL, V290, pF1315, DOI 10.1152/ajprenal.00450.2005; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; ULICK S, 1979, J CLIN ENDOCR METAB, V49, P757, DOI 10.1210/jcem-49-5-757; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Vassileva I, 2003, HYPERTENSION, V41, P1359, DOI 10.1161/01.HYP.0000070958.39174.7E; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WHORWOOD CB, 1994, ENDOCRINOLOGY, V135, P901, DOI 10.1210/en.135.3.901; Wolf SC, 2006, BIOCHEM PHARMACOL, V71, P1175, DOI 10.1016/j.bcp.2006.01.001; Wong S, 2007, ENDOCRINOLOGY, V148, P1511, DOI 10.1210/en.2006-0965; YORIKANE R, 1993, FEBS LETT, V332, P31, DOI 10.1016/0014-5793(93)80476-B	79	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30087	30096		10.1074/jbc.M109.030718	http://dx.doi.org/10.1074/jbc.M109.030718			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19638349	Green Published, hybrid			2022-12-25	WOS:000271090000011
J	Wei, G; de Leeuw, E; Pazgier, M; Yuan, WR; Zou, GZ; Wang, JF; Ericksen, B; Lu, WY; Lehrer, RI; Lu, WY				Wei, Gang; de Leeuw, Erik; Pazgier, Marzena; Yuan, Weirong; Zou, Guozhang; Wang, Jianfeng; Ericksen, Bryan; Lu, Wei-Yue; Lehrer, Robert I.; Lu, Wuyuan			Through the Looking Glass, Mechanistic Insights from Enantiomeric Human Defensins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUTROPHIL DEFENSINS; HUMAN ALPHA-DEFENSINS; D-AMINO ACIDS; CONSERVED SALT BRIDGE; ANTHRAX LETHAL TOXIN; HUMAN BETA-DEFENSINS; ANTIMICROBIAL PEPTIDES; LIPID-II; ESCHERICHIA-COLI; INNATE IMMUNITY	Despite the small size and conserved tertiary structure of defensins, little is known at a molecular level about the basis of their functional versatility. For insight into the mechanism(s) of defensin function, we prepared enantiomeric pairs of four human defensins, HNP1, HNP4, HD5, and HBD2, and studied their killing of bacteria, inhibition of anthrax lethal factor, and binding to HIV-1 gp120. Unstructured HNP1, HD5, and HBD3 and several other human alpha- and beta-defensins were also examined. Crystallographic analysis showed a plane of symmetry that related (L)HNP1 and (D)HNP1 to each other. Either D-enantiomerization or linearization significantly impaired the ability of HNP1 and HD5 to kill Staphylococcus aureus but not Escherichia coli. In contrast, (L)HNP4 and (D)HNP4 were equally bactericidal against both bacteria. D-Enantiomers were generally weaker inhibitors or binders of lethal factor and gp120 than their respective native, all-L forms, although activity differences were modest, particularly for HNP4. A strong correlation existed among these different functions. Our data indicate: (a) that HNP1 and HD5 kill E. coli by a process that is mechanistically distinct from their actions that kill S. aureus and (b) that chiral molecular recognition is not a stringent prerequisite for other functions of these defensins, including their ability to inhibit lethal factor and bind gp120 of HIV-1.	[Ericksen, Bryan; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wei, Gang; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University System of Maryland; University of Maryland Baltimore; Fudan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lu, WY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	wlu@ihv.umaryland.edu	Lu, Wuyuan/J-8452-2017; Lu, Weiyue/E-7938-2010; Lu, Wuyuan/B-2268-2010; Pazgier, Marzena/B-7295-2012; Ericksen, Bryan/F-9047-2012; Wei, Gang/AAH-7377-2019	Lu, Wuyuan/0000-0003-1318-9968; Wei, Gang/0000-0002-9600-0982; Ericksen, Bryan/0000-0002-8016-8289	National Institutes of Health [AI072732, AI061482]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R01AI072732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).	Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; BROCK TD, 1991, BIOL MICROORGANISMS, P54; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; CASTEELS P, 1994, BIOCHEM BIOPH RES CO, V199, P339, DOI 10.1006/bbrc.1994.1234; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Cho Y, 1998, INFECT IMMUN, V66, P2486, DOI 10.1128/IAI.66.6.2486-2493.1998; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1990, EUR J HAEMATOL, V44, P1; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guo CJ, 2004, AIDS, V18, P1217, DOI 10.1097/00002030-200405210-00020; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; KREIL G, 1994, SCIENCE, V266, P996, DOI 10.1126/science.7973683; Kreil G, 1997, ANNU REV BIOCHEM, V66, P337, DOI 10.1146/annurev.biochem.66.1.337; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1988, J CLIN INVEST, V81, P1829, DOI 10.1172/JCI113527; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2007, CURR OPIN HEMATOL, V14, P16, DOI 10.1097/00062752-200701000-00005; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Min DH, 2004, NAT BIOTECHNOL, V22, P717, DOI 10.1038/nbt973; Miyasaki KT, 1998, J PERIODONTAL RES, V33, P91; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PANYUTICH AV, 1994, FEBS LETT, V356, P169, DOI 10.1016/0014-5793(94)01261-X; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Shi JS, 2007, J IMMUNOL, V179, P1245, DOI 10.4049/jimmunol.179.2.1245; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; van den Berg RH, 1998, BLOOD, V92, P3898, DOI 10.1182/blood.V92.10.3898.422k03_3898_3903; van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wang W, 2006, J BIOL CHEM, V281, P32755, DOI 10.1074/jbc.M603614200; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	87	88	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29180	29192		10.1074/jbc.M109.018085	http://dx.doi.org/10.1074/jbc.M109.018085			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19640840	Green Published, hybrid			2022-12-25	WOS:000270678900073
J	Ameyar-Zazoua, M; Souidi, M; Fritsch, L; Robin, P; Thomas, A; Hamiche, A; Percipalle, P; Ait-Si-Ali, S; Harel-Bellan, A				Ameyar-Zazoua, Maya; Souidi, Mouloud; Fritsch, Lauriane; Robin, Philippe; Thomas, Audrey; Hamiche, Ali; Percipalle, Piergiorgio; Ait-Si-Ali, Slimane; Harel-Bellan, Annick			Physical and Functional Interaction between Heterochromatin Protein 1 alpha and the RNA-binding Protein Heterogeneous Nuclear Ribonucleoprotein U	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-U/SAF-A; SAF-A; MAMMALIAN HETEROCHROMATIN; POLYMERASE-II; IN-VIVO; HP1; DNA; TRANSCRIPTION; METHYLATION; DROSOPHILA	By combining biochemical purification and mass spectrometry, we identified proteins associated with human heterochromatin protein 1 alpha (HP1 alpha) both in the nucleoplasm and in chromatin. Some of these are RNA-binding proteins, and among them is the protein heterogeneous nuclear ribonucleoprotein U (hnRNP U)/SAF-A, which is linked to chromatin organization and transcriptional regulation. Here, we demonstrate that hnRNP U is a bona fide HP1 alpha-interacting molecule. More importantly, hnRNP U depletion reduces HP1 alpha-dependent gene silencing and disturbs HP1 alpha subcellular localization. Thus, our data demonstrate that hnRNP U is involved in HP1 alpha function, shedding new light on the mode of action of HP1 alpha and on the function of hnRNP U.	[Ameyar-Zazoua, Maya; Souidi, Mouloud; Fritsch, Lauriane; Robin, Philippe; Thomas, Audrey; Hamiche, Ali; Ait-Si-Ali, Slimane; Harel-Bellan, Annick] CNRS, IAL, FRE 2944, F-94800 Villejuif, France; [Ameyar-Zazoua, Maya; Souidi, Mouloud; Fritsch, Lauriane; Robin, Philippe; Thomas, Audrey; Hamiche, Ali; Ait-Si-Ali, Slimane; Harel-Bellan, Annick] Univ Paris 11, F-94801 Villejuif, France; [Percipalle, Piergiorgio] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet	Harel-Bellan, A (corresponding author), CNRS, IAL, FRE 2944, 7 Rue Guy Moquet, F-94800 Villejuif, France.	ahbellan@vjf.cnrs.fr	Harel-Bellan, Annick/M-9795-2015; SOUIDI, Mouloud/ABI-1444-2020	Harel-Bellan, Annick/0000-0002-2339-153X	CNRS; European Union 6th Framework Programme TRANS-REG [LSHG-CT-2004-502950]; SIROCCO [LSHG-CT-2006-037900]	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union 6th Framework Programme TRANS-REG(European Commission); SIROCCO	This work was supported by CNRS and by European Union 6th Framework Programme TRANS-REG Grant LSHG-CT-2004-502950 and SIROCCO Grant LSHG-CT-2006-037900.	Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Fackelmayer FO, 2005, J BIOL CHEM, V280, P1720, DOI 10.1074/jbc.C400531200; FACKELMAYER FO, 1994, BBA-GENE STRUCT EXPR, V1217, P232, DOI 10.1016/0167-4781(94)90044-2; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; Helbig R, 2003, CHROMOSOMA, V112, P173, DOI 10.1007/s00412-003-0258-0; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Malyavantham KS, 2008, J CELL BIOCHEM, V105, P391, DOI 10.1002/jcb.21834; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Sugimoto K, 2001, CELL STRUCT FUNCT, V26, P705, DOI 10.1247/csf.26.705; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062; Zofall M, 2006, COLD SPRING HARB SYM, V71, P487, DOI 10.1101/sqb.2006.71.059	24	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					27974	27979		10.1074/jbc.M109.037929	http://dx.doi.org/10.1074/jbc.M109.037929			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19617346	hybrid, Green Published			2022-12-25	WOS:000270676300025
J	Boniecki, MT; Rho, SB; Tukalo, M; Hsu, JL; Romero, EP; Martinis, SA				Boniecki, Michal T.; Rho, Seung Bae; Tukalo, Mikhail; Hsu, Jennifer L.; Romero, Eliana P.; Martinis, Susan A.			Leucyl-tRNA Synthetase-dependent and -independent Activation of a Group I Intron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST MITOCHONDRIA; MATURASE DEFICIENCY; SPLICING FUNCTION; DNA ENDONUCLEASE; CATALYTIC CORE; P4-P6 DOMAIN; PROTEIN; BINDING; CONNECTIONS; MUTATIONS	Leucyl-tRNA synthetase (LeuRS) is an essential RNA splicing factor for yeast mitochondrial introns. Intracellular experiments have suggested that it works in collaboration with a maturase that is encoded within the bI4 intron. RNA deletion mutants of the large bI4 intron were constructed to identify a competently folded intron for biochemical analysis. The minimized bI4 intron was active in RNA splicing and contrasts with previous proposals that the canonical core of the bI4 intron is deficient for catalysis. The activity of the minimized bI4 intron was enhanced in vitro by the presence of the bI4 maturase or LeuRS.	[Boniecki, Michal T.; Rho, Seung Bae; Tukalo, Mikhail; Hsu, Jennifer L.; Romero, Eliana P.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	martinis@uiuc.edu		Martinis, Susan/0000-0001-5730-8346; Tukalo, Michael/0000-0002-0982-2372	National Institutes of Health [GM63107]; Human Frontiers Science Program; Robert A. Welch Foundation; American Chemical Society Petroleum Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063107, R01GM063789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Robert A. Welch Foundation(The Welch Foundation); American Chemical Society Petroleum Research Fund(American Chemical Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63107. This work was also supported by grants from The Human Frontiers Science Program, The Robert A. Welch Foundation, and the American Chemical Society Petroleum Research Fund.	AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Caprara MG, 2001, J MOL BIOL, V308, P165, DOI 10.1006/jmbi.2001.4581; Chen X, 2000, J MOL BIOL, V301, P265, DOI 10.1006/jmbi.2000.3963; CHERNIACK AD, 1990, CELL, V62, P745, DOI 10.1016/0092-8674(90)90119-Y; DELAHODDE A, 1989, CELL, V56, P431, DOI 10.1016/0092-8674(89)90246-8; GAMPEL A, 1987, MOL CELL BIOL, V7, P2545, DOI 10.1128/MCB.7.7.2545; GOGUEL V, 1992, MOL CELL BIOL, V12, P696, DOI 10.1128/MCB.12.2.696; GUO QB, 1991, J BIOL CHEM, V266, P1809; Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; KAMPER U, 1992, MOL CELL BIOL, V12, P499; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; LABOUESSE M, 1987, EMBO J, V6, P713, DOI 10.1002/j.1460-2075.1987.tb04812.x; LABOUESSE M, 1985, CELL, V41, P133, DOI 10.1016/0092-8674(85)90068-6; LAMBOWITZ AM, 1999, RNA WORLD, V2, P451; Li GY, 1996, MOL GEN GENET, V252, P667, DOI 10.1007/BF02173972; Martinis SA, 2007, CHEM BIOL, V14, P1307, DOI 10.1016/j.chembiol.2007.12.001; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOHR G, 1994, NATURE, V370, P147, DOI 10.1038/370147a0; Mohr G, 2001, J MOL BIOL, V307, P75, DOI 10.1006/jmbi.2000.4460; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pathak HB, 2002, J BIOL CHEM, V277, P31551, DOI 10.1074/jbc.M204408200; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; Rangan P, 2003, J MOL BIOL, V329, P229, DOI 10.1016/S0022-2836(03)00430-3; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Rho SB, 2000, RNA, V6, P1882, DOI 10.1017/S1355838200001254; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; TANNER NK, 1995, J MOL BIOL, V252, P583; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6; Westhof E, 1996, FOLD DES, V1, pR78, DOI 10.1016/S1359-0278(96)00037-5	36	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26243	26250		10.1074/jbc.M109.031179	http://dx.doi.org/10.1074/jbc.M109.031179			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19622748	Green Published, hybrid			2022-12-25	WOS:000269969600004
J	Lamour, NF; Subramanian, P; Wijesinghe, DS; Stahelin, RV; Bonventre, JV; Chalfant, CE				Lamour, Nadia F.; Subramanian, Preeti; Wijesinghe, Dayanjan S.; Stahelin, Robert V.; Bonventre, Joseph V.; Chalfant, Charles E.			Ceramide 1-Phosphate Is Required for the Translocation of Group IVA Cytosolic Phospholipase A(2) and Prostaglandin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; TANDEM MASS-SPECTROMETRY; INTRACELLULAR CALCIUM; CATALYTIC DOMAIN; CELL-LINES; KINASE; LUNG; SPHINGOLIPIDS; EXPRESSION; PHOSPHORYLATION	Little is known about the regulation of eicosanoid synthesis proximal to the activation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha), the initial rate-limiting step. The current view is that cPLA(2)alpha associates with intracellular/phosphatidylcholine-rich membranes strictly via hydrophobic interactions in response to an increase of intracellular calcium. In opposition to this accepted mechanism of two decades, ceramide 1-phosphate (C1P) has been shown to increase the membrane association of cPLA(2)alpha in vitro via a novel site in the cationic beta-groove of the C2 domain (Stahelin, R. V., Subramanian, P., Vora, M., Cho, W., and Chalfant, C. E. (2007) J. Biol. Chem. 282, 20467-204741). In this study we demonstrate that C1P is a proximal and required bioactive lipid for the translocation of cPLA(2)alpha to intracellular membranes in response to inflammatory agonists (e. g. calcium ionophore and ATP). Last, the absolute requirement of the C1P/cPLA(2)alpha interaction was demonstrated for the production of eicosanoids using murine embryonic fibroblasts (cPLA(2)alpha(-/-)) coupled to "rescue" studies. Therefore, this study provides a paradigm shift in how cPLA(2)alpha is activated during inflammation.	[Lamour, Nadia F.; Subramanian, Preeti; Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem, Richmond, VA 23298 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, South Bend, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46556 USA; [Bonventre, Joseph V.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Renal Div,Dept Med, Boston, MA 02115 USA; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Indiana University System; Indiana University South Bend; University of Notre Dame; Walther Cancer Institute; University of Notre Dame; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Rm 2-016,Sanger Hall,1101 E Marshall St,POB 98061, Richmond, VA 23298 USA.	cechalfant@vcu.edu	Stahelin, Robert/L-3567-2019	, Preeti/0000-0002-6062-6158	National Institutes of Health [HL-072925, CA-117990, DK54741, DK39773]; Veterans Administration; Virginia Commonwealth University funds; American Heart Association [AHA0625502U];  [SDG 0735350N]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773, R01DK054741, R56DK054741, R01DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Virginia Commonwealth University funds; American Heart Association(American Heart Association); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-072925 and CA-117990 (to C. E. C.) and DK54741 and DK39773 (to J. V. B.). This work was also supported by grants from the Veterans Administration (VA Merit Review I and a Research Career Scientist award (to C. E. C.)), Virginia Commonwealth University funds (to C. E. C.), and American Heart Association Postdoctoral Fellowship AHA0625502U (to N. F. L.) and Research Grant SDG 0735350N (to R. V. S.)).	Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Blaine SA, 2005, CARCINOGENESIS, V26, P209, DOI 10.1093/carcin/bgh302; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Di Virgilio Francesco, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P85; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fosslien E, 2000, CRIT REV CL LAB SCI, V37, P431, DOI 10.1080/10408360091174286; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Graf C, 2008, BIOCHEM BIOPH RES CO, V373, P159, DOI 10.1016/j.bbrc.2008.06.002; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hida T, 1998, CANCER RES, V58, P3761; HUBBARD WC, 1989, CANCER RES, V49, P826; Huwiler A, 2001, FASEB J, V15, P7; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Malaviya R, 2006, EUR J PHARMACOL, V539, P195, DOI 10.1016/j.ejphar.2006.03.018; MCLEMORE TL, 1988, CANCER RES, V48, P3140; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; REYNOLDS LJ, 1993, BIOCHIM BIOPHYS ACTA, V1167, P272, DOI 10.1016/0005-2760(93)90229-3; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; TAY A, 1995, GENOMICS, V26, P138, DOI 10.1016/0888-7543(95)80093-2; Thomas W, 2006, STEROIDS, V71, P256, DOI 10.1016/j.steroids.2005.10.010; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; WIJESINGHE DS, 2009, J LIPID RES IN PRESS; Williams JL, 2001, CANCER RES, V61, P3285; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Wolff H, 1998, CANCER RES, V58, P4997; Zhang Yi, 2003, Sichuan Da Xue Xue Bao Yi Xue Ban, V34, P344	49	74	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26897	26907		10.1074/jbc.M109.001677	http://dx.doi.org/10.1074/jbc.M109.001677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632995	hybrid, Green Published			2022-12-25	WOS:000269969600070
J	Miller, G; Honig, A; Stein, H; Suzuki, N; Mittler, R; Zilberstein, A				Miller, Gad; Honig, Arik; Stein, Hanan; Suzuki, Nobuhiro; Mittler, Ron; Zilberstein, Aviah			Unraveling Delta(1)-Pyrroline-5-Carboxylate-Proline Cycle in Plants by Uncoupled Expression of Proline Oxidation Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC ASCORBATE PEROXIDASE-1; DELTA-AMINOTRANSFERASE CDNA; GENE-EXPRESSION; SALT STRESS; AMINO-ACIDS; PYRROLINE 5-CARBOXYLATE; DEHYDROGENASE GENES; ARABIDOPSIS; METABOLISM; WATER	The two-step oxidation of proline in all eukaryotes is performed at the inner mitochondrial membrane by the consecutive action of proline dehydrogenase (ProDH) that produces Delta(1)-pyrroline-5-carboxylate (P5C) and P5C dehydrogenase (P5CDH) that oxidizes P5C to glutamate. This catabolic route is down-regulated in plants during osmotic stress, allowing free Pro accumulation. We show here that overexpression of MsProDH in tobacco and Arabidopsis or impairment of P5C oxidation in the Arabidopsis p5cdh mutant did not change the cellular Pro to P5C ratio under ambient and osmotic stress conditions, indicating that P5C excess was reduced to Pro in a mitochondrial-cytosolic cycle. This cycle, involving ProDH and P5C reductase, exists in animal cells and now demonstrated in plants. As a part of the cycle, Pro oxidation by the ProDH-FAD complex delivers electrons to the electron transport chain. Hyperactivity of the cycle, e. g. when an excess of exogenous L-Pro is provided, generates mitochondrial reactive oxygen species (ROS) by delivering electrons to O-2, as demonstrated by the mitochondria-specific MitoSox staining of superoxide ions. Lack of P5CDH activity led to higher ROS production under dark and light conditions in the presence of Pro excess, as well as rendered plants hypersensitive to heat stress. Balancing mitochondrial ROS production during increased Pro oxidation is therefore critical for avoiding Pro-related toxic effects. Hence, normal oxidation of P5C to Glu by P5CDH is key to prevent P5C-Pro intensive cycling and avoid ROS production from electron run-off.	[Miller, Gad; Honig, Arik; Stein, Hanan; Zilberstein, Aviah] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Miller, Gad; Suzuki, Nobuhiro; Mittler, Ron] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Mittler, Ron] Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Tel Aviv University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Hebrew University of Jerusalem	Zilberstein, A (corresponding author), Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	aviah@post.tau.ac.il	Mittler, Ron/ABE-6496-2020; Suzuki, Nobuhiro/Y-2851-2019	Suzuki, Nobuhiro/0000-0002-0225-1597	EU-FP5 [EU QLK5-CT-2002-00841]; Israel Science Foundation [1432/08]	EU-FP5(European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported by EU-FP5 Grant EU QLK5-CT-2002-00841 (to A. Z.) and Israel Science Foundation Grant 1432/08.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bonner CA, 1996, PLANT SCI, V113, P43, DOI 10.1016/0168-9452(95)04284-9; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brosche M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r101; Budisa N, 1998, P NATL ACAD SCI USA, V95, P455, DOI 10.1073/pnas.95.2.455; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; DELAUNEY AJ, 1993, J BIOL CHEM, V268, P18673; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; DEUTCH CE, 1992, J GEN MICROBIOL, V138, P1593, DOI 10.1099/00221287-138-8-1593; Di Martino C, 2006, PLANTA, V223, P1123, DOI 10.1007/s00425-005-0166-z; ELTHON TE, 1984, PLANT PHYSIOL, V75, P951, DOI 10.1104/pp.75.4.951; ELTHON TE, 1982, PLANT PHYSIOL, V70, P567, DOI 10.1104/pp.70.2.567; FOWDEN L, 1967, ADV ENZYMOL RAMB, V29, P89; HAGEDORN CH, 1983, ARCH BIOCHEM BIOPHYS, V225, P95, DOI 10.1016/0003-9861(83)90010-3; Hanson J, 2008, PLANT J, V53, P935, DOI 10.1111/j.1365-313X.2007.03385.x; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hellmann H, 2000, PLANT PHYSIOL, V123, P779, DOI 10.1104/pp.123.2.779; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Hua XJ, 2001, PLANT J, V26, P157, DOI 10.1046/j.1365-313x.2001.01020.x; Hua XJ, 1997, PLANT PHYSIOL, V114, P1215, DOI 10.1104/pp.114.4.1215; KIM HR, 1994, ANAL BIOCHEM, V223, P205, DOI 10.1006/abio.1994.1574; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kiyosue T, 1996, PLANT CELL, V8, P1323, DOI 10.1105/tpc.8.8.1323; KONCZ C, 1989, P NATL ACAD SCI USA, V86, P8467, DOI 10.1073/pnas.86.21.8467; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Mani S, 2002, PLANT PHYSIOL, V128, P73, DOI 10.1104/pp.010572; Mattioni C, 1997, PHYSIOL PLANTARUM, V101, P787, DOI 10.1111/j.1399-3054.1997.tb01064.x; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Miller G, 2005, PLANTA, V222, P70, DOI 10.1007/s00425-005-1518-4; MIXSON AJ, 1988, J BIOL CHEM, V263, P10720; MOLLER IM, 2001, ANNU REV PLANT PHYS, V561, P591; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nakashima K, 1998, PLANT PHYSIOL, V118, P1233, DOI 10.1104/pp.118.4.1233; Nanjo T, 1999, PLANT J, V18, P185, DOI 10.1046/j.1365-313X.1999.00438.x; Nanjo T, 2003, PLANT CELL PHYSIOL, V44, P541, DOI 10.1093/pcp/pcg066; NEMOTO N, 1991, JPN J CANCER RES, V82, P901, DOI 10.1111/j.1349-7006.1991.tb01919.x; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Peng Z, 1996, MOL GEN GENET, V253, P334, DOI 10.1007/s004380050329; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; RAYAPATI PJ, 1991, PLANT PHYSIOL, V95, P787, DOI 10.1104/pp.95.3.787; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Ribarits A, 2007, PLANTA, V225, P1313, DOI 10.1007/s00425-006-0429-3; Rivera A, 2005, J BIOL CHEM, V280, P29346, DOI 10.1074/jbc.M504852200; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Roosens NH, 1999, PLANT PHYSIOL, V121, P1281, DOI 10.1104/pp.121.4.1281; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; SAVOURE A, 1995, FEBS LETT, V372, P13, DOI 10.1016/0014-5793(95)00935-3; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Takagi H, 1997, APPL MICROBIOL BIOT, V47, P405, DOI 10.1007/s002530050948; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verslues PE, 1999, PLANT PHYSIOL, V119, P1349, DOI 10.1104/pp.119.4.1349; Xue XN, 2009, BMB REP, V42, P28, DOI 10.5483/BMBRep.2009.42.1.028; Yang CW, 1999, PLANT GROWTH REGUL, V27, P189; YEH GC, 1988, J BIOL CHEM, V263, P13083; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	72	177	184	9	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26482	26492		10.1074/jbc.M109.009340	http://dx.doi.org/10.1074/jbc.M109.009340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635803	Green Published, hybrid			2022-12-25	WOS:000269969600029
J	Terabayashi, T; Funato, Y; Fukuda, M; Miki, H				Terabayashi, Takeshi; Funato, Yosuke; Fukuda, Mitsunori; Miki, Hiroaki			A Coated Vesicle-associated Kinase of 104 kDa (CVAK104) Induces Lysosomal Degradation of Frizzled 5 (Fzd5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; CYTOPLASMIC TAIL; FACTOR RECEPTOR; PROTEIN; ENDOCYTOSIS; MEMBRANE; INTERNALIZATION; PHOSPHORYLATION; LOCALIZATION	Receptor internalization is recognized as an important mechanism for controlling numerous cell surface receptors. This event contributes not only to regulate signal transduction but also to adjust the amount of cell surface receptors. Frizzleds (Fzds) are seven-pass transmembrane receptor family proteins for Wnt ligands. Recent studies indicated that Fzd5 is internalized in response to Wnt stimulation to activate downstream signaling pathways. After internalization, it appears that Fzd5 is recycled back to the plasma membrane. However, whether internalized Fzd5 is sorted to lysosomes for protein degradation remains unclear. We here report that a coated vesicle-associated kinase of 104 kDa (CVAK104) selectively induces lysosomal degradation of Fzd5. We identify CVAK104 as a novel binding partner of Dishevelled (Dvl), a scaffold protein in the Wnt signaling pathway. Interestingly, we find that CVAK104 also interacts with Fzd5 but not with Fzd1 or Fzd4. CVAK104 selectively induces intracellular accumulation of Fzd5 via the clathrin-mediated pathway, which is suppressed by coexpression of a dominant negative form of Rab5. Fzd5 is subsequently degraded by a lysosomal pathway. Indeed, knockdown of endogenous CVAK104 by RNA interference results in an increase in the amount of Fzd5. In contrast, Wnt treatment induces Fzd5 internalization but does not stimulate its degradation. Overexpression or knockdown of CVAK104 results in a significant suppression or activation of the Wnt/beta-catenin pathway, respectively. These results suggest that CVAK104 regulates the amount of Fzd5 by inducing lysosomal degradation, which probably contributes to the suppression of the Wnt signaling pathway.	[Terabayashi, Takeshi; Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Inst Prot Res, Lab Intracellular Signaling, Suita, Osaka 5650871, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Osaka University; Tohoku University	Miki, H (corresponding author), Osaka Univ, Inst Prot Res, Lab Intracellular Signaling, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@protein.osaka-u.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Terabayashi, Takeshi/0000-0001-7102-784X	Ministry of Education, Culture, Sports, Science, and Technology-Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology-Japan and the Japan Society for the Promotion of Science.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DEAN RT, 1984, BIOCHEM J, V217, P27, DOI 10.1042/bj2170027; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Penton A, 2002, GENETICS, V161, P747; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Terabayashi T, 2008, BIOCHEM BIOPH RES CO, V375, P660, DOI 10.1016/j.bbrc.2008.08.098; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	48	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26716	26724		10.1074/jbc.M109.039313	http://dx.doi.org/10.1074/jbc.M109.039313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19643732	Green Published, hybrid			2022-12-25	WOS:000269969600052
J	Borucki, B; Lamparter, T				Borucki, Berthold; Lamparter, Tilman			A Polarity Probe for Monitoring Light-induced Structural Changes at the Entrance of the Chromophore Pocket in a Bacterial Phytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PROTON RELEASE; AGROBACTERIUM-TUMEFACIENS; RECOMBINANT PHYTOCHROME; SIGNAL-TRANSDUCTION; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; CPH1 PHYTOCHROME; BINDING DOMAIN; LUMI-R; AGP1	Light-induced structural changes at the entrance of the chromophore pocket of Agp1 phytochrome were investigated by using a thiol-reactive fluorescein derivative that is covalently attached to the genuine chromophore binding site (Cys-20) and serves as a polarity probe. In the apoprotein, the absorption spectrum of bound fluorescein is red-shifted with respect to that of the free label suggesting that the probe enters the hydrophobic chromophore pocket. Assembly of this construct with the chromophores phycocyanobilin or biliverdin is associated with a blue-shift of the fluorescein absorption band indicating the displacement of the probe out of the pocket. The probe does not affect the photochromic and kinetic properties of the noncovalent bilin adducts. Upon photoconversion to P-fr, the probe spectrum undergoes again a bathochromic shift and a strong rise in CD indicating a more hydrophobic and asymmetric environment. We propose that the environmental changes of the probe reflect conformational changes at the entrance of the chromophore pocket and are indicative for rearrangements of the chromophore ring A. Flash photolysis measurements showed that the absorption changes of the probe are kinetically coupled to the formation of Meta-R-C and P-fr. In the biliverdin adduct, an additional component occurs that probably reflects a transition between two Meta-R-C substates. Analogous results to that of the noncovalent phycocyanobilin adduct were obtained with the mutant V249C in which probe and chromophore are covalently attached. The conformational changes of the chromophore are correlated to proton transfer to the protein surface.	[Borucki, Berthold; Lamparter, Tilman] Free Univ Berlin, Dept Phys, Biophys Grp, D-14195 Berlin, Germany; [Lamparter, Tilman] Free Univ Berlin, Dept Biol, Inst Plant Physiol, D-14195 Berlin, Germany	Free University of Berlin; Free University of Berlin	Lamparter, T (corresponding author), Free Univ Berlin, Dept Phys, Biophys Grp, Arnimallee 14, D-14195 Berlin, Germany.	borucki@zedat.fu-berlin.de	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737	Deutsche Forschungsgemeinschaft [BO 1911/1-2, Sfb 498 TP B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants BO 1911/1-2 (to B. B.) and Sfb 498 TP B2 (to T. L.).	ALEXIEV U, 1995, FEBS LETT, V373, P81, DOI 10.1016/0014-5793(95)00985-I; Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Borucki B, 2005, J PHYS CHEM B, V109, P629, DOI 10.1021/jp046515k; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Borucki B, 1999, J PHYS CHEM B, V103, P6371, DOI 10.1021/jp990679x; Borucki B, 2006, PHOTOCH PHOTOBIO SCI, V5, P553, DOI 10.1039/b603846h; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; Burghardt TP, 1998, BIOCHEMISTRY-US, V37, P8035, DOI 10.1021/bi980015y; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; EILFELD PH, 1989, J PHOTOCH PHOTOBIO B, V3, P209, DOI 10.1016/1011-1344(89)80063-6; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; FARRENS DL, 1989, J AM CHEM SOC, V111, P9162, DOI 10.1021/ja00208a004; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Giraud E, 2008, PHOTOSYNTH RES, V97, P141, DOI 10.1007/s11120-008-9323-0; Hahn J, 2008, J AM CHEM SOC, V130, P11170, DOI 10.1021/ja8031086; HAHN TR, 1981, BIOCHEMISTRY-US, V20, P2602, DOI 10.1021/bi00512a036; HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996; HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hubschmann T, 2001, EUR J BIOCHEM, V268, P2055, DOI 10.1046/j.1432-1327.2001.02083.x; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; LAGARIAS JC, 1989, P NATL ACAD SCI USA, V86, P5778, DOI 10.1073/pnas.86.15.5778; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; MATYSIK J, 1995, BIOCHEMISTRY-US, V34, P10497, DOI 10.1021/bi00033a023; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Otto H, 2003, BIOCHEMISTRY-US, V42, P5885, DOI 10.1021/bi026946y; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Quest B, 2004, EUR J BIOCHEM, V271, P1117, DOI 10.1111/j.1432-1033.2004.04015.x; Remberg A, 1997, BIOCHEMISTRY-US, V36, P13389, DOI 10.1021/bi971563z; Rohmer T, 2008, P NATL ACAD SCI USA, V105, P15229, DOI 10.1073/pnas.0805696105; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schafer E, 2002, EMBO REP, V3, P1042, DOI 10.1093/embo-reports/kvf222; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; SCHERRER P, 1994, BIOCHEMISTRY-US, V33, P13684, DOI 10.1021/bi00250a019; Schumann C, 2007, CHEMPHYSCHEM, V8, P1657, DOI 10.1002/cphc.200700210; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; YAMAMOTO KT, 1993, BIOCHIM BIOPHYS ACTA, V1163, P227, DOI 10.1016/0167-4838(93)90156-L; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; ZHANG CF, 1992, J AM CHEM SOC, V114, P4569, DOI 10.1021/ja00038a019	61	12	12	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26005	26016		10.1074/jbc.M109.049056	http://dx.doi.org/10.1074/jbc.M109.049056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640848	Green Published, hybrid			2022-12-25	WOS:000269738000057
J	Gao, J; He, JH; Zhai, YG; Wada, TR; Xie, W				Gao, Jie; He, Jinhan; Zhai, Yonggong; Wada, Taira; Xie, Wen			The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; MEDIATED GLUCOSE-METABOLISM; ALPHA-DEPENDENT INDUCTION; FREE FATTY-ACIDS; CROSS-TALK; DRUG-METABOLISM; HEPATIC STEATOSIS; ENHANCER MODULE; TARGET GENES; CAR	Obesity and type 2 diabetes are related metabolic disorders of high prevalence. The constitutive androstane receptor (CAR) was initially characterized as a xenobiotic receptor regulating the responses of mammals to xenotoxicants. In this study, we have uncovered an unexpected role of CAR in preventing obesity and alleviating type 2 diabetes. Using a high fat diet (HFD)-induced obesity model, we showed that treatment of wild type mice with the CAR agonist 1,4-bis[2-(3,5 dichloropyridyloxy)] benzene (TCPOBOP) efficiently prevented obesity from happening or reversed preinduced obesity. Treatment with TCPOBOP improved insulin sensitivity in both the HFD-induced type 2 diabetic model and the ob/ob mice. In contrast, CAR null mice maintained on a chow diet showed spontaneous insulin insensitivity, which cannot be relieved by TOPOBOP treatment. The hepatic steatosis in HFD-treated mice and ob/ob mice was markedly reduced by the TCPOBOP treatment. The metabolic benefits of CAR activation may have resulted from the combined effect of inhibition of lipogenesis, very low density lipoprotein secretion and export of triglycerides, and gluconeogenesis as well as increases in brown adipose tissue energy expenditure and peripheral fat mobilization. Moreover, the skeletal muscle of CAR-activated mice showed a decreased incomplete oxidation, despite having a lower expression level of peroxisome proliferator-activated receptor alpha and its target genes involved in fatty acid oxidation. In summary, our results have revealed an important metabolic function of CAR and may establish this "xenobiotic receptor" as a novel therapeutic target for the prevention and treatment of obesity and type 2 diabetes.	[Gao, Jie; He, Jinhan; Zhai, Yonggong; Wada, Taira; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Gao, Jie; He, Jinhan; Zhai, Yonggong; Wada, Taira; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, 633 Salk Hall, Pittsburgh, PA 15261 USA.	wex6@pitt.edu	Xie, Wen/M-1768-2016; Gao, Jie/C-1520-2017		National Institutes of Health [ES012479, CA107011]; NATIONAL CANCER INSTITUTE [R01CA107011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES012479 and CA107011 (to W. X.).	Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dong BN, 2009, HEPATOLOGY, V50, P622, DOI 10.1002/hep.23025; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; HANSON ES, 1995, J NEUROENDOCRINOL, V7, P273, DOI 10.1111/j.1365-2826.1995.tb00757.x; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; HOOVERPLOW J, 1985, J NUTR, V115, P303, DOI 10.1093/jn/115.3.303; Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; LAHTELA JT, 1984, RES COMMUN CHEM PATH, V44, P215; LAHTELA JT, 1985, DIABETES, V34, P911, DOI 10.2337/diabetes.34.9.911; Lee JH, 2008, ENDOCRINOLOGY, V149, P3778, DOI 10.1210/en.2007-1605; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; RANDLE PJ, 1963, LANCET, V1, P785; Roth A, 2008, PHARMACOGENET GENOM, V18, P325, DOI 10.1097/FPC.0b013e3282f706e0; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; VENKATESAN N, 1994, METABOLISM, V43, P348, DOI 10.1016/0026-0495(94)90103-1; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	38	167	180	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25984	25992		10.1074/jbc.M109.016808	http://dx.doi.org/10.1074/jbc.M109.016808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617349	Green Published, hybrid			2022-12-25	WOS:000269738000055
J	Little, GH; Saw, A; Bai, Y; Dow, J; Marjoram, P; Simkhovich, B; Leeka, J; Kedes, L; Kloner, RA; Poizat, C				Little, Gillian H.; Saw, Aman; Bai, Yan; Dow, Joan; Marjoram, Paul; Simkhovich, Boris; Leeka, Justin; Kedes, Larry; Kloner, Robert A.; Poizat, Coralie			Critical Role of Nuclear Calcium/Calmodulin-dependent Protein Kinase II delta B in Cardiomyocyte Survival in Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATA-4 TRANSCRIPTION FACTOR; CARDIAC-MUSCLE-CELLS; APOPTOSIS IN-VIVO; HEART-FAILURE; CAM KINASE; INHIBITION PROTECTS; GENE-EXPRESSION; HISTONE DEACETYLASE-4; RAT-HEART; DOXORUBICIN	Calcium/calmodulin-dependent protein kinase II (CaMKII) plays a central role in cardiac contractility and heart disease. However, the specific role of alternatively spliced variants of CaMKII in cardiac disease and apoptosis remains poorly explored. Here we report that the delta B subunit of CaMKII (CaMKII delta B), which is the predominant nuclear isoform of calcium/calmodulin- dependent protein kinases in heart muscle, acts as an anti-apoptotic factor and is a novel target of the antineoplastic and cardiomyopathic drug doxorubicin (Dox(adriamycin)). Hearts of rats that develop cardiomyopathy following chronic treatment with Dox also show down-regulation of CaMKII delta B mRNA, which correlates with decreased cardiac function in vivo, reduced expression of sarcomeric proteins, and increased tissue damage associated with Dox cardiotoxicity. Overexpression of CaMKII delta B in primary cardiac cells inhibits Dox-mediated apoptosis and prevents the loss of the antiapoptotic protein Bcl-2. Specific silencing of CaMKII delta B by small interfering RNA prevents the formation of organized sarcomeres and decreases the expression of Bcl-2, which all mimic the effect of Dox. CaMKII delta B is required for GATA-4-mediated co-activation and binding to the Bcl-2 promoter. These results reveal that CaMKII delta B plays an essential role in cardiomyocyte survival and provide a mechanism for the protective role of CaMKII delta B. These results suggest that selective targeting of CaMKII in the nuclear compartment might represent a strategy to regulate cardiac apoptosis and to reduce Dox-mediated cardiotoxicity.	[Little, Gillian H.; Saw, Aman; Bai, Yan; Kedes, Larry; Poizat, Coralie] Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Dow, Joan; Simkhovich, Boris; Leeka, Justin; Kloner, Robert A.] Univ So Calif, Dept Med, Inst Heart, Good Samaritan Hosp,Keck Sch Med, Los Angeles, CA 90017 USA; [Dow, Joan; Simkhovich, Boris; Leeka, Justin; Kloner, Robert A.] Univ So Calif, Div Cardiovasc Med, Inst Heart, Good Samaritan Hosp,Keck Sch Med, Los Angeles, CA 90017 USA; [Marjoram, Paul] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90017 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Poizat, C (corresponding author), Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Keck Sch Med, 2250 Alcazar St, Los Angeles, CA 90033 USA.	poizat@usc.edu			National Institutes of Health; NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014514, C06RR010600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health grants (to L.K.).	Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Arola OJ, 2000, CANCER RES, V60, P1789; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BALTAS LG, 1995, FEBS LETT, V373, P71, DOI 10.1016/0014-5793(95)00981-E; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; BROCKE L, 1995, J NEUROSCI, V15, P6797; Chen B, 2007, CARDIOVASC TOXICOL, V7, P114, DOI 10.1007/s12012-007-0005-5; Chen MH, 2008, CIRCULATION, V118, P84, DOI 10.1161/CIRCULATIONAHA.108.776831; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Hagemann D, 1999, J CELL BIOCHEM, V74, P202; Heckman CA, 2000, J BIOL CHEM, V275, P6499, DOI 10.1074/jbc.275.9.6499; ITO H, 1990, P NATL ACAD SCI USA, V87, P4275, DOI 10.1073/pnas.87.11.4275; Kang YJ, 2000, J BIOL CHEM, V275, P13690, DOI 10.1074/jbc.275.18.13690; Kawamura T, 2004, BIOCHEM BIOPH RES CO, V315, P733, DOI 10.1016/j.bbrc.2004.01.105; Khan M, 2006, J CARDIOVASC PHARM, V47, P9, DOI 10.1097/01.fjc.0000191520.48404.27; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Kitta K, 2003, J BIOL CHEM, V278, P4705, DOI 10.1074/jbc.M211616200; Kitta K, 2001, BIOCHEM J, V359, P375, DOI 10.1042/0264-6021:3590375; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Maeda A, 1997, CLIN EXP PHARMACOL P, V24, P720, DOI 10.1111/j.1440-1681.1997.tb02119.x; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mishra S, 2003, AM J PHYSIOL-HEART C, V284, pH876, DOI 10.1152/ajpheart.00266.2002; Netticadan T, 2000, CIRC RES, V86, P596, DOI 10.1161/01.RES.86.5.596; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; Reeve JLV, 2007, J CELL MOL MED, V11, P509, DOI 10.1111/j.1582-4934.2007.00042.x; Rodriguez-Mora OG, 2006, CANCER BIOL THER, V5, P1022, DOI 10.4161/cbt.5.8.2910; Schwarz ER, 1998, CARDIOVASC RES, V39, P216, DOI 10.1016/S0008-6363(98)00009-1; Simichovich BZ, 2003, ARCH BIOCHEM BIOPHYS, V420, P268, DOI 10.1016/j.abb.2003.06.001; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Singer HA, 1997, J BIOL CHEM, V272, P9393; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Ueno M, 2006, J PHARMACOL SCI, V101, P151, DOI 10.1254/jphs.FP0050980; Venkatakrishnan CD, 2006, AM J PHYSIOL-HEART C, V291, pH2680, DOI 10.1152/ajpheart.00395.2006; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	56	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24857	24868		10.1074/jbc.M109.003186	http://dx.doi.org/10.1074/jbc.M109.003186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602725	Green Published, hybrid			2022-12-25	WOS:000269734000020
J	Tsunaka, Y; Toga, J; Yamaguchi, H; Tate, S; Hirose, S; Morikawa, K				Tsunaka, Yasuo; Toga, Junko; Yamaguchi, Hiroto; Tate, Shin-ichi; Hirose, Susumu; Morikawa, Kosuke			Phosphorylated Intrinsically Disordered Region of FACT Masks Its Nucleosomal DNA Binding Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GROUP BOX PROTEIN; TRANSCRIPTION ELONGATION; CK2 PHOSPHORYLATES; CRYSTAL-STRUCTURE; CORE PARTICLE; GAGA FACTOR; SSRP1; CHROMATIN; DOMAIN	FACT is a heterodimer of SPT16 and SSRP1, which each contain several conserved regions in the primary structure. The interaction of FACT with nucleosomes induces chromatin remodeling through the combinatorial action of its distinct functional protein regions. However, there is little mechanistic insight into how these regions cooperatively contribute to FACT functions, particularly regarding the recognition of nucleosomal DNA. Here, we report the identification of novel phosphorylation sites of Drosophila melanogaster FACT (dFACT) expressed in Sf9 cells. These sites are densely concentrated in the acidic intrinsically disordered (ID) region of the SSRP1 subunit and control nucleosomal DNA binding by dFACT. This region and the adjacent segment of the HMG domain form weak electrostatic intramolecular interactions, which is reinforced by the phosphorylation, thereby blocking DNA binding competitively. Importantly, this control mechanism appears to support rapid chromatin transactions during early embryogenesis through the dephosphorylation of some sites in the maternally transmitted dSSRP1.	[Tsunaka, Yasuo; Toga, Junko; Yamaguchi, Hiroto; Morikawa, Kosuke] Osaka Univ, Inst Prot Res, Takara Bio Endowed Lab, Osaka 5650874, Japan; [Tsunaka, Yasuo] JSPS, Chiyoda Ku, Tokyo 1028472, Japan; [Tate, Shin-ichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Hirose, Susumu] Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan; [Morikawa, Kosuke] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Society for the Promotion of Science; Hiroshima University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Morikawa, K (corresponding author), Osaka Univ, Inst Prot Res, Takara Bio Endowed Lab, 6-2-3 Furuedai, Osaka 5650874, Japan.	morikako@protein.osaka-u.ac.jp	Hirose, Susumu/I-8865-2019; Tate, Shin-ichi/E-3057-2015	Tate, Shin-ichi/0000-0002-5556-7712; Tsunaka, Yasuo/0000-0002-7366-7610	Japan Society for the Promotion of Science (JSPS) [18GS0316]; Mitsubishi Foundation; MEXT Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the Japan Society for the Promotion of Science (JSPS), by the Mitsubishi Foundation, by a Grant-in-Aid for Basic Scientific Research (S) from MEXT Japan, by the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST), and by a Grant-in-Aid for Creative Scientific Research Program (18GS0316) from JSPS.	AIZAWA S, 1994, BIOCHEMISTRY-US, V33, P14690, DOI 10.1021/bi00253a006; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P411; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Gariglio M, 1997, EXP CELL RES, V236, P472, DOI 10.1006/excr.1997.3742; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Grasser KD, 1998, TRENDS PLANT SCI, V3, P260, DOI 10.1016/S1360-1385(98)01259-X; Grasser KD, 2003, PLANT MOL BIOL, V53, P281, DOI 10.1023/B:PLAN.0000007002.99408.ba; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kasai N, 2005, J BIOMOL NMR, V32, P83, DOI 10.1007/s10858-005-3662-3; Kawabata T, 2002, NUCLEIC ACIDS RES, V30, P294, DOI 10.1093/nar/30.1.294; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Krohn NM, 2003, J BIOL CHEM, V278, P12710, DOI 10.1074/jbc.M300250200; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Li YP, 2005, J BIOL CHEM, V280, P11869, DOI 10.1074/jbc.M413944200; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MILES J, 1992, P NATL ACAD SCI USA, V89, P1276, DOI 10.1073/pnas.89.4.1276; Miyagi A, 2008, CHEMPHYSCHEM, V9, P1859, DOI 10.1002/cphc.200800210; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rickards B, 2007, MOL CELL BIOL, V27, P937, DOI 10.1128/MCB.01584-06; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thomsen MS, 2004, BIOCHEMISTRY-US, V43, P8029, DOI 10.1021/bi0499009; Tsunaka Y, 2005, NUCLEIC ACIDS RES, V33, P3424, DOI 10.1093/nar/gki663; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	53	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24610	24621		10.1074/jbc.M109.001958	http://dx.doi.org/10.1074/jbc.M109.001958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605348	Green Published, hybrid			2022-12-25	WOS:000269380200070
J	Rahman, A; Ting, K; Cullen, KM; Braidy, N; Brew, BJ; Guillemin, GJ				Rahman, Abdur; Ting, Kaka; Cullen, Karen M.; Braidy, Nady; Brew, Bruce J.; Guillemin, Gilles J.			The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons	PLOS ONE			English	Article								Some of the tryptophan catabolites produced through the kynurenine pathway (KP), and more particularly the excitotoxin quinolinic acid (QA), are likely to play a role in the pathogenesis of Alzheimer's disease (AD). We have previously shown that the KP is over activated in AD brain and that QA accumulates in amyloid plaques and within dystrophic neurons. We hypothesized that QA in pathophysiological concentrations affects tau phosphorylation. Using immunohistochemistry, we found that QA is co-localized with hyperphosphorylated tau (HPT) within cortical neurons in AD brain. We then investigated in vitro the effects of QA at various pathophysiological concentrations on tau phosphorylation in primary cultures of human neurons. Using western blot, we found that QA treatment increased the phosphorylation of tau at serine 199/202, threonine 231 and serine 396/404 in a dose dependent manner. Increased accumulation of phosphorylated tau was also confirmed by immunocytochemistry. This increase in tau phosphorylation was paralleled by a substantial decrease in the total protein phosphatase activity. A substantial decrease in PP2A expression and modest decrease in PP1 expression were observed in neuronal cultures treated with QA. These data clearly demonstrate that QA can induce tau phosphorylation at residues present in the PHF in the AD brain. To induce tau phosphorylation, QA appears to act through NMDA receptor activation similar to other agonists, glutamate and NMDA. The QA effect was abrogated by the NMDA receptor antagonist memantine. Using PCR arrays, we found that QA significantly induces 10 genes in human neurons all known to be associated with AD pathology. Of these 10 genes, 6 belong to pathways involved in tau phosphorylation and 4 of them in neuroprotection. Altogether these results indicate a likely role of QA in the AD pathology through promotion of tau phosphorylation. Understanding the mechanism of the neurotoxic effects of QA is essential in developing novel therapeutic strategies for AD.			Rahman, A (corresponding author), Kuwait Univ, Coll Women, Dept Family Sci, Shuwaikh, Kuwait.	g.guillemin@unsw.edu.au	Cullen, Karen/B-4161-2012; McLean, Emma/F-4616-2012; Guillemin, Gilles J/C-3878-2015; Cullen, Karen M/S-6841-2019; Brew, Bruce/J-6513-2012; Braidy, Nady/G-4928-2012	Guillemin, Gilles J/0000-0001-8105-4470; Cullen, Karen M/0000-0001-6651-1418; Rahman, Abdur/0000-0002-5115-3053; Braidy, Nady/0000-0002-0497-5572; brew, bruce/0000-0003-0622-1392				Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; BRAIDY N, 2009, INT J TRYPTO RES, V1; Braidy N, 2008, NEUROTOX RES, V13, P173, DOI 10.1007/BF03033501; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Easom RA, 1998, BIOCHEM J, V329, P283; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Ferrer I, 2001, NEUROPATH APPL NEURO, V27, P343, DOI 10.1046/j.1365-2990.2001.00348.x; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GONG CX, 1994, J NEUROCHEM, V62, P803; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1984, ACTA NEUROPATHOL, V62, P259, DOI 10.1007/BF00687607; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2005, NEURODEGENER DIS, V2, P166, DOI 10.1159/000089622; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Guillemin GJ, 2005, NEUROTOX RES, V7, P103, DOI 10.1007/BF03033781; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P167; Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550; Guillemin GJ., 2007, INT C SER, V1304, P404, DOI DOI 10.1016/J.ICS.2007.07.012; Hata R, 2001, BIOCHEM BIOPH RES CO, V284, P310, DOI 10.1006/bbrc.2001.4968; Hernandez-Ortega K, 2007, J NEUROSCI RES, V85, P1744, DOI 10.1002/jnr.21301; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Kerr SJ, 1995, J NEUROVIROL, V1, P375, DOI 10.3109/13550289509111027; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Lee SC, 1999, J NEUROPATH EXP NEUR, V58, P1163, DOI 10.1097/00005072-199911000-00006; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maurer MH, 2008, CURR MED CHEM, V15, P1407, DOI 10.2174/092986708784567671; McShea A, 2007, BBA-MOL BASIS DIS, V1772, P467, DOI 10.1016/j.bbadis.2006.09.010; Mudher A, 2001, J NEUROSCI, V21, P4987, DOI 10.1523/JNEUROSCI.21-14-04987.2001; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Saez TE, 2004, IN VIVO, V18, P275; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Sengupta A, 2006, FEBS LETT, V580, P5925, DOI 10.1016/j.febslet.2006.09.060; STONE TW, 1993, PHARMACOL REV, V45, P309; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Stone TW, 2001, TOXICON, V39, P61, DOI 10.1016/S0041-0101(00)00156-2; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Tanji K, 2003, NEUROREPORT, V14, P413, DOI 10.1097/01.wnr.0000059783.23521.7c; Tarkowski E, 2001, ACTA NEUROL SCAND, V103, P166, DOI 10.1034/j.1600-0404.2001.103003166.x; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; WATANABE A, 1993, J BIOL CHEM, V268, P25712; WHETSELL WO, 1989, NEUROSCI LETT, V97, P271, DOI 10.1016/0304-3940(89)90609-5; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4	66	150	154	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6344	10.1371/journal.pone.0006344	http://dx.doi.org/10.1371/journal.pone.0006344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623258	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260100019
J	Cole, DK; Yuan, F; Rizkallah, PJ; Miles, JJ; Gostick, E; Price, DA; Gao, GF; Jakobsen, BK; Sewell, AK				Cole, David K.; Yuan, Fang; Rizkallah, Pierre J.; Miles, John J.; Gostick, Emma; Price, David A.; Gao, George F.; Jakobsen, Bent K.; Sewell, Andrew K.			Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; TUMOR-REACTIVE CTL; PEPTIDE VACCINES; STRUCTURAL BASIS; ANTIGEN; ALPHA; IMMUNOGENICITY; AFFINITY; CHAIN; USAGE	CD8(+) T-cells specific for MART-1-(26-35), a dominant melanoma epitope restricted by human leukocyte antigen (HLA)A* 0201, are exceptionally common in the naive T-cell repertoire. Remarkably, the TRAV12-2 gene is used to encode the T-cell receptor alpha(TCR alpha) chain in > 87% of these T-cells. Here, the molecular basis for this genetic bias is revealed from the structural and thermodynamic properties of an archetypal TRAV12-2-encoded TCR complexed to the clinically relevant heteroclitic peptide, ELAGIGILTV, bound to HLA-A*0201 (A2ELA). Unusually, the TRAV12-2 germ line-encoded regions of the TCR dominate the major atomic contacts with the peptide at the TCR/A2-ELA interface. This "innate" pattern of antigen recognition probably explains the unique characteristics and extraordinary frequencies of CD8(+) T-cell responses to this epitope.	[Cole, David K.; Rizkallah, Pierre J.; Miles, John J.; Gostick, Emma; Price, David A.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Yuan, Fang] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Rizkallah, Pierre J.] STFC Daresbury Lab, Warrington WA4 4AD, Cheshire, England; [Miles, John J.] Univ Queensland, Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China; [Jakobsen, Bent K.] Immunocore Ltd, Abingdon OX14 4RX, Oxon, England	Cardiff University; University of Oxford; STFC Daresbury Laboratory; QIMR Berghofer Medical Research Institute; University of Queensland; Chinese Academy of Sciences; Institute of Microbiology, CAS	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	sewellak@cardiff.ac.uk	Cole, David/C-8387-2012; Miles, John/H-4975-2011; Sewell, Andrew/GPT-4220-2022; Price, David A/C-7876-2013; Rizkallah, Pierre J/A-5367-2012; Gao, George Fu/ABD-5229-2021; Miles, John J/ABC-1105-2020	Sewell, Andrew/0000-0003-3194-3135; Price, David A/0000-0001-9416-2737; Rizkallah, Pierre J/0000-0002-9290-0369; Miles, John J/0000-0001-5506-6304; Cole, David/0000-0003-0028-9396	Cardiff University Link Chair Scheme; Biotechnology and Biological Sciences Research Council (BBSRC) UK [BB/H001085/1]; MRC [G0501963] Funding Source: UKRI; Medical Research Council [G0501963] Funding Source: researchfish	Cardiff University Link Chair Scheme; Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Cardiff University Link Chair Scheme and by Biotechnology and Biological Sciences Research Council (BBSRC) UK Grant BB/H001085/1, which enabled the establishment of protein crystallography at Cardiff University School of Medicine.	Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bins A, 2007, J IMMUNOTHER, V30, P234, DOI 10.1097/01.cji.0000211333.06762.47; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chen Qiyuan, 2005, Cancer Immun, V5, P5; Chodorowski Zygmunt, 2007, Przegl Lek, V64, P380; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dietrich PY, 2003, J IMMUNOL, V170, P5103, DOI 10.4049/jimmunol.170.10.5103; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Kawakami Y, 1997, Int Rev Immunol, V14, P173, DOI 10.3109/08830189709116851; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KRAUSA P, 1995, TISSUE ANTIGENS, V45, P223, DOI 10.1111/j.1399-0039.1995.tb02444.x; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meidenbauer N, 2003, J IMMUNOL, V170, P2161, DOI 10.4049/jimmunol.170.4.2161; Miles JJ, 2006, CURR MED CHEM, V13, P2725, DOI 10.2174/092986706778521959; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pittet MJ, 2002, TRENDS IMMUNOL, V23, P325, DOI 10.1016/S1471-4906(02)02244-5; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Speiser DE, 2002, EUR J IMMUNOL, V32, P731, DOI 10.1002/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Valmori D, 2000, J IMMUNOL, V165, P533, DOI 10.4049/jimmunol.165.1.533; Valmori D, 1998, J IMMUNOL, V160, P1750; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Voelter V, 2008, INT IMMUNOL, V20, P1087, DOI 10.1093/intimm/dxn066; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yoshioka T, 1997, J IMMUNOL METHODS, V201, P145, DOI 10.1016/S0022-1759(96)00221-9; Yuan F, 2007, ACTA CRYSTALLOGR F, V63, P758, DOI 10.1107/S1744309107037244	50	110	111	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27281	27289		10.1074/jbc.M109.022509	http://dx.doi.org/10.1074/jbc.M109.022509			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19605354	Green Published, hybrid			2022-12-25	WOS:000270232300029
J	Sarangi, A; Valadez, JG; Rush, S; Abel, TW; Thompson, RC; Cooper, MK				Sarangi, A.; Valadez, J. G.; Rush, S.; Abel, T. W.; Thompson, R. C.; Cooper, M. K.			Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival	ONCOGENE			English	Article						brain tumor; glioma; Hedgehog; xenotransplantation; cyclopamine	NEURAL STEM-CELLS; MOUSE MODELS; BRAIN-TUMORS; GROWTH; MEDULLOBLASTOMA; CLASSIFICATION; IDENTIFICATION; CYCLOPAMINE; DRIVEN	Hedgehog pathway activity has been demonstrated in malignant glioma. However, its role in tumor growth has not been determined. Here we demonstrate that pharmacological inhibition of the Hedgehog pathway in established orthotopic malignant glioma xenografts confers a survival advantage. Pathway inhibition is measured in transplanted human tumor cells and not in host mouse brain. Correspondingly, survival benefit is observed only in tumors with an operational Hedgehog pathway. These data indicate that Hedgehog signaling regulates the growth of select malignant gliomas. We also demonstrate that Hedgehog pathway component and gene target expression segregate to CD133(+) tumor initiating cells. Treated mice eventually succumb to disease, thus, targeting the Hedgehog pathway in CD133(+) cells produces significant, but incomplete tumor regression. Therefore, our studies suggest that more complete tumor regression may require the inclusion of other therapeutic targets, including CD133(-) cells. Oncogene (2009) 28, 3468-3476; doi: 10.1038/onc.2009.208; published online 20 July 2009	[Sarangi, A.; Valadez, J. G.; Cooper, M. K.] Vanderbilt Univ Sch Med, Dept Neurol, Nashville, TN 37232 USA; [Sarangi, A.; Cooper, M. K.] Vanderbilt Univ Sch Med, Vanderbilt Neurosci Grad Program, Nashville, TN 37232 USA; [Rush, S.] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Abel, T. W.] Vanderbilt Univ Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Thompson, R. C.] Vanderbilt Univ Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Thompson, R. C.] Vanderbilt Univ Sch Med, Dept Neurol Surg, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Cooper, MK (corresponding author), Vanderbilt Univ Sch Med, Dept Neurol, MRB3,Rm 6160,465 21st Ave S, Nashville, TN 37232 USA.	michael.cooper@vanderbilt.edu	Rush, Sarah/AAA-1701-2020		Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; MKC from the NINDS [K02 NS053614]; Burroughs Wellcome Fund; Doris Duke Charitable Foundation; VMC development funds; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS053614] Funding Source: NIH RePORTER	Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; MKC from the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); VMC development funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Infinity Pharmaceuticals for supplying cyclopamine. Histological services were performed, in part, by the Vanderbilt Medical Center (VMC) Human Tissue Acquisition and Pathology Shared Resource (supported by the Vanderbilt Ingram Cancer Center, P30 CA68485). Flow cytometry experiments were performed in the VMC Flow Cytometry Shared Resource (supported by the Vanderbilt Ingram Cancer Center, P30 CA68485, and the Vanderbilt Digestive Disease Research Center, DK058404). This work was supported by grants to MKC from the NINDS (K02 NS053614), the Burroughs Wellcome Fund and the Doris Duke Charitable Foundation (for human tissues) and VMC development funds (for animal studies).	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Ehtesham M, 2007, ONCOGENE, V26, P5752, DOI 10.1038/sj.onc.1210359; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gutmann David H, 2006, Cancer Res, V66, P10, DOI 10.1158/0008-5472.CAN-05-3180; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sanchez P, 2005, MECH DEVELOP, V122, P223, DOI 10.1016/j.mod.2004.10.002; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Xu QJ, 2008, STEM CELLS, V26, P3018, DOI 10.1634/stemcells.2008-0459; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	37	45	47	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	39					3468	3476		10.1038/onc.2009.208	http://dx.doi.org/10.1038/onc.2009.208			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	502RR	19617900	Green Accepted			2022-12-25	WOS:000270478300004
J	Radhakrishnan, A; Stein, A; Jahn, R; Fasshauer, D				Radhakrishnan, Anand; Stein, Alexander; Jahn, Reinhard; Fasshauer, Dirk			The Ca2+ Affinity of Synaptotagmin 1 Is Markedly Increased by a Specific Interaction of Its C2B Domain with Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MEMBRANE-PENETRATION ACTIVITY; NEUROTRANSMITTER RELEASE; BINDING-PROPERTIES; BOUND ORIENTATION; DISTINCT CA2+; C-2 DOMAINS; FUSION; CALCIUM; POSITION	The synaptic vesicle protein synaptotagmin 1 is thought to convey the calcium signal onto the core secretory machinery. Its cytosolic portion mainly consists of two C2 domains, which upon calcium binding are enabled to bind to acidic lipid bilayers. Despite major advances in recent years, it is still debated how synaptotagmin controls the process of neurotransmitter release. In particular, there is disagreement with respect to its calcium binding properties and lipid preferences. To investigate how the presence of membranes influences the calcium affinity of synaptotagmin, we have now measured these properties under equilibrium conditions using isothermal titration calorimetry and fluorescence resonance energy transfer. Our data demonstrate that the acidic phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), but not phosphatidylserine, markedly increases the calcium sensitivity of synaptotagmin. PI(4,5)P-2 binding is confined to the C2B domain but is not affected significantly by mutations of a lysine-rich patch. Together, our findings lend support to the view that synaptotagmin functions by binding in a trans configuration whereby the C2A domain binds to the synaptic vesicle and the C2B binds to the PI(4,5)P-2-enriched plasma membrane.	[Radhakrishnan, Anand; Stein, Alexander; Jahn, Reinhard; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Max Planck Society	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Fasshauer, Dirk/B-1563-2013; Stein, Alexander/I-4950-2012	Fasshauer, Dirk/0000-0002-1040-4282; Stein, Alexander/0000-0002-2696-0611; Jahn, Reinhard/0000-0003-1542-3498				Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Catherine CR, 2005, MOL CELL NEUROSCI, V29, P462, DOI 10.1016/j.mcn.2005.03.015; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frazier AA, 2003, BIOCHEMISTRY-US, V42, P96, DOI 10.1021/bi0268145; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Montaville P, 2008, PROTEIN SCI, V17, P1025, DOI 10.1110/ps.073326608; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; PERIN MS, 1991, J BIOL CHEM, V266, P623; POPOLI M, 1993, NEUROSCIENCE, V54, P323, DOI 10.1016/0306-4522(93)90255-E; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Torrecillas A, 2004, BIOCHEMISTRY-US, V43, P11727, DOI 10.1021/bi0489659; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xu GY, 1998, J MOL BIOL, V280, P485, DOI 10.1006/jmbi.1998.1874; Zheng L, 2000, J BIOL CHEM, V275, P19700, DOI 10.1074/jbc.M001945200	45	84	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25749	25760		10.1074/jbc.M109.042499	http://dx.doi.org/10.1074/jbc.M109.042499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632983	Green Published, hybrid			2022-12-25	WOS:000269738000033
J	Abboud, N; De Jesus, M; Nakouzi, A; Cordero, RJB; Pujato, M; Fiser, A; Rivera, J; Casadevall, A				Abboud, Nareen; De Jesus, Magdia; Nakouzi, Antonio; Cordero, Radames J. B.; Pujato, Mario; Fiser, Andras; Rivera, Johanna; Casadevall, Arturo			Identification of Linear Epitopes in Bacillus anthracis Protective Antigen Bound by Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; TOXIN; RESPONSES; PROTEINS; RECEPTOR; CHANNEL; BINDING; MICE	Protective antigen (PA), the binding subunit of anthrax toxin, is the major component in the current anthrax vaccine, but the fine antigenic structure of PA is not well defined. To identify linear neutralizing epitopes of PA, 145 overlapping peptides covering the entire sequence of the protein were synthesized. Six monoclonal antibodies (mAbs) and antisera from mice specific for PA were tested for their reactivity to the peptides by enzyme-linked immunosorbent assays. Three major linear immunodominant B-cell epitopes were mapped to residues Leu(156) to Ser(170), Val(196) to Ile(210), and Ser(312) to Asn(326) of the PA protein. Two mAbs with toxin-neutralizing activity recognized two different epitopes in close proximity to the furin cleavage site in domain 1. The three-dimensional complex structure of PA and its neutralizing mAbs 7.5G and 19D9 were modeled using the molecular docking method providing models for the interacting epitope and paratope residues. For both mAbs, LeTx neutralization was associated with interference with furin cleavage, but they differed in effectiveness depending on whether they bound on the N- or C-terminal aspect of the cleaved products. The two peptides containing these epitopes that include amino acids Leu(156)-Ser(170) and Val(196)-Ile(210) were immunogenic and elicited neutralizing antibody responses to PA. These results identify the first linear neutralizing epitopes of PA and show that peptides containing epitope sequences can elicit neutralizing antibody responses, a finding that could be exploited for vaccine design.	[Rivera, Johanna; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA; [Pujato, Mario; Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	casadeva@aecom.yu.edu	Cordero, Radamés JB/F-6912-2011	Cordero, Radamés JB/0000-0002-3026-7094	National Institutes of Health [2U54AI057158-06]; Department of Defense [DOD-071640041-002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2U54AI057158-06. This work was also supported by Department of Defense Grant DOD-071640041-002.	Abboud N, 2008, CLIN VACCINE IMMUNOL, V15, P1115, DOI 10.1128/CVI.00015-08; Baillie L, 2004, FEMS IMMUNOL MED MIC, V42, P267, DOI 10.1016/j.femsim.2004.05.011; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Beavis RC, 1996, METHOD ENZYMOL, V270, P519; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; De Jesus M, 2009, EUKARYOT CELL, V8, P96, DOI 10.1128/EC.00331-08; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Flick-Smith HC, 2002, INFECT IMMUN, V70, P1653, DOI 10.1128/IAI.70.3.1653-1656.2002; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gubbins MJ, 2006, FEMS IMMUNOL MED MIC, V47, P436, DOI 10.1111/j.1574-695X.2006.00114.x; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laffly E, 2005, ANTIMICROB AGENTS CH, V49, P3414, DOI 10.1128/AAC.49.8.3414-3420.2005; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Peterson JW, 2007, INFECT IMMUN, V75, P3414, DOI 10.1128/IAI.00352-07; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Reed DS, 2002, CYTOMETRY, V49, P1, DOI 10.1002/cyto.10134; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Subramanian GM, 2005, CLIN INFECT DIS, V41, P12, DOI 10.1086/430708; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Zhang J, 2006, BIOCHEM BIOPH RES CO, V341, P1164, DOI 10.1016/j.bbrc.2006.01.080	29	32	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25077	25086		10.1074/jbc.M109.022061	http://dx.doi.org/10.1074/jbc.M109.022061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617628	Green Published, hybrid			2022-12-25	WOS:000269734000042
J	Sanghani, PC; Davis, WI; Fears, SL; Green, SL; Zhai, LM; Tang, YP; Martin, E; Bryan, NS; Sanghani, SP				Sanghani, Paresh C.; Davis, Wilhelmina I.; Fears, Sharry L.; Green, Scheri-Lyn; Zhai, Lanmin; Tang, Yaoping; Martin, Emil; Bryan, Nathan S.; Sanghani, Sonal P.			Kinetic and Cellular Characterization of Novel Inhibitors of S-Nitrosoglutathione Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LIVER ALCOHOL-DEHYDROGENASE; DEPENDENT FORMALDEHYDE DEHYDROGENASE; BIOTIN-SWITCH ASSAY; NITRIC-OXIDE; GUANYLATE-CYCLASE; NITROSYLATION; NITROSOTHIOLS; BINDING; ACTIVATION	S-Nitrosoglutathione reductase (GSNOR) is an alcohol dehydrogenase involved in the regulation of S-nitrosothiols (SNOs) in vivo. Knock-out studies in mice have shown that GSNOR regulates the smooth muscle tone in airways and the function of beta-adrenergic receptors in lungs and heart. GSNOR has emerged as a target for the development of therapeutic approaches for treating lung and cardiovascular diseases. We report three compounds that exclude GSNOR substrate, S-nitrosoglutathione (GSNO) from its binding site in GSNOR and cause an accumulation of SNOs inside the cells. The new inhibitors selectively inhibit GSNOR among the alcohol dehydrogenases. Using the inhibitors, we demonstrate that GSNOR limits nitric oxide-mediated suppression of NF-kappa B and activation of soluble guanylyl cyclase. Our findings reveal GSNOR inhibitors to be novel tools for regulating nitric oxide bioactivity and assessing the role of SNOs in vivo.	[Sanghani, Paresh C.; Davis, Wilhelmina I.; Fears, Sharry L.; Green, Scheri-Lyn; Zhai, Lanmin; Sanghani, Sonal P.] Indiana Univ Purdue Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Tang, Yaoping; Martin, Emil; Bryan, Nathan S.] Univ Texas Houston Hlth Sci Ctr, Brown Fdn Inst Mol Med, Houston, TX 77030 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health Science Center Houston	Sanghani, PC (corresponding author), Indiana Univ Purdue Univ, Dept Biochem & Mol Biol, L3-316,1345 W 16th St, Indianapolis, IN 46202 USA.	psanghan@iupui.edu			National Institutes of Health [R21HL087816, R01HL088128]; Showalter Research trust; American Heart Association-National; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087816, R01HL088128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Research trust; American Heart Association-National(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21HL087816 (to P. C. S. and S. P. S.) and R01HL088128 (to E. M.). This work was also supported by the Showalter Research trust (to P. C. S. and S. P. S.), the Research Support Funds Grant (to P. C. S.), and the American Heart Association-National (to N. S. B.).	ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; CHADHA VK, 1983, J MED CHEM, V26, P916, DOI 10.1021/jm00360a024; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x; ENGELAND K, 1993, P NATL ACAD SCI USA, V90, P2491, DOI 10.1073/pnas.90.6.2491; ESTONIUS M, 1994, BIOCHEMISTRY-US, V33, P15080, DOI 10.1021/bi00254a017; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; IGNARRO LJ, 1980, FEBS LETT, V110, P275, DOI 10.1016/0014-5793(80)80091-3; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson MA, 2001, J BIOL CHEM, V276, P39872, DOI 10.1074/jbc.M102781200; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Martin E, 2001, P NATL ACAD SCI USA, V98, P12938, DOI 10.1073/pnas.231486198; MATHEWS WR, 1993, J PHARMACOL EXP THER, V267, P1529; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P15189, DOI 10.1021/bi026705q; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P10778, DOI 10.1021/bi0257639; Sanghani PC, 2000, BIOCHEMISTRY-US, V39, P10720, DOI 10.1021/bi9929711; SARMA RH, 1972, BIOCHEMISTRY-US, V11, P170, DOI 10.1021/bi00752a006; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Wang XD, 2008, FREE RADICAL BIO MED, V44, P1362, DOI 10.1016/j.freeradbiomed.2007.12.032; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wink DA, 1997, J BIOL CHEM, V272, P11147; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P874, DOI 10.1016/j.freeradbiomed.2004.12.012; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101	38	58	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24354	24362		10.1074/jbc.M109.019919	http://dx.doi.org/10.1074/jbc.M109.019919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19596685	hybrid, Green Published			2022-12-25	WOS:000269380200048
J	Seabrook-Davison, M; Huynen, L; Lambert, DM; Brunton, DH				Seabrook-Davison, Mark; Huynen, Leon; Lambert, David M.; Brunton, Dianne H.			Ancient DNA Resolves Identity and Phylogeny of New Zealand's Extinct and Living Quail (Coturnix sp.)	PLOS ONE			English	Article							SEQUENCE; GENOME; MODEL	Background: The New Zealand quail, Coturnix novaezealandiae, was widespread throughout New Zealand until its rapid extinction in the 1870's. To date, confusion continues to exist concerning the identity of C. novaezealandiae and its phylogenetic relationship to Coturnix species in neighbouring Australia, two of which, C. ypsilophora and C. pectoralis, were introduced into New Zealand as game birds. The Australian brown quail, C. ypsilophora, was the only species thought to establish with current populations distributed mainly in the northern part of the North Island of New Zealand. Owing to the similarities between C. ypsilophora, C. pectoralis, and C. novaezealandiae, uncertainty has arisen over whether the New Zealand quail is indeed extinct, with suggestions that remnant populations of C. novaezealandiae may have survived on offshore islands. Methodology/Principal Findings: Using fresh and historical samples of Coturnix sp. from New Zealand and Australia, DNA analysis of selected mitochondrial regions was carried out to determine phylogenetic relationships and species status. Results show that Coturnix sp. specimens from the New Zealand mainland and offshore island Tiritiri Matangi are not the New Zealand quail but are genetically identical to C. ypsilophora from Australia and can be classified as the same species. Furthermore, cytochrome b and COI barcoding analysis of the New Zealand quail and Australia's C. pectoralis, often confused in museum collections, show that they are indeed separate species that diverged approximately 5 million years ago (mya). Gross morphological analysis of these birds suggests a parallel loss of sustained flight with very little change in other phenotypic characters such as plumage or skeletal structure. Conclusion/Significance: Ancient DNA has proved invaluable for the detailed analysis and identification of extinct and morphologically cryptic taxa such as that of quail and can provide insights into the timing of evolutionary changes that influence morphology.			Seabrook-Davison, M (corresponding author), Massey Univ, Inst Nat Sci, Ecol & Conservat Grp, Auckland, New Zealand.	msd@massey.ac.nz	赵, 鹏/B-8401-2009	Lambert, David/0000-0002-5821-3637				ADAMS MP, 2003, B BOC S, V228, P338; Barker GM, 2002, BIOL J LINN SOC, V76, P165, DOI 10.1111/j.1095-8312.2002.tb02081.x; *BIRDL INT, 2008, FACTSH BIRD DISTR; Buller WL, 1873, HIST BIRDS NZ; Cooper J. H., 2005, Zoologische Mededelingen (Leiden), V79, P123; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FLEMING CHARLES A., 1962, TUATARA, V10, P53; FUMIHITO A, 1995, P NATL ACAD SCI USA, V92, P11053, DOI 10.1073/pnas.92.24.11053; Heather B.D., 1996, FIELD GUIDE BIRDS NZ; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Holdaway RN, 1999, J ROY SOC NEW ZEAL, V29, P91, DOI 10.1080/03014223.1999.9517586; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Kimball RT, 1999, MOL PHYLOGENET EVOL, V11, P38, DOI 10.1006/mpev.1998.0562; KNOX AG, 1994, EXTINCT ENDANGERED B, P1; MARCHANT S, 1993, HDB AUSTR NZ ANTARCT, P984; Martinson, 1991, NZ EXTINCT BIRDS; MCDOWALL RM, 1994, GAMEKEEPERS NATION S; Nishibori M, 2002, J HERED, V93, P439, DOI 10.1093/jhered/93.6.439; Nishibori M, 2001, ANIM GENET, V32, P380, DOI 10.1046/j.1365-2052.2001.00795.x; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rambaut A., 2007, TRACER V1 4; Robertson C.J.R., 2007, ATLAS BIRD DISTRIBUT; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shepherd LD, 2008, MOL ECOL, V17, P2174, DOI 10.1111/j.1365-294X.2008.03749.x; *SOTM, 2006, SUPP TIR MAT; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thompson G.M., 1922, NATURALISATION ANIMA; *UNEP WCMC, 2009, SPECIES DATABASE; [No title captured]	30	12	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6400	10.1371/journal.pone.0006400	http://dx.doi.org/10.1371/journal.pone.0006400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636374	Green Published, gold			2022-12-25	WOS:000268404900020
J	Coudeville, L; Van Rie, A; Getsios, D; Caro, JJ; Crepey, P; Nguyen, V				Coudeville, Laurent; Van Rie, Annelies; Getsios, Denis; Caro, J. Jaime; Crepey, Pascal; Nguyen, Van Hung			Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population Effects	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; ADVISORY-COMMITTEE; COST-EFFECTIVENESS; COMPUTER-SIMULATIONS; PREVENTING TETANUS; ADOLESCENTS; IMMUNIZATION; RECOMMENDATIONS; DIPHTHERIA; VACCINES	Background: Prior economic evaluations of adult and adolescent vaccination strategies against pertussis have reached disparate conclusions. Using static approaches only, previous studies failed to analytically include the indirect benefits derived from herd immunity as well as the impact of vaccination on the evolution of disease incidence over time. Methods: We assessed the impact of different pertussis vaccination strategies using a dynamic compartmental model able to consider pertussis transmission. We then combined the results with economic data to estimate the relative cost-effectiveness of pertussis immunization strategies for adolescents and adults in the US. The analysis compares combinations of programs targeting adolescents, parents of newborns (i.e. cocoon strategy), or adults of various ages. Results: In the absence of adolescent or adult vaccination, pertussis incidence among adults is predicted to more than double in 20 years. Implementing an adult program in addition to childhood and adolescent vaccination either based on 1) a cocoon strategy and a single booster dose or 2) a decennial routine vaccination would maintain a low level of pertussis incidence in the long run for all age groups (respectively 30 and 20 cases per 100,000 person years). These strategies would also result in significant reductions of pertussis costs (between -77% and -80% including additional vaccination costs). The cocoon strategy complemented by a single booster dose is the most cost-effective one, whereas the decennial adult vaccination is slightly more effective in the long run. Conclusions: By providing a high level of disease control, the implementation of an adult vaccination program against pertussis appears to be highly cost-effective and often cost-saving.			Coudeville, L (corresponding author), Sanofi Pasteur, Lyon, France.	Pascal.Crepey@sanofipasteur.com	Crépey, Pascal/G-5422-2011; Van Rie, Annelies/C-2082-2017; Datta, Samik/S-3822-2016	Crépey, Pascal/0000-0003-1852-0752; Van Rie, Annelies/0000-0001-7666-3263; Caro, Jaime/0000-0001-5470-3754				ANDERSON R M, 1991; Armstrong GL, 2007, PEDIATRICS, V119, pE22, DOI 10.1542/peds.2006-1572; Baron S, 1997, ARCH PEDIATRIE, V4, P744, DOI 10.1016/S0929-693X(97)83413-6; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Brisson M, 2006, MED DECIS MAKING, V26, P434, DOI 10.1177/0272989X06290485; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Caro J, 2005, PEDIATRICS, V116, P1263, DOI 10.1542/peds.2005-1829; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS48, DOI 10.1097/01.inf.0000160929.35004.86; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P616; COUDEVILLE L, 2007, EPIDEMIOL INFECT, P1; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; DEEN JL, 1995, CLIN INFECT DIS, V21, P1211, DOI 10.1093/clinids/21.5.1211; Drummond MF., 2005, METHODS EC EVALUATIO, P55; EDWARDS KM, 2004, VACCINES, P471; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; Halperin SA, 2007, NEW ENGL J MED, V356, P110, DOI 10.1056/NEJMp068288; Hethcote HW, 2004, VACCINE, V22, P2181, DOI 10.1016/j.vaccine.2003.11.053; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hethcote HW, 1999, MATH BIOSCI, V158, P47, DOI 10.1016/S0025-5564(99)00004-8; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; Lee GM, 2005, PEDIATRICS, V115, P1675, DOI 10.1542/peds.2004-2509; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; McNabb Scott J. N., 2006, Morbidity and Mortality Weekly Report, V55, P1; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; *NAT CTR IMM RESP, 2009, IMM COV US; Ortega-Sanchez IR, 2008, PEDIATRICS, V121, pS63, DOI 10.1542/peds.2007-1115H; Purdy KW, 2004, CLIN INFECT DIS, V39, P20, DOI 10.1086/421091; Strebel P, 2001, J INFECT DIS, V183, P1353, DOI 10.1086/319853; SUTTER RW, 1992, JAMA-J AM MED ASSOC, V267, P386, DOI 10.1001/jama.267.3.386; Trotter CL, 2006, MED DECIS MAKING, V26, P38, DOI 10.1177/0272989X05284109; Van Rie A, 2004, VACCINE, V22, P3154, DOI 10.1016/j.vaccine.2004.01.067; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Ward JI, 2006, CLIN INFECT DIS, V43, P151, DOI 10.1086/504803; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; 2005, MMWR MORB MORTAL WKL, V54, P1283; 2002, MMWR MORB MORTAL WKL, V51, P73	42	56	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6284	10.1371/journal.pone.0006284	http://dx.doi.org/10.1371/journal.pone.0006284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606227	gold, Green Published, Green Submitted			2022-12-25	WOS:000268036000018
J	Davis, SL; Be, NA; Lamichhane, G; Nimmagadda, S; Pomper, MG; Bishai, WR; Jain, SK				Davis, Stephanie L.; Be, Nicholas A.; Lamichhane, Gyanu; Nimmagadda, Sridhar; Pomper, Martin G.; Bishai, William R.; Jain, Sanjay K.			Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals	PLOS ONE			English	Article							INFECTIONS; MACROPHAGE	Background: Bacteria can be selectively imaged in experimentally-infected animals using exogenously administered 1-(2'deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-[(125)I]-iodouracil ([(125)I]-FIAU), a nucleoside analog substrate for bacterial thymidine kinase (TK). Our goal was to use this reporter and develop non-invasive methods to detect and localize Mycobacterium tuberculosis. Methodology/Principal Findings: We engineered a M. tuberculosis strain with chromosomally integrated bacterial TK under the control of hsp60 - a strong constitutive mycobacterial promoter. [(125)I] FIAU uptake, antimicrobial susceptibilities and in vivo growth characteristics were evaluated for this strain. Using single photon emission computed tomography (SPECT), M. tuberculosis P(hsp60) TK strain was evaluated in experimentally-infected BALB/c and C3HeB/FeJ mice using the thigh inoculation or low-dose aerosol infection models. M. tuberculosis P(hsp60) TK strain actively accumulated [(125)I] FIAU in vitro. Growth characteristics of the TK strain and susceptibility to common anti-tuberculous drugs were similar to the wild-type parent strain. M. tuberculosis P(hsp60) TK strain was stable in vivo and SPECT imaging could detect and localize this strain in both animal models tested. Conclusion: We have developed a novel tool for non-invasive assessment of M. tuberculosis in live experimentally-infected animals. This tool will allow real-time pathogenesis studies in animal models of TB and has the potential to simplify preclinical studies and accelerate TB research.			Davis, SL (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	sjain5@jhmi.edu	Nimmagadda, Sridhar/D-6135-2011	Nimmagadda, Sridhar/0000-0002-6413-7191; Jain, Sanjay/0000-0001-9620-7070; Davis, Stephanie/0000-0001-9606-5594; Lamichhane, Gyanu/0000-0002-2214-0114	NCI NIH HHS [U24 CA092871, CA92871, R24 CA092871] Funding Source: Medline; NIAID NIH HHS [AI079590, R01 AI079590, N01 AI030036] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA092871, R24CA092871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079590] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal N, 2006, NUCLEIC ACIDS RES, V34, P4245, DOI 10.1093/nar/gkl521; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; CANETTI G, 1965, AM REV RESPIR DIS, V92, P687; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; DAVIS S, 2008, COMMUNICATION    SEP; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Jain SK, 2005, CLIN PEDIATR, V44, P443, DOI 10.1177/000992280504400510; Lewinsohn DM, 2006, MICROBES INFECT, V8, P2587, DOI 10.1016/j.micinf.2006.07.007; NIMMAGADDA S, 2009, EUR J NUCL MED MOL I; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TIMM J, 1994, MOL MICROBIOL, V12, P491, DOI 10.1111/j.1365-2958.1994.tb01037.x; ZHANG Y, 2007, CANC RES	14	53	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6297	10.1371/journal.pone.0006297	http://dx.doi.org/10.1371/journal.pone.0006297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606217	Green Submitted, Green Published, gold			2022-12-25	WOS:000268036000020
J	Hvidsten, TR; Laegreid, A; Kryshtafovych, A; Andersson, G; Fidelis, K; Komorowski, J				Hvidsten, Torgeir R.; Laegreid, Astrid; Kryshtafovych, Andriy; Andersson, Gunnar; Fidelis, Krzysztof; Komorowski, Jan			A Comprehensive Analysis of the Structure-Function Relationship in Proteins Based on Local Structure Similarity	PLOS ONE			English	Article								Background: Sequence similarity to characterized proteins provides testable functional hypotheses for less than 50% of the proteins identified by genome sequencing projects. With structural genomics it is believed that structural similarities may give functional hypotheses for many of the remaining proteins. Methodology/Principal Findings: We provide a systematic analysis of the structure-function relationship in proteins using the novel concept of local descriptors of protein structure. A local descriptor is a small substructure of a protein which includes both short-and long-range interactions. We employ a library of commonly reoccurring local descriptors general enough to assemble most existing protein structures. We then model the relationship between these local shapes and Gene Ontology using rule-based learning. Our IF-THEN rule model offers legible, high resolution descriptions that combine local substructures and is able to discriminate functions even for functionally versatile folds such as the frequently occurring TIM barrel and Rossmann fold. By evaluating the predictive performance of the model, we provide a comprehensive quantification of the structure-function relationship based only on local structure similarity. Our findings are, among others, that conserved structure is a stronger prerequisite for enzymatic activity than for binding specificity, and that structure-based predictions complement sequence-based predictions. The model is capable of generating correct hypotheses, as confirmed by a literature study, even when no significant sequence similarity to characterized proteins exists. Conclusions/Significance: Our approach offers a new and complete description and quantification of the structure-function relationship in proteins. By demonstrating how our predictions offer higher sensitivity than using global structure, and complement the use of sequence, we show that the presented ideas could advance the development of meta-servers in function prediction.			Hvidsten, TR (corresponding author), Uppsala Univ, Linnaeus Ctr Bioinformat, Uppsala, Sweden.	jan.komorowski@lcb.uu.se	Hvidsten, Torgeir R./A-3409-2009; Komorowski, Jan/A-9175-2010; Komorowski, Jan/M-2667-2013; Komorowski, Jan/AAP-1685-2020	Hvidsten, Torgeir R./0000-0001-6097-2539; Komorowski, Jan/0000-0002-0766-8789; Komorowski, Jan/0000-0002-0766-8789; Kryshtafoych, Andriy/0000-0001-5066-7178	NLM NIH HHS [P41 LM007085, LM007085] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [P41LM007085] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Di Gennaro JA, 2001, J STRUCT BIOL, V134, P232, DOI 10.1006/jsbi.2001.4391; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ferre F, 2004, NUCLEIC ACIDS RES, V32, pD240, DOI 10.1093/nar/gkh054; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Hvidsten TR, 2003, BIOINFORMATICS, V19, pII81, DOI 10.1093/bioinformatics/btg1064; Hvidsten TR, 2009, PROTEINS, V75, P870, DOI 10.1002/prot.22296; Hvidsten TR, 2003, BIOINFORMATICS, V19, P1116, DOI 10.1093/bioinformatics/btg047; Jonassen I, 1999, PROTEINS, V34, P206, DOI 10.1002/(SICI)1097-0134(19990201)34:2<206::AID-PROT6>3.3.CO;2-E; Kasuya A, 1999, J MOL BIOL, V286, P1673, DOI 10.1006/jmbi.1999.2581; Kinoshita K, 2003, CURR OPIN STRUC BIOL, V13, P396, DOI 10.1016/S0959-440X(03)00074-5; KOMOROWSKI J, 2002, HDB DATA MINING KNOW, P554; Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753; Laegreid A, 2003, GENOME RES, V13, P965, DOI 10.1101/gr.1144503; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Murzin AG, 1999, CURR OPIN STRUC BIOL, V9, P359, DOI 10.1016/S0959-440X(99)80048-7; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Orengo CA, 1999, CURR OPIN STRUC BIOL, V9, P374, DOI 10.1016/S0959-440X(99)80051-7; Ouzounis CA, 2003, NAT REV GENET, V4, P508, DOI 10.1038/nrg1113; Pal D, 2005, STRUCTURE, V13, P121, DOI 10.1016/j.str.2004.10.015; PAWLAK Z, 1991, THEORY DECISION LIBR, P229; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Polacco BJ, 2006, BIOINFORMATICS, V22, P723, DOI 10.1093/bioinformatics/btk038; Rarey M, 1999, BIOINFORMATICS, V15, P243, DOI 10.1093/bioinformatics/15.3.243; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Shakhnovich BE, 2003, J MOL BIOL, V326, P1, DOI 10.1016/S0022-2836(02)01362-1; Skolnick J, 2000, TRENDS BIOTECHNOL, V18, P34, DOI 10.1016/S0167-7799(99)01398-0; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063; Zhang C, 2003, CURR OPIN CHEM BIOL, V7, P28, DOI 10.1016/S1367-5931(02)00015-7	42	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6266	10.1371/journal.pone.0006266	http://dx.doi.org/10.1371/journal.pone.0006266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603073	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000268035700012
J	Cinnamon, Y; Feine, O; Hochegger, H; Bershadsky, A; Brandeis, M				Cinnamon, Yuval; Feine, Oren; Hochegger, Helfrid; Bershadsky, Alexander; Brandeis, Michael			Cellular Contractility Requires Ubiquitin Mediated Proteolysis	PLOS ONE			English	Article							CLEAVAGE FURROW FORMATION; RHO-GTPASES; ANIMAL CYTOKINESIS; EXCHANGE FACTOR; HUMAN ECT2; CELLS; ADHESION; MICROTUBULES; ACTIN; DEPOLYMERIZATION	Background: Cellular contractility, essential for cell movement and proliferation, is regulated by microtubules, RhoA and actomyosin. The RhoA dependent kinase ROCK ensures the phosphorylation of the regulatory Myosin II Light Chain (MLC) Ser19, thereby activating actomyosin contractions. Microtubules are upstream inhibitors of contractility and their depolymerization or depletion cause cells to contract by activating RhoA. How microtubule dynamics regulates RhoA remains, a major missing link in understanding contractility. Principal Findings: We observed that contractility is inhibited by microtubules not only, as previously reported, in adherent cells, but also in non-adhering interphase and mitotic cells. Strikingly we observed that contractility requires ubiquitin mediated proteolysis by a Cullin-RING ubiquitin ligase. Inhibition of proteolysis, ubiquitination and neddylation all led to complete cessation of contractility and considerably reduced MLC Ser19 phosphorylation. Conclusions: Our results imply that cells express a contractility inhibitor that is degraded by ubiquitin mediated proteolysis, either constitutively or in response to microtubule depolymerization. This degradation seems to depend on a Cullin-RING ubiquitin ligase and is required for cellular contractions.			Cinnamon, Y (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	brandeis@cc.huji.ac.il		Hochegger, Helfrid/0000-0001-8366-6198; Bershadsky, Alexander/0000-0002-9571-7375				Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; CHENG SN, 2000, P INT WORKSH ANN COM, V1, P275; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Elbaum M, 1999, BIOCHEM SOC SYMP, V65, P147; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Harris AK, 1999, BIOCHEM SOC SYMP, V65, P315; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HIRSCHBERG J, 1982, J CELL PHYSIOL, V113, P159, DOI 10.1002/jcp.1041130125; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Komatsu S, 2004, J CELL BIOL, V165, P243, DOI 10.1083/jcb.200309056; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; LYASS LA, 1988, P NATL ACAD SCI USA, V85, P9538, DOI 10.1073/pnas.85.24.9538; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Oceguera-Yanez F, 2005, J CELL BIOL, V168, P221, DOI 10.1083/jcb.200408085; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Wadsworth P, 2005, CURR BIOL, V15, pR871, DOI 10.1016/j.cub.2005.10.021; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	47	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6155	10.1371/journal.pone.0006155	http://dx.doi.org/10.1371/journal.pone.0006155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597551	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035600001
J	Vidal, JE; Chen, JM; Li, JH; McClane, BA				Vidal, Jorge E.; Chen, Jianming; Li, Jihong; McClane, Bruce A.			Use of an EZ-Tn5-Based Random Mutagenesis System to Identify a Novel Toxin Regulatory Locus in Clostridium perfringens Strain 13	PLOS ONE			English	Article							VIRR RESPONSE REGULATOR; ALPHA-TOXIN; PERFRINGOLYSIN-O; VIRR/VIRS SYSTEM; VIRULENCE GENES; THETA-TOXIN; EXPRESSION; TRANSPOSITION; ELECTROPORATION; IDENTIFICATION	Background: Although useful for probing bacterial pathogenesis and physiology, current random mutagenesis systems suffer limitations for studying the toxin-producing bacterium Clostridium perfringens. Methodology/Principal Findings: An EZ-Tn5-based random mutagenesis approach was developed for use in C. perfringens. This mutagenesis system identified a new regulatory locus controlling toxin production by strain 13, a C. perfringens type A strain. The novel locus, encoding proteins with homology to the AgrB and AgrD components of the Agr quorum sensing system of Staphylococcus aureus and two hypothetical proteins, was found to regulate early production of both alpha toxin and perfringolysin O (PFO) by strain 13. PFO production by the strain 13 Delta agrB mutant could be restored by genetic complementation or by physical complementation, i.e. by co-culture of the strain 13 Delta agrB mutant with a pfoA mutant of either strain 13 or C. perfringens type C CN3685. A similar AgrB- and AgrD-encoding locus is identifiable in all sequenced C. perfringens strains, including type B, C, D, and E isolates, suggesting this regulatory locus contributes to toxin regulation by most C. perfringens strains. In strain 13, the agrB and agrD genes were found to be co-transcribed in an operon with two upstream genes encoding hypothetical proteins. Conclusions/Significance: The new Tn5-based random mutagenesis system developed in this study is more efficient and random than previously reported C. perfringens random mutagenesis approaches. It allowed identification of a novel C. perfringens toxin regulatory locus with homology to the Agr system of S. aureus and which functions as expected of an Agr-like quorum sensing system. Since previous studies have shown that alpha toxin and perfringolysin O are responsible for strain 13-induced clostridial myonecrosis in the mouse model, the new agr regulatory locus may have importance for strain 13 virulence.			Vidal, JE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	bamcc@pitt.edu	Chen, Jianming/F-4980-2012	Chen, Jianming/0000-0003-3004-9828	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056177] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI056177-06, R01 AI056177] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 1997, MICROB PATHOGENESIS, V22, P275, DOI 10.1006/mpat.1996.0115; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; BaThein W, 1996, J BACTERIOL, V178, P2514, DOI 10.1128/jb.178.9.2514-2520.1996; Briancesco Rossella, 2005, Ann Ist Super Sanita, V41, P353; Briolat V, 2002, J BACTERIOL, V184, P2333, DOI 10.1128/JB.184.9.2333-2343.2002; Carman RJ, 2008, ANAEROBE, V14, P102, DOI 10.1016/j.anaerobe.2008.01.003; CHEN CK, 1996, B FEMS MICROBIOL LET, V140, P185; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Chen Y, 2007, PLASMID, V58, P182, DOI 10.1016/j.plasmid.2007.04.002; Cheung JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005849; Cheung JK, 2000, J BACTERIOL, V182, P57, DOI 10.1128/JB.182.1.57-66.2000; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; Fisher DJ, 2006, INFECT IMMUN, V74, P5200, DOI 10.1128/IAI.00534-06; Garmory HS, 2000, EPIDEMIOL INFECT, V124, P61, DOI 10.1017/S0950268899003295; Gupta Phaguni, 2008, V435, P217, DOI 10.1007/978-1-59745-232-8_16; Heap John T., 2009, P179; Hickey MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000045; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Koenig RL, 2004, J BACTERIOL, V186, P7549, DOI 10.1128/JB.186.22.7549-7555.2004; Lanckriet A, 2009, APPL ENVIRON MICROB, V75, P2638, DOI 10.1128/AEM.02214-08; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000056; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; McClane BA, 2004, PROKARYOTES, V4, P698; McGowan S, 2003, J BACTERIOL, V185, P6205, DOI 10.1128/JB.185.20.6205-6208.2003; McGowan S, 2002, J MOL BIOL, V322, P997, DOI 10.1016/S0022-2836(02)00850-1; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; Ohtani K, 2003, FEMS MICROBIOL LETT, V222, P137, DOI 10.1016/S0378-1097(03)00255-6; Ohtani K, 2002, MOL MICROBIOL, V44, P171, DOI 10.1046/j.1365-2958.2002.02863.x; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; Pajunen MI, 2005, MICROBIOL-SGM, V151, P1209, DOI 10.1099/mic.0.27807-0; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Sayeed S, 2008, MOL MICROBIOL, V67, P15, DOI 10.1111/j.1365-2958.2007.06007.x; Shimizu T, 2002, J BACTERIOL, V184, P2587, DOI 10.1128/JB.184.10.2587-2594.2002; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Smidt H, 1999, J BACTERIOL, V181, P6882, DOI 10.1128/JB.181.22.6882-6888.1999; Vidal JE, 2009, CELL MICROBIOL, V11, P1306, DOI 10.1111/j.1462-5822.2009.01332.x; Wuster A, 2008, J BACTERIOL, V190, P743, DOI 10.1128/JB.01135-07	45	59	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6232	10.1371/journal.pone.0006232	http://dx.doi.org/10.1371/journal.pone.0006232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597556	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000268035600006
J	Geng, J; Song, YJ; Yang, L; Feng, YY; Qiu, YF; Li, G; Guo, JY; Bi, YJ; Qu, Y; Wang, W; Wang, XY; Guo, ZB; Yang, RF; Han, YP				Geng, Jing; Song, Yajun; Yang, Lei; Feng, Yanyan; Qiu, Yefeng; Li, Gang; Guo, Jingyu; Bi, Yujing; Qu, Yi; Wang, Wang; Wang, Xiaoyi; Guo, Zhaobiao; Yang, Ruifu; Han, Yanping			Involvement of the Post-Transcriptional Regulator Hfq in Yersinia pestis Virulence	PLOS ONE			English	Article								Background: Yersinia pestis is the causative agent of plague, which is transmitted primarily between fleas and mammals and is spread to humans through the bite of an infected flea or contact with afflicted animals. Hfq is proposed to be a global post-transcriptional regulator that acts by mediating interactions between many regulatory small RNAs (sRNAs) and their mRNA targets. Sequence comparisons revealed that Y. pestis appears to produce a functional homologue of E. coli Hfq. Methodology and Principal Findings: Phenotype comparisons using in vitro assays demonstrated that Y. pestis Hfq was involved in resistance to H2O2, heat and polymyxin B and contributed to growth under nutrient-limiting conditions. The role of Hfq in Y. pestis virulence was also assessed using macrophage and mouse infection models, and the gene expression affected by Hfq was determined using microarray-based transcriptome and real time PCR analysis. The macrophage infection assay showed that the Y. pestis hfq deletion strain did not have any significant difference in its ability to associate with J774A.1 macrophage cells. However, hfq deletion appeared to significantly impair the ability of Y. pestis to resist phagocytosis and survive within macrophages at the initial stage of infection. Furthermore, the hfq deletion strain was highly attenuated in mice after subcutaneous or intravenous injection. Transcriptome analysis supported the results concerning the attenuated phenotype of the hfq mutant and showed that the deletion of the hfq gene resulted in significant alterations in mRNA abundance of 243 genes in more than 13 functional classes, about 23% of which are known or hypothesized to be involved in stress resistance and virulence. Conclusions and Significance: Our results indicate that Hfq is a key regulator involved in Y. pestis stress resistance, intracellular survival and pathogenesis. It appears that Hfq acts by controlling the expression of many virulence- and stress-associated genes, probably in conjunction with small noncoding RNAs.			Geng, J (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; yanpinghan@gmail.com	Song, Yajun/F-3714-2011; Song, Yajun/GQQ-0476-2022	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Geng, Jing/0000-0002-5930-0388				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CHARNETZKY WT, 1985, INFECT IMMUN, V47, P234, DOI 10.1128/IAI.47.1.234-241.1985; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Fan Z L.Y., 1995, CHIN J CONTROL ENDEM, V10, P56; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Han YP, 2008, DNA CELL BIOL, V27, P453, DOI 10.1089/dna.2007.0657; Han YP, 2005, MICROBES INFECT, V7, P335, DOI 10.1016/j.micinf.2004.11.005; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Huang XZ, 2004, INFECT IMMUN, V72, P7212, DOI 10.1128/IAI.72.12.7212-7219.2004; Koleva RI, 2006, BIOCHEM BIOPH RES CO, V348, P662, DOI 10.1016/j.bbrc.2006.07.102; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Makoveichuk E, 2003, J LIPID RES, V44, P320, DOI 10.1194/jlr.M200182-JLR200; McArthur SD, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-52; McNealy TL, 2005, J BACTERIOL, V187, P1527, DOI 10.1128/JB.187.4.1527-1532.2005; Mitobe J, 2008, J BIOL CHEM, V283, P5738, DOI 10.1074/jbc.M710108200; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Monk IR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-96; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Nakano M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-155; Nakao H, 1995, MOL MICROBIOL, V18, P859, DOI 10.1111/j.1365-2958.1995.18050859.x; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; REED LJ, 1938, AM J HYG, V27; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Zavyalov VP, 1996, FEMS IMMUNOL MED MIC, V14, P53, DOI 10.1111/j.1574-695X.1996.tb00267.x; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	51	81	87	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6213	10.1371/journal.pone.0006213	http://dx.doi.org/10.1371/journal.pone.0006213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593436	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035300019
J	Li, Y; Ye, X; Tan, C; Hongo, JA; Zha, J; Liu, J; Kallop, D; Ludlam, MJC; Pei, L				Li, Y.; Ye, X.; Tan, C.; Hongo, J-A; Zha, J.; Liu, J.; Kallop, D.; Ludlam, M. J. C.; Pei, L.			Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis	ONCOGENE			English	Article						RTK; tumorigenesis; metastasis; angiogenesis; RNAi; therapeutic antibodies	RECEPTOR TYROSINE KINASE; ENDOTHELIAL-CELLS; MYELOID-LEUKEMIA; BREAST-CANCER; TAM RECEPTORS; GAS6; EXPRESSION; FAMILY; MICE; ACTIVATION	Dysregulation of Axl and its ligand growth arrest-specific 6 is implicated in the pathogenesis of several human cancers. In this study, we have used RNAi and monoclonal antibodies to assess further the oncogenic potential of Axl. Here we show that Axl knockdown reduces growth of lung and breast cancer xenograft tumors. Inhibition of Axl expression attenuates breast cancer cell migration and inhibits metastasis to the lung in an orthotopic model, providing the first in vivo evidence that links Axl directly to cancer metastasis. Axl knockdown in endothelial cells impaired tube formation and this effect was additive with anti-vascular endothelial growth factor (VEGF). Further analysis demonstrated that Axl regulates endothelial cell functions by modulation of signaling through angiopoietin/Tie2 and Dickkopf (DKK3) pathways. We have developed and characterized Axl monoclonal antibodies that attenuate non-small cell lung carcinoma xenograft growth by downregulation of receptor expression, reducing tumor cell proliferation and inducing apoptosis. Our data demonstrate that Axl plays multiple roles in tumorigenesis and that therapeutic antibodies against Axl may block Axl functions not only in malignant tumor cells but also in the tumor stroma. The additive effect of Axl inhibition with anti-VEGF suggests that blocking Axl function could be an effective approach for enhancing antiangiogenic therapy. Oncogene (2009) 28, 3442-3455; doi: 10.1038/onc.2009.212; published online 27 July 2009	[Li, Y.; Ye, X.; Pei, L.] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Tan, C.; Hongo, J-A] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Zha, J.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Liu, J.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Kallop, D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Ludlam, M. J. C.] Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Pei, L (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	lpei@gene.com		Liu, Jinfeng/0000-0002-0343-8222				Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Angelillo-Scherrer A, 2008, J CLIN INVEST, V118, P583, DOI 10.1172/JCI30375; Berclaz G, 2001, ANN ONCOL, V12, P819, DOI 10.1023/A:1011126330233; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Budagian V, 2005, MOL CELL BIOL, V25, P9324, DOI 10.1128/MCB.25.21.9324-9339.2005; Cao WM, 2001, ARTERIOSCL THROM VAS, V21, P1592, DOI 10.1161/hq1001.097062; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; D'Arcangelo D, 2006, CARDIOVASC RES, V71, P754, DOI 10.1016/j.cardiores.2006.06.002; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Gould WR, 2005, J THROMB HAEMOST, V3, P733, DOI 10.1111/j.1538-7836.2005.01186.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hasanbasic I, 2005, J THROMB HAEMOST, V3, P2790, DOI 10.1111/j.1538-7836.2005.01662.x; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; Katagiri M, 2001, J BIOL CHEM, V276, P7376, DOI 10.1074/jbc.M007393200; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Korshunov VA, 2006, CIRC RES, V98, P1446, DOI 10.1161/01.RES.0000223322.16149.9a; Korshunov VA, 2007, HYPERTENSION, V50, P1057, DOI 10.1161/HYPERTENSIONAHA.107.096289; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Melaragno MG, 1999, TRENDS CARDIOVAS MED, V9, P250, DOI 10.1016/S1050-1738(00)00027-X; Meric F, 2002, CLIN CANCER RES, V8, P361; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Sun WS, 2004, ONCOLOGY-BASEL, V66, P450, DOI 10.1159/000079499; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Untergasser G, 2008, INT J CANCER, V122, P1539, DOI 10.1002/ijc.23255; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Wu CW, 2002, ANTICANCER RES, V22, P1071; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	52	210	257	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	39					3442	3455		10.1038/onc.2009.212	http://dx.doi.org/10.1038/onc.2009.212			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	502RR	19633687				2022-12-25	WOS:000270478300002
J	Deng, XY; Gujjar, R; El Mazouni, F; Kaminsky, W; Malmquist, NA; Goldsmith, EJ; Rathod, PK; Phillips, MA				Deng, Xiaoyi; Gujjar, Ramesh; El Mazouni, Farah; Kaminsky, Werner; Malmquist, Nicholas A.; Goldsmith, Elizabeth J.; Rathod, Pradipsinh K.; Phillips, Margaret A.			Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FLEXIBILITY; INHIBITORS; IDENTIFICATION; COMPLEXES; DESIGN; POTENT; BIOSYNTHESIS; EXPRESSION; ENZYMES; REVEAL	Malaria remains a major global health burden and current drug therapies are compromised by resistance. Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) was validated as a new drug target through the identification of potent and selective triazolopyrimidine-based DHODH inhibitors with anti-malarial activity in vivo. Here we report x-ray structure determination of PfDHODH bound to three inhibitors from this series, representing the first of the enzyme bound to malaria specific inhibitors. We demonstrate that conformational flexibility results in an unexpected binding mode identifying a new hydrophobic pocket on the enzyme. Importantly this plasticity allows PfDHODH to bind inhibitors from different chemical classes and to accommodate inhibitor modifications during lead optimization, increasing the value of PfDHODH as a drug target. A second discovery, based on small molecule crystallography, is that the triazolopyrimidines populate a resonance form that promotes charge separation. These intrinsic dipoles allow formation of energetically favorable H-bond interactions with the enzyme. The importance of delocalization to binding affinity was supported by site-directed mutagenesis and the demonstration that triazolopyrimidine analogs that lack this intrinsic dipole are inactive. Finally, the PfDHODH-triazolopyrimidine bound structures provide considerable new insight into species-selective inhibitor binding in this enzyme family. Together, these studies will directly impact efforts to exploit PfDHODH for the development of anti-malarial chemotherapy.	[Gujjar, Ramesh; Kaminsky, Werner; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Deng, Xiaoyi; El Mazouni, Farah; Malmquist, Nicholas A.; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gujjar, Ramesh; Kaminsky, Werner; Rathod, Pradipsinh K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Goldsmith, Elizabeth J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rathod, PK (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	rathod@chem.washington.edu; margaret.phillips@UTSouthwestern.edu	Deng, Xiaoyi/E-4394-2011; Kaminsky, Werner/AAF-2578-2020	Kaminsky, Werner/0000-0002-9100-4909; Malmquist, Nicholas/0000-0003-2822-8245	National Institutes of Health [U01AI075594, AI053680]; Malaria Medicines Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053680, R21AI053680, R56AI053680, U01AI075594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaria Medicines Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants U01AI075594 and AI053680 (to M. A. P. and P. K. R.). This work was also supported by a grant from Malaria Medicines Venture (to M. A. P. and P. K. R.).	Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Amaro RE, 2008, J COMPUT AID MOL DES, V22, P693, DOI 10.1007/s10822-007-9159-2; B-Rao C, 2009, DRUG DISCOV TODAY, V14, P394, DOI 10.1016/j.drudis.2009.01.003; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; Baumgartner R, 2006, J MED CHEM, V49, P1239, DOI 10.1021/jm0506975; Boa AN, 2005, BIOORGAN MED CHEM, V13, P1945, DOI 10.1016/j.bmc.2005.01.017; Bowman AL, 2007, J AM CHEM SOC, V129, P3634, DOI 10.1021/ja068256d; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chene P, 2008, DRUG DISCOV TODAY, V13, P522, DOI 10.1016/j.drudis.2008.03.023; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; COPELAND RA, 1995, ARCH BIOCHEM BIOPHYS, V323, P79, DOI 10.1006/abbi.1995.0012; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Crespo A, 2008, MOL PHARMACEUT, V5, P430, DOI 10.1021/mp700148h; DeLano W, 2000, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrugia L.J., 1997, J APPL CRYSTALLOGR, V30, P565, DOI [10.1107/S0021889897003117, DOI 10.1107/S0021889897003117]; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Goldenberg MM, 1999, CLIN THER, V21, P1837, DOI 10.1016/S0149-2918(00)86732-6; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; GUTTERIDGE WE, 1970, J PROTOZOOL, V17, P89, DOI 10.1111/j.1550-7408.1970.tb05163.x; Heikkila T, 2006, BIOORG MED CHEM LETT, V16, P88, DOI 10.1016/j.bmcl.2005.09.045; Heikkila T, 2007, J MED CHEM, V50, P186, DOI 10.1021/jm060687j; Hornak V, 2007, DRUG DISCOV TODAY, V12, P132, DOI 10.1016/j.drudis.2006.12.011; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KIM HD, 1991, BIOCHEMISTRY-US, V30, P8171, DOI 10.1021/bi00247a012; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Knecht W, 1998, BIOCHEM PHARMACOL, V56, P1259, DOI 10.1016/S0006-2952(98)00145-2; LAKASCHUS G, 1992, BIOCHEM PHARMACOL, V43, P1025, DOI 10.1016/0006-2952(92)90609-M; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; MARCH J, 2006, ADV ORGANIC CHEM REA, P21; McCammon JA, 2005, BBA-PROTEINS PROTEOM, V1754, P221, DOI 10.1016/j.bbapap.2005.07.041; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Rosenthal PJ, 2008, NEW ENGL J MED, V358, P1829, DOI 10.1056/NEJMct0709050; Sheldrick G.M., 2015, ACTA CRYSTALLOGR C, V71, P3; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Ullrich A, 2001, EUR J BIOCHEM, V268, P1861, DOI 10.1046/j.1432-1033.2001.02061.x; WAASMAIER D, 1995, ACTA CRYSTALLOGR A, V51, P416, DOI 10.1107/S0108767394013292; Walse B, 2008, BIOCHEMISTRY-US, V47, P8929, DOI 10.1021/bi8003318; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]	56	89	92	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26999	27009		10.1074/jbc.M109.028589	http://dx.doi.org/10.1074/jbc.M109.028589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640844	Green Published, hybrid			2022-12-25	WOS:000269969600079
J	Feliciano, DM; Edelman, AM				Feliciano, David M.; Edelman, Arthur M.			Repression of Ca2+/Calmodulin-dependent Protein Kinase IV Signaling Accelerates Retinoic Acid-induced Differentiation of Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEOCORTICAL VENTRICULAR ZONE; DEPENDENT GENE-EXPRESSION; THYROID-HORMONE; NEURONAL DEVELOPMENT; MOLECULAR-CLONING; NERVOUS-SYSTEM; CREB FAMILY; STEM-CELLS; TRANSCRIPTIONAL REGULATION	Neuroblastoma cells having stem cell-like qualities are widely employed models for the study of neural stem/progenitor cell proliferation and differentiation. We find that human BE(2) C neuroblastoma cells possess a signaling cascade initiated by Ca2+ influx via voltage-dependent calcium channels and the N-methyl-D-aspartate (NMDA) receptor and culminating in nuclear calmodulin-dependent protein kinase IV (CaMKIV)-mediated phosphorylation and activation of the transcription factors Ca2+/cyclic AMP-response element-binding protein (CREB) and ATF1 (activating transcription factor-1). This pathway functions to maintain BE(2) C cells in an undifferentiated, proliferative state. Parallel to this Ca2+-dependent pathway is a hormone-responsive program by which retinoic acid (RA) initiates the differentiation of BE(2) C cells toward a neuronal lineage. This is evidenced by RA-dependent induction of the cell cycle inhibitor p21/Cip1 (Cdk-interacting protein 1) and cell cycle arrest, induction of the neuroblastic marker doublecortin and of the neuron-specific intermediate filament protein, peripherin, and by RA-stimulated extension of neuritic processes. During neuronal differentiation there is a complex antagonistic interplay between these two major signaling pathways. RA down-regulates expression of CaMKIV and one of its upstream activators, CaMKK1 (calmodulin-dependent protein kinase kinase 1). This is accompanied by RA-induced suppression of activating phosphorylation of CREB with a time course paralleling that of CaMKIV down-regulation. RA-induced repression of the Ca2+/calmodulin-dependent protein kinase kinase/CaMKIV/CREB pathway appears to be involved in regulating the timing of neuronal differentiation, as shown by the effect of RNA interference of CaMKIV to markedly accelerate RA-dependent up-regulation of p21/Cip1 and doublecortin expression and RA-promoted neurite outgrowth. RA-induced repression of the CaMKIV signaling pathway may represent an early event in retinoid-dependent neuronal differentiation.	[Feliciano, David M.; Edelman, Arthur M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Edelman, AM (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, 102 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	aedelman@acsu.buffalo.edu	Feliciano, David/ADM-6724-2022	Feliciano, David/0000-0001-5985-9109	National Institutes of Health [R21NS050385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21NS050385.	Aletta JM, 1996, J BIOL CHEM, V271, P20930, DOI 10.1074/jbc.271.34.20930; Ammer H, 1997, NEUROSCI LETT, V230, P143, DOI 10.1016/S0304-3940(97)00495-3; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Colomer J., 2007, V45, P169; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GORHAM JD, 1990, DEV BRAIN RES, V57, P235, DOI 10.1016/0165-3806(90)90049-5; Hansen MR, 2003, J NEUROSCI RES, V72, P169, DOI 10.1002/jnr.10551; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; ISHII K, 1990, J CELL PHYSIOL, V143, P569, DOI 10.1002/jcp.1041430323; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Krebs J, 1996, J BIOL CHEM, V271, P11055, DOI 10.1074/jbc.271.19.11055; Lawson ND, 1999, EXP HEMATOL, V27, P1682, DOI 10.1016/S0301-472X(99)00108-3; Lee MM, 1999, J NEUROSCI RES, V55, P702, DOI 10.1002/(SICI)1097-4547(19990315)55:6<702::AID-JNR5>3.3.CO;2-E; Lemrow SM, 2004, J BIOL CHEM, V279, P11664, DOI 10.1074/jbc.M312613200; Liu YY, 2005, ENDOCRINOLOGY, V146, P776, DOI 10.1210/en.2004-1177; Liu YY, 2002, MOL ENDOCRINOL, V16, P2439, DOI 10.1210/me.2001-0324; Long FX, 2001, DEVELOPMENT, V128, P541; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; MOORE TB, 1995, J PEDIAT HEMATOL ONC, V17, P311, DOI 10.1097/00043426-199511000-00006; Owens DF, 2000, DEV NEUROSCI-BASEL, V22, P25, DOI 10.1159/000017424; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Perez-Garcia MJ, 2008, J BIOL CHEM, V283, P4133, DOI 10.1074/jbc.M705477200; Perez-Juste G, 1999, ONCOGENE, V18, P5393, DOI 10.1038/sj.onc.1202906; Perez-Juste G, 1999, J BIOL CHEM, V274, P5026, DOI 10.1074/jbc.274.8.5026; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Sucharov CC, 2006, AM J PHYSIOL-CELL PH, V291, pC1029, DOI 10.1152/ajpcell.00059.2006; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wang SL, 2001, CELL GROWTH DIFFER, V12, P351; Wayman GA, 2000, J CELL BIOL, V151, P811, DOI 10.1083/jcb.151.4.811; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Yamamori E, 2004, J MOL ENDOCRINOL, V33, P639, DOI 10.1677/jme.1.01415; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	81	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26466	26481		10.1074/jbc.M109.027680	http://dx.doi.org/10.1074/jbc.M109.027680			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633294	Green Published, hybrid			2022-12-25	WOS:000269969600028
J	Tissieres, P; Araud, T; Ochoda, A; Drifte, G; Dunn-Siegrist, I; Pugin, J				Tissieres, Pierre; Araud, Tanguy; Ochoda, Agnieszka; Drifte, Genevieve; Dunn-Siegrist, Irene; Pugin, Jerome			Cooperation between PU.1 and CAAT/Enhancer-binding Protein beta Is Necessary to Induce the Expression of the MD-2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL REGULATION; PROMOTER ARCHITECTURE; TRANSCRIPTION FACTORS; MESSENGER-RNAS; SOLUBLE MD-2; TLR4; ETS; LIPOPOLYSACCHARIDE; RESPONSIVENESS; ASSOCIATION	Myeloid differentiation factor 2 (MD-2) binds Gram-negative bacterial lipopolysaccharide with high affinity and is essential for Toll-like receptor 4-dependent signal transduction. MD-2 has recently been recognized as a type II acute phase protein. Plasma concentrations of the soluble form of MD-2 increase markedly during the course of severe infections. Its production is regulated in hepatocytes and myeloid cells by interleukin-6 (IL-6) but not IL-1 beta. In the present work we show that two transcription factors (TF), PU.1 and CAAT/enhancer-binding protein beta (C/EBP beta), participate in the activation of the human MD-2 gene in hepatocytic cells after stimulation with IL-6. PU.1 TF and proximal PU.1 binding sites in the MD-2 promoter were shown to be critical for the basal activity of the promoter as well as for IL-6-induced soluble MD-2 production. Deletions of proximal portions of the MD-2 promoter containing PU.1 and/or NF-IL-6 consensus binding sites as well as site-directed mutagenesis of these binding sites abrogated IL-6-dependent MD-2 gene activation. We show that the cooperation between C/EBP beta and PU.1 is critical for the transcriptional activation of the MD-2 gene by IL-6. PU.1 was essentially known as a TF involved in the differentiation of myeloid precursor cells and the expression of surface receptors of the innate immunity. Herein, we show that it also participates in the regulation of an acute phase protein, MD-2, in nonmyeloid cells cooperatively with C/EBP beta, a classical IL-6-inducible TF.	[Tissieres, Pierre; Ochoda, Agnieszka; Drifte, Genevieve; Dunn-Siegrist, Irene; Pugin, Jerome] Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland; [Tissieres, Pierre; Araud, Tanguy; Ochoda, Agnieszka; Drifte, Genevieve; Dunn-Siegrist, Irene; Pugin, Jerome] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva	Pugin, J (corresponding author), Univ Hosp Geneva, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	jerome.pugin@unige.ch			Boninchi Foundation; Novartis Consumer Health Foundation; Roche Research Foundation [12-2005]; Swiss National Foundation for Scientific Research [32-105770]	Boninchi Foundation; Novartis Consumer Health Foundation; Roche Research Foundation; Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by the Boninchi Foundation, the Novartis Consumer Health Foundation, Roche Research Foundation Grant 12-2005, and Swiss National Foundation for Scientific Research Grant 32-105770.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Bondeva T, 2007, AM J NEPHROL, V27, P308, DOI 10.1159/000102551; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; GRABE N, 1998, MOLEKULARE BIOINFORM; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; HATTORI M, 1990, P NATL ACAD SCI USA, V87, P2364, DOI 10.1073/pnas.87.6.2364; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Jain V, 2008, BLOOD, V111, P4637, DOI 10.1182/blood-2007-11-126862; Kalvakolanu DV, 2005, J INTERF CYTOK RES, V25, P757, DOI 10.1089/jir.2005.25.757; Li CL, 2008, BIOL CELL, V100, P365, DOI 10.1042/BC20070140; Liang MD, 2006, J BIOL CHEM, V281, P9227, DOI 10.1074/jbc.M510700200; Lichtinger M, 2007, J BIOL CHEM, V282, P26874, DOI 10.1074/jbc.M703856200; MARUYAMA K, 1994, GENE, V138, P171; Mouri F, 2008, EUR J HAEMATOL, V80, P10, DOI 10.1111/j.1600-0609.2007.00981.x; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; Ohta S, 2004, BIOCHEM BIOPH RES CO, V323, P1103, DOI 10.1016/j.bbrc.2004.08.203; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Nicola JP, 2009, ENDOCRINOLOGY, V150, P500, DOI 10.1210/en.2008-0345; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Sandanger O, 2009, J IMMUNOL, V182, P588, DOI 10.4049/jimmunol.182.1.588; SCOTT GK, 1994, J BIOL CHEM, V269, P19848; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Tissieres P, 2009, CURR OPIN INFECT DIS, V22, P286, DOI 10.1097/QCO.0b013e32832ae2fc; Tsukada J, 1997, BLOOD, V90, P3142, DOI 10.1182/blood.V90.8.3142; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Wolfs TGAM, 2008, MOL IMMUNOL, V45, P3268, DOI 10.1016/j.molimm.2008.02.014; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	49	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26261	26272		10.1074/jbc.M109.042580	http://dx.doi.org/10.1074/jbc.M109.042580			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632992	Green Published, hybrid			2022-12-25	WOS:000269969600006
J	Guimond, SE; Puvirajesinghe, TM; Skidmore, MA; Kalus, I; Dierks, T; Yates, EA; Turnbull, JE				Guimond, Scott E.; Puvirajesinghe, Tania M.; Skidmore, Mark A.; Kalus, Ina; Dierks, Thomas; Yates, Edwin A.; Turnbull, Jeremy E.			Rapid Purification and High Sensitivity Analysis of Heparan Sulfate from Cells and Tissues TOWARD GLYCOMICS PROFILING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-O-ENDOSULFATASES; OLIGOSACCHARIDES; ELECTROPHORESIS; PROTEOGLYCANS; MICROANALYSIS; DISACCHARIDES; SEQUENCES; MICE; NMR; FGF	Studies on glycosaminoglycans and proteoglycans (PGs) have been hampered by difficulties in isolation and analysis by traditional methods that are laborious and lack sensitivity and throughput. Here we demonstrate a simple method for rapid isolation of proteoglycans (RIP) employing phenol/guanidine/chloroform reagent to purify heparan sulfate (HS) PGs quantitatively from various tissues and cells. We further show that this generic purification methodology, when applied in concert with a BODIPY (TM) fluorescent label, permits structural analyses on RIP-purified HS at similar to 1,000-fold higher sensitivity than standard UV detection methods and similar to 10-100-fold higher sensitivity than previous fluorescence detection methods. The utility of RIP-BODIPY methodology was demonstrated by rapid profiling of HS structural composition from small tissue samples, multiple mouse organs, and as little as a few thousand cultured cells. It was also used to generate novel insights into in vivo structural changes in HS from Sulf1 knock-out mice for the first time that differed significantly from previous observations limited to tissue culture experiments. RIP was also applied to purify HS for bioassay testing, exemplified by cell assays of fibroblast growth factor signaling activation; this generated data from 2-O-sulfotransferase knock-out mice and revealed an unexpected deficiency in fibroblast growth factor activation by HS from heterozygous mice. These data demonstrate that RIP will underpin emerging efforts to develop glycomics profiling strategies for HS and other glycosaminoglycans to explore their structure-function relationships in complex biological systems.	[Guimond, Scott E.; Puvirajesinghe, Tania M.; Skidmore, Mark A.; Yates, Edwin A.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England; [Kalus, Ina; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany	University of Liverpool; University of Bielefeld	Turnbull, JE (corresponding author), Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Crown St, Liverpool L69 7ZB, Merseyside, England.	j.turnbull@liverpool.ac.uk	Yates, Edwin A/I-4808-2013; Puvirajesinghe, Tania/AAD-9137-2020; Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Wang, Cong-Yi/0000-0001-7914-168X; Puvirajesinghe, Tania/0000-0002-8304-9824; Yates, Edwin/0000-0001-9365-5433; Guimond, Scott/0000-0002-5903-418X	Medical Research Council, UK; Wellcome Trust; Biotechnology and Biological Sciences Research Council; BBSRC [BB/D006325/1] Funding Source: UKRI; MRC [G117/423] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D006325/1] Funding Source: researchfish; Medical Research Council [G117/423] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council, UK (Senior Research Fellowship to J. E. T. and Ph. D. funding to T. P.), the Wellcome Trust (to E. A. Y., M. A. S., S. E. G., andJ. E. T.), and the Biotechnology and Biological Sciences Research Council (to E. A. Y., M. A. S., S. E. G., and J. E. T.).	Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brickman YG, 1998, GLYCOBIOLOGY, V8, P463, DOI 10.1093/glycob/8.5.463; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Drummond KJ, 2001, PROTEOMICS, V1, P304, DOI 10.1002/1615-9861(200102)1:2<304::AID-PROT304>3.0.CO;2-B; Ford-Perriss M, 2002, GLYCOBIOLOGY, V12, P721, DOI 10.1093/glycob/cwf072; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; JASEJA M, 1989, CAN J CHEM, V67, P1449, DOI 10.1139/v89-221; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; KARIYA Y, 1992, COMP BIOCHEM PHYS B, V103, P473, DOI 10.1016/0305-0491(92)90323-J; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Militsopoullou M, 2003, BIOMED CHROMATOGR, V17, P39, DOI 10.1002/bmc.207; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rudd TR, 2009, GLYCOBIOLOGY, V19, P52, DOI 10.1093/glycob/cwn103; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Staples GO, 2009, PROTEOMICS, V9, P686, DOI 10.1002/pmic.200701008; Toyoda H, 1997, J CHROMATOGR B, V704, P19, DOI 10.1016/S0378-4347(97)00478-7; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; TURNBULL JE, 1988, BIOCHEM J, V251, P597, DOI 10.1042/bj2510597; Turnbull JE, 2007, NAT CHEM BIOL, V3, P74, DOI 10.1038/nchembio0207-74; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Yates EA, 1996, CARBOHYD RES, V294, P15	39	35	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25714	25722		10.1074/jbc.M109.032755	http://dx.doi.org/10.1074/jbc.M109.032755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19596853	Green Published, hybrid			2022-12-25	WOS:000269738000029
J	Higgins, MA; Whitworth, GE; El Warry, N; Randriantsoa, M; Samain, E; Burke, RD; Vocadlo, DJ; Boraston, AB				Higgins, Melanie A.; Whitworth, Garrett E.; El Warry, Nahida; Randriantsoa, Mialy; Samain, Eric; Burke, Robert D.; Vocadlo, David J.; Boraston, Alisdair B.			Differential Recognition and Hydrolysis of Host Carbohydrate Antigens by Streptococcus pneumoniae Family 98 Glycoside Hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; BINDING; IDENTIFICATION; PROTEIN; DIVERSITY; MODEL; INSIGHTS; REGIONS; CLONING; GENOME	The presence of a fucose utilization operon in the Streptococcus pneumoniae genome and its established importance in virulence indicates a reliance of this bacterium on the harvesting of host fucose-containing glycans. The identities of these glycans, however, and how they are harvested is presently unknown. The biochemical and high resolution x-ray crystallographic analysis of two family 98 glycoside hydrolases (GH98s) from distinctive forms of the fucose utilization operon that originate from different S. pneumoniae strains reveal that one enzyme, the predominant type among pneumococcal isolates, has a unique endo-beta-galactosidase activity on the Lewis(Y) antigen. Altered active site topography in the other species of GH98 enzyme tune its endo-beta-galactosidase activity to the blood group A and B antigens. Despite their different specificities, these enzymes, and by extension all family 98 glycoside hydrolases, use an inverting catalytic mechanism. Many bacterial and viral pathogens exploit host carbohydrate antigens for adherence as a precursor to colonization or infection. However, this is the first evidence of bacterial endoglycosidase enzymes that are known to play a role in virulence and are specific for distinct host carbohydrate antigens. The strain-specific distribution of two distinct types of GH98 enzymes further suggests that S. pneumoniae strains may specialize to exploit host-specific antigens that vary from host to host, a factor that may feature in whether a strain is capable of colonizing a host or establishing an invasive infection.	[Higgins, Melanie A.; El Warry, Nahida; Burke, Robert D.; Boraston, Alisdair B.] Univ Victoria, Victoria, BC V8W 3P6, Canada; [Whitworth, Garrett E.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Randriantsoa, Mialy; Samain, Eric] CNRS, CERMAV, F-38041 Grenoble 9, France	University of Victoria; Simon Fraser University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Boraston, AB (corresponding author), Univ Victoria, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Burke, Robert/0000-0001-5527-4410; Boraston, Alisdair/0000-0001-6417-0592	Canadian Institutes of Health Research [MOP 86610]; Natural Sciences and Engineering Research Council (NSERC) of Canada; Michael Smith Foundation for Health Research (MSFHR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Grant MOP 86610 (to D. J. V. and A. B. B.).; Supported by doctoral fellowships from the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Michael Smith Foundation for Health Research (MSFHR).; Supported by a doctoral fellowship from the NSERC.	Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barik S, 1996, Methods Mol Biol, V57, P203; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; CUNDELL DR, 1994, MICROB PATHOGENESIS, V17, P361, DOI 10.1006/mpat.1994.1082; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2002, ACTA CRYSTALLOGR D, V58, P976, DOI 10.1107/S0907444902005486; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lillelund VH, 2002, CHEM REV, V102, P515, DOI 10.1021/cr000433k; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rigden DJ, 2005, FEBS LETT, V579, P5466, DOI 10.1016/j.febslet.2005.09.011; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaikh FA, 2008, BIOCHEM CELL BIOL, V86, P169, DOI 10.1139/O07-149; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tomasz A, 1999, AM J MED, V107, P55, DOI 10.1016/S0002-9343(99)00107-2; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Yuriev E, 2005, IMMUNOL CELL BIOL, V83, P709, DOI 10.1111/j.1440-1711.2005.01374.x	50	35	36	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26161	26173		10.1074/jbc.M109.024067	http://dx.doi.org/10.1074/jbc.M109.024067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19608744	hybrid, Green Published			2022-12-25	WOS:000269738000071
J	Keyamura, K; Abe, Y; Higashi, M; Ueda, T; Katayama, T				Keyamura, Kenji; Abe, Yoshito; Higashi, Masahiro; Ueda, Tadashi; Katayama, Tsutomu			DiaA Dynamics Are Coupled with Changes in Initial Origin Complexes Leading to Helicase Loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; DNAA-ATP HYDROLYSIS; HUMAN GINS COMPLEX; N-TERMINAL DOMAIN; REPLICATION-ORIGIN; HELICOBACTER-PYLORI; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; E. COLI	Chromosomal replication initiation requires the regulated formation of dynamic higher order complexes. Escherichia coli ATP-DnaA forms a specific multimer on oriC, resulting in DNA unwinding and DnaB helicase loading. DiaA, a DnaA-binding protein, directly stimulates the formation of ATP-DnaA multimers on oriC and ensures timely replication initiation. In this study, DnaA Phe-46 was identified as the crucial DiaA-binding site required for DiaA-stimulated ATP-DnaA assembly on oriC. Moreover, we show that DiaA stimulation requires only a subgroup of DnaA molecules binding to oriC, that DnaA Phe-46 is also important in the loading of DnaB helicase onto the oriC-DnaA complexes, and that this process also requires only a subgroup of DnaA molecules. Despite the use of only a DnaA subgroup, DiaA inhibited DnaB loading on oriC-DnaA complexes, suggesting that DiaA and DnaB bind to a common DnaA subgroup. Acellular factor can relieve the DiaA inhibition, allowing DnaB loading. Consistently, DnaA F46A caused retarded initiations in vivo in a DiaA-independent manner. It is therefore likely that DiaA dynamics are crucial in the regulated sequential progress of DnaA assembly and DnaB loading. We accordingly propose a model for dynamic structural changes of initial oriC complexes loading DiaA or DnaB helicase.	[Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan; [Abe, Yoshito; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyuhsu-u.ac.jp	Abe, Yoshito/D-8370-2012; Abe, Yoshito/AAH-6141-2021	Abe, Yoshito/0000-0002-0016-8490; Abe, Yoshito/0000-0002-0016-8490; Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Technology and Science of Japan	Ministry of Education, Culture, Sports, Technology and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Technology and Science of Japan.	Abe Y, 2007, BIOMOL NMR ASSIGM, V1, P57, DOI 10.1007/s12104-007-9015-2; Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Ishida T, 2004, J BIOL CHEM, V279, P45546, DOI 10.1074/jbc.M402762200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MASAI H, 1990, J BIOL CHEM, V265, P15134; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Natrajan G, 2007, MOL MICROBIOL, V65, P995, DOI 10.1111/j.1365-2958.2007.05843.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Polaczek P, 1997, MOL MICROBIOL, V26, P261, DOI 10.1046/j.1365-2958.1997.5701931.x; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Terradot L, 2004, MOL CELL PROTEOMICS, V3, P809, DOI 10.1074/mcp.M400048-MCP200; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zawilak-Pawlik A, 2007, MOL MICROBIOL, V65, P979, DOI 10.1111/j.1365-2958.2007.05853.x	46	65	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25038	25050		10.1074/jbc.M109.002717	http://dx.doi.org/10.1074/jbc.M109.002717			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19632993	Green Published, hybrid			2022-12-25	WOS:000269734000039
J	Tseng, CW; Kyme, P; Low, J; Rocha, MA; Alsabeh, R; Miller, LG; Otto, M; Arditi, M; Diep, BA; Nizet, V; Doherty, TM; Beenhouwer, DO; Liu, GY				Tseng, Ching Wen; Kyme, Pierre; Low, Jennifer; Rocha, Miguel A.; Alsabeh, Randa; Miller, Loren G.; Otto, Michael; Arditi, Moshe; Diep, Binh An; Nizet, Victor; Doherty, Terence M.; Beenhouwer, David O.; Liu, George Y.			Staphylococcus aureus Panton-Valentine Leukocidin Contributes to Inflammation and Muscle Tissue Injury	PLOS ONE			English	Article							VIRULENCE DETERMINANT; NECROTIZING PNEUMONIA; SUPEROXIDE ANION; SKIN INFECTIONS; AGED RATS; GENES; DISEASE; TOXINS; ASSOCIATION; INTERFERON	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) threatens public health worldwide, and epidemiologic data suggest that the Panton-Valentine Leukocidin (PVL) expressed by most CA-MRSA strains could contribute to severe human infections, particularly in young and immunocompetent hosts. PVL is proposed to induce cytolysis or apoptosis of phagocytes. However, recent comparisons of isogenic CA-MRSA strains with or without PVL have revealed no differences in human PMN cytolytic activity. Furthermore, many of the mouse studies performed to date have failed to demonstrate a virulence role for PVL, thereby provoking the question: does PVL have a mechanistic role in human infection? In this report, we evaluated the contribution of PVL to severe skin and soft tissue infection. We generated PVL mutants in CA-MRSA strains isolated from patients with necrotizing fasciitis and used these tools to evaluate the pathogenic role of PVL in vivo. In a model of necrotizing soft tissue infection, we found PVL caused significant damage of muscle but not the skin. Muscle injury was linked to induction of pro-inflammatory chemokines KC, MIP-2, and RANTES, and recruitment of neutrophils. Tissue damage was most prominent in young mice and in those strains of mice that more effectively cleared S. aureus, and was not significant in older mice and mouse strains that had a more limited immune response to the pathogen. PVL mediated injury could be blocked by pretreatment with anti-PVL antibodies. Our data provide new insights into CA-MRSA pathogenesis, epidemiology and therapeutics. PVL could contribute to the increased incidence of myositis in CA-MRSA infection, and the toxin could mediate tissue injury by mechanisms other than direct killing of phagocytes.			Tseng, CW (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA.	george.liu@cshs.org	Nizet, Victor/AAF-3190-2019	Otto, Michael/0000-0002-2222-4115; Nizet, Victor/0000-0003-3847-0422	NIAID NIH HHS [R01 AI074832, AI074832] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074832, ZIAAI000904] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; DAVILA DR, 1990, FASEB J, V4, P2906, DOI 10.1096/fasebj.4.11.2165948; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; FU YK, 1994, INFECT IMMUN, V62, P1; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Ginaldi L, 1999, IMMUNOL RES, V20, P117, DOI 10.1007/BF02786468; Girish V, 2004, Indian J Cancer, V41, P47; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; KONIG B, 1994, INFECT IMMUN, V62, P4831; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; Tseng CW, 2004, J BACTERIOL, V186, P1793, DOI 10.1128/JB.186.6.1793-1801.2004; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Yamasaki O, 2005, CLIN INFECT DIS, V40, P381, DOI 10.1086/427290	38	83	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6387	10.1371/journal.pone.0006387	http://dx.doi.org/10.1371/journal.pone.0006387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633710	Green Published, Green Submitted, gold			2022-12-25	WOS:000268404800011
J	van Vugt, JJFA; de Jager, M; Murawska, M; Brehm, A; van Noort, J; Logie, C				van Vugt, Joke J. F. A.; de Jager, Martijn; Murawska, Magdalena; Brehm, Alexander; van Noort, John; Logie, Colin			Multiple Aspects of ATP-Dependent Nucleosome Translocation by RSC and Mi-2 Are Directed by the Underlying DNA Sequence	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; YEAST SWI/SNF COMPLEX; ATOMIC-FORCE MICROSCOPY; TRANSCRIPTIONAL REPRESSION; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLATION; GLOBAL ANALYSIS; BUDDING YEAST; CORE PARTICLE; PROTEIN	Background: Chromosome structure, DNA metabolic processes and cell type identity can all be affected by changing the positions of nucleosomes along chromosomal DNA, a reaction that is catalysed by SNF2-type ATP-driven chromatin remodelers. Recently it was suggested that in vivo, more than 50% of the nucleosome positions can be predicted simply by DNA sequence, especially within promoter regions. This seemingly contrasts with remodeler induced nucleosome mobility. The ability of remodeling enzymes to mobilise nucleosomes over short DNA distances is well documented. However, the nucleosome translocation processivity along DNA remains elusive. Furthermore, it is unknown what determines the initial direction of movement and how new nucleosome positions are adopted. Methodology/Principal Findings: We have used AFM imaging and high resolution PAGE of mononucleosomes on 600 and 2500 bp DNA molecules to analyze ATP-dependent nucleosome repositioning by native and recombinant SNF2-type enzymes. We report that the underlying DNA sequence can control the initial direction of translocation, translocation distance, as well as the new positions adopted by nucleosomes upon enzymatic mobilization. Within a strong nucleosomal positioning sequence both recombinant Drosophila Mi-2 (CHD-type) and native RSC from yeast (SWI/SNF-type) repositioned the nucleosome at 10 bp intervals, which are intrinsic to the positioning sequence. Furthermore, RSC-catalyzed nucleosome translocation was noticeably more efficient when beyond the influence of this sequence. Interestingly, under limiting ATP conditions RSC preferred to position the nucleosome with 20 bp intervals within the positioning sequence, suggesting that native RSC preferentially translocates nucleosomes with 15 to 25 bp DNA steps. Conclusions/Significance: Nucleosome repositioning thus appears to be influenced by both remodeler intrinsic and DNA sequence specific properties that interplay to define ATPase-catalyzed repositioning. Here we propose a successive three-step framework consisting of initiation, translocation and release steps to describe SNF2-type enzyme mediated nucleosome translocation along DNA. This conceptual framework helps resolve the apparent paradox between the high abundance of ATP-dependent remodelers per nucleus and the relative success of sequence-based predictions of nucleosome positioning in vivo.			van Vugt, JJFA (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	j.vanvugt@ncmls.ru.nl; noort@physics.leidenuniv.nl; c.logie@ncmls.ru.nl	Logie, Colin/A-1528-2010; van Noort, John/B-1242-2008; Logie, Colin/L-9833-2019; van Vugt, Joke/C-7422-2013; van Vugt, J/F-2993-2014	Logie, Colin/0000-0002-8534-6582; van Noort, John/0000-0002-9094-5598; Logie, Colin/0000-0002-8534-6582; Murawska, Magdalena/0000-0001-8956-7545; van Vugt, Joke/0000-0002-4161-4004				Awad S, 2008, ANN NY ACAD SCI, V1138, P366, DOI 10.1196/annals.1414.038; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bash R, 2006, FEBS LETT, V580, P4757, DOI 10.1016/j.febslet.2006.06.101; Bash R, 2003, BIOCHEMISTRY-US, V42, P4681, DOI 10.1021/bi026887o; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; EDSALL JT, 1953, PROC R SOC SER B-BIO, V141, P97, DOI 10.1098/rspb.1953.0026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fischer CJ, 2007, BIOCHEMISTRY-US, V46, P12416, DOI 10.1021/bi700930n; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kunert N, 2009, EMBO J, V28, P533, DOI 10.1038/emboj.2009.3; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Logie C, 1999, BIOCHEMISTRY-US, V38, P2514, DOI 10.1021/bi982109d; LOGIE C, 1999, CHROMATIN REMODELLIN, P726; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Otsuki T, 2001, HUM MOL GENET, V10, P2651, DOI 10.1093/hmg/10.23.2651; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Sims HI, 2008, NUCLEIC ACIDS RES, V36, P6118, DOI 10.1093/nar/gkn623; Sims HI, 2007, BIOCHEMISTRY-US, V46, P11377, DOI 10.1021/bi7008823; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Sorel I, 2006, BIOCHEMISTRY-US, V45, P14675, DOI 10.1021/bi060293u; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Ulyanova NP, 2005, MOL CELL BIOL, V25, P11156, DOI 10.1128/MCB.25.24.11156-11170.2005; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Noort J, 2004, NUCLEIC ACIDS RES, V32, P6540, DOI 10.1093/nar/gkh999; van Vugt JJFA, 2007, BBA-GENE STRUCT EXPR, V1769, P153, DOI 10.1016/j.bbaexp.2007.01.013; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Willemsen OH, 1999, ULTRAMICROSCOPY, V80, P133, DOI 10.1016/S0304-3991(99)00099-6; WYMAN C, 1995, EMBO J, V14, P117, DOI 10.1002/j.1460-2075.1995.tb06981.x; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yu YC, 2005, CELL CYCLE, V4, P1043, DOI 10.4161/cc.4.8.1928; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	82	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6345	10.1371/journal.pone.0006345	http://dx.doi.org/10.1371/journal.pone.0006345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626125	Green Published, Green Submitted, gold			2022-12-25	WOS:000268260200003
J	Peric, M; Koglin, S; Dombrowski, Y; Gross, K; Bradac, E; Buchau, A; Steinmeyer, A; Zugel, U; Ruzicka, T; Schauber, J				Peric, Mark; Koglin, Sarah; Dombrowski, Yvonne; Gross, Katrin; Bradac, Eva; Buechau, Amanda; Steinmeyer, Andreas; Zuegel, Ulrich; Ruzicka, Thomas; Schauber, Juergen			Vitamin D Analogs Differentially Control Antimicrobial Peptide/"Alarmin" Expression in Psoriasis	PLOS ONE			English	Article								Antimicrobial peptides (AMPs) are strongly expressed in lesional skin in psoriasis and play an important role as proinflammatory "alarmins" in this chronic skin disease. Vitamin D analogs like calcipotriol have antipsoriatic effects and might mediate this effect by changing AMP expression. In this study, keratinocytes in lesional psoriatic plaques showed decreased expression of the AMPs beta-defensin (HBD) 2 and HBD3 after topical treatment with calcipotriol. At the same time, calcipotriol normalized the proinflammatory cytokine milieu and decreased interleukin (IL)-17A, IL-17F and IL-8 transcript abundance in lesional psoriatic skin. In contrast, cathelicidin antimicrobial peptide expression was increased by calcipotriol while psoriasin expression remained unchanged. In cultured human epidermal keratinocytes the effect of different vitamin D analogs on the expression of AMPs was further analyzed. All vitamin D analogs tested blocked IL-17A induced HBD2 expression by increasing I kappa B-alpha protein and inhibition of NF-kappa B signaling. At the same time vitamin D analogs induced cathelicidin through activation of the vitamin D receptor and MEK/ERK signaling. These studies suggest that vitamin D analogs differentially alter AMP expression in lesional psoriatic skin and cultured keratinocytes. Balancing AMP "alarmin" expression might be a novel goal in treatment of chronic inflammatory skin diseases.			Peric, M (corresponding author), Univ Munich, Dept Dermatol & Allergol, Munich, Germany.	juergen.schauber@med.uni-muenchen.de	Dombrowski, Yvonne/N-7020-2019	Dombrowski, Yvonne/0000-0003-1732-6288				Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Brown AJ, 2008, MOL ASPECTS MED, V29, P433, DOI 10.1016/j.mam.2008.04.001; Caproni M, 2009, J CLIN IMMUNOL, V29, P210, DOI 10.1007/s10875-008-9233-0; Carlberg C, 2003, J CELL BIOCHEM, V88, P274, DOI 10.1002/jcb.10337; CHAMORRO CI, 2008, J INVEST DERMATOL; Charakida A, 2006, EXPERT OPIN PHARMACO, V7, P597, DOI 10.1517/14656566.7.5.597; Duweb G, 2005, INT J TISSUE REACT, V27, P163; Fogh K, 1997, CLIN DERMATOL, V15, P705, DOI 10.1016/S0738-081X(97)00021-7; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gambichler T, 2008, INT ARCH ALLERGY IMM, V147, P17, DOI 10.1159/000128582; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Hata TR, 2008, J ALLERGY CLIN IMMUN, V122, P829, DOI 10.1016/j.jaci.2008.08.020; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; Nijenhuis T, 2006, FASEB J, V20, P2171, DOI 10.1096/fj.06-5515fje; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; Penna G, 2007, J IMMUNOL, V178, P145, DOI 10.4049/jimmunol.178.1.145; Peric M, 2009, DEUT MED WOCHENSCHR, V134, P35, DOI 10.1055/s-0028-1105888; Peric M, 2008, J IMMUNOL, V181, P8504, DOI 10.4049/jimmunol.181.12.8504; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Schittek Birgit, 2008, Infectious Disorders - Drug Targets, V8, P135; Toell A, 2001, MOL PHARMACOL, V59, P1478, DOI 10.1124/mol.59.6.1478; van Beelen AJ, 2007, CURR OPIN ALLERGY CL, V7, P374, DOI 10.1097/ACI.0b013e3282ef869e; vanderVleuten CJM, 1996, ARCH DERMATOL RES, V288, P366, DOI 10.1007/s004030050065; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Watanabe H, 2009, J INVEST DERMATOL, V129, P650, DOI 10.1038/jid.2008.294; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zheng Y, 2008, IMMUNOLOGY, V124, P357, DOI 10.1111/j.1365-2567.2007.02782.x; Zugel U, 2002, J INVEST DERMATOL, V119, P1434, DOI 10.1046/j.1523-1747.2002.19623.x	45	98	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6340	10.1371/journal.pone.0006340	http://dx.doi.org/10.1371/journal.pone.0006340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623255	Green Submitted, gold, Green Published			2022-12-25	WOS:000268260100016
J	Haimel, M; Proll, K; Rebhan, M				Haimel, Matthias; Proell, Karin; Rebhan, Michael			ProteinArchitect: Protein Evolution above the Sequence Level	PLOS ONE			English	Article								Background: While many authors have discussed models and tools for studying protein evolution at the sequence level, molecular function is usually mediated by complex, higher order features such as independently folding domains and linear motifs that are based on or embedded in a particular arrangment of features such as secondary structure elements, transmembrane domains and regions with intrinsic disorder. This 'protein architecture' can, in its most simplistic representation, be visualized as domain organization cartoons that can be used to compare proteins in terms of the order of their mostly globular domains. Methodology: Here, we describe a visual approach and a webserver for protein comparison that extend the domain organization cartoon concept. By developing an information-rich, compact visualization of different protein features above the sequence level, potentially related proteins can be compared at the level of propensities for secondary structure, transmembrane domains and intrinsic disorder, in addition to PFAM domains. A public Web server is available at www.proteinarchitect.net, while the code is provided at protarchitect.sourceforge.net. Conclusions/Significance: Due to recent advances in sequencing technologies we are now flooded with millions of predicted proteins that await comparative analysis. In many cases, mature tools focused on revealing hits with considerable global or local similarity to well-characterized proteins will not be able to lead us to testable hypotheses about a protein's function, or the function of a particular region. The visual comparison of different types of protein features with ProteinArchitect will be useful when assessing the relevance of similarity search hits, to discover subgroups in protein families and superfamilies, and to understand protein regions with conserved features outside globular regions. Therefore, this approach is likely to help researchers to develop testable hypotheses about a protein's function even if is somewhat distant from the more characterized proteins, by facilitating the discovery of features that are conserved above the sequence level for comparison and further experimental investigation.			Haimel, M (corresponding author), European Bioinformat Inst, Cambridge, England.	michael.rebhan@novartis.com		Haimel, Matthias/0000-0002-0320-0214				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chang GS, 2008, P NATL ACAD SCI USA, V105, P13474, DOI 10.1073/pnas.0803860105; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coggill Penny, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0205s23; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; *UNIPROT CONS, 2009, NUCL ACIDS RES 2008; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6176	10.1371/journal.pone.0006176	http://dx.doi.org/10.1371/journal.pone.0006176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603068	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035700002
J	Laridjani, M; Leboucher, P				Laridjani, Morteza; Leboucher, Pierre			The Structural Dilemma of Bulk Polyethylene: An Intermediary Structure	PLOS ONE			English	Article							X-RAY-DIFFRACTION; CRYSTALLINITY	Background: The Fourier space (reciprocal space) image of bulk polyethylene consists of lines superimposed on the coherent diffuse background. The mixed character of the image indicates the complex nature of these compounds. The inability in detecting full images of reciprocal space of polymeric substances without Compton radiation and the other undesirable diffuse scatterings has misled the structural analysis (structural characterisation) of these materials. Principal Findings: We propose the use of anomalous diffractometry where, it is possible to obtain a real image of reciprocal space without Compton radiation and other undesirable scatterings. By using classical diffractometry techniques this procedure is not possible. This methodology permitted us to obtain the "Direct Delta function'', in the case of polycrystalline substances that was not previously detected. A new procedure was proposed to interpret the image of reciprocal space of bulk polyethylene. The results show the predominance of the geometry of local order determination compared to the crystal unit cell. The analysis of x-ray diffraction images illustrates that the elementary structural unit is a tetrahedron. This structural unit illustrates the atoms in the network scatter in a coherent diffuse manner. Moreover, the interference function derived from the coherent diffuse scattering dampens out quickly and the degree of randomness is superior to a liquid state. The radial distribution function derived from this interference function shows bond shortening in the tetrahedron configuration. It is this particular effect, which stabilises polyethylene. Conclusion: Here we show by anomalous diffractometry that the traditional concept of the two-phase or the crystal-defect model is an oversimplification of the complex reality. The exploitation of anomalous diffractometry has illustrated that polyethylene has an intermediate ordered structure.			Laridjani, M (corresponding author), Univ Paris Sud, Phys Solides Lab, Orsay, France.	pierre.leboucher@college-de-france.fr						Bernal JD, 1964, P R SOC A, P284; BRIDLEY GW, 1961, XRAY IDENTIFICATION; BUNN CW, 1945, T FARADAY SOC, V41, P317, DOI 10.1039/tf9454100317; Bunn CW, 1939, T FARADAY SOC, V35, P0482, DOI 10.1039/tf9393500482; CHAMPETIER G, 1969, INTRO CHIMIE MACROMO, P403; CULLITY BD, 1956, HANWALT METHOD, P379; Eyring H, 1932, PHYS REV, V39, P746, DOI 10.1103/PhysRev.39.746; FINNEY JL, 1970, PROC R SOC LON SER-A, V319, P479, DOI [10.1098/rspa.1970.0189, 10.1098/rspa.1970.0190]; FLORY PG, 1956, PRINCIPLE POLYM CHEM, P400; FLORY PG, 1980, STAT MECH CHAIN MOL, P10; GANDER W, 1992, SOLVING PROBLEMS SCI; GUINIER A, 1952, XRAY CRYSTALLOGRAPHI, P231; GUINIER A, 1981, INTERMEDIARY STATES, P420; GUINIER A, 1963, XRAY STUDIES MAT, P71; HOLMES DR, 1953, NATURE, V171, P1104, DOI 10.1038/1711104b0; Hosemann R., 1962, DIRECT ANAL DIFFRACT; HUMEROTHERY W, 1954, ADV PHYS, V3, P149, DOI 10.1080/00018735400101193; JACCODINE R, 1955, NATURE, V176, P305, DOI 10.1038/176305b0; KAPLOW R, 1965, PHYS REV, P138; KELLER A, 1957, PHILOS MAG, V2, P1171, DOI 10.1080/14786435708242746; Klug BP, 1974, XRAY DIFFRACTION PRO, P144; LARIDJANI M, 1989, J PHYS-PARIS, V50, P1953, DOI 10.1051/jphys:0198900500140195300; LARIDJANI M, 1987, J NON-CRYST SOLIDS, V91, P217, DOI 10.1016/S0022-3093(87)80305-8; Laridjani M, 2004, J APPL CRYSTALLOGR, V37, P716, DOI 10.1107/S0021889804014657; Laridjani M, 2002, STRUCT CHEM, V13, P385, DOI 10.1023/A:1015832511433; Laridjani M, 1996, J PHYS I, V6, P1347, DOI 10.1051/jp1:1996140; LARIDJANI M, 1999, EUROPEAN PHYS J B, P585; LARIDJANI M, 1998, SPECTRA, V16, P128; LEBO M, 1974, METALL TRANS, V5, P1547, DOI 10.1007/BF02646325; LEBOUCHER P, 1985, 1337 ANVAR; Muller A, 1928, P R SOC LOND A-CONTA, V120, P437, DOI 10.1098/rspa.1928.0158; NARTEN AH, 1989, J CHEM PHYS, V90, P5857, DOI 10.1063/1.456391; RULAND W, 1961, ACTA CRYSTALLOGR, V14, P1180, DOI 10.1107/S0365110X61003429; SCHUUR G, 1955, COMMUNICATION; STATTON WO, 1967, J POLYMER SCI      C, V18, P33; Tsuneo S., 1968, JPN J APPL PHYS, V7, P31; Turnbull D., 1964, PHYSICS NONCRYSTALLI, P41; VONK CG, 1973, J APPL CRYSTALLOGR, V6, P148, DOI 10.1107/S0021889873008332; WALTER ER, 1956, J POLYM SCI, V21, P561, DOI 10.1002/pol.1956.120219925; Wolff P. M. de, 1957, ACTA CRYST, V10, P590; YOON DY, 1977, POLYMER, V18, P509, DOI 10.1016/0032-3861(77)90170-7; [No title captured]	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6228	10.1371/journal.pone.0006228	http://dx.doi.org/10.1371/journal.pone.0006228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597553	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035600003
J	Liu, X; Li, YM				Liu, Xuan; Li, Yiming			Aquaculture Enclosures Relate to the Establishment of Feral Populations of Introduced Species	PLOS ONE			English	Article							PROPAGULE PRESSURE; PLANT INVASIONS; FISH; CONSERVATION; BULLFROGS; DECLINE; BIOLOGY; DETERMINANTS; INFORMATION; AMPHIBIANS	Many species introduced by humans for social and economic benefits have invaded new ranges by escaping from captivity. Such invasive species can negatively affect biodiversity and economies. Understanding the factors that relate to the establishment of feral populations of introduced species is therefore of great importance for managing introduced species. The American Bullfrog (Lithobates catesbeianus) is one species that has escaped from farms, and it is now found in the wild in China. In this study, we examined influences of two types of bullfrog farm ( termed simple and elaborate farm enclosures) on the establishment of feral populations of this species in 137 water bodies in 66 plots in four provinces of China. The likelihood of establishment of bullfrog populations in water bodies in plots with simple enclosures (49/89 = 55.1%) was higher than those with elaborate enclosures (3/48 = 6.3%). Based on the Akaike Information Criterion, the minimum adequate model of generalized linear mixed models with a binomial error structure and a logit link function showed that the establishment or failure of bullfrog populations in water bodies was positively correlated with the presence of a simple enclosure, the number of bullfrogs raised and the presence of permanent water in a plot, but negatively correlated with distance from a bullfrog farm and the occurrence of frequent hunting. Results therefore suggest that a simple farm enclosure can increase the establishment of feral bullfrog populations compared with an elaborate enclosure. Our findings are the first to quantify the importance of improving farming enclosures to control and minimize the risk from introduced species.			Liu, X (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	liym@ioz.ac.cn	Liu, Xuan/AAF-3703-2020	Liu, Xuan/0000-0003-1572-1268				Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Adams MJ, 1999, J WILDLIFE MANAGE, V63, P1162, DOI 10.2307/3802834; Alcaraz C, 2005, DIVERS DISTRIB, V11, P289, DOI 10.1111/j.1366-9516.2005.00170.x; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Austin JD, 2004, GENETICS, V168, P1491, DOI 10.1534/genetics.104.027987; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Boone MD, 2007, ECOL APPL, V17, P291, DOI 10.1890/1051-0761(2007)017[0291:MSIACE]2.0.CO;2; Byers JE, 2001, ECOLOGY, V82, P1330, DOI 10.1890/0012-9658(2001)082[1330:ETMATO]2.0.CO;2; Colautti RI, 2007, BIOL INVASIONS, V9, P885, DOI 10.1007/s10530-006-9007-7; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Doubledee RA, 2003, J WILDLIFE MANAGE, V67, P424, DOI 10.2307/3802783; Duggan IC, 2006, BIOL INVASIONS, V8, P377, DOI 10.1007/s10530-004-2310-2; Duncan RP, 2001, J ANIM ECOL, V70, P621, DOI 10.1046/j.1365-2656.2001.00517.x; Elton C., 1958; Fei L., 1999, ATLAS AMPHIBIANS CHI; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Fisher RN, 1996, CONSERV BIOL, V10, P1387, DOI 10.1046/j.1523-1739.1996.10051387.x; Gertzen E, 2008, CAN J FISH AQUAT SCI, V65, P1265, DOI 10.1139/F08-056; Goldburg R, 2005, FRONT ECOL ENVIRON, V3, P21, DOI 10.2307/3868441; Govindarajulu P, 2005, ECOL APPL, V15, P2161, DOI 10.1890/05-0486; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Ingram William Marcus, 1943, AMER MIDLAND NAT, V29, P239, DOI 10.2307/2420996; JAEGER R, 1994, STANDARD TECHNIQUES, P97; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Kiesecker JM, 2001, ECOLOGY, V82, P1964, DOI 10.1890/0012-9658(2001)082[1964:PMUTDO]2.0.CO;2; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kupferberg SJ, 1997, ECOLOGY, V78, P1736; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Li YM, 2006, OECOLOGIA, V148, P129, DOI 10.1007/s00442-006-0355-x; Li Z., 2002, INVASIVE ALIEN SPECI; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lodge DM, 2003, CONSERV BIOL, V17, P31, DOI 10.1046/j.1523-1739.2003.02366.x; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Maret TJ, 2006, BIOL CONSERV, V127, P129, DOI 10.1016/j.biocon.2005.08.003; Moe H, 2007, AQUAC RES, V38, P91, DOI 10.1111/j.1365-2109.2006.01638.x; MOYLE PB, 1973, COPEIA, P18; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naylor R, 2005, BIOSCIENCE, V55, P427, DOI 10.1641/0006-3568(2005)055[0427:FSATRO]2.0.CO;2; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Pearl CA, 2005, WETLANDS, V25, P76, DOI 10.1672/0277-5212(2005)025[0076:AOAAII]2.0.CO;2; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rixon CAM, 2005, BIODIVERS CONSERV, V14, P1365, DOI 10.1007/s10531-004-9663-9; Rubbo MJ, 2005, CONSERV BIOL, V19, P504, DOI 10.1111/j.1523-1739.2005.000101.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Taylor BW, 2004, P NATL ACAD SCI USA, V101, P17725, DOI 10.1073/pnas.0405176101; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P1249, DOI 10.1098/rspb.2005.3090; Wang YH, 2009, J HERPETOL, V43, P205, DOI 10.1670/0022-1511-43.2.205; Weigle SM, 2005, CONSERV BIOL, V19, P213, DOI 10.1111/j.1523-1739.2005.00412.x; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; Whelan, 1985, ECOLOGY MANAGEMENT B; Wilcove DS, 1998, CONSERV BIOL, V12, P1405, DOI 10.1046/j.1523-1739.1998.97451.x; Willis Y. L., 1956, Copeia, P30; Wonham MJ, 2001, MAR ECOL PROG SER, V215, P1, DOI 10.3354/meps215001; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5; Xie P, 2001, SCIENCE, V294, P999; Yang D., 1991, AMPHIBIAN FAUNA YUNN; Zampella RA, 2000, J HERPETOL, V34, P210, DOI 10.2307/1565417	69	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6199	10.1371/journal.pone.0006199	http://dx.doi.org/10.1371/journal.pone.0006199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593446	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035400001
J	Chandrasekaran, S; Peterson, RE; Mani, SK; Addy, B; Buchholz, AL; Xu, L; Thiyagarajan, T; Kasiganesan, H; Kern, CB; Menick, DR				Chandrasekaran, Sangeetha; Peterson, Richard E.; Mani, Santhosh K.; Addy, Benjamin; Buchholz, Avery L.; Xu, Lin; Thiyagarajan, Thirumagal; Kasiganesan, Harinath; Kern, Christine B.; Menick, Donald R.			Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes	FASEB JOURNAL			English	Article						Nkx2.5; acetylation; cardiac hypertrophy; p300; transcriptional regulation	RABBIT VENTRICULAR MYOCYTES; CARDIAC-SPECIFIC EXPRESSION; SERUM RESPONSE FACTOR; NA+-CA2+ EXCHANGER; GENE-EXPRESSION; IN-VIVO; MUSCLE DIFFERENTIATION; TRANSCRIPTION FACTOR; NUCLEAR EXPORT; TRICHOSTATIN-A	It is becoming increasingly evident that histone deacetylases (HDACs) have a prominent role in the alteration of gene expression during the growth remodeling process of cardiac hypertrophy. HDACs are generally viewed as corepressors of gene expression. However, we demonstrate that class I and class II HDACs play an important role in the basal expression and up-regulation of the sodium calcium exchanger (Ncx1) gene in adult cardiomyocytes. Treatment with the HDAC inhibitor trichostatin A (TSA) prevented the pressure-overload-stimulated up-regulation of Ncx1 expression. Overexpression of HDAC5 resulted in the dose-dependent up-regulation of basal and alpha-adrenergic stimulated Ncx1 expression. We show that Nkx2.5 recruits HDAC5 to the Ncx1 promoter, where HDAC5 complexes with HDAC1. Nkx2.5 also interacts with transcriptional activator p300, which is recruited to the Ncx1 promoter. We demonstrate that when Nkx2.5 is acetylated, it is found associated with HDAC5, whereas deacetylated Nkx2.5 is in complex with p300. Notably, TSA treatment prevents p300 from being recruited to the endogenous Ncx1 promoter, resulting in the repression of Ncx1 expression. We propose a novel model for Ncx1 regulation in which deacetylation of Nkx2.5 is required for the recruitment of p300 and results in up-regulation of exchanger expression.-Chandrasekaran, S., Peterson, R. E., Mani, S. K., Addy, B., Buchholz, A. L., Xu, L., Thiyagarajan, T., Kasiganesan, H., Kern, C. B., Menick, D. R. Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes. FASEB J. 23, 3851-3864 (2009). www.fasebj.org	[Chandrasekaran, Sangeetha; Peterson, Richard E.; Mani, Santhosh K.; Addy, Benjamin; Buchholz, Avery L.; Xu, Lin; Thiyagarajan, Thirumagal; Kasiganesan, Harinath; Kern, Christine B.; Menick, Donald R.] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina	Menick, DR (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, 114 Doughty St,Box 250773, Charleston, SC 29425 USA.	menickd@musc.edu			NIH [R01 HL066223, P01 HL48788, RR016434, T32HL07260, RR16434]; American Heart Association [0765236]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048788, R01HL066223, T32HL007260] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Eric Olson (University of Texas Southwestern Medical Center, Dallas, TX, USA) for his suggestions and gift of the S259/498A HDAC5 and wild-type HDAC5 adenovirus. We also thank Ludivine Renaud for technical assistance. This work was supported, in part, by NIH grants R01 HL066223 and P01 HL48788 (project 3) to D. R. M. and American Heart Association grant 0765236 and NIH grant RR016434 to C. B. K. R. E. P was supported by NIH postdoctoral fellowship T32HL07260, and L. X. was supported in part by NIH grant RR16434.	Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Cheng GM, 1999, J BIOL CHEM, V274, P12819, DOI 10.1074/jbc.274.18.12819; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gallo P, 2008, CARDIOVASC RES, V80, P416, DOI 10.1093/cvr/cvn215; Golden KL, 2001, AM J PHYSIOL-HEART C, V280, pH1376, DOI 10.1152/ajpheart.2001.280.3.H1376; Golden KL, 2000, J MOL CELL CARDIOL, V32, P611, DOI 10.1006/jmcc.2000.1104; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; KENT RL, 1989, AM J PHYSIOL, V257, pH1717, DOI 10.1152/ajpheart.1989.257.5.H1717; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Li T, 2007, J MOL BIOL, V370, P976, DOI 10.1016/j.jmb.2007.05.033; Litwin SE, 1997, CIRC RES, V81, P1083; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey Timothy A, 2004, Novartis Found Symp, V259, P132; Menick DR, 2007, ANN NY ACAD SCI, V1099, P195, DOI 10.1196/annals.1387.058; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Muller JG, 2002, J MOL CELL CARDIOL, V34, P807, DOI 10.1006/jmcc.2002.2019; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Place RF, 2005, BIOCHEM PHARMACOL, V70, P394, DOI 10.1016/j.bcp.2005.04.030; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1999, CIRC RES, V85, P1009; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Ranu HK, 2002, J MOL CELL CARDIOL, V34, P389, DOI 10.1006/jmcc.2001.1521; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Roten L, 2000, J MOL CELL CARDIOL, V32, P109, DOI 10.1006/jmcc.1999.1052; Schillinger W, 2000, CIRC RES, V87, P581, DOI 10.1161/01.RES.87.7.581; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang CG, 2001, FRONT BIOSCI-LANDMRK, V6, pD610, DOI 10.2741/1wang1; Weisser-Thomas J, 2005, J CARD FAIL, V11, P380, DOI 10.1016/j.cardfail.2005.01.004; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Xu L, 2005, J MOL CELL CARDIOL, V38, P735, DOI 10.1016/j.yjmcc.2005.03.002; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	63	38	40	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3851	3864		10.1096/fj.09-132415	http://dx.doi.org/10.1096/fj.09-132415			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19638401	Green Published			2022-12-25	WOS:000271272500021
J	Joshi, MB; Kyriakakis, E; Pfaff, D; Rupp, K; Philippova, M; Erne, P; Resink, TJ				Joshi, Manjunath B.; Kyriakakis, Emmanouil; Pfaff, Dennis; Rupp, Katharina; Philippova, Maria; Erne, Paul; Resink, Therese J.			Extracellular cadherin repeat domains EC1 and EC5 of T-cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells	FASEB JOURNAL			English	Article						deletion mutant; lentivirus vector; signaling; proliferation; adhesion; migration	ADHESION MOLECULE; GENE-THERAPY; N-CADHERIN; HEPATOCELLULAR-CARCINOMA; TUMOR ANGIOGENESIS; HUMAN VASCULATURE; EXPRESSION; GROWTH; CANCER; PROTEINS	T-cadherin (T-cad) promotes survival, proliferation, and migration of endothelial cells and induces angiogenesis. We aimed to identify domains of T-cad functionally relevant to its effects on endothelial cell behavior. To specifically target the functional properties of the 5 cadherin repeat domains (EC1-EC5) of T-cad, endothelial cells were transduced with lentivectors containing specific T-cad-domain-deletion mutant constructs (Delta I, Delta II, Delta III, Delta IV, Delta V). Empty (E) lentivector-transduced cells served as control. Similarly to overexpression of native T-cad, cells expressing Delta II, Delta III, or Delta IV displayed elevated levels of p-Akt and p-GSK3 beta and increased proliferation rates (for Delta II, Delta III) vs. E. Delta I- and Delta V-transduced cells exhibited reduced levels of p-Akt and p-GSK3 beta and retarded growth rates vs. E. Stimulatory effects of native T-cad overexpression on Akt and GSK3 beta phosphorylation were dose dependently inhibited by coexpression of Delta I or Delta V. Subsequent functional analyses compared only Delta I-, Delta II-, and Delta V-mutant constructs with E as a negative control. Unlike Delta II cells, Delta I and Delta V cells failed to exhibit homophilic ligation and deadhesion responses on a substratum of T-cad protein. In the wound assay, migration was increased for Delta II cells but impaired for Delta I and Delta V cells. In endothelial cell-spheroid assay, angiogenic sprouting was augmented for Delta II cells but inhibited for Delta I and Delta V cells. We conclude that EC1 and EC5 domains of T-cad are essential for its proangiogenic effects. Delta I and Delta V constructs may serve as dominant-negative mutants and as potential tools targeting excessive angiogenesis.-Joshi, M. B., Kyriakakis, E., Pfaff, D., Rupp, K., Philippova, M., Erne, P., Resink, T. J. Extracellular cadherin repeat domains EC1 and EC5 of T-cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells. FASEB J. 23, 4011-4021 (2009). www.fasebj.org	[Joshi, Manjunath B.; Kyriakakis, Emmanouil; Pfaff, Dennis; Rupp, Katharina; Philippova, Maria; Resink, Therese J.] Univ Basel Hosp, Dept Biomed, Lab Signal Transduct, CH-4031 Basel, Switzerland; [Erne, Paul] Kantonsspital Luzern, Div Cardiol, Luzern, Switzerland	University of Basel; Lucerne Cantonal Hospital	Resink, TJ (corresponding author), Univ Basel Hosp, Dept Biomed, Lab Signal Transduct, ZLF 316,Hebelstr 20, CH-4031 Basel, Switzerland.	therese-j.resink@unibas.ch	Kyriakakis, Emmanouil/AAS-5754-2021; Joshi, Manjunath B/G-2052-2012; Filippova, Maria/GXH-7313-2022	Joshi, Manjunath/0000-0002-1310-5480; Filippova, Maria/0000-0003-3124-3155; Kyriakakis, Emmanouil/0000-0002-6796-0431	Swiss National Science Foundation [310000-118468/1]; Herzkreislauf Stiftung; Novartis Foundation for Medical Biological Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Herzkreislauf Stiftung; Novartis Foundation for Medical Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Dr. Danila Ivanov and Ms. Vanya Morf (Department of Biomedicine, Basel University Hospital, Basel, Switzerland) for their initial planning and construction of mutant plasmids. The authors are supported by the Swiss National Science Foundation (grant 310000-118468/1), the Herzkreislauf Stiftung, and the Novartis Foundation for Medical Biological Research.	Adachi Y, 2006, VIRCHOWS ARCH, V448, P311, DOI 10.1007/s00428-005-0098-9; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ahn A, 2008, CARDIOL REV, V16, P219, DOI 10.1097/CRD.0b013e3181620e50; Alajati A, 2008, NAT METHODS, V5, P439, DOI 10.1038/NMETH.1198; Bai S, 2007, J BIOL CHEM, V282, P27171, DOI 10.1074/jbc.M700691200; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Dames Sonja A, 2008, J Biol Chem, V283, P23485, DOI 10.1074/jbc.M708335200; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Ghosh S, 2007, FEBS LETT, V581, P4523, DOI 10.1016/j.febslet.2007.08.038; Griffioen AW, 2008, CANCER IMMUNOL IMMUN, V57, P1553, DOI 10.1007/s00262-008-0524-3; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hicklin DJ, 2001, DRUG DISCOV TODAY, V6, P517, DOI 10.1016/S1359-6446(01)01759-7; Igarashi T, 2003, GENE THER, V10, P219, DOI 10.1038/sj.gt.3301878; Islam S, 1996, J CELL BIOL, V135, P1643, DOI 10.1083/jcb.135.6.1643; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Ivanov D, 2004, EXP CELL RES, V293, P207, DOI 10.1016/j.yexcr.2003.09.030; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Joshi MB, 2008, BIOCHEM J, V416, P271, DOI 10.1042/BJ20080765; Joshi MB, 2005, FASEB J, V19, P1737, DOI 10.1096/fj.05-3834fje; Koga M, 2008, BIOCHEM BIOPH RES CO, V365, P279, DOI 10.1016/j.bbrc.2007.10.182; Korff T, 1999, J CELL SCI, V112, P3249; Kudrjashova E, 2002, HISTOCHEM CELL BIOL, V118, P281, DOI 10.1007/s00418-002-0463-6; Kuzmenko YS, 1998, BIOCHEM BIOPH RES CO, V246, P489, DOI 10.1006/bbrc.1998.8645; Machein MR, 1999, HUM GENE THER, V10, P1117, DOI 10.1089/10430349950018111; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Norvell SM, 1998, J CELL SCI, V111, P1305; Pan JP, 2008, CANCER IMMUNOL IMMUN, V57, P1105, DOI 10.1007/s00262-008-0452-2; Pepper MS, 1997, ARTERIOSCL THROM VAS, V17, P605, DOI 10.1161/01.ATV.17.4.605; Persano L, 2007, MOL ASPECTS MED, V28, P87, DOI 10.1016/j.mam.2006.12.005; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65; Philippova M, 2005, FASEB J, V19, P588, DOI 10.1096/fj.04-2430fje; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Riou P, 2006, FASEB J, V20, P2291, DOI 10.1096/fj.06-6085com; Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; TANDLE A, 2004, J TRANSL MED, V3, P2; Troxell ML, 1999, AM J PHYSIOL-CELL PH, V276, pC404, DOI 10.1152/ajpcell.1999.276.2.C404; Wyder L, 2000, CANCER RES, V60, P4682; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Youssoufian H, 2007, CLIN CANCER RES, V13, p5544S, DOI 10.1158/1078-0432.CCR-07-1107; Zanetta L, 2005, THROMB HAEMOSTASIS, V93, P1041, DOI 10.1160/TH04-10-0680; Zhang HT, 2003, MOL BIOTECHNOL, V25, P185, DOI 10.1385/MB:25:2:185; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	52	8	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					4011	4021		10.1096/fj.09-133611	http://dx.doi.org/10.1096/fj.09-133611			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19638398				2022-12-25	WOS:000271272500036
J	Mukherjee, S; Chen, LY; Papadimos, TJ; Huang, S; Zuraw, BL; Pan, ZK				Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J.; Huang, Shuang; Zuraw, Bruce L.; Pan, Zhixing K.			Lipopolysaccharide-driven Th2 Cytokine Production in Macrophages Is Regulated by Both MyD88 and TRAM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; ENDOTOXIN EXPOSURE; INHALED ENDOTOXIN; T-CELLS; RESPONSES; IL-4; INTERLEUKIN-4; EOSINOPHILS; ACTIVATION	Gram-negative bacterial lipopolysaccharide (LPS) activates macrophages by interacting with Toll-like receptor 4 (TLR4) and triggers the production of various pro-inflammatory Th1 type (type 1) cytokines such as IFN gamma, TNF alpha, and IL8. Though some recent studies cited macrophages as potential sources for Th2 type (type 2) cytokines, little however is known about the intracellular events that lead to LPS-induced type 2 cytokines in macrophages. To understand the mechanisms by which LPS induces type 2 cytokine gene expression, macrophages were stimulated with LPS, and the expression of IL-4 and IL-5 genes were examined. LPS, acting through TLR4, activates both type 1 and type 2 cytokine production both in vitro and in vivo by using macrophages from C3H/HeJ or C3H/HeOuJ mice. Although the baseline level of both TNF alpha and IL-4 protein was very low, TNF alpha was released rapidly after stimulation (within 4 h); however, IL-4 was released after 48 h LPS stimulation in secreted form. Silencing of myeloid differentiation protein (MyD88) and TRIF-related adaptor molecule (TRAM), using small interfering RNA abolished IL-4 induction induced by LPS whereas silencing of TRAM has no effect on TNF alpha induction, thereby indicating that LPS-induced TNF alpha is MyD88-dependent but IL-4 is required both MyD88 and TRAM. These findings suggest a novel function of LPS and the signaling pathways in the induction of IL-4 gene expression.	[Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J.; Pan, Zhixing K.] Univ Toledo, Med Ctr, Dept Med, Toledo, OH 43614 USA; [Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J.; Pan, Zhixing K.] Univ Toledo, Med Ctr, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA; [Huang, Shuang; Pan, Zhixing K.] Scripps Res Inst, Dept Immunol & Mol & Expt Med, La Jolla, CA 92037 USA; [Zuraw, Bruce L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zuraw, Bruce L.] Vet Affairs Hlth Care Syst, La Jolla, CA 92093 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Scripps Research Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pan, ZK (corresponding author), 3035 Arlington Ave, Toledo, OH 43614 USA.	kevin.pan@utoledo.edu		Papadimos, Thomas/0000-0002-4024-227X; Zuraw, Bruce/0000-0003-0640-6768	National Institutes of Health [M01RR00833]; USPHS [AI43524]; Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043524, R56AI043524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant M01RR00833 provided to the General Clinical Research Center of the Scripps Research Institute. This work was also supported by USPHS Grants AI43524 and by the Sam and Ross Stein Charitable Trust.	Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Buttner C, 1997, AM J RESP CELL MOL, V17, P315; Chen LY, 2003, AM J PHYSIOL-LUNG C, V284, pL607, DOI 10.1152/ajplung.00116.2002; Chen LY, 2002, J IMMUNOL, V169, P3934, DOI 10.4049/jimmunol.169.7.3934; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Dombrowicz D, 2001, CURR OPIN IMMUNOL, V13, P716, DOI 10.1016/S0952-7915(01)00284-9; Doucet C, 1998, INT IMMUNOL, V10, P1421, DOI 10.1093/intimm/10.10.1421; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eldridge MW, 2000, J ALLERGY CLIN IMMUN, V105, P475, DOI 10.1067/mai.2000.104552; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Goldstein DR, 2004, CURR OPIN IMMUNOL, V16, P538, DOI 10.1016/j.coi.2004.08.001; HOLT PG, 1995, PEDIAT ALLERG IMM-UK, V6, P1, DOI 10.1111/j.1399-3038.1995.tb00250.x; Honstettre A, 2004, J IMMUNOL, V172, P3695, DOI 10.4049/jimmunol.172.6.3695; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Matsukawa A, 1998, INFLAMM RES, V47, pS137; MICHEL O, 1992, AM REV RESPIR DIS, V146, P352, DOI 10.1164/ajrccm/146.2.352; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Michel O, 1997, AM J RESP CRIT CARE, V156, P1157, DOI 10.1164/ajrccm.156.4.97-02002; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; MOQBEL R, 1995, J IMMUNOL, V155, P4939; MOSER R, 1992, J IMMUNOL, V149, P1432; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PAUL WE, 1991, BLOOD, V77, P1859; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wan GH, 2000, CLIN EXP ALLERGY, V30, P426; Wenner CA, 1997, J IMMUNOL, V158, P765; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	39	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29391	29398		10.1074/jbc.M109.005272	http://dx.doi.org/10.1074/jbc.M109.005272			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19638630	hybrid, Green Published			2022-12-25	WOS:000270896800020
J	Poirier, S; Mayer, G; Poupon, V; McPherson, PS; Desjardins, R; Ly, K; Asselin, MC; Day, R; Duclos, FJ; Witmer, M; Parker, R; Prat, A; Seidah, NG				Poirier, Steve; Mayer, Gaetan; Poupon, Viviane; McPherson, Peter S.; Desjardins, Roxane; Ly, Kevin; Asselin, Marie-Claude; Day, Robert; Duclos, Franck J.; Witmer, Mark; Parker, Rex; Prat, Annik; Seidah, Nabil G.			Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation EVIDENCE FOR AN INTRACELLULAR ROUTE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE PCSK9; LDL RECEPTORS; IN-VITRO; MICE; HYPERCHOLESTEROLEMIA; CHOLESTEROL; EXPRESSION; PROTEIN; GENE; HEPATOCYTES	Elevated levels of plasma low density lipoprotein (LDL)-cholesterol, leading to familial hypercholesterolemia, are enhanced by mutations in at least three major genes, the LDL receptor (LDLR), its ligand apolipoprotein B, and the proprotein convertase PCSK9. Single point mutations in PCSK9 are associated with either hyper or hypocholesterolemia. Accordingly, PCSK9 is an attractive target for treatment of dyslipidemia. PCSK9 binds the epidermal growth factor domain A (EGF-A) of the LDLR and directs it to endosomes/lysosomes for destruction. Although the mechanism by which PCSK9 regulates LDLR degradation is not fully resolved, it seems to involve both intracellular and extracellular pathways. Here, we show that clathrin light chain small interfering RNAs that block intracellular trafficking from the trans-Golgi network to lysosomes rapidly increased LDLR levels within HepG2 cells in a PCSK9-dependent fashion without affecting the ability of exogenous PCSK9 to enhance LDLR degradation. In contrast, blocking the extracellular LDLR endocytosis/degradation pathway by a 4-, 6-, or 24-h incubation of cells with Dynasore or an EGF-AB peptide or by knockdown of endogenous autosomal recessive hypercholesterolemia did not significantly affect LDLR levels. The present data from HepG2 cells and mouse primary hepatocytes favor a model whereby depending on the dose and/or incubation period, endogenous PCSK9 enhances the degradation of the LDLR both extra and intracellularly. Therefore, targeting either pathway, or both, would be an effective method to reduce PCSK9 activity in the treatment of hypercholesterolemia and coronary heart disease.	[Poirier, Steve; Mayer, Gaetan; Asselin, Marie-Claude; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Poupon, Viviane; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Desjardins, Roxane; Ly, Kevin; Day, Robert] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Duclos, Franck J.; Witmer, Mark; Parker, Rex] Bristol Myers Squibb Co, Princeton, NJ 08543 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; University of Sherbrooke; Bristol-Myers Squibb	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Seidah, Nabil/I-3596-2013	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research [MOP-36496, CTP-82946, MOP-15396]; Strauss Foundation; Bristol-Myers Squibb; Canada Chair [201652]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Canada Chair	This work was supported in part by Canadian Institutes of Health Research Grants MOP-36496 and CTP-82946 (to N. G. S.) and MOP-15396 (to P. S. M.), a Strauss Foundation grant (to N. G. S.), a Bristol-Myers Squibb research grant, and Canada Chair 201652 (to N. G. S.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; DUBUC G, 2009, J LIPID RES IN PRESS; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Harada-Shiba M, 2004, CIRC RES, V95, P945, DOI 10.1161/01.RES.0000146946.78540.46; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Labonte P, 2009, HEPATOLOGY, V50, P17, DOI 10.1002/hep.22911; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Luo Y, 2009, J LIPID RES, V50, P1581, DOI 10.1194/jlr.M800542-JLR200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Varret M, 2008, CLIN GENET, V73, P1, DOI 10.1111/j.1399-0004.2007.00915.x; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	39	189	196	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28856	28864		10.1074/jbc.M109.037085	http://dx.doi.org/10.1074/jbc.M109.037085			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19635789	Green Published, hybrid			2022-12-25	WOS:000270678900042
J	Piccirillo, S; Filomeni, G; Brune, B; Rotilio, G; Ciriolo, MR				Piccirillo, Sara; Filomeni, Giuseppe; Bruene, Bernhard; Rotilio, Giuseppe; Ciriolo, Maria R.			Redox Mechanisms Involved in the Selective Activation of Nrf2-mediated Resistance Versus p53-dependent Apoptosis in Adenocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CACO-2 CELLS; CANCER-CELLS; P53 FUNCTION; DNA-DAMAGE; P38 MAPK; THIOREDOXIN; INDUCTION; KINASE; NRF2	We have investigated the role of reactive oxygen species and thiol-oxidizing agents in the induction of cell death and have shown that adenocarcinoma gastric(AGS) cells respond differently to the oxidative challenge according to the signaling pathways activated. In particular, apoptosis in AGS cells is induced via the mitochondrial pathway upon treatment with thiol-oxidizing agents, such as diamide. Apoptosis is associated with persistent oxidative damage, as evidenced by the increase in carbonylated proteins and the expression/activation of DNA damage-sensitive proteins histone H2A.X and DNA-dependent protein kinase. Resistance to hydrogen peroxide is instead associated with Keap1 oxidation and rapid translocation of Nrf2 into the nucleus. Sensitivity to diamide and resistance to hydrogen peroxide are correlated with GSH redox changes, with diamide severely increasing GSSG, and hydrogen peroxide transiently inducing protein-GSH mixed disulfides. We show that p53 is activated in response to diamide treatment by the oxidative induction of the Trx1/p38(MAPK) signaling pathway. Similar results were obtained with another carcinoma cell line, CaCo2, indicating that these findings are not limited to AGS cells. Our data suggest that thiol-oxidizing agents could be exploited as inducers of apoptosis in tumor histotypes resistant to ROS-producing chemotherapeutics.	[Piccirillo, Sara; Rotilio, Giuseppe; Ciriolo, Maria R.] Res Ctr IRCCS San Raffaele Pisana, I-00163 Rome, Italy; [Filomeni, Giuseppe; Rotilio, Giuseppe; Ciriolo, Maria R.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Bruene, Bernhard] Goethe Univ Frankfurt, Inst Biochem 1, ZAFES, Fac Med, D-60590 Frankfurt, Germany	IRCCS San Raffaele Pisana; University of Rome Tor Vergata; Goethe University Frankfurt	Ciriolo, MR (corresponding author), Res Ctr IRCCS San Raffaele Pisana, Via Bonacolsi, I-00163 Rome, Italy.	ciriolo@bio.uniroma2.it	Ciriolo, Maria Rosa/K-6572-2016	Filomeni, Giuseppe/0000-0002-2719-1412; Ciriolo, Maria Rosa/0000-0002-7863-9029	Ministero dell'Universita e della Ricerca Scientifica; Ministero della Salute	Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy)	This work was partially supported by grants from Ministero dell'Universita e della Ricerca Scientifica and Ministero della Salute.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Cabello CM, 2007, CURR OPIN INVEST DR, V8, P1022; Chen C, 2004, FREE RADICAL BIO MED, V37, P1578, DOI 10.1016/j.freeradbiomed.2004.07.021; Chen C, 2004, FREE RADICAL BIO MED, V36, P1505, DOI 10.1016/j.freeradbiomed.2004.03.015; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Djelloul S, 1997, FEBS LETT, V406, P234, DOI 10.1016/S0014-5793(97)00208-1; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Filomeni G, 2005, CANCER RES, V65, P11735, DOI 10.1158/0008-5472.CAN-05-3067; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; Filomeni G, 2002, FASEB J, V16, P64, DOI 10.1096/fj.02-0105fje; Filomeni G, 2007, J BIOL CHEM, V282, P12010, DOI 10.1074/jbc.M610927200; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Han ZY, 1996, J BIOL CHEM, V271, P25035, DOI 10.1074/jbc.271.40.25035; Hildesheim J, 2002, CANCER RES, V62, P7305; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim YC, 2003, ONCOGENE, V22, P1860, DOI 10.1038/sj.onc.1206369; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; ROTILIO G, 1985, ENVIRON HEALTH PERSP, V64, P259, DOI 10.2307/3430015; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wingler K, 2000, GASTROENTEROLOGY, V119, P420, DOI 10.1053/gast.2000.9521; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028	41	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27721	27733		10.1074/jbc.M109.014837	http://dx.doi.org/10.1074/jbc.M109.014837			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19643729	Green Published, hybrid			2022-12-25	WOS:000270232300073
J	Saha, S; Biswas, KH; Kondapalli, C; Isloor, N; Visweswariah, SS				Saha, Sayanti; Biswas, Kabir Hassan; Kondapalli, Chandana; Isloor, Nishitha; Visweswariah, Sandhya S.			The Linker Region in Receptor Guanylyl Cyclases Is a Key Regulatory Module MUTATIONAL ANALYSIS OF GUANYLYL CYCLASE C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-STABLE ENTEROTOXIN; CONE-ROD DYSTROPHY; NATRIURETIC PEPTIDE RECEPTORS; MULTIPLE SEQUENCE ALIGNMENT; STRUCTURE PREDICTION SERVER; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; COILED-COILS	Receptor guanylyl cyclases are multidomain proteins, and ligand binding to the extracellular domain increases the levels of intracellular cGMP. The intracellular domain of these receptors is composed of a kinase homology domain (KHD), a linker of similar to 70 amino acids, followed by the C-terminal guanylyl cyclase domain. Mechanisms by which these receptors are allosterically regulated by ligand binding to the extracellular domain and ATP binding to the KHD are not completely understood. Here we examine the role of the linker region in receptor guanylyl cyclases by a series of point mutations in receptor guanylyl cyclase C. The linker region is predicted to adopt a coiled coil structure and aid in dimerization, but we find that the effects of mutations neither follow a pattern predicted for a coiled coil peptide nor abrogate dimerization. Importantly, this region is critical for repressing the guanylyl cyclase activity of the receptor in the absence of ligand and permitting ligand-mediated activation of the cyclase domain. Mutant receptors with high basal guanylyl cyclase activity show no further activation in the presence of non-ionic detergents, suggesting that hydrophobic interactions in the basal and inactive conformation of the guanylyl cyclase domain are disrupted by mutation. Equivalent mutations in the linker region of guanylyl cyclase A also elevated the basal activity and abolished ligand-and detergent-mediated activation. We, therefore, have defined a key regulatory role for the linker region of receptor guanylyl cyclases which serves as a transducer of information from the extracellular domain via the KHD to the catalytic domain.	[Saha, Sayanti; Biswas, Kabir Hassan; Kondapalli, Chandana; Isloor, Nishitha; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Biswas, Kabir H/AAG-9156-2019; Visweswariah, Sandhya/Q-7500-2019	Biswas, Kabir H/0000-0001-9194-4127; Visweswariah, Sandhya/0000-0003-2786-7344	Departments of Science and Technology and Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology	Departments of Science and Technology and Biotechnology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by grants from the Departments of Science and Technology and Biotechnology, Government of India.; Supported by a senior research fellowship from the Council of Scientific and Industrial Research, Government of India.; Supported by a post-doctoral fellowship from the Department of Biotechnology.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Antos LK, 2005, J BIOL CHEM, V280, P26928, DOI 10.1074/jbc.M505648200; Bhandari R, 2001, BIOCHEMISTRY-US, V40, P9196, DOI 10.1021/bi002595g; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; Bryan PM, 2006, BIOCHEMISTRY-US, V45, P1295, DOI 10.1021/bi051253d; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Duda T, 1999, BIOCHEMISTRY-US, V38, P13912, DOI 10.1021/bi9915972; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Forte LR, 1999, REGUL PEPTIDES, V81, P25, DOI 10.1016/S0167-0115(99)00033-6; FORTE LR, 1989, AM J PHYSIOL, V257, pF874, DOI 10.1152/ajprenal.1989.257.5.F874; Ghanekar Y, 2004, BIOCHEM J, V379, P653, DOI 10.1042/BJ20040001; HIRAYAMA T, 1993, MICROB PATHOGENESIS, V15, P283, DOI 10.1006/mpat.1993.1078; Jaleel M, 2006, BIOCHEMISTRY-US, V45, P1888, DOI 10.1021/bi052089x; Jaleel M, 2002, BIOL REPROD, V67, P1975, DOI 10.1095/biolreprod.102.006445; Kitiratschky VBD, 2008, INVEST OPHTH VIS SCI, V49, P5015, DOI 10.1167/iovs.08-1901; Koch KW, 2002, MOL CELL BIOCHEM, V230, P97, DOI 10.1023/A:1014209711793; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nandi A, 1997, J CELL BIOCHEM, V66, P500, DOI 10.1002/(SICI)1097-4644(19970915)66:4<500::AID-JCB9>3.0.CO;2-P; Padayatti PS, 2004, PHARMACOL THERAPEUT, V104, P83, DOI 10.1016/j.pharmthera.2004.08.003; Qian X, 2000, ENDOCRINOLOGY, V141, P3210, DOI 10.1210/en.141.9.3210; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Seebeck B, 2008, PROTEINS, V71, P1237, DOI 10.1002/prot.21818; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; SINGH S, 1991, BIOCHEM BIOPH RES CO, V179, P1455, DOI 10.1016/0006-291X(91)91736-V; Smith M, 2007, EYE, V21, P1220, DOI 10.1038/sj.eye.6702612; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; Vijayachandra K, 2000, BIOCHEMISTRY-US, V39, P16075, DOI 10.1021/bi0013849; VISWESWARIAH SS, 1994, EUR J BIOCHEM, V219, P727, DOI 10.1111/j.1432-1033.1994.tb18551.x; Wedel BJ, 1997, P NATL ACAD SCI USA, V94, P459, DOI 10.1073/pnas.94.2.459; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Young JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000884; Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	52	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27135	27145		10.1074/jbc.M109.020032	http://dx.doi.org/10.1074/jbc.M109.020032			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19648115	Green Published, hybrid			2022-12-25	WOS:000270232300014
J	Novosyadlyy, R; Vijayakumar, A; Lann, D; Fierz, Y; Kurshan, N; LeRoith, D				Novosyadlyy, R.; Vijayakumar, A.; Lann, D.; Fierz, Y.; Kurshan, N.; LeRoith, D.			Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation	ONCOGENE			English	Article						oncogenes; polyoma virus middle T oncogene; insulin receptor; IGF-I receptor; crosstalk	MERKEL CELL POLYOMAVIRUS; EPIDERMAL GROWTH-FACTOR; BREAST-CANCER; TRANSFORMED PHENOTYPE; KAPOSIS-SARCOMA; MAMMARY-TUMORS; SRC KINASE; OVEREXPRESSION; TUMORIGENESIS; PROGRESSION	Polyoma virus middle T antigen (PyVmT) is a powerful viral oncogene; however, the mechanisms of PyVmT activation are poorly understood. The insulin-like growth factor I receptor (IGF-IR) and the insulin receptor (IR) are known to be implicated in the development of many cancers. Furthermore, PyVmT-overexpressing mouse mammary carcinoma Met-1 cells are highly responsive to IGF-I and insulin. Herein, we demonstrate that PyVmT physically interacts with IGF-IR and IR in Met-1 cells. Insulin and IGF-I increase association of the IR and IGF-IR with PyVmT, enhance tyrosine phosphorylation of PyVmT and augment the recruitment of Src and PLC gamma(1) to PyVmT. This is accompanied by robust and sustained phosphorylation of Akt and ERK1/2, which are implicated in both PyVmT and IGF-IR/IR signalling. Both ligands significantly increase proliferation, survival, migration and invasion of Met-1 cells. Furthermore, orthotopic inoculation of Met-1 cells with shRNAmir-mediated knockdown of IR or IGF-IR fails to initiate tumour growth in recipient mice. In conclusion, our data indicate that the physical and functional interaction between PyVmT and cellular receptor tyrosine kinases, including IR and IGF-IR, is critical for PyVmT activation and tumour initiation. These results also provide a novel mechanism for oncogene activation in the host cell. Oncogene (2009) 28, 3477-3486; doi: 10.1038/onc.2009.209; published online 20 July 2009	[Novosyadlyy, R.; Vijayakumar, A.; Lann, D.; Fierz, Y.; Kurshan, N.; LeRoith, D.] Mt Sinai Sch Med, Samuel Bronfman Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	LeRoith, D (corresponding author), Mt Sinai Sch Med, Samuel Bronfman Dept Med, Div Endocrinol Diabet & Bone Dis, 1 Gustave L Levy Pl,Box 1055, New York, NY 10029 USA.	derek.leroith@mssm.edu			National Institutes of Health/National Cancer Institute [1RO1CA128799-O1A1, T32 DK007792]; Swiss National Science Foundation [PBBSB-120851]; Novartis Foundation; NATIONAL CANCER INSTITUTE [R01CA128799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007792] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank SD Hurstings (Department of Nutritional Sciences, University of Texas, Austin, TX, USA and Department of Carcinogenesis, University of Texas-MD Anderson Cancer Center, Smithville, TX, USA) and NP Nunez (Department of Nutritional Sciences, University of Texas, Austin, TX, USA) for donating Met-1 cells. This work was funded by National Institutes of Health/National Cancer Institute grant 1RO1CA128799-O1A1. D Lann was supported by National Institutes of Health grant T32 DK007792. Y Fierz was funded by Swiss National Science Foundation grant PBBSB-120851 and Novartis Foundation grant.	Arbet-Engels C, 1999, J BIOL CHEM, V274, P5422, DOI 10.1074/jbc.274.9.5422; Bartucci M, 2001, CANCER RES, V61, P6747; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Catrina SB, 2005, BRIT J CANCER, V92, P1467, DOI 10.1038/sj.bjc.6602408; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; DiMaio D, 1998, ANNU REV MICROBIOL, V52, P397, DOI 10.1146/annurev.micro.52.1.397; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2008, EMERG INFECT DIS, V14, P1491, DOI 10.3201/eid1409.080651; FRITTITTA L, 1995, J CELL BIOCHEM, V57, P666, DOI 10.1002/jcb.240570411; GIORGINO F, 1991, MOL ENDOCRINOL, V5, P452, DOI 10.1210/mend-5-3-452; GROSS L, 1953, P SOC EXP BIOL MED, V83, P414; GROSS L, 1951, P SOC EXP BIOL MED, V76, P27; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Javier RT, 2008, CANCER RES, V68, P7693, DOI 10.1158/0008-5472.CAN-08-3301; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Lebrun P, 1998, J BIOL CHEM, V273, P32244, DOI 10.1074/jbc.273.48.32244; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; MORRIS JDH, 1995, LANCET, V346, P754, DOI 10.1016/S0140-6736(95)91510-9; ONO M, 1991, CELL GROWTH DIFFER, V2, P317; Pisani Paola, 2008, Archives of Physiology and Biochemistry, V114, P63, DOI 10.1080/13813450801954451 ; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rose PP, 2007, ONCOGENE, V26, P1995, DOI 10.1038/sj.onc.1210006; SEGAWA K, 1983, NATURE, V304, P742, DOI 10.1038/304742a0; Shepard CR, 2007, ONCOGENE, V26, P3020, DOI 10.1038/sj.onc.1210115; SOEDA E, 1980, NATURE, V285, P165, DOI 10.1038/285165a0; White MK, 2004, VIROLOGY, V324, P1, DOI 10.1016/j.virol.2004.03.025; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; zur Hausen H, 2008, INT J CANCER, V123, P247, DOI 10.1002/ijc.23620	35	17	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	39					3477	3486		10.1038/onc.2009.209	http://dx.doi.org/10.1038/onc.2009.209			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	502RR	19617901	Green Accepted			2022-12-25	WOS:000270478300005
J	Deikus, G; Bechhofer, DH				Deikus, Gintaras; Bechhofer, David H.			Bacillus subtilis trp Leader RNA RNase J1 ENDONUCLEASE CLEAVAGE SPECIFICITY AND PNPase PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; RIBOSOMAL-RNA; TRANSCRIPTION ATTENUATION; STEM-LOOP; IN-VIVO; DECAY; DEGRADATION; PROTEIN; ENDONUCLEASE	In the presence of ample tryptophan, transcription from the Bacillus subtilis trp operon promoter terminates to give a 140-nucleotide trp leader RNA. Turnover of trp leader RNA has been shown to depend on RNase J1 cleavage at a single-stranded, AU-rich region just upstream of the 3' transcription terminator. The small size of trp leader RNA and its strong dependence on RNase J1 cleavage for decay make it a suitable substrate for analyzing the requirements for RNase J1 target site specificity. trp leader RNAs with nucleotide changes around the RNase J1 target site were more stable than wild-type trp leader RNA, showing that sequences on either side of the cleavage site contribute to RNase J1 recognition. An analysis of decay intermediates from these mutants suggested limited 3'-to-5' exonuclease processing from the native 3' end. trp leader RNAs were designed that contained wild-type or mutant RNase J1 targets elsewhere on the molecule. The presence of an additional RNase J1 cleavage site resulted in faster RNA decay, depending on its location. Addition of a 5' tail containing 7 A residues caused destabilization of trp leader RNAs. Surprisingly, addition at the 5' end of a strong stem loop structure that is known to stabilize other RNAs did not result in a longer trp leader RNA half-life, suggesting that the RNase J1 cleavage site may be accessed directly. In the course of these experiments, we found evidence that polynucleotide phosphorylase processivity was inhibited by a GCGGCCGC sequence.	[Deikus, Gintaras; Bechhofer, David H.] NYU, Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Bechhofer, DH (corresponding author), Box 1603,1 Gustave L Levy Pl, New York, NY 10029 USA.	david.bechhofer@mssm.edu			United States Public Health Service [GM48804]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048804] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM48804 (to D. H. B.) from the National Institutes of Health.	Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; Bechhofer DH, 2009, PROG MOL BIOL TRANSL, V85, P231, DOI 10.1016/S0079-6603(08)00806-4; Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; BROSIUS J, 1992, METHOD ENZYMOL, V216, P469; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Choonee N, 2007, NUCLEIC ACIDS RES, V35, P1578, DOI 10.1093/nar/gkm011; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deikus G, 2004, P NATL ACAD SCI USA, V101, P2747, DOI 10.1073/pnas.0307343101; Deikus G, 2008, J BIOL CHEM, V283, P17158, DOI 10.1074/jbc.M801461200; Deikus G, 2007, J BIOL CHEM, V282, P20238, DOI 10.1074/jbc.M702747200; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; Hambraeus G, 2002, MICROBIOL-SGM, V148, P1795, DOI 10.1099/00221287-148-6-1795; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mcgraw AP, 2007, RNA, V13, P2020, DOI 10.1261/rna.719507; MCLAREN RS, 1991, J MOL BIOL, V221, P81, DOI 10.1016/0022-2836(91)90806-H; Ohki R, 2004, J BACTERIOL, V186, P7450, DOI 10.1128/JB.186.21.7450-7455.2004; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Sharp JS, 2005, MOL MICROBIOL, V57, P484, DOI 10.1111/j.1365-2958.2005.04683.x; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Yao SY, 2007, NUCLEIC ACIDS RES, V35, P4464, DOI 10.1093/nar/gkm460; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26394	26401		10.1074/jbc.M109.015875	http://dx.doi.org/10.1074/jbc.M109.015875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638340	Green Published, hybrid			2022-12-25	WOS:000269969600020
J	Ziegler, J; Brandt, W; Geissler, R; Facchini, PJ				Ziegler, Joerg; Brandt, Wolfgang; Geissler, Rene; Facchini, Peter J.			Removal of Substrate Inhibition and Increase in Maximal Velocity in the Short Chain Dehydrogenase/Reductase Salutaridine Reductase Involved in Morphine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; OPIUM POPPY; ALCOHOL-DEHYDROGENASE; PAPAVER-SOMNIFERUM; CARBONYL REDUCTASE; BENZYLISOQUINOLINE ALKALOIDS; CRYSTAL-STRUCTURE; LEISHMANIA-MAJOR; METABOLISM; PROTEINS	Salutaridine reductase (SalR, EC 1.1.1.248) catalyzes the stereospecific reduction of salutaridine to 7(S)-salutaridinol in the biosynthesis of morphine. It belongs to a new, plant-specific class of short-chain dehydrogenases, which are characterized by their monomeric nature and increased length compared with related enzymes. Homology modeling and substrate docking suggested that additional amino acids form a novel alpha-helical element, which is involved in substrate binding. Site-directed mutagenesis and subsequent studies on enzyme kinetics revealed the importance of three residues in this element for substrate binding. Further replacement of eight additional residues led to the characterization of the entire substrate binding pocket. In addition, a specific role in salutaridine binding by either hydrogen bond formation or hydrophobic interactions was assigned to each amino acid. Substrate docking also revealed an alternative mode for salutaridine binding, which could explain the strong substrate inhibition of SalR. An alternate arrangement of salutaridine in the enzyme was corroborated by the effect of various amino acid substitutions on substrate inhibition. In most cases, the complete removal of substrate inhibition was accompanied by a substantial loss in enzyme activity. However, some mutations greatly reduced substrate inhibition while maintaining or even increasing the maximal velocity. Based on these results, a double mutant of SalR was created that exhibited the complete absence of substrate inhibition and higher activity compared with wild-type SalR.	[Ziegler, Joerg; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Brandt, Wolfgang] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle, Germany; [Geissler, Rene] Leibniz Inst Plant Biochem, Dept Nat Prod Biotechnol, D-06120 Halle, Germany	University of Calgary; Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie	Facchini, PJ (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca	Ziegler, Jörg/W-7645-2019	Facchini, Peter/0000-0002-7693-290X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant (to P. J. F.).	Allen RS, 2008, PLANT BIOTECHNOL J, V6, P22, DOI 10.1111/j.1467-7652.2007.00293.x; Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; BJELDANES LF, 1972, J ORG CHEM, V37, P1453, DOI 10.1021/jo00974a041; Bomati EK, 2005, PLANT CELL, V17, P1598, DOI 10.1105/tpc.104.029983; Burton RL, 2007, J BIOL CHEM, V282, P31517, DOI 10.1074/jbc.M704032200; Choi HW, 2008, PLANT PHYSIOL, V148, P383, DOI 10.1104/pp.108.119461; Davis EM, 2005, PLANT PHYSIOL, V137, P873, DOI 10.1104/pp.104.053306; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Eszes CM, 1996, FEBS LETT, V399, P193, DOI 10.1016/S0014-5793(96)01317-8; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Frick S, 2004, TRANSGENIC RES, V13, P607, DOI 10.1007/s11248-004-2892-6; Frick S, 2007, METAB ENG, V9, P169, DOI 10.1016/j.ymben.2006.10.004; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; Gamage NU, 2003, J BIOL CHEM, V278, P7655, DOI 10.1074/jbc.M207246200; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin PJ, 2007, PLANT BIOTECHNOL J, V5, P26, DOI 10.1111/j.1467-7652.2006.00212.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luba J, 1998, BIOCHEMISTRY-US, V37, P4093, DOI 10.1021/bi972693a; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Pellegrini E, 2002, J PHYS CHEM A, V106, P1316, DOI 10.1021/jp0135050; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; POCKER Y, 1985, ALCOHOL, V2, P3, DOI 10.1016/0741-8329(85)90004-7; REARICK DE, 1970, TETRAHEDRON LETT, P507; Rehse PH, 2002, BIOCHEM J, V364, P165, DOI 10.1042/bj3640165; Ringer KL, 2003, ARCH BIOCHEM BIOPHYS, V418, P80, DOI 10.1016/S0003-9861(03)00390-4; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; TANAKA M, 1992, J BIOL CHEM, V267, P13451; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; Warner JR, 2008, BIOCHEMISTRY-US, V47, P3258, DOI 10.1021/bi702431n; WINBERG JO, 1994, BIOCHEM J, V301, P901, DOI 10.1042/bj3010901; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	45	18	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26758	26767		10.1074/jbc.M109.030957	http://dx.doi.org/10.1074/jbc.M109.030957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19648114	Green Published, hybrid			2022-12-25	WOS:000269969600057
J	Stylianou, DC; Maur, AAD; Kodack, DP; Henke, RT; Hohn, S; Toretsky, JA; Riegel, AT; Wellstein, A				Stylianou, D. C.; Maur, A. Auf Der; Kodack, D. P.; Henke, R. T.; Hohn, S.; Toretsky, J. A.; Riegel, A. T.; Wellstein, A.			Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor	ONCOGENE			English	Article						ALK; growth factor; PTN; single-chain antibody; tyrosine kinase receptor	TYROSINE-PHOSPHATASE-BETA/ZETA; GROWTH-FACTOR PLEIOTROPHIN; ACTIVATED PROTEIN-KINASE; SULFATE HYBRID CHAINS; NON-HODGKINS-LYMPHOMA; EMBRYONIC PIG BRAIN; MOLECULE HB-GAM; ZETA/RPTP-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; CHONDROITIN/DERMATAN SULFATE	The tyrosine kinase receptor anaplastic lymphoma kinase (ALK) and its ligand, the growth factor pleiotrophin (PTN), are highly expressed during the development of the nervous system and have been implicated in the malignant progression of different tumor types. Here, we describe human single-chain variable fragment (scFv) antibodies that target the ligand-binding domain (LBD) in ALK and show the effect in vitro and in vivo. The ALK LBD was used as a bait in a yeast two-hybdrid system to select human scFv from a library with randomized complementarity-determining region 3 domains. Surface plasmon resonance showed high-affinity binding of the selected scFv. The anti-ALK scFv competed for binding of PTN to ALK in intact cells and inhibited PTN-dependent signal transduction through endogenous ALK. Invasion of an intact endothelial cell monolayer by U87MG human glioblastoma cells was inhibited by the anti-ALK scFv. In addition, the growth of established tumor xenografts in mice was reversed after the induction of the conditional expression of the anti-ALK scFv. In archival malignant brain tumors expression levels of ALK and PTN were found elevated and appear correlated with poor patient survival. This suggests a rate-limiting function of the PTN/ALK interaction that may be exploited therapeutically. Oncogene (2009) 28, 3296-3306; doi:10.1038/onc.2009.184; published online 27 July 2009	[Wellstein, A.] Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Washington, DC 20057 USA; [Maur, A. Auf Der; Hohn, S.] Esbatech AG, Zurich, Switzerland	Georgetown University	Wellstein, A (corresponding author), Georgetown Univ, Med Ctr, Lombardi Canc Ctr, E315 TRB 3970 Reservoir Rd NW, Washington, DC 20057 USA.	wellstea@georgetown.edu	Stylianou, Dora/AAT-1074-2020; Stylianou, Dora/J-2697-2016	Stylianou, Dora/0000-0003-4167-1380; Stylianou, Dora/0000-0003-4167-1380; Wellstein, Anton/0000-0002-0570-4950	National Institute of Health [RO1 CA108440]; NATIONAL CANCER INSTITUTE [R01CA108440, T32CA009686, R01CA071508, P50CA058185, R01CA101811] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Emma T Bowden, Angera H Kuo and Gerald E Stoica (Georgetown University) for help with some of the experiments as well as discussions and suggestions. This work was supported by RO1 CA108440 from the National Institute of Health (to AW).	Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; AUFDERMAUR A, 2002, J BIOL CHEM, V277, P45075; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Chang YC, 2006, BIOCHEM BIOPH RES CO, V351, P336, DOI 10.1016/j.bbrc.2006.09.148; Chen HM, 2007, BLOOD, V110, P287, DOI 10.1182/blood-2006-08-042374; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; der Maur AA, 2001, FEBS LETT, V508, P407, DOI 10.1016/S0014-5793(01)03101-5; der Maur Adrian Auf, 2004, Methods (Amsterdam), V34, P215; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Grzelinski M, 2006, HUM GENE THER, V17, P751, DOI 10.1089/hum.2006.17.751; Hamma-Kourbali Y, 2008, J CELL PHYSIOL, V214, P250, DOI 10.1002/jcp.21191; Henke RT, 2006, METHODS, V38, P253, DOI 10.1016/j.ymeth.2005.11.013; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Kuo AH, 2007, ONCOGENE, V26, P859, DOI 10.1038/sj.onc.1209840; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; McCarthy N, 2008, NAT REV CANCER, V8, DOI 10.1038/nrc2305; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mentlein R, 2002, J NEUROCHEM, V83, P747, DOI 10.1046/j.1471-4159.2002.01179.x; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; MIURA M, 1995, J BIOL CHEM, V270, P22639, DOI 10.1074/jbc.270.38.22639; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Owada K, 1999, J NEUROCHEM, V73, P2084; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Peria FM, 2007, J NEURO-ONCOL, V84, P255, DOI 10.1007/s11060-007-9379-2; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sakaguchi N, 2003, NEUROSCI RES, V45, P219, DOI 10.1016/S0168-0102(02)00226-2; Schaerer-Brodbeck C, 2004, BIOTECHNIQUES, V37, P202, DOI 10.2144/04372BM05; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Weber D, 2000, CANCER RES, V60, P5284; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733; Zou P, 2006, LAB INVEST, V86, P645, DOI 10.1038/labinvest.3700428	63	32	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2009	28	37					3296	3306		10.1038/onc.2009.184	http://dx.doi.org/10.1038/onc.2009.184			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	495LS	19633684	Green Accepted			2022-12-25	WOS:000269893700004
J	Khatoon, M; Inagawa, K; Pospisil, P; Yamashita, A; Yoshioka, M; Lundin, B; Horie, J; Morita, N; Jajoo, A; Yamamoto, Y; Yamamoto, Y				Khatoon, Mahbuba; Inagawa, Kayo; Pospisil, Pavel; Yamashita, Amu; Yoshioka, Miho; Lundin, Bjoern; Horie, Junko; Morita, Noriko; Jajoo, Anjana; Yamamoto, Yoko; Yamamoto, Yasusi			Quality Control of Photosystem II THYLAKOID UNSTACKING IS NECESSARY TO AVOID FURTHER DAMAGE TO THE D1 PROTEIN AND TO FACILITATE D1 DEGRADATION UNDER LIGHT STRESS IN SPINACH THYLAKOIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYLAKOID MEMBRANES; SINGLET OXYGEN; 3-DIMENSIONAL STRUCTURE; GRANA STACKING; D1 PROTEIN; LIGHT; FTSH; ORGANIZATION; COMPLEX; PHOTOINHIBITION	Photosystem II is vulnerable to light damage. The reaction center-binding D1 protein is impaired during excessive illumination and is degraded and removed from photosystem II. Using isolated spinach thylakoids, we investigated the relationship between light-induced unstacking of thylakoids and damage to the D1 protein. Under light stress, thylakoids were expected to become unstacked so that the photodamaged photosystem II complexes in the grana and the proteases could move on the thylakoids for repair. Excessive light induced irreversible unstacking of thylakoids. By comparing the effects of light stress on stacked and unstacked thylakoids, photoinhibition of photosystem II was found to be more prominent in stacked thylakoids than in unstacked thylakoids. In accordance with this finding, EPR spin trapping measurements demonstrated higher production of hydroxyl radicals in stacked thylakoids than in unstacked thylakoids. We propose that unstacking of thylakoids has a crucial role in avoiding further damage to the D1 protein and facilitating degradation of the photodamaged D1 protein under light stress.	[Khatoon, Mahbuba; Inagawa, Kayo; Yamashita, Amu; Yoshioka, Miho; Lundin, Bjoern; Horie, Junko; Morita, Noriko; Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Pospisil, Pavel] Palacky Univ, Biophys Lab, Dept Expt Phys, Fac Sci, Olomouc 77146, Czech Republic; [Jajoo, Anjana] Devi Ahilya Univ, Sch Life Sci, Indore 452017, Madhya Pradesh, India; [Yamamoto, Yoko] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan	Okayama University; Palacky University Olomouc; Devi Ahilya University; Okayama University	Yamamoto, Y (corresponding author), 3-1-1 Tsushima Naka,Kita Ku, Okayama 7008530, Japan.	yasusiya@cc.okayama-u.ac.jp	POSPÍŠIL, Pavel/AAH-4451-2019; Yamamoto, Yasusi/B-2637-2011; Yoshioka-Nishimura, Miho/C-2745-2015	POSPÍŠIL, Pavel/0000-0001-9126-2011; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20570039, 18208008]; Wesco Science Promotion Foundation; Ryobi Foundation; Ministry of Education, Youth and Sports of the Czech Republic [MSM 6198959215]; Japan Society for the Promotion of Science; Department of Biotechnology, India	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wesco Science Promotion Foundation; Ryobi Foundation; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by Grant-in-Aid for Scientific Research 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Wesco Science Promotion Foundation and the Ryobi Foundation (to Yasusi Yamamoto); Ministry of Education, Youth and Sports of the Czech Republic Grant MSM 6198959215 (to P. P.); a Japan Society for the Promotion of Science fellowship (to B. L.); a grant from Department of Biotechnology, India, (to A. J.); and Grant-in-Aid for Scientific Research 18208008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Yoko Yamamoto).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ANDERSON JM, 1988, TRENDS BIOCHEM SCI, V13, P351, DOI 10.1016/0968-0004(88)90106-5; Anderson JM, 1999, AUST J PLANT PHYSIOL, V26, P625, DOI 10.1071/PP99070; ANDERSON JM, 1988, AUST J PLANT PHYSIOL, V15, P11, DOI 10.1071/PP9880011; ANDERSON JM, 1994, PHOTOSYNTH RES, V41, P315, DOI 10.1007/BF00019409; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barber J, 1998, BBA-BIOENERGETICS, V1365, P269, DOI 10.1016/S0005-2728(98)00079-6; Barber J, 2005, ADV PHOTO RESPIRAT, V22, P469; BENNETT J, 1980, P NATL ACAD SCI-BIOL, V77, P5253, DOI 10.1073/pnas.77.9.5253; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; CHOW WS, 1980, ARCH BIOCHEM BIOPHYS, V201, P347, DOI 10.1016/0003-9861(80)90520-2; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HIDEG E, 1994, PHOTOSYNTH RES, V39, P191, DOI 10.1007/BF00029386; Horton P, 1999, AUST J PLANT PHYSIOL, V26, P659, DOI 10.1071/PP99095; Jackowski G, 2001, BBA-BIOENERGETICS, V1504, P340, DOI 10.1016/S0005-2728(00)00262-0; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Komayama K, 2007, BBA-BIOENERGETICS, V1767, P838, DOI 10.1016/j.bbabio.2007.05.001; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Nilsson A, 1997, J BIOL CHEM, V272, P18350, DOI 10.1074/jbc.272.29.18350; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; POU S, 1994, ANAL BIOCHEM, V217, P76, DOI 10.1006/abio.1994.1085; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Staehelin LA, 2003, PHOTOSYNTH RES, V76, P185, DOI 10.1023/A:1024994525586; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; TELFER A, 1994, J BIOL CHEM, V269, P13244; Tjus SE, 2001, PLANT PHYSIOL, V125, P2007, DOI 10.1104/pp.125.4.2007; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Vass I, 2008, PRIMARY PROCESSES PH, P393; Witt HT, 2005, ADV PHOTO RESPIRAT, V22, P425; Yamamoto Y, 2004, METH MOL B, V274, P217; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; YAMAMOTO Y, 1981, PLANT PHYSIOL, V67, P1069, DOI 10.1104/pp.67.6.1069; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200	55	72	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25343	25352		10.1074/jbc.M109.007740	http://dx.doi.org/10.1074/jbc.M109.007740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617353	Green Published, hybrid			2022-12-25	WOS:000269734000067
J	Stern, G; Beel, J; Suki, B; Silverman, M; Westaway, J; Cernelc, M; Baldwin, D; Frey, U				Stern, Georgette; Beel, Julia; Suki, Bela; Silverman, Mike; Westaway, Jenny; Cernelc, Mateja; Baldwin, David; Frey, Urs			Long-Range Correlations in Rectal Temperature Fluctuations of Healthy Infants during Maturation	PLOS ONE			English	Article								Background: Control of breathing, heart rate, and body temperature are interdependent in infants, where instabilities in thermoregulation can contribute to apneas or even life-threatening events. Identifying abnormalities in thermoregulation is particularly important in the first 6 months of life, where autonomic regulation undergoes critical development. Fluctuations in body temperature have been shown to be sensitive to maturational stage as well as system failure in critically ill patients. We thus aimed to investigate the existence of fractal-like long-range correlations, indicative of temperature control, in night time rectal temperature (T-rec) patterns in maturing infants. Methodology/Principal Findings: We measured T-rec fluctuations in infants every 4 weeks from 4 to 20 weeks of age and before and after immunization. Long-range correlations in the temperature series were quantified by the correlation exponent, alpha using detrended fluctuation analysis. The effects of maturation, room temperature, and immunization on the strength of correlation were investigated. We found that T-rec fluctuations exhibit fractal long-range correlations with a mean (SD) alpha of 1.51 (0.11), indicating that T-rec is regulated in a highly correlated and hence deterministic manner. A significant increase in alpha with age from 1.42 (0.07) at 4 weeks to 1.58 (0.04) at 20 weeks reflects a change in long-range correlation behavior with maturation towards a smoother and more deterministic temperature regulation, potentially due to the decrease in surface area to body weight ratio in the maturing infant. alpha was not associated with mean room temperature or influenced by immunization Conclusions: This study shows that the quantification of long-range correlations using alpha derived from detrended fluctuation analysis is an observer-independent tool which can distinguish developmental stages of night time T-rec pattern in young infants, reflective of maturation of the autonomic system. Detrended fluctuation analysis may prove useful for characterizing thermoregulation in premature and other infants at risk for life-threatening events.			Stern, G (corresponding author), Univ Bern, Inselspital, Dept Pediat, Div Resp Med, CH-3010 Bern, Switzerland.	georgette.stern@insel.ch						ANDERSON ES, 1990, ARCH DIS CHILD, V65, P1308, DOI 10.1136/adc.65.12.1308; AZAZ Y, 1992, PEDIATR RES, V32, P417, DOI 10.1203/00006450-199210000-00010; Bach V, 1996, NEUROPHYSIOL CLIN, V26, P379, DOI 10.1016/S0987-7053(97)89152-6; BACH V, 1994, PEDIATRICS, V93, P789; Bach V, 2002, SLEEP MED REV, V6, P481, DOI 10.1053/smrv.2001.0177; Baldwin DN, 2004, J APPL PHYSIOL, V97, P1830, DOI 10.1152/japplphysiol.00298.2004; Cernelc M, 2002, J APPL PHYSIOL, V92, P1817, DOI 10.1152/japplphysiol.00675.2001; Chardon K, 2004, RESP PHYSIOL NEUROBI, V140, P145, DOI 10.1016/j.resp.2003.11.007; FLEMING PJ, 1992, J CLIN PATHOL, V45, P17; FLEMING PJ, 1984, J PHYSIOL-LONDON, V347, P1; FLEMING PJ, 1993, ACTA PAEDIATR, V82, P57, DOI 10.1111/j.1651-2227.1993.tb12878.x; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Guntheroth WG, 2001, PEDIATRICS, V107, P693, DOI 10.1542/peds.107.4.693; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; HOFFMAN HJ, 1988, ANN NY ACAD SCI, V533, P13, DOI 10.1111/j.1749-6632.1988.tb37230.x; HOPPENBROUWERS T, 1988, SLEEP, V11, P387, DOI 10.1093/sleep/11.4.387; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Hunt CE, 2001, AM J RESP CRIT CARE, V164, P346, DOI 10.1164/ajrccm.164.3.9910045; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jackson JA, 2001, ACTA PAEDIATR, V90, P1186, DOI 10.1080/080352501317061620; Kinney HC, 2005, J NEUROPATH EXP NEUR, V64, P689, DOI 10.1097/01.jnen.0000174334.27708.43; Larsen PD, 2004, RESP PHYSIOL NEUROBI, V139, P263, DOI 10.1016/j.resp.2003.11.001; LODEMORE M, 1991, ARCH DIS CHILD, V66, P521, DOI 10.1136/adc.66.4.521; LODEMORE MR, 1992, ARCH DIS CHILD, V67, P1259, DOI 10.1136/adc.67.10.1259; LYON A, 2004, CURRENT PAEDIAT, V14, P137; MASKREY M, 1995, CLIN EXP PHARMACOL P, V22, P527, DOI 10.1111/j.1440-1681.1995.tb02061.x; PENG CK, 1993, PHYS REV E, V47, P3730, DOI 10.1103/PhysRevE.47.3730; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Petersen SA, 2001, ARCH DIS CHILD-FETAL, V85, pF133, DOI 10.1136/fn.85.2.F133; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; RAWSON D, 1990, ARCH DIS CHILD, V65, P1305, DOI 10.1136/adc.65.12.1305; SCHEERS M, 2004, PEDIATRICS, V113, pE586; Tappin DM, 1996, ARCH DIS CHILD, V74, P427, DOI 10.1136/adc.74.5.427; TUFFNELL CS, 1995, ARCH DIS CHILD, V73, P443, DOI 10.1136/adc.73.5.443; Varela M, 2003, EUR J APPL PHYSIOL, V89, P230, DOI 10.1007/s00421-002-0790-2; Varela M, 2006, AM J RESP CRIT CARE, V174, P290, DOI 10.1164/rccm.200601-058OC; VASSALLO SU, 1989, J TOXICOL-CLIN TOXIC, V27, P199, DOI 10.3109/15563658908994419; WAIGHT PA, 1983, ARCH DIS CHILD, V58, P921, DOI 10.1136/adc.58.11.921; WAILOO MP, 1990, ARCH DIS CHILD, V65, P499, DOI 10.1136/adc.65.5.499; WAILOO MP, 1989, ARCH DIS CHILD, V64, P596, DOI 10.1136/adc.64.4.596; WAILOO MP, 1989, ARCH DIS CHILD, V64, P600, DOI 10.1136/adc.64.4.600; WESTAWAY J, 1995, ARCH DIS CHILD, V72, P432, DOI 10.1136/adc.72.5.432; YOUNG AJ, 1991, EXP AGING RES, V17, P205	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6431	10.1371/journal.pone.0006431	http://dx.doi.org/10.1371/journal.pone.0006431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641615	Green Published, gold			2022-12-25	WOS:000268494500031
J	Soares, DC; Barlow, PN; Newbery, HJ; Porteous, DJ; Abbott, CM				Soares, Dinesh C.; Barlow, Paul N.; Newbery, Helen J.; Porteous, David J.; Abbott, Catherine M.			Structural Models of Human eEF1A1 and eEF1A2 Reveal Two Distinct Surface Clusters of Sequence Variation and Potential Differences in Phosphorylation	PLOS ONE			English	Article								Background: Despite sharing 92% sequence identity, paralogous human translation elongation factor 1 alpha-1 (eEF1A1) and elongation factor 1 alpha-2 (eEF1A2) have different but overlapping functional profiles. This may reflect the differential requirements of the cell-types in which they are expressed and is consistent with complex roles for these proteins that extend beyond delivery of tRNA to the ribosome. Methodology/Principal Findings: To investigate the structural basis of these functional differences, we created and validated comparative three-dimensional (3-D) models of eEF1A1 and eEF1A2 on the basis of the crystal structure of homologous eEF1A from yeast. The spatial location of amino acid residues that vary between the two proteins was thereby pinpointed, and their surface electrostatic and lipophilic properties were compared. None of the variations amongst buried amino acid residues are judged likely to have a major structural effect on the protein fold, or to affect domain-domain interactions. Nearly all the variant surface-exposed amino acid residues lie on one face of the protein, in two proximal but distinct sub-clusters. The result of previously performed mutagenesis in yeast may be interpreted as confirming the importance of one of these clusters in actin-bundling and filament disorganization. Interestingly, some variant residues lie in close proximity to, and in a few cases show differences in interactions with, residues previously inferred to be directly involved in binding GTP/GDP, eEF1B alpha and aminoacyl-tRNA. Additional sequence-based predictions, in conjunction with the 3-D models, reveal likely differences in phosphorylation sites that could reconcile some of the functional differences between the two proteins. Conclusions: The revelation and putative functional assignment of two distinct sub-clusters on the surface of the protein models should enable rational site-directed mutagenesis, including homologous reverse-substitution experiments, to map surface binding patches onto these proteins. The predicted variant-specific phosphorylation sites also provide a basis for experimental verification by mutagenesis. The models provide a structural framework for interpretation of the resulting functional analysis.			Soares, DC (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Mol Med Ctr,Med Genet Sect, Edinburgh, Midlothian, Scotland.	Dinesh.Soares@ed.ac.uk; C.Abbott@ed.ac.uk	Barlow, Paul N/G-2853-2011; Porteous, David J/C-7289-2013; Soares, Dinesh C/A-4425-2012; Abbott, Catherine M/C-7306-2013; Porteous, David/AAA-3446-2021	Porteous, David J/0000-0003-1249-6106; Soares, Dinesh C/0000-0001-7557-0495; Porteous, David/0000-0003-1249-6106; Abbott, Catherine/0000-0001-8794-7173	Wellcome Trust Funding Source: Medline; Medical Research Council [G9900991B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cao HX, 2009, BIOCHEM BIOPH RES CO, V380, P11, DOI 10.1016/j.bbrc.2008.12.171; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chambers DM, 2001, GENOMICS, V77, P145, DOI 10.1006/geno.2001.6626; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Eckhardt K, 2007, CELL PHYSIOL BIOCHEM, V20, P227, DOI 10.1159/000104169; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; HEIDEN W, 1993, J COMPUT AID MOL DES, V7, P503, DOI 10.1007/BF00124359; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jeganathan S, 2008, MOL CELL BIOL, V28, P4549, DOI 10.1128/MCB.00150-08; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kanibolotsky DS, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-4; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; KRYCH M, 1994, J BIOL CHEM, V269, P13273; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; LEE S, 1992, J BIOL CHEM, V267, P24064; Li R, 2006, ONCOGENE, V25, P2628, DOI 10.1038/sj.onc.1209289; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Lund A, 1996, GENOMICS, V36, P359, DOI 10.1006/geno.1996.0475; LUTSEP HL, 1989, J NEUROPATH EXP NEUR, V48, P519, DOI 10.1097/00005072-198909000-00003; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; Marco E, 2004, J MED CHEM, V47, P4439, DOI 10.1021/jm0306428; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mita K, 1997, GENE, V187, P259, DOI 10.1016/S0378-1119(96)00764-0; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; NAGASHIMA K, 1986, GENE, V45, P265; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Newbery HJ, 2005, J NEUROPATH EXP NEUR, V64, P295, DOI 10.1093/jnen/64.4.295; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; PIZZUTI A, 1993, BIOCHEM BIOPH RES CO, V197, P154, DOI 10.1006/bbrc.1993.2454; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDBAKEN MG, 1988, GENETICS, V120, P923; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tomlinson VAL, 2007, BRIT J CANCER, V96, P1613, DOI 10.1038/sj.bjc.6603748; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; Vitagliano L, 2004, BIOCHEMISTRY-US, V43, P6630, DOI 10.1021/bi0363331; Vitagliano L, 2001, EMBO J, V20, P5305, DOI 10.1093/emboj/20.19.5305; VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zemla A, 2001, PROTEINS, P13; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	79	50	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6315	10.1371/journal.pone.0006315	http://dx.doi.org/10.1371/journal.pone.0006315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636410	Green Submitted, gold, Green Published			2022-12-25	WOS:000268404900003
J	Zhang, Y; Shao, ZY; Zhai, ZW; Shen, C; Powell-Coffman, JA				Zhang, Yi; Shao, Zhiyong; Zhai, Zhiwei; Shen, Chuan; Powell-Coffman, Jo Anne			The HIF-1 Hypoxia-Inducible Factor Modulates Lifespan in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HEAT-SHOCK FACTOR; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; LONGEVITY; DAF-16; OXYGEN; GENE; RECEPTOR; PATHWAY	During normal development or during disease, animal cells experience hypoxic (low oxygen) conditions, and the hypoxia-inducible factor (HIF) transcription factors implement most of the critical changes in gene expression that enable animals to adapt to this stress. Here, we examine the roles of HIF-1 in post-mitotic aging. We examined the effects of HIF-1 overexpression and of hif-1 loss-of-function mutations on longevity in C. elegans, a powerful genetic system in which adult somatic cells are post-mitotic. We constructed transgenic lines that expressed varying levels of HIF-1 protein and discovered a positive correlation between HIF-1 expression levels and lifespan. The data further showed that HIF-1 acted in parallel to the SKN-1/NRF and DAF-16/FOXO transcription factors to promote longevity. HIF-1 over-expression also conferred increased resistance to heat and oxidative stress. We isolated and characterized additional hif-1 mutations, and we found that each of 3 loss-of-function mutations conferred increased longevity in normal lab culture conditions, but, unlike HIF-1 overexpression, a hif-1 deletion mutation did not extend the lifespan of daf-16 or skn-1 mutants. We conclude that HIF-1 overexpression and hif-1 loss-of-function mutations promote longevity by different pathways. These data establish HIF-1 as one of the key stress-responsive transcription factors that modulate longevity in C. elegans and advance our understanding of the regulatory networks that link oxygen homeostasis and aging.			Zhang, Y (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	japc@iastate.edu		Powell-Coffman, Jo Anne/0000-0001-9164-7499	NIGMS NIH HHS [R01 GM078424, R01 GM078424-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078424] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; CHEN D, 2009, PLOS GENET IN PRESS; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Janes KA, 2008, CELL, V135, P343, DOI 10.1016/j.cell.2008.08.034; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Jiang JC, 2004, EXP GERONTOL, V39, P999, DOI 10.1016/j.exger.2004.03.026; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Mehta Revi, 2009, SCIENCE; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Praitis V, 2001, GENETICS, V157, P1217; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shen C, 2006, GENETICS, V174, P1205, DOI 10.1534/genetics.106.063594; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; TRENT C, 1983, GENETICS, V104, P619; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054	48	124	137	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6348	10.1371/journal.pone.0006348	http://dx.doi.org/10.1371/journal.pone.0006348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633713	Green Published, gold, Green Submitted			2022-12-25	WOS:000268404800003
J	Zhu, WL; Yang, L; Du, ZM				Zhu, Wenliang; Yang, Lei; Du, Zhimin			Layered Functional Network Analysis of Gene Expression in Human Heart Failure	PLOS ONE			English	Article								Background: Although dilated cardiomyopathy (DCM) is a leading cause of heart failure (HF), the mechanism underlying DCM is not well understood. Previously, it has been demonstrated that an integrative analysis of gene expression and protein-protein interaction (PPI) networks can provide insights into the molecular mechanisms of various diseases. In this study we develop a systems approach by linking public available gene expression data on ischemic dilated cardiomyopathy (ICM), a main pathological form of DCM, with data from a layered PPI network. We propose that the use of a layered PPI network, as opposed to a traditional PPI network, provides unique insights into the mechanism of DCM. Methods: Four Cytoscape plugins including BionetBuilder, NetworkAnalyzer, Cerebral and GenePro were used to establish the layered PPI network, which was based upon validated subcellular protein localization data retrieved from the HRPD and Entrez Gene databases. The DAVID function annotation clustering tool was used for gene ontology (GO) analysis. Results: The assembled layered PPI network was divided into four layers: extracellular, plasma membrane, cytoplasm and nucleus. The characteristics of the gene expression pattern of the four layers were compared. In the extracellular and plasma membrane layers, there were more proteins encoded by down-regulated genes than by up-regulated genes, but in the other two layers, the opposite trend was found. GO analysis established that proteins encoded by up-regulated genes, reflecting significantly over-represented biological processes, were mainly located in the nucleus and cytoplasm layers, while proteins encoded by down-regulated genes were mainly located in the extracellular and plasma membrane layers. The PPI network analysis revealed that the Janus family tyrosine kinase-signal transducer and activator of transcription (Jak-STAT) signaling pathway might play an important role in the development of ICM and could be exploited as a therapeutic target of ICM. In addition, glycogen synthase kinase 3 beta (GSK3B) may also be a potential candidate target, but more evidence is required. Conclusion: This study illustrated that by incorporating subcellular localization information into a PPI network based analysis, one can derive greater insights into the mechanisms underlying ICM.	[Zhu, Wenliang; Yang, Lei; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Univ Key Lab Hei Long Jiang Prov, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Du, ZM (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Univ Key Lab Hei Long Jiang Prov, Harbin, Heilongjiang, Peoples R China.	dzm1956@126.com						Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Camargo A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001347; Chapman NM, 2008, CURR TOP MICROBIOL, V323, P275; Dreger M, 2003, MASS SPECTROM REV, V22, P27, DOI 10.1002/mas.10047; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hober S, 2008, CURR OPIN BIOTECH, V19, P30, DOI 10.1016/j.copbio.2007.11.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; ILIANA AC, 2007, BIOINFORMATICS, V23, P392; JAMES V, 2006, BIOINFORMATICS, V22, P2178; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; KUOCHEN C, 2003, BIOCHEM BIOPH RES CO, V311, P743; KUOCHEN C, 2008, NAT PROTOC, V3, P153; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; MAZEN K, 2007, J CARDIOVASC PHARM, V50, P126; MITRA E, 2008, ANNU REV PATHOL-MECH, V3, P127; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma UC, 2005, J MOL CELL CARDIOL, V38, P425, DOI 10.1016/j.yjmcc.2004.12.016; STEFAN EH, 2007, CIRC RES, V90, P1055; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wittchen F, 2007, J MOL MED, V85, P253, DOI 10.1007/s00109-006-0122-9; 2007, GENE EXPRESSION OMNI; ENTREZ GENE DATABASE	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6288	10.1371/journal.pone.0006288	http://dx.doi.org/10.1371/journal.pone.0006288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629191	Green Published, Green Submitted, gold			2022-12-25	WOS:000268318900002
J	Hashimoto, H; Miyamoto, R; Watanabe, N; Shiba, D; Ozato, K; Inoue, C; Kubo, Y; Koga, A; Jindo, T; Narita, T; Naruse, K; Ohishi, K; Nogata, K; Shin-I, T; Asakawa, S; Shimizu, N; Miyamoto, T; Mochizuki, T; Yokoyama, T; Hori, H; Takeda, H; Kohara, Y; Wakamatsu, Y				Hashimoto, Hisashi; Miyamoto, Rieko; Watanabe, Naoki; Shiba, Dai; Ozato, Kenjiro; Inoue, Chikako; Kubo, Yuko; Koga, Akihiko; Jindo, Tomoko; Narita, Takanori; Naruse, Kiyoshi; Ohishi, Kazuko; Nogata, Keiko; Shin-I, Tadasu; Asakawa, Shuichi; Shimizu, Nobuyoshi; Miyamoto, Tomotsune; Mochizuki, Toshio; Yokoyama, Takahiko; Hori, Hiroshi; Takeda, Hiroyuki; Kohara, Yuji; Wakamatsu, Yuko			Polycystic Kidney Disease in the Medaka (Oryzias latipes) pc Mutant Caused by a Mutation in the Gli-Similar3 (glis3) Gene	PLOS ONE			English	Article								Polycystic kidney disease (PKD) is a common hereditary disease in humans. Recent studies have shown an increasing number of ciliary genes that are involved in the pathogenesis of PKD. In this study, the Gli-similar3 (glis3) gene was identified as the causal gene of the medaka pc mutant, a model of PKD. In the pc mutant, a transposon was found to be inserted into the fourth intron of the pc/glis3 gene, causing aberrant splicing of the pc/glis3 mRNA and thus a putatively truncated protein with a defective zinc finger domain. pc/glis3 mRNA is expressed in the epithelial cells of the renal tubules and ducts of the pronephros and mesonephros, and also in the pancreas. Antisense oligonucleotide-mediated knockdown of pc/glis3 resulted in cyst formation in the pronephric tubules of medaka fry. Although three other glis family members, glis1a, glis1b and glis2, were found in the medaka genome, none were expressed in the embryonic or larval kidney. In the pc mutant, the urine flow rate in the pronephros was significantly reduced, which was considered to be a direct cause of renal cyst formation. The cilia on the surface of the renal tubular epithelium were significantly shorter in the pc mutant than in wild-type, suggesting that shortened cilia resulted in a decrease in driving force and, in turn, a reduction in urine flow rate. Most importantly, EGFP-tagged pc/glis3 protein localized in primary cilia as well as in the nucleus when expressed in mouse renal epithelial cells, indicating a strong connection between pc/glis3 and ciliary function. Unlike human patients with GLIS3 mutations, the medaka pc mutant shows none of the symptoms of a pancreatic phenotype, such as impaired insulin expression and/or diabetes, suggesting that the pc mutant may be suitable for use as a kidney-specific model for human GLIS3 patients.			Hashimoto, H (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	hsshsmt@bio.nagoya-u.ac.jp	Narita, Takanori/F-1092-2011	Narita, Takanori/0000-0003-0295-5014				Ainsworth C, 2007, NATURE, V448, P638, DOI 10.1038/448638a; Andoh T, 2007, GEN COMP ENDOCR, V151, P308, DOI 10.1016/j.ygcen.2007.01.015; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bubenshchikova E, 2008, CLONING STEM CELLS, V10, P443, DOI 10.1089/clo.2008.0014; Calvet JP, 2003, NAT GENET, V33, P113, DOI 10.1038/ng1078; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Fedorova S, 2008, DEV DYNAM, V237, P2342, DOI 10.1002/dvdy.21687; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hostetter CL, 2003, DEV DYNAM, V228, P514, DOI 10.1002/dvdy.10371; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Igarashi P, 2007, J AM SOC NEPHROL, V18, P1371, DOI 10.1681/ASN.2007030299; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kim SC, 2005, NUCLEIC ACIDS RES, V33, P6805, DOI 10.1093/nar/gki985; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Marshall WF, 2004, CURR BIOL, V14, pR913, DOI 10.1016/j.cub.2004.10.011; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mochizuki E, 2005, KIDNEY INT, V68, P23, DOI 10.1111/j.1523-1755.2005.00378.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nakashima M, 2002, MECH DEVELOP, V119, P21, DOI 10.1016/S0925-4773(02)00291-5; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Ogoshi M, 2006, PEPTIDES, V27, P3154, DOI 10.1016/j.peptides.2006.09.011; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SAEKI H, 1984, J UROLOGY, V132, P1165, DOI 10.1016/S0022-5347(17)50080-4; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; Schottenfeld J, 2007, DEVELOPMENT, V134, P1605, DOI 10.1242/dev.02827; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Taha D, 2003, AM J MED GENET A, V122A, P269, DOI 10.1002/ajmg.a.20267; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; YAMAGAMI K, 1972, DEV BIOL, V29, P343, DOI 10.1016/0012-1606(72)90074-7; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101	68	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6299	10.1371/journal.pone.0006299	http://dx.doi.org/10.1371/journal.pone.0006299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609364	Green Submitted, gold, Green Published			2022-12-25	WOS:000268119500018
J	Graf, J; Scherzer, R; Grunfeld, C; Imboden, J				Graf, Jonathan; Scherzer, Rebecca; Grunfeld, Carl; Imboden, John			Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article								Objective: C-reactive protein (CRP) levels>3 mg/L and>10 mg/L are associated with high and very high cardiovascular risk, respectively, in the general population. Because rheumatoid arthritis (RA) confers excess cardiovascular mortality, we determined the prevalence of these CRP levels among RA patients stratified on the basis of their RA disease activity. Methods: We evaluated physician and patient global assessments of disease activity, tender and swollen 28 joint counts, erythrocyte sedimentation rate (ESR), and CRP measured in a single clinic visit for 151 RA patients. Disease activity was calculated using the Clinical Disease Activity Index (CDAI) and the Disease Activity Score 28 Joints (DAS28-ESR and DAS28-CRP). Results: Median CRP level was 5.3 mg/L. 68% of patients had CRP>3 mg/L, and 25% had CRP>10 mg/L. Of those with 0-1 swollen joints (n = 56), or 0-1 tender joints (n = 81), 64% and 67%, respectively, had CRP>3 mg/L, and 23% and 20%, respectively, had CRP>10 mg/L. Of those with remission or mildly active disease by CDAI (n = 58), DAS28-ESR (n = 39), or DAS28-CRP (n = 70), 49-66% had CRP>3 mg/L, and 10-14% had CRP>10 mg/L. Of patients with moderate disease activity by CDAI (n = 51), DAS28-ESR (n = 78), or DAS28-CRP (n = 66), 67-73% had CRP>3 mg/L, and 25-33% had CRP>10 mg/L. Conclusion: Even among RA patients whose disease is judged to be controlled by joint counts or standardized disease scores, a substantial proportion have CRP levels that are associated high or very high risk for future cardiovascular events in the general population.			Graf, J (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	jimboden@medsfgh.ucsf.edu						Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Baldassarre D, 2008, ANN MED, V40, P21, DOI 10.1080/07853890701645399; Book C, 2005, J RHEUMATOL, V32, P430; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dessein PH, 2006, ARTHRITIS RHEUM-US, V54, P2765, DOI 10.1002/art.22053; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Fries JF, 1997, J RHEUMATOL, V24, P1697; Galarraga B, 2008, RHEUMATOLOGY, V47, P1780, DOI 10.1093/rheumatology/ken386; Giles JT, 2008, ARTHRITIS RHEUM, V58, P2632, DOI 10.1002/art.23766; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gonzalez-Gay MA, 2005, J RHEUMATOL, V32, P1219; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goodson NJ, 2005, ARTHRITIS RHEUM-US, V52, P2293, DOI 10.1002/art.21204; Hollander M, 1973, NONPARAMETRIC STAT M; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; *NAT I HLTH CLIN E, 2007, RHEUM ARTHR AD ET IN; Pahor A, 2006, RHEUMATOL INT, V27, P119, DOI 10.1007/s00296-006-0176-6; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Solomon DH, 2006, ANN RHEUM DIS, V65, P1608, DOI 10.1136/ard.2005.050377; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; van Halm VP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2045; Vaudo G, 2004, ANN RHEUM DIS, V63, P31, DOI 10.1136/ard.2003.007740; Wang TJ, 2002, CIRCULATION, V106, P1189, DOI 10.1161/01.CIR.0000032135.98011.C4; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253	42	58	60	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6242	10.1371/journal.pone.0006242	http://dx.doi.org/10.1371/journal.pone.0006242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606218	Green Submitted, Green Published, gold			2022-12-25	WOS:000268036000003
J	Nielsen, OH; Bjerrum, JT; Csillag, C; Nielsen, FC; Olsen, J				Nielsen, Ole Haagen; Bjerrum, Jacob Tveiten; Csillag, Claudio; Nielsen, Finn Cilius; Olsen, Jorgen			Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease	PLOS ONE			English	Article								Background: The development and course of Crohn's disease (CD) is related to both genetic and environmental factors. Smoking has been found to exacerbate the course of CD by increasing the risk of developing fistulas and strictures as well as the need for surgery, possibly because of an interaction between smoking or nicotine on macrophage function and the intestinal microvasculature. Several genes are involved in the pathogenesis of CD, and in this study the gene expression differences of the descending colonic mucosa were investigated in CD (smokers or never smokers) and controls (smokers or never smokers). Aim: To identify any difference in gene expression of the descending colonic mucosa between smoking and never-smoking CD patients (and controls) by determining genetic expression profiles from microarray analysis. Methods: Fifty-seven specimens were obtained by routine colonoscopy from the included material: CD smokers (n = 28) or never-smokers (n = 14) as compared to fifteen healthy controls (8 smokers and 7 never-smokers). RNA was isolated and gene expression assessed with Affymetrix GeneChip Human Genome U133 Plus 2.0. Data were analyzed by principal component analysis (PCA), Wilcoxon rank sum test and multiple linear regressions. Real-time (RT) PCR was subsequently applied to verify microarray results. Results: The PCA analysis showed no intrinsic clustering of smokers versus never-smokers. However, when Wilcoxon rank sum test corrected with Q values were performed, six known genes were significantly expressed differently in the inflamed CD smokers as compared to the inflamed CD never-smokers: ring finger protein 138 (RNF138), metalothionein 2A (MT2A) and six transmembrane epithelial antigen of the prostate 3 (STEAP3), SA hypertension-associated homolog, PGM2L1 and KCNJ2. The subsequent RT-PCR-analyses verified, however, that only RNF138, MT2A and STEAP3 were significantly upregulated in CD smokers in specimens with inflammatory activity of the descending colon. Conclusions: The present study demonstrates that the genes, RNF138, MT2A, and STEAP3 are differently expressed in the inflamed descending colon of smoking versus never-smoking CD patients, which might be of relevance for the poorer clinical course among CD smokers. Many gastroenterologists are still not totally aware of the benefits of smoking cessation in relation to CD, and do not put much effort into getting the patients to quit, therefore more information on the negative effects of smoking, seems warranted.			Nielsen, OH (corresponding author), Univ Copenhagen, Dept Gastroenterol, Med Sect, Herlev Hosp, Copenhagen, Denmark.	ohn@dadlnet.dk	Nielsen, Finn Cilius/AAA-4926-2020; Nielsen, Ole Haagen/AAK-2482-2021; Olsen, Jørgen/K-5355-2019	Nielsen, Ole Haagen/0000-0003-4612-8635; Olsen, Jørgen/0000-0003-1974-6446; Nielsen, Finn Cilius/0000-0002-9829-1031; Bjerrum, Jacob/0000-0002-6249-3889				Aldhous MC, 2008, INFLAMM BOWEL DIS, V14, P1469, DOI 10.1002/ibd.20523; Amoruso A, 2007, LIFE SCI, V81, P906, DOI 10.1016/j.lfs.2007.07.017; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bentley E, 2002, J CLIN PATHOL, V55, P955, DOI 10.1136/jcp.55.12.955; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Blokzijl H, 2008, J BIOL CHEM, V283, P35630, DOI 10.1074/jbc.M804374200; Bridger S, 2002, GUT, V51, P21, DOI 10.1136/gut.51.1.21; CALKINS BM, 1989, DIGEST DIS SCI, V34, P1841, DOI 10.1007/BF01536701; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cosnes J, 2004, BEST PRACT RES CL GA, V18, P481, DOI 10.1016/j.bpg.2003.12.003; Cosnes J, 2004, CLIN GASTROENTEROL H, V2, P41, DOI 10.1016/S1542-3565(03)00290-8; Csillag C, 2005, SCAND J GASTROENTERO, V40, P369, DOI 10.1080/00365520510012226; Csillag C, 2007, SCAND J GASTROENTERO, V42, P834, DOI 10.1080/00365520601127166; Csillag C, 2007, SCAND J GASTROENTERO, V42, P454, DOI 10.1080/00365520600976266; Csillag C, 2007, AM J PHYSIOL-GASTR L, V292, pG298, DOI 10.1152/ajpgi.00321.2006; Cui YP, 2003, BIOCHEM BIOPH RES CO, V302, P904, DOI 10.1016/S0006-291X(03)00122-0; Genser D, 1999, EUR J CLIN NUTR, V53, P675, DOI 10.1038/sj.ejcn.1600764; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halliwell B., 2006, CIGARETTE SMOKE OXID; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hatoum OA, 2003, GASTROENTEROLOGY, V125, P58, DOI 10.1016/S0016-5085(03)00699-1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson GJ, 2005, ALIMENT PHARM THER, V21, P921, DOI 10.1111/j.1365-2036.2005.02424.x; Karban A, 2007, WORLD J GASTROENTERO, V13, P2150, DOI 10.3748/wjg.v13.i15.2150; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lewis CM, 2007, J MED GENET, V44, P689, DOI 10.1136/jmg.2007.051672; Mahid SS, 2007, DIGEST DIS SCI, V52, P2897, DOI 10.1007/s10620-006-9624-0; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; McGilligan VE, 2007, INFLAMM BOWEL DIS, V13, P108, DOI 10.1002/ibd.20020; McKie AT, 2005, NAT GENET, V37, P1159, DOI 10.1038/ng1105-1159; MUNKHOLM P, 1992, SCAND J GASTROENTERO, V27, P609, DOI 10.3109/00365529209000127; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; Ronco AM, 2006, TOXICOLOGY, V223, P46, DOI 10.1016/j.tox.2006.03.002; Russel MGVM, 1998, INFLAMM BOWEL DIS, V4, P182, DOI 10.1097/00054725-199808000-00002; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; THOMAS GAO, 1995, J ROY COLL PHYS LOND, V29, P392; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; WAKEFIELD AJ, 1989, LANCET, V2, P1057; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang L, 2007, BIOCONJUGATE CHEM, V18, P610, DOI 10.1021/bc060365u; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Yamamoto T, 2005, WORLD J GASTROENTERO, V11, P3971, DOI 10.3748/wjg.v11.i26.3971; Yang F, 2007, PROTEIN EXPRES PURIF, V53, P186, DOI 10.1016/j.pep.2006.12.007	49	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6210	10.1371/journal.pone.0006210	http://dx.doi.org/10.1371/journal.pone.0006210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603079	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035700003
J	Figueroa-Romero, C; Iniguez-Lluhi, JA; Stadler, J; Chang, CR; Arnoult, D; Keller, PJ; Hong, Y; Blackstone, C; Feldman, EL				Figueroa-Romero, Claudia; Iniguez-Lluhi, Jorge A.; Stadler, Julia; Chang, Chuang-Rung; Arnoult, Damien; Keller, Peter J.; Hong, Yu; Blackstone, Craig; Feldman, Eva L.			SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle	FASEB JOURNAL			English	Article						Ubc9; small ubiquitin-like modifier; post-translational modification	DYNAMIN-RELATED PROTEIN; SUMO E3 LIGASE; COATED VESICLE FORMATION; DOMINANT OPTIC ATROPHY; MAMMALIAN-CELLS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; OUTER-MEMBRANE; GTPASE DRP1; MORPHOLOGY	Dynamin-related protein (Drp) 1 is a key regulator of mitochondrial fission and is composed of GTP-binding, Middle, insert B, and C-terminal GTPase effector (GED) domains. Drp1 associates with mitochondrial fission sites and promotes membrane constriction through its intrinsic GTPase activity. The mechanisms that regulate Drp1 activity remain poorly understood but are likely to involve reversible post-translational modifications, such as conjugation of small ubiquitin-like modifier (SUMO) proteins. Through a detailed analysis, we find that Drp1 interacts with the SUMO-conjugating enzyme Ubc9 via multiple regions and demonstrate that Drp1 is a direct target of SUMO modification by all three SUMO isoforms. While Drp1 does not harbor consensus SUMOylation sequences, our analysis identified2 clusters of lysine residues within the B domain that serve as noncanonical conjugation sites. Although initial analysis indicates that mitochondrial recruitment of ectopically expressed Drp1 in response to staurosporine is unaffected by loss of SUMOylation, we find that Drp1 SUMOylation is enhanced in the context of the K38A mutation. This dominant-negative mutant, which is deficient in GTP binding and hydrolysis, does not associate with mitochondria and prevents normal mitochondrial fission. This finding suggests that SUMOylation of Drp1 is linked to its activity cycle and is influenced by Drp1 localization.-Figueroa-Romero, C., Iniguez-Lluhi, J. A., Stadler, J., Chang, C.-R., Arnoult, D., Keller, P. J., Hong, Y., Blackstone, C., Feldman, E. L. SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J. 23, 3917-3927 (2009). www.fasebj.org	[Figueroa-Romero, Claudia; Keller, Peter J.; Hong, Yu; Feldman, Eva L.] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI 48109 USA; [Iniguez-Lluhi, Jorge A.] Univ Michigan, Dept Pharmacol, Sch Med, Ann Arbor, MI 48109 USA; [Stadler, Julia; Chang, Chuang-Rung; Blackstone, Craig] Natl Inst Neurol Disorders & Stroke, Cellular Neurol Unit, Neurogenet Branch, NIH, Bethesda, MD USA; [Arnoult, Damien] INSERM, U542, Villejuif, France; [Arnoult, Damien] Univ Paris 11, Hop Paul Brousse, Villejuif, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Sch Med, 5017 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	efeldman@umich.edu	Chang, Chuang-Rung/C-1815-2012; Arnoult, Damien/R-2032-2018	Chang, Chuang-Rung/0000-0002-6124-5429; Feldman, Eva/0000-0002-9162-2694; Figueroa-Romero, Claudia/0000-0001-7546-4190; Iniguez-Lluhi, Jorge/0000-0001-7010-089X	U. S. Public Health Service [DK61656]; Program for Neurology Research and Discovery; A. Alfred Taubman Medical Research Institute; U. S. National Institutes of Health (NIH) [NIHU01 DK076160]; Intramural Research Program of the National Institute of Neurological Disorders and Stroke (NINDS); Agence Nationale de La Recherche sur le SIDA; Fondation pour La Recherche Medicale; Ligue contre le Cancer; Universite Paris Sud; National Institute of Diabetes and Digestive and Kidney Diseases [NIH5P60 DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK076160, P60DK020572, R56DK061656, R01DK061656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003025] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Program for Neurology Research and Discovery; A. Alfred Taubman Medical Research Institute; U. S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Agence Nationale de La Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); Fondation pour La Recherche Medicale(Fondation pour la Recherche Medicale); Ligue contre le Cancer(Ligue nationale contre le cancer); Universite Paris Sud; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U. S. Public Health Service grant DK61656 (J. A. I.), the Program for Neurology Research and Discovery, the A. Alfred Taubman Medical Research Institute, U. S. National Institutes of Health (NIH) grant NIHU01 DK076160 (C. F.-R., E. L. F., Y. H., P. J. K.), and in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke (NINDS), NIH (J. S., C.-R. C., C. B.) as well as the Agence Nationale de La Recherche sur le SIDA, Fondation pour La Recherche Medicale, the Ligue contre le Cancer, and the Universite Paris Sud (D. A.). This work utilized the sequencing core of the Michigan Diabetes Research and Training Center, funded by National Institute of Diabetes and Digestive and Kidney Diseases grant NIH5P60 DK20572. The authors also thank J. Nagle and D. Kauffman (NINDS DNA Sequencing Facility) for DNA sequencing.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baloh RH, 2008, NEUROSCIENTIST, V14, P12, DOI 10.1177/1073858407307354; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Ghafourifar P, 2008, FRONT BIOSCI-LANDMRK, V13, P3116, DOI 10.2741/2913; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Kamimoto T, 1998, J BIOL CHEM, V273, P1044, DOI 10.1074/jbc.273.2.1044; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Li MY, 2005, J MOL MED, V83, P504, DOI 10.1007/s00109-005-0645-5; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031; Mishra RK, 2004, J BIOL CHEM, V279, P31445, DOI 10.1074/jbc.M402911200; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; MUKHERJEE S, 2009, J BIOL CHEM; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Pountney DL, 2008, ACTA NEUROPATHOL, V116, P603, DOI 10.1007/s00401-008-0437-4; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; Zhang FP, 2008, MOL CELL BIOL, V28, P5381, DOI 10.1128/MCB.00651-08; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	83	140	146	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2009	23	11					3917	3927		10.1096/fj.09-136630	http://dx.doi.org/10.1096/fj.09-136630			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19638400	Green Published, Green Submitted			2022-12-25	WOS:000271272500027
J	Larson, ET; Parussini, F; Huynh, MH; Giebel, JD; Kelley, AM; Zhang, L; Bogyo, M; Merritt, EA; Carruthers, VB				Larson, Eric T.; Parussini, Fabiola; Huynh, My-Hang; Giebel, Jonathan D.; Kelley, Angela M.; Zhang, Li; Bogyo, Matthew; Merritt, Ethan A.; Carruthers, Vern B.			Toxoplasma gondii Cathepsin L Is the Primary Target of the Invasion-inhibitory Compound Morpholinurea-leucyl-homophenyl-vinyl Sulfone Phenyl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; STRUCTURE VALIDATION; RHOPTRY ORGANELLES; CRYSTAL-STRUCTURE; PARASITE; SECRETION; SURVIVAL; REVEALS; SYSTEM; POTENT	The protozoan parasite Toxoplasma gondii relies on posttranslational modification, including proteolysis, of proteins required for recognition and invasion of host cells. We have characterized the T. gondii cysteine protease cathepsin L (TgCPL), one of five cathepsins found in the T. gondii genome. We show that TgCPL is the primary target of the compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl (LHVS), which was previously shown to inhibit parasite invasion by blocking the release of invasion proteins from microneme secretory organelles. As shown by fluorescently labeled LHVS and TgCPL-specific antibodies, TgCPL is associated with a discrete vesicular structure in the apical region of extracellular parasites but is found in multiple puncta throughout the cytoplasm of intracellular replicating parasites. LHVS fails to label cells lacking TgCPL due to targeted disruption of the TgCPL gene in two different parasite strains. We present a structural model for the inhibition of TgCPL by LHVS based on a 2.0 angstrom resolution crystal structure of TgCPL in complex with its propeptide. We discuss possible roles for TgCPL as a protease involved in the degradation or limited proteolysis of parasite proteins involved in invasion.	[Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Larson, Eric T.; Kelley, Angela M.; Zhang, Li; Merritt, Ethan A.] Univ Washington, Med Struct Genom Pathogen Protozoa Consortium, Seattle, WA 98195 USA; [Larson, Eric T.; Kelley, Angela M.; Zhang, Li; Merritt, Ethan A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Parussini, Fabiola] Univ Vermont, Burlington, VT 05405 USA; [Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; Stanford University	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Larson, Eric T./0000-0002-2862-4291; Carruthers, Vern/0000-0001-6859-8895; Bogyo, Matthew/0000-0003-3753-4412	National Institutes of Health [RR020843, GM64655, AI067921, AI063263]; Stanley Medical Research Institute [04R-796]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063263, P01AI067921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RR020843 (to M. B.), GM64655 (to E. A. M.), AI067921 (to E. A. M.), and AI063263 (to V. B. C.). This work was also supported by Stanley Medical Research Institute Grant 04R-796 (to V. B. C). The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and NIGMS.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, BIOCHEM J, V315, P85; Brydges SD, 2008, BIOL CELL, V100, P253, DOI 10.1042/BC20070076; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Chowdhury SF, 2008, J MED CHEM, V51, P1361, DOI 10.1021/jm701190v; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Hoppe HC, 2000, NAT CELL BIOL, V2, P449, DOI 10.1038/35017090; Huang R, 2009, MOL BIOCHEM PARASIT, V164, P86, DOI 10.1016/j.molbiopara.2008.11.012; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ljunggren A, 2007, J MOL BIOL, V371, P137, DOI 10.1016/j.jmb.2007.05.005; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; McGrath ME, 1997, NAT STRUCT BIOL, V4, P105, DOI 10.1038/nsb0297-105; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; McMartin C, 1997, J COMPUT AID MOL DES, V11, P333, DOI 10.1023/A:1007907728892; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Ngo HM, 2003, J BIOL CHEM, V278, P5343, DOI 10.1074/jbc.M208291200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Que XC, 2007, J BIOL CHEM, V282, P4994, DOI 10.1074/jbc.M606764200; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Teo CF, 2007, ANTIMICROB AGENTS CH, V51, P679, DOI 10.1128/AAC.01059-06; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	51	47	47	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26839	26850		10.1074/jbc.M109.003780	http://dx.doi.org/10.1074/jbc.M109.003780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19596863	Green Published, hybrid			2022-12-25	WOS:000269969600065
J	Mertz, JA; Chadee, AB; Byun, H; Russell, R; Dudley, JP				Mertz, Jennifer A.; Chadee, Amanda B.; Byun, Hyewon; Russell, Rick; Dudley, Jaquelin P.			Mapping of the Functional Boundaries and Secondary Structure of the Mouse Mammary Tumor Virus Rem-responsive Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENV MESSENGER-RNA; CONSTITUTIVE TRANSPORT ELEMENT; INFECTIOUS-ANEMIA VIRUS; B LEUKEMOGENIC VIRUS; HTLV-I REX; NUCLEAR EXPORT; GENE-EXPRESSION; CONFORMATIONAL SWITCH; TARGET SEQUENCE; SIGNAL PEPTIDE	Mouse mammary tumor virus (MMTV) is a complex retrovirus that encodes at least three regulatory and accessory proteins, including Rem. Rem is required for nuclear export of unspliced viral RNA and efficient expression of viral proteins. Our previous data indicated that sequences at the envelope-3' long terminal repeat junction are required for proper export of viral RNA. To further map the Rem-responsive element (RmRE), reporter vectors containing various portions of the viral envelope gene and the 3' long terminal repeat were tested in the presence and absence of Rem in transient transfection assays. A 476-bp fragment that spans the envelope-long terminal repeat junction had activity equivalent to the entire 3'-end of the mouse mammary tumor virus genome, but further deletions at the 5'- or 3'- ends reduced Rem responsiveness. RNase structure mapping of the full-length RmRE and a 3'-truncation suggested multiple domains with local base pairing and intervening single-stranded segments. A secondary structure model constrained by these data is reminiscent of the RNA response elements of other complex retroviruses, with numerous local stem-loops and long-range base pairs near the 5'- and 3'- boundaries, and differs substantially from an earlier model generated without experimental constraints. Covariation analysis provides limited support for basic features of our model. Reporter assays in human and mouse cell lines revealed similar boundaries, suggesting that the RmRE does not require cell type-specific proteins to form a functional structure.	[Mertz, Jennifer A.; Byun, Hyewon; Dudley, Jaquelin P.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Chadee, Amanda B.; Russell, Rick] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Mertz, Jennifer A.; Chadee, Amanda B.; Byun, Hyewon; Russell, Rick; Dudley, Jaquelin P.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dudley, JP (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, 1 Univ Stn,A5000,NMS 2-104, Austin, TX 78712 USA.	jdudley@uts.cc.utexas.edu	Russell, Rick/A-9256-2012		National Institutes of Health [CA-116813, GM-070456]; NATIONAL CANCER INSTITUTE [R01CA116813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-116813 ( to J.P.D.) and GM-070456 ( to R. R.).	AHMED YF, 1990, GENE DEV, V4, P1014, DOI 10.1101/gad.4.6.1014; ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Askjaer P, 1998, J BIOL CHEM, V273, P11463, DOI 10.1074/jbc.273.19.11463; Belshan M, 2000, MOL CELL BIOL, V20, P3550, DOI 10.1128/MCB.20.10.3550-3557.2000; Belshan M, 1998, J VIROL, V72, P4421, DOI 10.1128/JVI.72.5.4421-4426.1998; BERGMAN AC, 1994, VIROLOGY, V204, P420, DOI 10.1006/viro.1994.1547; Bhadra S, 2006, PLOS PATHOG, V2, P1134, DOI 10.1371/journal.ppat.0020128; BOGERD H, 1993, J VIROL, V67, P2496, DOI 10.1128/JVI.67.5.2496-2502.1993; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; Caporale M, 2009, J VIROL, V83, P4591, DOI 10.1128/JVI.01833-08; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; ENGLAND TE, 1978, NATURE, V275, P560, DOI 10.1038/275560a0; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Ernst RK, 1997, RNA, V3, P210; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; GOLOVKINA TV, 1992, CELL, V69, P637, DOI 10.1016/0092-8674(92)90227-4; Gosser Y, 2001, NAT STRUCT BIOL, V8, P146, DOI 10.1038/84138; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HANLY SM, 1989, GENE DEV, V3, P1534, DOI 10.1101/gad.3.10.1534; HELD W, 1993, CELL, V74, P529, DOI 10.1016/0092-8674(93)80054-I; HOLLAND SM, 1990, J VIROL, V64, P5966, DOI 10.1128/JVI.64.12.5966-5975.1990; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Kusuhara K, 1999, J VIROL, V73, P8112, DOI 10.1128/JVI.73.10.8112-8119.1999; LAWRENCE JB, 1991, NEW BIOL, V3, P1220; Lee JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002272; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; MADORE SJ, 1994, VIROLOGY, V202, P186, DOI 10.1006/viro.1994.1334; Magin C, 2000, VIROLOGY, V274, P11, DOI 10.1006/viro.2000.0438; Magin-Lachmann C, 2001, J VIROL, V75, P10359, DOI 10.1128/JVI.75.21.10359-10371.2001; MAJORS JE, 1983, J VIROL, V47, P495, DOI 10.1128/JVI.47.3.495-504.1983; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; Mertz JA, 2005, J VIROL, V79, P14737, DOI 10.1128/JVI.79.23.14737-14747.2005; Mertz JA, 2001, J VIROL, V75, P2174, DOI 10.1128/JVI.75.5.2174-2184.2001; Mertz JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-10; MOORE R, 1987, J VIROL, V61, P480, DOI 10.1128/JVI.61.2.480-490.1987; Mullner M, 2008, NUCLEIC ACIDS RES, V36, P6284, DOI 10.1093/nar/gkn608; Mustafa F, 2003, J VIROL, V77, P3866, DOI 10.1128/JVI.77.6.3866-3870.2003; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; OLSEN HS, 1990, GENE DEV, V4, P1357, DOI 10.1101/gad.4.8.1357; Paca RE, 2000, J VIROL, V74, P9507, DOI 10.1128/JVI.74.20.9507-9514.2000; Payne SL, 2001, CURR PROTEIN PEPT SC, V2, P381, DOI 10.2174/1389203013381008; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; Rizvi TA, 2009, VIROLOGY, V385, P464, DOI 10.1016/j.virol.2008.12.027; SALMONS B, 1985, VIROLOGY, V144, P101, DOI 10.1016/0042-6822(85)90309-5; SEIKI M, 1988, P NATL ACAD SCI USA, V85, P7124, DOI 10.1073/pnas.85.19.7124; TOYOSHIMA H, 1990, J VIROL, V64, P2825, DOI 10.1128/JVI.64.6.2825-2832.1990; Yang J, 2000, RNA, V6, P1551, DOI 10.1017/S135583820000100X; Yang J, 1999, RNA, V5, P1645, DOI 10.1017/S1355838299991616; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25642	25652		10.1074/jbc.M109.012476	http://dx.doi.org/10.1074/jbc.M109.012476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632991	Green Published, hybrid			2022-12-25	WOS:000269738000022
J	Betzenhauser, MJ; Fike, JL; Wagner, LE; Yule, DI				Betzenhauser, Matthew J.; Fike, Jenna L.; Wagner, Larry E., II; Yule, David I.			Protein Kinase A Increases Type-2 Inositol 1,4,5-Trisphosphate Receptor Activity by Phosphorylation of Serine 937	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; TRISPHOSPHATE RECEPTORS; ACINAR-CELLS; IP3 RECEPTOR; MEDIATED PHOSPHORYLATION; CYTOSOLIC CALCIUM; ELEMENTARY EVENTS; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; AR4-2J CELLS	Protein kinase A (PKA) phosphorylation of inositol 1,4,5-trisphosphate receptors (InsP(3)Rs) represents a mechanism for shaping intracellular Ca2+ signals following a concomitant elevation in cAMP. Activation of PKA results in enhanced Ca2+ release in cells that express predominantly InsP(3)R2. PKA is known to phosphorylate InsP(3)R2, but the molecular determinants of this effect are not known. We have expressed mouse InsP(3)R2 in DT40-3KO cells that are devoid of endogenous InsP(3)R and examined the effects of PKA phosphorylation on this isoform in unambiguous isolation. Activation of PKA increased Ca2+ signals and augmented the single channel open probability of InsP(3)R2. A PKA phosphorylation site unique to the InsP(3)R2 was identified at Ser(937). The enhancing effects of PKA activation on this isoform required the phosphorylation of Ser(937), since replacing this residue with alanine eliminated the positive effects of PKA activation. These results provide a mechanism responsible for the enhanced Ca2+ signaling following PKA activation in cells that express predominantly InsP(3)R2.	[Betzenhauser, Matthew J.; Fike, Jenna L.; Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	David_Yule@urmc.rochester.edu			National Institutes of Health [RO1-DK054568, RO1-DE016999]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016999, T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK054568 and RO1-DE016999 (to D. I. Y.).	Arguin G, 2007, J ENDOCRINOL, V192, P659, DOI 10.1677/JOE-06-0179; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; HAJNOCZKY G, 1993, BIOCHEM J, V293, P413, DOI 10.1042/bj2930413; Hernandez E, 2007, J BIOL CHEM, V282, P10057, DOI 10.1074/jbc.M700746200; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Hirono C, 1998, J MEMBRANE BIOL, V164, P197, DOI 10.1007/s002329900405; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Parker I, 1996, CELL CALCIUM, V20, P105, DOI 10.1016/S0143-4160(96)90100-1; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Pieper AA, 2001, NEUROSCIENCE, V102, P433, DOI 10.1016/S0306-4522(00)00470-X; Regimbald-Dumas Y, 2007, J CELL BIOCHEM, V101, P609, DOI 10.1002/jcb.21221; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sheppard CA, 1997, J NEUROCHEM, V68, P2317; Soulsby MD, 2007, CELL CALCIUM, V42, P261, DOI 10.1016/j.ceca.2006.12.002; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Soulsby MD, 2004, FEBS LETT, V557, P181, DOI 10.1016/S0014-5793(03)01487-X; Straub SV, 2004, BIOL RES, V37, P593; Straub SV, 2002, J BIOL CHEM, V277, P31949, DOI 10.1074/jbc.M204318200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Swatton JE, 2002, J BIOL CHEM, V277, P17571, DOI 10.1074/jbc.M200524200; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; WALAAS SI, 1986, J NEUROSCI, V6, P954; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zhang XJ, 1999, BIOCHEM J, V340, P519, DOI 10.1042/0264-6021:3400519	62	50	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25116	25125		10.1074/jbc.M109.010132	http://dx.doi.org/10.1074/jbc.M109.010132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608738	Green Published, hybrid			2022-12-25	WOS:000269734000046
J	Caohuy, H; Jozwik, C; Pollard, HB				Caohuy, Hung; Jozwik, Catherine; Pollard, Harvey B.			Rescue of Delta F508-CFTR by the SGK1/Nedd4-2 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL NA+ CHANNEL; UBIQUITIN LIGASE NEDD4-2; INDUCIBLE KINASE SGK1; CYSTIC-FIBROSIS; SODIUM-CHANNEL; RNA INTERFERENCE; IMMATURE CFTR; CELL-LINE; SERUM	The most common mutation in cystic fibrosis (CF) is Delta F508, which is associated with failure of the mutant cystic fibrosis transmembrane conductance regulator (CFTR) to traffic to the plasma membrane. By a still unknown mechanism, the loss of correctly trafficked Delta F508-CFTR results in an excess of the epithelial sodium channel (ENaC) on the apical plasma membrane. ENaC trafficking is known to be regulated by a signaling pathway involving the glucocorticoid receptor, the serum-and glucocorticoid-regulated kinase SGK1, and the ubiquitin E3 ligase Nedd4-2. We show here that dexamethasone rescues functional expression of Delta F508-CFTR. The half-life of Delta F508-CFTR is also dramatically enhanced. Dexamethasone-activated Delta F508-CFTR rescue is blocked either by the glucocorticoid receptor antagonist RU38486 or by the phosphatidylinositol 3-kinase inhibitor LY294002. Co-immunoprecipitation studies indicate that Nedd4-2 binds to both wild-type-and Delta F508-CFTR. These complexes are inhibited by dexamethasone treatment, and CFTR ubiquitination is concomitantly decreased. We further show that knockdown of Nedd4-2 by small interfering RNA also corrects Delta F508-CFTR trafficking. Conversely, knockdown of SGK1 by small interfering RNA completely blocks dexamethasone-activated Delta F508-CFTR rescue. These data suggest that the SGK1/Nedd4-2 signaling pathway regulates both CFTR and ENaC trafficking in CF epithelial cells.	[Caohuy, Hung; Jozwik, Catherine; Pollard, Harvey B.] Uniformed Serv Univ Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Caohuy, H (corresponding author), 4301 Jones Bridge Rd,Bldg B, Bethesda, MD 20814 USA.	hcaohuy@usuhs.mil			National Institutes of Health [NO1-HV 28287, RO1-DK-35051]; Cystic Fibrosis Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants NO1-HV 28287 and RO1-DK-35051 (to H.B.P.). This work was also supported by the Cystic Fibrosis Foundation (to H.B.P.).	Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Bradbury Neil A., 1999, Physiological Reviews, V79, pS175; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Henke G, 2004, J CELL PHYSIOL, V199, P194, DOI 10.1002/jcp.10430; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Jilling T, 1997, INT REV CYTOL, V172, P193, DOI 10.1016/S0074-7696(08)62361-X; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Lang F, 2003, CELL PHYSIOL BIOCHEM, V13, P41, DOI 10.1159/000070248; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lukacs GL, 1997, BIOCHEM J, V328, P353; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Pondugula SR, 2004, AM J PHYSIOL-RENAL, V286, pF1127, DOI 10.1152/ajprenal.00387.2003; Quesnell RR, 2007, AM J PHYSIOL-CELL PH, V292, pC1739, DOI 10.1152/ajpcell.00369.2006; Rauz S, 2003, INVEST OPHTH VIS SCI, V44, P1643, DOI 10.1167/iovs.02-0514; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Thomas CP, 2004, AM J PHYSIOL-LUNG C, V287, pL843, DOI 10.1152/ajplung.00340.2003; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; West MR, 1996, ANAL BIOCHEM, V241, P51, DOI 10.1006/abio.1996.0377; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	47	67	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25241	25253		10.1074/jbc.M109.035345	http://dx.doi.org/10.1074/jbc.M109.035345			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19617352	Green Published, hybrid			2022-12-25	WOS:000269734000058
J	Buelow, B; Uzunparmak, B; Paddock, M; Scharenberg, AM				Buelow, Ben; Uzunparmak, Burak; Paddock, Marcia; Scharenberg, Andrew M.			Structure/Function Analysis of PARP-1 in Oxidative and Nitrosative Stress-Induced Monomeric ADPR Formation	PLOS ONE			English	Article								Poly adenosine diphosphate-ribose polymerase-1 (PARP-1) is a multifunctional enzyme that is involved in two major cellular responses to oxidative and nitrosative (O/N) stress: detection and response to DNA damage via formation of protein-bound poly adenosine diphosphate-ribose ( PAR), and formation of the soluble 2(nd) messenger monomeric adenosine diphosphate-ribose (mADPR). Previous studies have delineated specific roles for several of PARP-1's structural domains in the context of its involvement in a DNA damage response. However, little is known about the relationship between the mechanisms through which PARP-1 participates in DNA damage detection/ response and those involved in the generation of monomeric ADPR. To better understand the relationship between these events, we undertook a structure/function analysis of PARP-1 via reconstitution of PARP-1 deficient DT40 cells with PARP-1 variants deficient in catalysis, DNA binding, auto-PARylation, and PARP-1's BRCT protein interaction domain. Analysis of responses of the respective reconstituted cells to a model O/N stressor indicated that PARP-1 catalytic activity, DNA binding, and auto-PARylation are required for PARP-dependent mADPR formation, but that BRCT-mediated interactions are dispensable. As the BRCT domain is required for PARP-dependent recruitment of XRCC1 to sites of DNA damage, these results suggest that DNA repair and monomeric ADPR 2(nd) messenger generation are parallel mechanisms through which PARP-1 modulates cellular responses to O/N stress.			Buelow, B (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	andrewms@u.washington.edu		Uzunparmak, Burak/0000-0002-9791-8904; , Burak/0000-0001-7929-5902	NIGMS NIH HHS [T32 GM007266, R01 GM064316, R01GM64316] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, R01GM064316] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMEYER M, 2009, NUCL ACIDS RES; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Audebert M, 2008, BIOCHEM BIOPH RES CO, V369, P982, DOI 10.1016/j.bbrc.2007.11.132; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; DAWSON TM, 1994, PROG BRAIN RES, V103, P365; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Duriez PJ, 1997, BBA-GEN SUBJECTS, V1334, P65, DOI 10.1016/S0304-4165(96)00077-3; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; HILLYARD D, 1973, J CELL PHYSIOL, V82, P165, DOI 10.1002/jcp.1040820205; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; JACOBSON EL, 1994, MOL CELL BIOCHEM, V138, P207, DOI 10.1007/BF00928463; Jacobson MK, 1999, TRENDS BIOCHEM SCI, V24, P415, DOI 10.1016/S0968-0004(99)01481-4; KAWAICHI M, 1981, J BIOL CHEM, V256, P9483; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; KUPPER JH, 1995, MOL CELL BIOL, V15, P3154; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; PETERSON AR, 1974, CANCER RES, V34, P1600; PETERSON AR, 1974, CANCER RES, V34, P1592; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; RECHSTEINER M, 1976, J CELL PHYSIOL, V88, P207, DOI 10.1002/jcp.1040880210; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Song Y, 2008, J BIOMOL SCREEN, V13, P54, DOI 10.1177/1087057107310986; UCHIDA K, 1993, GENE, V137, P293, DOI 10.1016/0378-1119(93)90023-V; UCHIDA K, 1987, BIOCHEM BIOPH RES CO, V148, P617, DOI 10.1016/0006-291X(87)90921-1; Uchida M, 2001, MUTAT RES-FUND MOL M, V477, P89, DOI 10.1016/S0027-5107(01)00110-5; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813	48	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6339	10.1371/journal.pone.0006339	http://dx.doi.org/10.1371/journal.pone.0006339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641624	gold, Green Submitted, Green Published			2022-12-25	WOS:000268494500004
J	Natt, D; Lindqvist, N; Stranneheim, H; Lundeberg, J; Torjesen, PA; Jensen, P				Naett, Daniel; Lindqvist, Niclas; Stranneheim, Henrik; Lundeberg, Joakim; Torjesen, Peter A.; Jensen, Per			Inheritance of Acquired Behaviour Adaptations and Brain Gene Expression in Chickens	PLOS ONE			English	Article							EPIGENETIC VARIATION; RED JUNGLEFOWL; STRESS; HORMONES; TRANSMISSION; PLASTICITY; OBESITY; HEALTH; RATS; TOOL	Background: Environmental challenges may affect both the exposed individuals and their offspring. We investigated possible adaptive aspects of such cross-generation transmissions, and hypothesized that chronic unpredictable food access would cause chickens to show a more conservative feeding strategy and to be more dominant, and that these adaptations would be transmitted to the offspring. Methodology/Principal Findings: Parents were raised in an unpredictable (UL) or in predictable diurnal light rhythm (PL, 12:12 h light: dark). In a foraging test, UL birds pecked more at freely available, rather than at hidden and more attractive food, compared to birds from the PL group. Female offspring of UL birds, raised in predictable light conditions without parental contact, showed a similar foraging behavior, differing from offspring of PL birds. Furthermore, adult offspring of UL birds performed more food pecks in a dominance test, showed a higher preference for high energy food, survived better, and were heavier than offspring of PL parents. Using cDNA microarrays, we found that the differential brain gene expression caused by the challenge was mirrored in the offspring. In particular, several immunoglobulin genes seemed to be affected similarly in both UL parents and their offspring. Estradiol levels were significantly higher in egg yolk from UL birds, suggesting one possible mechanism for these effects. Conclusions/Significance: Our findings suggest that unpredictable food access caused seemingly adaptive responses in feeding behavior, which may have been transmitted to the offspring by means of epigenetic mechanisms, including regulation of immune genes. This may have prepared the offspring for coping with an unpredictable environment.			Natt, D (corresponding author), Linkoping Univ, IFM Biol Div Zool, Linkoping, Sweden.	perje@ifm.liu.se	Nätt, Daniel/E-9693-2011; Natt, Daniel/AAR-3928-2021	Nätt, Daniel/0000-0002-3801-5705; Natt, Daniel/0000-0001-9182-9401				Appleby M.C., 2004, POULTRY BEHAV WELFAR; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; BATESON M, 2003, INTERVAL TIMING OPTI, P113; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Cameron NM, 2008, J NEUROENDOCRINOL, V20, P795, DOI 10.1111/j.1365-2826.2008.01725.x; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Crews D, 2008, FRONT NEUROENDOCRIN, V29, P344, DOI 10.1016/j.yfrne.2008.01.003; Downing JA, 2008, PHYSIOL BEHAV, V95, P381, DOI 10.1016/j.physbeh.2008.07.001; Dufty AM, 2002, TRENDS ECOL EVOL, V17, P190, DOI 10.1016/S0169-5347(02)02498-9; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; FENG H, 1993, PHYSIOL BEHAV, V53, P215, DOI 10.1016/0031-9384(93)90196-M; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jablonka E., 2007, BEHAV BRAIN SCI, V30, P365; Jablonka E, 2007, BEHAV BRAIN SCI, V30, P353, DOI 10.1017/S0140525X07002221; Janczak AM, 2006, APPL ANIM BEHAV SCI, V96, P69, DOI 10.1016/j.applanim.2005.04.020; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Levay EA, 2008, BEHAV BRAIN RES, V191, P164, DOI 10.1016/j.bbr.2008.03.021; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; OPSTAD PK, 1983, EUR J APPL PHYSIOL O, V51, P97, DOI 10.1007/BF00952542; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; ROWLAND NE, 1976, SCIENCE, V191, P310, DOI 10.1126/science.1246617; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-208; Savolainen P, 2005, CYTOGENET GENOME RES, V111, P79, DOI 10.1159/000085674; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwarz JM, 2008, J NEUROCHEM, V105, P1561, DOI 10.1111/j.1471-4159.2008.05384.x; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Solomon MB, 2007, AM J PHYSIOL-REG I, V292, pR283, DOI 10.1152/ajpregu.00330.2006	44	62	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6405	10.1371/journal.pone.0006405	http://dx.doi.org/10.1371/journal.pone.0006405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636381	Green Published, gold, Green Submitted			2022-12-25	WOS:000268404900024
J	Chi, YM; Etienne-Cummings, R; Cauwenberghs, G				Chi, Yu M.; Etienne-Cummings, Ralph; Cauwenberghs, Gert			Focal-Plane Change Triggered Video Compression for Low-Power Vision Sensor Systems	PLOS ONE			English	Article								Video sensors with embedded compression offer significant energy savings in transmission but incur energy losses in the complexity of the encoder. Energy efficient video compression architectures for CMOS image sensors with focal-plane change detection are presented and analyzed. The compression architectures use pixel-level computational circuits to minimize energy usage by selectively processing only pixels which generate significant temporal intensity changes. Using the temporal intensity change detection to gate the operation of a differential DCT based encoder achieves nearly identical image quality to traditional systems (4dB decrease in PSNR) while reducing the amount of data that is processed by 67% and reducing overall power consumption reduction of 51%. These typical energy savings, resulting from the sparsity of motion activity in the visual scene, demonstrate the utility of focal-plane change triggered compression to surveillance vision systems.			Chi, YM (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	mikechi2@gmail.com	Etienne-Cummings, Ralph/A-3227-2010					Bandyopadhyay A, 2005, IEEE INT SYMP CIRC S, P5318, DOI 10.1109/ISCAS.2005.1465836; CHI YM, 2007, C INF SCI SYST, P244; Chi YM, 2008, IEEE INT SYMP CIRC S, P1862, DOI 10.1109/ISCAS.2008.4541804; Chi YM, 2007, IEEE J SOLID-ST CIRC, V42, P2187, DOI 10.1109/JSSC.2007.905295; Chiu YJ, 1999, IEEE T CIRC SYST VID, V9, P438, DOI 10.1109/76.754773; Culurciello E, 2006, ANALOG INTEGR CIRC S, V49, P39, DOI 10.1007/s10470-006-8737-x; Feng W.C., 2003, P ACM MULT, V1, P151; Gruev V, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL III, PROCEEDINGS, P683; Kawanami C, 1997, J GASTROENTEROL, V32, P12, DOI 10.1007/BF01213290; Leon-Salas WD, 2007, IEEE J SOLID-ST CIRC, V42, P2555, DOI 10.1109/JSSC.2007.907191; Liang J, 2001, IEEE T SIGNAL PROCES, V49, P3032, DOI 10.1109/78.969511; Lichtsteiner P, 2008, IEEE J SOLID-ST CIRC, V43, P566, DOI 10.1109/JSSC.2007.914337; Olyaei A, 2007, IEEE T CIRCUITS-I, V54, P26, DOI 10.1109/TCSI.2006.887976; Puri R, 2006, IEEE SIGNAL PROC MAG, V23, P94, DOI 10.1109/MSP.2006.1657820; QIANG L, 2002, IEE INT S CIRC SYST, V3, P325; TEKALP AM, 1995, PRENTICE HALL SIGNAL; TURICCHIA L, 2009, P SPIE BIOS IN PRESS	17	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6384	10.1371/journal.pone.0006384	http://dx.doi.org/10.1371/journal.pone.0006384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629187	Green Published, gold, Green Submitted			2022-12-25	WOS:000268318900012
J	Morales-Johansson, H; Puria, R; Brautigan, DL; Cardenas, ME				Morales-Johansson, Helena; Puria, Rekha; Brautigan, David L.; Cardenas, Maria E.			Human Protein Phosphatase PP6 Regulatory Subunits Provide Sit4-Dependent and Rapamycin-Sensitive Sap Function in Saccharomyces cerevisiae	PLOS ONE			English	Article							GENE-EXPRESSION; CELL-CYCLE; NUCLEAR-LOCALIZATION; MAMMALIAN PROTEIN; MASTER REGULATOR; TOR FUNCTION; YEAST; PATHWAY; SIT4P; 2A	In the budding yeast Saccharomyces cerevisiae the protein phosphatase Sit4 and four associated proteins (Sap4, Sap155, Sap185, and Sap190) mediate G(1) to S cell cycle progression and a number of signaling events controlled by the target of rapamycin TOR signaling cascade. Sit4 and the Sap proteins are ubiquitously conserved and their human orthologs, PP6 and three PP6R proteins, share significant sequence identity with their yeast counterparts. However, relatively little is known about the functions of the PP6 and PP6R proteins in mammalian cells. Here we demonstrate that the human PP6R proteins physically interact with Sit4 when expressed in yeast cells. Remarkably, expression of PP6R2 and PP6R3 but not expression of PP6R1 rescues the growth defect and rapamycin hypersensitivity of yeast cells lacking all four Saps, and these effects require Sit4. Moreover, PP6R2 and PP6R3 enhance cyclin G(1) gene expression and DNA synthesis, and partially abrogate the G(1) cell cycle delay and the budding defect of the yeast quadruple sap mutant strain. In contrast, the human PP6R proteins only modestly support nitrogen catabolite gene expression and are unable to restore normal levels of eIF2 alpha phosphorylation in the quadruple sap mutant strain. These results illustrate that the human PP6-associated proteins are capable of providing distinct rapamycin-sensitive and Sit4-dependent Sap functions in the heterologous context of the yeast cell. We hypothesize that the human Saps may play analogous roles in mTORC1-PP6 signaling events in metazoans.			Morales-Johansson, H (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	carde004@mc.duke.edu			NCI NIH HHS [R01 CA40024, R01 CA114107] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114107] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alarcon CM, 1996, GENE DEV, V10, P279, DOI 10.1101/gad.10.3.279; Bastians H, 1996, J CELL SCI, V109, P2865; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Dolinski K, 1997, MOL BIOL CELL, V8, P2267, DOI 10.1091/mbc.8.11.2267; FERNANDEZSARABIA MJ, 1992, GENE DEV, V6, P2417, DOI 10.1101/gad.6.12a.2417; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Jablonowski D, 2004, MOL BIOL CELL, V15, P1459, DOI 10.1091/mbc.E03-10-0750; Jablonowski D, 2001, GENETICS, V159, P1479; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Luke MM, 1996, MOL CELL BIOL, V16, P2744; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Manlandro CMA, 2005, EUKARYOT CELL, V4, P1041, DOI 10.1128/EC.4.6.1041-1049.2005; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Rohde JR, 2004, MOL CELL BIOL, V24, P8332, DOI 10.1128/MCB.24.19.8332-8341.2004; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6331	10.1371/journal.pone.0006331	http://dx.doi.org/10.1371/journal.pone.0006331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621075	Green Published, Green Submitted, gold			2022-12-25	WOS:000268147200016
J	Wang, J; Vernier, G; Fischer, A; Collier, RJ				Wang, Jie; Vernier, Gregory; Fischer, Audrey; Collier, R. John			Functions of Phenylalanine Residues within the beta-Barrel Stem of the Anthrax Toxin Pore	PLOS ONE			English	Article								Background: A key step of anthrax toxin action involves the formation of a protein-translocating pore within the endosomal membrane by the Protective Antigen (PA) moiety. Formation of this transmembrane pore by PA involves interaction of the seven 2 beta 2-2 beta 3 loops of the heptameric precursor to generate a 14-strand transmembrane beta barrel. Methodology/Principal Findings: We examined the effects on pore formation, protein translocation, and cytotoxicity, of mutating two phenylalanines, F313 and F314, that lie at the tip the b barrel, and a third one, F324, that lies part way up the barrel. Conclusions/Significance: Our results show that the function of these phenylalanine residues is to mediate membrane insertion and formation of stable transmembrane channels. Unlike F427, a key luminal residue in the cap of the pore, F313, F314, and F324 do not directly affect protein translocation through the pore. Our findings add to our knowledge of structure-function relationships of a key virulence factor of the anthrax bacillus.			Wang, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	jcollier@hms.harvard.edu		Collier, R John/0000-0002-2427-4239	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI022021] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI022021, AI057159, U54 AI057159, R01 AI022021] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101	13	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6280	10.1371/journal.pone.0006280	http://dx.doi.org/10.1371/journal.pone.0006280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609431	Green Published, Green Submitted, gold			2022-12-25	WOS:000268119500014
J	Bischerour, J; Chalmers, R				Bischerour, Julien; Chalmers, Ronald			Base Flipping in Tn10 Transposition: An Active Flip and Capture Mechanism	PLOS ONE			English	Article								The bacterial Tn5 and Tn10 transposases have a single active site that cuts both strands of DNA at their respective transposon ends. This is achieved using a hairpin intermediate that requires the DNA to change conformation during the reaction. In Tn5 these changes are controlled in part by a flipped nucleoside that is stacked on a tryptophan residue in a hydrophobic pocket of the transposase. Here we have investigated the base flipping mechanism in Tn10 transposition. As in Tn5 transposition, we find that base flipping takes place after the first nick and is required for efficient hairpin formation and resolution. Experiments with an abasic substrate show that the role of base flipping in hairpin formation is to remove the base from the DNA helix. Specific interactions between the flipped base and the stacking tryptophan residue are required for hairpin resolution later in the reaction. We show that base flipping in Tn10 transposition is not a passive reaction in which a spontaneously flipped base is captured and retained by the protein. Rather, it is driven in part by a methionine probe residue that helps to force the flipped base from the base stack. Overall, it appears that base flipping in Tn10 transposition is similar to that in Tn5 transposition.			Bischerour, J (corresponding author), CNRS, Ctr Genet Mol, UPR2167, Gif Sur Yvette, France.	chalmers@nottingham.ac.uk		chalmers, ronald/0000-0002-1395-7173	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ason B, 2002, J BIOL CHEM, V277, P11284, DOI 10.1074/jbc.M111119200; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Bischerour J, 2007, NUCLEIC ACIDS RES, V35, P2584, DOI 10.1093/nar/gkm186; Chalmers R, 2000, J BACTERIOL, V182, P2970, DOI 10.1128/JB.182.10.2970-2972.2000; Chalmers R, 1998, CELL, V93, P897, DOI 10.1016/S0092-8674(00)81449-X; CHALMERS RM, 1994, J BIOL CHEM, V269, P8029; Chalmers RM, 1996, EMBO J, V15, P5112, DOI 10.1002/j.1460-2075.1996.tb00892.x; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Correll CC, 2004, J SYNCHROTRON RADIAT, V11, P93, DOI 10.1107/S0909049503023896; Crellin P, 2004, MOL CELL, V13, P537, DOI 10.1016/S1097-2765(04)00052-8; Crellin P, 2001, EMBO J, V20, P3882, DOI 10.1093/emboj/20.14.3882; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Grundy GJ, 2007, P NATL ACAD SCI USA, V104, P3078, DOI 10.1073/pnas.0611293104; Hickman AB, 2005, NAT STRUCT MOL BIOL, V12, P715, DOI 10.1038/nsmb970; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; Klimasauskas S, 1998, EMBO J, V17, P317, DOI 10.1093/emboj/17.1.317; Liu D, 2005, NUCLEIC ACIDS RES, V33, P1982, DOI 10.1093/nar/gki348; Liu DX, 2006, MOL MICROBIOL, V62, P1522, DOI 10.1111/j.1365-2958.2006.05432.x; Lu CP, 2006, NAT STRUCT MOL BIOL, V13, P1010, DOI 10.1038/nsmb1154; Lynch TW, 2003, J MOL BIOL, V330, P493, DOI 10.1016/S0022-2836(03)00529-1; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SAKAI J, 1995, EMBO J, V14, P4374, DOI 10.1002/j.1460-2075.1995.tb00112.x; Serva S, 1998, NUCLEIC ACIDS RES, V26, P3473, DOI 10.1093/nar/26.15.3473; Sewitz S, 2003, NUCLEIC ACIDS RES, V31, P5868, DOI 10.1093/nar/gkg797; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; Szczepanowski RH, 2008, NUCLEIC ACIDS RES, V36, P6109, DOI 10.1093/nar/gkn622; Tamulaitis G, 2008, NUCLEIC ACIDS RES, V36, P6101, DOI 10.1093/nar/gkn621; Tamulaitis G, 2007, NUCLEIC ACIDS RES, V35, P4792, DOI 10.1093/nar/gkm513; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Wong I, 2002, J BIOL CHEM, V277, P19424, DOI 10.1074/jbc.M201198200; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157; Zhu ZY, 2004, J MOL BIOL, V337, P573, DOI 10.1016/j.jmb.2004.02.003	40	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6201	10.1371/journal.pone.0006201	http://dx.doi.org/10.1371/journal.pone.0006201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593448	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035300013
J	Lazrak, A; Iles, KE; Liu, G; Noah, DL; Noah, JW; Matalon, S				Lazrak, Ahmed; Iles, Karen E.; Liu, Gang; Noah, Diana L.; Noah, James W.; Matalon, Sadis			Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species	FASEB JOURNAL			English	Article						single channels; proteasome; Xenopus oocytes; protein kinase C; human airway cells	WNK1 ACTIVATES SGK1; M-2 ION-CHANNEL; NA+ CHANNEL; A VIRUS; BIOPHYSICAL PROPERTIES; MOLECULAR CHARACTERIZATION; FLUID TRANSPORT; KINASE-C; II CELLS; AMILORIDE	The mechanisms by which replicating influenza viruses decrease the expression and function of amiloride-sensitive epithelial sodium channels (ENaCs) have not been elucidated. We show that expression of M2, a transmembrane influenza protein, decreases ENaC membrane levels and amiloride-sensitive currents in both Xenopus oocytes, injected with human alpha-, beta-, and gamma-ENaCs, and human airway cells (H441 and A549), which express native ENaCs. Deletion of a 10-aa region within the M2 C terminus prevented 70% of this effect. The M2 ENaC down-regulation occurred at normal pH and was prevented by MG-132, a proteasome and lysosome inhibitor. M2 had no effect on Liddle ENaCs, which have decreased affinity for Nedd4-2. H441 and A549 cells transfected with M2 showed higher levels of reactive oxygen species, as shown by the activation of redox-sensitive dyes. Pretreatment with glutathione ester, which increases intracellular reduced thiol concentrations, or protein kinase C (PKC) inhibitors prevented the deleterious effects of M2 on ENaCs. The data suggest that M2 protein increases steady-state concentrations of reactive oxygen intermediates that simulate PKC and decrease ENaCs by enhancing endocytosis and its subsequent destruction by the proteasome. These novel findings suggest a mechanism for the influenza-induced rhinorrhea and life-threatening alveolar edema in humans.-Lazrak, A., Iles, K. E., Liu, G. Noah, D. L., Noah, J. W., Matalon, S. Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species. FASEB J. 23, 3829-3842 (2009). www.fasebj.org	[Lazrak, Ahmed; Iles, Karen E.; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Lazrak, Ahmed; Iles, Karen E.; Liu, Gang; Noah, Diana L.; Noah, James W.; Matalon, Sadis] Univ Alabama Birmingham, Pulm Injury & Repair Ctr, Birmingham, AL USA; [Iles, Karen E.; Matalon, Sadis] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL USA; [Liu, Gang] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Liu, Gang] Univ Alabama Birmingham, Sch Publ Hlth, Dept Med, Birmingham, AL 35294 USA; [Noah, Diana L.; Noah, James W.] So Res Inst, Birmingham, AL 35255 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), 901 19th St S,224 BMR2, Birmingham, AL 35205 USA.	sadis@uab.edu		, Gang/0000-0002-6999-7633; Lazrak, Ahmed/0000-0002-4127-1937; Liu, Gang/0000-0003-2615-131X	U.S. National Institutes of Health [HL031197, 5U01ES015676, 1U54ES017218, AI071393, 5P30DK072482]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031197, R37HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676, U54ES017218] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Peter Snyder (University of Iowa, Iowa City, IA, USA) for the gift of ENaC Liddle mutants, Dr. Honglong Ji for useful comments and generating some of the preliminary data, and Teri Potter for editorial assistance. This work was supported by U.S. National Institutes of Health grants HL031197, 5U01ES015676, and 1U54ES017218 to S. M.; AI071393 to J.W.N.; and 5P30DK072482 to G. L.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen L, 2004, AM J PHYSIOL-RENAL, V286, pF1202, DOI 10.1152/ajprenal.00352.2003; Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; DuVall MD, 1998, AM J PHYSIOL-CELL PH, V274, pC1417, DOI 10.1152/ajpcell.1998.274.5.C1417; Frank J, 2003, J BIOL CHEM, V278, P43939, DOI 10.1074/jbc.M304882200; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; Henkel JR, 1999, J BIOL CHEM, V274, P9854, DOI 10.1074/jbc.274.14.9854; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008; Ilyinskii PO, 2007, CELL CYCLE, V6, P2043, DOI 10.4161/cc.6.16.4564; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Ji HL, 2009, AM J PHYSIOL-LUNG C, V296, pL372, DOI 10.1152/ajplung.90437.2008; Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kunzelmann K, 2004, J BIOL CHEM, V279, P48760, DOI 10.1074/jbc.M409747200; Lazrak A, 2000, AM J PHYSIOL-CELL PH, V279, pC762, DOI 10.1152/ajpcell.2000.279.3.C762; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL848, DOI 10.1152/ajplung.2000.278.4.L848; LAZRAK A, 2009, AM J RESP CELL MOL B; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; LING BN, 1989, AM J PHYSIOL, V256, pF1094, DOI 10.1152/ajprenal.1989.256.6.F1094; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; Matalon S, 2003, AM J PHYSIOL-LUNG C, V285, pL1184, DOI 10.1152/ajplung.00281.2003; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Palmer-Densmore M, 2002, J GEN PHYSIOL, V120, P897, DOI 10.1085/jgp.20028608; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Shimbo K, 1996, BIOPHYS J, V70, P1335, DOI 10.1016/S0006-3495(96)79690-X; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smondyrev AM, 2002, BIOPHYS J, V83, P1987, DOI 10.1016/S0006-3495(02)73960-X; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Song WF, 2009, J BIOL CHEM, V284, P7294, DOI 10.1074/jbc.M806816200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; Tobler K, 1999, J VIROL, V73, P9695, DOI 10.1128/JVI.73.12.9695-9701.1999; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Wang HC, 2000, J BIOL CHEM, V275, P8600, DOI 10.1074/jbc.275.12.8600; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; YUE G, 1995, P NATL ACAD SCI USA, V92, P8418, DOI 10.1073/pnas.92.18.8418	62	67	70	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3829	3842		10.1096/fj.09-135590	http://dx.doi.org/10.1096/fj.09-135590			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19596899	Green Published			2022-12-25	WOS:000271272500019
J	Pless, SA; Lynch, JW				Pless, Stephan A.; Lynch, Joseph W.			Magnitude of a Conformational Change in the Glycine Receptor beta 1-beta 2 Loop Is Correlated with Agonist Efficacy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; DISTINCT STRUCTURAL-CHANGES; LIGAND-BINDING DOMAIN; GATED ION-CHANNEL; X-RAY-STRUCTURE; GABA(A) RECEPTOR; SINGLE-CHANNEL; ACTIVATION; SITE; PHARMACOLOGY	The efficacy of agonists at Cys-loop ion channel receptors is determined by the rate they isomerize receptors to a pre-open flip state. Once the flip state is reached, the shut-open reaction is similar for low and high efficacy agonists. The present study sought to identify a conformational change associated with the closed-flip transition in the beta 1-glycine receptor. We employed voltage-clamp fluorometry to compare ligand-binding domain conformational changes induced by the following agonists, listed from highest to lowest affinity and efficacy: glycine > beta-alanine > taurine. Voltage-clamp fluorometry involves labeling introduced cysteines with environmentally sensitive fluorophores and inferring structural rearrangements from ligand-induced fluorescence changes. Agonist affinity and efficacy correlated inversely with maximum fluorescence magnitudes at labeled residues in ligand-binding domain loops D and E, suggesting that large conformational changes in this region preclude efficacious gating. However, agonist affinity and efficacy correlated directly with maximum fluorescence magnitudes from a label attached to A52C in loop 2, near the transmembrane domain interface. Because glycine experiences the largest affinity increase between closed and flip states, we propose that the magnitude of this fluorescence signal is directly proportional to the agonist affinity increase. In contrast, labeled residues in loops C, F, and the pre-M1 domain yielded agonist-independent fluorescence responses. Our results support the conclusion that a closed-flip conformation change, with a magnitude proportional to the agonist affinity increase from closed to flip states, occurs in the microenvironment of Ala-52.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	Australian Research Council; National Health and Medical Research Council of Australia (NHMRC)	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia (NHMRC).	Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Chang YC, 1999, NAT NEUROSCI, V2, P219, DOI 10.1038/6313; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hogg RC, 2007, BIOCHEM PHARMACOL, V73, P459, DOI 10.1016/j.bcp.2006.08.010; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Khatri A, 2009, BIOPHYS J, V96, P45, DOI 10.1016/j.bpj.2008.09.011; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, 1995, MOL PHARMACOL, V48, P919; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001	38	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27370	27376		10.1074/jbc.M109.048405	http://dx.doi.org/10.1074/jbc.M109.048405			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19643731	Green Published, hybrid			2022-12-25	WOS:000270232300038
J	Plassmeyer, ML; Reiter, K; Shimp, RL; Kotova, S; Smith, PD; Hurt, DE; House, B; Zou, XY; Zhang, YL; Hickman, M; Uchime, O; Herrera, R; Nguyen, V; Glen, J; Lebowitz, J; Jin, AJ; Miller, LH; MacDonald, NJ; Wu, YM; Narum, DL				Plassmeyer, Matthew L.; Reiter, Karine; Shimp, Richard L., Jr.; Kotova, Svetlana; Smith, Paul D.; Hurt, Darrell E.; House, Brent; Zou, Xiaoyan; Zhang, Yanling; Hickman, Merrit; Uchime, Onyinyechukwu; Herrera, Raul; Nguyen, Vu; Glen, Jacqueline; Lebowitz, Jacob; Jin, Albert J.; Miller, Louis H.; MacDonald, Nicholas J.; Wu, Yimin; Narum, David L.			Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; CD8+ T-CELLS; IMMUNOLOGICAL CHARACTERIZATION; PROTECTIVE ANTIGEN; HEPARAN-SULFATE; LAYERED FOLD; SPOROZOITES; IMMUNITY; PEPTIDE; RECOGNITION	The Plasmodium falciparum circumsporozoite protein (CSP) is critical for sporozoite function and invasion of hepatocytes. Given its critical nature, a phase III human CSP malaria vaccine trial is ongoing. The CSP is composed of three regions as follows: an N terminus that binds heparin sulfate proteoglycans, a four amino acid repeat region (NANP), and a C terminus that contains a thrombospondin-like type I repeat (TSR) domain. Despite the importance of CSP, little is known about its structure. Therefore, recombinant forms of CSP were produced by expression in both Escherichia coli (Ec) and then refolded (EcCSP) or in the methylotrophic yeast Pichia pastoris (PpCSP) for structural analyses. To analyze the TSR domain of recombinant CSP, conformation-dependent monoclonal antibodies that recognized unfixed P. falciparum sporozoites and inhibited sporozoite invasion of HepG2 cells in vitro were identified. These monoclonal antibodies recognized all recombinant CSPs, indicating the recombinant CSPs contain a properly folded TSR domain structure. Characterization of both EcCSP and PpCSP by dynamic light scattering and velocity sedimentation demonstrated that both forms of CSP appeared as highly extended proteins (R-h 4.2 and 4.58 nm, respectively). Furthermore, high resolution atomic force microscopy revealed flexible, rod-like structures with a ribbon-like appearance. Using this information, we modeled the NANP repeat and TSR domain of CSP. Consistent with the biochemical and biophysical results, the repeat region formed a rod-like structure about 21-25 nm in length and 1.5 nm in width. Thus native CSP appears as a glycosylphosphatidylinositol-anchored, flexible rod-like protein on the sporozoite surface.	[Plassmeyer, Matthew L.; Reiter, Karine; Shimp, Richard L., Jr.; Zhang, Yanling; Hickman, Merrit; Uchime, Onyinyechukwu; Herrera, Raul; Nguyen, Vu; Glen, Jacqueline; Miller, Louis H.; MacDonald, Nicholas J.; Wu, Yimin; Narum, David L.] NIAID, Malaria Vaccine Dev Branch, NIH, Rockville, MD 20852 USA; [Kotova, Svetlana; Smith, Paul D.; Lebowitz, Jacob; Jin, Albert J.] Natl Inst Biomed Imaging & Bioengn, Lab Bioengn & Phys Sci, NIH, Bethesda, MD 20892 USA; [Hurt, Darrell E.] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct Computat Biol, NIH, Bethesda, MD 20892 USA; [House, Brent; Zou, Xiaoyan] USN, Naval Med Res Ctr, Silver Spring, MD 20910 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy	Narum, DL (corresponding author), NIAID, Malaria Vaccine Dev Branch, NIH, 5640 Fishers Ln,Twinbrook 1, Rockville, MD 20852 USA.	dnarum@niaid.nih.gov	Hurt, Darrell E/B-5076-2013; Zou, Xiaoyan/E-5564-2010	Hurt, Darrell E/0000-0002-9829-8567; Narum, David/0000-0003-3041-5402; Jin, Albert/0000-0003-3826-1081	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001004, ZIAAI000241, ZIAAI001003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program, including NIAID and National Institute of Biomedical Imaging and Bioengineering).	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bisang C, 1998, J AM CHEM SOC, V120, P7439, DOI 10.1021/ja980444j; BISANG C, 1995, J AM CHEM SOC, V117, P7904, DOI 10.1021/ja00135a008; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; COCHRANE AH, 1984, INFECT IMMUN, V45, P592, DOI 10.1128/IAI.45.3.592-595.1984; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eswar N., 2007, CURRENT PROTOCOLS PR; Franke ED, 2000, INFECT IMMUN, V68, P3403, DOI 10.1128/IAI.68.6.3403-3411.2000; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; Frevert Ute, 2008, V47, P182; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; HOLLINGDALE MR, 1982, J IMMUNOL, V128, P1929; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P682, DOI 10.4269/ajtmh.1983.32.682; Jin AJ, 2006, BIOPHYS J, V90, P3333, DOI 10.1529/biophysj.105.068742; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; KUMAR S, 1988, NATURE, V334, P258, DOI 10.1038/334258a0; Matsushima N, 2008, CURR PROTEIN PEPT SC, V9, P591, DOI 10.2174/138920308786733886; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Nanzer AP, 1997, J MOL BIOL, V267, P1012, DOI 10.1006/jmbi.1997.0911; Nardin EH, 2000, J INFECT DIS, V182, P1486, DOI 10.1086/315871; Narum DL, 2008, INFECT IMMUN, V76, P4876, DOI 10.1128/IAI.01717-07; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prudencio M, 2007, CELL HOST MICROBE, V2, P286, DOI 10.1016/j.chom.2007.10.008; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2001, YEAST, V18, P137, DOI 10.1002/1097-0061(20010130)18:2&lt;137::AID-YEA657&gt;3.0.CO;2-X; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tossavainen H, 2006, PROTEIN SCI, V15, P1760, DOI 10.1110/ps.052068506; Tsai CW, 2009, MOL BIOCHEM PARASIT, V164, P45, DOI 10.1016/j.molbiopara.2008.11.006; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; WEISS WR, 1993, J IMMUNOL, V151, P2690; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225	67	109	121	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26951	26963		10.1074/jbc.M109.013706	http://dx.doi.org/10.1074/jbc.M109.013706			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633296	Green Published, hybrid			2022-12-25	WOS:000269969600075
J	Srivastava, V; Manchanda, M; Gupta, S; Singla, R; Behera, D; Das, G; Natarajan, K				Srivastava, Varsha; Manchanda, Mini; Gupta, Shashank; Singla, Rupak; Behera, Digamber; Das, Gobardhan; Natarajan, Krishnamurthy			Toll-like Receptor 2 and DC-SIGNR1 Differentially Regulate Suppressors of Cytokine Signaling 1 in Dendritic Cells during Mycobacterium tuberculosis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; C-TYPE LECTIN; NF-KAPPA-B; DC-SIGN; IN-VIVO; PROTECTIVE IMMUNITY; MANNOSE RECEPTOR; ANTIGENS; ACTIVATION; IDENTIFICATION	A hallmark of protective immunity during Mycobacterium tuberculosis (M. tb) infection is the regulated secretion of pro-inflammatory and regulatory cytokines. Suppressors of Cytokine Signaling (SOCS) are key regulators of cytokine secretion and function. In this study we investigated regulation of Toll-like receptor 2 (TLR2) and dendritic cell-specific ICAM-3 grabbing non-integrin receptor 1 (DC-SIGNR1)-mediated SOCS1 expression in DCs during M. tb infection. We show that, compared with TLR2, stimulating DC-SIGNR1 on DCs induces higher SOCS1 expression and lower interleukin-12 production. Co-stimulating DC-SIGNR1 and TLR2 differentially regulates SOCS1 expression depending on the relative concentration of their ligands. Stimulating DC-SIGNR1 with M. tb infection increases SOCS1 expression, while stimulating TLR2 with M. tb infection reduces SOCS1 expression. Knockdown of SOCS1 in DCs by siRNA enhances interleukin-12 transcription and protein expression upon DC-SIGNR1 stimulation. Raf-1 and Syk differentially regulate TLR2- and DC-SIGNR1-mediated SOCS1 expression. In addition, DC-SIGNR1 shows greater association with SOCS1 when compared with TLR2. Interestingly, compared with healthy asymptomatic individuals, peripheral blood mononuclear cells of patients with active tuberculosis disease showed higher expression of SOCS1, which was reduced following chemotherapy. Similarly, stimulating DC-SIGNR1 on DCs from M. tb-infected TLR2(-/-) mice enhanced SOCS1 expression that was reduced following chemotherapy. Further, knockdown of SOCS1 in mouse DCs or human peripheral blood mononuclear cells resulted in increased killing of virulent M. tb. These results indicate that TLR2 and DC-SIGNR1 differentially regulate SOCS1 expression during M. tb infection. This in turn regulates M. tb survival by governing key cytokine expression.	[Srivastava, Varsha; Manchanda, Mini; Gupta, Shashank; Das, Gobardhan; Natarajan, Krishnamurthy] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Singla, Rupak; Behera, Digamber] Lala Ram Swarup Inst TB & Resp Dis, Dept TB & Resp Dis, New Delhi 110030, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Natarajan, K (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	natrajan@icgeb.res.in	Gupta, Shashank/E-7382-2016	Gupta, Shashank/0000-0003-0445-5195	Dept. of Biotechnology, Ministry of Science and Technology, Government of India	Dept. of Biotechnology, Ministry of Science and Technology, Government of India	This work was supported by grants from the Dept. of Biotechnology, Ministry of Science and Technology, Government of India (to K. N.).	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Caminschi I, 2006, INT IMMUNOL, V18, P741, DOI 10.1093/intimm/dxl011; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Gramberg T, 2006, VIROLOGY, V345, P482, DOI 10.1016/j.virol.2005.10.008; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hess J, 2000, ADV IMMUNOL, V75, P1, DOI 10.1016/S0065-2776(00)75001-2; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kaufmann SHE, 2003, J EXP MED, V197, P1, DOI 10.1084/jem.20021964; Koppel EA, 2004, IMMUNOBIOLOGY, V209, P117, DOI 10.1016/j.imbio.2004.03.003; Latchumanan VK, 2005, TUBERCULOSIS, V85, P377, DOI 10.1016/j.tube.2005.08.007; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Nikonenko BV, 2004, ANTIMICROB AGENTS CH, V48, P4550, DOI 10.1128/AAC.48.12.4550-4555.2004; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Smith AL, 2007, J EXP MED, V204, P421, DOI 10.1084/jem.20061604; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; von Meyenn F, 2006, IMMUNOBIOLOGY, V211, P557, DOI 10.1016/j.imbio.2006.05.004; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; World Health Organization (WHO), 2005, ELECTROMAGNETIC FIEL; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	45	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25532	25541		10.1074/jbc.M109.006221	http://dx.doi.org/10.1074/jbc.M109.006221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617348	Green Published, hybrid			2022-12-25	WOS:000269738000010
J	Victor, XV; Nguyen, TKN; Ethirajan, M; Tran, VM; Nguyen, KV; Kuberan, B				Victor, Xylophone V.; Nguyen, Thao K. N.; Ethirajan, Manivannan; Tran, Vy M.; Nguyen, Khiem V.; Kuberan, Balagurunathan			Investigating the Elusive Mechanism of Glycosaminoglycan Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-XYLOSIDE; PROTEIN-LINKAGE REGION; HEPARAN-SULFATE BIOSYNTHESIS; CHONDROITIN SULFATE; PROTEOGLYCAN SYNTHESIS; PROTEOCHONDROITIN SULFATE; TUMOR SUPPRESSORS; IN-VITRO; CARBOHYDRATE; CARTILAGE	Glycosaminoglycan (GAG) biosynthesis requires numerous biosynthetic enzymes and activated sulfate and sugar donors. Although the sequence of biosynthetic events is resolved using reconstituted systems, little is known about the emergence of cell-specific GAG chains (heparan sulfate, chondroitin sulfate, and dermatan sulfate) with distinct sulfation patterns. We have utilized a library of click-xylosides that have various aglycones to decipher the mechanism of GAG biosynthesis in a cellular system. Earlier studies have shown that both the concentration of the primers and the structure of the aglycone moieties can affect the composition of the newly synthesized GAG chains. However, it is largely unknown whether structural features of aglycone affect the extent of sulfation, sulfation pattern, disaccharide composition, and chain length of GAG chains. In this study, we show that aglycones can switch not only the type of GAG chains, but also their fine structures. Our findings provide suggestive evidence for the presence of GAGOSOMES that have different combinations of enzymes and their isoforms regulating the synthesis of cell-specific combinatorial structures. We surmise that click-xylosides are differentially recognized by the GAGOSOMES to generate distinct GAG structures as observed in this study. These novel click-xylosides offer new avenues to profile the cell-specific GAG chains, elucidate the mechanism of GAG biosynthesis, and to decipher the biological actions of GAG chains in model organisms.	[Victor, Xylophone V.; Ethirajan, Manivannan; Nguyen, Khiem V.; Kuberan, Balagurunathan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Nguyen, Thao K. N.; Tran, Vy M.; Kuberan, Balagurunathan] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kuberan, B (corresponding author), Univ Utah, Dept Med Chem, Skaggs Hall,Rm 307,30 S 2000 E, Salt Lake City, UT 84112 USA.	KUBY@pharm.utah.edu	Tran, Vy/GWC-8836-2022; Nguyen, Khiem/D-3544-2013	Nguyen, Thao/0000-0001-5740-6085; Balagurunathan, Kuberan/0000-0001-9203-8118	National Institutes of Health [GM075168]; Human Frontiers Science Program; Vietnam Education Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Vietnam Education Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM075168 (to B. K.). This work was also supported by Human Frontiers Science Program (to B. K.) and the Vietnam Education Fund (to T. K. N. N. and K. V. N.).	BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARRINO DA, 1994, MATRIX BIOL, V14, P121, DOI 10.1016/0945-053X(94)90002-7; Cheng F, 1997, GLYCOCONJUGATE J, V14, P297, DOI 10.1023/A:1018562426363; COSTER L, 1991, BIOCHEM J, V276, P533, DOI 10.1042/bj2760533; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FRANSSON LA, 1985, J BIOL CHEM, V260, P4722; FRITZ TA, 1994, J BIOL CHEM, V269, P300; GALLIGANI L, 1975, J BIOL CHEM, V250, P5400; GIBSON KD, 1977, BIOCHEM J, V168, P65, DOI 10.1042/bj1680065; GIBSON KD, 1977, BIOCHEM J, V162, P217, DOI 10.1042/bj1620217; GREGORY JD, 1964, J BIOL CHEM, V239, P3312; GREVE H, 1988, J BIOL CHEM, V263, P12886; HANDLEY CJ, 1977, BIOCHIM BIOPHYS ACTA, V500, P132; HJELLE JT, 1979, J EMBRYOL EXP MORPH, V53, P179; HOPWOOD JJ, 1977, J BIOL CHEM, V252, P4777; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; KANWAR YS, 1984, J CELL BIOL, V99, P715, DOI 10.1083/jcb.99.2.715; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kobayashi S, 2000, BIOCHEM BIOPH RES CO, V268, P860, DOI 10.1006/bbrc.2000.2219; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Kuberan B, 2003, J AM CHEM SOC, V125, P12424, DOI 10.1021/ja036737g; Kuberan B, 2004, J BIOL CHEM, V279, P5053, DOI 10.1074/jbc.C300492200; Kuberan B, 2008, CHEMBIOCHEM, V9, P198, DOI 10.1002/cbic.200700494; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; LEVITT D, 1973, P NATL ACAD SCI USA, V70, P2201, DOI 10.1073/pnas.70.8.2201; LIDHOLT K, 1988, BIOCHEM J, V254, P571, DOI 10.1042/bj2540571; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LINDAHL U, 1965, J BIOL CHEM, V240, P2821; LOHMANDER LS, 1986, ARCH BIOCHEM BIOPHYS, V250, P211, DOI 10.1016/0003-9861(86)90719-8; LOHMANDER LS, 1989, J BIOL CHEM, V264, P18775; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Malmberg J, 2006, BIOORGAN MED CHEM, V14, P6659, DOI 10.1016/j.bmc.2006.05.068; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MORRISSKAY GM, 1982, J ANAT, V134, P491; MUIR H, 1958, BIOCHEM J, V69, P195, DOI 10.1042/bj0690195; NISHIMOTO SK, 1982, J BIOL CHEM, V257, P1712; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; PLATT JL, 1987, DEV BIOL, V123, P293, DOI 10.1016/0012-1606(87)90388-5; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SANDY JD, 1980, BIOCHEM J, V188, P119, DOI 10.1042/bj1880119; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Seidler DG, 2002, J BIOL CHEM, V277, P42409, DOI 10.1074/jbc.M208442200; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SILBERT JE, 1993, BIOCHEM J, V296, P119, DOI 10.1042/bj2960119; SOBUE M, 1987, BIOCHEM J, V241, P591, DOI 10.1042/bj2410591; SUGAHARA K, 1992, EUR J BIOCHEM, V204, P401, DOI 10.1111/j.1432-1033.1992.tb16649.x; SUGAHARA K, 1992, J BIOL CHEM, V267, P6027; SUGAHARA K, 1992, J BIOL CHEM, V267, P1528; Sugumaran G, 1998, BIOCHEM J, V329, P203, DOI 10.1042/bj3290203; VERTEL BM, 1993, J BIOL CHEM, V268, P11105; YOST HJ, 1990, DEVELOPMENT, V110, P865	63	69	70	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25842	25853		10.1074/jbc.M109.043208	http://dx.doi.org/10.1074/jbc.M109.043208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628873	Green Published, hybrid			2022-12-25	WOS:000269738000042
J	Heikkinen, OK; Ruskamo, S; Konarev, PV; Svergun, DI; Iivanainen, T; Heikkinen, SM; Permi, P; Koskela, H; Kilpelainen, I; Ylanne, J				Heikkinen, Outi K.; Ruskamo, Salla; Konarev, Peter V.; Svergun, Dmitri I.; Iivanainen, Tatu; Heikkinen, Sami M.; Permi, Perttu; Koskela, Harri; Kilpelainen, Ilkka; Ylanne, Jari			Atomic Structures of Two Novel Immunoglobulin-like Domain Pairs in the Actin Cross-linking Protein Filamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; MOLECULAR-BASIS; BINDING; PROGRAM; COMPETITION; DISRUPTION; REVEALS; FILGAP	Filamins are actin filament cross-linking proteins composed of an N-terminal actin-binding domain and 24 immunoglobulin-like domains (IgFLNs). Filamins interact with numerous proteins, including the cytoplasmic domains of plasma membrane signaling and cell adhesion receptors. Thereby filamins mechanically and functionally link the cell membrane to the cytoskeleton. Most of the interactions have been mapped to the C-terminal IgFLNs 16-24. Similarly, as with the previously known compact domain pair of IgFLNa20-21, the two-domain fragments IgFLNa16-17 and IgFLNa18-19 were more compact in small angle x-ray scattering analysis than would be expected for two independent domains. Solution state NMR structures revealed that the domain packing in IgFLNa18-19 resembles the structure of IgFLNa20-21. In both domain pairs the integrin-binding site is masked, although the details of the domain-domain interaction are partly distinct. The structure of IgFLNa16-17 revealed a new domain packing mode where the adhesion receptor binding site of domain 17 is not masked. Sequence comparison suggests that similar packing of three tandem filamin domain pairs is present throughout the animal kingdom, and we propose that this packing is involved in the regulation of filamin interactions through a mechanosensor mechanism.	[Kilpelainen, Ilkka] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland; [Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Koskela, Harri] Univ Helsinki, Finnish Inst Verificat Chem Weap Convent, FI-00014 Helsinki, Finland; [Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Konarev, Peter V.; Svergun, Dmitri I.] DESY, EMBL Hamburg, D-22603 Hamburg, Germany; [Svergun, Dmitri I.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	University of Helsinki; University of Helsinki; University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Kilpelainen, I (corresponding author), Univ Helsinki, Dept Chem, POB 55, FIN-00014 Helsinki, Finland.	ilkka.kilpelainen@helsinki.fi; jylanne@bytl.jyu.fi	Konarev, Petr V/W-1380-2017	Svergun, Dmitri/0000-0003-0830-5696; Koskela, Harri/0000-0002-7552-3813; Ylanne, Jari/0000-0003-4627-021X; Ruskamo, Salla/0000-0002-9740-9077; Konarev, Petr/0000-0002-5606-1596	Finnish National Graduate School in Informational and Structural Biology; Academy of Finland [114713]; European Union Design Study SAXIER [011934]; European Union Framework Program 6 [RII3/CT/2004/506008]	Finnish National Graduate School in Informational and Structural Biology; Academy of Finland(Academy of Finland); European Union Design Study SAXIER; European Union Framework Program 6(European Commission)	This work was supported by funds from the Finnish National Graduate School in Informational and Structural Biology (to S. R. and O. K. H.), Academy of Finland Grant 114713 (to J. Y.), European Union Design Study SAXIER Contract 011934 (to D. I. S. and P. V. K.), and European Union Framework Program 6 Contract RII3/CT/2004/506008.	Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; CASE DA, 2004, AMBER 8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; Fabrice R, 2006, INT J BIOCHEM CELL B, V38, P404, DOI 10.1016/j.biocel.2005.09.020; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Heikkinen O, 2009, BIOMOL NMR ASSIGN, V3, P53, DOI 10.1007/s12104-008-9140-6; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	39	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25450	25458		10.1074/jbc.M109.019661	http://dx.doi.org/10.1074/jbc.M109.019661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19622754	Green Published, hybrid			2022-12-25	WOS:000269734000077
J	Runyan, CE; Hayashida, T; Hubchak, S; Curley, JF; Schnaper, HW				Runyan, Constance E.; Hayashida, Tomoko; Hubchak, Susan; Curley, Jessica F.; Schnaper, H. William			Role of SARA (SMAD Anchor for Receptor Activation) in Maintenance of Epithelial Cell Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; MESENCHYMAL TRANSITION; GROWTH; PATHWAY; INTERNALIZATION; SPECIFICITY; TRANSCRIPTION; FIBROBLASTS; DEGRADATION; PROTEINS	By inducing epithelial-to-mesenchymal transition (EMT), transforming growth factor-beta (TGF-beta) promotes cancer progression and fibrosis. Here we show that expression of the TGF-beta receptor-associated protein, SARA (Smad anchor for receptor activation), decreases within 72 h of exposure to TGF-beta and that this decline is both required and sufficient for the induction of several markers of EMT. It has been suggested recently that expression of the TGF-beta signaling mediators, Smad2 and Smad3, may have different functional effects, with Smad2 loss being more permissive for EMT progression. We find that the loss of SARA expression leads to a concomitant decrease in Smad2 expression and a disruption of Smad2-specific transcriptional activity, with no effect on Smad3 signaling or expression. Further, the effects of inducing the loss of Smad2 mimic those of the loss of SARA, enhancing expression of the EMT marker, smooth muscle alpha-actin. Smad2 mRNA levels are not affected by the loss of SARA. However, the ubiquitination of Smad2 is increased in SARA-deficient cells. We therefore examined the E3 ubiquitin ligase Smurf2 and found that although Smurf2 expression was unaltered in SARA-deficient cells, the interaction of Smad2 and Smurf2 was enhanced. These results describe a significant role for SARA in regulating cell phenotype and suggest that its effects are mediated through modification of the balance between Smad2 and Smad3 signaling. In part, this is achieved by enhancing the association of Smad2 with Smurf2, leading to Smad2 degradation.	[Runyan, Constance E.; Hayashida, Tomoko; Hubchak, Susan; Curley, Jessica F.; Schnaper, H. William] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University	Runyan, CE (corresponding author), 303 E Chicago Ave,Ward 12-110, Chicago, IL 60611 USA.	c-runyan@northwestern.edu		Hayashida, Tomoko/0000-0002-4160-7859	National Institutes of Health, NIDDK [R01-DK075663]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075663] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant R01-DK075663.	Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goto D, 2001, BIOCHEM BIOPH RES CO, V281, P1100, DOI 10.1006/bbrc.2001.4489; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; MIN BH, 1990, J BIOL CHEM, V265, P16667; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Runyan CE, 2006, CELL SIGNAL, V18, P2077, DOI 10.1016/j.cellsig.2006.05.009; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tan RY, 2008, AM J PHYSIOL-RENAL, V294, pF1076, DOI 10.1152/ajprenal.00323.2007; Tao Yan-Yan, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P909; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	32	34	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25181	25189		10.1074/jbc.M109.032847	http://dx.doi.org/10.1074/jbc.M109.032847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19620243	Green Published, hybrid			2022-12-25	WOS:000269734000052
J	Vedula, LS; Brannigan, G; Economou, NJ; Xi, J; Hall, MA; Liu, R; Rossi, MJ; Dailey, WP; Grasty, KC; Klein, ML; Eckenhoff, RG; Loll, PJ				Vedula, L. Sangeetha; Brannigan, Grace; Economou, Nicoleta J.; Xi, Jin; Hall, Michael A.; Liu, Renyu; Rossi, Matthew J.; Dailey, William P.; Grasty, Kimberly C.; Klein, Michael L.; Eckenhoff, Roderic G.; Loll, Patrick J.			A Unitary Anesthetic Binding Site at High Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSE-SPLEEN APOFERRITIN; HUMAN SERUM-ALBUMIN; L-CHAIN APOFERRITIN; GENERAL-ANESTHETICS; GABA(A) RECEPTOR; PROPOFOL ANALOGS; STRUCTURAL BASIS; IDENTIFICATION; CAVITY; MODULATION	Propofol is the most widely used injectable general anesthetic. Its targets include ligand-gated ion channels such as the GABA(A) receptor, but such receptor-channel complexes remain challenging to study at atomic resolution. Until structural biology methods advance to the point of being able to deal with systems such as the GABA(A) receptor, it will be necessary to use more tractable surrogates to probe the molecular details of anesthetic recognition. We have previously shown that recognition of inhalational general anesthetics by the model protein apoferritin closely mirrors recognition by more complex and clinically relevant protein targets; here we show that apoferritin also binds propofol and related GABAergic anesthetics, and that the same binding site mediates recognition of both inhalational and injectable anesthetics. Apoferritin binding affinities for a series of propofol analogs were found to be strongly correlated with the ability to potentiate GABA responses at GABA(A) receptors, validating this model system for injectable anesthetics. High resolution x-ray crystal structures reveal that, despite the presence of hydrogen bond donors and acceptors, anesthetic recognition is mediated largely by van der Waals forces and the hydrophobic effect. Molecular dynamics simulations indicate that the ligands undergo considerable fluctuations about their equilibrium positions. Finally, apoferritin displays both structural and dynamic responses to anesthetic binding, which may mimic changes elicited by anesthetics in physiologic targets like ion channels.	[Economou, Nicoleta J.; Rossi, Matthew J.; Grasty, Kimberly C.; Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Economou, Nicoleta J.; Rossi, Matthew J.] Drexel Univ, Coll Med, Grad Program Biochem, Philadelphia, PA 19102 USA; [Vedula, L. Sangeetha; Xi, Jin; Liu, Renyu; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Brannigan, Grace; Hall, Michael A.; Dailey, William P.; Klein, Michael L.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Drexel University; Drexel University; University of Pennsylvania; University of Pennsylvania	Loll, PJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,MS 497, Philadelphia, PA 19102 USA.	patrick.loll@drexelmed.edu	Brannigan, Grace/ABA-2750-2021	Brannigan, Grace/0000-0001-8949-2694; Eckenhoff, Roderic/0000-0002-5581-746X; Rossi, Matthew/0000-0002-7796-919X	National Institutes of Health [GM51595, GM55876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, R01GM051595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51595 and GM55876 (to R. G. E.).	AROSIO P, 2002, FERRITINS STRUCTURAL; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Breslow R, 2002, J AM CHEM SOC, V124, P3622, DOI 10.1021/ja012293h; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Chang CSS, 2003, J BIOL CHEM, V278, P42821, DOI 10.1074/jbc.M306978200; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Gallois B, 1997, J BIOL INORG CHEM, V2, P360, DOI 10.1007/s007750050143; Granier T, 1997, ACTA CRYSTALLOGR D, V53, P580, DOI 10.1107/S0907444997003314; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMES R, 1980, J MED CHEM, V23, P1350, DOI 10.1021/jm00186a013; Jenkins A, 2002, NEUROPHARMACOLOGY, V43, P669, DOI 10.1016/S0028-3908(02)00175-2; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Ko SH, 1997, ANESTH ANALG, V85, P719, DOI 10.1097/00000539-199710000-00002; Kotani Y, 2008, CNS NEUROSCI THER, V14, P95, DOI 10.1111/j.1527-3458.2008.00043.x; Krasowski MD, 2002, J MED CHEM, V45, P3210, DOI 10.1021/jm010461a; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Liu RY, 2004, BIOCHEM J, V380, P147, DOI 10.1042/BJ20031652; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mecozzi S, 1998, CHEM-EUR J, V4, P1016, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1016::AID-CHEM1016>3.0.CO;2-B; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; REYNOLDS JA, 1974, P NATL ACAD SCI USA, V71, P2925, DOI 10.1073/pnas.71.8.2925; Schofield CM, 2005, BRAIN RES, V1032, P30, DOI 10.1016/j.brainres.2004.11.002; Sewell JC, 2004, BRIT J ANAESTH, V92, P45, DOI 10.1093/bja/aeh016; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; THEIL EC, 2001, HDB METALLOPROTEINS; Thomas BR, 1998, J CRYST GROWTH, V187, P499, DOI 10.1016/S0022-0248(98)00033-5; Yoshizawa K, 2007, J BIOCHEM, V142, P707, DOI 10.1093/jb/mvm187	39	61	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24176	24184		10.1074/jbc.M109.017814	http://dx.doi.org/10.1074/jbc.M109.017814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605349	Green Published, hybrid			2022-12-25	WOS:000269380200031
J	Jansson, J; Willing, B; Lucio, M; Fekete, A; Dicksved, J; Halfvarson, J; Tysk, C; Schmitt-Kopplin, P				Jansson, Janet; Willing, Ben; Lucio, Marianna; Fekete, Ages; Dicksved, Johan; Halfvarson, Jonas; Tysk, Curt; Schmitt-Kopplin, Philippe			Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease	PLOS ONE			English	Article								The causes and etiology of Crohn's disease (CD) are currently unknown although both host genetics and environmental factors play a role. Here we used non-targeted metabolic profiling to determine the contribution of metabolites produced by the gut microbiota towards disease status of the host. Ion Cyclotron Resonance Fourier Transform Mass Spectrometry (ICR-FT/MS) was used to discern the masses of thousands of metabolites in fecal samples collected from 17 identical twin pairs, including healthy individuals and those with CD. Pathways with differentiating metabolites included those involved in the metabolism and or synthesis of amino acids, fatty acids, bile acids and arachidonic acid. Several metabolites were positively or negatively correlated to the disease phenotype and to specific microbes previously characterized in the same samples. Our data reveal novel differentiating metabolites for CD that may provide diagnostic biomarkers and/or monitoring tools as well as insight into potential targets for disease therapy and prevention.			Jansson, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA.	schmitt-kopplin@helmholtz-muenchen.de	Halfvarson, Jonas/AAU-4687-2020; Fekete, Agnes/C-8048-2019; Jansson, Janet/F-9951-2012; Jansson, Janet/H-5478-2018; Schmitt-Kopplin, Philippe/H-6271-2011	Fekete, Agnes/0000-0003-3058-7570; Jansson, Janet/0000-0002-5487-4315; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098; Dicksved, Johan/0000-0002-7515-4480; Halfvarson, Jonas/0000-0003-0122-7234				Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BEEKEN WL, 1976, SCAND J GASTROENTERO, V11, P735; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chen F, 2002, GASTROENTEROLOGY, V123, P2005, DOI 10.1053/gast.2002.37055; Chen J, 2008, ANAL CHEM, V80, P1280, DOI 10.1021/ac702089h; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; FernandezBanares F, 1997, CLIN NUTR, V16, P177, DOI 10.1016/S0261-5614(97)80003-9; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; HARVEY RF, 1980, LANCET, V1, P514; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Karlsson PC, 2005, J NUTR, V135, P2343; Lapidus A, 2006, WORLD J GASTROENTERO, V12, P70, DOI 10.3748/wjg.v12.i1.70; LEGENDRE P, 1998, NUMERICAL ECOLOGY, V132, P303; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lowes S, 2001, PFLUG ARCH EUR J PHY, V443, P265, DOI 10.1007/s004240100686; Magro F, 2006, DIGEST DIS SCI, V51, P2039, DOI 10.1007/s10620-006-9168-3; Magro F, 2002, DIGEST DIS SCI, V47, P216, DOI 10.1023/A:1013256629600; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ramakers JD, 2007, LIPIDS, V42, P687, DOI 10.1007/s11745-007-3071-3; Rossello-Mora R, 2008, ISME J, V2, P242, DOI 10.1038/ismej.2007.93; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783	32	379	392	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6386	10.1371/journal.pone.0006386	http://dx.doi.org/10.1371/journal.pone.0006386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636438	Green Submitted, gold, Green Published			2022-12-25	WOS:000268404900012
J	Buhusi, CV; Meck, WH				Buhusi, Catalin V.; Meck, Warren H.			Relativity Theory and Time Perception: Single or Multiple Clocks?	PLOS ONE			English	Article							PEAK-INTERVAL PROCEDURE; DIVIDED ATTENTION; FRONTAL-CORTEX; PIGEONS; MEMORY; GAP; METHAMPHETAMINE; DURATION; SIGNALS; TRIALS	Background: Current theories of interval timing assume that humans and other animals time as if using a single, absolute stopwatch that can be stopped or reset on command. Here we evaluate the alternative view that psychological time is represented by multiple clocks, and that these clocks create separate temporal contexts by which duration is judged in a relative manner. Two predictions of the multiple-clock hypothesis were tested. First, that the multiple clocks can be manipulated (stopped and/or reset) independently. Second, that an event of a given physical duration would be perceived as having different durations in different temporal contexts, i.e., would be judged differently by each clock. Methodology/Principal Findings: Rats were trained to time three durations (e. g., 10, 30, and 90 s). When timing was interrupted by an unexpected gap in the signal, rats reset the clock used to time the "short" duration, stopped the "medium" duration clock, and continued to run the "long" duration clock. When the duration of the gap was manipulated, the rats reset these clocks in a hierarchical order, first the "short", then the "medium", and finally the "long" clock. Quantitative modeling assuming re-allocation of cognitive resources in proportion to the relative duration of the gap to the multiple, simultaneously timed event durations was used to account for the results. Conclusions/Significance: These results indicate that the three event durations were effectively timed by separate clocks operated independently, and that the same gap duration was judged relative to these three temporal contexts. Results suggest that the brain processes the duration of an event in a manner similar to Einstein's special relativity theory: A given time interval is registered differently by independent clocks dependent upon the context.			Buhusi, CV (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	buhusi@musc.edu		Meck, Warren/0000-0002-6120-4790	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065561, R01MH073057] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH073057-02, R01 MH073057, R01 MH065561-08, R01 MH065561] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Buhusi CV, 2007, BEHAV PROCESS, V74, P159, DOI 10.1016/j.beproc.2006.10.004; Buhusi CV, 2006, J EXP PSYCHOL-ANIM B, V32, P329, DOI 10.1037/0097-7403.32.3.329; Buhusi CV, 2006, BEHAV PROCESS, V71, P116, DOI 10.1016/j.beproc.2005.10.006; Buhusi CV, 2006, BEHAV PROCESS, V71, P107, DOI 10.1016/j.beproc.2005.11.017; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buhusi CV, 2005, J EXP PSYCHOL-ANIM B, V31, P18, DOI 10.1037/0097-7403.31.1.18; Buhusi CV, 2002, J COMP PSYCHOL, V116, P381, DOI 10.1037//0735-7036.116.4.381; Buhusi CV, 2002, BEHAV NEUROSCI, V116, P291, DOI 10.1037//0735-7044.116.2.291; Buhusi CV, 2000, J EXP PSYCHOL ANIM B, V26, P305, DOI 10.1037//0097-7403.26.3.305; BUHUSI CV, 2003, METH NE FRO NEUROSCI, P317; BUHUSI CV, 2009, PHILOS T R SOC B, P1875; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burr D, 2006, CURR BIOL, V16, pR171, DOI 10.1016/j.cub.2006.02.038; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CHENG K, 1993, J EXP PSYCHOL ANIM B, V19, P56, DOI 10.1037/0097-7403.19.1.56; Church R.M., 1978, COGNITIVE PROCESS, P277; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Church RM, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P3; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Coull JT, 1998, J NEUROSCI, V18, P7426; DEVACA SC, 1994, J EXP PSYCHOL ANIM B, V20, P184; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; EINSTEIN A, J EXOTHERMIC SCI TEC, V1; FORTIN C, 2003, METH NE FRO NEUROSCI, P235; Kaiser DH, 2002, J EXP PSYCHOL ANIM B, V28, P416, DOI 10.1037//0097-7403.28.4.416; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Matell MS, 2006, PSYCHOPHARMACOLOGY, V188, P201, DOI 10.1007/s00213-006-0489-x; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matell MS, 2004, BEHAV NEUROSCI, V118, P150, DOI 10.1037/0735-7044.118.1.150; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Matell MS, 1999, BEHAV PROCESS, V45, P159, DOI 10.1016/S0376-6357(99)00016-9; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meck WH, 2007, BEHAV NEUROSCI, V121, P707, DOI 10.1037/0735-7044.121.4.707; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; MECK WH, 1984, BEHAV NEUROSCI, V98, P3, DOI 10.1037/0735-7044.98.1.3; MECK WH, 1984, J EXP PSYCHOL ANIM B, V10, P1, DOI 10.1037/0097-7403.10.1.1; MECK WH, 1987, BEHAV BRAIN RES, V23, P147, DOI 10.1016/0166-4328(87)90051-9; Mirsky S, 2002, SCI AM, V287, P102, DOI 10.1038/scientificamerican0902-102; OLTON DS, 1988, NEUROPSYCHOLOGIA, V26, P307, DOI 10.1016/0028-3932(88)90083-8; Pang KCH, 2001, NEUROSCIENCE, V103, P615, DOI 10.1016/S0306-4522(01)00018-5; Penney T.B., 2003, METH NE FRO NEUROSCI, P209, DOI 10.1080/17470218.2015.1023735; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; ROBERTS S, 1978, J EXP PSYCHOL ANIM B, V4, P318, DOI 10.1037/0097-7403.4.4.318; ROBERTS S, 1981, J EXP PSYCHOL ANIM B, V7, P242, DOI 10.1037/0097-7403.7.3.242; ROBERTS WA, 1989, J EXP PSYCHOL ANIM B, V15, P23, DOI 10.1037/0097-7403.15.1.23; SPETCH ML, 1992, LEARN MOTIV, V23, P117, DOI 10.1016/0023-9690(92)90013-C; SPETCH ML, 1992, COGNITIVE ASPECTS OF STIMULUS CONTROL, P47; SPETCH ML, 1983, DISS ABSTR INT, V43; Zakay D., 1989, TIME HUMAN COGNITION, P365, DOI [10.1016/S0166-4115(08)61047-X, DOI 10.1016/S0166-4115(08)61047-X]	49	75	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6268	10.1371/journal.pone.0006268	http://dx.doi.org/10.1371/journal.pone.0006268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CN	19623247	Green Published, Green Submitted, gold			2022-12-25	WOS:000268260100004
J	Canioni, D; Deau-Fischer, B; Taupin, P; Ribrag, V; Delarue, R; Bosq, J; Rubio, MT; Roux, D; Vasiliu, V; Varet, B; Brousse, N; Hermine, O				Canioni, Danielle; Deau-Fischer, Benedicte; Taupin, Pierre; Ribrag, Vincent; Delarue, Richard; Bosq, Jacques; Rubio, Marie-Therese; Roux, Damien; Vasiliu, Viorel; Varet, Bruno; Brousse, Nicole; Hermine, Olivier			Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases	PLOS ONE			English	Article							REED-STERNBERG CELLS; B-CELL; CD20 EXPRESSION; MAST-CELLS; DISEASE; BCL-2; PROLIFERATION; CHEMOTHERAPY; APOPTOSIS; ANTIBODY	Although most classical Hodgkin lymphoma patients are cured, a significant minority fail after primary therapy and may die as result of their disease. To date, there is no consensus on biological markers that add value to usual parameters (which comprise the International Prognostic Score) used at diagnosis to predict outcome. We evaluated 59 patients (18 with primary refractory or early relapse disease and 41 responders) for bcl2, Ki67, CD20, TiA1 and c-kit expression by semi-quantitative immunohistochemical study and correlated the results with the response to treatment. The results showed that expression of bcl2 and CD20 in Hodgkin and Reed Sternberg cells, and expression of TiA1 in micro-environmental lymphocytes, and c-kit positive mast cells in microenvironment, were independent prognostic markers. These novel cHL markers could be used in association with clinical parameters to identify newly diagnosed patients with favorable or unfavorable prognosis and to better tailor treatment for different risk groups.			Canioni, D (corresponding author), Univ Paris 05, Fac Med, AP HP, Dept Pathol,Necker Hosp, Paris, France.	danielle.canioni@nck.aphp.fr	AMSELLEM, Sophie/B-3645-2012; Roux, Damien/C-5618-2014; Hermine, Olivier/Q-7072-2018; Roux, Damien/L-3671-2014	Roux, Damien/0000-0002-6103-6416; Roux, Damien/0000-0002-6103-6416; Hermine, Olivier/0000-0003-2574-3874; DEAU FISCHER, Benedicte/0000-0002-7468-5466				Akin C, 2004, J ALLERGY CLIN IMMUN, V114, P13, DOI 10.1016/j.jaci.2004.04.046; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro-Naranjo T, 2005, LEUKEMIA LYMPHOMA, V46, P1581, DOI 10.1080/10428190500220654; Anderlini P, 2005, BONE MARROW TRANSPL, V35, P943, DOI 10.1038/sj.bmt.1704942; Bierman PJ, 2002, ANN ONCOL, V13, P1370, DOI 10.1093/annonc/mdf228; Brink AATP, 1998, MODERN PATHOL, V11, P376; DIEHL V, 2003, HEMATOLOGY AM SOC HE, V1, P225; Dillman RO, 2001, CANCER PRACT, V9, P71, DOI 10.1046/j.1523-5394.2001.009002071.x; Dimitriadou V, 1997, ANTICANCER RES, V17, P1541; Donnelly GB, 1999, BLOOD, V94, p598A; FEDERICO M, 2003, J CLIN ONCOL, V6, P555; Fischer M, 2003, INT J CANCER, V107, P197, DOI 10.1002/ijc.11370; Foran JM, 2000, J CLIN ONCOL, V18, P317, DOI 10.1200/JCO.2000.18.2.317; GARCIA JF, 2003, BLOOD, P101; Glimelius I, 2006, EUR J HAEMATOL, V76, P278, DOI 10.1111/j.1600-0609.2005.00613.x; Glimelius I, 2005, LEUKEMIA, V19, P2360, DOI 10.1038/sj.leu.2403992; Hahn T, 2005, BONE MARROW TRANSPL, V35, P557, DOI 10.1038/sj.bmt.1704789; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Josting A, 2000, BLOOD, V96, P1280, DOI 10.1182/blood.V96.4.1280.h8001280_1280_1286; Josting A, 2005, J CLIN ONCOL, V23, P1522, DOI 10.1200/JCO.2005.05.022; Kashkar H, 2002, CELL DEATH DIFFER, V9, P750, DOI 10.1038/sj.cdd.4401024; Kewalramani T, 2003, BONE MARROW TRANSPL, V32, P673, DOI 10.1038/sj.bmt.1704214; Kuppers R, 2002, ADV CANCER RES, V84, P277, DOI 10.1016/S0065-230X(02)84009-X; KURZROCK R, 1993, CANCER RES, V53, P2118; Lavoie JC, 2005, BLOOD, V106, P1473, DOI 10.1182/blood-2004-12-4689; Manches O, 2003, BLOOD, V101, P949, DOI 10.1182/blood-2002-02-0469; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; MIYASHITA T, 1993, BLOOD, V81, P151; Molin D, 2004, UPSALA J MED SCI, V109, P179, DOI 10.3109/2000-1967-084; Molin D, 2002, BRIT J HAEMATOL, V119, P122, DOI 10.1046/j.1365-2141.2002.03768.x; MOLOT RJ, 1994, AM J CLIN ONCOL-CANC, V17, P185, DOI 10.1097/00000421-199406000-00001; Montalban C, 2004, J CLIN ONCOL, V22, P1664, DOI 10.1200/JCO.2004.06.105; Morente MM, 1997, BLOOD, V90, P2429; Moskowitz C, 2004, SEMIN ONCOL, V31, P54, DOI 10.1053/j.seminoncol.2004.02.016; Nadali G, 1998, BLOOD, V91, P3011, DOI 10.1182/blood.V91.8.3011.3011_3011_3016; Pinto A, 1996, BLOOD, V88, P3299, DOI 10.1182/blood.V88.9.3299.bloodjournal8893299; Rajewsky K, 1997, ANN ONCOL, V8, P79, DOI 10.1023/A:1008294602841; Rassidakis GZ, 2002, J CLIN ONCOL, V20, P1278, DOI 10.1200/JCO.20.5.1278; Reynolds GM, 2002, BRIT J HAEMATOL, V118, P195, DOI 10.1046/j.1365-2141.2002.03575.x; Skinnider BF, 2001, BLOOD, V97, P250, DOI 10.1182/blood.V97.1.250; Smolewski P, 1998, NEOPLASMA, V45, P140; Spector N, 2005, LEUKEMIA LYMPHOMA, V46, P1301, DOI 10.1080/10428190500126034; Sup SJ, 2005, J CLIN ONCOL, V23, P3773, DOI 10.1200/JCO.2005.04.358; Tzankov A, 2003, CLIN CANCER RES, V9, P1381	46	32	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6341	10.1371/journal.pone.0006341	http://dx.doi.org/10.1371/journal.pone.0006341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623262	gold, Green Submitted, Green Published			2022-12-25	WOS:000268260100017
J	Basile, M; Lemasson, A; Blois-Heulin, C				Basile, Muriel; Lemasson, Alban; Blois-Heulin, Catherine			Social and Emotional Values of Sounds Influence Human (Homo sapiens) and Non-Human Primate (Cercopithecus campbelli) Auditory Laterality	PLOS ONE			English	Article							CAPTIVE GROUP; HEMISPHERIC-SPECIALIZATION; NEURAL LATERALIZATION; JAPANESE MACAQUES; MONKEYS; BRAIN; COMMUNICATION; VOCALIZATIONS; RECOGNITION; ASYMMETRIES	The last decades evidenced auditory laterality in vertebrates, offering new important insights for the understanding of the origin of human language. Factors such as the social (e. g. specificity, familiarity) and emotional value of sounds have been proved to influence hemispheric specialization. However, little is known about the crossed effect of these two factors in animals. In addition, human-animal comparative studies, using the same methodology, are rare. In our study, we adapted the head turn paradigm, a widely used non invasive method, on 8-9-year-old schoolgirls and on adult female Campbell's monkeys, by focusing on head and/or eye orientations in response to sound playbacks. We broadcast communicative signals (monkeys: calls, humans: speech) emitted by familiar individuals presenting distinct degrees of social value ( female monkeys: conspecific group members vs heterospecific neighbours, human girls: from the same vs different classroom) and emotional value (monkeys: contact vs threat calls; humans: friendly vs aggressive intonation). We evidenced a crossed-categorical effect of social and emotional values in both species since only "negative" voices from same class/group members elicited a significant auditory laterality (Wilcoxon tests: monkeys, T = 0 p = 0.03; girls: T = 4.5 p = 0.03). Moreover, we found differences between species as a left and right hemisphere preference was found respectively in humans and monkeys. Furthermore while monkeys almost exclusively responded by turning their head, girls sometimes also just moved their eyes. This study supports theories defending differential roles played by the two hemispheres in primates' auditory laterality and evidenced that more systematic species comparisons are needed before raising evolutionary scenario. Moreover, the choice of sound stimuli and behavioural measures in such studies should be the focus of careful attention.			Basile, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Paimpont, France.	basilemuriel@hotmail.com						ASBJORNSEN A, 1990, BRAIN LANG, V39, P447, DOI 10.1016/0093-934X(90)90150-F; BASILE M, 2009, SOCIALLY DEPENDENT A, DOI DOI 10.1007/S10071-009-0220-5; BERNDT TJ, 1985, DEV PSYCHOL, V21, P1007, DOI 10.1037/0012-1649.21.6.1007; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; BOROD JC, 1992, NEUROPSYCHOLOGIA, V30, P827, DOI 10.1016/0028-3932(92)90086-2; Bosacki SL, 2004, SEX ROLES, V50, P659, DOI 10.1023/B:SERS.0000027568.26966.27; BOYE M, 2005, EUR J NEUROSCI, DOI DOI 10.1111/1460-9568.2005.04005.X; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Buzzard PJ, 2006, PRIMATES, V47, P336, DOI 10.1007/s10329-006-0188-6; Casperd JM, 1996, BEHAV PROCESS, V37, P57, DOI 10.1016/0376-6357(95)00075-5; Chapelain AS, 2009, ANIM COGN, V12, P11, DOI 10.1007/s10071-008-0164-1; Csermely D, 2004, BEHAV PROCESS, V67, P511, DOI 10.1016/j.beproc.2004.08.008; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; Dadda M, 2006, ANIM BEHAV, V72, P523, DOI 10.1016/j.anbehav.2005.10.019; Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002; EcklundFlores L, 1996, DEV PSYCHOBIOL, V29, P205, DOI 10.1002/(SICI)1098-2302(199604)29:3<205::AID-DEV2>3.0.CO;2-V; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fernandez-Carriba S, 2002, BRAIN RES BULL, V57, P561, DOI 10.1016/S0361-9230(01)00685-2; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Gautier J.-P., 1977, ANIMALS COMMUNICATE, P890; GAUTIER JP, 1975, THESIS RENNES U; GEISSLER GB, 2006, EUR J NEUROSCI, V19, P1027; George I, 2005, J COMP NEUROL, V488, P48, DOI 10.1002/cne.20584; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; HAMMER M, 1977, THESIS CITY U NEW YO; HARPER LV, 1986, DEV PSYCHOL, V22, P553, DOI 10.1037/0012-1649.22.4.553; HARRINGTON A, 1995, BRAIN ASYM; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; Hauser MD, 2001, ANIM BEHAV, V61, P391, DOI 10.1006/anbe.2000.1588; HEFFNER HE, 1995, CURRENT TOPICS IN PRIMATE VOCAL COMMUNICATION, P207; HEFFNER HE, 1989, J NEUROPHYSIOL, V62, P789, DOI 10.1152/jn.1989.62.3.789; HISCOCK M, 1985, BRAIN COGNITION, V4, P140, DOI 10.1016/0278-2626(85)90066-1; Hopkins William D., 2002, P445, DOI 10.1017/CBO9780511546372.014; HORTACSU N, 1992, J NONVERBAL BEHAV, V16, P231, DOI 10.1007/BF01462004; KAHANAKALMAN R, 1998, INFANT BEHAV DEV, DOI DOI 10.1016/S0163-6383(98)91453-9; Lee V, 2002, J NONVERBAL BEHAV, V26, P3, DOI 10.1023/A:1014479919684; Lemasson A, 2005, J COMP PSYCHOL, V119, P220, DOI 10.1037/0735-7036.119.2.220; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; Lemasson A, 2004, J COMP PSYCHOL, V118, P347, DOI 10.1037/0735-7036.118.3.347; Lemasson A, 2003, CR BIOL, V326, P1185, DOI 10.1016/j.crvi.2003.10.005; Lemasson A, 2006, AM J PRIMATOL, V68, P1161, DOI 10.1002/ajp.20315; Ley R G, 1982, Brain Cogn, V1, P3, DOI 10.1016/0278-2626(82)90002-1; MOLFESE DL, 1979, DEV PSYCHOL, V15, P505, DOI 10.1037/0012-1649.15.5.505; Otake R, 2007, ACTA OTO-LARYNGOL, V127, P34, DOI 10.1080/03655230701595337; Palleroni A, 2003, SCIENCE, V299, P1195, DOI 10.1126/science.1078813; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; PETERSEN MR, 1984, BEHAV NEUROSCI, V98, P779, DOI 10.1037/0735-7044.98.5.779; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Range F, 2004, ETHOLOGY, V110, P301, DOI 10.1111/j.1439-0310.2004.00973.x; Richard J-P, 1991, BIOACOUSTICS, V3, P45, DOI DOI 10.1080/09524622.1991.9753156; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; ROGERS LJ, 2004, P ROY SOC LOND B BIO, V271, P420, DOI DOI 10.1098/RSBL.2004.0200; Sato W, 2006, BRAIN COGNITION, V62, P261, DOI 10.1016/j.bandc.2006.06.006; SAXBY L, 1984, DEV PSYCHOL, V20, P72, DOI 10.1037/0012-1649.20.1.72; Scheumann M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-3; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; SHIPLEYBROWN F, 1988, BRAIN LANG, V33, P16, DOI 10.1016/0093-934X(88)90051-X; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; STIFTER CA, 1987, J NONVERBAL BEHAV, V11, P43, DOI 10.1007/BF00999606; STRERI A, 2004, DROITIERS GAUCHERS A, P49; Taglialatela JP, 2009, CEREB CORTEX, V19, P1151, DOI 10.1093/cercor/bhn157; TAGLIALATELA JP, 2004, THESIS GEORGIA STATE; TEUFEL C, 2007, ANIM BEHAV, DOI DOI 10.1016/2006.04.011; TURKEWITZ G, 1975, DEV PSYCHOBIOL, V8, P85, DOI 10.1002/dev.420080112; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; WALKERANDREWS AS, 1991, INFANT BEHAV DEV, V14, P131, DOI 10.1016/0163-6383(91)90001-9; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; Wernicke C., 1874, WERNICKES WORKS APHA, P91; Wolters S, 2003, BEHAVIOUR, V140, P371, DOI 10.1163/156853903321826684; Zuberbuhler K, 2000, P ROY SOC B-BIOL SCI, V267, P713, DOI 10.1098/rspb.2000.1061; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914	77	17	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6295	10.1371/journal.pone.0006295	http://dx.doi.org/10.1371/journal.pone.0006295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472GV	19609434	Green Published, gold, Green Submitted			2022-12-25	WOS:000268119500017
J	Saini, V; Raghuvanshi, S; Talwar, GP; Ahmed, N; Khurana, JP; Hasnain, SE; Tyagi, AK; Tyagi, AK				Saini, Vikram; Raghuvanshi, Saurabh; Talwar, Gursaran P.; Ahmed, Niyaz; Khurana, Jitendra P.; Hasnain, Seyed E.; Tyagi, Akhilesh K.; Tyagi, Anil K.			Polyphasic Taxonomic Analysis Establishes Mycobacterium indicus pranii as a Distinct Species	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; SP-NOV.; W VACCINE; TUBERCULOSIS; GENE; SEQUENCE; IDENTIFICATION; PROPOSAL; STRAINS; COMPLEX	Background: Mycobacterium indicus pranii (MIP), popularly known as Mw, is a cultivable, non-pathogenic organism, which, based on its growth and metabolic properties, is classified in Runyon Group IV along with M. fortuitum, M. smegmatis and M. vaccae. The novelty of this bacterium was accredited to its immunological ability to undergo antigen driven blast transformation of leukocytes and delayed hypersensitivity skin test in leprosy patients, a disease endemic in the Indian subcontinent. Consequently, MIP has been extensively evaluated for its biochemical and immunological properties leading to its usage as an immunomodulator in leprosy and tuberculosis patients. However, owing to advances in sequencing and culture techniques, the citing of new strains with almost 100% similarity in the sequences of marker genes like 16S rRNA, has compromised the identity of MIP as a novel species. Hence, to define its precise taxonomic position, we have carried out polyphasic taxonomic studies on MIP that integrate its phenotypic, chemotaxonomic and molecular phylogenetic attributes. Methodology/Principal Findings: The comparative analysis of 16S rRNA sequence of MIP by using BLAST algorithm at NCBI (nr database) revealed a similarity of >= 99% with M. intracellulare, M. arosiense, M. chimaera, M. seoulense, M. avium subsp. hominissuis, M. avium subsp. paratuberculosis and M. bohemicum. Further analysis with other widely used markers like rpoB and hsp65 could resolve the phylogenetic relationship between MIP and other closely related mycobacteria apart from M. intracellulare and M. chimaera, which shares >= 99% similarity with corresponding MIP orthologues. Molecular phylogenetic analysis, based on the concatenation of candidate orthologues of 16S rRNA, hsp65 and rpoB, also substantiated its distinctiveness from all the related organisms used in the analysis excluding M. intracellulare and M. chimaera with which it exhibited a close proximity. This necessitated further analysis of MIP with more sensitive and segregating parameters to ascertain its precise taxonomic position as a new species. The analysis of MIP and its comparison with other mycobacterial reference strains based on cellular and biochemical features, growth characteristics and chemotaxonomic studies like FAME profiling confirmed that MIP is uniquely endowed with diverse metabolic attributes that effectively distinguishes it from all the closely related mycobacteria including M. intracellulare and M. chimaera. Conclusion: The results presented in this study coupled with the non-pathogenic nature and different biochemical and immunomodulatory properties of MIP affirm it as a distinct species belonging to M. avium complex (MAC). It is further proposed to use an earlier suggested name Mycobacterium indicus pranii for this newly established mycobacterial species. This study also exemplifies the growing need for a uniform, consensus based broader polyphasic frame work for the purpose of taxonomy and speciation, particularly in the genus Mycobacterium.			Saini, V (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Saini, Vikram/B-4547-2009; Ahmed, Niyaz/D-2589-2010	Saini, Vikram/0000-0002-0258-2871; Ahmed, Niyaz/0000-0001-6425-7583; Hasnain, Seyed/0000-0002-2967-0791				Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Bang D, 2008, INT J SYST EVOL MICR, V58, P2398, DOI 10.1099/ijs.0.65503-0; BARROW WW, 1993, INFECT IMMUN, V61, P5286, DOI 10.1128/IAI.61.12.5286-5293.1993; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Gupta S, 2008, J EUR ACAD DERMATOL, V22, P1089, DOI 10.1111/j.1468-3083.2008.02719.x; HAACK SK, 1994, APPL ENVIRON MICROB, V60, P2483, DOI 10.1128/AEM.60.7.2483-2493.1994; Janda JM, 2002, J CLIN MICROBIOL, V40, P1887, DOI 10.1128/JCM.40.6.1887-1891.2002; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Katoch V M, 1981, Lepr India, V53, P385; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kharkar Rajendra, 2002, J Indian Med Assoc, V100, P578; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kremer K, 2001, Methods Mol Med, V54, P359, DOI 10.1385/1-59259-147-7:359; Kumar M, 2008, INT J SYST EVOL MICR, V58, P861, DOI 10.1099/ijs.0.65574-0; Mun HS, 2007, INT J SYST EVOL MICR, V57, P594, DOI 10.1099/ijs.0.64744-0; Neumann M, 1997, APPL ENVIRON MICROB, V63, P547, DOI 10.1128/AEM.63.2.547-552.1997; Ozbek A, 2003, J INT MED RES, V31, P133, DOI 10.1177/147323000303100210; Patel Naresh, 2002, J Indian Med Assoc, V100, P191; Pineiro-Vidal M, 2008, LETT APPL MICROBIOL, V46, P548, DOI 10.1111/j.1472-765X.2008.02348.x; REDDI PP, 1994, INT J LEPROSY, V62, P229; Reischl U, 1998, INT J SYST BACTERIOL, V48, P1349, DOI 10.1099/00207713-48-4-1349; RUYON EH, 1967, AM REV RESPIR DIS, V95, P861; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALAH B, 2008, MICROBIOLOGY, V154, P3715; Saxena V K, 1978, Lepr India, V50, P588; Selvarangan R, 2004, J CLIN MICROBIOL, V42, P52, DOI 10.1128/JCM.42.1.52-59.2004; Senna SG, 2008, J CLIN MICROBIOL, V46, P3822, DOI 10.1128/JCM.00451-08; Sharma P, 2005, LEPROSY REV, V76, P127; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; SINGH IG, 1991, VACCINE, V9, P10, DOI 10.1016/0264-410X(91)90309-T; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Talwar G P, 1978, Lepr India, V50, P492; Talwar G P, 1999, Int Rev Immunol, V18, P229, DOI 10.3109/08830189909043027; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; Talwar GP, 2008, INFECT GENET EVOL, V8, P100, DOI 10.1016/j.meegid.2007.07.009; THIERRY D, 1993, J CLIN MICROBIOL, V31, P1048, DOI 10.1128/JCM.31.5.1048-1054.1993; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tonjum T, 1998, J CLIN MICROBIOL, V36, P918; Tortoli E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/ijs.0.02777-0; Wayne LG, 1986, BERGEYS MANUAL SYSTE, V2, P1435; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; ZAHEER SA, 1993, J INFECT DIS, V167, P401, DOI 10.1093/infdis/167.2.401; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	52	66	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6263	10.1371/journal.pone.0006263	http://dx.doi.org/10.1371/journal.pone.0006263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606228	gold, Green Published, Green Submitted			2022-12-25	WOS:000268036000016
J	Gu, L; Waliany, S; Kane, SE				Gu, Long; Waliany, Sarah; Kane, Susan E.			Darpp-32 and Its Truncated Variant t-Darpp Have Antagonistic Effects on Breast Cancer Cell Growth and Herceptin Resistance	PLOS ONE			English	Article							TRASTUZUMAB RESISTANCE; MONOCLONAL-ANTIBODY; FACTOR-RECEPTOR; PROTEIN-KINASE; PI3K PATHWAY; EFFICACY; GENE; AKT; CHEMOTHERAPY; CONTRIBUTES	Background: Herceptin ( trastuzumab) is a humanized monoclonal antibody that is approved for the treatment of metastatic breast cancer patients whose tumors overexpress Her2 (erbB2/neu). Up to 70% of Her2-positive breast cancers demonstrate a response to Herceptin-based therapies, but resistance almost inevitably arises within a year of the initial response. To help understand the mechanism of Herceptin resistance, we isolated clonal variants of Her2-positive BT474 human breast cancer cells (BT/Her(R)) that are highly resistant to Herceptin. These cell lines exhibit sustained PI3K/Akt signaling as an essential component of Herceptin-resistant proliferation. Several genes in the protein kinase A (PKA) signaling network have altered expression in BT/Her(R) cells, including PPP1R1B, which encodes a 32 kDa protein known as Darpp-32 and its amino-terminal truncated variant, t-Darpp. The purpose of the current work was to determine the role of Darpp-32 and t-Darpp in Herceptin resistance. Methodology and Results: We determined expression of Darpp-32 and t-Darpp in BT/Her(R) cells selected for resistance to Herceptin. Subsequently, cDNAs encoding the two isoforms of Darpp-32 were transfected, separately and together, into Her2-positive SK-Br-3 breast cancer cells. Transfected cells were tested for resistance to Herceptin and Herceptin-mediated dephosphorylation of Akt. DNA binding activity by the cAMP response element binding protein (CREB) was also measured. We found that BT/Her(R) cells overexpressed t-Darpp but not Darpp-32. Moreover, t-Darpp overexpression in SK-Br-3 cells was sufficient for conferring resistance to Herceptin and Herceptin-mediated dephosphorylation of Akt. Darpp-32 co-expression reversed t-Darpp's effects on Herceptin resistance and Akt phosphorylation. t-Darpp overexpression led to increased CREB binding activity, which was also reversible by Darpp-32. Conclusions: t-Darpp and Darpp-32 appear to have antagonistic effects on Herceptin resistance. We present a unified model by which these effects might be mediated via the PKA regulatory network.			Gu, L (corresponding author), Beckman Res Inst City Hope, Div Tumor Cell Biol, Duarte, CA USA.	skane@coh.org		Waliany, Sarah/0000-0001-5960-8801				Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Belkhiri A, 2005, CANCER RES, V65, P6583, DOI 10.1158/0008-5472.CAN-05-1433; Belkhiri A, 2008, CLIN CANCER RES, V14, P4564, DOI 10.1158/1078-0432.CCR-08-0121; Belkhiri A, 2008, CANCER RES, V68, P395, DOI 10.1158/0008-5472.CAN-07-1580; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan CT, 2005, BREAST CANCER RES TR, V91, P187, DOI 10.1007/s10549-004-7715-1; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Collins SP, 1997, J BIOL CHEM, V272, P18169, DOI 10.1074/jbc.272.29.18169; El-Rifai W, 2002, CANCER RES, V62, P4061; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Fujita T, 2006, BRIT J CANCER, V94, P247, DOI 10.1038/sj.bjc.6602926; Giuliani R, 2007, EUR J CANCER, V43, P725, DOI 10.1016/j.ejca.2006.11.019; HAMEL S, 2009, BREAST CANC RES TREA; Hung MC, 1999, SEMIN ONCOL, V26, P51; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Miller KD, 2004, ONCOLOGIST, V9, P16, DOI 10.1634/theoncologist.9-suppl_3-16; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Xu WP, 2003, CANCER RES, V63, P7777; Yakes FM, 2002, CANCER RES, V62, P4132; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	35	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6220	10.1371/journal.pone.0006220	http://dx.doi.org/10.1371/journal.pone.0006220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593441	gold, Green Submitted, Green Published			2022-12-25	WOS:000268035400005
J	Hou, P; Liu, DX; Ji, MJ; Liu, Z; Engles, JM; Wahl, RL; Xing, MZ				Hou, Peng; Liu, Dingxie; Ji, Meiju; Liu, Zhi; Engles, James M.; Wahl, Richard L.; Xing, Mingzhao			Induction of Thyroid Gene Expression and Radioiodine Uptake in Melanoma Cells: Novel Therapeutic Implications	PLOS ONE			English	Article							SODIUM/IODIDE SYMPORTER; SIGNALING PATHWAYS; CUTANEOUS MELANOMA; BRAF MUTATIONS; CANCER; RAS; RAS/RAF/MEK/ERK; PROLIFERATION; INHIBITION; CARCINOMA	Both the MAP kinase and PI3K/Akt pathways play an important role in the pathogenesis of melanoma. We conducted the present study to test the hypothesis that targeting the two pathways to potently induce cell inhibition accompanied with thyroid iodide-handling gene expression for adjunct radioiodine ablation could be a novel effective therapeutic strategy for melanoma. We used specific shRNA approaches and inhibitors to individually or dually suppress the MAP kinase and PI3K/Akt pathways and examined the effects on a variety of molecular and cellular responses of melanoma cells that harbored activating genetic alterations in the two pathways. Suppression of the MAP kinase and PI3K/Akt pathways showed potent anti-melanoma cell effects, including the inhibition of cell proliferation, transformation and invasion, induction of G(0)/G(1) cell cycle arrest and, when the two pathways were dually suppressed, cell apoptosis. Remarkably, suppression of the two pathways, particularly simultaneous suppression of them, also induced expression of genes that are normally expressed in the thyroid gland, such as the genes for sodium/iodide symporter and thyroid-stimulating hormone receptor. Melanoma cells were consequently conferred the ability to take up radioiodide. We conclude that dually targeting the MAP kinase and PI3K/Akt pathways for potent cell inhibition coupled with induction of thyroid gene expression for adjunct radioiodine ablation therapy may prove to be a novel and effective therapeutic strategy for melanoma.			Hou, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA.	mxing1@jhmi.edu	Hou, Peng/H-8073-2015; Liu, Zhi/D-2759-2012; Liu, Dingxie/C-2181-2011	Liu, Dingxie/0000-0002-8061-5704; WAHL, RICHARD L./0000-0002-7306-2590	NCI NIH HHS [R0-1 CA113507-01, R01 CA113507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113507] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker C. H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P167, DOI 10.2174/1568008043339839; Ball DW, 2007, J CLIN ENDOCR METAB, V92, P4712, DOI 10.1210/jc.2007-1184; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Buchsbaum DJ, 2005, J NUCL MED, V46, p179S; Cass LA, 2000, ONCOGENE, V19, P924, DOI 10.1038/sj.onc.1203393; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Cristotaro J, 2006, ENDOCR-RELAT CANCER, V13, P485, DOI 10.1677/erc.1.01164; Duntas LH, 2008, THYROID, V18, P509, DOI 10.1089/thy.2007.0331; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Dwyer RM, 2005, CLIN CANCER RES, V11, P1483, DOI 10.1158/1078-0432.CCR-04-1636; Ellerhorst JA, 2006, ENDOCR-RELAT CANCER, V13, P1269, DOI 10.1677/erc.1.01239; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Faivre J, 2004, CANCER RES, V64, P8045, DOI 10.1158/0008-5472.CAN-04-0893; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Garcia B, 2002, MOL ENDOCRINOL, V16, P342, DOI 10.1210/me.16.2.342; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kwong Lawrence, 2007, Adv Dermatol, V23, P99, DOI 10.1016/j.yadr.2007.07.015; Lasithiotakis KG, 2006, CANCER-AM CANCER SOC, V107, P1331, DOI 10.1002/cncr.22126; Liu DX, 2007, J CLIN ENDOCR METAB, V92, P2264, DOI 10.1210/jc.2006-1613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquette A, 2007, ARCH IMMUNOL THER EX, V55, P363, DOI 10.1007/s00005-007-0043-5; Mazzaferri EL, 2006, PRACTICAL MANAGEMENT OF THYROID CANCER: MULTIDISCIPLINARY APPROACH, P1, DOI 10.1007/1-84628-013-3_1; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Mian C, 2001, EXP CLIN ENDOCR DIAB, V109, P47, DOI 10.1055/s-2001-11012; Mian C, 2008, CLIN ENDOCRINOL, V68, P108, DOI 10.1111/j.1365-2265.2007.03008.x; Nilsson M, 2001, EXP CLIN ENDOCR DIAB, V109, P13, DOI 10.1055/s-2001-11014; Pohlenz J, 2000, J CLIN ENDOCR METAB, V85, P2366, DOI 10.1210/jc.85.7.2366; Ries L MD, 2008, SEER CANC STAT REV 1; Riesco-Eizaguirre G, 2006, ENDOCR-RELAT CANCER, V13, P257, DOI 10.1677/erc.1.01119; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Satyamoorthy K, 2003, CANCER RES, V63, P756; Schipper ML, 2007, EUR J NUCL MED MOL I, V34, P638, DOI 10.1007/s00259-006-0254-8; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Willhauck M, 2008, GENE THER, V15, P214, DOI 10.1038/sj.gt.3303057; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987	47	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6200	10.1371/journal.pone.0006200	http://dx.doi.org/10.1371/journal.pone.0006200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593429	gold, Green Submitted, Green Published			2022-12-25	WOS:000268035300012
J	Eggert, S; Midthune, B; Cottrell, B; Koo, EH				Eggert, Simone; Midthune, Brea; Cottrell, Barbara; Koo, Edward H.			Induced Dimerization of the Amyloid Precursor Protein Leads to Decreased Amyloid-beta Protein Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; INTRAMEMBRANE CLEAVAGE; A-BETA; TRANSMEMBRANE DOMAIN; TERMINAL FRAGMENT; GXXXG MOTIFS; CELL-SURFACE; HUMAN BRAIN; PRESENILIN	The amyloid precursor protein (APP) plays a central role in Alzheimer disease (AD) pathogenesis because sequential cleavages by beta- and gamma-secretase lead to the generation of the amyloid-beta (A beta) peptide, a key constituent in the amyloid plaques present in brains of AD individuals. In several studies APP has recently been shown to form homodimers, and this event appears to influence A beta generation. However, these studies have relied on APP mutations within the A beta sequence itself that may affect APP processing by interfering with secretase cleavages independent of dimerization. Therefore, the impact of APP dimerization on A beta production remains unclear. To address this question, we compared the approach of constitutive cysteine-induced APP dimerization with a regulatable dimerization system that does not require the introduction of mutations within the A beta sequence. To this end we generated an APP chimeric molecule by fusing a domain of the FK506-binding protein (FKBP) to the C terminus of APP. The addition of the synthetic membrane-permeant drug AP20187 induces rapid dimerization of the APP-FKBP chimera. Using this system we were able to induce up to 70% APP dimers. Our results showed that controlled homodimerization of APP-FKBP leads to a 50% reduction in total A beta levels in transfected N2a cells. Similar results were obtained with the direct precursor of beta-secretase cleavage, C99/SPA4CT-FKBP. Furthermore, there was no modulation of different A beta peptide species after APP dimerization in this system. Taken together, our results suggest that APP dimerization can directly affect gamma-secretase processing and that dimerization is not required for A beta production.	[Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, LBR, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, LBR, 9500 Gilman Dr, La Jolla, CA 92093 USA.	edkoo@ucsd.edu			National Institutes of Health [AG 12376]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE ON AGING [R01AG012376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG 12376 (to E. H. K.). This work was also supported in part by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (to S. E.).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Clackson T, 2006, CHEM BIOL DRUG DES, V67, P440, DOI 10.1111/j.1747-0285.2006.00403.x; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Florean C, 2008, BBA-MOL CELL RES, V1783, P1551, DOI 10.1016/j.bbamcr.2008.03.012; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goldsbury C, 2007, J NEUROSCI, V27, P3357, DOI 10.1523/JNEUROSCI.5024-06.2007; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rebelo S, 2007, J MOL NEUROSCI, V32, P1, DOI 10.1007/s12031-007-0001-z; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; WANG R, 1991, J BIOL CHEM, V266, P16960; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	54	74	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28943	28952		10.1074/jbc.M109.038646	http://dx.doi.org/10.1074/jbc.M109.038646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19596858	Green Published, hybrid			2022-12-25	WOS:000270678900051
J	Chen, C; Fu, ZJ; Kim, JJP; Barbieri, JT; Baldwin, MR				Chen, Chen; Fu, Zhuji; Kim, Jung-Ja P.; Barbieri, Joseph T.; Baldwin, Michael R.			Gangliosides as High Affinity Receptors for Tetanus Neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-C FRAGMENT; CHOLERA-TOXIN; PROTEIN-RECEPTOR; BOTULINUM TOXINS; BINDING-SITES; CELLS; ENDOCYTOSIS; EXPRESSION; DOMAIN	Tetanus neurotoxin (TeNT) is an exotoxin produced by Clostridium tetani that causes paralytic death to hundreds of thousands of humans annually. TeNT cleaves vesicle-associated membrane protein-2, which inhibits neurotransmitter release in the central nervous system to elicit spastic paralysis, but the molecular basis for TeNT entry into neurons remains unclear. TeNT is a similar to 150-kDa protein that has AB structure-function properties; the A domain is a zinc metalloprotease, and the B domain encodes a translocation domain and C-terminal receptor-binding domain (HCR/T). Earlier studies showed that HCR/T bound gangliosides via two carbohydrate-binding sites, termed the lactose-binding site (the "W" pocket) and the sialic acid-binding site (the "R" pocket). Here we report that TeNT high affinity binding to neurons is mediated solely by gangliosides. Glycan array and solid phase binding analyses identified gangliosides that bound exclusively to either the W pocket or the R pocket of TeNT; GM1a bound to the W pocket, and GD3 bound to the R pocket. Using these gangliosides and mutated forms of HCR/T that lacked one or both carbohydrate-binding pocket, gangliosides binding to both of the W and R pockets were shown to be necessary for high affinity binding to neuronal and non-neuronal cells. The crystal structure of a ternary complex of HCR/T with sugar components of two gangliosides bound to the W and R supported the binding of gangliosides to both carbohydrate pockets. These data show that gangliosides are functional dual receptors for TeNT.	[Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Chen, Chen; Barbieri, Joseph T.; Baldwin, Michael R.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu	Taylor, Graham/A-4027-2012		National Institutes of Health [1-U54-AI-057153, GM62116]; NIAID; National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases; NIGMS; NINDS, National Institutes of Health [1-K99-NS061763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Award 1-U54-AI-057153 (Region V Great Lakes Regional Center of Excellence), the NIAID, National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program, and NIGMS, National Institutes of Health Grant GM62116 to the Consortium for Functional Glycomics.; Supported by NINDS, National Institutes of Health Grant 1-K99-NS061763.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basu M, 1997, INDIAN J BIOCHEM BIO, V34, P142; Bilous J, 2006, LANCET, V367, P1464, DOI 10.1016/S0140-6736(06)68625-X; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; BURTON RM, 1962, BIOCHEM PHARMACOL, V11, P974, DOI 10.1016/0006-2952(62)90150-8; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; CRITCHLEY DR, 1986, J NEUROCHEM, V47, P213; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2000, J BIOL CHEM, V275, P8889, DOI 10.1074/jbc.275.12.8889; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Karlsson KA, 1998, ACTA BIOCHIM POL, V45, P429, DOI 10.18388/abp.1998_4237; Kitamura M, 2005, BBA-MOL BASIS DIS, V1741, P1, DOI 10.1016/j.bbadis.2005.04.005; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; MARGOLIS RU, 1984, FEBS LETT, V172, P339, DOI 10.1016/0014-5793(84)81153-9; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Mocchetti I, 2005, CELL MOL LIFE SCI, V62, P2283, DOI 10.1007/s00018-005-5188-y; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nakayama J, 1996, J BIOL CHEM, V271, P3684; Pappas G, 2008, INT J INFECT DIS, V12, P347, DOI 10.1016/j.ijid.2007.11.003; ROUSSEL A, 1999, TURBO FRODO; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; SCHIAVO G, 1990, INFECT IMMUN, V58, P4136, DOI 10.1128/IAI.58.12.4136-4141.1990; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sinha K, 2000, MOL MICROBIOL, V37, P1041, DOI 10.1046/j.1365-2958.2000.02091.x; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; VANHEYNINGEN S, 1976, FEBS LETT, V68, P4; WALTON KM, 1988, J BIOL CHEM, V263, P2055; Williamson LC, 1999, J BIOL CHEM, V274, P25173, DOI 10.1074/jbc.274.35.25173; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200	40	88	93	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26569	26577		10.1074/jbc.M109.027391	http://dx.doi.org/10.1074/jbc.M109.027391			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19602728	Green Published, hybrid			2022-12-25	WOS:000269969600038
J	Cottle, DL; McGrath, MJ; Wilding, BR; Cowling, BS; Kane, JM; D'Arcy, CE; Holdsworth, M; Hatzinisiriou, I; Prescott, M; Brown, S; Mitchell, CA				Cottle, Denny L.; McGrath, Meagan J.; Wilding, Brendan R.; Cowling, Belinda S.; Kane, Jordan M.; D'Arcy, Colleen E.; Holdsworth, Melissa; Hatzinisiriou, Irene; Prescott, Mark; Brown, Susan; Mitchell, Christina A.			SLIMMER (FHL1B/KyoT3) Interacts with the Proapoptotic Protein Siva-1 (CD27BP) and Delays Skeletal Myoblast Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RBP-J; MUSCULAR-DYSTROPHY; LIM PROTEIN; BINDING PROTEIN; SATELLITE CELLS; ALPHA-ACTININ; MUSCLE; EXPRESSION; GENE; FHL1	The fhl1 gene encoding four-and-a-half LIM protein-1 (FHL1) and its spliced isoform, SLIMMER, is mutated in reducing body myopathy, X-linked myopathy with postural muscle atrophy, scapuloperoneal myopathy, and rigid spine syndrome. In this study we have identified a novel function for SLIMMER in delaying skeletal muscle apoptosis via an interaction with the proapoptotic protein Siva-1. Siva-1 was identified as a SLIMMER-specific-interacting protein using yeast two-hybrid screening, direct-binding studies, and glutathione S-transferase pulldown analysis of murine skeletal muscle lysates. In C2C12 skeletal myoblasts, SLIMMER and Siva co-localized in the nucleus; however, both proteins exhibited redistribution to the cytoplasm following the differentiation of mononucleated myoblasts to multinucleated myotubes. In sections of mature skeletal muscle from wild type mice, SLIMMER and Siva-1 colocalized at the Z-line. SLIMMER and Siva-1 were also enriched in Pax-7-positive satellite cells, muscle stem cells that facilitate repair and regeneration. Significantly, SLIMMER delayed Siva-1-dependent apoptosis in C2C12 myoblasts. In skeletal muscle sections from the mdx mouse model of Duchenne muscular dystrophy, SLIMMER and Siva-1 co-localized in the nucleus of apoptotic myofibers. Therefore, SLIMMER may protect skeletal muscle from apoptosis.	[Cottle, Denny L.; McGrath, Meagan J.; Wilding, Brendan R.; Cowling, Belinda S.; Kane, Jordan M.; D'Arcy, Colleen E.; Holdsworth, Melissa; Hatzinisiriou, Irene; Prescott, Mark; Brown, Susan; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Bldg 76,Wellington Rd, Clayton, Vic 3800, Australia.	christina.mitchell@med.monash.edu.au	Cottle, Denny/AAN-1574-2020; Cottle, Denny/G-4278-2013; Cowling, Belinda S/O-2730-2016	Cottle, Denny/0000-0001-5047-6515; Cowling, Belinda S/0000-0001-6915-2596; McGrath, Meagan/0000-0002-9414-6558; Mitchell, Christina A/0000-0001-9372-3192	National Health and Medical Research Council, Australia [9284272]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant 9284272 from the National Health and Medical Research Council, Australia.	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Chu F, 2005, CANCER RES, V65, P5301, DOI 10.1158/0008-5472.CAN-04-3270; Chu F, 2004, APOPTOSIS, V9, P83, DOI 10.1023/B:APPT.0000012125.01799.4c; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Daoud SS, 2003, CANCER RES, V63, P2782; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Dirks AJ, 2005, SPORTS MED, V35, P473, DOI 10.2165/00007256-200535060-00002; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Greene WK, 1999, GENE, V232, P203, DOI 10.1016/S0378-1119(99)00125-0; Henke A, 2000, J VIROL, V74, P4284, DOI 10.1128/JVI.74.9.4284-4290.2000; Ikezoe K, 2004, ACTA NEUROPATHOL, V107, P439, DOI 10.1007/s00401-004-0831-5; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Jejurikar SS, 2006, EXP GERONTOL, V41, P828, DOI 10.1016/j.exger.2006.06.053; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; LANE BP, 1977, J HISTOCHEM CYTOCHEM, V25, P69, DOI 10.1177/25.1.833423; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Liang L, 2008, BBA-GENE REGUL MECH, V1779, P805, DOI 10.1016/j.bbagrm.2008.08.001; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Ljungberg K, 2007, J VIROL, V81, P13412, DOI 10.1128/JVI.01799-07; Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morgan MJ, 1999, BIOCHEM BIOPH RES CO, V255, P245, DOI 10.1006/bbrc.1999.0179; OKA C, 1995, DEVELOPMENT, V121, P3291; Padanilam BJ, 1998, KIDNEY INT, V54, P1967, DOI 10.1046/j.1523-1755.1998.00197.x; Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Qin HY, 2005, FEBS LETT, V579, P1220, DOI 10.1016/j.febslet.2005.01.022; Qin HY, 2004, NUCLEIC ACIDS RES, V32, P1492, DOI 10.1093/nar/gkh295; Qin LF, 2002, LIFE SCI, V70, P1677, DOI 10.1016/S0024-3205(01)01554-5; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; Raj GV, 2004, PROSTATE, V61, P105, DOI 10.1002/pros.20083; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; Sandri M, 1998, LAB INVEST, V78, P1005; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Sandri M, 1998, NEUROSCI LETT, V252, P123, DOI 10.1016/S0304-3940(98)00563-1; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Schessl J, 2009, BRAIN, V132, P452, DOI 10.1093/brain/awn325; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Severino A, 2007, J CELL PHYSIOL, V212, P118, DOI 10.1002/jcp.21011; Shalaby S, 2009, NEUROLOGY, V72, P375, DOI 10.1212/01.wnl.0000341311.84347.a0; Shalaby S, 2008, NEUROMUSCULAR DISORD, V18, P959, DOI 10.1016/j.nmd.2008.09.012; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; TIDBALL JG, 1995, J CELL SCI, V108, P2197; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004; Xue L, 2002, P NATL ACAD SCI USA, V99, P6925, DOI 10.1073/pnas.102182299; Yoon Y, 1999, ONCOGENE, V18, P7174, DOI 10.1038/sj.onc.1203144; 2008, MOL DIAGN THER, V12, P99	62	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26964	26977		10.1074/jbc.M109.036293	http://dx.doi.org/10.1074/jbc.M109.036293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19643733	Green Published, hybrid			2022-12-25	WOS:000269969600076
J	Munkonge, FM; Amin, V; Hyde, SC; Green, AM; Pringle, IA; Gill, DR; Smith, JWS; Hooley, RP; Xenariou, S; Ward, MA; Leeds, N; Leung, KY; Chan, M; Hillery, E; Geddes, DM; Griesenbach, U; Postel, EH; Dean, DA; Dunn, MJ; Alton, EWFW				Munkonge, Felix M.; Amin, Vaksha; Hyde, Stephen C.; Green, Anne-Marie; Pringle, Ian A.; Gill, Deborah R.; Smith, Joel W. S.; Hooley, Robert P.; Xenariou, Stefania; Ward, Malcolm A.; Leeds, Nicola; Leung, Kit-Yi; Chan, Mario; Hillery, Elizabeth; Geddes, Duncan M.; Griesenbach, Uta; Postel, Edith H.; Dean, David A.; Dunn, Michael J.; Alton, Eric W. F. W.			Identification and Functional Characterization of Cytoplasmic Determinants of Plasmid DNA Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENE EXPRESSION; MAMMALIAN-CELLS; GENE-TRANSFER; DIPHOSPHATE KINASE; PROTEIN; LOCALIZATION; SEQUENCES; TRANSPORT; REQUIRES; SIGNALS	Import of exogenous plasmid DNA (pDNA) into mammalian cell nuclei represents a key intracellular obstacle to efficient non-viral gene delivery. This includes access of the pDNA to the nuclei of non-dividing cells where the presence of an intact nuclear membrane is limiting for gene transfer. Here we identify, isolate, and characterize, cytoplasmic determinants of pDNA nuclear import into digitonin-permeabilized HeLa cells. Depletion of putative DNA-binding proteins, on the basis of their ability to bind immobilized pDNA, abolished pDNA nuclear import supporting the critical role of cytoplasmic factors in this process. Elution of pDNA-bound proteins, followed by two-dimensional sodium dodecyl polyacrylamide gel electrophoresis identified several candidate DNA shuttle proteins. We show that two of these, NM23-H2, a ubiquitous c-Myc transcription-activating nucleoside diphosphate kinase, and the core histone H2B can both reconstitute pDNA nuclear import. Further, we demonstrate a significant increase in gene transfer in non-dividing HeLa cells transiently transfected with pDNA containing binding sequences from two of the DNA shuttle proteins, NM23-H2 and the homeobox transcription factor Chx10. These data support the hypothesis that exogenous pDNA binds to cytoplasmic shuttle proteins and is then translocated to the nucleus using the minimal import machinery. Importantly, increasing the binding of pDNA to shuttle proteins by re-engineering reporter plasmids with shuttle binding sequences enhances gene transfer. Increasing the potential for exogenously added pDNA to bind intracellular transport cofactors may enhance the potency of non-viral gene transfer.	[Munkonge, Felix M.; Smith, Joel W. S.; Hooley, Robert P.; Xenariou, Stefania; Alton, Eric W. F. W.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Dept Gene Therapy, London SW3 6LR, England; [Munkonge, Felix M.; Hyde, Stephen C.; Green, Anne-Marie; Pringle, Ian A.; Gill, Deborah R.; Smith, Joel W. S.; Hooley, Robert P.; Xenariou, Stefania; Chan, Mario; Hillery, Elizabeth; Geddes, Duncan M.; Griesenbach, Uta; Alton, Eric W. F. W.] Kings Coll London, UK Cyst Fibrosis Gene Therapy Consortium, London SE5 8AF, England; [Amin, Vaksha; Ward, Malcolm A.; Leeds, Nicola; Leung, Kit-Yi] Kings Coll London, Inst Psychiat, S Wing Lab, London SE5 8AF, England; [Hyde, Stephen C.; Green, Anne-Marie; Pringle, Ian A.; Gill, Deborah R.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 0NR, England; [Postel, Edith H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA; [Dean, David A.] Univ Rochester, Sch Med & Dent, Div Neonatol, Rochester, NY 14642 USA; [Dunn, Michael J.] Univ Coll Dublin, Proteome Res Ctr, UCD Conway Inst Bimol & Biomed Res, Dublin 4, Ireland	Imperial College London; University of London; King's College London; University of London; King's College London; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Rochester; University College Dublin	Munkonge, FM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Dept Gene Therapy, London SW3 6LR, England.	f.munkonge@imperial.ac.uk		Griesenbach, Uta/0000-0002-8254-4540; Gill, Deborah/0000-0002-5264-054X; Hyde, Stephen/0000-0002-8877-4005	National Institutes of Health [HL59956]; Cystic Fibrosis Trust, UK; Wellcome Trust Senior Clinical Fellowship; NATIONAL CANCER INSTITUTE [R01CA076496] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Trust, UK; Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL59956 (to D. A. D.). This work was also supported by the Cystic Fibrosis Trust, UK and a Wellcome Trust Senior Clinical Fellowship (to E. W. F. W. A.).	Al-Mohanna MA, 2001, CARCINOGENESIS, V22, P573, DOI 10.1093/carcin/22.4.573; Basner-Tschakarjan E, 2004, GENE THER, V11, P765, DOI 10.1038/sj.gt.3302221; Cartier R, 2002, GENE THER, V9, P157, DOI 10.1038/sj.gt.3301635; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; Fritz JD, 1996, HUM GENE THER, V7, P1395, DOI 10.1089/hum.1996.7.12-1395; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hillery E, 2006, ANAL BIOCHEM, V352, P169, DOI 10.1016/j.ab.2006.02.021; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Karmirantzou M, 2001, PROTEIN ENG, V14, P465, DOI 10.1093/protein/14.7.465; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kuramoto T, 2006, J GENE MED, V8, P53, DOI 10.1002/jgm.812; Langer T, 2000, HISTOCHEM CELL BIOL, V113, P455; Langle-Rouault F, 1998, J VIROL, V72, P6181; Leung SM, 1997, J BIOL CHEM, V272, P2607, DOI 10.1074/jbc.272.5.2607; Mesika A, 2001, MOL THER, V3, P653, DOI 10.1006/mthe.2001.0312; Miller AM, 2008, GENE THER, V15, P1107, DOI 10.1038/gt.2008.83; Munkonge FM, 2003, ADV DRUG DELIVER REV, V55, P749, DOI 10.1016/S0169-409X(03)00050-4; Nair R, 2004, NUCLEIC ACIDS RES, V32, pW517, DOI 10.1093/nar/gkh441; Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836; OKUNO Y, 1993, EXP CELL RES, V206, P134, DOI 10.1006/excr.1993.1129; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; Thanaketpaisarn O, 2008, J BIOTECHNOL, V133, P36, DOI 10.1016/j.jbiotec.2007.08.047; Tseng WC, 1999, BBA-GENE STRUCT EXPR, V1445, P53, DOI 10.1016/S0167-4781(99)00039-1; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Vacik J, 1999, GENE THER, V6, P1006, DOI 10.1038/sj.gt.3300924; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025	29	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26978	26987		10.1074/jbc.M109.034850	http://dx.doi.org/10.1074/jbc.M109.034850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638341	hybrid, Green Published			2022-12-25	WOS:000269969600077
J	Lima, WF; Wu, HJ; Nichols, JG; Sun, H; Murray, HM; Crooke, ST				Lima, Walt F.; Wu, Hongjiang; Nichols, Josh G.; Sun, Hong; Murray, Heather M.; Crooke, Stanley T.			Binding and Cleavage Specificities of Human Argonaute2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MESSENGER-RNA; SILENCING COMPLEX; PAZ DOMAIN; C-ELEGANS; INTERFERENCE; PROTEIN; SIRNA	The endonuclease Argonaute2 (Ago2) mediates the degradation of the target mRNA within the RNA-induced silencing complex. We determined the binding and cleavage properties of recombinant human Ago2. Human Ago2 was unable to cleave preformed RNA duplexes and exhibited weaker binding affinity for RNA duplexes compared with the single strand RNA. The enzyme exhibited greater RNase H activity in the presence of Mn2+ compared with Mg2+. Human Ago2 exhibited weaker binding affinities and reduced cleavage activities for antisense RNAs with either a 5'-terminal hydroxyl or abasic nucleotide. Binding kinetics suggest that the 5'-terminal heterocycle base nucleates the interaction between the enzyme and the antisense RNA, and the 5'-phosphate stabilizes the interaction. Mn2+ ameliorated the effects of the 5'-terminal hydroxyl or abasic nucleotide on Ago2 cleavage activity and binding affinity. Nucleotide substitutions at the 3' terminus of the antisense RNA had no effect on human Ago2 cleavage activity, whereas 2'-methoxyethyl substitutions at position 2 reduced binding and cleavage activity and 12-14 reduced the cleavage activity. RNase protection assays indicated that human Ago2 interacts with the first 14 nucleotides at the 5'-pole of the antisense RNA. Human Ago2 preloaded with the antisense RNA exhibited greater binding affinities for longer sense RNAs suggesting that the enzyme interacts with regions in the sense RNA outside the site for antisense hybridization. Finally, transiently expressed human Ago2 immunoprecipitated from HeLa cells contained the double strand RNA-binding protein human immunodeficiency virus, type 1, trans-activating response RNA-binding protein, and deletion mutants of Ago2 showed that trans-activating response RNA-binding protein interacts with the PIWI domain of the enzyme.	[Lima, Walt F.; Wu, Hongjiang; Nichols, Josh G.; Sun, Hong; Murray, Heather M.; Crooke, Stanley T.] Isis Pharmaceut Inc, Dept Biol Mol & Struct, Carlsbad, CA 92008 USA	Isis Pharmaceuticals Inc	Lima, WF (corresponding author), Isis Pharmaceut Inc, Dept Biol Mol & Struct, Carlsbad, CA 92008 USA.	wlima@isisph.com	Murray, Heather/GQY-8016-2022					Ausubel FM., 1988, CURRENT PROTOCOLS MO; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Egli M, 1996, BIOCHEMISTRY-US, V35, P8489, DOI 10.1021/bi9607214; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Goedken ER, 2001, J BIOL CHEM, V276, P7266, DOI 10.1074/jbc.M009626200; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; IKEHARA M, 1986, P NATL ACAD SCI USA, V83, P4695, DOI 10.1073/pnas.83.13.4695; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; KATAYANAGI K, 1992, J MOL BIOL, V223, P1029, DOI 10.1016/0022-2836(92)90260-Q; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; Lima WF, 1997, BIOCHEMISTRY-US, V36, P390, DOI 10.1021/bi962230p; Lima WF, 2004, J BIOL CHEM, V279, P36317, DOI 10.1074/jbc.M405035200; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P24; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	41	84	97	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26017	26028		10.1074/jbc.M109.010835	http://dx.doi.org/10.1074/jbc.M109.010835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625255	Green Published, hybrid			2022-12-25	WOS:000269738000058
J	Zhang, YL; Yamaguchi, Y; Inouye, M				Zhang, Yonglong; Yamaguchi, Yoshihiro; Inouye, Masayori			Characterization of YafO, an Escherichia coli Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; YOEB TOXIN; TRANSLATION; SITE; ANTITOXIN; TOLUENE; INHIBITION; INITIATION; RIBOSOMES	YafO is a toxin encoded by the yafN-yafO antitoxin-toxin operon in the Escherichia coli genome. Our results show that YafO inhibits protein synthesis but not DNA or RNA synthesis. The in vivo [S-35] methionine incorporation was inhibited within 5 min after YafO induction. In in vivo primer extension experiments with two different mRNAs, the specific cleavage bands appeared 11-13 bases downstream of the initiation codon, AUG, 2.5 min after the induction of YafO. An identical band was also detected in in vitro toeprinting experiments when YafO was added to the reaction mixture containing 70 S ribosomes and the same mRNAs even in the absence of tRNA(f)(Met). Notably, this band was not detected in the presence of YafO alone, indicating that YafO by itself does not have endoribonuclease activity under the conditions used. The full-length mRNAs almost completely disappeared 30 min after YafO induction in in vivo primer extension experiments, consistent with Northern blotting analysis. Over 84% of [S-35]methionine-tRNA(f)(Met) was released from the translation initiation complex at 5.43 mu M YafO in vitro. We demonstrated that the 70 S ribosome peak significantly increased upon YafO induction, and when the 70 S ribosomes dissociated into 50 and 30 S subunits, YafO was found to be associated with 50 S subunits. These results demonstrate that YafO is a ribosome-dependent mRNA interferase inhibiting protein synthesis.	[Zhang, Yonglong; Yamaguchi, Yoshihiro; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Ln, Piscataway, NJ 08854 USA.	inouye@umdnj.edu		Yamaguchi, Yoshihiro/0000-0003-4663-6963	National Institutes of Health [1RO1GM081567]; Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1GM081567 ( to M. I.). This work was also supported by a grant from Takara Bio Inc.	Aoki H, 2002, ANTIMICROB AGENTS CH, V46, P1080, DOI 10.1128/AAC.46.4.1080-1085.2002; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Courcelle J, 2001, GENETICS, V158, P41; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du HS, 1998, J BIOL CHEM, V273, P20494, DOI 10.1074/jbc.273.32.20494; HALEGOUA S, 1976, EUR J BIOCHEM, V69, P163, DOI 10.1111/j.1432-1033.1976.tb10869.x; HALEGOUA S, 1976, J BACTERIOL, V126, P183, DOI 10.1128/JB.126.1.183-191.1976; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; McKenzie GJ, 2003, J BACTERIOL, V185, P3972, DOI 10.1128/JB.185.13.3972-3977.2003; Moll I, 2002, BIOCHEM BIOPH RES CO, V297, P1021, DOI 10.1016/S0006-291X(02)02333-1; MOSES RE, 1970, P NATL ACAD SCI USA, V67, P674, DOI 10.1073/pnas.67.2.674; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; PETERSON RL, 1971, J BACTERIOL, V107, P585, DOI 10.1128/JB.107.2.585-588.1971; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	25	43	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25522	25531		10.1074/jbc.M109.036624	http://dx.doi.org/10.1074/jbc.M109.036624			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617347	hybrid, Green Published			2022-12-25	WOS:000269738000009
J	Patwari, P; Chutkow, WA; Cummings, K; Verstraeten, VLRM; Lammerding, J; Schreiter, ER; Lee, RT				Patwari, Parth; Chutkow, William A.; Cummings, Kiersten; Verstraeten, Valerie L. R. M.; Lammerding, Jan; Schreiter, Eric R.; Lee, Richard T.			Thioredoxin-independent Regulation of Metabolism by the alpha-Arrestin Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING-PROTEIN; COUPLED RECEPTORS; OXIDATIVE STRESS; HELA-CELLS; BINDING; GENE; GLUCOSE; TXNIP; UBIQUITINATION; ENDOCYTOSIS	Thioredoxin-interacting protein (Txnip), originally characterized as an inhibitor of thioredoxin, is now known to be a critical regulator of glucose metabolism in vivo. Txnip is a member of the alpha-arrestin protein family; the alpha-arrestins are related to the classical beta-arrestins and visual arrestins. Txnip is the only alpha-arrestin known to bind thioredoxin, and it is not known whether the metabolic effects of Txnip are related to its ability to bind thioredoxin or related to conserved alpha-arrestin function. Here we show that wild type Txnip and Txnip C247S, a Txnip mutant that does not bind thioredoxin in vitro, both inhibit glucose uptake in mature adipocytes and in primary skin fibroblasts. Furthermore, we show that Txnip C247S does not bind thioredoxin in cells, using thiol alkylation to trap the Txnipthioredoxin complex. Because Txnip function was independent of thioredoxin binding, we tested whether inhibition of glucose uptake was conserved in the related alpha-arrestins Arrdc4 and Arrdc3. Both Txnip and Arrdc4 inhibited glucose uptake and lactate output, while Arrdc3 had no effect. Structure-function analysis indicated that Txnip and Arrdc4 inhibit glucose uptake independent of the C-terminal WW-domain binding motifs, recently identified as important in yeast alpha-arrestins. Instead, regulation of glucose uptake was intrinsic to the arrestin domains themselves. These data demonstrate that Txnip regulates cellular metabolism independent of its binding to thioredoxin and reveal the arrestin domains as crucial structural elements in metabolic functions of alpha-arrestin proteins.	[Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Cambridge, MA 02139 USA; [Lee, Richard T.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA; [Chutkow, William A.] Vet Adm Med Ctr, W Roxbury, MA 02132 USA; [Schreiter, Eric R.] Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA; [Schreiter, Eric R.] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA	Harvard University; Brigham & Women's Hospital; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico	Patwari, P (corresponding author), 65 Landsdowne St Rm 280, Cambridge, MA 02139 USA.	ppatwari@rics.bwh.harvard.edu	Lammerding, Jan/A-9498-2016; Schreiter, Eric/B-2641-2009	Lammerding, Jan/0000-0003-4335-8611; Lee, Richard/0000-0003-4687-1381; Schreiter, Eric/0000-0002-2864-7469	National Institutes of Health [K25 HL81523, K08 HL088977, P01 HL048743]; J. Ira and Nicki Harris Family award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. Ira and Nicki Harris Family award	This work was supported, in whole or in part, by National Institutes of Health Grants K25 HL81523, K08 HL088977, and P01 HL048743. This work was also supported by a J. Ira and Nicki Harris Family award.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Andoh T, 2002, FEBS LETT, V525, P131, DOI 10.1016/S0014-5793(02)03104-6; Boase NA, 2004, MOL MICROBIOL, V53, P929, DOI 10.1111/j.1365-2958.2004.04172.x; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; EAGLE H, 1958, J BIOL CHEM, V233, P551; Emilsson V. e. a., 2005, Patent No. [2005/111239, 2005111239]; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mittal R, 2009, EMBO REP, V10, P41, DOI 10.1038/embor.2008.240; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Yamamoto Y, 2001, CLIN CANCER RES, V7, P297; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515	41	139	153	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24996	25003		10.1074/jbc.M109.018093	http://dx.doi.org/10.1074/jbc.M109.018093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605364	Green Published, hybrid			2022-12-25	WOS:000269734000035
J	Stokasimov, E; Rubenstein, PA				Stokasimov, Ema; Rubenstein, Peter A.			Actin Isoform-specific Conformational Differences Observed with Hydrogen/Deuterium Exchange and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-EXCHANGE; YEAST ACTIN; STRUCTURAL DYNAMICS; PHALLOIDIN BINDING; ATOMIC MODEL; F-ACTIN; STATE; POLYMERIZATION; NUCLEOTIDE; MUSCLE	Actin can exist in multiple conformations necessary for normal function. Actin isoforms, although highly conserved in sequence, exhibit different biochemical properties and cellular roles. We used amide proton hydrogen/deuterium (HD) exchange detected by mass spectrometry to analyze conformational differences between Saccharomyces cerevisiae and muscle actins in the G and F forms to gain insight into these differences. We also utilized HD exchange to study interdomain and allosteric communication in yeast-muscle hybrid actins to better understand the conformational dynamics of actin. Areas showing differences in HD exchange between G-and F-actins are areas of intermonomer contacts, consistent with the current filament models. Our results showed greater exchange for yeast G-actin compared with muscle actin in the barbed end pivot region and areas in subdomains 1 and 2 and for F-actin in monomer-monomer contact areas. These results suggest greater flexibility of the yeast actin monomer and filament compared with muscle actin. For hybrid G-actins, the muscle-like and yeastlike parts of the molecule generally showed exchange characteristics resembling their parent actins. A few exceptions were a peptide on top of subdomain 2 and the pivot region between subdomains 1 and 3 with muscle actin-like exchange characteristics although the areas were yeastlike. These results demonstrate that there is cross-talk between subdomains 1 and 2 and the large and small domains. Hybrid F-actin data showing greater exchange compared with both yeast and muscle actins are consistent with mismatched yeast-muscle interfaces resulting in decreased stability of the hybrid filament contacts.	[Stokasimov, Ema; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 (to P.A.R.).	Allen PG, 1996, BIOCHEMISTRY-US, V35, P14062, DOI 10.1021/bi961326g; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chik JK, 2003, J MOL BIOL, V334, P373, DOI 10.1016/j.jmb.2003.09.044; COOK RK, 1992, J BIOL CHEM, V267, P9430; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Ehring H, 1999, ANAL BIOCHEM, V267, P252, DOI 10.1006/abio.1998.3000; Engen Jr, 2000, METH MOL B, V146, P95, DOI 10.1385/1-59259-045-4:95; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; KARLSSON R, 1991, MOL CELL BIOL, V11, P213, DOI 10.1128/MCB.11.1.213; Khaitlina S, 2008, ARCH BIOCHEM BIOPHYS, V477, P279, DOI 10.1016/j.abb.2008.06.016; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9609, DOI 10.1021/bi00088a013; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Musib R, 2002, J BIOL CHEM, V277, P22699, DOI 10.1074/jbc.M203096200; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Orlova A, 1997, J MOL BIOL, V271, P235, DOI 10.1006/jmbi.1997.1163; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prochniewicz E, 1999, BIOCHEMISTRY-US, V38, P14860, DOI 10.1021/bi991343g; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Scoville D, 2006, BIOCHEMISTRY-US, V45, P13576, DOI 10.1021/bi061229f; Shvetsov A, 2002, BIOCHEMISTRY-US, V41, P10787, DOI 10.1021/bi020205f; Shvetsov A, 2008, J MOL BIOL, V375, P793, DOI 10.1016/j.jmb.2007.10.076; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TIRION MM, 1993, J MOL BIOL, V230, P186, DOI 10.1006/jmbi.1993.1135; Wales TE, 2006, J MOL BIOL, V357, P1592, DOI 10.1016/j.jmb.2006.01.075; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wear MA, 2000, CURR BIOL, V10, pR891, DOI 10.1016/S0960-9822(00)00845-9; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zencheck WD, 2009, J MOL BIOL, V390, P414, DOI 10.1016/j.jmb.2009.03.028; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	41	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25421	25430		10.1074/jbc.M109.013078	http://dx.doi.org/10.1074/jbc.M109.013078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605362	hybrid, Green Published			2022-12-25	WOS:000269734000074
J	Warren, EM; Huang, H; Fanning, E; Chazin, WJ; Eichman, BF				Warren, Eric M. y; Huang, Hao; Fanning, Ellen; Chazin, Walter J.; Eichman, Brandt F.			Physical Interactions between Mcm10, DNA, and DNA Polymerase alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; CYCLIN-DEPENDENT KINASES; 70 KDA SUBUNIT; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; STRUCTURAL BASIS; BUDDING YEAST; CHROMATIN ASSOCIATION; CRYSTAL-STRUCTURE	Mcm10 is an essential eukaryotic protein required for the initiation and elongation phases of chromosomal replication. Specifically, Mcm10 is required for the association of several replication proteins, including DNA polymerase alpha (pol alpha), with chromatin. We showed previously that the internal (ID) and C-terminal (CTD) domains of Mcm10 physically interact with both single-stranded (ss) DNA and the catalytic p180 subunit of pol alpha. However, the mechanism by which Mcm10 interacts with pol alpha on and off DNA is unclear. As a first step toward understanding the structural details for these critical intermolecular interactions, x-ray crystallography and NMR spectroscopy were used to map the binary interfaces between Mcm10-ID, ssDNA, and p180. The crystal structure of an Mcm10-ID.ssDNA complex confirmed and extended our previous evidence that ssDNA binds within the oligonucleotide/oligosaccharide binding-fold cleft of Mcm10-ID. We show using NMR chemical shift perturbation and fluorescence spectroscopy that p180 also binds to the OB-fold and that ssDNA and p180 compete for binding to this motif. In addition, we map a minimal Mcm10 binding site on p180 to a small region within the p180 N-terminal domain (residues 286-310). These findings, together with data for DNA and p180 binding to an Mcm10 construct that contains both the ID and CTD, provide the first mechanistic insight into how Mcm10 might use a handoff mechanism to load and stabilize pol alpha within the replication fork.	[Warren, Eric M. y; Huang, Hao; Fanning, Ellen; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Warren, Eric M. y; Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Eichman, BF (corresponding author), VU Stn B, Box 351634, Nashville, TN 37235 USA.	brandt.eichman@vanderbilt.edu			National Institutes of Health [R01 GM080570, R01 GM65484, R01 GM52948, P30 ES000267, P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080570, R01GM052948, R01GM065484, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM080570 (to B. F. E.), R01 GM65484 (to W. J. C.), and R01 GM52948 (to E. F.). Additional support for crystallography and mass spectrometry facilities was provided by the Vanderbilt Center in Molecular Toxicology (National Institutes of Health Grant P30 ES000267) and the VanderbiltIngram Cancer Center (National Institutes of Health Grant P30 CA068485).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Berthet-Colominas C, 1998, EMBO J, V17, P2947, DOI 10.1093/emboj/17.10.2947; Bhattacharya S, 2004, J BIOMOL NMR, V28, P195, DOI 10.1023/B:JNMR.0000013818.02364.3a; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Daughdrill GW, 2003, NUCLEIC ACIDS RES, V31, P4176, DOI 10.1093/nar/gkg451; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; DURSO G, 1995, J CELL SCI, V108, P3109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fien K, 2006, J BIOL CHEM, V281, P22248, DOI 10.1074/jbc.M512997200; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435; Hart EA, 2002, CURR GENET, V41, P342, DOI 10.1007/s00294-002-0316-9; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; Homesley L, 2000, GENE DEV, V14, P913; HSI KL, 1990, NUCLEIC ACIDS RES, V18, P6231, DOI 10.1093/nar/18.21.6231; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kawasaki Y, 2000, GENES CELLS, V5, P975, DOI 10.1046/j.1365-2443.2000.00387.x; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LaRocque JR, 2007, GENETICS, V176, P1441, DOI 10.1534/genetics.107.073635; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, 2003, NUCLEIC ACIDS RES, V31, P4747, DOI 10.1093/nar/gkg683; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; MAINE GT, 1984, GENETICS, V106, P365; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Schub O, 2001, J BIOL CHEM, V276, P38076; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; SOLOMON NA, 1992, YEAST, V8, P273, DOI 10.1002/yea.320080405; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Taneja P, 2007, BIOCHEM J, V407, P313, DOI 10.1042/BJ20070794; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Williams DR, 2005, EUKARYOT CELL, V4, P166, DOI 10.1128/EC.4.1.166-177.2005; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	74	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24662	24672		10.1074/jbc.M109.020438	http://dx.doi.org/10.1074/jbc.M109.020438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19608746	hybrid, Green Published			2022-12-25	WOS:000269380200075
J	Berna, AZ; Anderson, AR; Trowell, SC				Berna, Amalia Z.; Anderson, Alisha R.; Trowell, Stephen C.			Bio-Benchmarking of Electronic Nose Sensors	PLOS ONE			English	Article								Background: Electronic noses, E-Noses, are instruments designed to reproduce the performance of animal noses or antennae but generally they cannot match the discriminating power of the biological original and have, therefore, been of limited utility. The manner in which odorant space is sampled is a critical factor in the performance of all noses but so far it has been described in detail only for the fly antenna. Methodology: Here we describe how a set of metal oxide (MOx) E-Nose sensors, which is the most commonly used type, samples odorant space and compare it with what is known about fly odorant receptors (ORs). Principal Findings: Compared with a fly's odorant receptors, MOx sensors from an electronic nose are on average more narrowly tuned but much more highly correlated with each other. A set of insect ORs can therefore sample broader regions of odorant space independently and redundantly than an equivalent number of MOx sensors. The comparison also highlights some important questions about the molecular nature of fly ORs. Conclusions: The comparative approach generates practical learnings that may be taken up by solid-state physicists or engineers in designing new solid-state electronic nose sensors. It also potentially deepens our understanding of the performance of the biological system.			Berna, AZ (corresponding author), CSIRO Entomol, Canberra, ACT, Australia.	Stephen.Trowell@csiro.au	Trowell, Stephen/AAG-8943-2019; Anderson, Alisha R/C-1499-2008; Trowell, Stephen C/B-8043-2008; Perez, Amalia Berna/C-2139-2008; Anderson, Alisha/AAC-3505-2021	Anderson, Alisha R/0000-0001-7013-116X; Trowell, Stephen C/0000-0002-0505-8741; Perez, Amalia Berna/0000-0003-4932-5415; Anderson, Alisha/0000-0001-7013-116X				Albert KJ, 2000, CHEM REV, V100, P2595, DOI 10.1021/cr980102w; Ampuero S, 2003, SENSOR ACTUAT B-CHEM, V94, P1, DOI 10.1016/S0925-4005(03)00321-6; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Auld DS, 2002, DRUG DISCOV TODAY, V7, P1206, DOI 10.1016/S1359-6446(02)02530-8; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berna AZ, 2008, J AGR FOOD CHEM, V56, P3238, DOI 10.1021/jf7037289; Cohen J., 1988, STAT POWER ANAL BEHA; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; GARDNER JW, 1999, ELECT NOSES PRINCIPL, P140; Gardner JW, 1999, ELECT NOSES PRINCIPL; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Haddad R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040018; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Nowotny T, 2005, BIOL CYBERN, V93, P436, DOI 10.1007/s00422-005-0019-7; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengupta P, 2007, PFLUG ARCH EUR J PHY, V454, P721, DOI 10.1007/s00424-006-0196-9; Stetter JR, 2000, SENSOR ACTUAT B-CHEM, V69, P410, DOI 10.1016/S0925-4005(00)00503-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	25	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6406	10.1371/journal.pone.0006406	http://dx.doi.org/10.1371/journal.pone.0006406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641604	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500008
J	Muller, B; Glosmann, M; Peichl, L; Knop, GC; Hagemann, C; Ammermuller, J				Mueller, Brigitte; Gloesmann, Martin; Peichl, Leo; Knop, Gabriel C.; Hagemann, Cornelia; Ammermueller, Josef			Bat Eyes Have Ultraviolet-Sensitive Cone Photoreceptors	PLOS ONE			English	Article							VISUAL PIGMENTS; COLOR-VISION; SPECTRAL SENSITIVITY; SUBTERRANEAN RODENT; RETINA; COEXPRESSION; DIVERSITY; RESPONSES; EVOLUTION	Mammalian retinae have rod photoreceptors for night vision and cone photoreceptors for daylight and colour vision. For colour discrimination, most mammals possess two cone populations with two visual pigments (opsins) that have absorption maxima at short wavelengths (blue or ultraviolet light) and long wavelengths (green or red light). Microchiropteran bats, which use echolocation to navigate and forage in complete darkness, have long been considered to have pure rod retinae. Here we use opsin immunohistochemistry to show that two phyllostomid microbats, Glossophaga soricina and Carollia perspicillata, possess a significant population of cones and express two cone opsins, a shortwave-sensitive (S) opsin and a longwave-sensitive (L) opsin. A substantial population of cones expresses S opsin exclusively, whereas the other cones mostly coexpress L and S opsin. S opsin gene analysis suggests ultraviolet (UV, wavelengths < 400 nm) sensitivity, and corneal electroretinogram recordings reveal an elevated sensitivity to UV light which is mediated by an S cone visual pigment. Therefore bats have retained the ancestral UV tuning of the S cone pigment. We conclude that bats have the prerequisite for daylight vision, dichromatic colour vision, and UV vision. For bats, the UV-sensitive cones may be advantageous for visual orientation at twilight, predator avoidance, and detection of UV-reflecting flowers for those that feed on nectar.			Muller, B (corresponding author), Max Planck Inst Brain Res, D-60496 Frankfurt, Germany.	bmueller@mpih-frankfurt.mpg.de	Glösmann, Martin/F-9349-2019; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Glösmann, Martin/0000-0002-2094-3247; Peichl, Leo/0000-0002-8141-0911				Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Altringham JD, 2003, BAT ECOLOGY, P90; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Biedinger N, 1993, TROP SUBTROP PFLANZE, V86, P1; Calderone JB, 1999, VISUAL NEUROSCI, V16, P53, DOI 10.1017/S0952523899161029; Chavez AE, 2003, INVEST OPHTH VIS SCI, V44, P2290, DOI 10.1167/iovs.02-0670; Cowing JA, 2008, P ROY SOC B-BIOL SCI, V275, P1491, DOI 10.1098/rspb.2008.0248; Deeb SS, 2003, MOL BIOL EVOL, V20, P1642, DOI 10.1093/molbev/msg181; DIETERICH CE, 1971, A GRAEF ARCH KLIN EX, V182, P261, DOI 10.1007/BF00411960; Douglas R.H., 1999, P95; Ekesten B, 1999, DOC OPHTHALMOL, V97, P23, DOI 10.1023/A:1001869212639; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Glosmann M, 2008, J VISION, V8, DOI 10.1167/8.4.23; Griffin D. R., 1970, P233; HOPE GM, 1979, EXPERIENTIA, V35, P1191, DOI 10.1007/BF01963280; HOPE GM, 1979, EXPERIENTIA, V35, P1189, DOI 10.1007/BF01963279; Hunt DM, 2007, PHOTOCHEM PHOTOBIOL, V83, P303, DOI 10.1562/2006-06-27-IR-952; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Kim TJ, 2008, MOL CELLS, V26, P373; Kunz TH, 2003, BAT ECOLOGY, P3; Lythgoe J.N., 1979, ECOLOGY VISION; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Muller B, 2007, BRAIN BEHAV EVOLUT, V70, P90, DOI 10.1159/000102971; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2005, J COMP NEUROL, V486, P197, DOI 10.1002/cne.20491; Suthers R. A., 1970, BIOL BATS, P265; Wang DY, 2004, MOL BIOL EVOL, V21, P295, DOI 10.1093/molbev/msh015; Williams GA, 2005, J COMP PHYSIOL A, V191, P125, DOI 10.1007/s00359-004-0578-4; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Yokoyama S, 2000, FEBS LETT, V486, P167, DOI 10.1016/S0014-5793(00)02269-9; Yokoyama S, 1998, FEBS LETT, V423, P155, DOI 10.1016/S0014-5793(98)00086-6	35	81	81	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6390	10.1371/journal.pone.0006390	http://dx.doi.org/10.1371/journal.pone.0006390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636375	Green Published, gold, Green Submitted			2022-12-25	WOS:000268404900014
J	Volkova, VV; Bailey, RH; Wills, RW				Volkova, Victoriya V.; Bailey, R. Hartford; Wills, Robert W.			Salmonella in Broiler Litter and Properties of Soil at Farm Location	PLOS ONE			English	Article								Contamination of litter in a broiler grow-out house with Salmonella prior to placement of a new flock has been shown to be a precursor of the flock's Salmonella contamination further down the production continuum. In the southern USA, broiler grow-out houses are primarily built on dirt pad foundations that are placed directly on top of the native soil surface. Broiler litter is placed directly on the dirt pad. Multiple grow-out flocks are reared on a single litter batch, and the litter is kept in the houses during downtime between flocks. The effects of environmental determinants on conditions in broiler litter, hence Salmonella ecology within it, has received limited attention. In a field study that included broiler farms in the states of Alabama, Mississippi and Texas we assessed Salmonella in broiler litter at the end of downtime between flocks, i.e. at the time of placement of a new flock for rearing. Here we utilized these results and the U. S. General Soil Map (STATSGO) data to test if properties of soil at farm location impacted the probability of Salmonella detection in the litter. The significance of soil properties as risk factors was tested in multilevel regression models after accounting for possible confounding differences among the farms, the participating broiler complexes and companies, and the farms' geographical positioning. Significant associations were observed between infiltration and drainage capabilities of soil at farm location and probability of Salmonella detection in the litter.			Volkova, VV (corresponding author), Univ Edinburgh, Sch Biol Sci, Ctr Infect Dis, Ashworth Labs,Epidemiol Grp, Edinburgh, Midlothian, Scotland.	Victoriya.Volkova@ed.ac.uk						BAILEY JS, 1987, FOOD TECHNOL-CHICAGO, V41, P88; Bailey JS, 2001, J FOOD PROTECT, V64, P1690, DOI 10.4315/0362-028X-64.11.1690; BHATIA TRS, 1979, AVIAN DIS, V23, P838, DOI 10.2307/1589599; BHATIA TRS, 1980, AVIAN DIS, V24, P616, DOI 10.2307/1589797; BLANKENSHIP LC, 1993, POULTRY SCI, V72, P1667, DOI 10.3382/ps.0721667; BOTTS CW, 1952, AM J VET RES, V13, P562; CALDWELL DJ, 1994, AVIAN DIS, V38, P461, DOI 10.2307/1592066; Cardinale E, 2004, PREV VET MED, V63, P151, DOI 10.1016/j.prevetmed.2004.03.002; CARR LE, 1995, AVIAN DIS, V39, P39, DOI 10.2307/1591980; Condon J, 2004, PREV VET MED, V64, P1, DOI 10.1016/j.prevetmed.2004.03.003; de Rezende CLE, 2001, J IND MICROBIOL BIOT, V26, P222, DOI 10.1038/sj.jim.7000116; Hayes JR, 2000, POULTRY SCI, V79, P1557, DOI 10.1093/ps/79.11.1557; Heyndrickx M, 2002, EPIDEMIOL INFECT, V129, P253, DOI 10.1017/S0950268802007380; HOSMER DW, 1989, APPL LOGISTIC REGRES; JACOBSREITSMA WF, 1994, POULTRY SCI, V73, P1260, DOI 10.3382/ps.0731260; KINGSTON DJ, 1981, AVIAN DIS, V25, P513, DOI 10.2307/1589943; Line JE, 2006, POULTRY SCI, V85, P1529, DOI 10.1093/ps/85.9.1529; Mallinson ET, 2001, J AM VET MED ASSOC, V218, P1919, DOI 10.2460/javma.2001.218.1919; MILNER KC, 1952, J INFECT DIS, V90, P81, DOI 10.1093/infdis/90.1.81; NURMI E, 1973, NATURE, V241, P210, DOI 10.1038/241210a0; OLESIUK OM, 1971, AVIAN DIS, V15, P118, DOI 10.2307/1588396; OPARA OO, 1992, AVIAN DIS, V36, P63, DOI 10.2307/1591717; OPARA OO, 1992, AVIAN DIS, V36, P664, DOI 10.2307/1591762; OPARA OO, 1994, AVIAN DIS, V38, P293, DOI 10.2307/1591952; Pope MJ, 2000, POULTRY SCI, V79, P1351, DOI 10.1093/ps/79.9.1351; Rose N, 1999, PREV VET MED, V39, P265, DOI 10.1016/S0167-5877(99)00002-1; Rose N, 2000, PREV VET MED, V44, P9, DOI 10.1016/S0167-5877(00)00100-8; Rose N, 2003, PREV VET MED, V59, P27, DOI 10.1016/S0167-5877(03)00056-4; Rybolt ML, 2005, POULTRY SCI, V84, P992, DOI 10.1093/ps/84.7.992; Schukken YH, 2003, PREV VET MED, V59, P223, DOI 10.1016/S0167-5877(03)00101-6; SNOEYENBOS GH, 1967, AVIAN DIS, V11, P653, DOI 10.2307/1588308; Soil Survey Staff Natural Resources Conservation Service, US GEN SOIL MAP STAT; TUCKER JF, 1967, BRIT VET J, V123, P92, DOI 10.1016/S0007-1935(17)40102-3; TURNBULL PCB, 1973, POULTRY SCI, V12, P72; Villafane IEG, 2003, BRIT POULTRY SCI, V44, P669, DOI 10.1080/00071660210001643642; VOLKOVA VV, 2009, ZOONOSES PU IN PRESS	36	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6403	10.1371/journal.pone.0006403	http://dx.doi.org/10.1371/journal.pone.0006403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636431	gold, Green Published, Green Submitted			2022-12-25	WOS:000268404900023
J	Camiolo, S; Rau, D; Porceddu, A				Camiolo, Salvatore; Rau, Domenico; Porceddu, Andrea			Mutational Biases and Selective Forces Shaping the Structure of Arabidopsis Genes	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; EXPRESSION; SEQUENCE; INTRONS; MODEL; THALIANA	Recently features of gene expression profiles have been associated with structural parameters of gene sequences in organisms representing a diverse set of taxa. The emerging picture indicates that natural selection, mediated by gene expression profiles, has a significant role in determining genic structures. However the current situation is less clear in plants as the available data indicates that the effect of natural selection mediated by gene expression is very weak. Moreover, the direction of the patterns in plants appears to contradict those observed in animal genomes. In the present work we analized expression data for >18000 Arabidopsis genes retrieved from public datasets obtained with different technologies (MPSS and high density chip arrays) and compared them with gene parameters. Our results show that the impact of natural selection mediated by expression on genes sequences is significant and distinguishable from the effects of regional mutational biases. In addition, we provide evidence that the level and the breadth of gene expression are related in opposite ways to many structural parameters of gene sequences. Higher levels of expression abundance are associated with smaller transcripts, consistent with the need to reduce costs of both transcription and translation. Expression breadth, however, shows a contrasting pattern, i.e. longer genes have higher breadth of expression, possibly to ensure those structural features associated with gene plasticity. Based on these results, we propose that the specific balance between these two selective forces play a significant role in shaping the structure of Arabidopsis genes.			Camiolo, S (corresponding author), Univ Sassari, Dipartimento Sci Agron & Genet Vegetale Agr DISAG, I-07100 Sassari, Italy.	aporceddu@uniss.it		Rau, Domenico/0000-0002-5294-9053; Camiolo, Salvatore/0000-0002-8874-9993				Anselmi C, 2000, BIOPHYS J, V79, P601, DOI 10.1016/S0006-3495(00)76319-3; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Carels N, 2000, GENETICS, V154, P1819; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Colinas J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003670; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Kreitman M., 1994, Experientia Supplementum (Basel), V69, P157; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li SW, 2007, BIOCHEM BIOPH RES CO, V360, P586, DOI 10.1016/j.bbrc.2007.06.085; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; RADIC MZ, 1987, CELL, V50, P1101, DOI 10.1016/0092-8674(87)90176-0; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Seoighe C, 2005, PLOS GENET, V1, P154, DOI 10.1371/journal.pgen.0010013; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov AE, 2006, GENOME RES, V16, P347, DOI 10.1101/gr.4318206; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Vinogradov AE, 2001, MOL BIOL EVOL, V18, P2195, DOI 10.1093/oxfordjournals.molbev.a003766; Wegmann D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003587; 2003, NUCL ACIDS RES, V31, P1838	25	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6356	10.1371/journal.pone.0006356	http://dx.doi.org/10.1371/journal.pone.0006356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633720	Green Published, Green Submitted, gold			2022-12-25	WOS:000268404800007
J	Willger, SD; Ernst, JF; Alspaugh, JA; Lengeler, KB				Willger, Sven D.; Ernst, Joachim F.; Alspaugh, J. Andrew; Lengeler, Klaus B.			Characterization of the PMT Gene Family in Cryptococcus neoformans	PLOS ONE			English	Article							PROTEIN-O-MANNOSYLTRANSFERASES; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; MANNOSYL-TRANSFERASE; VIRULENCE FACTOR; HUMAN PATHOGEN; SEXUAL CYCLE; VAR. GATTII; YEAST	Background: Protein-O-mannosyltransferases (Pmt's) catalyze the initial step of protein-O-glycosylation, the addition of mannose residues to serine or threonine residues of target proteins. Methodology/Principal Findings: Based on protein similarities, this highly conserved protein family can be divided into three subfamilies: the Pmt1 sub-family, the Pmt2 sub-family and the Pmt4 sub-family. In contrast to Saccharomyces cerevisiae and Candida albicans, but similar to filamentous fungi, three putative PMT genes (PMT1, PMT2, and PMT4) were identified in the genome of the human fungal pathogen Cryptococcus neoformans. Similar to Schizosaccharomyces pombe and C. albicans, C. neoformans PMT2 is an essential gene. In contrast, the pmt1 and pmt4 single mutants are viable; however, the pmt1/pmt4 deletions are synthetically lethal. Mutation of PMT1 and PMT4 resulted in distinct defects in cell morphology and cell integrity. The pmt1 mutant was more susceptible to SDS medium than wild-type strains and the mutant cells were enlarged. The pmt4 mutant grew poorly on high salt medium and demonstrated abnormal septum formation and defects in cell separation. Interestingly, the pmt1 and pmt4 mutants demonstrated variety-specific differences in the levels of susceptibility to osmotic and cell wall stress. Delayed melanin production in the pmt4 mutant was the only alteration of classical virulence-associated phenotypes. However, the pmt1 and pmt4 mutants showed attenuated virulence in a murine inhalation model of cryptococcosis. Conclusion/Significance: These findings suggest that C. neoformans protein-O-mannosyltransferases play a crucial role in maintaining cell morphology, and that reduced protein-O-glycosylation leads to alterations in stress resistance, cell wall composition, cell integrity, and survival within the host.			Willger, SD (corresponding author), Univ Dusseldorf, Inst Mikrobiol, Univ Str 1, D-4000 Dusseldorf, Germany.	sven.willger@montana.edu	Alspaugh, Andrew/AAB-1664-2019	Alspaugh, Andrew/0000-0003-3009-627X; Willger, Sven/0000-0002-9736-2926				Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bourdineaud JP, 1998, MOL MICROBIOL, V27, P85, DOI 10.1046/j.1365-2958.1998.00660.x; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Ernst JF, 2001, MED MYCOL, V39, P67, DOI 10.1080/714031008; Franzot SP, 1998, J CLIN MICROBIOL, V36, P2200, DOI 10.1128/JCM.36.8.2200-2204.1998; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; GRANGER DL, 1985, J CLIN INVEST, V76, P508, DOI 10.1172/JCI112000; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Heitman J, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P1; Heitman J, 1999, FUNGAL GENET BIOL, V28, P1, DOI 10.1006/fgbi.1999.1155; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; KWONCHUNG KJ, 1982, J BACTERIOL, V150, P1414, DOI 10.1128/JB.150.3.1414-1421.1982; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Li L, 2006, CELL MICROBIOL, V8, P1730, DOI 10.1111/j.1462-5822.2006.00742.x; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Lyalin D, 2006, GENETICS, V172, P343, DOI 10.1534/genetics.105.049650; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; MURPHY JW, 1988, REV INFECT DIS, V10, pS432; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Orchard MG, 2004, BIOORG MED CHEM LETT, V14, P3975, DOI 10.1016/j.bmcl.2004.05.050; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Pietrella D, 2005, INFECT IMMUN, V73, P820, DOI 10.1128/IAI.73.2.820-827.2005; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; RHODES JC, 1982, INFECT IMMUN, V36, P1175, DOI 10.1128/IAI.36.3.1175-1184.1982; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; Shaw BD, 2002, FUNGAL GENET BIOL, V37, P263, DOI 10.1016/S1087-1845(02)00531-5; Sia RA, 2000, FUNGAL GENET BIOL, V29, P153, DOI 10.1006/fgbi.2000.1192; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Sugita T, 2001, MICROBIOL IMMUNOL, V45, P757, DOI 10.1111/j.1348-0421.2001.tb01312.x; Tanaka R, 2003, J CLIN MICROBIOL, V41, P4457, DOI 10.1128/JCM.41.9.4457-4459.2003; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; Thompson JR, 1999, J BACTERIOL, V181, P444, DOI 10.1128/JB.181.2.444-453.1999; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Toffaletti DL, 1994, MOL BIOL PATHOGENIC, P303; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varma A, 1999, GENE, V232, P155, DOI 10.1016/S0378-1119(99)00132-8; VARTIVARIAN SE, 1993, J INFECT DIS, V167, P186, DOI 10.1093/infdis/167.1.186; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Wang YX, 1996, MOL BIOL CELL, V7, P1375, DOI 10.1091/mbc.7.9.1375; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	68	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6321	10.1371/journal.pone.0006321	http://dx.doi.org/10.1371/journal.pone.0006321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633715	Green Submitted, Green Published, gold			2022-12-25	WOS:000268404800001
J	Gerbault, P; Moret, C; Currat, M; Sanchez-Mazas, A				Gerbault, Pascale; Moret, Celine; Currat, Mathias; Sanchez-Mazas, Alicia			Impact of Selection and Demography on the Diffusion of Lactase Persistence	PLOS ONE			English	Article								Background: The lactase enzyme allows lactose digestion in fresh milk. Its activity strongly decreases after the weaning phase in most humans, but persists at a high frequency in Europe and some nomadic populations. Two hypotheses are usually proposed to explain the particular distribution of the lactase persistence phenotype. The gene-culture coevolution hypothesis supposes a nutritional advantage of lactose digestion in pastoral populations. The calcium assimilation hypothesis suggests that carriers of the lactase persistence allele(s) (LCT*P) are favoured in high-latitude regions, where sunshine is insufficient to allow accurate vitamin-D synthesis. In this work, we test the validity of these two hypotheses on a large worldwide dataset of lactase persistence frequencies by using several complementary approaches. Methodology: We first analyse the distribution of lactase persistence in various continents in relation to geographic variation, pastoralism levels, and the genetic patterns observed for other independent polymorphisms. Then we use computer simulations and a large database of archaeological dates for the introduction of domestication to explore the evolution of these frequencies in Europe according to different demographic scenarios and selection intensities. Conclusions: Our results show that gene-culture coevolution is a likely hypothesis in Africa as high LCT*P frequencies are preferentially found in pastoral populations. In Europe, we show that population history played an important role in the diffusion of lactase persistence over the continent. Moreover, selection pressure on lactase persistence has been very high in the North-western part of the continent, by contrast to the South-eastern part where genetic drift alone can explain the observed frequencies. This selection pressure increasing with latitude is highly compatible with the calcium assimilation hypothesis while the gene-culture coevolution hypothesis cannot be ruled out if a positively selected lactase gene was carried at the front of the expansion wave during the Neolithic transition in Europe.			Gerbault, P (corresponding author), Univ Geneva, Lab Anthropol Genet & Peopling Hist AGP, Dept Anthropol & Ecol, Geneva, Switzerland.	mathias.currat@unige.ch		SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432				Beaumont MA, 2002, GENETICS, V162, P2025; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P145; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; COOK GC, 1975, BMJ-BRIT MED J, V3, P135, DOI 10.1136/bmj.3.5976.135; COOK GC, 1978, T ROY SOC TROP MED H, V72, P277, DOI 10.1016/0035-9203(78)90208-0; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; FLATZ G, 1973, LANCET, V2, P76; FLATZ G, 1987, ADV HUM GENET, V16, P1; GAGE TB, 1998, ANNU REV ANTHROPOL, V27, P1841; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Helmer Daniel, 2005, P86; Holden C, 1997, HUM BIOL, V69, P605; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; KLOPFSTEIN S, 2005, MOL BIOL EVOL; Mack S. J., 2007, IMMUNOBIOLOGY HUMAN, P747; Mal?cot, 1955, COLD SPRING HARB SYM, V20, P52; MANTEL N, 1967, CANCER RES, V27, P209; McCracken R D, 1971, J Trop Pediatr Environ Child Health, V17, P7; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Murray Robert F., 1990, GENETIC VARIATION DI; Nei M, 1986, Prog Clin Biol Res, V214, P21; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; RAY N, COMMUNICATION; RENFREW C., 1989, ARCHAEOLOGY LANGUAGE; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; SABBAGH A, 2002, ETUDE DIVERSITE GENE; Sanchez-Mazas A., 2007, IMMUNOBIOLOGY HUMAN, P758; Sanchez-Mazas A, 2005, PEOPLING E ASIA PUTT, P273; Sanchez-Mazas A, 2007, TISSUE ANTIGENS, V69, P198, DOI 10.1111/j.1399-0039.2006.00802.x; SANCHEZMAZAS A, 1994, HUM BIOL, V66, P27; SANCHEZMAZAS A, PERSONAL DATABASE; SIMOONS FJ, 1970, AM J DIG DIS, V15, P695, DOI 10.1007/BF02235991; Sokal RR, 1995, BIOMETRY; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Sousa VC, 2009, GENETICS, V181, P1507, DOI 10.1534/genetics.108.098129; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Troelsen JT, 2005, BBA-GEN SUBJECTS, V1723, P19, DOI 10.1016/j.bbagen.2005.02.003; Zvelebil M., 2000, ARCHAEOGENETICS DNA, P57	51	87	90	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6369	10.1371/journal.pone.0006369	http://dx.doi.org/10.1371/journal.pone.0006369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629189	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000268318900009
J	Li, XL; Liu, YY; Knight, D; Odaka, Y; Mathis, JM; Shi, RH; Glass, J; Zhang, QJ				Li, Xiao-Lin; Liu, Yong-Yu; Knight, David; Odaka, Yoshinobu; Mathis, J. Michael; Shi, Runhua; Glass, Jonathan; Zhang, Qian-Jin			Effect of B7.1 Costimulation on T-Cell Based Immunity against TAP-Negative Cancer Can Be Facilitated by TAP1 Expression	PLOS ONE			English	Article								Tumors deficient in expression of the transporter associated with antigen processing (TAP) usually fail to induce T-cell-mediated immunity and are resistant to T-cell lysis. However, we have found that introduction of the B7.1 gene into TAP-negative (TAP(-)) or TAP1-transfected (TAP1(+)) murine lung carcinoma CMT.64 cells can augment the capacity of the cells to induce a protective immune response against wild-type tumor cells. Differences in the strength of the protective immune responses were observed between TAP(-) and TAP1(+) B7.1 expressing CMT.64 cells depending on the doses of gamma-irradiated cell immunization. While mice immunized with either high or low dose of B7.1-expressing TAP1(+) cells rejected TAP(-) tumors, only high dose immunization with B7.1-expressing TAP(-) cells resulted in tumor rejection. The induced protective immunity was T-cell dependent as demonstrated by dramatically reduced antitumor immunity in mice depleted of CD8 or CD4 cells. Augmentation of T-cell mediated immune response against TAP(-) tumor cells was also observed in a virally infected tumor cell system. When mice were immunized with a high dose of gamma-irradiated CMT.64 cells infected with vaccinia viruses carrying B7.1 and/or TAP1 genes, we found that the cells co-expressing B7.1 and TAP1, but not those expressing B7.1 alone, induced protective immunity against CMT.64 cells. In addition, inoculation with live tumor cells transfected with several different gene(s) revealed that only B7.1- and TAP1-coexpressing tumor cells significantly decreased tumorigenicity. These results indicate that B7.1- provoked antitumor immunity against TAP(-) cancer is facilitated by TAP1-expression, and thus both genes should be considered for cancer therapy in the future.			Li, XL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Cellular Biol & Anat,Gene Therapy Program, Shreveport, LA 71105 USA.	qzhang@lsuhsc.edu	Odaka, Yoshinobu/AAY-6918-2021; Mathis, J. Michael/J-1379-2018	Odaka, Yoshinobu/0000-0003-3966-5475; Liu, Yong-Yu/0000-0002-7968-0162; Mathis, J. Michael/0000-0001-5528-5195				Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BACIK I, 1994, J IMMUNOL, V152, P381; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Bour H, 1998, J IMMUNOL, V160, P5522; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Cohen PA, 2000, CRIT REV IMMUNOL, V20, P17; De Silva AD, 1999, J IMMUNOL, V163, P4413; GABATHULER R, 1994, J EXP MED, V180, P1415, DOI 10.1084/jem.180.4.1415; Gao FG, 2002, CANCER RES, V62, P6438; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Hallden G, 2003, MOL THER, V8, P412, DOI 10.1016/S1525-0016(03)00199-0; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HODGE JW, 1994, CANCER RES, V54, P5552; Johnston JV, 1996, J EXP MED, V183, P791, DOI 10.1084/jem.183.3.791; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; Li XL, 2008, TUMOR BIOL, V29, P359, DOI 10.1159/000178981; Liu YZ, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240600939867; Melief CJM, 2000, ADV IMMUNOL, V75, P235, DOI 10.1016/S0065-2776(00)75006-1; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Shi Y, 1998, J IMMUNOL, V160, P4305; Snyder HL, 1997, J EXP MED, V186, P1087, DOI 10.1084/jem.186.7.1087; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; Toes REM, 1998, SEMIN IMMUNOL, V10, P443, DOI 10.1006/smim.1998.0147; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Wolpert EZ, 1997, P NATL ACAD SCI USA, V94, P11496, DOI 10.1073/pnas.94.21.11496; Yao YX, 2007, CELL IMMUNOL, V246, P92, DOI 10.1016/j.cellimm.2007.06.005; Yu P, 2003, J EXP MED, V197, P985, DOI 10.1084/jem.20021804; Zhang Q. J., 2007, INT J CANC	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6385	10.1371/journal.pone.0006385	http://dx.doi.org/10.1371/journal.pone.0006385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629186	Green Submitted, Green Published, gold			2022-12-25	WOS:000268318900013
J	Buchhave, P; Blennow, K; Zetterberg, H; Stomrud, E; Londos, E; Andreasen, N; Minthon, L; Hansson, O				Buchhave, Peder; Blennow, Kaj; Zetterberg, Henrik; Stomrud, Erik; Londos, Elisabet; Andreasen, Niels; Minthon, Lennart; Hansson, Oskar			Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; TAU LEVELS; FOLLOW-UP; STABILITY; BETA-AMYLOID((1-42)); PROGRESSION; PREDICTION; DECLINE; RATIO	Background: The CSF biomarkers tau and A beta 42 can identify patients with AD, even during the preclinical stages. However, previous studies on longitudinal changes of tau and A beta 42 in individual patients with AD and elderly controls report somewhat inconsistent results. Methodology/Principal Findings: We investigated the levels of tau and A beta 42 at baseline and after 1 year in 100 patients with AD. In a second cohort of 45 AD patients we measured the CSF biomarkers at baseline and after 2 years. Moreover, in 34 healthy elderly controls the CSF biomarkers were followed for 4 years. The baseline levels of tau were increased with >60% in AD patients compared to controls (p<0.001), while baseline A beta 42 levels were decreased with >50% (p<0.001). In the AD group followed for 2 years, tau increased with 16% compared to the baseline levels (p<0.05). However, the levels of tau were stable over 4 years in the controls. The levels of A beta 42 did not change significantly over time in any of the groups. In the patients with AD, tau was moderately associated with worse cognitive performance already at baseline (p<0.05). Conclusions/Significance: Tau and A beta 42 in CSF seem to reflect the underlying disease state in both early and late stages of AD. The slight increase in tau over time observed in the patients with AD is modest when compared to the relatively large difference in absolute tau levels between AD patients and controls. Therefore, these markers maintain their usefulness as state markers over time and might serve as surrogate markers for treatment efficacy in clinical trials.			Buchhave, P (corresponding author), Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Lund, Sweden.	oskar.hansson@med.lu.se	Hansson, Oskar/A-7134-2013	Hansson, Oskar/0000-0001-8467-7286				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Andreasen N, 1999, NEUROLOGY, V53, P1488, DOI 10.1212/WNL.53.7.1488; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2007, NEUROSCI LETT, V419, P18, DOI 10.1016/j.neulet.2007.03.064; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bouwman FH, 2007, NEUROLOGY, V69, P1006, DOI 10.1212/01.wnl.0000271375.37131.04; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fleisher AS, 2007, NEUROLOGY, V68, P1588, DOI 10.1212/01.wnl.0000258542.58725.4c; Fox N, 2004, NEURORX, DOI [10.1602/neurorx.1.2.181, DOI 10.1602/NEURORX.1.2.181]; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hansson O, 2007, DEMENT GERIATR COGN, V23, P316, DOI 10.1159/000100926; Hansson O, 2009, NEUROBIOL AGING, V30, P165, DOI 10.1016/j.neurobiolaging.2007.06.009; Huey ED, 2006, DEMENT GERIATR COGN, V22, P48, DOI 10.1159/000093261; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kanai M, 1998, ANN NEUROL, V44, P17, DOI 10.1002/ana.410440108; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Stefani A, 2006, J NEUROL SCI, V251, P124, DOI 10.1016/j.jns.2006.09.014; Stomrud E, 2007, DEMENT GERIATR COGN, V24, P118, DOI 10.1159/000105017; Sunderland T, 1999, BIOL PSYCHIAT, V46, P750, DOI 10.1016/S0006-3223(99)00143-2; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307; Zetterberg Henrik, 2008, Handb Clin Neurol, V89, P261, DOI 10.1016/S0072-9752(07)01224-9	27	68	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6294	10.1371/journal.pone.0006294	http://dx.doi.org/10.1371/journal.pone.0006294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609443	gold, Green Published, Green Submitted			2022-12-25	WOS:000268119500016
J	Paruthiyil, S; Cvoro, A; Zhao, XY; Wu, ZJ; Sui, YX; Staub, RE; Baggett, S; Herber, CB; Griffin, C; Tagliaferri, M; Harris, HA; Cohen, I; Bjeldanes, LF; Speed, TP; Schaufele, F; Leitman, DC				Paruthiyil, Sreenivasan; Cvoro, Aleksandra; Zhao, Xiaoyue; Wu, Zhijin; Sui, Yunxia; Staub, Richard E.; Baggett, Scott; Herber, Candice B.; Griffin, Chandi; Tagliaferri, Mary; Harris, Heather A.; Cohen, Isaac; Bjeldanes, Leonard F.; Speed, Terence P.; Schaufele, Fred; Leitman, Dale C.			Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor beta-Selective Agonists	PLOS ONE			English	Article								Estrogens produce biological effects by interacting with two estrogen receptors, ER alpha and ER beta. Drugs that selectively target ERa or ERb might be safer for conditions that have been traditionally treated with non-selective estrogens. Several synthetic and natural ER beta-selective compounds have been identified. One class of ER beta-selective agonists is represented by ERB-041 (WAY-202041) which binds to ER beta much greater than ER alpha. A second class of ER beta-selective agonists derived from plants include MF101, nyasol and liquiritigenin that bind similarly to both ERs, but only activate transcription with ER beta. Diarylpropionitrile represents a third class of ER beta-selective compounds because its selectivity is due to a combination of greater binding to ER beta and transcriptional activity. However, it is unclear if these three classes of ER beta-selective compounds produce similar biological activities. The goals of these studies were to determine the relative ER beta selectivity and pattern of gene expression of these three classes of ER beta-selective compounds compared to estradiol (E(2)), which is a non-selective ER agonist. U2OS cells stably transfected with ER alpha or ER beta were treated with E(2) or the ER beta-selective compounds for 6 h. Microarray data demonstrated that ERB-041, MF101 and liquiritigenin were the most ER beta-selective agonists compared to estradiol, followed by nyasol and then diarylpropionitrile. FRET analysis showed that all compounds induced a similar conformation of ER beta, which is consistent with the finding that most genes regulated by the ER beta-selective compounds were similar to each other and E(2). However, there were some classes of genes differentially regulated by the ER beta agonists and E(2). Two ER beta-selective compounds, MF101 and liquiritigenin had cell type-specific effects as they regulated different genes in HeLa, Caco-2 and Ishikawa cell lines expressing ER beta. Our gene profiling studies demonstrate that while most of the genes were commonly regulated by ER beta-selective agonists and E(2), there were some genes regulated that were distinct from each other and E(2), suggesting that different ER beta-selective agonists might produce distinct biological and clinical effects.			Paruthiyil, S (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA.	dale@leitmanlab.com	wu, zhijin/J-4995-2016; Speed, Terence P/B-8085-2009; wu, zhijin/J-2282-2014	wu, zhijin/0000-0002-9596-9134; Speed, Terence P/0000-0002-5403-7998; 	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT002173, AT002173] Funding Source: Medline; NIGMS NIH HHS [R01 GM083084-03, R01 GM083084] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bowe J, 2006, J ENDOCRINOL, V191, P399, DOI 10.1677/joe.1.06919; Carpenter KD, 2006, ANN NY ACAD SCI, V1092, P361, DOI 10.1196/annals.1365.033; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Grady D, 2009, MENOPAUSE, V16, P458, DOI 10.1097/gme.0b013e31818e64dd; Han SJ, 2006, MOL ENDOCRINOL, V20, P45, DOI 10.1210/me.2005-0310; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; HARRIS HA, 2006, NUCL RECEPT SIGNAL, V4; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Imwalle DB, 2005, PHYSIOL BEHAV, V84, P157, DOI 10.1016/j.physbeh.2004.11.002; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Levy N, 2007, ENDOCRINOLOGY, V148, P3449, DOI 10.1210/en.2006-1632; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MacLennan AH, 2006, MENOPAUSE, V13, P28, DOI 10.1097/01.gme.0000191204.38664.61; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Rissman EF, 2002, P NATL ACAD SCI USA, V99, P3996, DOI 10.1073/pnas.012032699; Rocha BA, 2005, PSYCHOPHARMACOLOGY, V179, P637, DOI 10.1007/s00213-004-2078-1; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shim GJ, 2003, P NATL ACAD SCI USA, V100, P6694, DOI 10.1073/pnas.0731830100; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882	51	58	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6271	10.1371/journal.pone.0006271	http://dx.doi.org/10.1371/journal.pone.0006271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609440	gold, Green Published			2022-12-25	WOS:000268119500006
J	Toomey, D; Hoppe, HC; Brennan, MP; Nolan, KB; Chubb, AJ				Toomey, David; Hoppe, Heinrich C.; Brennan, Marian P.; Nolan, Kevin B.; Chubb, Anthony J.			Genomes2Drugs: Identifies Target Proteins and Lead Drugs from Proteome Data	PLOS ONE			English	Article								Background: Genome sequencing and bioinformatics have provided the full hypothetical proteome of many pathogenic organisms. Advances in microarray and mass spectrometry have also yielded large output datasets of possible target proteins/genes. However, the challenge remains to identify new targets for drug discovery from this wealth of information. Further analysis includes bioinformatics and/or molecular biology tools to validate the findings. This is time consuming and expensive, and could fail to yield novel drugs if protein purification and crystallography is impossible. To pre-empt this, a researcher may want to rapidly filter the output datasets for proteins that show good homology to proteins that have already been structurally characterised or proteins that are already targets for known drugs. Critically, those researchers developing novel antibiotics need to select out the proteins that show close homology to any human proteins, as future inhibitors are likely to cross-react with the host protein, causing off-target toxicity effects later in clinical trials. Methodology/Principal Findings: To solve many of these issues, we have developed a free online resource called Genomes2Drugs which ranks sequences to identify proteins that are (i) homologous to previously crystallized proteins or (ii) targets of known drugs, but are (iii) not homologous to human proteins. When tested using the Plasmodium falciparum malarial genome the program correctly enriched the ranked list of proteins with known drug target proteins. Conclusions/Significance: Genomes2Drugs rapidly identifies proteins that are likely to succeed in drug discovery pipelines. This free online resource helps in the identification of potential drug targets. Importantly, the program further highlights proteins that are likely to be inhibited by FDA-approved drugs. These drugs can then be rapidly moved into Phase IV clinical studies under 'change-of-application' patents.			Toomey, D (corresponding author), Royal Coll Surgeons Ireland, Mol Modelling Grp, Dublin 2, Ireland.	achubb@rcsi.ie	Brennan, Marian/D-7564-2013; Nolan, Kevin/D-7669-2012	Brennan, Marian/0000-0003-2368-5383; Hoppe, Heinrich/0000-0003-4409-1955; Chubb, Anthony/0000-0003-1875-7100				Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez JC, 2004, CURR OPIN CHEM BIOL, V8, P365, DOI 10.1016/j.cbpa.2004.05.001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Kersey P, 2005, NUCLEIC ACIDS RES, V33, pD297, DOI 10.1093/nar/gri039; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	10	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6195	10.1371/journal.pone.0006195	http://dx.doi.org/10.1371/journal.pone.0006195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593435	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035300008
J	Xu, XL; Lou, ZY; Ma, YL; Chen, XH; Yang, ZS; Tong, XH; Zhao, Q; Xu, YY; Deng, HY; Bartlam, M; Rao, ZH				Xu, Xiaoling; Lou, Zhiyong; Ma, Yanlin; Chen, Xuehui; Yang, Zhangsheng; Tong, Xiaohang; Zhao, Qi; Xu, Yuanyuan; Deng, Hongyu; Bartlam, Mark; Rao, Zihe			Crystal Structure of the C-Terminal Cytoplasmic Domain of Non-Structural Protein 4 from Mouse Hepatitis Virus A59	PLOS ONE			English	Article								Background: The replication of coronaviruses takes place on cytoplasmic double membrane vesicles (DMVs) originating in the endoplasmic reticulum (ER). Three trans-membrane non-structural proteins, nsp3, nsp4 and nsp6, are understood to be membrane anchors of the coronavirus replication complex. Nsp4 is localized to the ER membrane when expressed alone but is recruited into the replication complex in infected cells. It is revealed to contain four trans-membrane regions and its N- and C-termini are exposed to the cytosol. Methodology/Principal Findings: We have determined the crystal structures of the C-terminal hydrophilic domain of nsp4 (nsp4C) from MHV strain A59 and a C425S site-directed mutant. The highly conserved 89 amino acid region from T408 to Q496 is shown to possess a new fold. The wild-type (WT) structure features two monomers linked by a Cys425-Cys425 disulfide bond in one asymmetric unit. The monomers are arranged with their N- and C-termini in opposite orientations to form an "open'' conformation. Mutation of Cys425 to Ser did not affect the monomer structure, although the mutant dimer adopts strikingly different conformations by crystal packing, with the cross-linked C-termini and parallel N- termini of two monomers forming a "closed'' conformation. The WT nsp4C exists as a dimer in solution and can dissociate easily into monomers in a reducing environment. Conclusions/Significance: As nsp4C is exposed in the reducing cytosol, the monomer of nsp4C should be physiological. This structure may serve as a basis for further functional studies of nsp4.			Xu, XL (corresponding author), Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn	Zhao, Qi/H-7974-2012; Xu, Xiaoling/ABC-2449-2021; Yang, Zhangsheng/N-4080-2013; Zhao, Qi/C-6344-2013; Rao, Zihe/HCH-6944-2022	Xu, Xiaoling/0000-0001-8995-1213; Yang, Zhangsheng/0000-0003-2208-8632; Bartlam, Mark/0000-0001-5173-5080				Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Clementz MA, 2008, VIROLOGY, V375, P118, DOI 10.1016/j.virol.2008.01.018; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deming DJ, 2007, J VIROL, V81, P10280, DOI 10.1128/JVI.00017-07; Denison MR, 1999, J VIROL, V73, P6862, DOI 10.1128/JVI.73.8.6862-6871.1999; Denison MR, 1998, ADV EXP MED BIOL, V440, P121; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanjanahaluethai A, 2007, VIROLOGY, V361, P391, DOI 10.1016/j.virol.2006.12.009; KOOLEN MJM, 1987, J GEN VIROL, V68, P703, DOI 10.1099/0022-1317-68-3-703; LAVI E, 1984, NEUROLOGY, V34, P597, DOI 10.1212/WNL.34.5.597; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; OOSTRA M, 2007, J VIROL; Oostra M, 2008, J VIROL, V82, P12392, DOI 10.1128/JVI.01219-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Prentice E, 2004, J VIROL, V78, P9977, DOI 10.1128/JVI.78.18.9977-9986.2004; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Shi ST, 1999, J VIROL, V73, P5957, DOI 10.1128/JVI.73.7.5957-5969.1999; Sims AC, 2000, J VIROL, V74, P5647, DOI 10.1128/JVI.74.12.5647-5654.2000; SITIA R, 2004, SCI STKE, pPE27; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; SPARKS JS, 2007, J VIROL; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijms MA, 2003, J GEN VIROL, V84, P2317, DOI 10.1099/vir.0.19297-0; van der Meer Y, 1998, J VIROL, V72, P6689, DOI 10.1128/JVI.72.8.6689-6698.1998; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Ziebuhr J, 2006, ADV EXP MED BIOL, V581, P3	49	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6217	10.1371/journal.pone.0006217	http://dx.doi.org/10.1371/journal.pone.0006217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593433	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035300022
J	Sundaram, S; Roy, SK; Ambati, BK; Kompella, UB				Sundaram, Sneha; Roy, Shyamal K.; Ambati, Balamurali K.; Kompella, Uday B.			Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium	FASEB JOURNAL			English	Article						deslorelin; transferrin; anti-VEGF intraceptor; prostate cancer; gene therapy; poly-L-lactide-co-glycolide	GONADOTROPIN-RELEASING-HORMONE; HUMAN PROSTATE CANCERS; TRANSFERRIN-RECEPTOR; DRUG-DELIVERY; LHRH-RECEPTOR; BREAST-CANCER; GROWTH-FACTOR; IN-VITRO; EXPRESSION; TRANSPORT	The objective of this study was to determine whether surface-modified nanoparticles enhance permeability across nasal mucosa, while retaining the effectiveness of the payload. The uptake and permeability of polystyrene nanoparticles (PS-NPs; Fluo-Spheres) was evaluated across the various regions of the bovine nasal epithelia following conjugation with deslorelin and transferrin. Uptake and transport of PS-NPs, deslorelin-PS-NPs, and transferrin-PS-NPs exhibited regional differences in the order: inferior turbinate posterior (ITP) > medium turbinate posterior (MTP) > medium turbinate anterior (MTA). Uptake and transport also exhibited directionality and temperature dependence in these tissues. Further, uptake as well as transport of functionalized nanoparticles could be inhibited by excess free functionalizing ligand. Confocal microscopy indicated the presence of functionalized nanoparticles in respiratory epithelial cells, as well as other cell types of the nasal tissue. We chose the ITP region for further studies with deslorelin or transferrin-conjugated poly-L-lactide-co-glycolide nanoparticles (PLGA-NPs) encapsulating an anti-VEGF intraceptor (Flt23k) plasmid. Transport of the nanoparticles, as well as the plasmid from the nanoparticles, exhibited the following order: transferrin-PLGA-NPs > deslorelin-PLGA-NPs > PLGA-NPs >> plasmid. The ability of the nanoparticles transported across the nasal tissue to retain the effectiveness of the Flt23k plasmid was evaluated by measuring transfection efficiency (percentage of cells expressing GFP) and VEGF inhibition in LNCaP and PC-3 prostate cancer cells. Transfection efficiencies and VEGF inhibition in LNCaP and PC-3 cells exhibited the following trend: transferrin-PLGA-NPs >= deslorelin-PLGA-NPs > PLGA-NPs >> plasmid. Further, functionalized nanoparticles exhibited transfection efficiencies and VEGF inhibition significantly superior compared with the routinely used transfecting agent, lipofectamine. Formulating plasmids into nanoparticulate delivery systems enhances the transnasal delivery and gene therapy at remote target cancer cells, which can be further enhanced by nanoparticle functionalization with deslorelin or transferrin.-Sundaram, S., Roy, S. K., Ambati, B. K., Kompella, U. B. Surface functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium. FASEB J. 23, 3752-3765 (2009). www.fasebj.org	[Sundaram, Sneha; Kompella, Uday B.] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska, Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA; [Sundaram, Sneha; Kompella, Uday B.] Univ Colorado Denver, Dept Pharmaceut Sci, Denver, CO USA; [Ambati, Balamurali K.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Utah System of Higher Education; University of Utah	Kompella, UB (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, 12700 E 19th Ave, Aurora, CO 80045 USA.	uday.kompella@ucdenver.edu	Sundaram, Sneha/G-4607-2012; Kompella, U/C-9789-2011		U.S. National Institutes of Health [DK064172, EY013842]; Unviersity of Nebraska Medical Center (UNMC) Bukey Fellowship; American Heart Association; NATIONAL EYE INSTITUTE [R03EY013842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064172] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unviersity of Nebraska Medical Center (UNMC) Bukey Fellowship; American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by U.S. National Institutes of Health grants DK064172 and EY013842. S. S. was supported by a Unviersity of Nebraska Medical Center (UNMC) Bukey Fellowship and a Predoctoral Fellowship from the American Heart Association. We thank Prof. Ming-Fong Lin (Department of Biochemistry and Molecular Biology, UNMC) for kindly providing us with the prostate cancer cell lines used in this study. We thank Janice Taylor of the Confocal Laser Scanning Microscopy Core Facility at UNMC, which is supported by the Nebraska Research Initiative, for providing assistance with confocal microscopy. We thank Tom Bargar of the Electron Microscopy Facility for his assistance in obtaining nanoparticle images. We thank the Flow Cytometry Core Facility for assistance in FACS analysis for nanoparticle uptake.	Apel A, 2009, EXP CELL RES, V315, P498, DOI 10.1016/j.yexcr.2008.11.013; Bandi N, 2002, EUR J PHARMACOL, V437, P9, DOI 10.1016/S0014-2999(02)01267-0; BERGER H, 1991, REGUL PEPTIDES, V33, P299, DOI 10.1016/0167-0115(91)90232-6; Brooking J, 2001, J DRUG TARGET, V9, P267, DOI 10.3109/10611860108997935; Grundker C, 2002, EUR J ENDOCRINOL, V146, P1, DOI 10.1530/eje.0.1460001; Halmos G, 2000, J UROLOGY, V163, P623, DOI 10.1016/S0022-5347(05)67947-5; HAZUM E, 1980, P NATL ACAD SCI-BIOL, V77, P6692, DOI 10.1073/pnas.77.11.6692; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Kang SW, 2008, BIOMATERIALS, V29, P1109, DOI 10.1016/j.biomaterials.2007.11.004; KEER HN, 1990, J UROLOGY, V143, P381, DOI 10.1016/S0022-5347(17)39970-6; Koushik K, 2004, PHARM RES-DORDR, V21, P1034, DOI 10.1023/B:PHAM.0000029294.70707.74; Koushik KN, 2004, J PHARM PHARMACOL, V56, P861, DOI 10.1211/0022357023646; Li HY, 2002, TRENDS PHARMACOL SCI, V23, P206, DOI 10.1016/S0165-6147(02)01989-2; Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Mo Y, 2007, MOL VIS, V13, P746; *MOL PROB INV DET, 2004, WORK FLUOSPHERES FLU; Prost AC, 1998, INT J ONCOL, V13, P871; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Relf M, 1997, CANCER RES, V57, P963; Schmidt MC, 2000, J PHARM SCI, V89, P396, DOI 10.1002/(SICI)1520-6017(200003)89:3<396::AID-JPS10>3.0.CO;2-F; SHINDELMAN JE, 1981, INT J CANCER, V27, P329, DOI 10.1002/ijc.2910270311; Singh N, 2005, INVEST OPHTH VIS SCI, V46, P1647, DOI 10.1167/iovs.04-1172; Singh SR, 2009, GENE THER, V16, P645, DOI 10.1038/gt.2008.185; Straub B, 2001, CLIN CANCER RES, V7, P2340; SUNDARAM S, 2004, AM PHARM REV, V7, P130; Sundaram S, 2009, PEPTIDES, V30, P351, DOI 10.1016/j.peptides.2008.10.005; Widera A, 2003, ADV DRUG DELIVER REV, V55, P1439, DOI 10.1016/j.addr.2003.07.004; Widera A, 2003, PHARMACEUT RES, V20, P1231, DOI 10.1023/A:1025005232421; Wirsig-Wiechmann Celeste R., 2001, Keio Journal of Medicine, V50, P81, DOI 10.2302/kjm.50.81; YlaHerttuala S, 1997, CURR OPIN LIPIDOL, V8, P72	31	29	32	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3752	3765		10.1096/fj.09-129825	http://dx.doi.org/10.1096/fj.09-129825			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19608628	Green Published			2022-12-25	WOS:000271272500013
J	Coulouarn, C; Factor, VM; Andersen, JB; Durkin, ME; Thorgeirsson, SS				Coulouarn, C.; Factor, V. M.; Andersen, J. B.; Durkin, M. E.; Thorgeirsson, S. S.			Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties	ONCOGENE			English	Article						hepatocellular carcinoma; microRNA; differentiation; metastasis; microarray	HUMAN HEPATOCELLULAR-CARCINOMA; C VIRUS-RNA; GENE-EXPRESSION; MICRORNA EXPRESSION; FUNCTIONAL GENOMICS; TUMOR-SUPPRESSOR; CELL-LINES; IN-VIVO; MOUSE; IDENTIFICATION	Growing evidence indicates that microRNAs have a significant role in tumor development and may constitute robust biomarkers for cancer diagnosis and prognosis. In this study, we evaluated the clinical and functional relevance of microRNA-122 (miR-122) expression in human hepatocellular carcinoma (HCC). We report that miR-122 is specifically repressed in a subset of primary tumors that are characterized by poor prognosis. We further show that the loss of miR-122 expression in tumor cells segregates with specific gene expression profiles linked to cancer progression, namely the suppression of hepatic phenotype and the acquisition of invasive properties. We identify liver-enriched transcription factors as central regulatory molecules in the gene networks associated with loss of miR-122, and provide evidence suggesting that miR-122 is under the transcriptional control of HNF1A, HNF3A and HNF3B. We further show that loss of miR-122 results in an increase of cell migration and invasion and that restoration of miR-122 reverses this phenotype. In conclusion, miR-122 is a marker of hepatocyte-specific differentiation and an important determinant in the control of cell migration and invasion. From a clinical point of view, our study emphasizes miR-122 as a diagnostic and prognostic marker for HCC progression. Oncogene (2009) 28, 3526-3536; doi: 10.1038/onc.2009.211; published online 20 July 2009	[Coulouarn, C.; Factor, V. M.; Andersen, J. B.; Durkin, M. E.; Thorgeirsson, S. S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thorgeirsson, SS (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Room 4146A, Bethesda, MD 20892 USA.	snorri_s_thorgeirsson@nih.gov	Coulouarn, Cedric/E-5472-2011	Coulouarn, Cedric/0000-0002-5692-9586; Andersen, Jesper B/0000-0003-1760-5244	Intramural Research Program of the Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011170, ZIABC011173] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by the Intramural Research Program of the Center for Cancer Research.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Braconi C, 2008, HEPATOLOGY, V47, P1807, DOI 10.1002/hep.22326; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Coulouarn C, 2006, HEPATOLOGY, V44, P1003, DOI 10.1002/hep.21293; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Lee JS, 2002, HEPATOLOGY, V35, P1134, DOI 10.1053/jhep.2002.33165; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Lin CJF, 2008, BIOCHEM BIOPH RES CO, V375, P315, DOI 10.1016/j.bbrc.2008.07.154; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; YOSHIOKA K, 1995, FEBS LETT, V372, P25, DOI 10.1016/0014-5793(95)00937-5	46	559	617	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2009	28	40					3526	3536		10.1038/onc.2009.211	http://dx.doi.org/10.1038/onc.2009.211			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KI	19617899	Green Accepted			2022-12-25	WOS:000270851700002
J	Bao, R; Zhou, CZ; Jiang, CH; Lin, SX; Chi, CW; Chen, YX				Bao, Rui; Zhou, Cong-Zhao; Jiang, Chunhui; Lin, Sheng-Xiang; Chi, Cheng-Wu; Chen, Yuxing			The Ternary Structure of the Double-headed Arrowhead Protease Inhibitor API-A Complexed with Two Trypsins Reveals a Novel Reactive Site Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOWMAN-BIRK INHIBITOR; CRYSTAL-STRUCTURE; PROTEINASE-INHIBITORS; 2.3 ANGSTROM; CHYMOTRYPSIN INHIBITOR; ERYTHRINA-CAFFRA; PORCINE TRYPSIN; BOVINE TRYPSIN; BARLEY-SEEDS; KUNITZ	The double-headed arrowhead protease inhibitors API-A and -B from the tubers of Sagittaria sagittifolia (Linn) feature two distinct reactive sites, unlike other members of their family. Although the two inhibitors have been extensively characterized, the identities of the two P1 residues in both API-A and -B remain controversial. The crystal structure of a ternary complex at 2.48 angstrom resolution revealed that the two trypsins bind on opposite sides of API-A and are 34 angstrom apart. The overall fold of API-A belongs to the beta-trefoil fold and resembles that of the soybean Kunitz-type trypsin inhibitors. The two P1 residues were unambiguously assigned as Leu(87) and Lys(145), and their identities were further confirmed by site-directed mutagenesis. Reactive site 1, composed of residues P5 Met(83) to P5' Ala(92), adopts a novel conformation with the Leu87 completely embedded in the S1 pocket even though it is an unfavorable P1 residue for trypsin. Reactive site 2, consisting of residues P5 Cys(141) to P5' Glu(150), binds trypsin in the classic mode by employing a two-disulfide-bonded loop. Analysis of the two binding interfaces sheds light on atomic details of the inhibitor specificity and also promises potential improvements in enzyme activity by engineering of the reactive sites.	[Bao, Rui; Jiang, Chunhui; Chi, Cheng-Wu] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lin, Sheng-Xiang; Chi, Cheng-Wu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Tongji University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chi, CW (corresponding author), Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China.	zwqi@sibs.ac.cn; cyxing@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; bao, rui/AAM-9906-2020; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; bao, rui/0000-0002-6083-8716; Chen, Yuxing/0000-0002-7560-1922; jiang, chunhui/0000-0003-2074-0033; Lin, Sheng-Xiang/0000-0001-9149-375X	Ministry of Science and Technology of China [2006CB910202, 2006CB806501]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Ministry of Science and Technology of China Projects 2006CB910202 and 2006CB806501.	Araujo APU, 2005, BIOL CHEM, V386, P561, DOI 10.1515/BC.2005.066; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTELS K, 2003, AUTOMAR USERS GUIDE; Bauer RA, 2008, NUCLEIC ACIDS RES, V36, pW47, DOI 10.1093/nar/gkn285; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Bunnage ME, 2007, J MED CHEM, V50, P6095, DOI 10.1021/jm0702433; Capaldi S, 2007, J STRUCT BIOL, V158, P71, DOI 10.1016/j.jsb.2006.10.017; CHANG HY, 1979, SCI SINICA, V22, P1443; Dattagupta JK, 1999, PROTEINS, V35, P321, DOI 10.1002/(SICI)1097-0134(19990515)35:3<321::AID-PROT6>3.3.CO;2-P; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Sierra IL, 1999, J MOL BIOL, V285, P1195, DOI 10.1006/jmbi.1998.2351; de Meester P, 1998, ACTA CRYSTALLOGR D, V54, P589, DOI 10.1107/S0907444997015849; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodor K, 2006, BIOCHEMISTRY-US, V45, P2114, DOI 10.1021/bi0517133; Helland R, 1999, ACTA CRYSTALLOGR D, V55, P139, DOI 10.1107/S090744499801052X; ISHIKAWA A, 1994, PLANT CELL PHYSIOL, V35, P303; Ishikura H, 2007, LIFE SCI, V80, P1999, DOI 10.1016/j.lfs.2007.02.044; Kobayashi H, 2004, CANCER-AM CANCER SOC, V100, P869, DOI 10.1002/cncr.20034; Koepke J, 2000, J MOL BIOL, V298, P477, DOI 10.1006/jmbi.2000.3677; Krauchenco S, 2003, BIOCHEM BIOPH RES CO, V312, P1303, DOI 10.1016/j.bbrc.2003.11.062; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Li J, 2002, ACTA BIOCH BIOPH SIN, V34, P662; LIN GD, 1993, EUR J BIOCHEM, V212, P549, DOI 10.1111/j.1432-1033.1993.tb17692.x; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luo MJ, 1997, J BIOCHEM-TOKYO, V121, P991; MIZOBATA T, 1992, J BIOL CHEM, V267, P17773; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Ng TB, 2003, BIOL CHEM, V384, P289, DOI 10.1515/BC.2003.032; Nielsen PK, 2004, BBA-PROTEINS PROTEOM, V1696, P157, DOI 10.1016/j.bbapap.2003.09.019; ONESTI S, 1991, J MOL BIOL, V217, P153, DOI 10.1016/0022-2836(91)90618-G; Park EY, 2004, J MOL BIOL, V343, P173, DOI 10.1016/j.jmb.2004.08.027; Raj SSS, 2002, J BIOCHEM, V132, P927, DOI 10.1093/oxfordjournals.jbchem.a003306; Ravichandran S, 2001, PROTEIN ENG, V14, P349, DOI 10.1093/protein/14.5.349; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Schmidt AE, 2005, J BIOL CHEM, V280, P27832, DOI 10.1074/jbc.M504105200; Song HK, 1999, J MOL BIOL, V293, P1133, DOI 10.1006/jmbi.1999.3239; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; STRUKELJ B, 1992, BIOL CHEM H-S, V373, P477, DOI 10.1515/bchm3.1992.373.2.477; SWEET RM, 1974, BIOCHEMISTRY-US, V13, P4212, DOI 10.1021/bi00717a024; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Xie ZW, 1997, BIOCHEMISTRY-US, V36, P5846, DOI 10.1021/bi962993c; XIE ZW, 1996, SCI SINICA, V28, P700; YANG HL, 1992, J BIOCHEM-TOKYO, V111, P537, DOI 10.1093/oxfordjournals.jbchem.a123792; Zhu YS, 1999, J PROTEIN CHEM, V18, P505, DOI 10.1023/A:1020690931043	47	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26676	26684		10.1074/jbc.M109.022095	http://dx.doi.org/10.1074/jbc.M109.022095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640842	hybrid, Green Published			2022-12-25	WOS:000269969600048
J	Dumoutier, L; de Meester, C; Tavernier, J; Renauld, JC				Dumoutier, Laure; de Meester, Carole; Tavernier, Jan; Renauld, Jean-Christophe			New Activation Modus of STAT3 A TYROSINE-LESS REGION OF THE INTERLEUKIN-22 RECEPTOR RECRUITS STAT3 BY INTERACTING WITH ITS COILED-COIL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I INTERFERON RECEPTOR; SIGNAL TRANSDUCER; CYTOKINE RECEPTORS; STIMULATING FACTOR; MOUSE MODEL; PSORIASIS; IL-22; KERATINOCYTES; TYROSINE; DIFFERENTIATION	Activation of STAT proteins by cytokines is initiated by their Src homology 2 domain-mediated association with phosphotyrosine residues from the cytoplasmic domain of a receptor. Here, we show that the C terminus of the interleukin-22 receptor (IL-22R) recruits in a tyrosine-independent manner the coiled-coil domain of STAT3. Mutation of all IL-22R cytoplasmic tyrosines did not abolish activation of STAT3, in contrast to that of STAT1 and STAT5. Coimmunoprecipitation and glutathione S-transferase pulldown experiments showed that the coiled-coil domain of STAT3 is constitutively associated with the C-terminal part of IL-22R, and a chimeric STAT3-STAT5 protein containing the coiled-coil domain of STAT3 could be activated by this tyrosine-independent mechanism. Deletion of the C-terminal part of IL-22R dramatically decreased its ability to activate STAT3 and to mediate IL-22 activity in cell lines, demonstrating that preassociation of STAT3 with this cytokine receptor, independent from the interaction between the Src homology 2 domain and phosphotyrosines, is required for its full activity.	[Renauld, Jean-Christophe] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Dumoutier, Laure; de Meester, Carole; Renauld, Jean-Christophe] Catholic Univ Louvain, de Duve Inst, Expt Med Unit, B-1200 Brussels, Belgium; [Tavernier, Jan] Flanders Interuniv Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; [Tavernier, Jan] Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Ghent University	Renauld, JC (corresponding author), Ludwig Inst Canc Res, Ave Hippocrate 74, B-1200 Brussels, Belgium.	renauld@bru.licr.org	Tavernier, Jan/AAG-3636-2019; Renauld, Jean-Christophe/B-7268-2012	Renauld, Jean-Christophe/0000-0003-1736-2131; Dumoutier, Laure/0000-0002-6645-684X	Belgian Federal Service for Scientific Technical and Cultural Affairs; Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique	Belgian Federal Service for Scientific Technical and Cultural Affairs; Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique	This work was supported in part by the Belgian Federal Service for Scientific Technical and Cultural Affairs and the Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boniface K, 2005, EUR CYTOKINE NETW, V16, P309; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Demoulin JB, 1999, J BIOL CHEM, V274, P25855, DOI 10.1074/jbc.274.36.25855; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; DRUEZ C, 1990, J IMMUNOL, V145, P2494; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; Nadeau OW, 1999, J BIOL CHEM, V274, P4045, DOI 10.1074/jbc.274.7.4045; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Russell-Harde D, 2000, J BIOL CHEM, V275, P23981, DOI 10.1074/jbc.M002518200; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	38	52	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26377	26384		10.1074/jbc.M109.007955	http://dx.doi.org/10.1074/jbc.M109.007955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632985	Green Published, hybrid			2022-12-25	WOS:000269969600018
J	Rauen, T; Raffetseder, U; Frye, BC; Djudjaj, S; Muhlenberg, PJT; Eitner, F; Lendahl, U; Bernhagen, J; Dooley, S; Mertens, PR				Rauen, Thomas; Raffetseder, Ute; Frye, Bjoern C.; Djudjaj, Sonja; Muehlenberg, Philipp J. T.; Eitner, Frank; Lendahl, Urban; Bernhagen, Juergen; Dooley, Steven; Mertens, Peter R.			YB-1 Acts as a Ligand for Notch-3 Receptors and Modulates Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Y-BOX PROTEIN-1; AUTOSOMAL-DOMINANT ARTERIOPATHY; MUSCLE-CELL PHENOTYPE; SUBCORTICAL INFARCTS; MESSENGER-RNA; EXTRACELLULAR DOMAIN; GLOMERULAR-DISEASE; BINDING PROTEIN-1; CCL5 EXPRESSION; PATHWAY	Y-box (YB) protein-1 is secreted by mesangial and immune cells after cytokine challenge, but extracellular functions are unknown. Here, we demonstrate that extracellular YB-1 associates with outer cell membrane components and interacts with extracellular Notch-3 receptor domains. The interaction appears to be specific for Notch-3, as YB-1-green fluorescent protein binds to the extracellular domains and full-length forms of Notch-3 but not to Notch-1. YB-1-green fluorescent protein and Notch-3 proteins co-localize at cell membranes, and extracellular YB-1 activates Notch-3 signaling, resulting in nuclear translocation of the Notch-3 intracellular domain and up-regulation of Notch target genes. The YB-1/Notch-3 interaction may be of particular relevance for inflammatory mesangioproliferative disease, as both proteins co-localize in an experimental nephritis model and receptor activation temporally and spatially correlates with YB-1 expression.	[Djudjaj, Sonja; Mertens, Peter R.] Otto VonGuericke Univ Magdegurg, Dept Hypertens & Nephrol, D-39120 Magdeburg, Germany; [Rauen, Thomas; Raffetseder, Ute; Frye, Bjoern C.; Djudjaj, Sonja; Muehlenberg, Philipp J. T.; Eitner, Frank] Univ Hosp RWTH Aachen, Dept Nephrol & Clin Immunol, D-52057 Aachen, Germany; [Lendahl, Urban] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Bernhagen, Juergen] Univ Hosp RWTH Aachen, Inst Biochem & Mol Cell Biol, Dept Cell & Mol Biol, D-52057 Aachen, Germany; [Dooley, Steven] Univ Heidelberg, Univ Hosp Mannheim, Med Clin 2, D-68167 Mannheim, Germany	Otto von Guericke University; RWTH Aachen University; RWTH Aachen University Hospital; Karolinska Institutet; RWTH Aachen University; RWTH Aachen University Hospital; Ruprecht Karls University Heidelberg	Mertens, PR (corresponding author), Otto VonGuericke Univ Magdegurg, Dept Hypertens & Nephrol, Leipziger Str 44, D-39120 Magdeburg, Germany.	peter.mertens@med.ovgu.de	Dooley, Steven/T-6491-2018; Mertens, Peter/AAI-7310-2020; Djudjaj, Sonja/ABH-4777-2020	Dooley, Steven/0000-0002-4840-6240; Djudjaj, Sonja/0000-0003-2352-7537; Lendahl, Urban/0000-0001-9543-8141; Raffetseder, Ute/0000-0002-7236-9793	Deutsche Forschungsgemeinschaft [D0373/81]; START program;  [SFB 542]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START program(Austrian Science Fund (FWF)); 	This work was funded by SFB 542 projects A11, C4, and C12 (to P. R. M.) A7 (to J. B.), Deutsche Forschungsgemeinschaft Project D0373/81 (to S. D.), and the START program (Faculty of Medicine, RWTH-Aachen, Germany). 1 These authors contributed equally to this work.	Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; de Celis JF, 2000, DEVELOPMENT, V127, P1291; Dooley S, 2006, J BIOL CHEM, V281, P1784, DOI 10.1074/jbc.M510215200; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Guerrot D, 2008, AM J KIDNEY DIS, V52, P340, DOI 10.1053/j.ajkd.2008.04.017; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Katoh M, 2007, INT J ONCOL, V31, P461; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Kusaba T, 2007, CLIN NEPHROL, V67, P182; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mertens PR, 2008, NEPHROL DIAL TRANSPL, V23, P2743, DOI 10.1093/ndt/gfn279; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Patel K, 2003, J CELL PHYSIOL, V195, P435, DOI 10.1002/jcp.10267; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Raffetseder U, 2009, KIDNEY INT, V75, P185, DOI 10.1038/ki.2008.457; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Schnabel M, 2002, INT J MOL MED, V9, P229; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; van Roeyen CRC, 2005, J AM SOC NEPHROL, V16, P2985, DOI 10.1681/ASN.2004111009	47	77	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26928	26940		10.1074/jbc.M109.046599	http://dx.doi.org/10.1074/jbc.M109.046599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19640841	Green Published, hybrid			2022-12-25	WOS:000269969600073
J	Wang, C; Yan, RL; Luo, DX; Watabe, K; Liao, DF; Cao, DL				Wang, Chun; Yan, Ruilan; Luo, Dixian; Watabe, Kounosuke; Liao, Duan-Fang; Cao, Deliang			Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA-CARBOXYLASE; FATTY-ACID SYNTHASE; BREAST-CANCER CELLS; OXIDATIVE STRESS; GROWTH-INHIBITION; STRUCTURAL BASIS; PROSTATE-CANCER; AKR1B10; EXPRESSION; ALDEHYDES	Aldo-keto reductase family 1 member B10 (AKR1B10) is primarily expressed in the normal human colon and small intestine but overexpressed in liver and lung cancer. Our previous studies have shown that AKR1B10 mediates the ubiquitin-dependent degradation of acetyl-CoA carboxylase-alpha. In this study, we demonstrate that AKR1B10 is critical to cell survival. In human colon carcinoma cells (HCT-8) and lung carcinoma cells (NCI-H460), small-interfering RNA-induced AKR1B10 silencing resulted in caspase-3-mediated apoptosis. In these cells, the total and subspecies of cellular lipids, particularly of phospholipids, were decreased by more than 50%, concomitant with 2-3-fold increase in reactive oxygen species, mitochondrial cytochrome c efflux, and caspase-3 cleavage. AKR1B10 silencing also increased the levels of alpha,beta-unsaturated carbonyls, leading to the 2-3-fold increase of cellular lipid peroxides. Supplementing the HCT-8 cells with palmitic acid (80 mu M), the end product of fatty acid synthesis, partially rescued the apoptosis induced by AKR1B10 silencing, whereas exposing the HCT-8 cells to epalrestat, an AKR1B10 inhibitor, led to more than 2-fold elevation of the intracellular lipid peroxides, resulting in apoptosis. These data suggest that AKR1B10 affects cell survival through modulating lipid synthesis, mitochondrial function, and oxidative status, as well as carbonyl levels, being an important cell survival protein.	[Wang, Chun; Yan, Ruilan; Luo, Dixian; Watabe, Kounosuke; Cao, Deliang] So Illinois Univ, Sch Medicine, Dept Med Microbiol Immunol & Cell Biol, SimmonsCooper Canc Inst, Springfield, IL 62702 USA; [Wang, Chun; Liao, Duan-Fang] Univ S China, Coll Sci & Technol, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China	Southern Illinois University System; Southern Illinois University; University of South China	Cao, DL (corresponding author), So Illinois Univ, Sch Medicine, Dept Med Microbiol Immunol & Cell Biol, SimmonsCooper Canc Inst, 913 N Rutledge St, Springfield, IL 62702 USA.	dcao@siumed.edu			National Institutes of Health [CA122327, CA122622]; American Cancer Society [RSG-04-031-01-CCE]; National Major Basic Research Program of China (973 Program) [2006CB 503808]; NATIONAL CANCER INSTITUTE [R21CA122327, R21CA122622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Major Basic Research Program of China (973 Program)(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122327 and CA122622 through the NCI. This work was also supported by American Cancer Society Grant RSG-04-031-01-CCE and National Major Basic Research Program of China (973 Program) Grant 2006CB 503808.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Balendiran GK, 2009, CHEM-BIOL INTERACT, V178, P134, DOI 10.1016/j.cbi.2008.10.044; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; BOOTH RJ, 1993, CLIN EXP PHARMACOL P, V20, P207, DOI 10.1111/j.1440-1681.1993.tb01672.x; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Choudhary S, 2005, TOXICOL APPL PHARM, V204, P122, DOI 10.1016/j.taap.2004.08.023; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Dragnev K H, 2000, Oncologist, V5, P361, DOI 10.1634/theoncologist.5-5-361; EDER E, 1993, TOXICOL LETT, V67, P87, DOI 10.1016/0378-4274(93)90048-3; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; Hashimoto M, 2003, J BIOL CHEM, V278, P5044, DOI 10.1074/jbc.M210129200; HAUPTLORENZ S, 1985, BIOCHEM PHARMACOL, V34, P3803, DOI 10.1016/0006-2952(85)90428-9; HAYSTEAD TAJ, 1986, BIOCHEM J, V234, P279, DOI 10.1042/bj2340279; Hyndman DJ, 1998, BBA-GENE STRUCT EXPR, V1399, P198, DOI 10.1016/S0167-4781(98)00109-2; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Ji C, 2001, CHEM RES TOXICOL, V14, P1090, DOI 10.1021/tx000186f; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Li CP, 2008, PATHOL RES PRACT, V204, P295, DOI 10.1016/j.prp.2006.12.012; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Penning TM, 2005, CLIN CANCER RES, V11, P1687, DOI 10.1158/1078-0432.CCR-05-0071; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Quinn AM, 2008, CHEM RES TOXICOL, V21, P2207, DOI 10.1021/tx8002005; Raza H, 2006, TOXICOL APPL PHARM, V216, P309, DOI 10.1016/j.taap.2006.06.001; Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027; Scuric Z, 1998, HEPATOLOGY, V27, P943, DOI 10.1002/hep.510270408; Spite M, 2007, BIOCHEM J, V405, P95, DOI 10.1042/BJ20061743; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Verma M, 2008, EUR J PHARMACOL, V584, P213, DOI 10.1016/j.ejphar.2008.01.036; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x; Zhong LL, 2009, BIOCHEM BIOPH RES CO, V387, P245, DOI 10.1016/j.bbrc.2009.06.123; Zu XY, 2007, TOXICOL SCI, V97, P562, DOI 10.1093/toxsci/kfm033	45	107	112	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26742	26748		10.1074/jbc.M109.022897	http://dx.doi.org/10.1074/jbc.M109.022897			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19643728	hybrid, Green Published			2022-12-25	WOS:000269969600055
J	Osawa, M; Yokogawa, M; Muramatsu, T; Kimura, T; Mase, Y; Shimada, I				Osawa, Masanori; Yokogawa, Mariko; Muramatsu, Takahiro; Kimura, Tomomi; Mase, Yoko; Shimada, Ichio			Evidence for the Direct Interaction of Spermine with the Inwardly Rectifying Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; CYTOPLASMIC PORE; CRYSTAL-STRUCTURE; KIR2.1 CHANNELS; RECTIFICATION; POLYAMINES; MECHANISM; SITES; PERMEATION; CONSTANTS	The inwardly rectifying potassium channel (Kir) regulates resting membrane potential, K+ homeostasis, heart rate, and hormone secretion. The outward current is blocked in a voltage-dependent manner, upon the binding of intracellular polyamines or Mg2+ to the transmembrane pore domain. Meanwhile, electrophysiological studies have shown that mutations of several acidic residues in the intracellular regions affected the inward rectification. Although these acidic residues are assumed to bind polyamines, the functional role of the binding of polyamines and Mg2+ to the intracellular regions of Kirs remains unclear. Here, we report thermodynamic and structural studies of the interaction between polyamines and the cytoplasmic pore of mouse Kir3.1/GIRK1, which is gated by binding of G-protein beta gamma-subunit (G beta gamma). ITC analyses showed that two spermine molecules bind to a tetramer of Kir3.1/GIRK1 with a dissociation constant of 26 mu M, which is lower than other blockers. NMR analyses revealed that the spermine binding site is Asp-260 and its surrounding area. Small but significant chemical shift perturbations upon spermine binding were observed in the subunit-subunit interface of the tetramer, suggesting that spermine binding alters the relative orientations of the four subunits. Our ITC and NMR results postulated a spermine binding mode, where one spermine molecule bridges two Asp-260 side chains from adjacent subunits, with rearrangement of the subunit orientations. This suggests the functional roles of spermine binding to the cytoplasmic pore: stabilization of the resting state conformation of the channel, and instant translocation to the transmembrane pore upon activation through the G beta gamma-induced conformational rearrangement.	[Osawa, Masanori; Yokogawa, Mariko; Muramatsu, Takahiro; Kimura, Tomomi; Mase, Yoko; Shimada, Ichio] Univ Tokyo, Div Phys Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Osawa, Masanori/GRS-5726-2022	Osawa, Masanori/0000-0002-1285-4316	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a grant-in-aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. O. and I. S.), and a grant from Takeda Science Foundation (to M. O.).	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Frassineti C, 2003, ANAL BIOANAL CHEM, V376, P1041, DOI 10.1007/s00216-003-2020-0; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xie LH, 2003, J PHYSIOL-LONDON, V550, P67, DOI 10.1113/jphysiol.2003.043117; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yokogawa M, 2009, BIOMOL NMR ASSIGN, V3, P125, DOI 10.1007/s12104-009-9156-6	26	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26117	26126		10.1074/jbc.M109.029355	http://dx.doi.org/10.1074/jbc.M109.029355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620244	hybrid, Green Published			2022-12-25	WOS:000269738000067
J	Doyon, G; St-Jean, S; Darsigny, M; Asselin, C; Boudreau, F				Doyon, Genevieve; St-Jean, Stephanie; Darsigny, Mathieu; Asselin, Claude; Boudreau, Francois			Nuclear Receptor Co-repressor Is Required to Maintain Proliferation of Normal Intestinal Epithelial Cells in Culture and Down-modulates the Expression of Pigment Epithelium-derived Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; RETINOIC ACID; STEM-CELLS; TRANSCRIPTIONAL ACTIVATION; GENE-TRANSCRIPTION; DIFFERENTIATION; COREPRESSOR; CANCER; GROWTH; GAMMA	Stem cells of the gut epithelium constantly produce precursors that progressively undergo a succession of molecular changes resulting in growth arrest and commitment to a specific differentiation program. Few transcriptional repressors have been identified that maintain the normal intestinal epithelial cell (IEC) proliferation state. Herein, we show that the nuclear receptor co-repressor (NCoR1) is differentially expressed during the proliferation-to-differentiation IEC transition. Silencing of NCoR1 expression in proliferating cells of crypt origin resulted in a rapid growth arrest without associated cell death. A genechip profiling analysis identified several candidate genes to be up-regulated in NCoR1-deficient IEC. Pigment epithelium-derived factor (PEDF, also known as serpinf1), a suspected tumor suppressor gene that plays a key role in the inhibition of epithelial tissue growth, was significantly up-regulated in these cells. Chromatin immunoprecipitation experiments showed that the PEDF gene promoter was occupied by NCoR1 in proliferating epithelial cells. Multiple retinoid X receptor (RXR) heterodimers interacting sites of the PEDF promoter were confirmed to interact with RXR and retinoid acid receptor (RAR). Cotransfection assays showed that RXR and RAR were able to transactivate the PEDF promoter and that NCoR1 was repressing this effect. Finally, forced expression of PEDF in IEC resulted in a slower rate of proliferation. These observations suggest that NCoR1 expression is required to maintain IEC in a proliferative state and identify PEDF as a novel transcriptional target for NCoR1 repressive action.	[Doyon, Genevieve; St-Jean, Stephanie; Darsigny, Mathieu; Asselin, Claude; Boudreau, Francois] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Boudreau, F (corresponding author), Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	francois.boudreau@usherbrooke.ca			Natural Sciences and Engineering Research Council of Canada [262094-03]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada Grant Number 262094-03 (to F.B.).	Boudreau F, 2002, MOL CELL BIOL, V22, P5467, DOI 10.1128/MCB.22.15.5467-5478.2002; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F, 2001, J BIOL CHEM, V276, P32122, DOI 10.1074/jbc.M102002200; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheung LWT, 2006, ENDOCRINOLOGY, V147, P4179, DOI 10.1210/en.2006-0168; Cohen Ronald N, 2006, Nucl Recept Signal, V4, pe003; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Ek ETH, 2007, CANCER GENE THER, V14, P616, DOI 10.1038/sj.cgt.7701044; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Feng X, 2001, J BIOL CHEM, V276, P15066, DOI 10.1074/jbc.M011027200; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07; Gheorghiu I, 2001, J BIOL CHEM, V276, P44331, DOI 10.1074/jbc.M107591200; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gupta RA, 2003, J BIOL CHEM, V278, P22669, DOI 10.1074/jbc.M300637200; Hase R, 2005, CLIN CANCER RES, V11, P8737, DOI 10.1158/1078-0432.CCR-05-1323; HENNING SJ, 1985, ANNU REV PHYSIOL, V47, P231; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; HODIN RA, 1992, GASTROENTEROLOGY, V103, P1529, DOI 10.1016/0016-5085(92)91174-3; Hodin RA, 1996, SURGERY, V120, P138, DOI 10.1016/S0039-6060(96)80280-7; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Kubota H, 2001, EXP CELL RES, V263, P163, DOI 10.1006/excr.2000.5113; Laniel MA, 2000, METH MOL B, V148, P13; Lazar Mitchell A, 2003, Nucl Recept Signal, V1, pe001; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Malo MS, 2004, MOL ENDOCRINOL, V18, P1941, DOI 10.1210/me.2003-0351; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pignolo RJ, 2003, J CELL PHYSIOL, V195, P12, DOI 10.1002/jcp.10212; Pumiglia K, 2006, NAT NEUROSCI, V9, P299, DOI 10.1038/nn0306-299; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Suh E, 1996, MOL CELL BIOL, V16, P619; Tombran-Tink J, 2004, EXP EYE RES, V78, P945, DOI 10.1016/j.exer.2003.12.013; Tou LQ, 2004, MOL CELL BIOL, V24, P3132, DOI 10.1128/MCB.24.8.3132-3139.2004; Uchida H, 2005, EXP EYE RES, V80, P23, DOI 10.1016/j.exer.2004.08.004; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Vidrich A, 2003, CURR OPIN GASTROEN, V19, P583, DOI 10.1097/00001574-200311000-00012; Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117; Wu GD, 2003, GASTROENTEROLOGY, V124, P1538, DOI 10.1016/S0016-5085(03)00345-7; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775	56	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25220	25229		10.1074/jbc.M109.022632	http://dx.doi.org/10.1074/jbc.M109.022632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19608741	hybrid, Green Published			2022-12-25	WOS:000269734000056
J	Babelova, A; Moreth, K; Tsalastra-Greul, W; Zeng-Brouwers, J; Eickelberg, O; Young, MF; Bruckner, P; Pfeilschifter, J; Schaefer, RM; Grone, HJ; Schaefer, L				Babelova, Andrea; Moreth, Kristin; Tsalastra-Greul, Wasiliki; Zeng-Brouwers, Jinyang; Eickelberg, Oliver; Young, Marian F.; Bruckner, Peter; Pfeilschifter, Josef; Schaefer, Roland M.; Groene, Hermann-Josef; Schaefer, Liliana			Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCANS; INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; CASPASE-1; IL-1-BETA; HYALURONAN; GENE; ATP; MACROPHAGES; SECRETION	The role of endogenous inducers of inflammation is poorly understood. To produce the proinflammatory master cytokine interleukin (IL)-1 beta, macrophages need double stimulation with ligands to both Toll-like receptors (TLRs) for IL-1 beta gene transcription and nucleotide-binding oligomerization domain-like receptors for activation of the inflammasome. It is particularly intriguing to define how this complex regulation is mediated in the absence of an infectious trigger. Biglycan, a ubiquitous leucine-rich repeat proteoglycan of the extracellular matrix, interacts with TLR2/4 on macrophages. The objective of this study was to define the role of biglycan in the synthesis and activation of IL-1 beta. Here we show that in macrophages, soluble biglycan induces the NLRP3/ASC inflammasome, activating caspase-1 and releasing mature IL-1 beta without the need for additional costimulatory factors. This is brought about by the interaction of biglycan with TLR2/4 and purinergic P2X(4)/P2X7 receptors, which induces receptor cooperativity. Furthermore, reactive oxygen species formation is involved in biglycan-mediated activation of the inflammasome. By signaling through TLR2/4, biglycan stimulates the expression of NLRP3 and proIL-1 beta mRNA. Both in a model of non-infectious inflammatory renal injury (unilateral ureteral obstruction) and in lipopolysaccharide-induced sepsis, biglycan-deficient mice displayed lower levels of active caspase-1 and mature IL-1 beta in the kidney, lung, and circulation. Our results provide evidence for direct activation of the NLRP3 inflammasome by biglycan and describe a fundamental paradigm of how tissue stress or injury is monitored by innate immune receptors detecting the release of the extracellular matrix components and turning such a signal into a robust inflammatory response.	[Babelova, Andrea; Moreth, Kristin; Tsalastra-Greul, Wasiliki; Zeng-Brouwers, Jinyang; Pfeilschifter, Josef; Schaefer, Liliana] Univ Frankfurt Klinikum, Inst Allgemeine Pharmakol & Toxikol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany; [Moreth, Kristin; Zeng-Brouwers, Jinyang; Schaefer, Roland M.] Univ Munster, Dept Med D, D-48149 Munster, Germany; [Bruckner, Peter] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Moreth, Kristin; Zeng-Brouwers, Jinyang; Bruckner, Peter; Schaefer, Roland M.] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [Eickelberg, Oliver] Univ Munich, Comprehens Pneumol Ctr, D-85764 Neuherberg, Germany; [Young, Marian F.] NIH, Craniofacial & Skeletal Dis Branch, NIDCR, Bethesda, MD 20892 USA; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Munster; University of Munster; University of Munster; University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Helmholtz Association; German Cancer Research Center (DKFZ)	Schaefer, L (corresponding author), Univ Frankfurt Klinikum, Inst Allgemeine Pharmakol & Toxikol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Schaefer@med.uni-frankfurt.de	Eickelberg, Oliver/A-5461-2013; Babelova, Andrea/E-7768-2018; Bruckner, Peter/F-4817-2019	Eickelberg, Oliver/0000-0001-7170-0360; Babelova, Andrea/0000-0001-9548-6602; Bruckner, Peter/0000-0002-5566-5611; Schaefer, Liliana/0000-0002-3318-3005; Young, Marian F/0000-0003-0929-8854	Deutsche Forschungsgemeinschaft [SFB 815, SCHA 1082/2-1]; Excellence Cluster Cardiopulmonary System [SFB 405]; Interdisciplinary Center of Clinical Research, Muenster [Schae2/026/06, KliFo 118]; Else Kroner-Fresenius-Stiftung; National Institutes of Health; NIDCR; Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000379] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research, Muenster; Else Kroner-Fresenius-Stiftung; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Deutsche Forschungsgemeinschaft SFB 815, Project A5 ( to L. S.) and SCHA 1082/2-1( to L. S. and H.-J.G.), the Excellence Cluster Cardiopulmonary System ( to L. S. and O.E.), SFB 405, Project B10 ( to H.-J.G.), Interdisciplinary Center of Clinical Research, Muenster, Grant Schae2/026/06 ( to L. S., R. M. S., and P. B.), KliFo 118 ( to O. E.), and Else Kroner-Fresenius-Stiftung( to L. S.). This work was also supported in part by the National Institutes of Health, NIDCR, Intramural Research Program ( to M. F. Y.).	Adams J, 2005, AM J PATHOL, V167, P285, DOI 10.1016/S0002-9440(10)62973-2; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gay Nicholas J., 2008, V183, P181; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kresse H, 2001, J BIOL CHEM, V276, P13411, DOI 10.1074/jbc.M009321200; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; MATHEW MK, 1983, MOL CELL BIOCHEM, V50, P47; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Netea MG, 2008, EXPERT OPIN BIOL TH, V8, P1867, DOI [10.1517/14712590802494212, 10.1517/14712590802494212 ]; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Ogier-Denis E, 2008, SEMIN IMMUNOPATHOL, V30, P291, DOI 10.1007/s00281-008-0120-9; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pleskova M, 2005, FASEB J, V19, P139, DOI 10.1096/fj.05-3791fje; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raouf R, 2007, NEUROPHARMACOLOGY, V53, P496, DOI 10.1016/j.neuropharm.2007.06.010; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2003, J BIOL CHEM, V278, P26227, DOI 10.1074/jbc.M210574200; Schaefer L, 2001, FASEB J, V15, P559; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200	63	331	341	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24035	24048		10.1074/jbc.M109.014266	http://dx.doi.org/10.1074/jbc.M109.014266			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605353	Green Published, hybrid			2022-12-25	WOS:000269380200018
J	Mooren, OL; Kotova, TI; Moore, AJ; Schafer, DA				Mooren, Olivia L.; Kotova, Tatyana I.; Moore, Andrew J.; Schafer, Dorothy A.			Dynamin2 GTPase and Cortactin Remodel Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ARP2/3 COMPLEX; COATED PITS; F-ACTIN; DEPENDENT ENDOCYTOSIS; MEMBRANE FISSION; MOTILITY; CELLS; CYTOSKELETON; CONSTRICTION	The large GTPase dynamin, best known for its activities that remodel membranes during endocytosis, also regulates F-actin-rich structures, including podosomes, phagocytic cups, actin comet tails, subcortical ruffles, and stress fibers. The mechanisms by which dynamin regulates actin filaments are not known, but an emerging view is that dynamin influences F-actin via its interactions with proteins that interact directly or indirectly with actin filaments. We show here that dynamin2 GTPase activity remodels actin filaments in vitro via a mechanism that depends on the binding partner and F-actin-binding protein, cortactin. Tightly associated actin filaments crosslinked by dynamin2 and cortactin became loosely associated after GTP addition when viewed by transmission electron microscopy. Actin filaments were dynamically unraveled and fragmented after GTP addition when viewed in real time using total internal reflection fluorescence microscopy. Cortactin stimulated the intrinsic GTPase activity of dynamin2 and maintained a stable link between actin filaments and dynamin2, even in the presence of GTP. Filaments remodeled by dynamin2 GTPase in vitro exhibit enhanced sensitivity to severing by the actin depolymerizing factor, cofilin, suggesting that GTPase-dependent remodeling influences the interactions of actin regulatory proteins and F-actin. The global organization of the actomyosin cytoskeleton was perturbed in U2-OS cells depleted of dynamin2, implicating dynamin2 in remodeling actin filaments that comprise supramolecular F-actin arrays in vivo. We conclude that dynamin2 GTPase remodels actin filaments and plays a role in orchestrating the global actomyosin cytoskeleton.	[Mooren, Olivia L.; Kotova, Tatyana I.; Moore, Andrew J.; Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA; [Mooren, Olivia L.] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA	University of Virginia; University of Virginia; Washington University (WUSTL)	Schafer, DA (corresponding author), Univ Virginia, Dept Biol, McCormick Rd, Charlottesville, VA 22904 USA.	das9w@virginia.edu	Moore, Andrew/AAG-1905-2021	Moore, Andrew/0000-0002-3023-2502	National Institutes of Health [R01 GM067222, R01 GM038542]; NIGMS; Ruth L. Kirschstein National Research Service Award [F32 GM083538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542, R01GM067222, F32GM083538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM067222 (to D. A. S.) from the NIGMS and Ruth L. Kirschstein National Research Service Award F32 GM083538 (to O. L. M.). This work was also supported by National Institutes of Health R01 GM038542 (awarded to J. A. Cooper, Washington University School of Medicine).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; BRYAN J, 1986, METHOD ENZYMOL, V134, P13; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Di AK, 2003, MOL BIOL CELL, V14, P2016, DOI 10.1091/mbc.e02-09-0626; Eccleston JF, 2002, EUR BIOPHYS J BIOPHY, V31, P275, DOI 10.1007/s00249-002-0226-2; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Unsworth KE, 2007, CELL MICROBIOL, V9, P438, DOI 10.1111/j.1462-5822.2006.00801.x; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	62	82	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23995	24005		10.1074/jbc.M109.024398	http://dx.doi.org/10.1074/jbc.M109.024398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19605363	Green Published, hybrid			2022-12-25	WOS:000269380200014
J	Lyubarova, R; Itagaki, BK; Itagaki, MW				Lyubarova, Radmila; Itagaki, Brandon K.; Itagaki, Michael W.			The Impact of National Institutes of Health Funding on US Cardiovascular Disease Research	PLOS ONE			English	Article								Background: Intense interest surrounds the recent expansion of US National Institutes of Health (NIH) budgets as part of economic stimulus legislation. However, the relationship between NIH funding and cardiovascular disease research is poorly understood, making the likely impact of this policy change unclear. Methods: The National Library of Medicine's PubMed database was searched for articles published from 1996 to 2006, originating from U. S. institutions, and containing the phrases "cardiolog,'' "cardiovascular,'' or "cardiac,'' in the first author's department. Research methodology, journal of publication, journal impact factor, and receipt of NIH funding were recorded. Differences in means and trends were tested with t-tests and linear regression, respectively, with P <= 0.05 for significance. Results: Of 117,643 world cardiovascular articles, 36,684 (31.2%) originated from the U. S., of which 10,293 (28.1%) received NIH funding. The NIH funded 40.1% of U. S. basic science articles, 20.3% of overall clinical trials, 18.1% of randomized-controlled, and 12.2% of multicenter clinical trials. NIH-funded and total articles grew significantly (65 articles/year, P < 0.001 and 218 articles/year, P< 0.001, respectively). The proportion of articles receiving NIH funding was stable, but grew significantly for basic science and clinical trials (0.87%/ year, P < 0.001 and 0.67%/year, P = 0.029, respectively). NIH-funded articles had greater journal impact factors than non NIH-funded articles (5.76 vs. 3.71, P < 0.001). Conclusions: NIH influence on U. S. cardiovascular research expanded in the past decade, during the period of NIH budget doubling. A substantial fraction of research is now directly funded and thus likely sensitive to budget fluctuations, particularly in basic science research. NIH funding predicts greater journal impact.			Lyubarova, R (corresponding author), Albany Med Coll, Div Cardiol, Dept Med, Albany, NY 12208 USA.	mitagaki@mednet.ucla.edu						Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; CHEW FS, 1986, AM J ROENTGENOL, V147, P1045; Dimasi J. A., 1995, INT J ECON BUS, V2, P201, DOI DOI 10.1080/758519309; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Heinig SJ, 2007, NEW ENGL J MED, V357, P1042, DOI 10.1056/NEJMsb071774; Itagaki MW, 2008, RADIOLOGY, V247, P213, DOI 10.1148/radiol.2471070745; JAMIESON PW, 1992, ANN NEUROL, V32, P87, DOI 10.1002/ana.410320114; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; MUSSURAKIS S, 1994, AM J ROENTGENOL, V163, P973, DOI 10.2214/ajr.163.4.8092046; Mussurakis S., 1994, AM J ROENTGENOL, V163, P981; *NAT I BIOM IM BIO, 2006, NIBIB; *NAT LIB MED, BIBL SERV DIV DAT NE; *NAT LIB MED, PUBL CHAR PUBL TYP S; National Library of Medicine, FACT SHEET MEDLINE; Odland RM, 2001, OTOLARYNG HEAD NECK, V124, P155, DOI 10.1067/mhn.2001.112880; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Slone RM, 1996, AM J ROENTGENOL, V167, P571, DOI 10.2214/ajr.167.3.8751654; Steinbrook R, 2009, NEW ENGL J MED, V360, P1479, DOI 10.1056/NEJMp0901819; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; The National Institutes of Health, NIH ALM APPR; *THOMPS SCI, J CIT REP; Wilson MP, 2007, ACAD EMERG MED, V14, P635, DOI 10.1197/j.aem.2007.01.023; WRIGHT SW, 1994, ANN EMERG MED, V23, P1077, DOI 10.1016/S0196-0644(94)70107-5; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931	26	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6425	10.1371/journal.pone.0006425	http://dx.doi.org/10.1371/journal.pone.0006425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641617	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494500025
J	Trisciuoglio, L; Bianchi, ME				Trisciuoglio, Lisa; Bianchi, Marco Emilio			Several Nuclear Events during Apoptosis Depend on Caspase-3 Activation but Do Not Constitute a Common Pathway	PLOS ONE			English	Article							CHROMATIN PROTEIN HMGB1; DNA FRAGMENTATION; STERILE-20 KINASE; HISTONE H2B; CELLS; DEGRADATION; REQUIREMENT; BINDING; H2AX; PHOSPHORYLATION	A number of nuclear events occur during apoptosis, including DNA laddering, nuclear lamina breakdown, phosphorylation of histones H2B and histone H2AX, and the tight binding to chromatin of HMGB1 and CAD, the nuclease responsible for DNA laddering. We have performed an epistasis analysis to investigate whether these events cluster together in pathways. We find that all depend directly or indirectly on caspase-3 activation. CAD activation, H2AX phosphorylation and DNA laddering cluster together into a pathway, but all other events appear to be independent of each other downstream of caspase-3, and likely evolved subject to different functional pressures.			Trisciuoglio, L (corresponding author), Ist Sci San Raffaele, Chromatin Dynam Unit, I-20132 Milan, Italy.	bianchi.marco@hsr.it	Bianchi, Marco Emilio/K-3417-2018	Bianchi, Marco Emilio/0000-0002-5329-6445				Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bianchi ME, 2004, BBA-GENE STRUCT EXPR, V1677, P181, DOI 10.1016/j.bbaexp.2003.10.017; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LATORRE E, 2005, THESIS OPEN U; Lechardeur D, 2004, J CELL BIOL, V167, P851, DOI 10.1083/jcb.200404105; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Yang XH, 2001, CANCER RES, V61, P348	28	12	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6234	10.1371/journal.pone.0006234	http://dx.doi.org/10.1371/journal.pone.0006234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641621	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494500001
J	Kawahara, Y; Manabe, T; Matsumoto, M; Kajiume, T; Matsumoto, M; Yuge, L				Kawahara, Yumi; Manabe, Tomotaka; Matsumoto, Masaya; Kajiume, Teruyuki; Matsumoto, Masayasu; Yuge, Louis			LIF-Free Embryonic Stem Cell Culture in Simulated Microgravity	PLOS ONE			English	Article							DIFFERENTIATION	Background: Leukemia inhibitory factor (LIF) is an indispensable factor for maintaining mouse embryonic stem (ES) cell pluripotency. A feeder layer and serum are also needed to maintain an undifferentiated state, however, such animal derived materials need to be eliminated for clinical applications. Therefore, a more reliable ES cell culture technique is required. Methodology/Principal Findings: We cultured mouse ES cells in simulated microgravity using a 3D-clinostat. We used feeder-free and serum-free media without LIF. Conclusions/Significance: Here we show that simulated microgravity allows novel LIF-free and animal derived material-free culture methods for mouse ES cells.			Kawahara, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, Hiroshima, Japan.	ryuge@hiroshima-u.ac.jp		Kajiume, Teruyuki/0000-0002-4068-3921				Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hirasaka K, 2005, BBA-MOL CELL RES, V1743, P130, DOI 10.1016/j.bbamcr.2004.09.013; Ichigi J, 2001, IN VITRO CELL DEV-AN, V37, P31; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921	9	37	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6343	10.1371/journal.pone.0006343	http://dx.doi.org/10.1371/journal.pone.0006343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626124	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260200002
J	Peyot, ML; Gray, JP; Lamontagne, J; Smith, PJS; Holz, GG; Madiraju, SRM; Prentki, M; Heart, E				Peyot, Marie-Line; Gray, Joshua P.; Lamontagne, Julien; Smith, Peter J. S.; Holz, George G.; Madiraju, S. R. Murthy; Prentki, Marc; Heart, Emma			Glucagon-Like Peptide-1 Induced Signaling and Insulin Secretion Do Not Drive Fuel and Energy Metabolism in Primary Rodent Pancreatic beta-Cells	PLOS ONE			English	Article								Background: Glucagon like peptide-1 (GLP-1) and its analogue exendin-4 (Ex-4) enhance glucose stimulated insulin secretion (GSIS) and activate various signaling pathways in pancreatic beta-cells, in particular cAMP, Ca(2+) and protein kinase-B (PKB/Akt). In many cells these signals activate intermediary metabolism. However, it is not clear whether the acute amplification of GSIS by GLP-1 involves in part metabolic alterations and the production of metabolic coupling factors. Methodology/Prinicipal Findings: GLP-1 or Ex-4 at high glucose caused release (similar to 20%) of the total rat islet insulin content over 1 h. While both GLP-1 and Ex-4 markedly potentiated GSIS in isolated rat and mouse islets, neither had an effect on beta-cell fuel and energy metabolism over a 5 min to 3 h time period. GLP-1 activated PKB without changing glucose usage and oxidation, fatty acid oxidation, lipolysis or esterification into various lipids in rat islets. Ex-4 caused a rise in [Ca(2+)](i) and cAMP but did not enhance energy utilization, as neither oxygen consumption nor mitochondrial ATP levels were altered. Conclusions/Significance: The results indicate that GLP-1 barely affects beta-cell intermediary metabolism and that metabolic signaling does not significantly contribute to GLP-1 potentiation of GSIS. The data also indicate that insulin secretion is a minor energy consuming process in the beta-cell, and that the beta-cell is different from most cell types in that its metabolic activation appears to be primarily governed by a "push'' (fuel substrate driven) process, rather than a "pull'' mechanism secondary to enhanced insulin release as well as to Ca(2+), cAMP and PKB signaling.			Peyot, ML (corresponding author), Univ Montreal, Ctr Hosp, Ctr Rech, Mol Nutr Unit, Montreal, PQ, Canada.	marc.prentki@umontreal.ca	Holz, George G/A-3386-2012	Holz, George/0000-0002-1781-3580; Gray, Joshua/0000-0002-9704-3845; Gray, Joshua/0000-0003-4146-7902; Smith, Peter/0000-0003-4400-6853	NCRR NIH HHS [P41-RR-001395, P41 RR001395] Funding Source: Medline; NIDDK NIH HHS [DK045817, R01 DK069575, R01 DK045817] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045817, R29DK045817, R01DK069575] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; BERNE C, 1975, BIOCHEM J, V152, P667, DOI 10.1042/bj1520667; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Chepurny OG, 2007, J BIOMOL SCREEN, V12, P740, DOI 10.1177/1087057107301856; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Cunningham BA, 2003, BIOCHEM J, V369, P173, DOI 10.1042/BJ20021196; Dillon JS, 2005, EXP CLIN ENDOCR DIAB, V113, P182, DOI 10.1055/s-2005-837526; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Girard J, 2008, DIABETES METAB, V34, P550, DOI 10.1016/j.diabet.2008.09.001; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Heart E, 2007, AM J PHYSIOL-ENDOC M, V292, pE1295, DOI 10.1152/ajpendo.00648.2006; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARYNISSEN G, 1990, METABOLISM, V39, P87, DOI 10.1016/0026-0495(90)90153-4; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Mulder H, 2004, DIABETES, V53, P122, DOI 10.2337/diabetes.53.1.122; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Osbourn DM, 2005, ANAL CHEM, V77, P6999, DOI 10.1021/ac050326w; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; SENER A, 1990, BIOCHIM BIOPHYS ACTA, V1019, P42, DOI 10.1016/0005-2728(90)90122-K; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Widenmaier SB, 2009, J BIOL CHEM, V284, P10764, DOI 10.1074/jbc.M809116200; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Winzell MS, 2004, HORM METAB RES, V36, P795, DOI 10.1055/s-2004-826166; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; Xavier GD, 2003, BIOCHEM J, V371, P761; Yaney GC, 2001, DIABETES, V50, P56, DOI 10.2337/diabetes.50.1.56; ZHANG TM, 1994, BIOCHEM MED METAB B, V51, P129, DOI 10.1006/bmmb.1994.1017	63	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6221	10.1371/journal.pone.0006221	http://dx.doi.org/10.1371/journal.pone.0006221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593440	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000268035400006
J	De Angeli, A; Moran, O; Wege, S; Filleur, S; Ephritikhine, G; Thomine, S; Barbier-Brygoo, H; Gambale, F				De Angeli, Alexis; Moran, Oscar; Wege, Stefanie; Filleur, Sophie; Ephritikhine, Genevieve; Thomine, Sebastien; Barbier-Brygoo, Helene; Gambale, Franco			ATP Binding to the C Terminus of the Arabidopsis thaliana Nitrate/Proton Antiporter, AtCLCa, Regulates Nitrate Transport into Plant Vacuoles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLC-1 CHLORIDE CHANNELS; CYTOPLASMIC DOMAIN; MOLECULAR-DYNAMICS; SWISS-MODEL; PROTEIN; INHIBITION; CELLS; SIMULATIONS; ENVIRONMENT; REDUCTASE	Nitrate, one of the major nitrogen sources for plants, is stored in the vacuole. Nitrate accumulation within the vacuole is primarily mediated by the NO3-/H+ exchanger AtCLCa, which belongs to the chloride channel (CLC) family. Crystallography analysis of hCLC5 suggested that the C-terminal domain, composed by two cystathionine beta-synthetase motifs in all eukaryotic members of the CLC family is able to interact with ATP. However, interaction of nucleotides with a functional CLC protein has not been unambiguously demonstrated. Here we show that ATP reversibly inhibits AtCLCa by interacting with the C-terminal domain. Applying the patch clamp technique to isolated Arabidopsis thaliana vacuoles, we demonstrate that ATP reduces AtCLCa activity with a maximum inhibition of 60%. ATP inhibition of nitrate influx into the vacuole at cytosolic physiological nitrate concentrations suggests that ATP modulation is physiologically relevant. ADP and AMP do not decrease the AtCLCa transport activity; nonetheless, AMP (but not ADP) competes with ATP, preventing inhibition. A molecular model of the C terminus of AtCLCa was built by homology to hCLC5 C terminus. The model predicted the effects of mutations of the ATP binding site on the interaction energy between ATP and AtCLCa that were further confirmed by functional expression of site-directed mutated AtCLCa.	[De Angeli, Alexis; Moran, Oscar; Gambale, Franco] CNR, Ist Biofis, I-16149 Genoa, Italy; [Wege, Stefanie; Filleur, Sophie; Ephritikhine, Genevieve; Thomine, Sebastien; Barbier-Brygoo, Helene] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Filleur, Sophie; Ephritikhine, Genevieve] Univ Paris 07, UFR Sci Vivant, F-75205 Paris 13, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	De Angeli, A (corresponding author), Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland.	deangeli@access.uzh.ch	BARBIER-BRYGOO, HELENE/A-8435-2013; filleur, sophie/AAH-3070-2019; Moran, Oscar/W-4277-2019; Thomine, Sébastien/V-9029-2019; Wege, Stefanie/AAB-4083-2019	Wege, Stefanie/0000-0002-7232-5889; Thomine, Sebastien/0000-0003-0045-1701	EU_RTN [MRTN-CT-2006 035833]; Consiglio Nazionale delle Ricerche-CNRS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	EU_RTN; Consiglio Nazionale delle Ricerche-CNRS(Consiglio Nazionale delle Ricerche (CNR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by EU_RTN Project VaTEP Contract MRTN-CT-2006 035833 and Consiglio Nazionale delle Ricerche-CNRS bilateral project "Biophysical properties of the AtCLCa antiporter in A. thaliana."	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2008, J GEN PHYSIOL, V131, P104, DOI 10.1085/jgp.200709953; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bennetts B, 2007, J BIOL CHEM, V282, P32780, DOI 10.1074/jbc.M703259200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cookson SJ, 2005, PLANT PHYSIOL, V138, P1097, DOI 10.1104/pp.105.062349; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; GAMBALE F, 1994, EUR BIOPHYS J BIOPHY, V22, P399, DOI 10.1007/BF00180161; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000; HEDRICH R, 1989, EMBO J, V8, P2835, DOI 10.1002/j.1460-2075.1989.tb08430.x; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hosy E, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-14; JonesHertzog DK, 1997, J MED CHEM, V40, P1539, DOI 10.1021/jm960684e; KAISER WM, 1991, PLANT PHYSIOL, V96, P368, DOI 10.1104/pp.96.2.368; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; MARTINOIA E, 1981, NATURE, V289, P292, DOI 10.1038/289292a0; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; Wang W, 1999, PROTEINS, V34, P395, DOI 10.1002/(SICI)1097-0134(19990215)34:3<395::AID-PROT11>3.3.CO;2-W; Zhang XD, 2008, J GEN PHYSIOL, V132, P421, DOI 10.1085/jgp.200810023; Zifarelli G, 2008, J GEN PHYSIOL, V131, P109, DOI 10.1085/jgp.200709899	35	59	59	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26526	26532		10.1074/jbc.M109.005132	http://dx.doi.org/10.1074/jbc.M109.005132			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19636075	hybrid, Green Published			2022-12-25	WOS:000269969600034
J	Fulcher, JA; Chang, MH; Wang, S; Almazan, T; Hashimi, ST; Eriksson, AU; Wen, XS; Pang, M; Baum, LG; Singh, RR; Lee, B				Fulcher, Jennifer A.; Chang, Margaret H.; Wang, Shuo; Almazan, Tim; Hashimi, Sara T.; Eriksson, Anna U.; Wen, Xiangshu; Pang, Mabel; Baum, Linda G.; Singh, Ram Raj; Lee, Benhur			Galectin-1 Co-clusters CD43/CD45 on Dendritic Cells and Induces Cell Activation and Migration through Syk and Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; EXTRACELLULAR-MATRIX; CROSS-LINKING; MATURATION; TOLERANCE; RECEPTOR; CD43; DANGER; IMMUNE; RESPONSES	Galectin-1 is a galactoside-binding lectin expressed in multiple tissues that has pleiotropic immunomodulatory functions. We previously showed that galectin-1 activates human monocyte-derived dendritic cells (MDDCs) and triggers a specific genetic program that up-regulates DC migration through the extracellular matrix, an integral property of mucosal DCs. Here, we identify the galectin-1 receptors on MDDCs and immediate downstream effectors of galectin-1-induced MDDC activation and migration. Galectin-1 binding to surface CD43 and CD45 on MDDCs induced an unusual unipolar co-clustering of these receptors and activates a dose-dependent calcium flux that is abrogated by lactose. Using a kinome screen and a systems biology approach, we identified Syk and protein kinase C tyrosine kinases as mediators of the DC activation effects of galectin-1. Galectin-1, but not lipopolysaccharide, stimulated Syk phosphorylation and recruitment of phosphorylated Syk to the CD43 and CD45 co-cluster on MDDCs. Inhibitors of Syk and protein kinase C signaling abrogated galectin-1-induced DC activation as monitored by interleukin-6 production; and MMP-1, -10, and -12 gene up-regulation; and enhanced migration through the extracellular matrix. The latter two are specific features of galectin-1-activated DCs. Interestingly, we also found that galectin-1 can prime DCs to respond more quickly to low dose lipopolysaccharide stimulation. Finally, we underscore the biological relevance of galectin-1-enhanced DC migration by showing that intradermal injection of galectin-1 in MRL-fas mice, which have a defect in skin DC emigration, increased the in vivo migration of dermal DCs to draining lymph nodes.	[Fulcher, Jennifer A.; Chang, Margaret H.; Pang, Mabel; Baum, Linda G.; Singh, Ram Raj; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Wang, Shuo; Almazan, Tim; Hashimi, Sara T.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Eriksson, Anna U.; Wen, Xiangshu; Singh, Ram Raj] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lee, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, 257 BSRB,615 Charles E Young Dr E, Los Angeles, CA 90095 USA.	bleebhl@ucla.edu	Lee, Benhur/A-8554-2016; Singh, Ram/AFQ-2369-2022; Fulcher, Jennifer A./AAG-1495-2020	Lee, Benhur/0000-0003-0760-1709; Fulcher, Jennifer A./0000-0001-9895-8636	National Institutes of Health [AI060694, AI080778, AR056465, AI07126-30, HL096392, GM08042]; NATIONAL CANCER INSTITUTE [T32CA009120, P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060694, T32AI007126, R01AI080778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060694 (to B. L. and L. G. B.), Grants AI080778 and AR056465 (to R. R. S.), Training Grants AI07126-30 (to J. A. F.), Grant HL096392 (to M. H. C.), and Grant GM08042 (to J. A. F. and M. H. C.).	Ahmed H, 1996, J BIOCHEM, V120, P1007; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALVARADO M, 1995, EUR J IMMUNOL, V25, P1051, DOI 10.1002/eji.1830250429; Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BAUM LG, 1995, GLYCOCONJUGATE J, V12, P63, DOI 10.1007/BF00731870; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Corinti S, 1999, J IMMUNOL, V162, P6331; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Dupasquier M, 2004, J INVEST DERMATOL, V123, P876, DOI 10.1111/j.0022-202X.2004.23427.x; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Eriksson AU, 2008, J IMMUNOL, V181, P7468, DOI 10.4049/jimmunol.181.11.7468; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kikuchi K, 2003, IMMUNOL LETT, V89, P149, DOI 10.1016/S0165-2478(03)00134-2; Luft T, 2004, BLOOD, V104, P1066, DOI 10.1182/blood-2003-12-4146; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miura Y, 2001, BIOCHEM BIOPH RES CO, V288, P80, DOI 10.1006/bbrc.2001.5729; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pace KE, 1999, J IMMUNOL, V163, P3801; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; PedrazaAlva G, 1996, J BIOL CHEM, V271, P27564, DOI 10.1074/jbc.271.44.27564; Perone MJ, 2006, J IMMUNOL, V176, P7207, DOI 10.4049/jimmunol.176.12.7207; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Rabinovich GA, 2002, GLYCOCONJUGATE J, V19, P565, DOI 10.1023/B:GLYC.0000014087.41914.72; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shimomura H, 2003, INFECT IMMUN, V71, P5225, DOI 10.1128/IAI.71.9.5225-5230.2003; SILVERMAN LB, 1989, J IMMUNOL, V142, P4194; Spertini F, 2004, IMMUNOLOGY, V113, P441, DOI 10.1111/j.1365-2567.2004.01986.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; WONG RCK, 1990, J IMMUNOL, V144, P1455	50	66	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26860	26870		10.1074/jbc.M109.037507	http://dx.doi.org/10.1074/jbc.M109.037507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635795	Green Published, hybrid			2022-12-25	WOS:000269969600067
J	Chen, SY; Kesler, CT; Paschal, BM; Balk, SP				Chen, Shaoyong; Kesler, Cristina T.; Paschal, Bryce M.; Balk, Steven P.			Androgen Receptor Phosphorylation and Activity Are Regulated by an Association with Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TERMINAL DOMAIN; TRANSCRIPTION; PROTEASOME; IDENTIFICATION; STABILIZATION; ACTIVATION; COMPLEX; BINDING; SITES	Androgen receptor (AR) is phosphorylated at multiple sites in response to ligand binding, but the functional consequences and mechanisms regulating AR phosphorylation remain to be established. We observed initially that okadaic acid, an inhibitor of the major PPP family serine/threonine phosphatases PP2A and protein phosphatase 1 (PP1), had cell type-dependent effects on ARexpression. More specific inhibitors of PP2A (fostriecin) and PP1 (tautomycin and siRNA against the PP1 alpha catalytic subunit) demonstrated that PP1 and protein phosphatase 2A had opposite effects on AR protein and transcriptional activity. PP1 inhibition enhanced proteasome-mediated AR degradation, while PP1 alpha overexpression increased AR expression and markedly enhanced AR transcriptional activity. Coprecipitation experiments demonstrated an AR-PP1 interaction, while immunofluorescence and nuclear-cytoplasmic fractionation showed androgen-stimulated nuclear translocation of both AR and PP1 in prostate cancer cells. Studies with phosphospecific AR antibodies showed that PP1 inhibition dramatically increased phosphorylation of Ser-650, a site in the AR hinge region shown to mediate nuclear export. Significantly, PP1 inhibition caused a marked decrease in nuclear localization of the wild-type AR, but did not alter total or nuclear levels of a S650A mutant AR. These findings reveal a critical role of PP1 in regulating AR protein stability and nuclear localization through dephosphorylation of Ser-650. Moreover, AR may function as a PP1 regulatory subunit and mediate PP1 recruitment to chromatin, where it can modulate transcription and splicing.	[Chen, Shaoyong; Balk, Steven P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Hematol Oncol Div,Dept Med, Boston, MA 02215 USA; [Kesler, Cristina T.; Paschal, Bryce M.] Univ Virginia Hlth Syst, Ctr Cell Signaling, Dept Biochem & Mol Genet, Ctr Canc, Charlottesville, VA 22908 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Virginia	Chen, SY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Hematol Oncol Div,Dept Med, CLS 432,330 Brookline Ave, Boston, MA 02215 USA.	schen@bidmc.harvard.edu	CHEN, Shaoyong/ABF-3357-2021		Department of Defense (DOD) [PC060807]; National Institutes of Health [R01CA111803, P50 CA90381]; SPORE Career Development Award; DOD Postdoctoral Award [PC040499]; NIH [K99CA135592]; Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA090381, R01CA111803, K99CA135592] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE Career Development Award; DOD Postdoctoral Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Defense (DOD) Grant PC060807 and National Institutes of Health Grants R01CA111803 and P50 CA90381 ( to S. P. B.). This work was also supported by a SPORE Career Development Award, DOD Postdoctoral Award PC040499, and NIH K99CA135592 ( to S. C.), by the Hershey Family Prostate Cancer Research Fund, and by a Challenge Award from the Prostate Cancer Foundation.	Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cohen PTW, 2002, J CELL SCI, V115, P241; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Garcia A, 2004, CR BIOL, V327, P93, DOI 10.1016/j.crvi.2004.01.001; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; IKONEN T, 1994, ENDOCRINOLOGY, V135, P1359, DOI 10.1210/en.135.4.1359; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; KUIPER GGJM, 1995, BIOCHEMISTRY-US, V34, P1851, DOI 10.1021/bi00006a005; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Shank LC, 2008, J BIOL CHEM, V283, P10568, DOI 10.1074/jbc.M800810200; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Tanner T, 2004, ANN NY ACAD SCI, V1030, P587, DOI 10.1196/annals.1329.068; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Wong HY, 2004, BIOCHEM J, V383, P267, DOI 10.1042/BJ20040683; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Yang CS, 2007, MOL CELL BIOL, V27, P3390, DOI 10.1128/MCB.02411-06; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	31	58	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25576	25584		10.1074/jbc.M109.043133	http://dx.doi.org/10.1074/jbc.M109.043133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19622840	Green Published, hybrid			2022-12-25	WOS:000269738000015
J	Selvaraj, V; Soundarapandian, MM; Chechneva, O; Williams, AJ; Sidorov, MK; Soulika, AM; Pleasure, DE; Deng, WB				Selvaraj, Vimal; Soundarapandian, Mangala M.; Chechneva, Olga; Williams, Ambrose J.; Sidorov, Maxim K.; Soulika, Athena M.; Pleasure, David E.; Deng, Wenbin			PARP-1 Deficiency Increases the Severity of Disease in a Mouse Model of Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; APOPTOSIS-INDUCING FACTOR; GENE-EXPRESSION; CELL-DEATH; T-CELLS; DNA-DAMAGE; ANTIGEN PRESENTATION	Poly(ADP-ribose) polymerase-1 (PARP-1) has been implicated in the pathogenesis of several central nervous system (CNS) disorders. However, the role of PARP-1 in autoimmune CNS injury remains poorly understood. Therefore, we studied experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis in mice with a targeted deletion of PARP-1. We identified inherent physiological abnormalities in the circulating and splenic immune composition between PARP-1(-/-) and wild type (WT) mice. Upon EAE induction, PARP-1(-/-) mice had an earlier onset and developed a more severe EAE compared with WT cohorts. Splenic response was significantly higher in PARP-1(-/-) mice largely because of B cell expansion. Although formation of Th1 and Th17 effector T lymphocytes was unaffected, PARP-1(-/-) mice had significantly earlier CD4(+) T lymphocyte and macrophage infiltration into the CNS during EAE. However, we did not detect significant differences in cytokine profiles between PARP-1(-/-) and WT spinal cords at the peak of EAE. Expression analysis of different PARP isozymes in EAE spinal cords showed that PARP-1 was down-regulated in WT mice and that PARP-3 but not PARP-2 was dramatically up-regulated in both PARP-1(-/-) and WT mice, suggesting that these PARP isozymes could have distinct roles in different CNS pathologies. Together, our results indicate that PARP-1 plays an important role in regulating the physiological immune composition and in immune modulation during EAE; our finding identifies a new aspect of immune regulation by PARPs in autoimmune CNS pathology.	[Selvaraj, Vimal; Soundarapandian, Mangala M.; Chechneva, Olga; Williams, Ambrose J.; Sidorov, Maxim K.; Deng, Wenbin] Univ Calif Davis, Dept Cell Biol, Sch Med, Sacramento, CA 95817 USA; [Selvaraj, Vimal; Soundarapandian, Mangala M.; Chechneva, Olga; Williams, Ambrose J.; Sidorov, Maxim K.; Deng, Wenbin] Univ Calif Davis, Dept Human Anat, Sch Med, Sacramento, CA 95817 USA; [Pleasure, David E.] Univ Calif Davis, Dept Neurol, Sch Med, Sacramento, CA 95817 USA; [Soulika, Athena M.; Pleasure, David E.; Deng, Wenbin] Shriners Hosp Children, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Deng, WB (corresponding author), 2425 Stockton Blvd, Sacramento, CA 95817 USA.	wbdeng@ucdavis.edu	Selvaraj, Vimal/AAC-2853-2022		National Institutes of Health [RO1 NS059043, RO1 ES015988, RO1 NS025044]; National Multiple Sclerosis Society; Shriners Hospitals for Children; California Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059043, R01NS025044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Shriners Hospitals for Children; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS059043 and RO1 ES015988 (to W. D.) and RO1 NS025044 (to D. P. and A. S.). This work was also supported by grants from the National Multiple Sclerosis Society (to W. D.) and Shriners Hospitals for Children (to W. D.) and a postdoctoral fellowship from the California Institute for Regenerative Medicine (to M. M. S.).	Aldinucci A, 2007, J IMMUNOL, V179, P305, DOI 10.4049/jimmunol.179.1.305; Ambrose HE, 2009, IMMUNOLOGY, V127, P178, DOI 10.1111/j.1365-2567.2008.02921.x; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Carrillo A, 2004, NUCLEIC ACIDS RES, V32, P757, DOI 10.1093/nar/gkh239; CASSELL DJ, 1994, J EXP MED, V180, P1829, DOI 10.1084/jem.180.5.1829; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Chiarugi A, 2005, PHARMACOL RES, V52, P15, DOI 10.1016/j.phrs.2005.02.018; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Falcone M, 1997, J EXP MED, V185, P901, DOI 10.1084/jem.185.5.901; Fernet M, 2000, INT J RADIAT BIOL, V76, P1621, DOI 10.1080/09553000050201118; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; FINKELMAN FD, 1995, J EXP MED, V182, P279, DOI 10.1084/jem.182.2.279; Fritz RB, 1996, J NEUROSCI RES, V45, P471, DOI 10.1002/(SICI)1097-4547(19960815)45:4<471::AID-JNR17>3.0.CO;2-3; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gonzalez-Rey E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001071; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; Graziani G, 2005, PHARMACOL RES, V52, P109, DOI 10.1016/j.phrs.2005.02.013; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Ha HC, 2004, P NATL ACAD SCI USA, V101, P5087, DOI 10.1073/pnas.0306895101; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Juedes AE, 2001, J IMMUNOL, V166, P5168, DOI 10.4049/jimmunol.166.8.5168; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kauppinen TM, 2007, NEUROCHEM INT, V50, P954, DOI 10.1016/j.neuint.2006.11.010; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kauppinen TM, 2005, J NEUROSCI RES, V81, P190, DOI 10.1002/jnr.20525; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; KRIEGER JI, 1985, J IMMUNOL, V135, P2937; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Masutani M, 2005, CELL MOL LIFE SCI, V62, P769, DOI 10.1007/s00018-004-4509-x; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; METLAY JP, 1989, J EXP MED, V169, P239, DOI 10.1084/jem.169.1.239; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; NOTTBOHM AC, 2007, NEW FRONTIERS POSTGE, P163; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Phulwani NK, 2008, J NEUROCHEM, V106, P578, DOI 10.1111/j.1471-4159.2008.05403.x; PIELASMITH TH, 1992, J IMMUNOL, V148, P41; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Saenz L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-171; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Suarez-Pinzon WL, 2003, DIABETES, V52, P1683, DOI 10.2337/diabetes.52.7.1683; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Tartier L, 2003, MUTAGENESIS, V18, P411, DOI 10.1093/mutage/geg015; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007	80	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26070	26084		10.1074/jbc.M109.013474	http://dx.doi.org/10.1074/jbc.M109.013474			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628872	Green Published, hybrid			2022-12-25	WOS:000269738000063
J	Qi, YH; Wu, CM; Zhang, SX; Wang, ZH; Huang, SY; Dai, L; Wang, SC; Xia, LN; Wen, K; Cao, XY; Wu, YN; Shen, JZ				Qi, Yonghua; Wu, Congming; Zhang, Suxia; Wang, Zhanhui; Huang, Siyang; Dai, Lei; Wang, Shaochen; Xia, Lining; Wen, Kai; Cao, Xingyuan; Wu, Yongning; Shen, Jianzhong			Selection of Anti-Sulfadimidine Specific ScFvs from a Hybridoma Cell by Eukaryotic Ribosome Display	PLOS ONE			English	Article								Background: Ribosome display technology has provided an alternative platform technology for the development of novel low-cost antibody based on evaluating antibiotics derived residues in food matrixes. Methodology/Principal Findings: In our current studies, the single chain variable fragments (scFvs) were selected from hybridoma cell lines against sulfadimidine (SM2) by using a ribosome library technology. A DNA library of scFv antibody fragments was constructed for ribosome display, and then mRNA-ribosome-antibody (MRA) complexes were produced by a rabbit reticulocyte lysate system. The synthetic sulfadimidine-ovalbumin (SM2-OVA) was used as an antigen to pan MRA complexes and putative scFv-encoding genes were recovered by RT-PCR in situ following each panning. After four rounds of ribosome display, the expression vector pCANTAB5E containing the selected specific scFv DNA was constructed and transformed into Escherichia coli HB2151. Three positive clones (SAS14, SAS68 and SAS71) were screened from 100 clones and had higher antibody activity and specificity to SM2 by indirect ELISA. The three specific soluble scFvs were identified to be the same molecular weight (approximately 30 kDa) by Western-blotting analysis using anti-E tag antibodies, but they had different amino acids sequence by sequence analysis. Conclusions/Significance: The selection of anti-SM2 specific scFv by in vitro ribosome display technology will have an important significance for the development of novel immunodetection strategies for residual veterinary drugs.			Qi, YH (corresponding author), China Agr Univ, Coll Vet Med, Natl Ctr Vet Drug Safety Evaluat, Beijing 100094, Peoples R China.	sjz@cau.edu.cn	Wu, Yongning/F-5818-2019; Wang, Zhanhui/AAH-8601-2019; Shen, Jianzhong/AAH-8184-2019	Wu, Yongning/0000-0001-6430-1302; Wang, Zhanhui/0000-0002-0167-9559				Bashiardes Stavros, 2002, Stud Health Technol Inform, V91, P86; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Bruhlmann F, 1999, BIOTECHNOL BIOENG, V63, P544, DOI 10.1002/(SICI)1097-0290(19990605)63:5<544::AID-BIT4>3.0.CO;2-6; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chen Gang, 2007, Weishengwu Xuebao, V47, P1066; Cliquet P, 2003, J AGR FOOD CHEM, V51, P5835, DOI 10.1021/jf034316c; Deng Ping, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P354; Douthwaite JA, 2006, PROTEIN ENG DES SEL, V19, P85, DOI 10.1093/protein/gzj003; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hanes J, 1999, FEBS LETT, V450, P105, DOI 10.1016/S0014-5793(99)00475-5; Hanes J, 2000, METHOD ENZYMOL, V328, P404, DOI 10.1016/S0076-6879(00)28409-7; He JH, 2005, J FOOD SCI, V70, pC113, DOI 10.1111/j.1365-2621.2005.tb09012.x; He MY, 2007, NAT METHODS, V4, P281, DOI 10.1038/NMETH1001; He Mingyue, 2004, Methods Mol Biol, V248, P177; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; He MY, 1997, NUCLEIC ACIDS RES, V25, P5132, DOI 10.1093/nar/25.24.5132; He MY, 2005, EXPERT REV PROTEOMIC, V2, P421, DOI 10.1586/14789450.2.3.421; He MY, 2005, J IMMUNOL METHODS, V297, P73, DOI 10.1016/j.jim.2004.11.022; He MY, 1999, J IMMUNOL METHODS, V231, P105, DOI 10.1016/S0022-1759(99)00144-1; Heering W, 1998, ANALYST, V123, P2759, DOI 10.1039/a805047c; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Irving RA, 2001, J IMMUNOL METHODS, V248, P31, DOI 10.1016/S0022-1759(00)00341-0; Kimura T, 2003, INT IMMUNOPHARMACOL, V3, P1519, DOI 10.1016/S1567-5769(03)00179-6; Ko E, 2000, J VET MED SCI, V62, P1121, DOI 10.1292/jvms.62.1121; Korpimaki T, 2003, PROTEIN ENG, V16, P37, DOI 10.1093/proeng/gzg010; Lee MS, 2004, J IMMUNOL METHODS, V284, P147, DOI 10.1016/j.jim.2003.10.009; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; McEvoy JDG, 1999, VET REC, V144, P470; Muldoon MT, 2000, J AGR FOOD CHEM, V48, P545, DOI 10.1021/jf990377s; Rothe A, 2008, BIOL CHEM, V389, P433, DOI 10.1515/BC.2008.045; Rothe A, 2007, J BIOTECHNOL, V130, P448, DOI 10.1016/j.jbiotec.2007.05.012; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Schier Robert, 1996, Human Antibodies and Hybridomas, V7, P97; Shelver WL, 2008, J AGR FOOD CHEM, V56, P6609, DOI 10.1021/jf800657u; Yang LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002092; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	39	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6427	10.1371/journal.pone.0006427	http://dx.doi.org/10.1371/journal.pone.0006427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641611	Green Submitted, gold, Green Published			2022-12-25	WOS:000268494500027
J	Drexler, JF; Corman, VM; Gloza-Rausch, F; Seebens, A; Annan, A; Ipsen, A; Kruppa, T; Muller, MA; Kalko, EKV; Adu-Sarkodie, Y; Oppong, S; Drosten, C				Drexler, Jan Felix; Corman, Victor Max; Gloza-Rausch, Florian; Seebens, Antje; Annan, Augustina; Ipsen, Anne; Kruppa, Thomas; Mueller, Marcel A.; Kalko, Elisabeth K. V.; Adu-Sarkodie, Yaw; Oppong, Samuel; Drosten, Christian			Henipavirus RNA in African Bats	PLOS ONE			English	Article								Background: Henipaviruses (Hendra and Nipah virus) are highly pathogenic members of the family Paramyxoviridae. Fruit-eating bats of the Pteropus genus have been suggested as their natural reservoir. Human Henipavirus infections have been reported in a region extending from Australia via Malaysia into Bangladesh, compatible with the geographic range of Pteropus. These bats do not occur in continental Africa, but a whole range of other fruit bats is encountered. One of the most abundant is Eidolon helvum, the African Straw-coloured fruit bat. Methodology/Principal Findings: Feces from E. helvum roosting in an urban setting in Kumasi/Ghana were tested for Henipavirus RNA. Sequences of three novel viruses in phylogenetic relationship to known Henipaviruses were detected. Virus RNA concentrations in feces were low. Conclusions/Significance: The finding of novel putative Henipaviruses outside Australia and Asia contributes a significant extension of the region of potential endemicity of one of the most pathogenic virus genera known in humans.			Drexler, JF (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	drosten@virology-bonn.de	Corman, Victor M/K-1319-2019; Drexler, Jan Felix/GMW-5098-2022; Müller, Marcel A./O-2425-2019; Sylverken, Augustina Angelina/ABE-4664-2020; Drexler, Jan Felix/C-1004-2014	Corman, Victor M/0000-0002-3605-0136; Müller, Marcel A./0000-0003-2242-5117; SYLVERKEN, AUGUSTINA/0000-0002-7691-914X; Drexler, Jan Felix/0000-0002-3509-0232				[Anonymous], 1999, WALKERS MAMMALS WORL; Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; DEFREES SW, 1988, MAMMALIAN SPECIES, V312; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2005, CURR MOL MED, V5, P805, DOI 10.2174/156652405774962308; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Forster JL, 2008, J VIROL METHODS, V149, P190, DOI 10.1016/j.jviromet.2007.12.020; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Lamb RA., 2005, VIRUS TAXONOMY, P655; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Swensson J., 2005, BUSHMEAT TRADE TECHI; TAYLOR D, 2000, BATS; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Uhlenhaut C, 2005, J VIROL METHODS, V128, P189, DOI 10.1016/j.jviromet.2005.05.002; Vallo P, 2008, ACTA CHIROPTEROL, V10, P193, DOI 10.3161/150811008X414782; WACHARAPLUESADE.S, 2009, VECTOR BORNE ZOONOTI; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wang Lin-Fa, 2003, Current Genomics, V4, P263, DOI 10.2174/1389202033490385	47	134	136	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6367	10.1371/journal.pone.0006367	http://dx.doi.org/10.1371/journal.pone.0006367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636378	Green Submitted, Green Published, gold			2022-12-25	WOS:000268404900005
J	Zhang, NZ; Zhang, LF; Jiang, YN; Zhang, T; Xia, C				Zhang, Nian Zhi; Zhang, Li Feng; Jiang, Yi Nan; Zhang, Ting; Xia, Chun			Molecular Analysis of Spring Viraemia of Carp Virus in China: A Fatal Aquatic Viral Disease that Might Spread in East Asian	PLOS ONE			English	Article							PIKE FRY RHABDOVIRUS; CYPRINUS-CARPIO; FISH RHABDOVIRUSES; COMMON CARP; PH DOMAIN; RT-PCR; SEQUENCE; PROTEIN; INFECTION; GENES	Spring viraemia of carp (SVC) is a fatal viral disease for cyprinid fish, which is caused by spring viraemia of carp virus (SVCV). To date, no SVC outbreak has been reported in China. Between 1998 and 2002, outbreaks of SVC were reported in ornamental and wild fish in Europe and America, imported from multiple sources including China. Based on phylogenetic analysis, the viral strain isolated from America was shown to be originated from Asia. These outbreaks not only resulted in huge economic losses, but also raise an interesting question as to whether SVCV really exists in China and if so, is it responsible for SVC outbreaks? From 2002 to 2006, we screened 6700 samples from ornamental fish farms using the cell culture method of the Office International des Epizooties (OIE), and further verified the presence of SVCV by ELISA and real-time quantitative RT-PCR. Two infected samples were found and the complete genome of SVCV was sequenced from one of the isolates, termed SVCV-C1. Several unique hallmarks of SVCV-C1 were identified, including six amino acid (KSLANA) insertion in the viral RNA-dependent RNA polymerase (L) protein and ten nucleotide insertion in the region between glycoprotein (G) and L genes in European SVCV strains. Phylogenetic tree analysis of the full-length G protein of selected SVCV isolates from the United Kingdom and United States revealed that G proteins could be classified into Ia and Id sub genogroups. The Ia sub genogroup can be further divided into newly defined sub genogroups Ia-A and Ia-B. The isolates derived from the United States and China including the SVCV-C1 belongs to in the Ia-A sub genogroup. The SVCV-C1 G protein shares more than 99% homology with the G proteins of the SVCV strains from England and the United States, making it difficult to compare their pathogenicity. Comparison of the predicted three-dimensional structure based on the published G protein sequences from five SVCV strains revealed that the main differences were in the loops of the pleckstrin homology domains. Since SVCV is highly pathogenic, we speculate that SVC may therefore pose a serious threat to farmed cyprinid fish in China.			Zhang, NZ (corresponding author), China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China.	xiachun@cau.edu.cn	Zhang, Ting/X-4558-2019	Xia, Chun/0000-0002-3444-0624				ADAIR BMM, 1986, B EUR ASS FISH PATHO, V6; AHNE W, 1986, VET IMMUNOL IMMUNOP, V12, P383, DOI 10.1016/0165-2427(86)90144-3; Ahne W, 2002, DIS AQUAT ORGAN, V52, P261, DOI 10.3354/dao052261; AHNE W, 1985, J FISH DIS, V8, P241, DOI 10.1111/j.1365-2761.1985.tb01220.x; AHNE W, 1973, THESIS LUDWIG MAXIMI; BAUDOUY AM, 1980, ANN RECH VET, V11, P245; Bjorklund HV, 1996, VIRUS RES, V42, P65, DOI 10.1016/0168-1702(96)01300-7; BJORKLUND HV, 1995, VET RES, V26, P394; BLUMBERG BM, 1981, CELL, V23, P837, DOI 10.1016/0092-8674(81)90448-7; Cardoso TC, 1998, AVIAN PATHOL, V27, P450, DOI 10.1080/03079459808419368; CHAND K, 2009, J VIROL METHODS; Chen ZY, 2008, VET IMMUNOL IMMUNOP, V123, P266, DOI 10.1016/j.vetimm.2008.02.011; Dixon PF, 2005, DIS AQUAT ORGAN, V67, P25, DOI 10.3354/dao067025; FAISAL M, 1983, ZBL VET MED B, V30, P466; Fijan N, 1999, FISH DISEASES AND DISORDERS, VOL 3, P177; FIJAN N, 1984, S BIOL HUNG, V23, P233; Fijan N. N., 1972, Diseases of fish, P39; HAENEN OLM, 1993, DIS AQUAT ORGAN, V15, P87, DOI 10.3354/dao015087; Hoffmann B, 2002, VIRUS RES, V84, P89, DOI 10.1016/S0168-1702(01)00441-5; Johnson MC, 1999, VIRUS RES, V64, P95, DOI 10.1016/S0168-1702(99)00071-4; Kaattari S. L., 1996, The fish immune system: organism, pathogen, and environment, P207; Kanellos T, 2006, VACCINE, V24, P4927, DOI 10.1016/j.vaccine.2006.03.062; KIUCHI A, 1984, VIROLOGY, V134, P238, DOI 10.1016/0042-6822(84)90290-3; Koutna M, 2003, DIS AQUAT ORGAN, V55, P229, DOI 10.3354/dao055229; Liu ZX, 2008, J VIROL METHODS, V149, P103, DOI 10.1016/j.jviromet.2007.12.017; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Miller O, 2007, DIS AQUAT ORGAN, V76, P193, DOI 10.3354/dao076193; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Oreshkova SF, 1999, VIRUS RES, V63, P3, DOI 10.1016/S0168-1702(99)00052-0; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rowley H, 2001, DIS AQUAT ORGAN, V48, P7, DOI 10.3354/dao048007; ROY P, 1978, J VIROL, V25, P912, DOI 10.1128/JVI.25.3.912-916.1978; Sanders GE, 2003, COMPARATIVE MED, V53, P514; Scaife RM, 1997, CELL SIGNAL, V9, P395, DOI 10.1016/S0898-6568(97)00041-7; Shchelkunov I. S., 1989, Viruses of lower vertebrates., P333; Stone DM, 2003, DIS AQUAT ORGAN, V53, P203, DOI 10.3354/dao053203; Teng Y, 2007, ARCH VIROL, V152, P1457, DOI 10.1007/s00705-007-0971-8; Terasawa H, 1997, Tanpakushitsu Kakusan Koso, V42, P996; Walker P.J., 2000, 7 INT COMM TAX VIR, P563; Wang L, 2006, J INTERF CYTOK RES, V26, P256, DOI 10.1089/jir.2006.26.256; Warg JV, 2007, VIRUS GENES, V35, P87, DOI 10.1007/s11262-006-0042-3; Yue ZQ, 2008, J VIROL METHODS, V152, P43, DOI 10.1016/j.jviromet.2008.05.031	42	34	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6337	10.1371/journal.pone.0006337	http://dx.doi.org/10.1371/journal.pone.0006337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623265	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260100014
J	Hu, Z; Pan, XF; Wu, FQ; Ma, LY; Liu, DP; Liu, Y; Feng, TT; Meng, FY; Liu, XL; Jiang, QL; Chen, XQ; Liu, JL; Liu, P; Chen, Z; Chen, SJ; Zhou, GB				Hu, Zheng; Pan, Xiao-Fen; Wu, Fu-Qun; Ma, Li-Yuan; Liu, Da-Peng; Liu, Ying; Feng, Ting-Ting; Meng, Fan-Yi; Liu, Xiao-Li; Jiang, Qian-Li; Chen, Xiao-Qin; Liu, Jing-Lei; Liu, Ping; Chen, Zhu; Chen, Sai-Juan; Zhou, Guang-Biao			Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia	PLOS ONE			English	Article								Background: Resistance developed by leukemic cells, unsatisfactory efficacy on patients with chronic myeloid leukemia (CML) at accelerated and blastic phases, and potential cardiotoxity, have been limitations for imatinib mesylate (IM) in treating CML. Whether low dose IM in combination with agents of distinct but related mechanisms could be one of the strategies to overcome these concerns warrants careful investigation. Methods and Findings: We tested the therapeutic efficacies as well as adverse effects of low dose IM in combination with proteasome inhibitor, Bortezomib (BOR) or proteasome inhibitor I (PSI), in two CML murine models, and investigated possible mechanisms of action on CML cells. Our results demonstrated that low dose IM in combination with BOR exerted satisfactory efficacy in prolongation of life span and inhibition of tumor growth in mice, and did not cause cardiotoxicity or body weight loss. Consistently, BOR and PSI enhanced IM-induced inhibition of long-term clonogenic activity and short-term cell growth of CML stem/progenitor cells, and potentiated IM-caused inhibition of proliferation and induction of apoptosis of BCR-ABL+ cells. IM/BOR and IM/PSI inhibited Bcl-2, increased cytoplasmic cytochrome C, and activated caspases. While exerting suppressive effects on BCR-ABL, E2F1, and beta-catenin, IM/BOR and IM/PSI inhibited proteasomal degradation of protein phosphatase 2A (PP2A), leading to a re-activation of this important negative regulator of BCR-ABL. In addition, both combination therapties inhibited Bruton's tyrosine kinase via suppression of NFkB. Conclusion: These data suggest that combined use of tyrosine kinase inhibitor and proteasome inhibitor might be helpful for optimizing CML treatment.			Hu, Z (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Mol Target Based Therapy Canc, Guangzhou, Guangdong, Peoples R China.	sjchen@stn.sh.cn; gbzhou@ioz.ac.cn	Liu, Xiaoli/HGE-7614-2022; Zhou, Guangbiao/J-6575-2017; Zhou, Guang-Biao/ABG-5795-2021	Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Buchdunger E, 1996, CANCER RES, V56, P100; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Dai Y, 2004, BLOOD, V104, P509, DOI 10.1182/blood-2003-12-4121; Deming PB, 2004, MOL CELL BIOL, V24, P10289, DOI 10.1128/MCB.24.23.10289-10299.2004; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Di Bacco AMA, 2002, BRIT J HAEMATOL, V117, P588, DOI 10.1046/j.1365-2141.2002.03468.x; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dou QP, 1999, J PHARMACOL EXP THER, V289, P781; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Gatto S, 2003, HAEMATOLOGICA, V88, P853; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hacihanefioglu A, 2008, INT J HEMATOL, V88, P219, DOI 10.1007/s12185-008-0139-7; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HEANEY N, 2007, ASH ANN M, V110, P2943; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kraus M, 2007, LEUKEMIA, V21, P84, DOI 10.1038/sj.leu.2404414; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Lassila M, 2004, ARTERIOSCL THROM VAS, V24, P935, DOI 10.1161/01.ATV.0000124105.39900.db; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; LeBlanc R, 2002, CANCER RES, V62, P4996; Magill L, 2004, HAEMATOLOGICA, V89, P1428; MARANTEMENDES GP, 1998, BLOOD, V91, P1700; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x; Park YH, 2006, CANCER LETT, V243, P16, DOI 10.1016/j.canlet.2005.11.014; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Saad SY, 2006, J PHARM PHARMACOL, V58, P567, DOI 10.1211/jpp.58.4.0017; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schellings MWM, 2006, HYPERTENSION, V47, P467, DOI 10.1161/01.HYP.0000202487.68969.f7; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Servida F, 2005, LEUKEMIA, V19, P2324, DOI 10.1038/sj.leu.2403987; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Soligo D, 2001, BRIT J HAEMATOL, V113, P126, DOI 10.1046/j.1365-2141.2001.02683.x; STEWART MJ, 1995, LEUKEMIA, V9, P1499; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tong Y, 2004, BLOOD, V104, P4219, DOI 10.1182/blood-2004-04-1433; Topaly J, 2001, LEUKEMIA, V15, P342, DOI 10.1038/sj.leu.2402041; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Villuendas R, 2006, LEUKEMIA, V20, P1047, DOI 10.1038/sj.leu.2404197; Voortman J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-129; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737; Yu L, 2008, BLOOD, V111, P4617, DOI 10.1182/blood-2007-10-121137; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	71	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6257	10.1371/journal.pone.0006257	http://dx.doi.org/10.1371/journal.pone.0006257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606213	gold, Green Submitted, Green Published			2022-12-25	WOS:000268036000013
J	Pelletier, J; Leal, WS				Pelletier, Julien; Leal, Walter S.			Genome Analysis and Expression Patterns of Odorant-Binding Proteins from the Southern House Mosquito Culex pipiens quinquefasciatus	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; MALARIA VECTOR MOSQUITO; PHEROMONE-BINDING; DROSOPHILA-MELANOGASTER; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; IDENTIFICATION; FAMILY; GENES; RECEPTOR	Olfactory-based behaviors in mosquitoes are mediated by odorant-binding proteins (OBPs). They form a multigenic family involved in the peripheral events in insect olfaction, specifically the transport of odorants to membrane-bound odorant receptors. OBPs contribute to the remarkable sensitivity of the insect's olfactory system and may be involved in the selective transport of odorants. We have employed a combination of bioinformatics and molecular approaches to identify and characterize members of the "classic'' OBP family in the Southern House mosquito Culex pipiens quinquefasciatus (=Cx. quinquefasciatus), a vector of pathogens causing several human diseases. By taking advantage of the recently released genome sequences, we have identified fifty-three putative Cx. quinquefasciatus OBP genes by Blast searches. As a first step towards their molecular characterization, expression patterns by RT-PCR revealed thirteen genes that were detected exclusively and abundantly in chemosensory tissues. No clear differences were observed in the transcripts levels of olfactory-specific OBPs between antennae of both sexes using semi-quantitative RT-PCR. Phylogenetic and comparative analysis revealed orthologous of Cx. quinquefasciatus OBPs in Anopheles gambiae and Aedes aegypti. The identification of fifty-three putative OBP genes in Cx. quinquefasciatus highlights the diversity of this family. Tissue-specificity study suggests the existence of different functional classes within the mosquito OBP family. Most genes were detected in chemosensory as well as non chemosensory tissues indicating that they might be encapsulins, but not necessarily olfactory proteins. On the other hand, thirteen "true'' OBP genes were detected exclusively in olfactory tissues and might be involved specifically in the detection of "key'' semiochemicals. Interestingly, in Cx. quinquefasciatus olfactory-specific OBPs belong exclusively to four distinct phylogenetic groups which are particularly well conserved among three mosquito species.			Pelletier, J (corresponding author), Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058267] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Galindo K, 2001, GENETICS, V159, P1059; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Park SK, 2000, CELL TISSUE RES, V300, P181, DOI 10.1007/s004410050059; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sengul MS, 2008, INSECT MOL BIOL, V17, P631, DOI 10.1111/j.1365-2583.2008.00837.x; Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	48	70	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2009	4	7							e6237	10.1371/journal.pone.0006237	http://dx.doi.org/10.1371/journal.pone.0006237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DU	19606229	Green Published, gold, Green Submitted			2022-12-25	WOS:000268036000001
J	Kiyota, T; Yamamoto, M; Xiong, HG; Lambert, MP; Klein, WL; Gendelman, HE; Ransohoff, RM; Ikezu, T				Kiyota, Tomomi; Yamamoto, Masaru; Xiong, Huangui; Lambert, Mary P.; Klein, William L.; Gendelman, Howard E.; Ransohoff, Richard M.; Ikezu, Tsuneya			CCL2 Accelerates Microglia-Mediated A beta Oligomer Formation and Progression of Neurocognitive Dysfunction	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; TRANSGENIC MICE; BONE-MARROW; SYNAPTIC PLASTICITY; CLEARANCE; DISEASE; MODEL; OVEREXPRESSION; TRANSMISSION	Background: The linkages between neuroinflammation and Alzheimer's disease (AD) pathogenesis are well established. What is not, however, is how specific immune pathways and proteins affect the disease. To this end, we previously demonstrated that transgenic over-expression of CCL2 enhanced microgliosis and induced diffuse amyloid plaque deposition in Tg2576 mice. This rodent model of AD expresses a Swedish beta-amyloid (A beta) precursor protein mutant. Methodology/Principal Findings: We now report that CCL2 transgene expression accelerates deficits in spatial and working memory and hippocampal synaptic transmission in beta-amyloid precursor protein (APP) mice as early as 2-3 months of age. This is followed by increased numbers of microglia that are seen surrounding Ab oligomers. CCL2 does not suppress Ab degradation. Rather, CCL2 and tumor necrosis factor-alpha directly facilitated A beta uptake, intracellular Ab oligomerization, and protein secretion. Conclusions/Significance: We posit that CCL2 facilitates A beta oligomer formation in microglia and propose that such events accelerate memory dysfunction by affecting A beta seeding in the brain.			Kiyota, T (corresponding author), Univ Nebraska Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE USA.	tikezu@unmc.edu	Gendelman, Howard E/G-8242-2012	Ikezu, Tsuneya/0000-0002-3979-8596	NIA NIH HHS [R21 AG032600, R21 AG032600-02, R21 AG032600-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS32151, R37 NS036126, P01 NS043985, R37 NS36126, R01 NS032151] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151, R37NS036126, P01NS043985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032600] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; GALIMBERTI D, 2005, NEUROBIOL AGING; Good TA, 1996, P NATL ACAD SCI USA, V93, P15130, DOI 10.1073/pnas.93.26.15130; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang DR, 2002, J NEUROSCI, V22, P10633; Ikezu T, 2003, J NEUROCHEM, V85, P925, DOI 10.1046/j.1471-4159.2003.01739.x; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Sautter NB, 2006, JARO-J ASSOC RES OTO, V7, P361, DOI 10.1007/s10162-006-0051-x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; WISNIEWSKI HM, 1994, NEUROPATH APPL NEURO, V20, P192; Xiong HG, 2004, NEUROBIOL AGING, V25, P905, DOI 10.1016/j.neurobiolaging.2003.09.007; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yamamoto M, 2007, J NEUROIMMUNE PHARM, V2, P213, DOI 10.1007/s11481-006-9049-8; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Zink WE, 2002, J NEUROSCI, V22, P2096, DOI 10.1523/JNEUROSCI.22-06-02096.2002	43	80	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6197	10.1371/journal.pone.0006197	http://dx.doi.org/10.1371/journal.pone.0006197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593388	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035300010
J	McArthur, S; Yazid, S; Christian, H; Sirha, R; Flower, R; Buckingham, J; Solito, E				McArthur, Simon; Yazid, Samia; Christian, Helen; Sirha, Ravneet; Flower, Roderick; Buckingham, Julia; Solito, Egle			Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization	FASEB JOURNAL			English	Article						FPR; ROCK; phosphorylation; siRNA	ANTERIOR-PITUITARY GLAND; FORMYL PEPTIDE RECEPTORS; PROTEIN-KINASE-C; HUMAN NEUTROPHIL; IN-VITRO; CHROMAFFIN CELLS; LIPOCORTIN-I; RHO GTPASES; INVOLVEMENT; RAT	The glucocorticoid-regulated protein annexin A1 is a potent inhibitor of hormone exocytosis in the neuroendocrine system, acting in a paracrine/juxtacrine manner. The signaling mechanism employed by annexin A1 in this process is uncertain, although we have recently presented evidence for a role of the formyl peptide receptor in vivo. We sought to characterize the mechanism of action of annexin A1 on exocytosis using the release of adrenocorticotrophin from the corticotroph-like cell line AtT20 as an in vitro model system. Through the comparison of adrenocorticotrophin release from cells expressing either wildtype annexin A1 or mutant forms, we show a critical involvement of phosphorylation on serine 27 and 45 in the translocation of the protein to the membrane and its inhibitory action on exocytosis. Moreover, we show, for the first time, that annexin A1-dependent inhibition of adrenocorticotrophin release involves the enhancement of actin polymerization to prevent exocytosis via formyl peptide receptor and Rho kinase signaling pathways. This finding has significant implications for the inhibitory actions of annexin A1 on exocytosis in other endocrine and immune contexts.-McArthur, S., Yazid, S., Christian, H., Sirha, R., Flower, R., Buckingham, J., Solito, E. Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization. FASEB J. 23, 4000-4010 (2009). www.fasebj.org	[Solito, Egle] Univ London Imperial Coll Sci Technol & Med, Dept Cellular & Mol Neurosci, Fac Med, London W12 0NN, England; [Yazid, Samia; Flower, Roderick] Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, London EC1M 6BQ, England; [Christian, Helen] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Imperial College London; University of London; Queen Mary University London; University of Oxford	Solito, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Cellular & Mol Neurosci, Fac Med, Hammersmith Campus,Burlington Danes Bldg,Rm 515,D, London W12 0NN, England.	e.solito@imperial.ac.uk	McArthur, Simon/V-6839-2019	McArthur, Simon/0000-0001-8521-1808; McArthur, Simon/0000-0002-9603-4381; Solito, Egle/0000-0001-5279-0049; Christian, Helen/0000-0002-4263-5499	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to Prof. M. Perretti, for the help with qPCR experiments, and to our sponsor, Wellcome Trust. Many thanks to Dr. G. E. Gillies for helpful discussions during manuscript preparation.	AlvarezMartinez MT, 1997, BBA-PROTEIN STRUCT M, V1339, P331, DOI 10.1016/S0167-4838(97)00018-6; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Bandeira-Melo C, 2005, J PHARMACOL EXP THER, V313, P1416, DOI 10.1124/jpet.104.080473; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckingham JC, 2006, ANN NY ACAD SCI, V1088, P396, DOI 10.1196/annals.1366.002; Chapman LP, 2003, ENDOCRINOLOGY, V144, P1062, DOI 10.1210/en.2002-220650; Chodniewicz D, 2003, BLOOD, V102, P2251, DOI 10.1182/blood-2002-09-2936; Chodniewicz D, 2003, BLOOD, V101, P1181, DOI 10.1182/blood-2002-05-1435; Christian HC, 1999, J NEUROENDOCRINOL, V11, P707; Erlich R, 1998, MOL CELL ENDOCRINOL, V142, P87, DOI 10.1016/S0303-7207(98)00113-0; Gasman S, 1999, J CELL SCI, V112, P4763; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; John C, 2002, ENDOCRINOLOGY, V143, P3060, DOI 10.1210/en.143.8.3060; John CD, 2007, FASEB J, V21, P1037, DOI 10.1096/fj.06-7299com; LLORET S, 1994, EUR J PHARMACOL, V264, P379, DOI 10.1016/0014-2999(94)00500-1; LLORET S, 1992, BIOCHEM PHARMACOL, V44, P1437, DOI 10.1016/0006-2952(92)90546-U; LOXLEY HD, 1993, J NEUROENDOCRINOL, V5, P51, DOI 10.1111/j.1365-2826.1993.tb00363.x; McArthur S, 2008, FUND CLIN PHARMACOL, V22, P23; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; MOSS SE, 1992, PORTLAND PRESS RES M, V2; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; Perretti M, 2000, CELL BIOL INT, V24, P163, DOI 10.1006/cbir.1999.0468; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; SCHLAEPFER DD, 1987, J BIOL CHEM, V262, P6931; Simoes RL, 2005, J IMMUNOL, V175, P1843, DOI 10.4049/jimmunol.175.3.1843; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Solito E, 2000, J IMMUNOL, V165, P1573, DOI 10.4049/jimmunol.165.3.1573; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; Solito E, 1998, CYTOKINE, V10, P514, DOI 10.1006/cyto.1997.0325; Solito E, 1998, CELL GROWTH DIFFER, V9, P327; Solito E, 1998, BRIT J PHARMACOL, V124, P1675, DOI 10.1038/sj.bjp.0701991; Solito E, 2008, TRENDS PHARMACOL SCI, V29, P135, DOI 10.1016/j.tips.2007.12.003; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; TASAKA K, 1994, AGENTS ACTIONS, V41, pC106, DOI 10.1007/BF02007788; TAYLOR AD, 1993, NEUROENDOCRINOLOGY, V58, P430, DOI 10.1159/000126572; Taylor AD, 1997, ENDOCRINOLOGY, V138, P2909, DOI 10.1210/en.138.7.2909; Tierney T, 2003, J NEUROENDOCRINOL, V15, P1134, DOI 10.1111/j.1365-2826.2003.01111.x; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; WHITE MV, 1991, J IMMUNOL, V147, P667	43	28	30	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					4000	4010		10.1096/fj.09-131391	http://dx.doi.org/10.1096/fj.09-131391			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19625660				2022-12-25	WOS:000271272500035
J	Kumar, P; Vahedi-Faridi, A; Saenger, W; Merino, E; de Castro, JAL; Uchanska-Ziegler, B; Ziegler, A				Kumar, Pravin; Vahedi-Faridi, Ardeschir; Saenger, Wolfram; Merino, Elena; Lopez de Castro, Jose A.; Uchanska-Ziegler, Barbara; Ziegler, Andreas			Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANKYLOSING-SPONDYLITIS; PEPTIDE-BINDING; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; LIMITED PEPTIDE; VIRAL PEPTIDE; SELF-PEPTIDE; COMPLEX; SUBTYPES	The existence of cytotoxic T cells (CTL) cross-reacting with the human major histocompatibility antigens HLA-B14 and HLA-B27 suggests that their alloreactivity could be due to presentation of shared peptides in similar binding modes by these molecules. We therefore determined the crystal structures of the subtypes HLAB*1402, HLA-B*2705, and HLA-B*2709 in complex with a proven self-ligand, pCatA (peptide with the sequence IRAAPPPLF derived from cathepsin A (residues 2-10)), and of HLA-B*1402 in complex with a viral peptide, pLMP2 (RRRWRRLTV, derived from latent membrane protein 2 (residues 236-244) of Epstein-Barr virus). Despite the exchange of 18 residues within the binding grooves of HLA-B*1402 and HLA-B*2705 or HLA-B*2709, the pCatA peptide is presented in nearly identical conformations. However, pLMP2 is displayed by HLA-B*1402 in a conformation distinct from those previously found in the two HLA-B27 subtypes. In addition, the complexes of HLA-B*1402 with the two peptides reveal a nonstandard, tetragonal mode of the peptide N terminus anchoring in the binding groove because of the exchange of the common Tyr-171 by His-171 of the HLA-B*1402 heavy chain. This exchange appears also responsible for reduced stability of HLA-B14-peptide complexes in vivo and slow assembly in vitro. The studies with the pCatA peptide uncover that CTL cross-reactive between HLA-B14 and HLA-B27 might primarily recognize the common structural features of the bound peptide, thus neglecting amino acid replacements within the rim of the binding grooves. In contrast, structural alterations between the three complexes with the pLMP2 peptide indicate how heavy chain polymorphisms can influence peptide display and prevent CTL cross-reactivity between HLA-B14 and HLA-B27 antigens.	[Uchanska-Ziegler, Barbara; Ziegler, Andreas] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, D-14195 Berlin, Germany; [Vahedi-Faridi, Ardeschir; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Merino, Elena; Lopez de Castro, Jose A.] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Merino, Elena; Lopez de Castro, Jose A.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Ziegler, A (corresponding author), Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, Campus Benjamin Franklin,Thielallee 73, D-14195 Berlin, Germany.	andreas.ziegler@charite.de			VolkswagenStiftung [I/79 983]; Deutsche Forschungsgemeinschaft [SFB 449, TP B6, Z3]; Senate of Berlin NaFoG Fellowship; Spanish Plan Nacional de I+D [SAF2008/00461]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Senate of Berlin NaFoG Fellowship; Spanish Plan Nacional de I+D	This work was supported by VolkswagenStiftung Grant I/79 983 (to A. Z.) and a stipend (to P. K.), Deutsche Forschungsgemeinschaft Grants SFB 449, TP B6, and Z3 (to W. S., B. U.-Z., and A. Z.), the Senate of Berlin NaFoG Fellowship (to P. K.), and Spanish Plan Nacional de I+D Grant SAF2008/00461 (to J. A. L. d. C.).	Afzali B, 2007, TISSUE ANTIGENS, V69, P545, DOI 10.1111/j.1399-0039.2007.00834.x; Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beltrami A, 2008, J BIOL CHEM, V283, P27189, DOI 10.1074/jbc.M802818200; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BREWERTON DA, 1973, LANCET, V1, P904; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DFAZPENA R, 2008, J RHEUMATOL, V35, P2236; DIBRINO M, 1994, J BIOL CHEM, V269, P32426; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALK K, 1995, IMMUNOGENETICS, V41, P162, DOI 10.1007/BF00182332; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia-Peydro M, 1999, J IMMUNOL, V163, P2299; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hourigan CS, 2006, EUR J IMMUNOL, V36, P3288, DOI 10.1002/eji.200636234; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kamoun M, 2008, P NATL ACAD SCI USA, V105, P18883, DOI 10.1073/pnas.0810308105; Kazansky DB, 2008, J IMMUNOTOXICOL, V5, P369, DOI 10.1080/15476910802476708; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Kumar P, 2008, TRENDS BIOCHEM SCI, V33, P408, DOI 10.1016/j.tibs.2008.06.004; Kumar P, 2007, ACTA CRYSTALLOGR F, V63, P631, DOI 10.1107/S1744309107029077; Kumar P, 2009, PROTEIN SCI, V18, P37, DOI 10.1002/pro.4; Li X, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-22; LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508; Loll B, 2005, ACTA CRYSTALLOGR F, V61, P939, DOI 10.1107/S1744309105029234; de Castro JAL, 2009, ADV EXP MED BIOL, V649, P196; Lopez-Larrea C, 2002, ARTHRITIS RHEUM-US, V46, P2968, DOI 10.1002/art.10584; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Menssen R, 1999, J MOL BIOL, V285, P645, DOI 10.1006/jmbi.1998.2363; Merino E, 2005, J BIOL CHEM, V280, P35868, DOI 10.1074/jbc.M505641200; Merino E, 2008, ARTHRITIS RHEUM-US, V58, P3693, DOI 10.1002/art.24045; Morris GP, 2009, J IMMUNOL, V182, P6639, DOI 10.4049/jimmunol.0900638; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradela A, 1998, J IMMUNOL, V161, P5481; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Ramos M, 2002, TISSUE ANTIGENS, V60, P191, DOI 10.1034/j.1399-0039.2002.600301.x; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Sobao Y, 1999, ARTHRITIS RHEUM, V42, P175, DOI 10.1002/1529-0131(199901)42:1<175::AID-ANR21>3.0.CO;2-7; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Urvater JA, 2001, J IMMUNOL, V166, P3334, DOI 10.4049/jimmunol.166.5.3334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VILLADANGOS JA, 1995, EUR J IMMUNOL, V25, P2370, DOI 10.1002/eji.1830250837; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Wang W, 1998, J IMMUNOL, V160, P1091; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Yague J, 1999, TISSUE ANTIGENS, V53, P227, DOI 10.1034/j.1399-0039.1999.530302.x; YAMAGUCHI A, 1995, ARTHRITIS RHEUM-US, V38, P1672, DOI 10.1002/art.1780381120; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Ziegler A, 2009, ADV EXP MED BIOL, V649, P177	76	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29784	29797		10.1074/jbc.M109.038497	http://dx.doi.org/10.1074/jbc.M109.038497			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19617632	Green Published, hybrid			2022-12-25	WOS:000270896800059
J	Justilien, V; Fields, AP				Justilien, V.; Fields, A. P.			Ect2 links the PKC iota-Par6 alpha complex to Rac1 activation and cellular transformation	ONCOGENE			English	Article						gene amplification; anchorage-independent growth; invasion; Rac1; Mek-Erk signaling; cytokinesis	CYTOKINESIS REGULATOR ECT2; EXCHANGE FACTOR ECT2; KINASE-C-IOTA; DETECTS FREQUENT; LUNG-CANCER; G2/M PHASE; PROTEIN; CARCINOMAS; AMPLIFICATION; HYBRIDIZATION	Protein kinase C iota (PKC iota) promotes non-small cell lung cancer (NSCLC) by binding to Par6 alpha and activating a Rac1-Pak-Mek1,2-Erk1,2 signaling cascade. The mechanism by which the PKC iota-Par6 alpha complex regulates Rac1 is unknown. Here we show that epithelial cell transforming sequence 2 (Ect2), a guanine nucleotide exchange factor for Rho family GTPases, is coordinately amplified and overexpressed with PKC iota in NSCLC tumors. RNA interference-mediated knockdown of Ect2 inhibits Rac1 activity and blocks transformed growth, invasion and tumorigenicity of NSCLC cells. Expression of constitutively active Rac1 (RacV12) restores transformation to Ect2-deficient cells. Interestingly, the role of Ect2 in transformation is distinct from its well-established role in cytokinesis. In NSCLC cells, Ect2 is mislocalized to the cytoplasm where it binds the PKC iota-Par6 alpha complex. RNA interference-mediated knockdown of either PKC iota or Par6 alpha causes Ect2 to redistribute to the nucleus, indicating that the PKC iota-Par6 alpha complex regulates the cytoplasmic localization of Ect2. Our data indicate that Ect2 and PKC iota are genetically and functionally linked in NSCLC, acting to coordinately drive tumor cell proliferation and invasion through formation of an oncogenic PKC iota-Par6 alpha-Ect2 complex. Oncogene (2009) 28, 3597-3607; doi:10.1038/onc.2009.217; published online 20 July 2009	[Justilien, V.; Fields, A. P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Fields, AP (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, Griffin Canc Res Bldg,Rm 212,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu			National Institutes of Health [CA081436]; V Foundation for Cancer Research; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA081436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Dr Roderick P Regala for assistance with the ectopic tumor studies, Dr Andras Khoor and Capella Weems for analysis of primary NSCLC tumors, Pam Kreinest and Brandy Eden. eld for immunohistochemistry, Dr Lee Jamieson and Alyssa Kunz for technical assistance, and Drs E Aubrey Thompson and Nicole R Murray for critical review of the paper. This work was supported in part by grants from the National Institutes of Health (CA081436), The V Foundation for Cancer Research and The Mayo Foundation to APF.	Balsara BR, 1997, CANCER RES, V57, P2116; Brass N, 1996, EUR J CANCER, V32A, P1205, DOI 10.1016/0959-8049(96)00016-0; FREDERICK LA, 2008, ONCOGENE; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Liu XF, 2006, CELL SIGNAL, V18, P1604, DOI 10.1016/j.cellsig.2006.01.007; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Saito S, 2003, J CELL BIOCHEM, V90, P819, DOI 10.1002/jcb.10688; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Snaddon J, 2001, BRIT J CANCER, V84, P1630, DOI 10.1054/bjoc.2001.1848; Solski PA, 2004, J BIOL CHEM, V279, P25226, DOI 10.1074/jbc.M313792200; Sonoda G, 1997, GENE CHROMOSOME CANC, V20, P320; Sugita M, 2000, CANCER GENET CYTOGEN, V117, P9, DOI 10.1016/S0165-4608(99)00135-1; TAKAI S, 1995, GENOMICS, V27, P220, DOI 10.1006/geno.1995.1033; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200; Zhang ML, 2008, HEPATOB PANCREAT DIS, V7, P533	27	94	103	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2009	28	41					3597	3607		10.1038/onc.2009.217	http://dx.doi.org/10.1038/onc.2009.217			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KJ	19617897	Green Accepted			2022-12-25	WOS:000270851800001
J	Jeninga, EH; Bugge, A; Nielsen, R; Kersten, S; Hamers, N; Dani, C; Wabitsch, M; Berger, R; Stunnenberg, HG; Mandrup, S; Kalkhoven, E				Jeninga, Ellen H.; Bugge, Anne; Nielsen, Ronni; Kersten, Sander; Hamers, Nicole; Dani, Christian; Wabitsch, Martin; Berger, Ruud; Stunnenberg, Hendrik G.; Mandrup, Susanne; Kalkhoven, Eric			Peroxisome Proliferator-activated Receptor gamma Regulates Expression of the Anti-lipolytic G-protein-coupled Receptor 81 (GPR81/Gpr81)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC-ACID RECEPTOR; TYPE-2 DIABETES-MELLITUS; MATURE 3T3-L1 ADIPOCYTES; NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; FREE FATTY-ACIDS; PPAR-GAMMA; PUMA-G; INSULIN-RESISTANCE; MOLECULAR-IDENTIFICATION	The ligand-inducible nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) plays a key role in the differentiation, maintenance, and function of adipocytes and is the molecular target for the insulin-sensitizing thiazoledinediones (TZDs). Although a number of PPAR gamma target genes that may contribute to the reduction of circulating free fatty acids after TZD treatment have been identified, the relevant PPAR gamma target genes that may exert the anti-lipolytic effect of TZDs are unknown. Here we identified the anti-lipolytic human G-protein-coupled receptor 81 (GPR81), GPR109A, and the (human-specific) GPR109B genes as well as the mouse Gpr81 and Gpr109A genes as novel TZD-induced genes in mature adipocytes. GPR81/Gpr81 is a direct PPAR gamma target gene, because mRNA expression of GPR81/Gpr81 (and GPR109A/Gpr109A) increased in mature human and murine adipocytes as well as in vivo in epididymal fat pads of mice upon rosiglitazone stimulation, whereas small interfering RNA-mediated knockdown of PPAR gamma in differentiated 3T3-L1 adipocytes showed a significant decrease in Gpr81 protein expression. In addition, chromatin immunoprecipitation sequencing analysis in differentiated 3T3-L1 cells revealed a conserved PPAR: retinoid X receptor-binding site in the proximal promoter of the Gpr81 gene, which was proven to be functional by electromobility shift assay and reporter assays. Importantly, small interfering RNA-mediated knockdown of Gpr81 partly reversed the inhibitory effect of TZDs on lipolysis in 3T3-L1 adipocytes. The coordinated PPAR gamma-mediated regulation of the GPR81/Gpr81 and GPR109A/Gpr109A genes (and GPR109B in humans) presents a novel mechanism by which TZDs may reduce circulating free fatty acid levels and perhaps ameliorate insulin resistance in obese patients.	[Jeninga, Ellen H.; Hamers, Nicole; Berger, Ruud; Kalkhoven, Eric] UMC Utrecht, Dept Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands; [Jeninga, Ellen H.; Hamers, Nicole; Berger, Ruud; Kalkhoven, Eric] Netherlands Metabol Ctr, NL-2333 CC Leiden, Netherlands; [Bugge, Anne; Nielsen, Ronni; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, NL-6703 HD Wageningen, Netherlands; [Dani, Christian] Univ Nice Sophia Antipolis, CNRS, UMR6543, Inst Dev Biol & Canc, F-06108 Nice 2, France; [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol, D-89075 Ulm, Germany; [Stunnenberg, Hendrik G.] Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Kalkhoven, Eric] Univ Med Ctr Utrecht, Dept Pediat Immunol, NL-3584 EA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Southern Denmark; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Ulm University; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Kalkhoven, E (corresponding author), UMC Utrecht, Dept Metab & Endocrine Dis, Rm KE-03-139-2,Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	e.kalkhoven@umcutrecht.nl	DANI, Christian/G-3639-2014; Mandrup, Susanne/B-6693-2008; Kersten, Sander/A-1116-2011; Stunnenberg, Hendrik G./D-6875-2012	DANI, Christian/0000-0003-3228-0230; Kersten, Sander/0000-0003-4488-7734; Stunnenberg, Hendrik G./0000-0002-0066-1576; Mandrup, Susanne/0000-0002-0961-5787; Nielsen, Ronni/0000-0001-6331-7660; Bugge, Anne/0000-0001-5885-4541	Federation of European Biochemical Societies; Netherlands Metabolomics Centre; Danish Natural Science Research Council; STREP Project X-TRANET	Federation of European Biochemical Societies; Netherlands Metabolomics Centre; Danish Natural Science Research Council(Danish Natural Science Research Council); STREP Project X-TRANET	This work was supported in part by a short term fellowship of the Federation of European Biochemical Societies (to E. H. J.), the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research, the Danish Natural Science Research Council, and the STREP Project X-TRANET, as part of European Union FP6.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Boden G, 2003, METABOLISM, V52, P753, DOI 10.1016/S0026-0495(03)00055-6; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BOYD AE, 1974, METABOLISM, V23, P531, DOI 10.1016/0026-0495(74)90081-X; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; DEPERGOLA G, 1989, HORM METAB RES, V21, P210, DOI 10.1055/s-2007-1009193; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; Glass CK, 2000, GENE DEV, V14, P121; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Irukayama-Tomobe Y, 2009, P NATL ACAD SCI USA, V106, P3930, DOI 10.1073/pnas.0811844106; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lenhard JM, 1997, BIOCHEM PHARMACOL, V54, P801, DOI 10.1016/S0006-2952(97)00229-3; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; McTernan PG, 2002, DIABETES, V51, P1493, DOI 10.2337/diabetes.51.5.1493; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Racette SB, 2002, METABOLISM, V51, P169, DOI 10.1053/meta.2002.29981; REYNISDOTTIR S, 1995, CLIN SCI, V89, P421, DOI 10.1042/cs0890421; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Schaub A, 2001, EUR J IMMUNOL, V31, P3714, DOI 10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang P, 2007, DIABETOLOGIA, V50, P654, DOI 10.1007/s00125-006-0565-0; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Yajima H, 2007, BIOCHEM BIOPH RES CO, V352, P526, DOI 10.1016/j.bbrc.2006.11.054	53	56	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26385	26393		10.1074/jbc.M109.040741	http://dx.doi.org/10.1074/jbc.M109.040741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19633298	Green Published, hybrid			2022-12-25	WOS:000269969600019
J	Rajagopal, C; Stone, KL; Francone, VP; Mains, RE; Eipper, BA				Rajagopal, Chitra; Stone, Kathryn L.; Francone, Victor P.; Mains, Richard E.; Eipper, Betty A.			Secretory Granule to the Nucleus ROLE OF A MULTIPLY PHOSPHORYLATED INTRINSICALLY UNSTRUCTURED DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; PEPTIDE-PROCESSING ENZYME; CYTOSOLIC ROUTING DETERMINANTS; COOH-TERMINAL DOMAIN; MEMBRANE-PROTEIN; ATT-20 CELLS; ENDOCRINE-CELLS; EXPRESSION; TRAFFICKING; KINASE	Intrinsically unstructured domains occur in one-third of all proteins and are characterized by conformational flexibility, protease sensitivity, and the occurrence of multiple phosphorylation. They provide large interfaces for diverse protein-protein interactions. Peptidylglycine alpha-amidating monooxygenase (PAM), an enzyme essential for neuropeptide biosynthesis, is a secretory granule membrane protein. As one of the few proteins spanning the granule membrane, PAM is a candidate to relay information about the status of the granule pool and conditions in the granule lumen. Here, we show that the PAM cytosolic domain is unstructured. Mass spectroscopy and two-dimensional gel electrophoresis demonstrated phosphorylation at 10-12 sites in the cytosolic domain. Stimulation of exocytosis resulted in coupled phosphorylation and dephosphorylation of specific sites and in the endoproteolytic release of a soluble, proteasome-sensitive cytosolic domain fragment. Analysis of granule-rich tissues, such as pituitary and heart, showed that a similar fragment was generated endogenously and translocated to the nucleus. This multiply phosphorylated unstructured domain may act as a signaling molecule that relays information from secretory granules to both cytosol and nucleus.	[Francone, Victor P.; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Rajagopal, Chitra; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Mol Microbiol & Struct Biol, Farmington, CT 06030 USA; [Stone, Kathryn L.] Yale Univ, WM Keck Facil, New Haven, CT 06510 USA	University of Connecticut; University of Connecticut; Yale University	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu	, Chitra/AAC-9698-2021	, Chitra/0000-0003-2962-459X	National Institutes of Health, NIDDK [DK32949]; NIDA [P30 DA018343]; National Institutes of Health [UL1 RR024139, 1S10RR024617]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024617, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032949, R56DK032949, R01DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK32949; by NIDA Neuroproteomics Center Grant P30 DA018343; and by instrumentation obtained with funds from National Institutes of Health NCRR Clinical and Translational Science Award UL1 RR024139 and Shared Instrumentation Grant 1S10RR024617.	Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; BOHELER KR, 1992, J BIOL CHEM, V267, P12979; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Caldwell BD, 1999, J BIOL CHEM, V274, P34646, DOI 10.1074/jbc.274.49.34646; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; El Meskini R, 2001, J BIOL CHEM, V276, P3384, DOI 10.1074/jbc.M008062200; Ferraro F, 2005, J BIOL CHEM, V280, P25424, DOI 10.1074/jbc.M414156200; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; Jonker HRA, 2006, FEBS J, V273, P1430, DOI 10.1111/j.1742-4658.2006.05165.x; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lenz P, 2006, CURR BIOL, V16, P2150, DOI 10.1016/j.cub.2006.09.013; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; MALTESE JY, 1993, ENDOCRINOLOGY, V133, P2579, DOI 10.1210/en.133.6.2579; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Steveson TC, 1999, J BIOL CHEM, V274, P21128, DOI 10.1074/jbc.274.30.21128; Stone Kathryn L., 2007, V386, P57, DOI 10.1007/978-1-59745-430-8_2; STONE KL, 2004, CURR PROTOCOLS PROTE; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wasmeier C, 2001, J BIOL CHEM, V276, P31919, DOI 10.1074/jbc.M102580200; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Yao I, 2002, J NEUROSCI, V22, P5354; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; YUN HY, 1995, J BIOL CHEM, V270, P30075	48	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25723	25734		10.1074/jbc.M109.035782	http://dx.doi.org/10.1074/jbc.M109.035782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19635792	Green Published, hybrid			2022-12-25	WOS:000269738000030
J	Neel, BD; Lopez, J; Chabadel, A; Gillet, G				Neel, B. D.; Lopez, J.; Chabadel, A.; Gillet, G.			Lithium suppresses motility and invasivity of v-src-transformed cells by glutathione-dependent activation of phosphotyrosine phosphatases	ONCOGENE			English	Article						lithium; Src tyrosine kinase; PTPases; cell migration; glutathione	GLYCOGEN-SYNTHASE KINASE-3; ROUS-SARCOMA VIRUS; GENE-EXPRESSION; TYROSINE KINASE; NEURORETINAL CELLS; ENDOTHELIAL-CELLS; BIPOLAR DISORDER; FAMILY KINASES; CANCER CELLS; IN-VIVO	Lithium has long been used for the treatment and prophylaxis of bipolar mood disorder. However, nerve cells are not the sole targets of lithium. Indeed, lithium was reported to target numerous cell types, and affect cell proliferation, differentiation and death. Thus, the idea has been raised that lithium may act on signaling pathways involved in neoplastic transformation. Indeed, the effect of lithium on tumor progression is currently being tested in a limited number of clinical trials. However, the molecular mechanisms by which lithium affects neoplastic transformation remain to be characterized. Here, using mouse fibroblasts transformed by the v-src oncogene as a model, we show that lithium drastically inhibits cell motility and compromises the invasive phenotype of v-src-transformed cells. In addition, we show that this effect is mediated by the activation of phosphotyrosine phosphatases, but not by the direct inhibition of the v-Src tyrosine kinase. Finally, we show that lithium activates phosphotyrosine phosphatases by the modulation of the redox status of the cell, independently of the Wnt and the inositol phosphate canonical pathways. Thus, this study supports the idea that lithium, acting similar to an antioxydizer, may have antimetastatic properties in vivo. Oncogene (2009) 28, 3246-3260; doi: 10.1038/onc.2009.190; published online 13 July 2009	[Neel, B. D.; Lopez, J.; Gillet, G.] Univ Lyon 1, Inst Biol & Chim Prot, UMR 5086, CNRS,IFR 128, F-69367 Lyon 07, France; [Chabadel, A.] Univ Lyon, Lab Biol Mol Cellule, UMR 5239, CNRS,Ecole Normale Super Lyon,IFR 128, Lyon 07, France; [Lopez, J.] Hop Croix Rousse, Hosp Civils Lyon, F-69317 Lyon 04, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CHU Lyon	Gillet, G (corresponding author), Univ Lyon 1, Inst Biol & Chim Prot, UMR 5086, CNRS,IFR 128, 7 Passage Vercors, F-69367 Lyon 07, France.	g.gillet@ibcp.fr	gillet, germain/A-9095-2013	LOPEZ, Jonathan/0000-0003-3768-2378; GILLET, Germain/0000-0002-1514-327X	Association pour la Recherche sur le Cancer (ARC); the Ligue Nationale contre le Cancer; Region Rhone Alpes; Ministere de la Recherche; ARC	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); the Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Region Rhone Alpes(Region Auvergne-Rhone-Alpes); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); ARC(Australian Research Council)	We thank Pierre Jurdic and Philippe Gonzalo for helpfull discussions and critical reading of the paper. We acknowledge Aurelie Cornut for skillfull technical assistance. This work was supported by the Association pour la Recherche sur le Cancer (ARC), the Ligue Nationale contre le Cancer and the Region Rhone Alpes. BDN is a recipient of fellowships from the Ministere de la Recherche and the ARC.	Aghdam SY, 2007, CURR ALZHEIMER RES, V4, P21; Almeida CG, 2003, NEUROSCI LETT, V339, P127, DOI 10.1016/S0304-3940(02)01478-7; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Aouacheria A, 2002, ONCOGENE, V21, P1171, DOI 10.1038/sj.onc.1205170; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Benati D, 2008, CURR MED CHEM, V15, P1154, DOI 10.2174/092986708784310404; CAMPAGNE MMV, 1988, DEV GENET, V9, P589, DOI 10.1002/dvg.1020090435; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; CROSS FR, 1983, CELL, V34, P597, DOI 10.1016/0092-8674(83)90392-6; Cui J, 2007, NEUROSCIENCE, V144, P1447, DOI 10.1016/j.neuroscience.2006.11.010; D'Alessio M, 2004, FASEB J, V18, P1609, DOI 10.1096/fj.04-1813fje; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; GILLET G, 1993, ONCOGENE, V8, P565; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Hashimoto R, 2003, FEBS LETT, V538, P145, DOI 10.1016/S0014-5793(03)00167-4; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Johnson FM, 2007, ANTI-CANCER AGENT ME, V7, P651, DOI 10.2174/187152007784111278; JOVE R, 1986, J VIROL, V60, P840, DOI 10.1128/JVI.60.3.840-848.1986; KAO KR, 1989, DEV BIOL, V132, P81, DOI 10.1016/0012-1606(89)90207-8; Karlovic D, 2007, CELL BIOL TOXICOL, V23, P83, DOI 10.1007/s10565-006-0126-9; KMIECIK TE, 1988, MOL CELL BIOL, V8, P4541, DOI 10.1128/MCB.8.10.4541; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Mao CD, 2001, J BIOL CHEM, V276, P26180, DOI 10.1074/jbc.M101188200; Markova B, 2005, METHODS, V35, P22, DOI 10.1016/j.ymeth.2004.07.004; MARONEY AC, 1992, ONCOGENE, V7, P1207; Mathew S, 2008, J BIOL CHEM, V283, P22709, DOI 10.1074/jbc.M801319200; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; PESSAC B, 1974, SCIENCE, V185, P709, DOI 10.1126/science.185.4152.709; PIZARRO JG, 2008, J CELL MOL MED; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Seelan RS, 2008, NEUROSCIENCE, V151, P1184, DOI 10.1016/j.neuroscience.2007.10.045; Severus WE, 2008, BIPOLAR DISORD, V10, P231, DOI 10.1111/j.1399-5618.2007.00475.x; Smits VAJ, 1999, FEBS LETT, V457, P23, DOI 10.1016/S0014-5793(99)01002-9; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Stump RJW, 2006, J PATHOL, V210, P249, DOI 10.1002/path.2049; Sun AJ, 2007, PROSTATE, V67, P976, DOI 10.1002/pros.20586; Wada A, 2005, J PHARMACOL SCI, V99, P307, DOI 10.1254/jphs.CRJ05009X; WELSHONS WV, 1995, J CELL PHYSIOL, V165, P134, DOI 10.1002/jcp.1041650116; Yang B, 2003, CANCER RES, V63, P1520; Zhang WV, 2005, APOPTOSIS, V10, P75, DOI 10.1007/s10495-005-6063-x; Zhen XC, 2002, PSYCHOPHARMACOLOGY, V162, P379, DOI 10.1007/s00213-002-1126-y	52	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2009	28	36					3246	3260		10.1038/onc.2009.190	http://dx.doi.org/10.1038/onc.2009.190			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	492QF	19597466				2022-12-25	WOS:000269673400007
J	Zusev, M; Benayahu, D				Zusev, Margalit; Benayahu, Dafna			The Regulation of MS-KIF18A Expression and Cross Talk with Estrogen Receptor	PLOS ONE			English	Article								This study provides a novel view on the interactions between the MS-KIF18A, a kinesin protein, and estrogen receptor alpha (ER alpha) which were studied in vivo and in vitro. Additionally, the regulation of MS-KIF18A expression by estrogen was investigated at the gene and protein levels. An association between recombinant proteins; ER alpha and MS-KIF18A was demonstrated in vitro in a pull down assay. Such interactions were proven also for endogenous proteins in MBA-15 cells were detected prominently in the cytoplasm and are up-regulated by estrogen. Additionally, an association between these proteins and the transcription factor NF-kappa B was identified. MS-KIF18A mRNA expression was measured in vivo in relation to age and estrogen level in mice and rats models. A decrease in MS-KIF18A mRNA level was measured in old and in OVX-estrogen depleted rats as compared to young animals. The low MS-KIF18A mRNA expression in OVX rats was restored by estrogen treatment. We studied the regulation of MS-KIF18A transcription by estrogen using the luciferase reporter gene and chromatin immuno-percipitation (ChIP) assays. The luciferase reporter gene assay demonstrated an increase in MSKIF18A promoter activity in response to 10(-8) M estrogen and 10(-7) M ICI-182,780. Complimentary, the ChIP assay quantified the binding of ERa and pcJun to the MS-KIF18A promoter that was enhanced in cells treated by estrogen and ICI-182,780. In addition, cells treated by estrogen expressed higher levels of MS-KIF18A mRNA and protein and the protein turnover in MBA-15 cells was accelerated. Presented data demonstrated that ERa is a defined cargo of MS-KIF18A and added novel insight on the role of estrogen in regulation of MS-KIF18A expression both in vivo and in vitro.			Zusev, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	dafnab@post.tau.ac.il						Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Benayahu D, 1997, BIOCHEM BIOPH RES CO, V233, P30, DOI 10.1006/bbrc.1997.6401; Benayahu D, 2000, J CELL BIOCHEM, V79, P407, DOI 10.1002/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8; Biswas DK, 2005, SCI STKE, V288, ppe27; Braidman I, 2000, BONE, V26, P423, DOI 10.1016/S8756-3282(00)00246-5; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chambliss KL, 2002, STEROIDS, V67, P413, DOI 10.1016/S0039-128X(01)00177-5; Chen Fang-Ping, 2006, Taiwan J Obstet Gynecol, V45, P307; COLVARD D, 1989, CONNECT TISSUE RES, V20, P33, DOI 10.3109/03008208909023872; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Glidewell-Kenney C, 2005, MOL CELL ENDOCRINOL, V245, P53, DOI 10.1016/j.mce.2005.10.003; Gu G, 2005, APOPTOSIS, V10, P583, DOI 10.1007/s10495-005-1893-0; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Handelsman DJ, 2005, TRENDS ENDOCRIN MET, V16, P39, DOI 10.1016/j.tem.2005.01.002; Hirokawa N, 2003, TRENDS BIOCHEM SCI, V28, P558, DOI 10.1016/j.tibs.2003.08.006; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Hu P, 2008, J BIOL CHEM, V283, P6752, DOI 10.1074/jbc.M705937200; Ishihara A, 1999, J ELECTRON MICROSC, V48, P465, DOI 10.1093/oxfordjournals.jmicro.a023703; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lakamper S, 2006, J MUSCLE RES CELL M, V27, P161, DOI 10.1007/s10974-005-9052-3; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; LIEBERHERR M, 1993, J BONE MINER RES, V8, P1365; Liu ZD, 2000, J CELL BIOCHEM, V76, P509, DOI 10.1002/(SICI)1097-4644(20000301)76:3<509::AID-JCB17>3.0.CO;2-R; Luboshits G, 2007, J CELL BIOCHEM, V100, P693, DOI 10.1002/jcb.21000; Luboshits G, 2005, GENE, V351, P19, DOI 10.1016/j.gene.2005.02.009; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Massas R, 1998, J CELL BIOCHEM, V69, P282, DOI 10.1002/(SICI)1097-4644(19980601)69:3<282::AID-JCB6>3.0.CO;2-N; Migliaccio S, 1996, ENDOCRINOLOGY, V137, P2118, DOI 10.1210/en.137.5.2118; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Montano MM, 1997, P NATL ACAD SCI USA, V94, P2581, DOI 10.1073/pnas.94.6.2581; MORLEY P, 1992, ENDOCRINOLOGY, V131, P1305, DOI 10.1210/en.131.3.1305; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oreffo ROC, 1999, HISTOCHEM CELL BIOL, V111, P125, DOI 10.1007/s004180050342; Parker MG, 1998, BIOCHEM SOC SYMP, P45; Pastorelli R, 2005, PROTEOMICS, V5, P4936, DOI 10.1002/pmic.200401325; Penot G, 2005, ENDOCRINOLOGY, V146, P5474, DOI 10.1210/en.2005-0866; Polak P, 2006, ONCOGENE, V25, P665, DOI 10.1038/sj.onc.1209114; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rubio MF, 2006, ONCOGENE, V25, P1367, DOI 10.1038/sj.onc.1209176; Sanchez R, 2002, BIOESSAYS, V24, P244, DOI 10.1002/bies.10066; Sathya G, 1997, MOL ENDOCRINOL, V11, P1994, DOI 10.1210/me.11.13.1994; Shamay A, 1996, CELL BIOL INT, V20, P401, DOI 10.1006/cbir.1996.0050; Shur I, 2007, J CELL PHYSIOL, V210, P732, DOI 10.1002/jcp.20895; Shur I, 2006, STEM CELLS, V24, P1288, DOI 10.1634/stemcells.2005-0300; Sibonga JD, 1998, ENDOCRINOLOGY, V139, P3736, DOI 10.1210/en.139.9.3736; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Uht Rosalie M, 2004, Nucl Recept, V2, P2, DOI 10.1186/1478-1336-2-2; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Watts NB, 2000, OBSTET GYNECOL SURV, V55, pS49, DOI 10.1097/00006254-200012001-00001; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; WERNER H, 1992, MOL ENDOCRINOL, V6, P1545, DOI 10.1210/me.6.10.1545; Wiren KM, 2006, BONE, V38, P637, DOI 10.1016/j.bone.2005.10.029; Zafar A, 1995, BIOCHEM MOL BIOL INT, V36, P1197; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zusev M, 2008, J CELL PHYSIOL, V217, P618, DOI 10.1002/jcp.21525	67	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6407	10.1371/journal.pone.0006407	http://dx.doi.org/10.1371/journal.pone.0006407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636373	Green Submitted, Green Published, gold			2022-12-25	WOS:000268404900025
J	Barnett, DJ; Balicer, RD; Thompson, CB; Storey, JD; Omer, SB; Semon, NL; Bayer, S; Cheek, LV; Gateley, KW; Lanza, KM; Norbin, JA; Slemp, CC; Links, JM				Barnett, Daniel J.; Balicer, Ran D.; Thompson, Carol B.; Storey, J. Douglas; Omer, Saad B.; Semon, Natalie L.; Bayer, Steve; Cheek, Lorraine V.; Gateley, Kerry W.; Lanza, Kathryn M.; Norbin, Jane A.; Slemp, Catherine C.; Links, Jonathan M.			Assessment of Local Public Health Workers' Willingness to Respond to Pandemic Influenza through Application of the Extended Parallel Process Model	PLOS ONE			English	Article								Background: Local public health agencies play a central role in response to an influenza pandemic, and understanding the willingness of their employees to report to work is therefore a critically relevant concern for pandemic influenza planning efforts. Witte's Extended Parallel Process Model (EPPM) has been found useful for understanding adaptive behavior in the face of unknown risk, and thus offers a framework for examining scenario-specific willingness to respond among local public health workers. We thus aim to use the EPPM as a lens for examining the influences of perceived threat and efficacy on local public health workers' response willingness to pandemic influenza. Methodology/Principal Findings: We administered an online, EPPM-based survey about attitudes/beliefs toward emergency response (Johns Hopkins, Public Health Infrastructure Response Survey Tool), to local public health employees in three states between November 2006-December 2007. A total of 1835 responses were collected for an overall response rate of 83%. With some regional variation, overall 16% of the workers in 2006-7 were not willing to "respond to a pandemic flu emergency regardless of its severity". Local health department employees with a perception of high threat and high efficacy - i.e., those fitting a 'concerned and confident' profile in the EPPM analysis - had the highest declared rates of willingness to respond to an influenza pandemic if required by their agency, which was 31.7 times higher than those fitting a 'low threat/low efficacy' EPPM profile. Conclusions/Significance: In the context of pandemic influenza planning, the EPPM provides a useful framework to inform nuanced understanding of baseline levels of - and gaps in - local public health workers' response willingness. Within local health departments, 'concerned and confident' employees are most likely to be willing to respond. This finding may allow public health agencies to design, implement, and evaluate training programs focused on emergency response attitudes in health departments.			Barnett, DJ (corresponding author), Johns Hopkins Ctr Publ Hlth Preparedness, Baltimore, MD USA.	dbarnett@jhsph.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; Barnett, Daniel/0000-0003-1382-6197	PHS HHS [906860, 104264] Funding Source: Medline; OPHPR CDC HHS [U90 TP324236] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); OPHPR CDC HHS		[Anonymous], 2004, Bull World Health Organ, V82, P317; [Anonymous], [No title captured]; Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99; Barnett DJ, 2005, J PUBLIC HEALTH MAN, pS33; Cone David C, 2006, Am J Disaster Med, V1, P28; Cowan AE, 2005, BIOSECUR BIOTERROR, V3, P16, DOI 10.1089/bsp.2005.3.16; DiMaggio C, 2005, BIOSECUR BIOTERROR, V3, P331, DOI 10.1089/bsp.2005.3.331; Gershon RRM, 2007, HOME HLTH CARE MAN P, V20, P58, DOI 10.1177/1084822307305908; *HLTH RES SERV ADM, 2005, PUBL HLTH WORKF STUD; *I MED, 2007, HOSP BAS EM CAR BREA, P1; Irvin CB, 2008, PREHOSP DISASTER MED, V23, P328, DOI 10.1017/S1049023X00005963; Katz AR, 2006, J AM DENT ASSOC, V137, P461, DOI 10.14219/jada.archive.2006.0217; Levin PJ, 2007, PUBLIC HEALTH REP, V122, P573, DOI 10.1177/003335490712200503; McMahan S, 1998, HEALTH COMMUN, V10, P247, DOI 10.1207/s15327027hc1003_4; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; SANDMAN PM, 1993, RISK ANAL, V13, P585, DOI 10.1111/j.1539-6924.1993.tb01321.x; Slovic P., 1985, PERILOUS PROGR MANAG, P91; Smith RA, 2007, HEALTH COMMUN, V21, P55, DOI 10.1080/10410230701283389; Stein BD, 2004, MILBANK Q, V82, P413, DOI 10.1111/j.0887-378X.2004.00317.x; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276	22	88	88	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6365	10.1371/journal.pone.0006365	http://dx.doi.org/10.1371/journal.pone.0006365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629188	Green Submitted, gold, Green Published			2022-12-25	WOS:000268318900008
J	Huynh, DP; Maalouf, M; Silva, AJ; Schweizer, FE; Pulst, SM				Huynh, Duong P.; Maalouf, Marwan; Silva, Alcino J.; Schweizer, Felix E.; Pulst, Stefan M.			Dissociated Fear and Spatial Learning in Mice with Deficiency of Ataxin-2	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TASTE-AVERSION MEMORY; BASOLATERAL AMYGDALA; COGNITIVE DEFICITS; INSULAR CORTEX; GENE; RECEPTOR; EXPRESSION; PROTEIN; SCA2	Mouse models with physiological and behavioral differences attributable to differential plasticity of hippocampal and amygdalar neuronal networks are rare. We previously generated ataxin-2 (Atxn2) knockout mice and demonstrated that these animals lacked obvious anatomical abnormalities of the CNS, but showed marked obesity and reduced fertility. We now report on behavioral changes as a consequence of Atxn2-deficiency. Atxn2-deficiency was associated with impaired long-term potentiation (LTP) in the amygdala, but normal LTP in the hippocampus. Intact hippocampal plasticity was associated behaviorally with normal Morris Water maze testing. Impaired amygdala plasticity was associated with reduced cued and contextual fear conditioning. Conditioned taste aversion, however, was normal. In addition, knockout mice showed decreased innate fear in several tests and motor hyperactivity in open cage testing. Our results suggest that Atxn2-deficiency results in a specific set of behavioral and cellular disturbances that include motor hyperactivity and abnormal fear-related behaviors, but intact hippocampal function. This animal model may be useful for the study of anxiety disorders and should encourage studies of anxiety in patients with spinocerebellar ataxia type 2 (SCA2).			Huynh, DP (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	stefan.pulst@hsc.utah.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494	NIA NIH HHS [R01 AG013622, R01-AG13622] Funding Source: Medline; NIMH NIH HHS [P50-MH0779720] Funding Source: Medline; NINDS NIH HHS [R01 NS033123, K01 NS047548, K01-NS047548-01A4, R01 NS33123] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS047548, R01NS033123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Bryant CD, 2006, AM J PHYSIOL-REG I, V291, pR315, DOI 10.1152/ajpregu.00831.2005; Burk K, 1999, BRAIN, V122, P769, DOI 10.1093/brain/122.4.769; Burk K, 2003, J NEUROL, V250, P207, DOI 10.1007/s00415-003-0976-5; Dewachter I, 2009, NEUROBIOL AGING, V30, P241, DOI 10.1016/j.neurobiolaging.2007.06.011; Dhaka A, 2003, J NEUROSCI, V23, P748; Ding HK, 2008, LEARN MEMORY, V15, P290, DOI 10.1101/lm.905008; Furtado S, 2004, MOVEMENT DISORD, V19, P622, DOI 10.1002/mds.20074; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Hermann T, 1995, RNA, V1, P1009; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Miranda MI, 2008, LEARN MEMORY, V15, P468, DOI 10.1101/lm.964708; Kiehl TR, 2006, BIOCHEM BIOPH RES CO, V339, P17, DOI 10.1016/j.bbrc.2005.10.186; King BM, 2006, AM J PHYSIOL-REG I, V291, pR1201, DOI 10.1152/ajpregu.00199.2006; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Le Pira F, 2007, J NEUROL, V254, P1455, DOI 10.1007/s00415-007-0548-1; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Miranda MI, 2008, NEUROBIOL LEARN MEM, V90, P54, DOI 10.1016/j.nlm.2008.01.004; Nechiporuk T, 1998, HUM MOL GENET, V7, P1301, DOI 10.1093/hmg/7.8.1301; Neuwald AF, 1998, J MOL MED, V76, P3, DOI 10.1007/s109-1998-8098-0; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041; Zhang H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-38	40	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2009	4	7							e6235	10.1371/journal.pone.0006235	http://dx.doi.org/10.1371/journal.pone.0006235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472GW	19617910	Green Published, Green Submitted, gold			2022-12-25	WOS:000268119600001
J	Salem, MMAEL; Shalbaf, M; Gibbons, NCJ; Chavan, B; Thornton, JM; Schallreuter, KU				Salem, Mohamed M. A. E. L.; Shalbaf, Mohammad; Gibbons, Nicholas C. J.; Chavan, Bhaven; Thornton, J. M.; Schallreuter, Karin U.			Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage	FASEB JOURNAL			English	Review						peroxynitrite; catalase; 8-oxoG; p76(MDM2); cell cycle arrest; skin cancer; apoptosis	BASE-EXCISION-REPAIR; HYDROGEN-PEROXIDE H2O2; CELL-CYCLE CHECKPOINT; CATALASE GENE; INDUCED APOPTOSIS; ESCHERICHIA-COLI; COMPUTER-SIMULATION; REACTIVE OXYGEN; OGG1 GENE; IN-VIVO	Vitiligo is characterized by a patchy loss of inherited skin color affecting similar to 0.5% of individuals of all races. Despite the absence of the protecting pigment and the overwhelming evidence for hydrogen peroxide (H2O2)-induced oxidative stress in the entire epidermis of these patients, there is neither increased photodamage/skin aging nor a higher incidence for sun-induced nonmelanoma skin cancer. Here we demonstrate for the first time increased DNA damage via 8-oxoguanine in the skin and plasma in association with epidermal up-regulated phosphorylated/acetylated p53 and high levels of the p53 antagonist p76(MDM2). Short-patch base-excision repair via hOgg1, APE1, and polymerase beta DNA repair is up-regulated. Overexpression of Bcl-2 and low caspase 3 and cytochrome c levels argue against increased apoptosis in this disease. Moreover, we show the presence of high epidermal peroxynitrite (ONOO-) levels via nitrotyrosine together with high nitrated p53 levels. We demonstrate by EMSA that nitration of p53 by ONOO- (300 x 10(-6) M) abrogates DNA binding, while H2O2-oxidized p53 (10(-3) M) enhances DNA binding capacity and prevents ONOO--induced abrogation of DNA binding. Taken together, we add a novel reactive oxygen species to the list of oxidative stress inducers in vitiligo. Moreover, we propose up-regulated wild-type p53 together with p76(MDM2) as major players in the control of DNA damage/repair and prevention of photodamage and nonmelanoma skin cancer in vitiligo.-Salem, M. M. A. E. L., Shalbaf, M., Gibbons, N. C. J., Chavan, B., Thornton, J. M., Schallreuter, K. U. Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J. 23, 3790-3807 (2009). www.fasebj.org	[Salem, Mohamed M. A. E. L.; Shalbaf, Mohammad; Gibbons, Nicholas C. J.; Chavan, Bhaven; Thornton, J. M.; Schallreuter, Karin U.] Univ Bradford, Ctr Skin Sci, Sch Life Sci, Dept Biomed Sci, Bradford BD7 1DP, W Yorkshire, England; [Gibbons, Nicholas C. J.; Schallreuter, Karin U.] EM Arndt Univ, Inst Pigmentary Disorders, Greifswald, Germany	University of Bradford	Schallreuter, KU (corresponding author), Univ Bradford, Ctr Skin Sci, Sch Life Sci, Dept Biomed Sci, Bradford BD7 1DP, W Yorkshire, England.	k.schallreuter@bradford.ac.uk		Thornton, M Julie/0000-0002-3395-7066	Government of Egypt; Institute for Pigmentary Disorders; University of Bradford (Bradford, UK); Deutsche Vitiligo-Verein (Hamburg, Germany); American Vitiligo Research Foundation	Government of Egypt; Institute for Pigmentary Disorders; University of Bradford (Bradford, UK); Deutsche Vitiligo-Verein (Hamburg, Germany); American Vitiligo Research Foundation	This research is part of two Ph.D. theses (M. M. A. E. L. S. 2009; M. S. 2009). The work was supported by a stipend from the Government of Egypt and by the Institute for Pigmentary Disorders in association with E. M. Arndt University of Greifswald (Greifswald, Germany) and the University of Bradford (Bradford, UK). We are also very grateful for financial support by the Deutsche Vitiligo-Verein (Hamburg, Germany) and the American Vitiligo Research Foundation.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; ARONOFF S, 1965, SCIENCE, V150, P72, DOI 10.1126/science.150.3692.72; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BHAWAN J, 1983, J CUTAN PATHOL, V10, P207, DOI 10.1111/j.1600-0560.1983.tb00328.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boissy RE, 1997, PIGM CELL RES, V10, P12, DOI 10.1111/j.1600-0749.1997.tb00461.x; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; BOITEUX S, 1993, J PHOTOCH PHOTOBIO B, V19, P87, DOI 10.1016/1011-1344(93)87101-R; Boiteux S, 1999, BIOCHIMIE, V81, P59, DOI 10.1016/S0300-9084(99)80039-X; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; CALANCHINIPOSTIZZI E, 1987, DERMATOLOGICA, V174, P266, DOI 10.1159/000249197; Calmels S, 1997, CANCER RES, V57, P3365; Casp CB, 2002, PIGM CELL RES, V15, P62, DOI 10.1034/j.1600-0749.2002.00057.x; Chaudhry MA, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-15; Chazotte-Aubert L, 2000, BIOCHEM BIOPH RES CO, V267, P609, DOI 10.1006/bbrc.1999.2003; Cobbs CS, 2001, ARCH BIOCHEM BIOPHYS, V394, P167, DOI 10.1006/abbi.2001.2540; Cobbs CS, 2003, CANCER RES, V63, P8670; Crow JP, 1996, METHOD ENZYMOL, V269, P185; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dell'Anna ML, 2003, PIGM CELL RES, V16, P553, DOI 10.1034/j.1600-0749.2003.00087.x; DELLANNA ML, 2006, J INVEST DERMATOL S3, V126; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Dogliotti E, 2001, PROG NUCLEIC ACID RE, V68, P3; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elwary SMA, 2006, J INVEST DERMATOL, V126, P1879, DOI 10.1038/sj.jid.5700268; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Fortini P, 2003, MUTAT RES-FUND MOL M, V531, P127, DOI 10.1016/j.mrfmmm.2003.07.004; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gavalas NG, 2006, BIOCHEM BIOPH RES CO, V345, P1586, DOI 10.1016/j.bbrc.2006.05.063; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gibbons NQ, 2006, J INVEST DERMATOL, V126, P2576, DOI 10.1038/sj.jid.5700612; Gottifredi V, 2001, SCIENCE, V292, P1851, DOI 10.1126/science.1062238; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Halliwell B, 2002, ANN NY ACAD SCI, V962, P182, DOI 10.1111/j.1749-6632.2002.tb04067.x; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hasse S, 2004, J INVEST DERMATOL, V122, P307, DOI 10.1046/j.0022-202X.2004.22230.x; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; HILLAR A, 1994, BIOCHEM J, V300, P531, DOI 10.1042/bj3000531; Huang Carol L, 2002, Am J Clin Dermatol, V3, P301, DOI 10.2165/00128071-200203050-00001; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2001, J BIOSCI BIOENG, V92, P598, DOI 10.1263/jbb.92.598; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Kasai H, 2002, FREE RADICAL BIO MED, V33, P450, DOI 10.1016/S0891-5849(02)00818-3; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Kemp EH, 2001, AUTOIMMUNITY, V34, P65, DOI 10.3109/08916930108994127; KIISTALA U, 1968, J INVEST DERMATOL, V50, P129, DOI 10.1038/jid.1968.15; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lee M, 2001, FREE RADICAL BIO MED, V31, P1550, DOI 10.1016/S0891-5849(01)00633-5; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; LIU JH, 1999, PROGR ASIAN SOCIAL P, V2, P9; LOFT S, 1993, J TOXICOL ENV HEALTH, V40, P391, DOI 10.1080/15287399309531806; Maeda T, 2002, J INVEST DERMATOL, V119, P22, DOI 10.1046/j.1523-1747.2002.01781.x; Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801; Maresca V, 2006, J INVEST DERMATOL, V126, P182, DOI 10.1038/sj.jid.5700021; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; MESSMER UK, 1994, FEBS LETT, V355, P23; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; MOELLMANN G, 1982, J INVEST DERMATOL, V79, P321, DOI 10.1111/1523-1747.ep12500086; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; OBERPRIELER NG, 2007, THESIS U BRADFORD BR; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Parikh SS, 1997, STRUCTURE, V5, P1543, DOI 10.1016/S0969-2126(97)00303-1; Park ES, 2007, J DERMATOL SCI, V47, P141, DOI 10.1016/j.jdermsci.2007.03.009; Park HH, 2006, EXP DERMATOL, V15, P377, DOI 10.1111/j.0906-6705.2006.00423.x; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Perra MT, 2006, MOL VIS, V12, P1136; Perry ME, 2000, J BIOL CHEM, V275, P5733, DOI 10.1074/jbc.275.8.5733; PRIVES C, 1994, CELL, V78, P543, DOI 10.1016/0092-8674(94)90519-3; Ruiz-Argueelles A, 2007, J AUTOIMMUN, V29, P281, DOI 10.1016/j.jaut.2007.07.012; Saitoh T, 2001, MUTAT RES-DNA REPAIR, V486, P31, DOI 10.1016/S0921-8777(01)00078-7; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SALEM MMA, 2009, THESIS U BRADFORD BR; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 2006, J INVEST DERMATOL, V126, P1036, DOI 10.1038/sj.jid.5700257; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schallreuter KU, 2004, BIOCHEM BIOPH RES CO, V315, P502, DOI 10.1016/j.bbrc.2004.01.082; Schallreuter KU, 2003, EXP DERMATOL, V12, P268, DOI 10.1034/j.1600-0625.2003.00084.x; Schallreuter KU, 2002, DERMATOLOGY, V204, P194, DOI 10.1159/000057881; Schallreuter KU, 2001, J INVEST DERMATOL, V116, P167, DOI 10.1046/j.1523-1747.2001.00220.x; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shalbaf M, 2008, EXP DERMATOL, V17, P761, DOI 10.1111/j.1600-0625.2008.00697.x; Sheikh MS, 2000, BIOCHEM PHARMACOL, V59, P43, DOI 10.1016/S0006-2952(99)00291-9; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Song XZ, 2008, INT J MOL MED, V22, P9; Spencer JD, 2005, J ENDOCRINOL, V187, P293, DOI 10.1677/joe.1.06275; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tobin DJ, 2000, J PATHOL, V191, P407; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Van den Wijngaard RMJGJ, 2000, BRIT J DERMATOL, V143, P573, DOI 10.1046/j.1365-2133.2000.03712.x; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Vile GF, 1997, FEBS LETT, V412, P70, DOI 10.1016/S0014-5793(97)00748-5; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Westerhof W, 1997, CLIN EXP DERMATOL, V22, P54; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435; Wood JM, 2008, EXP DERMATOL, V17, P366, DOI 10.1111/j.1600-0625.2008.00699.x; Wood JM, 2006, J INVEST DERMATOL, V126, P13, DOI 10.1038/sj.jid.5700051; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055	115	59	62	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3790	3807		10.1096/fj.09-132621	http://dx.doi.org/10.1096/fj.09-132621			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19641144				2022-12-25	WOS:000271272500016
J	Gazit, K; Moshonov, S; Elfakess, R; Sharon, M; Mengus, G; Davidson, I; Dikstein, R				Gazit, Kfir; Moshonov, Sandra; Elfakess, Rofa; Sharon, Michal; Mengus, Gabrielle; Davidson, Irwin; Dikstein, Rivka			TAF4/4b.TAF12 Displays a Unique Mode of DNA Binding and Is Required for Core Promoter Function of a Subset of Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; HISTONE OCTAMER; DOWNSTREAM; INITIATOR; COMPLEX; ELEMENT; TAFS; RECOGNITION; DROSOPHILA	The major core promoter-binding factor in polymerase II transcription machinery is TFIID, a complex consisting of TBP, the TATA box-binding protein, and 13 to 14 TBP-associated factors (TAFs). Previously we found that the histone H2A-like TAF paralogs TAF4 and TAF4b possess DNA-binding activity. Whether TAF4/TAF4b DNA binding directs TFIID to a specific core promoter element or facilitates TFIID binding to established core promoter elements is not known. Here we analyzed the mode of TAF4b.TAF12 DNA binding and show that this complex binds DNA with high affinity. The DNA length required for optimal binding is similar to 70 bp. Although the complex displays a weak sequence preference, the nucleotide composition is less important than the length of the DNA for high affinity binding. Comparative expression profiling of wild-type and a DNA-binding mutant of TAF4 revealed common core promoter features in the down-regulated genes that include a TATA-box and an Initiator. Further examination of the PEL98 gene from this group showed diminished Initiator activity and TFIID occupancy in TAF4 DNA-binding mutant cells. These findings suggest that DNA binding by TAF4/4b-TAF12 facilitates the association of TFIID with the core promoter of a subset of genes.	[Gazit, Kfir; Moshonov, Sandra; Elfakess, Rofa; Sharon, Michal; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Mengus, Gabrielle; Davidson, Irwin] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dikstein, R (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il		MENGUS, Gabrielle/0000-0002-2844-1778; Davidson, Irwin/0000-0001-5533-1171; Sharon, Michal/0000-0003-3933-0595	Israel Science Foundation; Helen and Martin Kimmel Stem Cell Research Institute	Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel Stem Cell Research Institute	This work was supported by grants from the Israel Science Foundation and the Helen and Martin Kimmel Stem Cell Research Institute.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; EMANUEL PA, 1993, P NATL ACAD SCI USA, V90, P8449, DOI 10.1073/pnas.90.18.8449; Gershenzon NI, 2005, BIOINFORMATICS, V21, P1295, DOI 10.1093/bioinformatics/bti172; Hoffmann A, 1997, P NATL ACAD SCI USA, V94, P8928, DOI 10.1073/pnas.94.17.8928; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Moshonov S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-92; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Selleck W, 2001, NAT STRUCT BIOL, V8, P695, DOI 10.1038/90408; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Silkov A, 2002, J BIOL CHEM, V277, P17821, DOI 10.1074/jbc.M200696200; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; WANG JC, 1993, BIOCHIM BIOPHYS ACTA, V1216, P73, DOI 10.1016/0167-4781(93)90039-G; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yamit-Hezi E, 2000, J BIOL CHEM, V275, P18180, DOI 10.1074/jbc.275.24.18180; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	31	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26286	26296		10.1074/jbc.M109.011486	http://dx.doi.org/10.1074/jbc.M109.011486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19635797	Green Published, hybrid			2022-12-25	WOS:000269969600008
J	Prochazkova, K; Shuvalova, LA; Minasov, G; Voburka, Z; Anderson, WF; Satchell, KJF				Prochazkova, Katerina; Shuvalova, Ludmilla A.; Minasov, George; Voburka, Zdenek; Anderson, Wayne F.; Satchell, Karla J. F.			Structural and Molecular Mechanism for Autoprocessing of MARTX Toxin of Vibrio cholerae at Multiple Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE DOMAIN; COVALENT CROSS-LINKING; THERMAL SHIFT ASSAYS; RTX TOXIN; HIGH-THROUGHPUT; DRUG DISCOVERY; CLEAVAGE SITE; GENE-CLUSTER; IDENTIFICATION; ACTIN	The multifunctional autoprocessing repeats-in-toxin (MARTX) toxin of Vibrio cholerae causes destruction of the actin cytoskeleton by covalent cross-linking of actin and inactivation of Rho GTPases. The effector domains responsible for these activities are here shown to be independent proteins released from the large toxin by autoproteolysis catalyzed by an embedded cysteine protease domain (CPD). The CPD is activated upon binding inositol hexakisphosphate (InsP(6)). In this study, we demonstrated that InsP(6) is not simply an allosteric cofactor, but rather binding of InsP(6) stabilized the CPD structure, facilitating formation of the enzyme-substrate complex. The 1.95-angstrom crystal structure of this InsP(6)-bound unprocessed form of CPD was determined and revealed the scissile bond Leu(3428)-Ala(3429) captured in the catalytic site. Upon processing at this site, CPD was converted to a form with 500-fold reduced affinity for InsP(6), but was reactivated for high affinity binding of InsP(6) by cooperative binding of both a new substrate and InsP(6). Reactivation of CPD allowed cleavage of the MARTX toxin at other sites, specifically at leucine residues between the effector domains. Processed CPD also cleaved other proteins in trans, including the leucine-rich protein YopM, demonstrating that it is a promiscuous leucine-specific protease.	[Satchell, Karla J. F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Shuvalova, Ludmilla A.; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Shuvalova, Ludmilla A.; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Voburka, Zdenek] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague 16110 6, Czech Republic	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Satchell, KJF (corresponding author), 320 E Super Ave,Searle 3-525,MC S213, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Satchell, Karla/GSN-3100-2022	Minasov, George/0000-0001-5460-3462	National Institutes of Health, NIAID [RO1AI051490]; Dept. of Health and Human Services [HHSN272200700058C]; U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; The Searle Funds at the Chicago Community Trust; National Institute of Health [U54 AI057153]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dept. of Health and Human Services; U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; The Searle Funds at the Chicago Community Trust; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI051490 (to K. J. F. S.) from NIAID. This work was also supported by the Dept. of Health and Human Services under Contract HHSN272200700058C (to W. F. A.). Use of the Advanced Photon Source was supported by the U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of the Life Science Collaborative Access Team Sector 21 was supported in part by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817. FT-MS services were provided by the Chicago Biomedical Consortium-University of Illinois, Chicago Research Resources Center, which was established by funds from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium. Supported in part by a development project from National Institute of Health Grant U54 AI057153 to Great Lakes (Region V) Regional Center for Excellence in Biodefense and Emerging Infectious Diseases Research. Supported in part by a Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Award.	Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; FRENCH PJ, 1991, P ROY SOC B-BIOL SCI, V245, P193, DOI 10.1098/rspb.1991.0109; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Siebold C, 2005, P NATL ACAD SCI USA, V102, P16836, DOI 10.1073/pnas.0504997102; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116	38	64	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26557	26568		10.1074/jbc.M109.025510	http://dx.doi.org/10.1074/jbc.M109.025510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19620709	hybrid, Green Published			2022-12-25	WOS:000269969600037
J	Tchesnokov, EP; Obikhod, A; Schinazi, RF; Gotte, M				Tchesnokov, Egor P.; Obikhod, Aleksandr; Schinazi, Raymond F.; Gotte, Matthias			Engineering of a Chimeric RB69 DNA Polymerase Sensitive to Drugs Targeting the Cytomegalovirus Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; IMMUNODEFICIENCY-VIRUS TYPE-1; CATALYTIC SUBUNIT UL54; ANTIVIRAL DRUGS; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; RATCHET MODEL; UL97 PROTEIN; RESISTANCE; INHIBITION	Detailed structural and biochemical studies with the human cytomegalovirus(HCMVUL54) DNA polymerase are hampered by difficulties to obtain this enzyme in large quantities. The crystal structure of the related RB69 DNA polymerase (gp43) is often used as a model system to explain mechanisms of inhibition of DNA synthesis and drug resistance. However, here we demonstrate that gp43 is similar to 400-fold less sensitive to the pyrophosphate analog foscarnet, when compared with UL54. The RB69 enzyme is also able to discriminate against the nucleotide analog inhibitor acyclovir. In contrast, the HCMV polymerase is able to incorporate this compound with similar efficiency as observed with its natural counterpart. In an attempt to identify major determinants for drug activity, we replaced critical regions of the nucleotide-binding site of gp43 with equivalent regions of the HCMV enzyme. We show that chimeric gp43-UL54 enzymes that contain residues of helix N and helix P of UL54 are resensitized against foscarnet and acyclovir. Changing a region of three amino acids of helix N showed the strongest effects, and changes of two segments of three amino acids in helix P further contributed to the reversal of the phenotype. The engineered chimeric enzyme can be produced in large quantities and may therefore be a valuable surrogate system in drug development efforts. This system may likewise be used for detailed structural and biochemical studies on mechanisms associated with drug action and resistance.	[Tchesnokov, Egor P.; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Obikhod, Aleksandr; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res, Atlanta, GA 30322 USA; [Obikhod, Aleksandr; Schinazi, Raymond F.] Vet Affairs Med Res, Atlanta, GA 30322 USA	McGill University; Emory University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			National Institutes of Health [5R37-AI-041980, 4R37-AI-025899]; Canadian Institutes for Health Research; United States Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025899, R37AI041980, P30AI050409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37-AI-041980 and 4R37-AI-025899 (to R. F. S.). This work was also supported by the Canadian Institutes for Health Research (to M. G.) and by the United States Department of Veterans Affairs (to R. F. S.).	Andrei G, 2008, CURR OPIN INVEST DR, V9, P132; Baldanti F, 1995, SCAND J INFECT DIS, P103; Baldanti F, 2004, HUM IMMUNOL, V65, P403, DOI 10.1016/j.humimm.2004.02.007; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; BIRON KK, 1985, P NATL ACAD SCI USA, V82, P2473, DOI 10.1073/pnas.82.8.2473; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; Chaudhuri M, 2003, J BIOL CHEM, V278, P8996, DOI 10.1074/jbc.M210023200; Cihlar T, 1998, VIROLOGY, V248, P382, DOI 10.1006/viro.1998.9299; Cihlar T, 1998, J VIROL, V72, P5927, DOI 10.1128/JVI.72.7.5927-5936.1998; Cihlar T, 1996, MOL PHARMACOL, V50, P1502; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Copeiand R. A., 2005, EVALUATION ENZYME IN, P34; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; De Clercq E, 2005, NAT REV DRUG DISCOV, V4, P928, DOI 10.1038/nrd1877; De Clercq E, 2003, J ANTIMICROB CHEMOTH, V51, P1079, DOI 10.1093/jac/dkg205; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; DERSE D, 1981, J BIOL CHEM, V256, P1447; Deval J, 2005, J BIOL CHEM, V280, P3838, DOI 10.1074/jbc.M411559200; Deval J, 2009, DRUGS, V69, P151, DOI 10.2165/00003495-200969020-00002; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P3377, DOI 10.1128/AAC.47.11.3377-3383.2003; Ducancelle A, 2005, J VIROL METHODS, V125, P145, DOI 10.1016/j.jviromet.2005.01.005; ERIKSSON BFH, 1989, ANTIMICROB AGENTS CH, V33, P663, DOI 10.1128/AAC.33.5.663; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FURMAN PA, 1984, J BIOL CHEM, V259, P9575; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Gilbert C, 2005, ANTIMICROB AGENTS CH, V49, P873, DOI 10.1128/AAC.49.3.873-883.2005; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Gotte M, 2000, DRUG RESIST UPDATE, V3, P30, DOI 10.1054/drup.2000.0126; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffiths PD, 2005, CURR OPIN INFECT DIS, V18, P241, DOI 10.1097/01.qco.0000168385.39390.1b; Hassan J, 2007, CLIN EXP IMMUNOL, V149, P205, DOI 10.1111/j.1365-2249.2007.03454.x; HO HT, 1992, MOL PHARMACOL, V41, P197; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Huang L, 1999, P NATL ACAD SCI USA, V96, P447, DOI 10.1073/pnas.96.2.447; KATI WM, 1992, J BIOL CHEM, V267, P25988; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; LITTLER E, 1992, NATURE, V358, P160, DOI 10.1038/358160a0; Liu SP, 2006, J BIOL CHEM, V281, P18193, DOI 10.1074/jbc.M602414200; Ljungman P, 2002, J INFECT DIS, V186, pS99, DOI 10.1086/342962; Loregian A, 2004, J VIROL, V78, P158, DOI 10.1128/JVI.78.1.158-167.2004; Loregian A, 2003, J VIROL, V77, P8336, DOI 10.1128/JVI.77.15.8336-8344.2003; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mercorelli B, 2008, REV MED VIROL, V18, P177, DOI 10.1002/rmv.558; OBERG B, 1989, PHARMACOL THERAPEUT, V40, P213, DOI 10.1016/0163-7258(89)90097-1; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pescovitz MD, 2000, ANTIMICROB AGENTS CH, V44, P2811, DOI 10.1128/AAC.44.10.2811-2815.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picard-Jean F, 2007, BIOCHEM J, V407, P331, DOI 10.1042/BJ20070853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; REID R, 1988, J BIOL CHEM, V263, P3898; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Shi R, 2006, PROTEINS, V64, P301, DOI 10.1002/prot.21005; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; SULLIVAN V, 1992, NATURE, V358, P162, DOI 10.1038/358162a0; Talarico CL, 1999, ANTIMICROB AGENTS CH, V43, P1941, DOI 10.1128/AAC.43.8.1941; Tchesnokov EP, 2006, J VIROL, V80, P1440, DOI 10.1128/JVI.80.3.1440-1450.2006; WAGSTAFF AJ, 1994, DRUGS, V48, P199, DOI 10.2165/00003495-199448020-00007; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Xiong XF, 1997, ANTIMICROB AGENTS CH, V41, P594, DOI 10.1128/AAC.41.3.594; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924; Yang GW, 1999, BIOCHEMISTRY-US, V38, P8094, DOI 10.1021/bi990653w; Zimmermann A, 1997, ANTIVIR RES, V36, P35, DOI 10.1016/S0166-3542(97)00034-X	72	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26439	26446		10.1074/jbc.M109.012500	http://dx.doi.org/10.1074/jbc.M109.012500			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19622750	hybrid, Green Published			2022-12-25	WOS:000269969600025
J	Ventura, E; Sassi, F; Fossati, S; Parodi, A; Blalock, W; Balza, E; Castellani, P; Borsi, L; Carnemolla, B; Zardi, L				Ventura, Elisa; Sassi, Francesca; Fossati, Sara; Parodi, Arianna; Blalock, William; Balza, Enrica; Castellani, Patrizia; Borsi, Laura; Carnemolla, Barbara; Zardi, Luciano			Use of Uteroglobin for the Engineering of Polyvalent, Polyspecific Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ED-B DOMAIN; FIBRONECTIN ISOFORM; BLASTOCYST DEVELOPMENT; RECOMBINANT ANTIBODY; TARGETED DELIVERY; BLOOD-VESSELS; TNF-ALPHA; ANGIOGENESIS; MARKER; EXPRESSION	We report a novel strategy to engineer and express stable and soluble human recombinant polyvalent/polyspecific fusion proteins. The procedure is based on the use of a central skeleton of uteroglobin, a small and very soluble covalently linked homodimeric protein that is very resistant to proteolytic enzymes and to pH variations. Using a human recombinant antibody (scFv) specific for the angiogenesis marker domain B of fibronectin, interleukin 2, and an scFv able to neutralize tumor necrosis factor-alpha, we expressed various biologically active uteroglobin fusion proteins. The results demonstrate the possibility to generate monospecific divalent and tetravalent antibodies, immunocytokines, and dual specificity tetravalent antibodies. Furthermore, compared with similar fusion proteins in which uteroglobin was not used, the use of uteroglobin improved properties of solubility and stability. Indeed, in the reported cases it was possible to vacuum dry and reconstitute the proteins without any aggregation or loss in protein and biological activity.	[Zardi, Luciano] Ctr Biotecnol Avanzate, Lab Recombinant Therapeut Prot, I-16132 Genoa, Italy; [Fossati, Sara; Parodi, Arianna; Blalock, William; Zardi, Luciano] Ist Giannina Gaslini, Unit Innovat Therapies, I-16132 Genoa, Italy; [Balza, Enrica; Castellani, Patrizia; Borsi, Laura] Ist Nazl Ric Canc, Cell Biol Lab, I-16132 Genoa, Italy; [Carnemolla, Barbara] Ist Nazl Ric Canc, Immunol Lab, I-16132 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Zardi, L (corresponding author), Ctr Biotecnol Avanzate, Lab Recombinant Therapeut Prot, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	zardi43@yahoo.it	Blalock, William L/C-6959-2019; Castellani, Patrizia/J-7333-2018	Blalock, William L/0000-0002-8045-4840; Castellani, Patrizia/0000-0002-6326-5853; Ventura, Elisa/0000-0002-5999-7613	Comitato Interministeriale Programmazione Economica, Rome, Regione Liguria, Genoa; European Union [FP6 LSHC-CT-2003-503233-STROMA, FP6 LSHC-CT-2006-037489-ImmunoPDT]; Istituto Superiore di Sanita, Rome [ISS2006]; Italian Ministry of Health, Rome [RF-IST-2006-384590]; Alleanza Contro il Cancro [ACC2007]	Comitato Interministeriale Programmazione Economica, Rome, Regione Liguria, Genoa(Regione Liguria); European Union(European Commission); Istituto Superiore di Sanita, Rome; Italian Ministry of Health, Rome(Ministry of Health, Italy); Alleanza Contro il Cancro	This work was supported by the Comitato Interministeriale Programmazione Economica, Rome, Regione Liguria, Genoa (to L. Z.), European Union Grants FP6 LSHC-CT-2003-503233-STROMA and FP6 LSHC-CT-2006-037489-ImmunoPDT (to L. Z.), Istituto Superiore di Sanita, Rome, Grant ISS2006, rare diseases (to B. C. and L. B.), Italian Ministry of Health, Rome, Grant RF-IST-2006-384590 (to L. B.), and Alleanza Contro il Cancro Grant ACC2007 (to L. B.).	BEIER HM, 1968, BIOCHIM BIOPHYS ACTA, V160, P289, DOI 10.1016/0005-2795(68)90108-6; Birchler MT, 2003, LARYNGOSCOPE, V113, P1231, DOI 10.1097/00005537-200307000-00023; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; CORTI A, 1994, J IMMUNOL METHODS, V177, P191, DOI 10.1016/0022-1759(94)90156-2; CURIGLIANO G, 2007, J CLIN ONCOL, V25, pS18; DELCONTE G, 2008, J CLIN ONCOL, V26, pS15; Demartis S, 1999, J MOL BIOL, V286, P617, DOI 10.1006/jmbi.1998.2476; HILLSON JL, 1993, J EXP MED, V178, P331, DOI 10.1084/jem.178.1.331; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; KACZMAREK J, 1994, INT J CANCER, V59, P11, DOI 10.1002/ijc.2910590104; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; KRISHNAN RS, 1967, SCIENCE, V158, P490, DOI 10.1126/science.158.3800.490; Li EQ, 1997, PROTEIN ENG, V10, P731, DOI 10.1093/protein/10.6.731; Marvin JS, 2005, ACTA PHARMACOL SIN, V26, P649, DOI 10.1111/j.1745-7254.2005.00119.x; Meazza R, 1996, BRIT J CANCER, V74, P788, DOI 10.1038/bjc.1996.437; Menrad A, 2005, EXPERT OPIN THER TAR, V9, P491, DOI 10.1517/14728222.9.3.491; MORIZE I, 1987, J MOL BIOL, V194, P725, DOI 10.1016/0022-2836(87)90250-6; MUKHERJEE AB, 2000, UTEROGLOGLOBIN CLARA; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pilon AL, 2000, ANN NY ACAD SCI, V923, P280; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Santimaria M, 2003, CLIN CANCER RES, V9, P571; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Tarli L, 1999, BLOOD, V94, P192, DOI 10.1182/blood.V94.1.192.413k22_192_198; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trachsel E, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2115; Viti F, 1999, CANCER RES, V59, P347; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	38	6	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26646	26654		10.1074/jbc.M109.025924	http://dx.doi.org/10.1074/jbc.M109.025924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19632988	Green Published, hybrid			2022-12-25	WOS:000269969600045
J	Wan, X; Kim, SY; Guenther, LM; Mendoza, A; Briggs, J; Yeung, C; Currier, D; Zhang, H; Mackall, C; Li, WJ; Tuan, RS; Deyrup, AT; Khanna, C; Helman, L				Wan, X.; Kim, S. Y.; Guenther, L. M.; Mendoza, A.; Briggs, J.; Yeung, C.; Currier, D.; Zhang, H.; Mackall, C.; Li, W-J; Tuan, R. S.; Deyrup, A. T.; Khanna, C.; Helman, L.			Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin	ONCOGENE			English	Article						beta 4 integrin; osteosarcoma; metastases; ezrin; interaction	ALPHA-6-BETA-4 INTEGRIN; DOMAIN INTERACTIONS; BINDING; KINASE; EXPRESSION; TRANSDUCTION; INVASION; PATHWAY	The development of pulmonary metastasis is the major cause of death in osteosarcoma, and its molecular basis is poorly understood. In this study, we show that beta 4 integrin is highly expressed in human osteosarcoma cell lines and tumor samples. Furthermore, highly metastatic MNNG-HOS cells have increased levels of beta 4 integrin. Suppression of beta 4 integrin expression by shRNA and disruption of beta 4 integrin function by transfection of dominant-negative beta 4 integrin was sufficient to revert this highly metastatic phenotype in the MNNG-HOS model without significantly affecting primary tumor growth. These findings suggest a role for beta 4 integrin expression in the metastatic phenotype in human osteosarcoma cells. In addition, we identified a previously uncharacterized interaction between beta 4 integrin and ezrin, a membrane-cytoskeletal linker protein that is implicated in the metastatic behavior of osteosarcoma. The beta 4 integrin-ezrin interaction appears to be critical for maintenance of beta 4 integrin expression. These data begin to integrate ezrin and beta 4 integrin expression into a model of action for the mechanism of osteosarcoma metastases. Oncogene (2009) 28, 3401-3411; doi: 10.1038/onc.2009.206; published online 13 July 2009	[Wan, X.] NCI, Mol Oncol Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Li, W-J; Tuan, R. S.] NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Bethesda, MD 20892 USA; [Deyrup, A. T.] Emory Univ, Dept Pathol, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Emory University	Wan, X (corresponding author), NCI, Mol Oncol Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bldg 10,Rm CRC-1W-3750, Bethesda, MD 20892 USA.	xiaolinw@mail.nih.gov			NIH; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011074, ZIABC011024, ZIASC006892, ZIABC010566, ZIASC006891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr AM Mercurio for providing empty vector and beta 4 mutant (Y1494F), Dr L Trusolino for providing control-shRNA and beta 4-shRNA, Dr M Arpin for providing GST and GST-ezrin-CT, Dr R Nguyen for providing BSA and ezrinNT. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	ANDREOLI C, 1994, J CELL SCI, V107, P2509; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; GAFFNEY R, 2006, HUM PATHOL, V244, P799; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grossman HB, 2000, ONCOL REP, V7, P13; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Harris MB, 1998, J CLIN ONCOL, V16, P3641, DOI 10.1200/JCO.1998.16.11.3641; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kashiwagi H, 1997, J CELL BIOL, V137, P1433, DOI 10.1083/jcb.137.6.1433; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kim SY, 2008, CLIN EXP METASTAS, V25, P201, DOI 10.1007/s10585-007-9133-3; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; LIU S, 2002, J CELL SCI, V113, P3563; Liu XF, 2000, CANCER RES, V60, P4752; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; RHIM JS, 1975, NATURE, V256, P751, DOI 10.1038/256751a0; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wan XL, 2003, ONCOGENE, V22, P8205, DOI 10.1038/sj.onc.1206878	39	54	63	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3401	3411		10.1038/onc.2009.206	http://dx.doi.org/10.1038/onc.2009.206			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19597468	Green Accepted			2022-12-25	WOS:000270103300007
J	Fan, C; Chen, QY; Wang, QK				Fan, Chun; Chen, Qiuyun; Wang, Qing Kenneth			Functional Role of Transcriptional Factor TBX5 in Pre-mRNA Splicing and Holt-Oram Syndrome via Association with SC35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; MUTATIONS; PROTEIN; HEART; COACTIVATOR; BINDING; LIMB; SPECIFICITY; MECHANISMS; INTERACTS	TBX5 is a T-box transcriptional factor required for cardio-genesis and limb development. TBX5 mutations cause Holt-Oram syndrome characterized by congenital heart defects and upper limb deformations. Here we establish a novel function for TBX5 in pre-mRNA splicing, and we show that this function is relevant to the pathogenesis of Holt-Oram syndrome, providing a novel pathogenic mechanism for the disease. Proteomics in combination with affinity purification identifies splicing factor SC35 as a candidate TBX5-associating protein. Co-immunoprecipitation and glutathione S-transferase pulldown assays confirm the complex formation between TBX5 and SC35. TBX5 can bind to RNA homopolymers (polyribonucleotides) and to the 5'-splice site, which overrides the binding of SC35 to the same RNA. Overexpression of TBX5 increases the efficiency of pre-mRNA splicing and regulates alternative splice site selection. However, co-expression of TBX5 and SC35 antagonizes each other's positive effect on splicing. The most severe TBX5 mutation, G80R, with complete penetrance of the cardiac phenotype, strongly affects pre-mRNA splicing, whereas other mutations with incomplete penetrance of the cardiac phenotype, including R237Q, do not alter the splicing activity of TBX5. This study establishes TBX5 as the first cardiac gene and the first human disease gene with dual roles in both transcriptional activation and pre-mRNA splicing.	Cleveland Clin, Ctr Cardiovasc Genet, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Cleveland Clinic Foundation; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, QK (corresponding author), Cleveland Clin, Ctr Cardiovasc Genet NE40, Cleveland, OH 44195 USA.	wangq2@ccf.org			China Natural Science Foundation [30670857]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported in part by China Natural Science Foundation Grant 30670857 ( to Q. W.).	Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Fan C, 2003, J Med Genet, V40, pe29, DOI 10.1136/jmg.40.3.e29; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Inoue A, 1996, NUCLEIC ACIDS RES, V24, P2990, DOI 10.1093/nar/24.15.2990; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Li QY, 1997, NAT GENET, V15, P21; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Wang KG, 2003, J OPT B-QUANTUM S O, V5, P44, DOI 10.1088/1464-4266/5/1/306; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200	33	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25653	25663		10.1074/jbc.M109.041368	http://dx.doi.org/10.1074/jbc.M109.041368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19648116	hybrid, Green Published			2022-12-25	WOS:000269738000023
J	Imamura, K; Wallace, SS; Doublie, S				Imamura, Kayo; Wallace, Susan S.; Doublie, Sylvie			Structural Characterization of a Viral NEIL1 Ortholog Unliganded and Bound to Abasic Site-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; COLI ENDONUCLEASE-VIII; OXIDATIVELY DAMAGED DNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DIFFRACTION DATA; GLYCOSYLASES NEIL1; ZINC-FINGER; FPG PROTEIN; RECOGNITION	Endonuclease VIII (Nei) is a DNA glycosylase of the base excision repair pathway that recognizes and excises oxidized pyrimidines. We determined the crystal structures of a NEIL1 ortholog from the giant Mimivirus (MvNei1) unliganded and bound to DNA containing tetrahydrofuran (THF), which is the first structure of any Nei with an abasic site analog. The MvNei1 structures exhibit the same overall architecture as other enzymes of the Fpg/Nei family, which consists of two globular domains joined by a linker region. MvNei1 harbors a zincless finger, first described in human NEIL1, rather than the signature zinc finger generally found in the Fpg/Nei family. In contrast to Escherichia coli Nei, where a dramatic conformational change was observed upon binding DNA, the structure of MvNei1 bound to DNA does not reveal any substantial movement compared with the unliganded enzyme. A protein segment encompassing residues 217-245 in MvNei1 corresponds to the "missing loop" in E. coli Nei and the "alpha F-beta 10 loop" in E. coli Fpg, which has been reported to be involved in lesion recognition. Interestingly, the corresponding loop in MvNei1 is ordered in both the unliganded and furan-bound structures, unlike other Fpg/Nei enzymes where the loop is generally ordered in the unliganded enzyme or in complexes with a lesion, and disordered otherwise. In the MvNei1.tetrahydrofuran complex a tyrosine located at the tip of the putative lesion recognition loop stacks against the furan ring; the tyrosine is predicted to adopt a different conformation to accommodate a modified base.	[Wallace, Susan S.] Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Burlington, VT 05405 USA	University of Vermont	Wallace, SS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	Susan.Wallace@uvm.edu; Sylvie.Doublie@uvm.edu		Wallace, Susan S./0000-0002-3906-0321; Imamura, Kayo/0000-0002-2141-8495; Doublie, Sylvie/0000-0002-6294-5304	NCI [P01CA098993]; U. S. Department of Energy; NIH; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01CA098993 awarded by the NCI. Financial support of National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U. S. Department of Energy, and from the National Center for Research Resources of NIH.	Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bandaru V, 2007, DNA REPAIR, V6, P1629, DOI 10.1016/j.dnarep.2007.05.011; Bandaru V, 2006, METHOD ENZYMOL, V408, P15, DOI 10.1016/S0076-6879(06)08002-5; Blaisdell JO, 2007, NUCLEIC ACIDS RES, V35, P1601, DOI 10.1093/nar/gkm021; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Castaing B, 1999, NUCLEIC ACIDS RES, V27, P608, DOI 10.1093/nar/27.2.608; CHETSANGA CJ, 1981, BIOCHEMISTRY-US, V20, P5201, DOI 10.1021/bi00521a016; CHUNG MH, 1991, MUTAT RES, V254, P1, DOI 10.1016/0921-8777(91)90035-N; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; Coste F, 2008, CHEM BIOL, V15, P706, DOI 10.1016/j.chembiol.2008.05.014; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; de Jesus KP, 2005, NUCLEIC ACIDS RES, V33, P5936, DOI 10.1093/nar/gki879; Denver DR, 2003, MOL BIOL EVOL, V20, P1603, DOI 10.1093/molbev/msg177; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Golan G, 2005, NUCLEIC ACIDS RES, V33, P5006, DOI 10.1093/nar/gki796; GOYAL RN, 1982, J ELECTROANAL CHEM, V135, P75, DOI 10.1016/0022-0728(82)90006-7; Hailer MK, 2005, DNA REPAIR, V4, P41, DOI 10.1016/j.dnarep.2004.07.006; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Jia L, 2007, BIOCHEMISTRY-US, V46, P5305, DOI 10.1021/bi062269m; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krokan HE, 1997, BIOCHEM J, V325, P1; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Luo WC, 2000, ORG LETT, V2, P613, DOI 10.1021/ol9913643; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sidorkina OM, 1998, NUCLEIC ACIDS RES, V26, P5351, DOI 10.1093/nar/26.23.5351; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TCHOU J, 1993, J BIOL CHEM, V268, P26738; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wallace SS, 2003, DNA REPAIR, V2, P441, DOI 10.1016/S1568-7864(02)00182-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	58	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26174	26183		10.1074/jbc.M109.021907	http://dx.doi.org/10.1074/jbc.M109.021907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625256	Green Published, hybrid			2022-12-25	WOS:000269738000072
J	Mizuguchi, M; Asao, H; Hara, T; Higuchi, M; Fujii, M; Nakamura, M				Mizuguchi, Mariko; Asao, Hironobu; Hara, Toshifumi; Higuchi, Masaya; Fujii, Masahiro; Nakamura, Masataka			Transcriptional Activation of the Interleukin-21 Gene and Its Receptor Gene by Human T-cell Leukemia Virus Type 1 Tax in Human T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LONG TERMINAL REPEAT; HTLV-I TAX; CONSTITUTIVE ACTIVATION; MONOCLONAL-ANTIBODIES; TRANSACTIVATOR GENE; GAMMA-CHAIN; EXPRESSION; PROTEIN; IL-21	At the incipient stages of the development of adult T-cell leukemia, T-cells infected with human T-cell leukemia virus type 1 (HTLV-1) suffer disregulation in cell growth caused by aberrant expression of host genes by the HTLV-1 transactivator protein Tax (Tax1). Tax1-mediated growth promotion is thought to result from, at least in part, up-regulation of genes for growth factors and their receptors that induce T-cell growth. In the present study, we demonstrate that Tax1 transactivates the interleukin-21 (IL-21) and its receptor (IL-21R) genes in human T-cells. Introduction of Tax1 via recombinant adenoviruses induced expression of endogenous IL-21 and IL-21R. Isolated promoters of the IL-21 and IL-21R genes were activated by Tax1 in reporter assays, which further revealed that there were at least two Tax1-responsive elements in either the IL-21 promoter or the IL-21R promoter. Chromatin immunoprecipitation assay and gel mobility shift assay exhibited that the IL-21 promoter elements bound transcription factors AP-1 and NF-kappa B, and the IL-21R promoter elements were associated with AP-1 and interferon regulatory factor. Collectively, Tax1-dependent activation of these transcriptional factors presumably contributes to expression of the IL-21 gene and its receptor gene. The related virus HTLV-2 with Tax2 similar to Tax1 is known not to be pathogenic. Tax2 exhibited little, if any, or no induction of the IL-21 transcription in CD4(+) T-cells, in contrast to Tax1. The study suggests insights into cytokine-dependent aberrant growth of HTLV-1-infected T-cells and the molecular basis of different pathogenicity between HTLV-1 and HTLV-2.	[Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, Tokyo 1138510, Japan; [Asao, Hironobu] Yamagata Univ, Fac Med, Dept Immunol, Yamagata 9909585, Japan; [Higuchi, Masaya; Fujii, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata 9518510, Japan	Tokyo Medical & Dental University (TMDU); Yamagata University; Niigata University	Nakamura, M (corresponding author), Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	naka.gene@tmd.ac.jp	Higuchi, Masaya/L-2111-2019		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akagi T, 1996, ONCOGENE, V12, P1645; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Bowman, 1999, Cancer Control, V6, P615; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; GESSAIN A, 1985, LANCET, V2, P407; Good LF, 1996, EMBO J, V15, P3744, DOI 10.1002/j.1460-2075.1996.tb00744.x; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002; Haller K, 2000, AIDS RES HUM RETROV, V16, P1683, DOI 10.1089/08892220050193146; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; HIRAI H, 1992, ONCOGENE, V7, P1737; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Lewis MJ, 2000, VIROLOGY, V271, P142, DOI 10.1006/viro.2000.0284; Mariner JM, 2002, J IMMUNOL, V168, P5667, DOI 10.4049/jimmunol.168.11.5667; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Matsumoto K, 1997, J VIROL, V71, P4445, DOI 10.1128/JVI.71.6.4445-4451.1997; MCGUIRE KL, 1993, J VIROL, V67, P1590, DOI 10.1128/JVI.67.3.1590-1599.1993; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Mori N, 1999, BLOOD, V93, P2360; Mori N, 2000, BLOOD, V95, P3915; NAKAMURA M, 1989, J BIOL CHEM, V264, P20189; Niinuma A, 2005, J VIROL, V79, P11925, DOI 10.1128/JVI.79.18.11925-11934.2005; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; OHBO K, 1995, J BIOL CHEM, V270, P7479, DOI 10.1074/jbc.270.13.7479; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; OHTANI K, 1987, EMBO J, V6, P389, DOI 10.1002/j.1460-2075.1987.tb04767.x; OHTANI K, 1989, NUCLEIC ACIDS RES, V17, P1589, DOI 10.1093/nar/17.4.1589; Ohtani K, 2003, GANN MONOGR CANC RES, P43; Onoda T, 2007, INT IMMUNOL, V19, P1191, DOI 10.1093/intimm/dxm090; OSAME M, 1986, LANCET, V1, P1031; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rahman M, 2007, FEBS LETT, V581, P4001, DOI 10.1016/j.febslet.2007.07.034; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Ross TM, 1996, J VIROL, V70, P5194, DOI 10.1128/JVI.70.8.5194-5202.1996; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Takahashi Y, 2000, GENE DEV, V14, P804; TANAKA Y, 1991, INT J CANCER, V48, P623, DOI 10.1002/ijc.2910480423; TANAKA Y, 1986, MICROBIOL IMMUNOL, V30, P373, DOI 10.1111/j.1348-0421.1986.tb00954.x; Ueda M, 2005, BRIT J HAEMATOL, V128, P169, DOI 10.1111/j.1365-2141.2004.05255.x; White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9; Wu Z, 2005, MOL CELL BIOL, V25, P9741, DOI 10.1128/MCB.25.22.9741-9752.2005; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973	58	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25501	25511		10.1074/jbc.M109.010959	http://dx.doi.org/10.1074/jbc.M109.010959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617351	hybrid, Green Published			2022-12-25	WOS:000269738000007
J	Pike, JE; Burgers, PMJ; Campbell, JL; Bambara, RA				Pike, Jason E.; Burgers, Peter M. J.; Campbell, Judith L.; Bambara, Robert A.			Pif1 Helicase Lengthens Some Okazaki Fragment Flaps Necessitating Dna2 Nuclease/Helicase Action in the Two-nuclease Processing Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; ENDONUCLEASE ACTIVITY; PRIMER REMOVAL; LIGATABLE NICK; YEAST; MATURATION	We have developed a system to reconstitute all of the proposed steps of Okazaki fragment processing using purified yeast proteins and model substrates. DNA polymerase delta was shown to extend an upstream fragment to displace a downstream fragment into a flap. In most cases, the flap was removed by flap endonuclease 1 (FEN1), in a reaction required to remove initiator RNA in vivo. The nick left after flap removal could be sealed by DNA ligase I to complete fragment joining. An alternative pathway involving FEN1 and the nuclease/helicase Dna2 has been proposed for flaps that become long enough to bind replication protein A (RPA). RPA binding can inhibit FEN1, but Dna2 can shorten RPA-bound flaps so that RPA dissociates. Recent reconstitution results indicated that Pif1 helicase, a known component of fragment processing, accelerated flap displacement, allowing the inhibitory action of RPA. In results presented here, Pif1 promoted DNA polymerase delta to displace strands that achieve a length to bind RPA, but also to be Dna2 substrates. Significantly, RPA binding to long flaps inhibited the formation of the final ligation products in the reconstituted system without Dna2. However, Dna2 reversed that inhibition to restore efficient ligation. These results suggest that the two-nuclease pathway is employed in cells to process long flap intermediates promoted by Pif1.	[Pike, Jason E.; Bambara, Robert A.] Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA; [Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; Washington University (WUSTL); California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_bambara@urmc.rochester.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM024441, GM087666, GM32431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 (to R.A.B.), with additional support from Grants GM087666 ( to J.L.C.), and GM32431 (to P.M.B.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Zhou JQ, 2002, MOL BIOL CELL, V13, P2180, DOI 10.1091/mbc.02-02-0021	38	81	84	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25170	25180		10.1074/jbc.M109.023325	http://dx.doi.org/10.1074/jbc.M109.023325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605347	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000269734000051
J	Young, DC; Kasmar, A; Moraski, G; Cheng, TY; Walz, AJ; Hu, JD; Xu, YP; Endres, GW; Uzieblo, A; Zajonc, D; Costello, CE; Miller, MJ; Moody, DB				Young, David C.; Kasmar, Anne; Moraski, Garrett; Cheng, Tan-Yun; Walz, Andrew J.; Hu, Jingdan; Xu, Yanping; Endres, Gregory W.; Uzieblo, Adam; Zajonc, Dirk; Costello, Catherine E.; Miller, Marvin J.; Moody, D. Branch			Synthesis of Dideoxymycobactin Antigens Presented by CD1a Reveals T Cell Fine Specificity for Natural Lipopeptide Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE PEPTIDE-SYNTHESIS; SOLID-PHASE; AMINO-ACIDS; MYCOBACTERIUM-TUBERCULOSIS; ANTIMYCOBACTERIAL AGENTS; DENDRITIC CELLS; RECOGNITION; IRON; SIDEROPHORE; ANALOGS	Mycobacterium tuberculosis survival in cells requires mycobactin siderophores. Recently, the search for lipid antigens presented by the CD1a antigen-presenting protein led to the discovery of a mycobactin-like compound, dideoxymycobactin (DDM). Here we synthesize DDMs using solution phase and solid phase peptide synthesis chemistry. Comparison of synthetic standards to natural mycobacterial mycobactins by nuclear magnetic resonance and mass spectrometry allowed identification of an unexpected alpha-methyl serine unit in natural DDM. This finding further distinguishes these pre-siderophores as foreign compounds distinct from conventional peptides, and we provide evidence that this chemical variation influences the T cell response. One synthetic DDM recapitulated natural structures and potently stimulated T cells, making it suitable for patient studies of CD1a in infectious disease. DDM analogs differing in the stereochemistry of their butyrate or oxazoline moieties were not recognized by human T cells. Therefore, we conclude that T cells show precise specificity for both arms of the peptide, which are predicted to lie at the CD1a-T cell receptor interface.	[Young, David C.; Kasmar, Anne; Cheng, Tan-Yun; Moody, D. Branch] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Moraski, Garrett; Walz, Andrew J.; Hu, Jingdan; Xu, Yanping; Miller, Marvin J.] Univ Notre Dame, Dept Chem, Notre Dame, IN 46556 USA; [Moraski, Garrett; Walz, Andrew J.; Hu, Jingdan; Xu, Yanping; Miller, Marvin J.] Univ Notre Dame, Dept Biochem, Notre Dame, IN 46556 USA; [Endres, Gregory W.; Uzieblo, Adam] Cayman Chem Co, Ann Arbor, MI 48108 USA; [Zajonc, Dirk] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Costello, Catherine E.] Boston Univ, Sch Med, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Notre Dame; University of Notre Dame; La Jolla Institute for Immunology; Boston University	Moody, DB (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Dept Med,Brigham & Womens Hosp, Smith Bldg,Rm 538,1 Jimmy Fund Way, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu	Moraski, Garrett/AAH-3616-2021	Costello, Catherine/0000-0003-1594-5122	National Institutes of Health [AI054193, AR 046832, AI 049313, AI 074952]; Cancer Research Institute; National Center for Research [P41-RR10888]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074952, R56AI074952, R01AI049313, R01AI054193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; National Center for Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054193, AR 046832, AI 049313, and AI 074952. This work was also supported by a Cancer Research Institute Investigator Award (LIAI), National Center for Research Resources Grant P41-RR10888, and funds from the Howard Hughes Medical Institute Kwa-Zulu Natal Research Institute for Tuberculosis and HIV (K-RITH).	Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; CHANG CD, 1978, INT J PEPT PROT RES, V11, P246; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FLYNN EH, 1953, J AM CHEM SOC, V75, P5867, DOI 10.1021/ja01119a025; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GREATBANKS D, 1969, BIOCHEM J, V115, P1047, DOI 10.1042/bj1151047; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hu JD, 1997, J AM CHEM SOC, V119, P3462, DOI 10.1021/ja963968x; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; KAISER FE, 1974, J CHROMATOGR, V94, P113, DOI 10.1016/S0021-9673(01)92361-1; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; LEIMER KR, 1977, J CHROMATOGR, V141, P121, DOI 10.1016/S0021-9673(00)99131-3; MATSUTANI H, 1988, PHYTOCHEMISTRY, V27, P931, DOI 10.1016/0031-9422(88)84123-2; MAURER PJ, 1981, J ORG CHEM, V46, P2835, DOI 10.1021/jo00326a061; MAURER PJ, 1983, J AM CHEM SOC, V105, P240, DOI 10.1021/ja00340a017; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MERGLER M, 1988, TETRAHEDRON LETT, V29, P4009, DOI 10.1016/S0040-4039(00)80406-2; MERGLER M, 1988, TETRAHEDRON LETT, V29, P4005, DOI 10.1016/S0040-4039(00)80405-0; MERRIFIELD RB, 1964, BIOCHEMISTRY-US, V3, P1385, DOI 10.1021/bi00897a032; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Peerdeman A. F., 1951, P KONINKL NED AKAD B, VB54, P16; Phillips AJ, 2000, ORG LETT, V2, P1165, DOI 10.1021/ol005777b; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Poreddy AR, 2003, BIOORG MED CHEM LETT, V13, P2553, DOI 10.1016/S0960-894X(03)00473-6; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rosat JP, 1999, J IMMUNOL, V162, P366; Roura-Mir C, 2005, J IMMUNOL, V174, P3773, DOI 10.4049/jimmunol.174.6.3773; SERCKHANSSEN K, 1953, ARK KEMI, V5, P203; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SNOW GA, 1969, BIOCHEM J, V115, P1031, DOI 10.1042/bj1151031; SNOW GA, 1970, BACTERIOL REV, V34, P99, DOI 10.1128/MMBR.34.2.99-125.1970; STILL WC, 1983, TETRAHEDRON LETT, V24, P4405, DOI 10.1016/S0040-4039(00)85909-2; TAKAMURA N, 1967, CHEM PHARM BULL, V15, P1776; Tsukamoto M, 1997, J ANTIBIOT, V50, P815, DOI 10.7164/antibiotics.50.815; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Van Rhijn I, 2009, J EXP MED, V206, P1409, DOI 10.1084/jem.20082480; WADSWORTH W, 1961, J AM CHEM SOC, V83, P1733, DOI 10.1021/ja01468a042; Walz AJ, 2007, ORG BIOMOL CHEM, V5, P1621, DOI 10.1039/b703116e; Xu YP, 1998, J ORG CHEM, V63, P4314, DOI 10.1021/jo980063o; Young DC, 2006, GLYCOBIOLOGY, V16, p103R, DOI 10.1093/glycob/cwj111; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009	52	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25087	25096		10.1074/jbc.M109.000802	http://dx.doi.org/10.1074/jbc.M109.000802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605355	Green Published, hybrid			2022-12-25	WOS:000269734000043
J	Csoka, B; Nemeth, ZH; Mukhopadhyay, P; Spolarics, Z; Rajesh, M; Federici, S; Deitch, EA; Batkai, S; Pacher, P; Hasko, G				Csoka, Balazs; Nemeth, Zoltan H.; Mukhopadhyay, Partha; Spolarics, Zoltan; Rajesh, Mohanraj; Federici, Stephanie; Deitch, Edwin A.; Batkai, Sandor; Pacher, Pal; Hasko, Gyoergy			CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis	PLOS ONE			English	Article							ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; ADENOSINE RECEPTORS; IMIPENEM TREATMENT; IMPROVES SURVIVAL; INDUCED APOPTOSIS; WILD-TYPE; CELLS; MACROPHAGES; ACTIVATION	Background: Sepsis is a major healthcare problem and current estimates suggest that the incidence of sepsis is approximately 750,000 annually. Sepsis is caused by an inability of the immune system to eliminate invading pathogens. It was recently proposed that endogenous mediators produced during sepsis can contribute to the immune dysfunction that is observed in sepsis. Endocannabinoids that are produced excessively in sepsis are potential factors leading to immune dysfunction, because they suppress immune cell function by binding to G-protein-coupled CB2 receptors on immune cells. Here we examined the role of CB2 receptors in regulating the host's response to sepsis. Methods and Findings: The role of CB2 receptors was studied by subjecting CB2 receptor wild-type and knockout mice to bacterial sepsis induced by cecal ligation and puncture. We report that CB2 receptor inactivation by knockout decreases sepsis-induced mortality, and bacterial translocation into the bloodstream of septic animals. Furthermore, CB2 receptor inactivation decreases kidney and muscle injury, suppresses splenic nuclear factor (NF)-kB activation, and diminishes the production of IL-10, IL-6 and MIP-2. Finally, CB2 receptor deficiency prevents apoptosis in lymphoid organs and augments the number of CD11b(+) and CD19(+) cells during CLP. Conclusions: Taken together, our results establish for the first time that CB2 receptors are important contributors to septic immune dysfunction and mortality, indicating that CB2 receptors may be therapeutically targeted for the benefit of patients suffering from sepsis.			Csoka, B (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA.	pacher@mail.nih.gov; haskoge@umdnj.edu	Batkai, Sandor/G-3889-2010; Batkai, Sandor/H-7983-2014; Pacher, Pal/B-6378-2008	Mukhopadhyay, Partha/0000-0002-1178-1274; Mohanraj, Rajesh/0000-0003-2660-2184; Csoka, Balazs/0000-0002-7562-1130; Pacher, Pal/0000-0001-7036-8108	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066189, R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AA000375-02, Z99 AA999999] Funding Source: Medline; NIGMS NIH HHS [GM066189-05A2, R56 GM066189, R01 GM066189] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Chandra R, 2008, J LEUKOCYTE BIOL, V83, P1541, DOI 10.1189/jlb.1207838; Chung CS, 1998, ARCH SURG-CHICAGO, V133, P1213, DOI 10.1001/archsurg.133.11.1213; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Csoka B, 2007, PURINERG SIGNAL, V3, P447, DOI 10.1007/s11302-007-9075-x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; diMarzo V, 1996, BIOCHEM J, V316, P977, DOI 10.1042/bj3160977; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Enoh VT, 2006, AM J PHYSIOL-REG I, V290, pR685, DOI 10.1152/ajpregu.00678.2005; Enoh VT, 2006, AM J PHYSIOL-GASTR L, V290, pG277, DOI 10.1152/ajpgi.00338.2005; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jia W, 2006, MOL CANCER RES, V4, P549, DOI 10.1158/1541-7786.MCR-05-0193; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Leibovici L, 1997, SCAND J INFECT DIS, V29, P71, DOI 10.3109/00365549709008668; Lombard C, 2007, CLIN IMMUNOL, V122, P259, DOI 10.1016/j.clim.2006.11.002; Lyons A, 1997, ANN SURG, V226, P450, DOI 10.1097/00000658-199710000-00006; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; Matveyeva M, 2000, INT J IMMUNOPHARMACO, V22, P373, DOI 10.1016/S0192-0561(99)00092-2; McCoy KL, 1999, J PHARMACOL EXP THER, V289, P1620; McKallip RJ, 2002, J PHARMACOL EXP THER, V302, P451, DOI 10.1124/jpet.102.033506; McKallip RJ, 2006, MOL PHARMACOL, V70, P897, DOI 10.1124/mol.106.023937; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; OBERHOLZER A, 2002, CRIT CARE MED S1, V30, pS58; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; RIEDER SA, 2009, IMMUNOBIOLOGY; Shelley O, 2003, SHOCK, V20, P123, DOI 10.1097/01.shk.0000079426.52617.00; Song GY, 2000, J SURG RES, V91, P141, DOI 10.1006/jsre.2000.5928; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0; Wagner JA, 1998, J MOL MED-JMM, V76, P824, DOI 10.1007/s001090050287; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371; Wang Y, 2001, ANAL BIOCHEM, V294, P73, DOI 10.1006/abio.2001.5015; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373	54	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6409	10.1371/journal.pone.0006409	http://dx.doi.org/10.1371/journal.pone.0006409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641602	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500010
J	Salta, E; Panagiotidis, C; Teliousis, K; Petrakis, S; Eleftheriadis, E; Arapoglou, F; Grigoriadis, N; Nicolaou, A; Kaldrymidou, E; Krey, G; Sklaviadis, T				Salta, Evgenia; Panagiotidis, Cynthia; Teliousis, Konstantinos; Petrakis, Spyros; Eleftheriadis, Eleftherios; Arapoglou, Fotis; Grigoriadis, Nikolaos; Nicolaou, Anna; Kaldrymidou, Eleni; Krey, Grigorios; Sklaviadis, Theodoros			Evaluation of the Possible Transmission of BSE and Scrapie to Gilthead Sea Bream (Sparus aurata)	PLOS ONE			English	Article								In transmissible spongiform encephalopathies (TSEs), a group of fatal neurodegenerative disorders affecting many species, the key event in disease pathogenesis is the accumulation of an abnormal conformational isoform (PrP(Sc)) of the host-encoded cellular prion protein (PrP(C)). While the precise mechanism of the PrP(C) to PrP(Sc) conversion is not understood, it is clear that host Prp(C) expression is a prerequisite for effective infectious prion propagation. Although there have been many studies on TSEs in mammalian species, little is known about TSE pathogenesis in fish. Here we show that while gilthead sea bream (Sparus aurata) orally challenged with brain homogenates prepared either from a BSE infected cow or from scrapie infected sheep developed no clinical prion disease, the brains of TSE-fed fish sampled two years after challenge did show signs of neurodegeneration and accumulation of deposits that reacted positively with antibodies raised against sea bream PrP. The control groups, fed with brains from uninfected animals, showed no such signs. Remarkably, the deposits developed much more rapidly and extensively in fish inoculated with BSE-infected material than in the ones challenged with the scrapie-infected brain homogenate, with numerous deposits being proteinase K-resistant. These plaque-like aggregates exhibited congophilia and birefringence in polarized light, consistent with an amyloid-like component. The neurodegeneration and abnormal deposition in the brains of fish challenged with prion, especially BSE, raises concerns about the potential risk to public health. As fish aquaculture is an economically important industry providing high protein nutrition for humans and other mammalian species, the prospect of farmed fish being contaminated with infectious mammalian Prp(Sc), or of a prion disease developing in farmed fish is alarming and requires further evaluation.			Salta, E (corresponding author), Aristotle Univ Thessaloniki, Dept Pharmacol, GR-54006 Thessaloniki, Greece.	sklaviad@auth.gr	Dafou, Dimitra/N-6094-2015; Petrakis, Spyros/AAA-6778-2021; Sklaviadis, Theoodoros/AGK-6763-2022	Dafou, Dimitra/0000-0003-4170-0612; Petrakis, Spyros/0000-0001-9094-3480; Sklaviadis, Theodoros/0000-0002-0246-3100				Almer G, 1999, BRAIN, V122, P5, DOI 10.1093/brain/122.1.5; Aranguren R, 2002, J FISH DIS, V25, P317, DOI 10.1046/j.1365-2761.2002.00368.x; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Budka H, 2000, ARCH VIROL, P135; Burgos JS, 2008, ZEBRAFISH, V5, P323, DOI 10.1089/zeb.2008.0552; Butler AB, 2005, EVOLUTION ADAPTATION; Castric J, 2001, DIS AQUAT ORGAN, V47, P33, DOI 10.3354/dao047033; Christen B, 2008, FEBS J, V275, P263, DOI 10.1111/j.1742-4658.2007.06196.x; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Diaz-San Segundo F, 2006, ACTA NEUROPATHOL, V112, P587, DOI 10.1007/s00401-006-0133-1; Favre-Krey L, 2007, COMP BIOCHEM PHYS B, V147, P566, DOI 10.1016/j.cbpb.2007.03.011; FRIEDLAND RP, 2009, J ALZHEIMERS DIS; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gibbs CJ, 1997, MOL PSYCHIATR, V2, P146; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Howie AJ, 2008, LAB INVEST, V88, P232, DOI 10.1038/labinvest.3700714; Johansen R, 2002, DIS AQUAT ORGAN, V50, P161, DOI 10.3354/dao050161; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Liao MJ, 2005, AQUACULTURE, V249, P47, DOI 10.1016/j.aquaculture.2005.01.025; Maddison BC, 2005, J IMMUNOL METHODS, V306, P202, DOI 10.1016/j.jim.2005.09.001; McLennan NF, 2001, NEUROPATH APPL NEURO, V27, P373, DOI 10.1046/j.0305-1846.2001.00343.x; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Oidtmann B, 2003, FEBS LETT, V538, P96, DOI 10.1016/S0014-5793(03)00149-2; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Premzl M, 2004, MOL BIOL EVOL, V21, P2210, DOI 10.1093/molbev/msh245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Rivera-Milla E, 2003, TRENDS GENET, V19, P72, DOI 10.1016/S0168-9525(02)00032-X; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Salas C, 2006, ZEBRAFISH, V3, P157, DOI 10.1089/zeb.2006.3.157; Simonic T, 2000, FEBS LETT, V469, P33, DOI 10.1016/S0014-5793(00)01232-1; Strumbo B, 2001, FEBS LETT, V508, P170, DOI 10.1016/S0014-5793(01)03027-7; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Unterberger U, 2005, ACTA NEUROPATHOL, V109, P32, DOI 10.1007/s00401-004-0953-9; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; WILESMITH JW, 1988, VET REC, V123, P638; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zupanc G. K., 2008, SEMIN CELL DEV BIOL; EFSA J, V443, P1	48	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6175	10.1371/journal.pone.0006175	http://dx.doi.org/10.1371/journal.pone.0006175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636413	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000268404900001
J	Lie, HC; Simmons, LW; Rhodes, G				Lie, Hanne C.; Simmons, Leigh W.; Rhodes, Gillian			Does Genetic Diversity Predict Health in Humans?	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HETEROZYGOTE ADVANTAGE; PARASITE RESISTANCE; MICROSATELLITE LOCI; INBREEDING DEPRESSION; FACIAL ATTRACTIVENESS; MHC-HETEROZYGOSITY; SEXUAL SELECTION; HLA; SUSCEPTIBILITY	Genetic diversity, especially at genes important for immune functioning within the Major Histocompatibility Complex (MHC), has been associated with fitness-related traits, including disease resistance, in many species. Recently, genetic diversity has been associated with mate preferences in humans. Here we asked whether these preferences are adaptive in terms of obtaining healthier mates. We investigated whether genetic diversity (heterozygosity and standardized mean d(2)) at MHC and nonMHC microsatellite loci, predicted health in 153 individuals. Individuals with greater allelic diversity (d(2)) at nonMHC loci and at one MHC locus, linked to HLA-DRB1, reported fewer symptoms over a four-month period than individuals with lower d(2). In contrast, there were no associations between MHC or nonMHC heterozygosity and health. NonMHC-d(2) has previously been found to predict male preferences for female faces. Thus, the current findings suggest that nonMHC diversity may play a role in both natural and sexual selection acting on human populations.			Lie, HC (corresponding author), Univ Western Australia, Sch Psychol, Crawley, WA, Australia.	hannelie01@graduate.uwa.edu.au	Lie, Hanne Cathrine/AAL-8227-2020; Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518; Lie, Hanne Cathrine/0000-0002-8370-5422				Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI [10.1139/f02-066, 10.1139/F02-066]; *ASCO, 1997, AUSTR STAND CLASS OC; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Charpentier MJE, 2008, CONSERV GENET, V9, P1605, DOI 10.1007/s10592-007-9499-4; Coetzee V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000640; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cote SD, 2005, MOL ECOL, V14, P4159, DOI 10.1111/j.1365-294X.2005.02733.x; Coulson T, 1999, EVOLUTION, V53, P1951, DOI 10.1111/j.1558-5646.1999.tb04575.x; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Curik I, 2003, J HERED, V94, P125, DOI 10.1093/jhered/esg029; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; De Groot NG, 2008, MOL ECOL, V17, P2074, DOI 10.1111/j.1365-294X.2008.03716.x; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Duggal P, 2004, J INFECT DIS, V189, P520, DOI 10.1086/381272; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; GLASER R, 1986, BEHAV NEUROSCI, V100, P675, DOI 10.1037/0735-7044.100.5.675; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hedrick P, 2001, EVOLUTION, V55, P1256; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hill AVS, 1999, NATURE, V398, P668, DOI 10.1038/19431; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoglund J, 2002, P ROY SOC B-BIOL SCI, V269, P711, DOI 10.1098/rspb.2001.1937; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; Hume DK, 2001, EVOL HUM BEHAV, V22, P93, DOI 10.1016/S1090-5138(00)00065-9; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kekalainen J, 2009, P ROY SOC B-BIOL SCI, V276, P3133, DOI 10.1098/rspb.2009.0727; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kretzmann M, 2006, J HERED, V97, P555, DOI 10.1093/jhered/esl043; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; LYONS EJ, 2009, BIOL LETT IN PRESS; MacDougall-Shackleton EA, 2005, BIOL LETTERS, V1, P105, DOI 10.1098/rsbl.2004.0264; Madsen T, 2006, J EVOLUTION BIOL, V19, P1973, DOI 10.1111/j.1420-9101.2006.01158.x; Malkki M, 2005, TISSUE ANTIGENS, V66, P114, DOI 10.1111/j.1399-0039.2005.00453.x; Marsland AL, 2002, PHYSIOL BEHAV, V77, P711, DOI 10.1016/S0031-9384(02)00923-X; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MOLLER AP, 2001, IMPORTANT DIRECT FIT, V80, P401; Neff BD, 2004, J HERED, V95, P165, DOI 10.1093/jhered/esh021; Nieman David C, 2003, Curr Sports Med Rep, V2, P239; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Prus SG, 2007, SOCIOL HEALTH ILL, V29, P275, DOI 10.1111/j.1467-9566.2007.00547.x; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; Rossiter SJ, 2001, P ROY SOC B-BIOL SCI, V268, P1055, DOI 10.1098/rspb.2001.1612; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Santucci F, 2007, HEREDITY, V99, P340, DOI 10.1038/sj.hdy.6801006; Sauermann U, 2001, HUM GENET, V108, P249, DOI 10.1007/s004390100485; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Schwensow N, 2008, EVOL ECOL, V22, P617, DOI 10.1007/s10682-007-9186-4; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Slate J, 2002, J EVOLUTION BIOL, V15, P20, DOI 10.1046/j.1420-9101.2002.00373.x; STOKES JP, 1990, J SOC BEHAV PERS, V5, P173; Suri A, 2003, P NATL ACAD SCI USA, V100, P5330, DOI 10.1073/pnas.0330859100; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Tsitrone A, 2001, GENETICS, V159, P1845; VALDES AM, 1993, GENETICS, V133, P737; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wegner KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-124; Wegner KM, 2006, MOL ECOL, V15, P1153, DOI 10.1111/j.1365-294X.2006.02855.x; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002	83	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6391	10.1371/journal.pone.0006391	http://dx.doi.org/10.1371/journal.pone.0006391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	475YV	19633717	gold, Green Published, Green Submitted			2022-12-25	WOS:000268404800013
J	Calmels, N; Schmucker, S; Wattenhofer-Donze, M; Martelli, A; Vaucamps, N; Reutenauer, L; Messaddeq, N; Bouton, C; Koenig, M; Puccio, H				Calmels, Nadege; Schmucker, Stephane; Wattenhofer-Donze, Marie; Martelli, Alain; Vaucamps, Nadege; Reutenauer, Laurence; Messaddeq, Nadia; Bouton, Cecile; Koenig, Michel; Puccio, Helene			The First Cellular Models Based on Frataxin Missense Mutations That Reproduce Spontaneously the Defects Associated with Friedreich Ataxia	PLOS ONE			English	Article								Background: Friedreich ataxia (FRDA), the most common form of recessive ataxia, is due to reduced levels of frataxin, a highly conserved mitochondrial iron-chaperone involved in iron-sulfur cluster (ISC) biogenesis. Most patients are homozygous for a (GAA)(n) expansion within the first intron of the frataxin gene. A few patients, either with typical or atypical clinical presentation, are compound heterozygous for the GAA expansion and a micromutation. Methodology: We have developed a new strategy to generate murine cellular models for FRDA: cell lines carrying a frataxin conditional allele were used in combination with an EGFP-Cre recombinase to create murine cellular models depleted for endogenous frataxin and expressing missense-mutated human frataxin. We showed that complete absence of murine frataxin in fibroblasts inhibits cell division and leads to cell death. This lethal phenotype was rescued through transgenic expression of human wild type as well as mutant (hFXN(G130V) and hFXN(I154F)) frataxin. Interestingly, cells expressing the mutated frataxin presented a FRDA-like biochemical phenotype. Though both mutations affected mitochondrial ISC enzymes activities and mitochondria ultrastructure, the hFXN(I154F) mutant presented a more severe phenotype with affected cytosolic and nuclear ISC enzyme activities, mitochondrial iron accumulation and an increased sensitivity to oxidative stress. The differential phenotype correlates with disease severity observed in FRDA patients. Conclusions: These new cellular models, which are the first to spontaneously reproduce all the biochemical phenotypes associated with FRDA, are important tools to gain new insights into the in vivo consequences of pathological missense mutations as well as for large-scale pharmacological screening aimed at compensating frataxin deficiency.			Calmels, N (corresponding author), IGBMC, Illkirch Graffenstaden, France.	hpuccio@igbmc.fr	Puccio, Hélène/G-1717-2013	Puccio, Hélène/0000-0003-4711-2248; CALMELS, Nadege/0000-0001-8516-8184; Martelli, Alain/0000-0001-5246-565X				Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; AEBI H, 1981, ACTA BIOL MED GER, V40, P537; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Busi MV, 2006, PLANT J, V48, P873, DOI 10.1111/j.1365-313X.2006.02923.x; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Correia AR, 2008, FEBS J, V275, P3680, DOI 10.1111/j.1742-4658.2008.06512.x; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Filla A, 1996, AM J HUM GENET, V59, P554; Forrest SM, 1998, NEUROGENETICS, V1, P253, DOI 10.1007/s100480050037; Freshney RI., 2010, CULTURE ANIMAL CELLS, VSixth; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Kim S, 1999, J BIOL CHEM, V274, P33035, DOI 10.1074/jbc.274.46.33035; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lobmayr L, 2005, GENE, V354, P157, DOI 10.1016/j.gene.2005.04.040; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; MARTELLI A, 2007, HUM MOL GENET; McCabe DJH, 2002, ARCH NEUROL-CHICAGO, V59, P296, DOI 10.1001/archneur.59.2.296; MOULIS JM, 1982, BIOCHEMISTRY-US, V21, P4762, DOI 10.1021/bi00262a037; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Ribai P, 2007, ARCH NEUROL-CHICAGO, V64, P558, DOI 10.1001/archneur.64.4.558; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; SCHMUCKER S, 2008, HUM MOL GENET; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Sturm B, 2005, J BIOL CHEM, V280, P6701, DOI 10.1074/jbc.M408717200; Tan G, 2001, HUM MOL GENET, V10, P2099, DOI 10.1093/hmg/10.19.2099; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Ventura N, 2006, EXP GERONTOL, V41, P974, DOI 10.1016/j.exger.2006.06.060; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Zanella I, 2008, BBA-MOL BASIS DIS, V1782, P90, DOI 10.1016/j.bbadis.2007.11.006; ZHOU G, 1992, J BIOL CHEM, V267, P7936	57	42	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6379	10.1371/journal.pone.0006379	http://dx.doi.org/10.1371/journal.pone.0006379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629184	gold, Green Published			2022-12-25	WOS:000268318900010
J	Chowdhury, DR; Angov, E; Kariuki, T; Kumar, N				Chowdhury, Debabani Roy; Angov, Evelina; Kariuki, Thomas; Kumar, Nirbhay			A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli	PLOS ONE			English	Article								Malaria caused by Plasmodium falciparum is responsible for nearly 1 million deaths annually. Although much progress has been made in the recent past, the development of a safe, effective and affordable malaria vaccine has remained a challenge. A vaccine targeting sexual stages of the parasite will not only reduce malaria transmission by female Anopheles mosquitoes, but also reduce the spread of parasites able to evade immunity elicited by vaccines targeting pre-erythrocytic and erythrocytic asexual stages. We focused our studies on Pfs48/45, a protein expressed in the sexual stages developing within an infected person and one of the most promising transmission-blocking vaccine targets. Functional immunogenicity of Pfs48/45 protein requires proper disulfide bond formation, consequently evaluation of the immunogenicity of recombinant full-length Pfs48/45 has been hampered by difficulties in expressing properly folded protein to date. Here we present a strategy involving harmonization of codons for successful recombinant expression of full length Pfs48/45 in Escherichia coli. The purified protein, designated CH-rPfs48/45, was recognized by monoclonal antibodies directed against reduction-sensitive conformational epitopes in the native protein. Immunogenicity evaluation in mice revealed potent transmission blocking activity in membrane feeding assays of antisera elicited by CH-rPfs48/45 formulated in three different adjuvants, i.e. Alum, Montanide ISA-51 and complete Freund's adjuvant. More importantly, CH-rPfs48/45 formulated with Montanide ISA-51 when administered to nonhuman primates (Olive baboons, Papio anubis) resulted in uniformly high antibody responses (ELISA titers >2 million) in all five animals. Sera from these animals displayed greater than 93% blocking activity in membrane feeding assays after a single immunization, reaching nearly complete blocking after a booster dose of the vaccine. The relative ease of expression and induction of potent transmission blocking antibodies in mice and nonhuman primates provide a compelling rationale and basis for development of a CH-rPfs48/45 based malaria transmission blocking vaccine.			Chowdhury, DR (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	nkumar@jhsph.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047089] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI-047089, R01 AI047089] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Collins WE, 2006, AM J TROP MED HYG, V74, P215, DOI 10.4269/ajtmh.2006.74.215; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Dimopoulos G, 2002, CHEM IMMUNOL, V80, P27; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hillier CJ, 2005, INFECT IMMUN, V73, P2109, DOI 10.1128/IAI.73.4.2109-2115.2005; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Kaslow DC, 2002, CHEM IMMUNOL, V80, P287; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; KUMAR N, 1984, MOL BIOCHEM PARASIT, V13, P333, DOI 10.1016/0166-6851(84)90124-5; Kumar N, 2007, CURR SCI INDIA, V92, P1535; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; RENER J, 1983, J EXP MED, V158, P976, DOI 10.1084/jem.158.3.976; Roberts L, 2008, SCIENCE, V322, P26, DOI 10.1126/science.322.5898.26; ROEFFEN W, 1995, AM J TROP MED HYG, V52, P60, DOI 10.4269/ajtmh.1995.52.60; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; WHO, 2008, WHO WORLD MAL REP; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	33	101	108	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6352	10.1371/journal.pone.0006352	http://dx.doi.org/10.1371/journal.pone.0006352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623257	Green Published, Green Submitted, gold			2022-12-25	WOS:000268260100022
J	Thornhill, DJ; Xiang, Y; Fitt, WK; Santos, SR				Thornhill, Daniel J.; Xiang, Yu; Fitt, William K.; Santos, Scott R.			Reef Endemism, Host Specificity and Temporal Stability in Populations of Symbiotic Dinoflagellates from Two Ecologically Dominant Caribbean Corals	PLOS ONE			English	Article								Background: The dinoflagellate genus Symbiodinium forms symbioses with numerous protistan and invertebrate metazoan hosts. However, few data on symbiont genetic structure are available, hindering predictions of how these populations and their host associations will fair in the face of global climate change. Methodology/Principal Findings: Here, Symbiodinium population structure from two of the Caribbean's ecologically dominant scleractinian corals, Montastraea faveolata and M. annularis, was examined. Tagged colonies on Florida Keys and Bahamian (i.e., Exuma Cays) reefs were sampled from 2003 -2005 and their Symbiodinium diversity assessed via internal transcribed spacer 2 (ITS2) rDNA and three Symbiodinium Clade B-specific microsatellite loci. Generally, the majority of host individuals at a site harbored an identical Symbiodinium ITS2 "type'' B1 microsatellite genotype. Notably, symbiont genotypes were largely reef endemic, suggesting a near absence of dispersal between populations. Relative to the Bahamas, sympatric M. faveolata and M. annularis in the Florida Keys harbored unique Symbiodinium populations, implying regional host specificity in these relationships. Furthermore, within-colony Symbiodinium population structure remained stable through time and environmental perturbation, including a prolonged bleaching event in 2005. Conclusions/Significance: Taken together, the population-level endemism, specificity and stability exhibited by Symbiodinium raises concerns about the long-term adaptive capacity and persistence of these symbioses in an uncertain future of climate change.			Thornhill, DJ (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	thornhill.dan@gmail.com	Santos, Scott R/A-7472-2009					Andras JP, 2009, MOL ECOL RESOUR, V9, P989, DOI 10.1111/j.1755-0998.2009.02549.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Bay LK, 2006, MAR BIOL, V149, P1247, DOI 10.1007/s00227-006-0276-6; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; BLANK RJ, 1987, MAR BIOL, V94, P143, DOI 10.1007/BF00392906; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Budd AE, 2004, PALEOBIOLOGY, V30, P396, DOI 10.1666/0094-8373(2004)030<0396:OSBAHW>2.0.CO;2; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Carlon DB, 2008, MOL ECOL RESOUR, V8, P870, DOI 10.1111/j.1755-0998.2008.02095.x; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; CHANG FH, 1983, NEW ZEAL J MAR FRESH, V17, P279, DOI 10.1080/00288330.1983.9516003; CHANG SS, 1983, MAR BIOL, V76, P219, DOI 10.1007/BF00393021; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Coyne JA, 2004, SPECIATION; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Fitt W.K., 1985, PROC 5 TH INT CORAL, V6, P131; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Gou WL, 2003, J EXP MAR BIOL ECOL, V296, P135, DOI 10.1016/S0022-0981(03)00242-9; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Howells EJ, 2009, CORAL REEFS, V28, P215, DOI 10.1007/s00338-008-0450-z; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Kemp DW, 2008, CORAL REEFS, V27, P289, DOI 10.1007/s00338-007-0333-8; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Kirk NL, 2009, MAR BIOL, V156, P1609, DOI 10.1007/s00227-009-1196-z; Kirk NL, 2005, BIOL BULL-US, V209, P227, DOI 10.2307/3593112; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; LOEBLICH AR, 1979, J MAR BIOL ASSOC UK, V59, P195, DOI 10.1017/S0025315400046270; Magalon H, 2006, MAR BIOL, V148, P913, DOI 10.1007/s00227-005-0133-z; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Maruyama T, 1997, MAR BIOL, V127, P473, DOI 10.1007/s002270050035; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; MUSCATINE L, 1979, PROC R SOC SER B-BIO, V204, P131, DOI 10.1098/rspb.1979.0018; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; PFIESTER LA, 1987, DINOFLAGELLATE REPRO, P611; Porto I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002160; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2004, J PHYCOL, V40, P395, DOI 10.1111/j.1529-8817.2004.03186.x; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; Santos SR, 2003, MAR BIOL, V143, P111, DOI 10.1007/s00227-003-1065-0; Santos SR, 2003, BIOL BULL-US, V204, P10, DOI 10.2307/1543491; SCHOENBERG DA, 1980, PROC R SOC SER B-BIO, V207, P405, DOI 10.1098/rspb.1980.0031; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; STEELE RD, 1977, B MAR SCI, V27, P591; STEELE RD, 1975, BIOL BULL, V149, P590, DOI 10.2307/1540389; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Thornhill DJ, 2006, J EXP MAR BIOL ECOL, V338, P50, DOI 10.1016/j.jembe.2006.06.032; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; TRENCH RK, 1979, ANNU REV PLANT PHYS, V30, P485, DOI 10.1146/annurev.pp.30.060179.002413; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857	75	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2009	4	7							e6262	10.1371/journal.pone.0006262	http://dx.doi.org/10.1371/journal.pone.0006262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DR	19603078	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035700010
J	Banks, GT; Bros-Facer, V; Williams, HP; Chia, R; Achilli, F; Bryson, JB; Greensmith, L; Fisher, EMC				Banks, Gareth T.; Bros-Facer, Virginie; Williams, Hazel P.; Chia, Ruth; Achilli, Francesca; Bryson, J. Barney; Greensmith, Linda; Fisher, Elizabeth M. C.			Mutant Glycyl-tRNA Synthetase (Gars) Ameliorates SOD1(G93A) Motor Neuron Degeneration Phenotype but Has Little Affect on Loa Dynein Heavy Chain Mutant Mice	PLOS ONE			English	Article								Background: In humans, mutations in the enzyme glycyl-tRNA synthetase (GARS) cause motor and sensory axon loss in the peripheral nervous system, and clinical phenotypes ranging from Charcot-Marie-Tooth neuropathy to a severe infantile form of spinal muscular atrophy. GARS is ubiquitously expressed and may have functions in addition to its canonical role in protein synthesis through catalyzing the addition of glycine to cognate tRNAs. Methodology/Principal Findings: We have recently described a new mouse model with a point mutation in the Gars gene resulting in a cysteine to arginine change at residue 201. Heterozygous Gars(C201R/+) mice have locomotor and sensory deficits. In an investigation of genetic mutations that lead to death of motor and sensory neurons, we have crossed the Gars(C201R/+) mice to two other mutants: the TgSOD1(G93A) model of human amyotrophic lateral sclerosis and the Legs at odd angles mouse (Dync1h1(Loa)) which has a defect in the heavy chain of the dynein complex. We found the Dync1h1(Loa/+); Gars(C201R/+) double heterozygous mice are more impaired than either parent, and this is may be an additive effect of both mutations. Surprisingly, the Gars(C201R) mutation significantly delayed disease onset in the SOD1(G93A); Gars(C201R/+) double heterozygous mutant mice and increased lifespan by 29% on the genetic background investigated. Conclusions/Significance: These findings raise intriguing possibilities for the study of pathogenetic mechanisms in all three mouse mutant strains.			Banks, GT (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Fisher, Elizabeth MC/C-2168-2008	Chia, Ruth/0000-0002-4709-7423; Fisher, Elizabeth MC/0000-0003-2850-9936; Bryson, J. Barney/0000-0001-5486-0258; Banks, Gareth/0000-0002-8647-667X	MRC [G0601943, G0500288] Funding Source: UKRI; Medical Research Council [G0601943B] Funding Source: researchfish; Medical Research Council [G0601943, G0500288] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Achilli F, 2005, AMYOTROPH LATERAL SC, V6, P111, DOI 10.1080/14660820510035351; ACHILLI F, 2009, DIS MOD MEC IN PRESS; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; BANKS GT, 2008, MAMM GENOME; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc; James PA, 2006, BBA-MOL BASIS DIS, V1762, P986, DOI 10.1016/j.bbadis.2006.04.003; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kawamata H, 2008, J BIOL CHEM, V283, P28321, DOI 10.1074/jbc.M805599200; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kieran D, 2004, NEUROSCIENCE, V125, P427, DOI 10.1016/j.neuroscience.2004.01.046; Kunst CB, 2000, GENOMICS, V70, P181, DOI 10.1006/geno.2000.6379; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Monani UR, 2000, HUM MOL GENET, V9, P2451, DOI 10.1093/hmg/9.16.2451; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Parman Y, 2007, CURR OPIN NEUROL, V20, P542, DOI 10.1097/WCO.0b013e32826fbcb7; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; SKRE H, 1974, CLIN GENET, V6, P98; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Van den Bosch L, 2006, CURR NEUROL NEUROSCI, V6, P423, DOI 10.1007/s11910-996-0024-9; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228	41	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6218	10.1371/journal.pone.0006218	http://dx.doi.org/10.1371/journal.pone.0006218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593442	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035400003
J	Bax, DV; Rodgers, UR; Bilek, MMM; Weiss, AS				Bax, Daniel V.; Rodgers, Ursula R.; Bilek, Marcela M. M.; Weiss, Anthony S.			Cell Adhesion to Tropoelastin Is Mediated via the C-terminal GRKRK Motif and Integrin alpha(V)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTIN-DERIVED PEPTIDES; SMOOTH-MUSCLE; CUTIS LAXA; IN-VIVO; STRUCTURAL-CHANGES; ENDOTHELIAL-CELLS; DISEASE; DOMAIN; MUTATION; BINDS	Elastin fibers are predominantly composed of the secreted monomer tropoelastin. This protein assembly confers elasticity to all vertebrate elastic tissues including arteries, lung, skin, vocal folds, and elastic cartilage. In this study we examined the mechanism of cell interactions with recombinant human tropoelastin. Cell adhesion to human tropoelastin was divalent cation-dependent, and the inhibitory anti-integrin alpha(V)beta(3) antibody LM609 inhibited cell spreading on tropoelastin, identifying integrin alpha(V)beta(3) as the major fibroblast cell surface receptor for human tropoelastin. Cell adhesion was unaffected by lactose and heparin sulfate, indicating that the elastin-binding protein and cell surface glycosaminoglycans are not involved. The C-terminal GRKRK motif of tropoelastin can bind to cells in a divalent cation-dependent manner, identifying this as an integrin binding motif required for cell adhesion.	[Bax, Daniel V.; Rodgers, Ursula R.; Weiss, Anthony S.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Bax, Daniel V.; Bilek, Marcela M. M.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Bax, DV (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Bldg G08, Sydney, NSW 2006, Australia.	dbax@usyd.edu.au	Weiss, Anthony S/F-8103-2010; Weiss, Anthony S/GYV-0157-2022	Weiss, Anthony S/0000-0002-8106-4836; Bilek, Marcela/0000-0003-3363-2664	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council.	Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; AOTA S, 1994, J BIOL CHEM, V269, P24756; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Broekelmann TJ, 2008, MATRIX BIOL, V27, P631, DOI 10.1016/j.matbio.2008.06.001; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; DAVIS EC, 1993, CELL TISSUE RES, V272, P211, DOI 10.1007/BF00302726; Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007; Gibson MA, 1999, J BIOL CHEM, V274, P13060, DOI 10.1074/jbc.274.19.13060; GREEN LJ, 1999, ADV MOL CEL, V28, P3; Greiling D, 1997, J CELL SCI, V110, P861; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; HUMPHRIES MJ, 1998, CURR PROT CELL BIOL; Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407; Jung S, 1998, J NEUROPATH EXP NEUR, V57, P439, DOI 10.1097/00005072-199805000-00007; Karnik SK, 2003, MATRIX BIOL, V22, P409, DOI 10.1016/S0945-053X(03)00076-3; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kelleher CM, 2005, AM J RESP CELL MOL, V33, P355, DOI 10.1165/rcmb.2005-0206OC; Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Lemaire R, 2007, J BIOL CHEM, V282, P800, DOI 10.1074/jbc.M609692200; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mould AP, 1996, J CELL SCI, V109, P2613; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Newham P, 1996, MOL MED TODAY, V2, P304, DOI 10.1016/1357-4310(96)10021-6; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Ramirez F, 2000, MATRIX BIOL, V19, P455, DOI 10.1016/S0945-053X(00)00098-6; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022; Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002; Rodriguez-Revenga L, 2004, ARCH DERMATOL, V140, P1135, DOI 10.1001/archderm.140.9.1135; SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	46	128	135	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28616	28623		10.1074/jbc.M109.017525	http://dx.doi.org/10.1074/jbc.M109.017525			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19617625	Green Published, hybrid			2022-12-25	WOS:000270678900016
J	Castel, AL; Tomkinson, AE; Pearson, CE				Castel, Arturo Lopez; Tomkinson, Alan E.; Pearson, Christopher E.			CTG/CAG Repeat Instability Is Modulated by the Levels of Human DNA Ligase I and Its Interaction with Proliferating Cell Nuclear Antigen A DISTINCTION BETWEEN REPLICATION AND SLIPPED-DNA REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN MISMATCH REPAIR; POLYMERASE-DELTA; CAG REPEAT; STRAIN 46BR; TRINUCLEOTIDE REPEAT; STRUCTURAL BASIS; HUMAN PROTEINS; FREE-EXTRACTS; CLAMP LOADER	Mechanisms contributing to disease-associated trinucleotide repeat instability are poorly understood. DNA ligation is an essential step common to replication and repair, both potential sources of repeat instability. Using derivatives of DNA ligase I (hLigI)-deficient human cells (46BR.1G1), we assessed the effect of hLigI activity, overexpression, and its interaction with proliferating cell nuclear antigen (PCNA) upon the ability to replicate and repair trinucleotide repeats. Compared with LigI(+/+), replication progression through repeats was poor, and repair tracts were broadened beyond the slipped-repeat for all mutant extracts. Increased repeat instability was linked only to hLigI overexpression and expression of a mutant hLigI incapable of interacting with PCNA. The endogenous mutant version of hLigI with reduced ligation activity did not alter instability. We distinguished the DNA processes through which hLigI contributes to trinucleotide instability. The highest levels of repeat instability were observed under the hLigI overexpression and were linked to reduced slipped-DNAs repair efficiencies. Therefore, the replication-mediated instability can partly be attributed to errors during replication but also to the poor repair of slipped-DNAs formed during this process. However, repair efficiencies were unaffected by expression of a PCNA interaction mutant of hLigI, limiting this instability to the replication process. The addition of purified proteins suggests that disruption of LigI and PCNA interactions influences trinucleotide repeat instability. The variable levels of age- and tissue-specific trinucleotide repeat instability observed in myotonic dystrophy patients and transgenic mice may be influenced by varying steady state levels of DNA ligase I in these tissues and during different developmental windows.	Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Pearson, Christopher E.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; [Tomkinson, Alan E.] Univ Maryland, Sch Med, Radiat Oncol Res Lab, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Tomkinson, Alan E.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pearson, CE (corresponding author), Hosp Sick Children, Dept Genet & Genome Biol, TMDT Bldg,101 Coll St,E Tower,15th Floor,Rm 15-31, Toronto, ON M5G 1L7, Canada.	cepearson.Sickkids@gmail.com	Castel, Arturo López/AAL-9778-2020	Pearson, Christopher/0000-0001-9545-4205	National Institutes of Health [GM57479]; The Hospital for Sick Children; Canadian Institutes of Health Research; Muscular Dystrophy Association U. S. A; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hospital for Sick Children; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association U. S. A(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57479 (to A. T.).; Supported by a RESTRACOMP postdoctoral fellowship (The Hospital for Sick Children) and by grants to Christopher Pearson from the Canadian Institutes of Health Research and the Muscular Dystrophy Association U. S. A.	Araujo SJ, 2000, GENE DEV, V14, P349; Baida A, 2003, DNA REPAIR, V2, P827, DOI 10.1016/S1568-7864(03)00069-7; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; Bentley DJ, 2002, J CELL SCI, V115, P1551; Bhagwat AS, 1999, NUCLEIC ACIDS RES, V27, P4028, DOI 10.1093/nar/27.20.4028; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Corrette-Bennett SE, 2004, NUCLEIC ACIDS RES, V32, P6268, DOI 10.1093/nar/gkh965; Ferrari G, 2003, J BIOL CHEM, V278, P37761, DOI 10.1074/jbc.M304462200; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Goetz JDM, 2005, DNA REPAIR, V4, P649, DOI 10.1016/j.dnarep.2005.02.004; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Harrison C, 2002, CANCER RES, V62, P4065; HENDERSON LM, 1985, P NATL ACAD SCI USA, V82, P2044, DOI 10.1073/pnas.82.7.2044; Ireland MJ, 2000, GENETICS, V155, P1657; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; Jessberger R, 1997, NUCLEIC ACIDS RES, V25, P289, DOI 10.1093/nar/25.2.289; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kokoska RJ, 1999, GENETICS, V151, P511; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lee YCA, 2008, INT J CANCER, V122, P1630, DOI 10.1002/ijc.23274; LEHMANN AR, 1988, CANCER RES, V48, P6343; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Longley MJ, 1997, J BIOL CHEM, V272, P10917; LONN U, 1989, CARCINOGENESIS, V10, P981, DOI 10.1093/carcin/10.6.981; Lopez A, 2005, MUTAT RES-FUND MOL M, V570, P253, DOI 10.1016/j.mrfmmm.2004.11.005; Mackenney VJ, 1997, J BIOL CHEM, V272, P11550; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Martin IV, 2002, GENOME BIOL, V3; Mayanagia K, 2009, P NATL ACAD SCI USA, V106, P4647, DOI 10.1073/pnas.0811196106; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Mirkin SM, 2005, NAT STRUCT MOL BIOL, V12, P635, DOI 10.1038/nsmb0805-635; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; MONTECUCCO A, 1992, NUCLEIC ACIDS RES, V20, P6209, DOI 10.1093/nar/20.23.6209; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; Mossi R, 1998, J BIOL CHEM, V273, P14322, DOI 10.1074/jbc.273.23.14322; NOCENTINI S, 1981, CHROMOSOME DAMAGE RE, P329; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; Panigrahi GB, 2002, J BIOL CHEM, V277, P13926, DOI 10.1074/jbc.M109761200; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; POIRIER V, 1985, CARCINOGENESIS, V6, P837, DOI 10.1093/carcin/6.6.837; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Ramsden DA, 1997, NATURE, V388, P488, DOI 10.1038/41351; Refsland EW, 2005, GENETICS, V171, P923, DOI 10.1534/genetics.105.043448; Riva F, 2004, EXP CELL RES, V293, P357, DOI 10.1016/j.yexcr.2003.10.025; Rossi R, 1999, EMBO J, V18, P5745, DOI 10.1093/emboj/18.20.5745; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Savouret C, 2004, MOL CELL BIOL, V24, P629, DOI 10.1128/MCB.24.2.629-637.2004; Schweitzer JK, 1999, GENETICS, V152, P953; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; SOMIA NV, 1993, MUTAT RES, V294, P51, DOI 10.1016/0921-8777(93)90057-N; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; SQUIRES S, 1983, CARCINOGENESIS, V4, P565, DOI 10.1093/carcin/4.5.565; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Sun DY, 2001, CLIN CANCER RES, V7, P4143; TEO IA, 1983, CARCINOGENESIS, V4, P559, DOI 10.1093/carcin/4.5.559; TEO IA, 1983, MUTAT RES, V107, P371, DOI 10.1016/0027-5107(83)90177-X; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Veeraraghavan J, 2003, J BIOL CHEM, V278, P42854, DOI 10.1074/jbc.M305137200; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Vispe S, 2000, J BIOL CHEM, V275, P27386; Vitolo B, 2005, EUR J HISTOCHEM, V49, P349; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wu XH, 1999, BIOCHEMISTRY-US, V38, P2628, DOI 10.1021/bi982592s; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025; YANG SW, 1992, J BIOL CHEM, V267, P2345; Yang Z, 2003, AM J HUM GENET, V73, P1092, DOI 10.1086/379523; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	94	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26631	26645		10.1074/jbc.M109.034405	http://dx.doi.org/10.1074/jbc.M109.034405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19628465	Green Published, hybrid			2022-12-25	WOS:000269969600044
J	Djakovic, SN; Schwarz, LA; Barylko, B; DeMartino, GN; Patrick, GN				Djakovic, Stevan N.; Schwarz, Lindsay A.; Barylko, Barbara; DeMartino, George N.; Patrick, Gentry N.			Regulation of the Proteasome by Neuronal Activity and Calcium/Calmodulin-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; 26 S PROTEASOME; SYNAPTIC PLASTICITY; DENDRITIC SPINES; ORNITHINE-DECARBOXYLASE; HIPPOCAMPAL-NEURONS; FLUORESCENT PROTEIN; SURFACE EXPRESSION; UBIQUITIN SYSTEM; GAMMA-INTERFERON	Protein degradation via the ubiquitin proteasome system has been shown to regulate changes in synaptic strength that underlie multiple forms of synaptic plasticity. It is plausible, therefore, that the ubiquitin proteasome system is itself regulated by synaptic activity. By utilizing live-cell imaging strategies we report the rapid and dynamic regulation of the proteasome in hippocampal neurons by synaptic activity. We find that the blockade of action potentials (APs) with tetrodotoxin inhibited the activity of the proteasome, whereas the up-regulation of APs with bicuculline dramatically increased the activity of the proteasome. In addition, the regulation of the proteasome is dependent upon external calcium entry in part through N-methyl-D-aspartate receptors and L-type voltage-gated calcium channels and requires the activity of calcium/calmodulin-dependent protein kinase II (CaMKII). Using in vitro and in vivo assays we find that CaMKII stimulates proteasome activity and directly phosphorylates Rpt6, a subunit of the 19 S (PA700) sub-complex of the 26 S proteasome. Our data provide a novel mechanism whereby CaMKII may regulate the proteasome in neurons to facilitate remodeling of synaptic connections through protein degradation.	[Patrick, Gentry N.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas	Patrick, GN (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gpatrick@ucsd.edu	Schwarz, Lindsay/N-8125-2018	Schwarz, Lindsay/0000-0002-0613-5518	National Institutes of Health [DK46181, NS054732]; University of California San Diego; National Science Foundation; Ray Thomas Edwards Foundation; American Cancer Society [IRG-07-002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046181, R01DK046181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego(University of California System); National Science Foundation(National Science Foundation (NSF)); Ray Thomas Edwards Foundation; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK46181 (to G. N. D.) and NS054732 (to G. N. P.).; Supported by a University of California San Diego Neuroplasticity of Aging training grant.; Supported by a National Science Foundation graduate student fellowship.; Supported by the Ray Thomas Edwards Foundation, American Cancer Society Grant IRG-07-002, and University of California San Diego Startup funds.	Aizawa H, 1996, BIOCHEM BIOPH RES CO, V218, P224, DOI 10.1006/bbrc.1996.0039; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Blackstone C, 2002, FRONT BIOSCI, V7, pD872, DOI 10.2741/blacksto; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Cao XH, 2008, NEURON, V60, P353, DOI 10.1016/j.neuron.2008.08.027; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Dong CG, 2008, LEARN MEMORY, V15, P335, DOI 10.1101/lm.984508; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FONG YL, 1989, J BIOL CHEM, V264, P16759; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Haas KF, 2007, MOL CELL NEUROSCI, V35, P64, DOI 10.1016/j.mcn.2007.02.002; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; HENDIL KB, 1995, BIOCHEM J, V305, P245, DOI 10.1042/bj3050245; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoyt MA, 2005, METHOD ENZYMOL, V398, P399, DOI 10.1016/S0076-6879(05)98033-6; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; LUDEMANN R, 1993, J BIOL CHEM, V268, P17413; MA CP, 1994, J BIOL CHEM, V269, P3539; Makhinson M, 1999, J NEUROSCI, V19, P2500; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Mason GGF, 1998, FEBS LETT, V430, P269, DOI 10.1016/S0014-5793(98)00676-0; Mayford M, 2007, CURR OPIN NEUROBIOL, V17, P313, DOI 10.1016/j.conb.2007.05.001; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murray PF, 2002, ARCH BIOCHEM BIOPHYS, V404, P116, DOI 10.1016/S0003-9861(02)00248-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Piccoli G, 2007, J PROTEOME RES, V6, P3203, DOI 10.1021/pr0701308; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; REALINI C, 1995, J BIOL CHEM, V270, P29664; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Santella L, 2005, CELL MOL LIFE SCI, V62, P2405, DOI 10.1007/s00018-005-5083-6; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen H, 2007, J NEUROSCI, V27, P8903, DOI 10.1523/JNEUROSCI.1571-07.2007; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Valverde RHF, 2005, J BIOL CHEM, V280, P30611, DOI 10.1074/jbc.M501880200; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang FX, 2007, PHYSIOLOGY, V22, P373, DOI 10.1152/physiol.00026.2007; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	81	168	170	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26655	26665		10.1074/jbc.M109.021956	http://dx.doi.org/10.1074/jbc.M109.021956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19638347	Green Published, hybrid			2022-12-25	WOS:000269969600046
J	Eggink, D; Langedijk, JPM; Bonvin, AMJJ; Deng, YQ; Lu, M; Berkhout, B; Sanders, RW				Eggink, Dirk; Langedijk, Johannes P. M.; Bonvin, Alexandre M. J. J.; Deng, Yiqun; Lu, Min; Berkhout, Ben; Sanders, Rogier W.			Detailed Mechanistic Insights into HIV-1 Sensitivity to Three Generations of Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; 6-HELIX BUNDLE STRUCTURE; VIRAL MEMBRANE-FUSION; 44 KDA ECTODOMAIN; ENVELOPE GLYCOPROTEIN; BASE-LINE; ANTIRETROVIRAL ACTIVITY; PHENOTYPIC RESISTANCE; REVERSE-TRANSCRIPTASE; ENFUVIRTIDE TREATMENT	Peptides based on the second heptad repeat (HR2) of viral class I fusion proteins are effective inhibitors of virus entry. One such fusion inhibitor has been approved for treatment of human immunodeficiency virus-1 (T20, enfuvirtide). Resistance to T20 usually maps to the peptide binding site in HR1. To better understand fusion inhibitor potency and resistance, we combined virological, computational, and biophysical experiments with comprehensive mutational analyses and tested resistance to T20 and second and third generation inhibitors (T1249 and T2635). We found that most amino acid substitutions caused resistance to the first generation peptide T20. Only charged amino acids caused resistance to T1249, and none caused resistance to T2635. Depending on the drug, we can distinguish four mechanisms of drug resistance: reduced contact, steric obstruction, electrostatic repulsion, and electrostatic attraction. Implications for the design of novel antiviral peptide inhibitors are discussed.	[Eggink, Dirk; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Langedijk, Johannes P. M.] Pepscan Therapeut BV, NL-8423 RC Lelystad, Netherlands; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Deng, Yiqun; Lu, Min] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; Academic Medical Center Amsterdam; Pepscan Therapeutics B.V.; Utrecht University; Cornell University; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,CINIMA, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Bonvin, Alexandre M.J.J./A-5420-2009; Deng, Yiqun/K-7709-2013	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Deng, Yiqun/0000-0002-6838-3779; Eggink, Dirk/0000-0002-4248-6008	National Institutes of Health [AI42382]; AIDS Fund (Amsterdam) [2005021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042382, R21AI042382, R01AI042382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Fund (Amsterdam); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI42382 (to M. L.). This work was also supported in part by AIDS Fund (Amsterdam) Grant 2005021 (to B. B.).	Aquaro S, 2006, J ANTIMICROB CHEMOTH, V58, P714, DOI 10.1093/jac/dkl306; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; CANTOR C, 1980, BIOPHYSICAL CHEM 3, P1131; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chinnadurai R, 2005, AIDS, V19, P1401, DOI 10.1097/01.aids.0000180785.25800.de; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cladera J, 1999, J BIOL CHEM, V274, P29951, DOI 10.1074/jbc.274.42.29951; Das AT, 1999, J VIROL, V73, P81, DOI 10.1128/JVI.73.1.81-91.1999; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DECROLY E, 1994, J BIOL CHEM, V269, P12240; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P3377, DOI 10.1128/AAC.47.11.3377-3383.2003; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P547, DOI 10.1021/bi00854a024; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jacobs A, 2008, VACCINE, V26, P3026, DOI 10.1016/j.vaccine.2007.12.026; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Keulen W, 1996, ANTIVIR RES, V31, P45, DOI 10.1016/0166-3542(96)00944-8; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Mahalingam B, 1999, EUR J BIOCHEM, V263, P238, DOI 10.1046/j.1432-1327.1999.00514.x; Do Canto AMTM, 2008, J PEPT SCI, V14, P442, DOI 10.1002/psc.982; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Menzo S, 2004, MICROBIOLOGICA, V27, P51; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Ou W, 2005, J VIROL, V79, P4782, DOI 10.1128/JVI.79.8.4782-4792.2005; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; SANDERS RW, 2002, HIV SEQUENCE COMPEND, P43; Shu W, 1999, BIOCHEMISTRY-US, V38, P5378, DOI 10.1021/bi990199w; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Trivedi VD, 2003, PROTEIN ENG, V16, P311, DOI 10.1093/proeng/gzg036; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005; Zhu JQ, 2005, J MOL BIOL, V354, P601, DOI 10.1016/j.jmb.2005.08.078	74	66	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26941	26950		10.1074/jbc.M109.004416	http://dx.doi.org/10.1074/jbc.M109.004416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19617355	Green Published, hybrid			2022-12-25	WOS:000269969600074
J	Dobroff, AS; Wang, H; Melnikova, VO; Villares, GJ; Zigler, M; Huang, L; Bar-Eli, M				Dobroff, Andrey S.; Wang, Hua; Melnikova, Vladislava O.; Villares, Gabriel J.; Zigler, Maya; Huang, Li; Bar-Eli, Menashe			Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOGENIC FACTOR CYR61; CHAIN FV FRAGMENT; LUNG-CANCER CELLS; BREAST-CANCER; CCN FAMILY; TRANSCRIPTIONAL REGULATION; MALIGNANT-MELANOMA; DOWN-REGULATION; GROWTH-FACTOR; EXPRESSION	Metastatic progression of melanoma is associated with overexpression and activity of cAMP-response element-binding protein (CREB). However, the mechanism by which CREB contributes to tumor progression and metastasis remains unclear. Here, we demonstrate that stably silencing CREB expression in two human metastatic melanoma cell lines, A375SM and C8161-c9, suppresses tumor growth and experimental metastasis. Analysis of cDNA microarrays revealed that CREB silencing leads to increased expression of cysteine-rich protein 61 (CCN1/CYR61) known to mediate adhesion, chemostasis, survival, and angiogenesis. Promoter analysis and chromatin immunoprecipitation assays demonstrated that CREB acts as a negative regulator of CCN1/CYR61 transcription by directly binding to its promoter. Re-expression of CREB in CREB-silenced cells rescued the low CCN1/CYR61 expression phenotype. CCN1/CYR61 overexpression resulted in reduced tumor growth and metastasis and inhibited the activity of matrix metalloproteinase-2. Furthermore, its overexpression decreased melanoma cell motility and invasion through Matrigel, which was abrogated by silencing CCN1/CYR61 in low metastatic melanoma cells. Moreover, a significant decrease in angiogenesis as well as an increase in apoptosis was seen in tumors overexpressing CCN1/CYR61. Our results demonstrate that CREB promotes melanoma growth and metastasis by down-regulating CCN1/CYR61 expression, which acts as a suppressor of melanoma cell motility, invasion and angiogenesis.	[Dobroff, Andrey S.; Wang, Hua; Melnikova, Vladislava O.; Villares, Gabriel J.; Zigler, Maya; Huang, Li; Bar-Eli, Menashe] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bar-Eli, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 173,1515 Holcombe Blvd, Houston, TX 77030 USA.	mbareli@mdanderson.org	Dobroff, Andrey/A-9814-2016	Dobroff, Andrey/0000-0003-2162-9951	National Institute of Health [CA76098]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil); NATIONAL CANCER INSTITUTE [R01CA076098] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grant CA76098 (to M. B.-E.). This work was also supported by a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) (to A. S. D.).	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Aucoin R, 2004, J CELL BIOCHEM, V93, P215, DOI 10.1002/jcb.20231; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; de Braud F, 2003, CRIT REV ONCOL HEMAT, V47, P35, DOI 10.1016/S1040-8428(02)00077-X; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Gershenwald JE, 2001, ONCOGENE, V20, P3363, DOI 10.1038/sj.onc.1204450; Hofmann UB, 2003, CANCER RES, V63, P8221; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Holloway SE, 2005, J AM COLL SURGEONS, V200, P371, DOI 10.1016/j.jamcollsurg.2004.10.005; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leslie MC, 2007, GENE THER, V14, P316, DOI 10.1038/sj.gt.3302864; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Maeta N, 2007, ONCOLOGY-BASEL, V73, P118, DOI 10.1159/000121000; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald SL, 2004, CANCER BIOL THER, V3, P110, DOI 10.4161/cbt.3.1.662; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Mitra Aparna, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P167, DOI 10.1615/JEnvPathToxOncol.v22.i3.20; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nyormoi O, 2003, CLIN EXP METASTAS, V20, P251, DOI 10.1023/A:1022991302172; O'Kelly J, 2008, INT J ONCOL, V33, P59; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P103, DOI 10.1136/mp.54.2.103; Pilarsky CP, 1998, PROSTATE, V36, P85; RUTBERG SE, 1994, MOL CARCINOGEN, V10, P82, DOI 10.1002/mc.2940100205; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith AP, 2004, CANCER BIOL THER, V3, P104, DOI 10.4161/cbt.3.1.661; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; VERSCHRAEGEN CF, 1991, ANTICANCER RES, V11, P529; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Walker TM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1719; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; White PC, 2006, ONCOGENE, V25, P2170, DOI 10.1038/sj.onc.1209255; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie D, 2001, CANCER RES, V61, P8917; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Yang YM, 1996, ONCOGENE, V12, P2223; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	58	68	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26194	26206		10.1074/jbc.M109.019836	http://dx.doi.org/10.1074/jbc.M109.019836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19632997	Green Published, hybrid			2022-12-25	WOS:000269738000074
J	Huang, GR; Zhang, Y; Kim, B; Ge, GX; Annis, DS; Mosher, DF; Greenspan, DS				Huang, Guorui; Zhang, Yue; Kim, Byoungjae; Ge, Gaoxiang; Annis, Douglas S.; Mosher, Deane F.; Greenspan, Daniel S.			Fibronectin Binds and Enhances the Activity of Bone Morphogenetic Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; EXTRACELLULAR-MATRIX; PLASMA FIBRONECTIN; LYSYL OXIDASE; FIBROGENIC CELLS; METALLOPROTEINASES; COLLAGEN; FAMILY; FIBRILLOGENESIS; POLYMERIZATION	Bone morphogenetic protein-1-like proteinases play key roles in formation of the extracellular matrix (ECM) in vertebrates via biosynthetic processing of precursors into mature functional proteins involved in ECM assembly. Such processing includes proteolytic activation of the zymogen for lysyl oxidase. Fibronectin (FN) is an abundant protein component of the ECM that is capable of regulating manifold cellular functions through its interactions with various ECM and cell surface proteins. It was previously shown that proteolytic activation of lysyl oxidase is much reduced in cultures of FN-null mouse embryo fibroblasts (MEFs). Here we demonstrate that cellular fibronectin, the form produced by fibroblasts and various other tissue cell types, and plasma fibronectin bind BMP1 with dissociation constants (K-D) of similar to 100 nM, consistent with a physiological role. Also consistent with such a role, cellular fibronectin FN is shown to positively regulate BMP1 processing activity against Chordin, probiglycan, and type I procollagen in vitro. Endogenous FN and BMP1 are demonstrated to co-localize in cell layers and to form complexes in culture medium. In addition, processing of endogenous BMP1 substrates Chordin, probiglycan, and procollagen is demonstrated to be strikingly reduced in cultures of FN-/- MEFs compared with FN+/- MEF cultures despite similar levels of endogenous BMP1. These data support the conclusion that FN binds BMP1-like proteinases in vivo and that FN is an important determinant of the in vivo activity levels of BMP1-like proteinases.	[Huang, Guorui; Zhang, Yue; Kim, Byoungjae; Ge, Gaoxiang; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Zhang, Yue; Greenspan, Daniel S.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Greenspan, Daniel S.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Greenspan, DS (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 1300 Univ Ave, Madison, WI 53706 USA.	dsgreens@wisc.edu	Huang, Guorui/M-9641-2013		National Institutes of Health [GM71679, AR53815]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM71679 and AR53815 (to D. S. G.).	AKIYAMA SK, 1985, J BIOL CHEM, V260, P4492; ALLIO AE, 1988, J CELL PHYSIOL, V135, P459, DOI 10.1002/jcp.1041350313; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; BIDANSET DJ, 1992, J CELL BIOL, V118, P1523, DOI 10.1083/jcb.118.6.1523; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Coito A J, 2000, Dev Immunol, V7, P239, DOI 10.1155/2000/98187; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; HAUTANEN A, 1989, J BIOL CHEM, V264, P1437; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hynes RO, 1990, FIBRONECTINS; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; JOHANSSON S, 1980, BIOCHEM J, V187, P521, DOI 10.1042/bj1870521; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mitrovic S, 1995, Srp Arh Celok Lek, V123, P198; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; PROCKOP DJ, 1994, EXTRACELLULAR MATRIX, P47; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; SEKIGUCHI K, 1986, BIOCHEMISTRY-US, V25, P4936, DOI 10.1021/bi00365a032; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	49	65	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25879	25888		10.1074/jbc.M109.024125	http://dx.doi.org/10.1074/jbc.M109.024125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617627	hybrid, Green Published			2022-12-25	WOS:000269738000045
J	Koliwad, SK; Kuo, TY; Shipp, LE; Gray, NE; Backhed, F; So, AYL; Farese, RV; Wang, JC				Koliwad, Suneil K.; Kuo, Taiyi; Shipp, Lauren E.; Gray, Nora E.; Backhed, Fredrik; So, Alex Yick-Lun; Farese, Robert V., Jr.; Wang, Jen-Chywan			Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; PROTEIN-4; GENE; MICE; CHROMATIN; HYPERLIPIDEMIA; ANGIOGENESIS; OBESITY; PLASMA; DIET	Glucocorticoids are important regulators of lipid homeostasis, and chronically elevated glucocorticoid levels induce hypertriglyceridemia, hepatic steatosis, and visceral obesity. The occupied glucocorticoid receptor (GR) is a transcription factor. However, those genes regulating lipid metabolism under GR control are not fully known. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor), a protein inhibitor of lipoprotein lipase, is synthesized and secreted during fasting, when circulating glucocorticoid levels are physiologically increased. We therefore tested whether the ANGPTL4 gene (Angptl4) is transcriptionally controlled by GR. We show that treatment with the synthetic glucocorticoid dexamethasone increased Angptl4 mRNA levels in primary hepatocytes and adipocytes (2-3-fold) and in the livers and white adipose tissue of mice (similar to 4-fold). We tested the mechanism of this increase in H4IIE hepatoma cells and found that dexamethasone treatment increased the transcriptional rate of Angptl4. Using bioinformatics and chromatin immunoprecipitation, we identified a GR binding site with in the rat Angptl4 sequence. A reporter plasmid containing this site was markedly activated by dexamethasone, indicative of a functional glucocorticoid response element. Dexamethasone treatment also increased histone H4 acetylation and DNase I accessibility in genomic regions near this site, further supporting that it is a glucocorticoid response element. Glucocorticoids promote the flux of triglycerides from white adipose tissue to liver. We found that mice lacking ANGPTL4 (Angptl4(-/-)) had reductions in dexamethasone-induced hypertriglyceridemia and hepatic steatosis, suggesting that ANGPTL4 is required for this flux. Overall, we establish that ANGPTL4 is a direct GR target that participates in glucocorticoid-regulated triglyceride metabolism.	[Koliwad, Suneil K.; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Koliwad, Suneil K.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [So, Alex Yick-Lun] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Koliwad, Suneil K.; Farese, Robert V., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kuo, Taiyi; Shipp, Lauren E.; Gray, Nora E.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, SE-41345 Gothenburg, Sweden	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of Gothenburg; University of Gothenburg	Wang, JC (corresponding author), Morgan Hall,Rm 315, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Backhed, Fredrik/ABE-6613-2020; Wang, Jen-Chywan/AAX-4445-2020	Backhed, Fredrik/0000-0002-4871-8818; Wang, Jen-Chywan/0000-0001-6030-6886; Kuo, Taiyi/0000-0001-6167-0284	American Heart Association Beginning [0565157Y]; A. P. Giannini Foundation Fellowship	American Heart Association Beginning(American Heart Association); A. P. Giannini Foundation Fellowship	This work was supported by American Heart Association Beginning Grant-in-aid 0565157Y ( to J.C.W.) and an A. P. Giannini Foundation Fellowship ( to S. K. K.).	Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Deblois G, 2008, MOL ENDOCRINOL, V22, P1999, DOI 10.1210/me.2007-0546; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dolinsky VW, 2004, BIOCHEM J, V378, P967, DOI 10.1042/BJ20031320; Fletcher TM, 2000, MOL CELL BIOL, V20, P6466, DOI 10.1128/MCB.20.17.6466-6475.2000; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; SNYDER F, 1959, BIOCHIM BIOPHYS ACTA, V34, P244; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	39	126	131	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25593	25601		10.1074/jbc.M109.025452	http://dx.doi.org/10.1074/jbc.M109.025452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628874	Green Published, hybrid			2022-12-25	WOS:000269738000017
J	Lubelski, J; Khusainov, R; Kuipers, OP				Lubelski, Jacek; Khusainov, Rustem; Kuipers, Oscar P.			Directionality and Coordination of Dehydration and Ring Formation during Biosynthesis of the Lantibiotic Nisin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS; POSTTRANSLATIONAL MODIFICATION; PEPTIDES; TRANSPORTER; PRENISIN; CYCLASE; LACTOBACILLUS; RESIDUES; IMMUNITY; COMPLEX	The lantibiotic nisin is a potent antimicrobial substance, which contains unusual lanthionine rings and dehydrated amino acid residues and is produced by Lactococcus lactis. Recently, the nisin biosynthetic machinery has been applied to introduce lanthionine rings in peptides other than nisin with potential therapeutic use. Due to difficulties in the isolation of the proposed synthetase complex (NisBTC), mechanistic information concerning the enzymatic biosynthesis of nisin is scarce. Here, we present the molecular characterization of a number of nisin mutants that affect ring formation. We have investigated in a systematic manner how these mutations influence dehydration events, which are performed enzymatically by the dehydratase NisB. Specific mutations that hampered ring formation allowed for the dehydration of serine residues that directly follow the rings and are normally unmodified. The combined information leads to the conclusion that 1) nisin biosynthesis is an organized directional process that starts at the N terminus of the molecule and continues toward the C terminus, and 2) NisB and NisC are alternating enzymes, whose activities follow one after another in a repetitive way. Thus, the dehydration and cyclization processes are not separated in time and space. On the basis of these results and previous knowledge, a working model for the sequence of events in the maturation of nisin is proposed.	[Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, NL-9751 NN Haren, Netherlands; Kluyver Ctr Genom Ind Fermentat, NL-9751 NN Haren, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Dept Mol Genet, Kerklaan 30, NL-9751 NN Haren, Netherlands.	o.p.kuipers@rug.nl	Lubelski, Jacek/D-8639-2013; Khusainov, Rustem/E-1859-2012; Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735	Stichtling Technische Wetenschnappen [6927]; Aarden Levenswetenschappen-Nederlandse Organisatie voor Wetenschappelijk Onderzoek [816.02.005]	Stichtling Technische Wetenschnappen; Aarden Levenswetenschappen-Nederlandse Organisatie voor Wetenschappelijk Onderzoek	Supported by a grant from Stichtling Technische Wetenschnappen, Project 6927.; Supported by a grant from Aarden Levenswetenschappen-Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Project 816.02.005.	Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; ENGELKE G, 1992, APPL ENVIRON MICROB, V58, P3730, DOI 10.1128/AEM.58.11.3730-3743.1992; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Kluskens LD, 2005, BIOCHEMISTRY-US, V44, P12827, DOI 10.1021/bi050805p; Kluskens LD, 2009, J PHARMACOL EXP THER, V328, P849, DOI 10.1124/jpet.108.146431; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Kuipers A, 2006, APPL ENVIRON MICROB, V72, P7626, DOI 10.1128/AEM.01802-06; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li B, 2007, J BIOL CHEM, V282, P21169, DOI 10.1074/jbc.M701802200; Li B, 2009, METHOD ENZYMOL, V458, P533, DOI 10.1016/S0076-6879(09)04821-6; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2008, APPL ENVIRON MICROB, V74, P4680, DOI 10.1128/AEM.00112-08; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rink R, 2007, BIOCHEMISTRY-US, V46, P13179, DOI 10.1021/bi700106z; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; Rink R, 2007, APPL ENVIRON MICROB, V73, P1792, DOI 10.1128/AEM.02350-06; Rogers LA, 1928, J BACTERIOL, V16, P321, DOI 10.1128/JB.16.5.321-325.1928; Sambrook J., 2002, MOL CLONING LAB MANU; Siegers K, 1996, J BIOL CHEM, V271, P12294, DOI 10.1074/jbc.271.21.12294; van Saparoea HBV, 2008, APPL ENVIRON MICROB, V74, P5541, DOI 10.1128/AEM.00342-08	25	64	67	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25962	25972		10.1074/jbc.M109.026690	http://dx.doi.org/10.1074/jbc.M109.026690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19620240	hybrid, Green Published			2022-12-25	WOS:000269738000053
J	Rytinki, MM; Palvimo, JJ				Rytinki, Miia M.; Palvimo, Jorma J.			SUMOylation Attenuates the Function of PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES TRANSCRIPTIONAL REPRESSION; GAMMA COACTIVATOR 1-ALPHA; METABOLIC REGULATOR; ANDROGEN RECEPTOR; MODIFIER-1 SUMO-1; UBIQUITIN; PROTEIN; ACTIVATION; SIRT1; PGC-1	Peroxisome proliferator-activated receptor gamma-coactivator-1 alpha (PGC-1 alpha) is a key coordinator of gene programs in metabolism and energy homeostasis in mammals. It is highly responsive to changes in the cellular environment and physiological status of mammals and regulated by post-translational modifications: acetylation, phosphorylation, and methylation. Here, we show that PGC-1 alpha is covalently modified by small ubiquitin-like modifier (SUMO) 1 protein, an important regulator of signaling and transcription. Conserved lysine residue 183 located in the activation domain of PGC-1 alpha was identified as the major site of SUMO conjugation. Interestingly, the same Lys residue is also a target for acetylation. Therefore, the E185A mutation disrupting the SUMOylation consensus sequence was utilized to show that SUMOylation plays a role in the regulation of PGC-1 alpha function. Our results show that SUMOylation does not have an apparent effect on the subcellular localization or the stability of PGC-1 alpha, but it attenuates the transcriptional activity of the coactivator, probably by enhancing the interaction of PGC-1 alpha with corepressor RIP140. Mutation that abolished the SUMOylation augments the activity of PGC-1 alpha also in the context of PPAR gamma-dependent transcription. Thus, our findings showing that reversible SUMOylation can adjust the activity of PGC-1 alpha add a novel layer to the regulation of the coactivator.	[Rytinki, Miia M.; Palvimo, Jorma J.] Univ Kuopio, Inst Biomed Med Biochem, FI-70211 Kuopio, Finland	University of Eastern Finland	Palvimo, JJ (corresponding author), Univ Kuopio, Inst Biomed Med Biochem, POB 1627, FI-70211 Kuopio, Finland.	jorma.palvimo@uku.fi		Palvimo, Jorma/0000-0003-2373-0578	Academy of Finland; Finnish Cancer Foundation; Sigrid Juselius Foundation; Kuopio Graduate School of Molecular Medicine; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio Graduate School of Molecular Medicine; Emil Aaltonen Foundation	This work was supported by the Academy of Finland, the Finnish Cancer Foundation, the Sigrid Juselius Foundation, the Kuopio Graduate School of Molecular Medicine, and the Emil Aaltonen Foundation.	Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; HALLBERG M, 2008, MOL CELL BIOL; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; KAIKKONEN S, 2008, MOL ENDOCRINOL; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Spengler ML, 2005, CELL SIGNAL, V17, P153, DOI 10.1016/j.cellsig.2004.06.007; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Vertegaal ACO, 2007, BIOCHEM SOC T, V35, P1422, DOI 10.1042/BST0351422; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	50	79	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26184	26193		10.1074/jbc.M109.038943	http://dx.doi.org/10.1074/jbc.M109.038943			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19625249	Green Published, hybrid			2022-12-25	WOS:000269738000073
J	Zhang, G; Wang, XL; Sheng, H; Xie, XH; He, YX; Yao, XS; Li, ZR; Lee, KM; He, W; Leung, KS; Qin, L				Zhang, Ge; Wang, Xin-Luan; Sheng, Hui; Xie, Xin-Hui; He, Yi-Xin; Yao, Xin-Sheng; Li, Zi-Rong; Lee, Kwong-Man; He, Wei; Leung, Kwok-Sui; Qin, Ling			Constitutional Flavonoids Derived from Epimedium Dose-Dependently Reduce Incidence of Steroid-Associated Osteonecrosis Not via Direct Action by Themselves on Potential Cellular Targets	PLOS ONE			English	Article							BONE-MARROW; MECHANISM; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INHIBITION; THROMBOSIS; ICARITIN; CULTURES	Intravascular-thrombosis and extravascular-lipid-deposit are the two key pathogenic events considered to interrupt intraosseous blood supply during development of steroid-associated osteonecrosis ( ON). However, there are no clinically employed agents capable of simultaneously targeting these two key pathogenic events. The present experimental study demonstrated that constitutional flavonoid glycosides derived from herb Epimedium (EF, composed of seven flavonoid compounds with common stem nuclear) exerted dose-dependent effect on inhibition of both thrombosis and lipid-deposition and accordingly reducing incidence of steroid-associated ON in rabbits, which was not via direct action by themselves rather by their common metabolite on potential cellular targets involved in the two pathogenic pathways. The underlying mechanism could be explained by counteracting endothelium injury and excessive adipogenesis. These findings encourage designing clinical trials to investigate potential of EF in prevention of steroid-associated ON.			Zhang, G (corresponding author), Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	yaoxs@jnu.edu.cn	SHENG, Hui/V-6791-2017; SHENG, Hui/B-6577-2012; Qin, Ling/J-9047-2018; Zhang, Ge/N-4150-2013; Zhang, Ge/K-9118-2019	SHENG, Hui/0000-0003-1430-3224; Qin, Ling/0000-0001-6173-6167; Zhang, Ge/0000-0002-7807-7695; Zhang, Ge/0000-0002-7807-7695				Aaron R. K., 1998, ADULT HIP; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; BENSON RE, 1992, J LAB CLIN MED, V119, P420; BENSON RE, 1991, J IMMUNOASSAY, V12, P371, DOI 10.1080/01971529108055078; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Ejiri S, 2001, TRANSPLANTATION, V71, P721, DOI 10.1097/00007890-200103270-00006; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Glueck CJ, 2001, CLIN ORTHOP RELAT R, P19; Griffith JF, 2005, RADIOLOGY, V235, P168, DOI 10.1148/radiol.2351040100; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; KABATA T, 2000, J NEUROL ORTH MED S, V20, P41; Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7; Li Zi-rong, 2005, Zhonghua Wai Ke Za Zhi, V43, P1048; Lieberman Jay R, 2003, Instr Course Lect, V52, P337; Liu Y, 2003, J ALTERN COMPLEM MED, V9, P631, DOI 10.1089/107555303322524481; Motomura G, 2004, ARTHRITIS RHEUM-US, V50, P3387, DOI 10.1002/art.20517; Murase Y, 2006, EUR J PHARMACOL, V538, P1, DOI 10.1016/j.ejphar.2006.03.033; Netti PA, 1996, MICROVASC RES, V52, P27, DOI 10.1006/mvre.1996.0041; Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018; Shen J., 2004, COMPENSATION BENEFIT, V36, P15; Shen P, 2007, J CHROMATOGR B, V857, P47, DOI 10.1016/j.jchromb.2007.06.026; Wang GJ, 2000, CLIN ORTHOP RELAT R, P295, DOI 10.1097/00003086-200001000-00030; Wang X, 2005, COLLOID SURFACE B, V44, P211, DOI 10.1016/j.colsurfb.2005.04.016; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang G, 2007, BONE, V40, P685, DOI 10.1016/j.bone.2006.10.026; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035	29	31	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6419	10.1371/journal.pone.0006419	http://dx.doi.org/10.1371/journal.pone.0006419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641620	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494500020
J	Cornier, MA; Salzberg, AK; Endly, DC; Bessesen, DH; Rojas, DC; Tregellas, JR				Cornier, Marc-Andre; Salzberg, Andrea K.; Endly, Dawnielle C.; Bessesen, Daniel H.; Rojas, Donald C.; Tregellas, Jason R.			The Effects of Overfeeding on the Neuronal Response to Visual Food Cues in Thin and Reduced-Obese Individuals	PLOS ONE			English	Article								Background: The regulation of energy intake is a complex process involving the integration of homeostatic signals and both internal and external sensory inputs. The objective of this study was to examine the effects of short-term overfeeding on the neuronal response to food-related visual stimuli in individuals prone and resistant to weight gain. Methodology/Principal Findings: 22 thin and 19 reduced-obese (RO) individuals were studied. Functional magnetic resonance imaging (fMRI) was performed in the fasted state after two days of eucaloric energy intake and after two days of 30% overfeeding in a counterbalanced design. fMRI was performed while subjects viewed images of foods of high hedonic value and neutral non-food objects. In the eucaloric state, food as compared to non-food images elicited significantly greater activation of insula and inferior visual cortex in thin as compared to RO individuals. Two days of overfeeding led to significant attenuation of not only insula and visual cortex responses but also of hypothalamus response in thin as compared to RO individuals. Conclusions/Significance: These findings emphasize the important role of food-related visual cues in ingestive behavior and suggest that there are important phenotypic differences in the interactions between external visual sensory inputs, energy balance status, and brain regions involved in the regulation of energy intake. Furthermore, alterations in the neuronal response to food cues may relate to the propensity to gain weight.			Cornier, MA (corresponding author), Univ Colorado Denver, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA.	marc.cornier@ucdenver.edu	Rojas, Don/F-4296-2012; Tregellas, Jason/J-3637-2015; Rojas, Don/AAX-6678-2020	Rojas, Don/0000-0001-6560-9616	NCRR NIH HHS [UL1 RR025780, RR016185, K23 RR016185] Funding Source: Medline; NIDDK NIH HHS [DK48520, P30 DK048520, T32 DK007658] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780, K23RR016185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007658, P30DK048520] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Burguera B, 2000, NEUROENDOCRINOLOGY, V71, P187, DOI 10.1159/000054536; Chechlacz M, 2009, DIABETOLOGIA, V52, P524, DOI 10.1007/s00125-008-1253-z; Cornier MA, 2004, APPETITE, V43, P253, DOI 10.1016/j.appet.2004.06.003; Cornier MA, 2007, AM J CLIN NUTR, V86, P965, DOI 10.1093/ajcn/86.4.965; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; DelParigi A, 2004, INT J OBESITY, V28, P370, DOI 10.1038/sj.ijo.0802558; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Gordon CM, 2000, INT J EAT DISORDER, V27, P163, DOI 10.1002/(SICI)1098-108X(200003)27:2&lt;163::AID-EAT4&gt;3.0.CO;2-Y; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hill JO, 2000, MED CLIN N AM, V84, P333, DOI 10.1016/S0025-7125(05)70224-8; Hinton EC, 2004, EUR J NEUROSCI, V20, P1411, DOI 10.1111/j.1460-9568.2004.03589.x; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Le DSNT, 2006, AM J CLIN NUTR, V84, P725, DOI 10.1093/ajcn/84.4.725; Levy LM, 1999, J COMPUT ASSIST TOMO, V23, P499, DOI 10.1097/00004728-199907000-00002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; O'Doherty J, 2000, NEUROREPORT, V11, P399, DOI 10.1097/00001756-200002070-00035; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; ROLLS BJ, 1995, AM J CLIN NUTR, V61, p960S, DOI 10.1093/ajcn/61.4.960S; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; SCHUR EA, 2009, INT J OBES; Schwartz MW, 2006, OBESITY, V14, p1S, DOI 10.1038/oby.2006.275; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; St-Onge MP, 2005, J NUTR, V135, P1014, DOI 10.1093/jn/135.5.1014; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; Vandenbergh J, 2005, GASTROENTEROLOGY, V128, P564, DOI 10.1053/j.gastro.2004.11.054; Wadden TA, 2002, J CONSULT CLIN PSYCH, V70, P510, DOI 10.1037//0022-006X.70.3.510; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Watts AG, 2000, HORM BEHAV, V37, P261, DOI 10.1006/hbeh.2000.1581; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206	48	122	123	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6310	10.1371/journal.pone.0006310	http://dx.doi.org/10.1371/journal.pone.0006310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636426	Green Published, Green Submitted, gold			2022-12-25	WOS:000268404900002
J	Pala, I; Schartl, M; Thorsteinsdottir, S; Coelho, MM				Pala, Irene; Schartl, Manfred; Thorsteinsdottir, Solveig; Coelho, Maria Manuela			Sex Determination in the Squalius alburnoides Complex: An Initial Characterization of Sex Cascade Elements in the Context of a Hybrid Polyploid Genome	PLOS ONE			English	Article							MALE REGULATORY GENE; WILMS-TUMOR GENE; GONADAL DEVELOPMENT; DIMORPHIC EXPRESSION; CONSERVED SYNTENY; DMRT1 EXPRESSION; RAINBOW-TROUT; NILE TILAPIA; TELEOST FISH; WT1 SEQUENCE	Background: Sex determination processes vary widely among different vertebrate taxa, but no group offers as much diversity for the study of the evolution of sex determination as teleost fish. However, the knowledge about sex determination gene cascades is scarce in this species-rich group and further difficulties arise when considering hybrid fish taxa, in which mechanisms exhibited by parental species are often disrupted. Even though hybridisation is frequent among teleosts, gene based approaches on sex determination have seldom been conducted in hybrid fish. The hybrid polyploid complex of Squalius alburnoides was used as a model to address this question. Methodology/Principal Findings: We have initiated the isolation and characterization of regulatory elements (dmrt1, wt1, dax1 and figla) potentially involved in sex determination in S. alburnoides and in the parental species S. pyrenaicus and analysed their expression patterns by in situ hybridisation. In adults, an overall conservation in the cellular localization of the gene transcripts was observed between the hybrids and parental species. Some novel features emerged, such as dmrt1 expression in adult ovaries, and the non-dimorphic expression of figla, an ovarian marker in other species, in gonads of both sexes in S. alburnoides and S. pyrenaicus. The potential contribution of each gene to the sex determination process was assessed based on the timing and location of expression. Dmrt1 and wt1 transcripts were found at early stages of male development in S. alburnoides and are most likely implicated in the process of gonad development. Conclusions/Significance: For the first time in the study of this hybrid complex, it was possible to directly compare the gene expression patterns between the bisexual parental species and the various hybrid forms, for an extended set of genes. The contribution of these genes to gonad integrity maintenance and functionality is apparently unaltered in the hybrids, suggesting that no abrupt shifts in gene expression occurred as a result of hybridisation.			Pala, I (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal.	iapala@fc.ul.pt	Coelho, Maria M/B-8672-2009; Thorsteinsdottir, Solveig/ABG-4504-2021; Thorsteinsdottir, Solveig/M-3561-2013	Coelho, Maria M/0000-0003-3288-1693; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Schartl, Manfred/0000-0001-9882-5948				Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; Brunelli JP, 2001, GENOME, V44, P455, DOI 10.1139/gen-44-3-455; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chun SY, 1999, BIOL REPROD, V60, P365, DOI 10.1095/biolreprod60.2.365; Clipsham R, 2003, MOL GENET METAB, V80, P81, DOI 10.1016/j.ymgme.2003.08.023; Collares-Pereira MJ, 1998, GENET MOL BIOL, V21, P63, DOI 10.1590/S1415-47571998000100011; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Fedorova S, 2008, DEV DYNAM, V237, P2342, DOI 10.1002/dvdy.21687; Ferguson-Smith M, 2007, SEX DEV, V1, P2, DOI 10.1159/000096234; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Guan GJ, 2000, BIOCHEM BIOPH RES CO, V272, P662, DOI 10.1006/bbrc.2000.2840; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Ikeda Y, 2001, DEV DYNAM, V220, P363, DOI 10.1002/dvdy.1116; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Kanamori A, 2000, MOL REPROD DEV, V55, P31, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;31::AID-MRD5&gt;3.0.CO;2-7; KENT J, 1995, ONCOGENE, V11, P1781; Kim J, 1999, MOL CELL BIOL, V19, P2289; Kluver N, 2009, DEV BIOL, V325, P179, DOI 10.1016/j.ydbio.2008.10.009; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Kobayashi T, 2008, DEV DYNAM, V237, P297, DOI 10.1002/dvdy.21409; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Liang LF, 1997, DEVELOPMENT, V124, P4939; Liarte S, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-20; Maldonado LCT, 2002, GEN COMP ENDOCR, V129, P20, DOI 10.1016/S0016-6480(02)00511-7; Manolakou P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-59; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Martins RST, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-19; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nakamoto M, 2007, MOL REPROD DEV, V74, P1239, DOI 10.1002/mrd.20689; Nakatsuru Y, 2000, GENE, V245, P245, DOI 10.1016/S0378-1119(00)00016-0; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Nanda I, 2000, CYTOGENET CELL GENET, V89, P67, DOI 10.1159/000015567; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Ohno S., 1970, P1; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pala I, 2008, GENE, V410, P249, DOI 10.1016/j.gene.2007.12.018; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Schartl M, 2004, MECH DEVELOP, V121, P639, DOI 10.1016/j.mod.2004.03.001; Semba K, 1996, GENE, V175, P167, DOI 10.1016/0378-1119(96)00143-6; Shan Z, 2000, CYTOGENET CELL GENET, V89, P252, DOI 10.1159/000015626; Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Smith CA, 1999, GENE, V234, P395, DOI 10.1016/S0378-1119(99)00179-1; SMITH CA, 2000, GENE, V241, P223; Sousa-Santos C, 2006, J NAT HIST, V40, P1443, DOI 10.1080/00222930600934111; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Sugita J, 2001, GENE, V280, P67, DOI 10.1016/S0378-1119(01)00739-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tremblay AJ, 2001, BIOL REPROD, V64, P1191, DOI 10.1095/biolreprod64.4.1191; Veith AM, 2006, ZEBRAFISH, V3, P325, DOI 10.1089/zeb.2006.3.325; Veitia RA, 2001, MOL CELL ENDOCRINOL, V179, P3, DOI 10.1016/S0303-7207(01)00460-9; Volff JN, 2001, GENETICA, V111, P101, DOI 10.1023/A:1013795415808; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang DS, 2002, BIOCHEM BIOPH RES CO, V297, P632, DOI 10.1016/S0006-291X(02)02252-0; Wang ZJ, 2001, P NATL ACAD SCI USA, V98, P7988, DOI 10.1073/pnas.141543298; Western PS, 2000, GENE, V241, P223, DOI 10.1016/S0378-1119(99)00466-7; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Woolcock B, 2006, ZEBRAFISH, V3, P23, DOI 10.1089/zeb.2006.3.23; Yamaguchi A, 2006, COMP BIOCHEM PHYS D, V1, P59, DOI 10.1016/j.cbd.2005.08.003; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200; Zhao Y, 2006, MOL ENDOCRINOL, V20, P2630, DOI 10.1210/me.2005-0445	80	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6401	10.1371/journal.pone.0006401	http://dx.doi.org/10.1371/journal.pone.0006401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636439	Green Submitted, gold, Green Published			2022-12-25	WOS:000268404900021
J	Pennaneach, V; Kolodner, RD				Pennaneach, Vincent; Kolodner, Richard D.			Stabilization of Dicentric Translocations through Secondary Rearrangements Mediated by Multiple Mechanisms in S-cerevisiae	PLOS ONE			English	Article								Background: The gross chromosomal rearrangements (GCRs) observed in S. cerevisiae mutants with increased rates of accumulating GCRs include predicted dicentric GCRs such as translocations, chromosome fusions and isoduplications. These GCRs resemble the genome rearrangements found as mutations underlying inherited diseases as well as in the karyotypes of many cancers exhibiting ongoing genome instability Methodology/Principal Findings: The structures of predicted dicentric GCRs were analyzed using multiple strategies including array-comparative genomic hybridization, pulse field gel electrophoresis, PCR amplification of predicted breakpoints and sequencing. The dicentric GCRs were found to be unstable and to have undergone secondary rearrangements to produce stable monocentric GCRs. The types of secondary rearrangements observed included: nonhomologous end joining (NHEJ)-dependent intramolecular deletion of centromeres; chromosome breakage followed by NHEJ-mediated circularization or broken-end fusion to another chromosome telomere; and homologous recombination (HR)-dependent non-reciprocal translocations apparently mediated by break-induced replication. A number of these GCRs appeared to have undergone multiple bridge-fusion-breakage cycles. We also observed examples of chromosomes with extensive ongoing end decay in mec1 tlc1 mutants, suggesting that Mec1 protects chromosome ends from degradation and contributes to telomere maintenance by HR. Conclusions/Significance: HR between repeated sequences resulting in secondary rearrangements was the most prevalent pathway for resolution of dicentric GCRs regardless of the structure of the initial dicentric GCR, although at least three other resolution mechanisms were observed. The resolution of dicentric GCRs to stable rearranged chromosomes could in part account for the complex karyotypes seen in some cancers.			Pennaneach, V (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu		Pennaneach, Vincent/0000-0002-2518-0517	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26017, R37 GM026017, R01 GM026017] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROCK JAK, 1994, J CELL SCI, V107, P891; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Craven RJ, 2002, GENETICS, V161, P493; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; DUTRILLAUX B, 1978, CYTOGENET CELL GENET, V20, P70, DOI 10.1159/000130841; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Fasullo M, 2008, CELL CYCLE, V7, P2418, DOI 10.4161/cc.6411; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; GAME JC, 1989, GENETICS, V123, P695; Gisselsson D, 2005, SEMIN CANCER BIOL, V15, P13, DOI 10.1016/j.semcancer.2004.09.002; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; HABER JE, 1984, GENETICS, V106, P207; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; JAGER D, 1989, EMBO J, V8, P247, DOI 10.1002/j.1460-2075.1989.tb03370.x; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kanellis P, 2007, PLOS GENET, V3, P1438, DOI 10.1371/journal.pgen.0030134; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee SE, 2002, DNA REPAIR, V1, P27, DOI 10.1016/S1568-7864(01)00003-9; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lo AWI, 2002, NEOPLASIA, V4, P531, DOI 10.1038/sj.neo.7900267; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; MANN C, 1983, P NATL ACAD SCI-BIOL, V80, P228, DOI 10.1073/pnas.80.1.228; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2004, P NATL ACAD SCI USA, V101, P15980, DOI 10.1073/pnas.0407010101; Myung K, 2003, DNA REPAIR, V2, P243, DOI 10.1016/S1568-7864(02)00216-1; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; Pennaneach V, 2006, MOL MICROBIOL, V59, P1357, DOI 10.1111/j.1365-2958.2006.05026.x; Pennaneach V, 2004, NAT GENET, V36, P612, DOI 10.1038/ng1359; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Putnam CD, 2004, P NATL ACAD SCI USA, V101, P13262, DOI 10.1073/pnas.0405443101; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Sabatier L, 2005, MOL CANCER RES, V3, P139, DOI 10.1158/1541-7786.MCR-04-0194; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; Scholes DT, 2003, P NATL ACAD SCI USA, V100, P15736, DOI 10.1073/pnas.2136609100; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sikdar N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000290; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; SUROSKY RT, 1985, GENETICS, V110, P397; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Thrower DA, 2001, MOL BIOL CELL, V12, P2800, DOI 10.1091/mbc.12.9.2800; Umezu K, 2002, GENETICS, V160, P97; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Yu X, 2003, GENETICS, V163, P843	66	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6389	10.1371/journal.pone.0006389	http://dx.doi.org/10.1371/journal.pone.0006389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636429	Green Published, Green Submitted, gold			2022-12-25	WOS:000268404900013
J	Mieog, JC; Olsen, JL; Berkelmans, R; Bleuler-Martinez, SA; Willis, BL; van Oppen, MJH				Mieog, Jos C.; Olsen, Jeanine L.; Berkelmans, Ray; Bleuler-Martinez, Silvia A.; Willis, Bette L.; van Oppen, Madeleine J. H.			The Roles and Interactions of Symbiont, Host and Environment in Defining Coral Fitness	PLOS ONE			English	Article								Background: Reef-building corals live in symbiosis with a diverse range of dinoflagellate algae ( genus Symbiodinium) that differentially influence the fitness of the coral holobiont. The comparative role of symbiont type in holobiont fitness in relation to host genotype or the environment, however, is largely unknown. We addressed this knowledge gap by manipulating host-symbiont combinations and comparing growth, survival and thermal tolerance among the resultant holobionts in different environments. Methodology/Principal Findings: Offspring of the coral, Acropora millepora, from two thermally contrasting locations, were experimentally infected with one of six Symbiodinium types, which spanned three phylogenetic clades (A, C and D), and then outplanted to the two parental field locations (central and southern inshore Great Barrier Reef, Australia). Growth and survival of juvenile corals were monitored for 31-35 weeks, after which their thermo-tolerance was experimentally assessed. Our results showed that: (1) Symbiodinium type was the most important predictor of holobiont fitness, as measured by growth, survival, and thermo-tolerance; (2) growth and survival, but not heat-tolerance, were also affected by local environmental conditions; and (3) host population had little to no effect on holobiont fitness. Furthermore, coral-algal associations were established with symbiont types belonging to clades A, C and D, but three out of four symbiont types belonging to clade C failed to establish a symbiosis. Associations with clade A had the lowest fitness and were unstable in the field. Lastly, Symbiodinium types C1 and D were found to be relatively thermo-tolerant, with type D conferring the highest tolerance in A. millepora. Conclusions/Significance: These results highlight the complex interactions that occur between the coral host, the algal symbiont, and the environment to shape the fitness of the coral holobiont. An improved understanding of the factors affecting coral holobiont fitness will assist in predicting the responses of corals to global climate change.			Mieog, JC (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	josmieog@gmail.com	Mieog, Jos/AAV-3371-2021; Mieog, Jos/N-6522-2014; van Oppen, Madeleine JH/C-3261-2008; Olsen, Jeanine/D-3213-2013	Mieog, Jos/0000-0002-2153-8956; Mieog, Jos/0000-0002-2153-8956; van Oppen, Madeleine/0000-0003-4607-0744; Olsen, Jeanine L./0000-0003-3091-0163				Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2007, MAR ECOL PROG SER, V347, P307, DOI 10.3354/meps07220; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bhagooli R, 2004, COMP BIOCHEM PHYS A, V137, P547, DOI 10.1016/j.cbpb.2003.11.008; Bhagooli R, 2003, J EXP MAR BIOL ECOL, V291, P181, DOI 10.1016/S0022-0981(03)00121-7; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; COFFROTH MA, 2008, 11 INT COR REEF S 25, P25; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Day T, 2008, AM NAT, V171, pE72, DOI 10.1086/524956; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Fautin DG, 2004, HYDROBIOLOGIA, V530, P459, DOI 10.1007/s10750-004-2642-z; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Karako-Lampert S, 2005, J EXP MAR BIOL ECOL, V318, P11, DOI 10.1016/j.jembe.2004.11.024; KINNE O, 1962, COMP BIOCHEM PHYSIOL, V5, P265, DOI 10.1016/0010-406X(62)90056-7; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P1158, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Muscatine L., 1990, P75; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Reimer JD, 2006, PHYCOL RES, V54, P122, DOI 10.1111/j.1440-1835.2006.00419.x; Richmond Robert H., 1997, P175; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Savage AM, 2002, MAR ECOL PROG SER, V244, P17, DOI 10.3354/meps244017; Schaefer J, 2006, J FISH BIOL, V69, P1266, DOI 10.1111/j.1095-8649.2006.01268.x; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Smith LW, 2008, PAC SCI, V62, P57, DOI 10.2984/1534-6188(2008)62[57:EVGIOG]2.0.CO;2; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Thornhill DJ, 2006, J EXP MAR BIOL ECOL, V338, P50, DOI 10.1016/j.jembe.2006.06.032; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Turner P, 2002, MAR TECHNOL SOC J, V36, P70, DOI 10.4031/002533202787914160; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733	67	129	132	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6364	10.1371/journal.pone.0006364	http://dx.doi.org/10.1371/journal.pone.0006364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629182	gold, Green Published, Green Accepted			2022-12-25	WOS:000268318900007
J	Bovetti, S; Veyrac, A; Peretto, P; Fasolo, A; De Marchis, S				Bovetti, Serena; Veyrac, Alexandra; Peretto, Paolo; Fasolo, Aldo; De Marchis, Silvia			Olfactory Enrichment Influences Adult Neurogenesis Modulating GAD67 and Plasticity-Related Molecules Expression in Newborn Cells of the Olfactory Bulb	PLOS ONE			English	Article							NEWLY-GENERATED NEURONS; TYROSINE-HYDROXYLASE EXPRESSION; EXPERIENCE-DEPENDENT SURVIVAL; SUBVENTRICULAR ZONE; PSA-NCAM; GRANULE CELLS; TERM SURVIVAL; BORN NEURONS; MOUSE; DEPRIVATION	The olfactory bulb (OB) is a highly plastic region of the adult mammalian brain characterized by continuous integration of inhibitory interneurons of the granule (GC) and periglomerular cell (PGC) types. Adult-generated OB interneurons are selected to survive in an experience-dependent way but the mechanisms that mediate the effects of experience on OB neurogenesis are unknown. Here we focus on the new-generated PGC population which is composed by multiple subtypes. Using paradigms of olfactory enrichment and/or deprivation combined to BrdU injections and quantitative confocal immunohistochemical analyses, we studied the effects of olfactory experience on adult-generated PGCs at different survival time and compared PGC to GC modulation. We show that olfactory enrichment similarly influences PGCs and GCs, increasing survival of newborn cells and transiently modulating GAD67 and plasticity-related molecules expression. However, PGC maturation appears to be delayed compared to GCs, reflecting a different temporal dynamic of adult generated olfactory interneuron integration. Moreover, olfactory enrichment or deprivation do not selectively modulate the survival of specific PGC phenotypes, supporting the idea that the integration rate of distinct PGC subtypes is independent from olfactory experience.			Bovetti, S (corresponding author), Univ Turin, Dept Anim & Human Biol, Turin, Italy.	silvia.demarchis@unito.it	De+Marchis, Silvia/ABH-8872-2020; Veyrac, Alexandra/G-8313-2017	de marchis, silvia/0000-0002-8096-7670; Peretto, Paolo Marcello/0000-0001-9747-6379; VEYRAC, Alexandra/0000-0002-8063-4016; Bovetti, Serena/0000-0002-0471-4081				Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BAKER H, 1983, J NEUROSCI, V3, P69; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cremer H, 2000, INT J DEV NEUROSCI, V18, P213, DOI 10.1016/S0736-5748(99)00090-8; Cummings DM, 1997, J NEUROSCI, V17, P7433; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gomez-Lira G, 2005, J NEUROSCI, V25, P6939, DOI 10.1523/JNEUROSCI.1674-05.2005; Grubb MS, 2008, J NEUROSCI, V28, P2919, DOI 10.1523/JNEUROSCI.5550-07.2008; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Oboti L, 2009, EUR J NEUROSCI, V29, P679, DOI 10.1111/j.1460-9568.2009.06614.x; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Puche AC, 1999, J NEUROSCI, V19, P1359; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Whitman MC, 2007, DEV NEUROBIOL, V67, P1079, DOI 10.1002/dneu.20389; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	42	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6359	10.1371/journal.pone.0006359	http://dx.doi.org/10.1371/journal.pone.0006359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626121	gold, Green Published, Green Submitted			2022-12-25	WOS:000268260200005
J	Maher, AC; Fu, MH; Isfort, RJ; Varbanov, AR; Qu, XA; Tarnopolsky, MA				Maher, Amy C.; Fu, Minghua H.; Isfort, Robert J.; Varbanov, Alex R.; Qu, Xiaoyan A.; Tarnopolsky, Mark A.			Sex Differences in Global mRNA Content of Human Skeletal Muscle	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE ACTIVITY; TISSUE GLYCOGEN-METABOLISM; UNCOUPLING PROTEIN-2 GENE; ACTIVATED RECEPTOR-ALPHA; ALDEHYDE DEHYDROGENASES; SUBSTRATE UTILIZATION; GENDER DIFFERENCES; ACYL-COENZYME; FIBER TYPES; ENDURANCE EXERCISE	Women oxidize more fat as compared to men during endurance exercise and several groups have shown that the mRNA content of selected genes related to fat oxidation are higher in women (e. g. hormone sensitive lipase, beta-hydroxyacyl-CoA dehydrogenase, CD36). One of the possible mechanisms is that women tend to have a higher area percentage of type I skeletal muscle fibers as compared with men. Consequently, we hypothesized that sex would influence the basal mRNA and protein content for genes involved in metabolism and the determination of muscle fiber type. Muscle biopsies from the vastus lateralis were collected from healthy men and women. We examined mRNA content globally using Affymetrix GeneChips, and selected genes were examined and/or confirmed by RT-PCR. Furthermore, we examined protein content by Western blot analysis. Stringent gene array analysis revealed 66 differentially expressed genes representing metabolism, mitochondrial function, transport, protein biosynthesis, cell proliferation, signal transduction pathways, transcription and translation. Stringent gene array analysis and RT-PCR confirmed that mRNA for; acyl-coenzyme A acyltransferase 2 (ACAA2), trifunctional protein beta (HADHB), catalase, lipoprotein lipase (LPL), and uncoupling protein-2 (UCP-2) were higher in women. Targeted gene analysis revealed that myosin heavy chain I (MHCI), peroxisome proliferator-activated receptor (PPAR)delta were higher in women compared with men. Surprisingly, there were no significant sex based differences in protein content for HADHB, ACAA2, catalase, PPAR delta, and MHC1. In conclusion, the differences in the basal mRNA content in resting skeletal muscle suggest that men and women are transcriptionally "primed" for known physiological differences in metabolism however the mechanism behind sex differences in fiber type remains to be determined.			Maher, AC (corresponding author), McMaster Univ, Dept Med Sci, Hamilton, ON, Canada.	tarnopol@mcmaster.ca						Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Barbe P, 1998, J CLIN ENDOCR METAB, V83, P2450, DOI 10.1210/jc.83.7.2450; Barreiro E, 2006, FREE RADICAL BIO MED, V41, P797, DOI 10.1016/j.freeradbiomed.2006.05.027; Binnert C, 2000, AM J PHYSIOL-ENDOC M, V279, pE1072, DOI 10.1152/ajpendo.2000.279.5.E1072; BROOKE MH, 1969, NEUROLOGY, V19, P221, DOI 10.1212/WNL.19.3.221; Buemann B, 2001, INT J OBESITY, V25, P467, DOI 10.1038/sj.ijo.0801564; Carter SL, 2001, AM J PHYSIOL-ENDOC M, V280, pE898, DOI 10.1152/ajpendo.2001.280.6.E898; CHAN WCW, 2000, P SOC PHOTO-OPT INS, V1, P2; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Collard F, 2007, BIOCHIMIE, V89, P369, DOI 10.1016/j.biochi.2006.11.005; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; DEVRIES MC, 2006, AM J PHYSL REGUL INT; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Duscha BD, 2001, J APPL PHYSIOL, V90, P280, DOI 10.1152/jappl.2001.90.1.280; ELLIS GS, 1994, J APPL PHYSIOL, V77, P209, DOI 10.1152/jappl.1994.77.1.209; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Friedlander AL, 1998, J APPL PHYSIOL, V85, P1175, DOI 10.1152/jappl.1998.85.3.1175; Gagnon I, 2002, BBA-PROTEIN STRUCT M, V1596, P156, DOI 10.1016/S0167-4838(02)00213-3; GAUTHIER JM, 1992, MED SCI SPORT EXER, V24, P1252; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; GREEN HJ, 1984, J NEUROL SCI, V65, P323, DOI 10.1016/0022-510X(84)90095-9; Grimaldi PA, 2003, BIOCHEM SOC T, V31, P1130; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; HARDS JM, 1990, CHEST, V97, P1037, DOI 10.1378/chest.97.5.1037; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Hinkle RT, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-18; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Horton TJ, 1998, J APPL PHYSIOL, V85, P1823, DOI 10.1152/jappl.1998.85.5.1823; HOWEL D, 1994, ANAT REC, V240, P625, DOI 10.1002/ar.1092400418; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Joyce C, 1999, CURR OPIN LIPIDOL, V10, P89, DOI 10.1097/00041433-199904000-00002; KENDRICK ZV, 1987, J APPL PHYSIOL, V63, P492, DOI 10.1152/jappl.1987.63.2.492; KENDRICK ZV, 1991, J APPL PHYSIOL, V71, P1694, DOI 10.1152/jappl.1991.71.5.1694; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; Kiens B, 1997, MED SCI SPORT EXER, V29, P640, DOI 10.1097/00005768-199705000-00009; KIENS B, 2004, J APPL PHYSL; KOMI PV, 1978, ACTA PHYSIOL SCAND, V103, P210, DOI 10.1111/j.1748-1716.1978.tb06208.x; Urso M, 2006, J APPL PHYSIOL, V101, P1136, DOI 10.1152/japplphysiol.00180.2006; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; MAHONEY DJ, 2005, FASEB J; Maly IP, 1999, HISTOCHEM CELL BIOL, V111, P461, DOI 10.1007/s004180050382; Mannion AF, 1997, J ANAT, V190, P505, DOI 10.1046/j.1469-7580.1997.19040505.x; Melanson EL, 2002, J APPL PHYSIOL, V92, P1045, DOI 10.1152/japplphysiol.00706.2001; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Mittendorfer B, 2002, AM J PHYSIOL-ENDOC M, V283, pE58, DOI 10.1152/ajpendo.00504.2001; Nagy TR, 1996, J APPL PHYSIOL, V80, P1743, DOI 10.1152/jappl.1996.80.5.1743; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Orii KE, 1996, BIOCHEM BIOPH RES CO, V219, P773, DOI 10.1006/bbrc.1996.0309; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Porter MM, 2002, J APPL PHYSIOL, V92, P1451, DOI 10.1152/japplphysiol.00744.2001; Riddell MC, 2003, INT J SPORT NUTR EXE, V13, P407, DOI 10.1123/ijsnem.13.4.407; Roepstorff C, 2005, ACTA PHYSIOL SCAND, V184, P215, DOI 10.1111/j.1365-201X.2005.01442.x; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435, DOI 10.1152/ajpendo.00266.2001; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; SAKATA R, 2000, J ANIM SCI, V1, P1; Schrauwen P, 2002, J EXP BIOL, V205, P2275; SIMONEAU JA, 1985, CAN J PHYSIOL PHARM, V63, P30, DOI 10.1139/y85-005; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Staron RS, 1997, CAN J APPL PHYSIOL, V22, P307, DOI 10.1139/h97-020; Steffensen CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE634, DOI 10.1152/ajpendo.00078.2001; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; TARNOPOLSKY LJ, 1990, J APPL PHYSIOL, V68, P302, DOI 10.1152/jappl.1990.68.1.302; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360, DOI 10.1152/jappl.1995.78.4.1360; Tarnopolsky MA, 1997, J APPL PHYSIOL, V83, P1877, DOI 10.1152/jappl.1997.83.6.1877; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Vina J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; YIN SJ, 1994, ALCOHOL CLIN EXP RES, V18, P1256, DOI 10.1111/j.1530-0277.1994.tb00115.x; Yoshioka M, 2007, J MOL ENDOCRINOL, V39, P119, DOI 10.1677/JME-07-0027; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	90	51	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6335	10.1371/journal.pone.0006335	http://dx.doi.org/10.1371/journal.pone.0006335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623254	Green Published, gold, Green Submitted			2022-12-25	WOS:000268260100013
J	Mhlanga, MM; Bratu, DP; Genovesio, A; Rybarska, A; Chenouard, N; Nehrbass, U; Olivo-Marin, JC				Mhlanga, Musa M.; Bratu, Diana P.; Genovesio, Auguste; Rybarska, Agata; Chenouard, Nicolas; Nehrbass, Ulf; Olivo-Marin, Jean-Christophe			In Vivo Colocalisation of oskar mRNA and Trans-Acting Proteins Revealed by Quantitative Imaging of the Drosophila Oocyte	PLOS ONE			English	Article							MOLECULAR BEACONS; BINDING-PROTEIN; INTRACELLULAR-LOCALIZATION; TRANSLATIONAL REGULATION; POSTERIOR LOCALIZATION; PARTICLE TRACKING; HNRNPA/B HOMOLOG; AXIS FORMATION; STAUFEN; DIFFUSION	Efficient mRNA transport in eukaryotes requires highly orchestrated relationships between nuclear and cytoplasmic proteins. For oskar mRNA, the Drosophila posterior determinant, these spatio-temporal requirements remain opaque during its multi-step transport process. By in vivo covisualization of oskar mRNA with Staufen, its putative trafficking protein, we find oskar mRNA to be present in particles distinct from Staufen for part of its transport. oskar mRNA stably associated with Staufen near the posterior pole. We observe oskar mRNA to oligomerize as hundreds of copies forming large particles which are necessary for its long range transport and localization. We show the formation of these particles occurs in the nurse cell nucleus in an Hrp48-dependent manner. We present a more refined model of oskar mRNA transport in the Drosophila oocyte.			Mhlanga, MM (corresponding author), Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Biol Cellulaire Noyau, Paris, France.	musa@pasteur.fr	Mhlanga, Musa/D-1283-2011; Olivo-Marin, Jean-Christophe/K-4428-2015; GENOVESIO, Auguste/I-1656-2017	Mhlanga, Musa/0000-0003-1381-3409; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Genovesio, Auguste/0000-0003-1877-5595; Nehrbass, Ulf/0000-0002-7028-8076				Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; BOUCHAUD JP, 1990, PHYS REV A, V41, P1156, DOI 10.1103/PhysRevA.41.1156; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; Bratu Diana P., 2006, V319, P1; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Davis I, 2004, NAT CELL BIOL, V6, P285, DOI 10.1038/ncb0404-285; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dirks RW, 2001, HISTOCHEM CELL BIOL, V115, P3, DOI 10.1007/s004180000214; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Farina KL, 2002, TRENDS CELL BIOL, V12, P466, DOI 10.1016/S0962-8924(02)02357-7; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Genovesio A, 2006, IEEE T IMAGE PROCESS, V15, P1062, DOI 10.1109/TIP.2006.872323; GENOVESIO A, 2004, IM PROC 2004 ICIP 04; GENOVESIO A, 2004, BIOM IM MACR NAN 200, P1239; GENOVESIO A, 2004, PATT REC 2004 ICPR 2; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Havlin S, 2002, ADV PHYS, V51, P187, DOI 10.1080/00018730110116353; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Kim JH, 2005, EJC SUPPL, V3, P208; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Lorenz P, 2000, NUCLEIC ACIDS RES, V28, P582, DOI 10.1093/nar/28.2.582; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; MATUNIS EL, 1993, J CELL BIOL, V121, P219, DOI 10.1083/jcb.121.2.219; MATUNIS EL, 1992, J CELL BIOL, V116, P257, DOI 10.1083/jcb.116.2.257; MATUNIS MJ, 1992, J CELL BIOL, V116, P245, DOI 10.1083/jcb.116.2.245; Mhlanga MM, 2005, NUCLEIC ACIDS RES, V33, P1902, DOI 10.1093/nar/gki302; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Palacios IM, 2002, CURR BIOL, V12, pR50, DOI 10.1016/S0960-9822(01)00671-6; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; RONGO C, 1995, DEVELOPMENT, V121, P2737; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Spiller DG, 1998, BLOOD, V91, P4738, DOI 10.1182/blood.V91.12.4738.412k31_4738_4746; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tekotte H, 2006, DEV CELL, V10, P280, DOI 10.1016/j.devcel.2006.02.001; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tyagi S, 2004, BIOPHYS J, V87, P4153, DOI 10.1529/biophysj.104.045153; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2009	4	7							e6241	10.1371/journal.pone.0006241	http://dx.doi.org/10.1371/journal.pone.0006241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DQ	19597554	Green Published, gold			2022-12-25	WOS:000268035600008
J	Barbi, J; Snider, HM; Bhardwaj, N; Lezama-Davila, CM; Durbin, JE; Satoskar, AR				Barbi, Joseph; Snider, Heidi M.; Bhardwaj, Neeti; Lezama-Davila, Claudio M.; Durbin, Joan E.; Satoskar, Abhay R.			Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection	FASEB JOURNAL			English	Article						CXCR3; protozoa	MURINE LEISHMANIASIS; IFN-GAMMA; CUTANEOUS LEISHMANIASIS; CUTTING EDGE; STAT1; EXPRESSION; BET; INDUCTION; CD4(+); MICE	The signal transducer and activator of transcription 1 (STAT1) signaling pathway mediates the biological functions of IFN-gamma. We have previously shown that the STAT1 pathway is indispensable for host resistance against Leishmania major infection. In this study, we examined the role of STAT1 in lymphocytes and specifically CD4(+) and CD8(+) T cells in mediating immunity against L. major by transferring T cells from wild-type (WT) and STAT1(-/-) C57BL/6 mice into Rag2(-/-) C57BL/6 mice. Rag2(-/-) mice reconstituted with unfractionated STAT1(-/-) splenocytes (B cells and T cells) failed to mount an efficient Th1 response after L. major infection, produced more IL-4, and developed large lesions full of parasites. In contrast, Rag2(-/-) mice reconstituted with WT (STAT1(+/+)) splenocytes mounted a Th1 response and developed self-resolving lesions. Studies using Rag2(-/-) recipients that received a combination of purified CD4(+) and CD8(+) T cells from WT or STAT1(-/-) mice revealed that STAT1 deficiency in CD4(+) T cells, but not in CD8(+) T cells, leads to development of chronic, nonhealing lesions and systemic dissemination of parasites into the spleen after L. major infection. Further studies using Rag2(-/-) recipients of WT Thy1.1(+) and STAT1(-/-) Thy1.2(+) T cells showed that STAT1 in CD4(+) T cells was not required for Th1 differentiation during L. major infection. However, it was critical for up-regulation of CXCR3 on CD4(+) T cells and their migration to the regional lymph node and the cutaneous site of infection. Together, these studies indicate that the STAT1 pathway in CD4(+) T cells plays a critical role in immunity against L. major by controlling the migration of Th1 cells to the site of infection rather than their generation. Further, they reveal an essential role for CD4(+) T cell STAT1 in preventing systemic dissemination of L. major infection.-Barbi, J., Snider, H. M., Bhardwaj, N., Lezama-Davila, C. M., Durbin, J. E., Satoskar, A. R. Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection. FASEB J. 23, 3990-3999 (2009). www.fasebj.org	[Barbi, Joseph; Snider, Heidi M.; Bhardwaj, Neeti; Lezama-Davila, Claudio M.; Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Satoskar, Abhay R.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Durbin, Joan E.] Childrens Hosp, Dept Pathol, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Satoskar, AR (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	satoskar.2@osu.edu	Satoskar, Abhay/AAB-7748-2019		U. S. National Institutes of Health/National Institute of Allergy and Infectious Diseases [R56 AI 068829]; National Institute of Dental and Craniofacial Research [F30 DE020001-0109]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051823, R56AI068829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F30DE020001] Funding Source: NIH RePORTER	U. S. National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	N. B. was an M. Sc. student at Ohio State University; C. M. L. D. is an international scholar supported by Fundacion Pablo Garcia of the government of Campeche. This work received financial aid from a U. S. National Institutes of Health/National Institute of Allergy and Infectious Diseases grant (R56 AI 068829) to A. R. S. and a National Institute of Dental and Craniofacial Research fellowship (F30 DE020001-0109) to H. M. S. The authors declare no conflicts of interest.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; HEINZEL FP, 1991, P NATL ACAD SCI USA, V88, P7011, DOI 10.1073/pnas.88.16.7011; Heinzel FP, 1995, RES IMMUNOL, V146, P575, DOI 10.1016/0923-2494(96)83034-3; HOERAUF A, 1994, INT IMMUNOL, V6, P1117, DOI 10.1093/intimm/6.8.1117; Johnson LM, 2007, J IMMUNOL, V178, P7259, DOI 10.4049/jimmunol.178.11.7259; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; LIEW FY, 1993, ADV PARASIT, V32, P161, DOI 10.1016/S0065-308X(08)60208-0; LOCKSLEY RM, 1991, RES IMMUNOL, V142, P28, DOI 10.1016/0923-2494(91)90007-6; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Mikhak Z, 2006, J IMMUNOL, V176, P4959, DOI 10.4049/jimmunol.176.8.4959; Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686; MUNDER M, 1998, J EXP MED, V179, P1731; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rosas LE, 2005, EUR J IMMUNOL, V35, P515, DOI 10.1002/eji.200425422; Rosas LE, 2003, EUR J IMMUNOL, V33, P1799, DOI 10.1002/eji.200323163; Rosas LE, 2006, J IMMUNOL, V177, P22, DOI 10.4049/jimmunol.177.1.22; SHER A, 1983, CIBA F SYMP, V99, P174; SOBER D, 2001, J IMMUNOL, V167, P957; Suzue K, 2003, EUR J IMMUNOL, V33, P2666, DOI 10.1002/eji.200323292; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886	27	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3990	3999		10.1096/fj.09-138057	http://dx.doi.org/10.1096/fj.09-138057			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19641143	Green Published			2022-12-25	WOS:000271272500034
J	Meima, ME; Webb, BA; Witkowska, HE; Barber, DL				Meima, Marcel E.; Webb, Bradley A.; Witkowska, H. Ewa; Barber, Diane L.			The Sodium-Hydrogen Exchanger NHE1 Is an Akt Substrate Necessary for Actin Filament Reorganization by Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-H EXCHANGER; PROTEIN-KINASE-B; STRESS FIBER BREAKDOWN; CELL-CYCLE PROGRESSION; NA+/H+ EXCHANGER; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT PHOSPHORYLATION; MEDIATED PHOSPHORYLATION; TRANSCRIPTION FACTOR; PH DYNAMICS	The kinase Akt mediates signals from growth factor receptors for increased cell proliferation, survival, and migration, which contribute to the positive effects of Akt in cancer progression. Substrates are generally inhibited when phosphorylated by Akt; however, we show phosphorylation of the plasma membrane sodium-hydrogen exchanger NHE1 by Akt increases exchanger activity (H+ efflux). Our data fulfill criteria for NHE1 being a bona fide Akt substrate, including direct phosphorylation in vitro, using mass spectrometry and Akt phospho-substrate antibodies to identify Ser(648) as the Akt phosphorylation site and loss of increased exchanger phosphorylation and activity by insulin and platelet-derived growth factor in fibroblasts expressing a mutant NHE1-S648A. How Akt induces actin cytoskeleton remodeling to promote cell migration and tumor cell metastasis is unclear, but disassembly of actin stress fibers by platelet-derived growth factor and insulin and increased proliferation in growth medium are inhibited in fibroblasts expressing NHE1-S648A. We predict that other functions shared by Akt and NHE1, including cell growth and survival, might be regulated by increased H+ efflux.	[Meima, Marcel E.; Webb, Bradley A.; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Witkowska, H. Ewa] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Box 0512,513 Parnassus Ave, San Francisco, CA 94143 USA.	diane.barber@ucsf.edu	Webb, Bradley/F-6946-2013; Webb, Bradley/HDO-7820-2022	Webb, Bradley/0000-0002-5299-2852; 	National Institutes of Health [GM47413, T32-DE7306-11]; National Center for Research Resources [C06 RR16490]; Sandler Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Sandler Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM47413 (to D. L. B.). This work was also supported by Research Facilities Improvement Program Grant C06 RR16490 from the National Center for Research Resources, National Institutes of Health and by funds from the Sandler Family Foundation to the UCSF Sandler-Moore Core Mass Spectrometry Facility.; Supported by National Institutes of Health Training Grant T32-DE7306-11.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crouch MF, 1997, BIOCHEM BIOPH RES CO, V233, P193, DOI 10.1006/bbrc.1997.6419; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sario A, 2001, J HEPATOL, V34, P378, DOI 10.1016/S0168-8278(00)00062-3; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gillis D, 2001, J MEMBRANE BIOL, V181, P205, DOI 10.1007/s00232-001-0023-3; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; HERMAN B, 1985, J CELL BIOL, V100, P1031, DOI 10.1083/jcb.100.4.1031; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; JIMENEZ CR, 1998, PROTOCOLS PROTEIN SC; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199, DOI 10.1074/jbc.270.17.10199; Konstantinidis D, 2006, CELL PHYSIOL BIOCHEM, V18, P211, DOI 10.1159/000097668; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; MA YH, 1994, J BIOL CHEM, V269, P30734; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; McLachlin DT, 2001, CURR OPIN CHEM BIOL, V5, P591, DOI 10.1016/S1367-5931(00)00250-7; Nagano K, 2006, EMBO J, V25, P1871, DOI 10.1038/sj.emboj.7601059; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Patel H, 2005, J CELL BIOL, V169, P321, DOI 10.1083/jcb.200412145; Putney LK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-46; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Sauvage M, 2000, EUR J BIOCHEM, V267, P955, DOI 10.1046/j.1432-1327.2000.01084.x; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang H, 1997, BIOCHEMISTRY-US, V36, P9151, DOI 10.1021/bi970802f; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; Yang J, 2002, AM J PHYSIOL-ENDOC M, V283, pE1299, DOI 10.1152/ajpendo.00341.2002; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	69	81	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26666	26675		10.1074/jbc.M109.019448	http://dx.doi.org/10.1074/jbc.M109.019448			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19622752	Green Published, hybrid			2022-12-25	WOS:000269969600047
J	Choudhuri, K; Parker, M; Milicic, A; Cole, DK; Shaw, MK; Sewell, AK; Stewart-Jones, G; Dong, T; Gould, KG; van der Merwe, PA				Choudhuri, Kaushik; Parker, Mathew; Milicic, Anita; Cole, David K.; Shaw, Michael K.; Sewell, Andrew K.; Stewart-Jones, Guillaume; Dong, Tao; Gould, Keith G.; van der Merwe, P. Anton			Peptide-Major Histocompatibility Complex Dimensions Control Proximal Kinase-Phosphatase Balance during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECOGNITION; RECEPTOR; LYMPHOCYTES; RESPONSES; BINDING; LIGAND; MODEL; CHAIN	T cell antigen recognition requires binding of the T cell receptor (TCR) to a complex between peptide antigen and major histocompatibility complex molecules (pMHC), and this recognition occurs at the interface between the T cell and the antigen-presenting cell. The TCR and pMHC molecules are small compared with other abundant cell surface molecules, and it has been suggested that small size is functionally important. We show here that elongation of both mouse and human MHC class I molecules abrogates T cell antigen recognition as measured by cytokine production and target cell killing. This elongation disrupted tyrosine phosphorylation and Zap70 recruitment at the contact region without affecting TCR or coreceptor binding. Contact areas with elongated forms of pMHC showed an increase in intermembrane distance and less efficient segregation of CD3 from the large tyrosine phosphatase CD45. These findings demonstrate that T cell antigen recognition is strongly dependent on pMHC size and are consistent with models of TCR triggering requiring segregation or mechanical pulling of the TCR.	[Parker, Mathew; Gould, Keith G.] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Wright Fleming Inst, London W2 1PG, England; [Choudhuri, Kaushik; Shaw, Michael K.; van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Milicic, Anita] Univ Oxford, Jenner Inst, Oxford OX1 3RE, England; [Stewart-Jones, Guillaume; Dong, Tao] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX1 3RE, England; [Cole, David K.; Sewell, Andrew K.] Cardiff Univ, Dept Med Biochem & Immunol, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Imperial College London; University of Oxford; University of Oxford; Jenner Institute; University of Oxford; Cardiff University	Gould, KG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Wright Fleming Inst, Norfolk Pl, London W2 1PG, England.	k.gould@imperial.ac.uk; anton.vandermerwe@path.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011; Cole, David/C-8387-2012; Stewart-Jones, Guillaume/E-7013-2013; Milicic, Anita/B-7693-2011; Sewell, Andrew/GPT-4220-2022	Milicic, Anita/0000-0002-7984-1317; Sewell, Andrew/0000-0003-3194-3135; Cole, David/0000-0003-0028-9396; Gould, Keith/0000-0003-0913-5422; Choudhuri, Kaushik/0000-0002-3911-027X; Dong, Tao/0000-0003-3545-3758	Wellcome Trust; United Kingdom Medical Research Council; Medical Research Council [G9722488, MC_U137884178, G0600520, G0400091] Funding Source: researchfish; MRC [G9722488, G0400091, MC_U137884178, G0600520] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Wellcome Trust and by the United Kingdom Medical Research Council.	Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Choudhuri K, 2005, CURR BIOL, V15, pR382, DOI 10.1016/j.cub.2005.05.001; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Hutchinson SL, 2003, J BIOL CHEM, V278, P24285, DOI 10.1074/jbc.M300633200; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Laugel B, 2007, EUR J IMMUNOL, V37, P905, DOI 10.1002/eji.200636718; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; Palmowski MJ, 2009, J IMMUNOL, V182, P4565, DOI 10.4049/jimmunol.0803893; Price DA, 1998, CURR BIOL, V8, P355, DOI 10.1016/S0960-9822(98)70138-1; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Trautmann A, 2003, TRENDS IMMUNOL, V24, P425, DOI 10.1016/S1471-4906(03)00182-0; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 2003, FUNDAMENTAL IMMUNOLO, P321; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044	32	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26096	26105		10.1074/jbc.M109.039966	http://dx.doi.org/10.1074/jbc.M109.039966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19628870	Green Published, hybrid			2022-12-25	WOS:000269738000065
J	Martin, JL; Lin, MZ; McGowan, EM; Baxter, RC				Martin, Janet L.; Lin, Mike Z.; McGowan, Eileen M.; Baxter, Robert C.			Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; FACTOR RECEPTOR; SURFACE BINDING; DNA-SYNTHESIS; IGF ACTION; FACTOR-I; APOPTOSIS; EXPRESSION; IGFBP-3; SPHINGOSINE-1-PHOSPHATE	We have investigated the mechanism underlying potentiation of epidermal growth factor receptor (EGFR) and type 1 insulin-like growth factor receptor (IGFR1) signaling by IGF-binding protein-3 (IGFBP-3) in MCF-10A breast epithelial cells, focusing on a possible involvement of the sphingosine kinase (SphK) system. IGFBP-3 potentiated EGF-stimulated EGF receptor activation and DNA synthesis, and this was blocked by inhibitors of SphK activity or small interference RNA-mediated silencing of SphK1, but not SphK2, expression. Similarly, IGFR1 phosphorylation and DNA synthesis stimulated by LR3-IGF-I (an IGF-I analog not bound by IGFBP-3), were enhanced by IGFBP-3, and this was blocked by SphK1 silencing. SphK1 expression and activity were stimulated by IGFBP-3 similar to 2-fold over 24 h. Silencing of sphingosine 1-phosphate receptor 1 (S1P(1)) or S1P(3), but not S1P(2), abolished the effect of IGFBP-3 on EGF-stimulated EGFR activation. The effects of IGFBP-3 could be reproduced with exogenous S1P or medium conditioned by cells treated with IGFBP-3, and this was also blocked by inhibition of S1P1 and S1P3. These data indicate that potentiation of growth factor signaling by IGFBP-3 in MCF-10A cells requires SphK1 activity and S1P1/S1P3, suggesting that S1P, the product of SphK activity and ligand for S1P1 and S1P3, is the "missing link" mediating IGF and EGFR transactivation and cell growth stimulation by IGFBP-3.	[Martin, Janet L.; Lin, Mike Z.; Baxter, Robert C.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Grp, St Leonards, NSW 2065, Australia; [McGowan, Eileen M.] Centenary Inst, Sydney, NSW 2050, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Centenary Institute	Martin, JL (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Grp, St Leonards, NSW 2065, Australia.	janetlm@med.usyd.edu.au	Baxter, Robert C/F-3927-2012	Baxter, Robert C/0000-0001-5061-2142; McGowan, Eileen/0000-0001-6371-3751	National Health and Medical Research Council [302153]; Cancer Institute New South Wales Career Development and Support Fellowship; Cancer Institute New South Wales Early Career Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development and Support Fellowship; Cancer Institute New South Wales Early Career Award	This work was supported, in whole or in part, by National Health and Medical Research Council Grant 302153 ( to J.L.M. and R. C. B.). This work was also supported by a Cancer Institute New South Wales Career Development and Support Fellowship ( to J.L.M.) and a Cancer Institute New South Wales Early Career Award ( to E. M.).	Ahmad T, 2004, J BIOL CHEM, V279, P1713, DOI 10.1074/jbc.M306156200; Ali O, 2003, HORM METAB RES, V35, P726; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; BASOLO F, 1991, MOL CARCINOGEN, V4, P25, DOI 10.1002/mc.2940040106; BAXTER RC, 1986, J CLIN INVEST, V78, P1504, DOI 10.1172/JCI112742; Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; Butt AJ, 2002, ENDOCRINOLOGY, V143, P2693, DOI 10.1210/en.143.7.2693; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; CHEN JC, 1994, J CELL PHYSIOL, V158, P69, DOI 10.1002/jcp.1041580110; CONOVER CA, 1992, ENDOCRINOLOGY, V130, P3191, DOI 10.1210/en.130.6.3191; Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; El-Shewy HM, 2006, J BIOL CHEM, V281, P31399, DOI 10.1074/jbc.M605339200; Firth SM, 1998, BIOCHEM BIOPH RES CO, V246, P325, DOI 10.1006/bbrc.1998.8615; Firth SM, 1999, PROTEIN EXPRES PURIF, V16, P202, DOI 10.1006/prep.1999.1075; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes BE, 2002, EUR J BIOCHEM, V269, P961, DOI 10.1046/j.0014-2956.2001.02735.x; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Grill CJ, 2000, J CELL PHYSIOL, V183, P273, DOI 10.1002/(SICI)1097-4652(200005)183:2<273::AID-JCP14>3.3.CO;2-A; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kim JH, 2000, IUBMB LIFE, V50, P119, DOI 10.1080/713803698; Kwon YG, 2001, J BIOL CHEM, V276, P10627, DOI 10.1074/jbc.M011449200; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Martin JL, 1999, J BIOL CHEM, V274, P16407, DOI 10.1074/jbc.274.23.16407; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; McCaig C, 2002, J CELL SCI, V115, P4293, DOI 10.1242/jcs.00097; MURPHY LJ, 1995, J MOL ENDOCRINOL, V15, P293, DOI 10.1677/jme.0.0150293; OH YM, 1993, J BIOL CHEM, V268, P14964; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Perks C, 2003, HORM METAB RES, V35, P828; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; Rosenfeldt HM, 2001, BIOCHEM SOC T, V29, P836, DOI 10.1042/0300-5127:0290836; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Schedlich LJ, 2004, BIOCHEM BIOPH RES CO, V314, P83, DOI 10.1016/j.bbrc.2003.12.049; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang D, 2008, MOL CANCER THER, V7, P1993, DOI 10.1158/1535-7163.MCT-08-0088; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yamazaki K, 2003, ONCOGENE, V22, P847, DOI 10.1038/sj.onc.1206153; Yu H, 1996, BRIT J CANCER, V74, P1242, DOI 10.1038/bjc.1996.523	53	62	62	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25542	25552		10.1074/jbc.M109.007120	http://dx.doi.org/10.1074/jbc.M109.007120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19633297	Green Published, hybrid			2022-12-25	WOS:000269738000011
J	Sher, YP; Tzeng, TF; Kan, SF; Hsu, J; Xie, X; Han, Z; Lin, WC; Li, LY; Hung, MC				Sher, Y-P; Tzeng, T-F; Kan, S-F; Hsu, J.; Xie, X.; Han, Z.; Lin, W-C; Li, L-Y; Hung, M-C			Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival	ONCOGENE			English	Article						targeted gene therapy; lung cancer; BiKDD; VISA; survivin	CELL-DIVISION; EXPRESSION; APOPTOSIS; PROMOTER; CARCINOMA; PULMONARY; MODELS; TUMORS	Lung cancer is a leading cause of cancer death due to the high incidence of metastasis; therefore, novel and effective treatments are urgently needed. A current strategy is cancer-specific targeted gene therapy. Although many identified that cancer-specific promoters are highly specific, they tend to have low activity compared with the ubiquitous cytomegalovirus (CMV) promoter, limiting their application. We developed a targeted gene therapy expression system for lung cancer that is highly specific with strong activity. Our expression vector uses the survivin promoter, highly expressed in many cancers but not normal adult tissues. We enhanced the survivin promoter activity comparable to the CMV promoter in lung cancer cell lines using an established platform technology, whereas the survivin promoter remained weak in normal cells. In mouse models, the transgene was specifically expressed in the lung tumor tissue, compared with the CMV promoter that was expressed in both normal and tumor tissues. In addition, the therapeutic gene BikDD, a mutant form of pro-apoptotic Bcl2 interacting killer, induced cell killing in vitro, and inhibited cell growth and prolonged mouse survival in vivo. Importantly, there was virtually no toxicity when BikDD was expressed with our expression system. Thus, the current report provides a therapeutic efficacy and safe strategy worthy of development in clinical trials treating lung cancer. Oncogene (2009) 28, 3286-3295; doi:10.1038/onc.2009.187; published online 13 July 2009	[Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 079, Houston, TX 77030 USA; [Sher, Y-P; Tzeng, T-F; Kan, S-F; Li, L-Y; Hung, M-C] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Sher, Y-P; Tzeng, T-F; Kan, S-F; Li, L-Y; Hung, M-C] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung, Taiwan; [Lin, W-C] China Med Univ, Dept Pharmacol, Sch Med, Taichung, Taiwan; [Li, L-Y; Hung, M-C] Asia Univ, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 079, 1515 Holcombe Blvd, Houston, TX 77030 USA.	lyl@mail.cmu.edu.tw; mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Sher, Yuh-Pyng/0000-0002-6062-7556; Li, Long-Yuan/0000-0001-7472-8318	NRPGM [DOH97-TD-G-111-041]; MDACC SPORE [P20 CA101936, 1P50 CA116199, DOH97-TD-111-TM003]; National Health Research Institutes, Taiwan [PD9602]; NATIONAL CANCER INSTITUTE [R01CA109311, P50CA116199, P01CA099031, P20CA101936] Funding Source: NIH RePORTER	NRPGM; MDACC SPORE; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants from NRPGM in DOH97-TD-G-111-041 and MDACC SPORE grants in pancreatic (P20 CA101936) and breast (1P50 CA116199) cancer ( to M-C Hung) and DOH97-TD-111-TM003 ( to L-Y Li). YP Sher was also supported by a postdoctoral fellowship award from the National Health Research Institutes, Taiwan (PD9602). In memory of Mr Nan-Tu Huang, the late Chairman of Wei-Chuan Group in Taiwan for his courageous battle in lung cancer.	Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chen JS, 2004, CANCER GENE THER, V11, P740, DOI 10.1038/sj.cgt.7700752; Day CP, 2006, CANCER GENE THER, V13, P706, DOI 10.1038/sj.cgt.7700945; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; Fukazawa T, 2007, MOL CANCER THER, V6, P244, DOI 10.1158/1535-7163.MCT-06-0408; Gunther Michael, 2005, Curr Med Chem Anticancer Agents, V5, P157, DOI 10.2174/1568011053174855; Hay RJ, 1996, J CELL BIOCHEM, P107; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huang L., 2005, NONVIRAL VECTORS G 1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li YM, 2003, CANCER RES, V63, P7630; MCLEMORE TL, 1988, CANCER RES, V48, P2880; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Oshikiri T, 2006, CANCER GENE THER, V13, P856, DOI 10.1038/sj.cgt.7700953; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Retzer-Lidl M, 2007, INT J CANCER, V121, P66, DOI 10.1002/ijc.22619; Russ V, 2007, PHARM RES-DORDR, V24, P1047, DOI 10.1007/s11095-006-9233-9; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Xie XM, 2007, CANCER CELL, V12, P52, DOI 10.1016/j.ccr.2007.05.009; Zaffaroni N, 2005, J CELL MOL MED, V9, P360, DOI 10.1111/j.1582-4934.2005.tb00361.x	25	36	37	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2009	28	37					3286	3295		10.1038/onc.2009.187	http://dx.doi.org/10.1038/onc.2009.187			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	495LS	19597463	Green Accepted			2022-12-25	WOS:000269893700003
J	Adhikari, ND; Orler, R; Chory, J; Froehlich, JE; Larkin, RM				Adhikari, Neil D.; Orler, Robert; Chory, Joanne; Froehlich, John E.; Larkin, Robert M.			Porphyrins Promote the Association of GENOMES UNCOUPLED 4 and a Mg-chelatase Subunit with Chloroplast Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRINOGEN-IX-OXIDASE; INNER ENVELOPE MEMBRANE; MAGNESIUM-CHELATASE; TETRAPYRROLE BIOSYNTHESIS; UROPORPHYRINOGEN DECARBOXYLASE; SUBCELLULAR-LOCALIZATION; CHLOROPHYLL SYNTHESIS; GENE-EXPRESSION; ACTIVE PROTEIN; ANTISENSE RNA	In plants, chlorophylls and other tetrapyrroles are synthesized from a branched pathway that is located within chloroplasts. GUN4 (GENOMES UNCOUPLED 4) stimulates chlorophyll biosynthesis by activating Mg-chelatase, the enzyme that commits porphyrins to the chlorophyll branch. GUN4 stimulates Mg-chelatase by a mechanism that involves binding the ChlH subunit of Mg-chelatase, as well as a substrate (protoporphyrin IX) and product (Mg-protoporphyrin IX) of Mg-chelatase. We chose to test whether GUN4 might also affect interactions between Mg-chelatase and chloroplast membranes, the site of chlorophyll biosynthesis. To test this idea, we induced chlorophyll precursor levels in purified pea chloroplasts by feeding these chloroplasts with 5-aminolevulinic acid, determined the relative levels of GUN4 and Mg-chelatase subunits in soluble and membrane-containing fractions derived from these chloroplasts, and quantitated Mg-chelatase activity in membranes isolated from these chloroplasts. We also monitored GUN4 levels in the soluble and membrane-containing fractions derived from chloroplasts fed with various porphyrins. Our results indicate that 5-aminolevulinic acid feeding stimulates Mg-chelatase activity in chloroplast membranes and that the porphyrin-bound forms of GUN4 and possibly ChlH associate most stably with chloroplast membranes. These findings are consistent with GUN4 stimulating chlorophyll biosynthesis not only by activating Mg-chelatase but also by promoting interactions between ChlH and chloroplast membranes.	[Larkin, Robert M.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Adhikari, Neil D.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Larkin, Robert M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Michigan State University; Michigan State University; Michigan State University; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Larkin, RM (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, Rm 106,Plant Biol Bldg, E Lansing, MI 48824 USA.	larkinr@msu.edu		Adhikari, Neil/0000-0002-2935-1870	Department of Energy [DE-FG02-91ER20021]; National Science Foundation [IOB 0517841, DE-FG02-04ER15540]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Department of Energy Grant DE-FG02-91ER20021 and National Science Foundation Grants IOB 0517841 (to R.M.L.) and DE-FG02-04ER15540 (to J.C.).	Block MA, 2002, EUR J BIOCHEM, V269, P240, DOI 10.1046/j.0014-2956.2001.02643.x; BROWN SB, 1969, BIOCHEM J, V115, P279, DOI 10.1042/bj1150279; Bruce BD, 1994, PLANT MOL BIOL MAN J, VJ1, P1; Che FS, 2000, PLANT PHYSIOL, V124, P59, DOI 10.1104/pp.124.1.59; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Eichwurzel I, 2000, J PHOTOCH PHOTOBIO B, V54, P194, DOI 10.1016/S1011-1344(00)00016-6; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; FUESLER TP, 1981, PLANT PHYSIOL, V67, P246, DOI 10.1104/pp.67.2.246; FUFSLER TP, 1984, PLANT PHYSIOL, V74, P928, DOI 10.1104/pp.74.4.928; Gibson LCD, 1996, PLANT PHYSIOL, V111, P61, DOI 10.1104/pp.111.1.61; GOUGH S, 1972, BIOCHIM BIOPHYS ACTA, V286, P36, DOI 10.1016/0304-4165(72)90086-4; GRANICK S, 1961, J BIOL CHEM, V236, P1168; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; HARLOW E, 1999, USING ANTIBODIES LAB, P70; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jensen PE, 1999, FEBS LETT, V455, P349, DOI 10.1016/S0014-5793(99)00909-6; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Johnson ET, 2008, J BIOL CHEM, V283, P27776, DOI 10.1074/jbc.M804486200; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kohler RH, 2000, J CELL SCI, V113, P3921; KONCZ C, 1990, EMBO J, V9, P1337, DOI 10.1002/j.1460-2075.1990.tb08248.x; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lermontova I, 1997, P NATL ACAD SCI USA, V94, P8895, DOI 10.1073/pnas.94.16.8895; Luo MZ, 1999, PLANT MOL BIOL, V41, P721, DOI 10.1023/A:1006335317876; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Mock HP, 1999, J BIOL CHEM, V274, P4231, DOI 10.1074/jbc.274.7.4231; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; Mohapatra A, 2007, PHOTOSYNTH RES, V94, P401, DOI 10.1007/s11120-007-9209-6; Nakayama M, 1998, PLANT CELL PHYSIOL, V39, P275, DOI 10.1093/oxfordjournals.pcp.a029368; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Rebeiz CA, 2002, HEME CHLOROPHYLL BIL, P111; RIMINGTON C, 1960, BIOCHEM J, V75, P620, DOI 10.1042/bj0750620; Sambrook J, 2001, MOL CLONING LAB MANU; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Stephenson PG, 2008, PHOTOCH PHOTOBIO SCI, V7, P1243, DOI 10.1039/b802596g; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Suzuki T, 2002, J BIOL CHEM, V277, P4731, DOI 10.1074/jbc.M105613200; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; THOMAS J, 1990, PLANT PHYSIOL, V94, P1414, DOI 10.1104/pp.94.3.1414; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; van Lis R, 2005, PLANT PHYSIOL, V139, P1946, DOI 10.1104/pp.105.069732; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Vinti G, 2000, PLANT J, V24, P883, DOI 10.1046/j.1365-313x.2000.00936.x; WALKER CJ, 1991, P NATL ACAD SCI USA, V88, P5789, DOI 10.1073/pnas.88.13.5789; WALKER CJ, 1991, PLANT PHYSIOL, V95, P1189, DOI 10.1104/pp.95.4.1189; Watanabe N, 2001, J BIOL CHEM, V276, P20474, DOI 10.1074/jbc.M101140200; Wilde A, 2004, FEBS LETT, V571, P119, DOI 10.1016/j.febslet.2004.06.063; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714	65	50	52	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24783	24796		10.1074/jbc.M109.025205	http://dx.doi.org/10.1074/jbc.M109.025205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605356	Green Published, hybrid			2022-12-25	WOS:000269734000013
J	Cao, ZX; Wara, AK; Icli, B; Sun, XH; Packard, RRS; Esen, F; Stapleton, CJ; Subramaniam, M; Kretschmer, K; Apostolou, I; von Boehmer, H; Hansson, GK; Spelsberg, TC; Libby, P; Feinberg, MW				Cao, Zhuoxiao; Wara, Akm Khyrul; Icli, Basak; Sun, Xinghui; Packard, Rene R. S.; Esen, Fehim; Stapleton, Christopher J.; Subramaniam, Malayannan; Kretschmer, Karsten; Apostolou, Irina; von Boehmer, Harald; Hansson, Goran K.; Spelsberg, Thomas C.; Libby, Peter; Feinberg, Mark W.			Kruppel-like Factor KLF10 Targets Transforming Growth Factor-beta 1 to Regulate CD4(+)CD25(-) T Cells and T Regulatory Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FOXP3; TGF-BETA; CUTTING EDGE; TRANSPLANT ARTERIOSCLEROSIS; ACCELERATES ATHEROSCLEROSIS; AGGRAVATES ATHEROSCLEROSIS; VASCULAR INFLAMMATION; PERIPHERAL TOLERANCE; FACTOR EKLF	CD4(+)CD25(+) regulatory T cells (T regs) play a major role in the maintenance of self-tolerance and immune suppression, although the mechanisms controlling T reg development and suppressor function remain incompletely understood. Herein, we provide evidence that Kruppel-like factor 10 (KLF10/TIEG1) constitutes an important regulator of T regulatory cell suppressor function and CD4(+)CD25(-) T cell activation through distinct mechanisms involving transforming growth factor (TGF)-beta 1 and Foxp3. KLF10 overexpressing CD4(+)CD25(-) T cells induced both TGF-beta 1 and Foxp3 expression, an effect associated with reduced T-Bet (Th1 marker) and Gata3 (Th2 marker) mRNA expression. Consistently, KLF10(-/-) CD4(+)CD25(-) T cells have enhanced differentiation along both Th1 and Th2 pathways and elaborate higher levels of Th1 and Th2 cytokines. Furthermore, KLF10(-/-) CD4(+)CD25(-) T cell effectors cannot be appropriately suppressed by wild-type T regs. Surprisingly, KLF10(-/-) T reg cells have reduced suppressor function, independent of Foxp3 expression, with decreased expression and elaboration of TGF-beta 1, an effect completely rescued by exogenous treatment with TGF-beta 1. Mechanistic studies demonstrate that in response to TGF-beta 1, KLF10 can transactivate both TGF-beta 1 and Foxp3 promoters, implicating KLF10 in a positive feedback loop that may promote cell-intrinsic control of T cell activation. Finally, KLF10(-/-) CD4(+)CD25(-) T cells promoted atherosclerosis by similar to 2-fold in ApoE(-/-)/scid/scid mice with increased leukocyte accumulation and peripheral pro-inflammatory cytokines. Thus, KLF10 is a critical regulator in the transcriptional network controlling TGF-beta 1 in both CD4(+)CD25(-) T cells and T regs and plays an important role in regulating atherosclerotic lesion formation in mice.	[Cao, Zhuoxiao; Wara, Akm Khyrul; Icli, Basak; Sun, Xinghui; Packard, Rene R. S.; Esen, Fehim; Stapleton, Christopher J.; Libby, Peter; Feinberg, Mark W.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Cardiovasc Div, Boston, MA 02115 USA; [Subramaniam, Malayannan; Spelsberg, Thomas C.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA; [Kretschmer, Karsten; Apostolou, Irina; von Boehmer, Harald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; [Hansson, Goran K.] Karolinska Inst, Ctr Mol Med, SE-17176 Stockholm, Sweden; [Hansson, Goran K.] Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden; [Stapleton, Christopher J.] Harvard Univ, Sch Med, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mayo Clinic; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Karolinska Institutet; Karolinska Institutet; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute	Feinberg, MW (corresponding author), 77 Ave Louis Pasteur,NRB 742F, Boston, MA 02115 USA.	mfeinberg@rics.bwh.harvard.edu	Kretschmer, Karsten/E-8174-2010; Libby, Peter/AAY-6404-2021; Esen, Fehim/AAA-1283-2022; Hansson, Goran K/B-7423-2012; Stapleton, Christopher/AAZ-5389-2021	Kretschmer, Karsten/0000-0001-6770-4078; Libby, Peter/0000-0002-1502-502X; Esen, Fehim/0000-0002-9948-5575; Stapleton, Christopher/0000-0003-4805-0093; Hansson, Goran/0000-0003-4148-5190; Packard, Rene/0000-0002-8520-5843; Feinberg, Mark/0000-0001-9523-3859	National Institutes of Health [HL080174, HL091076, F32HL086157, F32HL088819, DE14036]; American Cancer Society Research Scholar Grant [RSG0719501-LIB]; Leducq Transatlantic Network on Atherothrombosis; Swedish Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL088819, R01HL091076, R01HL080174, F32HL086157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Leducq Transatlantic Network on Atherothrombosis; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080174 and HL091076 (to M.W.F.), F32HL086157 (to Z.C.), F32HL088819 (to A.K.W.), and DE14036 (to T.C.S. and M.S.). This work was also supported by American Cancer Society Research Scholar Grant RSG0719501-LIB (to M. W. F.), the Leducq Transatlantic Network on Atherothrombosis (to R.R.S.P., G.K.H., and P.L.), and the Swedish Research Council (to G.K.H.).	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Bommireddy R, 2006, LAB INVEST, V86, P1008, DOI 10.1038/labinvest.3700460; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Feinberg MW, 2005, PANMINERVA MED, V47, P169; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Koglin J, 1998, CIRC RES, V83, P652, DOI 10.1161/01.RES.83.6.652; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shi CW, 1999, J CLIN INVEST, V103, P469, DOI 10.1172/JCI4584; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Song A, 1999, IMMUNITY, V10, P93, DOI 10.1016/S1074-7613(00)80010-2; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Yang XXO, 2003, BLOOD, V101, P4492, DOI 10.1182/blood-2002-08-2579; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	62	73	74	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24914	24924		10.1074/jbc.M109.000059	http://dx.doi.org/10.1074/jbc.M109.000059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19602726	Green Published, hybrid			2022-12-25	WOS:000269734000025
J	Martinez-Iglesias, O; Garcia-Silva, S; Regadera, J; Aranda, A				Martinez-Iglesias, Olaia; Garcia-Silva, Susana; Regadera, Javier; Aranda, Ana			Hypothyroidism Enhances Tumor Invasiveness and Metastasis Development	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; CELL-SURFACE RECEPTOR; NUCLEAR RECEPTORS; PICROSIRIUS RED; BREAST-CANCER; LIVER-CANCER; EXPRESSION; GENE; BETA-1	Background: Whereas there is increasing evidence that loss of expression and/or function of the thyroid hormone receptors (TRs) could result in a selective advantage for tumor development, the relationship between thyroid hormone levels and human cancer is a controversial issue. It has been reported that hypothyroidism might be a possible risk factor for liver and breast cancer in humans, but a lower incidence of breast carcinoma has been also reported in hypothyroid patients Methodology/Principal Findings: In this work we have analyzed the influence of hypothyroidism on tumor progression and metastasis development using xenografts of parental and TR beta 1-expressing human hepatocarcinoma (SK-hep1) and breast cancer cells (MDA-MB-468). In agreement with our previous observations tumor invasiveness and metastasis formation was strongly repressed when TR beta-expressing cells were injected into euthyroid nude mice. Whereas tumor growth was retarded when cells were inoculated into hypothyroid hosts, tumors had a more mesenchymal phenotype, were more invasive and metastatic growth was enhanced. Increased aggressiveness and tumor growth retardation was also observed with parental cells that do not express TRs. Conclusions/Significance: These results show that changes in the stromal cells secondary to host hypothyroidism can modulate tumor progression and metastatic growth independently of the presence of TRs on the tumor cells. On the other hand, the finding that hypothyroidism can affect differentially tumor growth and invasiveness can contribute to the explanation of the confounding reports on the influence of thyroidal status in human cancer.			Martinez-Iglesias, O (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	aaranda@iib.uam.es	Martínez-Iglesias, Olaia Antía/A-9793-2018; Garcia-Silva, Susana/AAW-8528-2021; Aranda, Ana/ABG-8820-2020	Martínez-Iglesias, Olaia Antía/0000-0002-7021-6865; Garcia-Silva, Susana/0000-0003-1065-0245; Aranda, Ana/0000-0002-8338-9589				Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; ALVARADOPISANI AR, 1986, ANTICANCER RES, V6, P1347; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ARANDA A, 2009, TRENDS ENDO IN PRESS; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; BRONNEGARD M, 1994, J CLIN ENDOCR METAB, V79, P384, DOI 10.1210/jc.79.2.384; Chan IH, 2006, ONCOGENE, V25, P3576, DOI 10.1038/sj.onc.1209389; Cristofanilli M, 2005, CANCER-AM CANCER SOC, V103, P1122, DOI 10.1002/cncr.20881; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; DRABKIN H, 1988, P NATL ACAD SCI USA, V85, P9258, DOI 10.1073/pnas.85.23.9258; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hercbergs AA, 2003, ANTICANCER RES, V23, P617; Horkko TT, 2006, INT J CANCER, V118, P1653, DOI 10.1002/ijc.21556; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kamiya Y, 2002, CARCINOGENESIS, V23, P25, DOI 10.1093/carcin/23.1.25; Koren R, 2001, ACTA HISTOCHEM, V103, P151, DOI 10.1078/0065-1281-00587; Ledda-Columbano GM, 2003, TOXICOL PATHOL, V31, P113, DOI 10.1080/01926230390173851; Ledda-Columbano GM, 1999, CARCINOGENESIS, V20, P2299, DOI 10.1093/carcin/20.12.2299; Lee JW, 2000, BRIT J CANCER, V83, P1674, DOI 10.1054/bjoc.2000.1505; Li Z, 2002, CANCER RES, V62, P1939; Lin KH, 1997, ENDOCRINOLOGY, V138, P5308, DOI 10.1210/en.138.12.5308; Lin KH, 2001, ENDOCRINOLOGY, V142, P653, DOI 10.1210/en.142.2.653; Lin KH, 1999, MOL CARCINOGEN, V26, P53, DOI 10.1002/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z; MARKOWITZ S, 1989, J CLIN INVEST, V84, P1683, DOI 10.1172/JCI114349; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Perra A, 2009, HEPATOLOGY, V49, P1287, DOI 10.1002/hep.22750; Puzianowska-Kuznicka M, 2002, J CLIN ENDOCR METAB, V87, P1120, DOI 10.1210/jc.87.3.1120; Reddy A, 2007, CLIN GASTROENTEROL H, V5, P118, DOI 10.1016/j.cgh.2006.07.011; Rocha AS, 2007, J ENDOCRINOL, V192, P83, DOI 10.1677/JOE-06-0009; Safer JD, 2001, THYROID, V11, P281, DOI 10.1089/105072501750159750; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Smyth PPA, 1997, ANN MED, V29, P189, DOI 10.3109/07853899708999335; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Wang CS, 2002, CANCER LETT, V175, P121, DOI 10.1016/S0304-3835(01)00722-4; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yokoe T, 1997, ANTICANCER RES, V17, P695; YOKOTA J, 1988, ONCOGENE, V2, P283; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392	49	71	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6428	10.1371/journal.pone.0006428	http://dx.doi.org/10.1371/journal.pone.0006428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641612	Green Published, Green Submitted, gold			2022-12-25	WOS:000268494500028
J	Susilo, T; Crookes, K; McKone, E; Turner, H				Susilo, Tirta; Crookes, Kate; McKone, Elinor; Turner, Hannah			The Composite Task Reveals Stronger Holistic Processing in Children than Adults for Child Faces	PLOS ONE			English	Article							OWN-RACE; EARLY MATURITY; RECOGNITION; AGE; BIAS; PERCEPTION; DISTINCTIVENESS; INFORMATION; MEMORY; SEX	Background: While own-age faces have been reported to be better recognized than other-age faces, the underlying cause of this phenomenon remains unclear. One potential cause is holistic face processing, a special kind of perceptual and cognitive processing reserved for perceiving upright faces. Previous studies have indeed found that adults show stronger holistic processing when looking at adult faces compared to child faces, but whether a similar own-age bias exists in children remains to be shown. Methodology/Principal Findings: Here we used the composite face task - a standard test of holistic face processing - to investigate if, for child faces, holistic processing is stronger for children than adults. Results showed child participants (8-13 years) had a larger composite effect than adult participants (22-65 years). Conclusions/Significance: Our finding suggests that differences in strength of holistic processing may underlie the own-age bias on recognition memory. We discuss the origin of own-age biases in terms of relative experience, face-space tuning, and social categorization.			Susilo, T (corresponding author), Australian Natl Univ, Dept Psychol, Canberra, ACT, Australia.	tirta.susilo@anu.edu.au	Crookes, Kate/H-8011-2013; Susilo, Tirta/S-1558-2016	Crookes, Kate/0000-0001-6887-6197; Susilo, Tirta/0000-0002-1130-3475; McKone, Elinor/0000-0003-1655-4297				Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Carey S, 1981, PERCEIVING REMEMBERI, P9; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Cassia VM, 2009, DEVELOPMENTAL SCI, V12, P236, DOI 10.1111/j.1467-7687.2008.00765.x; Crookes K, 2009, COGNITION, V111, P219, DOI 10.1016/j.cognition.2009.02.004; de Heering A, 2007, J EXP CHILD PSYCHOL, V96, P57, DOI 10.1016/j.jecp.2006.07.001; de Heering A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002317; ELLIS H, 1973, J GENET PSYCHOL, V123, P173, DOI 10.1080/00221325.1973.10533202; Gilchrist A, 2003, VIS COGN, V10, P769, DOI 10.1080/13506280344000022; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; KUEFNER D, VISUAL COGN IN PRESS; Kuefner D, 2008, J EXP PSYCHOL HUMAN, V34, P811, DOI 10.1037/0096-1523.34.4.811; Lamont AC, 2005, MEM COGNITION, V33, P1017, DOI 10.3758/BF03193209; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2006, J EXP CHILD PSYCHOL, V94, P134, DOI 10.1016/j.jecp.2006.01.001; McKone E, 2007, COGNITION, V103, P331, DOI 10.1016/j.cognition.2006.05.014; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; MICHEL C, VISUAL COGN IN PRESS; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Pellicano E, 2003, PSYCHOL SCI, V14, P618, DOI 10.1046/j.0956-7976.2003.psci_1474.x; Pellicano E, 2006, DEVELOPMENTAL SCI, V9, P270, DOI 10.1111/j.1467-7687.2006.00489.x; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; Rehnman J, 2007, ACTA PSYCHOL, V124, P344, DOI 10.1016/j.actpsy.2006.04.004; Rhodes G., 2005, FITTING MIND WORLD A, P213, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0009; Robbins R, 2007, COGNITION, V103, P34, DOI 10.1016/j.cognition.2006.02.008; Rossion B, 2008, J VISION, V8, DOI 10.1167/8.4.3; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	34	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6460	10.1371/journal.pone.0006460	http://dx.doi.org/10.1371/journal.pone.0006460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CF	19641627	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500032
J	Simone, NL; Soule, BP; Ly, D; Saleh, AD; Savage, JE; DeGraff, W; Cook, J; Harris, CC; Gius, D; Mitchell, JB				Simone, Nicole L.; Soule, Benjamin P.; Ly, David; Saleh, Anthony D.; Savage, Jason E.; DeGraff, William; Cook, John; Harris, Curtis C.; Gius, David; Mitchell, James B.			Ionizing Radiation-Induced Oxidative Stress Alters miRNA Expression	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MICRORNAOME DEREGULATION; TRANSCRIPTION FACTOR; KAPPA-B; RESISTANCE; SIGNATURE	Background: MicroRNAs (miRNAs) are small, highly conserved, non-coding RNA that alter protein expression and regulate multiple intracellular processes, including those involved in the response to cellular stress. Alterations in miRNA expression may occur following exposure to several stress-inducing anticancer agents including ionizing radiation, etoposide, and hydrogen peroxide (H(2)O(2)). Methodology/Principal Findings: Normal human fibroblasts were exposed to radiation, H(2)O(2), or etoposide at doses determined by clonogenic cell survival curves. Total RNA was extracted and miRNA expression was determined by microarray. Time course and radiation dose responses were determined using RT-PCR for individual miRNA species. Changes in miRNA expression were observed for 17 miRNA species following exposure to radiation, 23 after H(2)O(2) treatment, and 45 after etoposide treatment. Substantial overlap between the miRNA expression changes between agents was observed suggesting a signature miRNA response to cell stress. Changes in the expression of selected miRNA species varied in response to radiation dose and time. Finally, production of reactive oxygen species (ROS) increased with increasing doses of radiation and pre-treatment with the thiol antioxidant cysteine decreased both ROS production and the miRNA response to radiation. Conclusions: These results demonstrate a common miRNA expression signature in response to exogenous genotoxic agents including radiation, H(2)O(2), and etoposide. Additionally, pre-treatment with cysteine prevented radiation-induced alterations in miRNA expression which suggests that miRNAs are responsive to oxidative stress. Taken together, these results imply that miRNAs play a role in cellular defense against exogenous stress and are involved in the generalized cellular response to genotoxic oxidative stress.			Simone, NL (corresponding author), NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	simonen@mail.nih.gov		Simone, Nicole/0000-0002-7662-7470	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC006321, ZIABC010033, ZIABC005795, ZIASC006387, Z01BC010033, Z01SC006387] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bruno I, 2006, CELL, V125, P1036, DOI 10.1016/j.cell.2006.06.003; Gius D, 1999, TOXICOL LETT, V106, P93, DOI 10.1016/S0378-4274(99)00024-7; Grana TM, 2002, CANCER RES, V62, P4142; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Ilnytskyy Y, 2008, BIOCHEM BIOPH RES CO, V377, P41, DOI 10.1016/j.bbrc.2008.09.080; Ishii Hideshi, 2006, Med Chem, V2, P555; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; Koturbash I, 2008, CELL CYCLE, V7, P1658, DOI 10.4161/cc.7.11.5981; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lee HJ, 2006, P NATL ACAD SCI USA, V103, P15669, DOI 10.1073/pnas.0605781103; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; *WHIT I BIOM RES, 2008, TARGETSCANHUMAN; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	24	255	269	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6377	10.1371/journal.pone.0006377	http://dx.doi.org/10.1371/journal.pone.0006377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633716	gold, Green Published, Green Submitted			2022-12-25	WOS:000268404800009
J	Kaur, S; Thankachan, S; Begum, S; Liu, M; Blanco-Centurion, C; Shiromani, PJ				Kaur, Satvinder; Thankachan, Stephen; Begum, Suraiya; Liu, Meng; Blanco-Centurion, Carlos; Shiromani, Priyattam J.			Hypocretin-2 Saporin Lesions of the Ventrolateral Periaquaductal Gray (vlPAG) Increase REM Sleep in Hypocretin Knockout Mice	PLOS ONE			English	Article								Ten years ago the sleep disorder narcolepsy was linked to the neuropeptide hypocretin (HCRT), also known as orexin. This disorder is characterized by excessive day time sleepiness, inappropriate triggering of rapid-eye movement (REM) sleep and cataplexy, which is a sudden loss of muscle tone during waking. It is still not known how HCRT regulates REM sleep or muscle tone since HCRT neurons are localized only in the lateral hypothalamus while REM sleep and muscle atonia are generated from the brainstem. To identify a potential neuronal circuit, the neurotoxin hypocretin-2-saporin (HCRT2-SAP) was used to lesion neurons in the ventral lateral periaquaductal gray (vlPAG). The first experiment utilized hypocretin knockout (HCRT-ko) mice with the expectation that deletion of both HCRT and its target neurons would exacerbate narcoleptic symptoms. Indeed, HCRT-ko mice (n = 8) given the neurotoxin HCRT2-SAP (16.5 ng/23nl/sec each side) in the vlPAG had levels of REM sleep and sleep fragmentation that were considerably higher compared to HCRT-ko given saline (+39%; n = 7) or wildtype mice (+177%; n = 9). However, cataplexy attacks did not increase, nor were levels of wake or non-REM sleep changed. Experiment 2 determined the effects in mice where HCRT was present but the downstream target neurons in the vlPAG were deleted by the neurotoxin. This experiment utilized an FVB-transgenic strain of mice where eGFP identifies GABA neurons. We verified this and also determined that eGFP neurons were immunopositive for the HCRT-2 receptor. vlPAG lesions in these mice increased REM sleep (+79% versus saline controls) and it was significantly correlated (r = 0.89) with loss of eGFP neurons. These results identify the vlPAG as one site that loses its inhibitory control over REM sleep, but does not cause cataplexy, as a result of hypocretin deficiency.			Kaur, S (corresponding author), Vet Affairs Boston Healthcare Syst, W Roxbury, MA USA.	pshiromani@hms.harvard.edu		Thankachan, Stephen/0000-0002-7499-9019; Blanco-Centurion, Carlos/0000-0002-3344-1713	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030140, R01NS052287] Funding Source: NIH RePORTER; NINDS NIH HHS [NS052287, R01 NS052287, R01 NS030140, NS030140] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beuckmann CT, 2004, J NEUROSCI, V24, P4469, DOI 10.1523/JNEUROSCI.5560-03.2004; Blanco-Centurion C, 2004, EUR J NEUROSCI, V19, P2741, DOI 10.1111/j.0953-816X.2004.03366.x; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Brischoux F, 2008, J COMP NEUROL, V510, P607, DOI 10.1002/cne.21803; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gerashchenko D, 2004, SLEEP, V27, P1275, DOI 10.1093/sleep/27.7.1275; Gerashchenko D, 2003, NEUROSCIENCE, V116, P223, DOI 10.1016/S0306-4522(02)00575-4; Gerashchenko D, 2001, J NEUROSCI, V21, P7273, DOI 10.1523/JNEUROSCI.21-18-07273.2001; Greco MA, 2001, MOL BRAIN RES, V88, P176, DOI 10.1016/S0169-328X(01)00039-0; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Holscher C, 2003, EUR J NEUROSCI, V18, P2037, DOI 10.1046/j.1460-9568.2003.02903.x; Hunsley MS, 2006, GENES BRAIN BEHAV, V5, P451, DOI 10.1111/j.1601-183X.2005.00179.x; Jones BE, 2004, ARCH ITAL BIOL, V142, P379; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu M, 2008, EUR J NEUROSCI, V28, P1382, DOI 10.1111/j.1460-9568.2008.06446.x; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Muir GM, 1998, HIPPOCAMPUS, V8, P526, DOI 10.1002/(SICI)1098-1063(1998)8:5<526::AID-HIPO10>3.3.CO;2-M; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; PETITJEAN F, 1975, BRAIN RES, V88, P439, DOI 10.1016/0006-8993(75)90656-3; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Thakkar MA, 2002, BRAIN RES, V945, P276, DOI 10.1016/S0006-8993(02)02914-1; Thankachan S, 2009, J NEUROSCI, V29, P1580, DOI 10.1523/JNEUROSCI.5151-08.2009; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Toth LA, 2003, BEHAV GENET, V33, P325, DOI 10.1023/A:1023402709896; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zhang SW, 2007, J PHYSIOL-LONDON, V581, P649, DOI 10.1113/jphysiol.2007.129510	38	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6346	10.1371/journal.pone.0006346	http://dx.doi.org/10.1371/journal.pone.0006346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623260	Green Submitted, Green Published, gold			2022-12-25	WOS:000268260100020
J	Brancucci, A; Dipinto, R; Mosesso, I; Tommasi, L				Brancucci, Alfredo; Dipinto, Rosanna; Mosesso, Ilaria; Tommasi, Luca			Vowel Identity between Note Labels Confuses Pitch Identification in Non-Absolute Pitch Possessors	PLOS ONE			English	Article							HEMISPHERE SPECIALIZATION; RELATIVE PITCH; SPEECH SOUNDS; PERCEPTION; STIMULI; DISCRIMINATION; MUSICIANS; LATERALIZATION; MEMORY; TONES	The simplest and likeliest assumption concerning the cognitive bases of absolute pitch (AP) is that at its origin there is a particularly skilled function which matches the height of the perceived pitch to the verbal label of the musical tone. Since there is no difference in sound frequency resolution between AP and non-AP (NAP) musicians, the hypothesis of the present study is that the failure of NAP musicians in pitch identification relies mainly in an inability to retrieve the correct verbal label to be assigned to the perceived musical note. The primary hypothesis is that, when asked to identify tones, NAP musicians confuse the verbal labels to be attached to the stimulus on the basis of their phonetic content. Data from two AP tests are reported, in which subjects had to respond in the presence or in the absence of visually presented verbal note labels (fixed Do solmization). Results show that NAP musicians confuse more frequently notes having a similar vowel in the note label. They tend to confuse e. g. a 261 Hz tone (Do) more often with Sol than, e. g., with La. As a second goal, we wondered whether this effect is lateralized, i.e. whether one hemisphere is more responsible than the other in the confusion of notes with similar labels. This question was addressed by observing pitch identification during dichotic listening. Results showed that there is a right hemispheric disadvantage, in NAP but not AP musicians, in the retrieval of the verbal label to be assigned to the perceived pitch. The present results indicate that absolute pitch has strong verbal bases, at least from a cognitive point of view.			Brancucci, A (corresponding author), Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy.	alfredo.brancucci@unich.it	Tommasi, Luca/F-3638-2012	Tommasi, Luca/0000-0003-0664-714X				Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; Bermudez P, 2005, J NEUROSCI, V25, P7718, DOI 10.1523/JNEUROSCI.1560-05.2005; Brancucci A, 2005, NEUROPSYCHOLOGIA, V43, P1916, DOI 10.1016/j.neuropsychologia.2005.03.005; Brancucci A, 2004, EUR J NEUROSCI, V19, P2329, DOI 10.1111/j.0953-816X.2004.03302.x; Brancucci A, 2003, NEUROPSYCHOLOGY, V17, P451, DOI 10.1037/0894-4105.17.3.451; Brancucci A, 1999, NEUROPSYCHOLOGIA, V37, P1445, DOI 10.1016/S0028-3932(99)00065-2; Brancucci A, 2008, NEUROPSYCHOLOGIA, V46, P2013, DOI 10.1016/j.neuropsychologia.2008.01.019; BURNS EM, 1994, J ACOUST SOC AM, V96, P2704, DOI 10.1121/1.411447; Della Penna S, 2007, CEREB CORTEX, V17, P2303, DOI 10.1093/cercor/bhl139; Gregersen PK, 2001, AM J MED GENET, V98, P280, DOI 10.1002/1096-8628(20010122)98:3<280::AID-AJMG1083>3.0.CO;2-6; Hamilton RH, 2004, NEUROREPORT, V15, P803, DOI 10.1097/00001756-200404090-00012; Hsieh IH, 2008, HEARING RES, V240, P73, DOI 10.1016/j.heares.2008.01.017; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; KIMURA D, 1967, CORTEX, V3, P168; Levitin D.J., 1999, INT J COMPUT INT SYS, V4, P255; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; Paivio, 1986, MENTAL REPRESENTATIO; Roederer JG, 1973, INTRO PHYS PSYCHOPHY; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; VERCOE BL, 1992, MANUAL AUDIO PROCESS; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; Wilson SJ, 2009, CEREB CORTEX, V19, P724, DOI 10.1093/cercor/bhn121; Wu C, 2008, NEUROREPORT, V19, P851, DOI 10.1097/WNR.0b013e3282ff63b1; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6327	10.1371/journal.pone.0006327	http://dx.doi.org/10.1371/journal.pone.0006327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	472QP	19621074	Green Published, gold, Green Submitted			2022-12-25	WOS:000268147200014
J	Smith, AJ; Karpova, Y; D'Agostino, R; Willingham, M; Kulik, G				Smith, Adrienne J.; Karpova, Yelena; D'Agostino, Ralph, Jr.; Willingham, Mark; Kulik, George			Expression of the Bcl-2 Protein BAD Promotes Prostate Cancer Growth	PLOS ONE			English	Article								BAD, a pro-apoptotic protein of the Bcl-2 family, has recently been identified as an integrator of several anti-apoptotic signaling pathways in prostate cancer cells. Thus, activation of EGFR, GPCRs or PI3K pathway leads to BAD phosphorylation and inhibition of apoptosis. Increased levels of BAD in prostate carcinomas have also been reported. It appears contradictory that instead of limiting expression of pro-apoptotic protein, prostate cancer cells choose to increase BAD levels while keeping it under tight phosphorylation control. Analysis of the effect of BAD on prostate cancer xenografts has shown that increased BAD expression enhances tumor growth, while knockdown of BAD expression by shRNA inhibits tumor growth. Tissue culture experiments demonstrated that increased BAD expression stimulates proliferation of prostate cancer cells. These results suggest that increased expression of BAD provides a proliferative advantage to prostate tumors, while BAD dephosphorylation increases sensitivity of prostate cancer cells to apoptosis. Combination of proliferative and apoptotic properties prompts prostate cancer cells to be "addicted'' to increased levels of phosphorylated BAD. Thus, kinases that phosphorylate BAD are plausible therapeutic targets; while monitoring BAD phosphorylation could be used to predict tumor response to treatments.			Smith, AJ (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA.	gkulik@wfubmc.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	NATIONAL CANCER INSTITUTE [R01CA118329, T32CA079448] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA079448, R01 CA118329] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chattopadhyay A, 2001, ONCOGENE, V20, P4507, DOI 10.1038/sj.onc.1204584; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Djakiew D, 2000, PROSTATE, V42, P150, DOI 10.1002/(SICI)1097-0045(20000201)42:2<150::AID-PROS10>3.0.CO;2-H; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fernando R, 2007, J BIOL CHEM, V282, P28864, DOI 10.1074/jbc.M700785200; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hadaschik BA, 2007, UROL ONCOL-SEMIN ORI, V25, P413, DOI 10.1016/j.urolonc.2007.05.010; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Krajewska M, 1996, AM J PATHOL, V148, P1567; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Maslyar DJ, 2001, ONCOGENE, V20, P5087, DOI 10.1038/sj.onc.1204662; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Royuela M, 2001, EUR CYTOKINE NETW, V12, P654; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; THALMANN GN, 1994, CANCER RES, V54, P2577; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	24	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6224	10.1371/journal.pone.0006224	http://dx.doi.org/10.1371/journal.pone.0006224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19593445	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035400008
J	Dong, XP; Wang, X; Shen, DB; Chen, S; Liu, M; Wang, YB; Mills, E; Cheng, XP; Delling, M; Xu, HX				Dong, Xian-ping; Wang, Xiang; Shen, Dongbiao; Chen, Su; Liu, Meiling; Wang, Yanbin; Mills, Eric; Cheng, Xiping; Delling, Markus; Xu, Haoxing			Activating Mutations of the TRPML1 Channel Revealed by Proline-scanning Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; VARITINT-WADDLER PHENOTYPE; RECEPTOR POTENTIAL CHANNEL; LYSOSOMAL EXOCYTOSIS; MEMBRANE-PROTEIN; RELEASE CHANNEL; CATION CHANNEL; CELLS; CALCIUM; MOUSE	The mucolipin TRP (TRPML) proteins are a family of endolysosomal cation channels with genetically established importance in humans and rodent. Mutations of human TRPML1 cause type IV mucolipidosis, a devastating pediatric neurodegenerative disease. Our recent electrophysiological studies revealed that, although a TRPML1-mediated current can only be recorded in late endosome and lysosome (LEL) using the lysosome patch clamp technique, a proline substitution in TRPML1 (TRPML1(V432P)) results in a large whole cell current. Thus, it remains unknown whether the large TRPML1(V432P)-mediated current results from an increased surface expression ( trafficking), elevated channel activity (gating), or both. Here we performed systemic Pro substitutions in a region previously implicated in the gating of various 6 transmembrane cation channels. We found that several Pro substitutions displayed gain-of-function (GOF) constitutive activities at both the plasma membrane ( PM) and endolysosomal membranes. Although wild-type TRPML1 and non-GOF Pro substitutions localized exclusively in LEL and were barely detectable in the PM, the GOF mutations with high constitutive activities were not restricted to LEL compartments, and most significantly, exhibited significant surface expression. Because lysosomal exocytosis is Ca2+-dependent, constitutive Ca2+ permeability due to Pro substitutions may have resulted in stimulus-independent intralysosomal Ca2+ release, hence the surface expression and whole cell current of TRPML1. Indeed, surface staining of lysosome-associated membrane protein-1 (Lamp-1) was dramatically increased in cells expressing GOF TRPML1 channels. We conclude that TRPML1 is an inwardly rectifying, proton-impermeable, Ca2+ and Fe2+/Mn2+ dually permeable cation channel that may be gated by unidentified cellular mechanisms through a conformational change in the cytoplasmic face of the transmembrane 5 (TM5). Furthermore, activation of TRPML1 in LEL may lead to the appearance of TRPML1 proteins at the PM.	[Cheng, Xiping; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Delling, Markus] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	xu, hao/GWQ-7394-2022	Dong, Xianping/0000-0002-4496-7104	National Institutes of Health [NS062792]; University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS062792 (to H. X.). This work was also supported by startup funds (to H. X.) from the Department of Molecular, Cellular, and Developmental Biology and Biological Science Scholar Program, University of Michigan, and by a pilot grant (to H. X.) from the University of Michigan Initiative on Rare Disease Research.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Atiba-Davies M, 2007, BBA-MOL BASIS DIS, V1772, P1028, DOI 10.1016/j.bbadis.2007.01.007; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cuajungco MP, 2008, PFLUG ARCH EUR J PHY, V457, P463, DOI 10.1007/s00424-008-0523-4; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Goldin E, 2008, INVEST OPHTH VIS SCI, V49, P3134, DOI 10.1167/iovs.07-1649; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kress GJ, 2002, J NEUROSCI, V22, P5848; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; ZHANG F, 2009, J CELL MOL IN PRESS; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	46	81	82	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32040	32052		10.1074/jbc.M109.037184	http://dx.doi.org/10.1074/jbc.M109.037184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19638346	Green Published, hybrid			2022-12-25	WOS:000271572700059
J	Yamagata, H; Shimizu, S; Nishida, Y; Watanabe, Y; Craigen, WJ; Tsujimoto, Y				Yamagata, H.; Shimizu, S.; Nishida, Y.; Watanabe, Y.; Craigen, W. J.; Tsujimoto, Y.			Requirement of voltage-dependent anion channel 2 for pro-apoptotic activity of Bax	ONCOGENE			English	Article						apoptosis; Bax; VDAC; mitochondria	OUTER MITOCHONDRIAL-MEMBRANE; CYTOCHROME-C RELEASE; CELL-DEATH; PROTEINS; FAMILY; VDAC; LIFE; OLIGOMERIZATION; ACTIVATION; MICE	Mitochondrial membrane permeabilization is central to apoptotic signaling and is directly regulated by the Bcl-2 family of proteins, consisting of anti-apoptotic members and pro-apoptotic members, although the precise mechanisms involved remain elusive. When cells are deficient in both pro-apoptotic multidomain members of this family (Bax and Bak), mitochondrial membrane permeabilization does not occur in response to various apoptotic stimuli. We have previously reported that the voltage-dependent anion channel (VDAC or porin) plays a role in apoptotic mitochondrial membrane permeabilization by interacting with Bcl-2 family members. Here, we have provided additional evidence that VDAC2 is required for pro-apoptotic activity of Bax in the absence of Bak. In the absence of Bak, VDAC2-deficient cells showed strong resistance to various apoptotic stimuli, whereas reintroduction of the Vdac2 gene restored their apoptotic response. Consistently, silencing of VDAC2 in Bak-deficient cells, but not Bax-deficient cells, also conferred resistance to various apoptotic stimuli. In the absence of VDAC2 and Bak, the activation of Bax (assessed by mitochondrial membrane integration, conformational changes and oligomerization) was markedly impaired. Taken together, these findings indicate that VDAC2 is required for pro-apoptotic activity of Bax in the absence of Bak. Oncogene (2009) 28, 3563-3572; doi: 10.1038/onc.2009.213; published online 20 July 2009	[Yamagata, H.; Shimizu, S.; Nishida, Y.; Tsujimoto, Y.] Osaka Univ, Dept Med Genet, Sch Med, Suita, Osaka 5650871, Japan; [Yamagata, H.; Watanabe, Y.] Yamaguchi Univ, Sch Med, Dept Neuropsychiat, Yamaguchi, Japan; [Shimizu, S.; Nishida, Y.] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Tokyo, Japan; [Craigen, W. J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Craigen, W. J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Osaka University; Yamaguchi University; Tokyo Medical & Dental University (TMDU); Baylor College of Medicine; Baylor College of Medicine	Tsujimoto, Y (corresponding author), Osaka Univ, Dept Med Genet, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsujimot@gene.med.osaka-u.ac.jp			SORST of the Japan Science and Technology Corporation (JST); Japan Society for the Promotion of Science; Ministry of Education, Science, Sports and Culture; Ministry of Health, Labor and Welfare, Japan	SORST of the Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	We are grateful to Dr Kitamura for providing of Plat-E cells. This study was supported in part by SORST of the Japan Science and Technology Corporation (JST), a grant for Creative Scientific Research from Japan Society for the Promotion of Science, a grant for the 21st Century COE Program from the Ministry of Education, Science, Sports and Culture, and a grant for Comprehensive Research on Aging and Health from the Ministry of Health, Labor and Welfare, Japan.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Neise D, 2008, ONCOGENE, V27, P1387, DOI 10.1038/sj.onc.1210773; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Ott M, 2007, J BIOL CHEM, V282, P27633, DOI 10.1074/jbc.M703155200; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Sampson MJ, 1996, GENOMICS, V33, P283, DOI 10.1006/geno.1996.0193; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	32	45	48	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2009	28	40					3563	3572		10.1038/onc.2009.213	http://dx.doi.org/10.1038/onc.2009.213			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	507KI	19617898	Bronze			2022-12-25	WOS:000270851700005
J	Bender, J; Rydzewski, K; Broich, M; Schunder, E; Heuner, K; Flieger, A				Bender, Jennifer; Rydzewski, Kerstin; Broich, Markus; Schunder, Eva; Heuner, Klaus; Flieger, Antje			Phospholipase PlaB of Legionella pneumophila Represents a Novel Lipase Family PROTEIN RESIDUES ESSENTIAL FOR LIPOLYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND HEMOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PSEUDOMONAS-AERUGINOSA; LYSOPHOSPHOLIPASE-A; GENE; EXOU; INFECTION; VIRULENCE; ENZYMES; CLONING; LYSOPHOSPHATIDYLCHOLINE	Legionella pneumophila possesses several phospholipases capable of host cell manipulation and lung damage. Recently, we discovered that the major cell-associated hemolytic phospholipase A(PlaB) shares no homology to described phospholipases and is dispensable for intracellular replication in vitro. Nevertheless, here we show that PlaB is the major lipolytic activity in L. pneumophila cell infections and that PlaB utilizes a typical catalytic triad of Ser-Asp-His for effective hydrolysis of phospholipid substrates. Crucial residues were found to be located within the N-terminal half of the protein, and amino acids embedding these active sites were unique for PlaB and homologs. We further showed that catalytic activity toward phosphatidylcholine but not phosphatidylglycerol is directly linked to hemolytic potential of PlaB. Although the function of the prolonged PlaB C terminus remains to be elucidated, it is essential for lipolysis, since the removal of 15 amino acids already abolishes enzyme activity. Additionally, we determined that PlaB preferentially hydrolyzes long-chain fatty acid substrates containing 12 or more carbon atoms. Since phospholipases play an important role as bacterial virulence factors, we examined cell-associated enzymatic activities among L. pneumophila clinical isolates and non-pneumophila species. All tested clinical isolates showed comparable activities, whereas of the non-pneumophila species, only Legionella gormanii and Legionella spiritensis possessed lipolytic activities similar to those of L. pneumophila and comprised plaB-like genes. Interestingly, phosphatidylcholine-specific phospholipase A activity and hemolytic potential were more pronounced in L. pneumophila. Therefore, hydrolysis of the eukaryotic membrane constituent phosphatidylcholine triggered by PlaB could be an important virulence tool for Legionella pathogenicity.	[Bender, Jennifer; Broich, Markus; Flieger, Antje] Robert Koch Inst, Div Bacterial Infect, D-38855 Wernigerode, Germany; [Bender, Jennifer; Rydzewski, Kerstin; Schunder, Eva; Heuner, Klaus; Flieger, Antje] Robert Koch Inst, Project Grp P26, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Flieger, A (corresponding author), Robert Koch Inst, Div Bacterial Infect, FG11,Burgstr 37, D-38855 Wernigerode, Germany.	fliegera@rki.de		Flieger, Antje/0000-0003-3819-2979	Deutsche Forschungsgemeinschaft [HE 2845/4-1, FL 359/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Bonn, Germany) Grants HE 2845/4-1 and FL 359/4-1 (to K. H. and A. F., respectively).	Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Banerji S, 2005, INFECT IMMUN, V73, P2899, DOI 10.1128/IAI.73.5.2899-2909.2005; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; BENDER J, 2009, MICROBIOLOG IN PRESS; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; BLACKMON JA, 1981, AM J PATHOL, V103, P429; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; FANG GD, 1989, MEDICINE, V68, P116, DOI 10.1097/00005792-198903000-00005; Flieger A, 2000, J BACTERIOL, V182, P1321, DOI 10.1128/JB.182.5.1321-1327.2000; Flieger A, 2000, FEMS MICROBIOL LETT, V188, P129; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Flieger A, 2001, J BACTERIOL, V183, P2121, DOI 10.1128/JB.183.6.2121-2124.2001; Hirakata Y, 2000, J INFECT DIS, V181, P765, DOI 10.1086/315276; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; JAEGER KE, 1993, FEBS LETT, V332, P143, DOI 10.1016/0014-5793(93)80501-K; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Jepson M, 2000, MICROBES INFECT, V2, P1277, DOI 10.1016/S1286-4579(00)01281-8; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; Liles MR, 1999, MOL MICROBIOL, V31, P959, DOI 10.1046/j.1365-2958.1999.01239.x; Muder RR, 2002, CLIN INFECT DIS, V35, P990, DOI 10.1086/342884; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Snijder HJ, 2000, BBA-MOL CELL BIOL L, V1488, P91, DOI 10.1016/S1388-1981(00)00113-X; Tannaes T, 2001, INFECT IMMUN, V69, P7334, DOI 10.1128/IAI.69.12.7334-7340.2001; Teo JWP, 2003, GENE, V312, P181, DOI 10.1016/S0378-1119(03)00615-2; Titball RV, 1999, ANAEROBE, V5, P51, DOI 10.1006/anae.1999.0191; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; VERNET T, 1993, J BIOL CHEM, V268, P26212; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; WINN WC, 1981, HUM PATHOL, V12, P401, DOI 10.1016/S0046-8177(81)80021-4	39	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27185	27194		10.1074/jbc.M109.026021	http://dx.doi.org/10.1074/jbc.M109.026021			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19640837	Green Published, hybrid			2022-12-25	WOS:000270232300019
J	Folco, EJ; Rocha, VZ; Lopez-Ilasaca, M; Libby, P				Folco, Eduardo J.; Rocha, Viviane Z.; Lopez-Ilasaca, Marco; Libby, Peter			Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; TNF-ALPHA PRODUCTION; COLLAGENOUS DOMAIN; INSULIN-RESISTANCE; DEFICIENT MICE; ATHEROSCLEROSIS; EXPRESSION; RESPONSES; PROTEIN	Macrophages participate pivotally in the pathogenesis of many chronic inflammatory diseases including atherosclerosis. Adiponectin, a vasculoprotective molecule with insulin-sensitizing and anti-atherogenic properties, suppresses pro-inflammatory gene expression in macrophages by mechanisms that remain incompletely understood. This study investigated the effects of adiponectin on major pro-inflammatory signaling pathways in human macrophages. We demonstrate that pretreatment of these cells with adiponectin inhibits phosphorylation of nuclear factor kappa B inhibitor (I kappa B), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK), induced by either lipopolysaccharide (LPS) or tumor necrosis factor (TNF) alpha, as well as STAT3 phosphorylation induced by interleukin-6 (IL6). Antagonism of IL10 by either neutralizing antibodies or siRNA-mediated silencing did not abrogate the anti-inflammatory actions of adiponectin, indicating that the ability of adiponectin to render human macrophages tolerant to various pro-inflammatory stimuli does not require this cytokine. A systematic search for adiponectin-inducible genes with established anti-inflammatory properties revealed that adiponectin augmented the expression of A20, suppressor of cytokine signaling (SOCS) 3, B-cell CLL/lymphoma (BCL) 3, TNF receptor-associated factor (TRAF) 1, and TNFAIP3-interacting protein (TNIP) 3. These results suggest that adiponectin triggers a multifaceted response in human macrophages by inducing the expression of various anti-inflammatory proteins that act at different levels in concert to suppress macrophage activation.	[Folco, Eduardo J.; Rocha, Viviane Z.; Lopez-Ilasaca, Marco; Libby, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, 77 Ave Louis Pasteur,NRB 741, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	National Institutes of Health NHLBI [R01-HL034636, R01-HL0831554]; Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034636] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grants R01-HL034636 ( to P. L.) and R01-HL0831554 ( to M. L. I.). This work was also supported by grants from the Donald W. Reynolds Foundation.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Isoda K, 2008, ATHEROSCLEROSIS, V198, P307, DOI 10.1016/j.atherosclerosis.2007.10.035; Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	42	98	107	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25569	25575		10.1074/jbc.M109.019786	http://dx.doi.org/10.1074/jbc.M109.019786			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19617629	hybrid, Green Published			2022-12-25	WOS:000269738000014
J	Korotkov, KV; Gray, MD; Kreger, A; Turley, S; Sandkvist, M; Hol, WGJ				Korotkov, Konstantin V.; Gray, Miranda D.; Kreger, Allison; Turley, Stewart; Sandkvist, Maria; Hol, Wim G. J.			Calcium Is Essential for the Major Pseudopilin in the Type 2 Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II PROTEIN SECRETION; THERMAL SHIFT ASSAYS; IV PILUS STRUCTURE; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; ESCHERICHIA-COLI; DIFFRACTION DATA; DRUG DISCOVERY; PILIN; COMPLEX	The pseudopilus is a key feature of the type 2 secretion system (T2SS) and is made up of multiple pseudopilins that are similar in fold to the type 4 pilins. However, pilins have disulfide bridges, whereas the major pseudopilins of T2SS do not. A key question is therefore how the pseudopilins, and in particular, the most abundant major pseudopilin, GspG, obtain sufficient stability to perform their function. Crystal structures of Vibrio cholerae, Vibrio vulnificus, and enterohemorrhagic Escherichia coli (EHEC) GspG were elucidated, and all show a calcium ion bound at the same site. Conservation of the calcium ligands fully supports the suggestion that calcium ion binding by the major pseudopilin is essential for the T2SS. Functional studies of GspG with mutated calcium ion-coordinating ligands were performed to investigate this hypothesis and show that in vivo protease secretion by the T2SS is severely impaired. Taking all evidence together, this allows the conclusion that, in complete contrast to the situation in the type 4 pili system homologs, in the T2SS, the major protein component of the central pseudopilus is dependent on calcium ions for activity.	[Korotkov, Konstantin V.; Kreger, Allison; Turley, Stewart; Hol, Wim G. J.] Univ Washington, Dept Biochem, Struct Biol Ctr, Seattle, WA 98195 USA; [Gray, Miranda D.; Sandkvist, Maria] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Hol, WGJ (corresponding author), 1959 Pacific Ave NE,Hlth Sci Bldg K418, Seattle, WA 98195 USA.	wghol@u.washington.edu		Korotkov, Konstantin/0000-0002-2182-6843	National Institutes of Health [AI34501, AI49294]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034501, R56AI049294, R01AI049294, R56AI034501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI34501 ( to W.G.J.H.) and AI49294 ( to M. S.).	Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Keizer DW, 2001, J BIOL CHEM, V276, P24186, DOI 10.1074/jbc.M100659200; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; PUGSLEY AP, 1993, MOL MICROBIOL, V10, P665, DOI 10.1111/j.1365-2958.1993.tb00938.x; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	39	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25466	25470		10.1074/jbc.C109.037655	http://dx.doi.org/10.1074/jbc.C109.037655			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19640838	Green Published, hybrid			2022-12-25	WOS:000269738000003
J	Zhang, HM; Kenaan, C; Hamdane, D; Hoa, GHB; Hollenberg, PF				Zhang, Haoming; Kenaan, Cesar; Hamdane, Djemel; Hoa, Gaston Hui Bon; Hollenberg, Paul F.			Effect of Conformational Dynamics on Substrate Recognition and Specificity as Probed by the Introduction of a de Novo Disulfide Bond into Cytochrome P450 2B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; HEME SPIN-STATE; HIGH-PRESSURE; MOLECULAR-DYNAMICS; ACTIVE-SITE; STRUCTURAL BASIS; BINDING-SITE; AMINO-ACID; P450; IDENTIFICATION	The conformational dynamics of cytochrome P450 2B1 (CYP2B1) were investigated through the introduction of a disulfide bond to link the I- and K-helices by generation of a double Cys variant, Y309C/S360C. The consequences of the disulfide bonding were examined both experimentally and in silico by molecular dynamics simulations. Under high hydrostatic pressures, the partial inactivation volume for the Y309C/S360C variant was determined to be -21 cm(3)mol(-1), which is more than twice as much as those of the wild type (WT) and single Cys variants (Y309C, S360C). This result indicates that the engineered disulfide bond has substantially reduced the protein plasticity of the Y309C/S360C variant. Under steady-state turnover conditions, the S360C variant catalyzed the N-demethylation of benzphetamine and O-deethylation of 7-ethoxy-trifluoromethylcoumarin as the WT did, whereas the Y309C variant retained only 39% of the N-demethylation activity and 66% of the O-deethylation activity compared with the WT. Interestingly, the Y309C/S360C variant restored the N-demethylation activity to the same level as that of the WT but decreased the O-deethylation activity to only 19% of the WT. Furthermore, the Y309C/S360C variant showed increased substrate specificity for testosterone over androstenedione. Molecular dynamics simulations revealed that the engineered disulfide bond altered substrate access channels. Taken together, these results suggest that protein dynamics play an important role in regulating substrate entry and recognition.	[Zhang, Haoming; Kenaan, Cesar; Hollenberg, Paul F.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Hamdane, Djemel; Hoa, Gaston Hui Bon] INSERM, U779, F-94275 Le Kremlin Bicetre, France	University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hollenberg, PF (corresponding author), 1150 W Med Ctr Dr,MSRB 3, Ann Arbor, MI 48109 USA.	phollen@umich.edu	Hollenberg, Paul F/A-7538-2009; Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394	National Institutes of Health [CA16954]; NATIONAL CANCER INSTITUTE [R37CA016954, R01CA016954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA16954 ( to P. F. H.).	Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Domanski TL, 2001, ARCH BIOCHEM BIOPHYS, V394, P21, DOI 10.1006/abbi.2001.2504; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; GOTOH O, 1992, J BIOL CHEM, V267, P83; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hamdane D, 2005, J BIOL CHEM, V280, P36809, DOI 10.1074/jbc.M506253200; Hanna IH, 1998, BIOCHEMISTRY-US, V37, P311, DOI 10.1021/bi971528s; Harris DL, 2004, PROTEINS, V55, P895, DOI 10.1002/prot.20062; HE YA, 1992, BIOCHEMISTRY-US, V31, P9220, DOI 10.1021/bi00153a015; HE YA, 1994, BIOCHEMISTRY-US, V33, P4419, DOI 10.1021/bi00180a040; HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011; Hoa GHB, 2002, BBA-PROTEIN STRUCT M, V1595, P297, DOI 10.1016/S0167-4838(01)00352-1; HOA GHB, 1982, ANAL BIOCHEM, V120, P125, DOI 10.1016/0003-2697(82)90327-X; Hollenberg PF, 2008, CHEM RES TOXICOL, V21, P189, DOI 10.1021/tx7002504; Honma W, 2005, ARCH BIOCHEM BIOPHYS, V435, P157, DOI 10.1016/j.abb.2004.12.014; Kent UM, 2002, J PHARMACOL EXP THER, V300, P549, DOI 10.1124/jpet.300.2.549; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WH, 2005, DRUG METAB DISPOS, V33, P910, DOI 10.1124/dmd.105.004200; Lin HL, 2003, J PHARMACOL EXP THER, V306, P744, DOI 10.1124/jpet.103.050260; Lin HL, 2003, CHEM RES TOXICOL, V16, P129, DOI 10.1021/tx020040b; Luo Zongshu, 1994, Archives of Biochemistry and Biophysics, V309, P52; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Nguyen TA, 2008, MOL PHARMACOL, V73, P1122, DOI 10.1124/mol.107.042861; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Reed JR, 2003, J INORG BIOCHEM, V93, P152, DOI 10.1016/S0162-0134(02)00597-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Seifert A, 2009, PROTEINS, V74, P1028, DOI 10.1002/prot.22242; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Smith SV, 2000, BIOCHEMISTRY-US, V39, P5731, DOI 10.1021/bi000129l; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tschirret-Guth RA, 1998, J AM CHEM SOC, V120, P3590, DOI 10.1021/ja973909z; Von Weymarn LB, 2004, J PHARMACOL EXP THER, V311, P71, DOI 10.1124/jpet.104.069757; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Williams PA, 2000, J INORG BIOCHEM, V81, P183, DOI 10.1016/S0162-0134(00)00102-1; Yao H, 2007, PROTEINS, V69, P125, DOI 10.1002/prot.21508; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	47	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25678	25686		10.1074/jbc.M109.032748	http://dx.doi.org/10.1074/jbc.M109.032748			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19605359	Green Published, hybrid			2022-12-25	WOS:000269738000025
J	Sasaki, M; Yoshitane, H; Du, NH; Okano, T; Fukada, Y				Sasaki, Momoko; Yoshitane, Hikari; Du, Ngoc-Hien; Okano, Toshiyuki; Fukada, Yoshitaka			Preferential Inhibition of BMAL2-CLOCK Activity by PER2 Reemphasizes Its Negative Role and a Positive Role of BMAL2 in the Circadian Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIOD HOMOLOGS; CKI-EPSILON; CLOCK; GENE; EXPRESSION; MPER2; PHOSPHORYLATION; IDENTIFICATION; OSCILLATIONS; ACTIVATION	In the molecular oscillatory mechanism governing circadian rhythms, positive regulators, including CLOCK and BMAL1, transactivate Per and Cry genes through E-box elements, and translated PER and CRY proteins negatively regulate their own transactivation. Like BMAL1, its paralog BMAL2 dimerizes with CLOCK to activate the E-box-dependent transcription, but the role of BMAL2 in the circadian clockwork is still elusive. Here we characterized BMAL2 function in NIH3T3 cells and found that the cellular rhythms monitored by Bmal1 promoter-driven bioluminescence signals were blunted by RNA interference-mediated suppression of Bmal2 as well as that of Bmal1. Transcription assays with a 2.1-kb mPer1 promoter revealed that CRY2 inhibited the transactivation mediated by BMAL1-CLOCK more strongly than that by BMAL2-CLOCK. In contrast, PER2 showed a stronger inhibitory effect on BMAL2-CLOCK than on BMAL1-CLOCK. The molecular link between BMAL2 and PER2 was further strengthened by the fact that PER2 exhibited a greater affinity for BMAL2 than for BMAL1 in co-immunoprecipitation experiments. These results indicate a functional partnership between BMAL2 and PER2 and reemphasize the negative role of PER2 in the circadian transcription. As a broad spectrum function, BMAL2-CLOCK activated transcription from a variety of SV40-driven reporters harboring various E/E'-box-containing sequences present in the upstream regions of clock and clock-controlled genes. Importantly, the efficiencies of BMAL2-CLOCK-mediated transactivation relative to that achieved by BMAL1-CLOCK were dependent heavily on the E-box-containing sequences, supporting distinguishable roles of the two BMALs. Collectively, it is strongly suggested that BMAL2 plays an active role in the circadian transcription.	[Sasaki, Momoko; Yoshitane, Hikari; Du, Ngoc-Hien; Okano, Toshiyuki; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Okano, Toshiyuki] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1628480, Japan	University of Tokyo; Waseda University	Fukada, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	Du, Ngoc-Hien/AAX-5215-2020; 吉孝, 深田/G-5090-2014	Okano, Toshiyuki/0000-0001-6740-6265; Yoshitane, Hikari/0000-0001-6319-3354	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Loop S, 2005, EMBO REP, V6, P341, DOI 10.1038/sj.embor.7400372; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Okano T, 2001, GENES CELLS, V6, P825, DOI 10.1046/j.1365-2443.2001.00462.x; Okano T, 2001, NEUROSCI LETT, V300, P111, DOI 10.1016/S0304-3940(01)01581-6; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takano A, 2004, J BIOL CHEM, V279, P32578, DOI 10.1074/jbc.M403433200; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	43	38	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25149	25159		10.1074/jbc.M109.040758	http://dx.doi.org/10.1074/jbc.M109.040758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19605937	Green Published, hybrid			2022-12-25	WOS:000269734000049
J	Klausmeyer, KR; Shaw, MR				Klausmeyer, Kirk R.; Shaw, M. Rebecca			Climate Change, Habitat Loss, Protected Areas and the Climate Adaptation Potential of Species in Mediterranean Ecosystems Worldwide	PLOS ONE			English	Article							DISPERSAL CORRIDORS; ATMOSPHERIC CO2; BIODIVERSITY; CONSERVATION; FIRE; CAPE; PERSISTENCE; PROTEACEAE; VEGETATION; RICHNESS	Mediterranean climate is found on five continents and supports five global biodiversity hotspots. Based on combined downscaled results from 23 atmosphere-ocean general circulation models (AOGCMs) for three emissions scenarios, we determined the projected spatial shifts in the mediterranean climate extent (MCE) over the next century. Although most AOGCMs project a moderate expansion in the global MCE, regional impacts are large and uneven. The median AOGCM simulation output for the three emissions scenarios project the MCE at the end of the 21(st) century in Chile will range from 129-153% of its current size, while in Australia, it will contract to only 77-49% of its current size losing an area equivalent to over twice the size of Portugal. Only 4% of the land area within the current MCE worldwide is in protected status ( compared to a global average of 12% for all biome types), and, depending on the emissions scenario, only 50-60% of these protected areas are likely to be in the future MCE. To exacerbate the climate impact, nearly one third (29-31%) of the land where the MCE is projected to remain stable has already been converted to human use, limiting the size of the potential climate refuges and diminishing the adaptation potential of native biota. High conversion and low protection in projected stable areas make Australia the highest priority region for investment in climate-adaptation strategies to reduce the threat of climate change to the rich biodiversity of the mediterranean biome.			Klausmeyer, KR (corresponding author), Nature Conservancy, San Francisco, CA USA.	kklausmeyer@tnc.org						Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; ASCHMANN H, 1973, MEDITERRANEAN TYPE E, V12; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Cheddadi R, 2001, LANDSCAPE ECOL, V16, P667, DOI 10.1023/A:1013149831734; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Dallman P.R., 1998, PLANT LIFE WORLDS ME; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; *EUR COMM JOINT RE, 2004, LAND COV WORLD YEAR; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fried JS, 2004, CLIMATIC CHANGE, V64, P169, DOI 10.1023/B:CLIM.0000024667.89579.ed; Gutierrez AG, 2008, GLOBAL CHANGE BIOL, V14, P161, DOI 10.1111/j.1365-2486.2007.01482.x; Hammill KA, 1998, AUST J BOT, V46, P407, DOI 10.1071/BT96116; Hannah L, 2005, BIOSCIENCE, V55, P231, DOI 10.1641/0006-3568(2005)055[0231:TVFTCE]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Huston M. A., 1994, BIOL DIVERSITY; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Mackey Brendan G., 2008, Biodiversity (Ottawa), V9, P11; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schurr FM, 2007, GLOBAL ECOL BIOGEOGR, V16, P449, DOI 10.1111/j.1466-8238.2006.00293.x; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soule M. E., 2004, Pacific Conservation Biology, V10, P266; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; *WORLD DAT PROT AR, 2006, WORLD DAT PROT AR	43	262	268	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6392	10.1371/journal.pone.0006392	http://dx.doi.org/10.1371/journal.pone.0006392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641600	gold, Green Submitted, Green Published			2022-12-25	WOS:000268494500007
J	Wu, MZ; Katta, A; Gadde, MK; Liu, H; Kakarla, SK; Fannin, J; Paturi, S; Arvapalli, RK; Rice, KM; Wang, YL; Blough, ER				Wu, Miaozong; Katta, Anjaiah; Gadde, Murali K.; Liu, Hua; Kakarla, Sunil K.; Fannin, Jacqueline; Paturi, Satyanarayana; Arvapalli, Ravi K.; Rice, Kevin M.; Wang, Yeling; Blough, Eric R.			Aging-Associated Dysfunction of Akt/Protein Kinase B: S-Nitrosylation and Acetaminophen Intervention	PLOS ONE			English	Article								Background: Aged skeletal muscle is characterized by an increased incidence of metabolic and functional disorders, which if allowed to proceed unchecked can lead to increased morbidity and mortality. The mechanism(s) underlying the development of these disorders in aging skeletal muscle are not well understood. Protein kinase B (Akt/PKB) is an important regulator of cellular metabolism and survival, but it is unclear if aged muscle exhibits alterations in Akt function. Here we report a novel dysfunction of Akt in aging muscle, which may relate to S-nitrosylation and can be prevented by acetaminophen intervention. Principal Findings: Compared to 6- and 27-month rats, the phosphorylation of Akt (Ser473 and Thr308) was higher in soleus muscles of very aged rats (33-months). Paradoxically, these increases in Akt phosphorylation were associated with diminished mammalian target of rapamycin (mTOR) phosphorylation, along with decreased levels of insulin receptor beta (IR-beta), phosphoinositide 3-kinase (PI3K), phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and phosphorylation of phosphoinositide-dependent kinase-1 (PDK1) (Ser241). In vitro Akt kinase measurements and ex vivo muscle incubation experiments demonstrated age-related impairments of Akt kinase activity, which were associated with increases in Akt S-nitrosylation and inducible nitric oxide synthase (iNOS). Impairments in Akt function occurred parallel to increases in myocyte apoptosis and decreases in myocyte size and the expression of myosin and actin. These age-related disorders were attenuated by treating aged (27-month) animals with acetaminophen (30 mg/kg body weight/day) for 6-months. Conclusions: These data demonstrate that Akt dysfunction and increased S-nitrosylation of Akt may contribute to age-associated disorders in skeletal muscle and that acetaminophen may be efficacious for the treatment of age-related muscle dysfunction.			Wu, MZ (corresponding author), Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA.	blough@marshall.edu	Wu, Miaozong/C-1344-2009	Wu, Miaozong/0000-0002-2903-9625; Rice, Kevin/0000-0002-5785-3405	NATIONAL INSTITUTE ON AGING [R15AG027103] Funding Source: NIH RePORTER; NIA NIH HHS [R15 AG027103, AG-027103-1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BROWN M, 1987, AGE AGEING, V16, P244, DOI 10.1093/ageing/16.4.244; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CRETTAZ M, 1980, BIOCHEM J, V186, P525, DOI 10.1042/bj1860525; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008; Jejurikar SS, 2006, EXP GERONTOL, V41, P828, DOI 10.1016/j.exger.2006.06.053; Kurowski TG, 1999, DIABETES, V48, P658, DOI 10.2337/diabetes.48.3.658; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Lu XM, 2005, J MASS SPECTROM, V40, P1140, DOI 10.1002/jms.885; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Oku A, 2001, AM J PHYSIOL-ENDOC M, V280, pE816, DOI 10.1152/ajpendo.2001.280.5.E816; Ono H, 2001, MOL ENDOCRINOL, V15, P1411, DOI 10.1210/me.15.8.1411; Pacheco ME, 2006, EUR J PHARMACOL, V538, P115, DOI 10.1016/j.ejphar.2006.03.052; Rice KM, 2008, J PHARMACOL SCI, V108, P393, DOI 10.1254/jphs.08R02CP; Ryu YS, 2000, BIOCHEM BIOPH RES CO, V272, P758, DOI 10.1006/bbrc.2000.2863; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; SEGAL SS, 1985, AM J PHYSIOL, V248, pC265, DOI 10.1152/ajpcell.1985.248.3.C265; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Wu Men-Dar, 1997, Okajimas Folia Anatomica Japonica, V74, P155; Wu M, 2009, DIABETES-METAB RES, V25, P279, DOI 10.1002/dmrr.932; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	31	68	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6430	10.1371/journal.pone.0006430	http://dx.doi.org/10.1371/journal.pone.0006430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641606	Green Published, gold, Green Submitted			2022-12-25	WOS:000268494500030
J	Luedeling, E; Zhang, MH; Girvetz, EH				Luedeling, Eike; Zhang, Minghua; Girvetz, Evan H.			Climatic Changes Lead to Declining Winter Chill for Fruit and Nut Trees in California during 1950-2099	PLOS ONE			English	Article							TEMPERATURE-DEPENDENCE; DORMANCY BREAKING; MODEL; SIMULATION; IMPACTS; PLANTS	Background: Winter chill is one of the defining characteristics of a location's suitability for the production of many tree crops. We mapped and investigated observed historic and projected future changes in winter chill in California, quantified with two different chilling models (Chilling Hours, Dynamic Model). Methodology/Principal Findings: Based on hourly and daily temperature records, winter chill was modeled for two past temperature scenarios (1950 and 2000), and 18 future scenarios (average conditions during 2041-2060 and 2080-2099 under each of the B1, A1B and A2 IPCC greenhouse gas emissions scenarios, for the CSIRO-MK3, HadCM3 and MIROC climate models). For each scenario, 100 replications of the yearly temperature record were produced, using a stochastic weather generator. We then introduced and mapped a novel climatic statistic, "safe winter chill", the 10% quantile of the resulting chilling distributions. This metric can be interpreted as the amount of chilling that growers can safely expect under each scenario. Winter chill declined substantially for all emissions scenarios, with the area of safe winter chill for many tree species or cultivars decreasing 50-75% by mid-21(st) century, and 90-100% by late century. Conclusions/Significance: Both chilling models consistently projected climatic conditions by the middle to end of the 21(st) century that will no longer support some of the main tree crops currently grown in California, with the Chilling Hours Model projecting greater changes than the Dynamic Model. The tree crop industry in California will likely need to develop agricultural adaptation measures (e. g. low-chill varieties and dormancy-breaking chemicals) to cope with these projected changes. For some crops, production might no longer be possible.			Luedeling, E (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	eluedeling@ucdavis.edu; mhzhang@ucdavis.edu	Girvetz, Evan/B-3533-2010; Luedeling, Eike/I-3269-2019; Luedeling, Eike/A-5662-2012	Luedeling, Eike/0000-0002-7316-3631; Luedeling, Eike/0000-0002-7316-3631				Almorox J, 2005, ENERG CONVERS MANAGE, V46, P1465, DOI 10.1016/j.enconman.2004.07.007; ANCONELLI S, 2002, MICROMETEOROLOGICAL, P1103; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; BENNETT J. P., 1949, CALIFORNIA AGRIC, V3, P12; Bennett JP, 1949, CALIF AGR, V4, P12; Chandler WH, 1942, DECIDUOUS ORCHARDS; *CIMIS, 2008, CAL IRR MAN INF SYST; Erez A, 1998, ACTA HORTIC, P507, DOI 10.17660/ActaHortic.1998.465.63; Erez A, 1995, ACTA HORTIC, P81, DOI 10.17660/ActaHortic.1995.395.7; Erez A., 1988, Acta Horticulturae, P76; EREZ A, 1990, ACTA HORTICULTURAE I; FISHMAN S, 1987, J THEOR BIOL, V126, P309, DOI 10.1016/S0022-5193(87)80237-0; FISHMAN S, 1987, J THEOR BIOL, V124, P473, DOI 10.1016/S0022-5193(87)80221-7; *GLCF, 2008, EARTH SCI DAT INT GL; Gradziel TM, 2007, HORTSCIENCE, V42, P1725, DOI 10.21273/HORTSCI.42.7.1725; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Knight T. A., 1801, PHILOS T R SOC LOND, V91, P333; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LINSLEYNOAKES GC, 1994, SCI HORTIC-AMSTERDAM, V59, P107, DOI 10.1016/0304-4238(94)90077-9; Lobell DB, 2007, CLIMATIC CHANGE, V81, P187, DOI 10.1007/s10584-006-9141-3; Lobell DB, 2006, AGR FOREST METEOROL, V141, P208, DOI 10.1016/j.agrformet.2006.10.006; Lopez G, 2007, CALIF AGR, V61, P31, DOI 10.3733/ca.v061n01p31; LUEDELING E, AGR FOREST MET UNPUB; LUEDELING E, CLIMATIC CH IN PRESS, DOI DOI 10.1007/S10584-10009-19581-10587; LUEDELING E, AGR ECOSYST IN PRESS, DOI DOI 10.1016/J.AGEE.2009.1004.1016; *NCDC, 2008, DAT NAT CLIM DAT CTR; Oukabli Ahmed, 2007, Biotechnologie Agronomie Societe et Environnement, V11, P133; Perez FJ, 2008, CHIL J AGR RES, V68, P198, DOI 10.4067/S0718-58392008000200010; Purkey DR, 2008, CLIMATIC CHANGE, V87, pS109, DOI 10.1007/s10584-007-9375-8; Ruiz D, 2007, ENVIRON EXP BOT, V61, P254, DOI 10.1016/j.envexpbot.2007.06.008; Salvador F. R. de, 2003, Informatore Agrario, V59, P63; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; Semenov MA, 2008, CLIM RES, V35, P203, DOI 10.3354/cr00731; Sharma RR, 2006, SCI HORTIC-AMSTERDAM, V109, P118, DOI 10.1016/j.scienta.2006.03.010; Spencer J.W., 1971, SEARCH, V2, P172; Vegis A., 1961, HDB PFLANZENPHYSIOLO, V16, P168; WEINBERGER JH, 1950, P AM SOC HORTIC SCI, V56, P122; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wold S., 1995, CHEMOMETRIC METHODS, P195	40	160	165	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6166	10.1371/journal.pone.0006166	http://dx.doi.org/10.1371/journal.pone.0006166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19606220	Green Submitted, gold, Green Published			2022-12-25	WOS:000268260100001
J	Steinke, D; Zemlak, TS; Hebert, PDN				Steinke, Dirk; Zemlak, Tyler S.; Hebert, Paul D. N.			Barcoding Nemo: DNA-Based Identifications for the Ornamental Fish Trade	PLOS ONE			English	Article							GENETIC DETECTION; BIASED DISPERSAL; REEF; SOFTWARE	Background: Trade in ornamental fishes represents, by far, the largest route for the importation of exotic vertebrates. There is growing pressure to regulate this trade with the goal of ensuring that species are sustainably harvested and that their point of origin is accurately reported. One important element of such regulation involves easy access to specimen identifications, a task that is currently difficult for all but specialists because of the large number of species involved. The present study represents an important first step in making identifications more accessible by assembling a DNA barcode reference sequence library for nearly half of the ornamental fish species imported into North America. Methodology/Principal Findings: Analysis of the cytochrome c oxidase subunit I (COI) gene from 391 species from 8 coral reef locations revealed that 98% of these species exhibit distinct barcode clusters, allowing their unambiguous identification. Most species showed little intra-specific variation (adjusted mean = 0.21%), but nine species included two or three lineages showing much more divergence (2.19-6.52%) and likely represent overlooked species complexes. By contrast, three genera contained a species pair or triad that lacked barcode divergence, cases that may reflect hybridization, young taxa or taxonomic over-splitting. Conclusions/Significance: Although incomplete, this barcode library already provides a new species identification tool for the ornamental fish industry, opening a realm of applications linked to collection practices, regulatory control and conservation.			Steinke, D (corresponding author), Univ Guelph, Biodivers Inst Ontario, Canadian Ctr DNA Barcoding, Guelph, ON N1G 2W1, Canada.	dsteinke@uoguelph.ca	Hebert, Paul DN/C-4161-2013; Steinke, Dirk/D-4700-2009; 赵, 鹏/B-8401-2009	Hebert, Paul DN/0000-0002-3081-6700; Steinke, Dirk/0000-0002-8992-575X				Allen Gerald R., 1991, P1; BARLOW GW, 1974, AM ZOOL, V14, P9; Bekkevold D, 2004, MOL ECOL, V13, P1707, DOI 10.1111/j.1365-294X.2004.02156.x; Berrebi P, 2005, ESTUAR COAST SHELF S, V65, P708, DOI 10.1016/j.ecss.2005.07.008; Bleeker P., 1857, ACTA SOC REGIAE SCI, V2, P1; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; EDWARDS AJ, 1992, ENVIRON CONSERV, V19, P61, DOI 10.1017/S0376892900030265; FAO, 2008, FAO YB; Fessler JL, 2007, MOL PHYLOGENET EVOL, V45, P50, DOI 10.1016/j.ympev.2007.05.018; FOWLER HW, 1946, AUS P ACAD NATURAL S, V98, P123; FROESE R, 2006, WORLD WIDE WEB ELECT; Guiasu RC, 1998, B MAR SCI, V63, P277; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HINGCO TG, 1991, ICLARM C P, V22, P249; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hutchings JA, 2002, P ROY SOC B-BIOL SCI, V269, P2487, DOI 10.1098/rspb.2002.2176; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jordan DS, 1914, MEM CARNEGIE MUS, V6, P205, DOI DOI 10.5962/BHL.TITLE.43189; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KUITER RH, 1998, J ICHTHYOLOGY AQUATI, V3, P85; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lecchini D, 2006, FISHERIES SCI, V72, P40, DOI 10.1111/j.1444-2906.2006.01114.x; Lima D, 2005, J EXP MAR BIOL ECOL, V320, P211, DOI 10.1016/j.jembe.2004.12.031; Nelson JS, 1984, FISHES WORLD; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Randall JE, 2001, RAFFLES B ZOOL, V49, P19; Randall John E., 2000, Aqua (Graffignana), V4, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Steinke D, 2005, PHILOS T R SOC B, V360, P1975, DOI 10.1098/rstb.2005.1729; STEINKE D, 2009, MARINE BIOL IN PRESS; Steinke D, 2009, ICHTHYOL RES, V56, P210, DOI 10.1007/s10228-008-0068-8; Timm J, 2008, MOL PHYLOGENET EVOL, V49, P268, DOI 10.1016/j.ympev.2008.04.024; Victor Benjamin C., 2008, Journal of the Ocean Science Foundation, V1, P1; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Ward R.D., 2008, J FISH BIOL, V73, P1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	40	138	150	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2009	4	7							e6300	10.1371/journal.pone.0006300	http://dx.doi.org/10.1371/journal.pone.0006300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472QP	19621079	gold, Green Submitted, Green Published			2022-12-25	WOS:000268147200007
J	Padron, B; Traveset, A; Biedenweg, T; Diaz, D; Nogales, M; Olesen, JM				Padron, Benigno; Traveset, Anna; Biedenweg, Tine; Diaz, Diana; Nogales, Manuel; Olesen, Jens M.			Impact of Alien Plant Invaders on Pollination Networks in Two Archipelagos	PLOS ONE			English	Article							INVASIONAL MELTDOWN; POLLEN TRANSFER; NESTEDNESS; OPUNTIA	Mutualistic interactions between plants and animals promote integration of invasive species into native communities. In turn, the integrated invaders may alter existing patterns of mutualistic interactions. Here we simultaneously map in detail effects of invaders on parameters describing the topology of both plant-pollinator (bi-modal) and plant-plant (uni-modal) networks. We focus on the invader Opuntia spp., a cosmopolitan alien cactus. We compare two island systems: Tenerife (Canary Islands) and Menorca (Balearic Islands). Opuntia was found to modify the number of links between plants and pollinators, and was integrated into the new communities via the most generalist pollinators, but did not affect the general network pattern. The plant uni-modal networks showed disassortative linkage, i.e. species with many links tended to connect to species with few links. Thus, by linking to generalist natives, Opuntia remained peripheral to network topology, and this is probably why native network properties were not affected at least in one of the islands. We conclude that the network analytical approach is indeed a valuable tool to evaluate the effect of invaders on native communities.			Padron, B (corresponding author), Inst Mediterrani Estudis Avancats CSIC UIB, Mallorca, Balearic Isl, Spain.	beni.padron@uib.es	Nogales, Manuel/I-9831-2014; Traveset, Anna V/D-7802-2011; Olesen, Jens M/A-3011-2009	Nogales, Manuel/0000-0002-5327-3104; Olesen, Jens M/0000-0003-1998-1083; Olesen, Jes/0000-0002-6712-2702				Abe T, 2006, ANN BOT-LONDON, V98, P317, DOI 10.1093/aob/mcl117; Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; ARMBRUSTER WS, 1984, ANN MO BOT GARD, V71, P1, DOI 10.2307/2399053; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; BARBERA G, 1992, ECON BOT, V46, P10, DOI 10.1007/BF02985249; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bell JM, 2005, ECOLOGY, V86, P762, DOI 10.1890/04-0694; Bourgeois K, 2005, ECOSCIENCE, V12, P248, DOI 10.2980/i1195-6860-12-2-248.1; Brualdi RA, 1999, OECOLOGIA, V119, P256, DOI 10.1007/s004420050784; Carvalheiro LG, 2008, J APPL ECOL, V45, P1419, DOI 10.1111/j.1365-2664.2008.01518.x; Cox PA, 2000, CONSERV BIOL, V14, P1237, DOI 10.1046/j.1523-1739.2000.00017.x; DUPONT YL, 2009, OIKOS IN PRESS; Feldman TS, 2004, OIKOS, V105, P197, DOI 10.1111/j.0030-1299.2004.12845.x; Foster JT, 2007, CONSERV BIOL, V21, P1248, DOI 10.1111/j.1523-1739.2007.00781.x; FRAGA P, 2004, CATALEG FLORA VASCUL, P368; Gimeno I, 2002, ACTA OECOL, V23, P239, DOI 10.1016/S1146-609X(02)01143-8; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; IZQUIERDO I, 2004, LISTA ESPECIES SILVE; Jakobsson A, 2008, BIOL CONSERV, V141, P136, DOI 10.1016/j.biocon.2007.09.005; Jordano P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P173; Kenta T, 2007, BIOL CONSERV, V134, P298, DOI 10.1016/j.biocon.2006.07.023; LAVERTY TM, 1992, OECOLOGIA, V89, P502, DOI 10.1007/BF00317156; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Morales CL, 2006, J ECOL, V94, P171, DOI 10.1111/j.1365-2745.2005.01069.x; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOOY WD, 2005, EXPLORATORY SOCIAL N; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Reyes-Aguero JA, 2006, J ARID ENVIRON, V64, P549, DOI 10.1016/j.jaridenv.2005.06.018; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Valido A, 2003, J HERPETOL, V37, P741, DOI 10.1670/15-02AN; Walter TR, 2002, INT J EARTH SCI, V91, P615, DOI 10.1007/s00531-001-0245-8	45	88	92	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2009	4	7							e6275	10.1371/journal.pone.0006275	http://dx.doi.org/10.1371/journal.pone.0006275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	472GV	19609437	gold, Green Submitted, Green Published			2022-12-25	WOS:000268119500010
J	Deniaud, A; Goulielmakis, A; Coves, J; Pebay-Peyroula, E				Deniaud, Aurelien; Goulielmakis, Aurelie; Coves, Jacques; Pebay-Peyroula, Eva			Differences between CusA and AcrB Crystallisation Highlighted by Protein Flexibility	PLOS ONE			English	Article								Background: Until very recently, AcrB was the only Resistance Nodulation and cell Division transporter for which the structure has been elucidated. Towards a general understanding of this protein family, CusA and AcrB were compared. Methodology/Principal Findings: In dodecylmaltoside, AcrB crystallised in many different conditions, while CusA does not. This could be due to the difference in dynamic between these proteins as judged from limited proteolysis assays. Addition of various compounds, in particular heavy metal cations, stabilises CusA. Conclusion/Significance: This approach could constitute a first step towards CusA crystallisation.			Deniaud, A (corresponding author), Univ Grenoble 1, CNRS, UMR5075, Inst Biol Struct Jean Pierre Ebel,CEA, Grenoble, France.	eva.pebay-peyroula@ibs.fr	Deniaud, Aurelien/L-5093-2019					Breyton C, 2004, FEBS LETT, V564, P312, DOI 10.1016/S0014-5793(04)00227-3; Chabaud E, 1998, BIOCHIMIE, V80, P515, DOI 10.1016/S0300-9084(00)80017-6; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230; Lebaupain F, 2006, LANGMUIR, V22, P8881, DOI 10.1021/la061083l; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Murakami S, 2003, CURR OPIN STRUC BIOL, V13, P443, DOI 10.1016/S0959-440X(03)00109-X; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nieves-Alicea R, 1998, BBA-PROTEIN STRUCT M, V1388, P500, DOI 10.1016/S0167-4838(98)00210-6; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; SEEGER MA, 2009, BIOCHEMISTRY; Sendra V, 2006, BIOCHEMISTRY-US, V45, P5557, DOI 10.1021/bi060328q; Stroebel D, 2007, BBA-BIOMEMBRANES, V1768, P1567, DOI 10.1016/j.bbamem.2007.03.008; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6214	10.1371/journal.pone.0006214	http://dx.doi.org/10.1371/journal.pone.0006214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593437	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035300020
J	Riveline, D				Riveline, Daniel			Explaining Lengths and Shapes of Yeast by Scaling Arguments	PLOS ONE			English	Article								Lengths and shapes are approached in different ways in different fields: they serve as a read-out for classifying genes or proteins in cell biology whereas they result from scaling arguments in condensed matter physics. Here, we propose a combined approach with examples illustrated for the fission yeast Schizosaccharomyces pombe.			Riveline, D (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	daniel.riveline@ujf-grenoble.fr	Riveline, Daniel/GXV-6609-2022					Almagro S, 2003, EUROPHYS LETT, V63, P908, DOI 10.1209/epl/i2003-00609-3; [Anonymous], 2005, GOUTTES BULLES PERLE; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Boudaoud A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018104; Castagnetti S, 2007, J CELL SCI, V120, P2205, DOI 10.1242/jcs.03464; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Chang F, 2003, NAT CELL BIOL, V5, P294, DOI 10.1038/ncb0403-294; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; D'Arcy Thompson W, 1917, GROWTH FORM; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Ge WZ, 2005, MOL BIOL CELL, V16, P4124, DOI 10.1091/mbc.e04-11-0976; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Konomi M, 2003, YEAST, V20, P427, DOI 10.1002/yea.974; KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; MITCHISON JM, 1985, J CELL SCI, V75, P357; MONEY NP, 1992, P NATL ACAD SCI USA, V89, P4245, DOI 10.1073/pnas.89.10.4245; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prost J, 2007, BIOPHYS J, V93, P1124, DOI 10.1529/biophysj.106.098038; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sato M, 1996, CELL STRUCT FUNCT, V21, P167, DOI 10.1247/csf.21.167; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Sens P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031918; Smith AE, 2000, P NATL ACAD SCI USA, V97, P9871, DOI 10.1073/pnas.97.18.9871; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Terenna CR, 2008, CURR BIOL, V18, P1748, DOI 10.1016/j.cub.2008.09.047; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6205	10.1371/journal.pone.0006205	http://dx.doi.org/10.1371/journal.pone.0006205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593452	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035300015
J	Dong, LM; Brennan, P; Karami, S; Hung, RJ; Menashe, I; Berndt, SI; Yeager, M; Chanock, S; Zaridze, D; Matveev, V; Janout, V; Kollarova, H; Bencko, V; Schwartz, K; Davis, F; Navratilova, M; Szeszenia-Dabrowska, N; Mates, D; Colt, JS; Holcatova, I; Boffetta, P; Rothman, N; Chow, WH; Rosenberg, PS; Moore, LE				Dong, Linda M.; Brennan, Paul; Karami, Sara; Hung, Rayjean J.; Menashe, Idan; Berndt, Sonja I.; Yeager, Meredith; Chanock, Stephen; Zaridze, David; Matveev, Vsevolod; Janout, Vladimir; Kollarova, Hellena; Bencko, Vladimir; Schwartz, Kendra; Davis, Faith; Navratilova, Marie; Szeszenia-Dabrowska, Neonila; Mates, Dana; Colt, Joanne S.; Holcatova, Ivana; Boffetta, Paolo; Rothman, Nathaniel; Chow, Wong-Ho; Rosenberg, Philip S.; Moore, Lee E.			An Analysis of Growth, Differentiation and Apoptosis Genes with Risk of Renal Cancer	PLOS ONE			English	Article								We conducted a case-control study of renal cancer (987 cases and 1298 controls) in Central and Eastern Europe and analyzed genomic DNA for 319 tagging single-nucleotide polymorphisms (SNPs) in 21 genes involved in cellular growth, differentiation and apoptosis using an Illumina Oligo Pool All (OPA). A haplotype-based method (sliding window analysis of consecutive SNPs) was used to identify chromosome regions of interest that remained significant at a false discovery rate of 10%. Subsequently, risk estimates were generated for regions with a high level of signal and individual SNPs by unconditional logistic regression adjusting for age, gender and study center. Three regions containing genes associated with renal cancer were identified: caspase 1/5/ 4/12(CASP 1/5/ 4/12), epidermal growth factor receptor (EGFR), and insulin-like growth factor binding protein-3 (IGFBP3). We observed that individuals with CASP1/5/4/12 haplotype (spanning area upstream of CASP1 through exon 2 of CASP5) GGGCTCAGT were at higher risk of renal cancer compared to individuals with the most common haplotype (OR: 1.40, 95% CI: 1.10-1.78, p-value = 0.007). Analysis of EGFR revealed three strong signals within intron 1, particularly a region centered around rs759158 with a global p = 0.006 (GGG: OR: 1.26, 95% CI: 1.04-1.53 and ATG: OR: 1.55, 95% CI: 1.14-2.11). A region in IGFBP3 was also associated with increased risk (global p = 0.04). In addition, the number of statistically significant (p-value, 0.05) SNP associations observed within these three genes was higher than would be expected by chance on a gene level. To our knowledge, this is the first study to evaluate these genes in relation to renal cancer and there is need to replicate and extend our findings. The specific regions associated with risk may have particular relevance for gene function and/or carcinogenesis. In conclusion, our evaluation has identified common genetic variants in CASP1, CASP5, EGFR, and IGFBP3 that could be associated with renal cancer risk.	[Dong, Linda M.; Karami, Sara; Menashe, Idan; Berndt, Sonja I.; Colt, Joanne S.; Rothman, Nathaniel; Chow, Wong-Ho; Rosenberg, Philip S.; Moore, Lee E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brennan, Paul] Intl Agcy Res Canc, Lyon, France; [Hung, Rayjean J.; Boffetta, Paolo] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Yeager, Meredith; Chanock, Stephen] NCI, Core Genotyping Facil, Gaithersburg, MD USA; [Zaridze, David; Matveev, Vsevolod] Inst Carcinogenesis, Moscow, Russia; [Janout, Vladimir; Kollarova, Hellena] Palacky Univ, Olomouc, Czech Republic; [Bencko, Vladimir; Holcatova, Ivana] Inst Hyg & Epidemiol, Prague, Czech Republic; [Schwartz, Kendra] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Schwartz, Kendra] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Davis, Faith] Univ Illinois, Dept Biostat & Epidemiol, Chicago, IL 60680 USA; [Navratilova, Marie] Masaryk Memorial Canc Inst, Brno, Czech Republic; [Szeszenia-Dabrowska, Neonila] Inst Occupat Med, Lodz, Poland; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Palacky University Olomouc; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Masaryk Memorial Cancer Institute; Nofer Institute of Occupational Medicine	Dong, LM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	donglm@mail.nih.gov	Menashe, Idan/W-6214-2019; Liao, Linda M/B-3960-2011; Janout, Vladimir/M-5133-2014; Szeszenia-Dabrowska, Neonila/F-7190-2010; Hung, Rayjean J/A-7439-2013; Boffetta, Paolo/AAI-7767-2021; Holcatova, Ivana/C-8327-2017; Bencko, Vladimir/H-8598-2017; Menashe, Idan/AAC-8670-2020; Matveev, Vsevolod B/O-7476-2017; Zaridze, David/K-5605-2013; Berndt, Sonja I/J-8423-2016; Yeager, Meredith/AAA-5322-2020	Liao, Linda M/0000-0002-1923-5294; Boffetta, Paolo/0000-0002-3811-2791; Holcatova, Ivana/0000-0002-1366-0337; Bencko, Vladimir/0000-0003-1935-2228; Menashe, Idan/0000-0003-1961-1461; Matveev, Vsevolod B/0000-0001-7748-9527; Rosenberg, Philip/0000-0001-6349-9126; Kollarova, Helena/0000-0001-6951-6716; mates, dana/0000-0002-6219-9807; Hung, Rayjean/0000-0002-4486-7496	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010120] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; Abe A, 2002, TOHOKU J EXP MED, V198, P181, DOI 10.1620/tjem.198.181; Araujo A, 2007, ONCOLOGIST, V12, P201, DOI 10.1634/theoncologist.12-2-201; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buerger H, 2004, J PATHOL, V203, P545, DOI 10.1002/path.1542; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cheng I, 2007, J CLIN ENDOCR METAB, V92, P3660, DOI 10.1210/jc.2007-0790; Cheng I, 2006, CANCER EPIDEM BIOMAR, V15, P1993, DOI 10.1158/1055-9965.EPI-06-0361; Cheung CW, 2004, KIDNEY INT, V65, P1272, DOI 10.1111/j.1523-1755.2004.00535.x; Chi D. D., 1992, Human Molecular Genetics, V1, P135, DOI 10.1093/hmg/1.2.135; Chow WH, 2008, CANCER J, V14, P288, DOI 10.1097/PPO.0b013e3181867628; Chuang ST, 2008, J UROLOGY, V179, P445, DOI 10.1016/j.juro.2007.09.106; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gebhardt F, 2000, INT J BIOL MARKER, V15, P105, DOI 10.1177/172460080001500120; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hosgood HD, 2008, CARCINOGENESIS, V29, P1938, DOI 10.1093/carcin/bgn178; Hosomi Y, 2003, INT J MOL MED, V12, P443; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kawai Y, 2007, EUR UROL, V52, P1147, DOI 10.1016/j.eururo.2007.01.073; LEE WS, 1994, J BIOL CHEM, V269, P12032; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; LIN J, 2008, CARCINOGENESIS; Liu WQ, 2005, CANCER RES, V65, P46; Maher ER, 1996, BRIT J UROL, V78, P542, DOI 10.1046/j.1464-410X.1996.01749.x; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mathew A, 2002, EUR J CANCER PREV, V11, P171, DOI 10.1097/00008469-200204000-00010; Moore LE, 2007, CARCINOGENESIS, V28, P1960, DOI 10.1093/carcin/bgm151; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Offman J, 2005, MOL CANCER RES, V3, P251, DOI 10.1158/1541-7786.MCR-04-0182; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Press OA, 2008, CANCER RES, V68, P3037, DOI 10.1158/0008-5472.CAN-07-2718; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rosenberg PS, 2006, STAT MED, V25, P3134, DOI 10.1002/sim.2407; Rosendahl AH, 2006, KIDNEY INT, V70, P1584, DOI 10.1038/sj.ki.5001805; Schottenfeld D., 2006, CANC EPIDEMIOLOGY PR; Smith WM, 2001, HUM GENET, V109, P146, DOI 10.1007/s004390100563; Soung YH, 2008, HUM PATHOL, V39, P895, DOI 10.1016/j.humpath.2007.10.015; Tabernero J, 2005, ANN ONCOL, V16, P1740, DOI 10.1093/annonc/mdi355; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Yamaguchi T, 2006, DIS COLON RECTUM, V49, P399, DOI 10.1007/s10350-005-0293-4	49	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2009	4	3							e4895	10.1371/journal.pone.0004895	http://dx.doi.org/10.1371/journal.pone.0004895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PI	19603096	Green Published, gold, Green Submitted			2022-12-25	WOS:000265499000004
J	Tian, HG; Peng, H; Yao, Q; Chen, HX; Xie, Q; Tang, B; Zhang, WQ				Tian, Honggang; Peng, Han; Yao, Qiong; Chen, Hongxin; Xie, Qi; Tang, Bin; Zhang, Wenqing			Developmental Control of a Lepidopteran Pest Spodoptera exigua by Ingestion of Bacteria Expressing dsRNA of a Non-Midgut Gene	PLOS ONE			English	Article							CHITIN SYNTHASE GENE; RNA INTERFERENCE; AMINOPEPTIDASE-N; SYSTEMIC RNAI	Background: RNA interference (RNAi) induced through double stranded RNA (dsRNA) has been used widely to study gene function in insects. Recently, it has been reported that gene knockdown in several insects can be induced successfully through feeding with dsRNA. However, it is still unknown whether phenotypic silencing of genes not expressed in the midgut occurs after ingestion of insect dsRNA. Principal Findings: Using chitin synthase gene A (SeCHSA) as the target gene, which is expressed in the cuticle and tracheae of the lepidopteran pest Spodoptera exigua, we showed that the growth and development of S. exigua larvae fed Escherichia coli expressing dsRNA of SeCHSA was disturbed, resulting in lethality. In the 4th and 5th larval instars, prepupae, and pupae, the mean survival rates of insects fed the dsRNA-containing diet were 88.64%, 74.24%, 68.43% and 62.63% respectively. The survival rates in the 5(th) instar larvae, prepupae and pupae stages were significantly lower than those of all controls, and significant lethality differences were also found between dsSeCHSA treatment and dsControl or ddH(2)O control in the 4(th) instar larvae. The effects of ingesting bacterially expressed dsRNA on transcription of the target gene, tissue structure, and survival rates of insects were dose-dependent. Conclusions: Our results suggest that SeCHSA dsRNA may be useful as a means of insect pest control.			Tian, HG (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsszwq@mail.sysu.edu.cn	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; Li Guanghong, 2002, Chinese Journal of Biological Control, V18, P132; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Retnakaran A., 1987, Chitin and benzoylphenyl ureas., P205; Ronco M, 2008, DEV BIOL, V313, P80, DOI 10.1016/j.ydbio.2007.09.059; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenllado F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-3; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	38	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2009	4	7							e6225	10.1371/journal.pone.0006225	http://dx.doi.org/10.1371/journal.pone.0006225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DO	19381341	Green Submitted, gold, Green Published			2022-12-25	WOS:000268035400009
J	Tian, Z; Palmer, N; Schmid, P; Yao, H; Galdzicki, M; Berger, B; Wu, EX; Kohane, IS				Tian, Ze; Palmer, Nathan; Schmid, Patrick; Yao, Hui; Galdzicki, Michal; Berger, Bonnie; Wu, Erxi; Kohane, Isaac S.			A Practical Platform for Blood Biomarker Study by Using Global Gene Expression Profiling of Peripheral Whole Blood	PLOS ONE			English	Article							OLIGONUCLEOTIDE ARRAY DATA; MESSENGER-RNA REDUCTION; SAMPLES; CELLS; PCR	Background: Although microarray technology has become the most common method for studying global gene expression, a plethora of technical factors across the experiment contribute to the variable of genome gene expression profiling using peripheral whole blood. A practical platform needs to be established in order to obtain reliable and reproducible data to meet clinical requirements for biomarker study. Methods and Findings: We applied peripheral whole blood samples with globin reduction and performed genome-wide transcriptome analysis using Illumina BeadChips. Real-time PCR was subsequently used to evaluate the quality of array data and elucidate the mode in which hemoglobin interferes in gene expression profiling. We demonstrated that, when applied in the context of standard microarray processing procedures, globin reduction results in a consistent and significant increase in the quality of beadarray data. When compared to their pre-globin reduction counterparts, post-globin reduction samples show improved detection statistics, lowered variance and increased sensitivity. More importantly, gender gene separation is remarkably clearer in post-globin reduction samples than in pre-globin reduction samples. Our study suggests that the poor data obtained from pre-globin reduction samples is the result of the high concentration of hemoglobin derived from red blood cells either interfering with target mRNA binding or giving the pseudo binding background signal. Conclusion: We therefore recommend the combination of performing globin mRNA reduction in peripheral whole blood samples and hybridizing on Illumina BeadChips as the practical approach for biomarker study.			Tian, Z (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Informat Program, Boston, MA 02115 USA.	bab@mit.edu; erxi.wu@ndsu.edu	Galdzicki, Michal/F-5682-2010; Kohane, Isaac Kohane/K-3716-2012; Tian, Honggang/AAW-4772-2020; zhang, wenqing/GYA-0786-2022; tian, ze/HDM-4308-2022; Yao, Huiqin/AAX-3787-2020	Galdzicki, Michal/0000-0002-8392-8183; Kohane, Isaac Kohane/0000-0003-2192-5160; Tian, Honggang/0000-0002-2205-0784; Yao, Huiqin/0000-0003-4742-8971; Chen, Hongxin/0000-0002-2955-4619; Wu, Erxi/0000-0002-1680-3639	NIGMS NIH HHS [R01 GM081871] Funding Source: Medline; NLM NIH HHS [2 T15 LM007092-16, T15 LM007092] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey S, 2006, GENOMICS, V87, P653, DOI 10.1016/j.ygeno.2005.11.010; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Field LA, 2007, CLIN BIOCHEM, V40, P499, DOI 10.1016/j.clinbiochem.2007.01.004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Rainen L, 2002, CLIN CHEM, V48, P1883; Team. RDC, 2007, R LANG ENV STAT COMP; Thach DC, 2003, J IMMUNOL METHODS, V283, P269, DOI 10.1016/j.jim.2003.10.004; TIAN Z, 2008, CANC CHEMOTHER PHARM; Witten I. H., 2005, DATA MINING PRACTICA; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794	22	261	309	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5157	10.1371/journal.pone.0005157	http://dx.doi.org/10.1371/journal.pone.0005157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19381341	Green Published, gold, Green Submitted			2022-12-25	WOS:000265510800002
